Citrus Sinensis ID: 002346
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 933 | 2.2.26 [Sep-21-2011] | |||||||
| P43298 | 942 | Probable receptor protein | no | no | 0.957 | 0.947 | 0.510 | 0.0 | |
| Q9LJF3 | 1164 | Receptor-like protein kin | no | no | 0.845 | 0.677 | 0.304 | 5e-82 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.792 | 0.619 | 0.321 | 1e-81 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.797 | 0.728 | 0.311 | 6e-80 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.861 | 0.689 | 0.299 | 1e-79 | |
| Q9FN37 | 1036 | Phytosulfokine receptor 2 | no | no | 0.818 | 0.737 | 0.294 | 3e-78 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.790 | 0.669 | 0.302 | 3e-76 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.861 | 0.643 | 0.291 | 1e-75 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.808 | 0.624 | 0.298 | 6e-75 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.806 | 0.623 | 0.297 | 2e-74 |
| >sp|P43298|TMK1_ARATH Probable receptor protein kinase TMK1 OS=Arabidopsis thaliana GN=TMK1 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 874 bits (2257), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 474/928 (51%), Positives = 613/928 (66%), Gaps = 35/928 (3%)
Query: 28 DGSVMLKLAQSLQNLPSD--WSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPE 85
D S ML L +SL N PS WS C+WT I C + RVT I + SGL GTLSP+
Sbjct: 28 DLSAMLSLKKSL-NPPSSFGWSDPDP---CKWTHIVCTGTKRVTRIQIGHSGLQGTLSPD 83
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ +L++LE L Q NNI+G +PSL+ SLQ + L NNNF S+P+ F GLT+LQ + +
Sbjct: 84 LRNLSELERLELQWNNISGPVPSLSGLASLQVLMLSNNNFDSIPSDVFQGLTSLQSVEID 143
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF--DSFSNLQNLRLSYNNFTGSL 203
+NP W P L +++L ++AN+ G +P F D F L L L++NN G L
Sbjct: 144 NNP-FKSWEIPESLRNASALQNFSANSANVSGSLPGFLGPDEFPGLSILHLAFNNLEGEL 202
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P S A S +Q+LW+N Q+L +G + VL MT L++VWLH N+F+GP+PD S + L L
Sbjct: 203 PMSLAGSQVQSLWLNGQKL--TGDITVLQNMTGLKEVWLHSNKFSGPLPDFSGLKELESL 260
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQ-KVSLDHNNFCKNSSDA 322
SLRDN TG VPAS++SL +L ++L NN LQGP P+F S V + D N+FC +S
Sbjct: 261 SLRDNSFTGPVPASLLSLESLKVVNLTNNHLQGPVPVFKSSVSVDLDKDSNSFCLSSPGE 320
Query: 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382
CDP+V +LL IA YP L++SW+GN+ C W + CS G I I+L L G
Sbjct: 321 ---CDPRVKSLLLIASSFDYPPRLAESWKGNDPCTNWIGIACSNGNITVISLEKMELTGT 377
Query: 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTV 442
ISP + + SL+ + L NNLTG IP LT L +L+ LDVS+N L GKVP F SNV
Sbjct: 378 ISPEFGAIKSLQRIILGINNLTGMIPQELTTLPNLKTLDVSSNKLFGKVPGFRSNVVVNT 437
Query: 443 SPGNPFIGTNVDTTPGGAGTPGSKPSGPS---GSPAASSKSKLSVGTIVAIVVVVVIFIA 499
+ GNP IG + + + S SG KS +G IV V+ ++ I
Sbjct: 438 N-GNPDIGKDKSSLSSPGSSSPSGGSGSGINGDKDRRGMKSSTFIGIIVGSVLGGLLSIF 496
Query: 500 VVFFVVYKFIARRKHRKFGRVKNPEV---------GNEMNKNGVTGGNGTNGYNGVPSEL 550
++ +V+ + +R+ R G + V NE K V G + + G G+
Sbjct: 497 LIGLLVFCWYKKRQKRFSGSESSNAVVVHPRHSGSDNESVKITVAGSSVSVG--GISDTY 554
Query: 551 HSQSSGDVSDR-HLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIA 609
+ +V D + E GN+ ISI+VLR VT+NFS NILG GGFGVVY GEL DGTKIA
Sbjct: 555 TLPGTSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIA 614
Query: 610 VKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQH 669
VKRME+ + KG +EF++EIAVLTKVRHRHLV LLGYC++G+E+LLVYEYMP+GTL++H
Sbjct: 615 VKRMENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRH 674
Query: 670 LFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729
LFEW + G PL WKQR+T+ALDVARGVEYLH LA QSFIHRDLKPSNIL+GDDMRAKVA
Sbjct: 675 LFEWSEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVA 734
Query: 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALD 789
DFGLV+ AP+GK S+ETR+AGTFGYLAPEYA TGRVTTK+DVY+FGV+LME ITGRK+LD
Sbjct: 735 DFGLVRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLD 794
Query: 790 DTMPDDRAHLVTWFRRVLISKE-NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQ 848
++ P++ HLV+WF+R+ I+KE + KAID ++LDEET+ S++ VAELAGHC AREP Q
Sbjct: 795 ESQPEESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQ 854
Query: 849 RPDMGHAVNVLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEG---TSTMFGDV 905
RPDMGHAVN+L LVE WKP+ + ED YGIDL MSLPQAL++WQA EG + +
Sbjct: 855 RPDMGHAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLESSTSSL 914
Query: 906 SSSYSQSHSSIPSKPSGFADTFNSADCR 933
S + SIP++P GFA++F S D R
Sbjct: 915 LPSLDNTQMSIPTRPYGFAESFTSVDGR 942
|
Probable receptor. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LJF3|BRL3_ARATH Receptor-like protein kinase BRI1-like 3 OS=Arabidopsis thaliana GN=BRL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 306 bits (784), Expect = 5e-82, Method: Compositional matrix adjust.
Identities = 268/879 (30%), Positives = 419/879 (47%), Gaps = 90/879 (10%)
Query: 35 LAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGT-LSPEISSLTQLE 93
L ++L+ L D S S TG + +C + + +++L + LSG LS +S L+++
Sbjct: 300 LCRTLEVL--DLSGNSLTGQLPQSFTSCGS---LQSLNLGNNKLSGDFLSTVVSKLSRIT 354
Query: 94 TLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLS-LSDNPNL 150
L NNI+G++P SL N ++L+ + L +N FT VP+G F L + VL L N
Sbjct: 355 NLYLPFNNISGSVPISLTNCSNLRVLDLSSNEFTGEVPSG-FCSLQSSSVLEKLLIANNY 413
Query: 151 APWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA-- 208
P EL K SL T+ + + GLIP + L +L + NN TG +P S
Sbjct: 414 LSGTVPVELGKCKSLKTIDLSFNALTGLIPKEIWTLPKLSDLVMWANNLTGGIPESICVD 473
Query: 209 KSDIQNLWMNDQQLGLSGTL-DVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLR 266
+++ L +N+ L +G+L + +S T + + L N TG IP + K E L L L
Sbjct: 474 GGNLETLILNNNLL--TGSLPESISKCTNMLWISLSSNLLTGEIPVGIGKLEKLAILQLG 531
Query: 267 DNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSKVQKV---SLDHNNFCKNSSDA 322
+N LTG +P+ + + L+ + L +N L G P S+ V S+ F ++
Sbjct: 532 NNSLTGNIPSELGNCKNLIWLDLNSNNLTGNLPGELASQAGLVMPGSVSGKQFAFVRNEG 591
Query: 323 GKPCD-------------------PQVTT-------------LLQIAGDMGYPAILSDSW 350
G C P V + + G M Y + ++
Sbjct: 592 GTDCRGAGGLVEFEGIRAERLEHFPMVHSCPKTRIYSGMTMYMFSSNGSMIYLDLSYNAV 651
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
G+ P + G + +NL + LL G I ++ L ++ L L N+L G +P
Sbjct: 652 SGS-----IPLGYGAMGYLQVLNLGHNLLTGTIPDSFGGLKAIGVLDLSHNDLQGFLPGS 706
Query: 411 LTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTP---GSKP 467
L L+ L +LDVSNNNL+G +P G F + T G G P S
Sbjct: 707 LGGLSFLSDLDVSNNNLTGPIPFGGQLTTFPL--------TRYANNSGLCGVPLPPCSSG 758
Query: 468 SGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGN 527
S P+ S A K ++ G IV F+ +V ++ + AR+ +K
Sbjct: 759 SRPTRSHAHPKKQSIATGMSAGIVFS---FMCIVMLIMALYRARKVQKK----------E 805
Query: 528 EMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEAN 587
+ + + + + S +H S +V+ FE ++ L + T+ FS +
Sbjct: 806 KQREKYIESLPTSGSSSWKLSSVHEPLSINVAT---FEKPLRKLTFAHLLEATNGFSADS 862
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
++G GGFG VY +L DG+ +A+K++ T +G EF AE+ + K++HR+LV LLGY
Sbjct: 863 MIGSGGFGDVYKAKLADGSVVAIKKLIQVT--GQGDREFMAEMETIGKIKHRNLVPLLGY 920
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C G ERLLVYEYM G+L L E G L W R IA+ ARG+ +LH
Sbjct: 921 CKIGEERLLVYEYMKYGSLETVLHEKTKKGGIFLDWSARKKIAIGAARGLAFLHHSCIPH 980
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPEYAATGRV 765
IHRD+K SN+L+ D A+V+DFG+ + +A D SV T LAGT GY+ PEY + R
Sbjct: 981 IIHRDMKSSNVLLDQDFVARVSDFGMARLVSALDTHLSVST-LAGTPGYVPPEYYQSFRC 1039
Query: 766 TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDE 825
T K DVY++GV+L+E ++G+K +D + +LV W +++ K + +DP L D+
Sbjct: 1040 TAKGDVYSYGVILLELLSGKKPIDPEEFGEDNNLVGWAKQLYREKRG-AEILDPELVTDK 1098
Query: 826 ETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864
+ ++A C P +RP M + + LV+
Sbjct: 1099 SGDVELLHYLKIASQCLDDRPFKRPTMIQVMTMFKELVQ 1137
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Binds brassinolide. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 305 bits (781), Expect = 1e-81, Method: Compositional matrix adjust.
Identities = 265/824 (32%), Positives = 394/824 (47%), Gaps = 85/824 (10%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS-LANATSLQDIYLDNNNFT 126
+ + L + +G + + T L + N + G +P+ + NA SL+ + L +N T
Sbjct: 426 LMALDLDSNNFTGEIPKSLWKSTNLMEFTASYNRLEGYLPAEIGNAASLKRLVLSDNQLT 485
Query: 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
LT+L VL+L N N+ P EL TSLTTL + + N+ G IPD +
Sbjct: 486 GEIPREIGKLTSLSVLNL--NANMFQGKIPVELGDCTSLTTLDLGSNNLQGQIPDKITAL 543
Query: 187 SNLQNLRLSYNNFTGSLP----ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWL 242
+ LQ L LSYNN +GS+P A F + ++ +L G D L
Sbjct: 544 AQLQCLVLSYNNLSGSIPSKPSAYFHQIEMPDLSFLQHH----GIFD------------L 587
Query: 243 HKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF 301
N+ +GPIP+ L +C L ++SL +N L+G +PAS+ L L + L N L G P
Sbjct: 588 SYNRLSGPIPEELGECLVLVEISLSNNHLSGEIPASLSRLTNLTILDLSGNALTGSIPKE 647
Query: 302 PS---KVQKVSLDHNNFCKNSSDAGKPCDPQVT-TLLQIAGDMGYPAILSDSWE------ 351
K+Q ++L +N + ++ V L + D PA L + E
Sbjct: 648 MGNSLKLQGLNLANNQLNGHIPESFGLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDL 707
Query: 352 -GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
NN + +++ + + G I NLT L+ L + +N L+G IP
Sbjct: 708 SFNNLSGELSSELSTMEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTK 767
Query: 411 LTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKP--S 468
+ L +L+ L+++ NNL G+VP G V P A G+K
Sbjct: 768 ICGLPNLEFLNLAKNNLRGEVPSDG-----------------VCQDPSKALLSGNKELCG 810
Query: 469 GPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNE 528
GS +KL + I +++ F +VF V+ R+ RVK +
Sbjct: 811 RVVGSDCKIEGTKLR--SAWGIAGLMLGFTIIVFVFVFSL---RRWAMTKRVKQRDDPER 865
Query: 529 MNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANI 588
M ++ + G N Y S S +++ +FE + + + + + TD+FS+ NI
Sbjct: 866 MEESRLKGFVDQNLYFLSGSRSREPLSINIA---MFEQPLLKVRLGDIVEATDHFSKKNI 922
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G GGFG VY LP +AVK++ E+ T GN+ EF AE+ L KV+H +LV+LLGY
Sbjct: 923 IGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNR---EFMAEMETLGKVKHPNLVSLLGY 979
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C E+LLVYEYM G+L H L W +R+ IA+ ARG+ +LH
Sbjct: 980 CSFSEEKLLVYEYMVNGSL-DHWLRNQTGMLEVLDWSKRLKIAVGAARGLAFLHHGFIPH 1038
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
IHRD+K SNIL+ D KVADFGL + + V T +AGTFGY+ PEY + R TT
Sbjct: 1039 IIHRDIKASNILLDGDFEPKVADFGLARLISACESHVSTVIAGTFGYIPPEYGQSARATT 1098
Query: 768 KIDVYAFGVVLMETITGRKALDDTMPD----DRAHLVTWFRRVLISKENIPKA---IDPN 820
K DVY+FGV+L+E +TG+ + T PD + +LV W I K N KA IDP
Sbjct: 1099 KGDVYSFGVILLELVTGK---EPTGPDFKESEGGNLVGWA----IQKINQGKAVDVIDP- 1150
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864
L + S R+ ++A C A P +RP+M ++VL L E
Sbjct: 1151 LLVSVALKNSQLRLLQIAMLCLAETPAKRPNM---LDVLKALKE 1191
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 299 bits (766), Expect = 6e-80, Method: Compositional matrix adjust.
Identities = 269/863 (31%), Positives = 403/863 (46%), Gaps = 119/863 (13%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS-LANATSLQDIYLDN 122
N + V + LA + LSG++ E+ L+ L L+ Q N ++GA+ S L ++L + + +
Sbjct: 204 NCSSVEYLGLASNNLSGSIPQELFQLSNLSVLALQNNRLSGALSSKLGKLSNLGRLDISS 263
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N F+ F L L S NL P L+ S S++ L + N + G I
Sbjct: 264 NKFSGKIPDVFLELNKLWYFSAQS--NLFNGEMPRSLSNSRSISLLSLRNNTLSGQIYLN 321
Query: 183 FDSFSNLQNLRLSYNNFTGSLPA-----------SFAK----SDIQNLWMNDQQL----- 222
+ +NL +L L+ N+F+GS+P+ +FAK + I + N Q L
Sbjct: 322 CSAMTNLTSLDLASNSFSGSIPSNLPNCLRLKTINFAKIKFIAQIPESFKNFQSLTSLSF 381
Query: 223 ------GLSGTLDVLSGMTQLRQVWLHKN-------------------------QFTGPI 251
+S L++L L+ + L N Q G +
Sbjct: 382 SNSSIQNISSALEILQHCQNLKTLVLTLNFQKEELPSVPSLQFKNLKVLIIASCQLRGTV 441
Query: 252 PD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV-- 308
P LS SL L L NQL+G +P + SL +L + L NN G P + +Q +
Sbjct: 442 PQWLSNSPSLQLLDLSWNQLSGTIPPWLGSLNSLFYLDLSNNTFIGEIPHSLTSLQSLVS 501
Query: 309 --------SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG-- 358
S D F K +++AG LQ +P ++ S+ N+ +G
Sbjct: 502 KENAVEEPSPDFPFFKKKNTNAGG---------LQYNQPSSFPPMIDLSY---NSLNGSI 549
Query: 359 WP-FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASL 417
WP F Q + +NL N L+GNI + +TSL+ L L NNL+G IP L KL+ L
Sbjct: 550 WPEFGDLRQLHV--LNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLSGNIPPSLVKLSFL 607
Query: 418 QNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAAS 477
V+ N LSG +P + V+F P + F G G G S SP S
Sbjct: 608 STFSVAYNKLSGPIP---TGVQFQTFPNSSFEGNQ-----GLCGEHASPCHITDQSPHGS 659
Query: 478 S-KSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTG 536
+ KSK ++ IVA V V + VF + + + G V +PE + ++
Sbjct: 660 AVKSKKNIRKIVA--VAVGTGLGTVFLLTVTLLIILRTTSRGEV-DPEKKADADE----- 711
Query: 537 GNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGV 596
EL S+S ++ N +S++ + + T +F++ANI+G GGFG+
Sbjct: 712 -----------IELGSRSVVLFHNKD----SNNELSLDDILKSTSSFNQANIIGCGGFGL 756
Query: 597 VYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656
VY LPDGTK+A+KR+ +T + EFQAE+ L++ +H +LV LLGYC +++LL
Sbjct: 757 VYKATLPDGTKVAIKRLSGDT--GQMDREFQAEVETLSRAQHPNLVHLLGYCNYKNDKLL 814
Query: 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716
+Y YM G+L L E D G L WK R+ IA A G+ YLH + +HRD+K S
Sbjct: 815 IYSYMDNGSLDYWLHEKVD-GPPSLDWKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSS 873
Query: 717 NILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGV 776
NIL+ D A +ADFGL + V T L GT GY+ PEY T K DVY+FGV
Sbjct: 874 NILLSDTFVAHLADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGV 933
Query: 777 VLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAE 836
VL+E +TGR+ +D P L++W ++ K + DP + D++ E + V E
Sbjct: 934 VLLELLTGRRPMDVCKPRGSRDLISWVLQMKTEKRE-SEIFDPFI-YDKDHAEEMLLVLE 991
Query: 837 LAGHCTAREPQQRPDMGHAVNVL 859
+A C P+ RP V+ L
Sbjct: 992 IACRCLGENPKTRPTTQQLVSWL 1014
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 298 bits (763), Expect = 1e-79, Method: Compositional matrix adjust.
Identities = 274/916 (29%), Positives = 433/916 (47%), Gaps = 112/916 (12%)
Query: 6 PQVSICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNS 65
P++S+ L++L L+ + + LPS +++ C W
Sbjct: 295 PELSLLCKTLVILDLSGNTFSGE-------------LPSQFTA------CVW-------- 327
Query: 66 NRVTTISLAKSGLSGT-LSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNN 123
+ ++L + LSG L+ +S +T + L NNI+G++P SL N ++L+ + L +N
Sbjct: 328 --LQNLNLGNNYLSGDFLNTVVSKITGITYLYVAYNNISGSVPISLTNCSNLRVLDLSSN 385
Query: 124 NFT-SVPTGCFDGLTNLQVLS--LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
FT +VP+G F L + VL L N N P EL K SL T+ + + G IP
Sbjct: 386 GFTGNVPSG-FCSLQSSPVLEKILIAN-NYLSGTVPMELGKCKSLKTIDLSFNELTGPIP 443
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLP--ASFAKSDIQNLWMNDQQLGLSGTL-DVLSGMTQL 237
NL +L + NN TG++P +++ L +N+ L +G++ + +S T +
Sbjct: 444 KEIWMLPNLSDLVMWANNLTGTIPEGVCVKGGNLETLILNNNLL--TGSIPESISRCTNM 501
Query: 238 RQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
+ L N+ TG IP + L L L +N L+G VP + + +L+ + L +N L G
Sbjct: 502 IWISLSSNRLTGKIPSGIGNLSKLAILQLGNNSLSGNVPRQLGNCKSLIWLDLNSNNLTG 561
Query: 297 PYP-LFPSKVQKV---SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
P S+ V S+ F ++ G C G + + I ++ E
Sbjct: 562 DLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGA-------GGLVEFEGIRAERLER 614
Query: 353 NNACDGWP----------FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNN 402
P + + G +I +++ ++G I P Y N+ L+ L L N
Sbjct: 615 LPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNR 674
Query: 403 LTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT----VSPGN-----PFIGTNV 453
+TG IPD L ++ LD+S+NNL G +P ++ F VS N PF G +
Sbjct: 675 ITGTIPDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLTGPIPF-GGQL 733
Query: 454 DTTP--------GGAGTP----GSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVV 501
T P G G P GS P P S + K ++ I I + F+ +V
Sbjct: 734 TTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHAKKQTVATAVIAGIAFSFMCFVMLV 793
Query: 502 FFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDR 561
+ ++K +K R K E + T G+ + + VP L S +V+
Sbjct: 794 MALYRVRKVQKKEQK--REKYIE-------SLPTSGSCSWKLSSVPEPL----SINVAT- 839
Query: 562 HLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK 621
FE ++ L + T+ FS ++G GGFG VY +L DG+ +A+K++ T +
Sbjct: 840 --FEKPLRKLTFAHLLEATNGFSAETMVGSGGFGEVYKAQLRDGSVVAIKKLIRIT--GQ 895
Query: 622 GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTP 680
G EF AE+ + K++HR+LV LLGYC G ERLLVYEYM G+L L E G
Sbjct: 896 GDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWGSLETVLHEKSSKKGGIY 955
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAP 738
L W R IA+ ARG+ +LH IHRD+K SN+L+ +D A+V+DFG+ + +A
Sbjct: 956 LNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSAL 1015
Query: 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH 798
D SV T LAGT GY+ PEY + R T K DVY++GV+L+E ++G+K +D + +
Sbjct: 1016 DTHLSVST-LAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNN 1074
Query: 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858
LV W +++ K + +DP L D+ ++ ++A C P +RP M
Sbjct: 1075 LVGWAKQLYREKRG-AEILDPELVTDKSGDVELFHYLKIASQCLDDRPFKRPTMIQ---- 1129
Query: 859 LGPLVEQWKPATREDE 874
L + ++ K T EDE
Sbjct: 1130 LMAMFKEMKADTEEDE 1145
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FN37|PSKR2_ARATH Phytosulfokine receptor 2 OS=Arabidopsis thaliana GN=PSKR2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 294 bits (752), Expect = 3e-78, Method: Compositional matrix adjust.
Identities = 254/862 (29%), Positives = 411/862 (47%), Gaps = 98/862 (11%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI-PSLANATSLQDIY 119
NC S + + + + L+G L + S+ +LE LS N ++G + +L+N + L+ +
Sbjct: 205 NCSKS--IQQLHIDSNRLTGQLPDYLYSIRELEQLSLSGNYLSGELSKNLSNLSGLKSLL 262
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+ N F+ V F LT L+ L +S N FP L++ + L L + N ++ G I
Sbjct: 263 ISENRFSDVIPDVFGNLTQLEHLDVSSNK--FSGRFPPSLSQCSKLRVLDLRNNSLSGSI 320
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFA---KSDIQNLWMND----------------- 219
F F++L L L+ N+F+G LP S K I +L N+
Sbjct: 321 NLNFTGFTDLCVLDLASNHFSGPLPDSLGHCPKMKILSLAKNEFRGKIPDTFKNLQSLLF 380
Query: 220 ------QQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTG 272
+ S T++VL L + L KN IP+ ++ ++L L+L + L G
Sbjct: 381 LSLSNNSFVDFSETMNVLQHCRNLSTLILSKNFIGEEIPNNVTGFDNLAILALGNCGLRG 440
Query: 273 VVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTT 332
+P+ +++ L + L N G P + K++ SL + +F N+ P +T
Sbjct: 441 QIPSWLLNCKKLEVLDLSWNHFYGTIPHWIGKME--SLFYIDFSNNTLTGAIPV--AITE 496
Query: 333 LLQIAGDMGYPAILSDS------WEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPA 386
L + G + ++DS + N + +G P+ S+ +I L N L G I P
Sbjct: 497 LKNLIRLNGTASQMTDSSGIPLYVKRNKSSNGLPYNQVSRFPP-SIYLNNNRLNGTILPE 555
Query: 387 YANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKF------ 440
L L L L +NN TG IPD ++ L +L+ LD+S N+L G +P ++ F
Sbjct: 556 IGRLKELHMLDLSRNNFTGTIPDSISGLDNLEVLDLSYNHLYGSIPLSFQSLTFLSRFSV 615
Query: 441 -------TVSPGNPFIGTNVDTTPGGAG------TPGSKPSGPSGSPAASSKS-----KL 482
+ G F + G G +P +P SS+ K
Sbjct: 616 AYNRLTGAIPSGGQFYSFPHSSFEGNLGLCRAIDSPCDVLMSNMLNPKGSSRRNNNGGKF 675
Query: 483 SVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNG 542
+IV + + + I I ++ V+ I+R+ R+ N++++ ++G + G
Sbjct: 676 GRSSIVVLTISLAIGITLLLSVILLRISRKDVDD--RI------NDVDEETISGVSKALG 727
Query: 543 YNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGEL 602
PS++ S D +S+E L + T+NFS+ANI+G GGFG+VY
Sbjct: 728 ----PSKIVLFHSCGCKD----------LSVEELLKSTNNFSQANIIGCGGFGLVYKANF 773
Query: 603 PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662
PDG+K AVKR+ + + EFQAE+ L++ H++LV+L GYC +G++RLL+Y +M
Sbjct: 774 PDGSKAAVKRLSGDC--GQMEREFQAEVEALSRAEHKNLVSLQGYCKHGNDRLLIYSFME 831
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722
G+L L E D G L W R+ IA ARG+ YLH + + + IHRD+K SNIL+ +
Sbjct: 832 NGSLDYWLHERVD-GNMTLIWDVRLKIAQGAARGLAYLHKVCEPNVIHRDVKSSNILLDE 890
Query: 723 DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETI 782
A +ADFGL + V T L GT GY+ PEY+ + T + DVY+FGVVL+E +
Sbjct: 891 KFEAHLADFGLARLLRPYDTHVTTDLVGTLGYIPPEYSQSLIATCRGDVYSFGVVLLELV 950
Query: 783 TGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL--NLDEETIESIYRVAELAGH 840
TGR+ ++ LV+ ++ K + ID + N++E T + + E+A
Sbjct: 951 TGRRPVEVCKGKSCRDLVSRVFQMKAEKRE-AELIDTTIRENVNERT---VLEMLEIACK 1006
Query: 841 CTAREPQQRPDMGHAVNVLGPL 862
C EP++RP + V L L
Sbjct: 1007 CIDHEPRRRPLIEEVVTWLEDL 1028
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 287 bits (734), Expect = 3e-76, Method: Compositional matrix adjust.
Identities = 253/836 (30%), Positives = 385/836 (46%), Gaps = 98/836 (11%)
Query: 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVP 129
+ L ++GL+GT+ EI +L+ + F N + G IP L N L+ +YL N T
Sbjct: 294 LYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTI 353
Query: 130 TGCFDGLTNLQVLSLSDNPNLAPWP--------------FPNELTKS--------TSLTT 167
L NL L LS N P P F N L+ + + L
Sbjct: 354 PVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWV 413
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF--AKSDIQNLWMNDQQLGLS 225
L M + ++ G IP + SN+ L L NN +G++P K+ +Q + +G
Sbjct: 414 LDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRF 473
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPAL 284
+ L + + L +N+F G IP ++ C +L L L DN TG +P + L L
Sbjct: 474 PS--NLCKQVNVTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQL 531
Query: 285 LNISLQNNKLQGPYP--LFPSK-VQKVSLDHNNFCKN-SSDAGKPCDPQVTTLLQ----- 335
+++ +NKL G P +F K +Q++ + NNF S+ G ++ L
Sbjct: 532 GTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSG 591
Query: 336 -IAGDMGYPAILSDSWEGNNACDG-WPFVTCS-QGRIITINLANKLLAGNISPAYANLTS 392
I +G + L++ G N +G P S G I +NL+ L G I P +NL
Sbjct: 592 TIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVM 651
Query: 393 LKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGN-----P 447
L+ L L NNL+G IP L+SL + S N+L+G +P N+ + GN P
Sbjct: 652 LEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIPLL-RNISMSSFIGNEGLCGP 710
Query: 448 FIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVFFVVYK 507
+ + T P PS +G P SK I+AI V+ ++++ +
Sbjct: 711 PLNQCIQTQP-------FAPSQSTGKPGGMRSSK-----IIAITAAVIGGVSLMLIALIV 758
Query: 508 FIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGG 567
++ RR R ++ +G PSE+ ++
Sbjct: 759 YLMRRPVRTVA---------------------SSAQDGQPSEM---------SLDIYFPP 788
Query: 568 NVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG---NKGLS 624
+ + L TDNF E+ ++GRG G VY LP G +AVK++ SN G N +
Sbjct: 789 KEGFTFQDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDN 848
Query: 625 EFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWK 684
F+AEI L +RHR++V L G+C + LL+YEYMP+G+L + L HD L W
Sbjct: 849 SFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEIL---HDPSCN-LDWS 904
Query: 685 QRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744
+R IAL A+G+ YLH + HRD+K +NIL+ D A V DFGL K
Sbjct: 905 KRFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKS 964
Query: 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804
+ +AG++GY+APEYA T +VT K D+Y++GVVL+E +TG+ + D +V W R
Sbjct: 965 MSAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPI--DQGGDVVNWVR 1022
Query: 805 RVLISKENIPKAIDPNLNLDEETIES-IYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+ +D L L++E I S + V ++A CT+ P RP M V +L
Sbjct: 1023 SYIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLML 1078
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 285 bits (729), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 278/953 (29%), Positives = 413/953 (43%), Gaps = 149/953 (15%)
Query: 9 SICA--VVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTG--------YCEWT 58
SIC+ L L L+ T L + V L QSL+ L D S+ S G E T
Sbjct: 330 SICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQL--DLSNNSLAGSIPEALFELVELT 387
Query: 59 GINCDNSNRVTTIS-------------LAKSGLSGTLSPEISSLTQLETLSFQMNNIAGA 105
+ N+ T+S L + L G L EIS+L +LE L N +G
Sbjct: 388 DLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGE 447
Query: 106 IP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWP---------- 154
IP + N TSL+ I + N+F L L +L L N + P
Sbjct: 448 IPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLN 507
Query: 155 ------------FPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202
P+ L L + N ++ G +PD S NL + LS+N G+
Sbjct: 508 ILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGT 567
Query: 203 L-----PASFAKSDIQNLWMNDQ---QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-D 253
+ +S+ D+ N D+ +LG S LD L L KNQ TG IP
Sbjct: 568 IHPLCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLR---------LGKNQLTGKIPWT 618
Query: 254 LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV---SL 310
L K L L + N LTG +P ++ L +I L NN L GP P + K+ ++ L
Sbjct: 619 LGKIRELSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKL 678
Query: 311 DHNNFCKNSSDAGKPCDPQVTTLL----------QIAGDMGYPAILSDSWEGNNACDGWP 360
N F ++ C + L Q G++G +L+ + N P
Sbjct: 679 SSNQFVESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLN--LDKNQFSGSLP 736
Query: 361 FVTCSQGRIITINLANKLLAGNISPAYANLTSLKN-LYLQQNNLTGPIPDGLTKLASLQN 419
++ + L+ L G I L L++ L L NN TG IP + L+ L+
Sbjct: 737 QAMGKLSKLYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLET 796
Query: 420 LDVSNNNLSGKVP-----------------DFGSNVK--FTVSPGNPFIGTNVDTTPGGA 460
LD+S+N L+G+VP + G +K F+ P + F+G G
Sbjct: 797 LDLSHNQLTGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNT-----GLC 851
Query: 461 GTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRV 520
G+P S+ + + S SV I AI + I + ++ ++ +++H F +V
Sbjct: 852 GSPLSRCNRVRSNNKQQGLSARSVVIISAISALTAIGLMILVIALF---FKQRHDFFKKV 908
Query: 521 KNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGG--NVAISIEVLRQ 578
G+G+ Y S + + + LF G I E + +
Sbjct: 909 ----------------GHGSTAYTSSSSSSQA------THKPLFRNGASKSDIRWEDIME 946
Query: 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTKV 636
T N SE ++G GG G VY EL +G +AVK++ + + M NK F E+ L ++
Sbjct: 947 ATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNKS---FSREVKTLGRI 1003
Query: 637 RHRHLVALLGYCINGSE--RLLVYEYMPRGTLAQHLFEWH---DHGYTPLTWKQRVTIAL 691
RHRHLV L+GYC + SE LL+YEYM G++ L E + L W+ R+ IA+
Sbjct: 1004 RHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDWEARLRIAV 1063
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---NAPDGKYSVETRL 748
+A+GVEYLH +HRD+K SN+L+ +M A + DFGL K D T
Sbjct: 1064 GLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDTNTDSNTWF 1123
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL- 807
A ++GY+APEYA + + T K DVY+ G+VLME +TG+ D + +V W L
Sbjct: 1124 ACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAE-MDMVRWVETHLE 1182
Query: 808 ISKENIPKAIDPNLN-LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
++ K IDP L L ++ +V E+A CT PQ+RP A + L
Sbjct: 1183 VAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 283 bits (723), Expect = 6e-75, Method: Compositional matrix adjust.
Identities = 246/825 (29%), Positives = 390/825 (47%), Gaps = 71/825 (8%)
Query: 71 ISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSV 128
+ ++ + SG L + +S L+ ++T+ N G +P S +N L+ + + +NN T V
Sbjct: 357 VDISYNNFSGKLPVDTLSKLSNIKTMVLSFNKFVGGLPDSFSNLLKLETLDMSSNNLTGV 416
Query: 129 -PTG-CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
P+G C D + NL+VL L +N L P P+ L+ + L +L + + G IP S
Sbjct: 417 IPSGICKDPMNNLKVLYLQNN--LFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSL 474
Query: 187 SNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDV-LSGMTQLRQVWLHK 244
S L++L L N +G +P ++NL ++ L +G + LS T+L + L
Sbjct: 475 SKLKDLILWLNQLSGEIPQELMYLQALENLILDFNDL--TGPIPASLSNCTKLNWISLSN 532
Query: 245 NQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLF 301
NQ +G IP L + +L L L +N ++G +PA + + +L+ + L N L G P PLF
Sbjct: 533 NQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLF 592
Query: 302 PSK--VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG---------DMGYPAILSDSW 350
+ L + +D K C LL+ G +P + +
Sbjct: 593 KQSGNIAVALLTGKRYVYIKNDGSKECH-GAGNLLEFGGIRQEQLDRISTRHPCNFTRVY 651
Query: 351 EG-----NNACDGWPFVTCSQGRI--------------ITINLANKLLAGNISPAYANLT 391
G N F+ S ++ +NL + L+G I L
Sbjct: 652 RGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLK 711
Query: 392 SLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGT 451
++ L L N G IP+ LT L L +D+SNNNLSG +P+ + F P F
Sbjct: 712 NVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPE---SAPFDTFPDYRFANN 768
Query: 452 NVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIF-IAVVFFVVYKFIA 510
++ P P SGP KS ++ V + ++F + +F ++ I
Sbjct: 769 SLCGYP----LPIPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIE 824
Query: 511 RRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVA 570
+K R+ E E +G + N S + S + FE
Sbjct: 825 TKKRRR-----KKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAA----FEKPLRK 875
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEI 630
++ L + T+ F +++G GGFG VY +L DG+ +A+K++ + +G EF AE+
Sbjct: 876 LTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEM 933
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
+ K++HR+LV LLGYC G ERLLVYEYM G+L L + G L W R IA
Sbjct: 934 ETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHDRKKIG-IKLNWPARRKIA 992
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRL 748
+ ARG+ +LH IHRD+K SN+L+ +++ A+V+DFG+ + +A D SV T L
Sbjct: 993 IGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST-L 1051
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808
AGT GY+ PEY + R +TK DVY++GVVL+E +TG++ D D +LV W + L
Sbjct: 1052 AGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDN-NLVGWVK--LH 1108
Query: 809 SKENIPKAIDPNLNLDEETIE-SIYRVAELAGHCTAREPQQRPDM 852
+K I D L ++ +IE + + ++A C +RP M
Sbjct: 1109 AKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTM 1153
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 281 bits (718), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 246/827 (29%), Positives = 390/827 (47%), Gaps = 75/827 (9%)
Query: 71 ISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSV 128
+ ++ + SG L + + L+ ++T+ N G +P S +N L+ + + +NN T +
Sbjct: 357 VDISNNNFSGKLPVDTLLKLSNIKTMVLSFNKFVGGLPDSFSNLPKLETLDMSSNNLTGI 416
Query: 129 -PTG-CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
P+G C D + NL+VL L +N L P P+ L+ + L +L + + G IP S
Sbjct: 417 IPSGICKDPMNNLKVLYLQNN--LFKGPIPDSLSNCSQLVSLDLSFNYLTGSIPSSLGSL 474
Query: 187 SNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDV-LSGMTQLRQVWLHK 244
S L++L L N +G +P ++NL ++ L +G + LS T+L + L
Sbjct: 475 SKLKDLILWLNQLSGEIPQELMYLQALENLILDFNDL--TGPIPASLSNCTKLNWISLSN 532
Query: 245 NQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLF 301
NQ +G IP L + +L L L +N ++G +PA + + +L+ + L N L G P PLF
Sbjct: 533 NQLSGEIPASLGRLSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTNFLNGSIPPPLF 592
Query: 302 PSK--VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG---------DMGYPAILSDSW 350
+ L + +D K C LL+ G +P + +
Sbjct: 593 KQSGNIAVALLTGKRYVYIKNDGSKECH-GAGNLLEFGGIRQEQLDRISTRHPCNFTRVY 651
Query: 351 EG-----NNACDGWPFVTCSQGRI--------------ITINLANKLLAGNISPAYANLT 391
G N F+ S ++ +NL + L+G I L
Sbjct: 652 RGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHNDLSGMIPQQLGGLK 711
Query: 392 SLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGT 451
++ L L N G IP+ LT L L +D+SNNNLSG +P+ + F P F
Sbjct: 712 NVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPE---SAPFDTFPDYRFANN 768
Query: 452 NVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIF-IAVVFFVVYKFIA 510
++ P P SGP KS ++ V + ++F + +F ++ I
Sbjct: 769 SLCGYP----LPLPCSSGPKSDANQHQKSHRRQASLAGSVAMGLLFSLFCIFGLIIVAIE 824
Query: 511 RRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVA 570
+K R+ E E +G + N S + S + FE
Sbjct: 825 TKKRRR-----KKEAALEAYMDGHSHSATANSAWKFTSAREALSINLAA----FEKPLRK 875
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEI 630
++ L + T+ F +++G GGFG VY +L DG+ +A+K++ + +G EF AE+
Sbjct: 876 LTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH--VSGQGDREFTAEM 933
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYT--PLTWKQRVT 688
+ K++HR+LV LLGYC G ERLLVYEYM G+L L HD T L W R
Sbjct: 934 ETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVL---HDRKKTGIKLNWPARRK 990
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVET 746
IA+ ARG+ +LH IHRD+K SN+L+ +++ A+V+DFG+ + +A D SV T
Sbjct: 991 IAIGAARGLAFLHHNCIPHIIHRDMKSSNVLLDENLEARVSDFGMARLMSAMDTHLSVST 1050
Query: 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806
LAGT GY+ PEY + R +TK DVY++GVVL+E +TG++ D D +LV W +
Sbjct: 1051 -LAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKQPTDSADFGDN-NLVGWVK-- 1106
Query: 807 LISKENIPKAIDPNLNLDEETIE-SIYRVAELAGHCTAREPQQRPDM 852
L +K I D L ++ +IE + + ++A C +RP M
Sbjct: 1107 LHAKGKITDVFDRELLKEDASIEIELLQHLKVACACLDDRHWKRPTM 1153
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 933 | ||||||
| 297831152 | 930 | leucine-rich repeat family protein [Arab | 0.958 | 0.961 | 0.652 | 0.0 | |
| 15229508 | 928 | leucine-rich repeat protein kinase-like | 0.956 | 0.961 | 0.648 | 0.0 | |
| 224142687 | 900 | predicted protein [Populus trichocarpa] | 0.949 | 0.984 | 0.658 | 0.0 | |
| 224589575 | 928 | leucine-rich repeat receptor-like protei | 0.956 | 0.961 | 0.647 | 0.0 | |
| 147798019 | 921 | hypothetical protein VITISV_043132 [Viti | 0.975 | 0.988 | 0.657 | 0.0 | |
| 356568467 | 928 | PREDICTED: probable receptor protein kin | 0.983 | 0.989 | 0.662 | 0.0 | |
| 449445686 | 930 | PREDICTED: probable receptor protein kin | 0.962 | 0.965 | 0.666 | 0.0 | |
| 296089594 | 897 | unnamed protein product [Vitis vinifera] | 0.953 | 0.992 | 0.667 | 0.0 | |
| 449505141 | 930 | PREDICTED: LOW QUALITY PROTEIN: probable | 0.962 | 0.965 | 0.666 | 0.0 | |
| 224130728 | 908 | predicted protein [Populus trichocarpa] | 0.947 | 0.973 | 0.654 | 0.0 |
| >gi|297831152|ref|XP_002883458.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] gi|297329298|gb|EFH59717.1| leucine-rich repeat family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1198 bits (3099), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 604/925 (65%), Positives = 730/925 (78%), Gaps = 31/925 (3%)
Query: 24 SLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLS 83
S+ DDG+ ML LA+S PSDWS+T+ST +C+W+G+ C RV ISLA L+G ++
Sbjct: 22 SVADDGTAMLALAKSFNPPPSDWSTTTSTDFCKWSGVRC-TGGRVNIISLADKSLTGFIA 80
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
PEIS+L++L+++S Q N ++G IPS A +SLQ+IY+D+N F V TG F GLT+LQ+LS
Sbjct: 81 PEISTLSELKSVSIQRNKLSGKIPSFAKLSSLQEIYMDDNFFVGVETGAFAGLTSLQILS 140
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
LSDN N+ W FP+EL STSLT +Y+DN NI G++PD FDSF++LQ+LRLSYNN TG L
Sbjct: 141 LSDNKNITAWSFPSELVDSTSLTKIYLDNTNIVGVLPDIFDSFASLQDLRLSYNNITGVL 200
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P S AKS IQNLW+N+Q+LG+SGT++VLS MT L Q WLHKNQF GPIPDLSK E+LFDL
Sbjct: 201 PPSLAKSSIQNLWINNQELGMSGTIEVLSSMTSLSQAWLHKNQFFGPIPDLSKSENLFDL 260
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAG 323
LRDNQLTG+VP +++SL +L NISL NNK QGP PLFPS+V KV++DHN+FC ++ AG
Sbjct: 261 QLRDNQLTGIVPPTLLSLGSLKNISLDNNKFQGPLPLFPSEV-KVTIDHNDFC--TTKAG 317
Query: 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGR-IITINLANKLLAG 381
+ C PQV TLL +AG +GYP++L++SW+G++AC GW +VTC S G+ ++T+NL AG
Sbjct: 318 QTCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVTCDSAGKNVVTLNLGKHGFAG 377
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
ISPA ANLTSLK++YL NNLTG IP LT + SLQ +DVSNNNL G++P F + VKF
Sbjct: 378 FISPAIANLTSLKSIYLNDNNLTGVIPKELTFMTSLQLIDVSNNNLRGEIPKFPAAVKFN 437
Query: 442 VSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVV 501
PGN +GTN G G+ GS +S VG IV ++V V++F+A++
Sbjct: 438 YKPGNALLGTN-----AGDGSTPGTGGASGGSGGSSGGGGSKVGVIVGVIVAVLVFLAIL 492
Query: 502 FFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNG----------TNGYNGVPSELH 551
FVVYKF+ +RK+ +F R + G + + V+ G N +N L+
Sbjct: 493 GFVVYKFVMKRKYGRFNRTDPEKAGKILVSDAVSNGGSGGGGYANGHGANNFNA----LN 548
Query: 552 SQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVK 611
S SSGD SDR L EGG+V I +EVLRQVT+NFSE NILGRGGFGVVY GEL DGTK AVK
Sbjct: 549 SPSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVK 608
Query: 612 RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF 671
RME MGNKG+SEFQAEIAVLTKVRHRHLVALLGYC+NG+ERLLVYEYMP+G L QHLF
Sbjct: 609 RMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLF 668
Query: 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731
EW + GY+PLTWKQRV+IALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADF
Sbjct: 669 EWRELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADF 728
Query: 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK+DVYAFGVVLME +TGRKALDDT
Sbjct: 729 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMEILTGRKALDDT 788
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
+PD+R+HLVTWFRR+LI+KENIPKA+D L DEET+ESIYRVAELAGHCTAREPQQRPD
Sbjct: 789 LPDERSHLVTWFRRILINKENIPKALDQTLEADEETMESIYRVAELAGHCTAREPQQRPD 848
Query: 852 MGHAVNVLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGT--STMF-GDVSSS 908
MGHAVNVLGPLVE+WKP+ +E+E+ +GID++MSLPQALQRWQ NEGT STMF GD S
Sbjct: 849 MGHAVNVLGPLVEKWKPSCQEEEESFGIDVNMSLPQALQRWQ-NEGTSSSTMFHGDF--S 905
Query: 909 YSQSHSSIPSKPSGFADTFNSADCR 933
YSQ+ SSIP K SGF +TF+SAD R
Sbjct: 906 YSQTQSSIPPKASGFPNTFDSADGR 930
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15229508|ref|NP_189017.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|9293948|dbj|BAB01851.1| unnamed protein product [Arabidopsis thaliana] gi|332643288|gb|AEE76809.1| leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1183 bits (3060), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 600/925 (64%), Positives = 724/925 (78%), Gaps = 33/925 (3%)
Query: 24 SLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLS 83
S+ DD + ML LA+S PSDWSST T +C+W+G+ C RVTTISLA L+G ++
Sbjct: 22 SVADDQTAMLALAKSFNPPPSDWSST--TDFCKWSGVRC-TGGRVTTISLADKSLTGFIA 78
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
PEIS+L++L+++S Q N ++G IPS A +SLQ+IY+D NNF V TG F GLT+LQ+LS
Sbjct: 79 PEISTLSELKSVSIQRNKLSGTIPSFAKLSSLQEIYMDENNFVGVETGAFAGLTSLQILS 138
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
LSDN N+ W FP+EL STSLTT+Y+DN NI G++PD FDS ++LQNLRLSYNN TG L
Sbjct: 139 LSDNNNITTWSFPSELVDSTSLTTIYLDNTNIAGVLPDIFDSLASLQNLRLSYNNITGVL 198
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P S KS IQNLW+N+Q LG+SGT++VLS MT L Q WLHKN F GPIPDLSK E+LFDL
Sbjct: 199 PPSLGKSSIQNLWINNQDLGMSGTIEVLSSMTSLSQAWLHKNHFFGPIPDLSKSENLFDL 258
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAG 323
LRDN LTG+VP ++++L +L NISL NNK QGP PLF +V KV++DHN FC ++ AG
Sbjct: 259 QLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPEV-KVTIDHNVFC--TTKAG 315
Query: 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGR-IITINLANKLLAG 381
+ C PQV TLL +AG +GYP++L++SW+G++AC GW +V+C S G+ ++T+NL G
Sbjct: 316 QSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCDSAGKNVVTLNLGKHGFTG 375
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
ISPA ANLTSLK+LYL N+LTG IP LT + SLQ +DVSNNNL G++P F + VKF+
Sbjct: 376 FISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVSNNNLRGEIPKFPATVKFS 435
Query: 442 VSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVV 501
PGN +GTN GG G+ G +S VG IV ++V V++F+A++
Sbjct: 436 YKPGNALLGTN-----GGDGSSPGTGGASGGPGGSSGGGGSKVGVIVGVIVAVLVFLAIL 490
Query: 502 FFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGV----------TGGNGTNGYNGVPSELH 551
FVVYKF+ +RK+ +F R +VG + + V G+G N +N L+
Sbjct: 491 GFVVYKFVMKRKYGRFNRTDPEKVGKILVSDAVSNGGSGNGGYANGHGANNFNA----LN 546
Query: 552 SQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVK 611
S SSGD SDR L EGG+V I +EVLRQVT+NFSE NILGRGGFGVVY GEL DGTK AVK
Sbjct: 547 SPSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVK 606
Query: 612 RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF 671
RME MGNKG+SEFQAEIAVLTKVRHRHLVALLGYC+NG+ERLLVYEYMP+G L QHLF
Sbjct: 607 RMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLF 666
Query: 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731
EW + GY+PLTWKQRV+IALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADF
Sbjct: 667 EWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADF 726
Query: 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK+DVYAFGVVLME +TGRKALDD+
Sbjct: 727 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMEILTGRKALDDS 786
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
+PD+R+HLVTWFRR+LI+KENIPKA+D L DEET+ESIYRVAELAGHCTAREPQQRPD
Sbjct: 787 LPDERSHLVTWFRRILINKENIPKALDQTLEADEETMESIYRVAELAGHCTAREPQQRPD 846
Query: 852 MGHAVNVLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGT--STMF-GDVSSS 908
MGHAVNVLGPLVE+WKP+ +E+E+ +GID++MSLPQALQRWQ NEGT STMF GD S
Sbjct: 847 MGHAVNVLGPLVEKWKPSCQEEEESFGIDVNMSLPQALQRWQ-NEGTSSSTMFHGDF--S 903
Query: 909 YSQSHSSIPSKPSGFADTFNSADCR 933
YSQ+ SSIP K SGF +TF+SAD R
Sbjct: 904 YSQTQSSIPPKASGFPNTFDSADGR 928
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224142687|ref|XP_002324686.1| predicted protein [Populus trichocarpa] gi|222866120|gb|EEF03251.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1182 bits (3059), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 603/916 (65%), Positives = 707/916 (77%), Gaps = 30/916 (3%)
Query: 32 MLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQ 91
MLKLA +L P WS+T++ GYC+W G+ CDNSN V +I+LA GLSGTL E+S+L+Q
Sbjct: 1 MLKLASALTPTPKGWSTTNTNGYCKWNGVKCDNSNNVISINLASQGLSGTLPSELSTLSQ 60
Query: 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151
L++ S Q N + G +PSLAN L+++Y+ NNFTS+P F GLT+LQ LS+ N NL
Sbjct: 61 LQSFSLQDNKLIGPLPSLANLAFLREVYIGTNNFTSIPADFFKGLTSLQTLSMDANINLE 120
Query: 152 PWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSD 211
PW +LT+S+SL T +ANIFG IP+ F SF +LQNLRLSYNN TG LP SFA S
Sbjct: 121 PWVLSTDLTESSSLNTFEASHANIFGAIPNMFASFPSLQNLRLSYNNLTGGLPPSFANSG 180
Query: 212 IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT 271
IQNLW+N+Q++GLSGT++VL M QL QVWL KNQFTGPIPD SK +SLFDL LRDNQ T
Sbjct: 181 IQNLWLNNQEMGLSGTIEVLPSMEQLSQVWLQKNQFTGPIPDFSKSKSLFDLQLRDNQFT 240
Query: 272 GVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVT 331
G+ P S+ S LLNIS NNKLQGP P F V+ + NNFC ++ AG C PQVT
Sbjct: 241 GIFPVSLSSQAGLLNISFYNNKLQGPVPQFGKGVKVDNSGLNNFCVDT--AGVACHPQVT 298
Query: 332 TLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR--IITINLANKLLAGNISPAYAN 389
TLL+IAG GYP +LSDSW+GN+AC+GWPFVTC + +IT++L + G ISPA+ N
Sbjct: 299 TLLEIAGGFGYPVMLSDSWKGNDACNGWPFVTCDSQKKTVITVSLGKQHFGGIISPAFVN 358
Query: 390 LTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFI 449
LT+L L L NNL+GPIPD L KL+ L LDVSNNNL+GK+P F S+VK T++PGNPF+
Sbjct: 359 LTTLTTLKLNDNNLSGPIPDSLIKLSQLSLLDVSNNNLTGKIPAFASSVKLTITPGNPFL 418
Query: 450 GTNVDTTPG---------GAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAV 500
G+ + G TPG P+G + K+S G ++A VV +VI A+
Sbjct: 419 GSGGGSGSGGTPSSGSDSNTTTPGGVPNG-----RGNGGKKVSPG-VIAGVVGIVIVGAI 472
Query: 501 VFFVVYKFIARRKHRKFGRVKNPEVGNEMN---KNGVTGGNGTNGYNGVPSELHSQSSGD 557
FFV++K ++K K GRV + E GN +N KNG + TNGY GV SE+ SQSSG+
Sbjct: 473 GFFVLFKVNRKKKRGKSGRVNDQESGNGINALVKNGSSCC--TNGY-GVLSEIQSQSSGN 529
Query: 558 VSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNT 617
S RH FEGGNV ISIEVLRQVTDNFSE NILG+GGFGVVY GEL DGTKIAVKRMES
Sbjct: 530 HSGRHFFEGGNVVISIEVLRQVTDNFSENNILGKGGFGVVYKGELHDGTKIAVKRMESGA 589
Query: 618 MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG 677
MG KG++EFQAEIAVLTKVRHRHLVALLGYCING+ERLLVYEYMP+GTLAQHLFEW + G
Sbjct: 590 MGTKGMNEFQAEIAVLTKVRHRHLVALLGYCINGNERLLVYEYMPQGTLAQHLFEWQELG 649
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
Y PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADFGLVKNA
Sbjct: 650 YPPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNA 709
Query: 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA 797
PDGKYS+ETRLAGTFGYLAPEYAATGRVTTK+DVYAFGV+LME +TGRKALDDT+PD+RA
Sbjct: 710 PDGKYSMETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVILMEIMTGRKALDDTVPDERA 769
Query: 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
HLVTWFRRVL++K+N+PKAID LN DEET SI++VAELAGHCTAREP QRPDMGHAVN
Sbjct: 770 HLVTWFRRVLVNKDNLPKAIDQTLNPDEETFVSIFKVAELAGHCTAREPHQRPDMGHAVN 829
Query: 858 VLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGTSTMFGDVSSSYSQSHSSIP 917
VLGPLVEQWKP E+E GIDLHMSLPQ LQRWQA+EGTST F ++ SYSQS SSI
Sbjct: 830 VLGPLVEQWKPTNHEEEGNSGIDLHMSLPQFLQRWQADEGTSTTFNNM--SYSQSQSSI- 886
Query: 918 SKPSGFADTFNSADCR 933
P GF+D+F S DCR
Sbjct: 887 --PGGFSDSFTSTDCR 900
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224589575|gb|ACN59321.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1180 bits (3053), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 599/925 (64%), Positives = 723/925 (78%), Gaps = 33/925 (3%)
Query: 24 SLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLS 83
S+ DD + ML LA+S PSDWSST T +C+W+G+ C RVTTISLA L+G ++
Sbjct: 22 SVADDQTAMLALAKSFNPPPSDWSST--TDFCKWSGVRC-TGGRVTTISLADKSLTGFIA 78
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
PEIS+L++L+++S Q N ++G IPS A +SLQ+IY+D NNF V TG F GLT+LQ+LS
Sbjct: 79 PEISTLSELKSVSIQRNKLSGTIPSFAKLSSLQEIYMDENNFVGVETGAFAGLTSLQILS 138
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
LSDN N+ W FP+EL STSLTT+Y+DN NI G++PD FDS ++LQNLRLSYNN TG L
Sbjct: 139 LSDNNNITTWSFPSELVDSTSLTTIYLDNTNIAGVLPDIFDSLASLQNLRLSYNNITGVL 198
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P S KS IQNLW+N+Q LG+SGT++VLS MT L Q WLHKN F GPIPDLSK E+LFDL
Sbjct: 199 PPSLGKSSIQNLWINNQDLGMSGTIEVLSSMTSLSQAWLHKNHFFGPIPDLSKSENLFDL 258
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAG 323
LRDN LTG+VP ++++L +L NISL NNK QGP PLF +V KV++DHN FC ++ AG
Sbjct: 259 QLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPEV-KVTIDHNVFC--TTKAG 315
Query: 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGR-IITINLANKLLAG 381
+ C PQV TLL +AG +GYP++L++SW+G++AC GW +V+C S G+ ++T+NL G
Sbjct: 316 QSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCDSAGKNVVTLNLGKHGFTG 375
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
ISPA ANLTSLK+LYL N+LTG IP LT + SLQ +DVSNNNL G++P F + VKF+
Sbjct: 376 FISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVSNNNLRGEIPKFPATVKFS 435
Query: 442 VSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVV 501
PGN +GTN GG G+ G +S VG IV ++V V++F+A++
Sbjct: 436 YKPGNALLGTN-----GGDGSSPGTGGASGGPGGSSGGGGSKVGVIVGVIVAVLVFLAIL 490
Query: 502 FFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGV----------TGGNGTNGYNGVPSELH 551
FVVYKF+ +RK+ +F R +VG + + V G+G N +N L+
Sbjct: 491 GFVVYKFVMKRKYGRFNRTDPEKVGKILVSDAVSNGGSGNGGYANGHGANNFNA----LN 546
Query: 552 SQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVK 611
S SSGD SDR L EGG+V I +EVLRQVT+NFSE NILGRGGFGVVY GEL DGTK AVK
Sbjct: 547 SPSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVVYAGELHDGTKTAVK 606
Query: 612 RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF 671
ME MGNKG+SEFQAEIAVLTKVRHRHLVALLGYC+NG+ERLLVYEYMP+G L QHLF
Sbjct: 607 GMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLVYEYMPQGNLGQHLF 666
Query: 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731
EW + GY+PLTWKQRV+IALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADF
Sbjct: 667 EWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADF 726
Query: 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK+DVYAFGVVLME +TGRKALDD+
Sbjct: 727 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMEILTGRKALDDS 786
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
+PD+R+HLVTWFRR+LI+KENIPKA+D L DEET+ESIYRVAELAGHCTAREPQQRPD
Sbjct: 787 LPDERSHLVTWFRRILINKENIPKALDQTLEADEETMESIYRVAELAGHCTAREPQQRPD 846
Query: 852 MGHAVNVLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGT--STMF-GDVSSS 908
MGHAVNVLGPLVE+WKP+ +E+E+ +GID++MSLPQALQRWQ NEGT STMF GD S
Sbjct: 847 MGHAVNVLGPLVEKWKPSCQEEEESFGIDVNMSLPQALQRWQ-NEGTSSSTMFHGDF--S 903
Query: 909 YSQSHSSIPSKPSGFADTFNSADCR 933
YSQ+ SSIP K SGF +TF+SAD R
Sbjct: 904 YSQTQSSIPPKASGFPNTFDSADGR 928
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147798019|emb|CAN69461.1| hypothetical protein VITISV_043132 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1177 bits (3045), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 613/933 (65%), Positives = 725/933 (77%), Gaps = 23/933 (2%)
Query: 8 VSICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINC----D 63
VS+C LL L T++L DD +VM L + L PS W+ + +C W GINC D
Sbjct: 5 VSLC----LLFSLLTSALADDAAVMDNLRKGLSXTPSGWTGSD---FCSWEGINCGNTGD 57
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
++ VT I++A GLSGTL +++ L+QL TLSFQ N++ G++PSLAN LQBIYL++N
Sbjct: 58 SNGXVTAINMASKGLSGTLPSDLNQLSQLVTLSFQSNSLXGSLPSLANLQFLQBIYLNSN 117
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
NF S+ F LT+LQ +SL +NP+LAPW P+ L++S SL Y NANI G IPD+F
Sbjct: 118 NFXSIDKDFFTNLTSLQTVSLGENPDLAPWSIPDGLSQSKSLAIFYASNANIEGSIPDWF 177
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
S +L LRLSYNN GSLP+S + IQ LWMN+QQ GLSGT+DVL+ M L QVWL
Sbjct: 178 GSMPSLNELRLSYNNLNGSLPSSLPGTSIQKLWMNNQQSGLSGTIDVLAAMPDLXQVWLQ 237
Query: 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS 303
N FTGPIPDLS C LFDL LRDNQ TG+VP+S+ SLP L+NI+L+NNKLQGP P F +
Sbjct: 238 ANAFTGPIPDLSNCTQLFDLQLRDNQFTGIVPSSLTSLPQLVNITLKNNKLQGPVPEFST 297
Query: 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363
V V LD+N FC+ S PCD QVTTLL++AG +GYP L+DSWEGN+ACB W F++
Sbjct: 298 GV-NVELDNNKFCRTSV---GPCDSQVTTLLEVAGALGYPTTLADSWEGNDACBQWAFIS 353
Query: 364 C-SQGRIITI-NLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLD 421
C +QG+ +TI N A + G ISPA+ANLTSL+NLYL N LTG IP+ LT L LQ LD
Sbjct: 354 CDTQGKNVTIVNFAKRGFTGTISPAFANLTSLRNLYLNDNKLTGSIPESLTSLTQLQVLD 413
Query: 422 VSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAAS-SKS 480
VSNNNL+G +P FG VK T + GN +G D+ G + + G+ + PSG+PA S + S
Sbjct: 414 VSNNNLTGGIPKFGDGVKVTTT-GNLLLGNGTDSGSGDSPSSGTDTTSPSGTPAGSPNGS 472
Query: 481 KLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGT 540
S G I AIVV VVIFI VV FV YK R++H+KFGRV NPE G EM N V G
Sbjct: 473 TPSAGVIAAIVVAVVIFIGVVLFVSYKCYVRKQHKKFGRVDNPENGKEMVVNKVM--GGM 530
Query: 541 NGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGG 600
GY GVPSELHSQSSGD SD +FEGGN+AISI+VLRQVT+NFSE NILGRGGFGVVY G
Sbjct: 531 GGYGGVPSELHSQSSGDHSDIPVFEGGNIAISIQVLRQVTNNFSEDNILGRGGFGVVYKG 590
Query: 601 ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660
EL DGTKIAVKRMES +G KG++EFQAEIAVLTKVRHRHLVALLG+C+NG+ERLLVYEY
Sbjct: 591 ELHDGTKIAVKRMESAAVGTKGMNEFQAEIAVLTKVRHRHLVALLGFCVNGNERLLVYEY 650
Query: 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720
MP+GTL QHLF+W ++GY PLTWKQRVTIALDV RGVEYLHSLAQQSFIHRDLKPSNIL+
Sbjct: 651 MPQGTLGQHLFDWRENGYPPLTWKQRVTIALDVGRGVEYLHSLAQQSFIHRDLKPSNILL 710
Query: 721 GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLME 780
GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK+DVYAFGVVLME
Sbjct: 711 GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLME 770
Query: 781 TITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGH 840
ITGRKALD+TMPD+R+HLV+WFRRVLI+K+N+ KAID L+ DEET+ SI +VAELAGH
Sbjct: 771 LITGRKALDETMPDERSHLVSWFRRVLINKDNLQKAIDQTLDPDEETLASICKVAELAGH 830
Query: 841 CTAREPQQRPDMGHAVNVLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGTST 900
CTAREP QRP+MGHAVN+LGPLVEQWKP ++++ YGIDLHMSLPQALQRWQA+EGTS
Sbjct: 831 CTAREPYQRPEMGHAVNILGPLVEQWKPVRPDEDESYGIDLHMSLPQALQRWQADEGTSM 890
Query: 901 MFGDVSSSYSQSHSSIPSKPSGFADTFNSADCR 933
M D SYS++ SSIPSKPSGFADTF+S DCR
Sbjct: 891 MVND--HSYSRTQSSIPSKPSGFADTFDSMDCR 921
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356568467|ref|XP_003552432.1| PREDICTED: probable receptor protein kinase TMK1-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1174 bits (3036), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 621/937 (66%), Positives = 731/937 (78%), Gaps = 19/937 (2%)
Query: 2 MRKKPQVSICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGIN 61
+++KP +S+C + LLLL L T++ DDG M KLA++L PS W+ +S +C+WTG+
Sbjct: 6 LKQKPLLSLCKLFLLLLSLACTAIADDGVFMSKLAKALIPSPSGWTGSS---FCQWTGVK 62
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLD 121
C ++NRVT I +A L GTL P+++SL+QL +LS Q N ++GA+PSLAN + L+ ++LD
Sbjct: 63 C-SANRVTIIKIASQSLGGTLPPDLNSLSQLTSLSLQNNKLSGALPSLANLSMLESVFLD 121
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
NNFTS+P GCF GLT+LQ LS++D+ NLAPW P ELT S +L L + NAN+ G +PD
Sbjct: 122 GNNFTSIPDGCFQGLTSLQTLSMADSVNLAPWTIPTELTDSNNLVKLDLGNANLIGTLPD 181
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQ-LGLSGTLDVLSGMTQLRQV 240
FD F +LQ LRLSYNN TG LP SF S+IQNLW+N+Q G SG+++VL+ MT L QV
Sbjct: 182 VFDKFVSLQELRLSYNNLTGGLPKSFGGSEIQNLWLNNQNGFGFSGSIEVLASMTHLSQV 241
Query: 241 WLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300
WL KNQFTGPIPDLS C +LFDL LRDNQLTGVVP S++SL +L N+SL NN LQGP P
Sbjct: 242 WLQKNQFTGPIPDLSNCTTLFDLQLRDNQLTGVVPPSLMSLSSLQNVSLDNNALQGPVPS 301
Query: 301 FPSKVQKVSLDH-NNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGW 359
F V K +LD N+FC D G PCD +++TLL IA GYP L+ SW GN+ CD W
Sbjct: 302 FEKGV-KFTLDGINSFCLK--DVG-PCDSRISTLLDIAAGFGYPLQLARSWTGNDPCDDW 357
Query: 360 PFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQN 419
FV C+ G+IIT+NLA + L G ISPA+ANLT L+NL+L NNL G IP LT LA L+
Sbjct: 358 SFVVCAGGKIITVNLAKQNLTGTISPAFANLTDLRNLFLNDNNLGGSIPGSLTNLAQLEV 417
Query: 420 LDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKPSG--PSGSPAAS 477
L+VSNNNLSG VP F + VKFT + GN +G + G TP SK SG PSGSP+
Sbjct: 418 LNVSNNNLSGDVPKFPTKVKFTTA-GNDLLGRSDGGGGGSGTTP-SKGSGDAPSGSPSTG 475
Query: 478 -SKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTG 536
S LS I IV++ V F+AVV FV K A+ +H KFGRV NPE G K +
Sbjct: 476 PGGSSLSPAWIAGIVLIAVFFVAVVVFVFCKCHAKNRHGKFGRVNNPENGKGEVKIDMMS 535
Query: 537 GNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGV 596
+NGY GVPSEL SQ S + SD H+FEGGN ISI+VLRQVTDNFSE NILGRGGFGV
Sbjct: 536 VTNSNGYGGVPSELQSQGS-ERSDVHVFEGGNATISIQVLRQVTDNFSEKNILGRGGFGV 594
Query: 597 VYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656
VY GEL DGT+IAVKRMES G+KGL+EFQAEIAVL+KVRHRHLVALLGYCING+ERLL
Sbjct: 595 VYKGELHDGTQIAVKRMESVATGSKGLNEFQAEIAVLSKVRHRHLVALLGYCINGNERLL 654
Query: 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716
VYEYMP+GTL QHLF+W ++G PLTWKQRV IALDVARGVEYLHSLAQQSFIHRDLKPS
Sbjct: 655 VYEYMPQGTLTQHLFDWGENGCAPLTWKQRVAIALDVARGVEYLHSLAQQSFIHRDLKPS 714
Query: 717 NILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGV 776
NIL+GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK+DVYAFGV
Sbjct: 715 NILLGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGV 774
Query: 777 VLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAE 836
VLME ITGR+ALDDT+PD+R+HLV+WFRRVLI+KENIPKAID L+ DEET+ESIY+VAE
Sbjct: 775 VLMELITGRRALDDTVPDERSHLVSWFRRVLINKENIPKAIDQTLDPDEETMESIYKVAE 834
Query: 837 LAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANE 896
LAGHCTAREP QRPDMGHAVNVLGPLVEQWKP T E+E+GYGIDLHMSLPQAL+RWQANE
Sbjct: 835 LAGHCTAREPYQRPDMGHAVNVLGPLVEQWKPTTHEEEEGYGIDLHMSLPQALRRWQANE 894
Query: 897 GTSTMFGDVSSSYSQSHSSIPSKPSGFADTFNSADCR 933
GTSTMF S SQ+ SSIP+KPSGFAD+F+S DCR
Sbjct: 895 GTSTMF---DMSISQTQSSIPAKPSGFADSFDSMDCR 928
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449445686|ref|XP_004140603.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1172 bits (3031), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 611/917 (66%), Positives = 715/917 (77%), Gaps = 19/917 (2%)
Query: 26 GDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPE 85
DD +V+ KLA +L PS WSS +T +C W I CD+S+RVT+I+LA LSG L +
Sbjct: 24 ADDSAVIQKLAAALSPTPSGWSS--NTPFCSWKEIRCDSSSRVTSINLASKSLSGVLPSD 81
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
++SL+QL +LS Q N++ G IPS AN + LQ +YLDNNNF+SV G F GLT+LQVLSL+
Sbjct: 82 LNSLSQLTSLSLQRNSLTGPIPSFANLSFLQSLYLDNNNFSSVSPGAFQGLTSLQVLSLT 141
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205
N NLAPW P +LT+++SL +LY NANI G +PDFFDSF++LQ LRLSYNN TG LP
Sbjct: 142 QNVNLAPWSIPTDLTQASSLVSLYAGNANIVGSLPDFFDSFASLQELRLSYNNLTGVLPK 201
Query: 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSL 265
S S I++LW+N+Q GLSG++D+LS MTQL QVWL KNQFTG IPD SKCE LFDL L
Sbjct: 202 SLGGSGIKSLWLNNQLNGLSGSIDLLSSMTQLSQVWLQKNQFTGQIPDFSKCEGLFDLQL 261
Query: 266 RDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKP 325
RDNQ TG+VP S++SL +LLN+SL NNKLQGP P+F S+VQ N FCK + D P
Sbjct: 262 RDNQFTGIVPPSLMSLSSLLNVSLDNNKLQGPLPVFDSRVQATFSSVNRFCKTTPD---P 318
Query: 326 CDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385
CD QV+ LL +AG GYP L+D+WEGNN C W FV C++G++ T+N + L G ISP
Sbjct: 319 CDAQVSVLLAVAGAFGYPISLADAWEGNNVCLDWSFVICTEGKVTTVNFGKQHLVGVISP 378
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPG 445
A+ANLTSLKNLYL NNL G IP+ LT L LQNLDVSNNNLSG+VP F + V+ + G
Sbjct: 379 AFANLTSLKNLYLNDNNLVGEIPESLTTLTQLQNLDVSNNNLSGQVPKFATTVRLN-TKG 437
Query: 446 NPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVV-------IFI 498
NP IGT++ GG S + S V+ +F+
Sbjct: 438 NPLIGTSLGPGNGGNDGGAGGGKIDSNGTTIDGTTSGSSNGSSVSAGVIAGVVIAVIVFV 497
Query: 499 AVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDV 558
AV+ FVV+K +H+KFG+V NPE G E+ K+ GG+G NGY GVPSEL SQSS D
Sbjct: 498 AVLLFVVFKCYVSNRHKKFGKVNNPENGKEIMKS--DGGSGLNGYAGVPSELQSQSSEDF 555
Query: 559 S-DRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNT 617
S D ++FEGG+VAISI+VL+QVT+NFSE N+LGRGGFGVVY GEL DGTKIAVKRMES
Sbjct: 556 SNDINVFEGGSVAISIQVLKQVTNNFSEDNVLGRGGFGVVYKGELHDGTKIAVKRMESGP 615
Query: 618 MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG 677
MG KG+SEFQAEIAVLTKVRHRHLVALLGYCING+ERLLVYEYMP+GTL QHLF+W ++G
Sbjct: 616 MGTKGMSEFQAEIAVLTKVRHRHLVALLGYCINGNERLLVYEYMPQGTLTQHLFDWQENG 675
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
Y PLTWKQR+TIALDVARGVEYLHSLAQQSFIHRDLKPSNIL+ DDMRAKVADFGLV+NA
Sbjct: 676 YPPLTWKQRITIALDVARGVEYLHSLAQQSFIHRDLKPSNILLSDDMRAKVADFGLVRNA 735
Query: 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA 797
PDGKYSVETRLAGTFGYLAPEYAATGRVTTK+DVYAFGVVLME ITGRKALDDTMPD+R+
Sbjct: 736 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMEIITGRKALDDTMPDERS 795
Query: 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
HLVTWFRRVLI KENIPKAID LN DEET+ESI +VAELAGHCTAREP QRPDMGHAVN
Sbjct: 796 HLVTWFRRVLIMKENIPKAIDQTLNPDEETMESILKVAELAGHCTAREPHQRPDMGHAVN 855
Query: 858 VLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGTST-MFGDVSSSYSQSHSSI 916
+LGPLVEQWKP+ + +E+ GIDLHMSLPQALQRWQANEGTST MF D+ SYSQ+H+SI
Sbjct: 856 ILGPLVEQWKPSNQHEEETDGIDLHMSLPQALQRWQANEGTSTMMFSDM--SYSQTHTSI 913
Query: 917 PSKPSGFADTFNSADCR 933
PSKPSGFADTF+S DCR
Sbjct: 914 PSKPSGFADTFDSMDCR 930
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296089594|emb|CBI39413.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1172 bits (3031), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 607/909 (66%), Positives = 717/909 (78%), Gaps = 19/909 (2%)
Query: 32 MLKLAQSLQNLPSDWSSTSSTGYCEWTGINC----DNSNRVTTISLAKSGLSGTLSPEIS 87
M L + L + PS W+ + +C W GINC D++ RVT I++A GLSGTL +++
Sbjct: 1 MDNLRKGLSSTPSGWTGSD---FCSWEGINCGNTGDSNGRVTAINMASKGLSGTLPSDLN 57
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
L+QL TLSFQ N+++G++PSLAN LQDIYL++NNFTS+ F LT+LQ +SL +N
Sbjct: 58 QLSQLVTLSFQSNSLSGSLPSLANLQFLQDIYLNSNNFTSIDKDFFTNLTSLQTVSLGEN 117
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
P+LAPW P+ L++S SL Y NANI G IPD+F S +L LRLSYNN GSLP+S
Sbjct: 118 PDLAPWSIPDGLSQSKSLAIFYASNANIEGSIPDWFGSMPSLNELRLSYNNLNGSLPSSL 177
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRD 267
+ IQ LWMN+QQ GLSGT+DVL+ M LRQVWL N FTGPIPDLS C LFDL LRD
Sbjct: 178 PGTSIQKLWMNNQQSGLSGTIDVLAAMPDLRQVWLQANAFTGPIPDLSNCTQLFDLQLRD 237
Query: 268 NQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD 327
NQ TG+VP+S+ SLP L+NI+L+NNKLQGP P F + V V LD+N FC+ S PCD
Sbjct: 238 NQFTGIVPSSLTSLPKLVNITLKNNKLQGPVPEFSTGV-NVELDNNKFCRTSV---GPCD 293
Query: 328 PQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGRIITI-NLANKLLAGNISP 385
QVTTLL++AG +GYP L+DSWEGN+AC+ W F++C +QG+ +TI N A + G ISP
Sbjct: 294 SQVTTLLEVAGALGYPTTLADSWEGNDACNQWAFISCDTQGKNVTIVNFAKRGFTGTISP 353
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPG 445
A+ANLTSL+NLYL N LTG IP+ LT L LQ LDVSNNNL+G +P FG VK T + G
Sbjct: 354 AFANLTSLRNLYLNDNKLTGSIPESLTSLTQLQVLDVSNNNLTGGIPKFGDGVKVTTT-G 412
Query: 446 NPFIGTNVDTTPGGAGTPGSKPSGPSGSPAAS-SKSKLSVGTIVAIVVVVVIFIAVVFFV 504
N +G D+ G + + G+ + PSG+PA S + S S G I AIVV VVIFI VV FV
Sbjct: 413 NLLLGNGTDSGSGDSPSSGTDTTSPSGTPAGSPNGSTPSAGVIAAIVVAVVIFIGVVLFV 472
Query: 505 VYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLF 564
YK R++H+KFGRV NPE G EM N V G GY GVPSELHSQSSGD SD +F
Sbjct: 473 SYKCYVRKQHKKFGRVDNPENGKEMVVNKVM--GGMGGYGGVPSELHSQSSGDHSDIPVF 530
Query: 565 EGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLS 624
EGGN+AISI+VLRQVT+NFSE NILGRGGFGVVY GEL DGTKIAVKRMES +G KG++
Sbjct: 531 EGGNIAISIQVLRQVTNNFSEDNILGRGGFGVVYKGELHDGTKIAVKRMESAAVGTKGMN 590
Query: 625 EFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWK 684
EFQAEIAVLTKVRHRHLVALLG+C+NG+ERLLVYEYMP+GTL QHLF+W ++GY PLTWK
Sbjct: 591 EFQAEIAVLTKVRHRHLVALLGFCVNGNERLLVYEYMPQGTLGQHLFDWRENGYPPLTWK 650
Query: 685 QRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744
QRVTIALDV RGVEYLHSLAQQSFIHRDLKPSNIL+GDDMRAKVADFGLVKNAPDGKYSV
Sbjct: 651 QRVTIALDVGRGVEYLHSLAQQSFIHRDLKPSNILLGDDMRAKVADFGLVKNAPDGKYSV 710
Query: 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804
ETRLAGTFGYLAPEYAATGRVTTK+DVYAFGVVLME ITGRKALD+TMPD+R+HLV+WFR
Sbjct: 711 ETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMELITGRKALDETMPDERSHLVSWFR 770
Query: 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864
RVLI+K+N+ KAID L+ DEET+ SI +VAELAGHCTAREP QRP+MGHAVN+LGPLVE
Sbjct: 771 RVLINKDNLQKAIDQTLDPDEETLASICKVAELAGHCTAREPYQRPEMGHAVNILGPLVE 830
Query: 865 QWKPATREDEDGYGIDLHMSLPQALQRWQANEGTSTMFGDVSSSYSQSHSSIPSKPSGFA 924
QWKP ++++ YGIDLHMSLPQALQRWQA+EGTSTM D+ SYS++ SSIPSKPSGFA
Sbjct: 831 QWKPVRPDEDESYGIDLHMSLPQALQRWQADEGTSTMVNDL--SYSRTQSSIPSKPSGFA 888
Query: 925 DTFNSADCR 933
DTF+S DCR
Sbjct: 889 DTFDSMDCR 897
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449505141|ref|XP_004162388.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor protein kinase TMK1-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1170 bits (3028), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 611/917 (66%), Positives = 715/917 (77%), Gaps = 19/917 (2%)
Query: 26 GDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPE 85
DD +V+ KLA +L PS WSS +T +C W I CD+S+RVT+I+LA LSG L +
Sbjct: 24 ADDSAVIQKLAAALSPXPSGWSS--NTPFCSWKEIRCDSSSRVTSINLASKSLSGVLPSD 81
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
++SL+QL +LS Q N++ G IPS AN + LQ +YLDNNNF+SV G F GLT+LQVLSL+
Sbjct: 82 LNSLSQLTSLSLQRNSLTGPIPSFANLSFLQSLYLDNNNFSSVSPGAFQGLTSLQVLSLT 141
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205
N NLAPW P +LT+++SL +LY NANI G +PDFFDSF++LQ LRLSYNN TG LP
Sbjct: 142 QNVNLAPWSIPTDLTQASSLVSLYAGNANIVGSLPDFFDSFASLQELRLSYNNLTGVLPK 201
Query: 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSL 265
S S I++LW+N+Q GLSG++D+LS MTQL QVWL KNQFTG IPD SKCE LFDL L
Sbjct: 202 SLGGSGIKSLWLNNQLNGLSGSIDLLSSMTQLSQVWLQKNQFTGQIPDFSKCEGLFDLQL 261
Query: 266 RDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKP 325
RDNQ TG+VP S++SL +LLN+SL NNKLQGP P+F S+VQ N FCK + D P
Sbjct: 262 RDNQFTGIVPPSLMSLSSLLNVSLDNNKLQGPLPVFDSRVQATFSSVNRFCKTTPD---P 318
Query: 326 CDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385
CD QV+ LL +AG GYP L+D+WEGNN C W FV C++G++ T+N + L G ISP
Sbjct: 319 CDAQVSVLLAVAGAFGYPISLADAWEGNNVCLDWSFVICTEGKVTTVNFGKQHLVGVISP 378
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPG 445
A+ANLTSLKNLYL NNL G IP+ LT L LQNLDVSNNNLSG+VP F + V+ + G
Sbjct: 379 AFANLTSLKNLYLNDNNLVGEIPESLTTLTQLQNLDVSNNNLSGQVPKFATTVRLN-TKG 437
Query: 446 NPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVV-------IFI 498
NP IGT++ GG S + S V+ +F+
Sbjct: 438 NPLIGTSLGPGNGGNDGGAGGGKIDSNGTTIDGTTSGSSNGSSVSAGVIAGVVIAVIVFV 497
Query: 499 AVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDV 558
AV+ FVV+K +H+KFG+V NPE G E+ K+ GG+G NGY GVPSEL SQSS D
Sbjct: 498 AVLLFVVFKCYVSNRHKKFGKVNNPENGKEIMKS--DGGSGLNGYAGVPSELQSQSSEDF 555
Query: 559 S-DRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNT 617
S D ++FEGG+VAISI+VL+QVT+NFSE N+LGRGGFGVVY GEL DGTKIAVKRMES
Sbjct: 556 SNDINVFEGGSVAISIQVLKQVTNNFSEDNVLGRGGFGVVYKGELHDGTKIAVKRMESGP 615
Query: 618 MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG 677
MG KG+SEFQAEIAVLTKVRHRHLVALLGYCING+ERLLVYEYMP+GTL QHLF+W ++G
Sbjct: 616 MGTKGMSEFQAEIAVLTKVRHRHLVALLGYCINGNERLLVYEYMPQGTLTQHLFDWQENG 675
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
Y PLTWKQR+TIALDVARGVEYLHSLAQQSFIHRDLKPSNIL+ DDMRAKVADFGLV+NA
Sbjct: 676 YPPLTWKQRITIALDVARGVEYLHSLAQQSFIHRDLKPSNILLSDDMRAKVADFGLVRNA 735
Query: 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA 797
PDGKYSVETRLAGTFGYLAPEYAATGRVTTK+DVYAFGVVLME ITGRKALDDTMPD+R+
Sbjct: 736 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMEIITGRKALDDTMPDERS 795
Query: 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
HLVTWFRRVLI KENIPKAID LN DEET+ESI +VAELAGHCTAREP QRPDMGHAVN
Sbjct: 796 HLVTWFRRVLIMKENIPKAIDQTLNPDEETMESILKVAELAGHCTAREPHQRPDMGHAVN 855
Query: 858 VLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGTST-MFGDVSSSYSQSHSSI 916
+LGPLVEQWKP+ + +E+ GIDLHMSLPQALQRWQANEGTST MF D+ SYSQ+H+SI
Sbjct: 856 ILGPLVEQWKPSNQHEEETDGIDLHMSLPQALQRWQANEGTSTMMFSDM--SYSQTHTSI 913
Query: 917 PSKPSGFADTFNSADCR 933
PSKPSGFADTF+S DCR
Sbjct: 914 PSKPSGFADTFDSMDCR 930
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224130728|ref|XP_002328361.1| predicted protein [Populus trichocarpa] gi|222838076|gb|EEE76441.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1163 bits (3009), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 596/911 (65%), Positives = 706/911 (77%), Gaps = 27/911 (2%)
Query: 26 GDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSN-RVTTISLAKSGLSGTLSP 84
DDGS ++KLA S+ LPS WS+ SSTG+C W GI CD+SN RVT+ISL+K +SGTL P
Sbjct: 22 ADDGSAIIKLASSITPLPSGWSTKSSTGFCSWRGIKCDSSNTRVTSISLSKLSISGTLPP 81
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
EIS+L++L++L+FQ N ++GAIPSLAN T+LQ I LD+NNFTS+ G GLT+LQ LS+
Sbjct: 82 EISTLSELQSLTFQDNQLSGAIPSLANLTNLQIILLDSNNFTSISPGFLQGLTSLQTLSV 141
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
DN NL PW P +L + TSLTTL + N+FG IPD F S +LQNLRLSYNNFTG+LP
Sbjct: 142 GDNVNLFPWILPTDLEQCTSLTTLTAKDCNLFGSIPDVFGSLPSLQNLRLSYNNFTGALP 201
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
SFA S IQNLW+N+QQ GL+G+++V+ MTQL QVWLHKN+FTGPIPDL++C+S+FDL
Sbjct: 202 PSFANSGIQNLWLNNQQNGLTGSIEVIGSMTQLAQVWLHKNEFTGPIPDLTECKSIFDLQ 261
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGK 324
LRDNQL+G+VPAS++SLP L+N+SL NNK QGP P FP V KV D NN K + G
Sbjct: 262 LRDNQLSGIVPASLVSLPKLVNVSLSNNKFQGPVPQFPPSVTKVDNDGNN--KYCAPPGV 319
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS--QGRIITINLANKLLAGN 382
CD QV TLL IAG GYP+ILSD W+ NNAC GW FVTC + ++T+NLA + G
Sbjct: 320 SCDAQVMTLLGIAGGFGYPSILSDGWDDNNAC-GWAFVTCDVDKKNVVTVNLAKQHFPGR 378
Query: 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTV 442
IS ++ANLTSLKNLYL NNLTG IPD L KL L DVSNNNLSGK+P+F ++VKF
Sbjct: 379 ISSSFANLTSLKNLYLNDNNLTGSIPDSLIKLPELVTFDVSNNNLSGKIPNFPASVKFIT 438
Query: 443 SPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIFIAVVF 502
PGNPF+GT VDT G GT S G +K S G I +I+V VIFIAV+
Sbjct: 439 KPGNPFLGTKVDT---GGGTTTSSDVG---------TTKKSGGMIASIIVAAVIFIAVLS 486
Query: 503 FVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRH 562
V+YK+ R + K + + G + NGV GG GYN V EL SQSS + ++
Sbjct: 487 IVLYKYRKRPRKYK--KKVGWDSGKALFNNGVAGG----GYNEVSIELSSQSSVGENGKN 540
Query: 563 LFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKG 622
+FE GNVA+ IEV+RQ TDNF E NI GRGGFGVVY GEL DGTKIAVKRMES MG KG
Sbjct: 541 IFEDGNVALPIEVIRQATDNFHEINITGRGGFGVVYRGELHDGTKIAVKRMESTVMGTKG 600
Query: 623 LSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLT 682
+SEFQAEIAVLTKVRHRHLVALLGYCING+ERLLVYEYMP+GTL QHLFE HD+GYTPLT
Sbjct: 601 MSEFQAEIAVLTKVRHRHLVALLGYCINGNERLLVYEYMPQGTLGQHLFECHDYGYTPLT 660
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
WKQR+TIALDVARGVEYLHSLAQQSFIHRDLKPSNIL+GD MRAKVADFGLVKNAPDGKY
Sbjct: 661 WKQRITIALDVARGVEYLHSLAQQSFIHRDLKPSNILLGDSMRAKVADFGLVKNAPDGKY 720
Query: 743 SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW 802
SVETRLAGTFGYLAPEYAATGRVTTK+DVYAFGVVLME ITGRK LDD+MPD+ AHLV W
Sbjct: 721 SVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVVLMEIITGRKTLDDSMPDEEAHLVPW 780
Query: 803 FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862
FRR+L++KENIPKAID +LN DEET+ +IY V+ELAGHCTAREP QRPDMGHAVN+L PL
Sbjct: 781 FRRILMTKENIPKAIDESLNPDEETLATIYTVSELAGHCTAREPHQRPDMGHAVNILAPL 840
Query: 863 VEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGTSTMFGDVSSSYSQSHSSIPSKPSG 922
VEQW+PA+++D+ + ID +L + L+RWQ EGTS + D +S+S++ SS+PS PS
Sbjct: 841 VEQWRPASQQDQS-FDIDQDTNLSETLRRWQTEEGTSMISDD--ASFSRTQSSVPSMPSR 897
Query: 923 FADTFNSADCR 933
F +TF S DCR
Sbjct: 898 FVNTFTSTDCR 908
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 933 | ||||||
| TAIR|locus:2095188 | 928 | AT3G23750 [Arabidopsis thalian | 0.979 | 0.984 | 0.599 | 6.7e-294 | |
| TAIR|locus:2013825 | 942 | TMK1 "transmembrane kinase 1" | 0.406 | 0.402 | 0.630 | 5.7e-224 | |
| TAIR|locus:2059703 | 943 | AT2G01820 [Arabidopsis thalian | 0.413 | 0.409 | 0.629 | 1.3e-222 | |
| TAIR|locus:2024016 | 886 | AT1G24650 [Arabidopsis thalian | 0.362 | 0.381 | 0.626 | 2.7e-193 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.293 | 0.273 | 0.392 | 2.2e-77 | |
| TAIR|locus:2169965 | 1003 | BAM1 "BARELY ANY MERISTEM 1" [ | 0.292 | 0.272 | 0.390 | 5.5e-77 | |
| TAIR|locus:2182870 | 1192 | EMS1 "EXCESS MICROSPOROCYTES1" | 0.311 | 0.244 | 0.388 | 6.2e-76 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.301 | 0.25 | 0.371 | 7.6e-75 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.324 | 0.242 | 0.356 | 3.4e-73 | |
| TAIR|locus:2139885 | 1013 | AT4G28650 [Arabidopsis thalian | 0.320 | 0.295 | 0.327 | 4.7e-73 |
| TAIR|locus:2095188 AT3G23750 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2822 (998.5 bits), Expect = 6.7e-294, P = 6.7e-294
Identities = 563/939 (59%), Positives = 676/939 (71%)
Query: 6 PQVSICAVVXXXXXXXXXXXGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNS 65
P + V+ DD + ML LA+S PSDWSST T +C+W+G+ C
Sbjct: 4 PTPLLLLVLLTTITFFTTSVADDQTAMLALAKSFNPPPSDWSST--TDFCKWSGVRC-TG 60
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
RVTTISLA L+G ++PEIS+L++L+++S Q N ++G IPS A +SLQ+IY+D NNF
Sbjct: 61 GRVTTISLADKSLTGFIAPEISTLSELKSVSIQRNKLSGTIPSFAKLSSLQEIYMDENNF 120
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
V TG F GLT+LQ+LSLSDN N+ W FP+EL STSLTT+Y+DN NI G++PD FDS
Sbjct: 121 VGVETGAFAGLTSLQILSLSDNNNITTWSFPSELVDSTSLTTIYLDNTNIAGVLPDIFDS 180
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
++LQNLRLSYNN TG LP S KS IQNLW+N+Q LG+SGT++VLS MT L Q WLHKN
Sbjct: 181 LASLQNLRLSYNNITGVLPPSLGKSSIQNLWINNQDLGMSGTIEVLSSMTSLSQAWLHKN 240
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305
F GPIPDLSK E+LFDL LRDN LTG+VP ++++L +L NISL NNK QGP PLF +V
Sbjct: 241 HFFGPIPDLSKSENLFDLQLRDNDLTGIVPPTLLTLASLKNISLDNNKFQGPLPLFSPEV 300
Query: 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC- 364
KV++DHN FC ++ AG+ C PQV TLL +AG +GYP++L++SW+G++AC GW +V+C
Sbjct: 301 -KVTIDHNVFC--TTKAGQSCSPQVMTLLAVAGGLGYPSMLAESWQGDDACSGWAYVSCD 357
Query: 365 SQGR-IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423
S G+ ++T+NL G ISPA ANLTSLK+LYL N+LTG IP LT + SLQ +DVS
Sbjct: 358 SAGKNVVTLNLGKHGFTGFISPAIANLTSLKSLYLNGNDLTGVIPKELTFMTSLQLIDVS 417
Query: 424 NNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDXXXXXXXXXXXXXXXXXXXXXXXXXXXLS 483
NNNL G++P F + VKF+ PGN +GTN
Sbjct: 418 NNNLRGEIPKFPATVKFSYKPGNALLGTNGGDGSSPGTGGASGGPGGSSGGGGS-----K 472
Query: 484 VGTXXXXXXXXXXXXXXXXXXXYKFIARRKHRKFGRVKNPEVGNEM------NKXXXXXX 537
VG YKF+ +RK+ +F R +VG + N
Sbjct: 473 VGVIVGVIVAVLVFLAILGFVVYKFVMKRKYGRFNRTDPEKVGKILVSDAVSNGGSGNGG 532
Query: 538 XXXXXXXXXPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILXXXXXXXX 597
+ L+S SSGD SDR L EGG+V I +EVLRQVT+NFSE NIL
Sbjct: 533 YANGHGANNFNALNSPSSGDNSDRFLLEGGSVTIPMEVLRQVTNNFSEDNILGRGGFGVV 592
Query: 598 XXXELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657
EL DGTK AVKRME MGNKG+SEFQAEIAVLTKVRHRHLVALLGYC+NG+ERLLV
Sbjct: 593 YAGELHDGTKTAVKRMECAAMGNKGMSEFQAEIAVLTKVRHRHLVALLGYCVNGNERLLV 652
Query: 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSN 717
YEYMP+G L QHLFEW + GY+PLTWKQRV+IALDVARGVEYLHSLAQQSFIHRDLKPSN
Sbjct: 653 YEYMPQGNLGQHLFEWSELGYSPLTWKQRVSIALDVARGVEYLHSLAQQSFIHRDLKPSN 712
Query: 718 ILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVV 777
IL+GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK+DVYAFGVV
Sbjct: 713 ILLGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKVDVYAFGVV 772
Query: 778 LMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAEL 837
LME +TGRKALDD++PD+R+HLVTWFRR+LI+KENIPKA+D L DEET+ESIYRVAEL
Sbjct: 773 LMEILTGRKALDDSLPDERSHLVTWFRRILINKENIPKALDQTLEADEETMESIYRVAEL 832
Query: 838 AGHCTAREPQQRPDMGHAVNVLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEG 897
AGHCTAREPQQRPDMGHAVNVLGPLVE+WKP+ +E+E+ +GID++MSLPQALQRWQ NEG
Sbjct: 833 AGHCTAREPQQRPDMGHAVNVLGPLVEKWKPSCQEEEESFGIDVNMSLPQALQRWQ-NEG 891
Query: 898 TS--TMF-GDVXXXXXXXXXXXXXXXXGFADTFNSADCR 933
TS TMF GD GF +TF+SAD R
Sbjct: 892 TSSSTMFHGDFSYSQTQSSIPPKAS--GFPNTFDSADGR 928
|
|
| TAIR|locus:2013825 TMK1 "transmembrane kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1256 (447.2 bits), Expect = 5.7e-224, Sum P(2) = 5.7e-224
Identities = 242/384 (63%), Positives = 294/384 (76%)
Query: 555 SGDVSDR-HLFEGGNVAISIEVLRQVTDNFSEANILXXXXXXXXXXXELPDGTKIAVKRM 613
+ +V D + E GN+ ISI+VLR VT+NFS NIL EL DGTKIAVKRM
Sbjct: 559 TSEVGDNIQMVEAGNMLISIQVLRSVTNNFSSDNILGSGGFGVVYKGELHDGTKIAVKRM 618
Query: 614 ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW 673
E+ + KG +EF++EIAVLTKVRHRHLV LLGYC++G+E+LLVYEYMP+GTL++HLFEW
Sbjct: 619 ENGVIAGKGFAEFKSEIAVLTKVRHRHLVTLLGYCLDGNEKLLVYEYMPQGTLSRHLFEW 678
Query: 674 HDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ G PL WKQR+T+ALDVARGVEYLH LA QSFIHRDLKPSNIL+GDDMRAKVADFGL
Sbjct: 679 SEEGLKPLLWKQRLTLALDVARGVEYLHGLAHQSFIHRDLKPSNILLGDDMRAKVADFGL 738
Query: 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP 793
V+ AP+GK S+ETR+AGTFGYLAPEYA TGRVTTK+DVY+FGV+LME ITGRK+LD++ P
Sbjct: 739 VRLAPEGKGSIETRIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELITGRKSLDESQP 798
Query: 794 DDRAHLVTWFRRVLISKE-NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
++ HLV+WF+R+ I+KE + KAID ++LDEET+ S++ VAELAGHC AREP QRPDM
Sbjct: 799 EESIHLVSWFKRMYINKEASFKKAIDTTIDLDEETLASVHTVAELAGHCCAREPYQRPDM 858
Query: 853 GHAVNVLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGTSTMFGDVXXXXXXX 912
GHAVN+L LVE WKP+ + ED YGIDL MSLPQAL++WQA EG S +
Sbjct: 859 GHAVNILSSLVELWKPSDQNPEDIYGIDLDMSLPQALKKWQAYEGRSDLESSTSSLLPSL 918
Query: 913 XXXXXXXXX---GFADTFNSADCR 933
GFA++F S D R
Sbjct: 919 DNTQMSIPTRPYGFAESFTSVDGR 942
|
|
| TAIR|locus:2059703 AT2G01820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1265 (450.4 bits), Expect = 1.3e-222, Sum P(2) = 1.3e-222
Identities = 248/394 (62%), Positives = 293/394 (74%)
Query: 548 SELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILXXXXXXXXXXXELPDGTK 607
S+ +S S SD H+ E GN+ ISI+VLR VT+NFSE NIL EL DGTK
Sbjct: 550 SDSYSHSGSAASDIHVVEAGNLVISIQVLRNVTNNFSEENILGRGGFGTVYKGELHDGTK 609
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
IAVKRMES+ + +KGL+EF++EI VLTK+RHRHLVALLGYC++G+ERLLVYEYMP+GTL+
Sbjct: 610 IAVKRMESSVVSDKGLTEFKSEITVLTKMRHRHLVALLGYCLDGNERLLVYEYMPQGTLS 669
Query: 668 QHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727
QHLF W + G PL W +R+ IALDVARGVEYLH+LA QSFIHRDLKPSNIL+GDDMRAK
Sbjct: 670 QHLFHWKEEGRKPLDWTRRLAIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMRAK 729
Query: 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKA 787
V+DFGLV+ APDGKYS+ETR+AGTFGYLAPEYA TGRVTTK+D+++ GV+LME ITGRKA
Sbjct: 730 VSDFGLVRLAPDGKYSIETRVAGTFGYLAPEYAVTGRVTTKVDIFSLGVILMELITGRKA 789
Query: 788 LDDTMPDDRAHLVTWFRRVLISK-ENIPK-AIDPNLNLDEETIESIYRVAELAGHCTARE 845
LD+T P+D HLVTWFRRV SK EN K AIDPN++LD++T+ SI +V ELAGHC ARE
Sbjct: 790 LDETQPEDSVHLVTWFRRVAASKDENAFKNAIDPNISLDDDTVASIEKVWELAGHCCARE 849
Query: 846 PQQRPDMGHAVNVLGPLVEQWKPATREDEDGYGIDLHMSLPQALQRWQANEGTSTMFGDV 905
P QRPDM H VNVL L QWKP + +D YGID M LPQ L++WQA EG S D
Sbjct: 850 PYQRPDMAHIVNVLSSLTVQWKPTETDPDDVYGIDYDMPLPQVLKKWQAFEGLSQTADDS 909
Query: 906 XXXXXXXXXXXXXXXX------GFADTFNSADCR 933
GFAD+F S D R
Sbjct: 910 GSSSSAYGSKDNTQTSIPTRPSGFADSFTSVDGR 943
|
|
| TAIR|locus:2024016 AT1G24650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1104 (393.7 bits), Expect = 2.7e-193, Sum P(2) = 2.7e-193
Identities = 213/340 (62%), Positives = 258/340 (75%)
Query: 552 SQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILXXXXXXXXXXXELPDGTKIAVK 611
S+S +D HL E GN+ ISI+VLR T NF E NIL EL DGTKIAVK
Sbjct: 516 SESGFSGNDAHLGEAGNIVISIQVLRDATYNFDEKNILGRGGFGIVYKGELHDGTKIAVK 575
Query: 612 RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF 671
RMES+ + KGL EF++EIAVLT+VRHR+LV L GYC+ G+ERLLVY+YMP+GTL++H+F
Sbjct: 576 RMESSIISGKGLDEFKSEIAVLTRVRHRNLVVLHGYCLEGNERLLVYQYMPQGTLSRHIF 635
Query: 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731
W + G PL W +R+ IALDVARGVEYLH+LA QSFIHRDLKPSNIL+GDDM AKVADF
Sbjct: 636 YWKEEGLRPLEWTRRLIIALDVARGVEYLHTLAHQSFIHRDLKPSNILLGDDMHAKVADF 695
Query: 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
GLV+ AP+G S+ET++AGTFGYLAPEYA TGRVTTK+DVY+FGV+LME +TGRKALD
Sbjct: 696 GLVRLAPEGTQSIETKIAGTFGYLAPEYAVTGRVTTKVDVYSFGVILMELLTGRKALDVA 755
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
++ HL TWFRR+ I+K + PKAID + ++EET+ SI VAELA C++REP+ RPD
Sbjct: 756 RSEEEVHLATWFRRMFINKGSFPKAIDEAMEVNEETLRSINIVAELANQCSSREPRDRPD 815
Query: 852 MGHAVNVLGPLVEQWKPATR--EDEDGYGIDLHMSLPQAL 889
M H VNVL LV QWKP R + ED YGID LPQ +
Sbjct: 816 MNHVVNVLVSLVVQWKPTERSSDSEDIYGIDYDTPLPQLI 855
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 474 (171.9 bits), Expect = 2.2e-77, Sum P(2) = 2.2e-77
Identities = 111/283 (39%), Positives = 154/283 (54%)
Query: 579 VTDNFSEANILXXXXXXXXXXXELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
V D+ E NI+ +P G +AVKR+ + + G+ F AEI L ++RH
Sbjct: 686 VLDSLKEDNIIGKGGAGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRH 745
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
RH+V LLG+C N LLVYEYMP G+L + L H L W R IAL+ A+G+
Sbjct: 746 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL---HGKKGGHLHWNTRYKIALEAAKGLC 802
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD-GKYSVETRLAGTFGYLAP 757
YLH +HRD+K +NIL+ + A VADFGL K D G + +AG++GY+AP
Sbjct: 803 YLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 862
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-KENIPKA 816
EYA T +V K DVY+FGVVL+E ITG+K + + D +V W R + S K+ + K
Sbjct: 863 EYAYTLKVDEKSDVYSFGVVLLELITGKKPVGEF--GDGVDIVQWVRSMTDSNKDCVLKV 920
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
ID L L + + V +A C + +RP M V +L
Sbjct: 921 ID--LRLSSVPVHEVTHVFYVALLCVEEQAVERPTMREVVQIL 961
|
|
| TAIR|locus:2169965 BAM1 "BARELY ANY MERISTEM 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 488 (176.8 bits), Expect = 5.5e-77, Sum P(2) = 5.5e-77
Identities = 111/284 (39%), Positives = 160/284 (56%)
Query: 579 VTDNFSEANILXXXXXXXXXXXELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
V D+ E NI+ +P+G +AVKR+ + + G+ F AEI L ++RH
Sbjct: 690 VLDSLKEDNIIGKGGAGIVYKGVMPNGDLVAVKRLAAMSRGSSHDHGFNAEIQTLGRIRH 749
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
RH+V LLG+C N LLVYEYMP G+L + L H L W R IAL+ A+G+
Sbjct: 750 RHIVRLLGFCSNHETNLLVYEYMPNGSLGEVL---HGKKGGHLHWDTRYKIALEAAKGLC 806
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD-GKYSVETRLAGTFGYLAP 757
YLH +HRD+K +NIL+ + A VADFGL K D G + +AG++GY+AP
Sbjct: 807 YLHHDCSPLIVHRDVKSNNILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAP 866
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-KENIPKA 816
EYA T +V K DVY+FGVVL+E +TGRK + + D +V W R++ S K+++ K
Sbjct: 867 EYAYTLKVDEKSDVYSFGVVLLELVTGRKPVGEF--GDGVDIVQWVRKMTDSNKDSVLKV 924
Query: 817 IDPNLN-LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+DP L+ + + ++ VA L C + +RP M V +L
Sbjct: 925 LDPRLSSIPIHEVTHVFYVAML---CVEEQAVERPTMREVVQIL 965
|
|
| TAIR|locus:2182870 EMS1 "EXCESS MICROSPOROCYTES1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 472 (171.2 bits), Expect = 6.2e-76, Sum P(2) = 6.2e-76
Identities = 119/306 (38%), Positives = 168/306 (54%)
Query: 563 LFEGGNVAISIEVLRQVTDNFSEANILXXXXXXXXXXXELPDGTKIAVKRM-ESNTMGNK 621
+FE + + + + + TD+FS+ NI+ LP +AVK++ E+ T GN+
Sbjct: 897 MFEQPLLKVRLGDIVEATDHFSKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNR 956
Query: 622 GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPL 681
EF AE+ L KV+H +LV+LLGYC E+LLVYEYM G+L H L
Sbjct: 957 ---EFMAEMETLGKVKHPNLVSLLGYCSFSEEKLLVYEYMVNGSL-DHWLRNQTGMLEVL 1012
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741
W +R+ IA+ ARG+ +LH IHRD+K SNIL+ D KVADFGL + +
Sbjct: 1013 DWSKRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACE 1072
Query: 742 YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALD-DTMPDDRAHLV 800
V T +AGTFGY+ PEY + R TTK DVY+FGV+L+E +TG++ D + +LV
Sbjct: 1073 SHVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLV 1132
Query: 801 TWFRRVLISKENIPKAID--PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858
W I K N KA+D L + S R+ ++A C A P +RP+M ++V
Sbjct: 1133 GW----AIQKINQGKAVDVIDPLLVSVALKNSQLRLLQIAMLCLAETPAKRPNM---LDV 1185
Query: 859 LGPLVE 864
L L E
Sbjct: 1186 LKALKE 1191
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 453 (164.5 bits), Expect = 7.6e-75, Sum P(2) = 7.6e-75
Identities = 111/299 (37%), Positives = 160/299 (53%)
Query: 572 SIEVLRQVTDNFSEANILXXXXXXXXXXXELPDGTKIAVKRMESNTMGNKGLSE-----F 626
+++ + + T F ++ I+ +P G IAVK++ESN GN S F
Sbjct: 808 TVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSF 867
Query: 627 QAEIAVLTKVRHRHLVALLGYCIN-GSE-RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWK 684
+AEI L K+RHR++V L +C + GS LL+YEYM RG+L + L H + W
Sbjct: 868 RAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGKSHS---MDWP 924
Query: 685 QRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKY 742
R IAL A G+ YLH + IHRD+K +NILI ++ A V DFGL K + P K
Sbjct: 925 TRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSK- 983
Query: 743 SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW 802
SV +AG++GY+APEYA T +VT K D+Y+FGVVL+E +TG+ + + L TW
Sbjct: 984 SVSA-VAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPL--EQGGDLATW 1040
Query: 803 FRRVLISKENIPKAIDPNLNL--DEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
R + + +DP L D+ + + V ++A CT P RP M V +L
Sbjct: 1041 TRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 439 (159.6 bits), Expect = 3.4e-73, Sum P(2) = 3.4e-73
Identities = 115/323 (35%), Positives = 166/323 (51%)
Query: 552 SQSSGDVSDRHLFEGGNVAISI--EVLRQVTDNFSEANILXXXXXXXXXXXELPDGTKIA 609
S SS + + LF G I E + + T N SE ++ EL +G +A
Sbjct: 918 SSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVA 977
Query: 610 VKRM--ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE--RLLVYEYMPRGT 665
VK++ + + M NK F E+ L ++RHRHLV L+GYC + SE LL+YEYM G+
Sbjct: 978 VKKILWKDDLMSNKS---FSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGS 1034
Query: 666 LAQHLFEWH---DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722
+ L E + L W+ R+ IA+ +A+GVEYLH +HRD+K SN+L+
Sbjct: 1035 IWDWLHEDKPVLEKKKKLLDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDS 1094
Query: 723 DMRAKVADFGLVKNAP---DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLM 779
+M A + DFGL K D T A ++GY+APEYA + + T K DVY+ G+VLM
Sbjct: 1095 NMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLM 1154
Query: 780 ETITGRKALDDTMPDDRAHLVTWFRRVL-ISKENIPKAIDPNLN--LDEETIESIYRVAE 836
E +TG+ D + +V W L ++ K IDP L L E ++ +V E
Sbjct: 1155 EIVTGKMPTDSVFGAEM-DMVRWVETHLEVAGSARDKLIDPKLKPLLPFEE-DAACQVLE 1212
Query: 837 LAGHCTAREPQQRPDMGHAVNVL 859
+A CT PQ+RP A + L
Sbjct: 1213 IALQCTKTSPQERPSSRQACDSL 1235
|
|
| TAIR|locus:2139885 AT4G28650 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 440 (159.9 bits), Expect = 4.7e-73, Sum P(2) = 4.7e-73
Identities = 100/305 (32%), Positives = 167/305 (54%)
Query: 585 EANILXXXXXXXXXXXELP-DGTKIAVKRMESNTMG-NKGLS-EFQAEIAVLTKVRHRHL 641
E+N++ E+ T +AVK++ + G + +F E+ +L K+RHR++
Sbjct: 701 ESNMIGMGATGIVYKAEMSRSSTVLAVKKLWRSAADIEDGTTGDFVGEVNLLGKLRHRNI 760
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
V LLG+ N ++VYE+M G L + + G + W R IAL VA G+ YLH
Sbjct: 761 VRLLGFLYNDKNMMIVYEFMLNGNLGDAIHGKNAAGRLLVDWVSRYNIALGVAHGLAYLH 820
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA 761
IHRD+K +NIL+ ++ A++ADFGL + K +V + +AG++GY+APEY
Sbjct: 821 HDCHPPVIHRDIKSNNILLDANLDARIADFGLARMMARKKETV-SMVAGSYGYIAPEYGY 879
Query: 762 TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821
T +V KID+Y++GVVL+E +TGR+ L+ + +V W RR + ++ +A+DPN+
Sbjct: 880 TLKVDEKIDIYSYGVVLLELLTGRRPLEPEFGES-VDIVEWVRRKIRDNISLEEALDPNV 938
Query: 822 NLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPATREDEDGYGI-D 880
E + V ++A CT + P+ RP M +++LG + K + E+ + +
Sbjct: 939 GNCRYVQEEMLLVLQIALLCTTKLPKDRPSMRDVISMLGEAKPRRKSNSNEENTSRSLAE 998
Query: 881 LHMSL 885
H S+
Sbjct: 999 KHSSV 1003
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | fgenesh2_kg.3__2591__AT3G23750.1 | annotation not avaliable (930 aa) | |||||||||
(Arabidopsis lyrata) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 933 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-55 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-52 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 5e-52 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-50 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 5e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 5e-42 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-36 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-36 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-35 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-33 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 9e-33 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-31 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-31 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-30 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-30 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-29 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-29 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 4e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-29 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-28 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-28 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-28 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 5e-28 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-28 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-28 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-27 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-27 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-26 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 7e-26 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-25 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 3e-25 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-25 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-25 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-25 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 6e-25 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-25 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 8e-25 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-25 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-24 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-24 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-24 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-23 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-23 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-23 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-23 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-23 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 9e-23 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-22 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-22 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 5e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-22 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 7e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-22 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 9e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-21 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-21 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-21 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-21 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 6e-21 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-20 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-20 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-20 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-20 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-20 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-20 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-20 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-20 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-20 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-20 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 4e-20 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-20 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-19 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-19 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-19 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 5e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-19 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-19 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 9e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-18 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-18 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-18 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-18 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-18 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-17 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-17 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-17 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-17 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-17 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-17 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-17 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-17 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-17 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 7e-17 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 7e-17 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-16 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 5e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-16 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-15 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-15 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 4e-15 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-15 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 6e-15 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-14 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 1e-14 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-14 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-14 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-14 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-14 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-14 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-14 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-13 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 1e-13 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-13 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-13 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-13 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 3e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 3e-13 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 3e-13 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-13 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 5e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-13 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 6e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 7e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 9e-13 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-12 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-12 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-12 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-12 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-12 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-12 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-12 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-12 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-12 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-12 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-12 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-12 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-12 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-12 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-11 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-11 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-11 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-11 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-11 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-11 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 6e-11 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-10 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-10 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-10 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-10 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 5e-10 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 5e-10 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 7e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 8e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 9e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 1e-09 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-09 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-09 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-09 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-09 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-09 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-09 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 6e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-08 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-08 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-08 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-08 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-08 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 6e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 8e-08 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 9e-08 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-07 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-06 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 5e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 8e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-05 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 7e-05 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 1e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-04 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 5e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.002 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 5e-55
Identities = 212/802 (26%), Positives = 345/802 (43%), Gaps = 101/802 (12%)
Query: 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT-SV 128
I L + LSG + EI LT L L NN+ G IP SL N +LQ ++L N + +
Sbjct: 217 IYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPI 276
Query: 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188
P F L L L LSDN P + + +L L++ + N G IP S
Sbjct: 277 PPSIF-SLQKLISLDLSDN--SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPR 333
Query: 189 LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL-GLSGTL-DVLSGMTQLRQVWLHKNQ 246
LQ L+L N F+G +P + K + NL + D L+G + + L L ++ L N
Sbjct: 334 LQVLQLWSNKFSGEIPKNLGKHN--NLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391
Query: 247 FTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL----F 301
G IP L C SL + L+DN +G +P+ LP + + + NN LQG
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451
Query: 302 PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQ--IAGD-----MGYPAILSDSWEGNN 354
PS +Q +SL N F D+ + L + +G ++ N
Sbjct: 452 PS-LQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENK 510
Query: 355 ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414
P S ++++++L++ L+G I +++ + L L L QN L+G IP L +
Sbjct: 511 LSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNV 570
Query: 415 ASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGTNVDTTPGGAGTPGSKPSGPSGSP 474
SL +++S+N+L G +P G+ F+ N G G + SG P
Sbjct: 571 ESLVQVNISHNHLHGSLPSTGA-----------FLAINASAVAGNIDLCGGDTT--SGLP 617
Query: 475 AAS--SKSKLSVGTIVAIVVVVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKN 532
K+ I + ++ V F V FI R + + RV+N + E+
Sbjct: 618 PCKRVRKTPSWWFYITCTLGAFLVLALVAFGFV--FIRGRNNLELKRVENEDGTWEL--- 672
Query: 533 GVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRG 592
F V+ SI + + + E N++ RG
Sbjct: 673 ------------------------------QFFDSKVSKSITI-NDILSSLKEENVISRG 701
Query: 593 GFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651
G Y G+ + +G + VK + N S +EIA + K++H ++V L+G C +
Sbjct: 702 KKGASYKGKSIKNGMQFVVKEI------NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE 755
Query: 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHR 711
L++EY+ L++ L L+W++R IA+ +A+ + +LH + +
Sbjct: 756 KGAYLIHEYIEGKNLSEVL--------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 712 DLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDV 771
+L P I+I D ++ + G +T+ + Y+APE T +T K D+
Sbjct: 808 NLSPEKIII------DGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDI 861
Query: 772 YAFGVVLMETITGRKALDDTMPDDRAH--LVTWFRRVLISKENIPKAIDPNLNLDEETIE 829
Y FG++L+E +TG+ D + H +V W R S ++ IDP++ D +
Sbjct: 862 YGFGLILIELLTGKSPAD---AEFGVHGSIVEW-ARYCYSDCHLDMWIDPSIRGDVSVNQ 917
Query: 830 S-IYRVAELAGHCTAREPQQRP 850
+ I V LA HCTA +P RP
Sbjct: 918 NEIVEVMNLALHCTATDPTARP 939
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 184 bits (469), Expect = 1e-52
Identities = 86/279 (30%), Positives = 134/279 (48%), Gaps = 33/279 (11%)
Query: 588 ILGRGGFGVVYGGEL---PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG VY G L DG ++ AVK ++ + + + EF E ++ K+ H ++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDAS-EQQIEEFLREARIMRKLDHPNIV 64
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
LLG C ++V EYMP G L +L + L+ ++ AL +ARG+EYL S
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYL---RKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT 762
++FIHRDL N L+G+++ K++DFGL ++ D Y ++APE
Sbjct: 122 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178
Query: 763 GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR--AHLVTWFRRVLISKENIPKAIDPN 820
G+ T+K DV++FGV+L E T + M + +L +R L N P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYR--LPKPPNCPPE---- 232
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+Y++ C A +P+ RP V +L
Sbjct: 233 ----------LYKLMLQ---CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 4e-52
Identities = 83/275 (30%), Positives = 121/275 (44%), Gaps = 29/275 (10%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G FG VY G +AVK ++ + +K + EI +L ++ H ++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ LV EY G L +L PL+ + IAL + RG+EYLHS
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR-----GGPLSEDEAKKIALQILRGLEYLHS---N 117
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPEYAATGR 764
IHRDLKP NIL+ ++ K+ADFGL K + GT Y+APE G
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT---FVGTPWYMAPEVLLGGN 174
Query: 765 -VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823
K+DV++ GV+L E +TG+ D + I + + P L
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILD-------------QLQLIRRILGPPLEF 221
Query: 824 DEETIESIYRVA-ELAGHCTAREPQQRPDMGHAVN 857
DE S A +L C ++P +RP +
Sbjct: 222 DEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 5e-52
Identities = 80/270 (29%), Positives = 128/270 (47%), Gaps = 30/270 (11%)
Query: 588 ILGRGGFGVVYGGEL---PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG VY G+L K+ AVK ++ + + + EF E ++ K+ H ++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDAS-EQQIEEFLREARIMRKLDHPNVV 64
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
LLG C +V EYM G L +L + L+ ++ AL +ARG+EYL S
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYL---RKNRPK-LSLSDLLSFALQIARGMEYLES 120
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT 762
++FIHRDL N L+G+++ K++DFGL ++ D Y + ++APE
Sbjct: 121 ---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177
Query: 763 GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLN 822
G+ T+K DV++FGV+L E T + M ++ L + +P+ P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV------LEYLKNGYRLPQ---P--- 225
Query: 823 LDEETIESIYRVAELAGHCTAREPQQRPDM 852
+Y + C A +P+ RP
Sbjct: 226 --PNCPPELYDLMLQ---CWAEDPEDRPTF 250
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 178 bits (455), Expect = 3e-51
Identities = 72/195 (36%), Positives = 101/195 (51%), Gaps = 12/195 (6%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG GGFG VY G K+A+K ++ + L E EI +L K+ H ++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDS-SSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ + LV EY G+L L E L+ + + I L + G+EYLHS
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENE----GKLSEDEILRILLQILEGLEYLHS---NG 112
Query: 708 FIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE-YAATGRV 765
IHRDLKP NIL+ D+ + K+ADFGL K K S+ + GT Y+APE G
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-SLLKTIVGTPAYMAPEVLLGKGYY 171
Query: 766 TTKIDVYAFGVVLME 780
+ K D+++ GV+L E
Sbjct: 172 SEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 7e-50
Identities = 82/276 (29%), Positives = 128/276 (46%), Gaps = 32/276 (11%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG VY G+L T++AVK ++ + + +F E V+ K+ H ++V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS-EEERKDFLKEARVMKKLGHPNVV 59
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL----FEWHDHGYTPLTWKQRVTIALDVARGVE 698
LLG C LV EYM G L +L + + L+ K ++ A+ +A+G+E
Sbjct: 60 RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT-FGYLAP 757
YL S + F+HRDL N L+G+D+ K++DFGL ++ D Y + ++AP
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176
Query: 758 EYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816
E G T+K DV++FGV+L E T G + ++ L +PK
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-LSNEE------VLEYLRKGYRLPK- 228
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
P DE +Y + C +P+ RP
Sbjct: 229 --PEYCPDE-----LYELML---SCWQLDPEDRPTF 254
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 171 bits (437), Expect = 3e-48
Identities = 72/266 (27%), Positives = 117/266 (43%), Gaps = 29/266 (10%)
Query: 587 NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG VY + G +A+K ++ + K EI +L K++H ++V L
Sbjct: 5 EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKI-KKDRERILREIKILKKLKHPNIVRLY 63
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ + LV EY G L L G L+ + + +EYLHS
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLL---KKRG--RLSEDEARFYLRQILSALEYLHS--- 115
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV 765
+ +HRDLKP NIL+ +D K+ADFGL + G+ T GT Y+APE
Sbjct: 116 KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGY 173
Query: 766 TTKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLISKENIPKAIDPNLNLD 824
+D+++ GV+L E +TG+ P L+ F+++ + P P ++
Sbjct: 174 GKAVDIWSLGVILYELLTGK------PPFPGDDQLLELFKKI---GKPKPPFPPPEWDIS 224
Query: 825 EETIESIYRVAELAGHCTAREPQQRP 850
E + I + ++P++R
Sbjct: 225 PEAKDLIRK-------LLVKDPEKRL 243
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 5e-47
Identities = 74/202 (36%), Positives = 108/202 (53%), Gaps = 14/202 (6%)
Query: 589 LGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
LG G FG VY G L TK+AVK ++ + EF E +++ K+ H ++V
Sbjct: 7 LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGAS-EEEREEFLEEASIMKKLSHPNIVR 65
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
LLG C G +V EYMP G L L HG LT K + +AL +A+G+EYL S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL---RKHG-EKLTLKDLLQMALQIAKGMEYLES- 120
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPEYAAT 762
++F+HRDL N L+ +++ K++DFGL ++ D Y ++APE
Sbjct: 121 --KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKD 178
Query: 763 GRVTTKIDVYAFGVVLMETITG 784
G+ T+K DV++FGV+L E T
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 5e-42
Identities = 70/270 (25%), Positives = 119/270 (44%), Gaps = 32/270 (11%)
Query: 587 NILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+LGRG FG VY D G +AVK +E + + L + EI +L+ ++H ++V
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 646 GYCIN--GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
G + + + EY+ G+L+ L + L + G+ YLHS
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLPEPVIRKYTRQILEGLAYLHS- 119
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYLAPEYAAT 762
+HRD+K +NIL+ D K+ADFG K D + T + GT ++APE
Sbjct: 120 --NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG 177
Query: 763 GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE--NIPKAIDPN 820
D+++ G ++E TG+ + + + ++ S E IP+
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSEL--GNPMAALY---KIGSSGEPPEIPE----- 227
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRP 850
+L EE + + + C R+P++RP
Sbjct: 228 -HLSEEAKDFLRK-------CLRRDPKKRP 249
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-36
Identities = 123/442 (27%), Positives = 191/442 (43%), Gaps = 96/442 (21%)
Query: 44 SDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLET-------LS 96
S+W+S++ C W GI C+NS+RV +I L+ +SG +S I L ++T LS
Sbjct: 49 SNWNSSAD--VCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLS 106
Query: 97 FQM------------------NNIAGAIPS----------LANATSLQDIYLDNNNFTS- 127
+ NN G+IP L+N +I D +F+S
Sbjct: 107 GPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSL 166
Query: 128 -------------VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174
+P LT+L+ L+L+ N + P EL + SL +Y+ N
Sbjct: 167 KVLDLGGNVLVGKIP-NSLTNLTSLEFLTLASNQLVGQ--IPRELGQMKSLKWIYLGYNN 223
Query: 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTL-DVLS 232
+ G IP ++L +L L YNN TG +P+S ++Q L++ Q LSG + +
Sbjct: 224 LSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFL--YQNKLSGPIPPSIF 281
Query: 233 GMTQLRQVWLHKNQFTGPIPDL-SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ +L + L N +G IP+L + ++L L L N TG +P ++ SLP L + L +
Sbjct: 282 SLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS 341
Query: 292 NKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
NK G P K HNN T+L ++
Sbjct: 342 NKFSGEIPKNLGK-------HNNL----------------TVLDLST------------- 365
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
NN P CS G + + L + L G I + SL+ + LQ N+ +G +P
Sbjct: 366 -NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424
Query: 412 TKLASLQNLDVSNNNLSGKVPD 433
TKL + LD+SNNNL G++
Sbjct: 425 TKLPLVYFLDISNNNLQGRINS 446
|
Length = 968 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-36
Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+GGFG VY G ++A+K ++ + K + EI +L K +H ++V G
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKK--EKIINEIQILKKCKHPNIVKYYGS 65
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E +V E+ G+L L LT Q + ++ +G+EYLHS
Sbjct: 66 YLKKDELWIVMEFCSGGSLKDLL----KSTNQTLTESQIAYVCKELLKGLEYLHS---NG 118
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
IHRD+K +NIL+ D K+ DFGL D K + GT ++APE
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK--ARNTMVGTPYWMAPEVINGKPYDY 176
Query: 768 KIDVYAFGVVLMETITGR 785
K D+++ G+ +E G+
Sbjct: 177 KADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 88/287 (30%), Positives = 134/287 (46%), Gaps = 63/287 (21%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G+G FG V G+ G K+AVK ++ ++ F AE +V+T +RH +LV LLG
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCLKDDS---TAAQAFLAEASVMTTLRHPNLVQLLGVV 69
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ G+ +V EYM +G+L +L G +T Q++ ALDV G+EYL ++F
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEE---KNF 123
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNA----PDGKYSVETRLAGTFGYLAPEYAATGR 764
+HRDL N+L+ +D+ AKV+DFGL K A GK V+ + APE +
Sbjct: 124 VHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK--------WTAPEALREKK 175
Query: 765 VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLD 824
+TK DV++FG++L E + F RV P P + L
Sbjct: 176 FSTKSDVWSFGILLWEIYS-------------------FGRV-------PY---PRIPLK 206
Query: 825 E--ETIESIYR----------VAELAGHCTAREPQQRPDMGHAVNVL 859
+ +E YR V ++ C +P +RP L
Sbjct: 207 DVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 75/200 (37%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ G TK+AVK ++ TM F E ++ K+RH LV L C
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+V EYM +G+L L L Q V +A +A G+ YL S +++
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNY 124
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF--GYLAPEYAATGRVT 766
IHRDL NIL+G+++ K+ADFGL + D +Y R F + APE A GR T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEY--TAREGAKFPIKWTAPEAANYGRFT 182
Query: 767 TKIDVYAFGVVLMETIT-GR 785
K DV++FG++L E +T GR
Sbjct: 183 IKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 9e-33
Identities = 83/282 (29%), Positives = 128/282 (45%), Gaps = 47/282 (16%)
Query: 589 LGRGGFGVVYGGEL----PDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG V+ GE P+ K +AVK ++ N +F+ E +LT +H ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIV 71
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL---------FEWHDHGYTPLTWKQRVTIALDV 693
G C G ++V+EYM G L + L + D LT Q + IA+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE-TRLAGT- 751
A G+ Y LA Q F+HRDL N L+G D+ K+ DFG+ ++ Y+ + R+ G
Sbjct: 132 ASGMVY---LASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV----YTTDYYRVGGHT 184
Query: 752 ---FGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVL 807
++ PE + TT+ DV++FGVVL E T G++ ++ +T R+L
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ-GRLL 243
Query: 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQR 849
P +Y + C R+PQQR
Sbjct: 244 QRPRTCPS--------------EVYDIML---GCWKRDPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 76/217 (35%), Positives = 112/217 (51%), Gaps = 24/217 (11%)
Query: 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIA 631
SI++LR+ LG G FG V+ G + T +AVK ++ TM K +F AE
Sbjct: 7 SIQLLRK----------LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK---DFLAEAQ 53
Query: 632 VLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
++ K+RH L+ L C +V E M G+L ++L L Q + +A
Sbjct: 54 IMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAA 110
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
VA G+ YL + Q++IHRDL N+L+G++ KVADFGL + + Y E R
Sbjct: 111 QVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY--EAREGAK 165
Query: 752 F--GYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GR 785
F + APE A R + K DV++FG++L E +T GR
Sbjct: 166 FPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 126 bits (315), Expect = 5e-31
Identities = 85/354 (24%), Positives = 135/354 (38%), Gaps = 26/354 (7%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRH-RHLVALLG 646
LG G FG VY D +A+K + E F EI +L + H ++V L
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ + LV EY+ G+L L PL+ + + I + +EYLHS +
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLL--KKIGRKGPLSESEALFILAQILSALEYLHS---K 120
Query: 707 SFIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYSVETR-----LAGTFGYLAPEYA 760
IHRD+KP NIL+ D K+ DFGL K PD + GT GY+APE
Sbjct: 121 GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180
Query: 761 A---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817
++ D+++ G+ L E +TG + + I E ++
Sbjct: 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-----LKIILELPTPSL 235
Query: 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPATREDEDGY 877
L+ + S ++L A++P+ R + ++ L+ K + D
Sbjct: 236 ASPLSPSNPELISK-AASDLLKKLLAKDPKNRLSS--SSDLSHDLLAHLKLKESDLSDLL 292
Query: 878 GIDLHMSLPQALQRWQANEGTSTMFGDVSSSYSQSHSSIPSKPSGFADTFNSAD 931
D L +L +S +S S + S SK +S
Sbjct: 293 KPDDSAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPH 346
|
Length = 384 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 9e-31
Identities = 68/205 (33%), Positives = 108/205 (52%), Gaps = 17/205 (8%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
F+ LG G FG V+ G + ++A+K ++S+ + +FQ E+ L ++RH+HL+
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK--QQDFQKEVQALKRLRHKHLI 65
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP----LTWKQRVTIALDVARGVE 698
+L C G ++ E M +G+L L +P L + +A VA G+
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFL-------RSPEGQVLPVASLIDMACQVAEGMA 118
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YL Q+ IHRDL NIL+G+D+ KVADFGL + + Y + + + APE
Sbjct: 119 YLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPE 174
Query: 759 YAATGRVTTKIDVYAFGVVLMETIT 783
A+ G +TK DV++FG++L E T
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 84/272 (30%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G+G FG VY G L T++AVK S T+ +F E +L + H ++V L+G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRS-TLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ +V E +P G+L L + + LT K+ + ++LD A G+EYL S ++
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLES---KNC 114
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT-FGYLAPEYAATGRVTT 767
IHRDL N L+G++ K++DFG+ + G Y+V L + APE GR T+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 768 KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEET 827
+ DV+++G++L ET + M + + R + S +P P L
Sbjct: 175 ESDVWSYGILLWETFSLGDTPYPGMSNQQT------RERIESGYRMPA---PQL-----C 220
Query: 828 IESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
E IYR+ C A +P+ RP N L
Sbjct: 221 PEEIYRLML---QCWAYDPENRPSFSEIYNEL 249
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 7e-30
Identities = 71/215 (33%), Positives = 105/215 (48%), Gaps = 19/215 (8%)
Query: 583 FSEANILGRGGFGVVYGGEL--PDGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
ILG G FG V G+L DG+ K+AVK M+ + + EF +E A + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 639 RHLVALLGYCINGSER------LLVYEYMPRGTLAQHLFEWHDHG---YTPLTWKQRVTI 689
+++ L+G C S +++ +M G L L G PL + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPL--QTLLKF 118
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
+D+A G+EYL + ++FIHRDL N ++ +DM VADFGL K G Y + R+A
Sbjct: 119 MVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 750 GT-FGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
++A E A T+K DV+AFGV + E T
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 75/264 (28%), Positives = 114/264 (43%), Gaps = 31/264 (11%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FGVV+ G+ +A+K + M +F E V+ K+ H +LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLSHPNLVQLYGVC 68
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+V EYM G L +L E T + + + DV +EYL S F
Sbjct: 69 TKQRPIFIVTEYMANGCLLNYLRERKGKLGT----EWLLDMCSDVCEAMEYLES---NGF 121
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK 768
IHRDL N L+G+D KV+DFGL + D +Y+ + PE R ++K
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181
Query: 769 IDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETI 828
DV++FGV++ E + K MP +R S + +++ L +
Sbjct: 182 SDVWSFGVLMWEVFSEGK-----MPYER-----------FSNSEVVESVSAGYRLYRPKL 225
Query: 829 --ESIYRVAELAGHCTAREPQQRP 850
+Y + C +P+ RP
Sbjct: 226 APTEVY---TIMYSCWHEKPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 87/275 (31%), Positives = 129/275 (46%), Gaps = 53/275 (19%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ G TK+AVK ++ TM + F E ++ K+RH LV L Y
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPES---FLEEAQIMKKLRHDKLVQL--YA 68
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E + +V EYM +G+L L D L V +A VA G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIERM---N 122
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
+IHRDL+ +NIL+GD + K+ADFGL + D +Y+ + APE A GR T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 768 KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDE-- 825
K DV++FG++L E L++K +P P +N E
Sbjct: 183 KSDVWSFGILLTE--------------------------LVTKGRVPY---PGMNNREVL 213
Query: 826 ETIESIYRVA----------ELAGHCTAREPQQRP 850
E +E YR+ EL C ++P++RP
Sbjct: 214 EQVERGYRMPCPQDCPISLHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 86/282 (30%), Positives = 127/282 (45%), Gaps = 38/282 (13%)
Query: 587 NILGRGGFGVVYGGE---LPDGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG G FG V L D T ++AVK + + + S+F+ EI +L + H ++
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS-GEEQHRSDFEREIEILRTLDHENI 68
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
V G C R L+ EY+P G+L +L D + K+ + + + +G++Y
Sbjct: 69 VKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQICKGMDY 124
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK---YSVETRLAGTFGYLA 756
L S Q +IHRDL NIL+ + K++DFGL K P+ K Y E + F Y A
Sbjct: 125 LGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-A 180
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETIT-GRKA-------LDDTMPDDRAHLVTWFRRVLI 808
PE T + ++ DV++FGV L E T G + L +VT +L
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240
Query: 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
E +P+ P DE V +L C EPQ RP
Sbjct: 241 EGERLPR---PPSCPDE--------VYDLMKLCWEAEPQDRP 271
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 5e-29
Identities = 70/236 (29%), Positives = 103/236 (43%), Gaps = 19/236 (8%)
Query: 589 LGRGGFGVVYG-GELPDGTKIAVKRMESNTMGNKGLSEF-QAEIAVLTKVRHRHLVALLG 646
LG+G FG V + G A+K ++ + + E E +L+++ H +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
Y E+L LV EY P G L HL G + A ++ +EYLHS
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFSEERARF--YAAEIVLALEYLHS--- 111
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV 765
I+RDLKP NIL+ D K+ DFGL K T GT YLAPE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGY 170
Query: 766 TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821
+D ++ GV+L E +TG+ +DR + + ++L P+ + P
Sbjct: 171 GKAVDWWSLGVLLYEMLTGKPPFYA---EDRKEI---YEKILKDPLRFPEFLSPEA 220
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 84/263 (31%), Positives = 130/263 (49%), Gaps = 29/263 (11%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG+G FG V+ G T++A+K ++ TM + F E V+ K+RH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA---FLQEAQVMKKLRHEKLVQL--YA 68
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E + +V EYM +G+L L L Q V +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERM---N 122
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
++HRDL+ +NIL+G+++ KVADFGL + D +Y+ + APE A GR T
Sbjct: 123 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 768 KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEET 827
K DV++FG++L E T + M + R VL E + P E
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVN---------REVLDQVERGYRMPCPP-----EC 228
Query: 828 IESIYRVAELAGHCTAREPQQRP 850
ES++ +L C +EP++RP
Sbjct: 229 PESLH---DLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 587 NILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+ LG G +G VY G +AVK ++ +TM + EF E AV+ +++H +LV LL
Sbjct: 12 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLL 68
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C ++ E+M G L +L E + + + +A ++ +EYL
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLEK--- 122
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV 765
++FIHRDL N L+G++ KVADFGL + Y+ + APE A +
Sbjct: 123 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 766 TTKIDVYAFGVVLMETIT 783
+ K DV+AFGV+L E T
Sbjct: 183 SIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 85/279 (30%), Positives = 125/279 (44%), Gaps = 41/279 (14%)
Query: 589 LGRGGFGVVYGGE----LPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG V+ E LP+ K +AVK ++ + + +FQ E +LT ++H+H+V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESAR--QDFQREAELLTVLQHQHIV 70
Query: 643 ALLGYCINGSERLLVYEYMPRGTL----------AQHLFEWHDHGYTPLTWKQRVTIALD 692
G C G L+V+EYM G L A+ L D LT Q + IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDGKYSVETRLAGT 751
+A G+ YL SL F+HRDL N L+G + K+ DFG+ ++ Y V R
Sbjct: 131 IASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP 187
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISK 810
++ PE + TT+ D+++FGVVL E T G++ + +T R +
Sbjct: 188 IRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL---- 243
Query: 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQR 849
P+ P V + C REPQQR
Sbjct: 244 -ERPRTCPP-------------EVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 5e-28
Identities = 79/269 (29%), Positives = 112/269 (41%), Gaps = 32/269 (11%)
Query: 589 LGRGGFGVVYGGEL--PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FGVV GE G I AVK ++S+ + + + +F E A++ + H +L+ L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRL 61
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
G + ++V E P G+L L A+ +A G+ YL
Sbjct: 62 YGVVLTHP-LMMVTELAPLGSLLDRL---RKDALGHFLISTLCDYAVQIANGMRYLE--- 114
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYLAPEYAAT 762
+ FIHRDL NIL+ D + K+ DFGL++ P + Y +E L F + APE T
Sbjct: 115 SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174
Query: 763 GRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821
+ DV+ FGV L E T G P W +S I K ID
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGE------EP--------W---AGLSGSQILKKIDKEG 217
Query: 822 NLDEETIESIYRVAELAGHCTAREPQQRP 850
E + + C A P RP
Sbjct: 218 ERLERPEACPQDIYNVMLQCWAHNPADRP 246
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 74/263 (28%), Positives = 122/263 (46%), Gaps = 29/263 (11%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G G FG+V+ G + K+A+K + M + +F E V+ K+ H LV L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
S LV+E+M G L+ +L + + + + LDV G+ YL +
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGK----FSQETLLGMCLDVCEGMAYLE---SSNV 121
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK 768
IHRDL N L+G++ KV+DFG+ + D +Y+ T + +PE + + ++K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 769 IDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLISKENIPKAIDPNLNLDEET 827
DV++FGV++ E + K P ++R S + + I+ L +
Sbjct: 182 SDVWSFGVLMWEVFSEGK-----TPYENR------------SNSEVVETINAGFRLYKPR 224
Query: 828 IESIYRVAELAGHCTAREPQQRP 850
+ S V EL HC P+ RP
Sbjct: 225 LASQS-VYELMQHCWKERPEDRP 246
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 7e-28
Identities = 85/263 (32%), Positives = 134/263 (50%), Gaps = 29/263 (11%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG+G FG V+ G TK+A+K ++ TM + F E ++ K+RH LV L Y
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEA---FLQEAQIMKKLRHDKLVPL--YA 68
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E + +V E+M +G+L L E D Y L Q V +A +A G+ Y+ + +
Sbjct: 69 VVSEEPIYIVTEFMGKGSLLDFLKE-GDGKYLKL--PQLVDMAAQIADGMAYIERM---N 122
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
+IHRDL+ +NIL+GD++ K+ADFGL + D +Y+ + APE A GR T
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182
Query: 768 KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEET 827
K DV++FG++L E +T + M + R VL E + + + +
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVN---------REVL---EQVERGY--RMPCPQGC 228
Query: 828 IESIYRVAELAGHCTAREPQQRP 850
ES++ EL C ++P +RP
Sbjct: 229 PESLH---ELMKLCWKKDPDERP 248
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 73/200 (36%), Positives = 108/200 (54%), Gaps = 19/200 (9%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
I+G G FG V GE G K+AVK ++ + F E AV+TK+ H++LV LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA----FLEETAVMTKLHHKNLVRLLGV 67
Query: 648 CI-NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ NG +V E M +G L L G ++ Q + +LDVA G+EYL S +
Sbjct: 68 ILHNGLY--IVMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLES---K 119
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVT 766
+HRDL NIL+ +D AKV+DFGL + G + ++L + APE + +
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDN--SKLP--VKWTAPEALKHKKFS 175
Query: 767 TKIDVYAFGVVLMETIT-GR 785
+K DV+++GV+L E + GR
Sbjct: 176 SKSDVWSYGVLLWEVFSYGR 195
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 10/205 (4%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
N+ +++GRG FGVVY G L G +A+K++ + + L EI +L ++H +
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+V +G ++ EY G+L Q + + P V +G+ YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII-----KKFGPFPESLVAVYVYQVLQGLAYL 115
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
H +Q IHRD+K +NIL D K+ADFG+ D + + GT ++APE
Sbjct: 116 H---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS-VVGTPYWMAPEVI 171
Query: 761 ATGRVTTKIDVYAFGVVLMETITGR 785
+T D+++ G ++E +TG
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 68/216 (31%), Positives = 110/216 (50%), Gaps = 24/216 (11%)
Query: 583 FSEANILGRGGFGVVYGGEL--PDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
F E LG G FG VY GEL P+ T +A+K ++ N K EF+ E +++ +
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP-KVQQEFRQEAELMSDL 65
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF-----------EWHDHGYTPLTWKQ 685
+H ++V LLG C +++EY+ G L + L + + L
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK-YSV 744
+ IA+ +A G+EYL S F+HRDL N L+G+ + K++DFGL ++ Y V
Sbjct: 126 FLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRV 182
Query: 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLME 780
+++ ++ PE G+ TT+ D+++FGVVL E
Sbjct: 183 QSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWE 218
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 32/275 (11%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+ + +G G G VY + G ++A+K+M + + EI ++ +H
Sbjct: 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM---RLRKQNKELIINEILIMKDCKH 74
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V + G E +V EYM G+L + + + Q + +V +G+E
Sbjct: 75 PNIVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNF---VRMNEPQIAYVCREVLQGLE 130
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR--LAGTFGYLA 756
YLHS IHRD+K NIL+ D K+ADFG A R + GT ++A
Sbjct: 131 YLHSQNV---IHRDIKSDNILLSKDGSVKLADFGF---AAQLTKEKSKRNSVVGTPYWMA 184
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816
PE K+D+++ G++ +E G P RA LI+ + IP
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLR-EPPLRA-------LFLITTKGIPPL 236
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
+P E + + + C ++P++RP
Sbjct: 237 KNPE-KWSPEFKDFLNK-------CLVKDPEKRPS 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 68/194 (35%), Positives = 107/194 (55%), Gaps = 16/194 (8%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G FG V G+ G K+AVK ++++ F AE +V+T++RH +LV LLG
Sbjct: 13 TIGKGEFGDVMLGDY-RGNKVAVKCIKNDATAQA----FLAEASVMTQLRHSNLVQLLGV 67
Query: 648 CINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ L +V EYM +G+L +L G + L + +LDV +EYL +
Sbjct: 68 IVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEA---N 121
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVT 766
+F+HRDL N+L+ +D AKV+DFGL K A + + + + T APE + +
Sbjct: 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFS 177
Query: 767 TKIDVYAFGVVLME 780
TK DV++FG++L E
Sbjct: 178 TKSDVWSFGILLWE 191
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 66/196 (33%), Positives = 103/196 (52%), Gaps = 8/196 (4%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+LG+G FG V+ G L D T +AVK + + + +F +E +L + H ++V L+G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGV 60
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C +V E +P G L + D L KQ V ALD A G+ YL S ++
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLES---KN 113
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
IHRDL N L+G++ K++DFG+ + DG YS + APE GR ++
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173
Query: 768 KIDVYAFGVVLMETIT 783
+ DV+++G++L ET +
Sbjct: 174 ESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 79/231 (34%), Positives = 116/231 (50%), Gaps = 19/231 (8%)
Query: 587 NILGRGGFGVVYGGEL--PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G+G FG VY G L DG KI AVK + T + + +F E ++ H +++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 643 ALLGYCI--NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+LLG C+ GS L+V YM G L + + P T K + L VA+G+EYL
Sbjct: 60 SLLGICLPSEGSP-LVVLPYMKHGDLRNFI---RSETHNP-TVKDLIGFGLQVAKGMEYL 114
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTF--GYLAP 757
A + F+HRDL N ++ + KVADFGL ++ D +Y SV ++A
Sbjct: 115 ---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMAL 171
Query: 758 EYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVL 807
E T + TTK DV++FGV+L E +T G D D + RR+L
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL 222
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 80/289 (27%), Positives = 124/289 (42%), Gaps = 30/289 (10%)
Query: 582 NFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
N E LGRG FG V+ + T + VK ++ T SEF+ E+ + K
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK-TKDENLQSEFRRELDMFRK 64
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF----EWHDHGYTPLTWKQRVTIAL 691
+ H+++V LLG C ++ EY G L Q L + PL+ KQ+V +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
+A G+++ L+ F+HRDL N L+ KV+ L K+ + +Y
Sbjct: 125 QIALGMDH---LSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIP 181
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811
+LAPE +TK DV++FGV++ E T + + D+ VL
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---------EVL---- 228
Query: 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860
N +A L + E +Y+ L C A P+ RP V+ LG
Sbjct: 229 NRLQAGKLELPVPEGCPSRLYK---LMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 71/212 (33%), Positives = 104/212 (49%), Gaps = 19/212 (8%)
Query: 587 NILGRGGFGVVYGG----ELPDGT---KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
N LG G FG VY G L G+ ++AVK + + EF E +++ H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE-KKEFLKEAHLMSNFNHP 59
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTP-LTWKQRVTIALDVARGV 697
++V LLG C+ + ++ E M G L +L + + P LT K+ + I LDVA+G
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 698 EYLHSLAQQSFIHRDLKPSNILI----GDDMR-AKVADFGLVKNA-PDGKYSVETRLAGT 751
YL Q FIHRDL N L+ D R K+ DFGL ++ Y E
Sbjct: 120 VYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLP 176
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
++APE G+ TT+ DV++FGV++ E +T
Sbjct: 177 VRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 3e-25
Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 30/214 (14%)
Query: 589 LGRGGFGVVYGGELPD------GTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG+G FG+VY G T++A+K + E+ +M + EF E +V+ + H+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRER--IEFLNEASVMKEFNCHHV 71
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLF-----EWHDHGYTPLTWKQRVTIALDVARG 696
V LLG G L+V E M +G L +L ++ G P T ++ + +A ++A G
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADG 131
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-------PDGKYSVETRLA 749
+ YL + F+HRDL N ++ +D+ K+ DFG+ ++ GK + R
Sbjct: 132 MAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR-- 186
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
++APE G TTK DV++FGVVL E T
Sbjct: 187 ----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 71/220 (32%), Positives = 106/220 (48%), Gaps = 36/220 (16%)
Query: 589 LGRGGFGVVYGGELP------DGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKVRHR 639
+G+G FG V+ P T +AVK ++ S M +FQ E A++ + H
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA----DFQREAALMAEFDHP 68
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------------FEWHDHGYTPLT 682
++V LLG C G L++EYM G L + L PL+
Sbjct: 69 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--APDG 740
+++ IA VA G+ YL +++ F+HRDL N L+G++M K+ADFGL +N + D
Sbjct: 129 CTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD- 184
Query: 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLME 780
Y A ++ PE R TT+ DV+A+GVVL E
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWE 224
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 6e-25
Identities = 61/195 (31%), Positives = 95/195 (48%), Gaps = 10/195 (5%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FGVV+ G+ K+A+K + M + +F E V+ K+ H LV L G C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+V E+M G L +L + L+ +++ DV G+EYL + SF
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLE---RNSF 121
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK 768
IHRDL N L+ KV+DFG+ + D +Y+ + + PE + ++K
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 769 IDVYAFGVVLMETIT 783
DV++FGV++ E T
Sbjct: 182 SDVWSFGVLMWEVFT 196
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 86/296 (29%), Positives = 130/296 (43%), Gaps = 54/296 (18%)
Query: 589 LGRGGFGVVYGGE------LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG V+ E D +AVK ++ T+ + +FQ E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--KDFQREAELLTNLQHEHIV 70
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY--------TPLTWK------QRVT 688
G C +G ++V+EYM G L + L HG P K Q +
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFL---RAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRL 748
IA +A G+ Y LA Q F+HRDL N L+G ++ K+ DFG+ ++ Y R+
Sbjct: 128 IASQIASGMVY---LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YRV 181
Query: 749 AG----TFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWF 803
G ++ PE + TT+ DV++FGV+L E T G++ + +T
Sbjct: 182 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ- 240
Query: 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
RVL PK V ++ C REPQQR ++ +L
Sbjct: 241 GRVLERPRVCPK-----------------EVYDIMLGCWQREPQQRLNIKEIYKIL 279
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 8e-25
Identities = 70/208 (33%), Positives = 99/208 (47%), Gaps = 15/208 (7%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FGVV G+ +A+K ++ +M EF E V+ K+ H LV L G C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+V EYM G L +L E H + P Q + + DV G+ YL S + F
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLRE-HGKRFQP---SQLLEMCKDVCEGMAYLES---KQF 121
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK 768
IHRDL N L+ D KV+DFGL + D +Y+ + PE + ++K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181
Query: 769 IDVYAFGVVLMETITGRKALDDTMPDDR 796
DV+AFGV++ E + K MP +R
Sbjct: 182 SDVWAFGVLMWEVYSLGK-----MPYER 204
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 8e-25
Identities = 82/284 (28%), Positives = 122/284 (42%), Gaps = 47/284 (16%)
Query: 589 LGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FG V+ E P+ KI V + +F E +LT ++H H+V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG-----------YTPLTWKQRVTIALDV 693
G C+ G ++V+EYM G L + L HG LT Q + IA +
Sbjct: 73 YGVCVEGDPLIMVFEYMKHGDLNKFL---RAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG--- 750
A G+ Y LA Q F+HRDL N L+G+++ K+ DFG+ ++ Y R+ G
Sbjct: 130 AAGMVY---LASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY---YRVGGHTM 183
Query: 751 -TFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLI 808
++ PE + TT+ DV++ GVVL E T G++ ++ +T RVL
Sbjct: 184 LPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ-GRVLQ 242
Query: 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
PK V +L C REP R ++
Sbjct: 243 RPRTCPK-----------------EVYDLMLGCWQREPHMRLNI 269
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 80/274 (29%), Positives = 133/274 (48%), Gaps = 33/274 (12%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ G TK+A+K ++ +M F AE ++ +++H LV L Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRL--YA 68
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ E + ++ EYM G+L L G LT + + +A +A G+ ++ +++
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLKT--PEG-IKLTINKLIDMAAQIAEGMAFIE---RKN 122
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
+IHRDL+ +NIL+ + + K+ADFGL + D +Y+ + APE G T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182
Query: 768 KIDVYAFGVVLMETIT-GRKALDD-TMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDE 825
K DV++FG++L E +T GR T P+ +L +R + +N P
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR--MPRPDNCP----------- 229
Query: 826 ETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
E +Y EL C +P++RP + +VL
Sbjct: 230 ---EELY---ELMRLCWKEKPEERPTFEYLRSVL 257
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-24
Identities = 87/303 (28%), Positives = 138/303 (45%), Gaps = 52/303 (17%)
Query: 587 NILGRGGFGVVYGGEL-PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLV 642
+++G G FG V + DG ++ A+KRM+ + +F E+ VL K+ H +++
Sbjct: 13 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNII 71
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVTIAL 691
LLG C + L EY P G L L F + + L+ +Q + A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
DVARG++YL +Q+ FIHRDL NIL+G++ AK+ADFGL + E + T
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKT 181
Query: 752 FGYLAPEYAATGRV-----TTKIDVYAFGVVLMETIT--GRKALDDTMPDDRAHLVTWFR 804
G L + A + TT DV+++GV+L E ++ G T + L +R
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241
Query: 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864
++ LN D+E V +L C +P +RP + L ++E
Sbjct: 242 ------------LEKPLNCDDE-------VYDLMRQCWREKPYERPSFAQILVSLNRMLE 282
Query: 865 QWK 867
+ K
Sbjct: 283 ERK 285
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 7e-24
Identities = 57/218 (26%), Positives = 95/218 (43%), Gaps = 29/218 (13%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G FG VY DG +K ++ + M K + E+ +L K+ H +++
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE- 66
Query: 648 CINGSERLL-VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+L V EY G L+Q + + P +Q + + + ++YLHS +
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI-KKQKKEGKPFPEEQILDWFVQLCLALKYLHS---R 122
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF-G---YLAPE---- 758
+HRD+KP NI + + K+ DFG+ K S LA T G YL+PE
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISK-----VLSSTVDLAKTVVGTPYYLSPELCQN 177
Query: 759 --YAATGRVTTKIDVYAFGVVLMETITGRKALD-DTMP 793
Y K D+++ G VL E T + + + +
Sbjct: 178 KPY------NYKSDIWSLGCVLYELCTLKHPFEGENLL 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 7e-24
Identities = 68/207 (32%), Positives = 102/207 (49%), Gaps = 16/207 (7%)
Query: 589 LGRGGFGVVYGGELPDGT---KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG V G+L K+AVK M+ + +F +E + + H +++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 646 GYCINGSER------LLVYEYMPRGTLAQHLFEWHDHGYTP--LTWKQRVTIALDVARGV 697
G C+ E +++ +M G L L + G P L + V D+A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLL-YSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT-FGYLA 756
EYL S +SFIHRDL N ++ ++M VADFGL K +G Y + R+A ++A
Sbjct: 126 EYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETIT 783
E A TTK DV++FGV + E T
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 72/218 (33%), Positives = 108/218 (49%), Gaps = 29/218 (13%)
Query: 588 ILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRH 640
LG G FG V E + + +AVK ++ + K LS+ +E+ ++ + +H++
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKN 77
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL--------FEWHDHGYTP---LTWKQRVTI 689
++ LLG C +V EY G L L + D P LT K V+
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET--- 746
A VARG+E+L A + IHRDL N+L+ +D K+ADFGL ++ Y +T
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 747 RLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETIT 783
RL ++APE A RV T + DV++FGV+L E T
Sbjct: 195 RLP--VKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 69/206 (33%), Positives = 107/206 (51%), Gaps = 12/206 (5%)
Query: 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRH 640
F + +LG+GGFG V ++ G A K++E + KG S E +L KV R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V+L Y + L LV M G L H++ + G+ + V A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLED 117
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
LH Q+ ++RDLKP NIL+ D +++D GL + P+G+ +++ R+ GT GY+APE
Sbjct: 118 LH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGRV-GTVGYMAPEV 172
Query: 760 AATGRVTTKIDVYAFGVVLMETITGR 785
R T D +A G +L E I G+
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 66/220 (30%), Positives = 102/220 (46%), Gaps = 36/220 (16%)
Query: 588 ILGRGGFGVVYGGE-LPDGTKI----AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
+LG G FG VY G +P+G K+ A+K + T K E E V+ V H H+V
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVV 72
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYL 700
LLG C+ S+ L+ + MP G L ++ D+ L W + +A+G+ YL
Sbjct: 73 RLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW------CVQIAKGMSYL 125
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---------NAPDGKYSVETRLAGT 751
++ +HRDL N+L+ K+ DFGL K +A GK ++
Sbjct: 126 E---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIK------ 176
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDD 790
++A E T K DV+++GV + E +T G K +
Sbjct: 177 --WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 71/206 (34%), Positives = 107/206 (51%), Gaps = 22/206 (10%)
Query: 589 LGRGGFGVV----YGGELPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG+G FG V Y L D T +AVK+++ +T + L +F+ EI +L ++H ++V
Sbjct: 12 LGKGNFGSVELCRYD-PLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIV 68
Query: 643 ALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
G C + R LV EY+P G+L +L + H L ++ + A + +G+EYL
Sbjct: 69 KYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRE---RLDHRKLLLYASQICKGMEYL 124
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG---TFGYLAP 757
+ ++HRDL NIL+ + R K+ DFGL K P K + R G F Y AP
Sbjct: 125 ---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-AP 180
Query: 758 EYAATGRVTTKIDVYAFGVVLMETIT 783
E + + DV++FGVVL E T
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (248), Expect = 8e-23
Identities = 67/210 (31%), Positives = 102/210 (48%), Gaps = 31/210 (14%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVAL 644
LG G +GVVY + G +A+K++ + +G+ A EI++L +++H ++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLD-NEEEGIPS-TALREISLLKELKHPNIVKL 63
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
L + LV+EY L ++L D PL+ +I + RG+ Y HS
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYL----DKRPGPLSPNLIKSIMYQLLRGLAYCHS-- 116
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPE---- 758
+HRDLKP NILI D K+ADFGL + P Y+ E T Y APE
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV---TLWYRAPEILLG 172
Query: 759 ---YAATGRVTTKIDVYAFGVVLMETITGR 785
Y +T +D+++ G + E ITG+
Sbjct: 173 SKHY------STAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 9e-23
Identities = 59/195 (30%), Positives = 100/195 (51%), Gaps = 9/195 (4%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ G + TK+AVK ++ TM + F E ++ ++H LV L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS---VQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
++ EYM +G+L L D G + + + + +A G+ Y+ ++++
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKS--DEG-GKVLLPKLIDFSAQIAEGMAYIE---RKNY 124
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK 768
IHRDL+ +N+L+ + + K+ADFGL + D +Y+ + APE G T K
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184
Query: 769 IDVYAFGVVLMETIT 783
DV++FG++L E +T
Sbjct: 185 SDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 2e-22
Identities = 80/289 (27%), Positives = 122/289 (42%), Gaps = 40/289 (13%)
Query: 589 LGRGGFGVV----YGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
LG G FG V Y G +AVK ++ G + S ++ EI +L + H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVK 70
Query: 644 LLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
G C + L+ EY+P G+L +L + L Q + A + G+ YLH
Sbjct: 71 YKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLH 124
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG---TFGYLAPE 758
S Q +IHRDL N+L+ +D K+ DFGL K P+G R G F Y A E
Sbjct: 125 S---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVE 180
Query: 759 YAATGRVTTKIDVYAFGVVLMETITG--------RKALDDTMPDDRAHLVTWFRRVLISK 810
+ + DV++FGV L E +T +K + P V +L
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG 240
Query: 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+P P N +E +Y + + +C E + RP + +L
Sbjct: 241 MRLPC---PK-NCPQE----VYILMK---NCWETEAKFRPTFRSLIPIL 278
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 2e-22
Identities = 76/293 (25%), Positives = 122/293 (41%), Gaps = 51/293 (17%)
Query: 589 LGRGGFGVVY----------------GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAV 632
LG G FG V+ + D + ++ + +F E+ +
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKI 72
Query: 633 LTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHD------HGYTPLTWKQR 686
L+++ ++ LLG C ++ EYM G L Q L + L++
Sbjct: 73 LSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTL 132
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS-VE 745
+ +A +A G+ YL SL +F+HRDL N L+G + K+ADFG+ +N Y V+
Sbjct: 133 LYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ 189
Query: 746 TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDR-----AHL 799
R ++A E G+ TTK DV+AFGV L E +T R+ + + D + H
Sbjct: 190 GRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHF 249
Query: 800 VTWF-RRVLISK-ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
R++ + + N PK IY EL C R+ + RP
Sbjct: 250 FRDDGRQIYLPRPPNCPK--------------DIY---ELMLECWRRDEEDRP 285
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 3e-22
Identities = 66/212 (31%), Positives = 109/212 (51%), Gaps = 26/212 (12%)
Query: 589 LGRGGFGVVYGG-------ELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG+G FG+VY G + P+ T++A+K + E+ +M + EF E +V+ + H
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPE-TRVAIKTVNEAASMRER--IEFLNEASVMKEFNCHH 70
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLF-----EWHDHGYTPLTWKQRVTIALDVAR 695
+V LLG G L++ E M RG L +L ++ P + K+ + +A ++A
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT---- 751
G+ YL++ F+HRDL N ++ +D K+ DFG+ ++ + Y R G
Sbjct: 131 GMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLP 184
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
+++PE G TT DV++FGVVL E T
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 63/211 (29%), Positives = 95/211 (45%), Gaps = 36/211 (17%)
Query: 589 LGRGGFGVVYGGEL-PDGTKIAVKR--MESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG+G GVVY P G A+K+ ++ + K L E+ L ++V
Sbjct: 9 LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLL---RELKTLRSCESPYVVKCY 65
Query: 646 G-YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV--TIALDVARGVEYLHS 702
G + G + V EYM G+LA L + V IA + +G++YLH+
Sbjct: 66 GAFYKEGEISI-VLEYMDGGSLADLL-------KKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE---- 758
IHRD+KPSN+LI K+ADFG+ K + T + GT Y++PE
Sbjct: 118 KRHI--IHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQG 174
Query: 759 ----YAATGRVTTKIDVYAFGVVLMETITGR 785
YAA D+++ G+ L+E G+
Sbjct: 175 ESYSYAA--------DIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 22/215 (10%)
Query: 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSE--FQAEIAVLT 634
D+ + LG G FG VY G D ++ V +++ E F E +++
Sbjct: 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVA-VKTLPESCSEQDESDFLMEALIMS 64
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP--LTWKQRVTIALD 692
K H+++V L+G R ++ E M G L L E P LT K + A D
Sbjct: 65 KFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARD 124
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLA 749
VA+G +YL FIHRD+ N L+ G AK+ADFG+ ++ Y R
Sbjct: 125 VAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY---YRKG 178
Query: 750 GT----FGYLAPEYAATGRVTTKIDVYAFGVVLME 780
G ++ PE G T+K DV++FGV+L E
Sbjct: 179 GRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWE 213
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 5e-22
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 22/205 (10%)
Query: 589 LGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G G G+V+ + G +A+K++ + ++ EI L +H ++V LL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+GS +LV EYMP L++ L + PL Q + + +GV Y+H+
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHAN---G 119
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGK-YS--VETRLAGTFGYLAPE--YA 760
+HRDLKP+N+LI D K+ADFGL + + + + YS V TR Y APE Y
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRW-----YRAPELLYG 174
Query: 761 ATGRVTTKIDVYAFGVVLMETITGR 785
A + +D++A G + E + G
Sbjct: 175 AR-KYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 7e-22
Identities = 82/289 (28%), Positives = 135/289 (46%), Gaps = 42/289 (14%)
Query: 583 FSEANILGRGGFGVVYGGELP--DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
F+ +LG+G FG V +L DG+ K+AVK ++++ + + EF E A + + H
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60
Query: 639 RHLVALLGYCINGSER------LLVYEYMPRGTLAQHLFEWHDH-GYTPLTWKQRVTI-- 689
+++ L+G + + +++ +M G L H F G P T + +
Sbjct: 61 PNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL--HTFLLMSRIGEEPFTLPLQTLVRF 118
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE---T 746
+D+A G+EYL S ++FIHRDL N ++ ++M VADFGL K G Y + +
Sbjct: 119 MIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCAS 175
Query: 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRR 805
+L +LA E A TT DV+AFGV + E +T G+ + + + +
Sbjct: 176 KLP--VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNY--- 227
Query: 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGH 854
LI + + D +E +Y EL C + EP+ RP H
Sbjct: 228 -LIKGNRLKQPPD--------CLEDVY---ELMCQCWSPEPKCRPSFQH 264
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 9e-22
Identities = 65/213 (30%), Positives = 102/213 (47%), Gaps = 36/213 (16%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESN--TMGNKGLSEFQA--EIAVLTKVRHRHLVA 643
LG G + VVY G +A+K+++ G++ F A EI +L +++H +++
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGIN-FTALREIKLLQELKHPNIIG 66
Query: 644 LL-----GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
LL IN LV+E+M T + + + TP K L RG+E
Sbjct: 67 LLDVFGHKSNIN-----LVFEFME--TDLEKVIKDKSIVLTPADIKS---YMLMTLRGLE 116
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--APDGKYS--VETRLAGTFGY 754
YLHS +HRDLKP+N+LI D K+ADFGL ++ +P+ K + V TR Y
Sbjct: 117 YLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-----Y 168
Query: 755 LAPE--YAATGRVTTKIDVYAFGVVLMETITGR 785
APE + A +D+++ G + E +
Sbjct: 169 RAPELLFGAR-HYGVGVDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 9e-22
Identities = 77/294 (26%), Positives = 124/294 (42%), Gaps = 57/294 (19%)
Query: 588 ILGRGGFGVVYGGE------LPDGTKIAVKRMESNTMGNKG---LSEFQAEIAVLTKVRH 638
LG G FG V T +AVK ++ N ++ LSEF +L +V H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFN----LLKQVNH 62
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFE------------------WHDH-GYT 679
H++ L G C LL+ EY G+L L E + D+
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-P 738
LT ++ A ++RG++YL A+ +HRDL N+L+ + + K++DFGL ++
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797
+ Y ++ ++A E TT+ DV++FGV+L E +T G P+
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239
Query: 798 HLV-TWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
+L+ T +R + E E +Y L C +EP +RP
Sbjct: 240 NLLKTGYR----------------MERPENCSEEMYN---LMLTCWKQEPDKRP 274
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-21
Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 12/200 (6%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG+GGFG V ++ K+ A K+++ + KG E +L KV R +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
Y + L LV M G L H++ + G + + A + G+E+LH Q
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIY---NVGEPGFPEARAIFYAAQIICGLEHLH---Q 113
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV 765
+ ++RDLKP N+L+ D +++D GL GK AGT GY+APE
Sbjct: 114 RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI--KGRAGTPGYMAPEVLQGEVY 171
Query: 766 TTKIDVYAFGVVLMETITGR 785
+D +A G L E I GR
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-21
Identities = 67/207 (32%), Positives = 105/207 (50%), Gaps = 14/207 (6%)
Query: 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRH 640
F + +LG+GGFG V ++ G A KR+E + KG S E +L KV +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDVARGVE 698
+V L Y + L LV M G L H++ + G+ ++R A ++ G+E
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFE----EERALFYAAEILCGLE 116
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
LH +++ ++RDLKP NIL+ D +++D GL P+G+ S+ R+ GT GY+APE
Sbjct: 117 DLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-SIRGRV-GTVGYMAPE 171
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGR 785
R T D + G ++ E I G+
Sbjct: 172 VLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 65/200 (32%), Positives = 101/200 (50%), Gaps = 20/200 (10%)
Query: 589 LGRGGFGVVYGG--ELPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FG V G + G ++ AVK ++ + G EF E +V+ ++ H +V L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAA-GKKEFLREASVMAQLDHPCIVRL 61
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+G C G +LV E P G L ++L P+ +A VA G+ YL S
Sbjct: 62 IGVCK-GEPLMLVMELAPLGPLLKYL---KKRREIPV--SDLKELAHQVAMGMAYLES-- 113
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTF--GYLAPEYA 760
+ F+HRDL N+L+ + +AK++DFG+ + A Y T AG + + APE
Sbjct: 114 -KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATT--AGRWPLKWYAPECI 170
Query: 761 ATGRVTTKIDVYAFGVVLME 780
G+ ++K DV+++GV L E
Sbjct: 171 NYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 1e-21
Identities = 58/190 (30%), Positives = 100/190 (52%), Gaps = 19/190 (10%)
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
+AVK + + N ++F E+ +L++++ +++ LLG C++ ++ EYM G L
Sbjct: 49 VAVKILRPDANKN-ARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 668 QHLFEWH--------------DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL 713
Q L H H +++ + +AL +A G++YL SL +F+HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDL 164
Query: 714 KPSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVY 772
N L+G+++ K+ADFG+ +N G Y ++ R ++A E G+ TT DV+
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVW 224
Query: 773 AFGVVLMETI 782
AFGV L E +
Sbjct: 225 AFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 2e-21
Identities = 86/302 (28%), Positives = 133/302 (44%), Gaps = 50/302 (16%)
Query: 587 NILGRGGFGVVYGGELP-DGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVA 643
+++G G FG V + DG K+ A +M +F E+ VL K+ H +++
Sbjct: 8 DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWH----------DHGY-TPLTWKQRVTIALD 692
LLG C N + EY P G L L + +HG + LT +Q + A D
Sbjct: 68 LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
VA G++YL +++ FIHRDL N+L+G+++ +K+ADFGL + E + T
Sbjct: 128 VATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGE-------EVYVKKTM 177
Query: 753 GYLAPEYAATGRV-----TTKIDVYAFGVVLMETIT--GRKALDDTMPDDRAHLVTWFRR 805
G L + A + TTK DV++FGV+L E ++ G T + L +R
Sbjct: 178 GRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 236
Query: 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
++ N D+E V EL C P +RP L ++E
Sbjct: 237 -----------MEKPRNCDDE-------VYELMRQCWRDRPYERPPFAQISVQLSRMLEA 278
Query: 866 WK 867
K
Sbjct: 279 RK 280
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 59/208 (28%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 587 NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
N +G G FG VY L G +AVK + K + E E+ VL ++H +LV
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYT-PLTWKQRVTIALDVARGVEYLHSLA 704
G ++ + + EY GTL + L +HG + T+ L G+ YLHS
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELL----EHGRILDEHVIRVYTLQL--LEGLAYLHS-- 117
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG---YLAPEYAA 761
+HRD+KP+NI + + K+ DFG + ++ + G Y+APE
Sbjct: 118 -HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176
Query: 762 TGRVTTK---IDVYAFGVVLMETITGRK 786
G+ D+++ G V++E TG++
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 24/211 (11%)
Query: 589 LGRGGFGVVYGGELPD------GTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG+G FG+VY G D T++AVK + ES ++ + EF E +V+ H+
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER--IEFLNEASVMKGFTCHHV 71
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEW-----HDHGYTPLTWKQRVTIALDVARG 696
V LLG G L+V E M G L +L ++ G P T ++ + +A ++A G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT----F 752
+ YL++ + F+HRDL N ++ D K+ DFG+ ++ + Y R G
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPV 185
Query: 753 GYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
++APE G TT D+++FGVVL E +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 6e-21
Identities = 60/203 (29%), Positives = 109/203 (53%), Gaps = 15/203 (7%)
Query: 587 NILGRGGFGVVYGG--ELPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G G FG V G +LP +I A+K +++ +K +F E +++ + H +++
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA-GSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G +++ EYM G+L + L E +D G T Q V + +A G++YL
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLRE-ND-GK--FTVGQLVGMLRGIASGMKYL-- 122
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG--YLAPEYA 760
++ +++HRDL NIL+ ++ KV+DFGL + D + + T+ G + APE
Sbjct: 123 -SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTK-GGKIPIRWTAPEAI 180
Query: 761 ATGRVTTKIDVYAFGVVLMETIT 783
A + T+ DV++FG+V+ E ++
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 62/207 (29%), Positives = 105/207 (50%), Gaps = 23/207 (11%)
Query: 589 LGRGGFGVVYGGEL----PDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG V EL P+G +AVK ++ + GN +++ + EI +L + H +
Sbjct: 12 LGEGHFGKV---ELCRYDPEGDNTGEQVAVKSLKPESGGNH-IADLKKEIEILRNLYHEN 67
Query: 641 LVALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
+V G C L+ E++P G+L ++L + + KQ++ A+ + +G++
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK----INLKQQLKYAVQICKGMD 123
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYLA 756
YL S + ++HRDL N+L+ + + K+ DFGL K K Y+V+ L + A
Sbjct: 124 YLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYA 180
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETIT 783
PE + DV++FGV L E +T
Sbjct: 181 PECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 56/184 (30%), Positives = 99/184 (53%), Gaps = 12/184 (6%)
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
+AVK + ++ ++F EI +++++++ +++ LLG C++ ++ EYM G L
Sbjct: 47 VAVKMLRADVTKT-ARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105
Query: 668 QHLFE-------WHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720
Q L + H + ++ + +A+ +A G++YL SL +F+HRDL N L+
Sbjct: 106 QFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLV 162
Query: 721 GDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLM 779
G+ K+ADFG+ +N G Y ++ R ++A E G+ TT DV+AFGV L
Sbjct: 163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLW 222
Query: 780 ETIT 783
E T
Sbjct: 223 EMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 76/286 (26%), Positives = 137/286 (47%), Gaps = 39/286 (13%)
Query: 588 ILGRGGFGVVYGGELP-DGTK---IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
++G G FG V+ G L G K +A+K ++ K +F +E +++ + H +++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIR 70
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L G +++ EYM G L ++L + HD ++ Q V + +A G++YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRD-HDGEFSSY---QLVGMLRGIAAGMKYL--- 123
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYSVETRLAGTFG--YLAPE 758
+ +++HRDL NIL+ ++ KV+DFGL +++ P+G Y T G + APE
Sbjct: 124 SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY---TTSGGKIPIRWTAPE 180
Query: 759 YAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817
A + T+ DV++FG+V+ E ++ G + D +S + KAI
Sbjct: 181 AIAYRKFTSASDVWSFGIVMWEVMSFGERPYWD-----------------MSNHEVMKAI 223
Query: 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863
+ L ++ V +L C ++ +RP VN+L L+
Sbjct: 224 NDGFRL-PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 2e-20
Identities = 65/226 (28%), Positives = 109/226 (48%), Gaps = 29/226 (12%)
Query: 581 DNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAV 632
D + LG G FG V E + +AVK ++ + K LS+ +E+ +
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEM 73
Query: 633 LTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTP 680
+ + +H++++ LLG C ++ EY +G L ++L ++
Sbjct: 74 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740
+T+K V+ VARG+EYL A Q IHRDL N+L+ ++ K+ADFGL ++ +
Sbjct: 134 MTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 741 KYSVET---RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
Y +T RL ++APE T + DV++FGV++ E T
Sbjct: 191 DYYKKTTNGRLP--VKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 56/207 (27%), Positives = 97/207 (46%), Gaps = 27/207 (13%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRM----ESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+G G +GVVY + G +A+K++ ES + L E I +L ++ H +++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALRE----IKLLKELNHPNIIK 62
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
LL + + LV+E+M L++ L + + +G+ + HS
Sbjct: 63 LLDVFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS- 116
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA--PDGKYS--VETRLAGTFGYLAPEY 759
+HRDLKP N+LI + K+ADFGL ++ P Y+ V TR Y APE
Sbjct: 117 --HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-----YRAPEL 169
Query: 760 AATGRV-TTKIDVYAFGVVLMETITGR 785
+ +T +D+++ G + E ++ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 2e-20
Identities = 74/227 (32%), Positives = 114/227 (50%), Gaps = 31/227 (13%)
Query: 581 DNFSEANILGRGGFGVV-----YG--GELPDGT-KIAVKRMESNTMGNKGLSEFQAEIAV 632
D LG G FG V YG PD T +AVK ++ N +K L++ +E+ +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMEL 70
Query: 633 LTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTP 680
+ + +H++++ LLG C ++ EY +G L + L F+
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740
L++K V+ A VARG+EYL S + IHRDL N+L+ +D K+ADFGL + D
Sbjct: 131 LSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 741 KYSVET---RLAGTFGYLAPEYAATGRVTT-KIDVYAFGVVLMETIT 783
Y +T RL ++APE A RV T + DV++FG+++ E T
Sbjct: 188 DYYKKTSNGRLP--VKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-20
Identities = 82/299 (27%), Positives = 131/299 (43%), Gaps = 50/299 (16%)
Query: 587 NILGRGGFGVVYGGELP-DGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVA 643
+++G G FG V + DG ++ A + +F E+ VL K+ H +++
Sbjct: 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFE----------WHDHGY-TPLTWKQRVTIALD 692
LLG C + L EY P G L L + + + L+ +Q + A D
Sbjct: 61 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
VARG++YL +Q+ FIHRDL NIL+G++ AK+ADFGL + E + T
Sbjct: 121 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ-------EVYVKKTM 170
Query: 753 GYLAPEYAATGRV-----TTKIDVYAFGVVLMETIT--GRKALDDTMPDDRAHLVTWFRR 805
G L + A + TT DV+++GV+L E ++ G T + L +R
Sbjct: 171 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR- 229
Query: 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864
++ LN D+E V +L C +P +RP + L ++E
Sbjct: 230 -----------LEKPLNCDDE-------VYDLMRQCWREKPYERPSFAQILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 63/198 (31%), Positives = 103/198 (52%), Gaps = 11/198 (5%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG V+ TK+AVK M+ +M + F AE V+ ++H LV L
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKL-HAV 69
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ ++ E+M +G+L L + + PL + + + +A G+ ++ Q+++
Sbjct: 70 VTKEPIYIITEFMAKGSLLDFL-KSDEGSKQPL--PKLIDFSAQIAEGMAFIE---QRNY 123
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTK 768
IHRDL+ +NIL+ + K+ADFGL + D +Y+ + APE G T K
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183
Query: 769 IDVYAFGVVLMETIT-GR 785
DV++FG++LME +T GR
Sbjct: 184 SDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 3e-20
Identities = 72/218 (33%), Positives = 113/218 (51%), Gaps = 29/218 (13%)
Query: 589 LGRGGFGVVYGGEL-------PDG-TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V E P+ TK+AVK ++S+ K LS+ +E+ ++ + +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHK 84
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWH----DHGYTP-------LTWKQRVT 688
+++ LLG C ++ EY +G L ++L ++ Y P L++K V+
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET-- 746
A VARG+EYL A + IHRDL N+L+ +D K+ADFGL ++ Y +T
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 747 -RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
RL ++APE T + DV++FGV+L E T
Sbjct: 202 GRLP--VKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-20
Identities = 55/183 (30%), Positives = 94/183 (51%), Gaps = 11/183 (6%)
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
+AVK + + N ++F EI ++++++ +++ LL CI ++ EYM G L
Sbjct: 49 VAVKMLREDANKN-ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 668 QHLFEWH------DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721
Q L +++ + +A +A G++YL SL +F+HRDL N L+G
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVG 164
Query: 722 DDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLME 780
+ K+ADFG+ +N G Y ++ R +++ E G+ TT DV+AFGV L E
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWE 224
Query: 781 TIT 783
+T
Sbjct: 225 ILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 62/200 (31%), Positives = 93/200 (46%), Gaps = 15/200 (7%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G GVV P G +AVK + E N K + E+ +L K ++V
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCNSPYIVGFY 65
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G N + + EYM G+L + L + + IA+ V +G+ YLH +
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHE--K 119
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV 765
IHRD+KPSNIL+ + K+ DFG+ + S+ GT Y+APE
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN---SLAKTFVGTSSYMAPERIQGNDY 176
Query: 766 TTKIDVYAFGVVLMETITGR 785
+ K D+++ G+ L+E TGR
Sbjct: 177 SVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 4e-20
Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 27/273 (9%)
Query: 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+GRG FG V+ G L D T +AVK T+ ++F E +L + H ++V L+G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C +V E + G L L K+ + + + A G+EYL S +
Sbjct: 62 CTQKQPIYIVMELVQGGDFLTFLRTEGPR----LKVKELIQMVENAAAGMEYLES---KH 114
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT-FGYLAPEYAATGRVT 766
IHRDL N L+ + K++DFG+ + DG Y+ + + APE GR +
Sbjct: 115 CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYS 174
Query: 767 TKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEE 826
++ DV++FG++L E + + + + ++E I + + L E
Sbjct: 175 SESDVWSFGILLWEAFSLGAVPYANLSNQQ------------TREAIEQGV--RLPCPEL 220
Query: 827 TIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+++YR+ E C +P QRP L
Sbjct: 221 CPDAVYRLME---RCWEYDPGQRPSFSTVHQEL 250
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 587 NILGRGGFGVVYG-GELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G+G FG V DG + K ++ M K + +E+ +L +++H ++V
Sbjct: 6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65
Query: 646 GYCINGSERLL--VYEYMPRGTLAQHLFEWH-DHGYTP--LTWK--QRVTIALDVARGVE 698
I+ S + L V EY G LAQ + + + Y W+ ++ +AL
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY------ 119
Query: 699 YLH--SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
H S + +HRDLKP+NI + + K+ DFGL K +T GT Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT-YVGTPYYMS 178
Query: 757 PEYAATGRVTTKIDVYAFGVVLME 780
PE K D+++ G ++ E
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 89.9 bits (223), Expect = 7e-20
Identities = 70/276 (25%), Positives = 117/276 (42%), Gaps = 36/276 (13%)
Query: 582 NFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+F N +G+G FGVV+ D A+K+++ + M + E E VL K+ +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLT----WKQRVTIALDVARG 696
++ ++ + +V EY G L + L PL W+ + I L G
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL---KMQRGRPLPEDQVWRFFIQILL----G 113
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+ +LHS + +HRD+K N+ + K+ D G+ K D T + GT YL+
Sbjct: 114 LAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLS 169
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK-ENIPK 815
PE K DV+A GVVL E TG+ D +++ L+ +++ + +
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFD---ANNQGALI---LKIIRGVFPPVSQ 223
Query: 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
L A+L C ++ +QRPD
Sbjct: 224 MYSQQL-------------AQLIDQCLTKDYRQRPD 246
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 8e-20
Identities = 64/207 (30%), Positives = 100/207 (48%), Gaps = 17/207 (8%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
++G G VVY LP+ K+A+KR++ + E + E+ +++ H ++V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKC-QTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL---DVARGVEYLHS 702
+ G E LV Y+ G+L + + Y P IA +V +G+EYLHS
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLL-DIMK---SSY-PRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG---KYSVETRLAGTFGYLAPEY 759
Q IHRD+K NIL+G+D K+ADFG+ + DG V GT ++APE
Sbjct: 121 NGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEV 177
Query: 760 AATGR-VTTKIDVYAFGVVLMETITGR 785
K D+++FG+ +E TG
Sbjct: 178 MEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 63/217 (29%), Positives = 101/217 (46%), Gaps = 37/217 (17%)
Query: 590 GRGGFGVVY---GGELPDGTKIAVKRMESNTMGNKGLSEFQA---EIAVLTKVRHRHLVA 643
GRG +G VY DG + A+K+ + + G+S Q+ EIA+L +++H ++V+
Sbjct: 9 GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGIS--QSACREIALLRELKHENVVS 66
Query: 644 LLGYCINGSERL--LVYEYMPRGTLAQHLFEW--HDHGYTPLTWKQRVTIA------LDV 693
L+ + +++ L+++Y A+H H + L+
Sbjct: 67 LVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN- 119
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILI-GDDM---RAKVADFGLVK--NAPDGKYSVETR 747
GV YLHS +HRDLKP+NIL+ G+ K+ D GL + NAP +
Sbjct: 120 --GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDP 174
Query: 748 LAGTFGYLAPEYAATGRVTTK-IDVYAFGVVLMETIT 783
+ T Y APE R TK ID++A G + E +T
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-19
Identities = 69/218 (31%), Positives = 107/218 (49%), Gaps = 29/218 (13%)
Query: 589 LGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V E +AVK ++ + +K LS+ +E+ ++ + +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHK 78
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY-----------TPLTWKQRVT 688
+++ LLG C ++ EY +G L ++L G LT+K V+
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET-- 746
A VARG+EYL A Q IHRDL N+L+ +D K+ADFGL ++ + Y +T
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 747 -RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
RL ++APE T + DV++FGV+L E T
Sbjct: 196 GRLP--VKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 1e-19
Identities = 74/289 (25%), Positives = 128/289 (44%), Gaps = 38/289 (13%)
Query: 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMES-NTMGNKGLSEFQAEIAVLTKVR 637
NF +G+G F VVY L DG +A+K+++ M K + EI +L ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYT---PLTWKQRVTIALDVA 694
H +++ L I +E +V E G L++ + + WK V +
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC---- 116
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVET----RLA 749
+E++HS + +HRD+KP+N+ I K+ D GL G++ S +T L
Sbjct: 117 SALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSLV 167
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809
GT Y++PE K D+++ G +L E AL D+ +L + ++ I
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKK--IE 221
Query: 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858
K + P P + EE + +L C +P++RPD+ + + V
Sbjct: 222 KCDYPPL--PADHYSEE-------LRDLVSRCINPDPEKRPDISYVLQV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 21/207 (10%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALLG 646
+ +G +G V+ + G A+K ++ M K + + E +L++ + ++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
Y G + L LV EY+P G LA L + G R+ IA ++ +EYLHS
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLL---ENVGSLDEDVA-RIYIA-EIVLALEYLHSN-- 112
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVK------NAPDGKYSVET-RLAGTFGYLAPE 758
IHRDLKP NILI + K+ DFGL K E R+ GT Y+APE
Sbjct: 113 -GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171
Query: 759 YAATGRVTTK-IDVYAFGVVLMETITG 784
G+ +K +D ++ G +L E + G
Sbjct: 172 -VILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 3e-19
Identities = 62/203 (30%), Positives = 103/203 (50%), Gaps = 17/203 (8%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FG VY G L DG AVK + + G + + + + EIA+L+K++H ++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 645 LGYCINGSERLLVY-EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
LG + L ++ E +P G+LA+ L + Y + G+EYLH
Sbjct: 68 LGTEREE-DNLYIFLELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHD- 120
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY-AAT 762
++ +HRD+K +NIL+ + K+ADFG+ K ++S G+ ++APE A
Sbjct: 121 --RNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVIAQQ 176
Query: 763 GRVTTKIDVYAFGVVLMETITGR 785
G D+++ G ++E TG+
Sbjct: 177 GGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 22/213 (10%)
Query: 589 LGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
LG FG +Y G L +A+K ++ + EFQ E +++ ++ H ++V
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQ-WGEFQQEASLMAELHHPNIVC 71
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG------------YTPLTWKQRVTIAL 691
LLG +++EY+ +G L + L H + L + IA+
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAG 750
+A G+EYL S F+H+DL NILIG+ + K++D GL + Y V+ +
Sbjct: 132 QIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 751 TFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
++ PE G+ ++ D+++FGVVL E +
Sbjct: 189 PIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (220), Expect = 4e-19
Identities = 63/217 (29%), Positives = 91/217 (41%), Gaps = 40/217 (18%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVA 643
+G G +G VY G +A+K++ +G A EI +L K+RH ++V
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFP-ITAIREIKLLQKLRHPNIVR 62
Query: 644 LLGYCINGSERL----LVYEYMPRGTLAQHLFEWHD------HGYTPLTWKQRVTIALDV 693
L I S+ +V+EYM HD T Q +
Sbjct: 63 L--KEIVTSKGKGSIYMVFEYMD-----------HDLTGLLDSPEVKFTESQIKCYMKQL 109
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYSVETRLAG 750
G++YLHS +HRD+K SNILI +D K+ADFGL Y T
Sbjct: 110 LEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY---TNRVI 163
Query: 751 TFGYLAPE--YAATGRVTTKIDVYAFGVVLMETITGR 785
T Y PE AT R ++D+++ G +L E G+
Sbjct: 164 TLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRH 640
F +LG+GGFG V ++ G A K++E + KG + E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V+L Y + L LV M G L H++ + G+ ++ V A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDE---ERAVFYAAEITCGLED 117
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
LH + ++RDLKP NIL+ D +++D GL P+G+ ++ R+ GT GY+APE
Sbjct: 118 LHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-TIRGRV-GTVGYMAPEV 172
Query: 760 AATGRVTTKIDVYAFGVVLMETITGR 785
R T D + G ++ E I G+
Sbjct: 173 VKNERYTFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 5e-19
Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 34/218 (15%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVK---RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+LG G FG VY G +P+G + + ++ + T G K EF E ++ + H HLV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLH 701
LLG C++ + +L V + MP G L ++ E D+ L W + +A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---------NAPDGKYSVETRLAGTF 752
++ +HRDL N+L+ K+ DFGL + NA GK ++
Sbjct: 127 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK------- 176
Query: 753 GYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALD 789
++A E + T + DV+++GV + E +T G K D
Sbjct: 177 -WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 5e-19
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G +G VY G +A+K + L E EI++L + ++V G
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYG 65
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
++ +V EY G+++ + + + LT ++ I +G+EYLHS
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSD-IMKITN---KTLTEEEIAAILYQTLKGLEYLHS---N 118
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVT 766
IHRD+K NIL+ ++ +AK+ADFG+ D T + GT ++APE
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 177
Query: 767 TKIDVYAFGVVLMETITGRKALDDTMP 793
K D+++ G+ +E G+ D P
Sbjct: 178 NKADIWSLGITAIEMAEGKPPYSDIHP 204
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 6e-19
Identities = 71/283 (25%), Positives = 133/283 (46%), Gaps = 33/283 (11%)
Query: 588 ILGRGGFGVVYGGELPDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
++G G FG V G L K +A+K +++ K +F +E +++ + H +++
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIH 69
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L G ++V EYM G+L L + HD +T + Q V + +A G++YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVI---QLVGMLRGIASGMKYL--- 122
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG--YLAPEYAA 761
+ ++HRDL NIL+ ++ KV+DFGL + D + T G + APE A
Sbjct: 123 SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 762 TGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
+ T+ DV+++G+V+ E ++ G + + +S +++ KAI+
Sbjct: 183 YRKFTSASDVWSYGIVMWEVMSYGERPYWE-----------------MSNQDVIKAIEEG 225
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863
L ++ + +L C ++ +RP V++L L+
Sbjct: 226 YRL-PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 8e-19
Identities = 71/225 (31%), Positives = 110/225 (48%), Gaps = 39/225 (17%)
Query: 583 FSEANILGRGGFGVVYGG-ELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVR--- 637
+ E +G G +G VY +L G +A+K++ + LS + EIA+L ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLR-EIALLKQLESFE 59
Query: 638 HRHLVALLGYC-INGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
H ++V LL C ++R LV+E++ + LA +L + G P T K +
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKD---LMRQ 115
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG-- 750
+ RGV++LHS +HRDLKP NIL+ D + K+ADFGL + YS E L
Sbjct: 116 LLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLAR-----IYSFEMALTSVV 167
Query: 751 -TFGYLAPE------YAATGRVTTKIDVYAFGVVLMETITGRKAL 788
T Y APE YA T +D+++ G + E + R+ L
Sbjct: 168 VTLWYRAPEVLLQSSYA------TPVDMWSVGCIFAE-LFRRRPL 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 87.2 bits (217), Expect = 9e-19
Identities = 61/228 (26%), Positives = 93/228 (40%), Gaps = 32/228 (14%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
D+F I+G G F V E + A+K ++ + K + + E VLT++
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H ++ L Y E L V EY P G L Q++ +G + A ++
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTR--FYAAEILLA 114
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA------- 749
+EYLHS IHRDLKP NIL+ DM K+ DFG K +
Sbjct: 115 LEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171
Query: 750 ------------GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
GT Y++PE D++A G ++ + +TG+
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 1e-18
Identities = 62/206 (30%), Positives = 98/206 (47%), Gaps = 14/206 (6%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVALL 645
LG+GGFG V ++ + G A K+++ + K E A E +L KV +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKS-GEKMALLEKEILEKVNSPFIVNL- 58
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
Y L LV M G L H++ + G L ++ + + + G+ +LHS+
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERG---LEMERVIHYSAQITCGILHLHSM- 114
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR 764
++RD+KP N+L+ D +++D GL DGK T+ AGT GY+APE
Sbjct: 115 --DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI--TQRAGTNGYMAPEILKEEP 170
Query: 765 VTTKIDVYAFGVVLMETITGRKALDD 790
+ +D +A G + E + GR D
Sbjct: 171 YSYPVDWFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 65/207 (31%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRH 640
F +LG+GGFG V ++ G A K++E + KG + E +L KV R
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR-VTIALDVARGVE 698
+V+L Y + L LV M G L H++ + G+ +QR + A ++ G+E
Sbjct: 62 VVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFD----EQRAIFYAAELCCGLE 116
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
L ++ ++RDLKP NIL+ D +++D GL P+G+ +V R+ GT GY+APE
Sbjct: 117 DLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-TVRGRV-GTVGYMAPE 171
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGR 785
+ T D + G ++ E I G+
Sbjct: 172 VINNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 3e-18
Identities = 75/278 (26%), Positives = 128/278 (46%), Gaps = 40/278 (14%)
Query: 577 RQVTDNFSEANILGRGGFGVV-YGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R+ D+F + +G G G+V E G ++AVK+M+ + L E+ ++
Sbjct: 21 REYLDSFIK---IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL--LFNEVVIMRD 75
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H ++V + + G E +V E++ G L + +T + +Q T+ L V R
Sbjct: 76 YHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIV------THTRMNEEQIATVCLSVLR 129
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV----KNAPDGKYSVETRLAGT 751
+ YLH+ Q IHRD+K +IL+ D R K++DFG K P K L GT
Sbjct: 130 ALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRK-----SLVGT 181
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811
++APE + T++D+++ G++++E I G + P + RR+ ++
Sbjct: 182 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP------LQAMRRI---RD 232
Query: 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQR 849
N+P P + D + S+ R REP QR
Sbjct: 233 NLP----PRVK-DSHKVSSVLRG--FLDLMLVREPSQR 263
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 21/205 (10%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKI----AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
+LG G FG V+ G +P+G I A+K ++ + G + E + + + H ++V
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIV 72
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP---LTWKQRVTIALDVARGVEY 699
LLG C G+ LV + P G+L H+ + H P L W + +A+G+ Y
Sbjct: 73 RLLGIC-PGASLQLVTQLSPLGSLLDHVRQ-HRDSLDPQRLLNW------CVQIAKGMYY 124
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDGKYSVETRLAGTFGYLAPE 758
L + +HR+L NIL+ D ++ADFG+ PD K + ++A E
Sbjct: 125 LE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALE 181
Query: 759 YAATGRVTTKIDVYAFGVVLMETIT 783
GR T + DV+++GV + E ++
Sbjct: 182 SILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 5e-18
Identities = 72/282 (25%), Positives = 127/282 (45%), Gaps = 39/282 (13%)
Query: 582 NFSEANILGRGGFGVVYGG-ELPDGTKIAVKRME--SNTMGN--KGLSEFQAEIAVLTKV 636
+ + LG G F Y ++ GT +AVK++ NT + + + EI ++ ++
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA--LDVA 694
H H++ +LG S L E+M G+++ L +G +K+ V I +
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLL---SKYG----AFKEAVIINYTEQLL 113
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFG-LVKNAPDGKYSVETR--L 748
RG+ YLH + IHRD+K +N+LI G +R +ADFG + A G + E + L
Sbjct: 114 RGLSYLH---ENQIIHRDVKGANLLIDSTGQRLR--IADFGAAARLAAKGTGAGEFQGQL 168
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808
GT ++APE + DV++ G V++E T + + + HL F+ I
Sbjct: 169 LGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN--HLALIFK---I 223
Query: 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
+ +I +L+ + ++ C +P+ RP
Sbjct: 224 ASATTAPSIPEHLSPG---------LRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 6e-18
Identities = 57/195 (29%), Positives = 90/195 (46%), Gaps = 19/195 (9%)
Query: 605 GTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL-VYEYMP 662
G ++A+K + + F+ E A+ ++ H ++VALL L V+EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-- 720
TL + L G L + + L V + H+ Q +HRDLKP NI++
Sbjct: 63 GRTLREVL---AADG--ALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQ 114
Query: 721 -GDDMRAKVADFGLVKNAPDGKYSVETRLA------GTFGYLAPEYAATGRVTTKIDVYA 773
G AKV DFG+ P + + L GT Y APE VT D+YA
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174
Query: 774 FGVVLMETITGRKAL 788
+G++ +E +TG++ +
Sbjct: 175 WGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 7e-18
Identities = 65/232 (28%), Positives = 105/232 (45%), Gaps = 52/232 (22%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLT 634
V + + +G G +G+V P G K+A+K++ E T + L E I +L
Sbjct: 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLRE----IKILR 58
Query: 635 KVRHRHLVALLGYCINGS-----ERLLVYEYMP----RGTLAQHLFEWHDHG----YTPL 681
+ +H +++ +L S + +V E M + QHL DH Y L
Sbjct: 59 RFKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN--DHIQYFLYQIL 116
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDG 740
RG++Y+HS + +HRDLKPSN+L+ + K+ DFGL + A P+
Sbjct: 117 -------------RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH 160
Query: 741 KYS------VETRLAGTFGYLAPEYAATGRVTTK-IDVYAFGVVLMETITGR 785
++ V TR Y APE + TK ID+++ G +L E ++ R
Sbjct: 161 DHTGFLTEYVATRW-----YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 60/211 (28%), Positives = 107/211 (50%), Gaps = 21/211 (9%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKG-------LSEFQAEIAVLTKVRHR 639
++G G FG VY G G +AVK++E ++ L EIA+L +++H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V LG ++ + EY+P G++A L +++G T + + +G+ Y
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALL---NNYGAFEETLVR--NFVRQILKGLNY 121
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-----LAGTFGY 754
LH+ + IHRD+K +NIL+ + K++DFG+ K S +T L G+ +
Sbjct: 122 LHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
+APE T K D+++ G +++E +TG+
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-18
Identities = 70/270 (25%), Positives = 122/270 (45%), Gaps = 32/270 (11%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
F++ +G+G FG V+ G + + T+ +A+K ++ ++ + + Q EI VL++ +
Sbjct: 6 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPY 63
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ G + G++ ++ EY+ G+ L P Q T+ ++ +G++YL
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYL 117
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
HS + IHRD+K +N+L+ + K+ADFG+ D + T GT ++APE
Sbjct: 118 HS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 173
Query: 761 ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
+K D+++ G+ +E G D P RVL IPK P
Sbjct: 174 QQSAYDSKADIWSLGITAIELAKGEPPNSDMHP----------MRVLF---LIPKNNPPT 220
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRP 850
L T E E C ++P RP
Sbjct: 221 L-----TGEFSKPFKEFIDACLNKDPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 84.7 bits (210), Expect = 9e-18
Identities = 73/221 (33%), Positives = 104/221 (47%), Gaps = 26/221 (11%)
Query: 575 VLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIA 631
R VT F + N +G G +G+VY + G +A+K RM+ N +S + EI
Sbjct: 2 RCRSVT-EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMD-NERDGIPISSLR-EIT 58
Query: 632 VLTKVRHRHLVALLGYCINGSER---LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT 688
+L +RH ++V L + G LV EY Q L D+ TP + Q
Sbjct: 59 LLLNLRHPNIVELK-EVVVGKHLDSIFLVMEY-----CEQDLASLLDNMPTPFSESQVKC 112
Query: 689 IALDVARGVEYLHSLAQQSFI-HRDLKPSNILIGDDMRAKVADFGLVKN--APDGKYSVE 745
+ L + RG++YLH +FI HRDLK SN+L+ D K+ADFGL + P
Sbjct: 113 LMLQLLRGLQYLHE----NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM--- 165
Query: 746 TRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGR 785
T T Y APE TT ID++A G +L E + +
Sbjct: 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 67/240 (27%), Positives = 109/240 (45%), Gaps = 26/240 (10%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+++ +G G +G VY ++ G +A+K + G+ Q EI++L + RH
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIK-VIKLEPGD-DFEIIQQEISMLKECRHP 60
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++VA G + + +V EY G+L + + PL+ Q + + +G+ Y
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQ----DIYQVTRGPLSELQIAYVCRETLKGLAY 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
LH + IHRD+K +NIL+ +D K+ADFG V + GT ++APE
Sbjct: 117 LH---ETGKIHRDIKGANILLTEDGDVKLADFG-VSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 760 AA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL--ISKENIP 814
AA G K D++A G+ +E + + D P R L ISK N P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP----------MRALFLISKSNFP 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQ--------AEIAVLTKVRH 638
++G+G +G VY + G +AVK++E Q +EI L + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 639 RHLVALLGYCINGSERLLVY-EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL--DVAR 695
++V LG E L ++ EY+P G++ L T +++++ V
Sbjct: 68 LNIVQYLG-FETTEEYLSIFLEYVPGGSIGSCL-------RTYGRFEEQLVRFFTEQVLE 119
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE-TRLAGTFGY 754
G+ YLHS + +HRDLK N+L+ D K++DFG+ K + D + + + G+ +
Sbjct: 120 GLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFW 176
Query: 755 LAPEYAATGR--VTTKIDVYAFGVVLMETITGRK 786
+APE + + K+D+++ G V++E GR+
Sbjct: 177 MAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 28/208 (13%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
+G G +GVV G +A+K+ E + K E+ VL ++RH ++V L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTA---LREVKVLRQLRHENIVNL 65
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
LV+EY+ R L L E G P + + + + + Y HS
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLL--ELLEASPGGLPPDAVR---SYIWQLLQAIAYCHSH- 119
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE------ 758
+ IHRD+KP NIL+ + K+ DFG + S T T Y APE
Sbjct: 120 --NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177
Query: 759 -YAATGRVTTKIDVYAFGVVLMETITGR 785
Y +DV+A G ++ E + G
Sbjct: 178 NYGKP------VDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 83.1 bits (206), Expect = 1e-17
Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 44/223 (19%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGL--------SEFQAEIAV 632
+F ++G+G FG V + D K+ A+K M NK + E +
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYM------NKQKCVEKGSVRNVLN-ERRI 53
Query: 633 LTKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
L ++ H LV L Y E + LV + + G L HL Q+V +
Sbjct: 54 LQELNHPFLVNLW-YSFQDEENMYLVVDLLLGGDLRYHL-------------SQKVKFSE 99
Query: 692 DVAR--------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743
+ + +EYLHS + IHRD+KP NIL+ + + DF + +
Sbjct: 100 EQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT 156
Query: 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRK 786
T +GT GY+APE + +D ++ GV E + G++
Sbjct: 157 TST--SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 2e-17
Identities = 65/216 (30%), Positives = 104/216 (48%), Gaps = 25/216 (11%)
Query: 581 DNFSEANILGRGGFGVV-----YGGELPDGT-KIAVKRMESNTMGNKGLSEFQA---EIA 631
+N S LG G FG V YG D K+AVK ++ SE +A E+
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH----SSEREALMSELK 90
Query: 632 VLTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
+++ + H ++V LLG C G L++ EY G L L + LT + ++ +
Sbjct: 91 IMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL---RRKRESFLTLEDLLSFS 147
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVE--TR 747
VA+G+ +L A ++ IHRDL N+L+ K+ DFGL ++ D Y V+ R
Sbjct: 148 YQVAKGMAFL---ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNAR 204
Query: 748 LAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
L ++APE T + DV+++G++L E +
Sbjct: 205 LP--VKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (208), Expect = 2e-17
Identities = 74/247 (29%), Positives = 103/247 (41%), Gaps = 28/247 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESN-TMGNKGLSEFQAEIAVLTKVRH 638
D+F LG G FG V K A+K + + K + E +L +RH
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ----RVTIALDVA 694
LV L G + S LV EY+P G L HL G P + +V +AL
Sbjct: 61 PFLVNLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPVARFYAAQVVLAL--- 114
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
EYLHSL ++RDLKP N+L+ D K+ DFG K Y+ L GT Y
Sbjct: 115 ---EYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT----LCGTPEY 164
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814
LAPE + +D +A G+++ E + G D P + ++L K P
Sbjct: 165 LAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI------YEKILEGKVRFP 218
Query: 815 KAIDPNL 821
P+
Sbjct: 219 SFFSPDA 225
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 52/214 (24%), Positives = 94/214 (43%), Gaps = 10/214 (4%)
Query: 582 NFSEANILGRGGFG--VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
++ +LG+G FG +Y D + + K + + K + EI +L+ ++H
Sbjct: 1 HYIPIRVLGKGAFGEATLYR-RTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHP 59
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+++A + ++ + L+ EY GTL + + + + V Y
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSY 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
+H + +HRD+K NI + K+ DFG+ K ET + GT Y++PE
Sbjct: 117 IH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPEL 172
Query: 760 AATGRVTTKIDVYAFGVVLMETITGRKALDDTMP 793
+ K D++A G VL E +T ++ D T P
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 60/209 (28%), Positives = 98/209 (46%), Gaps = 16/209 (7%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKVR 637
N+ +LG+G FG VY ++ G ++AVK++ + K ++ + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 638 HRHLVALLGYCINGSERLLVY-EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H +V G C+ E L ++ EYMP G++ L Y LT + G
Sbjct: 63 HERIVQYYG-CLRDDETLSIFMEYMPGGSVKDQL-----KAYGALTETVTRKYTRQILEG 116
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGY 754
VEYLHS +HRD+K +NIL K+ DFG K + + GT +
Sbjct: 117 VEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYW 173
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETIT 783
++PE + K DV++ G ++E +T
Sbjct: 174 MSPEVISGEGYGRKADVWSVGCTVVEMLT 202
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 55/205 (26%), Positives = 98/205 (47%), Gaps = 8/205 (3%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+F LG+G +G VY + L D A+K ++ +M K + EI +L V H +
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+++ ++G++ +V EY P G L++ + + + ++ I + + RG++ L
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQAL 119
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
H Q +HRDLK +NIL+ + K+ D G+ K + GT Y+APE
Sbjct: 120 HE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVW 173
Query: 761 ATGRVTTKIDVYAFGVVLMETITGR 785
+ K D+++ G +L E T
Sbjct: 174 KGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 22/210 (10%)
Query: 591 RGGFGVVY-GGELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G FG VY + G A+K + +S+ + ++ +AE A++ VA L Y
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 649 INGSERL-LVYEYMPRG---TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+ L LV EY+ G +L + L G P W + +V GVE LH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTL------GGLPEDWAK--QYIAEVVLGVEDLH--- 114
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR 764
Q+ IHRD+KP N+LI K+ DFGL +N + K + GT YLAPE
Sbjct: 115 QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENK-----KFVGTPDYLAPETILGVG 169
Query: 765 VTTKIDVYAFGVVLMETITGRKALDDTMPD 794
D ++ G V+ E + G PD
Sbjct: 170 DDKMSDWWSLGCVIFEFLFGYPPFHAETPD 199
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.6 bits (205), Expect = 3e-17
Identities = 63/216 (29%), Positives = 96/216 (44%), Gaps = 45/216 (20%)
Query: 589 LGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIAVLTKV-RHRHL 641
LG G FG VY G +A+K+M K ++ E+ L K+ H ++
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKM------KKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
V L E V+EYM G L Q L + D P + +I + +G+ ++H
Sbjct: 61 VKLKEVFRENDELYFVFEYM-EGNLYQ-LMK--DRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYS--VETRLAGTFGYLA 756
+ F HRDLKP N+L+ K+ADFGL +++ P Y+ V TR Y A
Sbjct: 117 ---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--YTDYVSTRW-----YRA 166
Query: 757 PE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
PE Y ++ +D++A G ++ E T R
Sbjct: 167 PEILLRSTSY------SSPVDIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 69/270 (25%), Positives = 117/270 (43%), Gaps = 32/270 (11%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
F++ +G+G FG V+ G K+ ++ + + Q EI VL++ ++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
G + ++ ++ EY+ G+ A L E PL Q TI ++ +G++YLHS
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS-ALDLLE-----PGPLDETQIATILREILKGLDYLHS 119
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT 762
+ IHRD+K +N+L+ + K+ADFG+ D + GT ++APE
Sbjct: 120 ---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK-RNTFVGTPFWMAPEVIKQ 175
Query: 763 GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLN 822
+K D+++ G+ +E G + P + F LI K N P
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPHSELHP-----MKVLF---LIPKNNPP-------- 219
Query: 823 LDEETIESIYR--VAELAGHCTAREPQQRP 850
T+E Y + E C +EP RP
Sbjct: 220 ----TLEGNYSKPLKEFVEACLNKEPSFRP 245
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 4e-17
Identities = 64/243 (26%), Positives = 100/243 (41%), Gaps = 50/243 (20%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
+G+G FG VY + +A+K + E+ + + Q EI L++ R ++
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAED----EIEDIQQEIQFLSQCRSPYITKY 64
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
G + GS+ ++ EY G+ L + L I +V G+EYLH
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCL-DLLK-----PGKLDETYIAFILREVLLGLEYLHE-- 116
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRL----------AGTFGY 754
+ IHRD+K +NIL+ ++ K+ADFG V +L GT +
Sbjct: 117 -EGKIHRDIKAANILLSEEGDVKLADFG-----------VSGQLTSTMSKRNTFVGTPFW 164
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL--ISKEN 812
+APE K D+++ G+ +E G L D P RVL I K N
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHP----------MRVLFLIPKNN 214
Query: 813 IPK 815
P
Sbjct: 215 PPS 217
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 5e-17
Identities = 72/270 (26%), Positives = 123/270 (45%), Gaps = 32/270 (11%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
F++ +G+G FG VY G + + TK +A+K ++ ++ + + Q EI VL++ +
Sbjct: 6 FTKLERIGKGSFGEVYKG-IDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPY 63
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ G + G++ ++ EY+ G+ L PL TI ++ +G++YL
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP------GPLEETYIATILREILKGLDYL 117
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
HS + IHRD+K +N+L+ + K+ADFG+ D + T GT ++APE
Sbjct: 118 HS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVI 173
Query: 761 ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
K D+++ G+ +E G D P RVL IPK P
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHP----------MRVLFL---IPKNSPPT 220
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRP 850
L E ++ E C ++P+ RP
Sbjct: 221 L---EGQYSKPFK--EFVEACLNKDPRFRP 245
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-17
Identities = 58/213 (27%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 577 RQVTDNFSEANILGRGGFGVV-YGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R + +N+ + +G G G+V E G ++AVK M+ + L E+ ++
Sbjct: 20 RSLLENYIK---IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL--LFNEVVIMRD 74
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+H+++V + + G E ++ E++ G L + + T L +Q T+ V +
Sbjct: 75 YQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------TRLNEEQIATVCESVLQ 128
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPDGKYSVETRLAGT 751
+ YLHS Q IHRD+K +IL+ D R K++DFG + K+ P K L GT
Sbjct: 129 ALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRK-----SLVGT 180
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784
++APE + T++D+++ G++++E + G
Sbjct: 181 PYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 6e-17
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 583 FSEANILGRGGFGVVYGG-ELPDGTKI----AVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
F + +LG G FG VY G +P+G K+ A+K + T K E E V+ V
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVD 67
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVAR 695
+ H+ LLG C+ + +L + + MP G L ++ E D+ L W + +A+
Sbjct: 68 NPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 120
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFG 753
G+ YL ++ +HRDL N+L+ K+ DFGL K A + +Y E
Sbjct: 121 GMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV-PIK 176
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALD 789
++A E T + DV+++GV + E +T G K D
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 7e-17
Identities = 68/278 (24%), Positives = 126/278 (45%), Gaps = 40/278 (14%)
Query: 577 RQVTDNFSEANILGRGGFGVV-YGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R DNF + +G G G+V + G ++AVK+M+ + L E+ ++
Sbjct: 18 RSYLDNFVK---IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL--LFNEVVIMRD 72
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+H ++V + + G E +V E++ G L + +T + +Q T+ L V +
Sbjct: 73 YQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV------THTRMNEEQIATVCLAVLK 126
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET----RLAGT 751
+ +LH+ Q IHRD+K +IL+ D R K++DFG + S E L GT
Sbjct: 127 ALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFC-----AQVSKEVPRRKSLVGT 178
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811
++APE + T++D+++ G++++E + G + P + +R+ ++
Sbjct: 179 PYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP------LQAMKRI---RD 229
Query: 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQR 849
N+P P L + R+ R+P QR
Sbjct: 230 NLP----PKLK---NLHKVSPRLRSFLDRMLVRDPAQR 260
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 7e-17
Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVR 637
D E +LG+G +G+VY +L +IA+K + E ++ + L E EIA+ + ++
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE---EIALHSYLK 63
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL---DVA 694
HR++V LG + E +P G+L+ L + PL ++ TI +
Sbjct: 64 HRNIVQYLGSDSENGFFKIFMEQVPGGSLSALL----RSKWGPLKDNEQ-TIIFYTKQIL 118
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
G++YLH +HRD+K N+L+ K++DFG K ET GT
Sbjct: 119 EGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET-FTGTLQ 174
Query: 754 YLAPEYAATGR--VTTKIDVYAFGVVLMETITGR 785
Y+APE G D+++ G ++E TG+
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 7e-17
Identities = 63/204 (30%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 589 LGRGGFGVVYG------GELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG+GGFG V G+L K+ KR++ KG E +L KV R +V
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKR----KGYEGAMVEKRILAKVHSRFIV 56
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
+L ++ LV M G L H++ D + + G+E+LH
Sbjct: 57 SLAYAFQTKTDLCLVMTIMNGGDLRYHIYNV-DEENPGFPEPRACFYTAQIISGLEHLH- 114
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYLAPEYAA 761
Q+ I+RDLKP N+L+ +D +++D GL DG+ +T+ AGT G++APE
Sbjct: 115 --QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQ 170
Query: 762 TGRVTTKIDVYAFGVVLMETITGR 785
+D +A GV L E I R
Sbjct: 171 GEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 55/215 (25%), Positives = 102/215 (47%), Gaps = 17/215 (7%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNT----MGNKGLSEFQAEIAVLTKVRH 638
+++ +LG+G +G VY G G IAVK++E +T K + Q E+ +L ++H
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKH 61
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V LG C++ + + E++P G+++ L + + PL + GV
Sbjct: 62 VNIVQYLGTCLDDNTISIFMEFVPGGSISSIL-----NRFGPLPEPVFCKYTKQILDGVA 116
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-----NAPDGKYSVETRLAGTFG 753
YLH +HRD+K +N+++ + K+ DFG + ++ + GT
Sbjct: 117 YLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPY 173
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKAL 788
++APE K D+++ G + E TG+ L
Sbjct: 174 WMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 57/206 (27%), Positives = 107/206 (51%), Gaps = 20/206 (9%)
Query: 588 ILGRGGFGVVYGGEL-PDGTK---IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
++G G FG V G L G + +A+K ++S K +F +E +++ + H +++
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIMGQFDHPNIIH 69
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L G +++ E+M G L L +D +T + Q V + +A G++YL
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVI---QLVGMLRGIAAGMKYL--- 122
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVK----NAPDGKYSVETRLAGTFG--YLAP 757
++ +++HRDL NIL+ ++ KV+DFGL + + D Y+ + L G + AP
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYT--SSLGGKIPIRWTAP 180
Query: 758 EYAATGRVTTKIDVYAFGVVLMETIT 783
E A + T+ DV+++G+V+ E ++
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 24/217 (11%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ + ++GRG FG+V+ D + +K++ M Q E VL + H +
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY- 699
++ + ++V EY P GTLA+++ ++R LD + +
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYI-------------QKRCNSLLDEDTILHFF 107
Query: 700 ------LHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
LH + + +HRDLK NIL+ M K+ DFG+ K S + GT
Sbjct: 108 VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTP 165
Query: 753 GYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALD 789
Y++PE K D++A G VL E + ++A +
Sbjct: 166 CYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 3e-16
Identities = 57/198 (28%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G G VY ++ G ++A+K+M K L EI V+ + +H ++V L
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKHPNIVNYLDS 84
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ G E +V EY+ G+L + E T + Q + + + +E+LHS
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQ 135
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPEYAATGRVT 766
IHRD+K NIL+G D K+ DFG P+ S + + GT ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYG 193
Query: 767 TKIDVYAFGVVLMETITG 784
K+D+++ G++ +E + G
Sbjct: 194 PKVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-16
Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 33/272 (12%)
Query: 583 FSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--- 638
+ ++GRG +G VY G +P G +A+K + +T + +S+ Q E+A+L+++R
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQP 61
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++ G + G ++ EY G++ + L + P+ K I +V ++
Sbjct: 62 PNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMK-----AGPIAEKYISVIIREVLVALK 115
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y+H IHRD+K +NIL+ + K+ DFG+ S + GT ++APE
Sbjct: 116 YIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-SKRSTFVGTPYWMAPE 171
Query: 759 YAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817
G+ TK D+++ G+ + E TG D FR +++ IPK+
Sbjct: 172 VITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA---------FRAMML----IPKSK 218
Query: 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQR 849
P L + + + E C EP++R
Sbjct: 219 PPRLEDNGYSKL----LREFVAACLDEEPKER 246
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 69/249 (27%), Positives = 102/249 (40%), Gaps = 44/249 (17%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN-KGLSEFQA--EIAVLTK 635
++ LG G FG VY ++ G +A+K++ M N K A EI +L K
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKI---LMHNEKDGFPITALREIKILKK 63
Query: 636 VRHRHLVALLGYCINGSE-----RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT-- 688
++H ++V L+ + + R VY P + DH + L V
Sbjct: 64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTP----------YMDHDLSGLLENPSVKLT 113
Query: 689 ------IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK----NAP 738
L + G+ YLH + +HRD+K +NILI + K+ADFGL + P
Sbjct: 114 ESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
Query: 739 DGKYSVE------TRLAGTFGYLAPEY-AATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
+ K T L T Y PE R TT +D++ G V E T R L
Sbjct: 171 NPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK 230
Query: 792 MPDDRAHLV 800
D+ HL+
Sbjct: 231 SDIDQLHLI 239
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 64/214 (29%), Positives = 103/214 (48%), Gaps = 21/214 (9%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
NF + +G G +GVVY G +A+K++ +T S EI++L ++ H +
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH---GYTPLTWKQRVTIALDVARGV 697
+V LL ++ LV+E+ L Q L ++ D PL + L +G+
Sbjct: 61 IVKLLDVIHTENKLYLVFEF-----LHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGL 113
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYL 755
+ HS +HRDLKP N+LI + K+ADFGL + P Y+ E T Y
Sbjct: 114 AFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV---TLWYR 167
Query: 756 APEYAATGRV-TTKIDVYAFGVVLMETITGRKAL 788
APE + +T +D+++ G + E +T R+AL
Sbjct: 168 APEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 55/197 (27%), Positives = 88/197 (44%), Gaps = 13/197 (6%)
Query: 588 ILGRGGFGVVYGG--ELPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+G G FG VY G P+ KI AVK ++ T + +F E ++ + H H+V
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-EKFLQEAYIMRQFDHPHIVK 71
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+G + +V E P G L +L L + + ++ + YL S
Sbjct: 72 LIGVITE-NPVWIVMELAPLGELRSYLQVNKYS----LDLASLILYSYQLSTALAYLES- 125
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG 763
+ F+HRD+ N+L+ K+ DFGL + D Y ++ ++APE
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFR 183
Query: 764 RVTTKIDVYAFGVVLME 780
R T+ DV+ FGV + E
Sbjct: 184 RFTSASDVWMFGVCMWE 200
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 1e-15
Identities = 65/219 (29%), Positives = 100/219 (45%), Gaps = 36/219 (16%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKI----AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
+LG G FG VY G +PDG + A+K + NT K E E V+ V ++
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVC 72
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYL 700
LLG C+ + +L V + MP G L ++ E D L W + +A+G+ YL
Sbjct: 73 RLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYL 125
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---------NAPDGKYSVETRLAGT 751
+ +HRDL N+L+ K+ DFGL + +A GK ++
Sbjct: 126 EEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK------ 176
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALD 789
++A E R T + DV+++GV + E +T G K D
Sbjct: 177 --WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 19/208 (9%)
Query: 589 LGRGGFGVVYGGELPDGTKIA---VKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G FG V GE G A VK + ++ ++ L F E+ ++ H +++ L
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLL-FLQEVQPYRELNHPNVLQCL 61
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSL 703
G CI LLV E+ P G L +L QR +A +VA G+ +LH
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQR--MACEVASGLLWLH-- 117
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRLAGTFGYLAPEYAA- 761
Q FIH DL N + D+ K+ D+GL ++ P+ Y + A +LAPE
Sbjct: 118 -QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEI 176
Query: 762 ------TGRVTTKIDVYAFGVVLMETIT 783
T K ++++ GV + E T
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.5 bits (191), Expect = 2e-15
Identities = 67/248 (27%), Positives = 102/248 (41%), Gaps = 34/248 (13%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
D+ +G G FG V+ + A+K M + K E VL +V H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 639 RHLVALLGYCINGSERLL--VYEYMPRGTLAQHL-----FEWHDHGYTPLTWKQRVTIAL 691
++ L + +R L + EY+P G L +L F T L + + AL
Sbjct: 61 PFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS----NSTGLFYASEIVCAL 114
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
EYLHS ++RDLKP NIL+ + K+ DFG K D ++ L GT
Sbjct: 115 ------EYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT----LCGT 161
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811
YLAPE + +D +A G+++ E + G D P + ++L K
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKILAGKL 215
Query: 812 NIPKAIDP 819
P+ +D
Sbjct: 216 EFPRHLDL 223
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 4e-15
Identities = 60/209 (28%), Positives = 97/209 (46%), Gaps = 31/209 (14%)
Query: 588 ILGRGGFGVVYGGELPD-GTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
++G G +G+V + + G +A+K+ E + M K EI +L ++RH +LV
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR---EIRMLKQLRHENLVN 64
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+ LV+E++ L E + +G ++ + RG+E+ HS
Sbjct: 65 LIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRK---YLFQILRGIEFCHS- 118
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYS--VETRLAGTFGYLAPEY 759
+ IHRD+KP NIL+ K+ DFG + AP Y+ V TR Y APE
Sbjct: 119 --HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW-----YRAPEL 171
Query: 760 ----AATGRVTTKIDVYAFGVVLMETITG 784
GR +D++A G ++ E +TG
Sbjct: 172 LVGDTKYGR---AVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 5e-15
Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 35/220 (15%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKR--MESNTMGNKGLSEFQA----EIAVL 633
D + + N + G +GVVY + G +A+K+ ME G F EI +L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG------FPITSLREINIL 58
Query: 634 TKVRHRHLVAL----LGYCINGSERLLVYEYMPRGTLAQH-LFEWHDHGYTPLTWKQRVT 688
K++H ++V + +G ++ + +V EY+ +H L + P +
Sbjct: 59 LKLQHPNIVTVKEVVVGSNLD--KIYMVMEYV------EHDLKSLMETMKQPFLQSEVKC 110
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVET 746
+ L + GV +LH +HRDLK SN+L+ + K+ DFGL + +P Y T
Sbjct: 111 LMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPY---T 164
Query: 747 RLAGTFGYLAPE-YAATGRVTTKIDVYAFGVVLMETITGR 785
+L T Y APE +T ID+++ G + E +T +
Sbjct: 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.7 bits (187), Expect = 5e-15
Identities = 66/243 (27%), Positives = 101/243 (41%), Gaps = 32/243 (13%)
Query: 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG GGFG V ++ A+K ++ + G E +E +L + H +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 647 YCINGSERLLVY---EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
++ +Y EY G L L D G + R IA V EYLH+
Sbjct: 61 TF---KDKKYIYMLMEYCLGGELWTIL---RDRGLFD-EYTARFYIAC-VVLAFEYLHN- 111
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYLAPEYAA 761
+ I+RDLKP N+L+ + K+ DFG K G+ ++ GT Y+APE
Sbjct: 112 --RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT----FCGTPEYVAPEIIL 165
Query: 762 TGRVTTKIDVYAFGVVLMETITGRK--ALDDTMPDDRAHLVTWFRRVLISKENI--PKAI 817
+D ++ G++L E +TGR DD P + + +L + P I
Sbjct: 166 NKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-----MEI-YNDILKGNGKLEFPNYI 219
Query: 818 DPN 820
D
Sbjct: 220 DKA 222
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 6e-15
Identities = 76/327 (23%), Positives = 141/327 (43%), Gaps = 43/327 (13%)
Query: 559 SDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNT 617
SD + E +S+ ++ F + +G+G G VY ++ G ++A+++M
Sbjct: 1 SDEEILEKLRSIVSVGDPKKKYTRFEK---IGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 618 MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG 677
K L EI V+ + ++ ++V L + G E +V EY+ G+L + E
Sbjct: 58 QPKKEL--IINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE----- 110
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
T + Q + + + +E+LHS IHRD+K NIL+G D K+ DFG
Sbjct: 111 -TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA 797
+ S + + GT ++APE K+D+++ G++ +E I G + P
Sbjct: 167 TP-EQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
Query: 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD------ 851
+ LI+ P+ +P E + +I+R + C + ++R
Sbjct: 226 Y--------LIATNGTPELQNP------EKLSAIFR--DFLNRCLDMDVEKRGSAKELLQ 269
Query: 852 -----MGHAVNVLGPLVEQWKPATRED 873
+ ++ L PL+ K AT+ +
Sbjct: 270 HQFLKIAKPLSSLTPLIAAAKEATKNN 296
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 52/205 (25%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 605 GTKIAVKRMESNT-MGNK-----GLSEFQA----EIAVLTKVRHRHLVALLGYCINGSER 654
G+ VK + + T M K S + E+ ++ + R ++V+ G +N +
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78
Query: 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714
+ E+M G+L + + P+ + IA+ V G+ YL++ +HRD+K
Sbjct: 79 CMCMEFMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIK 131
Query: 715 PSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAF 774
PSNIL+ + K+ DFG+ + S+ GT Y++PE G+ T K DV++
Sbjct: 132 PSNILVNSRGQIKLCDFGVSGELIN---SIADTFVGTSTYMSPERIQGGKYTVKSDVWSL 188
Query: 775 GVVLMETITGRKALDDTMPDDRAHL 799
G+ ++E G+ + DD
Sbjct: 189 GISIIELALGKFPFAFSNIDDDGQD 213
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 64/241 (26%), Positives = 103/241 (42%), Gaps = 33/241 (13%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G FG VY + + G A K ++ + L +F EI +L++ +H ++V L
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEE--LEDFMVEIDILSECKHPNIVGLYEA 70
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
++ ++ E+ G L + E LT Q + + + +LHS
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLHS---HK 123
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR--LAGTFGYLAPEYAATGRV 765
IHRDLK NIL+ D K+ADFG+ + K +++ R GT ++APE A
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGV---SAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180
Query: 766 TT-----KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
K D+++ G+ L+E + P RVL+ I K+ P
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEPPHHELNP----------MRVLL---KILKSEPPT 227
Query: 821 L 821
L
Sbjct: 228 L 228
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 60/223 (26%), Positives = 93/223 (41%), Gaps = 41/223 (18%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRM---ESNTMGNKGLSEFQAEIAVLTKVR 637
+ E + LG G G V L + I + + N K + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---ELEINKSCK 57
Query: 638 HRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWK-----QRV--T 688
++V G ++ S + EY G+L D Y + + ++V
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL--------DSIYKKVKKRGGRIGEKVLGK 109
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE--T 746
IA V +G+ YLHS + IHRD+KPSNIL+ + K+ DFG+ S E
Sbjct: 110 IAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGV---------SGELVN 157
Query: 747 RLAGTFG----YLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
LAGTF Y+APE + DV++ G+ L+E R
Sbjct: 158 SLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 46/162 (28%), Positives = 69/162 (42%), Gaps = 21/162 (12%)
Query: 679 TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--- 735
PL Q + I + G+ YLH Q IHRD+K NI I D + + D G +
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV 208
Query: 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKAL---DDTM 792
AP LAGT APE A + +K D+++ G+VL E + + +
Sbjct: 209 VAPA-----FLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPST 263
Query: 793 PDD-----RAHLVTWFRRVLISKENIPKAIDPNLNLDEETIE 829
P++ +HL+ + + E P+ DP L IE
Sbjct: 264 PEEYVKSCHSHLLKIISTLKVHPEEFPR--DPGSRLVRGFIE 303
|
Length = 357 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 68/235 (28%), Positives = 95/235 (40%), Gaps = 40/235 (17%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
D+F ++GRG FG V+ D ++ A+K + + M + ++ +AE +L
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+V L Y E L LV EYMP G L L P + L +A
Sbjct: 61 PWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLI---RKDVFPEETARFYIAELVLA--- 113
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS-------------- 743
L S+ + FIHRD+KP NILI D K+ADFGL K K
Sbjct: 114 --LDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRD 171
Query: 744 ---VETRL-----------AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784
V R GT Y+APE + D ++ GV+L E + G
Sbjct: 172 NVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 24/206 (11%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G +GVVY + G +A+K R+E+ G S EI++L ++ H ++V LL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVP--STAIREISLLKELNHPNIVRLL 64
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA---LDVARGVEYLHS 702
+ ++ LV+E+ L L ++ D +PLT I + +G+ Y HS
Sbjct: 65 DVVHSENKLYLVFEF-----LDLDLKKYMDS--SPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPEYA 760
+HRDLKP N+LI + K+ADFGL + P Y+ E T Y APE
Sbjct: 118 ---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV---TLWYRAPEIL 171
Query: 761 ATGR-VTTKIDVYAFGVVLMETITGR 785
R +T +D+++ G + E + R
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 63/210 (30%), Positives = 88/210 (41%), Gaps = 31/210 (14%)
Query: 588 ILGRGGFGVVYGGE------------LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
+LGRG FG V E L G IA +ES M K + E
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVES-LMCEKRIFE------TANS 58
Query: 636 VRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
RH LV L C + + V EY G L H+ H ++ + V A V
Sbjct: 59 ERHPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHI---HTDVFSE---PRAVFYAACVV 111
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
G++YLH + ++RDLK N+L+ + K+ADFGL K G + GT +
Sbjct: 112 LGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM-GFGDRTSTFCGTPEF 167
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETITG 784
LAPE T +D + GV++ E + G
Sbjct: 168 LAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 1e-14
Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 28/282 (9%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMES-NTMGNKGLSEFQAEIAVLTKVRHR 639
NF +GRG F VY L D +A+K+++ M K + EI +L ++ H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG-YTP--LTWKQRVTIALDVARG 696
+++ L I +E +V E G L+Q + + P WK V +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLC----SA 118
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
VE++HS + +HRD+KP+N+ I K+ D GL + K + L GT Y++
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816
PE K D+++ G +L E AL D+ +L + ++ I + + P
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLFSLCQK--IEQCDYPP- 227
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858
L E R EL C +P QRPD+G+ +
Sbjct: 228 ------LPTEHYSEKLR--ELVSMCIYPDPDQRPDIGYVHQI 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-14
Identities = 64/245 (26%), Positives = 103/245 (42%), Gaps = 44/245 (17%)
Query: 588 ILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALL 645
++G+GG G VY P ++A+K++ + N L + F E + + H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 646 GYCINGSERLLVYEYMP--RGTLAQHLFE--WH-DHGYTPLTWKQRV----TIALDVARG 696
C S+ VY MP G + L + W + L K V +I +
Sbjct: 69 SIC---SDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--------------NAPDGKY 742
+EY+HS + +HRDLKP NIL+G + D+G + + Y
Sbjct: 126 IEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182
Query: 743 SVET---RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT---------GRK-ALD 789
S T ++ GT Y+APE + D+YA GV+L + +T GRK +
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR 242
Query: 790 DTMPD 794
D +
Sbjct: 243 DVILS 247
|
Length = 932 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (186), Expect = 2e-14
Identities = 59/231 (25%), Positives = 104/231 (45%), Gaps = 41/231 (17%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRM----ESNTMGNKGLSEFQAEIAV 632
V + +G G +GVV + G K+A+K++ + T+ + L E + +
Sbjct: 2 DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRE----LKI 57
Query: 633 LTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHD----------HGYTPLT 682
L +H +++A+ P G + ++ D H PLT
Sbjct: 58 LRHFKHDNIIAIRDI------------LRPPGADFKDVYVVMDLMESDLHHIIHSDQPLT 105
Query: 683 WKQRVTIAL-DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---NAP 738
++ + L + RG++Y+HS + IHRDLKPSN+L+ +D ++ DFG+ + ++P
Sbjct: 106 -EEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP 161
Query: 739 DGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKAL 788
T T Y APE + TT ID+++ G + E + GR+ L
Sbjct: 162 TEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRM---ESNTMGNK-GLSEFQAEIAVLTKVRHRHLVA 643
+G G +GVV+ + G +A+K+ E + + K L E I +L +++H +LV
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALRE----IRMLKQLKHPNLVN 64
Query: 644 LLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L+ +L LV+EY L + E + G K+ I + V + H
Sbjct: 65 LI-EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKK---IIWQTLQAVNFCH- 117
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYS--VETRLAGTFGYLAPE 758
+ + IHRD+KP NILI + K+ DFG + P Y+ V TR Y APE
Sbjct: 118 --KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-----YRAPE 170
Query: 759 Y-AATGRVTTKIDVYAFGVVLMETITG 784
+ +DV+A G V E +TG
Sbjct: 171 LLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 68/201 (33%), Positives = 96/201 (47%), Gaps = 14/201 (6%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTK-VRHRHLVAL 644
++G+G FG V+ DG+ AVK ++ T + K + AE VL K ++H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
Y +E+L V +Y+ G L HL L + R A +VA + YLHSL
Sbjct: 62 -HYSFQTAEKLYFVLDYVNGGELFFHL----QRERCFLEPRARF-YAAEVASAIGYLHSL 115
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG 763
+ I+RDLKP NIL+ + DFGL K + + + T GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTST-FCGTPEYLAPEVLRKE 171
Query: 764 RVTTKIDVYAFGVVLMETITG 784
+D + G VL E + G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 2e-14
Identities = 54/197 (27%), Positives = 96/197 (48%), Gaps = 13/197 (6%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G G VY ++ G ++A+K+M K L EI V+ + ++ ++V L
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL--IINEILVMRENKNPNIVNYLDS 84
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ G E +V EY+ G+L + E T + Q + + + +++LHS
Sbjct: 85 YLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQ 135
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
IHRD+K NIL+G D K+ DFG + S + + GT ++APE
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 768 KIDVYAFGVVLMETITG 784
K+D+++ G++ +E + G
Sbjct: 195 KVDIWSLGIMAIEMVEG 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 62/209 (29%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGL-SEFQAEIAVLTKVRHR 639
NF + LG G + VY G G +A+K E + +G S EI+++ +++H
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALK--EIHLDAEEGTPSTAIREISLMKELKHE 58
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V L ++ +LV+EYM L +++ G + T L +G+ +
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAF 115
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAP 757
H + +HRDLKP N+LI K+ADFGL + P +S E T Y AP
Sbjct: 116 CH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV---TLWYRAP 169
Query: 758 EYAATGRV-TTKIDVYAFGVVLMETITGR 785
+ R +T ID+++ G ++ E ITGR
Sbjct: 170 DVLLGSRTYSTSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-14
Identities = 74/247 (29%), Positives = 107/247 (43%), Gaps = 30/247 (12%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALLG 646
+G+GG+G V+ + D +I A+KRM+ + + + E +LT + LV LL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL- 67
Query: 647 YCINGSERL-LVYEYMPRG---TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
Y E L L EY+P G TL +L + R +A V+ LH
Sbjct: 68 YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSED-------HARFYMAEMFE-AVDALHE 119
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT 762
L +IHRDLKP N LI K+ DFGL K SV G+ Y+APE
Sbjct: 120 LG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV----VGSPDYMAPEVLRG 172
Query: 763 GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI--PKAIDPN 820
+D ++ G +L E + G + P++ TW + KE + P DP
Sbjct: 173 KGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE-----TW-ENLKYWKETLQRPVYDDPR 226
Query: 821 LNLDEET 827
NL +E
Sbjct: 227 FNLSDEA 233
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-14
Identities = 41/127 (32%), Positives = 64/127 (50%), Gaps = 12/127 (9%)
Query: 371 TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430
+INL+ + GNI P+ ++TSL+ L L N+ G IP+ L +L SL+ L+++ N+LSG+
Sbjct: 446 SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGR 505
Query: 431 VPDFGSNVKFTVSPGNPFIGT--NVDTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIV 488
VP G N G G PG + GP S +K ++ G V
Sbjct: 506 VP--------AALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS--VGAKIGIAFGVSV 555
Query: 489 AIVVVVV 495
A + +V+
Sbjct: 556 AFLFLVI 562
|
Length = 623 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 56/213 (26%), Positives = 101/213 (47%), Gaps = 24/213 (11%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R DNF + +G G G+V + G +AVK+M+ + L E+ ++
Sbjct: 19 RTYLDNFIK---IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRREL--LFNEVVIMRD 73
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+H ++V + + G E +V E++ G L + +T + +Q + L V +
Sbjct: 74 YQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIV------THTRMNEEQIAAVCLAVLK 127
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV----KNAPDGKYSVETRLAGT 751
+ LH+ Q IHRD+K +IL+ D R K++DFG K P K L GT
Sbjct: 128 ALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK-----SLVGT 179
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784
++APE + ++D+++ G++++E + G
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 70/282 (24%), Positives = 124/282 (43%), Gaps = 28/282 (9%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMES-NTMGNKGLSEFQAEIAVLTKVRHR 639
NF +GRG F VY L DG +A+K+++ + M K ++ EI +L ++ H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY---TPLTWKQRVTIALDVARG 696
+++ I +E +V E G L++ + + WK V +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLC----SA 118
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+E++HS + +HRD+KP+N+ I K+ D GL + K + L GT Y++
Sbjct: 119 LEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF-SSKTTAAHSLVGTPYYMS 174
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816
PE K D+++ G +L E AL D+ +L + ++ I +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGDKMNLYSLCKK-------IEQC 223
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858
P L D + E + +L C +P++RPD+ + +V
Sbjct: 224 DYPPLPSDHYSEE----LRQLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 28/214 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGL---------SEFQAEIA 631
D+F + LG G GVV TK+ + R M K + ++ E+
Sbjct: 1 DDFEKLGELGAGNGGVV--------TKV-LHRPSGLIMARKLIHLEIKPAIRNQIIRELK 51
Query: 632 VLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
VL + ++V G + E + E+M G+L Q L + G P +++IA
Sbjct: 52 VLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK---AGRIPENILGKISIA- 107
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
V RG+ YL + +HRD+KPSNIL+ K+ DFG+ D S+ GT
Sbjct: 108 -VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGT 161
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
Y++PE T + D+++ G+ L+E GR
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 61/212 (28%), Positives = 105/212 (49%), Gaps = 26/212 (12%)
Query: 589 LGRGGFGVVYGGELPDGT---KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+GRG +G VY + DG + A+K++E + E IA+L +++H +++AL
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACRE----IALLRELKHPNVIALQ 64
Query: 646 GYCINGSER--LLVYEYMPRGTLAQHLFEWH---DHGYTPLTWKQRVTIAL--DVARGVE 698
++ S+R L+++Y H+ ++H P+ + + +L + G+
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLW--HIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 699 YLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGLVK--NAPDGKYSVETRLAGTF 752
YLH+ +HRDLKP+NIL+ + R K+AD G + N+P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 753 GYLAPEYAATGRVTTK-IDVYAFGVVLMETIT 783
Y APE R TK ID++A G + E +T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 583 FSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVRHRH 640
F++ +G G FG VY ++ +A+K+M S N+ + E+ L ++RH +
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ G + LV EY G+ A + E H PL + I +G+ YL
Sbjct: 77 TIEYKGCYLREHTAWLVMEYC-LGS-ASDILEVHK---KPLQEVEIAAICHGALQGLAYL 131
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFG---LVKNAPDGKYSVETRLAGTFGYLAP 757
HS + IHRD+K NIL+ + K+ADFG LV A GT ++AP
Sbjct: 132 HSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPA--------NSFVGTPYWMAP 180
Query: 758 EYAAT---GRVTTKIDVYAFGVVLME 780
E G+ K+DV++ G+ +E
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIE 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 66/201 (32%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTK-VRHRHLVAL 644
++G+G FG V DG AVK ++ + K AE VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
Y +++L V +Y+ G L HL + P + R A ++A + YLHSL
Sbjct: 62 -HYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPEP---RARF-YAAEIASALGYLHSL 115
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG 763
+ I+RDLKP NIL+ + DFGL K + + T GT YLAPE
Sbjct: 116 ---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTST-FCGTPEYLAPEVLRKQ 171
Query: 764 RVTTKIDVYAFGVVLMETITG 784
+D + G VL E + G
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 24/216 (11%)
Query: 582 NFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVR 637
N+ +LG+G FG VY D G ++AVK+++ + +K ++ + EI +L +
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 638 HRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +V G + ER L E+MP G++ L Y LT +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQILE 117
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN------APDGKYSVETRLA 749
GV YLHS +HRD+K +NIL K+ DFG K + G SV
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV----T 170
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
GT +++PE + K D+++ G ++E +T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 18/213 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
D++ + LG G + VY G+ +G +A+K + + + E ++L ++H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 640 HLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V LL I+ E L LV+EY+ L Q++ + H G P K + RG+
Sbjct: 64 NIV-LLHDIIHTKETLTLVFEYV-HTDLCQYM-DKHPGGLHPENVK---LFLFQLLRGLS 117
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVETRLAGTFGYLA 756
Y+H Q+ +HRDLKP N+LI D K+ADFGL K+ P YS E T Y
Sbjct: 118 YIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV---TLWYRP 171
Query: 757 PE-YAATGRVTTKIDVYAFGVVLMETITGRKAL 788
P+ + +T +D++ G + +E I G A
Sbjct: 172 PDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 65/283 (22%), Positives = 124/283 (43%), Gaps = 35/283 (12%)
Query: 588 ILGRGGFGVVYGG--ELPDGTK--IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
ILG G FG + G +LP + +A+ + + + F AE L + H ++V
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALTLGQFDHSNIVR 70
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L G G+ ++V EYM G L L + H+ L Q + + +A G++Y L
Sbjct: 71 LEGVITRGNTMMIVTEYMSNGALDSFLRK-HE---GQLVAGQLMGMLPGLASGMKY---L 123
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL--APEYAA 761
++ ++H+ L +L+ D+ K++ F ++ D ++ T ++G L APE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE--DKSEAIYTTMSGKSPVLWAAPEAIQ 181
Query: 762 TGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
++ DV++FG+V+ E ++ G + D +S +++ KA++
Sbjct: 182 YHHFSSASDVWSFGIVMWEVMSYGERPYWD-----------------MSGQDVIKAVEDG 224
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863
L + +L C +E +RP ++L +V
Sbjct: 225 FRL-PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 72.1 bits (176), Expect = 1e-13
Identities = 69/297 (23%), Positives = 131/297 (44%), Gaps = 40/297 (13%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G G V+ ++ G ++A+K++ K L EI V+ ++++ ++V L
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL--IINEILVMKELKNPNIVNFLDS 84
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ G E +V EY+ G+L + E T + Q + + + +E+LH+
Sbjct: 85 FLVGDELFVVMEYLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQ 135
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
IHRD+K N+L+G D K+ DFG + S + + GT ++APE
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRKAYGP 194
Query: 768 KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEET 827
K+D+++ G++ +E + G + P + LI+ P+ +P E
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALY--------LIATNGTPELQNP------EK 240
Query: 828 IESIYRVAELAGHC---------TAREPQQRP--DMGHAVNVLGPLVEQWKPATRED 873
+ I+R + C +A+E Q P + ++ L PL+ K A + +
Sbjct: 241 LSPIFR--DFLNRCLEMDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAMKSN 295
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 60/216 (27%), Positives = 100/216 (46%), Gaps = 24/216 (11%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKVR 637
N+ +LG+G FG VY ++ G ++A K+++ + +K +S + EI +L ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 638 HRHLVALLGYCINGSERLLV--YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +V G + +E+ L EYMP G++ L Y LT +
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILE 117
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN------APDGKYSVETRLA 749
G+ YLHS +HRD+K +NIL K+ DFG K + G SV
Sbjct: 118 GMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSV----T 170
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
GT +++PE + K DV++ G ++E +T +
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 68/236 (28%), Positives = 103/236 (43%), Gaps = 63/236 (26%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
D+ LGRG +GVV +P GT +AVKR+ + V ++ + R
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRAT---------------VNSQEQKR 45
Query: 640 HLVALLGYCINGSERLLVYEYMPR--GTLAQHLFEW-----------------HDHGYTP 680
L+ L + S R + Y G L + W +D G
Sbjct: 46 LLMDL-----DISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKG--- 97
Query: 681 LTWKQRV--TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738
LT + + IA+ + + +EYLHS + S IHRD+KPSN+LI + + K+ DFG+
Sbjct: 98 LTIPEDILGKIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155
Query: 739 DGKYSVETRLAGTFGYLAPEYAATGRVT---------TKIDVYAFGVVLMETITGR 785
D +T AG Y+APE R+ K DV++ G+ ++E TGR
Sbjct: 156 DS--VAKTIDAGCKPYMAPE-----RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 62/201 (30%), Positives = 96/201 (47%), Gaps = 22/201 (10%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G FG VY + + G A K +E T + L ++ EI +L H ++V LLG
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIE--TKSEEELEDYMVEIEILATCNHPYIVKLLGA 77
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+ ++ E+ P G + + E D G LT Q I + ++YLHS+
Sbjct: 78 FYWDGKLWIMIEFCPGGAVDAIMLEL-DRG---LTEPQIQVICRQMLEALQYLHSM---K 130
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETR--LAGTFGYLAPEYAATGR 764
IHRDLK N+L+ D K+ADFG+ KN +++ R GT ++APE
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK----TLQRRDSFIGTPYWMAPEVVMCET 186
Query: 765 VTT-----KIDVYAFGVVLME 780
+ K D+++ G+ L+E
Sbjct: 187 MKDTPYDYKADIWSLGITLIE 207
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 65/211 (30%), Positives = 95/211 (45%), Gaps = 32/211 (15%)
Query: 588 ILGRGGFGVVYGGELP-DGTKIAVKRMESN----------TMGNKGLSEFQAEIAVLTKV 636
+LG+G FG V+ EL A+K ++ + TM K + E LT
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT-- 59
Query: 637 RHRHLVALLGYC-INGSERLL-VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
HL YC E L V EY+ G L H+ H T+ A ++
Sbjct: 60 ---HL-----YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATF-----YAAEII 106
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
G+++LHS + ++RDLK NIL+ D K+ADFG+ K G T GT Y
Sbjct: 107 CGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCT-FCGTPDY 162
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
+APE + T +D ++FGV+L E + G+
Sbjct: 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 589 LGRGGFGVVYGGELPDGTK---IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG V G K +A+K +++ + E E ++ ++ + ++V ++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV-RDEMMREAEIMHQLDNPYIVRMI 61
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C +LV E G L + L D +T V + V+ G++YL
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSGKKDE----ITVSNVVELMHQVSMGMKYLE---G 113
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPEYAATG 763
++F+HRDL N+L+ + AK++DFGL K A D Y + + APE
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR 173
Query: 764 RVTTKIDVYAFGVVLMETIT-GRK 786
+ +++ DV+++G+ + E + G+K
Sbjct: 174 KFSSRSDVWSYGITMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 13/208 (6%)
Query: 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVRH 638
++++ +G G +GVVY G G +A+K R+ES G S EI++L +++H
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVP--STAIREISLLKELQH 58
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V L + S L++E++ L ++L Y + + +G+
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYL--YQILQGIL 115
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+ HS + +HRDLKP N+LI + K+ADFGL + A V T T Y APE
Sbjct: 116 FCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR-AFGIPVRVYTHEVVTLWYRAPE 171
Query: 759 -YAATGRVTTKIDVYAFGVVLMETITGR 785
+ R +T +D+++ G + E T +
Sbjct: 172 VLLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 54/230 (23%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA------------EIAVL 633
LG G +G V G +A+K+++ + N + Q E+ ++
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 634 TKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDV 693
+++H +++ L+ + G LV + M L + + + LT Q I L +
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKK-VVD----RKIRLTESQVKCILLQI 128
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---------VKNAPDGKYSV 744
G+ LH F+HRDL P+NI I K+ADFGL +
Sbjct: 129 LNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 745 ETRLAG----TFGYLAPE--YAATGRVTTKIDVYAFGVVLMETITGRKAL 788
T Y APE A + +D+++ G + E +TG K L
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAE-KYHFAVDMWSVGCIFAELLTG-KPL 233
|
Length = 335 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 21/213 (9%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
++T+ + + +G G FG+V + G +A+K++ E+ +L +
Sbjct: 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL 66
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT-IALDVA 694
RH ++++L I+ E + V E + GT L PL KQ + +
Sbjct: 67 RHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLT-----SRPLE-KQFIQYFLYQIL 118
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFG 753
RG++Y+HS +HRDLKPSNILI ++ K+ DFGL + P V TR
Sbjct: 119 RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 754 YLAPEYAAT-GRVTTKIDVYAFGVVLMETITGR 785
Y APE T + ++D+++ G + E + G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 56/221 (25%), Positives = 100/221 (45%), Gaps = 20/221 (9%)
Query: 576 LRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQ-----AEI 630
+ D + +++L G FG ++ G L D + + T+ + SE Q E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKD-HASEIQVTLLLQES 59
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLV-YEYMPRGTLAQHLFEWHD---HGYTPLTWKQR 686
+L + H++++ +L CI E V Y YM G L L + + L+ +Q
Sbjct: 60 CLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQL 119
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV-- 744
V +A+ +A G+ YLH IH+D+ N +I ++++ K+ D L ++ Y
Sbjct: 120 VHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176
Query: 745 --ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
E R ++A E ++ DV++FGV+L E +T
Sbjct: 177 DNENR---PVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 3e-13
Identities = 76/273 (27%), Positives = 114/273 (41%), Gaps = 48/273 (17%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V+ E G A+K + + K ++ E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL- 60
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------G 696
Y +RL V EY G L HL ++RV + AR
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLS------------RERV-FTEERARFYGAEIVSA 107
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+EYLHS + ++RD+K N+++ D K+ DFGL K +++T GT YLA
Sbjct: 108 LEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT-FCGTPEYLA 163
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816
PE +D + GVV+ E + GR + D L F +L+ + P+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERL---FELILMEEIRFPRT 217
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQR 849
+ P + LAG ++P+QR
Sbjct: 218 LSPEAK------------SLLAG-LLKKDPKQR 237
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 68/250 (27%), Positives = 110/250 (44%), Gaps = 23/250 (9%)
Query: 582 NFSEANILGRGGFGVVY-----GGELPDGTKIAVKRMESNTMGNKG--LSEFQAEIAVLT 634
NF +LG G +G V+ GG G A+K ++ T+ K + E VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 635 KVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDV 693
VR + L Y +L L+ +Y+ G L HL++ + + + RV IA ++
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQ---REHFTES-EVRVYIA-EI 114
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTF 752
+++LH Q I+RD+K NIL+ + + DFGL K + + + GT
Sbjct: 115 VLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYS-FCGTI 170
Query: 753 GYLAPEYAATGRV--TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810
Y+APE G +D ++ GV+ E +TG T+ ++ RR+L SK
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPF--TVDGEQNSQSEISRRILKSK 228
Query: 811 ENIPKAIDPN 820
PK +
Sbjct: 229 PPFPKTMSAE 238
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-13
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 24/214 (11%)
Query: 582 NFSEANILGRGGFGVVYGGELPD-GTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKVR 637
N+ +LGRG FG VY D G ++AVK++ + +K ++ + EI +L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 638 HRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +V G + E+ L EYMP G++ L Y LT + +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQ 117
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN------APDGKYSVETRLA 749
GV YLHS +HRD+K +NIL K+ DFG K + G SV
Sbjct: 118 GVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV----T 170
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
GT +++PE + K DV++ ++E +T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 67/212 (31%), Positives = 98/212 (46%), Gaps = 34/212 (16%)
Query: 588 ILGRGGFGVVYGGELP-DGTKIAVKRMESN----------TMGNKGLSEFQAEIAVLTKV 636
+LG+G FG V EL G AVK ++ + TM K + E LT
Sbjct: 2 VLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLT-- 59
Query: 637 RHRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDV 693
HL YC ++ L V E++ G L H+ D G L R T A ++
Sbjct: 60 ---HL-----YCTFQTKEHLFFVMEFLNGGDLMFHI---QDKGRFDL---YRATFYAAEI 105
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
G+++LHS + I+RDLK N+++ D K+ADFG+ K G T GT
Sbjct: 106 VCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPD 161
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
Y+APE + T +D ++FGV+L E + G+
Sbjct: 162 YIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-13
Identities = 72/244 (29%), Positives = 110/244 (45%), Gaps = 22/244 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKV 636
D+F + LG G GVV + P G +A K + + N+ + E Q VL +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
++V G + E + E+M G+L Q L E P +V+IA V RG
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEILGKVSIA--VLRG 115
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+ YL + +HRD+KPSNIL+ K+ DFG+ D S+ GT Y++
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 170
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF-RRVLISKENIPK 815
PE + + D+++ G+ L+E GR + P D L F R V+ +E P
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIP---PPDAKELEAIFGRPVVDGEEGEPH 227
Query: 816 AIDP 819
+I P
Sbjct: 228 SISP 231
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 56/181 (30%), Positives = 89/181 (49%), Gaps = 20/181 (11%)
Query: 629 EIAVLTKVRHRHLVALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR 686
E+++L ++H ++V L + I +ER LV+EY+ L Q+L D+ ++
Sbjct: 53 EVSLLKNLKHANIVTL--HDIIHTERCLTLVFEYL-DSDLKQYL----DNCGNLMSMHNV 105
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSV 744
+ RG+ Y H ++ +HRDLKP N+LI + K+ADFGL K+ P YS
Sbjct: 106 KIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN 162
Query: 745 ETRLAGTFGYLAPE-YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF 803
E T Y P+ + +T ID++ G +L E TGR + + HL+ F
Sbjct: 163 EVV---TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI--F 217
Query: 804 R 804
R
Sbjct: 218 R 218
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 57/217 (26%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 589 LGRGGFGVVYGG--ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G + V+ G +L + +A+K + + + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
LV+EY L + L ++ D ++ + RG+ Y H ++
Sbjct: 72 IVHTDKSLTLVFEY-----LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCH---RR 123
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVETRLAGTFGYLAPE-YAATG 763
+HRDLKP N+LI + K+ADFGL K+ P YS E T Y P+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV---TLWYRPPDVLLGSS 180
Query: 764 RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV 800
+T+ID++ G + E +GR + +D HL+
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-13
Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 27/220 (12%)
Query: 651 GSERLLVYEYMP-RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFI 709
G +L + P E D +PLT + + + VARG+E+L A + I
Sbjct: 140 GQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFL---ASRKCI 196
Query: 710 HRDLKPSNILIGDDMRAKVADFGLVKNA---PDGKYSVETRLAGTFGYLAPEYAATGRVT 766
HRDL NIL+ ++ K+ DFGL ++ PD RL ++APE T
Sbjct: 197 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP--LKWMAPESIFDKVYT 254
Query: 767 TKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID-PNLNLDE 825
T+ DV++FGV+L E + + P + V I++E + D + E
Sbjct: 255 TQSDVWSFGVLLWEIFSLGAS-----P---------YPGVQINEEFCQRLKDGTRMRAPE 300
Query: 826 ETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
IYR+ LA C +P++RP V +LG L+++
Sbjct: 301 NATPEIYRIM-LA--CWQGDPKERPTFSALVEILGDLLQE 337
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 7e-13
Identities = 67/213 (31%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 589 LGRGGFGVVYGGELP-DGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVA 643
LG G + VY G G +A+K R+E +G F A E ++L ++H ++V
Sbjct: 13 LGEGSYATVYKGRSKLTGQLVALKEIRLEHE----EGAP-FTAIREASLLKDLKHANIV- 66
Query: 644 LLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL-DVARGVEYLH 701
L I+ + L LV+EY+ L Q++ + G + V + L + RG+ Y H
Sbjct: 67 TLHDIIHTKKTLTLVFEYLDT-DLKQYM-DDCGGGLSM----HNVRLFLFQLLRGLAYCH 120
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVETRLAGTFGYLAP-- 757
Q+ +HRDLKP N+LI + K+ADFGL K+ P YS E T Y P
Sbjct: 121 ---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV---TLWYRPPDV 174
Query: 758 -----EYAATGRVTTKIDVYAFGVVLMETITGR 785
EY +T +D++ G + E TGR
Sbjct: 175 LLGSTEY------STSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 7e-13
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 589 LGRGGFGVVYGG--ELPDGTKIAVKRMESNTMGNKGLS-EFQAEIAVLTKVRHRHLVALL 645
LG G FG V G ++ K ++ N + L E E V+ ++ + ++V ++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C +LV E G L + L + + H +T K + V+ G++YL +
Sbjct: 63 GIC-EAESWMLVMELAELGPLNKFL-QKNKH----VTEKNITELVHQVSMGMKYLE---E 113
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLAPEYAATG 763
+F+HRDL N+L+ AK++DFGL K A + Y +T + APE
Sbjct: 114 TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173
Query: 764 RVTTKIDVYAFGVVLMETIT-GRK 786
+ ++K DV++FGV++ E + G+K
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQK 197
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 18/203 (8%)
Query: 583 FSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVRHRH 640
F++ +G G FG VY ++ +A+K+M S N+ + E+ L +++H +
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ G + LV EY G+ A L E H PL + I +G+ YL
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGS-ASDLLEVHK---KPLQEVEIAAITHGALQGLAYL 141
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
HS + IHRD+K NIL+ + + K+ADFG A S GT ++APE
Sbjct: 142 HS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIA-----SPANSFVGTPYWMAPEVI 193
Query: 761 AT---GRVTTKIDVYAFGVVLME 780
G+ K+DV++ G+ +E
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIE 216
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 55/210 (26%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 589 LGRGGFGVVYGGELPDG--TKIAVKRM--------ESNTMGNKGLSEFQAEIAVLTK-VR 637
LG G FG VY + +A+K + + +K + + +E+ ++ + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQH---LFEWHDHGYTPLTWKQRVTIALDVA 694
H ++V + +V + + L +H L E W V + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL--- 124
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFG 753
+ YLH ++ +HRDL P+NI++G+D + + DFGL K P+ K T + GT
Sbjct: 125 -ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKL---TSVVGTIL 178
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
Y PE K DV+AFG +L + T
Sbjct: 179 YSCPEIVKNEPYGEKADVWAFGCILYQMCT 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 69.9 bits (172), Expect = 1e-12
Identities = 68/230 (29%), Positives = 95/230 (41%), Gaps = 62/230 (26%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA---------EIAVLTKV 636
+G G +GVV G K+A+K++ SN F EI +L +
Sbjct: 6 KPIGSGAYGVVCSAVDKRTGRKVAIKKI-SNV--------FDDLIDAKRILREIKLLRHL 56
Query: 637 RHRHLVALLG-YCINGSERL----LVYEYMPRGT-LAQHLFEWHDHGYTPLTWKQRVTIA 690
RH +++ LL E +V E M T L + + PLT
Sbjct: 57 RHENIIGLLDILRPPSPEDFNDVYIVTELME--TDLHKVI-----KSPQPLTDDHIQYFL 109
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGK-----Y 742
+ RG++YLHS + IHRDLKPSNIL+ + K+ DFGL V D K Y
Sbjct: 110 YQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEY 166
Query: 743 SVETRLAGTFGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
V TR Y APE Y T ID+++ G + E +T +
Sbjct: 167 -VVTRW-----YRAPELLLSSSRY------TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 63/207 (30%), Positives = 98/207 (47%), Gaps = 23/207 (11%)
Query: 588 ILGRGGFGVVYGGELPDGT---KI-AVKRMESNTM--GNKGLSEFQAEIAVLTKVRHRHL 641
+LG+GG+G V+ G KI A+K ++ T+ K + +AE +L V+H +
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY----TPLTWKQRVTIALDVARGV 697
V L+ G + L+ EY+ G L HL G T + +++AL
Sbjct: 63 VDLIYAFQTGGKLYLILEYLSGGELFMHL---EREGIFMEDTACFYLSEISLAL------ 113
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
E+LH QQ I+RDLKP NIL+ K+ DFGL K + +V GT Y+AP
Sbjct: 114 EHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-TVTHTFCGTIEYMAP 169
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITG 784
E +D ++ G ++ + +TG
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-12
Identities = 59/217 (27%), Positives = 99/217 (45%), Gaps = 18/217 (8%)
Query: 589 LGRGGFGVVYGG--ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G + VY G +L D +A+K + + + E+++L ++H ++V L
Sbjct: 14 LGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHD 71
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
LV+EY+ + L Q+L D + + RG+ Y H ++
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYL----DDCGNSINMHNVKLFLFQLLRGLNYCH---RR 123
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVETRLAGTFGYLAPE-YAATG 763
+HRDLKP N+LI + K+ADFGL K+ P YS E T Y P+ +
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV---TLWYRPPDILLGST 180
Query: 764 RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV 800
+T+ID++ G + E TGR + +++ H +
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 15/207 (7%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ +G G FG +Y D +K ++ M K + E+ +L K++H +
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP---LTWKQRVTIALDVARGV 697
+V +V EY G L + + ++ L+W V I+L G+
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISL----GL 114
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+++H + +HRD+K NI + + M AK+ DFG+ + D T GT YL+
Sbjct: 115 KHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLS 170
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETIT 783
PE K D+++ G VL E T
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 1e-12
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 30/214 (14%)
Query: 589 LGRGGFGVVYGG---ELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVR-HRHLV 642
LG+G +G+V E + +A+K++ +N K L++ +A E+ +L R H+++
Sbjct: 8 LGQGAYGIVCSARNAETSEEETVAIKKI-TNVFSKKILAK-RALRELKLLRHFRGHKNIT 65
Query: 643 ALL------GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
L N L +YE + L Q + PLT + + G
Sbjct: 66 CLYDMDIVFPGNFNE---LYLYEELMEADLHQII-----RSGQPLTDAHFQSFIYQILCG 117
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE---TRLAGTFG 753
++Y+HS + +HRDLKP N+L+ D K+ DFGL + + T T
Sbjct: 118 LKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRW 174
Query: 754 YLAPEYAATGRVTTK-IDVYAFGVVLMETITGRK 786
Y APE + + TK IDV++ G +L E + GRK
Sbjct: 175 YRAPEIMLSFQSYTKAIDVWSVGCILAE-LLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 64/245 (26%), Positives = 108/245 (44%), Gaps = 30/245 (12%)
Query: 588 ILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL-- 644
I+GRGGFG VYG D K+ A+K ++ + K Q E L + LV+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGD 55
Query: 645 ------LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ Y + ++L + + M G L HL + HG + K+ A ++ G+
Sbjct: 56 CPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQ---HGV--FSEKEMRFYATEIILGL 110
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
E++H+ + ++RDLKP+NIL+ + +++D GL + K GT GY+AP
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAP 164
Query: 758 EYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816
E G + D ++ G +L + + G D+ + R L +P +
Sbjct: 165 EVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID---RMTLTVNVELPDS 221
Query: 817 IDPNL 821
P L
Sbjct: 222 FSPEL 226
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 1e-12
Identities = 66/249 (26%), Positives = 98/249 (39%), Gaps = 40/249 (16%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKIAV----KRMESNTMGNKGLSEFQAEIAVLTKVR 637
+F LG G FG V + + K+ E M K + E ++L ++
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKM--KQVQHVAQEKSILMELS 76
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
H +V ++ + + + E++ G L HL G P DVA+
Sbjct: 77 HPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPN----------DVAKFY 123
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
EYLHS I+RDLKP N+L+ + KV DFG K PD ++ L
Sbjct: 124 HAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT----LC 176
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809
GT YLAPE + +D + GV+L E I G D P + ++L
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP------FRIYEKILAG 230
Query: 810 KENIPKAID 818
+ P D
Sbjct: 231 RLKFPNWFD 239
|
Length = 329 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 32/222 (14%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGL-SEFQAEIAVLTKVRH 638
D + + +G G +G VY + G +A+K+ M +G+ EI++L +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE-MDEEGIPPTALREISLLQMLSE 59
Query: 639 R-HLVALLGYCI------NGSERL-LVYEYMPRGTLAQHLFEWHDHGY----TPLTWKQR 686
++V LL + NG L LV+EY L L ++ D PL K
Sbjct: 60 SIYIVRLL--DVEHVEEKNGKPSLYLVFEY-----LDSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLVKN--APDGKYS 743
+ + +GV + H +HRDLKP N+L+ K+AD GL + P Y+
Sbjct: 113 KSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 744 VETRLAGTFGYLAPEYAATGR-VTTKIDVYAFGVVLMETITG 784
E T Y APE +T +D+++ G + E
Sbjct: 170 HEIV---TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 59/212 (27%), Positives = 104/212 (49%), Gaps = 26/212 (12%)
Query: 589 LGRGGFGVVYGGELPDGTK---IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+GRG +G VY + DG A+K++E + E IA+L +++H ++++L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 64
Query: 646 GYCINGSER--LLVYEYMPRGTLAQHLFEWH---DHGYTPLTWKQRVTIAL--DVARGVE 698
++ ++R L+++Y H+ ++H P+ + + +L + G+
Sbjct: 65 KVFLSHADRKVWLLFDYAEHDLW--HIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 122
Query: 699 YLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGLVK--NAPDGKYSVETRLAGTF 752
YLH+ +HRDLKP+NIL+ + R K+AD G + N+P + + TF
Sbjct: 123 YLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 753 GYLAPEYAATGRVTTK-IDVYAFGVVLMETIT 783
Y APE R TK ID++A G + E +T
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-12
Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 46/300 (15%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G G FG VY ++ AVK+M S N+ + E+ L +++H + + G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ LV EY G+ A L E H PL + I +G+ YLHS
Sbjct: 89 CYLKEHTAWLVMEYC-LGS-ASDLLEVHK---KPLQEVEIAAITHGALQGLAYLHS---H 140
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT---G 763
+ IHRD+K NIL+ + + K+ADFG + S GT ++APE G
Sbjct: 141 NMIHRDIKAGNILLTEPGQVKLADFGSASKS-----SPANSFVGTPYWMAPEVILAMDEG 195
Query: 764 RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823
+ K+DV++ G+ +E + L + + + +I + P L
Sbjct: 196 QYDGKVDVWSLGITCIELAERKPPLFNM-------------NAMSALYHIAQNDSPTLQS 242
Query: 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHAV-----------NVLGPLVEQWKPATRE 872
+E T +S + +C + PQ+RP + VL L+++ K A RE
Sbjct: 243 NEWT-DSFRGFVD---YCLQKIPQERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRE 298
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 37/213 (17%)
Query: 588 ILGRGGFGVVY------GGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+LG+G FG V+ G PD G A+K ++ T+ + + E +L +V H
Sbjct: 3 VLGQGSFGKVFLVRKITG---PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPF 59
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHL-----FEWHDHGYTPLTWKQRVTIALDVA 694
+V L Y +L L+ +++ G L L F D + ++A
Sbjct: 60 IVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA----------ELA 108
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK---YSVETRLAGT 751
+++LHSL I+RDLKP NIL+ ++ K+ DFGL K + D + YS GT
Sbjct: 109 LALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS----FCGT 161
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784
Y+APE T D ++FGV++ E +TG
Sbjct: 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 2e-12
Identities = 63/234 (26%), Positives = 106/234 (45%), Gaps = 25/234 (10%)
Query: 577 RQVTDNFSEANILGRGGFGVVYG------GELPDGTKIAVKRMESNTMGNKGLSEFQAEI 630
R ++F +G G +G VY GEL I V ++E + + Q EI
Sbjct: 5 RNPQEDFELIQRIGSGTYGDVYKARNVNTGEL---AAIKVIKLEPG----EDFAVVQQEI 57
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
++ +H ++VA G + + + E+ G+L Q ++ H PL+ Q ++
Sbjct: 58 IMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL-QDIY----HVTGPLSESQIAYVS 112
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
+ +G+ YLHS + +HRD+K +NIL+ D+ K+ADFG V + G
Sbjct: 113 RETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFG-VSAQITATIAKRKSFIG 168
Query: 751 TFGYLAPEYAATGR---VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT 801
T ++APE AA R D++A G+ +E + + D P L+T
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMT 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 41/222 (18%)
Query: 582 NFSE---ANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ SE N +G G G VY P G A+K + N + + EI +L V
Sbjct: 72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGN-HEDTVRRQICREIEILRDVN 130
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H ++V + E ++ E+M G+L + +A + G+
Sbjct: 131 HPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHI-ADEQ--------FLADVARQILSGI 181
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPDGKYSVETRLAGTFG 753
YLH + +HRD+KPSN+LI K+ADFG L + SV GT
Sbjct: 182 AYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-----GTIA 233
Query: 754 YLAPEYAATGRVTTKI----------DVYAFGVVLMETITGR 785
Y++PE R+ T + D+++ GV ++E GR
Sbjct: 234 YMSPE-----RINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 583 FSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVRHRH 640
FS+ +G G FG VY ++ + +A+K+M S N+ + E+ L K+RH +
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ G + LV EY G+ A L E H PL + + +G+ YL
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGS-ASDLLEVHK---KPLQEVEIAAVTHGALQGLAYL 131
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFGYLAPEY 759
HS + IHRD+K NIL+ + K+ DFG AP + GT ++APE
Sbjct: 132 HS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF------VGTPYWMAPEV 182
Query: 760 AAT---GRVTTKIDVYAFGVVLME 780
G+ K+DV++ G+ +E
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE 206
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 589 LGRGGFGVVYGG-ELPDGTK-IAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVA 643
+G G +G V+ +L +G + +A+KR+ T E+AVL + H ++V
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 644 LLGYC-INGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
L C ++ ++R LV+E++ + L +L + + G T K + + RG++
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD---MMFQLLRGLD 124
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG---TFGYL 755
+LHS +HRDLKP NIL+ + K+ADFGL + YS + L T Y
Sbjct: 125 FLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR-----IYSFQMALTSVVVTLWYR 176
Query: 756 APEYAATGRVTTKIDVYAFGVVLME 780
APE T +D+++ G + E
Sbjct: 177 APEVLLQSSYATPVDLWSVGCIFAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 61/213 (28%), Positives = 93/213 (43%), Gaps = 36/213 (16%)
Query: 588 ILGRGGFGVVYGGELPDGTK--IAVKRMESN----------TMGNKGLSEFQAEIAVLTK 635
+LG+G FG V EL GT AVK ++ + TM K +
Sbjct: 2 VLGKGSFGKVLLAEL-KGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG------- 53
Query: 636 VRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
+H L L C +RL V EY+ G L H+ + A ++
Sbjct: 54 -KHPFLTQLHS-CFQTKDRLFFVMEYVNGGDLMFHI-----QRSGRFDEPRARFYAAEIV 106
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG-KYSVETR-LAGTF 752
G+++LH ++ I+RDLK N+L+ + K+ADFG+ K +G V T GT
Sbjct: 107 LGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTP 160
Query: 753 GYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
Y+APE + +D +A GV+L E + G+
Sbjct: 161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 20/236 (8%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V+ E G A+K ++ + K ++ E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL- 60
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDVARGVEYLHSL 703
Y +RL V EY G L HL + ++ + R ++ ++YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSR--ERVFS----EDRARFYGAEIVSALDYLH-- 112
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG 763
++++ ++RDLK N+++ D K+ DFGL K +++T GT YLAPE
Sbjct: 113 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT-FCGTPEYLAPEVLEDN 171
Query: 764 RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819
+D + GVV+ E + GR + D L F +L+ + P+ + P
Sbjct: 172 DYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHEKL---FELILMEEIRFPRTLSP 221
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-12
Identities = 71/268 (26%), Positives = 124/268 (46%), Gaps = 30/268 (11%)
Query: 531 KNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILG 590
KN G+ + +L + ++ E I ++ R ++ NI+G
Sbjct: 16 KNHKANKGGSGKFEMNDKKLDEEERSHNNNAGEDEDEEKMIDNDINRSPNKSYKLGNIIG 75
Query: 591 RGGFGVVYGGELPDGT-KIAVKR-MESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY- 647
G FGVVY D + K+A+K+ ++ N+ E+ ++ + H +++ L Y
Sbjct: 76 NGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-------ELLIMKNLNHINIIFLKDYY 128
Query: 648 ---CINGSERLL----VYEYMPRGTLAQHLFEWHDHGYT-PLTWKQRVTIALDVARGVEY 699
C +E+ + V E++P+ T+ +++ + + + PL + + L R + Y
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQL--CRALAY 185
Query: 700 LHSLAQQSFI-HRDLKPSNILIGDDMRA-KVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
+HS FI HRDLKP N+LI + K+ DFG KN G+ SV + + F Y AP
Sbjct: 186 IHS----KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSV-SYICSRF-YRAP 239
Query: 758 EYA-ATGRVTTKIDVYAFGVVLMETITG 784
E TT ID+++ G ++ E I G
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 3e-12
Identities = 37/101 (36%), Positives = 54/101 (53%), Gaps = 18/101 (17%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA---------PDGKYSVE 745
+ ++Y+HS + IHRDLKPSNIL+ D R K+ADFGL ++ P V
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 746 TRLAGTFGYLAPE-YAATGRVTTKIDVYAFGVVLMETITGR 785
TR Y APE + R T +D+++ G +L E + G+
Sbjct: 175 TRW-----YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 4e-12
Identities = 64/208 (30%), Positives = 91/208 (43%), Gaps = 26/208 (12%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEI-----AVLTKVRHRHLV 642
+G G G VY G +AVK+M GNK E I VL ++V
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRT--GNK---EENKRILMDLDVVLKSHDCPYIV 77
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
GY I S+ + E M T L + P ++T+A+ V+ LH
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPI-PEDILGKMTVAI-----VKALHY 129
Query: 703 LAQ-QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY-- 759
L + IHRD+KPSNIL+ K+ DFG+ D K +TR AG Y+APE
Sbjct: 130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK--AKTRSAGCAAYMAPERID 187
Query: 760 --AATGRVTTKIDVYAFGVVLMETITGR 785
+ + DV++ G+ L+E TG+
Sbjct: 188 PPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 581 DNFSEANILGRGGFGVVYG-GELPDGTKIAVKRME---SNTMGNKGLSEFQAEIAVLTKV 636
D+F + + LG G GVV+ P G +A K + + N+ + E Q VL +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQ----VLHEC 60
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
++V G + E + E+M G+L Q L G P +V+IA V +G
Sbjct: 61 NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIA--VIKG 115
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
+ YL + +HRD+KPSNIL+ K+ DFG+ D S+ GT Y++
Sbjct: 116 LTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 170
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGR 785
PE + + D+++ G+ L+E GR
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 63/214 (29%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRH 638
+F +++GRG FG V E G A+K M +S + + +S F+ E +L+
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ L Y + L LV EY P G L L + D + +A V
Sbjct: 61 PWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM-------AQFYLAELV 112
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
+HS+ Q ++HRD+KP N+LI K+ADFG K GT Y+AP
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAP 172
Query: 758 EYAAT------GRVTTKIDVYAFGVVLMETITGR 785
E T G + D ++ GV+ E I GR
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-12
Identities = 63/221 (28%), Positives = 101/221 (45%), Gaps = 18/221 (8%)
Query: 580 TDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNT-MGNKGLSEFQAEIAVLTKVR 637
NF +LG+G FG V E ++ A+K ++ + + + + E VL
Sbjct: 1 DFNFL--MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD 58
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
+ L C +RL V EY+ G L H+ Q V A +++ G
Sbjct: 59 KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPQAVFYAAEISVG 113
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETR-LAGTFGY 754
+ +LH ++ I+RDLK N+++ + K+ADFG+ K + DG V TR GT Y
Sbjct: 114 LFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG---VTTRTFCGTPDY 167
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD 795
+APE A +D +A+GV+L E + G+ D D+
Sbjct: 168 IAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-EIAVLTKVRHRHLVALLG 646
+G G +G V+ +A+KR+ + ++G+ EI +L +++H+++V L
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHD--HGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+ + LV+EY Q L ++ D +G + L +G+ + HS
Sbjct: 67 VLHSDKKLTLVFEYCD-----QDLKKYFDSCNGDIDPEIVKSFMFQL--LKGLAFCHS-- 117
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--APDGKYSVETRLAGTFGYLAPE--YA 760
+ +HRDLKP N+LI + K+ADFGL + P YS E T Y P+ +
Sbjct: 118 -HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV---TLWYRPPDVLFG 173
Query: 761 ATGRVTTKIDVYAFGVVLME 780
A +T ID+++ G + E
Sbjct: 174 AKL-YSTSIDMWSAGCIFAE 192
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-12
Identities = 68/235 (28%), Positives = 101/235 (42%), Gaps = 41/235 (17%)
Query: 569 VAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQ 627
A I LR ++F ++GRG FG V ++ A+K + M + S F
Sbjct: 31 AAEKITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFF 90
Query: 628 AEIAVLTKVRHRHLVAL--------LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGY 678
E R ++A L Y + L +V EYMP G L +L +D
Sbjct: 91 WE--------ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV-NLMSNYD--- 138
Query: 679 TPLTWKQ----RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL- 733
P W + V +ALD +HS+ FIHRD+KP N+L+ K+ADFG
Sbjct: 139 IPEKWARFYTAEVVLALDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTC 189
Query: 734 VKNAPDGKYSVETRLAGTFGYLAPEY----AATGRVTTKIDVYAFGVVLMETITG 784
+K +G +T + GT Y++PE G + D ++ GV L E + G
Sbjct: 190 MKMDANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 6e-12
Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 35/212 (16%)
Query: 588 ILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL-- 644
I+GRGGFG VYG D K+ A+K ++ + K Q E L + LV+
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMK-----QGETLALNERIMLSLVSTGD 55
Query: 645 ------LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ Y + ++L + + M G L HL + HG + + A ++ G+
Sbjct: 56 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ---HGV--FSEAEMRFYAAEIILGL 110
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV----KNAPDGKYSVETRLAGTFG 753
E++H+ + ++RDLKP+NIL+ + +++D GL K P SV GT G
Sbjct: 111 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA--SV-----GTHG 160
Query: 754 YLAPEYAATGRV-TTKIDVYAFGVVLMETITG 784
Y+APE G + D ++ G +L + + G
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 7e-12
Identities = 65/207 (31%), Positives = 101/207 (48%), Gaps = 22/207 (10%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVALL 645
LG G + VY G +G +A+K + T +G+ F A E ++L ++H ++V LL
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVP-FTAIREASLLKGLKHANIV-LL 68
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
I+ E L V+EYM LAQ++ + H G P + + RG+ Y+H
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQ-HPGGLHPYNVR---LFMFQLLRGLAYIH--- 120
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLV--KNAPDGKYSVETRLAGTFGYLAPE-YAA 761
Q +HRDLKP N+LI K+ADFGL K+ P YS E T Y P+
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV---TLWYRPPDVLLG 177
Query: 762 TGRVTTKIDVYAFGVVLMETITGRKAL 788
++ +D++ G + +E + G+ A
Sbjct: 178 ATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 8e-12
Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 28/216 (12%)
Query: 589 LGRGGFGVVYGGELPDGT------KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG FG VY G L +A+K ++ G EF+ E + ++++H ++V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPL-REEFKHEAMMRSRLQHPNIV 71
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR-----------VTIAL 691
LLG +++ Y L + L H T + V I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
+A G+E+L S +H+DL N+L+ D + K++D GL + Y +L G
Sbjct: 132 QIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY---YKLMGN 185
Query: 752 ----FGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
+++PE G+ + D++++GVVL E +
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 67/242 (27%), Positives = 106/242 (43%), Gaps = 39/242 (16%)
Query: 588 ILGRGGFGVVYGGELPDGTKI-AVKRMESN----------TMGNKGLSEFQAEIAVLTKV 636
+LG+G FG V EL + A+K ++ + TM + + E LT
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT-- 59
Query: 637 RHRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDV 693
HL +C ++ L V EY+ G L H+ + R A ++
Sbjct: 60 ---HL-----FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD------EARARFYAAEI 105
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
G+++LH + I+RDLK N+L+ D K+ADFG+ K +G+ T GT
Sbjct: 106 ICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPD 161
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKAL----DDTMPDDRAHLVTWFRRVLIS 809
Y+APE + +D ++FGV+L E + G+ +D + D + F R IS
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR-WIS 220
Query: 810 KE 811
KE
Sbjct: 221 KE 222
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 8e-12
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTK--IAVKRMESNTM-GNKGLSEFQAEIAVLTKVRH 638
+F+ +LG+G FG V E GT A+K ++ + + + + E VL
Sbjct: 1 DFNFLMVLGKGSFGKVMLAE-RKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK 59
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ L C +RL V EY+ G L H+ V A ++A G+
Sbjct: 60 PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI-----QQVGKFKEPHAVFYAAEIAIGL 114
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETR-LAGTFGYL 755
+LHS + I+RDLK N+++ + K+ADFG+ K N GK TR GT Y+
Sbjct: 115 FFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTPDYI 168
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGRKALD 789
APE A +D +AFGV+L E + G+ D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 9e-12
Identities = 63/249 (25%), Positives = 106/249 (42%), Gaps = 23/249 (9%)
Query: 582 NFSEANILGRGGFGVVY-----GGELPDGTKIAVKRMESNTMGNKGLS--EFQAEIAVLT 634
NF +LG G +G V+ G G A+K ++ T+ K + + E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 635 KVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL-D 692
+R + L Y +L L+ +Y+ G L HL + +Q V I +
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFK------EQEVQIYSGE 113
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ +E+LH L I+RD+K NIL+ + + DFGL K + + GT
Sbjct: 114 IVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 753 GYLAPEYAATGRV--TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810
Y+AP+ G +D ++ GV++ E +TG T+ ++ RR+L S+
Sbjct: 171 EYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF--TVDGEKNSQAEISRRILKSE 228
Query: 811 ENIPKAIDP 819
P+ +
Sbjct: 229 PPYPQEMSA 237
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 9e-12
Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 56/210 (26%)
Query: 675 DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734
+ PLT + ++ + VARG+E+L A + IHRDL NIL+ ++ K+ DFGL
Sbjct: 164 ELYKEPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLA 220
Query: 735 KNA---PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
++ PD + RL ++APE TT+ DV++FGV+L E +
Sbjct: 221 RDIYKDPDYVRKGDARLP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS-------- 270
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEE----------------TIESIYRVA 835
+ + P + +DEE IY +
Sbjct: 271 ---------------------LGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIM 309
Query: 836 ELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
L C P+ RP V +LG L+++
Sbjct: 310 -LD--CWHNNPEDRPTFSELVEILGDLLQE 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 27/208 (12%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V+ E G A+K ++ + K ++ E VL RH L +L
Sbjct: 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL- 60
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT-------IALDVARGV 697
Y +RL V EY+ G L HL ++RV ++ +
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLS------------RERVFSEDRTRFYGAEIVSAL 108
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
+YLHS ++RDLK N+++ D K+ DFGL K +++T GT YLAP
Sbjct: 109 DYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT-FCGTPEYLAP 164
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGR 785
E +D + GVV+ E + GR
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 59/198 (29%), Positives = 95/198 (47%), Gaps = 19/198 (9%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G +G VY L G AVK ++E S Q EI ++ + +H ++VA
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKIIKLEPG----DDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G ++ + + EY G+L Q ++ H PL+ Q + + +G+ YLHS +
Sbjct: 73 GSYLSREKLWICMEYCGGGSL-QDIY----HVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA---T 762
+HRD+K +NIL+ D+ K+ADFG V + GT ++APE AA
Sbjct: 128 ---MHRDIKGANILLTDNGDVKLADFG-VAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 763 GRVTTKIDVYAFGVVLME 780
G D++A G+ +E
Sbjct: 184 GGYNQLCDIWAVGITAIE 201
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 64/214 (29%), Positives = 99/214 (46%), Gaps = 23/214 (10%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVR 637
D + + +G G +GVVY + IA+K R+E G S EI++L +++
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVP--STAIREISLLKEMQ 59
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H ++V L + LV+EY+ L +H+ D P K T + RG+
Sbjct: 60 HGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSPDFAKNPRLIK---TYLYQILRGI 115
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRA---KVADFGLVK--NAPDGKYSVETRLAGTF 752
Y HS +HRDLKP N+LI D R K+ADFGL + P ++ E T
Sbjct: 116 AYCHS---HRVLHRDLKPQNLLI--DRRTNALKLADFGLARAFGIPVRTFTHEVV---TL 167
Query: 753 GYLAPEYAATGR-VTTKIDVYAFGVVLMETITGR 785
Y APE R +T +D+++ G + E + +
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 47/206 (22%), Positives = 91/206 (44%), Gaps = 9/206 (4%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQ-AEIAVLTKVRHR 639
+ F ++G G +GVV + +I + ++ N+ + E E+ +L ++
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V L + LV+EY+ + L L E +G P + + + + + +
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNML--ELLEEMPNGVPPEKVRSYI---YQLIKAIHW 115
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
H + +HRD+KP N+LI + K+ DFG +N +G + T T Y +PE
Sbjct: 116 CH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172
Query: 760 AATGRVTTKIDVYAFGVVLMETITGR 785
+D+++ G +L E G+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 2e-11
Identities = 64/210 (30%), Positives = 89/210 (42%), Gaps = 31/210 (14%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V+ E G A+K ++ + K ++ E VL RH L AL
Sbjct: 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL- 60
Query: 646 GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------G 696
Y +RL V EY G L HL ++RV + D AR
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLS------------RERV-FSEDRARFYGAEIVSA 107
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+ YLHS ++RDLK N+++ D K+ DFGL K + GT YL
Sbjct: 108 LGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYL 162
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGR 785
APE +D + GVV+ E + GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 56/204 (27%), Positives = 89/204 (43%), Gaps = 25/204 (12%)
Query: 587 NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQ----AEIAVLTKVRHRHL 641
ILG G G VY L +AVK + + E Q +E+ +L K ++
Sbjct: 7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-----VELQKQIMSELEILYKCDSPYI 61
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+ G + + E+M G+L + P R+ +A V +G+ YL
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVY-------RKIPEHVLGRIAVA--VVKGLTYLW 112
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA 761
SL +HRD+KPSN+L+ + K+ DFG+ + S+ GT Y+APE +
Sbjct: 113 SL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN---SIAKTYVGTNAYMAPERIS 166
Query: 762 TGRVTTKIDVYAFGVVLMETITGR 785
+ DV++ G+ ME GR
Sbjct: 167 GEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-11
Identities = 54/222 (24%), Positives = 97/222 (43%), Gaps = 34/222 (15%)
Query: 578 QVTDNFSEANILGRGGFGVV-YGGELPDGTKIAVKRM----ESNTMGNKGLSEFQAEIAV 632
+V D + + +G G +G V + G K+A+K++ +S + E + +
Sbjct: 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELR----L 67
Query: 633 LTKVRHRHLVALLGYCINGSERL-------LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ 685
L ++H +++ LL L LV +M GT L + +
Sbjct: 68 LKHMKHENVIGLLD-VFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLS------ED 118
Query: 686 RVT-IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744
R+ + + +G++Y+H+ IHRDLKP N+ + +D K+ DFGL + S
Sbjct: 119 RIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SE 171
Query: 745 ETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGR 785
T T Y APE T +D+++ G ++ E +TG+
Sbjct: 172 MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 3e-11
Identities = 52/151 (34%), Positives = 74/151 (49%), Gaps = 18/151 (11%)
Query: 591 RGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGL-SEFQAEIAVLTKVRHRHLVALLGYC 648
RG FG VY G + +K+ AVK ++ M NK + + QAE L + +V L
Sbjct: 14 RGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL 73
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGY----TPLTWKQRVTIALDVARGVEYLHSLA 704
+ + LV EY+ G + L H +GY + + V +ALD YLH
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLL---HIYGYFDEEMAVKYISEVALALD------YLH--- 121
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
+ IHRDLKP N+LI ++ K+ DFGL K
Sbjct: 122 RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-11
Identities = 64/201 (31%), Positives = 92/201 (45%), Gaps = 14/201 (6%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTK-VRHRHLVAL 644
++G+G FG V+ DG AVK ++ + N K AE VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
Y +E+L V +++ G L HL + + R A ++A + YLHS+
Sbjct: 62 -HYSFQTTEKLYFVLDFVNGGELFFHL----QRERSFPEPRARFYAA-EIASALGYLHSI 115
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG 763
+ ++RDLKP NIL+ + DFGL K + T GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGI-AQSDTTTTFCGTPEYLAPEVIRKQ 171
Query: 764 RVTTKIDVYAFGVVLMETITG 784
+D + G VL E + G
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-11
Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 17/219 (7%)
Query: 573 IEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIA 631
I LR +++ ++GRG FG V K+ A+K + M + S F E
Sbjct: 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 632 VLTKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
+ + V L Y L +V EYMP G L + + + V +A
Sbjct: 95 DIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLA 154
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRLA 749
LD +HS+ FIHRD+KP N+L+ K+ADFG +K +G +T +
Sbjct: 155 LDA------IHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV- 204
Query: 750 GTFGYLAPEY----AATGRVTTKIDVYAFGVVLMETITG 784
GT Y++PE G + D ++ GV L E + G
Sbjct: 205 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 4e-11
Identities = 59/234 (25%), Positives = 87/234 (37%), Gaps = 50/234 (21%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG+G G V+ L G A+K ++ M NK + E +L + H L L
Sbjct: 9 LGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNK-VKRVLTEQEILATLDHPFLPTL- 66
Query: 646 GYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLT----WKQRVTIALDVARGVEY 699
Y +E LV +Y P G L L + + V +AL EY
Sbjct: 67 -YASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAEVLLAL------EY 118
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG------------------K 741
LH L ++RDLKP NIL+ + ++DF L K +
Sbjct: 119 LHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 742 YSVETRLA----------GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
ET GT Y+APE + + +D + G++L E + G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 4e-11
Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 32/227 (14%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+F+ +LG+G FG V E ++ A+K ++ + + Q + T V R
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVV-------IQDDDVECTMVEKR- 52
Query: 641 LVALLG---------YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
++AL G C +RL V EY+ G L + + V A
Sbjct: 53 VLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQ-----VGRFKEPHAVFYA 107
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETR-L 748
++A G+ +LHS + I+RDLK N+++ + K+ADFG+ K N DG V T+
Sbjct: 108 AEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG---VTTKTF 161
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD 795
GT Y+APE A +D +AFGV+L E + G+ + D+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 6e-11
Identities = 54/176 (30%), Positives = 83/176 (47%), Gaps = 12/176 (6%)
Query: 589 LGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G FG V GE+ G ++ VK + + + +F E ++H +L+ L
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHD-HGYTP-LTWKQRVTIALDVARGVEYLHSL 703
G C + LLV E+ P G L +L TP T QR +A ++A G+ +LH
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR--MACEIALGLLHLH-- 117
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET-RLAGTFGYLAPE 758
+ +FIH DL N L+ D+ K+ D+GL N Y V +L ++APE
Sbjct: 118 -KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPE 172
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-11
Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
++G+G +GVV + G K+A+K++ + EI +L +RH +V +
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKH 66
Query: 647 YCINGSER-----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+ S R +V+E M + + + +D LT + + R ++Y+H
Sbjct: 67 IMLPPSRREFKDIYVVFELM--ESDLHQVIKANDD----LTPEHHQFFLYQLLRALKYIH 120
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDGKYSV-ETRLAGTFGYLAPEY 759
+ + HRDLKP NIL D + K+ DFGL + A D ++ T T Y APE
Sbjct: 121 T---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177
Query: 760 AAT--GRVTTKIDVYAFGVVLMETITGR 785
+ + T ID+++ G + E +TG+
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-11
Identities = 51/251 (20%), Positives = 101/251 (40%), Gaps = 18/251 (7%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+ + + L+ + + +L + +L L+ L N+++ L+N ++L ++ L N
Sbjct: 138 LKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLDLSGN 196
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ +P + L+ L+ L LS+N + + L+ +L+ L + N N +P+
Sbjct: 197 KISDLPPE-IELLSALEELDLSNNSII---ELLSSLSNLKNLSGLELSN-NKLEDLPESI 251
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
+ SNL+ L LS NN S+ + + ++++ L ++ L + L L L L
Sbjct: 252 GNLSNLETLDLS-NNQISSISSLGSLTNLRELDLSGNSLSNALPLIAL---LLLLLELLL 307
Query: 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS 303
T +L L + ++ N T S P L+I N L
Sbjct: 308 NLLLTLKALELKLNSILLNNNILSNGET--------SSPEALSILESLNNLWTLDNALDE 359
Query: 304 KVQKVSLDHNN 314
+ N
Sbjct: 360 SNLNRYIVKNP 370
|
Length = 394 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 17/215 (7%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
++ + +GRG FG V P GT +AVKR+ S K ++ V+ +
Sbjct: 2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTV-DEKEQKRLLMDLDVVMRSS 60
Query: 638 H-RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV--TIALDVA 694
++V G + + E M ++ F + + + + IA+
Sbjct: 61 DCPYIVKFYGALFREGDCWICMELM---DISLDKFYKYVYEVLKSVIPEEILGKIAVATV 117
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFG 753
+ + YL + IHRD+KPSNIL+ + K+ DFG+ D S+ +TR AG
Sbjct: 118 KALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRP 172
Query: 754 YLAPEYAATGRVT---TKIDVYAFGVVLMETITGR 785
Y+APE + DV++ G+ L E TG+
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 6e-11
Identities = 66/227 (29%), Positives = 101/227 (44%), Gaps = 40/227 (17%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVK--RMESNTMGNKGLSEFQA----EIAVL 633
D F +G G +G VY D G +A+K R+++ G F EI +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEG------FPITAIREIKIL 60
Query: 634 TKVRHRHLVALLGYCINGSERL----------LVYEYMPR---GTLAQHLFEW-HDHGYT 679
++ HR++V L + + L LV+EYM G L L + DH +
Sbjct: 61 RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKS 120
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739
+ KQ L+ G+ Y H +++F+HRD+K SNIL+ + + K+ADFGL +
Sbjct: 121 FM--KQ----LLE---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168
Query: 740 GKYSVETRLAGTFGYLAPE-YAATGRVTTKIDVYAFGVVLMETITGR 785
+ T T Y PE R IDV++ G +L E T +
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 7e-11
Identities = 54/188 (28%), Positives = 83/188 (44%), Gaps = 24/188 (12%)
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-- 737
LT + + + VA+G+E+L A + IHRDL NIL+ ++ K+ DFGL ++
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 738 -PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR 796
PD + RL ++APE T + DV++FGV+L E + + P
Sbjct: 232 DPDYVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPG 284
Query: 797 AHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAV 856
+ F R L KE + + T +Y+ C EP QRP V
Sbjct: 285 VKIDEEFCRRL--KEGT------RMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELV 333
Query: 857 NVLGPLVE 864
LG L++
Sbjct: 334 EHLGNLLQ 341
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 59/282 (20%), Positives = 112/282 (39%), Gaps = 53/282 (18%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA--- 643
++G+G +G V DG + +K++ + + E +L++++H ++VA
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 644 -----------LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
++G+C G + E + + EW +
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF----------------VQ 110
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+A ++YLH ++ +HRDLK N+ + KV D G+ + + + + + L GT
Sbjct: 111 IAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIAR-VLENQCDMASTLIGTP 166
Query: 753 GYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812
Y++PE + K DV+A G + E T + A + D LV +R +
Sbjct: 167 YYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN---AKDMNSLV--YRIIEGKLPP 221
Query: 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGH 854
+PK P L EL ++ P++RP +
Sbjct: 222 MPKDYSPEL-------------GELIATMLSKRPEKRPSVKS 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 58/218 (26%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 588 ILGRGGFGVVYGGELP-DGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG V L G AVK ++ + + + + E +L+ R+ + L
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 646 GYCINGSERLL-VYEYMPRGTLAQHL-----FEWHDHGYTPLTWKQRVTI-ALDVARGVE 698
C +RL V E++ G L H+ F+ + R A ++ +
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD-----------EARARFYAAEITSALM 110
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDGKYSVETRLAGTFGYLAP 757
+LH + I+RDLK N+L+ + K+ADFG+ K +GK + + GT Y+AP
Sbjct: 111 FLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT--STFCGTPDYIAP 165
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD 795
E +D +A GV+L E + G + DD
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 57/200 (28%), Positives = 90/200 (45%), Gaps = 20/200 (10%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
LG G FG VY + + +A ++ +T + L ++ EI +L H ++V LL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKV-IDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ ++ E+ G + + E PLT Q + + YLH +
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKI 124
Query: 709 IHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETR--LAGTFGYLAPEYA--ATG 763
IHRDLK NIL D K+ADFG+ KN +++ R GT ++APE T
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNT----RTIQRRDSFIGTPYWMAPEVVMCETS 180
Query: 764 R---VTTKIDVYAFGVVLME 780
+ K DV++ G+ L+E
Sbjct: 181 KDRPYDYKADVWSLGITLIE 200
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 18/204 (8%)
Query: 589 LGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G FG V E+ ++ VK +++N +K +EF + ++H +++ L
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDH-GYTPLTWKQRVTIALDVARGVEYLHSLA 704
G C+ LLV+EY G L +L + H + L QR +A ++A GV ++H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQR--MACEIAAGVTHMH--- 116
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRLAGTFGYLAPEYAA-- 761
+ +F+H DL N + D+ KV D+G+ + E +LAPE
Sbjct: 117 KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEF 176
Query: 762 -----TGRVTTKIDVYAFGVVLME 780
T T +V+A GV L E
Sbjct: 177 HGGLITAEQTKPSNVWALGVTLWE 200
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 37/95 (38%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
RG++Y+HS + +HRDLKPSN+L+ + K+ DFGL + K T T Y
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTT-SEKGDFMTEYVVTRWY 174
Query: 755 LAPE-YAATGRVTTKIDVYAFGVVLMETITGRKAL 788
APE TT IDV++ G + E + GRK L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 18/203 (8%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTK-VRHRHLVAL 644
++G+G FG V+ + AVK ++ + K +E VL K V+H LV L
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
+ +++L V +Y+ G L HL L + R A ++A + YLHSL
Sbjct: 62 -HFSFQTADKLYFVLDYINGGELFYHL----QRERCFLEPRARF-YAAEIASALGYLHSL 115
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--APDGKYSVETRLAGTFGYLAPEYAA 761
+ ++RDLKP NIL+ + DFGL K +G S GT YLAPE
Sbjct: 116 ---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTST---FCGTPEYLAPEVLH 169
Query: 762 TGRVTTKIDVYAFGVVLMETITG 784
+D + G VL E + G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 4e-10
Identities = 37/100 (37%), Positives = 53/100 (53%), Gaps = 24/100 (24%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD--GKYSVETRLAGTF 752
RG++Y+HS IHRDLKPSNI + +D K+ DFGL ++ D Y V TR
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY-VATRW---- 180
Query: 753 GYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
Y APE Y T +D+++ G ++ E +TG+
Sbjct: 181 -YRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 4e-10
Identities = 56/235 (23%), Positives = 99/235 (42%), Gaps = 22/235 (9%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAV 632
+ + +V + + + +G G +G V + G ++AVK++ E+ +
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69
Query: 633 LTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT---- 688
L ++H +++ LL E L HL + Q++T
Sbjct: 70 LKHMKHENVIGLLDVFTPARS----LEEFNDVYLVTHLM---GADLNNIVKCQKLTDDHV 122
Query: 689 --IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746
+ + RG++Y+HS IHRDLKPSN+ + +D K+ DFGL ++ D T
Sbjct: 123 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM----T 175
Query: 747 RLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV 800
T Y APE +D+++ G ++ E +TGR T D+ L+
Sbjct: 176 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLI 230
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-10
Identities = 60/259 (23%), Positives = 101/259 (38%), Gaps = 31/259 (11%)
Query: 79 SGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTN 138
S S + +L L +L +N + I L T+L + LDNNN T +P +N
Sbjct: 82 SLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSN 141
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198
L+ L LSDN + P+ L +L L + ++ L + SNL NL LS N
Sbjct: 142 LKELDLSDNKIES---LPSPLRNLPNLKNLDLSFNDLSDLPKLLSNL-SNLNNLDLSGNK 197
Query: 199 FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCE 258
+ LP + ++ L ++ L N + LS +
Sbjct: 198 IS-DLP------------------------PEIELLSALEELDLSNNSIIELLSSLSNLK 232
Query: 259 SLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCK 317
+L L L +N+L +P S+ +L L + L NN++ L + ++++ L N+
Sbjct: 233 NLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISSLGSLTNLRELDLSGNSLSN 291
Query: 318 NSSDAGKPCDPQVTTLLQI 336
L +
Sbjct: 292 ALPLIALLLLLLELLLNLL 310
|
Length = 394 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 5e-10
Identities = 70/297 (23%), Positives = 119/297 (40%), Gaps = 65/297 (21%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
D+F ++GRG FG V + D I A+K++ + M K ++ +AE +L + +
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADN 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ-RVTIALDVARG 696
+V L Y L L+ EY+P G + L + T ++ R IA +
Sbjct: 61 PWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMK-----KDTFTEEETRFYIA-ETILA 113
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL----------------VKNAPDG 740
++ +H L +IHRD+KP N+L+ K++DFGL P
Sbjct: 114 IDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSN 170
Query: 741 KYSVETR-----------------LA----GTFGYLAPE-YAATGRVTTKIDVYAFGVVL 778
++ LA GT Y+APE + TG + D ++ GV++
Sbjct: 171 FLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIM 229
Query: 779 METITGRKAL--DDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYR 833
E + G D+ +R+++ KE + + L E + I R
Sbjct: 230 YEMLVGYPPFCSDNPQ--------ETYRKIINWKETLQ--FPDEVPLSPEAKDLIKR 276
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 7e-10
Identities = 59/229 (25%), Positives = 100/229 (43%), Gaps = 41/229 (17%)
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
+++++V H HL + G C+ GSE ++V E++ G L L + + G P+ WK +T+A
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWK--ITVA 123
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILI-------GDDMRAKVADFGLVKNAPDGKYS 743
+A + YL ++ +H ++ NIL+ G K++D G+ A +
Sbjct: 124 QQLASALSYLED---KNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREER 180
Query: 744 VETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMET-ITGRKALDDTMPDDRAHLVT 801
VE R+ ++APE G ++T D ++FG L+E G L + P ++
Sbjct: 181 VE-RIP----WIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYE 235
Query: 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
K +P+ L A L C EP QRP
Sbjct: 236 -------KKHRLPEPSCKEL-------------ATLISQCLTYEPTQRP 264
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 35/96 (36%), Positives = 55/96 (57%), Gaps = 9/96 (9%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYSVETRLA---G 750
RG++Y+HS + +HRDLKP+N+ I +D+ K+ DFGL + D YS + L+
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLAR-IVDPHYSHKGYLSEGLV 180
Query: 751 TFGYLAPEYAATGRVTTK-IDVYAFGVVLMETITGR 785
T Y +P + TK ID++A G + E +TG+
Sbjct: 181 TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 8e-10
Identities = 63/249 (25%), Positives = 105/249 (42%), Gaps = 24/249 (9%)
Query: 582 NFSEANILGRGGFGVVY-----GGELPDGTKI-AVKRMESNTMGNKG--LSEFQAEIAVL 633
NF +LG G +G V+ G D K+ A+K ++ + K + + E VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTG--HDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVL 58
Query: 634 TKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
VR + L Y +L L+ +Y+ G + HL++ D+ + R +
Sbjct: 59 EHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQ-RDNFSED---EVRFYSG-E 113
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ +E+LH L ++RD+K NIL+ + + DFGL K + GT
Sbjct: 114 IILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 753 GYLAPEY--AATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810
Y+APE G +D ++ G+++ E +TG T+ +R RR+L
Sbjct: 171 EYMAPEIIRGKGGH-GKAVDWWSLGILIFELLTGASPF--TLEGERNTQSEVSRRILKCD 227
Query: 811 ENIPKAIDP 819
P I P
Sbjct: 228 PPFPSFIGP 236
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 9e-10
Identities = 63/200 (31%), Positives = 92/200 (46%), Gaps = 15/200 (7%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G+G FG V D +I A+K + +++ + ++ AE VL +V +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ E+L LV ++ G L HL G L+ + T L A +E LH
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHL---QREGRFDLSRARFYTAELLCA--LENLHKF-- 112
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFGYLAPEYAATGR 764
+ I+RDLKP NIL+ + DFGL K N D + GT YLAPE
Sbjct: 113 -NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKT--NTFCGTPEYLAPELLLGHG 169
Query: 765 VTTKIDVYAFGVVLMETITG 784
T +D + GV+L E +TG
Sbjct: 170 YTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 49/170 (28%), Positives = 67/170 (39%), Gaps = 20/170 (11%)
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746
+ I V R ++YLH + IHRD+K NI I + DFG D +
Sbjct: 185 LAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY 241
Query: 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG------RKALDDTMPDDRAHLV 800
AGT APE A +D+++ G+VL E T + LD DR +
Sbjct: 242 GWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDR-QIK 300
Query: 801 TWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
RR P ID NLDE I + ++R+P RP
Sbjct: 301 LIIRRSGTHPNEFP--IDAQANLDEIYIGLAKK--------SSRKPGSRP 340
|
Length = 391 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 51/159 (32%), Positives = 81/159 (50%), Gaps = 18/159 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
++F ++G+G FG V + D KI A+K + + M K L+ +AE VL +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT---IALDVA 694
+V+L Y ++ L L+ E++P G L L ++ T+ + VT +A +
Sbjct: 61 PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYD-------TFSEDVTRFYMA-ECV 111
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+E +H L FIHRD+KP NILI K++DFGL
Sbjct: 112 LAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 59/230 (25%), Positives = 99/230 (43%), Gaps = 44/230 (19%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDG-TKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
++F ++ G +G VY + + A+K++ + + + + E +LT +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAEN 60
Query: 639 RHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR- 695
+V++ +C ++R L V EY+ G A L K + +D+AR
Sbjct: 61 PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLL-------------KNIGALPVDMARM 105
Query: 696 -------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--------NAPDG 740
+EYLH+ +HRDLKP N+LI K+ DFGL K N +G
Sbjct: 106 YFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEG 162
Query: 741 KYSVETR------LAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784
+TR + GT Y+APE +D +A G++L E + G
Sbjct: 163 HIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 64/227 (28%), Positives = 96/227 (42%), Gaps = 44/227 (19%)
Query: 588 ILGRGGFGVVYGGELPDGTKI-AVKRMESN----------TMGNKGLSEFQAEIAVLTKV 636
+LG+G FG V EL ++ A+K ++ + TM K + A
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-------- 53
Query: 637 RHRHLVALLGYCINGSERLL-VYEYMPRGTL------AQHLFEWHDHGYTPLTWKQRVTI 689
+H L AL C +RL V EY+ G L ++ E Y VT+
Sbjct: 54 KHPFLTALHC-CFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYA-----AEVTL 107
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRL 748
AL +LH + I+RDLK NIL+ + K+ADFG+ K +G + T
Sbjct: 108 AL------MFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT--TTF 156
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD 795
GT Y+APE +D +A GV++ E + G+ + DD
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD 203
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-09
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 25/240 (10%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRHRHLVALL 645
++GRG + V L +I ++ + ++ + Q E V + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGL 61
Query: 646 GYCINGSERL-LVYEYMPRGTLAQH------LFEWHDHGYTPLTWKQRVTIALDVARGVE 698
C + RL LV EY+ G L H L E H Y + IAL+
Sbjct: 62 HSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYA-----AEICIALN------ 110
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+LH ++ I+RDLK N+L+ D K+ D+G+ K G + GT Y+APE
Sbjct: 111 FLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL-GPGDTTSTFCGTPNYIAPE 166
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE-NIPKAI 817
+D +A GV++ E + GR D + + + +V++ K IP+ +
Sbjct: 167 ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFL 226
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 30/219 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRH 638
D+F ++GRG FG V ++ + ++ A+K + M + + F+ E VL
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVN-GD 59
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
R + L Y L LV +Y G L L ++ D + D+AR
Sbjct: 60 RRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR------------LPEDMARFY 107
Query: 696 ---GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG-LVKNAPDGKYSVETRLA-G 750
V + S+ Q ++HRD+KP N+L+ + ++ADFG ++ DG +V++ +A G
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG--TVQSNVAVG 165
Query: 751 TFGYLAPEY-----AATGRVTTKIDVYAFGVVLMETITG 784
T Y++PE GR + D ++ GV + E + G
Sbjct: 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 60/216 (27%), Positives = 89/216 (41%), Gaps = 33/216 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGT--KIAVKRME-SNTMGNKGLSEFQAEIAVLTKVR 637
++F+ LG G FG V + +A+KR E S + K + +E +L +
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN 89
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT------IAL 691
H V L G + S LV E++ G +T L +R A
Sbjct: 90 HPFCVNLYGSFKDESYLYLVLEFVIGGEF-----------FTFLRRNKRFPNDVGCFYAA 138
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR---L 748
+ EYL SL + ++RDLKP N+L+ D K+ DFG K V+TR L
Sbjct: 139 QIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAK-------VVDTRTYTL 188
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784
GT Y+APE D + G+ + E + G
Sbjct: 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 50/210 (23%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 589 LGRGGFGVVYGG---ELPDG-----TKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHR 639
LG+G F ++ G E+ D T++ +K ++ + ++ SE F ++++++ H+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHK 59
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
HLV G C+ G E ++V EY+ G+L +L + + ++WK L+VA+ + +
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKK--NKNLINISWK------LEVAKQLAW 111
Query: 700 -LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETR--LAGTFGYL 755
LH L + H ++ N+L+ + K + +K + P +V + L ++
Sbjct: 112 ALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWV 171
Query: 756 APEYAATGR-VTTKIDVYAFGVVLMETITG 784
PE + ++ D ++FG L E +G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 3e-09
Identities = 63/231 (27%), Positives = 100/231 (43%), Gaps = 23/231 (9%)
Query: 576 LRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
LR F ++G G +G VY G + G A+K M+ G++ E + EI +L
Sbjct: 1 LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD--VTGDEE-EEIKQEINMLK 57
Query: 635 KV-RHRHLVALLGYCINGS------ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
K HR++ G I + + LV E+ G++ + + G T L +
Sbjct: 58 KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI--KNTKGNT-LKEEWIA 114
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
I ++ RG+ +LH Q IHRD+K N+L+ ++ K+ DFG V D
Sbjct: 115 YICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTVGRRNT 170
Query: 748 LAGTFGYLAPEYAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMP 793
GT ++APE A K D+++ G+ +E G L D P
Sbjct: 171 FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 221
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-09
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 8/94 (8%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV-KNAPDGKYSVE-TRLAGTF 752
RG++YLHS +HRD+KP N+L+ + K+ DFGL PD S T+ T
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE--SKHMTQEVVTQ 168
Query: 753 GYLAPEYAATGR-VTTKIDVYAFGVVLMETITGR 785
Y APE R T+ +D+++ G + E + R
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 4e-09
Identities = 62/244 (25%), Positives = 101/244 (41%), Gaps = 31/244 (12%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN--KGLSEFQAEIAVLTKVRHRHLVALL 645
++GRG + V L +I ++ + N + + Q E V + + + L
Sbjct: 2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61
Query: 646 GYCINGSERLL-VYEYMPRGTLAQH------LFEWHDHGYTPLTWKQRVTIALDVARGVE 698
C RL V EY+ G L H L E H Y+ +++AL+
Sbjct: 62 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYS-----AEISLALN------ 110
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA--PDGKYSVETRLAGTFGYLA 756
YLH ++ I+RDLK N+L+ + K+ D+G+ K P S GT Y+A
Sbjct: 111 YLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIA 164
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT---WFRRVLISKENI 813
PE +D +A GV++ E + GR D D T F+ +L + I
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 224
Query: 814 PKAI 817
P+++
Sbjct: 225 PRSL 228
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 27/210 (12%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG+G +G VY P G +A+K R+E + ++ E+ +L K ++V
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKFNQIIMELDILHKAVSPYIVDFY 65
Query: 646 G-YCINGSERLLVY---EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
G + I G+ VY EYM G+L + P +R+T A V +G+++L
Sbjct: 66 GAFFIEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYA--VVKGLKFLK 119
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY-- 759
+ + IHRD+KP+N+L+ + + K+ DFG+ N S+ G Y+APE
Sbjct: 120 E--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIK 174
Query: 760 ----AATGRVTTKIDVYAFGVVLMETITGR 785
T + DV++ G+ ++E GR
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 14/205 (6%)
Query: 589 LGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G G FG + DG + +K + + M K E + E+AVL+ ++H ++V
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP---LTWKQRVTIALDVARGVEYLHSLA 704
+V +Y G L + + + L W ++ +AL +++H
Sbjct: 68 FEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLAL------KHVHD-- 119
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR 764
+ +HRD+K NI + D K+ DFG+ + + + GT YL+PE
Sbjct: 120 -RKILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELARTCIGTPYYLSPEICENRP 177
Query: 765 VTTKIDVYAFGVVLMETITGRKALD 789
K D++A G VL E T + A +
Sbjct: 178 YNNKSDIWALGCVLYEMCTLKHAFE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 5e-09
Identities = 34/94 (36%), Positives = 47/94 (50%), Gaps = 13/94 (13%)
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG----KYSVETRLAGT 751
G+++LHS IHRDLKPSNI++ D K+ DFGL + A Y V TR
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVV-TRY--- 182
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
Y APE +D+++ G ++ E I G
Sbjct: 183 --YRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 57/214 (26%), Positives = 93/214 (43%), Gaps = 35/214 (16%)
Query: 587 NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN--KGLSEFQA--EIAVLTKVRHRHL 641
+G+G FG V+ +A+K++ M N +G A EI +L ++H ++
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKV---LMENEKEGFP-ITALREIKILQLLKHENV 73
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR------ 695
V L+ C + Y +G+ +FE+ +H L + V L +
Sbjct: 74 VNLIEICRTKATPYNRY----KGSFYL-VFEFCEHDLAGLLSNKNVKFTLSEIKKVMKML 128
Query: 696 --GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV------KNAPDGKYSVETR 747
G+ Y+H +HRD+K +NILI D K+ADFGL KN+ +Y+ R
Sbjct: 129 LNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT--NR 183
Query: 748 LAGTFGYLAPEYAATGR-VTTKIDVYAFGVVLME 780
+ T Y PE R ID++ G ++ E
Sbjct: 184 VV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAE 216
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-09
Identities = 56/214 (26%), Positives = 92/214 (42%), Gaps = 22/214 (10%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V + + +G G G+V + G +AVK++ E+ +L V
Sbjct: 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN 78
Query: 638 HRHLVALLGYCI------NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
H+++++LL + LV E M L Q + DH +R++ L
Sbjct: 79 HKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHMELDH--------ERMSYLL 129
Query: 692 -DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
+ G+++LHS IHRDLKPSNI++ D K+ DFGL + A + T
Sbjct: 130 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN--FMMTPYVV 184
Query: 751 TFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784
T Y APE +D+++ G ++ E + G
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 19/220 (8%)
Query: 573 IEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIA 631
I L+ +++ ++GRG FG V K+ A+K + M + S F E
Sbjct: 35 IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEER 94
Query: 632 VLTKVRHRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
+ + V L +C ++ L V EYMP G L +L +D P W + T
Sbjct: 95 DIMAFANSPWVVQL-FCAFQDDKYLYMVMEYMPGGDLV-NLMSNYD---VPEKWAKFYTA 149
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRL 748
+V ++ +HS+ IHRD+KP N+L+ K+ADFG +K G +T +
Sbjct: 150 --EVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV 204
Query: 749 AGTFGYLAPEY----AATGRVTTKIDVYAFGVVLMETITG 784
GT Y++PE G + D ++ GV L E + G
Sbjct: 205 -GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 29/214 (13%)
Query: 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLS-EFQAEIAVLTKVR---HRHLVA 643
+G G +G VY P G +A+K + T GL E+A+L ++ H ++V
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQT-NEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 644 LLGYCING-----SERLLVYEYMPRGTLAQHLFEWHDHGYTP-LTWKQRVTIALDVARGV 697
L+ C ++ LV+E++ Q L + D P L + + RG+
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVD-----QDLRTYLDKVPPPGLPAETIKDLMRQFLRGL 121
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG---TFGY 754
++LH+ +HRDLKP NIL+ + K+ADFGL + YS + L T Y
Sbjct: 122 DFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR-----IYSCQMALTPVVVTLWY 173
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETITGRKAL 788
APE T +D+++ G + E RK L
Sbjct: 174 RAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-08
Identities = 72/297 (24%), Positives = 108/297 (36%), Gaps = 62/297 (20%)
Query: 583 FSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRH 640
F + +G G FG V D + A+K + + + + +AE +L + +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V L Y + L V +Y+P G + L G R IA ++ +E
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRL---GIFEEDLA-RFYIA-ELTCAIES 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN---APDGKY-------------- 742
+H + FIHRD+KP NILI D K+ DFGL D KY
Sbjct: 117 VHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173
Query: 743 -------------SVETR------------LAGTFGYLAPEYAATGRVTTKIDVYAFGVV 777
+E R L GT Y+APE T D ++ GV+
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 233
Query: 778 LMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRV 834
L E + G+ P + V + L +IP L E + I R+
Sbjct: 234 LYEMLVGQPPFLADTPAETQLKVINWETTL----HIP----SQAKLSREASDLILRL 282
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 58/214 (27%), Positives = 99/214 (46%), Gaps = 20/214 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
D+F ++GRG FG V ++ +I A+K + M + + F+ E VL
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ + L Y L LV +Y G L L ++ D + +A V
Sbjct: 61 QWITTL-HYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMA-------RFYIAEMV 112
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG-LVKNAPDGKYSVETRLA-GTFGYL 755
+HS+ Q ++HRD+KP N+L+ + ++ADFG +K DG +V++ +A GT Y+
Sbjct: 113 LAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG--TVQSSVAVGTPDYI 170
Query: 756 APEYA-----ATGRVTTKIDVYAFGVVLMETITG 784
+PE G+ + D ++ GV + E + G
Sbjct: 171 SPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 60/236 (25%), Positives = 97/236 (41%), Gaps = 23/236 (9%)
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAE 629
I + LR F ++G G +G VY G + G A+K M+ + E + E
Sbjct: 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLE 62
Query: 630 IAVLTKV-RHRHLVALLGYCINGS------ERLLVYEYMPRGTLAQHLFEWHDHGYTPLT 682
I +L K HR++ G I S + LV E+ G++ + +
Sbjct: 63 INMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKE-D 121
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
W I ++ RG+ +LH+ IHRD+K N+L+ ++ K+ DFG V D
Sbjct: 122 WI--AYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFG-VSAQLDRTV 175
Query: 743 SVETRLAGTFGYLAPEYAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMP 793
GT ++APE A + D+++ G+ +E G L D P
Sbjct: 176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 1e-08
Identities = 74/326 (22%), Positives = 128/326 (39%), Gaps = 57/326 (17%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+LG G G V+ + DG AVK ++ M + QAE+ L +V
Sbjct: 39 VLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHE 98
Query: 647 YCINGSER--------LLVYEYMPRGTLAQHL---------FEWHDHGYTPLTWKQRVTI 689
R LV +Y G L Q + F H+ G +
Sbjct: 99 DFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGL----------L 148
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRL 748
+ V V ++HS + IHRD+K +NIL+ + K+ DFG K A V
Sbjct: 149 FIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808
GT Y+APE + K D+++ GV+L E +T ++ D ++ H + L
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH------KTLA 259
Query: 809 SK-ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867
+ + +P +I P + E+ + +P++RP +N+ P+ + +
Sbjct: 260 GRYDPLPPSISPEM-------------QEIVTALLSSDPKRRPSSSKLLNM--PICKLFI 304
Query: 868 PATRE---DEDGYGIDLHMSLPQALQ 890
E + G+ L ++ + +Q
Sbjct: 305 SGLLEIVQTQPGFSGPLRDTISRQIQ 330
|
Length = 496 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 58/213 (27%), Positives = 91/213 (42%), Gaps = 28/213 (13%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN--KGLSEFQAEIAVL-TKVRHRHLVAL 644
++GRG + V EL +I ++ + N + + Q E V T H LV L
Sbjct: 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61
Query: 645 LGYCINGSERL-LVYEYMPRGTLAQH------LFEWHDHGYTPLTWKQRVTIALDVARGV 697
C RL V E++ G L H L E H Y+ +++AL+
Sbjct: 62 HS-CFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYS-----AEISLALN----- 110
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFGYLA 756
+LH + I+RDLK N+L+ + K+ D+G+ K G + + GT Y+A
Sbjct: 111 -FLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT--STFCGTPNYIA 164
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALD 789
PE +D +A GV++ E + GR D
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 2e-08
Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 54/290 (18%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTKVRH 638
D+F ++GRG FG V + D I ++ +++ + + ++ +AE +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+V + Y L L+ E++P G + L + T + T +A V
Sbjct: 61 AWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKD-------TLSEEAT-QFYIAETV 111
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----------------LVKNAP--- 738
+ ++ Q FIHRD+KP N+L+ K++DFG L N P
Sbjct: 112 LAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 739 -----DGKYSVET------RLA----GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
+ K ET +LA GT Y+APE D ++ GV++ E +
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 784 GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYR 833
G P + +R+V+ KE + P + + E+ + I R
Sbjct: 232 GYPPFCSETPQET------YRKVMNWKETL--VFPPEVPISEKAKDLILR 273
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 57/215 (26%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
++F ++GRG FG V +L + K+ A+K + M + + F+ E VL +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLT--WKQRVTIALDVARG 696
+ + L + + LV +Y G L L ++ D + + + IA+D
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID---- 116
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG-LVKNAPDGKYSVETRLA-GTFGY 754
S+ Q ++HRD+KP NIL+ + ++ADFG +K DG +V++ +A GT Y
Sbjct: 117 -----SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--TVQSSVAVGTPDY 169
Query: 755 LAPEYA-----ATGRVTTKIDVYAFGVVLMETITG 784
++PE G+ + D ++ GV + E + G
Sbjct: 170 ISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.7 bits (135), Expect = 3e-08
Identities = 70/303 (23%), Positives = 110/303 (36%), Gaps = 59/303 (19%)
Query: 576 LRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
L T F ++G G +G VY G +A+K M+ + E + E +L
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE---EIKEEYNILR 57
Query: 635 KV-RHRHLVALLG------YCINGSERLLVYEYMPRGT---LAQHLFEWHDHGYTPLTWK 684
K H ++ G N + LV E G+ L + L
Sbjct: 58 KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL----------RKKG 107
Query: 685 QRVT------IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738
+R+ I + RG+ YLH + IHRD+K NIL+ + K+ DFG+ +
Sbjct: 108 KRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGV---SA 161
Query: 739 DGKYSVETR--LAGTFGYLAPE-----YAATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
++ R GT ++APE + DV++ G+ +E G+ L D
Sbjct: 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD- 220
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
M RA IP+ P L E + + C + +QRP
Sbjct: 221 MHPMRALFK------------IPRNPPPTLKSPENWSKKFN---DFISECLIKNYEQRPF 265
Query: 852 MGH 854
M
Sbjct: 266 MEE 268
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 4e-08
Identities = 54/201 (26%), Positives = 83/201 (41%), Gaps = 20/201 (9%)
Query: 589 LGRGGFGVVY---------GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
LG+G FG VY L +I V + N E +L+K+ H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-----EAQLLSKLDHP 62
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V + ++ EY L L E G T L+ Q + + GV Y
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT-LSENQVCEWFIQLLLGVHY 121
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
+H Q+ +HRDLK NI + +++ K+ DFG V G + T GT Y++PE
Sbjct: 122 MH---QRRILHRDLKAKNIFLKNNL-LKIGDFG-VSRLLMGSCDLATTFTGTPYYMSPEA 176
Query: 760 AATGRVTTKIDVYAFGVVLME 780
+K D+++ G +L E
Sbjct: 177 LKHQGYDSKSDIWSLGCILYE 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 4e-08
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 8/92 (8%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
RG++Y+HS IHRDLKPSN+ + +D ++ DFGL + A D T T Y
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM----TGYVATRWY 181
Query: 755 LAPEYAATG-RVTTKIDVYAFGVVLMETITGR 785
APE +D+++ G ++ E + G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 5e-08
Identities = 57/202 (28%), Positives = 90/202 (44%), Gaps = 15/202 (7%)
Query: 589 LGRGGFGVVYGGELPDGTKI-AVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRH---LVA 643
+G+G FG VY D +I A+K + + K ++ E +L + +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L S+ LV +YM G L HL + ++ + + IA ++ +E+LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFS--EDRAKFYIA-ELVLALEHLH-- 113
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG 763
+ ++RDLKP NIL+ + DFGL K A GT YLAPE
Sbjct: 114 -KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTTNTFCGTTEYLAPEVLLDE 171
Query: 764 RVTTK-IDVYAFGVVLMETITG 784
+ TK +D ++ GV++ E G
Sbjct: 172 KGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-08
Identities = 33/90 (36%), Positives = 47/90 (52%), Gaps = 5/90 (5%)
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
G+++LHS IHRDLKPSNI++ D K+ DFGL + A G + T T Y
Sbjct: 138 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRYYR 192
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGR 785
APE +D+++ G ++ E I G
Sbjct: 193 APEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-08
Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APD 739
L++ V + VA G+E+L A ++ +HRDL N+LI + K+ DFGL ++ D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
Query: 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
Y + ++APE TT DV++FG++L E T
Sbjct: 293 SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 8e-08
Identities = 35/132 (26%), Positives = 59/132 (44%), Gaps = 12/132 (9%)
Query: 603 PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662
P T +AVK++ ++ + L Q EI +++H +++ + I SE +V M
Sbjct: 23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIAL---DVARGVEYLHSLAQQSFIHRDLKPSNIL 719
G+ L G L IA DV ++Y+HS FIHR +K S+IL
Sbjct: 83 YGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSKG---FIHRSVKASHIL 133
Query: 720 IGDDMRAKVADF 731
+ D + ++
Sbjct: 134 LSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 9e-08
Identities = 65/270 (24%), Positives = 106/270 (39%), Gaps = 44/270 (16%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRH 638
++F ++GRG FG V + D G A+K + M K + +AE +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
+V + + L+ E++P G + L + T + T +A V
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD-------TLTEEET-QFYIAETVL 112
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAP----------------- 738
+ S+ Q FIHRD+KP N+L+ K++DFGL +K A
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 739 ----DGKYSVET------RLA----GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784
+ K ET +LA GT Y+APE D ++ GV++ E + G
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 785 RKALDDTMPDDRAHLVTWFRRVLISKENIP 814
P + V ++ LI +P
Sbjct: 233 YPPFCSETPQETYKKVMNWKETLIFPPEVP 262
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-07
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 12/94 (12%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS--VETRLAGTF 752
G++Y+HS IHRDLKP N+ + +D K+ DFGL ++A D + + V TR
Sbjct: 128 CGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHA-DAEMTGYVVTRW---- 179
Query: 753 GYLAPEYAATG-RVTTKIDVYAFGVVLMETITGR 785
Y APE +D+++ G ++ E +TG+
Sbjct: 180 -YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 52/212 (24%), Positives = 88/212 (41%), Gaps = 42/212 (19%)
Query: 589 LGRGGFGVV---YGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+G G G+V Y L +A+K++ E+ ++ V H+++++LL
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82
Query: 646 GYCINGSERLLVYEYMPRGTLAQH-----LFEWHDHGYTPLTWKQRVTIALDVAR----- 695
+ P+ +L + + E D Q + + LD R
Sbjct: 83 NV------------FTPQKSLEEFQDVYLVMELMDANLC-----QVIQMELDHERMSYLL 125
Query: 696 -----GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
G+++LHS IHRDLKPSNI++ D K+ DFGL + A G + T
Sbjct: 126 YQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVV 180
Query: 751 TFGYLAPEYAATGRVTTKIDVYAFGVVLMETI 782
T Y APE +D+++ G ++ E +
Sbjct: 181 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 1e-07
Identities = 39/173 (22%), Positives = 73/173 (42%), Gaps = 20/173 (11%)
Query: 619 GNKGLSEFQAEIAVLTKVRHRHLVAL--------LGYCINGSERLLVYEYMPRGTLAQHL 670
G++ + + EI L ++ H +++ + Y I +Y +M
Sbjct: 203 GSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA----- 257
Query: 671 FEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730
F+W D PL + R I + VEY+H + IHRD+K NI + D + + D
Sbjct: 258 FDWKD---RPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENIFLNCDGKIVLGD 310
Query: 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
FG + + + GT +PE A D+++ G++L++ ++
Sbjct: 311 FGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 2e-07
Identities = 33/98 (33%), Positives = 56/98 (57%), Gaps = 8/98 (8%)
Query: 57 WTGINC--DNSNR---VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLA 110
W+G +C D++ + + L GL G + +IS L L++++ N+I G IP SL
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 111 NATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDN 147
+ TSL+ + L N+F S+P LT+L++L+L+ N
Sbjct: 464 SITSLEVLDLSYNSFNGSIPES-LGQLTSLRILNLNGN 500
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 2e-07
Identities = 39/140 (27%), Positives = 59/140 (42%), Gaps = 29/140 (20%)
Query: 148 PNLAPWPFPNELTKSTS----LTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
P PW + ST + L +DN + G IP+ +LQ++ LS N+ G++
Sbjct: 399 PQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNI 458
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFD 262
P S G+ +T L + L N F G IP+ L + SL
Sbjct: 459 PPSL------------------GS------ITSLEVLDLSYNSFNGSIPESLGQLTSLRI 494
Query: 263 LSLRDNQLTGVVPASVISLP 282
L+L N L+G VPA++
Sbjct: 495 LNLNGNSLSGRVPAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 4/110 (3%)
Query: 675 DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734
D G LT ++ VARG+E+L A ++ +HRDL N+L+ K+ DFGL
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLA 284
Query: 735 KN-APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
++ D Y + ++APE TT DV+++G++L E +
Sbjct: 285 RDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 46/139 (33%), Positives = 67/139 (48%), Gaps = 23/139 (16%)
Query: 655 LLVYEYMPRGTL--------AQHL-FEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
LL+ EY G L +HL F+ ++ G L + Q + +ALD +HS
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG---LLFYQ-IVLALD------EVHS--- 187
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG-KYSVETRLAGTFGYLAPEYAATGR 764
+ +HRDLK +NI + K+ DFG K D V + GT YLAPE R
Sbjct: 188 RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKR 247
Query: 765 VTTKIDVYAFGVVLMETIT 783
+ K D+++ GV+L E +T
Sbjct: 248 YSKKADMWSLGVILYELLT 266
|
Length = 478 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 2e-07
Identities = 33/94 (35%), Positives = 49/94 (52%), Gaps = 15/94 (15%)
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA----PDGKYSVETRLAG 750
+ ++++H + HRD+KP NILI DD K+ADFG + P +Y + TR
Sbjct: 111 KSLDHMH---RNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEY-ISTRW-- 163
Query: 751 TFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETIT 783
Y APE T G K+D++A G V E ++
Sbjct: 164 ---YRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 48.3 bits (116), Expect = 2e-07
Identities = 26/86 (30%), Positives = 37/86 (43%), Gaps = 26/86 (30%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+L+ + L NN T +P G F GL NL+VL LS N
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGN-------------------------- 34
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNF 199
N+ + P+ F +L++L LS NN
Sbjct: 35 NLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 75/310 (24%), Positives = 128/310 (41%), Gaps = 48/310 (15%)
Query: 563 LFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYG-GELPDGTKIAVKRMESNTMGNK 621
LF + + +E L TD + +G+G +G VY DG+ AVK ++ + ++
Sbjct: 4 LFPYNSSMLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE 63
Query: 622 GLSEFQAEIAVLTKV-RHRHLVALLGYC-----INGSERLLVYEYMPRGTLAQHLFEWHD 675
E +AE +L + H ++V G + G + LV E G++ + +
Sbjct: 64 ---EIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV----- 115
Query: 676 HGYTPLTWKQRVT------IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729
G L QR+ I G+++LH+ IHRD+K +NIL+ + K+
Sbjct: 116 KGL--LICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLV 170
Query: 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR-----VTTKIDVYAFGVVLMETITG 784
DFG+ + T + GT ++APE A + + DV++ G+ +E G
Sbjct: 171 DFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229
Query: 785 RKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAR 844
L D P + T F+ IP+ P L E+ S C +
Sbjct: 230 DPPLFDMHP-----VKTLFK--------IPRNPPPTLLHPEKWCRSF---NHFISQCLIK 273
Query: 845 EPQQRPDMGH 854
+ + RP + H
Sbjct: 274 DFEARPSVTH 283
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 3e-07
Identities = 43/196 (21%), Positives = 91/196 (46%), Gaps = 19/196 (9%)
Query: 597 VYGGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLGYCINGSERL 655
+Y G + ++ ++ + G+K L + + EI L ++ +++ + G+ I+ + L
Sbjct: 36 IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 656 ----LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHR 711
L+ EY RG L + L + D L++K ++ +A+D +G+ L+ + ++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEKD-----LSFKTKLDMAIDCCKGLYNLYKYTNKP--YK 147
Query: 712 DLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT--GRVTTKI 769
+L + L+ ++ + K+ GL K + + Y + + T K
Sbjct: 148 NLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKD 203
Query: 770 DVYAFGVVLMETITGR 785
D+Y+ GVVL E TG+
Sbjct: 204 DIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 41/158 (25%), Positives = 71/158 (44%), Gaps = 21/158 (13%)
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARGVE 698
++V L Y ++ LV ++ G L H+ ++ + W + +ALD
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALD------ 99
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYSVETRLAGTFGYL 755
+L ++ + RDL P+NIL+ D ++ F V+++ DG+ +VE Y
Sbjct: 100 ---ALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGE-AVENM------YC 149
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP 793
APE T D ++ G +L E +TG K L + P
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTG-KTLVECHP 186
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-06
Identities = 66/270 (24%), Positives = 101/270 (37%), Gaps = 59/270 (21%)
Query: 583 FSEANILGRGGFG-VVYGGELPDGTKIAVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRH 640
F + LG G FG V ++ A+K + + + + ++ +AE +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V L Y + L V +Y+P G + L G P + L A VE
Sbjct: 63 VVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCA--VES 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN---APDGKY-------------- 742
+H + FIHRD+KP NILI D K+ DFGL D KY
Sbjct: 117 VHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173
Query: 743 -----------------SVETR------------LAGTFGYLAPEYAATGRVTTKIDVYA 773
+E R L GT Y+APE T D ++
Sbjct: 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233
Query: 774 FGVVLMETITGRKALDDTMP-DDRAHLVTW 802
GV+L E + G+ P + + ++ W
Sbjct: 234 VGVILYEMLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 10/161 (6%)
Query: 629 EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT 688
EI +L + HR ++ L+ S +V MP+ LF + D PL +Q +T
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYK--CDLFTYVD-RSGPLPLEQAIT 189
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR- 747
I + + YLH + IHRD+K NI + + A + DFG + +
Sbjct: 190 IQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG 246
Query: 748 LAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKAL 788
+GT +PE A K D+++ G+VL E L
Sbjct: 247 WSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.3 bits (122), Expect = 3e-06
Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 28/187 (14%)
Query: 624 SEFQAEIAVLTKVRHRHLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPL 681
S+ E+ V+ +++H+++V + +N + + L + E+ G L++++ + + + +
Sbjct: 57 SQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM-FGKI 115
Query: 682 TWKQRVTIALDVARGVEYLHSLAQ----QSFIHRDLKPSNILIGDDMR------------ 725
V I + + Y H+L + +HRDLKP NI + +R
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 726 -----AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA--ATGRVTTKIDVYAFGVVL 778
AK+ DFGL KN G S+ GT Y +PE T K D++A G ++
Sbjct: 176 NGRPIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII 233
Query: 779 METITGR 785
E +G+
Sbjct: 234 YELCSGK 240
|
Length = 1021 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 3e-06
Identities = 32/102 (31%), Positives = 55/102 (53%), Gaps = 4/102 (3%)
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-AP 738
PL + + VA+G+++L A ++ IHRD+ N+L+ D AK+ DFGL ++
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLME 780
D Y V+ ++APE T + DV+++G++L E
Sbjct: 265 DSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 306
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 65/270 (24%), Positives = 103/270 (38%), Gaps = 59/270 (21%)
Query: 583 FSEANILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRH 640
F + LG G FG V ++ A+K + + N+ ++ +AE +L + +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+V L Y + L V +Y+P G + L P + L +A +E
Sbjct: 63 VVKLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRM---EVFPEVLARFYIAELTLA--IES 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN---APDGKY-------------- 742
+H + FIHRD+KP NILI D K+ DFGL + KY
Sbjct: 117 VHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173
Query: 743 -----------------SVETR------------LAGTFGYLAPEYAATGRVTTKIDVYA 773
++E R L GT Y+APE T D ++
Sbjct: 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233
Query: 774 FGVVLMETITGRKA-LDDTMPDDRAHLVTW 802
GV+L E + G+ L T + + ++ W
Sbjct: 234 VGVILFEMLVGQPPFLAPTPTETQLKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 4e-06
Identities = 19/60 (31%), Positives = 29/60 (48%), Gaps = 3/60 (5%)
Query: 91 QLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
L++L N + IP + +L+ + L NN TS+ F GL +L+ L LS N
Sbjct: 1 NLKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 5e-06
Identities = 30/89 (33%), Positives = 48/89 (53%), Gaps = 4/89 (4%)
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGT 751
VA+G+ +L A ++ IHRDL NIL+ K+ DFGL ++ D Y V+
Sbjct: 223 VAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLME 780
++APE T + DV+++G++L E
Sbjct: 280 VKWMAPESIFNCVYTFESDVWSYGILLWE 308
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 8e-06
Identities = 33/121 (27%), Positives = 52/121 (42%), Gaps = 6/121 (4%)
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739
PL Q +A + ++Y+H + IHRD+K N+L+ + DFG A
Sbjct: 256 PLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFA-R 311
Query: 740 GKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA 797
G +S +AGT APE A T +D+++ G+V+ E +L D
Sbjct: 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDER 371
Query: 798 H 798
Sbjct: 372 R 372
|
Length = 461 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 25/115 (21%), Positives = 45/115 (39%), Gaps = 14/115 (12%)
Query: 626 FQAEIAVLTKVRHRHLVA--LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTW 683
+ E+A+L + + L +L + L+ E++ TL ++
Sbjct: 38 REREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------------DEVSE 85
Query: 684 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738
+++ IA +A + LH L H DL P NIL+ D + D+ P
Sbjct: 86 EEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 57/211 (27%), Positives = 94/211 (44%), Gaps = 34/211 (16%)
Query: 589 LGRGGFGVVYGGEL---PDGTKIAVKRMESNTM------GNKGLSEFQAEIAVLTKVRHR 639
LG+G F +Y G L D + + S + L+ F ++++++ H+
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLA-FFETASLMSQLSHK 61
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG-VE 698
HLV L G C+ E ++V EY+ G L L ++ L WK LDVA+
Sbjct: 62 HLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNN--VSLHWK------LDVAKQLAS 112
Query: 699 YLHSLAQQSFIHRDLKPSNILI---GDDMR----AKVADFGLVKNAPDGKYSVETRLAGT 751
LH L + +H ++ NIL+ G + K++D G+ P S E R+
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI----PITVLSREERVERI 168
Query: 752 FGYLAPEYAATGRVTTKI--DVYAFGVVLME 780
++APE G+ + I D ++FG L+E
Sbjct: 169 -PWIAPECIRNGQASLTIAADKWSFGTTLLE 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 3e-05
Identities = 29/98 (29%), Positives = 41/98 (41%), Gaps = 24/98 (24%)
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
VE L+ L + + IH D+K N+L R + D+GL K + GT Y
Sbjct: 119 VEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTPSCYDGTLDYF 173
Query: 756 APEYAATGRVTTKI---------DVYAFGVVLMETITG 784
+PE KI D +A GV+ E +TG
Sbjct: 174 SPE---------KIKGHNYDVSFDWWAVGVLTYELLTG 202
|
Length = 267 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 4e-05
Identities = 49/194 (25%), Positives = 75/194 (38%), Gaps = 35/194 (18%)
Query: 132 CFDGLTN---LQVLSLSDNP----NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF- 183
GLT LQ L LSDN L +S+SL L ++N +
Sbjct: 73 LLQGLTKGCGLQELDLSDNALGPDGCGVLE---SLLRSSSLQELKLNNNGLGDRGLRLLA 129
Query: 184 ----DSFSNLQNLRLSYNNFTGSLPASFAK-----SDIQNLWMNDQQLGLSGTLDVLSGM 234
D L+ L L N G+ + AK D++ L + + +G +G + G+
Sbjct: 130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGL 189
Query: 235 ---TQLRQVWLHKNQFT--GPIPDLSKC----ESLFDLSLRDNQLTGV-----VPASVIS 280
L + L+ N T G L++ +SL L+L DN LT A +
Sbjct: 190 KANCNLEVLDLNNNGLTDEGAS-ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSP 248
Query: 281 LPALLNISLQNNKL 294
+LL +SL N +
Sbjct: 249 NISLLTLSLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 7e-05
Identities = 48/196 (24%), Positives = 77/196 (39%), Gaps = 14/196 (7%)
Query: 603 PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662
P GT + V+ + + L Q E+ + RH +++ GS ++ +M
Sbjct: 23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722
G+ L + G + I RG+ YLH Q +IHR++K S+ILI
Sbjct: 83 YGSANSLLKTYFPEGMSEALIG---NILFGALRGLNYLH---QNGYIHRNIKASHILISG 136
Query: 723 DMRAKVAD----FGLVKNAPDGK--YSVETRLAGTFGYLAPEYAATGR--VTTKIDVYAF 774
D ++ + LV+N K Y +L+PE K D+Y+
Sbjct: 137 DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196
Query: 775 GVVLMETITGRKALDD 790
G+ E TGR D
Sbjct: 197 GITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 56/229 (24%), Positives = 99/229 (43%), Gaps = 26/229 (11%)
Query: 580 TDNFSEANILGRGGFGVVYG-GELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR- 637
+D + +G+G +G V+ +G+K AVK ++ ++ E +AE +L +
Sbjct: 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE---EIEAEYNILKALSD 73
Query: 638 HRHLVALLGY-----CINGSERLLVYEYMPRGT---LAQHLFEWHDHGYTPLTWKQRVTI 689
H ++V G NG + LV E G+ L + + + P+ I
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPII----AYI 129
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
+ G+++LH IHRD+K +NIL+ + K+ DFG+ + T +
Sbjct: 130 LHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV- 185
Query: 750 GTFGYLAPEYAATGR-----VTTKIDVYAFGVVLMETITGRKALDDTMP 793
GT ++APE A + + DV++ G+ +E G L D P
Sbjct: 186 GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 52/210 (24%), Positives = 82/210 (39%), Gaps = 25/210 (11%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQ---SLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTI 71
L L L+ +LG DG +L+ SLQ L + + G D + +
Sbjct: 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKL 142
Query: 72 SLAKSGLSGT----LSPEISSLTQLETLSFQMNNIAGA-IPSLANA----TSLQDIYLDN 122
L ++ L G L+ + + L+ L+ N I A I +LA +L+ + L+N
Sbjct: 143 VLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNN 202
Query: 123 NNFT----SVPTGCFDGLTNLQVLSLSDNPNLAPWPF----PNELTKSTSLTTLYMDNAN 174
N T S L +L+VL+L DN NL L+ + SL TL + +
Sbjct: 203 NGLTDEGASALAETLASLKSLEVLNLGDN-NLTDAGAAALASALLSPNISLLTLSLSCND 261
Query: 175 I----FGLIPDFFDSFSNLQNLRLSYNNFT 200
I + + +L L L N F
Sbjct: 262 ITDDGAKDLAEVLAEKESLLELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 71/288 (24%), Positives = 117/288 (40%), Gaps = 64/288 (22%)
Query: 589 LGRGGFGVVYGGEL-------PDGT------KIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
LGRG +Y G L DG K+ +K ++ + + L+ F+ +++ +
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETA-SMMRQ 60
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
V H+H+V L G C+ E ++V E++ G L + D TP WK +V A +A
Sbjct: 61 VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTP--WKFKV--AKQLAS 116
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILI---GDDMRA----KVADFGLVKNAPDGKYSVETRL 748
+ YL + +H ++ NIL+ G D K++D G+ + VE R+
Sbjct: 117 ALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVE-RI 172
Query: 749 AGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMET-ITGRKALDDTMPDDRAHLVTWFRRV 806
++APE + + D ++FG L E G L D +
Sbjct: 173 P----WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD--------------KT 214
Query: 807 LISKENIPKA----IDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
L KE + + P S +A+L HC +P QRP
Sbjct: 215 LAEKERFYEGQCMLVTP----------SCKELADLMTHCMNYDPNQRP 252
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-04
Identities = 68/304 (22%), Positives = 111/304 (36%), Gaps = 31/304 (10%)
Query: 138 NLQVLSLSDNPNLAPWPFPNELTKSTSLTT--LYMDNANIFGLIPDFF-DSFSNLQNLRL 194
N LS N N ++L + + N+ S S L +L L
Sbjct: 15 NTLREVLSSNTYHTTPQSINLNFPDSNLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDL 74
Query: 195 SYNNFTGSLPASFAKSDIQNLWMNDQQL-GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD 253
+ SL S ++ L D L L + L +T L + L N T IP
Sbjct: 75 LSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNISELLELTNLTSLDLDNNNIT-DIPP 133
Query: 254 LSK--CESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVS 309
L +L +L L DN++ +P+ + +LP L N+ L N L L S + +
Sbjct: 134 LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPKLLSNLSNLNNLD 192
Query: 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
L N + L ++ D+ +I+ +N +
Sbjct: 193 LSGNKISDLPPEIELLSA-----LEEL--DLSNNSIIELLSSLSN-----------LKNL 234
Query: 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
+ L+N L NL++L+ L L N ++ L L +L+ LD+S N+LS
Sbjct: 235 SGLELSNNKLEDLPES-IGNLSNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSN 291
Query: 430 KVPD 433
+P
Sbjct: 292 ALPL 295
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 19/39 (48%), Positives = 25/39 (64%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
L +LK L L NNLT P+ + L SL++LD+S NNL
Sbjct: 22 GLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 40/159 (25%), Positives = 69/159 (43%), Gaps = 15/159 (9%)
Query: 629 EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP---LTWKQ 685
E +L K++H ++VA +V EY G L Q + + L W
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSV 744
++ + GV+++H ++ +HRD+K NI + + + K+ DFG + G Y+
Sbjct: 108 QMCL------GVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC 158
Query: 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
GT Y+ PE K D+++ G +L E T
Sbjct: 159 T--YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 2e-04
Identities = 38/166 (22%), Positives = 60/166 (36%), Gaps = 26/166 (15%)
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRL 748
+ L + LH A K NIL+ D K+ G V + E
Sbjct: 22 VCLQCLGALRELHRQA---------KSGNILLTWDGLLKL--DGSV-----AFKTPEQSR 65
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808
+ ++APE T K D+Y+ G+ L +ALD +P + + +L
Sbjct: 66 PDPY-FMAPEVIQGQSYTEKADIYSLGITL------YEALDYELPYNEEREL---SAILE 115
Query: 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGH 854
N A DP + E + + + C +R PQ+R H
Sbjct: 116 ILLNGMPADDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREAANH 161
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 5e-04
Identities = 17/43 (39%), Positives = 21/43 (48%), Gaps = 5/43 (11%)
Query: 25 LGDDGSVMLKLAQSLQNLP----SDWSSTSSTGYCEWTGINCD 63
L DD +L SL P S W+ SS+ C WTG+ CD
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNP-SSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 0.001
Identities = 40/147 (27%), Positives = 64/147 (43%), Gaps = 21/147 (14%)
Query: 316 CKNSSD------AGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP---FVTCSQ 366
C NSS +GK ++++ + P I + + N P F T S
Sbjct: 65 CNNSSRVVSIDLSGKNISGKISSAI-----FRLPYIQTINLSNNQLSGPIPDDIFTTSSS 119
Query: 367 GRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNN 426
R + NL+N G+I L+ L L N L+G IP+ + +SL+ LD+ N
Sbjct: 120 LRYL--NLSNNNFTGSIPRGSIPN--LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNV 175
Query: 427 LSGKVPDFGSNV---KFTVSPGNPFIG 450
L GK+P+ +N+ +F N +G
Sbjct: 176 LVGKIPNSLTNLTSLEFLTLASNQLVG 202
|
Length = 968 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 14/38 (36%), Positives = 24/38 (63%), Gaps = 2/38 (5%)
Query: 391 TSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
T+L+ L L N +T +P L+ L +L+ LD+S N ++
Sbjct: 1 TNLETLDLSNNQITD-LP-PLSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 36.7 bits (86), Expect = 0.002
Identities = 14/36 (38%), Positives = 19/36 (52%), Gaps = 2/36 (5%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
T+L+ + L NN T +P L NL+ L LS N
Sbjct: 1 TNLETLDLSNNQITDLPP--LSNLPNLETLDLSGNK 34
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.4 bits (85), Expect = 0.003
Identities = 20/61 (32%), Positives = 29/61 (47%), Gaps = 3/61 (4%)
Query: 236 QLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
L+ + L N+ T IPD +L L L N LT + P + LP+L ++ L N
Sbjct: 1 NLKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 294 L 294
L
Sbjct: 60 L 60
|
Length = 60 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 933 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.98 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.98 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.98 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.96 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.94 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.88 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.86 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.85 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.84 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.83 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.81 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.8 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.8 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.79 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.72 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.71 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.68 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.66 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.57 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.54 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.41 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.4 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.38 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.34 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.34 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.33 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.29 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.24 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.21 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.18 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.13 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.1 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.04 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.03 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.02 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.97 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.92 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.87 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.86 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.76 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.72 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.61 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.56 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.5 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.46 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.46 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.43 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.36 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-84 Score=812.98 Aligned_cols=790 Identities=26% Similarity=0.436 Sum_probs=476.3
Q ss_pred HHHHHHHHHHHhccCCccchHHHHHHHHHhcCCC---CCCCCCCCCCCCccccceEeCCCCCEEEEEecCCCCccccCcc
Q 002346 9 SICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNL---PSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPE 85 (933)
Q Consensus 9 ~~~~~~~~~~~~~~~~~~~d~~~l~~~~~~~~~~---~~~w~~~~~~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~ 85 (933)
+++++++++....+-+.++|+.||++||+++.+. ..+|. ...+||.|.||+|++.++|+.|+|++++++|.++..
T Consensus 11 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~--~~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~ 88 (968)
T PLN00113 11 YLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWN--SSADVCLWQGITCNNSSRVVSIDLSGKNISGKISSA 88 (968)
T ss_pred hHHHHHHHHHHHccCCCHHHHHHHHHHHHhCCCCcccCCCCC--CCCCCCcCcceecCCCCcEEEEEecCCCccccCChH
Confidence 3333333334445555778999999999999643 24564 466899999999998889999999999999999999
Q ss_pred ccCCcccceeecccccccccCC-C-ccCcCcCceeccccccccC----------------------CCCCcccCCCCCCE
Q 002346 86 ISSLTQLETLSFQMNNIAGAIP-S-LANATSLQDIYLDNNNFTS----------------------VPTGCFDGLTNLQV 141 (933)
Q Consensus 86 ~~~l~~L~~L~l~~N~l~~~~p-~-~~~l~~L~~L~Ls~N~l~~----------------------~~~~~~~~l~~L~~ 141 (933)
+..+++|+.|+|++|++++.+| . +..+++|++|+|++|++++ ..+..++++++|++
T Consensus 89 ~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~ 168 (968)
T PLN00113 89 IFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKV 168 (968)
T ss_pred HhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCE
Confidence 9999999999999999987776 3 3467777777777776653 22333445555555
Q ss_pred EEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccc
Q 002346 142 LSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQ 220 (933)
Q Consensus 142 L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n 220 (933)
|+|++|.+.+ .+|..+.++++|++|+|++|++.+.+|..++.+++|++|+|++|++++.+|..+.. .+|++|++.+|
T Consensus 169 L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n 246 (968)
T PLN00113 169 LDLGGNVLVG--KIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYN 246 (968)
T ss_pred EECccCcccc--cCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCc
Confidence 5555555544 34555555555555555555555555555555555555555555555555554443 34555555555
Q ss_pred cCCcccccccccCCccCcEEEecCCccCC------------------------CCCC-CCCCCCCCEEEccCCcccccCc
Q 002346 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTG------------------------PIPD-LSKCESLFDLSLRDNQLTGVVP 275 (933)
Q Consensus 221 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~------------------------~~~~-~~~~~~L~~L~L~~N~l~~~~p 275 (933)
.+... .+..+.++++|+.|+|++|++++ .+|. +..+++|+.|++++|.+++.+|
T Consensus 247 ~l~~~-~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~ 325 (968)
T PLN00113 247 NLTGP-IPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIP 325 (968)
T ss_pred eeccc-cChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCC
Confidence 43211 11123334444444444444443 3332 3344444444444444444444
Q ss_pred ccccCCCCCCEEEccCccCccCCCCC---CCCccEEeccCCcCCCCCCCCCCCCC----------------ch----hhh
Q 002346 276 ASVISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCD----------------PQ----VTT 332 (933)
Q Consensus 276 ~~l~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~l~~n~~~~~~~~~~~~~~----------------~~----~~~ 332 (933)
..+..+++|+.|+|++|.+++.+|.. ..+|+.|+|++|++.+..+....... +. ...
T Consensus 326 ~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~ 405 (968)
T PLN00113 326 VALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRS 405 (968)
T ss_pred hhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCC
Confidence 44555555555555555555444432 12445555555555433222111000 00 000
Q ss_pred hH-----------hhhc------------------------------------------------ccCCCccccCCCCCC
Q 002346 333 LL-----------QIAG------------------------------------------------DMGYPAILSDSWEGN 353 (933)
Q Consensus 333 ~~-----------~~~~------------------------------------------------~~~~~~~l~~~~~~~ 353 (933)
+. .++. .......-..++.+|
T Consensus 406 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n 485 (968)
T PLN00113 406 LRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRN 485 (968)
T ss_pred CCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCC
Confidence 00 0000 000000111233445
Q ss_pred CCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC
Q 002346 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (933)
Q Consensus 354 ~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 433 (933)
...+.+|..+.++++|+.|+|++|++.+.+|..++++++|++|+|++|+++|.+|..|..+++|+.|+|++|+++|.+|.
T Consensus 486 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 565 (968)
T PLN00113 486 QFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565 (968)
T ss_pred ccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCCh
Confidence 55556666666677777777777777777777777777777777777777777777777777777777777777777764
Q ss_pred CCC---CcccccCCCCCCcCCCC-------------CCCCCCCCCCCCCCCCCCCCCCCCCCCCccceeehhhhHHHHHH
Q 002346 434 FGS---NVKFTVSPGNPFIGTNV-------------DTTPGGAGTPGSKPSGPSGSPAASSKSKLSVGTIVAIVVVVVIF 497 (933)
Q Consensus 434 ~~~---~~~~~~~~~n~~~~~~~-------------~~~~~~~g~~~s~~~~~~~~~~~~~~~~~~~~~i~~~v~~~~~~ 497 (933)
... .++...+.+|++.+.-. ...+..||.+.....++. ....+ ...+..+++++++++++
T Consensus 566 ~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c---~~~~~-~~~~~~~~~~~~~~~~~ 641 (968)
T PLN00113 566 NLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPC---KRVRK-TPSWWFYITCTLGAFLV 641 (968)
T ss_pred hHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCC---ccccc-cceeeeehhHHHHHHHH
Confidence 321 12222334555443111 011111111100000000 01111 11222233333332222
Q ss_pred HHHHHHHHHHHHhhhcccccCCCCCCccccccccCCccCCCCCCCCCCCCCccccCCCCCCCCCccccCC-ceeecHHHH
Q 002346 498 IAVVFFVVYKFIARRKHRKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGG-NVAISIEVL 576 (933)
Q Consensus 498 i~~~~~~~~~~~~rr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l 576 (933)
++++++++ .++++|++.+..+..... +. .. ...+... ...+..
T Consensus 642 ~~~~~~~~-~~~~~~~~~~~~~~~~~~--------------~~---~~---------------~~~~~~~~~~~~~~--- 685 (968)
T PLN00113 642 LALVAFGF-VFIRGRNNLELKRVENED--------------GT---WE---------------LQFFDSKVSKSITI--- 685 (968)
T ss_pred HHHHHHHH-HHHHhhhccccccccccc--------------cc---cc---------------ccccccccchhhhH---
Confidence 22222222 222222211111100000 00 00 0000000 011222
Q ss_pred HHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
......|...+.||+|+||.||+|.. .++..||||++..... ....|++.+++++|||||+++++|.++...+
T Consensus 686 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~ 759 (968)
T PLN00113 686 NDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAY 759 (968)
T ss_pred HHHHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCE
Confidence 23345678889999999999999965 5789999999865421 1235688999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.++++. ++|.++.+|+.|+++|++|||..+.++|+||||||+||+++.++.+++. ||...
T Consensus 760 lv~Ey~~~g~L~~~l~~--------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~ 830 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN--------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPG 830 (968)
T ss_pred EEEeCCCCCcHHHHHhc--------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccc
Confidence 99999999999999942 7899999999999999999996555899999999999999999988875 66554
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
..... ....|++.|+|||++.+..++.++|||||||++|||+||+.||+.... .....+.|.+.... ......
T Consensus 831 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~-~~~~~~ 903 (968)
T PLN00113 831 LLCTD-----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYS-DCHLDM 903 (968)
T ss_pred ccccC-----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcC-ccchhh
Confidence 33221 223688999999999999999999999999999999999999965432 23345556554322 223344
Q ss_pred ccCCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 816 AIDPNLNLD-EETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 816 ~~d~~l~~~-~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.+|+.+... ....+++.++.+++.+|++.+|++||+|+|+++.|+++...
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 455554322 23345667888999999999999999999999999887543
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-52 Score=457.19 Aligned_cols=290 Identities=47% Similarity=0.824 Sum_probs=253.4
Q ss_pred CceeecHHHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEe
Q 002346 567 GNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646 (933)
Q Consensus 567 ~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 646 (933)
....|++++++.+|++|...+.||+|+||.||+|.+.+|+.||||++....... .++|.+|+.++++++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456799999999999999999999999999999999999999999887654221 456999999999999999999999
Q ss_pred EeeeCc-eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 647 YCINGS-ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 647 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
||.+++ +.+||||||++|+|.++|+..... +++|.+|++||.++|+||+|||+.+..+||||||||+|||+|++++
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~ 215 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN 215 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC
Confidence 999988 599999999999999999773221 8999999999999999999999988789999999999999999999
Q ss_pred EEEecccccccCCC-CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 726 AKVADFGLVKNAPD-GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 726 ~kl~DfGla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
+||+|||+|+..+. ........ .||.+|+|||++..+..+.|+|||||||+++|++||+.|.+...+.....++.|..
T Consensus 216 aKlsDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~ 294 (361)
T KOG1187|consen 216 AKLSDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAK 294 (361)
T ss_pred EEccCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHH
Confidence 99999999976654 32221111 89999999999999999999999999999999999999999776666666899987
Q ss_pred HHhhccCCCCcccCCCCCCChhh-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 805 RVLISKENIPKAIDPNLNLDEET-IESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~-~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
..+. ...+.+.+|+.+...... .+++.++..++.+|++.+|++||+|.||+++|+.+.
T Consensus 295 ~~~~-~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 295 PLLE-EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHH-CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 6665 448999999998744444 378888999999999999999999999999996543
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=382.10 Aligned_cols=250 Identities=25% Similarity=0.420 Sum_probs=208.4
Q ss_pred ccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc-eeEEEEeec
Q 002346 584 SEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-ERLLVYEYM 661 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~ 661 (933)
+.++.||+|..|+|||+.. .+++.+|+|++... ..+...+++.+|++++++.+||+||.+||.|.... ...++||||
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYM 160 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYM 160 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhc
Confidence 3467899999999999955 57899999999544 35666789999999999999999999999999988 599999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
++|+|++++.. .+.+++....+|+.+|++||.|||+ .++||||||||+|||++.+|+|||||||.++...+.
T Consensus 161 DgGSLd~~~k~-----~g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS- 232 (364)
T KOG0581|consen 161 DGGSLDDILKR-----VGRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS- 232 (364)
T ss_pred CCCCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-
Confidence 99999999965 2569999999999999999999996 389999999999999999999999999999876654
Q ss_pred ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh-ccCCCCcccCCC
Q 002346 742 YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI-SKENIPKAIDPN 820 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~d~~ 820 (933)
....++||..|||||.+.+..|+.++||||||++++|+++|+.|+....+ ......+.+..+.. ....+++.
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~ppP~lP~~---- 305 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDEPPPRLPEG---- 305 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcCCCCCCCcc----
Confidence 44567999999999999999999999999999999999999999987521 11122222223332 12222221
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....++..++..|+++||.+||++.|+++
T Consensus 306 --------~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 306 --------EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred --------cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 12246889999999999999999999987
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-45 Score=393.93 Aligned_cols=260 Identities=34% Similarity=0.556 Sum_probs=213.0
Q ss_pred ccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc-eeEEEEeecC
Q 002346 584 SEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-ERLLVYEYMP 662 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~~ 662 (933)
.+.+.||+|+||+||+|.+.....||||++.....+....++|.+|+.+|++++|||||+++|+|.+.. ..++||||++
T Consensus 44 ~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~ 123 (362)
T KOG0192|consen 44 PIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMP 123 (362)
T ss_pred hhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCC
Confidence 345669999999999999954444999999887666555789999999999999999999999999887 7899999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-eEecCCCCCcEEecCCC-cEEEecccccccCCCC
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS-FIHRDLKPSNILIGDDM-RAKVADFGLVKNAPDG 740 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~~ 740 (933)
+|+|.++++.. ....+++..++.++.+||+|+.|||+ .+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 124 ~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 124 GGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred CCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 99999999763 24679999999999999999999999 66 99999999999999998 9999999999866543
Q ss_pred CceeecccccccCcccccccC--CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 741 KYSVETRLAGTFGYLAPEYAA--TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
. ...+...||+.|||||++. ...|+.|+||||||+++|||+||+.||....+... .. .... ... +..+.
T Consensus 198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~---~~---~v~~-~~~-Rp~~p 268 (362)
T KOG0192|consen 198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV---AS---AVVV-GGL-RPPIP 268 (362)
T ss_pred c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH---HH---HHHh-cCC-CCCCC
Confidence 2 1223368999999999999 56899999999999999999999999987654211 11 1111 111 11111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
.. ....+..++.+||+.||++||++.+++..|+.++....
T Consensus 269 ~~---------~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~ 308 (362)
T KOG0192|consen 269 KE---------CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHIS 308 (362)
T ss_pred cc---------CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence 11 22467789999999999999999999999998876544
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-45 Score=392.78 Aligned_cols=249 Identities=24% Similarity=0.464 Sum_probs=216.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.+|...++||+|||+.||.++. ..|+.||+|++.+... .....+...+|+++.++|+|||||+++++|++....|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5789999999999999999965 8999999999987543 3455678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
|+|++++|.+++++ .+++++.+++.+++||+.||.|||+ ++|||||||..|++++++.++||+|||+|....
T Consensus 98 ELC~~~sL~el~Kr-----rk~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR-----RKPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE 169 (592)
T ss_pred EecCCccHHHHHHh-----cCCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeec
Confidence 99999999999965 3679999999999999999999999 899999999999999999999999999999887
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.+.. .....+|||.|.|||++.....+..+||||+||+||.|++|++||+... +.+...++...+..+|..+.
T Consensus 170 ~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~------vkety~~Ik~~~Y~~P~~ls 242 (592)
T KOG0575|consen 170 YDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT------VKETYNKIKLNEYSMPSHLS 242 (592)
T ss_pred Cccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch------HHHHHHHHHhcCcccccccC
Confidence 5433 2345799999999999998899999999999999999999999998642 22334444444444444222
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+..++|.++|+.+|.+||++++|+.
T Consensus 243 -------------~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 243 -------------AEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred -------------HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 34669999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=364.45 Aligned_cols=262 Identities=25% Similarity=0.388 Sum_probs=216.5
Q ss_pred cCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEe-EeeeCce-eEEE
Q 002346 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG-YCINGSE-RLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv 657 (933)
.+|++.++||+|.||+|||+ ++.+|..||.|.+.-+..+.+..++...|+.++++|+|||||++++ .+.++.+ .++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 45778899999999999999 6779999999999988788888899999999999999999999998 4444444 7899
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccC-CCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ-QSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~-~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||++|+|.+.++..+.+ .+.+++.++|+++.|+++||.++|+... .-|+||||||.||+++.+|.|||+|||+++.
T Consensus 99 mE~c~~GDLsqmIk~~K~q-kr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~ 177 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQ-KRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRF 177 (375)
T ss_pred HHhhcccCHHHHHHHHHhc-cccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhH
Confidence 9999999999999886654 4779999999999999999999998432 2488999999999999999999999999998
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
..... .....++|||.||+||.+.+..|+.|+||||+||++|||+.-++||.+. .+.....++... +.+.
T Consensus 178 l~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~------n~~~L~~KI~qg--d~~~- 247 (375)
T KOG0591|consen 178 LSSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD------NLLSLCKKIEQG--DYPP- 247 (375)
T ss_pred hcchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc------cHHHHHHHHHcC--CCCC-
Confidence 77644 3446689999999999999999999999999999999999999999864 233333343332 2211
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
++ .......+..+|..|+..||+.||+...+++.+..
T Consensus 248 ----~p----~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 248 ----LP----DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred ----Cc----HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 11 12233457789999999999999996666555544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=373.11 Aligned_cols=206 Identities=29% Similarity=0.512 Sum_probs=186.3
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
..+|...+.||.|+||+||+|+. +++..||||.+.+.....+..+.+..|+.+++.++|||||++++++..++..|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35788888999999999999955 46899999999888766777788899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC------CcEEEeccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD------MRAKVADFG 732 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~------~~~kl~DfG 732 (933)
|||.||+|.+|++. .+.+++.+++.++.|+|.|+++||+ ++||||||||+|||++.. -.+||+|||
T Consensus 89 EyC~gGDLs~yi~~-----~~~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR-----RGRLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred EeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 99999999999977 2469999999999999999999999 999999999999999865 468999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCch
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD 795 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~ 795 (933)
+|+...++. .....+|+|-|||||++..++|+.|+|+||+|+++||+++|+.||+...+.+
T Consensus 161 fAR~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 161 FARFLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred hhhhCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 999887644 2345799999999999999999999999999999999999999998765543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-45 Score=372.56 Aligned_cols=261 Identities=28% Similarity=0.459 Sum_probs=210.7
Q ss_pred HhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCch-----hHHHHHHHHHHHHhcCCCcceeEEeEeeeCc
Q 002346 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNK-----GLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 652 (933)
..+.|.+.+.||+|+||.|-+| ..++|+.||||++.+...... .....++|+++|++|+|||||++++++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4577888999999999999999 567899999999987643321 1234679999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC---CcEEEe
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVA 729 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~ 729 (933)
..|+||||++||+|.+++-. .+.+.+.....+++|++.|+.|||+ +||+||||||+|||+..+ ..+||+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-----nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKIt 321 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-----NKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKIT 321 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-----ccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEec
Confidence 99999999999999999966 3557788889999999999999999 999999999999999766 789999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCC---CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV---TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
|||+|+....+ .....++|||.|.|||++.+..+ ..|+|+||+||++|-+++|.+||....... .+.. .+
T Consensus 322 DFGlAK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e---QI 394 (475)
T KOG0615|consen 322 DFGLAKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE---QI 394 (475)
T ss_pred ccchhhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH---HH
Confidence 99999988743 34556799999999999976543 348899999999999999999998754322 1111 11
Q ss_pred hhccCCCCcccCCCCCCChhhH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCCC
Q 002346 807 LISKENIPKAIDPNLNLDEETI-ESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPAT 870 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~-~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~ 870 (933)
....... ....| ....+..++|.+||..||++||+++|+++ ++|....
T Consensus 395 ~~G~y~f----------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~------hpW~~~~ 443 (475)
T KOG0615|consen 395 LKGRYAF----------GPLQWDRISEEALDLINWMLVVDPENRPSADEALN------HPWFKDA 443 (475)
T ss_pred hcCcccc----------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc------Chhhhcc
Confidence 1111111 11122 22346779999999999999999999987 7887543
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=381.69 Aligned_cols=253 Identities=32% Similarity=0.527 Sum_probs=213.1
Q ss_pred cCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
.++.||+|-||.||.|.+.....||+|.++....+ .++|.+|+++|++|+|++||+++|+|..++..+||||||+.|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 45789999999999999977779999999876443 368999999999999999999999999988999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 744 (933)
+|.+||+. .....+...+.+.++.|||+|++||++ +++|||||.++||||+++..+||+|||+|+...++.+..
T Consensus 287 sLl~yLr~---~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~ 360 (468)
T KOG0197|consen 287 SLLDYLRT---REGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA 360 (468)
T ss_pred cHHHHhhh---cCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence 99999975 234668999999999999999999999 899999999999999999999999999999777777766
Q ss_pred ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
.....-+..|.|||.+..+.++.|||||||||+||||+| |+.|+......+. +. .+.....++.
T Consensus 361 ~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev---~~----~le~GyRlp~-------- 425 (468)
T KOG0197|consen 361 SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV---LE----LLERGYRLPR-------- 425 (468)
T ss_pred cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH---HH----HHhccCcCCC--------
Confidence 666566779999999999999999999999999999999 7778776543222 11 1222333322
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
...+ +.++.+++..||+.+|++|||++.+...|+++..
T Consensus 426 P~~C---P~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 426 PEGC---PDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred CCCC---CHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 1122 2356789999999999999999999888877654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=394.61 Aligned_cols=261 Identities=29% Similarity=0.480 Sum_probs=214.8
Q ss_pred cCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.+....+.||+|+||+||+|+.. +...||||.++... +.+...+|++|++++..++|||||+++|.|.+++..
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 34456788999999999999653 35679999998764 445788999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccC-----CC----CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDH-----GY----TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~-----~~----~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
++|+|||..|||.+||...... +. .+++..+.+.||.|||.|++||-+ +.+|||||..+|+||.++..
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~ 641 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLV 641 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceE
Confidence 9999999999999999764221 12 238999999999999999999998 89999999999999999999
Q ss_pred EEEecccccccCCCCCceeec-ccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYSVET-RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWF 803 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~ 803 (933)
|||+|||+++.....+++... ...-..+|||||.+..++||.+||||||||+|||+++ |+.||.+...++....+.
T Consensus 642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~-- 719 (774)
T KOG1026|consen 642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR-- 719 (774)
T ss_pred EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH--
Confidence 999999999977666654432 3345679999999999999999999999999999999 889998865544332221
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
.+.+-. -+.+.+.++..|+..||+..|++||+++||-..|+...
T Consensus 720 ------~g~lL~----------~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~ 763 (774)
T KOG1026|consen 720 ------AGQLLS----------CPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA 763 (774)
T ss_pred ------cCCccc----------CCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence 111100 11122346789999999999999999999999987654
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=362.54 Aligned_cols=243 Identities=26% Similarity=0.424 Sum_probs=206.6
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCch-hHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|+++++||+|+||.||.++. ++++.+|+|++++...... +.+...+|..++.+++||.||+++..|++++..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 36789999999999999999954 5689999999998765443 567889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
+||+.||.|..+|.+ .+.+++..+.-++.+|+.||.|||+ ++|||||+||+|||+|.+|+++|+|||+++..
T Consensus 104 ld~~~GGeLf~hL~~-----eg~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~ 175 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR-----EGRFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKED 175 (357)
T ss_pred EeccCCccHHHHHHh-----cCCcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence 999999999999965 3679999999999999999999999 99999999999999999999999999999955
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc-CCCCcc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK-ENIPKA 816 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 816 (933)
..... .+..++||+.|||||++.+..|+.++|.||+|+++|||++|.+||..... ..++..+...+ ...+..
T Consensus 176 ~~~~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~------~~~~~~I~~~k~~~~p~~ 248 (357)
T KOG0598|consen 176 LKDGD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV------KKMYDKILKGKLPLPPGY 248 (357)
T ss_pred ccCCC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH------HHHHHHHhcCcCCCCCcc
Confidence 44332 33457999999999999999999999999999999999999999987532 23344444433 111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP 850 (933)
++ .+..+++.+++..+|++|.
T Consensus 249 ls-------------~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 249 LS-------------EEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CC-------------HHHHHHHHHHhccCHHHhc
Confidence 21 3466899999999999996
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=351.28 Aligned_cols=262 Identities=25% Similarity=0.415 Sum_probs=215.0
Q ss_pred hcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.+.|++.+.||.|..++||+| ..+.++.||||++..+..... .+.+++|+..|+.++||||++.+..|..+...|+||
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 367899999999999999999 556789999999988764443 789999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
.||.+|++.+.++.....+ +++..+..|.+++++||.|||. +|.||||||+.||||+.+|.|||+|||.+....
T Consensus 104 pfMa~GS~ldIik~~~~~G---l~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYPDG---LEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred hhhcCCcHHHHHHHHcccc---ccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 9999999999998765544 8999999999999999999998 899999999999999999999999999876443
Q ss_pred CCCceee---cccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 739 DGKYSVE---TRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 739 ~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
+...... ...+||++|||||++.. ..|+.|+||||||++..||.+|+.||....|.....+ .+... .
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~------tLqn~--p 249 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL------TLQND--P 249 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH------HhcCC--C
Confidence 3322221 45689999999999654 3689999999999999999999999998876544221 12211 2
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+...-..+. .+........+.+++..|+++||++|||++++++
T Consensus 250 p~~~t~~~~-~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 PTLLTSGLD-KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CCcccccCC-hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 211111111 2233444557889999999999999999999875
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=359.44 Aligned_cols=270 Identities=24% Similarity=0.340 Sum_probs=214.0
Q ss_pred hcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 656 (933)
.+.|+.+++||+|+||.||+| +..+|+.||+|+++.+...+.......+||.+|++|+||||+++.+...+. ...|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 355677788999999999999 567899999999998876666777789999999999999999999998876 68999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
|+|||+. +|.-++.. ....+++.++..++.|+++||+|||+ ++|+|||||.+|||||.+|.+||+|||+|+.
T Consensus 196 VFeYMdh-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~ 267 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARF 267 (560)
T ss_pred EEecccc-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceee
Confidence 9999976 88777743 23579999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc----cC
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS----KE 811 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----~~ 811 (933)
+........+..+-|..|.|||.+.+. .|+.+.|+||.||+|.||++|++.|.+..+.++.+.+--+-..... ..
T Consensus 268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~ 347 (560)
T KOG0600|consen 268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVS 347 (560)
T ss_pred ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccc
Confidence 877665556777889999999988765 7999999999999999999999999887654443332211110000 01
Q ss_pred CCC--cccCCCCCC----ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIP--KAIDPNLNL----DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~--~~~d~~l~~----~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.++ ..+.+.-.. .+..........+|+..+|..||.+|.|+.++++
T Consensus 348 kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 348 KLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred cCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111 111111110 0111122345678999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=360.47 Aligned_cols=251 Identities=24% Similarity=0.397 Sum_probs=213.2
Q ss_pred hcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCch-hHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
..+|..++.||+|+|++||+| +.+.++.||||++.+.-...+ ..+-..+|-.+|.+| .||.|++++..|.++...|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 467889999999999999999 456799999999987654332 234567899999999 89999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
|+||+++|+|.++|+. .+.+++...+.++.+|+.||+|||+ +|||||||||+|||+|++|++||.|||.|+.
T Consensus 152 vLe~A~nGdll~~i~K-----~Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKK-----YGSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEecCCCcHHHHHHH-----hCcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeecccccc
Confidence 9999999999999976 3679999999999999999999999 9999999999999999999999999999986
Q ss_pred CCCCCc----------eee--cccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 737 APDGKY----------SVE--TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 737 ~~~~~~----------~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
..+... ... ..++||..|.+||++..+..+..+|+|+|||++|+|+.|++||.+..+ ...++
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne------yliFq 297 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE------YLIFQ 297 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH------HHHHH
Confidence 543221 111 458999999999999999999999999999999999999999977532 23355
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+++.....+++.++ ..+.+|+.+.|..||.+|++.+||.+
T Consensus 298 kI~~l~y~fp~~fp-------------~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 298 KIQALDYEFPEGFP-------------EDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred HHHHhcccCCCCCC-------------HHHHHHHHHHHccCccccccHHHHhh
Confidence 55555555555443 24569999999999999999998876
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.29 Aligned_cols=248 Identities=25% Similarity=0.398 Sum_probs=215.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|.+.+.||+|.||.||||+. .+.+.||+|.+.+....+++.+.+.+|+++++.++|||||.++++|+...+.|+|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 5788889999999999999954 568999999999888788888999999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+.| +|.+++.+ .+.++++.+..|+.+++.||.|||+ .+|+|||+||+|||++..+++|++|||+|+....
T Consensus 82 ~a~g-~L~~il~~-----d~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~ 152 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-----DGKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMST 152 (808)
T ss_pred hhhh-hHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence 9976 99999966 3669999999999999999999999 8999999999999999999999999999997665
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
. ..+.+...|||-|||||...++.|+..+|.||+||++||+++|++||... . +...+..+..+....+.
T Consensus 153 ~-t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---s---i~~Lv~~I~~d~v~~p~---- 221 (808)
T KOG0597|consen 153 N-TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---S---ITQLVKSILKDPVKPPS---- 221 (808)
T ss_pred C-ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---H---HHHHHHHHhcCCCCCcc----
Confidence 3 35567789999999999999999999999999999999999999999753 2 22233333332222221
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+..++...+.+||.+|.+..+++.
T Consensus 222 ---------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 222 ---------TASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred ---------cccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 33356789999999999999999999875
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=375.22 Aligned_cols=281 Identities=25% Similarity=0.436 Sum_probs=227.1
Q ss_pred CCCccccCCceeecHHHHHHHhcCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHH
Q 002346 559 SDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634 (933)
Q Consensus 559 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~ 634 (933)
.+++.+++++..+-.-.-+.-.....+.++||.|.||.||+|+++ ....||||.++.. .+++++.+|..|+.+|.
T Consensus 607 iDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMG 685 (996)
T KOG0196|consen 607 IDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMG 685 (996)
T ss_pred cCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcc
Confidence 344555554433222122222345678899999999999999764 2457999999876 46778899999999999
Q ss_pred hcCCCcceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCC
Q 002346 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (933)
Q Consensus 635 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 714 (933)
+++||||+++.|+.......++|+|||++|+|+.||+.. .+.+++-+...++++||.|+.||.+ .++|||||.
T Consensus 686 QFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~----DGqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLA 758 (996)
T KOG0196|consen 686 QFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN----DGQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLA 758 (996)
T ss_pred cCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc----CCceEeehHHHHHHHHHHHhHHHhh---cCchhhhhh
Confidence 999999999999999999999999999999999999762 2459999999999999999999999 899999999
Q ss_pred CCcEEecCCCcEEEecccccccCCCCCceeeccccc--ccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCC
Q 002346 715 PSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG--TFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDT 791 (933)
Q Consensus 715 ~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~ 791 (933)
++|||++.+..+|++|||+++...++.....+...| ..+|.|||.+...+++.++||||||++|||.++ |.+||.+.
T Consensus 759 ARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm 838 (996)
T KOG0196|consen 759 ARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 838 (996)
T ss_pred hhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc
Confidence 999999999999999999999776655333333333 469999999999999999999999999999887 99999887
Q ss_pred CCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
..++... .+.....+|..+ +.+..+.+|+..||++|-.+||.++|++..|.+++.+
T Consensus 839 SNQdVIk-------aIe~gyRLPpPm-----------DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 839 SNQDVIK-------AIEQGYRLPPPM-----------DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred chHHHHH-------HHHhccCCCCCC-----------CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 5543322 222344444433 3345688999999999999999999999999988644
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=335.10 Aligned_cols=267 Identities=22% Similarity=0.342 Sum_probs=206.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+.|+.+.++|+|+||+|||.+. .+|+.||||++.....++...+-..+|++++++++|+|+|.++++|......++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4677888999999999999965 469999999998776566666778999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
||+. ++.+-|..+. ..++...+.++++|+++|+.|+|+ +++|||||||+|||++.+|.+||||||+|+....
T Consensus 82 ~~dh-TvL~eLe~~p----~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 82 YCDH-TVLHELERYP----NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred ecch-HHHHHHHhcc----CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 9976 4444444322 237888999999999999999999 8999999999999999999999999999997763
Q ss_pred CCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHH--------HHHHHhhcc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT--------WFRRVLISK 810 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~--------~~~~~~~~~ 810 (933)
. ....+.++.|..|.|||.+.+ ..|+..+|||++||++.||++|.+-|.+.++-+....+. ....++...
T Consensus 154 p-gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 P-GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred C-cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccC
Confidence 2 233467789999999999877 689999999999999999999999888765444322211 001111111
Q ss_pred C-----CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 E-----NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 ~-----~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. .+|+.-++.-- +..-.....-+++++..|++.||++|++-+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epL-e~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPL-ERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccch-hhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 1 11111111100 0011122234679999999999999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=349.31 Aligned_cols=252 Identities=28% Similarity=0.499 Sum_probs=200.6
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc--eeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS--ERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv 657 (933)
.+|...+.||+|+||.||++... +|+..|||.+.... ....+.+.+|+.+|++++|||||+.+|...... .++++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 45777899999999999999654 48999999987762 122677899999999999999999999855444 68899
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-CCcEEEeccccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKN 736 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~ 736 (933)
|||+++|+|.+++.+. +. .+++..+..+.+||++||+|||+ ++||||||||+|||++. ++.+||+|||+++.
T Consensus 95 mEy~~~GsL~~~~~~~---g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~ 167 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRY---GG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKK 167 (313)
T ss_pred eeccCCCcHHHHHHHc---CC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence 9999999999999662 22 69999999999999999999998 99999999999999999 79999999999986
Q ss_pred CCC--CCceeecccccccCcccccccCCCC-CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 737 APD--GKYSVETRLAGTFGYLAPEYAATGR-VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 737 ~~~--~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
... ..........||+.|||||++..+. ...++||||+||++.||+||++||.... + ...++-.+.... ..
T Consensus 168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~--~---~~~~~~~ig~~~-~~ 241 (313)
T KOG0198|consen 168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFF--E---EAEALLLIGRED-SL 241 (313)
T ss_pred cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhc--c---hHHHHHHHhccC-CC
Confidence 653 2222234578999999999998643 3459999999999999999999997641 1 111111222111 22
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
| .+...+. .+..+++.+|+..+|++||||+++++
T Consensus 242 P-~ip~~ls---------~~a~~Fl~~C~~~~p~~Rpta~eLL~ 275 (313)
T KOG0198|consen 242 P-EIPDSLS---------DEAKDFLRKCFKRDPEKRPTAEELLE 275 (313)
T ss_pred C-CCCcccC---------HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 2 2222222 35669999999999999999999987
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=326.78 Aligned_cols=238 Identities=29% Similarity=0.434 Sum_probs=210.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|+..+.||.|+||.|..++. .+|..+|+|++.+... ..++.+...+|..+++.+.||+++++++.+.+.+..++||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 4677889999999999999955 4688999999987653 3345677889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||++||.|..++++ .+.+++..++-+|.||+.|++|||+ .+|++||+||+|||+|.+|.+||.|||.|+...
T Consensus 124 eyv~GGElFS~Lrk-----~~rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~ 195 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK-----SGRFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS 195 (355)
T ss_pred eccCCccHHHHHHh-----cCCCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence 99999999999976 3679999999999999999999999 899999999999999999999999999999887
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.. +...+|||.|+|||.+.+..|..++|.|+|||++|||+.|.+||....+ ...+.+++..+-..|..++
T Consensus 196 ~r----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~------~~iY~KI~~~~v~fP~~fs 265 (355)
T KOG0616|consen 196 GR----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP------IQIYEKILEGKVKFPSYFS 265 (355)
T ss_pred Cc----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh------HHHHHHHHhCcccCCcccC
Confidence 64 3457999999999999999999999999999999999999999998765 2345566766767776665
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCC
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQR 849 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~R 849 (933)
+ .+.+|+...++.|-.+|
T Consensus 266 ~-------------~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 266 S-------------DAKDLLKKLLQVDLTKR 283 (355)
T ss_pred H-------------HHHHHHHHHHhhhhHhh
Confidence 4 34589999999999999
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=358.26 Aligned_cols=267 Identities=26% Similarity=0.467 Sum_probs=215.2
Q ss_pred HHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 574 EVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 574 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
++.+...+.+.+.+.||+|.||+||+|.+. -.||||++.....+++..+.|+.|+.++++-+|.||+-+.|||..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444445566678899999999999999985 369999999998888899999999999999999999999999998877
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.+|+-+|+|.+|+.++|..+ ..++..+.+.||+|||+|+.|||. ++|||||+|..||++.+++.|||+|||+
T Consensus 463 -AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGL 534 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGL 534 (678)
T ss_pred -eeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccc
Confidence 99999999999999998732 568999999999999999999999 9999999999999999999999999999
Q ss_pred cccCC--CCCceeecccccccCcccccccCCC---CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 734 VKNAP--DGKYSVETRLAGTFGYLAPEYAATG---RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 734 a~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
+.... .+.. ......|...|||||++..+ +|+..+||||||+++|||+||..||.....+... | ..
T Consensus 535 atvk~~w~g~~-q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi----f----mV 605 (678)
T KOG0193|consen 535 ATVKTRWSGEQ-QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII----F----MV 605 (678)
T ss_pred eeeeeeecccc-ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE----E----Ee
Confidence 86322 1111 11234578899999999644 6899999999999999999999999843222111 1 11
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
..+.+.... .....+...+|.+|+..||..++++||.+.+++..|+.+...
T Consensus 606 GrG~l~pd~------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~ 656 (678)
T KOG0193|consen 606 GRGYLMPDL------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS 656 (678)
T ss_pred cccccCccc------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence 122111111 111223445788999999999999999999999988877543
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=358.29 Aligned_cols=250 Identities=24% Similarity=0.440 Sum_probs=209.9
Q ss_pred hcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
...|...++||+|+.|.||.| +..+++.||||++.... ....+-+.+|+.+|+..+|+|||.+++.|..+++.|+||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~--Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK--QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEecc--CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 356788899999999999999 56688999999998764 333456889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
|||+||+|.+.+.. ..+++.++..|++++++||+|||. ++|+|||||.+|||++.+|.+||+|||++....
T Consensus 350 Eym~ggsLTDvVt~------~~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~ 420 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK------TRMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQIS 420 (550)
T ss_pred eecCCCchhhhhhc------ccccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccc
Confidence 99999999999855 458999999999999999999999 999999999999999999999999999988776
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... .....+|||.|||||+.....|+.|.||||||++++||+-|.+||....+-....+.. ....++.
T Consensus 421 ~~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa--------~ng~P~l-- 489 (550)
T KOG0578|consen 421 EEQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--------TNGTPKL-- 489 (550)
T ss_pred cccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh--------hcCCCCc--
Confidence 5543 4456799999999999999999999999999999999999999998654432221111 1111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ........+.+++.+||+.|+++|+++.|+++
T Consensus 490 ---k---~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 ---K---NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred ---C---CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1 11122346779999999999999999999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=359.32 Aligned_cols=258 Identities=25% Similarity=0.411 Sum_probs=214.1
Q ss_pred HhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCC---chhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCce
Q 002346 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSE 653 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 653 (933)
..++|.+.+.||+|+||.|+.| ...+++.||+|++...... ....+.+.+|+.+++.++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3578999999999999999999 4557899999977664221 123456778999999998 9999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-CcEEEeccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFG 732 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfG 732 (933)
.++||||+.+|+|.+++.. .+++.+.++..+++|++.|++|||+ ++|+||||||+|||++.+ +++||+|||
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-----~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG 166 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-----KGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFG 166 (370)
T ss_pred EEEEEEecCCccHHHHHHH-----cCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccc
Confidence 9999999999999999965 3668899999999999999999999 899999999999999999 999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCC-CC-CccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGR-VT-TKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
++.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||++... .....++....
T Consensus 167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~------~~l~~ki~~~~ 239 (370)
T KOG0583|consen 167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV------PNLYRKIRKGE 239 (370)
T ss_pred cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH------HHHHHHHhcCC
Confidence 998774 2222345579999999999999877 75 789999999999999999999987322 22233344445
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
..++..++ ..++..++.+|+..+|.+|+++.++++ ++|...
T Consensus 240 ~~~p~~~~------------S~~~~~Li~~mL~~~P~~R~t~~~i~~------h~w~~~ 280 (370)
T KOG0583|consen 240 FKIPSYLL------------SPEARSLIEKMLVPDPSTRITLLEILE------HPWFQK 280 (370)
T ss_pred ccCCCCcC------------CHHHHHHHHHHcCCCcccCCCHHHHhh------Chhhcc
Confidence 55555552 135679999999999999999999984 566543
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=317.27 Aligned_cols=266 Identities=26% Similarity=0.386 Sum_probs=209.1
Q ss_pred cCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|...++||+|.||.||+| +.++|+.||||+++.....+.......+|++.++.++|+||+.++++|.+.+..-+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 46888899999999999999 56789999999999876555555678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
||+ .+|...+++ ....++..++..++.++++|++|||+ +.|+||||||.|+|++++|.+||+|||+|+.+..
T Consensus 82 fm~-tdLe~vIkd----~~i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~ 153 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD----KNIILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGS 153 (318)
T ss_pred ecc-ccHHHHhcc----cccccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence 995 599988855 34679999999999999999999999 8999999999999999999999999999998776
Q ss_pred CCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh-ccCCCCccc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI-SKENIPKAI 817 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 817 (933)
.... .+..+-|..|.|||.+.+. .|+...||||.||++.||+-|.+-|.+..+-++ +...++..-. ....+++.-
T Consensus 154 p~~~-~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ--L~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 154 PNRI-QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ--LSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred CCcc-cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH--HHHHHHHcCCCCcccCcccc
Confidence 5432 2333778999999988664 689999999999999999999877766543222 2222221100 011122111
Q ss_pred ---C-------CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 ---D-------PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 ---d-------~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
| |.......-........+++..++..+|.+|.+++|+++
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 0 000111111223345689999999999999999999987
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=346.50 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=209.3
Q ss_pred HhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCc-eeE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS-ERL 655 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~ 655 (933)
+.++|.++++||.|+||.||+|+ ..+|+.||||+++....+.++. --.||++.+++|+ |||||++.+.+.+.+ ..+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 45789999999999999999994 5679999999998876553322 2358999999998 999999999999887 899
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||| ..+|.+.++++ ...+++.+++.|+.||++||+|+|. +|+.|||+||+|||+..+..+||+|||+||
T Consensus 87 fVfE~M-d~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLAR 158 (538)
T KOG0661|consen 87 FVFEFM-DCNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAR 158 (538)
T ss_pred eeHHhh-hhhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccc
Confidence 999999 56999999763 4789999999999999999999998 999999999999999999999999999999
Q ss_pred cCCCCCceeecccccccCccccccc-CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-----
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYA-ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS----- 809 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~----- 809 (933)
...... ..+.++.|..|+|||++ .++.|+.+.|+|++||+++|+++=++-|.+..+.++..-+ ..++-.
T Consensus 159 ev~Skp--PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KI---c~VLGtP~~~~ 233 (538)
T KOG0661|consen 159 EVRSKP--PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKI---CEVLGTPDKDS 233 (538)
T ss_pred ccccCC--CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHH---HHHhCCCcccc
Confidence 776533 23667889999999987 5567899999999999999999999998876543332111 111100
Q ss_pred -----------cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 -----------KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 -----------~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...++......+ ..--.....+.++++.+|+..||.+|||++|+++
T Consensus 234 ~~eg~~La~~mnf~~P~~~~~~l--~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 234 WPEGYNLASAMNFRFPQVKPSPL--KDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred chhHHHHHHHhccCCCcCCCCCh--HHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 011111111111 1111224567889999999999999999999987
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=348.83 Aligned_cols=249 Identities=25% Similarity=0.427 Sum_probs=213.7
Q ss_pred cCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
..|+..+.||+|.||.|||| +...++.||+|++..+. ...+.++.++|+.++.+++++||.+.|+.+..+...+++||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe 91 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME 91 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence 35667789999999999999 55679999999998875 45567899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
||.||++.+.+.. ...+.+.+..-|++++..|+.|+|. ++.+|||||+.|||+..+|.+|++|||++.....
T Consensus 92 y~~gGsv~~lL~~-----~~~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~ 163 (467)
T KOG0201|consen 92 YCGGGSVLDLLKS-----GNILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTN 163 (467)
T ss_pred HhcCcchhhhhcc-----CCCCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeec
Confidence 9999999999965 2344888888899999999999999 8999999999999999999999999999987776
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
..... ..++|||.|||||++....|+.|+||||||++.+||++|.+|+....|+... ..+++...|
T Consensus 164 ~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl-------------flIpk~~PP 229 (467)
T KOG0201|consen 164 TVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL-------------FLIPKSAPP 229 (467)
T ss_pred hhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE-------------EeccCCCCC
Confidence 55443 5679999999999999889999999999999999999999999987774332 223344444
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+.. .....+.+++..|++++|+.||++.++++
T Consensus 230 ~L~~-----~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 230 RLDG-----DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred cccc-----ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 4442 23345889999999999999999999775
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=353.68 Aligned_cols=248 Identities=25% Similarity=0.397 Sum_probs=213.1
Q ss_pred cCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccc-cCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.-|+.++.||+|+-|.|-.| ...+|+.+|||++.+. ..+......+.+|+.+|+.+.||||+++|+.+++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34778899999999999999 4568999999999876 344555678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|.|.+++-. .+++++.++.++++||+.|+.|||. .+|+|||+||+|+|+|.++.+||+|||+|....
T Consensus 92 Eyv~gGELFdylv~-----kG~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~ 163 (786)
T KOG0588|consen 92 EYVPGGELFDYLVR-----KGPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEV 163 (786)
T ss_pred EecCCchhHHHHHh-----hCCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeeccc
Confidence 99999999999965 3779999999999999999999999 899999999999999999999999999998666
Q ss_pred CCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
++.- -...+|+|.|+|||++.+.+| +.++||||+||+||.|+||+.||++. . +.....++..+...+|..+
T Consensus 164 ~gkl--LeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---N---ir~LLlKV~~G~f~MPs~I 235 (786)
T KOG0588|consen 164 PGKL--LETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---N---IRVLLLKVQRGVFEMPSNI 235 (786)
T ss_pred CCcc--ccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---c---HHHHHHHHHcCcccCCCcC
Confidence 5442 234599999999999999988 57999999999999999999999853 2 2223334445555565544
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. .+..+|+.+|+..||++|.|++||.+
T Consensus 236 s-------------~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 236 S-------------SEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred C-------------HHHHHHHHHHhccCccccccHHHHhh
Confidence 3 24669999999999999999999987
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=341.25 Aligned_cols=268 Identities=28% Similarity=0.413 Sum_probs=216.1
Q ss_pred HHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
+...+...+.++||+|-||.|.......+..||||.++... ......+|.+|+++|.+++|||||+++|+|..++.+++
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicm 612 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCM 612 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHH
Confidence 44456778899999999999999999778999999998774 34456899999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
|+|||++|+|.+|+..+.. ..+.-....+|+.|||.|++||.+ ..+||||+.++|+|++.++++||+|||+++.
T Consensus 613 I~EYmEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 613 ITEYMENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred HHHHHhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccc
Confidence 9999999999999977321 224556677899999999999999 8999999999999999999999999999996
Q ss_pred CCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc--CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 737 APDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT--GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 737 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
...+++ +...+.+-+.+|||||.+.-++++.++|||+||+++||+++ ...||.....++. ++-....+...+
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v---ven~~~~~~~~~-- 761 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV---VENAGEFFRDQG-- 761 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH---HHhhhhhcCCCC--
Confidence 655554 44566677889999999999999999999999999999765 7788876543322 222222221111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
...+-+. +.....++.+++.+||+.+-++||+++++...|.+.
T Consensus 762 ~~~~l~~------P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 762 RQVVLSR------PPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred cceeccC------CCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 1111111 112234677999999999999999999999888654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=342.45 Aligned_cols=253 Identities=24% Similarity=0.399 Sum_probs=206.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++++.||+|+||.||.++. .+|+.+|+|++++..+- ..+.+.+..|..+|....+|.||+++..|++.+..|||
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 47899999999999999999954 56999999999987643 34577889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||++||++...|.. .+.+++..+..++.+++-|++.+|. .|+|||||||+|+|||..|++||+|||++.-.
T Consensus 220 MEylPGGD~mTLL~~-----~~~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMR-----KDTLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEecCCccHHHHHHh-----cCcCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999966 4679999999999999999999998 89999999999999999999999999997521
Q ss_pred CC----------------------CCce-----ee-------------------cccccccCcccccccCCCCCCCccch
Q 002346 738 PD----------------------GKYS-----VE-------------------TRLAGTFGYLAPEYAATGRVTTKIDV 771 (933)
Q Consensus 738 ~~----------------------~~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~~~~~Dv 771 (933)
.. .+.. .. ...+|||.|+|||++.+..|+..+|.
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw 371 (550)
T KOG0605|consen 292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW 371 (550)
T ss_pred hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence 10 0000 00 11369999999999999999999999
Q ss_pred HhHHHHHHHHHcCCCCCCCCCCchh-hHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC
Q 002346 772 YAFGVVLMETITGRKALDDTMPDDR-AHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850 (933)
Q Consensus 772 ~SlG~~l~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP 850 (933)
||+||++|||+.|.+||....+.+. ..++.|...... |+..+ + ..+..++|.+|+. ||++|.
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~f-----P~~~~--~---------s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKF-----PEEVD--L---------SDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccC-----CCcCc--c---------cHHHHHHHHHHhc-CHHHhc
Confidence 9999999999999999998877543 334444332221 11111 1 1356799999999 999998
Q ss_pred C---HHHHHH
Q 002346 851 D---MGHAVN 857 (933)
Q Consensus 851 s---~~evl~ 857 (933)
. ++||.+
T Consensus 435 G~~G~~EIK~ 444 (550)
T KOG0605|consen 435 GSKGAEEIKK 444 (550)
T ss_pred CcccHHHHhc
Confidence 6 555543
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=355.68 Aligned_cols=264 Identities=25% Similarity=0.442 Sum_probs=206.2
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC-
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING- 651 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 651 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++..+ +||||++++++|...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 46899999999999999999953 235689999987542 334456799999999999 899999999988764
Q ss_pred ceeEEEEeecCCCChhhHhhhcccC-------------------------------------------------------
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDH------------------------------------------------------- 676 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 676 (933)
...++||||+++|+|.+++......
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 4578999999999999998753210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce-eecccccccC
Q 002346 677 --GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFG 753 (933)
Q Consensus 677 --~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~ 753 (933)
...++++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++........ ......+++.
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 01358899999999999999999999 89999999999999999999999999999865432221 1223456789
Q ss_pred cccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHH
Q 002346 754 YLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIY 832 (933)
Q Consensus 754 y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 832 (933)
|+|||++.+..++.++|||||||++|||++ |+.||........ .. ........ .. ... ....
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~----~~~~~~~~-~~-~~~---------~~~~ 304 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC----QRLKDGTR-MR-APE---------NATP 304 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH----HHHhcCCC-CC-CCC---------CCCH
Confidence 999999998899999999999999999997 9999976433211 11 11111111 10 000 1123
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 833 RVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 833 ~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.+.+++.+|++.||++||++.|+++.|+.+.+
T Consensus 305 ~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 305 EIYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 57799999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=375.42 Aligned_cols=266 Identities=29% Similarity=0.484 Sum_probs=215.9
Q ss_pred cCCccCCccccCCCeEEEEEEeCC--Cc----EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD--GT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
++.+..+.||+|.||.||.|...+ |. .||||.++... +..+..+|.+|..+|+.++|||||+++|.|.+....
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~ 770 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP 770 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence 445667899999999999996543 33 48999988763 566788999999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccCC--CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHG--YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
++++|||++|+|..||++.+... ...++..+.+.++.+||+|+.||++ +++|||||.++|+|+++...|||+|||
T Consensus 771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFG 847 (1025)
T KOG1095|consen 771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADFG 847 (1025)
T ss_pred EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEcccc
Confidence 99999999999999998743222 3458999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeeccc-ccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 733 LVKNAPDGKYSVETRL-AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 733 la~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
+|+...+.++...... .-..+|||||.+..+.++.|+|||||||++||++| |..||......+.... ... .
T Consensus 848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~------~~~-g 920 (1025)
T KOG1095|consen 848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD------VLE-G 920 (1025)
T ss_pred hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH------HHh-C
Confidence 9996665555443332 33469999999999999999999999999999999 7788876544332211 111 2
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
+.+ ....++. ..+.+++..||+.+|++||++..+++.+..+.....+
T Consensus 921 gRL--------~~P~~CP---~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~ 967 (1025)
T KOG1095|consen 921 GRL--------DPPSYCP---EKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG 967 (1025)
T ss_pred Ccc--------CCCCCCC---hHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence 221 1122222 3566999999999999999999999999888766544
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-39 Score=351.01 Aligned_cols=244 Identities=25% Similarity=0.410 Sum_probs=205.6
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
-++|...++||+|.||+|+.+.. .+++.+|||++++..+ ..++.+..+.|-+++... +||.++.++.+++..++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 46899999999999999999965 4688999999998764 456678889999998888 59999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+.||++..+.+. +.+++..+.-++..|+-||+|||+ ++|||||||.+|||+|.+|++||+|||+++.
T Consensus 447 vmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccc
Confidence 9999999995544432 569999999999999999999999 9999999999999999999999999999996
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
...... .++.++|||.|||||++.+..|+.++|.|||||+||||+.|..||.+..+++ .+..++..+...|.
T Consensus 518 ~m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee------~FdsI~~d~~~yP~- 589 (694)
T KOG0694|consen 518 GMGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE------VFDSIVNDEVRYPR- 589 (694)
T ss_pred cCCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCCCCCCC-
Confidence 553322 4566899999999999999999999999999999999999999998754332 22333333322222
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
....+.+.++++++.++|++|..+
T Consensus 590 ------------~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 ------------FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ------------cccHHHHHHHHHHhccCcccccCC
Confidence 223467799999999999999977
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=315.80 Aligned_cols=253 Identities=24% Similarity=0.397 Sum_probs=211.2
Q ss_pred hcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++.|++.+.||+|.|+.||+. ...+|+.+|+|.+.....+....+++.+|+++-+.|+|||||++.+.+.+....|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 467888899999999999998 6678999999998877777777889999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC---CcEEEecccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADFGLVK 735 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~DfGla~ 735 (933)
|+|+|++|..-+-.. .-+++..+-..++||++||.|+|. ++|||||+||+|+++... ..+|++|||+|.
T Consensus 90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEE
Confidence 999999998766441 347788899999999999999999 999999999999999643 359999999999
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
....+ .....++|||+|||||++...+|+..+|||+.||++|-|+.|.+||.+.... ..+.++.....+++.
T Consensus 162 ~l~~g--~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~------rlye~I~~g~yd~~~ 233 (355)
T KOG0033|consen 162 EVNDG--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH------RLYEQIKAGAYDYPS 233 (355)
T ss_pred EeCCc--cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH------HHHHHHhccccCCCC
Confidence 88733 3456679999999999999999999999999999999999999999874322 123334443433332
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+.+. .+..+++++|+..||.+|.|+.|+++
T Consensus 234 ~~w~~is---------~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 234 PEWDTVT---------PEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred cccCcCC---------HHHHHHHHHHhccChhhhccHHHHhC
Confidence 1111121 34669999999999999999999886
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=350.72 Aligned_cols=260 Identities=27% Similarity=0.462 Sum_probs=208.4
Q ss_pred CCccCCccccCCCeEEEEEEeCC--C---cEEEEEEeccc-cCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 582 NFSEANILGRGGFGVVYGGELPD--G---TKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
+....++||+|+||.||+|.+.. + ..||||..+.. ........+|..|+++|++++|||||++||++......+
T Consensus 158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ 237 (474)
T KOG0194|consen 158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM 237 (474)
T ss_pred CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence 34456899999999999996643 2 23899998863 356778899999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+|||+|.||+|.++|+... ..++..++..++.+.|+||+|||+ +++|||||.++|+|++.++.+||+|||+++
T Consensus 238 ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~ 310 (474)
T KOG0194|consen 238 LVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSR 310 (474)
T ss_pred EEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCcccccc
Confidence 9999999999999997622 259999999999999999999999 999999999999999999999999999987
Q ss_pred cCCCCCceeec-ccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 736 NAPDGKYSVET-RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 736 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
.... +.... ...-+.+|+|||.+..+.|+.++|||||||++||+++ |..||.+.... .... ++.. ...
T Consensus 311 ~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~---~v~~---kI~~--~~~ 380 (474)
T KOG0194|consen 311 AGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY---EVKA---KIVK--NGY 380 (474)
T ss_pred CCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH---HHHH---HHHh--cCc
Confidence 5541 11111 1124579999999999999999999999999999999 78888765332 2222 1211 112
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
+..... ..+..+..++.+|+..+|++||+|.++.+.++.+.....
T Consensus 381 r~~~~~---------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 381 RMPIPS---------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred cCCCCC---------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 221111 122356678889999999999999999999988865544
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=341.17 Aligned_cols=266 Identities=27% Similarity=0.466 Sum_probs=204.9
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC-----------------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcce
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD-----------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 642 (933)
.++|++.+.||+|+||.||++...+ +..||+|.+.... ......+|.+|++++.+++||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCee
Confidence 3578899999999999999996432 3469999987653 334467899999999999999999
Q ss_pred eEEeEeeeCceeEEEEeecCCCChhhHhhhccc--------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCe
Q 002346 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHD--------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708 (933)
Q Consensus 643 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 708 (933)
++++++.+.+..++||||+++|+|.+++..... .....+++.+++.++.|+++||+|||+ .+|
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i 159 (304)
T cd05096 83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNF 159 (304)
T ss_pred EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 999999999999999999999999999865321 112357889999999999999999999 899
Q ss_pred EecCCCCCcEEecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc--CC
Q 002346 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT--GR 785 (933)
Q Consensus 709 vH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt--G~ 785 (933)
+||||||+||+++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||++ +.
T Consensus 160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999999986544332 22234456889999999988899999999999999999987 55
Q ss_pred CCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 786 KALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 786 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.||........ ...................+. .....+.+++.+||+.+|++||++.++.+.|+
T Consensus 240 ~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~ 303 (304)
T cd05096 240 QPYGELTDEQV---IENAGEFFRDQGRQVYLFRPP--------PCPQGLYELMLQCWSRDCRERPSFSDIHAFLT 303 (304)
T ss_pred CCCCcCCHHHH---HHHHHHHhhhccccccccCCC--------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence 67765432221 111211111111000000000 11245789999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=399.07 Aligned_cols=384 Identities=28% Similarity=0.409 Sum_probs=285.4
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|++++.+|..|+++++|++|+|++|.+++.+| .+.++++|++|+|++|.+++..+..+.++++|+.|+|
T Consensus 212 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 291 (968)
T PLN00113 212 KSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDL 291 (968)
T ss_pred CCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEEC
Confidence 478889999999999999999999999999999999988887 7888999999999999998877777888999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCC
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLG 223 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~ 223 (933)
++|.+.+ .+|..+.++++|+.|++++|.+.+.+|..+..+++|+.|+|++|++++.+|..+.. ..|+.|+++.|.+.
T Consensus 292 s~n~l~~--~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~ 369 (968)
T PLN00113 292 SDNSLSG--EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLT 369 (968)
T ss_pred cCCeecc--CCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeE
Confidence 9998887 57888888889999999988888888888888888899999888888888887765 56778888887764
Q ss_pred cccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCC--
Q 002346 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-- 300 (933)
Q Consensus 224 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-- 300 (933)
... ...+..+++|+.|++++|.+.+.+|. +..+++|+.|+|++|++++.+|..+..+++|+.|++++|.+++.+|.
T Consensus 370 ~~~-p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~ 448 (968)
T PLN00113 370 GEI-PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448 (968)
T ss_pred eeC-ChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhh
Confidence 322 22344455566666666666555543 55556666666666666655665566666666666666666555543
Q ss_pred -CCCCccEEeccCCcCCCCCCCCCCCCCchhhhhH------hhhccc-CCCccccCCCCCCCCCCCCCccccCCCceeEE
Q 002346 301 -FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLL------QIAGDM-GYPAILSDSWEGNNACDGWPFVTCSQGRIITI 372 (933)
Q Consensus 301 -~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~------~~~~~~-~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L 372 (933)
...+|+.|+|++|++.+..+........+...+. .++..+ ..+.....++.+|+..+.+|..+..+++|+.|
T Consensus 449 ~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 528 (968)
T PLN00113 449 WDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSL 528 (968)
T ss_pred ccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEE
Confidence 2234555555555554433332211000000000 000011 11222345677888889999999999999999
Q ss_pred EccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCCCCCcccc--cCCCCCCcC
Q 002346 373 NLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT--VSPGNPFIG 450 (933)
Q Consensus 373 ~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~--~~~~n~~~~ 450 (933)
+|++|.++|.+|..|+++++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|..+....+. ...+||..|
T Consensus 529 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc 608 (968)
T PLN00113 529 DLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLC 608 (968)
T ss_pred ECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCcccc
Confidence 999999999999999999999999999999999999999999999999999999999999876544432 456888887
Q ss_pred CC
Q 002346 451 TN 452 (933)
Q Consensus 451 ~~ 452 (933)
..
T Consensus 609 ~~ 610 (968)
T PLN00113 609 GG 610 (968)
T ss_pred CC
Confidence 53
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.08 Aligned_cols=268 Identities=27% Similarity=0.467 Sum_probs=203.3
Q ss_pred CccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc--CCCcceeEEeEeeeCc----eeEE
Q 002346 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV--RHRHLVALLGYCINGS----ERLL 656 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~~----~~~l 656 (933)
.+..++||+|.||.||||.+ +++.||||++.. ++.+.|+.|-.+.+.. +|+||++++++-..+. +++|
T Consensus 212 l~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL 285 (534)
T KOG3653|consen 212 LQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL 285 (534)
T ss_pred hhhHHHhhcCccceeehhhc-cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence 34567899999999999999 569999999864 4567899998887765 7999999999877655 8899
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc------CCCeEecCCCCCcEEecCCCcEEEec
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA------QQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
|+||.+.|+|.+||.. ..++|.+..+|+..+++||+|||+.. +++|+|||||.+|||+..|+++.|+|
T Consensus 286 Vt~fh~kGsL~dyL~~------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 286 VTEFHPKGSLCDYLKA------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred EeeeccCCcHHHHHHh------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 9999999999999976 56999999999999999999999743 57899999999999999999999999
Q ss_pred ccccccCCCCCce-eecccccccCcccccccCCCC-CC-----CccchHhHHHHHHHHHcCCCCCCC-CCCchhh-----
Q 002346 731 FGLVKNAPDGKYS-VETRLAGTFGYLAPEYAATGR-VT-----TKIDVYAFGVVLMETITGRKALDD-TMPDDRA----- 797 (933)
Q Consensus 731 fGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Dv~SlG~~l~elltG~~p~~~-~~~~~~~----- 797 (933)
||+|..+..+... .....+||.+|||||++.+.. +. .+.||||+|.++|||+++-..++. ..++-..
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 9999877654422 223479999999999996542 22 368999999999999997654431 1111000
Q ss_pred ----HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 798 ----HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 798 ----~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
-..+.++.....+..- |.++.....-..+.-+.+.+..||+.||+.|.|+.=|-+.+.++...+.
T Consensus 440 vG~hPt~e~mq~~VV~kK~R-----P~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQR-----PKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred hcCCCCHHHHHHHHHhhccC-----CCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 0011111111111111 1222122222445667899999999999999999999998887765554
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=349.90 Aligned_cols=246 Identities=26% Similarity=0.402 Sum_probs=202.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 5788999999999999999965 4689999999876532 2234567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 98 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 169 (329)
T PTZ00263 98 EFVVGGELFTHLRK-----AGRFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP 169 (329)
T ss_pred cCCCCChHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence 99999999999965 2458899999999999999999999 899999999999999999999999999998664
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... ....|++.|+|||++.+..++.++|||||||++|||++|+.||....+.. ...........++..+
T Consensus 170 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~------~~~~i~~~~~~~p~~~- 238 (329)
T PTZ00263 170 DRT----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR------IYEKILAGRLKFPNWF- 238 (329)
T ss_pred CCc----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH------HHHHHhcCCcCCCCCC-
Confidence 432 23579999999999998889999999999999999999999997643221 1122222221222211
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
...+.+++.+||+.||++||+ ++++++
T Consensus 239 ------------~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 239 ------------DGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred ------------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 134679999999999999997 566654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=336.89 Aligned_cols=248 Identities=18% Similarity=0.346 Sum_probs=200.1
Q ss_pred CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCch-hHHHHHHHHHHHHhcCCCcceeEEeEeee----CceeEEEEee
Q 002346 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERLLVYEY 660 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~ 660 (933)
...||+|++|.||+|.. +|+.||||+++....... ..+.|.+|+.++++++|||||++++++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 36799999999999988 789999999986543332 24778899999999999999999999876 3467899999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++|+|.+++.. ...+++..+..++.+++.|++|||+ ..+++||||||+||++++++.+||+|||+++.....
T Consensus 104 ~~~g~L~~~l~~-----~~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~ 176 (283)
T PHA02988 104 CTRGYLREVLDK-----EKDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP 176 (283)
T ss_pred CCCCcHHHHHhh-----CCCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc
Confidence 999999999965 2468899999999999999999997 248889999999999999999999999998865432
Q ss_pred CceeecccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 741 KYSVETRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
. ....|+..|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...........+ ++
T Consensus 177 ~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~--~~ 244 (283)
T PHA02988 177 P----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI------YDLIINKNNSLK--LP 244 (283)
T ss_pred c----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCCCCC--CC
Confidence 2 23468899999999976 6899999999999999999999999986533211 111111111111 11
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
. .....+.+++.+||+.||++||+++|+++.|+.+
T Consensus 245 ~---------~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~ 279 (283)
T PHA02988 245 L---------DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY 279 (283)
T ss_pred C---------cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence 1 1123578999999999999999999999998765
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=322.82 Aligned_cols=251 Identities=23% Similarity=0.399 Sum_probs=210.6
Q ss_pred HhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
...+|++.+.||+|.||.|-+| ....|+.||||.++++.+.. ...-.+.+|+++|+.|+||||+.+|.+|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 3467888999999999999999 44689999999998876543 345678999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||..+|.|++|+.+ .+.+++.+++.+++||+.|+.|+|. ++++|||+|.+|||+|.++++||+|||++..
T Consensus 131 vMEYaS~GeLYDYiSe-----r~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNl 202 (668)
T KOG0611|consen 131 VMEYASGGELYDYISE-----RGSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNL 202 (668)
T ss_pred EEEecCCccHHHHHHH-----hccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhh
Confidence 9999999999999966 3679999999999999999999998 8999999999999999999999999999987
Q ss_pred CCCCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
+.+... -..++|+|-|.+||++.+.+| .+.+|-|||||++|.|+.|..||++.. ...++..+. .+...+
T Consensus 203 y~~~kf--LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~D---hk~lvrQIs-----~GaYrE 272 (668)
T KOG0611|consen 203 YADKKF--LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRD---HKRLVRQIS-----RGAYRE 272 (668)
T ss_pred hccccH--HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCch---HHHHHHHhh-----cccccC
Confidence 766542 356799999999999999988 578999999999999999999998752 222332221 111111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
|.- +....-+|++|+..+|++|-|..+|....
T Consensus 273 ---P~~---------PSdA~gLIRwmLmVNP~RRATieDiAsHW 304 (668)
T KOG0611|consen 273 ---PET---------PSDASGLIRWMLMVNPERRATIEDIASHW 304 (668)
T ss_pred ---CCC---------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence 111 12344799999999999999999998743
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=342.01 Aligned_cols=269 Identities=19% Similarity=0.272 Sum_probs=205.1
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||++... +++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46899999999999999999664 68899999998664444556778899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|++++.+..+... ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 9998776654422 2458899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH--------HHhhccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR--------RVLISKE 811 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 811 (933)
..........|++.|+|||++.+..++.++|||||||++|||++|+.||......+......... .......
T Consensus 153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07848 153 GSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNP 232 (287)
T ss_pred cccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccc
Confidence 33323334578999999999988889999999999999999999999998654322211111000 0000000
Q ss_pred CCCcccCCCCCCCh-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIPKAIDPNLNLDE-----ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~~~~d~~l~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......+...... ........+.+++.+|++.||++||+++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 233 RFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000 00012345889999999999999999999886
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=307.99 Aligned_cols=249 Identities=27% Similarity=0.450 Sum_probs=210.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++++.||+|-||.||.|+. +++-.||+|++.++.... ...+++.+|+++-+.|+||||+++|+++.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 5788999999999999999954 567889999998765432 23467899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||..+|++...|+.. ....+++.....++.|+|.|+.|+|. ++||||||||+|+|++.++..||+|||.+...+
T Consensus 102 Eya~~gel~k~L~~~---~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEG---RMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 175 (281)
T ss_pred EecCCchHHHHHHhc---ccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence 999999999999752 23568899999999999999999998 999999999999999999999999999987655
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
. ......+||..|.+||...+..++.++|+|++|++.||++.|.+||.....+ . .++++...+...+..+.
T Consensus 176 ~---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---e---tYkrI~k~~~~~p~~is 246 (281)
T KOG0580|consen 176 S---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---E---TYKRIRKVDLKFPSTIS 246 (281)
T ss_pred C---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---H---HHHHHHHccccCCcccC
Confidence 3 2335579999999999999999999999999999999999999999875421 1 12233333333333222
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....++|.+|+..+|.+|.+..|+++
T Consensus 247 -------------~~a~dlI~~ll~~~p~~r~~l~~v~~ 272 (281)
T KOG0580|consen 247 -------------GGAADLISRLLVKNPIERLALTEVMD 272 (281)
T ss_pred -------------hhHHHHHHHHhccCccccccHHHHhh
Confidence 34679999999999999999999986
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=329.47 Aligned_cols=262 Identities=27% Similarity=0.412 Sum_probs=205.1
Q ss_pred eecHHHHHHHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCC------------chhHHHHHHHHHHHHhc
Q 002346 570 AISIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG------------NKGLSEFQAEIAVLTKV 636 (933)
Q Consensus 570 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~------------~~~~~~~~~E~~~l~~l 636 (933)
.+...+-...-++|++.+.||+|.||.|-+|. ..+++.||+|++.+.... ....++..+|+.+|+++
T Consensus 86 ~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl 165 (576)
T KOG0585|consen 86 RYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL 165 (576)
T ss_pred eecCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc
Confidence 33444445556789999999999999999994 457999999999765321 11245889999999999
Q ss_pred CCCcceeEEeEeee--CceeEEEEeecCCCChhhHhhhcccCCCCC-CCHHHHHHHHHHHHHHHHHhhhccCCCeEecCC
Q 002346 637 RHRHLVALLGYCIN--GSERLLVYEYMPRGTLAQHLFEWHDHGYTP-LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL 713 (933)
Q Consensus 637 ~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 713 (933)
+|||||+++++..+ .+..|||+|||..|.+...-- .++ +++.++++++++++.||+|||. ++||||||
T Consensus 166 ~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~------d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDI 236 (576)
T KOG0585|consen 166 HHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP------DKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDI 236 (576)
T ss_pred CCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC------CcccccHHHHHHHHHHHHHHHHHHHh---cCeecccc
Confidence 99999999999876 467899999999888754331 234 9999999999999999999999 89999999
Q ss_pred CCCcEEecCCCcEEEecccccccCCCCCc----eeecccccccCcccccccCCCC----CCCccchHhHHHHHHHHHcCC
Q 002346 714 KPSNILIGDDMRAKVADFGLVKNAPDGKY----SVETRLAGTFGYLAPEYAATGR----VTTKIDVYAFGVVLMETITGR 785 (933)
Q Consensus 714 k~~Nill~~~~~~kl~DfGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~~l~elltG~ 785 (933)
||+|+|++++|+|||+|||.+.....+.. ..-...+|||.|+|||...++. .+.+.||||+||+||.|+.|+
T Consensus 237 KPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~ 316 (576)
T KOG0585|consen 237 KPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQ 316 (576)
T ss_pred chhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhcc
Confidence 99999999999999999999886633211 1113368999999999987643 357899999999999999999
Q ss_pred CCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 786 KALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 786 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.||.+... ...+.++....-.+++. .+....+.++|.++|++||++|.+..+|..
T Consensus 317 ~PF~~~~~------~~l~~KIvn~pL~fP~~-----------pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 317 LPFFDDFE------LELFDKIVNDPLEFPEN-----------PEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred CCcccchH------HHHHHHHhcCcccCCCc-----------ccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 99976432 22333443322222211 133356779999999999999999999975
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=341.54 Aligned_cols=251 Identities=28% Similarity=0.453 Sum_probs=205.5
Q ss_pred ceeecHHHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeE
Q 002346 568 NVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647 (933)
Q Consensus 568 ~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~ 647 (933)
...++++++.. ++-||.|+.|.||.|++ .++.||||+++.- -..+++-|++|+||||+.+.|+
T Consensus 118 ~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl-~netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGV 180 (904)
T KOG4721|consen 118 LWEIPFEEISE-------LEWLGSGAQGAVFLGRL-HNETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGV 180 (904)
T ss_pred hccCCHHHhhh-------hhhhccCcccceeeeec-cCceehhHHHhhh---------hhhhHHHHHhccCcceeeEeee
Confidence 34556666543 57799999999999999 5789999987532 2367899999999999999999
Q ss_pred eeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEE
Q 002346 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (933)
Q Consensus 648 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~k 727 (933)
|.....++||||||..|-|.+.|+. ..++.......+..+||.|+.|||. +.|||||||.-||||..+..||
T Consensus 181 CtqsPcyCIiMEfCa~GqL~~VLka-----~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VK 252 (904)
T KOG4721|consen 181 CTQSPCYCIIMEFCAQGQLYEVLKA-----GRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVK 252 (904)
T ss_pred ecCCceeEEeeeccccccHHHHHhc-----cCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEE
Confidence 9999999999999999999999966 3678888999999999999999998 8999999999999999999999
Q ss_pred EecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 728 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
|+|||-++...+. .....++||..|||||++...+.++|+||||||||||||+||..||.+...... ++.
T Consensus 253 IsDFGTS~e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI------IwG-- 322 (904)
T KOG4721|consen 253 ISDFGTSKELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI------IWG-- 322 (904)
T ss_pred eccccchHhhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee------EEe--
Confidence 9999999876553 234568999999999999999999999999999999999999999976432111 000
Q ss_pred hccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.....+.-.+. ...+..++-|+++||+..|..||++.+++..|+-+
T Consensus 323 VGsNsL~LpvP---------stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 323 VGSNSLHLPVP---------STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred ccCCcccccCc---------ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 00111111111 12234577899999999999999999999988654
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=341.90 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=202.2
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 4788999999999999999965 4689999999875432 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~ 152 (291)
T cd05612 81 EYVPGGELFSYLRN-----SGRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152 (291)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence 99999999999965 2468899999999999999999999 899999999999999999999999999988654
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... ....|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...........++..+
T Consensus 153 ~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~~~~i~~~~~~~~~~~- 221 (291)
T cd05612 153 DRT----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------IYEKILAGKLEFPRHL- 221 (291)
T ss_pred CCc----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCcCCCccC-
Confidence 322 23478999999999998889999999999999999999999997653321 1122222222222211
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
...+.+++.+|++.||.+||+ ++++++
T Consensus 222 ------------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 222 ------------DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ------------CHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 134679999999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.54 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=205.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 652 (933)
.++|++.+.||+|+||.||+|.. .++..||||+++... .....+.+.+|+.++..+ +||||++++++|..++
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc-CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 35688899999999999999953 245689999987543 233456789999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhccc---------------------------------------------------------
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHD--------------------------------------------------------- 675 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 675 (933)
..++||||+++|+|.++++....
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 99999999999999999965321
Q ss_pred -------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 002346 676 -------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 676 -------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 742 (933)
.....+++..+..++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 269 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN 269 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence 011357899999999999999999998 8999999999999999999999999999986544322
Q ss_pred e-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 743 S-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 743 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||....... ....++. ... ... .+.
T Consensus 270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~--~~~-~~~ 340 (375)
T cd05104 270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGY--RML-SPE 340 (375)
T ss_pred ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCc--cCC-CCC
Confidence 1 1222345678999999999999999999999999999998 888887543221 1111111 110 000 011
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
. ...++.+++.+|++.||++||++.|+++.|++.
T Consensus 341 ~--------~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 341 C--------APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C--------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 123578999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=348.20 Aligned_cols=263 Identities=24% Similarity=0.425 Sum_probs=206.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 652 (933)
.++|++.+.||+|+||.||+|.. .++..||||++.... .......+.+|+++++.+ +|+|||+++++|....
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 35788999999999999999853 234579999997653 233456789999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhccc---------------------------------------------------------
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHD--------------------------------------------------------- 675 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 675 (933)
..++||||+++|+|.++++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 99999999999999999864211
Q ss_pred --------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce-eec
Q 002346 676 --------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS-VET 746 (933)
Q Consensus 676 --------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~ 746 (933)
....++++.++++++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+++........ ...
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~ 272 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG 272 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence 011357899999999999999999999 89999999999999999999999999999865433221 122
Q ss_pred ccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCCh
Q 002346 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDE 825 (933)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 825 (933)
...+++.|+|||++.+..++.++|||||||++|||++ |+.||........ .. ...... ........
T Consensus 273 ~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~~----~~~~~~--~~~~~~~~----- 339 (374)
T cd05106 273 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--FY----KMVKRG--YQMSRPDF----- 339 (374)
T ss_pred CCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--HH----HHHHcc--cCccCCCC-----
Confidence 2345678999999988899999999999999999997 9999976433211 11 111111 11101001
Q ss_pred hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 826 ETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 826 ~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
...++.+++.+|++.+|++||++.+++++|++++
T Consensus 340 ----~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 340 ----APPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred ----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 1235789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=337.82 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=201.6
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.|+..+.||+|+||.||+|.. .+|+.||+|++...... ......+.+|+.++++++|++|+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999954 57999999998765322 2234567899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~g~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05631 81 IMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE 154 (285)
T ss_pred ecCCCcHHHHHHhh---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence 99999999888542 22468999999999999999999998 8999999999999999999999999999986543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... .....|++.|+|||++.+..++.++|||||||++|||++|+.||........... .......... .+..
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~--~~~~~~~~~~----~~~~ 226 (285)
T cd05631 155 GET--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREE--VDRRVKEDQE----EYSE 226 (285)
T ss_pred CCe--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHH--HHHHhhcccc----cCCc
Confidence 321 2345799999999999999999999999999999999999999986543221111 1111111011 1111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
.+ ...+.+++.+||+.+|++||+ ++++++
T Consensus 227 ~~---------s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 227 KF---------SEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred cC---------CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 11 235679999999999999997 677765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=312.66 Aligned_cols=267 Identities=24% Similarity=0.334 Sum_probs=206.7
Q ss_pred CCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--CceeEEEE
Q 002346 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLLVY 658 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 658 (933)
.|+.++.|++|+||.||+|+ .++++.||+|+++.+.......-.-.+|+.++.+++|||||.+..+... -+..|+||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 46667899999999999994 4578999999998765333333456899999999999999999888764 45789999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
|||+. +|...+.... .++...++..++.|+++|++|||. +.|+|||+|++|+|+...|.+||+|||+|+.+.
T Consensus 157 e~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 157 EYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred HHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 99965 8999886622 579999999999999999999999 899999999999999999999999999999887
Q ss_pred CCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... ...+..+-|..|.|||.+.+. .|+.+.|+||+||++.||+++++-|.+..+.++.+.+ ++. -+.-.+.+
T Consensus 229 sp~-k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~I--f~l----lGtPte~i 301 (419)
T KOG0663|consen 229 SPL-KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKI--FKL----LGTPSEAI 301 (419)
T ss_pred CCc-ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHH--HHH----hCCCcccc
Confidence 653 234566789999999988765 6899999999999999999999999877654443322 111 11111111
Q ss_pred CCCCC---------CChhhH--------H--HHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 818 DPNLN---------LDEETI--------E--SIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 818 d~~l~---------~~~~~~--------~--~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
.|.+. ....+. . ....-.+++..++..||.+|-|+.|.++ +.|+..
T Consensus 302 wpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~------h~~F~e 366 (419)
T KOG0663|consen 302 WPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK------HEYFRE 366 (419)
T ss_pred CCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc------cccccc
Confidence 11110 000000 0 1134568999999999999999999986 666643
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.07 Aligned_cols=257 Identities=22% Similarity=0.379 Sum_probs=204.8
Q ss_pred hcCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|++.+.||+|+||.||+|.+. .+..||+|.++... +....+.|.+|+.++++++||||+++++++..+...+
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 82 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM 82 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence 356889999999999999999642 46689999987653 3344567999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++... ...+++.+++.++.|++.|++|||+ ++++||||||+||+++.++.+|++|||.+.
T Consensus 83 lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~ 155 (266)
T cd05064 83 IVTEYMSNGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQ 155 (266)
T ss_pred EEEEeCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccc
Confidence 999999999999999652 2468999999999999999999998 899999999999999999999999999876
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
..............++..|+|||++.+..++.++|||||||++||+++ |+.||......+ ... . .......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~---~-~~~~~~~~ 228 (266)
T cd05064 156 EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIK---A-VEDGFRLP 228 (266)
T ss_pred cccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---H-HHCCCCCC
Confidence 543222111122345678999999998999999999999999999775 999997654322 111 1 11111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
..+ .....+.+++.+||+.+|++||++.++.+.|+++
T Consensus 229 --~~~---------~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 229 --APR---------NCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred --CCC---------CCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 111 1224577899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=324.18 Aligned_cols=274 Identities=26% Similarity=0.402 Sum_probs=213.3
Q ss_pred ecHHHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHh--cCCCcceeEEeEe
Q 002346 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK--VRHRHLVALLGYC 648 (933)
Q Consensus 571 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~ 648 (933)
.+.-..+.+..+..+.+.||+|.||.||+|++ .|+.||||++... +.+.+.+|.++.+. |+|+||+.+++.-
T Consensus 201 lplLVQRTiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD 274 (513)
T KOG2052|consen 201 LPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAAD 274 (513)
T ss_pred chhHhHHhhhheeEEEEEecCccccceeeccc-cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhcc
Confidence 34556677888999999999999999999999 7999999999654 23566777777665 4999999999876
Q ss_pred eeC----ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh-----ccCCCeEecCCCCCcEE
Q 002346 649 ING----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS-----LAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 649 ~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~-----~~~~~ivH~Dik~~Nil 719 (933)
..+ .+.|||++|.+.|||.+||.+ .+++....++++..+|.||+|||. +.++.|.|||||+.|||
T Consensus 275 ~~~~gs~TQLwLvTdYHe~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNIL 348 (513)
T KOG2052|consen 275 NKDNGSWTQLWLVTDYHEHGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL 348 (513)
T ss_pred ccCCCceEEEEEeeecccCCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEE
Confidence 543 377999999999999999976 578999999999999999999995 34678999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcee---ecccccccCcccccccCCCC----C--CCccchHhHHHHHHHHHcC------
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKYSV---ETRLAGTFGYLAPEYAATGR----V--TTKIDVYAFGVVLMETITG------ 784 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~----~--~~~~Dv~SlG~~l~elltG------ 784 (933)
+.+++.+.|+|+|+|.......... ....+||.+|||||++...- + -..+||||||.++||++.+
T Consensus 349 VKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi 428 (513)
T KOG2052|consen 349 VKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGI 428 (513)
T ss_pred EccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCE
Confidence 9999999999999998665543222 34579999999999996542 1 2359999999999999863
Q ss_pred ----CCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 785 ----RKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 785 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
+.||.+..+.+... +.+++++ ..+.+.|.++......+.+..+.++++.||..+|..|.|+-.+.+.|.
T Consensus 429 ~eey~~Pyyd~Vp~DPs~--eeMrkVV-----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~ 501 (513)
T KOG2052|consen 429 VEEYQLPYYDVVPSDPSF--EEMRKVV-----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLA 501 (513)
T ss_pred ehhhcCCcccCCCCCCCH--HHHhcce-----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHH
Confidence 35776544432211 1111111 122233444434445567788999999999999999999999999887
Q ss_pred hhh
Q 002346 861 PLV 863 (933)
Q Consensus 861 ~~~ 863 (933)
++.
T Consensus 502 ~l~ 504 (513)
T KOG2052|consen 502 KLS 504 (513)
T ss_pred HHh
Confidence 764
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=345.15 Aligned_cols=253 Identities=22% Similarity=0.335 Sum_probs=199.5
Q ss_pred CCccCCccccCCCeEEEEEEe----CCCcEEEEEEeccccC--CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCcee
Q 002346 582 NFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSER 654 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 654 (933)
+|++.+.||+|+||.||++.. .+++.||+|++.+... .....+.+..|+.++..+ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478899999999999999854 3688999999875432 123346788999999999 599999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 81 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~ 152 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-----RDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLS 152 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence 999999999999999865 2458999999999999999999998 89999999999999999999999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
+..............||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... ............+
T Consensus 153 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~~~~~~~ 230 (332)
T cd05614 153 KEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRILKCDPPF 230 (332)
T ss_pred ccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHhcCCCCC
Confidence 86544333333346799999999998765 47889999999999999999999997543222111 1111112111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
+. .+ ...+.+++.+|++.||++|| +++++++
T Consensus 231 ~~----~~---------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 231 PS----FI---------GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CC----CC---------CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 11 11 13467899999999999999 5667765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=341.89 Aligned_cols=243 Identities=26% Similarity=0.386 Sum_probs=197.3
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
+.||+|+||.||++.. .+|+.||+|+++.... .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999954 5789999999976532 2334567889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 744 (933)
+|.+++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~ 151 (323)
T cd05571 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-c
Confidence 99999865 2468999999999999999999999 8999999999999999999999999999875332211 1
Q ss_pred ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCC
Q 002346 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLD 824 (933)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 824 (933)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||....... . ..........++.. +
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~---~~~~~~~~~~~p~~----~--- 218 (323)
T cd05571 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L---FELILMEEIRFPRT----L--- 218 (323)
T ss_pred ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---H---HHHHHcCCCCCCCC----C---
Confidence 234579999999999998899999999999999999999999997643211 1 11111111122211 1
Q ss_pred hhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 825 EETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 825 ~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
..++.+++.+|++.||++|| ++.++++
T Consensus 219 ------~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 219 ------SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred ------CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 23567999999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=334.98 Aligned_cols=253 Identities=23% Similarity=0.321 Sum_probs=216.2
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce-eEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE-RLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~ 658 (933)
++|..++++|+|+||.++..+. .++..||+|++.....+....+....|+.++++++|||||.+++.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 5788999999999999998843 468899999999888788888889999999999999999999999999888 89999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
+|++||++.+.+.+.+ ..-++++.+..++.|++.|+.|||+ ..|+|||||+.||+++.++.|||+|||+|+...
T Consensus 84 ~Y~eGg~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~ 157 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN 157 (426)
T ss_pred eecCCCCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence 9999999999997744 3568999999999999999999998 899999999999999999999999999999877
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... .....++|||.|+.||.+.+.+|..|+|||||||++|||++-+++|..... ..++. ++.... ++
T Consensus 158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m---~~Li~---ki~~~~------~~ 224 (426)
T KOG0589|consen 158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM---SELIL---KINRGL------YS 224 (426)
T ss_pred Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch---HHHHH---HHhhcc------CC
Confidence 654 234557999999999999999999999999999999999999999987532 22222 222111 11
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
..+..+..++..++..|++.+|+.||++.+++..
T Consensus 225 ------Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 225 ------PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred ------CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 1112233567799999999999999999999986
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-37 Score=338.01 Aligned_cols=202 Identities=27% Similarity=0.407 Sum_probs=177.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||++.. .++..||+|.+.... .....+++.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence 36899999999999999999965 468899999987652 3344578999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++.. ...+++..+..++.|+++|++|||+ ..+|+||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 83 EHMDGGSLDQVLKE-----AKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 99999999999965 2458899999999999999999997 2469999999999999999999999999987554
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTM 792 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~ 792 (933)
... .....|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 156 DSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred ccc---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 234579999999999998899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=326.85 Aligned_cols=255 Identities=25% Similarity=0.459 Sum_probs=208.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.++||+|+||.||+|...+++.||+|.+.... ...+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT---MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc---hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 36789999999999999999988788899999886542 235689999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ....+++.++..++.|+++|++|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 82 YMAKGSLLDFLKSD---EGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred cCCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999999999652 23458899999999999999999998 8999999999999999999999999999987654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........++..|+|||++..+.++.++|||||||++|||++ |+.||....... ....+.. ....+ ..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~----~~~~~--~~ 226 (261)
T cd05072 156 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQR----GYRMP--RM 226 (261)
T ss_pred CceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHc----CCCCC--CC
Confidence 43333333456778999999988889999999999999999998 999997543221 1111111 11111 00
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
. .....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 ~---------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 227 E---------NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred C---------CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 1 112357799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=343.11 Aligned_cols=253 Identities=26% Similarity=0.386 Sum_probs=204.4
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|... +++.||+|++....... .....+.+|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999654 68999999997654322 44567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++... ..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~ 152 (350)
T cd05573 81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMN 152 (350)
T ss_pred cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence 999999999999652 468999999999999999999999 899999999999999999999999999987654
Q ss_pred CCC----------------------------ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCC
Q 002346 739 DGK----------------------------YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDD 790 (933)
Q Consensus 739 ~~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~ 790 (933)
... ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~ 232 (350)
T cd05573 153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS 232 (350)
T ss_pred ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence 332 1112335799999999999999999999999999999999999999986
Q ss_pred CCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 002346 791 TMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-MGHAVN 857 (933)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-~~evl~ 857 (933)
...... .................. ....+.+++.+|++ +|.+||+ +.++++
T Consensus 233 ~~~~~~------~~~i~~~~~~~~~p~~~~---------~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 233 DTLQET------YNKIINWKESLRFPPDPP---------VSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCHHHH------HHHHhccCCcccCCCCCC---------CCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 543211 111111011111000000 12457789999997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=331.13 Aligned_cols=259 Identities=29% Similarity=0.524 Sum_probs=207.5
Q ss_pred cCCccCCccccCCCeEEEEEEeCC------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
++|++.+.||+|+||.||+|.... ...||+|.+.... ......+|.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT 83 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence 468889999999999999996532 2579999887543 334456799999999999999999999999988899
Q ss_pred EEEEeecCCCChhhHhhhcccCCC-----------CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGY-----------TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
+++|||+++++|.+++........ ..+++.+++.++.|++.||+|||+ .+++||||||+||+++++
T Consensus 84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEG 160 (283)
T ss_pred EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCC
Confidence 999999999999999976322111 468899999999999999999999 899999999999999999
Q ss_pred CcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHH
Q 002346 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~ 801 (933)
+.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+. ..
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~---~~ 237 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV---IE 237 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH
Confidence 9999999999986543322 22334467889999999988899999999999999999998 9999986543221 11
Q ss_pred HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
.+. ....+. .. .....++.+++.+||+.+|++||+++|+++.|+.
T Consensus 238 ~i~-----~~~~~~-~~---------~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIR-----SRQLLP-CP---------EDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHH-----cCCcCC-Cc---------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 111 111111 11 1122468899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=325.54 Aligned_cols=251 Identities=28% Similarity=0.465 Sum_probs=204.1
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|++.+.||+|+||.||++...++..+|+|.+..... ..++|..|+.++++++||||+++++++..+...++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~ 80 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF 80 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence 45788899999999999999888888999998875432 246789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++|+|.++++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||.++.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05114 81 MENGCLLNYLRQR----QGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCC
Confidence 9999999998642 1358899999999999999999998 89999999999999999999999999998866544
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+ .. .... ..+
T Consensus 154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i---~~-~~~~---~~~ 223 (256)
T cd05114 154 EYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMI---SR-GFRL---YRP 223 (256)
T ss_pred ceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---HC-CCCC---CCC
Confidence 3332333345678999999988889999999999999999999 899997643221 11111 11 1110 111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
.. ....+.+++.+|++.+|++||+++++++.|
T Consensus 224 ~~--------~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 224 KL--------ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CC--------CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 113578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=316.12 Aligned_cols=266 Identities=26% Similarity=0.371 Sum_probs=205.5
Q ss_pred HHhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee-----C
Q 002346 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-----G 651 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~ 651 (933)
.+...|...+.||+|+||.|+++ +..+|+.||+|++..........++..+|+++++.++|+||+.+++.+.. -
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34566777899999999999999 55689999999998655556667889999999999999999999998865 3
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
...|+|+|+| +.+|.+.++. ...++...+..+++|+++||.|+|+ .+|+|||+||+|++++.+...||+||
T Consensus 99 ~DvYiV~elM-etDL~~iik~-----~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DF 169 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKS-----QQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDF 169 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHc-----CccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccc
Confidence 5789999999 6799999865 3459999999999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCC-ceeecccccccCccccccc-CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHH--------
Q 002346 732 GLVKNAPDGK-YSVETRLAGTFGYLAPEYA-ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT-------- 801 (933)
Q Consensus 732 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~-------- 801 (933)
|+|+...... ....+.++.|..|.|||.+ ....|+.+.||||.||++.||++|++-|.+...-+...+..
T Consensus 170 GLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~ 249 (359)
T KOG0660|consen 170 GLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE 249 (359)
T ss_pred cceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH
Confidence 9999775421 1223667889999999987 45689999999999999999999999887653322211110
Q ss_pred ---------HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 802 ---------WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 802 ---------~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.++..+......+. ......-........+++.+||..||.+|+|++|+++
T Consensus 250 e~l~~i~s~~ar~yi~slp~~p~-----~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 250 EDLQKIRSEKARPYIKSLPQIPK-----QPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHHhccHHHHHHHHhCCCCCC-----CCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 00111111111110 0000000112234679999999999999999999987
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=341.90 Aligned_cols=254 Identities=22% Similarity=0.324 Sum_probs=203.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||++.. .+|+.||+|+++.... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4688999999999999999954 4789999999986543 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 153 (330)
T cd05601 81 EYQPGGDLLSLLNRY----EDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLT 153 (330)
T ss_pred CCCCCCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence 999999999999652 1468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceeecccccccCcccccccC------CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAA------TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||........ +.........
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~ 227 (330)
T cd05601 154 ANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRF 227 (330)
T ss_pred CCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCc
Confidence 44433334457999999999986 45678999999999999999999999976533211 1122111111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. . +... ......+.+++..|++ +|++||++.++++
T Consensus 228 ~-~-~~~~-------~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 228 L-K-FPED-------PKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred c-C-CCCC-------CCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1 0 0000 0112356789999998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=339.51 Aligned_cols=240 Identities=25% Similarity=0.342 Sum_probs=194.2
Q ss_pred cccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
||+|+||.||+|.. .+++.||+|++..... .......+.+|+.++.+++||||+++++++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999965 4688999999875432 334456788999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeec
Q 002346 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 746 (933)
.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~ 151 (312)
T cd05585 81 FHHLQR-----EGRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTN 151 (312)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccc
Confidence 999965 2458999999999999999999998 899999999999999999999999999987543322 1223
Q ss_pred ccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChh
Q 002346 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEE 826 (933)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 826 (933)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ............++..+
T Consensus 152 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~~~~~~~~~~~~~~~--------- 216 (312)
T cd05585 152 TFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMYRKILQEPLRFPDGF--------- 216 (312)
T ss_pred cccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHHHHHHcCCCCCCCcC---------
Confidence 457999999999999989999999999999999999999999764321 12222222222222211
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 002346 827 TIESIYRVAELAGHCTAREPQQRPDMGHAV 856 (933)
Q Consensus 827 ~~~~~~~~~~li~~cl~~~P~~RPs~~evl 856 (933)
...+.+++.+||+.||++||++..+.
T Consensus 217 ----~~~~~~li~~~L~~dp~~R~~~~~~~ 242 (312)
T cd05585 217 ----DRDAKDLLIGLLSRDPTRRLGYNGAQ 242 (312)
T ss_pred ----CHHHHHHHHHHcCCCHHHcCCCCCHH
Confidence 13567999999999999998654433
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=342.17 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=204.8
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|... +++.||+|+++..... ......+.+|+.++..++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 36889999999999999999664 5899999999765322 234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN-----LGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999965 2468899999999999999999998 899999999999999999999999999987554
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.... +.... .....+...+
T Consensus 153 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~-~~~~~~~~~~ 224 (333)
T cd05600 153 T----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN---LKYWK-ETLQRPVYDD 224 (333)
T ss_pred c----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH---HHhcc-ccccCCCCCc
Confidence 3 22345799999999999988999999999999999999999999986543322111 11100 0000111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+. .....++.+++.+|++.+|++||++.++++
T Consensus 225 ~~-------~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 225 PR-------FNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred cc-------cccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 11 112245778999999999999999999986
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=342.34 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=201.0
Q ss_pred cCCccCCccccCCCeEEEEEEeCC--CcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD--GTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
++|++.+.||+|+||.||+|.... +..||+|++..... .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 578899999999999999996433 36899999875432 233456788999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 110 ~Ey~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~ 181 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR-----NKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181 (340)
T ss_pred EeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeec
Confidence 999999999999965 2468999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
.... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....+... ...........+..
T Consensus 182 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i~~~~~~~p~~- 250 (340)
T PTZ00426 182 DTRT----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKILEGIIYFPKF- 250 (340)
T ss_pred CCCc----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHHhcCCCCCCCC-
Confidence 4322 235799999999999888899999999999999999999999986533211 11222211112211
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
+. ..+.+++.+|++.+|++|+ +++++++
T Consensus 251 ---~~---------~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 251 ---LD---------NNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred ---CC---------HHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 11 2466899999999999995 7888765
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=338.27 Aligned_cols=243 Identities=27% Similarity=0.432 Sum_probs=196.2
Q ss_pred CccccCCCeEEEEEEe----CCCcEEEEEEeccccC--CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 587 NILGRGGFGVVYGGEL----PDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+.||+|+||.||++.. .+++.||+|+++.... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999964 3578999999876432 223345678999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++.. ...+.+..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (323)
T cd05584 82 LSGGELFMHLER-----EGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE 153 (323)
T ss_pred CCCchHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence 999999999865 2457889999999999999999999 89999999999999999999999999998754332
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ...........++. .
T Consensus 154 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~~~~~~~~~~~----~ 222 (323)
T cd05584 154 GT-VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDKILKGKLNLPP----Y 222 (323)
T ss_pred CC-cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCC----C
Confidence 21 2234579999999999988889999999999999999999999997643221 12222222222221 1
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
+. ..+.+++.+|++.+|++|| ++.++++
T Consensus 223 ~~---------~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 223 LT---------PEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred CC---------HHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 11 3567999999999999999 7777765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=338.88 Aligned_cols=241 Identities=26% Similarity=0.407 Sum_probs=192.2
Q ss_pred CccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHH---HhcCCCcceeEEeEeeeCceeEEE
Q 002346 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVL---TKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+.+|++++ +.++||||+++++++..+...++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 66789999999999999955 4689999999976532 223345677776655 566799999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|..+++. ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 999999999988854 458999999999999999999999 89999999999999999999999999998753
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......|++.|+|||++.+..++.++|||||||++|||++|+.||......+. ...........+.
T Consensus 152 ~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~------~~~i~~~~~~~p~-- 222 (324)
T cd05589 152 MGFGD-RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSIVNDEVRYPR-- 222 (324)
T ss_pred CCCCC-cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCCCC--
Confidence 32221 22345799999999999988999999999999999999999999976533211 1122221111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
.+ ...+.+++.+|++.||.+||++
T Consensus 223 --~~---------~~~~~~li~~~L~~dP~~R~~~ 246 (324)
T cd05589 223 --FL---------SREAISIMRRLLRRNPERRLGS 246 (324)
T ss_pred --CC---------CHHHHHHHHHHhhcCHhHcCCC
Confidence 11 1346789999999999999953
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=333.52 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=200.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|.. .+++.||+|+++... .......+.+|++++++++||||+++++++..+...++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH-EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc-cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 5689999999999999999954 478999999987543 22234577899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|++ ++|.+++... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~ 155 (288)
T cd07871 84 YLD-SDLKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSV 155 (288)
T ss_pred CCC-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccC
Confidence 997 5999988542 2357899999999999999999998 8999999999999999999999999999875543
Q ss_pred CCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc--cCCCCc-
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS--KENIPK- 815 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~- 815 (933)
... ......|++.|+|||++.+ ..++.++||||+||++|||++|+.||......+..... ...... ...++.
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 231 (288)
T cd07871 156 PTK-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI---FRLLGTPTEETWPGI 231 (288)
T ss_pred CCc-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHHhCCCChHHhhcc
Confidence 221 1233468999999998865 56899999999999999999999999765433222111 111100 000000
Q ss_pred --------ccCCCCCCCh---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 --------AIDPNLNLDE---ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 --------~~d~~l~~~~---~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+...... .......+..+++.+|++.||.+|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 232 TSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred ccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0001100000 00011235679999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=343.73 Aligned_cols=261 Identities=21% Similarity=0.238 Sum_probs=197.9
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
..+|++.+.||+|+||.||++. ..+++.||+|+... ..+.+|++++++++|||||++++++......++|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~ 162 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLIL 162 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEE
Confidence 3679999999999999999994 45789999996532 35689999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
|++. ++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 163 e~~~-~~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~ 233 (391)
T PHA03212 163 PRYK-TDLYCYLAA-----KRNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPV 233 (391)
T ss_pred ecCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCcccccc
Confidence 9994 789888854 2458899999999999999999999 899999999999999999999999999997543
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCch-----hhHHHHHHHHHhhccCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD-----RAHLVTWFRRVLISKENI 813 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~~~ 813 (933)
...........||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ...+...+...-......
T Consensus 234 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 234 DINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 322222334679999999999998899999999999999999999998875432111 111111110000000000
Q ss_pred Cc-----------------ccCCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PK-----------------AIDPNLNLD-EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~-----------------~~d~~l~~~-~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+. ...+..... .........+.+++.+||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00 000000000 011123446789999999999999999999986
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=338.94 Aligned_cols=243 Identities=26% Similarity=0.387 Sum_probs=196.7
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
+.||+|+||.||++.. .+|+.||+|++..... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999954 5789999999976532 2334567889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 744 (933)
+|..++.. ...+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 151 (323)
T cd05595 81 ELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA-T 151 (323)
T ss_pred cHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-c
Confidence 99988855 2468999999999999999999998 8999999999999999999999999999875332221 1
Q ss_pred ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCC
Q 002346 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLD 824 (933)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 824 (933)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........++..+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~~~~~~~~~p~~~------- 218 (323)
T cd05595 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL------FELILMEEIRFPRTL------- 218 (323)
T ss_pred cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCCCCCCCCC-------
Confidence 2335799999999999988999999999999999999999999976433211 111111121222211
Q ss_pred hhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 825 EETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 825 ~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
...+.+++.+|++.||++|| ++.++++
T Consensus 219 ------~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 219 ------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred ------CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 13567999999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=342.09 Aligned_cols=253 Identities=24% Similarity=0.363 Sum_probs=197.4
Q ss_pred CCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.|+.++.||+|+||.||+|. ..+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 58889999999999999995 45788999999976532 23445678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~ 153 (381)
T cd05626 82 YIPGGDMMSLLIR-----MEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW 153 (381)
T ss_pred cCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence 9999999999865 2458899999999999999999998 8999999999999999999999999999753211
Q ss_pred CC----------------------------------------------ceeecccccccCcccccccCCCCCCCccchHh
Q 002346 740 GK----------------------------------------------YSVETRLAGTFGYLAPEYAATGRVTTKIDVYA 773 (933)
Q Consensus 740 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 773 (933)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (381)
T cd05626 154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS 233 (381)
T ss_pred ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence 00 00012357999999999998888999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHH--cccCCCCCCCC
Q 002346 774 FGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGH--CTAREPQQRPD 851 (933)
Q Consensus 774 lG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~--cl~~~P~~RPs 851 (933)
|||++|||++|+.||....+..... .......... +.+... ...++.+++.+ |+..+|..||+
T Consensus 234 lG~il~elltG~~Pf~~~~~~~~~~------~i~~~~~~~~--~~~~~~-------~s~~~~dli~~ll~~~~~~~~R~~ 298 (381)
T cd05626 234 VGVILFEMLVGQPPFLAPTPTETQL------KVINWENTLH--IPPQVK-------LSPEAVDLITKLCCSAEERLGRNG 298 (381)
T ss_pred hhhHHHHHHhCCCCCcCCCHHHHHH------HHHccccccC--CCCCCC-------CCHHHHHHHHHHccCcccccCCCC
Confidence 9999999999999998654322111 1111011110 111111 11345677776 55666777999
Q ss_pred HHHHHH
Q 002346 852 MGHAVN 857 (933)
Q Consensus 852 ~~evl~ 857 (933)
+.++++
T Consensus 299 ~~~~l~ 304 (381)
T cd05626 299 ADDIKA 304 (381)
T ss_pred HHHHhc
Confidence 999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=342.03 Aligned_cols=263 Identities=27% Similarity=0.431 Sum_probs=207.2
Q ss_pred hcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 652 (933)
.++|.+.++||+|+||.||+|... .+..||||++.... .....+.+.+|++++++++ |||||+++++|.+..
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 467889999999999999999642 23479999997643 3344568999999999996 999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccC--------------------------------------------------------
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDH-------------------------------------------------------- 676 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~-------------------------------------------------------- 676 (933)
..++||||+++|+|.++++.....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 999999999999999998653210
Q ss_pred -----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec
Q 002346 677 -----------------------------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721 (933)
Q Consensus 677 -----------------------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 721 (933)
....+++.++..++.|+++||+|||+ .+|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEe
Confidence 11347889999999999999999998 8999999999999999
Q ss_pred CCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHH
Q 002346 722 DDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHL 799 (933)
Q Consensus 722 ~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~ 799 (933)
.++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||........ .
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~ 349 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F 349 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence 999999999999986543221 12233457789999999988899999999999999999997 9999876432211 1
Q ss_pred HHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 800 VTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
. ......... .... .....+.+++.+||+.+|++||++.++.++|+.+.
T Consensus 350 ~----~~~~~~~~~--~~~~---------~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 350 Y----NKIKSGYRM--AKPD---------HATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H----HHHhcCCCC--CCCc---------cCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 111111111 0111 12246789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=335.74 Aligned_cols=239 Identities=26% Similarity=0.374 Sum_probs=188.6
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHH-HHHhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIA-VLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+++.||+|++..... ......++..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 4688999999876432 1223345555654 57888999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
++|..++.. ...+++.++..++.||++||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (321)
T cd05603 81 GELFFHLQR-----ERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-E 151 (321)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-C
Confidence 999988854 2458889999999999999999998 899999999999999999999999999987532222 1
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....... ........... +.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~----~~~~--- 218 (321)
T cd05603 152 TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ------MYDNILHKPLQ----LPGG--- 218 (321)
T ss_pred ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH------HHHHHhcCCCC----CCCC---
Confidence 2234579999999999998899999999999999999999999997643211 11222211111 1111
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMG 853 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ 853 (933)
....+.+++.+|++.+|.+||++.
T Consensus 219 ------~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 219 ------KTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------CCHHHHHHHHHHccCCHhhcCCCC
Confidence 113577999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=337.99 Aligned_cols=243 Identities=25% Similarity=0.384 Sum_probs=197.2
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
+.||+|+||.||++.. .+++.||+|++..... .......+.+|+.+++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999954 5789999999976532 2344567889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 744 (933)
+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~-~ 151 (328)
T cd05593 81 ELFFHLSR-----ERVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA-T 151 (328)
T ss_pred CHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc-c
Confidence 99988854 2468999999999999999999998 8999999999999999999999999999875432211 1
Q ss_pred ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCC
Q 002346 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLD 824 (933)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 824 (933)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........++. .+
T Consensus 152 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~~~~~~~p~----~~--- 218 (328)
T cd05593 152 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILMEDIKFPR----TL--- 218 (328)
T ss_pred cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhccCCccCCC----CC---
Confidence 2345799999999999988999999999999999999999999976432211 1111111111221 11
Q ss_pred hhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 825 EETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 825 ~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
...+.+++.+|++.||++|| ++.++++
T Consensus 219 ------~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 219 ------SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred ------CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 13567999999999999997 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=339.74 Aligned_cols=258 Identities=21% Similarity=0.291 Sum_probs=201.3
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
+....++|++.+.||+|+||.||++.. .+++.||+|++.+... .....+.+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 344467899999999999999999965 4688999999875322 22334568899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~------~~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSN------YDVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEeccc
Confidence 9999999999999999854 347889999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCC----CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATG----RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
+...............||+.|+|||++.+. .++.++||||+||++|||++|+.||....... .+......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~------~~~~i~~~ 262 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG------TYSKIMDH 262 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH------HHHHHHhC
Confidence 986644332223456799999999998653 37889999999999999999999997643211 11122211
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQ--RPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~evl~ 857 (933)
...+. +.... .....+.+++..|++.++.+ ||++.|+++
T Consensus 263 ~~~~~--~p~~~-------~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~ 303 (370)
T cd05621 263 KNSLN--FPEDV-------EISKHAKNLICAFLTDREVRLGRNGVEEIKQ 303 (370)
T ss_pred CcccC--CCCcc-------cCCHHHHHHHHHHccCchhccCCCCHHHHhc
Confidence 11111 11100 11234668888999855544 889999886
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=331.60 Aligned_cols=266 Identities=23% Similarity=0.328 Sum_probs=197.7
Q ss_pred cCCccCCccccCCCeEEEEEEe--CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc---CCCcceeEEeEeee-----
Q 002346 581 DNFSEANILGRGGFGVVYGGEL--PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCIN----- 650 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----- 650 (933)
++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.+ +||||++++++|..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3789999999999999999965 3468899999876543343445667788777766 69999999998852
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
....++||||++ ++|.+++.... ...+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~D 153 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLAD 153 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEcc
Confidence 356789999996 69999986522 2458999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh-hc
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL-IS 809 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~ 809 (933)
||+++...... ......|++.|+|||++.+..++.++|||||||++|||++|++||......+.. ...+.... ..
T Consensus 154 fg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~--~~i~~~~~~~~ 229 (290)
T cd07862 154 FGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL--GKILDVIGLPG 229 (290)
T ss_pred ccceEeccCCc--ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH--HHHHHHhCCCC
Confidence 99998654331 223457899999999998888999999999999999999999999875432211 11111100 00
Q ss_pred cCCCCc-------ccCCCCC--CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPK-------AIDPNLN--LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~-------~~d~~l~--~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...++. .+.+... ......+....+.+++.+|++.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 001110 0000000 00000112245679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=342.33 Aligned_cols=253 Identities=22% Similarity=0.394 Sum_probs=200.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+++.||||++..... .......+.+|+.++..++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999955 4689999999976432 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK-----KDTFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999965 2458999999999999999999999 899999999999999999999999999987533
Q ss_pred CCCce-------------------------------------eecccccccCcccccccCCCCCCCccchHhHHHHHHHH
Q 002346 739 DGKYS-------------------------------------VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMET 781 (933)
Q Consensus 739 ~~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~el 781 (933)
..... .....+||+.|+|||++....++.++|||||||++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el 232 (364)
T cd05599 153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232 (364)
T ss_pred ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence 21100 01124699999999999988999999999999999999
Q ss_pred HcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 002346 782 ITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD---MGHAVN 857 (933)
Q Consensus 782 ltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs---~~evl~ 857 (933)
++|+.||....+... ..........+. +..... ....+.+++.+|+. +|.+|++ +.++++
T Consensus 233 ~~G~~Pf~~~~~~~~------~~~i~~~~~~~~--~~~~~~-------~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 233 LVGYPPFCSDNPQET------YRKIINWKETLQ--FPDEVP-------LSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCCCCCHHHH------HHHHHcCCCccC--CCCCCC-------CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 999999986543221 111111111111 111111 11346688999986 9999998 888865
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=322.78 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=206.5
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|...+++.||+|.++.... ..+++.+|+.++++++||||+++++++......++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 467889999999999999999877788999999876532 34678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.... ...+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05068 82 LMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKE 155 (261)
T ss_pred cccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence 999999999996522 2468999999999999999999998 8999999999999999999999999999986654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||....... ... . .......+ ..
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~---~-~~~~~~~~--~~ 226 (261)
T cd05068 156 DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ---Q-VDQGYRMP--CP 226 (261)
T ss_pred CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---H-HHcCCCCC--CC
Confidence 32222222233468999999998899999999999999999999 999987543221 111 1 11111110 11
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
. .....+.+++.+|++.+|++||++.++++.|++
T Consensus 227 ~---------~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~ 260 (261)
T cd05068 227 P---------GCPKELYDIMLDCWKEDPDDRPTFETLQWKLED 260 (261)
T ss_pred C---------cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence 1 112457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=340.46 Aligned_cols=254 Identities=25% Similarity=0.365 Sum_probs=196.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|+..+.||+|+||.||+|.. .+++.||||++.... .......+.+|+++++.++|+||+++++++..++..++|||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 3456678999999999999965 468999999986542 33445678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+.. ...+..+..++.||++||+|||+ ++|+||||||+|||+++++.+||+|||+++....
T Consensus 153 ~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 153 FMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred cCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99999986532 24577888999999999999998 8999999999999999999999999999886543
Q ss_pred CCceeecccccccCcccccccCC-----CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
... ......||..|+|||++.. ...+.++|||||||++|||++|+.||......+...... ...... .
T Consensus 221 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~~~---~ 293 (353)
T PLN00034 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC---AICMSQ---P 293 (353)
T ss_pred ccc-cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH---HHhccC---C
Confidence 221 1234579999999998743 234568999999999999999999997433222111111 111100 0
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
..... ....++.+++.+||+.+|++||++.|+++ ++|...
T Consensus 294 ~~~~~---------~~~~~l~~li~~~l~~~P~~Rpt~~ell~------hp~~~~ 333 (353)
T PLN00034 294 PEAPA---------TASREFRHFISCCLQREPAKRWSAMQLLQ------HPFILR 333 (353)
T ss_pred CCCCC---------ccCHHHHHHHHHHccCChhhCcCHHHHhc------Cccccc
Confidence 00011 11235789999999999999999999987 566543
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.44 Aligned_cols=264 Identities=24% Similarity=0.375 Sum_probs=197.0
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----ceeE
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SERL 655 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~ 655 (933)
+|++.+.||+|+||.||+|.. .+++.||||++...........++.+|+.++++++||||+++++++... ...+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588899999999999999954 5789999999875433344456789999999999999999999988643 2479
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+. ++|.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~ 151 (338)
T cd07859 81 VVFELME-SDLHQVIKA-----NDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLAR 151 (338)
T ss_pred EEEecCC-CCHHHHHHh-----cccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence 9999995 689988854 2458999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCc--eeecccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc--
Q 002346 736 NAPDGKY--SVETRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-- 809 (933)
Q Consensus 736 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-- 809 (933)
....... .......|++.|+|||++.+ ..++.++|||||||++|||++|+.||........... +......
T Consensus 152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~---~~~~~~~~~ 228 (338)
T cd07859 152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDL---ITDLLGTPS 228 (338)
T ss_pred ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHH---HHHHhCCCC
Confidence 5432221 11234579999999999865 6789999999999999999999999976432211110 0000000
Q ss_pred --------cCCCC---cccCCCCC--CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 --------KENIP---KAIDPNLN--LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 --------~~~~~---~~~d~~l~--~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..... ..+..... ...........+.+++.+|++.+|++||+++|+++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 00000000 00000011235679999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=322.89 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=205.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.+|++.+.||+|+||.||+|.. ..++.||+|++... .....++.+|+++++.++||||+++++++..+...++|||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC---chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 4577889999999999999955 45889999998754 2335678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ....+++..++.++.|+++||+|||+ .+++||||||+||++++++.+||+|||++.....
T Consensus 83 ~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 83 FMTYGNLLDYLREC---NRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred eCCCCcHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 99999999998652 22458999999999999999999998 8999999999999999999999999999987655
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........++..|+|||++.+..++.++|||||||++|||++ |..||......+ . ...... . ......
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~---~~~~~~-~--~~~~~~ 227 (263)
T cd05052 157 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V---YELLEK-G--YRMERP 227 (263)
T ss_pred ceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHHHHC-C--CCCCCC
Confidence 43332223345678999999988899999999999999999998 889987543221 1 111111 1 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.. ....+.+++.+|++.+|++||++.+++++|+.+
T Consensus 228 ~~---------~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 228 EG---------CPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred CC---------CCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 11 124577999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-37 Score=312.81 Aligned_cols=270 Identities=24% Similarity=0.314 Sum_probs=204.5
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCc-ceeEEeEeeeCc-----
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH-LVALLGYCINGS----- 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----- 652 (933)
...|..+++||+|+||+||+|+ ..+|+.||+|+++.....+.......+|+.+++.++|+| ||++++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 3456667889999999999994 457899999999877543333456789999999999999 999999998877
Q ss_pred -eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 653 -ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 653 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
..++||||++ -+|..++....... ..++...+..+++|+++|++|||+ ++|+||||||+|||++++|.+||+||
T Consensus 90 ~~l~lvfe~~d-~DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDF 164 (323)
T KOG0594|consen 90 GKLYLVFEFLD-RDLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADF 164 (323)
T ss_pred ceEEEEEEeec-ccHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeecc
Confidence 7889999994 59999997643221 346668899999999999999999 99999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh-hc
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL-IS 809 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~ 809 (933)
|+|+...-... ..+..++|..|.|||++.+. .|+...||||+||++.||++++.-|.+..+.+. +...++..- ..
T Consensus 165 GlAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q--l~~If~~lGtP~ 241 (323)
T KOG0594|consen 165 GLARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ--LFRIFRLLGTPN 241 (323)
T ss_pred chHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH--HHHHHHHcCCCC
Confidence 99996553322 23445789999999999876 789999999999999999999998887654222 222222111 11
Q ss_pred cCCCCccc---C--CCCCCCh----hhHHH---HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAI---D--PNLNLDE----ETIES---IYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~---d--~~l~~~~----~~~~~---~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+..++... + ..+.... ..... .....+++.+|++.+|.+|.++..+++
T Consensus 242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~ 301 (323)
T KOG0594|consen 242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALT 301 (323)
T ss_pred ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhc
Confidence 12222221 1 1111000 00111 125678999999999999999999987
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=298.25 Aligned_cols=264 Identities=23% Similarity=0.339 Sum_probs=207.8
Q ss_pred HhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----c
Q 002346 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----S 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 652 (933)
..++|++.+.||+|||+-||.+ ...+++.||+|++.... .+..+..++|++..++++||||+++++++..+ .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 3578999999999999999999 46789999999998773 56678899999999999999999999987543 3
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..|++++|...|+|.+.+...... ...+++.+.+.|+.+|++||++||+. ..+++||||||.|||+.+.+.+++.|||
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~G 174 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLG 174 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEecc
Confidence 489999999999999999875444 35799999999999999999999982 2359999999999999999999999999
Q ss_pred ccccCCCCCcee--------ecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHH
Q 002346 733 LVKNAPDGKYSV--------ETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 733 la~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~ 801 (933)
.+....-..... ...-..|..|.|||.+. +...++++|||||||++|+|+.|..||+.....
T Consensus 175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~------- 247 (302)
T KOG2345|consen 175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ------- 247 (302)
T ss_pred CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc-------
Confidence 887544211100 01124688999999884 345789999999999999999999999753221
Q ss_pred HHHHHhhccCCCCcc-cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 802 WFRRVLISKENIPKA-IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~-~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.+.+.-. ....+....... ..+.+.+++.+|++.||.+||++.+++..+..+
T Consensus 248 --------GgSlaLAv~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 248 --------GGSLALAVQNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred --------CCeEEEeeeccccccCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 1111111 111111111111 446788999999999999999999999887654
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.82 Aligned_cols=241 Identities=26% Similarity=0.441 Sum_probs=191.1
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+++.||+|+++.... .....+.+..|..++... +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 4578999999976532 123345566677777654 899999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~ 151 (316)
T cd05592 81 GDLMFHIQS-----SGRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-G 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-C
Confidence 999999865 2458999999999999999999999 899999999999999999999999999997543322 2
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... . ...........+. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~---~~~i~~~~~~~~~----~~-- 219 (316)
T cd05592 152 KASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---L---FDSILNDRPHFPR----WI-- 219 (316)
T ss_pred ccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHcCCCCCCC----CC--
Confidence 2334579999999999998899999999999999999999999997643221 1 1111111111111 11
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHA 855 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev 855 (933)
...+.+++.+|++.+|++||++.+.
T Consensus 220 -------~~~~~~ll~~~l~~~P~~R~~~~~~ 244 (316)
T cd05592 220 -------SKEAKDCLSKLFERDPTKRLGVDGD 244 (316)
T ss_pred -------CHHHHHHHHHHccCCHHHcCCChHH
Confidence 1346789999999999999998643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=338.28 Aligned_cols=254 Identities=21% Similarity=0.304 Sum_probs=201.7
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 46899999999999999999955 4688999999875432 223345678999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++...
T Consensus 122 ~Ey~~gg~L~~~l~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~ 192 (370)
T cd05596 122 MEYMPGGDLVNLMSN------YDIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (370)
T ss_pred EcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeec
Confidence 999999999999854 347888899999999999999999 89999999999999999999999999999865
Q ss_pred CCCCceeecccccccCcccccccCCC----CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATG----RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
............||+.|+|||++.+. .++.++|||||||++|||++|+.||....... .+.........+
T Consensus 193 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~i~~~~~~~ 266 (370)
T cd05596 193 DANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMDHKNSL 266 (370)
T ss_pred cCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH------HHHHHHcCCCcC
Confidence 44332222345799999999988643 47899999999999999999999997643211 111222111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQ--RPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~evl~ 857 (933)
. ++... .....+.+++.+|++.+|++ ||++.++++
T Consensus 267 ~--~~~~~-------~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 267 T--FPDDI-------EISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred C--CCCcC-------CCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 1 11100 11245679999999999988 999999976
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=331.90 Aligned_cols=202 Identities=26% Similarity=0.401 Sum_probs=176.4
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||++... ++..+|+|.+.... .......+.+|++++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 82 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence 478999999999999999999654 68899999887652 3344577999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++.. ...+++..+..++.++++|++|||+ ..+|+||||||+||+++.++.+||+|||++....
T Consensus 83 e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 83 EHMDGGSLDQVLKK-----AGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 99999999999965 2458899999999999999999997 2479999999999999999999999999987553
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTM 792 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~ 792 (933)
.. ......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 156 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 156 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred hh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 32 1233578999999999998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=352.02 Aligned_cols=259 Identities=24% Similarity=0.357 Sum_probs=208.0
Q ss_pred HHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc----
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS---- 652 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 652 (933)
...++|++.+.||+|+||.||+|. ..+|+.||||++.....+......+.+|+.++..++|+||+++++.+...+
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 345799999999999999999995 457999999999876656666778999999999999999999988765432
Q ss_pred ----eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 653 ----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 653 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
..++||||+++|+|.++++.... ....+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~-~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL 184 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAK-TNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKL 184 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEE
Confidence 36799999999999999976332 23578999999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 729 ADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 729 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+....
T Consensus 185 ~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~~~ 258 (496)
T PTZ00283 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHKTL 258 (496)
T ss_pred EecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHh
Confidence 99999986543221 1223457999999999999989999999999999999999999999764321 1122222
Q ss_pred hccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
... . ..+.+.+ ..++.+++.+||+.+|++||++.++++.
T Consensus 259 ~~~--~-~~~~~~~---------~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 259 AGR--Y-DPLPPSI---------SPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred cCC--C-CCCCCCC---------CHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 111 1 1111111 2357799999999999999999999863
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=344.48 Aligned_cols=259 Identities=26% Similarity=0.362 Sum_probs=208.5
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCC-cEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeE-eee------
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDG-TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGY-CIN------ 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~------ 650 (933)
..++++.+.|.+|||+.||.|....+ ..||+|++... +....+...+|+++|++|+ |+|||.+++. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 45678899999999999999977665 99999998876 5667889999999999996 9999999993 221
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
.-+++|.||||.||.|-+++..+.. ..|++.++++|+.++++|+++||. ++.+|||||||-+||||..++..||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCc
Confidence 2467899999999999999976332 339999999999999999999998 457899999999999999999999999
Q ss_pred ccccccCCCCCcee--------ecccccccCccccccc---CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHH
Q 002346 731 FGLVKNAPDGKYSV--------ETRLAGTFGYLAPEYA---ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHL 799 (933)
Q Consensus 731 fGla~~~~~~~~~~--------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~ 799 (933)
||.|.......... .....-|+.|+|||++ .+...++|+|||+|||+||-|+....||+....-.
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---- 265 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---- 265 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee----
Confidence 99886332221100 0113568999999977 56688999999999999999999999998753211
Q ss_pred HHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 800 VTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
++.....+|. ...+...|.+||+.||+.+|.+||++.||+..+-++...
T Consensus 266 ------Ilng~Y~~P~-----------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 266 ------ILNGNYSFPP-----------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred ------EEeccccCCC-----------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 1111222221 124556789999999999999999999999999887654
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=341.62 Aligned_cols=253 Identities=22% Similarity=0.367 Sum_probs=197.6
Q ss_pred cCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||++. ..+++.||||++..... .....+.+.+|++++++++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 478899999999999999995 45789999999875432 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~ 152 (377)
T cd05629 81 EFLPGGDLMTMLIK-----YDTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH 152 (377)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence 99999999999865 2458899999999999999999999 899999999999999999999999999986322
Q ss_pred CCCc------------e----------------------------------eecccccccCcccccccCCCCCCCccchH
Q 002346 739 DGKY------------S----------------------------------VETRLAGTFGYLAPEYAATGRVTTKIDVY 772 (933)
Q Consensus 739 ~~~~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~ 772 (933)
.... . ......||+.|+|||++.+..++.++|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 232 (377)
T cd05629 153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence 1000 0 00124699999999999988999999999
Q ss_pred hHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCC---
Q 002346 773 AFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQR--- 849 (933)
Q Consensus 773 SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~R--- 849 (933)
||||++|||++|+.||....+.+. +.........+. +.... .....+.+++.+|+. +|.+|
T Consensus 233 SlGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~~--~p~~~-------~~s~~~~dli~~lL~-~~~~r~~r 296 (377)
T cd05629 233 SLGAIMFECLIGWPPFCSENSHET------YRKIINWRETLY--FPDDI-------HLSVEAEDLIRRLIT-NAENRLGR 296 (377)
T ss_pred ecchhhhhhhcCCCCCCCCCHHHH------HHHHHccCCccC--CCCCC-------CCCHHHHHHHHHHhc-CHhhcCCC
Confidence 999999999999999976543221 111111111110 00000 011356789999997 66665
Q ss_pred CCHHHHHH
Q 002346 850 PDMGHAVN 857 (933)
Q Consensus 850 Ps~~evl~ 857 (933)
+++.|+++
T Consensus 297 ~~~~~~l~ 304 (377)
T cd05629 297 GGAHEIKS 304 (377)
T ss_pred CCHHHHhc
Confidence 58888876
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=332.30 Aligned_cols=271 Identities=23% Similarity=0.343 Sum_probs=202.3
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE-EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc-cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 368999999999999999999654 789999999875532 223356788999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+. ++|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 83 EYVH-TDLCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred ECCC-cCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 9995 6888887542 2458899999999999999999999 899999999999999999999999999987543
Q ss_pred CCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc--CCCCc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--ENIPK 815 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 815 (933)
... .......|++.|+|||++.+ ..++.++||||+||++|||++|+.||....... .....+....... ...+.
T Consensus 155 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 155 VPS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred CCC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccc
Confidence 322 11233568999999998865 457899999999999999999999998643211 1111111111000 00000
Q ss_pred -----ccCCC-CC-CChhh----H---HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 816 -----AIDPN-LN-LDEET----I---ESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 816 -----~~d~~-l~-~~~~~----~---~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.+++. .. ..... . .....+.+++.+|++.||++|||+.|+++ ++|..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~------h~~f~ 292 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS------HEYFS 292 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc------Ccccc
Confidence 00000 00 00000 0 01235679999999999999999999986 66664
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=333.45 Aligned_cols=264 Identities=27% Similarity=0.451 Sum_probs=205.9
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee-C
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN-G 651 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-~ 651 (933)
.++|++.+.||+|+||.||+|.. .+++.||+|+++... .....+.+.+|+.++.++ +|+||++++++|.. +
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 35789999999999999999943 235789999987543 334456788999999999 89999999998865 4
Q ss_pred ceeEEEEeecCCCChhhHhhhcccC-------------------------------------------------------
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDH------------------------------------------------------- 676 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 676 (933)
...+++|||+++++|.+++......
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 5678999999999999998642110
Q ss_pred -CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee-ecccccccCc
Q 002346 677 -GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGY 754 (933)
Q Consensus 677 -~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y 754 (933)
...++++..+..++.||++||+|||+ .+|+||||||+||++++++.+||+|||+++......... .....++..|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y 241 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 241 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence 01368999999999999999999998 899999999999999999999999999998654332222 2234567789
Q ss_pred ccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHH
Q 002346 755 LAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYR 833 (933)
Q Consensus 755 ~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 833 (933)
+|||++.+..++.++|||||||++|||++ |+.||......+. ... ... .. .....+. ....+
T Consensus 242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~-~~-~~~~~~~---------~~~~~ 304 (337)
T cd05054 242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLK-EG-TRMRAPE---------YATPE 304 (337)
T ss_pred cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHh-cc-CCCCCCc---------cCCHH
Confidence 99999999999999999999999999998 9999976433221 111 111 11 1111111 11235
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 834 VAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 834 ~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
+.+++.+|++.+|++||++.|+++.|+.+++
T Consensus 305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 305 IYSIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7899999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=338.32 Aligned_cols=240 Identities=26% Similarity=0.387 Sum_probs=196.2
Q ss_pred CccccCCCeEEEEEEe----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecC
Q 002346 587 NILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
+.||+|+||.||++.. .+|+.||+|++............+..|++++++++||||+++++++..++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999854 368999999998754444445677889999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 742 (933)
+|+|.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 153 (318)
T cd05582 82 GGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK 153 (318)
T ss_pred CCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence 9999999854 2458999999999999999999999 8999999999999999999999999999886543321
Q ss_pred eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCC
Q 002346 743 SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLN 822 (933)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 822 (933)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........ ..........++..+
T Consensus 154 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~------~~~i~~~~~~~p~~~----- 221 (318)
T cd05582 154 -KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKET------MTMILKAKLGMPQFL----- 221 (318)
T ss_pred -ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHH------HHHHHcCCCCCCCCC-----
Confidence 22345799999999999888899999999999999999999999976432211 111222122222211
Q ss_pred CChhhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 002346 823 LDEETIESIYRVAELAGHCTAREPQQRPDMGH 854 (933)
Q Consensus 823 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~e 854 (933)
...+.+++.+|++.||++||++.+
T Consensus 222 --------~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 222 --------SPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred --------CHHHHHHHHHHhhcCHhHcCCCCC
Confidence 134678999999999999999766
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=320.41 Aligned_cols=252 Identities=29% Similarity=0.452 Sum_probs=203.7
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|++.+.||+|+||.||+|+..++..||+|.+..... ..++|.+|+.++++++||||+++++++......++||||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY 80 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence 46788899999999999999887777899999875432 236789999999999999999999999988889999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+.+|+|.+++... ...+++.+++.++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||.++.....
T Consensus 81 ~~~~~l~~~i~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~ 153 (256)
T cd05113 81 MSNGCLLNYLREH----GKRFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD 153 (256)
T ss_pred CCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCC
Confidence 9999999998652 1358999999999999999999998 89999999999999999999999999998866544
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.........++..|+|||+..+..++.++||||||+++|||++ |+.||......+ ... .... .... .. +
T Consensus 154 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~---~~~~-~~~~--~~-~ 223 (256)
T cd05113 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVE---KVSQ-GLRL--YR-P 223 (256)
T ss_pred ceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHH---HHhc-CCCC--CC-C
Confidence 3322223346678999999988889999999999999999999 999987543221 111 1111 1110 00 0
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.. ....+.+++.+||+.+|++||++.++++.++
T Consensus 224 ~~--------~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 224 HL--------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CC--------CCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 00 1246789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-38 Score=331.57 Aligned_cols=245 Identities=26% Similarity=0.432 Sum_probs=201.4
Q ss_pred CccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 583 FSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
|..++.||.|+||.||-| +..+.+.||||++..... +.+.+.++..|+..+.+++|||+|.+.|||..+...|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 455677999999999999 456788999999987643 345678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
| -|+-.+.+.-+ .+++.+.++..|..+.+.||+|||+ ++.||||||+.|||+++.|.|||+|||.|....+.
T Consensus 108 C-lGSAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 108 C-LGSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred H-hccHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 9 46777777542 2678999999999999999999999 89999999999999999999999999998766543
Q ss_pred CceeecccccccCccccccc---CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 741 KYSVETRLAGTFGYLAPEYA---ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..++|||.|||||++ ..+.|+-|+||||||+++.||..+++|......+.. ...+...+.
T Consensus 180 -----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------LYHIAQNes------ 242 (948)
T KOG0577|consen 180 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQNES------ 242 (948)
T ss_pred -----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------HHHHHhcCC------
Confidence 357999999999987 457899999999999999999999999876533221 111222111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
|.+. ..+....+..++..|+++-|.+|||.+++++
T Consensus 243 -PtLq----s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 243 -PTLQ----SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred -CCCC----CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 2222 2233456889999999999999999998654
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=351.00 Aligned_cols=252 Identities=22% Similarity=0.314 Sum_probs=202.4
Q ss_pred CCccCCccccCCCeEEEEEEe-CC-CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.|.+.+.||+|+||.||+|.. .+ ++.||+|.+... .......+.+|+.+++.++|||||++++++..++..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 388899999999999999954 34 678888876544 23445678889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++..... ...++++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 146 ~~~gg~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLK-EHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221 (478)
T ss_pred CCCCCCHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCC
Confidence 9999999998865322 23568999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+........ . .+.
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~------~~~~~~~~~~--~-~~~ 292 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE------IMQQVLYGKY--D-PFP 292 (478)
T ss_pred ccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCC--C-CCC
Confidence 321 12344579999999999998999999999999999999999999997543211 1222221111 0 011
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. ....+.+++.+|++.+|++||++.++++
T Consensus 293 ~~---------~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 293 CP---------VSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred cc---------CCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 11 1135779999999999999999999864
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=334.16 Aligned_cols=244 Identities=25% Similarity=0.385 Sum_probs=196.5
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
+.||+|+||.||++.. .+|+.||+|++..... ......++..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999954 5789999999976532 2234567788999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 744 (933)
+|.+++.. ...+++.++..++.|++.||+|||+ ..+|+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 ~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~ 152 (325)
T cd05594 81 ELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-T 152 (325)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-c
Confidence 99998854 2468999999999999999999996 26999999999999999999999999999875432221 1
Q ss_pred ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCC
Q 002346 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLD 824 (933)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 824 (933)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ..........++..+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~i~~~~~~~p~~~------- 219 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILMEEIRFPRTL------- 219 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHHHhcCCCCCCCCC-------
Confidence 2235799999999999988999999999999999999999999976433211 111111122222211
Q ss_pred hhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 825 EETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 825 ~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
...+.+++.+|++.||++|+ ++.++++
T Consensus 220 ------~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 220 ------SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ------CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 13467999999999999997 8888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=319.72 Aligned_cols=256 Identities=25% Similarity=0.446 Sum_probs=205.9
Q ss_pred cCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
++|++.+.||+|+||.||+|.+. +...||||.++... ......+|.+|+.++++++||||+++++++......++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 57889999999999999999764 24579999887553 34456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++++|.+++... ...+++.+++.++.|++.|++|||+ ++|+||||||+||++++++.++|+|||+++.
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~ 155 (266)
T cd05033 83 ITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRR 155 (266)
T ss_pred EEEcCCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence 99999999999998652 1368999999999999999999998 8999999999999999999999999999987
Q ss_pred CCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 737 APDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 737 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
...... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||....... ....+ ......+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~~ 228 (266)
T cd05033 156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGYRLP 228 (266)
T ss_pred ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCCCC
Confidence 652221 11222345678999999998899999999999999999998 999986543221 11111 1111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
. . ......+.+++.+|++.+|++||++.++++.|+++
T Consensus 229 ~--~---------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 229 P--P---------MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred C--C---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 0 01124577999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=324.61 Aligned_cols=258 Identities=31% Similarity=0.510 Sum_probs=206.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
++|.+.+.||+|+||.||+|... +++.||||.+.... ..+..++|.+|+++++.++|+||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 56888899999999999999653 35789999987653 233467899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcc---------cCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 655 LLVYEYMPRGTLAQHLFEWH---------DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
++||||+++++|.+++.... ......+++.++..++.|++.|++|||+ ++++||||||+||+++.++.
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence 99999999999999997532 1123458899999999999999999998 89999999999999999999
Q ss_pred EEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWF 803 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~ 803 (933)
+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ....+
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~ 237 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI 237 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence 99999999875433222 12233456789999999999999999999999999999998 999987653322 11111
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
. ...... ... .....+.+++.+||+.+|++||++.|+++.|+
T Consensus 238 ~-----~~~~~~-~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~ 279 (280)
T cd05049 238 T-----QGRLLQ-RPR---------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ 279 (280)
T ss_pred H-----cCCcCC-CCC---------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence 1 111111 111 11245789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=324.14 Aligned_cols=260 Identities=26% Similarity=0.449 Sum_probs=204.9
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 652 (933)
.+++|++.+.||+|+||.||+|... .++.||+|++.... ......+|.+|+.+++.++||||+++++++..+.
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~ 82 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 82 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4678999999999999999998642 35679999886542 2344567899999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEE
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDH-----GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~k 727 (933)
..++||||+++++|.+++...... ....+++..+..++.|+++|++|||+ .+++||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence 999999999999999998653221 12346889999999999999999998 8999999999999999999999
Q ss_pred EecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHH
Q 002346 728 VADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 728 l~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~ 805 (933)
|+|||+++......... .....+++.|+|||++.++.++.++|||||||++|||++ |..||........ .. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~---~~---~ 233 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV---LR---F 233 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---H
Confidence 99999987654433221 122355788999999998889999999999999999999 6888875433211 11 1
Q ss_pred HhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 806 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.. ...... ... .....+.+++.+|++.+|++||++.|+++.|+
T Consensus 234 ~~--~~~~~~-~~~---------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 276 (277)
T cd05062 234 VM--EGGLLD-KPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 276 (277)
T ss_pred HH--cCCcCC-CCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence 11 111111 001 11235789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=336.75 Aligned_cols=205 Identities=24% Similarity=0.416 Sum_probs=176.8
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||++.. .+++.||+|++..... .......+.+|+.++.+++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999954 4689999999976432 2234467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK-----KDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999965 2568999999999999999999998 899999999999999999999999999987543
Q ss_pred CCCc----------------------------------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcC
Q 002346 739 DGKY----------------------------------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784 (933)
Q Consensus 739 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG 784 (933)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G 232 (363)
T cd05628 153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (363)
T ss_pred ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence 2110 001235799999999999988999999999999999999999
Q ss_pred CCCCCCCCC
Q 002346 785 RKALDDTMP 793 (933)
Q Consensus 785 ~~p~~~~~~ 793 (933)
+.||....+
T Consensus 233 ~~Pf~~~~~ 241 (363)
T cd05628 233 YPPFCSETP 241 (363)
T ss_pred CCCCCCCCH
Confidence 999976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=339.41 Aligned_cols=253 Identities=22% Similarity=0.310 Sum_probs=196.8
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.+|++.+.||+|+||.||+|+. .+++.||||++..... .......+.+|++++++++||||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3689999999999999999954 5689999999875432 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 81 E~~~~g~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~ 152 (376)
T cd05598 81 DYIPGGDMMSLLIR-----LGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152 (376)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence 99999999999965 2458889999999999999999999 899999999999999999999999999975221
Q ss_pred CCC------------------------------------------ceeecccccccCcccccccCCCCCCCccchHhHHH
Q 002346 739 DGK------------------------------------------YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGV 776 (933)
Q Consensus 739 ~~~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~ 776 (933)
... ........||+.|+|||++.+..++.++|||||||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 232 (376)
T cd05598 153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 232 (376)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence 000 00012347999999999999989999999999999
Q ss_pred HHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC---CHH
Q 002346 777 VLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP---DMG 853 (933)
Q Consensus 777 ~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP---s~~ 853 (933)
++|||++|+.||....+.+... .......... +..... ....+.+++.+|+ .+|.+|+ ++.
T Consensus 233 ilyell~G~~Pf~~~~~~~~~~------~i~~~~~~~~--~~~~~~-------~s~~~~~li~~l~-~~p~~R~~~~t~~ 296 (376)
T cd05598 233 ILYEMLVGQPPFLADTPAETQL------KVINWETTLH--IPSQAK-------LSREASDLILRLC-CGAEDRLGKNGAD 296 (376)
T ss_pred eeeehhhCCCCCCCCCHHHHHH------HHhccCcccc--CCCCCC-------CCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence 9999999999998754322211 1111011100 000000 1124567777765 5999999 788
Q ss_pred HHHH
Q 002346 854 HAVN 857 (933)
Q Consensus 854 evl~ 857 (933)
++++
T Consensus 297 ell~ 300 (376)
T cd05598 297 EIKA 300 (376)
T ss_pred HHhC
Confidence 8875
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=324.03 Aligned_cols=261 Identities=29% Similarity=0.490 Sum_probs=208.0
Q ss_pred cCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
++|.+.+.||+|+||.||++.. .++..+|+|.+... .....+.+.+|++++++++||||+++++++..+...
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 5788999999999999999963 23456899988754 344567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhccc--------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcE
Q 002346 655 LLVYEYMPRGTLAQHLFEWHD--------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 726 (933)
++||||+++++|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcE
Confidence 999999999999999965321 112358999999999999999999998 899999999999999999999
Q ss_pred EEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHH
Q 002346 727 KVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 727 kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 804 (933)
||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~---~~--- 233 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE--- 233 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---
Confidence 9999999886543322 12223446788999999998889999999999999999998 8999876543221 11
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.... ..... .... ....+.+++.+|++.+|.+||++.++.+.|+++..
T Consensus 234 ~i~~--~~~~~-~~~~---------~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 234 CITQ--GRVLQ-RPRT---------CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HHHc--CCcCC-CCCC---------CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 1111 11111 0000 11357899999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=338.67 Aligned_cols=264 Identities=23% Similarity=0.349 Sum_probs=200.4
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc-----eeE
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-----ERL 655 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 655 (933)
+|++.+.||+|+||.||++.. .+++.||+|++..........+++.+|+.+++.++||||+++++++.... ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999964 57999999998754333445578899999999999999999999998766 789
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+. ++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 81 lv~e~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~ 151 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLAR 151 (372)
T ss_pred EEeeccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEecccccee
Confidence 9999996 688887744 2468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHH------------
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW------------ 802 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~------------ 802 (933)
..............+++.|+|||++.+. .++.++||||+||++|||++|+.||....+.+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~ 231 (372)
T cd07853 152 VEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRS 231 (372)
T ss_pred ecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence 6544332223345689999999998764 578999999999999999999999986544322111100
Q ss_pred ----HHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 803 ----FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 803 ----~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...........+........ .......++.+++.+|++.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 232 ACEGARAHILRGPHKPPSLPVLYT---LSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred hhHHHHHHHHhCCCCCCchHHhcc---cCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 00000000000000000000 00011245779999999999999999999986
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=322.06 Aligned_cols=256 Identities=29% Similarity=0.479 Sum_probs=208.5
Q ss_pred HhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
...+|++.+.||.|+||.||+|...+++.+|+|.+.... .....++.+|+.+++.++|+||+++++++......++||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 81 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIIT 81 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEE
Confidence 346788999999999999999988789999999987653 334567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++... ....+++.++..++.|++.|++|||+ ++|+||||||+||++++++.+||+|||.+....
T Consensus 82 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 82 ELMEKGSLLAFLRSP---EGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred eecccCCHHHHHhcC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcC
Confidence 999999999999652 23568999999999999999999998 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... .....++..|+|||++....++.++||||||+++|+|++ |+.||......+ ....+. . .... ..
T Consensus 156 ~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~---~-~~~~--~~ 225 (261)
T cd05148 156 EDVYL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQIT---A-GYRM--PC 225 (261)
T ss_pred Ccccc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHH---h-CCcC--CC
Confidence 43322 223356778999999988889999999999999999998 889996543221 111111 1 1111 01
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
.. .....+.+++.+|++.+|++||+++++++.|+.
T Consensus 226 ~~---------~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 226 PA---------KCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred CC---------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 11 112357799999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=332.63 Aligned_cols=256 Identities=21% Similarity=0.327 Sum_probs=197.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||++.. .+++.||+|++.+... .....+.+.+|+.++..++|+||+++++++.++...++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4789999999999999999965 4689999999875322 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||++....
T Consensus 81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 153 (331)
T cd05597 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL 153 (331)
T ss_pred ecCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence 999999999999642 2458899999999999999999999 899999999999999999999999999987654
Q ss_pred CCCceeecccccccCcccccccCC-----CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
...........||+.|+|||++.. +.++.++||||+||++|||++|+.||......+ ............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~ 227 (331)
T cd05597 154 ADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKEHF 227 (331)
T ss_pred CCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HHHHHHcCCCcc
Confidence 433222233569999999999863 457889999999999999999999997643221 111221111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCC--CCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREP--QQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P--~~RPs~~evl~ 857 (933)
. +.+.. ......+.+++.+|+..++ ..||++.++++
T Consensus 228 ~--~~~~~------~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~ 265 (331)
T cd05597 228 Q--FPPDV------TDVSEEAKDLIRRLICSPETRLGRNGLQDFKD 265 (331)
T ss_pred c--CCCcc------CCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence 0 11110 0112346678888775533 34789998876
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=332.81 Aligned_cols=244 Identities=23% Similarity=0.383 Sum_probs=192.8
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||++.. .+++.||+|+++..... ....+.+.+|..++..+ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999955 46889999999865332 23456788999999998 799999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .
T Consensus 81 g~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~ 151 (329)
T cd05588 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-D 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-C
Confidence 999988854 2468999999999999999999998 899999999999999999999999999987432211 1
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCch--hhHHHHHHHHHh-hccCCCCcccCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD--RAHLVTWFRRVL-ISKENIPKAIDPN 820 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~d~~ 820 (933)
......||+.|+|||++.+..++.++|||||||++|||++|+.||+.....+ ......+..... .....++..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~---- 227 (329)
T cd05588 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS---- 227 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCC----
Confidence 2234579999999999999999999999999999999999999997432111 111112222211 111112211
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
+ ...+.+++.+|++.||.+||++
T Consensus 228 ~---------~~~~~~li~~~L~~dP~~R~~~ 250 (329)
T cd05588 228 L---------SVKASSVLKGFLNKDPKERLGC 250 (329)
T ss_pred C---------CHHHHHHHHHHhccCHHHcCCC
Confidence 1 1356799999999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=320.09 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=201.3
Q ss_pred CccCCccccCCCeEEEEEEeCC-Cc--EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------ce
Q 002346 583 FSEANILGRGGFGVVYGGELPD-GT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------SE 653 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 653 (933)
|.+.+.||+|+||.||+|...+ +. .||+|.++.........+.+.+|+++++.++|+||+++++++... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999997644 32 689999877654556678899999999999999999999987532 24
Q ss_pred eEEEEeecCCCChhhHhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHD-HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
.++||||+++|+|.+++..... .....+++..+..++.|++.||+|||+ ++|+||||||+||++++++.+||+|||
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg 157 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG 157 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence 6899999999999998753221 122458999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCCceee-cccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 733 LVKNAPDGKYSVE-TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 733 la~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
+++.......... ....+++.|+|||+..+..++.++||||||+++|||++ |+.||...... .... . ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~---~-~~~~ 230 (272)
T cd05075 158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYD---Y-LRQG 230 (272)
T ss_pred cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH---H-HHcC
Confidence 9986654332221 22346778999999998899999999999999999999 78888653321 1111 1 1111
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
...+ ..+. ....+.+++.+|++.+|++||++.++++.|+++
T Consensus 231 ~~~~--~~~~---------~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 231 NRLK--QPPD---------CLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred CCCC--CCCC---------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1111 1111 123577999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.66 Aligned_cols=240 Identities=26% Similarity=0.389 Sum_probs=190.3
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHH-HHHhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIA-VLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+|+.||+|++...... .....++..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999965 47899999998764321 223345555554 56788999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~ 151 (323)
T cd05575 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-K 151 (323)
T ss_pred CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-C
Confidence 999999865 2468899999999999999999998 899999999999999999999999999987543222 1
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...........+ .+.+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~~----~~~~-- 219 (323)
T cd05575 152 TTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNILNKPLRL----KPNI-- 219 (323)
T ss_pred ccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHHcCCCCC----CCCC--
Confidence 2234579999999999999899999999999999999999999997643211 112222211111 1111
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMGH 854 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~e 854 (933)
...+.+++.+|++.+|++||++.+
T Consensus 220 -------~~~~~~li~~~l~~~p~~R~~~~~ 243 (323)
T cd05575 220 -------SVSARHLLEGLLQKDRTKRLGAKD 243 (323)
T ss_pred -------CHHHHHHHHHHhhcCHHhCCCCCC
Confidence 235679999999999999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=324.64 Aligned_cols=250 Identities=33% Similarity=0.586 Sum_probs=194.2
Q ss_pred cCCccccCCCeEEEEEEeC-----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 585 EANILGRGGFGVVYGGELP-----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
..+.||.|.||.||+|.+. .+..|+||.+... ...+..+.|.+|++.+++++||||++++|++...+..++|||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e 81 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVME 81 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeeccccccccccccccccccccccccccccccc
Confidence 4578999999999999775 3678999999653 344457899999999999999999999999998888999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++... ....+++.++..|+.|+++||+|||+ .+++|+||+++||++++++.+||+|||++.....
T Consensus 82 ~~~~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~ 155 (259)
T PF07714_consen 82 YCPGGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISE 155 (259)
T ss_dssp --TTEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTT
T ss_pred cccccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence 99999999999773 23568999999999999999999999 8999999999999999999999999999987633
Q ss_pred CC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 740 GK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 740 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
.. ........+...|+|||.+....++.++||||||+++||+++ |+.||...... .... .... .... . .
T Consensus 156 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~---~~~~---~~~~-~~~~-~-~ 226 (259)
T PF07714_consen 156 KSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE---EIIE---KLKQ-GQRL-P-I 226 (259)
T ss_dssp SSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH---HHHH---HHHT-TEET-T-S
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccc---cccc-cccc-e-e
Confidence 22 222333457789999999988889999999999999999999 67888665322 1111 1111 1111 1 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
.... ...+.+++..||+.+|++||++.++++.|
T Consensus 227 ~~~~---------~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 227 PDNC---------PKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp BTTS---------BHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccch---------hHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1111 23577999999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=316.16 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=195.4
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc---ee--E
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS---ER--L 655 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---~~--~ 655 (933)
.|+..+++|.|+||.||+|.. .+++.||||++-.+.. --.+|+++|+.++|||||+++.+|.... +. .
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 466789999999999999965 4579999999866531 2247999999999999999999886532 22 4
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-CcEEEeccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLV 734 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGla 734 (933)
+|||||+. +|.++++.+... ...++.-.+.-+.+|+.+||+|||+ .+|+||||||+|+|+|.+ |.+||||||.|
T Consensus 99 lVleymP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSA 173 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSA 173 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence 89999964 999999764333 2567778888899999999999999 999999999999999976 89999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc--C
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--E 811 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~ 811 (933)
+....+... ..+.-|..|+|||.+.+. .|+.+.||||.||++.||+-|++-|.+....+. ++..+ +++-.. +
T Consensus 174 K~L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIi-k~lG~Pt~e 248 (364)
T KOG0658|consen 174 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEII-KVLGTPTRE 248 (364)
T ss_pred eeeccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHH-HHhCCCCHH
Confidence 977765543 344568899999988664 799999999999999999999999987543222 22222 211000 0
Q ss_pred CC-------CcccCCCCCCCh----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NI-------PKAIDPNLNLDE----ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~-------~~~~d~~l~~~~----~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
++ .+.-.+.+.... .......+.++++.++++.+|.+|.++.|++.
T Consensus 249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 00 011111111111 12223456789999999999999999999886
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=324.34 Aligned_cols=261 Identities=29% Similarity=0.476 Sum_probs=208.4
Q ss_pred cCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.+|.+.+.||+|+||.||+|.. .++..+++|.+... .....+.+.+|++++++++|+||+++++++..+...
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc--cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 4678889999999999999963 23567899988654 334456799999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 655 LLVYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
++||||+++++|.+++..... .....+++..++.++.|++.|++|||+ ++|+||||||+||+++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGAN 159 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccC
Confidence 999999999999999965321 112358999999999999999999998 899999999999999999
Q ss_pred CcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHH
Q 002346 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~ 801 (933)
+.++|+|||++........ .......|+..|+|||++.+..++.++||||||+++|||+| |+.||....... ...
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~ 236 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VIE 236 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 9999999999976544322 22233457889999999998899999999999999999999 999987654322 111
Q ss_pred HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.. . ....... .. .....+.+++.+|++.+|++||++.+++++|+.+.+
T Consensus 237 ~~---~--~~~~~~~-~~---------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CI---T--QGRVLER-PR---------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HH---h--CCCCCCC-Cc---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 11 1 1111111 00 112457899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=334.91 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=201.1
Q ss_pred HHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc
Q 002346 575 VLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (933)
Q Consensus 575 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 652 (933)
+++...++|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..+.
T Consensus 37 ~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~ 116 (371)
T cd05622 37 DLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR 116 (371)
T ss_pred hcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence 3444568999999999999999999965 4688999999865322 2233456789999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 117 ~~~lv~Ey~~gg~L~~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 117 YLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred EEEEEEcCCCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence 99999999999999999854 347888999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCC----CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATG----RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
+++..............||+.|+|||++... .++.++|||||||++|||++|+.||....... .+..+..
T Consensus 188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~ 261 (371)
T cd05622 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN 261 (371)
T ss_pred ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence 9986654332233456799999999998653 37899999999999999999999997643211 1122221
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQ--RPDMGHAVN 857 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~evl~ 857 (933)
....+.-...+ .....+.+++.+|++.++.+ ||++.++++
T Consensus 262 ~~~~~~~~~~~---------~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~ 303 (371)
T cd05622 262 HKNSLTFPDDN---------DISKEAKNLICAFLTDREVRLGRNGVEEIKR 303 (371)
T ss_pred CCCcccCCCcC---------CCCHHHHHHHHHHcCChhhhcCCCCHHHHhc
Confidence 11111100001 11235678999999844433 778888876
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=319.41 Aligned_cols=262 Identities=24% Similarity=0.370 Sum_probs=209.4
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+++.||||.+..... ......++.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999965 4789999998865332 3344567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++..... ....+++..+..++.|+++|++|||+ ++++||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~ 157 (267)
T cd08228 82 ELADAGDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence 99999999998865322 23458899999999999999999998 899999999999999999999999999988654
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||....... ..+..... ....+.
T Consensus 158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~~~~~--~~~~~~--- 227 (267)
T cd08228 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLCQKIE--QCDYPP--- 227 (267)
T ss_pred chhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHHHHHh--cCCCCC---
Confidence 4321 1123468899999999988889999999999999999999999986543211 11111111 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.. .......+.+++.+||+.+|++||++.++++.++++
T Consensus 228 --~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~ 265 (267)
T cd08228 228 --LP----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM 265 (267)
T ss_pred --CC----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence 10 112234578999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=332.21 Aligned_cols=240 Identities=24% Similarity=0.372 Sum_probs=192.9
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+++.||||++..... .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999965 4688999999876432 233456778888888877 699999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-----~~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~- 151 (320)
T cd05590 81 GDLMFHIQK-----SRRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK- 151 (320)
T ss_pred chHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-
Confidence 999998865 2458999999999999999999998 8999999999999999999999999999875432221
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............+.. +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~~~~i~~~~~~~~~~----~-- 219 (320)
T cd05590 152 TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDEVVYPTW----L-- 219 (320)
T ss_pred cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCCCCCCCC----C--
Confidence 2234579999999999998899999999999999999999999997653221 111222211111111 1
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMGH 854 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~e 854 (933)
...+.+++.+|++.||++||++.+
T Consensus 220 -------~~~~~~li~~~L~~dP~~R~~~~~ 243 (320)
T cd05590 220 -------SQDAVDILKAFMTKNPTMRLGSLT 243 (320)
T ss_pred -------CHHHHHHHHHHcccCHHHCCCCCC
Confidence 135679999999999999999843
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=318.58 Aligned_cols=255 Identities=31% Similarity=0.486 Sum_probs=204.3
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.++||+|+||.||+|...+...||+|+++.... ..++|.+|+++++.++||||+++++++. ....++|||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 357899999999999999999877777899999876432 2357899999999999999999999874 456789999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++... ....+++..+..++.|+++||+|+|+ .+|+||||||+||++++++.+||+|||.++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 81 YMSKGSLLDFLKGE---MGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred cCCCCcHHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 99999999999652 12457899999999999999999998 8999999999999999999999999999986654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........++..|+|||+..+..++.++||||||+++|||++ |+.||........ . .... .....+ ..
T Consensus 155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~---~~~~-~~~~~~--~~ 225 (262)
T cd05071 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---L---DQVE-RGYRMP--CP 225 (262)
T ss_pred cccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---H---HHHh-cCCCCC--Cc
Confidence 43322233456778999999988899999999999999999999 7888865432211 1 1111 111110 11
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
......+.+++.+|++.+|++||+++++++.|+..
T Consensus 226 ---------~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 ---------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ---------cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 12234578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=326.48 Aligned_cols=260 Identities=24% Similarity=0.372 Sum_probs=214.4
Q ss_pred HHhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCcee
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSER 654 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 654 (933)
...+.|++.+.||+|.||.||++..+ +|+.+|+|.+.+..... .....+.+|+++|+++. |||||.+++++++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34567889999999999999999654 59999999998775432 34578999999999998 99999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC----CcEEEec
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD----MRAKVAD 730 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~----~~~kl~D 730 (933)
++|||++.||.|.+.+... .+++..+..++.|++.|++|||+ .+|+|||+||+|+|+... +.+|++|
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~D 182 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLID 182 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEee
Confidence 9999999999999999763 28999999999999999999999 999999999999999643 5799999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
||++.....+ ......+||+.|+|||++....|+.++||||+||++|.|++|..||.......... .+....
T Consensus 183 FGla~~~~~~--~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~------~i~~~~ 254 (382)
T KOG0032|consen 183 FGLAKFIKPG--ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL------AILRGD 254 (382)
T ss_pred CCCceEccCC--ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH------HHHcCC
Confidence 9999988772 23456799999999999999999999999999999999999999998765432211 222222
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
..+..... ........+++..|+..||.+|+++.++++ ++|...
T Consensus 255 ~~f~~~~w---------~~is~~akd~i~~ll~~dp~~R~ta~~~L~------HpWi~~ 298 (382)
T KOG0032|consen 255 FDFTSEPW---------DDISESAKDFIRKLLEFDPRKRLTAAQALQ------HPWIKS 298 (382)
T ss_pred CCCCCCCc---------cccCHHHHHHHHHhcccCcccCCCHHHHhc------CccccC
Confidence 21111111 112345679999999999999999999998 677543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=318.32 Aligned_cols=255 Identities=27% Similarity=0.462 Sum_probs=206.2
Q ss_pred HhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
..++|++.++||+|+||.||+|..++++.||+|.+..... ...++.+|+.++++++|+||+++++++. .+..++||
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIIT 79 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEE
Confidence 3568899999999999999999888899999999876532 3467899999999999999999999864 45689999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++... ....+++.++..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 80 EYMENGSLVDFLKTP---EGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred EcCCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999999998652 23468999999999999999999998 899999999999999999999999999987665
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
...........++..|+|||++....++.++||||||+++||+++ |+.||......+ ...... .....+ .
T Consensus 154 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~----~~~~~~--~ 224 (260)
T cd05067 154 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQNLE----RGYRMP--R 224 (260)
T ss_pred CCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHHHH----cCCCCC--C
Confidence 333323333456788999999998889999999999999999999 999997643221 111111 111110 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
.. ....++.+++.+|++.+|++||+++++.+.|+.
T Consensus 225 ~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 225 PD---------NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred CC---------CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 11 112358899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=324.80 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=195.9
Q ss_pred cccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
||+|+||+||++.. .+++.||+|++...... ....+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999954 47899999998765322 22346778899999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeec
Q 002346 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 746 (933)
.+++..... ....+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++........ ...
T Consensus 81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~ 155 (280)
T cd05608 81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTK 155 (280)
T ss_pred HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-ccc
Confidence 988854222 23568999999999999999999999 8999999999999999999999999999876554332 123
Q ss_pred ccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChh
Q 002346 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEE 826 (933)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 826 (933)
...|++.|+|||++.+..++.++|||||||++|||++|+.||......... ............ .+.+
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~----~~~~------- 222 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRILNDSV----TYPD------- 222 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhcccCC----CCcc-------
Confidence 457899999999999999999999999999999999999999764322111 111111111110 1111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 827 TIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 827 ~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
.....+.+++.+|++.+|++|| +++++++
T Consensus 223 --~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 --KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 1224577999999999999999 5566654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=319.34 Aligned_cols=259 Identities=29% Similarity=0.454 Sum_probs=204.1
Q ss_pred CccCCccccCCCeEEEEEEeCC----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce-----
Q 002346 583 FSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE----- 653 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 653 (933)
|.+.+.||+|+||.||+|.... +..||+|+++...........+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 5678999999999999996532 3679999998765555556789999999999999999999998876554
Q ss_pred -eEEEEeecCCCChhhHhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 654 -RLLVYEYMPRGTLAQHLFEWHDH-GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 654 -~~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
.++||||+++|+|.+++...... ....+++..+..++.|++.||+|||+ .+|+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence 68999999999999998653321 22468999999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 732 GLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 732 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|+++......... .....++..|+|||++....++.++||||||+++|||++ |..||......+ ...+. ..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~---~~- 230 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYL---RH- 230 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH---Hc-
Confidence 9998654433221 122345678999999988889999999999999999999 888886543221 11111 11
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
... .. .. ......+.+++.+|++.+|++||++.|+++.|+++
T Consensus 231 ~~~-~~-~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 231 GNR-LK-QP---------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCC-CC-CC---------cCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111 11 00 11224678999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=323.07 Aligned_cols=261 Identities=26% Similarity=0.431 Sum_probs=205.7
Q ss_pred CCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 582 NFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
+|++.+.||+|+||.||+|... ....+|+|.+.... ......++.+|+.+++.++||||+++++++..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 4778899999999999999542 23578899887553 3344578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhccc-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCC
Q 002346 656 LVYEYMPRGTLAQHLFEWHD-------------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~ 716 (933)
+||||+.+++|.+++..... ....++++.+++.++.|++.||+|||+ .+|+||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhh
Confidence 99999999999999865321 112458899999999999999999998 89999999999
Q ss_pred cEEecCCCcEEEecccccccCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCc
Q 002346 717 NILIGDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPD 794 (933)
Q Consensus 717 Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~ 794 (933)
||++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....+.
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999998755332211 1222345678999999988889999999999999999999 99999764332
Q ss_pred hhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 795 DRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
. +..+... .... .... .....+.+++.+|++.+|++||+++++++.|++++.
T Consensus 237 ~---~~~~~~~----~~~~--~~~~---------~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 R---LFNLLKT----GYRM--ERPE---------NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred H---HHHHHhC----CCCC--CCCC---------CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 2 1111111 1000 0010 112357799999999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=317.43 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=201.5
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
.+|++.+.||+|+||.||+|..+++..+|+|++..... ...+|.+|+.++++++||||+++++++...+..++||||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY 80 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence 35788899999999999999887778899999865432 235788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++... ...+++..++.++.|++.|++|||+ .+|+||||||+||++++++.+||+|||+++...+.
T Consensus 81 ~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~ 153 (256)
T cd05059 81 MANGCLLNYLRER----KGKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD 153 (256)
T ss_pred CCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccc
Confidence 9999999998652 1358999999999999999999999 89999999999999999999999999998765443
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.........++..|+|||++.+..++.++||||||+++|||++ |+.||....+.+ ... .... ..... ...
T Consensus 154 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~~~-~~~~~--~~~ 224 (256)
T cd05059 154 QYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVE---SVSA-GYRLY--RPK 224 (256)
T ss_pred cccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHH---HHHc-CCcCC--CCC
Confidence 2222222234568999999998899999999999999999999 788987543221 111 1111 10000 000
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
....++.+++.+|++.+|++||++.++++.|
T Consensus 225 ---------~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 ---------LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1224678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=332.68 Aligned_cols=243 Identities=26% Similarity=0.402 Sum_probs=195.0
Q ss_pred CCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCC-cceeEEeEeeeCceeEEEE
Q 002346 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHR-HLVALLGYCINGSERLLVY 658 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~ 658 (933)
+|++.+.||+|+||.||+|... +++.||||++..... .....+.+..|.+++..++|+ +|+++++++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999654 578999999976532 233456788899999999764 6888999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~ 152 (324)
T cd05587 81 EYVNGGDLMYHIQQ-----VGKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI 152 (324)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence 99999999999865 2458899999999999999999999 899999999999999999999999999987533
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... ......||+.|+|||++.+..++.++||||+||++|||+||+.||....... . ...........+..+
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~---~~~i~~~~~~~~~~~- 224 (324)
T cd05587 153 FGGK-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---L---FQSIMEHNVSYPKSL- 224 (324)
T ss_pred CCCC-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHHcCCCCCCCCC-
Confidence 2221 1234579999999999999899999999999999999999999997653221 1 111111121122111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
..++.+++.+|++.+|.+|++.
T Consensus 225 ------------~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 225 ------------SKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred ------------CHHHHHHHHHHhhcCHHHcCCC
Confidence 1356799999999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=317.95 Aligned_cols=254 Identities=31% Similarity=0.501 Sum_probs=203.9
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|...++..||+|.+..... ..+++.+|+.++++++|+|++++++++. ....++|||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 357889999999999999999888888999999876533 2357999999999999999999999875 456789999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.++++.. ....+++.++..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 81 YMSKGSLLDFLKDG---EGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred ecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999999999652 23458999999999999999999999 8999999999999999999999999999986554
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........++..|+|||++.+..++.++||||||+++|||++ |+.||...... .....+. . ....+ ..
T Consensus 155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~---~~~~~~~---~-~~~~~--~~ 225 (260)
T cd05070 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR---EVLEQVE---R-GYRMP--CP 225 (260)
T ss_pred cccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHH---c-CCCCC--CC
Confidence 33222223345678999999988889999999999999999999 88888654322 1111111 1 11110 00
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
......+.+++.+|++.+|++||+++++.+.|++
T Consensus 226 ---------~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 226 ---------QDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---------CcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1112457899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=332.41 Aligned_cols=243 Identities=25% Similarity=0.363 Sum_probs=195.0
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+++.||+|++..... .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999965 4578999999876532 233456678899998876 799999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|..++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~- 151 (321)
T cd05591 81 GDLMFQIQR-----SRKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV- 151 (321)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-
Confidence 999998865 2458899999999999999999999 8999999999999999999999999999875433221
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....+... ...........+.. +
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~------~~~i~~~~~~~p~~----~-- 219 (321)
T cd05591 152 TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL------FESILHDDVLYPVW----L-- 219 (321)
T ss_pred cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHH------HHHHHcCCCCCCCC----C--
Confidence 22345799999999999988999999999999999999999999986543211 11222211111111 1
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRP-------DMGHAVN 857 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RP-------s~~evl~ 857 (933)
..++.+++.+|++.+|++|| ++.++++
T Consensus 220 -------~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 220 -------SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred -------CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 13577999999999999999 6677664
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=332.46 Aligned_cols=244 Identities=24% Similarity=0.390 Sum_probs=192.0
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+++.||+|+++..... ....+.+.+|+.++.++ +||||+++++++..+...++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 46889999999865322 33456688899988877 799999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|..++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~- 151 (329)
T cd05618 81 GDLMFHMQR-----QRKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD- 151 (329)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-
Confidence 999988854 2468999999999999999999999 8999999999999999999999999999875332211
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCch--hhHHHHHHHH-HhhccCCCCcccCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD--RAHLVTWFRR-VLISKENIPKAIDPN 820 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~d~~ 820 (933)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ......+... .......++. .
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~----~ 227 (329)
T cd05618 152 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR----S 227 (329)
T ss_pred ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC----C
Confidence 1234579999999999999999999999999999999999999996321111 1111122222 1211112221 1
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
+ ...+.+++.+|++.||++||++
T Consensus 228 ~---------~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 228 L---------SVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred C---------CHHHHHHHHHHhcCCHHHcCCC
Confidence 1 1356799999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=325.37 Aligned_cols=253 Identities=26% Similarity=0.396 Sum_probs=201.1
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+|++.+.||+|+||.||++.. .+++.||||++....... .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999965 468999999987643322 223567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++... ....+++..+..++.|++.|++|||+ .+|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05605 81 LMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154 (285)
T ss_pred ccCCCcHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence 99999999888542 22468999999999999999999999 8999999999999999999999999999886543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... .....|++.|+|||++.+..++.++||||+||++|||++|+.||......... ..+...... ....+.+
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~---~~~~~~~ 226 (285)
T cd05605 155 GET--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKE---DQEEYSE 226 (285)
T ss_pred CCc--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhh---cccccCc
Confidence 321 12347899999999999889999999999999999999999999864332111 111111110 0111111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
.....+.+++.+|++.||++|| +++++++
T Consensus 227 ---------~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 227 ---------KFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred ---------ccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 1223567999999999999999 7778765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=311.35 Aligned_cols=254 Identities=26% Similarity=0.355 Sum_probs=206.3
Q ss_pred cCCccCCccccCCCeEEEEEEeCC-CcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
+.|+.++.||+|.-|+||.+++.+ +..+|+|++.+.... .....+.+.|-+||+.++||.++.+|+.++.+...++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345667899999999999997754 588999999887654 455678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
|||+||+|...++++. ...+++..++-++.+|+-||+|||- .|||+||+||+||||.++|++.|+||.++....
T Consensus 157 eyCpGGdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~ 230 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCP 230 (459)
T ss_pred ecCCCccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence 9999999999997633 4669999999999999999999998 899999999999999999999999999865321
Q ss_pred C---------------------------------CCc----------------------eeecccccccCcccccccCCC
Q 002346 739 D---------------------------------GKY----------------------SVETRLAGTFGYLAPEYAATG 763 (933)
Q Consensus 739 ~---------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~ 763 (933)
. ... .....++||-.|.|||++.+.
T Consensus 231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~ 310 (459)
T KOG0610|consen 231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE 310 (459)
T ss_pred CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence 1 000 011235799999999999999
Q ss_pred CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHccc
Q 002346 764 RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTA 843 (933)
Q Consensus 764 ~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~ 843 (933)
..+.++|.|+|||++|||+.|..||.+..... .+. .++.....+++. ......+.+||+++|.
T Consensus 311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~--Tl~----NIv~~~l~Fp~~-----------~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKE--TLR----NIVGQPLKFPEE-----------PEVSSAAKDLIRKLLV 373 (459)
T ss_pred CCCchhhHHHHHHHHHHHHhCCCCcCCCCchh--hHH----HHhcCCCcCCCC-----------CcchhHHHHHHHHHhc
Confidence 99999999999999999999999998764322 222 222222222211 1233467899999999
Q ss_pred CCCCCCCC----HHHHHH
Q 002346 844 REPQQRPD----MGHAVN 857 (933)
Q Consensus 844 ~~P~~RPs----~~evl~ 857 (933)
+||++|.. ++||.+
T Consensus 374 KdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred cChhhhhccccchHHhhc
Confidence 99999997 777765
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.96 Aligned_cols=259 Identities=26% Similarity=0.487 Sum_probs=204.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
++|++.+.||+|+||.||+|.. .++..||+|.+.... ......+|.+|+.+++.++||||+++++++..+...+
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 83 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC 83 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence 4678889999999999999963 356789999987543 3344578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhccc------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 656 LVYEYMPRGTLAQHLFEWHD------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
+||||+++++|.+++..... .....+++.++..++.|++.||+|||+ ++|+||||||+||+++++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQ 160 (283)
T ss_pred EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCC
Confidence 99999999999999854211 012358899999999999999999998 899999999999999999
Q ss_pred CcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHH
Q 002346 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~ 801 (933)
+.+||+|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||....+.. ...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~ 237 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIE 237 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH
Confidence 9999999999986543321 22233456778999999988889999999999999999998 988987643221 111
Q ss_pred HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
... .....+ .... ...++.+++.+|++.+|++||++.++.+.|..
T Consensus 238 ~~~----~~~~~~--~~~~---------~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVR----KRQLLP--CSED---------CPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHH----cCCcCC--CCCC---------CCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 111 111110 1111 12357789999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=322.20 Aligned_cols=268 Identities=28% Similarity=0.455 Sum_probs=209.8
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 652 (933)
..++|++.+.||+|+||.||+|... .+..||+|.+.... ......++.+|+.+++.++||||+++++++....
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4678999999999999999998542 24589999886543 2334457889999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEE
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHD-----HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~k 727 (933)
..++||||+++|+|.+++..... .+....++..+..++.|++.||+|||+ ++|+||||||+||++++++.++
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence 99999999999999999975321 122456788899999999999999998 8999999999999999999999
Q ss_pred EecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHH
Q 002346 728 VADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 728 l~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~ 805 (933)
|+|||+++......... .....++..|+|||++.++.++.++|||||||++|||++ |..||......+ .. ..
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~---~~ 233 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VL---KF 233 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---HH
Confidence 99999988554332211 122345778999999988899999999999999999998 788886543221 11 11
Q ss_pred HhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 806 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
... . .... ... .....+.+++.+|++.+|++||++.++++.|++.+.++..
T Consensus 234 ~~~-~-~~~~-~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 234 VMD-G-GYLD-QPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFP 284 (288)
T ss_pred HHc-C-CCCC-CCC---------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCC
Confidence 111 1 1111 000 1124678999999999999999999999999887766554
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=294.94 Aligned_cols=256 Identities=28% Similarity=0.422 Sum_probs=206.8
Q ss_pred HHHhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCc------hhHHHHHHHHHHHHhc-CCCcceeEEeEe
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGN------KGLSEFQAEIAVLTKV-RHRHLVALLGYC 648 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 648 (933)
......|...+.||.|..++|-+. ..++|..+|+|++....... +-.+.-.+|+.+++++ .||+|+++.++|
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 344567888899999999999887 45678999999987643221 1234456799999999 699999999999
Q ss_pred eeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 649 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
+.+...++|+|.|+.|.|.++|.. ...+++++..+|++|+.+|++|||. +.|||||+||+|||+|++.++||
T Consensus 93 es~sF~FlVFdl~prGELFDyLts-----~VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~i 164 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS-----KVTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKI 164 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh-----heeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEE
Confidence 999999999999999999999965 3679999999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCceeecccccccCcccccccC------CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHH
Q 002346 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA------TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW 802 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~ 802 (933)
+|||.++....+.. -...+|||+|.|||.+. ...|+...|+|++||++|.|+.|.+||..... .-.
T Consensus 165 sDFGFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ------mlM 236 (411)
T KOG0599|consen 165 SDFGFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ------MLM 236 (411)
T ss_pred eccceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH------HHH
Confidence 99999998887653 34579999999999884 34578899999999999999999999975311 111
Q ss_pred HHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 803 FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 803 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+.+..++..+. .++-.+......++|.+|++.||++|.|+.|+++
T Consensus 237 LR~ImeGkyqF~---------speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 237 LRMIMEGKYQFR---------SPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred HHHHHhcccccC---------CcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 222232222211 1111233345779999999999999999999886
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=317.30 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=197.3
Q ss_pred ccccCCCeEEEEEEe---CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 588 ILGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 588 ~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
.||+|+||.||+|.+ .++..||+|++..........+++.+|+.+++.++||||+++++++. ++..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999954 35789999998766544555678999999999999999999999885 45678999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 744 (933)
+|.+++.. ...+++..+..++.|++.|++|||+ ++|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~ 152 (257)
T cd05116 81 PLNKFLQK-----NKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY 152 (257)
T ss_pred cHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence 99999854 2458899999999999999999998 899999999999999999999999999998654433221
Q ss_pred --ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCC
Q 002346 745 --ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821 (933)
Q Consensus 745 --~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 821 (933)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...... .....+. ....+. ..+.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~-----~~~~~~-~~~~- 222 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIE-----SGERME-CPQR- 222 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH-----CCCCCC-CCCC-
Confidence 122244678999999988889999999999999999998 99999764332 1222111 111111 1111
Q ss_pred CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 822 NLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
....+.+++.+|++.+|++||++++|++.|++
T Consensus 223 --------~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~ 254 (257)
T cd05116 223 --------CPPEMYDLMKLCWTYGVDERPGFAVVELRLRN 254 (257)
T ss_pred --------CCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence 12357799999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=331.25 Aligned_cols=245 Identities=23% Similarity=0.368 Sum_probs=193.7
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+++.||+|+++..... ....+.+.+|+.++.++ +||+|+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 46789999999865332 23456788999999888 699999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|..++.. ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 151 (327)
T cd05617 81 GDLMFHMQR-----QRKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD- 151 (327)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC-
Confidence 999988854 2468999999999999999999999 8999999999999999999999999999875322211
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh-hccCCCCcccCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL-ISKENIPKAIDPNLN 822 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~d~~l~ 822 (933)
......||+.|+|||++.+..++.++|||||||++|||++|+.||.............+..... .....++..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~----- 226 (327)
T cd05617 152 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFL----- 226 (327)
T ss_pred ceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCC-----
Confidence 1234579999999999999999999999999999999999999997533221111112222221 1111222211
Q ss_pred CChhhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 002346 823 LDEETIESIYRVAELAGHCTAREPQQRPDMG 853 (933)
Q Consensus 823 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ 853 (933)
...+.+++.+|++.||++||+++
T Consensus 227 --------~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 227 --------SVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --------CHHHHHHHHHHhccCHHHcCCCC
Confidence 13467999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=338.06 Aligned_cols=204 Identities=26% Similarity=0.385 Sum_probs=174.6
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+|++++.||+|+||.||+|.. .+++.||+|++..... .......+.+|+.++++++|||||++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588899999999999999954 5688999999876432 23345678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++.+ ...+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~ 153 (382)
T cd05625 82 YIPGGDMMSLLIR-----MGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW 153 (382)
T ss_pred CCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence 9999999999865 2458899999999999999999999 8999999999999999999999999999753210
Q ss_pred CC----------------------------------------------ceeecccccccCcccccccCCCCCCCccchHh
Q 002346 740 GK----------------------------------------------YSVETRLAGTFGYLAPEYAATGRVTTKIDVYA 773 (933)
Q Consensus 740 ~~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~S 773 (933)
.. ........||+.|+|||++.+..++.++||||
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS 233 (382)
T cd05625 154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS 233 (382)
T ss_pred cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence 00 00012346999999999999889999999999
Q ss_pred HHHHHHHHHcCCCCCCCCCC
Q 002346 774 FGVVLMETITGRKALDDTMP 793 (933)
Q Consensus 774 lG~~l~elltG~~p~~~~~~ 793 (933)
+||++|||++|+.||....+
T Consensus 234 lGvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 234 VGVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred chHHHHHHHhCCCCCCCCCH
Confidence 99999999999999986543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=326.66 Aligned_cols=257 Identities=25% Similarity=0.436 Sum_probs=202.9
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCc----EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.+|++.+.||+|+||.||+|.+. +++ .||+|+++... .....+++.+|+.+++.++||||++++|+|... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 46899999999999999999653 343 48999987542 344567899999999999999999999999764 567
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+|+||+++|+|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~ 157 (316)
T cd05108 85 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (316)
T ss_pred eeeecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccc
Confidence 999999999999999652 2358899999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCceee-cccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 736 NAPDGKYSVE-TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 736 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
.......... ....++..|+|||++....++.++||||||+++|||++ |+.||......+ ... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~ 230 (316)
T cd05108 158 LLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL 230 (316)
T ss_pred cccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhCCCCC
Confidence 6654332221 22334678999999998999999999999999999998 999997643221 111 11111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
+. .+. ....+.+++.+|++.+|++||++.+++..+..+..
T Consensus 231 ~~--~~~---------~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 231 PQ--PPI---------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred CC--CCC---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 11 111 11356789999999999999999999999877653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=308.91 Aligned_cols=247 Identities=26% Similarity=0.441 Sum_probs=207.9
Q ss_pred CccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeec
Q 002346 583 FSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
|.++++||+|+||.|||| +...|..||+|++..+ ...+++..|+.+|++++.|++|++||.|......|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 556789999999999999 5568999999999765 34678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
..|+..+.++.. .+++++.++..+++..++||+|||. ..-||||||+.|||++.+|.+|++|||.|....+.-
T Consensus 111 GAGSiSDI~R~R----~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM 183 (502)
T KOG0574|consen 111 GAGSISDIMRAR----RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM 183 (502)
T ss_pred CCCcHHHHHHHh----cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhH
Confidence 999999998652 3789999999999999999999999 577999999999999999999999999998765532
Q ss_pred ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCC
Q 002346 742 YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 821 (933)
.....+.|||.|||||++..-.|..++||||+|++..||..|++||.+-.|+.... . ++.--.|.+
T Consensus 184 -AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------M----IPT~PPPTF 249 (502)
T KOG0574|consen 184 -AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------M----IPTKPPPTF 249 (502)
T ss_pred -HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------e----ccCCCCCCC
Confidence 23445789999999999999999999999999999999999999998876643211 1 111112222
Q ss_pred CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 822 NLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. .+.....++-++++.|+-+.|++|-|+.++++
T Consensus 250 ~---KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 250 K---KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred C---ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 2 22334457889999999999999999988765
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=315.53 Aligned_cols=252 Identities=24% Similarity=0.372 Sum_probs=202.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC---chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
++|.+.+.||+|++|.||++.. .+++.||+|.+...... ....+.+.+|++++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5789999999999999999954 56899999998754322 2234678999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++++|.+++.. ...+++..+..++.|++.|++|||+ .+|+||||+|+||++++++.++|+|||+++.
T Consensus 82 v~e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~ 153 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-----YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKR 153 (263)
T ss_pred EEEECCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence 9999999999999865 2458899999999999999999999 8999999999999999999999999999875
Q ss_pred CCCCCceee--cccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 737 APDGKYSVE--TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 737 ~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
......... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||......... . .... .. ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~---~~~~-~~-~~ 225 (263)
T cd06625 154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---F---KIAT-QP-TN 225 (263)
T ss_pred ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---H---HHhc-cC-CC
Confidence 543221111 2346788999999999888999999999999999999999999764322111 1 1111 11 11
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+... ....+.+++.+|++.+|.+||++.++++
T Consensus 226 ~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 226 PQLPSH---------VSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred CCCCcc---------CCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 111111 1235679999999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=327.64 Aligned_cols=242 Identities=26% Similarity=0.410 Sum_probs=192.2
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+|+.||+|+++..... ......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999965 46889999999765321 23345667788887765 899999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~i~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05620 81 GDLMFHIQD-----KGRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN- 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCC-
Confidence 999999865 2458899999999999999999999 8999999999999999999999999999875432221
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ... ..........+..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~---~~~~~~~~~~~~~~------ 219 (316)
T cd05620 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELF---ESIRVDTPHYPRWI------ 219 (316)
T ss_pred ceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHH---HHHHhCCCCCCCCC------
Confidence 223457999999999999999999999999999999999999999754321 111 11111111111111
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMG-HAV 856 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~-evl 856 (933)
..++.+++.+|++.||++||++. ++.
T Consensus 220 -------~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 220 -------TKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -------CHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 13567899999999999999985 444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=332.57 Aligned_cols=263 Identities=26% Similarity=0.431 Sum_probs=205.9
Q ss_pred hcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 652 (933)
.++|.+.+.||+|+||.||+|.+. .++.||+|+++... .....+.+.+|+.++.++. |||||+++++|...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 346778899999999999999753 34689999997653 2333467899999999997 999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhccc---------------------------------------------------------
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHD--------------------------------------------------------- 675 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------- 675 (933)
..++||||+++|+|.++++....
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 99999999999999999975321
Q ss_pred ------------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 676 ------------------------------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 676 ------------------------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
.....+++..++.++.|++.||+|||+ .+|+||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEE
Confidence 011347888899999999999999998 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~ 797 (933)
+++++.+||+|||+++....... .......+++.|+|||++....++.++||||||+++|||++ |+.||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986433221 11223457889999999988889999999999999999998 8889865432221
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
.. ......... ..... ...++.+++.+||+.+|++||+++++++.|++++
T Consensus 351 -~~----~~~~~~~~~--~~p~~---------~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 -FY----NAIKRGYRM--AKPAH---------ASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred -HH----HHHHcCCCC--CCCCC---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11 111111110 01111 1246789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=315.29 Aligned_cols=253 Identities=30% Similarity=0.473 Sum_probs=202.9
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|.+.+.||+|+||.||+|....+..||+|++.... ...+.+.+|+++++.++|+|++++++++. ....++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT---MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC---ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 5688899999999999999988777789999886543 23467899999999999999999999875 4567899999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.++++.. ....+++..+..++.|++.||+|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05069 82 MGKGSLLDFLKEG---DGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDN 155 (260)
T ss_pred CCCCCHHHHHhhC---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCC
Confidence 9999999999652 22458999999999999999999998 89999999999999999999999999999765443
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.........++..|+|||+..+..++.++||||||+++|||++ |+.||....+.+ ...++. .... .....
T Consensus 156 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~~--~~~~~ 226 (260)
T cd05069 156 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVE----RGYR--MPCPQ 226 (260)
T ss_pred cccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCCC--CCCCc
Confidence 3222223456778999999988899999999999999999999 889987643221 111111 1111 01111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
.....+.+++.+|++.+|++||+++++++.|++
T Consensus 227 ---------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 227 ---------GCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ---------ccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 122467899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=330.69 Aligned_cols=243 Identities=25% Similarity=0.375 Sum_probs=195.0
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEE
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 658 (933)
+|.+.+.||+|+||.||+|.. .+++.||+|++.+... .....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 478899999999999999955 4678999999876532 223345677788888877 5899999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+|||+++++.+||+|||+++...
T Consensus 81 E~~~~g~L~~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~ 152 (323)
T cd05616 81 EYVNGGDLMYQIQQ-----VGRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM 152 (323)
T ss_pred cCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence 99999999998855 2458899999999999999999998 899999999999999999999999999987543
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... +. ..........+.
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~---~~i~~~~~~~p~--- 222 (323)
T cd05616 153 WDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LF---QSIMEHNVAYPK--- 222 (323)
T ss_pred CCCC-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCCCCCC---
Confidence 2221 2234579999999999999999999999999999999999999997653321 11 112211111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
.+ ..++.+++.+|++.+|++|++.
T Consensus 223 -~~---------s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 223 -SM---------SKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred -cC---------CHHHHHHHHHHcccCHHhcCCC
Confidence 11 2356799999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=320.98 Aligned_cols=264 Identities=27% Similarity=0.429 Sum_probs=203.1
Q ss_pred cCCccCCccccCCCeEEEEEEeCC---------------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD---------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 645 (933)
++|++.+.||+|+||.||++.... ...||+|.++... .......|.+|++++++++|+||++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 578999999999999999985532 2358999987542 344566899999999999999999999
Q ss_pred eEeeeCceeEEEEeecCCCChhhHhhhccc-------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcE
Q 002346 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHD-------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNI 718 (933)
Q Consensus 646 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Ni 718 (933)
+++......++||||+++++|.+++..... .....+++..++.++.|+++|++|||+ .+++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence 999999999999999999999999865211 111347899999999999999999998 8999999999999
Q ss_pred EecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc--CCCCCCCCCCch
Q 002346 719 LIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT--GRKALDDTMPDD 795 (933)
Q Consensus 719 ll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt--G~~p~~~~~~~~ 795 (933)
++++++.+||+|||++........ .......++..|+|||++..+.++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999876543322 22233456779999999988899999999999999999998 566776543322
Q ss_pred hhHHHHHHHHHhhccCC-CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 796 RAHLVTWFRRVLISKEN-IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 796 ~~~~~~~~~~~~~~~~~-~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
... ........... ......+. ....+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 ~~~---~~~~~~~~~~~~~~~~~~~~---------~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~ 294 (295)
T cd05097 241 VIE---NTGEFFRNQGRQIYLSQTPL---------CPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR 294 (295)
T ss_pred HHH---HHHHhhhhccccccCCCCCC---------CCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence 111 11111110100 00001111 1236889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=311.90 Aligned_cols=248 Identities=29% Similarity=0.467 Sum_probs=199.4
Q ss_pred CccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
++||+|+||.||+|...++..||+|++.... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3699999999999988889999999887653 334455789999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeec
Q 002346 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 746 (933)
.+++... ...+++.++..++.|++.|+.|+|+ ++++||||||+||+++.++.+||+|||++............
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (250)
T cd05085 80 LSFLRKK----KDELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG 152 (250)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence 9998542 2357899999999999999999998 89999999999999999999999999998755433322222
Q ss_pred ccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCCh
Q 002346 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDE 825 (933)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 825 (933)
...+++.|+|||++.++.++.++||||||+++||+++ |..||........ .. . ..... .......
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~---~-~~~~~--~~~~~~~----- 218 (250)
T cd05085 153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---RE---Q-VEKGY--RMSCPQK----- 218 (250)
T ss_pred CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HH---H-HHcCC--CCCCCCC-----
Confidence 2345678999999998899999999999999999998 9999975432211 11 1 11111 1011111
Q ss_pred hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 826 ETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 826 ~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
....+.+++.+|++.+|++||++.++++.|.
T Consensus 219 ----~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 219 ----CPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ----CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1246789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=331.33 Aligned_cols=243 Identities=25% Similarity=0.355 Sum_probs=191.5
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHH-HHHhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIA-VLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+|+.||+|++..... ......++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999954 5789999999876432 2233445566655 46778999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|..++.. ...+++.++..++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~ 151 (325)
T cd05604 81 GELFFHLQR-----ERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-D 151 (325)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-C
Confidence 999988854 2568999999999999999999998 899999999999999999999999999987533221 1
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .......... .+.+..
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~~~~~~~~~~----~~~~~~-- 219 (325)
T cd05604 152 TTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------MYDNILHKPL----VLRPGA-- 219 (325)
T ss_pred CcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------HHHHHHcCCc----cCCCCC--
Confidence 2234579999999999999999999999999999999999999997643221 1122221111 111111
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+.+++.+|++.+|++||++.+.++
T Consensus 220 -------~~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 220 -------SLTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred -------CHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 134668999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=318.08 Aligned_cols=256 Identities=24% Similarity=0.416 Sum_probs=200.5
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCc----EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
++|++.+.||+|+||.||+|.+. +++ .|++|.+.... ......++..|+..+++++||||+++++++. +...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 46788899999999999999653 444 47778775432 2334567888999999999999999999875 45577
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+++||+++|+|.+++... ...+++..+..++.|+++|++|||+ ++++||||||+||++++++.+||+|||+++
T Consensus 85 ~i~e~~~~gsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~ 157 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQH----RDSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVAD 157 (279)
T ss_pred EEEEeCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccce
Confidence 899999999999999652 2468999999999999999999998 899999999999999999999999999998
Q ss_pred cCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 736 NAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 736 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
........ ......++..|+|||++.++.++.++||||||+++||+++ |+.||....+... ... .. ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~---~~~----~~-~~~~ 229 (279)
T cd05111 158 LLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV---PDL----LE-KGER 229 (279)
T ss_pred eccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HHH----HH-CCCc
Confidence 65433221 1233457789999999998899999999999999999998 9999976543221 111 11 1111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
.. .+.. ....+.+++.+|+..+|++||++.|+++.|..+.
T Consensus 230 ~~--~~~~--------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~ 269 (279)
T cd05111 230 LA--QPQI--------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA 269 (279)
T ss_pred CC--CCCC--------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence 10 1111 1134678999999999999999999999987765
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=328.42 Aligned_cols=256 Identities=19% Similarity=0.294 Sum_probs=198.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||++.. .+++.||+|++..... .......+.+|+.++..++|++|+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999965 4688999999875321 2233456888999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 153 (331)
T cd05624 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN 153 (331)
T ss_pred eCCCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999652 2458899999999999999999998 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCC-----CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
...........|++.|+|||++.+ +.++.++|||||||++|||++|+.||......+ ............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~ 227 (331)
T cd05624 154 QDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHEERF 227 (331)
T ss_pred CCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------HHHHHHcCCCcc
Confidence 433323334579999999998865 567889999999999999999999997643221 111222111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQ--RPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~evl~ 857 (933)
+ +++... +...++.+++.+|+..++++ |++++++++
T Consensus 228 ~--~p~~~~------~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 228 Q--FPSHIT------DVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred c--CCCccc------cCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 0 111110 11245678899988865544 457777765
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=314.72 Aligned_cols=251 Identities=27% Similarity=0.411 Sum_probs=206.5
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|+||.||+|.. .+++.|++|.+..........+++.+|+++++.++||||+++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 477889999999999999965 4689999999876655566678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++.... ...+++.+++.++.|++.|++|||+ .+++||||||+||++++++.++|+|||+++.....
T Consensus 81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~ 154 (256)
T cd08529 81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN 154 (256)
T ss_pred CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence 99999999997621 2568999999999999999999998 89999999999999999999999999998865543
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
... .....|++.|+|||+..+..++.++||||||+++|||++|+.||...... ... ..... ...+. +..
T Consensus 155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~---~~~~~--~~~~~-~~~- 223 (256)
T cd08529 155 TNF-ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALI---LKIIR--GVFPP-VSQ- 223 (256)
T ss_pred cch-hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHH---HHHHc--CCCCC-Ccc-
Confidence 221 23346889999999999888999999999999999999999999765321 111 11111 11111 110
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+.+++.+|++.+|++||++.++++
T Consensus 224 --------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 224 --------MYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred --------ccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 12245789999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=319.82 Aligned_cols=254 Identities=28% Similarity=0.510 Sum_probs=203.1
Q ss_pred CccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeec
Q 002346 583 FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
|++++.||+|+||.||++... +++.||+|++..............+|+.++++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 677899999999999999654 5678999999887544444445567999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
++++|.+++.. ...+++.+++.++.|+++||+|||+ .+|+|+||||+||+++.++.++|+|||.+......
T Consensus 81 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~- 151 (260)
T PF00069_consen 81 PGGSLQDYLQK-----NKPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN- 151 (260)
T ss_dssp TTEBHHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST-
T ss_pred ccccccccccc-----ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc-
Confidence 99999999973 2568999999999999999999999 89999999999999999999999999998754221
Q ss_pred ceeecccccccCcccccccC-CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 742 YSVETRLAGTFGYLAPEYAA-TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
........+++.|+|||++. +..++.++||||+|+++|+|++|+.||......+................. ..
T Consensus 152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~----- 225 (260)
T PF00069_consen 152 NENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS-QQ----- 225 (260)
T ss_dssp TSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT-TS-----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc-cc-----
Confidence 22334567899999999998 788999999999999999999999999875222222222111110000000 00
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......+.+++.+|++.+|++||++.++++
T Consensus 226 ------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 ------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000157889999999999999999999986
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.71 Aligned_cols=263 Identities=29% Similarity=0.450 Sum_probs=208.4
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 651 (933)
..++|++.+.||+|+||.||++... ....||+|.+.... ..+...++.+|+.++.++ +|+||+++++++..+
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 3467889999999999999999653 23689999987653 344456789999999999 899999999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
+..++||||+++|+|.+++..... .....+++..++.++.|++.|++|||+ .+|+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeEEE
Confidence 999999999999999999965321 223568999999999999999999998 899999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhH
Q 002346 721 GDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAH 798 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~ 798 (933)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~- 244 (293)
T cd05053 166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF- 244 (293)
T ss_pred cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-
Confidence 999999999999998665433221 222345678999999988899999999999999999998 88998754322211
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
. ........ . ... .....+.+++.+|++.+|++||++.++++.|+.++
T Consensus 245 --~----~~~~~~~~-~-~~~---------~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 --K----LLKEGYRM-E-KPQ---------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred --H----HHHcCCcC-C-CCC---------CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1 11111110 0 011 11235779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=325.95 Aligned_cols=243 Identities=25% Similarity=0.447 Sum_probs=197.6
Q ss_pred ccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 588 ILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 588 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
+||+|.||+||.|+. .+...+|||.++.. ..+..+-+..|+.+-++++|.|||+++|.+.+++..-+.||-++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 699999999999955 45678899998765 344456788999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCC--CHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec-CCCcEEEecccccccCCCCCce
Q 002346 667 AQHLFEWHDHGYTPL--TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfGla~~~~~~~~~ 743 (933)
.+.|+.. -+++ .+.++-.+.+||++||.|||+ ..|||||||-+|||++ -.|.+||+|||-++....- ..
T Consensus 660 SsLLrsk----WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP 731 (1226)
T KOG4279|consen 660 SSLLRSK----WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NP 731 (1226)
T ss_pred HHHHHhc----cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccC-Cc
Confidence 9999652 2456 788899999999999999999 8999999999999996 5788999999998865432 23
Q ss_pred eecccccccCcccccccCCC--CCCCccchHhHHHHHHHHHcCCCCCCCCCC-chhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 744 VETRLAGTFGYLAPEYAATG--RVTTKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~elltG~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.+..+.||..|||||++..+ .|+.++|||||||++.||.||++||..... ......+. +.+ +.|.
T Consensus 732 ~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-----------myK-vHP~ 799 (1226)
T KOG4279|consen 732 CTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-----------MYK-VHPP 799 (1226)
T ss_pred cccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-----------cee-cCCC
Confidence 45567899999999999766 488999999999999999999999976432 22111111 001 1122
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+ +.+...+...+|.+|+.++|.+||++.++++
T Consensus 800 i-----Peelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 800 I-----PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred C-----cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 2 2233456779999999999999999999986
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=324.02 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=213.4
Q ss_pred cCCccCCccccCCCeEEEEEEeCC-CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.+....++||-|-||.||.|.|+. .-.||||.++.+ ....++|..|+.+|+.++|||+|+++|+|..+...|||+|
T Consensus 267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE 343 (1157)
T KOG4278|consen 267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE 343 (1157)
T ss_pred hheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence 455677899999999999998754 567999999876 3456899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
||..|+|.+||++..+ ..++.-..+.+|.||+.|++||.. +.+||||+.++|+|+.++..|||+|||+++....
T Consensus 344 fM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg 417 (1157)
T KOG4278|consen 344 FMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG 417 (1157)
T ss_pred cccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence 9999999999977443 457778889999999999999998 8999999999999999999999999999999888
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
+.+.......-...|.|||-+....++.|+|||+|||+|||+.| |-.||.+-.-.... ..+.....+
T Consensus 418 DTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY-------~LLEkgyRM----- 485 (1157)
T KOG4278|consen 418 DTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------GLLEKGYRM----- 485 (1157)
T ss_pred CceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH-------HHHhccccc-----
Confidence 87777666666789999999999999999999999999999999 66677654222211 112111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
...+. +...+.++++.||+..|.+||+++|+-+.++.+..
T Consensus 486 ---~~PeG---CPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 486 ---DGPEG---CPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred ---cCCCC---CCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 11111 22357789999999999999999999999987754
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=320.68 Aligned_cols=263 Identities=29% Similarity=0.441 Sum_probs=204.8
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCc--EEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
++|++.+.||+|+||.||+|... ++. .+++|.++... .....+.|.+|+.++.++ +||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 57889999999999999999664 333 47888876432 334456789999999999 79999999999999899999
Q ss_pred EEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 657 VYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
||||+++++|.++++..... ....+++..++.++.|++.|++|||+ ++|+||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCe
Confidence 99999999999999653211 11358899999999999999999998 89999999999999999999
Q ss_pred EEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 804 (933)
+||+|||++...... ........+..|+|||++.+..++.++|||||||++|||++ |+.||......+. ..
T Consensus 158 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~------~~ 229 (297)
T cd05089 158 SKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL------YE 229 (297)
T ss_pred EEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HH
Confidence 999999998643221 11111223567999999988889999999999999999997 9999976543221 11
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
.... . ........ ....+.+++.+|++.+|.+||+++++++.|+.+...+.
T Consensus 230 ~~~~-~--~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 230 KLPQ-G--YRMEKPRN---------CDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred HHhc-C--CCCCCCCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111 1 10001111 12357799999999999999999999999988876554
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.22 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=196.7
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGT 665 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs 665 (933)
+.||+|+||.||+|.. .+++.||+|.+.... ..+....+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999965 478999999876542 34455789999999999999999999999999999999999999999
Q ss_pred hhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceee
Q 002346 666 LAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE 745 (933)
Q Consensus 666 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~ 745 (933)
|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++...........
T Consensus 80 L~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 152 (252)
T cd05084 80 FLTFLRTE----GPRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST 152 (252)
T ss_pred HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence 99998541 2458899999999999999999998 8999999999999999999999999999875443221111
Q ss_pred -cccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 746 -TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 746 -~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
....++..|+|||.+.++.++.++||||||+++|||++ |..||........ .. ..... .+.....
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~---~~----~~~~~--~~~~~~~---- 219 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT---RE----AIEQG--VRLPCPE---- 219 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH---HH----HHHcC--CCCCCcc----
Confidence 11123457999999998899999999999999999998 8888865432211 11 11111 1111111
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.....+.+++.+|++.+|++||++.++.++|+
T Consensus 220 -----~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 220 -----LCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred -----cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=348.88 Aligned_cols=265 Identities=23% Similarity=0.337 Sum_probs=205.7
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.++||+|+||.||+|.. .+|+.||+|++...... ....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 5799999999999999999955 46899999999764322 234567999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 659 EYMPRGTLAQHLFEWHDH------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
||+++|+|.+++...... .....++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence 999999999998653211 12346778889999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCC-----------------ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCch
Q 002346 733 LVKNAPDGK-----------------YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD 795 (933)
Q Consensus 733 la~~~~~~~-----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~ 795 (933)
+++...... ........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 998652110 001123579999999999999999999999999999999999999997632211
Q ss_pred hhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhhhh
Q 002346 796 RAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP-DMGHAVNVLGPLVE 864 (933)
Q Consensus 796 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-s~~evl~~L~~~~~ 864 (933)
.. . ...... +..+.+. .+....+.+++.+|++.||++|| +++++.+.|+..+.
T Consensus 239 i~----~-~~~i~~----P~~~~p~-------~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS----Y-RDVILS----PIEVAPY-------REIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh----h-hhhccC----hhhcccc-------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 0 000000 0000000 11223567899999999999996 66777777776654
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=317.65 Aligned_cols=256 Identities=27% Similarity=0.392 Sum_probs=194.2
Q ss_pred CccccCCCeEEEEEEeCC---CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|...+ +..+|+|.++... .......+.+|+.++++++||||+++++++.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA-SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 358999999999996543 4579999887653 233445789999999999999999999999998899999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++...........++..+..++.|+++|++|||+ .+++||||||+||+++.++.+||+|||+++........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~ 156 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY 156 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence 999999976433233456788889999999999999998 89999999999999999999999999998754433322
Q ss_pred e-ecccccccCcccccccCCC-------CCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 744 V-ETRLAGTFGYLAPEYAATG-------RVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 744 ~-~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
. .....|+..|+|||++... .++.++||||||+++|||++ |+.||....+.+.. ... .. ....
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~---~~~--~~---~~~~ 228 (269)
T cd05087 157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL---TYT--VR---EQQL 228 (269)
T ss_pred ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH---HHH--hh---cccC
Confidence 2 2234678899999988542 35789999999999999996 99999765432211 110 00 1111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
...++.+.. .....+.+++..|+ .+|++||+++||++.|.
T Consensus 229 ~~~~~~~~~-----~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 229 KLPKPRLKL-----PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCCCCccCC-----CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111122110 01124668889998 68999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=322.67 Aligned_cols=269 Identities=26% Similarity=0.403 Sum_probs=201.8
Q ss_pred CC-ccCCccccCCCeEEEEEEe-----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ce
Q 002346 582 NF-SEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SE 653 (933)
Q Consensus 582 ~~-~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 653 (933)
+| +..+.||+|+||+||++.. .++..||+|.+.... .......|.+|++++++++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG 82 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence 44 8889999999999987642 367899999987652 233456788999999999999999999988653 35
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++++|.+++.. ..+++.+++.++.|++.|++|||+ ++|+||||||+||++++++.+||+|||+
T Consensus 83 ~~lv~e~~~~~~l~~~~~~------~~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~ 153 (283)
T cd05080 83 LQLIMEYVPLGSLRDYLPK------HKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGL 153 (283)
T ss_pred EEEEecCCCCCCHHHHHHH------cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeeccc
Confidence 7899999999999999965 358999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCce--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 734 VKNAPDGKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 734 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
++........ ......++..|+|||.+....++.++||||||+++|||+||+.|+......-. ....+.... ....
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~-~~~~ 231 (283)
T cd05080 154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQ-MTVV 231 (283)
T ss_pred ccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccc-cchh
Confidence 8866543221 11223456679999999888899999999999999999999999865432110 000000000 0000
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
.+.+.++.... .........++.+++.+|++.+|++||++++++++|+.+.
T Consensus 232 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 232 RLIELLERGMR-LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhhhhcCCC-CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 00000000000 0001112346889999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=327.41 Aligned_cols=243 Identities=26% Similarity=0.410 Sum_probs=195.0
Q ss_pred CccccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|... +++.||||+++.... .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999654 578999999986532 233456778899999888 699999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|..++.. ...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~- 151 (318)
T cd05570 81 GDLMFHIQR-----SGRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV- 151 (318)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-
Confidence 999998865 2468999999999999999999998 8999999999999999999999999999875322221
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .. ...........+. .+
T Consensus 152 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~---~~~i~~~~~~~~~----~~-- 219 (318)
T cd05570 152 TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---EL---FQSILEDEVRYPR----WL-- 219 (318)
T ss_pred cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HH---HHHHHcCCCCCCC----cC--
Confidence 123356899999999999999999999999999999999999999754321 11 1111111111111 11
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDM-----GHAVN 857 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~-----~evl~ 857 (933)
...+.+++.+||+.||.+||++ .++++
T Consensus 220 -------~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 220 -------SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -------CHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 1356799999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=326.08 Aligned_cols=242 Identities=26% Similarity=0.424 Sum_probs=192.1
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+++.||||+++.... .......+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999965 4578999999876532 123345667788888765 899999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 151 (316)
T cd05619 81 GDLMFHIQS-----CHKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA- 151 (316)
T ss_pred CcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-
Confidence 999999865 2458899999999999999999998 8999999999999999999999999999875432221
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... ... .........+. .+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~---~i~~~~~~~~~----~~-- 219 (316)
T cd05619 152 KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQ---SIRMDNPCYPR----WL-- 219 (316)
T ss_pred ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHH---HHHhCCCCCCc----cC--
Confidence 2234579999999999998899999999999999999999999997643221 111 11111111111 11
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMG-HAV 856 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~-evl 856 (933)
...+.+++.+|++.+|++||++. ++.
T Consensus 220 -------~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 220 -------TREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred -------CHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 13467999999999999999997 543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.53 Aligned_cols=265 Identities=25% Similarity=0.427 Sum_probs=203.3
Q ss_pred cCCccCCccccCCCeEEEEEEeC-----------------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCccee
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-----------------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 643 (933)
++|++.+.||+|+||.||++... ++..||+|++.... ......+|.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 57899999999999999998432 24468999987542 3344578999999999999999999
Q ss_pred EEeEeeeCceeEEEEeecCCCChhhHhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCc
Q 002346 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSN 717 (933)
Q Consensus 644 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~N 717 (933)
+++++..++..++||||+++++|.+++...... ....+++.++..++.|++.|++|||+ .+++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence 999999999999999999999999999763211 12357889999999999999999998 899999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc--CCCCCCCCCCc
Q 002346 718 ILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT--GRKALDDTMPD 794 (933)
Q Consensus 718 ill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt--G~~p~~~~~~~ 794 (933)
|+++.++.++|+|||+++....... .......+++.|+|||+...+.++.++|||||||++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999886543322 11223345678999999888889999999999999999998 77888654332
Q ss_pred hhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 795 DRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
+..... ..... ........ +... .....+.+++.+|++.+|++||++.++++.|+
T Consensus 241 ~~~~~~---~~~~~-~~~~~~~~-~~~~------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~ 295 (296)
T cd05095 241 QVIENT---GEFFR-DQGRQVYL-PKPA------LCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295 (296)
T ss_pred HHHHHH---HHHHh-hccccccC-CCCC------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 221111 11110 00000000 0000 11246779999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=339.84 Aligned_cols=263 Identities=24% Similarity=0.364 Sum_probs=193.6
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------ 651 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 651 (933)
..++|++.+.||+|+||.||+|.. .+++.||||++.... ....+|+.+++.++|||||++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 356899999999999999999955 568999999886432 2345799999999999999999886432
Q ss_pred --ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEE
Q 002346 652 --SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKV 728 (933)
Q Consensus 652 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl 728 (933)
...++||||++ ++|.+++..... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++.++ .+||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceee
Confidence 23568999996 578777754322 23568999999999999999999999 8999999999999999665 6999
Q ss_pred ecccccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|++||......+. +...+. ..
T Consensus 213 ~DFGla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~--~~~i~~-~~ 287 (440)
T PTZ00036 213 CDFGSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ--LVRIIQ-VL 287 (440)
T ss_pred eccccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH-Hh
Confidence 99999986654322 234578999999998865 4689999999999999999999999976543222 111111 00
Q ss_pred hc---------cCCCCcccCCCCCCCh----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 IS---------KENIPKAIDPNLNLDE----ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ~~---------~~~~~~~~d~~l~~~~----~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. .....+.--+...... .+.....++.+++.+||+.+|.+||++.|+++
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 00 0000000000000000 00012246789999999999999999999985
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.70 Aligned_cols=262 Identities=22% Similarity=0.347 Sum_probs=209.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+++.||||.+..... ......++.+|+.+++.++||||+++++++..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4688889999999999999964 5799999998875432 2334568899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++..... ....+++.+++.++.|+++|++|||+ .+++|+||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 99999999999865222 23568999999999999999999998 899999999999999999999999999987654
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..... .....|+..|+|||++.+..++.++||||||+++|||++|..||....... ......... . ..
T Consensus 158 ~~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~--~-----~~ 225 (267)
T cd08229 158 SKTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLCKKIEQ--C-----DY 225 (267)
T ss_pred cCCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHhhhhhc--C-----CC
Confidence 33221 223468899999999988889999999999999999999999996532211 111111111 0 01
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
+... .......+.+++.+|++.+|++||||.+|+++++++
T Consensus 226 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~ 265 (267)
T cd08229 226 PPLP----SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM 265 (267)
T ss_pred CCCC----cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence 1111 011234678999999999999999999999998765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=324.03 Aligned_cols=200 Identities=28% Similarity=0.408 Sum_probs=175.4
Q ss_pred CCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-C-----CcceeEEeEeeeCcee
Q 002346 582 NFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-H-----RHLVALLGYCINGSER 654 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~~~ 654 (933)
+|.+.+.||+|+||.|.|+ +.++++.||||+++.. .....+.+.|+.+|+.|+ | -|+|+++++|....+.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 8999999999999999999 6677999999999865 344567788999999996 4 4999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC--CcEEEeccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD--MRAKVADFG 732 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~--~~~kl~DfG 732 (933)
|||+|.+ .-+|.++++.. .+..++...++.|+.||+.||..||+ .+|||+||||+||||.+. ..+||+|||
T Consensus 264 ciVfELL-~~NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 264 CIVFELL-STNLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred eeeehhh-hhhHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecc
Confidence 9999999 56999999763 34569999999999999999999998 899999999999999754 479999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCch
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD 795 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~ 795 (933)
.|......-+ .+.-+..|+|||++.+.+|+.+.|||||||+++||++|.+-|.+..+.+
T Consensus 337 SSc~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D 395 (586)
T KOG0667|consen 337 SSCFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD 395 (586)
T ss_pred cccccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence 9987765433 4566788999999999999999999999999999999988887665443
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=320.10 Aligned_cols=259 Identities=25% Similarity=0.417 Sum_probs=205.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 652 (933)
.++|.+.+.||+|+||.||++.. ..+..||||.++... .....+.+.+|+.+++++ +||||+++++++...+
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 35789999999999999999953 235579999887653 234456899999999999 7999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||+.+|+|.++++... ...+++.++..++.|++.|++|||+ ++|+|+||||+||+++.++.++++|||
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg 186 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFG 186 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCc
Confidence 9999999999999999996522 2348999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 733 LVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 733 la~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
+++....... .......++..|+|||++.+..++.++||||+||++|||++ |+.||........ ... .....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~----~~~~~ 260 (302)
T cd05055 187 LARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYK----LIKEG 260 (302)
T ss_pred ccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHH----HHHcC
Confidence 9886544322 12223456788999999998899999999999999999998 9999876433211 111 11111
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
....... ....++.+++.+|++.+|++||++.|+++.|+++
T Consensus 261 --~~~~~~~---------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 --YRMAQPE---------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --CcCCCCC---------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1100000 1123578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=314.94 Aligned_cols=262 Identities=23% Similarity=0.379 Sum_probs=209.8
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|... +|+.||+|.++.... .....+++.+|++++++++|+||+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57899999999999999999665 799999998875432 2334678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++..... ....+++.+++.++.++++|++|||+ .+|+||||+|+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~ 157 (267)
T cd08224 82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence 99999999999865322 23568999999999999999999998 899999999999999999999999999987554
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... .......... ...+.
T Consensus 158 ~~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~--~~~~~--- 227 (267)
T cd08224 158 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCKKIEK--CDYPP--- 227 (267)
T ss_pred CCCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHhhhhc--CCCCC---
Confidence 3221 122346889999999998888999999999999999999999998654311 1111111111 11111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.. .......+.+++.+|++.+|++||++.+++++|+++
T Consensus 228 --~~----~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~ 265 (267)
T cd08224 228 --LP----ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM 265 (267)
T ss_pred --CC----hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence 00 012224577999999999999999999999999765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=319.14 Aligned_cols=266 Identities=26% Similarity=0.422 Sum_probs=206.2
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC-----------------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcce
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD-----------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 642 (933)
..+|++.+.||+|+||.||+|...+ +..||+|++.... .....+++.+|++++++++||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~ 82 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIA 82 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEe
Confidence 3578999999999999999986532 3468999987653 334567899999999999999999
Q ss_pred eEEeEeeeCceeEEEEeecCCCChhhHhhhcccC------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCC
Q 002346 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716 (933)
Q Consensus 643 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~ 716 (933)
++++++..+...++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+
T Consensus 83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~ 159 (296)
T cd05051 83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATR 159 (296)
T ss_pred EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchh
Confidence 9999999999999999999999999999764321 12368999999999999999999998 89999999999
Q ss_pred cEEecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc--CCCCCCCCCC
Q 002346 717 NILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT--GRKALDDTMP 793 (933)
Q Consensus 717 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt--G~~p~~~~~~ 793 (933)
||+++.++.++|+|||+++....... .......+++.|+|||++.++.++.++|||||||++|||++ |..||.....
T Consensus 160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 239 (296)
T cd05051 160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD 239 (296)
T ss_pred ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence 99999999999999999875543322 22334567789999999988889999999999999999998 6677765432
Q ss_pred chhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 794 DDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.. .......... ........+ . ......++.+++.+|++.+|++||++.|+++.|+
T Consensus 240 ~~---~~~~~~~~~~-~~~~~~~~~-~------~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 240 QQ---VIENAGHFFR-DDGRQIYLP-R------PPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred HH---HHHHHHhccc-cccccccCC-C------ccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 21 1111111110 001010000 0 0111246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=330.11 Aligned_cols=266 Identities=24% Similarity=0.332 Sum_probs=199.1
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc-----
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----- 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 652 (933)
+.++|++.+.||+|+||.||++.. .+|+.||||++...........++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 457899999999999999999954 56899999999765444455677889999999999999999999986443
Q ss_pred -eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 653 -ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 653 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
..++||||+++ +|.+.++ ..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Df 167 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 167 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-------ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecC
Confidence 46899999964 6766663 247889999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH-------------
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH------------- 798 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~------------- 798 (933)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...
T Consensus 168 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 168 GLARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF 245 (359)
T ss_pred CCccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence 9987543321 2234578999999999998899999999999999999999999997653211100
Q ss_pred ---HHHHHHHHhhccCCCC-----cccCCCC-CC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 799 ---LVTWFRRVLISKENIP-----KAIDPNL-NL-DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 799 ---~~~~~~~~~~~~~~~~-----~~~d~~l-~~-~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...............+ +.+.... .. ..........+.+++.+|++.||++||++.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000000000010000 0000000 00 0000111245779999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=316.83 Aligned_cols=263 Identities=23% Similarity=0.422 Sum_probs=209.8
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC-----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee-Cce
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD-----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~ 653 (933)
.++|++.+.||+|+||.||+|...+ +..||+|++... ........+.+|+.+++.++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 5788999999999999999997655 688999988644 244556788999999999999999999998876 467
Q ss_pred eEEEEeecCCCChhhHhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDH---GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
.++++||+++++|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECC
Confidence 88999999999999998663221 12468999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 731 FGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 731 fGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
||+++......... .....++..|+|||++....++.++||||||+++||+++ |+.||....+.+ +..+...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~--- 234 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKD--- 234 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHc---
Confidence 99998654433222 222346778999999988889999999999999999999 999997643322 2221111
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
...... .. .....+.+++.+|++.+|++||++.++++.|+.+.+
T Consensus 235 -~~~~~~--~~---------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 235 -GYRLAQ--PI---------NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred -CCCCCC--CC---------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 111111 00 112357899999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=319.33 Aligned_cols=259 Identities=22% Similarity=0.373 Sum_probs=202.8
Q ss_pred cCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.+|++.+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.+++.++||||+++++++......
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 34677889999999999999653 35789999987553 233456789999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 655 LLVYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
++++||+.+++|.+++..... .....+++..+..++.|+++||+|+|+ ++|+||||||+||+++++
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDK 160 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCC
Confidence 999999999999999853210 112358899999999999999999998 899999999999999999
Q ss_pred CcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHH
Q 002346 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~ 801 (933)
+.+||+|||+++....... .......+++.|+|||++.++.++.++||||||+++|||++ |..||......+ .
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~-- 235 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---V-- 235 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---H--
Confidence 9999999999886543322 22233456789999999988889999999999999999998 888886543321 1
Q ss_pred HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
........ .. .+.. +....+.+++.+|++.+|++||+++++++.|+.
T Consensus 236 -~~~i~~~~--~~-~~~~---------~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 236 -IEMIRNRQ--VL-PCPD---------DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -HHHHHcCC--cC-CCCC---------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 11111111 10 0111 112347799999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=313.56 Aligned_cols=255 Identities=32% Similarity=0.519 Sum_probs=206.6
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|...++..||||.+..... ..+++.+|+.++++++|+||+++++++......++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 578999999999999999999887888999999876532 34679999999999999999999999998889999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ....+++.++..++.+++.|++|||+ .+++|+||||+||++++++.+||+|||+++....
T Consensus 82 ~~~~~~L~~~i~~~---~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 82 YMSKGSLLDFLKSG---EGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred ccCCCCHHHHHhcc---ccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999652 22468999999999999999999998 8999999999999999999999999999886654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........++..|+|||.+.+..++.++||||+|+++||+++ |+.||....... ... .... . .....+
T Consensus 156 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~---~~~~-~--~~~~~~ 226 (261)
T cd05034 156 DEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLE---QVER-G--YRMPRP 226 (261)
T ss_pred hhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHc-C--CCCCCC
Confidence 32222222345678999999998889999999999999999999 999986543211 111 1111 1 010011
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
.. ....+.+++.+|++.+|++||+++++.+.|+.
T Consensus 227 ~~---------~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 227 PN---------CPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred CC---------CCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 11 12357899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.77 Aligned_cols=264 Identities=30% Similarity=0.452 Sum_probs=206.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeC--------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 650 (933)
.++|.+.+.||+|+||.||++... ++..||+|.+.... ......++.+|+.+++.+ +||||+++++++..
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 357899999999999999999542 23579999987642 344456788999999999 79999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
.+..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ .+++||||||+||+
T Consensus 96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil 172 (307)
T cd05098 96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 172 (307)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheE
Confidence 99999999999999999999763221 12358999999999999999999998 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~ 797 (933)
++.++.+||+|||.++......... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~-- 250 (307)
T cd05098 173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 250 (307)
T ss_pred EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH--
Confidence 9999999999999987654322111 112234578999999988889999999999999999998 888886543211
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
. ... .... ... .... .....+.+++.+|++.+|++||++.++++.|++++..
T Consensus 251 -~---~~~-~~~~-~~~-~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 251 -L---FKL-LKEG-HRM-DKPS---------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred -H---HHH-HHcC-CCC-CCCC---------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1 111 1111 110 0111 1124677899999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=315.09 Aligned_cols=259 Identities=22% Similarity=0.369 Sum_probs=215.3
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
..-|...+.||+|.|++|-.|+ .-.|+.||||++.+...+......+.+|++.|+.++|||||++|++.......|||.
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 3456777889999999999883 458999999999998877777788999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec-CCCcEEEecccccccC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFGLVKNA 737 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfGla~~~ 737 (933)
|.=++|+|++|+..+ . ..+.+.-+.+++.||++|+.|+|. ..+||||+||+||.+- +-|-|||.|||++-.+
T Consensus 97 ELGD~GDl~DyImKH-e---~Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf 169 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKH-E---EGLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF 169 (864)
T ss_pred EecCCchHHHHHHhh-h---ccccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccC
Confidence 999999999999763 2 348899999999999999999998 7999999999999775 5688999999999877
Q ss_pred CCCCceeecccccccCcccccccCCCCCC-CccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVT-TKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
.++.. -+..+|+..|-|||++.+..|+ +++|||||||++|-|++|+.||+...+.+.. .+++..+..+|..
T Consensus 170 ~PG~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL------TmImDCKYtvPsh 241 (864)
T KOG4717|consen 170 QPGKK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL------TMIMDCKYTVPSH 241 (864)
T ss_pred CCcch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh------hhhhcccccCchh
Confidence 77653 3456899999999999999885 6899999999999999999999876443221 1223323333322
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCCCcC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPATRE 872 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~ 872 (933)
...++.++|..|+..||++|-+.+||+. ..|....++
T Consensus 242 -------------vS~eCrdLI~sMLvRdPkkRAslEeI~s------~~Wlq~~D~ 278 (864)
T KOG4717|consen 242 -------------VSKECRDLIQSMLVRDPKKRASLEEIVS------TSWLQAGDR 278 (864)
T ss_pred -------------hhHHHHHHHHHHHhcCchhhccHHHHhc------cccccCCCC
Confidence 2346789999999999999999999986 566554443
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.65 Aligned_cols=263 Identities=27% Similarity=0.456 Sum_probs=207.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe--------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 650 (933)
.++|.+.+.||+|+||.||+|.. .++..||+|.+.... .....+++.+|+.+++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 46788899999999999999953 134579999887542 344567899999999999 89999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
....++||||+++|+|.+++...... ....+++.++..++.|+++||+|||+ ++|+||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceEE
Confidence 99999999999999999999763221 12358899999999999999999998 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~ 797 (933)
+++++.+||+|||+++......... .....+++.|+|||++.+..++.++||||||+++|||++ |..||......+
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-- 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH--
Confidence 9999999999999998665433222 222345678999999988889999999999999999998 778886543221
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
+..... ..... .... .....+.+++.+|++.+|++||++.++++.|+++..
T Consensus 248 ----~~~~~~-~~~~~--~~~~---------~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 248 ----LFKLLK-EGHRM--DKPA---------NCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ----HHHHHH-cCCcC--CCCC---------CCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 111111 11110 0000 122457789999999999999999999999987753
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.48 Aligned_cols=259 Identities=29% Similarity=0.490 Sum_probs=206.1
Q ss_pred hcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
.++|++.+.||+|+||.||+|... .+..||+|.+.... .......+.+|+.+++.++||||+++++++..+..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~ 83 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP 83 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence 467889999999999999999653 24689999986543 23445678999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccC-----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDH-----GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
.++||||+++++|.+++...... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||
T Consensus 84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl 160 (277)
T cd05032 84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence 99999999999999999753321 12357899999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHH
Q 002346 729 ADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 729 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+|||+++....... .......++..|+|||.+.++.++.++|||||||++||+++ |+.||....... ...+..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~~-- 235 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFVI-- 235 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHHh--
Confidence 99999875543322 12233457789999999988889999999999999999998 889986543322 111111
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
...... .... ....+.+++.+|++.+|++||++.++++.|+
T Consensus 236 ---~~~~~~-~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~ 276 (277)
T cd05032 236 ---DGGHLD-LPEN---------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK 276 (277)
T ss_pred ---cCCCCC-CCCC---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence 111111 1111 1246789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=315.41 Aligned_cols=259 Identities=27% Similarity=0.429 Sum_probs=202.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
+++|.+.+.||+|+||.||+|... .+..||+|.+.... .......|..|+.+++.++|+||+++++++.+...
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 467899999999999999999664 35688999876542 23345679999999999999999999999998889
Q ss_pred eEEEEeecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC---cEEE
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKV 728 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl 728 (933)
.++||||+++++|.+++...... ....+++.++..++.||+.|++|||+ ++++||||||+||+++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEe
Confidence 99999999999999999763221 12358999999999999999999999 8999999999999998765 5999
Q ss_pred ecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHH
Q 002346 729 ADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||........ .. ..
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~---~~---~~ 234 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV---ME---FV 234 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH---HH
Confidence 9999998664322211 112234568999999988899999999999999999997 9999976443221 11 11
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
. ..... ...... ...+.+++.+|++.+|++||++.++++.|+
T Consensus 235 ~-~~~~~--~~~~~~---------~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 235 T-GGGRL--DPPKGC---------PGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred H-cCCcC--CCCCCC---------CHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1 11111 011111 245779999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.22 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=205.8
Q ss_pred HhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
..++|++.+.||+|+||.||+|...++..+|+|.+... ....+.|.+|+++++.++|+||+++++++.+ ...+++|
T Consensus 4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~ 79 (260)
T cd05073 4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT 79 (260)
T ss_pred cccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence 35789999999999999999998877888999988754 2335688999999999999999999999877 7789999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++... ....+++.++..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||.+....
T Consensus 80 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 153 (260)
T cd05073 80 EFMAKGSLLDFLKSD---EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIE 153 (260)
T ss_pred EeCCCCcHHHHHHhC---CccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeecc
Confidence 999999999999652 23458899999999999999999998 899999999999999999999999999987655
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
...........++..|+|||++..+.++.++|||||||++||+++ |+.||...... ....++ ......+ .
T Consensus 154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~---~~~~~~----~~~~~~~--~ 224 (260)
T cd05073 154 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP---EVIRAL----ERGYRMP--R 224 (260)
T ss_pred CCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH---HHHHHH----hCCCCCC--C
Confidence 433332333456778999999988889999999999999999999 89998754321 111111 1111110 0
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
.. .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus 225 ~~---------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 225 PE---------NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred cc---------cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 01 112457799999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=328.60 Aligned_cols=244 Identities=24% Similarity=0.355 Sum_probs=190.6
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHH-HHHhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIA-VLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+++.||+|++...... .....++..|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999965 46788999998764321 122334444544 56788999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~- 151 (325)
T cd05602 81 GELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG- 151 (325)
T ss_pred CcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC-
Confidence 999999865 2457888999999999999999999 8999999999999999999999999999875432221
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
......||+.|+|||++.+..++.++||||+||++|||++|+.||....... . .......... +.+.+.
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~---~~~i~~~~~~----~~~~~~- 220 (325)
T cd05602 152 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---M---YDNILNKPLQ----LKPNIT- 220 (325)
T ss_pred CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---H---HHHHHhCCcC----CCCCCC-
Confidence 2234579999999999999999999999999999999999999997643221 1 1111111111 112221
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
..+.+++.+|++.+|.+||++.+.+..
T Consensus 221 --------~~~~~li~~~l~~~p~~R~~~~~~~~~ 247 (325)
T cd05602 221 --------NSARHLLEGLLQKDRTKRLGAKDDFME 247 (325)
T ss_pred --------HHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence 356799999999999999998765443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=315.93 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=198.6
Q ss_pred cCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.++||+|+||.||+|. ..+++.||+|.+.... .....+++.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 367888999999999999995 4578999999987542 34445679999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|..+. .+++..+..++.|++.|++|||+ .+|+|+||||+||+++.++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 99999996542 36788899999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH-HHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH-LVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d 818 (933)
.. .....|+..|+|||++.+..++.++||||||+++|||++|+.||.......... .......... ...
T Consensus 148 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~----- 217 (279)
T cd06619 148 SI---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVD--EDP----- 217 (279)
T ss_pred cc---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhc--cCC-----
Confidence 22 233578999999999998899999999999999999999999997543221110 0111111110 000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.+... ....++.+++.+|++.+|++||+++++++
T Consensus 218 ~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~eil~ 252 (279)
T cd06619 218 PVLPVG----QFSEKFVHFITQCMRKQPKERPAPENLMD 252 (279)
T ss_pred CCCCCC----cCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence 111100 11235779999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=321.08 Aligned_cols=261 Identities=29% Similarity=0.471 Sum_probs=202.8
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCc--EEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
++|++.+.||+|+||.||+|... ++. .+|+|.+.... ......++.+|+.++.++ +||||+++++++..++..++
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l 85 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 85 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence 57888999999999999999653 454 45777765432 344557889999999999 89999999999999999999
Q ss_pred EEeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 657 VYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
||||+++++|.++++.... .....+++.+++.++.|+++|++|||+ ++|+||||||+||+++.++.
T Consensus 86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 162 (303)
T ss_pred EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence 9999999999999975321 112358999999999999999999998 89999999999999999999
Q ss_pred EEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 804 (933)
+||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||......+. ..
T Consensus 163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~ 234 (303)
T cd05088 163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE 234 (303)
T ss_pred EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------HH
Confidence 9999999986432111 1112234678999999988889999999999999999998 9999975432211 11
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.... ..... .. ......+.+++.+|++.+|++||+++++++.|+++.+.
T Consensus 235 ~~~~-~~~~~------~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 235 KLPQ-GYRLE------KP-----LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred HHhc-CCcCC------CC-----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 1111 10000 00 01123577999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=316.16 Aligned_cols=256 Identities=25% Similarity=0.373 Sum_probs=198.7
Q ss_pred cccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
||+|+||.||++.. .+|+.||+|++....... .....+..|++++++++||||+++++++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999965 468999999987543322 2234566799999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeec
Q 002346 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 746 (933)
.+++... ....+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~ 152 (277)
T cd05607 81 KYHIYNV---GERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TIT 152 (277)
T ss_pred HHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eee
Confidence 9888542 23458899999999999999999998 899999999999999999999999999987665432 223
Q ss_pred ccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChh
Q 002346 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEE 826 (933)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 826 (933)
...|++.|+|||++.+..++.++||||+||++|||++|+.||........ ........... .... ...
T Consensus 153 ~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~--~~~~-~~~------- 220 (277)
T cd05607 153 QRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED--EVKF-EHQ------- 220 (277)
T ss_pred ccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc--cccc-ccc-------
Confidence 35789999999999888899999999999999999999999975432211 11111111111 1100 000
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 827 TIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 827 ~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....++.+++.+||+.+|++||+++|+++... .++|..
T Consensus 221 --~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~--~h~~f~ 258 (277)
T cd05607 221 --NFTEESKDICRLFLAKKPEDRLGSREKNDDPR--KHEFFK 258 (277)
T ss_pred --cCCHHHHHHHHHHhccCHhhCCCCccchhhhh--cChhhc
Confidence 11235779999999999999999988764332 255553
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=315.96 Aligned_cols=258 Identities=30% Similarity=0.465 Sum_probs=203.9
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
..+|...+.||+|+||.||++.. .++..+|+|.+... .......|.+|+++++.++|+||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 81 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP 81 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence 35678899999999999999953 24668999987754 34456789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhccc----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHD----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
.++||||+++++|.+++..... .....+++.+++.++.|++.|++|||+ .+|+||||||+||+++++
T Consensus 82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~ 158 (280)
T cd05092 82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQG 158 (280)
T ss_pred eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCC
Confidence 9999999999999999975321 011358999999999999999999998 899999999999999999
Q ss_pred CcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHH
Q 002346 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~ 801 (933)
+.+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.. .
T Consensus 159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~ 235 (280)
T cd05092 159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI---E 235 (280)
T ss_pred CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH---H
Confidence 9999999999875543322 11223345788999999998899999999999999999998 89998654332211 1
Q ss_pred HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
...... .. ..+.. ....+.+++.+||+.+|++||++.++.+.|+
T Consensus 236 ---~~~~~~-~~--~~~~~---------~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~ 279 (280)
T cd05092 236 ---CITQGR-EL--ERPRT---------CPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ 279 (280)
T ss_pred ---HHHcCc-cC--CCCCC---------CCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence 111110 00 01111 1135779999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=313.03 Aligned_cols=256 Identities=25% Similarity=0.438 Sum_probs=204.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
.+|++.+.||+|+||.||+|... .+..+|+|.++... .....+.|.+|+.++++++||||+++++++..++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 57889999999999999999653 23479999987643 34456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++++|.+++... ...+++.++..++.|++.|++|||+ .+++||||||+||+++.++.++++|||++..
T Consensus 83 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~ 155 (267)
T cd05066 83 VTEYMENGSLDAFLRKH----DGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRV 155 (267)
T ss_pred EEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence 99999999999999652 2458999999999999999999998 8999999999999999999999999999986
Q ss_pred CCCCCceeec--ccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 737 APDGKYSVET--RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 737 ~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
.......... ...++..|+|||++.+..++.++||||||+++||+++ |+.||......+ ....+ ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~----~~~~~~ 228 (267)
T cd05066 156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAI----EEGYRL 228 (267)
T ss_pred cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHH----hCCCcC
Confidence 6543322221 1233568999999998889999999999999999887 999997653322 11111 111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
+.. ......+.+++.+|++.+|.+||++.++++.|+++
T Consensus 229 ~~~-----------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 229 PAP-----------MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CCC-----------CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 110 01123567999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=330.80 Aligned_cols=267 Identities=22% Similarity=0.319 Sum_probs=200.5
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING----- 651 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 651 (933)
.+.++|++.+.||+|+||.||++.. ..++.||||++...........++.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 3457899999999999999999954 4688999999976544455567888999999999999999999988643
Q ss_pred -ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 652 -SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 652 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
...++||||++ +++.+.+. ..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 94 ~~~~~lv~e~~~-~~l~~~~~-------~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~D 162 (355)
T cd07874 94 FQDVYLVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 162 (355)
T ss_pred cceeEEEhhhhc-ccHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEee
Confidence 35689999996 46777663 247889999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHH----------
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV---------- 800 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~---------- 800 (933)
||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.....
T Consensus 163 fg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (355)
T cd07874 163 FGLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_pred CcccccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 99998654322 223457899999999999889999999999999999999999999764322111000
Q ss_pred ------HHHHHHhhccCCC-----CcccCCC-CCCC-hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 801 ------TWFRRVLISKENI-----PKAIDPN-LNLD-EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 801 ------~~~~~~~~~~~~~-----~~~~d~~-l~~~-~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
............. +..+... .... .........+.+++.+|++.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0000000000000 0000000 0000 001112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=337.95 Aligned_cols=275 Identities=21% Similarity=0.279 Sum_probs=199.3
Q ss_pred HHHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCC------CcceeEEe
Q 002346 574 EVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH------RHLVALLG 646 (933)
Q Consensus 574 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~ 646 (933)
+++....++|++.+.||+|+||.||+|.. ..++.||||+++.. ....+++..|+++++.++| ++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~ 198 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQR 198 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEE
Confidence 34455678999999999999999999954 46889999998643 2223456778888777754 45889999
Q ss_pred EeeeC-ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-
Q 002346 647 YCING-SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM- 724 (933)
Q Consensus 647 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~- 724 (933)
++..+ .+.++|||++ +++|.+++.. ...+++..+..|+.||+.||+|||+ +.+||||||||+|||++.++
T Consensus 199 ~~~~~~~~~~iv~~~~-g~~l~~~l~~-----~~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~ 270 (467)
T PTZ00284 199 YFQNETGHMCIVMPKY-GPCLLDWIMK-----HGPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDT 270 (467)
T ss_pred EEEcCCceEEEEEecc-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCc
Confidence 88764 5788999988 7889988865 2468999999999999999999996 14999999999999998765
Q ss_pred ---------------cEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCC
Q 002346 725 ---------------RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALD 789 (933)
Q Consensus 725 ---------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~ 789 (933)
.+||+|||.+..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||+
T Consensus 271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~ 346 (467)
T PTZ00284 271 VVDPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYD 346 (467)
T ss_pred ccccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence 499999998764322 2234689999999999999999999999999999999999999998
Q ss_pred CCCCchhhHHHHHH---------HH--------HhhccCCCCcccCCC----C-C-CChhhHHHHHHHHHHHHHcccCCC
Q 002346 790 DTMPDDRAHLVTWF---------RR--------VLISKENIPKAIDPN----L-N-LDEETIESIYRVAELAGHCTAREP 846 (933)
Q Consensus 790 ~~~~~~~~~~~~~~---------~~--------~~~~~~~~~~~~d~~----l-~-~~~~~~~~~~~~~~li~~cl~~~P 846 (933)
.....+........ .. .......+....++. + . ...........+.+|+.+||+.||
T Consensus 347 ~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP 426 (467)
T PTZ00284 347 THDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDR 426 (467)
T ss_pred CCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcCh
Confidence 65432222111100 00 000000000000000 0 0 000000112356799999999999
Q ss_pred CCCCCHHHHHHHHhhhhhhcCCC
Q 002346 847 QQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 847 ~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
++||++.|+++ ++|...
T Consensus 427 ~~R~ta~e~L~------Hp~~~~ 443 (467)
T PTZ00284 427 QKRLNARQMTT------HPYVLK 443 (467)
T ss_pred hhCCCHHHHhc------Cccccc
Confidence 99999999986 666653
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=326.17 Aligned_cols=244 Identities=26% Similarity=0.399 Sum_probs=195.1
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEEE
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 658 (933)
+|+..+.||+|+||.||+|.. .+|+.||+|++..... .....+.+..|..++..+. |++|+++++++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467789999999999999954 5789999999876432 2234566788999988885 577888999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 Ey~~~g~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~ 152 (323)
T cd05615 81 EYVNGGDLMYHIQQ-----VGKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM 152 (323)
T ss_pred cCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence 99999999999855 2468999999999999999999998 899999999999999999999999999987543
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... ......||+.|+|||++.+..++.++||||+||++|||++|+.||....+.. . ...........+..
T Consensus 153 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~---~~~i~~~~~~~p~~-- 223 (323)
T cd05615 153 VDGV-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---L---FQSIMEHNVSYPKS-- 223 (323)
T ss_pred CCCc-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCCCCCCcc--
Confidence 3221 1234569999999999998899999999999999999999999997653321 1 11222212112211
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMG 853 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ 853 (933)
+ ...+.+++.+|++.+|.+|++..
T Consensus 224 --~---------~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 224 --L---------SKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred --C---------CHHHHHHHHHHcccCHhhCCCCC
Confidence 1 13567899999999999999854
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=317.78 Aligned_cols=260 Identities=30% Similarity=0.496 Sum_probs=205.3
Q ss_pred hcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
.++|++.+.||+|+||.||+|... ++..||+|++.... ......+|.+|+.++++++||||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 467899999999999999999653 46789999987543 33445779999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhccc-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCC
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHD-----------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~ 716 (933)
.++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||+ ++++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence 9999999999999999975321 112357899999999999999999998 89999999999
Q ss_pred cEEecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCc
Q 002346 717 NILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPD 794 (933)
Q Consensus 717 Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~ 794 (933)
||++++++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~ 239 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE 239 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875433221 11222345678999999988899999999999999999998 88888654322
Q ss_pred hhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 795 DRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
+ . ..... ...... ... ....++.+++.+|++.+|++||++.|+++.|++
T Consensus 240 ~---~---~~~~~--~~~~~~-~~~---------~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 E---V---IYYVR--DGNVLS-CPD---------NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred H---H---HHHHh--cCCCCC-CCC---------CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 1 11111 111111 011 112467899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=315.75 Aligned_cols=254 Identities=26% Similarity=0.397 Sum_probs=200.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~ 85 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP--GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM 85 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc--cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence 35799999999999999999964 578899999987542 233457889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.++++. ..++++.++..++.|+++|++|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 86 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 86 EYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999999864 2468899999999999999999998 899999999999999999999999999988654
Q ss_pred CCCceeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
.... ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+...... .......
T Consensus 158 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~--------~~~~~~~- 227 (267)
T cd06646 158 ATIA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL--------MSKSNFQ- 227 (267)
T ss_pred cccc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee--------eecCCCC-
Confidence 3221 122346889999999874 34578899999999999999999999865432211100 0001100
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
.+... ........+.+++.+|++.+|++||+++++++.
T Consensus 228 --~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 228 --PPKLK---DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred --CCCCc---cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 01110 011123467899999999999999999999863
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=317.46 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=199.5
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.|+..+.||+|+||.||+|.. .+++.||+|.+....... .....+.+|++++++++|+||+++.+++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 366778999999999999955 578999999987653322 223567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... +...+++..+..++.|++.||.|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 154 (285)
T cd05632 81 IMNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE 154 (285)
T ss_pred eccCccHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCC
Confidence 99999999888542 22469999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... .....|++.|+|||++.+..++.++|+||||+++|||++|+.||......... ..+.......... +.+
T Consensus 155 ~~~--~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~~~~~~~~~~~~----~~~ 226 (285)
T cd05632 155 GES--IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EEVDRRVLETEEV----YSA 226 (285)
T ss_pred CCc--ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhhhccccc----cCc
Confidence 221 13347899999999998889999999999999999999999999764332111 1111111111111 111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
.+ ...+.+++..|++.+|++||+ +.++++
T Consensus 227 ~~---------~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 227 KF---------SEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cC---------CHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 11 134678999999999999999 555554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=325.98 Aligned_cols=266 Identities=23% Similarity=0.335 Sum_probs=198.9
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC---
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--- 651 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--- 651 (933)
...+.++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 345678999999999999999999954 5788999999876543334456788999999999999999999987543
Q ss_pred ---ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 652 ---SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 652 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEE
Confidence 3568999988 7899888743 458999999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. +..+....-
T Consensus 160 ~Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~ 233 (343)
T cd07878 160 LDFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQ--LKRIMEVVG 233 (343)
T ss_pred cCCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhC
Confidence 999999865432 234578999999999876 5688999999999999999999999975432111 111110000
Q ss_pred hccCCCCccc---------C--CCCCCCh---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 ISKENIPKAI---------D--PNLNLDE---ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ~~~~~~~~~~---------d--~~l~~~~---~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.........+ . +...... ........+.+++.+|++.||++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 0 0000000 00001124679999999999999999999986
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=328.67 Aligned_cols=266 Identities=22% Similarity=0.308 Sum_probs=199.8
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------ 651 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 651 (933)
+.++|++.+.||+|+||.||++.. ..++.||||++...........++.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 457899999999999999999954 4688999999986544455567788999999999999999999987543
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
...++||||++ ++|.+++. ..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Df 170 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDF 170 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHH-------hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeC
Confidence 35799999996 57777773 247889999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHH----------
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT---------- 801 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~---------- 801 (933)
|+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.
T Consensus 171 G~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 171 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 248 (364)
T ss_pred CCccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHH
Confidence 9998654322 2234578999999999999999999999999999999999999997654322111000
Q ss_pred ------HHHHHhhccCCCCcc----cCCCCCC---ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 802 ------WFRRVLISKENIPKA----IDPNLNL---DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 802 ------~~~~~~~~~~~~~~~----~d~~l~~---~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
............... ..+.... ..........+.+++.+|++.||++|||+.|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000000 0000000 0001112245779999999999999999999987
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=326.03 Aligned_cols=264 Identities=27% Similarity=0.436 Sum_probs=203.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC-
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING- 651 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~- 651 (933)
.++|++.+.||+|+||.||+|.. .+++.||||+++... .......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPG 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence 36799999999999999999953 357899999997643 234456788999999999 689999999988654
Q ss_pred ceeEEEEeecCCCChhhHhhhcccC-------------------------------------------------------
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDH------------------------------------------------------- 676 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~------------------------------------------------------- 676 (933)
...++||||+++|+|.++++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 4678999999999999998652110
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc-eeeccc
Q 002346 677 -------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVETRL 748 (933)
Q Consensus 677 -------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~ 748 (933)
....+++..+..++.|+++||+|||+ ++|+||||||+||++++++.+||+|||++........ ......
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 01247889999999999999999998 8999999999999999999999999999876533221 112223
Q ss_pred ccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhh
Q 002346 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEET 827 (933)
Q Consensus 749 ~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~ 827 (933)
.+++.|+|||++.+..++.++||||||+++|||++ |..||........ .. ......... . . +..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~----~~~~~~~~~-~-~-~~~------ 306 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC----RRLKEGTRM-R-A-PDY------ 306 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH----HHHhccCCC-C-C-CCC------
Confidence 45678999999988899999999999999999997 8889875432211 11 111111110 0 0 000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 828 IESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 828 ~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
...++.+++.+|++.+|++||++.++++.|+.+++
T Consensus 307 --~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 --TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred --CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11357799999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=330.07 Aligned_cols=258 Identities=22% Similarity=0.383 Sum_probs=200.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||++.. .+++.||+|++..... .......+.+|+.++.+++||+|+++++++.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4688999999999999999955 4689999999975432 2334567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 81 E~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK-----KDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999865 2458999999999999999999998 899999999999999999999999999987442
Q ss_pred CCCc----------------------------------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcC
Q 002346 739 DGKY----------------------------------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG 784 (933)
Q Consensus 739 ~~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG 784 (933)
.... ......+||+.|+|||++.+..++.++|||||||++|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG 232 (360)
T cd05627 153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232 (360)
T ss_pred cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence 2110 001234799999999999999999999999999999999999
Q ss_pred CCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHHHhh
Q 002346 785 RKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD---MGHAVNVLGP 861 (933)
Q Consensus 785 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs---~~evl~~L~~ 861 (933)
+.||....+... ..........+ .+.+... ...++.+++.+++ .+|.+|++ +.++++
T Consensus 233 ~~Pf~~~~~~~~------~~~i~~~~~~~--~~p~~~~-------~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~---- 292 (360)
T cd05627 233 YPPFCSETPQET------YRKVMNWKETL--VFPPEVP-------ISEKAKDLILRFC-TDSENRIGSNGVEEIKS---- 292 (360)
T ss_pred CCCCCCCCHHHH------HHHHHcCCCce--ecCCCCC-------CCHHHHHHHHHhc-cChhhcCCCCCHHHHhc----
Confidence 999986544321 11111111111 1111111 1124567777766 49999996 455543
Q ss_pred hhhhcCC
Q 002346 862 LVEQWKP 868 (933)
Q Consensus 862 ~~~~~~~ 868 (933)
++|..
T Consensus 293 --hp~f~ 297 (360)
T cd05627 293 --HPFFE 297 (360)
T ss_pred --CCCCC
Confidence 56654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=321.00 Aligned_cols=263 Identities=29% Similarity=0.436 Sum_probs=206.3
Q ss_pred cCCccCCccccCCCeEEEEEEeC--------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC
Q 002346 581 DNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 651 (933)
.+|++.+.||+|+||.||+|... .+..||+|.+.... .....+++.+|+++++++ +||||+++++++..+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 46889999999999999999532 12368999887542 344567899999999999 799999999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
+..++||||+++|+|.+++..... .....+++.++..++.|+++||+|||+ ++|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill 167 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV 167 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence 999999999999999999975321 112458899999999999999999998 899999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhH
Q 002346 721 GDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAH 798 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~ 798 (933)
+.++.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--- 244 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--- 244 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence 999999999999988654432211 122234568999999998899999999999999999998 888886543221
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
....... .. ... ... .....+.+++.+|++.+|++||++.|+++.|+.+...
T Consensus 245 ---~~~~~~~-~~-~~~-~~~---------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~ 296 (334)
T cd05100 245 ---LFKLLKE-GH-RMD-KPA---------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV 296 (334)
T ss_pred ---HHHHHHc-CC-CCC-CCC---------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence 1111111 11 111 111 1123577999999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=318.62 Aligned_cols=265 Identities=24% Similarity=0.334 Sum_probs=195.2
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc---CCCcceeEEeEeee-----Cc
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCIN-----GS 652 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~~ 652 (933)
+|++.+.||+|+||.||+|.. .+++.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 588899999999999999954 4789999999876533333334566777777665 69999999998864 34
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||+. ++|.+++.... ...+++.++..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg 153 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFG 153 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccC
Confidence 5789999997 58988886522 2458999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh-ccC
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI-SKE 811 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~ 811 (933)
+++...... ......|++.|+|||++.+..++.++||||+||++|||++|++||......+. +......... ...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~ 229 (288)
T cd07863 154 LARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDLIGLPPED 229 (288)
T ss_pred ccccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHH--HHHHHHHhCCCChh
Confidence 988654322 12345689999999999888999999999999999999999999975433221 1111111000 000
Q ss_pred CCCc-------ccCCCCCC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIPK-------AIDPNLNL--DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~~-------~~d~~l~~--~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.++. .+.+.... .........++.+++.+|++.||++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 0110 00000000 0000112345679999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=320.13 Aligned_cols=259 Identities=25% Similarity=0.365 Sum_probs=201.8
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||++.. .++..||+|.+.... ......++.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 4688999999999999999954 468889999887542 23345678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. ...+++..+..++.|+++||+|||+ ..+++||||||+||+++.++.+||+|||++.....
T Consensus 80 y~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (308)
T cd06615 80 HMDGGSLDQVLKK-----AGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 152 (308)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence 9999999999965 2558899999999999999999997 25899999999999999999999999999875533
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC------
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI------ 813 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------ 813 (933)
.. .....|++.|+|||++.+..++.++||||||+++|||++|+.||........ ..+...........
T Consensus 153 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 226 (308)
T cd06615 153 SM---ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPV 226 (308)
T ss_pred cc---cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCcccc
Confidence 21 2345789999999999888899999999999999999999999965432211 11111100000000
Q ss_pred --------------------CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 --------------------PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 --------------------~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+.+.. .....++.+++.+|++.+|++||++.++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 286 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPS----GAFSDEFQDFVDKCLKKNPKERADLKELTK 286 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcC----cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0000000000 012235789999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=348.04 Aligned_cols=259 Identities=20% Similarity=0.353 Sum_probs=201.8
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--Ccee
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSER 654 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 654 (933)
...++|.+++.||+|+||.||++.. ..+..||+|++............|..|+.++++++|||||++++++.. ....
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 3456899999999999999999955 467889999988765555667789999999999999999999998854 3568
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc----CCCeEecCCCCCcEEecC--------
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA----QQSFIHRDLKPSNILIGD-------- 722 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----~~~ivH~Dik~~Nill~~-------- 722 (933)
|+||||+++|+|.++|..... ....+++..++.|+.||+.||+|||+.. .++||||||||+|||++.
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 999999999999999975322 2356999999999999999999999732 135999999999999964
Q ss_pred ---------CCcEEEecccccccCCCCCceeecccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcCCCCCCCC
Q 002346 723 ---------DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITGRKALDDT 791 (933)
Q Consensus 723 ---------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG~~p~~~~ 791 (933)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||...
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 3358999999998654322 2234579999999998854 45889999999999999999999999754
Q ss_pred CCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... .+ +.. +.....++ ... ....+.++|..||+.+|.+||++.|++.
T Consensus 247 ~~~~--ql---i~~-lk~~p~lp--------i~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 247 NNFS--QL---ISE-LKRGPDLP--------IKG----KSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CcHH--HH---HHH-HhcCCCCC--------cCC----CCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 3211 11 111 11111111 000 1235779999999999999999999984
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.04 Aligned_cols=253 Identities=24% Similarity=0.386 Sum_probs=199.2
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC----
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING---- 651 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~---- 651 (933)
.+++.|++.+.||+|+||.||+|.. .+++.||+|++.... ....++.+|+.++.++ +|+||+++++++...
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC---ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 3567888999999999999999965 468899999986542 3346788999999998 799999999998753
Q ss_pred --ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEe
Q 002346 652 --SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (933)
Q Consensus 652 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 729 (933)
...++||||+++++|.+++... ....+++..+..++.|++.|++|||+ ++|+||||||+||++++++.++|+
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~ 153 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNT---KGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLV 153 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEc
Confidence 4678999999999999998652 22468999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
|||++....... .......|++.|+|||++. ...++.++|||||||++|||++|+.||....+..... .
T Consensus 154 Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~ 227 (272)
T cd06637 154 DFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----L 227 (272)
T ss_pred cCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----H
Confidence 999987654322 1223457899999999885 3457889999999999999999999997543221111 0
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. ....+...+.. ....+.+++.+|++.+|.+||++.++++
T Consensus 228 --~~-~~~~~~~~~~~---------~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 228 --IP-RNPAPRLKSKK---------WSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred --Hh-cCCCCCCCCCC---------cCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 00 11111111111 1235779999999999999999999976
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=313.40 Aligned_cols=258 Identities=26% Similarity=0.434 Sum_probs=202.9
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCc----EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.++|++.+.||+|+||.||+|.+ .+++ .||+|++.... ......++.+|+.+++.++||||+++++++... ..
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~ 83 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TV 83 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-Cc
Confidence 35788899999999999999964 3454 48999987543 344457889999999999999999999998754 56
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
+++|||+++|+|.++++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||++++++.+||+|||++
T Consensus 84 ~l~~~~~~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~ 156 (279)
T cd05109 84 QLVTQLMPYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLA 156 (279)
T ss_pred EEEEEcCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCce
Confidence 7999999999999998652 2458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 735 KNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 735 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+......... .....+++.|+|||...+..++.++|||||||++|||++ |..||....... +..++.. ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~----~~~ 229 (279)
T cd05109 157 RLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEK----GER 229 (279)
T ss_pred eecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC----CCc
Confidence 8665332221 112345678999999988899999999999999999998 889987543221 2222211 111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.+. .+ .....+.+++.+|++.||++||++.++++.|+.+..
T Consensus 230 ~~~--~~---------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 230 LPQ--PP---------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred CCC--Cc---------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 110 11 112357799999999999999999999998877643
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=312.09 Aligned_cols=258 Identities=25% Similarity=0.449 Sum_probs=204.8
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CC---cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|+..+.||+|+||.||+|... ++ ..+|+|.+.... .....+++..|++++++++||||+++.+++...+..+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM 82 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence 356788899999999999999664 33 379999886542 3444678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++++|.+++... ...+++.++..++.|++.|++|||+ .+++||||||+||++++++.+||+|||++.
T Consensus 83 lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 155 (268)
T cd05063 83 IITEYMENGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSR 155 (268)
T ss_pred EEEEcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccce
Confidence 999999999999998651 2468999999999999999999998 899999999999999999999999999987
Q ss_pred cCCCCCceee--cccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 736 NAPDGKYSVE--TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 736 ~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
.......... .....++.|+|||++....++.++|||||||++|||++ |+.||...... ... ..... ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~---~~~---~~i~~-~~~ 228 (268)
T cd05063 156 VLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH---EVM---KAIND-GFR 228 (268)
T ss_pred ecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH---HHH---HHHhc-CCC
Confidence 6543322111 11223467999999988889999999999999999998 99999754322 111 11111 111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
.+.. .+...++.+++.+|++.+|++||++.++++.|++++
T Consensus 229 ~~~~-----------~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~~ 268 (268)
T cd05063 229 LPAP-----------MDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268 (268)
T ss_pred CCCC-----------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhhC
Confidence 1111 012246789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=317.68 Aligned_cols=253 Identities=27% Similarity=0.426 Sum_probs=200.1
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.|+..+.||+|+||.||++.. .+++.||||.+....... ...+.+..|+.++++++|++|+++++.+..++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999954 478999999987653322 223567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... +...+++.++..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~g~~L~~~l~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 154 (285)
T cd05630 81 LMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 154 (285)
T ss_pred ecCCCcHHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCC
Confidence 99999999988542 22458999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... .....|+..|+|||++.+..++.++||||+|+++|||++|+.||............... .. .....+..
T Consensus 155 ~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~---~~---~~~~~~~~ 226 (285)
T cd05630 155 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERL---VK---EVQEEYSE 226 (285)
T ss_pred Ccc--ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhh---hh---hhhhhcCc
Confidence 321 12347899999999999889999999999999999999999999864322111111100 00 00111111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
. ....+.+++.+|++.||++||+ +.|+++
T Consensus 227 ~---------~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 227 K---------FSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred c---------CCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 1 1134679999999999999999 778775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.55 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=190.4
Q ss_pred ccccCCCeEEEEEEeCC---CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 588 ILGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 588 ~lg~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
.||+|+||.||+|...+ ...+|+|.+.... .......|.+|+..++.++||||+++++++......++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 58999999999996543 4578888776442 3344567889999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 744 (933)
+|.+++...........++..+..++.|++.|++|||+ ++|+||||||+||++++++.+||+|||++..........
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999976433323446788899999999999999999 899999999999999999999999999987543332211
Q ss_pred -ecccccccCcccccccCC-------CCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 745 -ETRLAGTFGYLAPEYAAT-------GRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 745 -~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
.....+++.|+|||+... ..++.++|||||||++|||++ |..||....+.+. +.. ........++
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~---~~~~~~~~~~- 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV--LKQ---VVREQDIKLP- 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH--HHH---HhhccCccCC-
Confidence 233456778999998642 356889999999999999999 7788865432211 111 0111111111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
++.+. ......+.+++..|+ .||++||++++|++.|
T Consensus 232 --~~~~~-----~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 232 --KPQLD-----LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred --CCccc-----ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11111 112234567888888 5999999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=316.75 Aligned_cols=249 Identities=23% Similarity=0.399 Sum_probs=201.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..+...++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC--cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5788899999999999999954 578999999987653 2334678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. ..+++.++..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 98 ~~~~~~L~~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred ccCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 9999999999854 357899999999999999999998 8999999999999999999999999999875443
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ......|++.|+|||++.+..++.++|||||||++|||++|+.||....+... . ... .. ...+..-.
T Consensus 169 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~---~~~-~~--~~~~~~~~- 238 (296)
T cd06654 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--L---YLI-AT--NGTPELQN- 238 (296)
T ss_pred ccc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--H---HHH-hc--CCCCCCCC-
Confidence 221 12234688999999999888899999999999999999999999976543211 1 111 10 01111000
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......+.+++.+|+..+|++||++.++++
T Consensus 239 -------~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 239 -------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred -------ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0112245778999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.37 Aligned_cols=248 Identities=21% Similarity=0.369 Sum_probs=194.9
Q ss_pred ccccCCCeEEEEEEeC---CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 588 ILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 588 ~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
.||+|+||.||+|.+. .+..||+|++.... .....++|.+|+.++++++||||+++++++. ....++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 3899999999999653 35579999887552 3344567999999999999999999999885 45678999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 744 (933)
+|.+++... ...+++.+++.++.|+++|++|||+ ++++||||||+||+++.++.+||+|||++..........
T Consensus 80 ~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 152 (257)
T cd05115 80 PLNKFLSGK----KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY 152 (257)
T ss_pred CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccce
Confidence 999998641 2468999999999999999999998 899999999999999999999999999987554432211
Q ss_pred e--cccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCC
Q 002346 745 E--TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821 (933)
Q Consensus 745 ~--~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 821 (933)
. ....+++.|+|||++....++.++||||||+++||+++ |+.||......+. ...+ .. . . +...++.
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~---~~-~-~-~~~~~~~- 222 (257)
T cd05115 153 KARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV---MSFI---EQ-G-K-RLDCPAE- 222 (257)
T ss_pred eccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH---HHHH---HC-C-C-CCCCCCC-
Confidence 1 12233578999999988889999999999999999996 9999976533221 1111 11 1 1 1111111
Q ss_pred CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 822 NLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
...++.+++.+||+.+|++||++.++.+.|+..
T Consensus 223 --------~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 223 --------CPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 124677999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=322.93 Aligned_cols=256 Identities=20% Similarity=0.303 Sum_probs=197.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||++... +++.||+|++.+... .......+..|+.++..++|++|+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47889999999999999999654 578899999865322 2233456888999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.+. ...+++..+..++.|++.|++|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 81 ey~~~g~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999999652 2458999999999999999999999 899999999999999999999999999987654
Q ss_pred CCCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
...........||+.|+|||++. ...++.++|||||||++|||++|+.||....... ............
T Consensus 154 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~ 227 (332)
T cd05623 154 EDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TYGKIMNHKERF 227 (332)
T ss_pred cCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------HHHHHhCCCccc
Confidence 33333333457999999999885 3467899999999999999999999997643221 122222111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQ--RPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~evl~ 857 (933)
. +.... ......+.+++.+|+..++.+ |+++.++++
T Consensus 228 ~--~p~~~------~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~ 265 (332)
T cd05623 228 Q--FPAQV------TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQ 265 (332)
T ss_pred c--CCCcc------ccCCHHHHHHHHHHccChhhhcCCCCHHHHhC
Confidence 0 11100 111235668888888654444 688988876
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=309.17 Aligned_cols=251 Identities=29% Similarity=0.511 Sum_probs=202.7
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
.+|++.+.||+|+||.||+|...+++.+|+|++..... ...+|.+|++++++++|||++++++++......++||||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF 80 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence 46788899999999999999877788999999875533 235789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++... ...+++..++.++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 153 (256)
T cd05112 81 MEHGCLSDYLRAQ----RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD 153 (256)
T ss_pred CCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccC
Confidence 9999999998642 2457899999999999999999998 89999999999999999999999999998765443
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.........++.+|+|||++.++.++.++||||||+++|||++ |+.||....... ... .... .. ....+
T Consensus 154 ~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~-~~---~~~~~ 223 (256)
T cd05112 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---VVE---TINA-GF---RLYKP 223 (256)
T ss_pred cccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---HHH---HHhC-CC---CCCCC
Confidence 3222223345678999999988889999999999999999998 999987543211 111 1111 00 11111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
... ..++.+++.+|++.+|++||++.++++.|
T Consensus 224 ~~~--------~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 224 RLA--------SQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCC--------CHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 111 24578999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=308.34 Aligned_cols=248 Identities=27% Similarity=0.466 Sum_probs=196.7
Q ss_pred CccccCCCeEEEEEEeCC----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecC
Q 002346 587 NILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
+.||+|+||.||+|.... +..||+|.+...... ...+++.+|+++++.++|+||+++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 469999999999995422 268999998866433 45578999999999999999999999876 456799999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 742 (933)
+++|.+++... ..+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~ 150 (257)
T cd05060 79 LGPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150 (257)
T ss_pred CCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCc
Confidence 99999999652 368999999999999999999998 8999999999999999999999999999886544332
Q ss_pred eeec--ccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 743 SVET--RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 743 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.... ...++..|+|||.+.+..++.++||||||+++|||++ |+.||...... ....++.. ....+ ...
T Consensus 151 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~~----~~~~~--~~~ 221 (257)
T cd05060 151 YYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLES----GERLP--RPE 221 (257)
T ss_pred ccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHc----CCcCC--CCC
Confidence 2111 1223568999999988899999999999999999998 99999764322 22222211 11110 000
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.....+.+++.+|++.+|++||++.++++.|+++
T Consensus 222 ---------~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 222 ---------ECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---------CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 1123577999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=318.35 Aligned_cols=262 Identities=28% Similarity=0.453 Sum_probs=205.4
Q ss_pred cCCccCCccccCCCeEEEEEEeC--------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC
Q 002346 581 DNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 651 (933)
++|.+.+.||+|+||.||+|... ....||+|.+.... ......++..|+.+++++ +||||+++++++...
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 57888999999999999999531 24578999887543 344567889999999999 699999999999988
Q ss_pred ceeEEEEeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
...++||||+++|+|.+++..... .....+++.++..++.|++.||+|||+ ++|+||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEEE
Confidence 899999999999999999976321 112458999999999999999999998 899999999999999
Q ss_pred cCCCcEEEecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhH
Q 002346 721 GDDMRAKVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAH 798 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~ 798 (933)
+.++.+||+|||+++......... .....++..|+|||++.++.++.++||||||+++|||++ |+.||......+
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--- 244 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--- 244 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH---
Confidence 999999999999998654322211 112234568999999988889999999999999999999 888886543222
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
..... . ...... ... .....+.+++.+|++.+|++||++.++++.|+++..
T Consensus 245 ~~~~~----~-~~~~~~-~~~---------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKLL----R-EGHRMD-KPS---------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHH----H-cCCCCC-CCC---------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 11111 1 111111 111 112357789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=322.86 Aligned_cols=266 Identities=22% Similarity=0.348 Sum_probs=198.8
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|.+.+.||+|+||.||+|.. .+++.||+|+++.... ......+.+|+.++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 5788999999999999999965 4688999999876532 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|++ ++|.+++... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 156 (309)
T cd07872 85 YLD-KDLKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSV 156 (309)
T ss_pred CCC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCC
Confidence 997 4888887542 2457899999999999999999998 8999999999999999999999999999875433
Q ss_pred CCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc--
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA-- 816 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 816 (933)
... ......+++.|+|||++.+ ..++.++||||+||++|||+||+.||......+............. ...++..
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 234 (309)
T cd07872 157 PTK-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPT-EETWPGISS 234 (309)
T ss_pred Ccc-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-HHHHhhhcc
Confidence 221 1223467899999998864 4688999999999999999999999976544322211110000000 0000000
Q ss_pred ----cC---CCCCCC---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 ----ID---PNLNLD---EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ----~d---~~l~~~---~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+ +..... ........++.+++.+|++.||++|||+.|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 235 NDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 00 000000 000011235679999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=315.27 Aligned_cols=267 Identities=24% Similarity=0.335 Sum_probs=200.1
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 478889999999999999965 4689999999876544444456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
++ ++|.+++..... ...+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 154 (285)
T cd07861 81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154 (285)
T ss_pred CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence 97 689888865222 2568999999999999999999998 89999999999999999999999999998754332
Q ss_pred CceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc---------
Q 002346 741 KYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--------- 810 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 810 (933)
. .......+++.|+|||++.+. .++.++||||||+++|||+||+.||....+.+. ............
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 231 (285)
T cd07861 155 V-RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ--LFRIFRILGTPTEDVWPGVTS 231 (285)
T ss_pred c-ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhhhcchh
Confidence 2 122334678999999987654 578899999999999999999999976533211 111111000000
Q ss_pred -CCCCcccCCCCC--CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 -ENIPKAIDPNLN--LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 -~~~~~~~d~~l~--~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......++.... ..........++.+++.+|++.||++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 000000000000 00000012245679999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=308.66 Aligned_cols=250 Identities=32% Similarity=0.511 Sum_probs=204.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|.. .|+.||+|.+..... ..+++.+|+.+++.++|+||+++++++......++|||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 35788899999999999999987 488999999976532 45789999999999999999999999998899999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.... ...+++..+..++.|++.|++|||+ ++++||||||+||+++.++.+||+|||.++....
T Consensus 81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~ 154 (256)
T cd05039 81 YMAKGSLVDYLRSRG---RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154 (256)
T ss_pred ecCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccc
Confidence 999999999996521 2368999999999999999999998 8999999999999999999999999999886643
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... ...++..|+|||++..+.++.++||||||+++||+++ |+.||......+ +.... .... .....
T Consensus 155 ~~~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~~--~~~~~ 221 (256)
T cd05039 155 GQD----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKGY--RMEAP 221 (256)
T ss_pred ccc----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hcCC--CCCCc
Confidence 221 2234668999999988889999999999999999997 999987543221 11111 1110 10011
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
. .....+.+++.+|+..+|++||++.+++++|+.
T Consensus 222 ~---------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 222 E---------GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred c---------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 1 112457799999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.71 Aligned_cols=253 Identities=30% Similarity=0.481 Sum_probs=196.0
Q ss_pred CccccCCCeEEEEEEeC-CCc--EEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecC
Q 002346 587 NILGRGGFGVVYGGELP-DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
+.||+|+||.||+|... ++. .+|+|.++... .....+.+.+|++++.++ +||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 36899999999999764 343 46888876432 334456889999999999 79999999999999999999999999
Q ss_pred CCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 663 RGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 663 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
+|+|.+++..... .....+++.++..++.|++.|++|||+ ++++||||||+||++++++.+||+||
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~df 156 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADF 156 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCC
Confidence 9999999975321 112358899999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
|++....... .......+..|+|||++....++.++||||||+++|||++ |+.||......+ . ...... .
T Consensus 157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~~~~~~-~ 227 (270)
T cd05047 157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L---YEKLPQ-G 227 (270)
T ss_pred CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H---HHHHhC-C
Confidence 9986322111 1111234567999999988889999999999999999997 999996543211 1 111111 1
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
... + ... .....+.+++.+|++.+|.+||+++++++.|+++.
T Consensus 228 ~~~-~-~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 228 YRL-E-KPL---------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CCC-C-CCC---------cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 110 0 000 11235779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.06 Aligned_cols=254 Identities=22% Similarity=0.379 Sum_probs=202.6
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 658 (933)
...|+++++||+||.+.||++...+.+.||+|++.....+.....-|..|+..|.+|+ |.+||++++|-..++..|+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm 439 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM 439 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence 4568889999999999999999888899999988877777788899999999999994 999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||= ..+|..+|.... .....| .++.+..|++.|+.++|. +||||.||||.|+|+ -+|.+||+|||+|....
T Consensus 440 E~G-d~DL~kiL~k~~---~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 440 ECG-DIDLNKILKKKK---SIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQ 510 (677)
T ss_pred ecc-cccHHHHHHhcc---CCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEE-EeeeEEeeeechhcccC
Confidence 975 679999997632 123334 788899999999999999 999999999999999 56789999999999777
Q ss_pred CCCcee-ecccccccCcccccccCCC-----------CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH
Q 002346 739 DGKYSV-ETRLAGTFGYLAPEYAATG-----------RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 739 ~~~~~~-~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
.+.... ....+||+.||+||.+... +.++++||||+||++|+|+.|+.||.... ....-+..
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-----n~~aKl~a- 584 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-----NQIAKLHA- 584 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-----HHHHHHHh-
Confidence 655433 4567999999999988432 25679999999999999999999996431 11111111
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.||.-.++........+++++++.||..||.+||+..++++
T Consensus 585 ---------I~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 585 ---------ITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred ---------hcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 222221111111111223789999999999999999999987
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-35 Score=317.25 Aligned_cols=256 Identities=22% Similarity=0.388 Sum_probs=205.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
..+|++.+.||+|+||.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|+||+++++++..+...++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 36889999999999999999964 579999999987653 233467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++.. ..+++.++..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 96 e~~~~~~L~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~ 166 (297)
T cd06656 96 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 166 (297)
T ss_pred cccCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEcc
Confidence 99999999999854 457899999999999999999998 899999999999999999999999999987654
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... ......|++.|+|||++.+..++.++|||||||++|++++|+.||....+...... ......+....
T Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--------~~~~~~~~~~~ 237 (297)
T cd06656 167 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--------IATNGTPELQN 237 (297)
T ss_pred CCcc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--------eccCCCCCCCC
Confidence 3322 12334688999999999888899999999999999999999999976433211100 00000111000
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
.......+.+++.+|++.+|++||++.++++ ++|...
T Consensus 238 --------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~------~~~~~~ 274 (297)
T cd06656 238 --------PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ------HPFLKL 274 (297)
T ss_pred --------ccccCHHHHHHHHHHccCChhhCcCHHHHhc------Cchhcc
Confidence 1112234678999999999999999999987 566543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.78 Aligned_cols=257 Identities=27% Similarity=0.477 Sum_probs=211.3
Q ss_pred cCCccCCccccCCCeEEEEEEeCC---C--cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD---G--TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
+.....++||.|-||.||+|.+.+ | -.||||..+.+. +.+..+.|..|..+|++++|||||+++|.|.+ ...|
T Consensus 389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~W 466 (974)
T KOG4257|consen 389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMW 466 (974)
T ss_pred hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-ccee
Confidence 445567899999999999995532 3 358899887754 44557899999999999999999999999975 5689
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+|||.++-|.|..||+..+ ..++..+...++.|++.||+|||+ ..+|||||.++|||+.....||++|||+++
T Consensus 467 ivmEL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 467 IVMELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred EEEecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhh
Confidence 9999999999999997632 458899999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
...+..++..+...-+..|||||.+.-.+++.++|||.|||.+||++. |..||......+... .+...+.+|
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnGeRlP 612 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENGERLP 612 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCCCCCC
Confidence 998887766665455679999999999999999999999999999887 999998754332210 111122221
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
. .+ ..+..+..++.+||..+|.+||.+.++...|..+..
T Consensus 613 ~--------P~---nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 613 C--------PP---NCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred C--------CC---CCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1 11 222356789999999999999999999999988765
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=323.39 Aligned_cols=194 Identities=25% Similarity=0.349 Sum_probs=165.9
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
...+|++.+.||+|+||.||+|... +++.||+|+.... ....|+.++++++||||+++++++..+...++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 3467999999999999999999654 5788999975433 235689999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+ .++|.+++... ...+++.++..|+.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 136 LPHY-SSDLYTYLTKR----SRPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred EEcc-CCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 9999 56898888541 2568999999999999999999999 89999999999999999999999999998754
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCC
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDD 790 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~ 790 (933)
.... ......||+.|+|||++.+..++.++|||||||++|||+++..|+..
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~ 258 (357)
T PHA03209 208 VVAP--AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE 258 (357)
T ss_pred ccCc--ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence 3221 12345799999999999988999999999999999999997665543
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=313.20 Aligned_cols=262 Identities=27% Similarity=0.437 Sum_probs=200.2
Q ss_pred cCCccCCccccCCCeEEEEEEe-----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--Cce
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 653 (933)
.+|++.+.||+|+||.||++.. .+++.||+|++... .....+.|.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 4688899999999999999864 35889999998755 34456789999999999999999999998754 346
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~ 154 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKH----RERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGL 154 (284)
T ss_pred eEEEEEecCCCCHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcc
Confidence 78999999999999999642 2458999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCcee--ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh---------hHHHHH
Q 002346 734 VKNAPDGKYSV--ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR---------AHLVTW 802 (933)
Q Consensus 734 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~---------~~~~~~ 802 (933)
++......... .....++..|+|||++.+..++.++||||||+++|||++|..++......-. ......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd05081 155 TKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYH 234 (284)
T ss_pred cccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHH
Confidence 98665432211 1122344569999999888899999999999999999999876643211000 000000
Q ss_pred HHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 803 FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 803 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
...........+ .. ......+.+++.+|++.+|++|||+.++++.|+.+
T Consensus 235 ~~~~~~~~~~~~--~~---------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 235 LIELLKNNGRLP--AP---------PGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HHHHHhcCCcCC--CC---------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 001111111000 00 11124578999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.42 Aligned_cols=252 Identities=21% Similarity=0.346 Sum_probs=206.9
Q ss_pred CCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|+..+.||+|+||.||.++ ..+++.+++|++.....+....+++.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 58889999999999999984 45689999999877655666678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++.... ...+++.++..++.|+++|++|||+ .+++||||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 99999999996522 2468999999999999999999998 89999999999999999999999999998865443
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.. ......|++.|+|||+..+..++.++||||||+++|||++|+.||......+. ...... ..... ..
T Consensus 155 ~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~--~~~~~-~~-- 222 (256)
T cd08221 155 YS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIVQ--GNYTP-VV-- 222 (256)
T ss_pred cc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHc--CCCCC-Cc--
Confidence 32 22345789999999999888889999999999999999999999976433211 111111 11111 11
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
.....++.+++.+|++.+|++||++.++++.
T Consensus 223 -------~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 223 -------SVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred -------cccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1112457799999999999999999999873
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=308.98 Aligned_cols=250 Identities=20% Similarity=0.309 Sum_probs=202.3
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|+||.||++.. .+++.||+|.++... .....+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 578889999999999999955 468999999986543 234567888999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++... ....+++..++.++.|+++|++|||+ ++|+|+||||+||++++++.++++|||.+......
T Consensus 80 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 153 (255)
T cd08219 80 CDGGDLMQKIKLQ---RGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153 (255)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccc
Confidence 9999999988542 22457899999999999999999998 89999999999999999999999999998755432
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.. ......|++.|+|||++.+..++.++||||||+++|+|++|+.||........ ...... .... .+...
T Consensus 154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~~~~~--~~~~-~~~~~ 223 (255)
T cd08219 154 GA-YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------ILKVCQ--GSYK-PLPSH 223 (255)
T ss_pred cc-ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HHHHhc--CCCC-CCCcc
Confidence 21 12335789999999999888899999999999999999999999976432111 111111 1111 11111
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....+.+++.+||+.+|++||++.+++.
T Consensus 224 ---------~~~~~~~li~~~l~~~P~~Rp~~~~il~ 251 (255)
T cd08219 224 ---------YSYELRSLIKQMFKRNPRSRPSATTILS 251 (255)
T ss_pred ---------cCHHHHHHHHHHHhCCcccCCCHHHHhh
Confidence 1235679999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=330.71 Aligned_cols=263 Identities=21% Similarity=0.273 Sum_probs=199.5
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC---CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
...+|.+.+.||+|+||.||++... .+..||+|.+... ..+.+|++++++++|||||++++++......+
T Consensus 90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 3468999999999999999998542 4678999987643 24568999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+|||++. ++|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 163 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 163 MVMPKYK-CDLFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAAC 233 (392)
T ss_pred EEehhcC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCcccc
Confidence 9999995 688888843 2568999999999999999999998 899999999999999999999999999997
Q ss_pred cCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhh-HHHHHHHHHhhccCCC
Q 002346 736 NAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA-HLVTWFRRVLISKENI 813 (933)
Q Consensus 736 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~ 813 (933)
........ ......||+.|+|||++....++.++|||||||++|||++|+.||......... .+...+..........
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 65443222 223467999999999999889999999999999999999999999765432211 1111111100000000
Q ss_pred Cc---------------ccCCCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PK---------------AIDPNLNLDE--ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~---------------~~d~~l~~~~--~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+. ...+...... ........+.+++.+|++.||++||++.|++.
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 0000000000 00011235678999999999999999999987
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=312.40 Aligned_cols=263 Identities=26% Similarity=0.448 Sum_probs=202.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ce
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 653 (933)
..|++.+.||+|+||.||++.. .++..||+|.++... .......+.+|+++++.++||||+++++++... ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 82 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCc
Confidence 3568899999999999999963 357899999987553 344457899999999999999999999998775 56
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++++|.+++... ...+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~ 155 (284)
T cd05079 83 IKLIMEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 155 (284)
T ss_pred eEEEEEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcc
Confidence 78999999999999998542 2358999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCc--eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCc--------hhhHHHHHH
Q 002346 734 VKNAPDGKY--SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD--------DRAHLVTWF 803 (933)
Q Consensus 734 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~--------~~~~~~~~~ 803 (933)
++....... .......|+..|+|||++.+..++.++||||||+++|||++++.|....... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 156 TKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred ccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 886544322 1223345777899999998888999999999999999999988765432110 000000111
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
..........+ .. ......+.+++.+|++.+|++||++.++++.++.+
T Consensus 236 ~~~~~~~~~~~--~~---------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 236 VRVLEEGKRLP--RP---------PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHcCccCC--CC---------CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 11111111100 00 01224688999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=330.01 Aligned_cols=262 Identities=22% Similarity=0.284 Sum_probs=196.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
...|.+.+.||+|+||.||++.. ..++.||||.... ..+.+|++++++++|+|||++++++..++..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 45799999999999999999965 4578999996432 24678999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
|++ .++|.+++... ...+++.+++.|+.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 240 e~~-~~~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~ 311 (461)
T PHA03211 240 PKY-RSDLYTYLGAR----LRPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFAR 311 (461)
T ss_pred Ecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence 999 47898888541 2469999999999999999999998 899999999999999999999999999997654
Q ss_pred CCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCc-----hhhHHHHHHHHHhhccCC
Q 002346 739 DGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD-----DRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 739 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~ 812 (933)
.... .......||+.|+|||++.+..++.++|||||||++|||++|..|+...... ....+...+.........
T Consensus 312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~ 391 (461)
T PHA03211 312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE 391 (461)
T ss_pred cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence 3221 1223457999999999999999999999999999999999988766432211 111122222211110111
Q ss_pred CCcccCCCC--------------CCChhhH----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNL--------------NLDEETI----ESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l--------------~~~~~~~----~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+......+ ......+ .....+.+++.+||+.||++||++.|+++
T Consensus 392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~ 454 (461)
T PHA03211 392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR 454 (461)
T ss_pred CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence 111000000 0000001 11125678999999999999999999987
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=309.76 Aligned_cols=249 Identities=29% Similarity=0.476 Sum_probs=199.1
Q ss_pred CccccCCCeEEEEEEeCC--C--cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecC
Q 002346 587 NILGRGGFGVVYGGELPD--G--TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+++.+|+.++++++||||+++++++.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999996533 3 36999999876543 566789999999999999999999999988 88899999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 742 (933)
+++|.+++..... ..+++..++.++.|+++||+|||+ .+++||||||+||+++.++.+||+|||+++.......
T Consensus 79 ~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 152 (257)
T cd05040 79 LGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152 (257)
T ss_pred CCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEecccccccccccccc
Confidence 9999999966221 468999999999999999999998 8999999999999999999999999999986644221
Q ss_pred e--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 743 S--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 743 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
. ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+ ....... ...... ..
T Consensus 153 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~~~~--~~- 223 (257)
T cd05040 153 HYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EGERLE--RP- 223 (257)
T ss_pred ceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cCCcCC--CC-
Confidence 1 1223457789999999998899999999999999999999 999997543322 1111111 111110 00
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
......+.+++.+|++.+|++||+++++++.|.
T Consensus 224 --------~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 --------EACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred --------ccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 011245779999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.52 Aligned_cols=256 Identities=23% Similarity=0.400 Sum_probs=204.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||++.. .+++.||+|++.... .....+.+.+|+++++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 5688889999999999999965 468899999886543 34446789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. .+++++..+..++.++++|+.|||+ .++++||||||+||++++++.++|+|||++.....
T Consensus 84 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 84 FMDCGSLDRIYKK-----GGPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred cCCCCCHHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 9999999998854 2468999999999999999999996 25899999999999999999999999999865432
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCc-----hhhHHHHHHHHHhhccCCCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD-----DRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 814 (933)
.. .....|+..|+|||++.+..++.++|||||||++||+++|+.||....+. .......+........
T Consensus 157 ~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 229 (284)
T cd06620 157 SI---ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---- 229 (284)
T ss_pred hc---cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc----
Confidence 21 12357899999999998888999999999999999999999999865432 1111222222222111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
.+.+.. ......+.+++.+|++.+|++||++.|+++.
T Consensus 230 ---~~~~~~----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 230 ---PPRLPS----SDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred ---CCCCCc----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 011110 0123457899999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.43 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=202.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CC---cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
.+|++.+.||+|+||.||+|... ++ ..||||.+.... ......+|..|+.+++.++||||+++++++..+...++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l 82 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI 82 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence 35788999999999999999654 23 369999987542 34556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++++|.+++... ...+++.+++.++.|++.|++|||+ ++++||||||+||+++.++.+||+|||++..
T Consensus 83 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~ 155 (269)
T cd05065 83 ITEFMENGALDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 155 (269)
T ss_pred EEecCCCCcHHHHHhhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccc
Confidence 99999999999998642 2458999999999999999999998 8999999999999999999999999999875
Q ss_pred CCCCCcee--ecccc--cccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 737 APDGKYSV--ETRLA--GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 737 ~~~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
........ ..... .+..|+|||++.+..++.++|||||||++||+++ |..||...... ....++. ...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~----~~~ 228 (269)
T cd05065 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIE----QDY 228 (269)
T ss_pred cccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHH----cCC
Confidence 54322111 11111 2457999999998899999999999999999887 99999765332 1222211 111
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
..+. .+ +....+.+++.+|++.+|++||++.+++..|+.+
T Consensus 229 ~~~~--~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 229 RLPP--PM---------DCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred cCCC--cc---------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1111 01 1123567899999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.28 Aligned_cols=252 Identities=24% Similarity=0.443 Sum_probs=201.7
Q ss_pred CCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC----chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 582 NFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG----NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+|++.+.||+|+||.||+|...+++.+|+|.+...... ......+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 47889999999999999998778999999988754321 23346789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++.+ ..++++..+..++.|++.|++|||+ .+|+|+||+|+||++++++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR-----FGPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999965 2457899999999999999999998 89999999999999999999999999998754
Q ss_pred CCCC-----ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 738 PDGK-----YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 738 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
.... ........|+..|+|||++.+..++.++||||||+++|||++|+.||........ . .........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~--~----~~~~~~~~~ 226 (265)
T cd06631 153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA--M----FYIGAHRGL 226 (265)
T ss_pred hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH--H----HHhhhccCC
Confidence 3211 1112235689999999999988899999999999999999999999975432111 1 011111111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+. +... ...++.+++.+|++.+|++||++.++++
T Consensus 227 ~~~-~~~~---------~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 227 MPR-LPDS---------FSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred CCC-CCCC---------CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 1111 1245779999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=307.57 Aligned_cols=248 Identities=30% Similarity=0.459 Sum_probs=198.8
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEee-eCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI-NGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||++.. .|+.||+|.+... ...+.|.+|+.++++++|+|++++++++. .+...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 4788899999999999999977 5888999988643 23467899999999999999999999765 4567899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ....+++..++.++.|++.||+|||+ ++|+||||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 81 YMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccc
Confidence 99999999998652 22458899999999999999999998 8999999999999999999999999999875443
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.. ....++..|+|||++....++.++|||||||++|||++ |+.||..... ......+.. . ......
T Consensus 155 ~~----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~-----~-~~~~~~ 221 (256)
T cd05082 155 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEK-----G-YKMDAP 221 (256)
T ss_pred cC----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc-----C-CCCCCC
Confidence 22 22345678999999988889999999999999999998 9999865422 111111111 1 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
+. ....+.+++.+|++.+|++||+++++++.|+.
T Consensus 222 ~~---------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 255 (256)
T cd05082 222 DG---------CPPVVYDVMKQCWHLDAATRPSFLQLREQLEH 255 (256)
T ss_pred CC---------CCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence 11 12457799999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=308.29 Aligned_cols=250 Identities=25% Similarity=0.459 Sum_probs=200.1
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-------hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-------KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
+|.+.+.||+|+||.||+|.. .+++.||+|.+....... ...+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999954 468899999887653221 123578899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++++|.+++.. ...+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~ 152 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-----YGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGI 152 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-----ccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCC
Confidence 9999999999999999965 2458899999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCce-----eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 734 VKNAPDGKYS-----VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 734 a~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
++........ ......|+..|+|||.+.+..++.++||||+|+++|||++|+.||........ . .....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~ 226 (267)
T cd06628 153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA--I----FKIGE 226 (267)
T ss_pred CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH--H----HHHhc
Confidence 8865422111 11224588999999999888899999999999999999999999976432111 1 11110
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....++. .....+.+++.+|++.+|.+||++.++++
T Consensus 227 ---~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 227 ---NASPEIPS---------NISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---cCCCcCCc---------ccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 11111111 11245779999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=310.45 Aligned_cols=259 Identities=29% Similarity=0.480 Sum_probs=203.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
++|++.+.||+|+||.||+|..+ +.+.||+|.+.... .....+++.+|++++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 57889999999999999999753 34679999886542 223457899999999999999999999999988899
Q ss_pred EEEEeecCCCChhhHhhhcccCC----CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHG----YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
++||||+++|+|.+++....... ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999997632111 1258999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
||+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||....... ... ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~---~~~~- 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN---RLQA- 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH---HHHc-
Confidence 99987544333222333456788999999988888999999999999999999 778886533211 111 1111
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.......... ....+.+++.+|++.+|++||++.|+++.|.
T Consensus 234 -~~~~~~~~~~---------~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 -GKLELPVPEG---------CPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred -CCcCCCCCCC---------CCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 1111111111 1236779999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=310.15 Aligned_cols=249 Identities=25% Similarity=0.414 Sum_probs=203.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||.|+||.||+|.. .+++.||+|.+.... .......+.+|+++++.++|+||+++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3688889999999999999965 468999999987653 34445778999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. .++++..++.++.|++.|+.|||+ ++++||||+|+||++++++.++|+|||+++....
T Consensus 80 ~~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 150 (274)
T cd06609 80 YCGGGSCLDLLKP------GKLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTS 150 (274)
T ss_pred eeCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecc
Confidence 9999999999864 268999999999999999999998 8999999999999999999999999999886654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.. .......|++.|+|||++.+..++.++||||||+++|||+||+.||....+... ..... ....+.....
T Consensus 151 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~~~~--~~~~~~~~~~ 221 (274)
T cd06609 151 TM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LFLIP--KNNPPSLEGN 221 (274)
T ss_pred cc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HHHhh--hcCCCCCccc
Confidence 32 122345788999999999888899999999999999999999999976432211 11111 1111111110
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ....+.+++.+|++.+|++||+++++++
T Consensus 222 ~---------~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 222 K---------FSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred c---------cCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 2235778999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.56 Aligned_cols=258 Identities=26% Similarity=0.423 Sum_probs=204.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|.+.+.||+|+||.||+|...+ ...||+|...... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~ 82 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW 82 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence 3568889999999999999996533 3468999886553 24456789999999999999999999998875 5578
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++++|.+++... ...+++.+++.++.+++.|++|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 83 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~ 155 (270)
T cd05056 83 IVMELAPLGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155 (270)
T ss_pred EEEEcCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceee
Confidence 999999999999999652 2358999999999999999999998 899999999999999999999999999988
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
..............+++.|+|||.+....++.++||||||+++||+++ |+.||......+. ..++. . ....+
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~---~-~~~~~ 228 (270)
T cd05056 156 YLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIE---N-GERLP 228 (270)
T ss_pred ecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHH---c-CCcCC
Confidence 665443322233345678999999988889999999999999999986 9999976533211 11111 1 11111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
..+. ....+.+++.+|+..+|++||++.++++.|+++..
T Consensus 229 --~~~~---------~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 229 --MPPN---------CPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred --CCCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 1111 12357789999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.52 Aligned_cols=268 Identities=22% Similarity=0.293 Sum_probs=202.1
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|... +|+.||+|++..........+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 46889999999999999999664 68999999987654333344678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|++++.|..++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07847 81 YCDHTVLNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTG 152 (286)
T ss_pred ccCccHHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence 9999888877643 2458999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHH-HHHHH------hhccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT-WFRRV------LISKE 811 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~-~~~~~------~~~~~ 811 (933)
... ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+...... ..... .....
T Consensus 153 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07847 153 PGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTN 231 (286)
T ss_pred Ccc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccc
Confidence 321 1223467889999999865 457899999999999999999999997654322211110 00000 00000
Q ss_pred C-CCcccCCCCCC--C--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 N-IPKAIDPNLNL--D--EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~-~~~~~d~~l~~--~--~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ......+.... . .........+.+++.+|++.+|++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 232 QFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred cccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0 00000000000 0 000112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=319.56 Aligned_cols=259 Identities=20% Similarity=0.311 Sum_probs=195.8
Q ss_pred cCCccccC--CCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeec
Q 002346 585 EANILGRG--GFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 585 ~~~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
++++||+| +|++||++.. .+|+.||+|++..........+.+++|+.+++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 45789999 6789999954 67899999999876544455667888999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
++|+|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.++++||+.........
T Consensus 82 ~~~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~ 155 (327)
T cd08227 82 AYGSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG 155 (327)
T ss_pred CCCcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence 9999999986522 2358999999999999999999998 899999999999999999999999998654322111
Q ss_pred ce------eecccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 742 YS------VETRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 742 ~~------~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........ ..... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~------~~~~ 227 (327)
T cd08227 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKL------NGTV 227 (327)
T ss_pred ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHh------cCCc
Confidence 10 0112356778999999875 4588999999999999999999999975432111 11100 0001
Q ss_pred CcccC-------------------CCC----------------CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAID-------------------PNL----------------NLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d-------------------~~l----------------~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+..++ ... ............+.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 10000 000 000011122346789999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=315.50 Aligned_cols=249 Identities=21% Similarity=0.408 Sum_probs=202.6
Q ss_pred cCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.+|++.+.||.|+||.||+|. ..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc--CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 468999999999999999995 4678999999987543 3345678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 97 YLAGGSLTDVVTE------TCMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred ecCCCcHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 9999999998854 458999999999999999999999 8999999999999999999999999999876543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+..... .. .. ...+....+
T Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~---~~---~~--~~~~~~~~~ 238 (296)
T cd06655 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LI---AT--NGTPELQNP 238 (296)
T ss_pred ccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH---Hh--cCCcccCCc
Confidence 322 1223468899999999988889999999999999999999999997754322211 11 10 001110000
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......+.+++.+||..+|++||++.++++
T Consensus 239 --------~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 239 --------EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred --------ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011235678999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=311.11 Aligned_cols=252 Identities=23% Similarity=0.389 Sum_probs=199.8
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|.. .+++.||+|+++... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 5788889999999999999954 568999999987652 3334578899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. ...+++.++..++.|++.|++|||+ .+++|+||||+||+++.++.+||+|||++.....
T Consensus 87 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06645 87 FCGGGSLQDIYHV-----TGPLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158 (267)
T ss_pred ccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence 9999999999854 2468999999999999999999999 8999999999999999999999999999875543
Q ss_pred CCceeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
.. .......|++.|+|||++. .+.++.++|||||||++|||++|+.||....+....... .. ....+..
T Consensus 159 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~------~~-~~~~~~~ 230 (267)
T cd06645 159 TI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------TK-SNFQPPK 230 (267)
T ss_pred cc-cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh------hc-cCCCCCc
Confidence 22 1223457899999999874 456889999999999999999999998754432221110 00 0000111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..... .....+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~~~-------~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 231 LKDKM-------KWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred ccccC-------CCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 11000 11134679999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.40 Aligned_cols=198 Identities=26% Similarity=0.401 Sum_probs=161.6
Q ss_pred CCccccCCCeEEEEEEeC---CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--CceeEEEEee
Q 002346 586 ANILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLLVYEY 660 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 660 (933)
.++||+|+||.||+|... +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 468999999999999653 567899999875432 2457889999999999999999998854 4567899999
Q ss_pred cCCCChhhHhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe----cCCCcEEEeccc
Q 002346 661 MPRGTLAQHLFEWHD----HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFG 732 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~DfG 732 (933)
+. ++|.+++..... .....+++..+..++.|++.||+|||+ ++|+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 85 588888754221 112358999999999999999999999 899999999999999 456789999999
Q ss_pred ccccCCCCCc--eeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCC
Q 002346 733 LVKNAPDGKY--SVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDT 791 (933)
Q Consensus 733 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~ 791 (933)
+++....... .......||+.|+|||++.+ ..++.++||||+||++|||++|++||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9986543221 12234578999999999876 45899999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=306.66 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=202.0
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee-CceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 659 (933)
+|++.+.||+|++|.||++.. .+++.||+|++..........+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488899999999999999954 467899999997665455566788999999999999999999998764 446789999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ....+++.++..++.+++.|++|||+ .+|+||||||+||+++.++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~l~~~---~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ---KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999999652 22468999999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.. .......|++.|+|||++.+..++.++||||+|+++|||++|+.||....... ....... ...+. +.
T Consensus 155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~------~~~~~~~--~~~~~-~~- 223 (257)
T cd08223 155 QC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS------LVYRIIE--GKLPP-MP- 223 (257)
T ss_pred cC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHh--cCCCC-Cc-
Confidence 22 12234568999999999998899999999999999999999999997543211 1111111 11111 11
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......+.+++.+|++.+|++||++.++++
T Consensus 224 --------~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 224 --------KDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --------cccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 112245779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=313.52 Aligned_cols=263 Identities=23% Similarity=0.372 Sum_probs=203.9
Q ss_pred ecHHHHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEe
Q 002346 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYC 648 (933)
Q Consensus 571 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 648 (933)
+.++.+..+.++|++.+.||+|+||.||++.. .+++.||+|++.... ....++.+|+.+++.+ +||||+++++++
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 84 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMY 84 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence 34466677789999999999999999999954 468899999876432 2235788899999999 699999999987
Q ss_pred e-----eCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 649 I-----NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 649 ~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
. .+...++||||+++++|.+++...... ...+++..+..++.|+++|+.|||+ .+|+||||||+||+++++
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~ 160 (286)
T cd06638 85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTE 160 (286)
T ss_pred eecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCC
Confidence 4 345689999999999999988653222 3568899999999999999999998 899999999999999999
Q ss_pred CcEEEecccccccCCCCCceeecccccccCcccccccCC-----CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH
Q 002346 724 MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH 798 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~ 798 (933)
+.+||+|||+++....... ......|++.|+|||++.. ..++.++||||+||++|||++|+.||....+...
T Consensus 161 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-- 237 (286)
T cd06638 161 GGVKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-- 237 (286)
T ss_pred CCEEEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH--
Confidence 9999999999876543222 1223468999999998753 4578899999999999999999999976433211
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.. .. ....+...++.. ....+.+++.+|++.+|++||++.|+++
T Consensus 238 ~~~----~~--~~~~~~~~~~~~--------~~~~~~~li~~~l~~~p~~Rps~~ell~ 282 (286)
T cd06638 238 LFK----IP--RNPPPTLHQPEL--------WSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282 (286)
T ss_pred Hhh----cc--ccCCCcccCCCC--------cCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 100 00 111111111111 1135779999999999999999999987
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=307.52 Aligned_cols=239 Identities=24% Similarity=0.415 Sum_probs=187.3
Q ss_pred CccccCCCeEEEEEEeCC-------------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 587 NILGRGGFGVVYGGELPD-------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
+.||+|+||.||+|...+ ...||+|.+.... ......|.+|+.+++.++||||+++++++.....
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999996532 2358899876542 3345678899999999999999999999999889
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc-------E
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR-------A 726 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-------~ 726 (933)
.++||||+++++|..++... ...+++..++.++.|+++|++|||+ ++|+||||||+||+++.++. +
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~ 151 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFI 151 (262)
T ss_pred CEEEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCcee
Confidence 99999999999999888541 2458999999999999999999998 89999999999999987664 8
Q ss_pred EEecccccccCCCCCceeecccccccCcccccccC-CCCCCCccchHhHHHHHHHHH-cCCCCCCCCCCchhhHHHHHHH
Q 002346 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA-TGRVTTKIDVYAFGVVLMETI-TGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 727 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~ell-tG~~p~~~~~~~~~~~~~~~~~ 804 (933)
+++|||++...... ....|+..|+|||++. +..++.++|||||||++|||+ +|+.|+......+.. .+
T Consensus 152 ~l~d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~----~~- 221 (262)
T cd05077 152 KLSDPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE----RF- 221 (262)
T ss_pred EeCCCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH----HH-
Confidence 99999998754322 2246788999999886 467899999999999999998 588887653221110 00
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
. .... ....+ ....+.+++.+||+.||++||++.++++.+
T Consensus 222 --~--~~~~-~~~~~----------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 222 --Y--EGQC-MLVTP----------SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred --H--hcCc-cCCCC----------ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 0 0100 00110 123577999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=309.26 Aligned_cols=254 Identities=25% Similarity=0.382 Sum_probs=189.0
Q ss_pred CccccCCCeEEEEEEeCCC---cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|...++ ..+++|.+.... .....+.|.+|+.+++.++||||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 3599999999999965443 345677665442 234467899999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC-c
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK-Y 742 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~-~ 742 (933)
|+|.+++...... ....++..+..++.|+++||+|||+ .+++||||||+||+++.++.+||+|||++....... .
T Consensus 80 ~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~ 155 (268)
T cd05086 80 GDLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI 155 (268)
T ss_pred CcHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence 9999999763221 2456778888999999999999998 899999999999999999999999999986432221 1
Q ss_pred eeecccccccCcccccccCC-------CCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 743 SVETRLAGTFGYLAPEYAAT-------GRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
.......|+..|+|||++.. ..++.++||||||+++|||++ |..||....+.+. +..... ....
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~--~~~~ 227 (268)
T cd05086 156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV------LNHVIK--DQQV 227 (268)
T ss_pred hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHh--hccc
Confidence 12234568899999998743 245789999999999999997 4667765432211 111111 1112
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
...++.+... ....+.+++..|+ .+|++||+++++++.|
T Consensus 228 ~~~~~~~~~~-----~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l 266 (268)
T cd05086 228 KLFKPQLELP-----YSERWYEVLQFCW-LSPEKRATAEEVHRLL 266 (268)
T ss_pred ccCCCccCCC-----CcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence 2223332211 1134667888999 6799999999999876
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=307.88 Aligned_cols=252 Identities=32% Similarity=0.516 Sum_probs=202.3
Q ss_pred CccccCCCeEEEEEEeCC----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecC
Q 002346 587 NILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
+.||+|+||.||+|.... +..||+|.+....... ..+.+.+|+++++.++|+||+++++++..+...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 469999999999996643 8899999998764332 46789999999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccC----CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 663 RGTLAQHLFEWHDH----GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 663 ~gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
+++|.+++...... ....+++.+++.++.|+++|++|||+ ++++||||||+||++++++.+||+|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999763111 02568999999999999999999998 899999999999999999999999999998665
Q ss_pred CCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 739 DGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 739 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
.... .......+++.|+|||.+....++.++||||+|+++|||++ |+.||....... ... .... .... .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~---~~~~-~~~~--~ 227 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE---YLRK-GYRL--P 227 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHH---HHHc-CCCC--C
Confidence 4321 12234567889999999988889999999999999999999 589997653221 111 1111 1110 0
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
... ....++.+++.+|++.+|++||++.++++.|+
T Consensus 228 ~~~---------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 KPE---------YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCc---------cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 001 11246789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=307.01 Aligned_cols=257 Identities=22% Similarity=0.391 Sum_probs=202.6
Q ss_pred CCccCCccccCCCeEEEEEEeCC--CcEEEEEEecccc--------CCchhHHHHHHHHHHHHh-cCCCcceeEEeEeee
Q 002346 582 NFSEANILGRGGFGVVYGGELPD--GTKIAVKRMESNT--------MGNKGLSEFQAEIAVLTK-VRHRHLVALLGYCIN 650 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~ 650 (933)
+|++.+.||+|+||.||+|.... ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999997654 6889999876432 122345667888888875 699999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
++..++||||+++++|.+++...... ...+++..++.++.|++.|+.|||+ ..+++||||+|+||+++.++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~d 157 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEK-KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITD 157 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEec
Confidence 99999999999999999988553222 3568999999999999999999995 26899999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
||++....... ......|+..|+|||++.+..++.++||||||+++|||++|+.||........ ......
T Consensus 158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~~~~-- 227 (269)
T cd08528 158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATKIVE-- 227 (269)
T ss_pred ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHHHhh--
Confidence 99988655432 23345789999999999988899999999999999999999999975432211 111111
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
........ ......+.+++.+|++.||++||++.|+.++++
T Consensus 228 ~~~~~~~~---------~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 228 AVYEPLPE---------GMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ccCCcCCc---------ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11110000 011235779999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.97 Aligned_cols=254 Identities=23% Similarity=0.400 Sum_probs=197.9
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
..++++.....||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455666667899999999999964 467889999887552 3345689999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCC--CHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-CCcEEEecccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPL--TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGL 733 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGl 733 (933)
||||+++++|.+++.... .++ ++..+..++.|+++|++|||+ .+|+||||||+||+++. ++.++|+|||+
T Consensus 83 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~ 155 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGT 155 (268)
T ss_pred EEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchh
Confidence 999999999999996521 234 788899999999999999998 89999999999999986 67999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCCC--CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATGR--VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
+........ ......|++.|+|||++.... ++.++||||||+++|||++|+.||........ ..+.........
T Consensus 156 ~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~ 231 (268)
T cd06624 156 SKRLAGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMFKIHP 231 (268)
T ss_pred heecccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhhccCC
Confidence 875543221 122346889999999986543 78899999999999999999999975422111 111111111011
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.++ .. ...++.+++.+|++.+|++||++.|+++
T Consensus 232 ~~~----~~---------~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 232 EIP----ES---------LSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred CCC----cc---------cCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 111 11 1235778999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=315.22 Aligned_cols=265 Identities=22% Similarity=0.288 Sum_probs=198.3
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|+||.||+|.. .+|+.||+|+++...........+.+|++++++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478889999999999999965 4789999999876543344446788899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
++ ++|.+++... ...+++..++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 152 (284)
T cd07839 81 CD-QDLKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP 152 (284)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence 96 5888887541 2458999999999999999999998 89999999999999999999999999998755432
Q ss_pred CceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc--------C
Q 002346 741 KYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--------E 811 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~ 811 (933)
.. ......+++.|+|||++.+. .++.++|||||||++|||+||+.|+....... ..+ ..+....... .
T Consensus 153 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07839 153 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQL-KRIFRLLGTPTEESWPGVS 229 (284)
T ss_pred CC-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHH-HHHHHHhCCCChHHhHHhh
Confidence 21 12234678999999988664 46899999999999999999999875433211 111 1111110000 0
Q ss_pred CCCccc-CCCCCC----ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIPKAI-DPNLNL----DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~~~~-d~~l~~----~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+... -+.... .........++.+++.+|++.||.+|||++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 000000 000000 0001112346779999999999999999999976
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=320.88 Aligned_cols=238 Identities=25% Similarity=0.358 Sum_probs=184.9
Q ss_pred cccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc---CCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV---RHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
||+|+||.||+|.. .+++.||||++..... .......+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999955 4689999999865432 122334556677776665 699999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++.. ...+++..+..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~-----~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~- 151 (330)
T cd05586 81 GELFWHLQK-----EGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK- 151 (330)
T ss_pred ChHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-
Confidence 999998864 2458999999999999999999999 8999999999999999999999999999875432221
Q ss_pred eecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLN 822 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 822 (933)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ...........++. ..+
T Consensus 152 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~~~---~~~- 221 (330)
T cd05586 152 TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------MYRNIAFGKVRFPK---NVL- 221 (330)
T ss_pred CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------HHHHHHcCCCCCCC---ccC-
Confidence 12345799999999998654 47999999999999999999999997643211 11122211111111 011
Q ss_pred CChhhHHHHHHHHHHHHHcccCCCCCCCCHH
Q 002346 823 LDEETIESIYRVAELAGHCTAREPQQRPDMG 853 (933)
Q Consensus 823 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ 853 (933)
...+.+++.+|++.+|++||++.
T Consensus 222 --------~~~~~~li~~~L~~~P~~R~~~~ 244 (330)
T cd05586 222 --------SDEGRQFVKGLLNRNPQHRLGAH 244 (330)
T ss_pred --------CHHHHHHHHHHcCCCHHHCCCCC
Confidence 13466899999999999999543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=319.23 Aligned_cols=250 Identities=24% Similarity=0.401 Sum_probs=202.5
Q ss_pred CCccCCccccCCCeEEEEEEeCC-CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
-|.++..||.|+||.||+|..++ +-..|.|++... +.++.++|.-|++++..++||+||++++.|+.++..|+..||
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 35567789999999999996544 344567777654 567788999999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
|.||-.+..+-.. ...+.+.++..+++|++.||.|||+ +.|||||+|+.|||++-+|.++|+|||.+......
T Consensus 111 C~GGAVDaimlEL----~r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t 183 (1187)
T KOG0579|consen 111 CGGGAVDAIMLEL----GRVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST 183 (1187)
T ss_pred cCCchHhHHHHHh----ccccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH
Confidence 9999999887542 3679999999999999999999999 89999999999999999999999999987543321
Q ss_pred CceeecccccccCccccccc-----CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 741 KYSVETRLAGTFGYLAPEYA-----ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
. .....+.|||+|||||+. ...+|++++||||||++|.||..+.+|-....++... -++ .+...|-
T Consensus 184 ~-qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl------lKi--aKSePPT 254 (1187)
T KOG0579|consen 184 R-QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKI--AKSEPPT 254 (1187)
T ss_pred H-hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH------HHH--hhcCCCc
Confidence 1 223457899999999977 4568999999999999999999999998766554321 111 1222333
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+.|. .....+.+++.+|+.++|..||+++++++
T Consensus 255 LlqPS--------~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LLQPS--------HWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred ccCcc--------hhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 33222 23356889999999999999999999876
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=308.66 Aligned_cols=249 Identities=24% Similarity=0.375 Sum_probs=197.6
Q ss_pred CccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeec
Q 002346 583 FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
|++.+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 677889999999999999654 5788899988654 3445678899999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
++++|..++... ..++++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 85 ~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 85 AGGAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred CCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 999999887541 2468999999999999999999999 899999999999999999999999999987554322
Q ss_pred ceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 742 YSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
.......|++.|+|||++. ...++.++|||||||++|||++|+.||....+... ... ..... .+..
T Consensus 158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~----~~~~~--~~~~ 228 (282)
T cd06643 158 -QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLK----IAKSE--PPTL 228 (282)
T ss_pred -cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHH----HhhcC--CCCC
Confidence 1223356899999999873 34578899999999999999999999976432111 111 11100 0110
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+ ......+.+++.+|++.+|.+||++.++++
T Consensus 229 ~~~--------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 AQP--------SRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred CCc--------cccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 011245779999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=315.77 Aligned_cols=269 Identities=23% Similarity=0.365 Sum_probs=202.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|.. .+++.||+|.++.... ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 5789999999999999999955 4688999999875532 2334567889999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|++ ++|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 85 ~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 156 (301)
T cd07873 85 YLD-KDLKQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSI 156 (301)
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCC
Confidence 996 6898888652 2458899999999999999999999 8999999999999999999999999999875443
Q ss_pred CCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc--cCCCCcc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS--KENIPKA 816 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 816 (933)
... ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+...... ...++..
T Consensus 157 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 232 (301)
T cd07873 157 PTK-TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGI 232 (301)
T ss_pred CCC-cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCChhhchhh
Confidence 221 1123457899999998765 4578899999999999999999999976543221 1111111100 0001110
Q ss_pred cC---------CCCCCC---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 817 ID---------PNLNLD---EETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 817 ~d---------~~l~~~---~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
++ +..... .........+.+++.+|++.||.+|||++|+++ ++|..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~------h~~f~ 290 (301)
T cd07873 233 LSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK------HPYFH 290 (301)
T ss_pred hccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc------Ccccc
Confidence 00 000000 000111235679999999999999999999986 56654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=312.85 Aligned_cols=265 Identities=25% Similarity=0.358 Sum_probs=203.9
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.++++++||||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 578899999999999999965 4789999999987654455567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+ +++|.+++.... .++++.+++.++.|+++||+|||+ .+++|+||||+||+++.++.++|+|||++......
T Consensus 81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 999999986522 568999999999999999999998 89999999999999999999999999998866543
Q ss_pred CceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc---------
Q 002346 741 KYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--------- 810 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 810 (933)
.........|+..|+|||++.+. .++.++||||+|+++|||++|++||....+.. ...++.......
T Consensus 153 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred CCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhcc
Confidence 32223345789999999988654 46899999999999999999988776543211 111111111000
Q ss_pred --CCCCcccCCC---CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 --ENIPKAIDPN---LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 --~~~~~~~d~~---l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
........+. ........+....+.+++.+|++.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 0000000000 0000000122357889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.93 Aligned_cols=266 Identities=22% Similarity=0.326 Sum_probs=204.1
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|... +++.||+|+++.........+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36889999999999999999654 68899999987654445556789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|++++.+..+... ...+++.++..++.|+++|++|||+ .+++||||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~ 152 (288)
T cd07833 81 YVERTLLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRA 152 (288)
T ss_pred cCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence 9988766655532 2448999999999999999999998 8999999999999999999999999999886655
Q ss_pred CCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh----------
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI---------- 808 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~---------- 808 (933)
..........++..|+|||++.+. .++.++||||||+++|||++|+.||......+.. ........
T Consensus 153 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 153 RPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL---YLIQKCLGPLPPSHQELF 229 (288)
T ss_pred CccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHhhhc
Confidence 433233445788999999999887 7899999999999999999999999764332211 11111000
Q ss_pred -ccC-----CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 809 -SKE-----NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 809 -~~~-----~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... ..++..++.............++.+++.+|++.+|++||+++++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 0000000000000000112456889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=305.54 Aligned_cols=251 Identities=22% Similarity=0.366 Sum_probs=204.3
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|+||.||++.. .+|+.||+|++..........+++.+|+.++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588899999999999999954 5789999999876544455567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++... ....+++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++......
T Consensus 81 ~~~~~l~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~ 154 (256)
T cd08218 81 CEGGDLYKKINAQ---RGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST 154 (256)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence 9999999998652 12357899999999999999999998 89999999999999999999999999998765443
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
... .....|++.|+|||+..+..++.++|||||||++|||++|+.||......+ ....... ...+. +..
T Consensus 155 ~~~-~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~~--~~~~~-~~~- 223 (256)
T cd08218 155 VEL-ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKIIR--GSYPP-VSS- 223 (256)
T ss_pred hhh-hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHhc--CCCCC-Ccc-
Confidence 221 223468899999999988889999999999999999999999997543211 1112111 11111 111
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+.+++.+|++.+|++||++.++++
T Consensus 224 --------~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 224 --------HYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred --------cCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11245789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=302.41 Aligned_cols=248 Identities=31% Similarity=0.501 Sum_probs=198.9
Q ss_pred CccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
++||+|+||.||++...+++.||+|++...... .....+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 469999999999998766999999988765432 4567899999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceee-
Q 002346 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE- 745 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~- 745 (933)
.+++... ...+++..+..++.+++.|++|||+ ++++||||||+||+++.++.+||+|||++...........
T Consensus 80 ~~~l~~~----~~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 152 (251)
T cd05041 80 LTFLRKK----KNRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD 152 (251)
T ss_pred HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence 9998542 2357899999999999999999998 8999999999999999999999999999886543322221
Q ss_pred cccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCC
Q 002346 746 TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLD 824 (933)
Q Consensus 746 ~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 824 (933)
....++..|+|||++.++.++.++||||||+++|||++ |..||....+..... . ........ ..
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~------~-~~~~~~~~--~~------ 217 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRE------R-IESGYRMP--AP------ 217 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHH------H-HhcCCCCC--CC------
Confidence 12234667999999988899999999999999999999 788886543322111 1 11111000 00
Q ss_pred hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 825 EETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 825 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
......+.+++.+|++.+|++||++.|+++.|+
T Consensus 218 ---~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 218 ---QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred ---ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 011246789999999999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=335.23 Aligned_cols=276 Identities=17% Similarity=0.239 Sum_probs=193.1
Q ss_pred HHhcCCccCCccccCCCeEEEEEEeC--CCcEEEEEE--------------eccc-cCCchhHHHHHHHHHHHHhcCCCc
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGELP--DGTKIAVKR--------------MESN-TMGNKGLSEFQAEIAVLTKVRHRH 640 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~--------------~~~~-~~~~~~~~~~~~E~~~l~~l~h~n 640 (933)
...++|++++.||+|+||.||++..+ .+..+++|. +.+. .........+.+|+.++++++|||
T Consensus 145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence 34578999999999999999998543 222222221 1110 112233457889999999999999
Q ss_pred ceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 641 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
||++++++...+..++|+|++ +++|.+++..............++..|+.|++.||+|||+ ++||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEE
Confidence 999999999999999999998 4678887754322212234466788999999999999999 899999999999999
Q ss_pred cCCCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCC-CCCCCCchhhHH
Q 002346 721 GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKA-LDDTMPDDRAHL 799 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p-~~~~~~~~~~~~ 799 (933)
+.++.+||+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.+ +..........+
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999987655433333456799999999999999999999999999999999999864 433322222222
Q ss_pred HHHHHHHhhccCCCCcc-------cC--------CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 800 VTWFRRVLISKENIPKA-------ID--------PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 800 ~~~~~~~~~~~~~~~~~-------~d--------~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+.........+++. ++ ..+............+.+++.+|++.||++||++.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 22221111001111100 00 000000000001124567899999999999999999986
|
|
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.79 Aligned_cols=249 Identities=26% Similarity=0.448 Sum_probs=203.2
Q ss_pred cCCccCCccccCCCeEEEEEEeCC-CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|+..+.||+|+||.||+|...+ ++.||+|.+.... ..+++.+|++++++++||||+++++++..+...+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 578899999999999999997654 7899999987542 16789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ...+++..+..++.|+++|++|||+ .+++||||+|+||+++.++.+||+|||++.....
T Consensus 79 ~~~~~~L~~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 79 YCGAGSVSDIMKIT----NKTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred cCCCCcHHHHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999998541 2568999999999999999999998 8999999999999999999999999999886654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.||....+...... . ..... +
T Consensus 152 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--------~-~~~~~----~ 217 (256)
T cd06612 152 TMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--------I-PNKPP----P 217 (256)
T ss_pred Ccc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--------h-ccCCC----C
Confidence 321 22334588999999999888999999999999999999999999976433221100 0 00000 0
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+. ........+.+++.+|++.+|++||++.|+++
T Consensus 218 ~~~---~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 218 TLS---DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred CCC---chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 111 11112245789999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=311.10 Aligned_cols=263 Identities=29% Similarity=0.464 Sum_probs=204.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC-----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--Cce
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~ 653 (933)
+.|+..+.||+|+||.||+|... +++.||||++...... ...++|.+|+++++.++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46778899999999999999653 3689999999866432 356789999999999999999999999877 557
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+++||||||+||+++.++.++|+|||.
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~ 155 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGL 155 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccc
Confidence 899999999999999996521 258999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCce--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhh--------HHHHHH
Q 002346 734 VKNAPDGKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA--------HLVTWF 803 (933)
Q Consensus 734 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~--------~~~~~~ 803 (933)
+......... ......++..|+|||+..+..++.++||||||+++|||++|+.|+......... ......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05038 156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL 235 (284)
T ss_pred ccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH
Confidence 9866533221 112234566799999998888999999999999999999999998653221100 000111
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
..........+. . .....++.+++.+|++.+|++||++.|++++|+.+
T Consensus 236 ~~~~~~~~~~~~--~---------~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 236 LELLKEGERLPR--P---------PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HHHHHcCCcCCC--C---------ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 111111111100 0 11124688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=309.69 Aligned_cols=238 Identities=24% Similarity=0.439 Sum_probs=186.8
Q ss_pred ccccCCCeEEEEEEeCC-------------------------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcce
Q 002346 588 ILGRGGFGVVYGGELPD-------------------------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642 (933)
Q Consensus 588 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv 642 (933)
.||+|+||.||+|.... ...||+|++.... .....+|.+|+.+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 69999999999996421 2358899886542 23346788999999999999999
Q ss_pred eEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC
Q 002346 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (933)
Q Consensus 643 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~ 722 (933)
++++++..+...++||||+++|+|..++... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~ 152 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLAR 152 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEec
Confidence 9999999999999999999999999988541 2458899999999999999999998 89999999999999976
Q ss_pred CC-------cEEEecccccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHH-cCCCCCCCCCC
Q 002346 723 DM-------RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETI-TGRKALDDTMP 793 (933)
Q Consensus 723 ~~-------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~ell-tG~~p~~~~~~ 793 (933)
.+ .+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||....+
T Consensus 153 ~~~~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~ 227 (274)
T cd05076 153 LGLAEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP 227 (274)
T ss_pred cCcccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence 43 3899999987644322 12357888999998865 56899999999999999994 79999976543
Q ss_pred chhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 794 DDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
.... .... .....+... ...+.+++.+||+.+|++||++.++++.|
T Consensus 228 ~~~~---~~~~----~~~~~~~~~-------------~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 228 SEKE---RFYE----KKHRLPEPS-------------CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred HHHH---HHHH----hccCCCCCC-------------ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 3221 1111 111111110 12477999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=307.52 Aligned_cols=258 Identities=27% Similarity=0.465 Sum_probs=205.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||.|+||.||+|.. .++..+|+|++....... ..+.+.+|+++++.++|+||+++++.+..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999964 468899999987654333 56789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++..... ...+++..+..++.|++.|++|||+ .+|+||||+|+||++++++.++|+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 80 YLSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred ccCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 9999999999965221 2458999999999999999999998 8999999999999999999999999999876554
Q ss_pred CCce---eecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 740 GKYS---VETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 740 ~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
.... ......|+..|+|||++... .++.++||||||+++|||++|+.||....+... ... ..... +.
T Consensus 155 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~----~~~~~---~~ 225 (267)
T cd06610 155 GGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LML----TLQND---PP 225 (267)
T ss_pred CccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHH----HhcCC---CC
Confidence 3322 22334689999999998776 789999999999999999999999976533211 111 11111 00
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+............+.+++.+|++.+|++||++.++++
T Consensus 226 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 226 ----SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred ----CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 11100001122346779999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=308.92 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=199.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+.|++.+.||+|+||.||+|.. .+++.||+|.+... .....+++.+|+.+++.++||||+++++++..+...++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 6788999999999999999965 45889999998754 34556789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|..++.+. ...+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 90 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 162 (292)
T cd06644 90 FCPGGAVDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK 162 (292)
T ss_pred cCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence 99999998887542 2458999999999999999999998 8999999999999999999999999998875433
Q ss_pred CCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
.. .......+++.|+|||++. ...++.++|||||||++|||++|+.||....+... ..... ....+
T Consensus 163 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~--~~~~~ 233 (292)
T cd06644 163 TL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIA--KSEPP 233 (292)
T ss_pred cc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHh--cCCCc
Confidence 21 1123346889999999884 34568899999999999999999999976432111 11111 11111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... .......+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~--------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 TLSQ--------PSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred cCCC--------CcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1000 0111235778999999999999999999986
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=307.03 Aligned_cols=259 Identities=29% Similarity=0.476 Sum_probs=202.0
Q ss_pred CccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc------
Q 002346 583 FSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 652 (933)
|.+.+.||+|+||.||+|... +++.||||++..........+++.+|++++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 567889999999999999642 3688999999876555566778999999999999999999999886532
Q ss_pred eeEEEEeecCCCChhhHhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHD-HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
..++++||+.+|+|.+++..... .....+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence 23788999999999998754221 112357899999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 732 GLVKNAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 732 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|+++........ ......+++.|++||.+....++.++||||||+++|||++ |+.||...... ....+.. .
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~---~- 230 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI---K- 230 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH---c-
Confidence 998865433221 1122345678999999988889999999999999999999 88888654321 1222111 1
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
..... ..+ .....+.+++.+|++.+|++||++.++++.|+++
T Consensus 231 ~~~~~--~~~---------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 231 GNRLK--QPP---------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCcCC--CCC---------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111 001 1124678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=310.89 Aligned_cols=249 Identities=25% Similarity=0.443 Sum_probs=201.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+.|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3466778899999999999954 468899999887553 23445789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. ..+++..+..++.|+++|++|||+ ++++|+||+|+||++++++.++++|||++.....
T Consensus 83 ~~~~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 83 YLGGGSALDLLKP------GPLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred ccCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccC
Confidence 9999999998853 458899999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ......|+..|+|||++.+..++.++||||||+++|||++|+.|+....+.... . . . .... .+
T Consensus 154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~---~---~-~-~~~~-----~~ 219 (277)
T cd06642 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL---F---L-I-PKNS-----PP 219 (277)
T ss_pred cch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH---h---h-h-hcCC-----CC
Confidence 321 122346889999999999888999999999999999999999998754332211 0 0 0 0111 11
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
.+. ......+.+++.+|++.+|++||++.++++.
T Consensus 220 ~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 220 TLE-----GQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCC-----cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 111 1122457799999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=305.35 Aligned_cols=256 Identities=21% Similarity=0.317 Sum_probs=205.4
Q ss_pred CCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--CceeEEEE
Q 002346 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLLVY 658 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~ 658 (933)
+|++.+.||.|+||.||++. ..+++.||+|++..........+++..|+++++.++||||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 47888999999999999995 4578899999998765556667789999999999999999999998754 45678999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA--QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||+++++|.+++..... ...++++..++.++.|++.|++|||..+ ..+++|+||||+||+++.++.+||+|||++..
T Consensus 81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 99999999999976322 2357899999999999999999999221 28999999999999999999999999999886
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
....... .....|++.|+|||++....++.++||||||+++|+|++|+.||...... .....+ . .... ..
T Consensus 160 ~~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~~---~--~~~~-~~ 229 (265)
T cd08217 160 LGHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASKI---K--EGKF-RR 229 (265)
T ss_pred ccCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHHH---h--cCCC-CC
Confidence 6543321 23346899999999998888999999999999999999999999765321 111111 1 1111 11
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.. .....+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~---------~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 230 IPY---------RYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred Ccc---------ccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 111 12246779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=318.41 Aligned_cols=250 Identities=25% Similarity=0.448 Sum_probs=202.5
Q ss_pred ccCCccccCCCeEEEEEEeC--CCc--EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 584 SEANILGRGGFGVVYGGELP--DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
...++||+|.||.|++|.|. +|+ .||||.++...... ...+|.+|+.+|.+|+|||++++||...+ ....+|||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 34688999999999999664 454 57999998875443 67899999999999999999999999876 67789999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
.++.|+|.+.|++ .....+-......++.|||.|+.||.+ +++||||+.++|+++.....|||+|||+.+....
T Consensus 191 LaplGSLldrLrk---a~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ 264 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK---AKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGE 264 (1039)
T ss_pred hcccchHHHHHhh---ccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence 9999999999976 223568889999999999999999999 9999999999999999999999999999997665
Q ss_pred CCc-ee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 740 GKY-SV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 740 ~~~-~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
.+. +. .....-...|+|||.+....++.++|||+|||++|||+| |..||-+......... +...+.+++
T Consensus 265 ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~-------iD~~erLpR- 336 (1039)
T KOG0199|consen 265 NEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN-------IDAGERLPR- 336 (1039)
T ss_pred CCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh-------ccccccCCC-
Confidence 432 22 223344568999999999999999999999999999999 6678876543222111 112222221
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
. ..+.+.+.+++..||..+|++||++..+.+.+
T Consensus 337 -------P---k~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 337 -------P---KYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred -------C---CCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1 23345788999999999999999999998544
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=304.90 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=195.4
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC---chhHHHHHHHHHHHHhcCCCcceeEEeEeee--Ccee
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~ 654 (933)
.+|+..+.||+|+||.||+|.. .++..||+|++...... ......+.+|+.++++++||||+++++++.. +...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688999999999999999954 56899999988754322 2345678899999999999999999998865 3567
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
+++|||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 82 ~l~~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~ 153 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-----YGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence 899999999999999965 2458899999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCC--ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 735 KNAPDGK--YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 735 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+...... ........++..|+|||++.+..++.++||||+||++|||++|+.||........ +..... ...
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~-~~~ 226 (266)
T cd06651 154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIAT-QPT 226 (266)
T ss_pred cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhc-CCC
Confidence 7543211 1111234688999999999888899999999999999999999999975432111 111111 100
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+.+. ......+.+++ +|+..+|++||++.|+++
T Consensus 227 -----~~~~~-----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 -----NPQLP-----SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred -----CCCCc-----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 11111 11123345666 688899999999999976
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=305.57 Aligned_cols=251 Identities=29% Similarity=0.461 Sum_probs=192.3
Q ss_pred CccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEee-eCceeEEEEeec
Q 002346 587 NILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI-NGSERLLVYEYM 661 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~ 661 (933)
+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.+++.++||||+++++++. .+...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 46899999999999643 24579999875432 2344678899999999999999999999876 455678999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
.+++|.+++... ....++..+..++.|+++|++|||+ .+++||||||+||++++++.+||+|||+++......
T Consensus 80 ~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~ 152 (262)
T cd05058 80 KHGDLRNFIRSE----THNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE 152 (262)
T ss_pred CCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence 999999999652 1346788889999999999999998 899999999999999999999999999987554322
Q ss_pred cee---ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCC-CCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 742 YSV---ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR-KALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 742 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... .....+++.|+|||++.+..++.++||||||+++|||++|. +||..... ..... .... ..... .
T Consensus 153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~---~~~~-~~~~~--~ 223 (262)
T cd05058 153 YYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITV---YLLQ-GRRLL--Q 223 (262)
T ss_pred ceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHH---HHhc-CCCCC--C
Confidence 111 12335677899999998889999999999999999999965 55544322 11111 1111 11110 0
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
+.. ....+.+++.+||+.+|++||++.++++.|+++.
T Consensus 224 ~~~---------~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 224 PEY---------CPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred CCc---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 100 1235779999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=305.79 Aligned_cols=257 Identities=26% Similarity=0.421 Sum_probs=203.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCc----EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.+|++.+.||+|+||.||+|... +|+ .||+|.+.... ......++.+|+.++++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 57888999999999999999653 333 58999887653 23445788999999999999999999999987 7889
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++... ...+++..+..++.|+++|++|||+ ++|+||||||+||++++++.+||+|||+++
T Consensus 85 ~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~ 157 (279)
T cd05057 85 LITQLMPLGCLLDYVRNH----KDNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAK 157 (279)
T ss_pred EEEecCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccc
Confidence 999999999999999652 2358999999999999999999998 899999999999999999999999999998
Q ss_pred cCCCCCceee-cccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 736 NAPDGKYSVE-TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 736 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
.......... ....++..|+|||.+....++.++||||||+++||+++ |+.||......+ ... .... ....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~---~~~~-~~~~ 230 (279)
T cd05057 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPD---LLEK-GERL 230 (279)
T ss_pred cccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHH---HHhC-CCCC
Confidence 6654332211 12234568999999988889999999999999999999 999997653322 111 1111 1111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
+ .+.. ....+.+++.+|+..+|.+||++.++++.|+++..
T Consensus 231 ~--~~~~---------~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 231 P--QPPI---------CTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred C--CCCC---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 1 0111 11346789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.32 Aligned_cols=254 Identities=22% Similarity=0.383 Sum_probs=200.6
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||++... +++.||+|.+.... .......+.+|+.++++++||||+++++++......++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 46888999999999999999664 78999999887542 33445789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.... ....+++..+..++.|++.|+.|||+ +.+|+||||||+||+++.++.+||+|||++.....
T Consensus 80 ~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 155 (286)
T cd06622 80 YMDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVA 155 (286)
T ss_pred ecCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccC
Confidence 999999999886521 12468999999999999999999996 25999999999999999999999999999875533
Q ss_pred CCceeecccccccCcccccccCCC------CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATG------RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
.. .....|++.|+|||++.+. .++.++|||||||++|||++|+.||........ ......... . .
T Consensus 156 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~--~-~ 226 (286)
T cd06622 156 SL---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI---FAQLSAIVD--G-D 226 (286)
T ss_pred Cc---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH---HHHHHHHhh--c-C
Confidence 21 2234688899999988544 357899999999999999999999975432211 111111111 1 1
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+..+.+ .....+.+++.+|++.+|++||++.+++.
T Consensus 227 ~~~~~~---------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 227 PPTLPS---------GYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCCCCc---------ccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111111 12245779999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=303.60 Aligned_cols=249 Identities=27% Similarity=0.458 Sum_probs=201.2
Q ss_pred CCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccC---CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM---GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+|+..+.||+|+||.||+|... +++.||+|.+..... ..+..+.+.+|+++++.++|+||+++++++..+...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999665 789999998865432 233557899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++.. ..++++..+..++.|+++|++|||+ .+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~ 152 (258)
T cd06632 81 LELVPGGSLAKLLKK-----YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQV 152 (258)
T ss_pred EEecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence 999999999999865 2458899999999999999999998 89999999999999999999999999998765
Q ss_pred CCCCceeecccccccCcccccccCCCC-CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGR-VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
.... ......|++.|+|||.+.... ++.++|+||||+++|+|++|+.||....+... .. .... ....+ .
T Consensus 153 ~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~----~~~~-~~~~~-~ 222 (258)
T cd06632 153 VEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VF----KIGR-SKELP-P 222 (258)
T ss_pred cccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HH----HHHh-cccCC-C
Confidence 4332 223456889999999987766 89999999999999999999999976542111 11 1110 01111 1
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.+.. ...+.+++.+|++.+|++||++.++++
T Consensus 223 ~~~~~---------~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 223 IPDHL---------SDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCCc---------CHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11111 135678999999999999999999985
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.79 Aligned_cols=248 Identities=26% Similarity=0.466 Sum_probs=203.2
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
..|+..+.||+|+||.||+|.. .+++.||+|.+.... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 4577889999999999999965 468899999887543 23456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. .++++.++..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 83 YLGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred cCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 9999999999854 458899999999999999999998 8999999999999999999999999999876544
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ......++..|+|||++.+..++.++||||||+++|||++|+.||....+...... . .... + +
T Consensus 154 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~-~~~~-~----~ 219 (277)
T cd06640 154 TQI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------I-PKNN-P----P 219 (277)
T ss_pred Ccc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------h-hcCC-C----C
Confidence 321 12334688899999999888899999999999999999999999976543221110 0 0110 0 1
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ........+.+++.+|++.+|++||++.++++
T Consensus 220 ~-----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 220 T-----LTGEFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred C-----CchhhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 1 11223456789999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=314.65 Aligned_cols=268 Identities=23% Similarity=0.367 Sum_probs=201.4
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+++++.++||||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46889999999999999999764 58999999987654444445678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.++... ...+++.++..++.|+++|++|||+ .+|+||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY-----PNGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999988887643 2348999999999999999999998 8999999999999999999999999999886544
Q ss_pred CCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhh-HHHHHHHH-------Hhhcc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA-HLVTWFRR-------VLISK 810 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~-~~~~~~~~-------~~~~~ 810 (933)
.. .......++..|+|||++.+ ..++.++||||||+++|||++|++||......+.. ....+... .....
T Consensus 153 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (286)
T cd07846 153 PG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN 231 (286)
T ss_pred Cc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence 32 22233568899999998865 45788999999999999999999998754321111 11100000 00000
Q ss_pred CCCCcccCCCCCCCh----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 ENIPKAIDPNLNLDE----ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~----~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
........+...... ........+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 000000000000000 00112356789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=304.14 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=204.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|.. .+++.+|+|.+.... ....+.+.+|++++++++||||+++++++..+...+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 6788999999999999999965 467899999987653 2356789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ...+++.++..++.|++.|++|||+ .+|+||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 153 (262)
T cd06613 81 YCGGGSLQDIYQVT----RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA 153 (262)
T ss_pred CCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence 99999999988652 1458899999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeecccccccCcccccccCCC---CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATG---RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
... ......|+..|+|||.+... .++.++||||||+++|||++|+.||....+....... . ......
T Consensus 154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~------~--~~~~~~- 223 (262)
T cd06613 154 TIA-KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI------S--KSNFPP- 223 (262)
T ss_pred hhh-ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------H--hccCCC-
Confidence 221 12335688899999998776 7899999999999999999999999765433221110 0 110000
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.+. ........+.+++.+|++.+|.+||++.+++.
T Consensus 224 --~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 --PKLK---DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred --cccc---chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0011 11223456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=310.29 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=201.4
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCc----EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
++|+..+.||+|+||.||+|.. .+|+ .||+|.+.... ......++.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 5678889999999999999965 3444 57888876543 233345789999999999999999999998754 467
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+++||+++|+|.+++... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 85 ~v~e~~~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred eeehhcCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEccccccc
Confidence 899999999999998652 2358899999999999999999998 899999999999999999999999999998
Q ss_pred cCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 736 NAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 736 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....... ...+. ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~~ 230 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKGERL 230 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCCC
Confidence 65433221 1122345778999999988889999999999999999997 889987543222 11211 111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
+. .+. ....+.+++..|+..+|++||+++++++.|+.+.+.
T Consensus 231 ~~--~~~---------~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 231 PQ--PPI---------CTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CC--CCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 10 000 123567899999999999999999999999887544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=302.45 Aligned_cols=250 Identities=22% Similarity=0.368 Sum_probs=203.6
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|+..+.||+|+||.||++.. .+++.+|+|++............+.+|++++++++||||+++++.+..+...++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 578899999999999999854 5788999999987665666678899999999999999999999999989999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEEecccccccCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAPD 739 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~ 739 (933)
+++++|.+++.... ...+++..+..++.++++|++|||+ ++|+||||||+||++++++ .+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 99999999996522 2458999999999999999999998 8999999999999998654 689999999886654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........ . ....... .. .+..
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~---~~~~~~~--~~-~~~~ 223 (256)
T cd08220 155 KSK--AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---V---LKIMSGT--FA-PISD 223 (256)
T ss_pred Ccc--ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---H---HHHHhcC--CC-CCCC
Confidence 321 2234688999999999888899999999999999999999999976533211 1 1111111 11 1111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ....+.+++.+|++.+|++||++.|+++
T Consensus 224 ~---------~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 224 R---------YSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C---------cCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 1235779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=302.81 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=203.0
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|+||.||+|.. .+++.||+|.++.........+.+.+|+.+++.++|+||+++++++......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 588899999999999999965 4789999999987654445678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++.. ...+++..+..++.++++|++|||+ .+|+|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~ 152 (264)
T cd06626 81 CSGGTLEELLEH-----GRILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152 (264)
T ss_pred CCCCcHHHHHhh-----cCCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence 999999999865 2357899999999999999999998 89999999999999999999999999998866543
Q ss_pred Cceeec---ccccccCcccccccCCCC---CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 741 KYSVET---RLAGTFGYLAPEYAATGR---VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 741 ~~~~~~---~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
...... ...+++.|+|||++.+.. ++.++||||||+++||+++|+.||........ . ...... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~---~~~~~~---~~~ 224 (264)
T cd06626 153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--I---MFHVGA---GHK 224 (264)
T ss_pred CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--H---HHHHhc---CCC
Confidence 322211 346788999999997766 88999999999999999999999975432111 1 111111 111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+.... .....+.+++.+|++.+|++||++.+++.
T Consensus 225 ~~~~~~~-------~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 225 PPIPDSL-------QLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCCccc-------ccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 1111111 11234678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=310.49 Aligned_cols=246 Identities=29% Similarity=0.416 Sum_probs=201.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||++.. .+++.||+|++..... .....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4688999999999999999955 4689999999876432 2334577899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+|+||||+|+||+++.++.+||+|||+++...
T Consensus 81 e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 152 (290)
T cd05580 81 EYVPGGELFSHLRK-----SGRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK 152 (290)
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999865 2568999999999999999999999 899999999999999999999999999988665
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.. .....|++.|+|||.+.+...+.++||||||+++|+|++|+.||....... . ..........++..+
T Consensus 153 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~---~~~~~~~~~~~~~~~- 221 (290)
T cd05580 153 GR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---I---YEKILEGKVRFPSFF- 221 (290)
T ss_pred CC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHhcCCccCCccC-
Confidence 43 233468999999999988888999999999999999999999997643211 1 111111111111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
...+.+++.+|++.+|.+|| +++|+++
T Consensus 222 ------------~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 222 ------------SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred ------------CHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 23567999999999999999 6666654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=302.81 Aligned_cols=247 Identities=32% Similarity=0.489 Sum_probs=198.0
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|++.+.||+|+||.||++.. +++.||+|.+.... ..+.+.+|+.+++.++||||+++++++... ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4688999999999999999975 68889999986542 246789999999999999999999998654 47899999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++... ....+++.++..++.|+++|++|||+ .+++||||||+||+++.++.+||+|||++......
T Consensus 80 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~ 153 (254)
T cd05083 80 MSKGNLVNFLRTR---GRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG 153 (254)
T ss_pred CCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceecccc
Confidence 9999999999652 22458899999999999999999998 89999999999999999999999999998754332
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
. .....+..|+|||++.++.++.++||||||+++|||++ |+.||......+. .. . .. ...... ...
T Consensus 154 ~----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~---~-~~-~~~~~~-~~~ 220 (254)
T cd05083 154 V----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV---KE---C-VE-KGYRME-PPE 220 (254)
T ss_pred C----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH---HH---H-Hh-CCCCCC-CCC
Confidence 1 12234578999999988899999999999999999997 9999876533221 11 1 11 111111 011
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
.....+.+++.+|++.+|++||+++++++.|++
T Consensus 221 ---------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 221 ---------GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 112457799999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=309.67 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=201.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+++.||+|.+... .....+.|.+|++++++++||||+++++++..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 36788999999999999999965 46899999998754 3445578999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++... ...+++.++..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||++....
T Consensus 82 e~~~~~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 82 EFCDGGALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred eccCCCcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 999999999998552 2468999999999999999999999 899999999999999999999999999887544
Q ss_pred CCCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
.... ......|++.|+|||++. ...++.++||||||+++|||++|+.||........ . ..... ...
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~--~~~ 225 (280)
T cd06611 155 STLQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--L----LKILK--SEP 225 (280)
T ss_pred cccc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--H----HHHhc--CCC
Confidence 3221 123346899999999874 34567899999999999999999999976532211 1 11111 111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+. ++. .......+.+++.+|++.+|++||++.++++
T Consensus 226 ~~-~~~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 226 PT-LDQ-------PSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CC-cCC-------cccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 11 100 0011235778999999999999999999976
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=315.00 Aligned_cols=250 Identities=24% Similarity=0.385 Sum_probs=212.5
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
...|.+.+.||+|.|+.|..|. ..++..||+|.+.+........+.+.+|+++|..++|||||+++.+.......|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4578899999999999999994 457999999999998777777777999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+.+|.+.+++... +...+.++..++.|+.+|++|||+ +.|||||||++||||+.+..+||+|||++..+.
T Consensus 135 eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~ 206 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFD 206 (596)
T ss_pred EeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeec
Confidence 999999999999763 334558889999999999999999 999999999999999999999999999998776
Q ss_pred CCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
.+. .....+|++.|+|||++.+..| ++++|+||+|+++|-|+.|..||++..-. ....+++..+..++..+
T Consensus 207 ~~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk------~Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 207 YGL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK------ELRPRVLRGKYRIPFYM 278 (596)
T ss_pred ccc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc------cccchheeeeeccccee
Confidence 432 3455799999999999998876 67999999999999999999999865322 11223344444555444
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
.. ++.+++++++-.+|.+|++++++.+-
T Consensus 279 s~-------------dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 279 SC-------------DCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred ec-------------hhHHHHHHhhccCccccCCHHHhhhh
Confidence 33 34589999999999999999998764
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=290.12 Aligned_cols=243 Identities=26% Similarity=0.412 Sum_probs=202.3
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|..+++||+|.||.|-.++ ...++.+|+|+++++.. ..++...-..|-++++..+||.+..+...++..++.++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 4678889999999999999984 45799999999998754 334556677899999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||..||.|.-+|.+ ...+++...+-+-.+|+.||.|||+ ++||.||+|.+|.|+|.+|++||.|||+.+.-
T Consensus 247 MeyanGGeLf~HLsr-----er~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~ 318 (516)
T KOG0690|consen 247 MEYANGGELFFHLSR-----ERVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEE 318 (516)
T ss_pred EEEccCceEeeehhh-----hhcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhc
Confidence 999999999988865 3568888899999999999999999 89999999999999999999999999998843
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
-... .....++|||.|.|||++....|..++|.|.+||++|||++|+.||.....+ .+ +.-++..+-..|..+
T Consensus 319 I~~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kL---FeLIl~ed~kFPr~l 391 (516)
T KOG0690|consen 319 IKYG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KL---FELILMEDLKFPRTL 391 (516)
T ss_pred cccc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HH---HHHHHhhhccCCccC
Confidence 3222 2345679999999999999999999999999999999999999999865322 12 222333344444443
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP 850 (933)
.+ +...++...+.+||.+|.
T Consensus 392 s~-------------eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 392 SP-------------EAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred CH-------------HHHHHHHHHhhcChHhhc
Confidence 32 345788899999999997
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=309.62 Aligned_cols=262 Identities=24% Similarity=0.364 Sum_probs=203.3
Q ss_pred cHHHHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEee
Q 002346 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCI 649 (933)
Q Consensus 572 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 649 (933)
..+++..+.++|++.+.||+|+||.||++.. .+++.+|+|++.... .....+.+|+.++.++ +|||++++++++.
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3455556678999999999999999999965 578899999986542 2235678899999999 8999999999987
Q ss_pred eC-----ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC
Q 002346 650 NG-----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM 724 (933)
Q Consensus 650 ~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 724 (933)
.. ...++||||+++++|.++++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~ 165 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEG 165 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCC
Confidence 53 357999999999999998865322 23568999999999999999999998 8999999999999999999
Q ss_pred cEEEecccccccCCCCCceeecccccccCcccccccCCC-----CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHH
Q 002346 725 RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG-----RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHL 799 (933)
Q Consensus 725 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~ 799 (933)
.+||+|||++......... .....|+..|+|||++... .++.++|||||||++|||++|+.||....+... +
T Consensus 166 ~~kl~dfg~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~ 242 (291)
T cd06639 166 GVKLVDFGVSAQLTSTRLR-RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--L 242 (291)
T ss_pred CEEEeecccchhccccccc-ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--H
Confidence 9999999998765433221 2234688999999987543 368899999999999999999999976432211 1
Q ss_pred HHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 800 VTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. .. ....+...++ ......+.+++.+|++.+|++||++.|+++
T Consensus 243 ~~----~~--~~~~~~~~~~--------~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 243 FK----IP--RNPPPTLLHP--------EKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HH----Hh--cCCCCCCCcc--------cccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 11 1111111111 112235789999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=312.49 Aligned_cols=248 Identities=25% Similarity=0.410 Sum_probs=198.1
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
.|.....||+|+||.||++.. .++..||||++... .....+.+.+|+.+++.++|+||+++++.+..++..++||||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 344456799999999999955 46889999998654 234456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++.. ..+++.++..++.|++.|++|||+ ++|+||||||+||++++++.++|+|||++......
T Consensus 101 ~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~ 171 (292)
T cd06658 101 LEGGALTDIVTH------TRMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE 171 (292)
T ss_pred CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccc
Confidence 999999998843 358899999999999999999999 89999999999999999999999999998754332
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.. ......|++.|+|||+..+..++.++||||||+++|||++|+.||....+.... ..+.. ..+..+..
T Consensus 172 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~------~~~~~~~~- 240 (292)
T cd06658 172 VP-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIRD------NLPPRVKD- 240 (292)
T ss_pred cc-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh------cCCCcccc-
Confidence 21 123356899999999998888999999999999999999999999764332211 11111 01111100
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......+.+++.+|+..+|.+||+++++++
T Consensus 241 ------~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 271 (292)
T cd06658 241 ------SHKVSSVLRGFLDLMLVREPSQRATAQELLQ 271 (292)
T ss_pred ------ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 0011235678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=306.63 Aligned_cols=254 Identities=23% Similarity=0.413 Sum_probs=201.0
Q ss_pred CCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCC----chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG----NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
+|+..+.||+|+||.||+|. ..+++.||+|++...... ....+.+.+|++++++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 47888999999999999995 467899999998754321 1235688999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEEecccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVK 735 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~ 735 (933)
||||+++++|.+++.+ ..++++..+..++.|++.|++|||+ ++++|+||||+||+++.++ .+||+|||.+.
T Consensus 81 v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~ 152 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-----YGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA 152 (268)
T ss_pred EEeccCCCcHHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence 9999999999999865 2468899999999999999999999 8999999999999998776 59999999987
Q ss_pred cCCCCCce---eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 736 NAPDGKYS---VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 736 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
........ ......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........... ...... . .
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~-~-~ 227 (268)
T cd06630 153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIAS-A-T 227 (268)
T ss_pred ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhc-c-C
Confidence 65432211 12234688999999999888899999999999999999999999975432221111 111110 0 0
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....++ ......+.+++.+|++.+|++||++.++++
T Consensus 228 ~~~~~~---------~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 228 TAPSIP---------EHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CCCCCc---------hhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 011111 112245778999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=308.73 Aligned_cols=264 Identities=24% Similarity=0.356 Sum_probs=199.0
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|+..+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999965 4689999999876544444456789999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+. ++|.+++... ....+++..+..++.|+++|++|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 81 ~~-~~l~~~~~~~---~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~ 153 (284)
T cd07860 81 LH-QDLKKFMDAS---PLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 153 (284)
T ss_pred cc-cCHHHHHHhC---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 95 6898888542 23568999999999999999999998 89999999999999999999999999998755432
Q ss_pred CceeecccccccCcccccccCCCC-CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc---------
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGR-VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--------- 810 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 810 (933)
.. ......+++.|+|||++.+.. ++.++||||||+++|||+||+.||......+ .....+.......
T Consensus 154 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07860 154 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS 230 (284)
T ss_pred cc-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHhCCCChhhhhhhhH
Confidence 21 122335788999999886544 5889999999999999999999997543221 1111111100000
Q ss_pred -----CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 -----ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 -----~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+......+ .........++.+++.+|++.||++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 231 LPDYKPSFPKWARQDF--SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHHHhhcccccccCH--HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 0000011234678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=308.26 Aligned_cols=240 Identities=21% Similarity=0.395 Sum_probs=187.9
Q ss_pred CccccCCCeEEEEEEeCC--------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 587 NILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
+.||+|+||.||+|.... ...||+|.+... .....+.+..|+.+++.++||||+++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 469999999999995432 335888887644 2334567889999999999999999999999989999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc--------EEEec
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR--------AKVAD 730 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--------~kl~D 730 (933)
||+++|+|.++++.. ...+++..+..++.|++.|++|||+ ++|+||||||+||+++.++. ++++|
T Consensus 79 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d 151 (258)
T cd05078 79 EYVKFGSLDTYLKKN----KNLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD 151 (258)
T ss_pred ecCCCCcHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEecc
Confidence 999999999999652 1358899999999999999999998 89999999999999987765 69999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCC-CCCCCCCCchhhHHHHHHHHHhh
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGR-KALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~-~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
||++...... ....++..|+|||++.+ ..++.++||||||+++|||++|. .|+....+.... . ...
T Consensus 152 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~---~----~~~ 219 (258)
T cd05078 152 PGISITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL---Q----FYE 219 (258)
T ss_pred cccccccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH---H----HHH
Confidence 9988654432 23467889999999976 45789999999999999999995 555433221111 1 111
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
....++.. ...++.+++.+|++.+|++||+++++++.|+
T Consensus 220 ~~~~~~~~-------------~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 DRHQLPAP-------------KWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred ccccCCCC-------------CcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11111111 1135779999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=306.03 Aligned_cols=252 Identities=30% Similarity=0.512 Sum_probs=197.4
Q ss_pred CccccCCCeEEEEEEeCC-------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 587 NILGRGGFGVVYGGELPD-------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+.||+|+||.||+|...+ ++.||+|.+.... ......++.+|+.+++.++||||+++++++...+..++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 369999999999996532 2579999886542 23446789999999999999999999999999899999999
Q ss_pred ecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-----cEEEeccc
Q 002346 660 YMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-----RAKVADFG 732 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-----~~kl~DfG 732 (933)
|+++++|.+++...... ....+++.++..++.|+++|++|||+ .+++|+||||+||+++.++ .++++|||
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg 156 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFG 156 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcc
Confidence 99999999999753221 12347899999999999999999998 8999999999999999887 89999999
Q ss_pred ccccCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 733 LVKNAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 733 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
+++........ ......++..|+|||++.++.++.++||||||+++|||++ |+.||...... .....+ ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~---~~~~~~----~~~ 229 (269)
T cd05044 157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ---EVLQHV----TAG 229 (269)
T ss_pred cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH---HHHHHH----hcC
Confidence 98755433221 1223356788999999999999999999999999999998 99998654321 111111 111
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
... . .. ......+.+++.+|++.+|++||++.++++.|+
T Consensus 230 ~~~-~-~~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~ 268 (269)
T cd05044 230 GRL-Q-KP---------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ 268 (269)
T ss_pred Ccc-C-Cc---------ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence 100 0 00 112245779999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=282.30 Aligned_cols=248 Identities=25% Similarity=0.407 Sum_probs=195.8
Q ss_pred cCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEEEeecC
Q 002346 585 EANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
.+..||.|+-|.||+++. ..|...|||.+.... ..++.+++.+.+.++...+ +|+||+.+|||..+...++.||.|.
T Consensus 96 ~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 96 NLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 356699999999999965 458899999998875 4455678888888877774 9999999999999999999999983
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 742 (933)
.-++..+++ ..+++++..+-++...++.||.||.+ +++|+|||+||+|||+|+.|.+|+||||++....+..
T Consensus 175 -~C~ekLlkr----ik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk- 246 (391)
T KOG0983|consen 175 -TCAEKLLKR----IKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK- 246 (391)
T ss_pred -HHHHHHHHH----hcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence 233334433 23679999999999999999999998 5999999999999999999999999999997665533
Q ss_pred eeecccccccCcccccccCC---CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 743 SVETRLAGTFGYLAPEYAAT---GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
..+..+|.+.|||||.+.- ..|+-++||||||++++||.||+.||.....+= +...+++. ..+..++.
T Consensus 247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-----e~ltkvln---~ePP~L~~ 317 (391)
T KOG0983|consen 247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-----EVLTKVLN---EEPPLLPG 317 (391)
T ss_pred -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-----HHHHHHHh---cCCCCCCc
Confidence 3456789999999999854 368889999999999999999999998743221 11222222 11222222
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.-. ....+.+++..|+++|+.+||.+.++++
T Consensus 318 ~~g-------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 318 HMG-------FSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred ccC-------cCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 211 2245789999999999999999999986
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=314.23 Aligned_cols=198 Identities=26% Similarity=0.403 Sum_probs=161.0
Q ss_pred CCccccCCCeEEEEEEeC---CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--CceeEEEEee
Q 002346 586 ANILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLLVYEY 660 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~ 660 (933)
..+||+|+||.||+|... ++..||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 367999999999999754 457899998875432 2467899999999999999999998854 4577899999
Q ss_pred cCCCChhhHhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe----cCCCcEEEeccc
Q 002346 661 MPRGTLAQHLFEWHD----HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFG 732 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~DfG 732 (933)
++ ++|.+++..... .....+++..++.++.|+++||+|||+ .+|+||||||+||++ +.++.+||+|||
T Consensus 82 ~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07867 82 AE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred eC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence 86 588887753211 112358899999999999999999998 899999999999999 566789999999
Q ss_pred ccccCCCCCce--eecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCC
Q 002346 733 LVKNAPDGKYS--VETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDT 791 (933)
Q Consensus 733 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~ 791 (933)
+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||++||...
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 99865443211 1234578999999999876 45799999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=317.30 Aligned_cols=252 Identities=27% Similarity=0.437 Sum_probs=203.9
Q ss_pred cCCccccCCCeEEEEEEe-CCCc----EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 585 EANILGRGGFGVVYGGEL-PDGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
..++||+|+||+||||.+ +.|+ +||+|++.... ..+...++.+|+-+|.+++|||+++++|+|.... ..||++
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 468899999999999954 4444 68999887653 4556789999999999999999999999998766 789999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
||+.|+|.+|++.++ ..+.....+.+..|||+|+.|||. +++|||||.++|||+.+-..+||.|||+++....
T Consensus 778 ~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~ 850 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP 850 (1177)
T ss_pred hcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence 999999999997733 457888999999999999999998 8999999999999999999999999999997665
Q ss_pred CCceee-cccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 740 GKYSVE-TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 740 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
+..... ....-.+.|||-|.+....|+.++|||||||++||++| |..|++....++..++ +...+.++.
T Consensus 851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dl-------le~geRLsq-- 921 (1177)
T KOG1025|consen 851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDL-------LEKGERLSQ-- 921 (1177)
T ss_pred ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHH-------HhccccCCC--
Confidence 443222 22233568999999999999999999999999999999 9999987654443322 222222221
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
|. -....+..++.+||..|++.||+++++...+.+..
T Consensus 922 -Pp--------iCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a 958 (1177)
T KOG1025|consen 922 -PP--------ICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA 958 (1177)
T ss_pred -CC--------CccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence 11 11234668889999999999999999998886653
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=304.67 Aligned_cols=237 Identities=24% Similarity=0.469 Sum_probs=188.3
Q ss_pred CccccCCCeEEEEEEeCCCc-----------EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 587 NILGRGGFGVVYGGELPDGT-----------KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
+.||+|+||.||+|...+.. .|++|.+..... ....|.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46999999999999765432 578887765421 15789999999999999999999999988 7789
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-------cEEE
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-------RAKV 728 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-------~~kl 728 (933)
+||||+++|+|.+++.... ..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++ .+||
T Consensus 77 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl 149 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKL 149 (259)
T ss_pred EEEEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEe
Confidence 9999999999999996521 268999999999999999999998 8999999999999999888 7999
Q ss_pred ecccccccCCCCCceeecccccccCcccccccCCC--CCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHH
Q 002346 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG--RVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~ 805 (933)
+|||++..... .....++..|+|||++... .++.++||||||+++|||++ |..||......... .+..
T Consensus 150 ~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~---~~~~- 220 (259)
T cd05037 150 SDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE---RFYQ- 220 (259)
T ss_pred CCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH---HHHh-
Confidence 99999886543 1223567889999998776 78999999999999999999 56777654322111 1111
Q ss_pred HhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 806 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
.....+. +. ...+.+++.+|+..+|.+||++.++++.|
T Consensus 221 ---~~~~~~~---~~----------~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 221 ---DQHRLPM---PD----------CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred ---cCCCCCC---CC----------chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0111110 00 04678999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=307.41 Aligned_cols=255 Identities=24% Similarity=0.435 Sum_probs=198.5
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC--------chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG--------NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 652 (933)
+|.+.+.||+|+||.||+|.. .+|+.||+|.++..... ....+.+.+|+.+++.++||||+++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477889999999999999954 47899999988643211 112356888999999999999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||+++++|.+++... ..+++..+..++.|++.|+.|||+ .+++||||+|+||+++.++.++++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~ 153 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFG 153 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeecc
Confidence 999999999999999999652 468999999999999999999998 899999999999999999999999999
Q ss_pred ccccCCCCCce-eecccccccCcccccccCCCC--CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 733 LVKNAPDGKYS-VETRLAGTFGYLAPEYAATGR--VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 733 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
+++........ ......|+..|+|||++.... ++.++||||||+++||+++|+.||........ ... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~----~~-- 225 (272)
T cd06629 154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFK----LG-- 225 (272)
T ss_pred ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHH----hh--
Confidence 98755432211 123346889999999987654 78999999999999999999999964322111 111 00
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......++... .......+.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~-----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 226 NKRSAPPIPPDV-----SMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred ccccCCcCCccc-----cccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 011111111111 1112346789999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=307.24 Aligned_cols=258 Identities=24% Similarity=0.405 Sum_probs=200.8
Q ss_pred HHHHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee
Q 002346 573 IEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (933)
Q Consensus 573 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 650 (933)
...+....+.|++.+.||+|+||.||+|.. .+++.||+|++... .....++..|+.++.++ +|+||+++++++..
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 8 LSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 344445668899999999999999999965 56889999988654 23446788999999999 69999999999853
Q ss_pred ------CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC
Q 002346 651 ------GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM 724 (933)
Q Consensus 651 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 724 (933)
....++||||+++|+|.+++.... ...+++..+..++.|+++|++|||+ .+|+||||||+||++++++
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~ 158 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENA 158 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCC
Confidence 457799999999999999986522 2457888999999999999999999 8999999999999999999
Q ss_pred cEEEecccccccCCCCCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHH
Q 002346 725 RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHL 799 (933)
Q Consensus 725 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~ 799 (933)
.++|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|+.||....+......
T Consensus 159 ~~~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 159 EVKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237 (282)
T ss_pred CEEEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence 999999999875432211 123356899999999875 34678899999999999999999999976433221110
Q ss_pred HHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 800 VTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. ....+. .. .......+.+++.+||+.+|.+||++.|+++
T Consensus 238 ------~~--~~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 ------IP--RNPPPK-----LK----SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred ------Hh--hCCCCC-----Cc----ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 00 000011 11 0112246789999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=300.49 Aligned_cols=252 Identities=31% Similarity=0.550 Sum_probs=200.6
Q ss_pred CccCCccccCCCeEEEEEEeCC-----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 583 FSEANILGRGGFGVVYGGELPD-----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+++.+.||+|+||.||++...+ +..||+|++.... .....+.+..|+.++..++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999996643 4889999987653 223567899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++..... ..+++.++..++.|++.|++|||+ .+++||||||+||++++++.++|+|||++...
T Consensus 80 ~e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~ 153 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153 (258)
T ss_pred EeccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceec
Confidence 999999999999965221 128999999999999999999998 89999999999999999999999999999866
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
............+++.|+|||.+.+..++.++||||+|+++|||++ |+.||...... ...... .. . ....
T Consensus 154 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~---~~-~-~~~~- 224 (258)
T smart00219 154 YDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EVLEYL---KK-G-YRLP- 224 (258)
T ss_pred ccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHH---hc-C-CCCC-
Confidence 6543322222347889999999988889999999999999999998 77887653221 111111 11 1 1110
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
... ....++.+++.+|+..+|++||++.|+++.|
T Consensus 225 ~~~---------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 225 KPE---------NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CCC---------cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 1234678899999999999999999998753
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.46 Aligned_cols=248 Identities=25% Similarity=0.462 Sum_probs=200.2
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC---CCcceeEEeEeeeCceeEEE
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv 657 (933)
.|+..+.||+|+||.||+|.. .+++.||+|.+.... ......++.+|+.++++++ |||++++++++..+...++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 477889999999999999964 578999999987643 3344577899999999996 99999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++.. .++++..++.++.|+++|++|||+ .+|+||||+|+||++++++.++|+|||++...
T Consensus 81 ~e~~~~~~L~~~~~~------~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 151 (277)
T cd06917 81 MEYAEGGSVRTLMKA------GPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALL 151 (277)
T ss_pred EecCCCCcHHHHHHc------cCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeec
Confidence 999999999999854 368999999999999999999998 89999999999999999999999999998866
Q ss_pred CCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
..... ......|+..|+|||++.++ .++.++||||||+++|+|++|+.||........ ... . ...
T Consensus 152 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~------~~~-~-~~~----- 217 (277)
T cd06917 152 NQNSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA------MML-I-PKS----- 217 (277)
T ss_pred CCCcc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh------hhc-c-ccC-----
Confidence 54332 22334789999999988654 468899999999999999999999976432111 100 0 010
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+.+.... ....+.+++.+|++.+|++||++.++++
T Consensus 218 ~~~~~~~~~----~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 218 KPPRLEDNG----YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCCccc----CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 111111110 2246789999999999999999999986
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=309.38 Aligned_cols=265 Identities=25% Similarity=0.334 Sum_probs=200.0
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC---chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+|+..+.||+|+||.||+|.. .+++.||+|++...... ......+..|++++++++|+||+++++++.+....++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 477889999999999999965 46899999999866433 22345678899999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+ +++|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.++|+|||+++..
T Consensus 81 ~e~~-~~~L~~~i~~~----~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~ 152 (298)
T cd07841 81 FEFM-ETDLEKVIKDK----SIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSF 152 (298)
T ss_pred Eccc-CCCHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence 9999 89999999651 1368999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-------
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS------- 809 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~------- 809 (933)
..... ......+++.|+|||.+.+ ..++.++|||||||++|||++|.+||....+.+. +..........
T Consensus 153 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 229 (298)
T cd07841 153 GSPNR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPG 229 (298)
T ss_pred cCCCc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhh
Confidence 54321 1223356788999998854 4678999999999999999999887765433221 11111110000
Q ss_pred cCCCCcccC----CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAID----PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d----~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....+.... +..............+.+++.+|++.+|++||++.|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 230 VTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred cccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 000000000 000000011122356789999999999999999999987
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=309.17 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=200.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||++.. ..++.||+|.+..... .....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688899999999999999955 4678999999876532 2234567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++.. ...+++..+..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||+++...
T Consensus 81 e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~ 152 (305)
T cd05609 81 EYVEGGDCATLLKN-----IGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL 152 (305)
T ss_pred ecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence 99999999999955 2468999999999999999999998 899999999999999999999999999886321
Q ss_pred CCC--------------ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 739 DGK--------------YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 739 ~~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
... ........|+..|+|||++....++.++||||||+++|||++|+.||....+.. ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~ 226 (305)
T cd05609 153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFG 226 (305)
T ss_pred cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHH
Confidence 100 001112457889999999988889999999999999999999999997543221 111
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.........+.. +. .....+.+++.+|++.+|++||++.++.+.|+
T Consensus 227 ~~~~~~~~~~~~-~~---------~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 227 QVISDDIEWPEG-DE---------ALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred HHHhcccCCCCc-cc---------cCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 111111111110 00 11235679999999999999999766666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=304.67 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=202.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 657 (933)
++|...+.||.|++|.||++.. .+++.||+|.+.... ......++.+|++++++++||||+++++++... ...++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 4678889999999999999966 468899999987653 234457799999999999999999999998653 467999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++..... ....+++..+..++.|+++||+|||+ .+++|+||+|+||+++.++.++|+|||++...
T Consensus 80 ~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~ 155 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGEL 155 (287)
T ss_pred EEecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccc
Confidence 999999999998765322 23568899999999999999999998 89999999999999999999999999998754
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCC--chhhHHHHHHHHHhhccCCCCc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP--DDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
.... .....++..|+|||.+.+..++.++||||+|+++|||++|+.||..... ........+.... ....++.
T Consensus 156 ~~~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 230 (287)
T cd06621 156 VNSL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNM--PNPELKD 230 (287)
T ss_pred cccc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcC--Cchhhcc
Confidence 4322 1234678899999999988999999999999999999999999986532 1112222221110 0111111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... .......+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~-------~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 231 EPGN-------GIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred CCCC-------CCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 1100 0112346789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=309.90 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=201.8
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|... +++.||+|.+....... ...+.+..|+++++.++|+||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888999999999999999654 58999999998764332 35567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+.+++|.+++... ....+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ---PGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC---CCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998642 12568999999999999999999998 899999999999999999999999999987543
Q ss_pred CCCce----------------------------eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCC
Q 002346 739 DGKYS----------------------------VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDD 790 (933)
Q Consensus 739 ~~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~ 790 (933)
..... ......|+..|+|||++.+..++.++||||||+++|+|++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~ 234 (316)
T cd05574 155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG 234 (316)
T ss_pred ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence 22110 01124688999999999988899999999999999999999999975
Q ss_pred CCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 002346 791 TMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD----MGHAVN 857 (933)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs----~~evl~ 857 (933)
...... . ..........+.. ......+.+++.+|++.+|++||+ +.++++
T Consensus 235 ~~~~~~--~----~~~~~~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 235 SNRDET--F----SNILKKEVTFPGS-----------PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CchHHH--H----HHHhcCCccCCCc-----------cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 432211 1 1111111111110 012346789999999999999999 555554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=308.08 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=201.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|.+.+.||+|+||.||++.. .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 6788999999999999999954 468899999986542 3335678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. ..+++.++..++.|++.|++|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 97 ~~~~~~L~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 97 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred cCCCCcHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 9999999999854 347899999999999999999998 8999999999999999999999999998875544
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ......|++.|+|||++....++.++||||||+++||+++|+.||....+...... .. ....+
T Consensus 168 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~--~~~~~----- 233 (293)
T cd06647 168 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IA--TNGTP----- 233 (293)
T ss_pred ccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hh--cCCCC-----
Confidence 322 12334688999999999888899999999999999999999999976433211100 00 00000
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+. ........+.+++.+||+.+|++||++.+++.
T Consensus 234 ~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 268 (293)
T cd06647 234 ELQ---NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 268 (293)
T ss_pred CCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 01112235779999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=310.77 Aligned_cols=246 Identities=24% Similarity=0.381 Sum_probs=197.0
Q ss_pred ccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecC
Q 002346 584 SEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
.....||+|+||.||+|.. .+++.||+|++.... ....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 24 ~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~ 101 (297)
T cd06659 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ 101 (297)
T ss_pred HhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc--cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence 3445799999999999954 478999999986542 2335678899999999999999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 742 (933)
+++|.+++.. ..+++..++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++........
T Consensus 102 ~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~ 172 (297)
T cd06659 102 GGALTDIVSQ------TRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP 172 (297)
T ss_pred CCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence 9999988744 458899999999999999999998 8999999999999999999999999999875443221
Q ss_pred eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCC
Q 002346 743 SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLN 822 (933)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 822 (933)
......|++.|+|||++.+..++.++|||||||++|||++|+.||....+... ...... ....... ...
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~~---~~~~~~~-~~~--- 241 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRD---SPPPKLK-NAH--- 241 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhc---cCCCCcc-ccC---
Confidence 12335689999999999888899999999999999999999999975433221 111110 0000000 000
Q ss_pred CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 823 LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 823 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+.+++.+|++.+|++||++.++++
T Consensus 242 ------~~~~~l~~~i~~~l~~~P~~Rps~~~ll~ 270 (297)
T cd06659 242 ------KISPVLRDFLERMLTREPQERATAQELLD 270 (297)
T ss_pred ------CCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 11234678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=300.93 Aligned_cols=251 Identities=24% Similarity=0.360 Sum_probs=195.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC---chhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--cee
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 654 (933)
.+|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4788999999999999999965 46899999988643221 23456789999999999999999999988763 467
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~ 153 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-----YGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGAS 153 (265)
T ss_pred EEEEEecCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccc
Confidence 899999999999999865 2457889999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCCc--eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 735 KNAPDGKY--SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 735 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
........ .......|+..|+|||++.+..++.++||||||+++|||++|+.||........ +..... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~~- 225 (265)
T cd06652 154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIAT-QP- 225 (265)
T ss_pred cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHhc-CC-
Confidence 75432111 112234688999999999888899999999999999999999999975422111 111111 10
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. .+.. +......+.+++.+|+. +|++||+++++++
T Consensus 226 ~----~~~~-----~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 T----NPVL-----PPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred C----CCCC-----chhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 0111 11222456788888984 9999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=305.01 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=194.7
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHH-HHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAV-LTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+|+.||+|+++....... ..++..|+.. ++..+||||+++++++..+...++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4788999999999999999965 4699999999876543322 3455556665 66678999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
||++ |+|.+++...... ...+++..++.++.|++.|++|||+ + +++||||||+||+++.++.+||+|||++...
T Consensus 80 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~ 154 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDK-GLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYL 154 (283)
T ss_pred hhhc-ccHHHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccc
Confidence 9996 7898888653322 2568999999999999999999998 5 9999999999999999999999999998765
Q ss_pred CCCCceeecccccccCcccccccCC----CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAAT----GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
.... ......|+..|+|||.+.+ ..++.++|+||||+++|||++|+.||...... ...+ ..... ...
T Consensus 155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~----~~~~~--~~~ 225 (283)
T cd06617 155 VDSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP-FQQL----KQVVE--EPS 225 (283)
T ss_pred cccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC-HHHH----HHHHh--cCC
Confidence 4321 1233468899999998864 45688999999999999999999999653221 1111 11111 111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+...... ...++.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~---------~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 226 PQLPAEK---------FSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CCCCccc---------cCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1110011 1245789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=285.66 Aligned_cols=273 Identities=23% Similarity=0.307 Sum_probs=203.1
Q ss_pred cCCccCCccccCCCeEEEEEEeC---C--CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee-Ccee
Q 002346 581 DNFSEANILGRGGFGVVYGGELP---D--GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~ 654 (933)
..|+....||+|+||.||+|... + ...+|+|+++.+...........+|+.+++.++||||+.+..++.. +...
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 46889999999999999999332 2 2378999998774333334567899999999999999999998877 7788
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC----CcEEEec
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD----MRAKVAD 730 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~----~~~kl~D 730 (933)
++++||.+. +|...++.++......++...+..|+.||+.|+.|||+ +-|+|||+||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence 999999975 89999887666666789999999999999999999999 889999999999999877 8999999
Q ss_pred ccccccCCCCCcee--ecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCc---hhhHHHHHHH
Q 002346 731 FGLVKNAPDGKYSV--ETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPD---DRAHLVTWFR 804 (933)
Q Consensus 731 fGla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~---~~~~~~~~~~ 804 (933)
||+++.+.+.-... ...++-|..|.|||.+.+. .|+.+.|||+.||++.||+|-.+-|.+.... ......+...
T Consensus 180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~ 259 (438)
T KOG0666|consen 180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD 259 (438)
T ss_pred ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence 99999776543222 2446779999999998765 6899999999999999999999888653221 0011122222
Q ss_pred HHhhccCCCCcccCCCCCCChhh-----------------HHH-------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 RVLISKENIPKAIDPNLNLDEET-----------------IES-------IYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~-----------------~~~-------~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+++.--+...+...|.+..-.+. ... .....+++.++++.||.+|.|+.++++
T Consensus 260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle 336 (438)
T KOG0666|consen 260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE 336 (438)
T ss_pred HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence 22221111111111111100000 000 011468999999999999999999987
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=307.76 Aligned_cols=266 Identities=23% Similarity=0.306 Sum_probs=197.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
+++|.+.+.||+|+||.||+|.. .+++.||+|++..... ......+.+|+.+++.++|+||+++++++..+...++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 46899999999999999999954 5689999999876532 233346788999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+. +++.+++... ...+.+..+..++.|+++||+|||+ .+|+|+||||+||+++.++.+||+|||+++...
T Consensus 83 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 154 (291)
T cd07870 83 EYMH-TDLAQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKS 154 (291)
T ss_pred eccc-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence 9995 7887777441 1347788899999999999999998 899999999999999999999999999987543
Q ss_pred CCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh---------
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI--------- 808 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~--------- 808 (933)
..... .....+++.|+|||++.+. .++.++||||||+++|||++|+.||+...+... .+.. ......
T Consensus 155 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~-~~~~~~~~~~~~~~~ 231 (291)
T cd07870 155 IPSQT-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEK-IWTVLGVPTEDTWPG 231 (291)
T ss_pred CCCCC-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHH-HHHHcCCCChhhhhh
Confidence 32211 1233578999999998654 578899999999999999999999976543211 1111 000000
Q ss_pred --c-cCCCCcccC----CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 809 --S-KENIPKAID----PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 809 --~-~~~~~~~~d----~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ....++... ..+............+.+++.+|++.||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0 000000000 000000000111345678999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=302.15 Aligned_cols=248 Identities=25% Similarity=0.458 Sum_probs=201.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+-|+..+.||+|+||.||+|.. .+++.||+|.+.... .....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 3467788999999999999954 578999999886543 23445789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.. ..+++..+..++.|++.|++|||+ .+++|+||+|+||+++.++.++|+|||++.....
T Consensus 83 ~~~~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 83 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 9999999999854 458899999999999999999998 8999999999999999999999999999876543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ......|+..|+|||++.+..++.++|||||||++|||++|+.||....+... ..... ... ...++.
T Consensus 154 ~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~--~~~-~~~~~~ 223 (277)
T cd06641 154 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLIP--KNN-PPTLEG 223 (277)
T ss_pred chh-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHHHh--cCC-CCCCCc
Confidence 221 12234688899999999888899999999999999999999999975432111 11111 111 111111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ....+.+++.+|++.+|.+||++.++++
T Consensus 224 ~---------~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 224 N---------YSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred c---------cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1 1245778999999999999999999987
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=305.15 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=204.0
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|+..+.||+|+||.||++... +++.||+|++..... ....+++.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36778899999999999999664 689999999876542 3456788999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.... .++++..+..++.|+++|++|||+ ..+++||||||+||++++++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~ 153 (265)
T cd06605 80 YMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN 153 (265)
T ss_pred ecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence 999999999986521 568899999999999999999997 36999999999999999999999999999875533
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ....|+..|+|||++.+..++.++||||||+++|+|++|+.||...... ............... . +
T Consensus 154 ~~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~--~-----~ 222 (265)
T cd06605 154 SLA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDP-PDGIFELLQYIVNEP--P-----P 222 (265)
T ss_pred HHh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccc-cccHHHHHHHHhcCC--C-----C
Confidence 211 1257889999999998889999999999999999999999999754321 111222222222111 0 1
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+... .....+.+++.+|+..+|++||++.+++.
T Consensus 223 ~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 223 RLPSG----KFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCChh----hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 11100 02345779999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=343.47 Aligned_cols=258 Identities=24% Similarity=0.393 Sum_probs=208.9
Q ss_pred HHHHHhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 575 VLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 575 ~l~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
.+..++-+|+-...||.|.||.||.| ...+|+-.|+|.+.......+..+...+|+.++..++|||+|+.+|+-.+++.
T Consensus 1229 ~lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek 1308 (1509)
T KOG4645|consen 1229 SLSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK 1308 (1509)
T ss_pred HhccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH
Confidence 35566778889999999999999998 66789999999987766556667788999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.+|.||||++|+|.+.+.. .+-.++.....+..|++.|++|||+ +|||||||||.||+++.+|.+|++|||.
T Consensus 1309 v~IFMEyC~~GsLa~ll~~-----gri~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGs 1380 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH-----GRIEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGS 1380 (1509)
T ss_pred HHHHHHHhccCcHHHHHHh-----cchhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccc
Confidence 9999999999999999965 2345666777788999999999999 9999999999999999999999999999
Q ss_pred cccCCCCCceee---cccccccCcccccccCCCC---CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 734 VKNAPDGKYSVE---TRLAGTFGYLAPEYAATGR---VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 734 a~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
|........... ...+||+.|||||++.+.. -..++||||+|||+.||+||++||..... .|.....
T Consensus 1381 a~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dn-------e~aIMy~ 1453 (1509)
T KOG4645|consen 1381 AVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDN-------EWAIMYH 1453 (1509)
T ss_pred eeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccc-------hhHHHhH
Confidence 987665432222 3468999999999996543 45789999999999999999999986532 1332222
Q ss_pred hccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+..|.. + .....+-.+++.+|++.||++|-++.|+++
T Consensus 1454 V~~gh~Pq~-----P-----~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1454 VAAGHKPQI-----P-----ERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred HhccCCCCC-----c-----hhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 223332221 1 112234568999999999999988887765
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=305.13 Aligned_cols=249 Identities=22% Similarity=0.334 Sum_probs=203.0
Q ss_pred CCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|++++++++||||+++++++..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5788999999999999999664 68999999997654322 456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+.+++|.+++... .++++.++..++.|+++||+|||+ .+++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 99999999999651 468999999999999999999998 8999999999999999999999999999876554
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.. ......|+..|+|||++.+..++.++|+||||+++|+|++|+.||............ ..... ....+.+
T Consensus 153 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~----~~~~~---~~~~~~~ 223 (258)
T cd05578 153 DT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR----AKQET---ADVLYPA 223 (258)
T ss_pred Cc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH----HHhcc---ccccCcc
Confidence 32 123356888999999998888999999999999999999999999865432121111 11110 1111111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDM--GHAV 856 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~--~evl 856 (933)
.. ...+.+++.+|++.+|.+||++ +|++
T Consensus 224 ~~---------~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 224 TW---------STEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred cC---------cHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 11 2467799999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=304.10 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=200.4
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc----
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS---- 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---- 652 (933)
.+++|++.+.||+|+||.||+|.. .+++.|++|++.... ...+++.+|+.+++++ +|+||+++++++....
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 468899999999999999999966 467899999987652 2346799999999999 7999999999997644
Q ss_pred --eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 653 --ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 653 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
..++||||+++++|.+++..... ....+++..+..++.|+++||+|||+ .+++||||+|+||++++++.+||+|
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d 156 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRK-KGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVD 156 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECC
Confidence 48999999999999999865321 13568999999999999999999998 8999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCC-----CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 805 (933)
||++....... .......|++.|+|||++.. ..++.++||||||+++|||++|+.||....+... .. .
T Consensus 157 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~ 229 (275)
T cd06608 157 FGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF----K 229 (275)
T ss_pred Cccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH----H
Confidence 99987554322 12233568999999998753 3467899999999999999999999975432211 11 1
Q ss_pred HhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 806 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. ....+ .+. ........+.+++.+|++.||++||++.++++
T Consensus 230 ~~--~~~~~-----~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 230 IP--RNPPP-----TLK---SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred hh--ccCCC-----CCC---chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 11 11111 111 11123346789999999999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=289.31 Aligned_cols=256 Identities=24% Similarity=0.370 Sum_probs=201.2
Q ss_pred ccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeec
Q 002346 584 SEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
+....||.|+||+|+|. ..+.|+..|||+++.... ..+.+++..|.+...+- ++||||++||.+..++..|+.||.|
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34567999999999998 556799999999988753 45667888888875554 7999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
..+|+.+.+.........+++...-+|...++.||.||.. ...||||||||+|||++..|.+||||||++....+.
T Consensus 146 -d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S- 221 (361)
T KOG1006|consen 146 -DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS- 221 (361)
T ss_pred -hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH-
Confidence 4677665543222233568899999999999999999998 489999999999999999999999999998755442
Q ss_pred ceeecccccccCcccccccCCC--CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 742 YSVETRLAGTFGYLAPEYAATG--RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
...+.-+|...|||||.+... .|+-++||||||++|||+.||+.|+..-. ...+.+..+.... .+
T Consensus 222 -iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~-----svfeql~~Vv~gd--pp----- 288 (361)
T KOG1006|consen 222 -IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD-----SVFEQLCQVVIGD--PP----- 288 (361)
T ss_pred -HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH-----HHHHHHHHHHcCC--CC-----
Confidence 223445799999999998543 48889999999999999999999997532 1233333333222 22
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+..+..+.+....+..+|.-|+.+|-.+||.+.++.+
T Consensus 289 ~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 289 ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 22223444555667889999999999999999999876
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=307.85 Aligned_cols=265 Identities=24% Similarity=0.359 Sum_probs=196.5
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|... +++.||+|.+..... ......+.+|++++++++|+||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE-EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc-cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 67889999999999999999654 689999999876432 2223457789999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|++ ++|.+++... ...+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~L~~~~~~~----~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 155 (291)
T cd07844 84 YLD-TDLKQYMDDC----GGGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSV 155 (291)
T ss_pred cCC-CCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCC
Confidence 997 4999988652 1358899999999999999999998 8999999999999999999999999999875432
Q ss_pred CCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc--cCCCCc-
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS--KENIPK- 815 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~- 815 (933)
.... .....++..|+|||++.+ ..++.++||||+|+++|||++|+.||........ ....+...... ....+.
T Consensus 156 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 156 PSKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred CCcc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhh
Confidence 2111 122356889999998865 4578999999999999999999999975432111 11111110000 000000
Q ss_pred -----ccC---CCCCCCh-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 -----AID---PNLNLDE-----ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 -----~~d---~~l~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... +...... ........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 000 0000000 00111245679999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.87 Aligned_cols=251 Identities=22% Similarity=0.384 Sum_probs=202.6
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|+||.||+|.. .+|..||+|.+..........+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 578889999999999999965 4688999999877644445567889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEEecccccccCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAPD 739 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~ 739 (933)
+++++|.+++... ....+++..+..++.|+++|++|||+ .+++|+||||+||++++++ .+||+|||.+.....
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ---RGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999998652 12357999999999999999999998 8999999999999999886 469999999876544
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ......|++.|+|||+..+..++.++||||||+++|||++|+.||...... .+...... ..... +.+
T Consensus 155 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~--~~~~~-~~~ 224 (257)
T cd08225 155 SME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ--GYFAP-ISP 224 (257)
T ss_pred Ccc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc--ccCCC-CCC
Confidence 322 122346899999999998888999999999999999999999999754321 11111111 11111 111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. ...+.+++.+|++.+|++||++.++++
T Consensus 225 ~~---------~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 225 NF---------SRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CC---------CHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11 135779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=332.15 Aligned_cols=255 Identities=28% Similarity=0.467 Sum_probs=193.6
Q ss_pred HHhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee------
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------ 650 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 650 (933)
+...+|+..++||+||||.|||++.+ ||+.||||++.... +........+|+..+++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 45567888899999999999999543 89999999999876 66777889999999999999999998741100
Q ss_pred ------------------------------------------------------------------------C-------
Q 002346 651 ------------------------------------------------------------------------G------- 651 (933)
Q Consensus 651 ------------------------------------------------------------------------~------- 651 (933)
+
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 0
Q ss_pred ----------------------------------ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHH
Q 002346 652 ----------------------------------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697 (933)
Q Consensus 652 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l 697 (933)
...||-||||+..++.+++++.+... .....++++++|++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHH
Confidence 12378899998888877776532211 4678899999999999
Q ss_pred HHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC------C-----------CCceeecccccccCccccccc
Q 002346 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP------D-----------GKYSVETRLAGTFGYLAPEYA 760 (933)
Q Consensus 698 ~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~ 760 (933)
+|+|+ +|||||||||.||++|++..|||+|||+|.... + ......+..+||.-|+|||++
T Consensus 711 aYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll 787 (1351)
T KOG1035|consen 711 AYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELL 787 (1351)
T ss_pred HHHHh---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHh
Confidence 99999 899999999999999999999999999998611 0 011123557899999999998
Q ss_pred CCC---CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHH
Q 002346 761 ATG---RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAEL 837 (933)
Q Consensus 761 ~~~---~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~l 837 (933)
.+. .|+.|+|+||+||+++||+. ||... +++.....-.+ .+.++.. +.+.. +....=+.+
T Consensus 788 ~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR-----~g~iP~~--~~f~~-----~~~~~e~sl 850 (1351)
T KOG1035|consen 788 SDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR-----KGSIPEP--ADFFD-----PEHPEEASL 850 (1351)
T ss_pred cccccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc-----cCCCCCC--ccccc-----ccchHHHHH
Confidence 654 49999999999999999994 56543 33333332222 3334433 11111 111233589
Q ss_pred HHHcccCCCCCCCCHHHHHH
Q 002346 838 AGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 838 i~~cl~~~P~~RPs~~evl~ 857 (933)
|+++++.||.+|||+.|++.
T Consensus 851 I~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 851 IRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHHHhcCCCccCCCHHHHhh
Confidence 99999999999999999986
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=301.75 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=204.5
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
...+.|+.-++||+||||.||-.+. .+|+.||.|++.+..... ....-...|-.++++++.+.||.+-..|+..+..+
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 3346788889999999999999844 479999999987765432 23345678999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+|+..|.||+|.-+|.. .+...+++..+.-++.+|+-||++||+ .+||+||+||+|||+|++|+++|+|.|+|.
T Consensus 262 lVLtlMNGGDLkfHiyn---~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAv 335 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYN---HGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAV 335 (591)
T ss_pred EEEEeecCCceeEEeec---cCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEE
Confidence 99999999999998854 344679999999999999999999998 899999999999999999999999999999
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
....+.. ....+||.+|||||++..+.|+...|.||+||++|||+.|+.||...-..... .+.-++.+......++
T Consensus 336 ei~~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~--eEvdrr~~~~~~ey~~ 411 (591)
T KOG0986|consen 336 EIPEGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKR--EEVDRRTLEDPEEYSD 411 (591)
T ss_pred ecCCCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhH--HHHHHHHhcchhhccc
Confidence 8887653 23459999999999999999999999999999999999999999764322111 1112223333333332
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs 851 (933)
-+ ..+...+-+..|++||.+|..
T Consensus 412 kF-------------S~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 412 KF-------------SEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred cc-------------CHHHHHHHHHHHccCHHHhcc
Confidence 22 234567888899999999983
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=305.12 Aligned_cols=257 Identities=25% Similarity=0.359 Sum_probs=195.4
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e 659 (933)
+|...+.||+|+||.||++.. .+++.||+|++...... .....+.+|+.++.++. |+||+++++++..+...+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 455678899999999999954 56899999998765432 44567899999999996 9999999999999899999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+. +++.++...........+++..+..++.+++.|++|||+ ..+|+||||||+||+++.++.+||+|||+++....
T Consensus 84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 985 466554322111223568999999999999999999997 25999999999999999999999999999875543
Q ss_pred CCceeecccccccCcccccccCCC---CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATG---RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
... .....|++.|+|||++.+. .++.++|||||||++|||++|+.||..... .......... ...+
T Consensus 161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~--~~~~-- 229 (288)
T cd06616 161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVK--GDPP-- 229 (288)
T ss_pred CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcC--CCCC--
Confidence 221 1234688999999998766 688999999999999999999999975421 1111111111 1111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+. .........++.+++.+|++.+|++||++.++++
T Consensus 230 ---~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 230 ---ILS-NSEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred ---cCC-CcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 111 0011123346789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=306.47 Aligned_cols=265 Identities=23% Similarity=0.314 Sum_probs=199.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 657 (933)
++|++.+.||+|+||.||+|... +++.||+|.++...........+.+|+.++.+++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 47888999999999999999664 688999999976644444445678899999999999999999998877 889999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||++ ++|.+++.... ..+++.+++.++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++...
T Consensus 85 ~e~~~-~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~ 156 (293)
T cd07843 85 MEYVE-HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREY 156 (293)
T ss_pred ehhcC-cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence 99996 59998886521 358999999999999999999998 89999999999999999999999999998866
Q ss_pred CCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh---------
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL--------- 807 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~--------- 807 (933)
..... ......+++.|+|||++.+. .++.++|+||+|+++|||++|+.||......+.... ......
T Consensus 157 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~--~~~~~~~~~~~~~~~ 233 (293)
T cd07843 157 GSPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNK--IFKLLGTPTEKIWPG 233 (293)
T ss_pred cCCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHhCCCchHHHHH
Confidence 54321 12234578899999988654 468999999999999999999999976543221111 000000
Q ss_pred ------hccCCCCcccCCCCCCChhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 ------ISKENIPKAIDPNLNLDEETIE-SIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ------~~~~~~~~~~d~~l~~~~~~~~-~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.............+. ...... ....+.+++.+|++.+|++||++.|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 234 FSELPGAKKKTFTKYPYNQLR-KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hhccchhcccccccccchhhh-ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 000000000000000 000000 1345679999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=309.90 Aligned_cols=270 Identities=24% Similarity=0.336 Sum_probs=200.2
Q ss_pred HHhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC--ce
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING--SE 653 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~ 653 (933)
.+.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.+++++ +||||+++++++... ..
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 34678999999999999999999654 688999999865433344456788899999999 999999999988643 46
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||++ ++|.+++.. ..+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~ 153 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRA------NILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGL 153 (337)
T ss_pred EEEEecccc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccc
Confidence 799999996 599888854 267899999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCc----eeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH--
Q 002346 734 VKNAPDGKY----SVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV-- 806 (933)
Q Consensus 734 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~-- 806 (933)
+........ .......|++.|+|||++.+ ..++.++||||||+++|||++|+.||....+.+...........
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 233 (337)
T cd07852 154 ARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPS 233 (337)
T ss_pred hhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 886544322 12234578999999998754 45788999999999999999999999765432221111000000
Q ss_pred ------h--hccCCCCcccC-CC-CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 807 ------L--ISKENIPKAID-PN-LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 807 ------~--~~~~~~~~~~d-~~-l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. .....+.+.+. .. .............+.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 234 AEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred HHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 0 00000000000 00 0000000112346789999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=303.28 Aligned_cols=265 Identities=25% Similarity=0.345 Sum_probs=199.0
Q ss_pred CccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeec
Q 002346 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
|++.+.||.|++|.||+|.. .+|+.||+|++............+.+|+++++.++|||++++++++.++...++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999955 47999999998766444444567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
+ ++|.+++.... ...+++..++.++.|+++||+|||+ ++++||||+|+||+++.++.++|+|||++.......
T Consensus 81 ~-~~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~ 153 (283)
T cd07835 81 D-LDLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV 153 (283)
T ss_pred C-cCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence 4 69999986522 1368999999999999999999998 899999999999999999999999999987554322
Q ss_pred ceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC-------CC
Q 002346 742 YSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE-------NI 813 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-------~~ 813 (933)
. ......+++.|+|||++.+. .++.++||||||+++|||++|+.||....... .+....+....... .+
T Consensus 154 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 230 (283)
T cd07835 154 R-TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSL 230 (283)
T ss_pred c-ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhc
Confidence 1 11233568899999987654 57889999999999999999999997643321 11111111000000 00
Q ss_pred Cc---ccCCC--CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PK---AIDPN--LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~---~~d~~--l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
++ .+... .............+.+++.+|++.+|++||++.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 00000 0000001111245779999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=300.10 Aligned_cols=248 Identities=24% Similarity=0.409 Sum_probs=198.6
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
.|...+.||+|++|.||++.. .+++.||+|++... .....+.+.+|+.+++.++||||+++++++..++..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 344567899999999999964 57899999988644 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++.. ..+++.++..++.|++.|++|||+ ++|+||||+|+||+++.++.++|+|||.+......
T Consensus 98 ~~~~~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~ 168 (285)
T cd06648 98 LEGGALTDIVTH------TRMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168 (285)
T ss_pred cCCCCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence 999999999854 458899999999999999999999 89999999999999999999999999987754432
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.. ......|++.|+|||.+.+..++.++||||||+++|||++|+.||....+... ........ .+....
T Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~~~--~~~~~~-- 237 (285)
T cd06648 169 VP-RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRDNL--PPKLKN-- 237 (285)
T ss_pred Cc-ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHhcC--CCCCcc--
Confidence 21 12334689999999999888899999999999999999999999976432211 11111111 000000
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......+.+++.+|++.+|++||++.++++
T Consensus 238 ------~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 238 ------LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred ------cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0011235789999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=305.07 Aligned_cols=270 Identities=22% Similarity=0.272 Sum_probs=198.7
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCce-----
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSE----- 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----- 653 (933)
++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4688999999999999999965 46899999998765433334567889999999995 6999999999877655
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-CCcEEEeccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFG 732 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfG 732 (933)
.++||||+++ +|.+++..........+++..++.++.||++||+|||+ ++|+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999975 89998865433323568999999999999999999998 89999999999999998 8899999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
+++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|..||....+.. .+...+........
T Consensus 157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~ 233 (295)
T cd07837 157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ--QLLHIFKLLGTPTE 233 (295)
T ss_pred cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHhCCCCh
Confidence 9875433211 1122356889999998865 457899999999999999999999997643221 11111111000000
Q ss_pred -CCCcccC-------CCCC---CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 -NIPKAID-------PNLN---LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 -~~~~~~d-------~~l~---~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+.... +... ..........++.+++.+|++.+|++||++.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 0000000 0000 00000112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=283.55 Aligned_cols=253 Identities=23% Similarity=0.324 Sum_probs=199.8
Q ss_pred HHhcCCccC-CccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee----
Q 002346 578 QVTDNFSEA-NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN---- 650 (933)
Q Consensus 578 ~~~~~~~~~-~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 650 (933)
.++++|++- ++||-|-.|.|... +..+|+.+|+|++... ...++|++.--.. .|||||.++++|..
T Consensus 58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 346677654 68999999999987 5567999999998754 3567888875555 69999999998864
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---CCcEE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAK 727 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~k 727 (933)
....++|||+|+||.|...+.+ .+...++++++..|+.||+.|+.|||+ ..|.||||||+|+|.+. |..+|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~---~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lK 204 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQD---RGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLK 204 (400)
T ss_pred ceeeEeeeecccchHHHHHHHH---cccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceE
Confidence 3566799999999999999976 345679999999999999999999999 89999999999999974 45799
Q ss_pred EecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 728 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
|+|||+|+...... .-...+-||.|.|||++...+|+..+|+||+||++|-|++|.+||........ -....+++.
T Consensus 205 LtDfGFAK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai--spgMk~rI~ 280 (400)
T KOG0604|consen 205 LTDFGFAKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SPGMKRRIR 280 (400)
T ss_pred ecccccccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC--ChhHHhHhh
Confidence 99999999765422 12345779999999999999999999999999999999999999987543111 000011111
Q ss_pred hccCCCCcccCCCCCCChhhHHHHHH-HHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 ISKENIPKAIDPNLNLDEETIESIYR-VAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~~~~~~~~~~-~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ....+...+|.++.+ .+++|+.+|..+|++|.|+.+++.
T Consensus 281 ~----------gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 281 T----------GQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred c----------cCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 1 122234455666655 458999999999999999999986
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=296.24 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=206.5
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|++|.||+|... +++.||||++...... .....+.+|+.++++++|+||+++++++..+...++|||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888999999999999999665 5999999998776432 456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... .++++..++.++.|+++|++|||+. .+++||||+|+||+++.++.++|+|||.+.....
T Consensus 80 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~ 152 (264)
T cd06623 80 YMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN 152 (264)
T ss_pred ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 99999999999652 5689999999999999999999962 6999999999999999999999999999886544
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||.............++. .... ..++.
T Consensus 153 ~~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~-----~~~~-~~~~~ 225 (264)
T cd06623 153 TLDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC-----DGPP-PSLPA 225 (264)
T ss_pred CCCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh-----cCCC-CCCCc
Confidence 3322 123467899999999998889999999999999999999999997654312222222111 1111 11111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. .....+.+++.+|++.+|++||++.++++
T Consensus 226 ~--------~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 226 E--------EFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred c--------cCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1 02246789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=308.97 Aligned_cols=272 Identities=22% Similarity=0.295 Sum_probs=199.3
Q ss_pred CCccCCccccCCCeEEEEEEeC---CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ceeE
Q 002346 582 NFSEANILGRGGFGVVYGGELP---DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERL 655 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~ 655 (933)
+|++.+.||+|+||.||+|... +++.||+|.+..... .....+.+.+|+.++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4788899999999999999654 478999999987431 122346778899999999999999999999887 7899
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC----CCcEEEecc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD----DMRAKVADF 731 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~----~~~~kl~Df 731 (933)
+||||++ ++|.+++..........+++..++.++.|++.|++|||+ .+|+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 9999996 477777755333333478999999999999999999998 89999999999999999 999999999
Q ss_pred cccccCCCCCc--eeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCch-------hhHHHH
Q 002346 732 GLVKNAPDGKY--SVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDD-------RAHLVT 801 (933)
Q Consensus 732 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~-------~~~~~~ 801 (933)
|++........ .......+++.|+|||++.+. .++.++||||||+++|||++|+.||....... ...+..
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER 236 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence 99886543221 112335678999999987654 57899999999999999999999997544322 011111
Q ss_pred HHHHHhhc----------cCCCCc---ccC-CCCCCCh-hh---H--HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 802 WFRRVLIS----------KENIPK---AID-PNLNLDE-ET---I--ESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 802 ~~~~~~~~----------~~~~~~---~~d-~~l~~~~-~~---~--~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+...... ...... ... ....... .. . ....++.+++.+|++.+|++||++.|+++
T Consensus 237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11100000 000000 000 0000000 00 0 22346789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=298.65 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=206.3
Q ss_pred CCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|+||.||++. ..+++.+|+|++...........++.+|++++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 57888999999999999995 45788999999987655555667888999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++.+.. .....+++..++.++.|+++|++|||+ .+++||||+|+||++++++.+|++|||++......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999986632 223568999999999999999999998 89999999999999999999999999999866554
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
. .....|++.|+|||+..+..++.++|+||+|+++|||++|+.||........ .. ... ....+..
T Consensus 157 ~---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~---~~~--~~~~~~~---- 221 (256)
T cd08530 157 M---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL---RY---KVQ--RGKYPPI---- 221 (256)
T ss_pred C---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHh--cCCCCCC----
Confidence 1 2234688999999999988899999999999999999999999976533211 11 111 1111111
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......+.+++.+|++.+|++||++.++++
T Consensus 222 ------~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 222 ------PPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ------chhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1122346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=312.17 Aligned_cols=267 Identities=22% Similarity=0.328 Sum_probs=200.2
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING----- 651 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----- 651 (933)
.+.++|++.+.||+|+||.||+|.. .+++.||+|++...........++.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence 4568899999999999999999954 5789999999876543444556788899999999999999999988643
Q ss_pred -ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 652 -SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 652 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
...++||||+. ++|.+.+.. .+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|
T Consensus 93 ~~~~~lv~e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~D 161 (353)
T cd07850 93 FQDVYLVMELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILD 161 (353)
T ss_pred cCcEEEEEeccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEcc
Confidence 35699999995 588888743 27889999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH-HH---------
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH-LV--------- 800 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~-~~--------- 800 (933)
||+++....... .....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... +.
T Consensus 162 fg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 239 (353)
T cd07850 162 FGLARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDE 239 (353)
T ss_pred CccceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 999986544321 233468899999999998899999999999999999999999997543211100 00
Q ss_pred --HH----HHHHhhccCC-----CCcccCCCCCC---ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 801 --TW----FRRVLISKEN-----IPKAIDPNLNL---DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 801 --~~----~~~~~~~~~~-----~~~~~d~~l~~---~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. .......... +.+.+...... ..........+.+++.+|++.||++||++.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 0000000000 00001000000 0001123445779999999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=301.37 Aligned_cols=243 Identities=23% Similarity=0.356 Sum_probs=186.4
Q ss_pred ccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchh-HHHHHHHHHHHH---hcCCCcceeEEeEeeeCceeEEEEeecC
Q 002346 588 ILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLT---KVRHRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 588 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
.||+|+||.||++.. .+++.||+|.+......... ...+.+|..+++ ..+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999965 46899999998765432222 233444544333 3479999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 742 (933)
+++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~- 151 (279)
T cd05633 81 GGDLHYHLSQ-----HGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (279)
T ss_pred CCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-
Confidence 9999998864 2468999999999999999999999 899999999999999999999999999987554322
Q ss_pred eeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCC
Q 002346 743 SVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821 (933)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 821 (933)
.....|++.|+|||.+.. ..++.++||||+||++|||++|+.||........... ..... .....+.+.
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~---~~~~~~~~~- 221 (279)
T cd05633 152 --PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI----DRMTL---TVNVELPDS- 221 (279)
T ss_pred --ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHH----HHHhh---cCCcCCccc-
Confidence 123468999999998864 5678999999999999999999999976433222111 11110 011111111
Q ss_pred CCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 822 NLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
...++.+++.+|++.+|++|| +++++++
T Consensus 222 --------~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 222 --------FSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred --------cCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 124577999999999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=305.81 Aligned_cols=271 Identities=27% Similarity=0.344 Sum_probs=200.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l 656 (933)
.++|++.+.||+|+||.||+|.. .+|+.||+|+++...........+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 36789999999999999999965 4689999999876543333334567899999999999999999998754 46799
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||++ ++|.+++... ...+++.++..++.|+++|++|||+ .+++||||||+||+++.++.+||+|||++..
T Consensus 86 v~e~~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~ 157 (309)
T cd07845 86 VMEYCE-QDLASLLDNM----PTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLART 157 (309)
T ss_pred EEecCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeee
Confidence 999996 5888888542 2568999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-cCCCC
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-KENIP 814 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 814 (933)
...... ......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||....+.+.... +...... .....
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (309)
T cd07845 158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL---IIQLLGTPNESIW 233 (309)
T ss_pred cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChhhc
Confidence 654321 1122346788999998865 4578999999999999999999999986543322111 1111000 00000
Q ss_pred -c--------cc--CC-CCC-CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 815 -K--------AI--DP-NLN-LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 815 -~--------~~--d~-~l~-~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
. .+ .. ... ...........+.+++.+|++.||++||++.++++ ++|..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~------h~~f~ 294 (309)
T cd07845 234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE------SSYFK 294 (309)
T ss_pred hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc------Chhhc
Confidence 0 00 00 000 00000012345678999999999999999999986 66654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=303.67 Aligned_cols=267 Identities=24% Similarity=0.326 Sum_probs=197.4
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|++|.||+|.. .+|+.||+|++..........+.+.+|++++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4788999999999999999965 478999999987654334445678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-CCcEEEecccccccCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAP 738 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~ 738 (933)
|++ ++|.+++... ....+++..+..++.||+.||+|||+ ++++||||+|+||+++. ++.+||+|||++....
T Consensus 82 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS---PDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC---CCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 995 5888887442 12346888899999999999999998 89999999999999985 5679999999987554
Q ss_pred CCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC-----
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN----- 812 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~----- 812 (933)
... .......|++.|+|||++.+. .++.++||||+|+++|+|+||+.||....+.+.. ...+.........
T Consensus 155 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 231 (294)
T PLN00009 155 IPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDEL--FKIFRILGTPNEETWPGV 231 (294)
T ss_pred CCc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChhhcccc
Confidence 321 112234678899999988654 5789999999999999999999999764332211 1111000000000
Q ss_pred --CCcccC--CCCCCC---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 --IPKAID--PNLNLD---EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 --~~~~~d--~~l~~~---~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
++.... +..... ........++.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 232 TSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred ccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000000 000000 000111245779999999999999999999986
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=307.59 Aligned_cols=268 Identities=23% Similarity=0.312 Sum_probs=196.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc-------
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------- 652 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 652 (933)
++|++.+.||+|+||.||+|.. .+++.||||++............+.+|++++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 5799999999999999999965 46899999998765433333456778999999999999999999987643
Q ss_pred -eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 653 -ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 653 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
..++||||+. ++|.+++... ...+++.+++.++.|++.||+|||+ ++++|+||||+||+++.++.+||+||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~df 163 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADF 163 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcC
Confidence 4599999996 5888887541 2358999999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCce---eecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 732 GLVKNAPDGKYS---VETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 732 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
|++......... ......++..|+|||++.+. .++.++||||||+++|||++|+.||....+.........+....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 164 GLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 998755432211 11234678899999988654 47889999999999999999999997654432222221111000
Q ss_pred hccCCCCcc-----cCC-CCCCCh---h-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 ISKENIPKA-----IDP-NLNLDE---E-----TIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ~~~~~~~~~-----~d~-~l~~~~---~-----~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+.. .+. ...... . .......+.+++.+|++.+|++||+++++++
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 244 -TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred -ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000000 000 000000 0 0001234668999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=309.52 Aligned_cols=266 Identities=22% Similarity=0.342 Sum_probs=200.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee----Ccee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSER 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 654 (933)
.++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|+.++++++||||+++++++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 47899999999999999999954 569999999998654444456778899999999999999999988753 3467
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+. ++|.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+||++++++.+||+|||++
T Consensus 84 ~lv~e~~~-~~l~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~ 154 (334)
T cd07855 84 YVVMDLME-SDLHHIIHS-----DQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMA 154 (334)
T ss_pred EEEEehhh-hhHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccc
Confidence 99999995 689888854 2458999999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCCce---eecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-
Q 002346 735 KNAPDGKYS---VETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS- 809 (933)
Q Consensus 735 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~- 809 (933)
......... ......|+..|+|||++.+ ..++.++||||||+++|||++|+.||......... ..+......
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~~g~~ 231 (334)
T cd07855 155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSVLGSP 231 (334)
T ss_pred eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHHhCCC
Confidence 755432211 1123578899999998765 46889999999999999999999999764332111 111100000
Q ss_pred ---------cCCCCcc---cCCCCCC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 ---------KENIPKA---IDPNLNL--DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ---------~~~~~~~---~d~~l~~--~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+.+. ....... ..........+.+++.+|++.+|++||++++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000000 0000000 0001122456889999999999999999999887
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=299.10 Aligned_cols=252 Identities=25% Similarity=0.431 Sum_probs=203.7
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++.|+..+.||+|+||.||+|... +++.||+|++..... ..+.+.+|+++++.++|+||+++++++..+...++|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 3567888899999999999999665 689999999876532 456789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+ .+|+|+||+|+||+++.++.++|+|||++...
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~ 166 (286)
T cd06614 94 MEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL 166 (286)
T ss_pred EeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhh
Confidence 99999999999997621 369999999999999999999998 89999999999999999999999999987654
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......+++.|+|||++.+..++.++||||||+++|||++|+.||....+.... . ... ....+...
T Consensus 167 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~----~~~--~~~~~~~~ 237 (286)
T cd06614 167 TKEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--F----LIT--TKGIPPLK 237 (286)
T ss_pred ccchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHH--hcCCCCCc
Confidence 43221 122345788999999998888999999999999999999999999754332111 1 111 11111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
++ ......+.+++.+|++.+|.+||++.++++
T Consensus 238 ~~--------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 238 NP--------EKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred ch--------hhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 10 112245779999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=294.94 Aligned_cols=249 Identities=27% Similarity=0.484 Sum_probs=204.7
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|++|.||++.. .+++.||+|.+..........+.+.+|++++++++|+|++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478889999999999999955 4688999999987755445678899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++... ..+++..+..++.|++.|++|||+ .+|+||||||+||+++.++.++|+|||++......
T Consensus 81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (254)
T cd06627 81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV 152 (254)
T ss_pred CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence 9999999998652 568999999999999999999998 89999999999999999999999999999866544
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
... .....|+..|+|||...+..++.++|||++|+++|+|++|+.||....+.. ... ..... . ...+.+.
T Consensus 153 ~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~--~~~---~~~~~---~-~~~~~~~ 222 (254)
T cd06627 153 SKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA--ALF---RIVQD---D-HPPLPEG 222 (254)
T ss_pred ccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH--HHH---HHhcc---C-CCCCCCC
Confidence 321 233468899999999988888999999999999999999999997543211 111 11111 1 1111111
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ...+.+++.+|++.+|++||++.+++.
T Consensus 223 ~---------~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 223 I---------SPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C---------CHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 245779999999999999999999975
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-33 Score=302.14 Aligned_cols=247 Identities=25% Similarity=0.406 Sum_probs=196.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
+.|+..+.||+|+||.||+|.. .+++.||+|++..... .....+++.+|+.+++.++||||+++++++..++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 5688889999999999999965 4689999999865432 2344567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+. |++.+++... ...+++..+..++.|++.||.|||+ .+|+||||+|+||++++++.++|+|||++....
T Consensus 95 e~~~-g~l~~~~~~~----~~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEVH----KKPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHHc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9996 6777776431 2458999999999999999999998 899999999999999999999999999987554
Q ss_pred CCCceeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
.. ....|++.|+|||++. .+.++.++||||||+++|||++|+.||........ . ..... ...
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~---~---~~~~~--~~~-- 231 (307)
T cd06607 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---YHIAQ--NDS-- 231 (307)
T ss_pred CC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH---H---HHHhc--CCC--
Confidence 32 2346888999999874 45688999999999999999999999976432211 1 11110 011
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.+. .......+.+++.+||+.+|++||++.+++.
T Consensus 232 ---~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 232 ---PTLS----SNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred ---CCCC----chhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1111 1112346789999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.11 Aligned_cols=249 Identities=27% Similarity=0.461 Sum_probs=204.0
Q ss_pred CCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|+..+.||+|++|.||++... +++.|++|++..... ...+.+.+|++++++++|++|+++++++..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4778899999999999999664 689999999976532 4567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++.... ..+++..+..++.|+++|++|||+ .+++||||+|+||++++++.++|+|||.+......
T Consensus 79 ~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 79 CSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999999986521 468999999999999999999998 89999999999999999999999999998866554
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.. .....|+..|+|||++.+..++.++||||||+++|+|++|+.||........... . . ....+...++.
T Consensus 152 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~---~---~--~~~~~~~~~~~ 221 (253)
T cd05122 152 KA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK---I---A--TNGPPGLRNPE 221 (253)
T ss_pred cc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---H---H--hcCCCCcCccc
Confidence 32 2345788999999999888899999999999999999999999976532221111 0 0 11111111110
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+.+++.+|++.+|++||++.++++
T Consensus 222 --------~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 222 --------KWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred --------ccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01245789999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=283.63 Aligned_cols=269 Identities=22% Similarity=0.335 Sum_probs=218.7
Q ss_pred HHHHHHHhcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEe
Q 002346 573 IEVLRQVTDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646 (933)
Q Consensus 573 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~ 646 (933)
..++..-.++++...++-+|.||.||+|.+ .+.+.|-||.++... ++-+...+..|...+..+.|||+.++.+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 455666678899999999999999999944 334567788776553 5566778899999999999999999999
Q ss_pred EeeeC-ceeEEEEeecCCCChhhHhhhcc---cCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC
Q 002346 647 YCING-SERLLVYEYMPRGTLAQHLFEWH---DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (933)
Q Consensus 647 ~~~~~-~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~ 722 (933)
.+.++ +..+++|.++.-|+|..|+...+ ....+.++-.+...++.|++.|++|||+ ++|||.||.++|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehh
Confidence 98764 56789999999999999997433 2234568888899999999999999999 99999999999999999
Q ss_pred CCcEEEecccccccCCCCCceeecc-cccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHH
Q 002346 723 DMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLV 800 (933)
Q Consensus 723 ~~~~kl~DfGla~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~ 800 (933)
.-++||+|=.+++...+.+++.-+. -..+..||+||.+....|+.++|||||||++|||+| |+.|+..-+|.+..++.
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl 511 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL 511 (563)
T ss_pred heeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH
Confidence 9999999999999888777665332 234568999999999999999999999999999999 89999887776655443
Q ss_pred HHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 801 TWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 801 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
. ....+...+ +.+.++..++..||...|++||+++|++..|.+..
T Consensus 512 k-------dGyRlaQP~-----------NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 512 K-------DGYRLAQPF-----------NCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred h-------ccceecCCC-----------CCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 2 222222211 22346778999999999999999999999987654
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=292.65 Aligned_cols=253 Identities=23% Similarity=0.407 Sum_probs=207.4
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||.|+||.||++.. .+++.||+|++..........+++.+|+++++.++|||++++++.+..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 578889999999999999965 3689999999987655556677899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++++|.+++..... ....+++.++..++.++++|++|||+ .+++|+||+|+||++++++.++|+|||.+......
T Consensus 81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 999999999976332 23679999999999999999999999 89999999999999999999999999998866544
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
. .......|++.|+|||...+..++.++||||+|+++|+|++|+.||....... ....... .... .+..
T Consensus 157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~--~~~~-~~~~- 225 (258)
T cd08215 157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILK--GQYP-PIPS- 225 (258)
T ss_pred c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhc--CCCC-CCCC-
Confidence 3 12233578899999999988889999999999999999999999997643211 1111111 1111 1111
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+.+++.+|+..+|++||++.++++
T Consensus 226 --------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 226 --------QYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred --------CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11245779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=311.70 Aligned_cols=265 Identities=23% Similarity=0.375 Sum_probs=196.6
Q ss_pred HhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----c
Q 002346 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----S 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 652 (933)
++++|++.+.||+|+||.||+|. ..+|+.||+|++.... ......++.+|+.++++++||||+++++++... .
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 35789999999999999999995 4578999999986432 233456788999999999999999999987643 3
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||++ ++|.+.+.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg 151 (336)
T cd07849 82 DVYIVQELME-TDLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFG 151 (336)
T ss_pred eEEEEehhcc-cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECccc
Confidence 5799999996 588877743 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCce--eecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 733 LVKNAPDGKYS--VETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 733 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
++......... ......|++.|+|||.+.+ ..++.++||||+||++|||++|+.||....... ....+...+..
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~ 228 (336)
T cd07849 152 LARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGT 228 (336)
T ss_pred ceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCC
Confidence 98765432211 1133578999999998654 568899999999999999999999996542211 11111110000
Q ss_pred c--CCCC-----------cccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 K--ENIP-----------KAID--PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~--~~~~-----------~~~d--~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. +... .... +.............++.+++.+|++.+|++||++.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~ 291 (336)
T cd07849 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALA 291 (336)
T ss_pred CCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0000 0000 000000000112345789999999999999999999987
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=294.71 Aligned_cols=252 Identities=25% Similarity=0.403 Sum_probs=205.4
Q ss_pred CCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ceeEEEE
Q 002346 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLVY 658 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~ 658 (933)
+|+..+.||+|++|.||+|... +++.|++|++..........+.+.+|+.++++++||||+++++++... ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999664 789999999987654445678899999999999999999999999988 8899999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++... ..+++.+++.++.|+++|++|||+ .+++|+||+|+||+++.++.++|+|||.+....
T Consensus 81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 152 (260)
T cd06606 81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLG 152 (260)
T ss_pred EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence 999999999999652 378999999999999999999999 899999999999999999999999999988665
Q ss_pred CCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......++..|+|||...+...+.++||||||+++|+|++|+.||....... ........ ....+. +
T Consensus 153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~~~~~-~~~~~~-~ 225 (260)
T cd06606 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPM-----AALYKIGS-SGEPPE-I 225 (260)
T ss_pred cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH-----HHHHhccc-cCCCcC-C
Confidence 54321 1233568899999999988889999999999999999999999997654111 11111110 011111 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. .....+.+++.+|++.+|++||++.++++
T Consensus 226 ~~---------~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 226 PE---------HLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred Cc---------ccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 11 11346789999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.35 Aligned_cols=251 Identities=24% Similarity=0.358 Sum_probs=197.2
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEecccc---CCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--cee
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNT---MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~ 654 (933)
.+|++.+.||+|+||.||+|.. .+++.||+|++.... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4788999999999999999954 568999999875432 1234456899999999999999999999998764 457
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++++|.+++.. ...+++..+..++.|++.|++|||+ .+++|+||||+||+++.++.++|+|||++
T Consensus 82 ~~v~e~~~~~~L~~~~~~-----~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~ 153 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-----YGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGAS 153 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccc
Confidence 899999999999999864 2457899999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCC--ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 735 KNAPDGK--YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 735 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+...... ........|+..|+|||++.+..++.++|||||||++|||++|+.||........ . ..... ..
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~----~~~~~--~~ 225 (264)
T cd06653 154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--I----FKIAT--QP 225 (264)
T ss_pred cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--H----HHHHc--CC
Confidence 7543211 1111235688999999999888899999999999999999999999975422211 1 11111 11
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....++.. ....+.+++.+|++ +|.+||++.+++.
T Consensus 226 ~~~~~p~~---------~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 226 TKPMLPDG---------VSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred CCCCCCcc---------cCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 11111111 12457799999999 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=302.78 Aligned_cols=256 Identities=25% Similarity=0.361 Sum_probs=200.7
Q ss_pred CCccCCccccCCCeEEEEEEe----CCCcEEEEEEeccccCC--chhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCcee
Q 002346 582 NFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSER 654 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 654 (933)
+|++.+.||+|+||.||++.. .+++.||||.++..... ....+.+.+|++++.++ +||||+++++++..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 477889999999999999853 35789999998754221 23346788999999999 599999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||||+||+++.++.++|+|||++
T Consensus 81 ~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~ 152 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-----REHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLS 152 (288)
T ss_pred EEEEecCCCCcHHHHHhh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccc
Confidence 999999999999999854 2458899999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccCcccccccCCCC--CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATGR--VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+..............|+..|+|||.+.+.. .+.++||||||+++|||++|+.||....... ...............
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~ 230 (288)
T cd05583 153 KEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILKSKPP 230 (288)
T ss_pred cccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHccCCC
Confidence 765443332233456899999999987655 7889999999999999999999996432211 111111222211111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.+..+ ...+.+++.+|++.+|++||++.++.+.|+
T Consensus 231 ~~~~~-------------~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 231 FPKTM-------------SAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred CCccc-------------CHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 11111 134678999999999999999988877664
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=307.29 Aligned_cols=262 Identities=21% Similarity=0.351 Sum_probs=198.8
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc--
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-- 652 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 652 (933)
+..+.++|++.+.||+|+||.||+|. ..+++.||||++............+.+|+.++++++||||+++++++..+.
T Consensus 10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07880 10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL 89 (343)
T ss_pred hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence 34467899999999999999999995 557999999998654333444567889999999999999999999987543
Q ss_pred ----eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 653 ----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 653 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
..++||||+ +++|.+++.. ..+++..+..++.|+++|++|||+ .+|+||||||+||+++.++.+||
T Consensus 90 ~~~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 90 DRFHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred cccceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEE
Confidence 458999999 7799888743 458999999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
+|||++...... .....+++.|+|||++.+ ..++.++||||+|+++|++++|+.||........ ... ..
T Consensus 160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~----~~ 229 (343)
T cd07880 160 LDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LME----IM 229 (343)
T ss_pred eecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHH----HH
Confidence 999998765432 123467899999998865 4588999999999999999999999975432111 111 00
Q ss_pred hccCCCCcccC---------------CCCCCC---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 ISKENIPKAID---------------PNLNLD---EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ~~~~~~~~~~d---------------~~l~~~---~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......+..+. +..... .........+.+++.+|++.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 230 KVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000000000 000000 000011235779999999999999999999985
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=301.36 Aligned_cols=264 Identities=25% Similarity=0.325 Sum_probs=200.3
Q ss_pred CccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ceeEEEEe
Q 002346 583 FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLVYE 659 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e 659 (933)
|++.+.||+|+||.||+|... +++.||+|++............+.+|++++++++|+|++++++++... +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 567889999999999999664 589999999987643344456788999999999999999999999887 78999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|++ ++|.+++... ...+++.+++.++.|+++|++|||+ .+++|+||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~ 152 (287)
T cd07840 81 YMD-HDLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTK 152 (287)
T ss_pred ccc-ccHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence 997 4888888541 1468999999999999999999998 8999999999999999999999999999886655
Q ss_pred CCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc--cCCCCcc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS--KENIPKA 816 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 816 (933)
..........++..|+|||.+.+ ..++.++||||||+++|||++|+.||.......... .+...... ....+..
T Consensus 153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGV 229 (287)
T ss_pred CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhcccc
Confidence 43222334467889999997754 457899999999999999999999997654322211 11111000 0000000
Q ss_pred --------cCCCCCCCh-----hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 --------IDPNLNLDE-----ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 --------~d~~l~~~~-----~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+...... ........+.+++.+|++.+|++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000 00001456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=308.06 Aligned_cols=263 Identities=23% Similarity=0.351 Sum_probs=198.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----ce
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 653 (933)
.++|.+.+.||+|+||.||+|.. .+++.||||++...........++.+|+.+++.++|+||+++++++... ..
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 46799999999999999999954 5789999999876533344456778899999999999999999987643 34
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+ ++++||||||+||+++.++.+||+|||+
T Consensus 84 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~ 154 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS-----SQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGL 154 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence 799999995 789888854 2468999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc---
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS--- 809 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--- 809 (933)
++...... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||........ ...+......
T Consensus 155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~ 230 (337)
T cd07858 155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQ---LKLITELLGSPSE 230 (337)
T ss_pred ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHH---HHHHHHHhCCCCh
Confidence 98654432 11233467889999998764 4688999999999999999999999975432111 1101100000
Q ss_pred -------cCC-------CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 -------KEN-------IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 -------~~~-------~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... .+...++.. ..........+.+++.+|++.+|++||+++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSF--ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCH--HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 000 000000000 0001122345789999999999999999999987
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-33 Score=295.11 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=196.0
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 589 LGRGGFGVVYGGELP-DGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 589 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
||+|+||.||++... +++.||+|++...... ....+.+.+|+.+++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999664 5899999998765432 34457899999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeec
Q 002346 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 746 (933)
.+++.. ...+++..+..++.|++.||+|||+ ++++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~ 150 (262)
T cd05572 81 WTILRD-----RGLFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTW 150 (262)
T ss_pred HHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccc
Confidence 999965 2458899999999999999999998 899999999999999999999999999988665432 123
Q ss_pred ccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChh
Q 002346 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEE 826 (933)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 826 (933)
...|++.|+|||++....++.++|+||+|+++|||++|+.||.....+. .............. .+....
T Consensus 151 ~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~~~~--~~~~~~----- 219 (262)
T cd05572 151 TFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGNGKL--EFPNYI----- 219 (262)
T ss_pred cccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccCCCC--CCCccc-----
Confidence 3468899999999988889999999999999999999999997654211 11122222101110 011111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 827 TIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 827 ~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
...+.+++.+|++.+|++||+ +.|+++
T Consensus 220 ----~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 220 ----DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ----CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 245789999999999999999 566654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=307.90 Aligned_cols=246 Identities=23% Similarity=0.386 Sum_probs=195.4
Q ss_pred cCCccccCCCeEEEEE-EeCCCcEEEEEEecccc--CCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce--eEEEEe
Q 002346 585 EANILGRGGFGVVYGG-ELPDGTKIAVKRMESNT--MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE--RLLVYE 659 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~lv~e 659 (933)
...+||+|+|-+|||| +-.+|..||=-.++... .++...++|..|+.+|+.|+|||||++|.++.+... .-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3467999999999999 44567777633322222 245556899999999999999999999999987655 678999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-CCcEEEecccccccCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAP 738 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~ 738 (933)
.+..|+|..|++++ +.++.+.+..|++||++||.|||+. .++|||||||-+||+|+. .|.|||+|.|+|....
T Consensus 124 L~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred cccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 99999999999873 4578889999999999999999984 579999999999999975 5899999999998665
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... .....|||.|||||+.. ..|.+.+||||||+.++||+|+..||...... ...++++. .+..|..+.
T Consensus 198 ~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~-----AQIYKKV~--SGiKP~sl~ 266 (632)
T KOG0584|consen 198 KSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNP-----AQIYKKVT--SGIKPAALS 266 (632)
T ss_pred ccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCH-----HHHHHHHH--cCCCHHHhh
Confidence 432 23478999999999887 78999999999999999999999999754321 22233332 222333332
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.-- ..++.++|.+|+.. ..+||++.|++.
T Consensus 267 kV~---------dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 267 KVK---------DPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred ccC---------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111 13577999999999 999999999986
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=300.36 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=196.7
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.|...+.||+|+||.||+|.. .++..||+|++..... ..+...++.+|+++++.++|||++++++++..+...++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 366788999999999999964 4689999999875432 23445678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+. |+|.+.+... ..++++.++..++.|++.|+.|||+ .+|+||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~-g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~ 177 (317)
T cd06635 106 YCL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP 177 (317)
T ss_pred CCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC
Confidence 996 5887777441 2458999999999999999999998 8999999999999999999999999998875443
Q ss_pred CCceeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
. ....|++.|+|||++. .+.++.++|||||||++|||++|+.||........ . ....... .+..
T Consensus 178 ~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~----~~~~~~~--~~~~ 244 (317)
T cd06635 178 A-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--L----YHIAQNE--SPTL 244 (317)
T ss_pred c-----ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--H----HHHHhcc--CCCC
Confidence 2 2346889999999873 45688999999999999999999999876422111 1 1111111 1100
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.. ......+.+++.+|++.+|.+||++.++++...
T Consensus 245 ~~---------~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~ 279 (317)
T cd06635 245 QS---------NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMF 279 (317)
T ss_pred CC---------ccccHHHHHHHHHHccCCcccCcCHHHHHhChh
Confidence 00 112235779999999999999999999997543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=299.17 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=192.3
Q ss_pred cccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 589 lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
||+|+||+||++.. .+|+.||+|.+...... ......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999954 46899999998764322 22345678899999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeec
Q 002346 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 746 (933)
.+++.... ...+++.++..++.|++.|+.|||+ .+++||||+|+||++++++.+||+|||.+....... ...
T Consensus 81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 152 (277)
T cd05577 81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIK 152 (277)
T ss_pred HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccc
Confidence 99996522 2468999999999999999999998 899999999999999999999999999987654321 123
Q ss_pred ccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChh
Q 002346 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEE 826 (933)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 826 (933)
...++..|+|||++.+..++.++||||+|+++|+|++|+.||........... ........... +.+..
T Consensus 153 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~----~~~~~----- 221 (277)
T cd05577 153 GRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEE--LKRRTLEMAVE----YPDKF----- 221 (277)
T ss_pred cccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHH--HHhcccccccc----CCccC-----
Confidence 34678899999999888899999999999999999999999976543111110 00111110111 11111
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 827 TIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 827 ~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
...+.+++.+|++.+|++|| ++.++++
T Consensus 222 ----~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 222 ----SPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred ----CHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 23567999999999999999 5555543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=302.99 Aligned_cols=269 Identities=26% Similarity=0.340 Sum_probs=200.5
Q ss_pred HHhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc----
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS---- 652 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---- 652 (933)
+..++|++.+.||+|+||.||+|... +|+.||+|+++...........+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 45678999999999999999999664 6899999998765433344567889999999999999999999987654
Q ss_pred ------eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcE
Q 002346 653 ------ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (933)
Q Consensus 653 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 726 (933)
..++|+||+++ ++..++... ...+++..++.++.|++.||+|||+ .+|+||||||+||++++++.+
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~ 155 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQI 155 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcE
Confidence 78999999975 777777541 2468999999999999999999999 899999999999999999999
Q ss_pred EEecccccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH
Q 002346 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 727 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 805 (933)
||+|||++...............++..|+|||.+.+ ..++.++|||||||++|||++|++||....... .+.. +..
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~-~~~ 232 (302)
T cd07864 156 KLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLEL-ISR 232 (302)
T ss_pred EeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHH-HHH
Confidence 999999988655433222223356788999998754 457889999999999999999999997543221 1111 111
Q ss_pred Hhhc--cCCCCcc--------cCCCCC----CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 806 VLIS--KENIPKA--------IDPNLN----LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 806 ~~~~--~~~~~~~--------~d~~l~----~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... ....+.. .+.... ...........+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1100 0000100 000000 00000012346789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=300.63 Aligned_cols=253 Identities=23% Similarity=0.355 Sum_probs=196.9
Q ss_pred CCccCCccccCCCeEEEEEEe----CCCcEEEEEEeccccC--CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCcee
Q 002346 582 NFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSER 654 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 654 (933)
+|++.+.||+|+||.||++.. .+|+.||+|++..... .....+++.+|+++++++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478889999999999999965 4789999999875432 122346788999999999 599999999999998899
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+ .+++||||+|+||+++.++.+||+|||++
T Consensus 81 ~lv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~ 152 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-----RERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 152 (290)
T ss_pred EEEEecCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence 999999999999999865 2458899999999999999999998 89999999999999999999999999998
Q ss_pred ccCCCCCceeecccccccCcccccccCCC--CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATG--RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
...............|+..|+|||++... .++.++||||||+++|+|++|+.||....... ....+..........
T Consensus 153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~--~~~~~~~~~~~~~~~ 230 (290)
T cd05613 153 KEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN--SQAEISRRILKSEPP 230 (290)
T ss_pred eecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc--cHHHHHHHhhccCCC
Confidence 86544332222345689999999998653 46789999999999999999999996432211 111112221111111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
.+.. ....+.+++.+|++.+|++|| ++.+++.
T Consensus 231 ~~~~-------------~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 231 YPQE-------------MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred CCcc-------------CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 1111 123567999999999999997 5566554
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=294.64 Aligned_cols=249 Identities=20% Similarity=0.258 Sum_probs=192.8
Q ss_pred HHHHHHhcCCccCCcc--ccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEee
Q 002346 574 EVLRQVTDNFSEANIL--GRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCI 649 (933)
Q Consensus 574 ~~l~~~~~~~~~~~~l--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~ 649 (933)
.+.....++|++.+.+ |+|+||.||++.. .+++.+|+|.+....... .|+.....+ +||||+++++++.
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~ 79 (267)
T PHA03390 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVT 79 (267)
T ss_pred HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEe
Confidence 3444455778888877 9999999999954 578899999987543211 122222222 7999999999999
Q ss_pred eCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEE
Q 002346 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKV 728 (933)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl 728 (933)
.++..++||||+++++|.+++.. ..++++.++..++.|+++|++|||+ .+++||||||+||+++.++ .++|
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l 151 (267)
T PHA03390 80 TLKGHVLIMDYIKDGDLFDLLKK-----EGKLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYL 151 (267)
T ss_pred cCCeeEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEE
Confidence 99999999999999999999965 1378999999999999999999999 8999999999999999998 9999
Q ss_pred ecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
+|||++...... ....|+..|+|||++.+..++.++||||+|+++|||++|+.||...... ......+.... .
T Consensus 152 ~dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~-~ 224 (267)
T PHA03390 152 CDYGLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE-ELDLESLLKRQ-Q 224 (267)
T ss_pred ecCccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcc-hhhHHHHHHhh-c
Confidence 999998755432 2246889999999999888999999999999999999999999854332 21222222221 1
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-MGHAVN 857 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-~~evl~ 857 (933)
....... .....+.+++.+|++.+|++||+ ++++++
T Consensus 225 ~~~~~~~-------------~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 225 KKLPFIK-------------NVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ccCCccc-------------ccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 1111111 12235779999999999999996 588875
|
|
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=298.07 Aligned_cols=266 Identities=23% Similarity=0.321 Sum_probs=199.2
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|++.+.||+|++|.||+|.. .+|+.||||++..... ....+.+.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588899999999999999966 4689999999876532 23346778899999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++ +|.+++..... ...+++..+..++.|+++||+|||+ .+++||||||+||++++++.++|+|||++......
T Consensus 80 ~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~ 153 (284)
T cd07836 80 MDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP 153 (284)
T ss_pred CCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC
Confidence 974 89888865221 2468999999999999999999998 89999999999999999999999999998754332
Q ss_pred CceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh----------hc
Q 002346 741 KYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL----------IS 809 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~----------~~ 809 (933)
.. ......+++.|++||++.+. .++.++||||||+++|||++|+.||......+... ....... ..
T Consensus 154 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 154 VN-TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL--KIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred cc-ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHhCCCChhhHHHHhc
Confidence 11 11234578899999988654 57889999999999999999999997654322111 1110000 00
Q ss_pred cCCCCcccCCCCCC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAIDPNLNL--DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d~~l~~--~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......+...... ..........+.+++.+|++.+|.+||++.++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000000000 0000112345779999999999999999999985
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=300.01 Aligned_cols=244 Identities=24% Similarity=0.422 Sum_probs=195.6
Q ss_pred CCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 586 ANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
...||+|+||.||++.. .+++.||+|++... .......+.+|+.+++.++|+||+++++++..++..++||||++++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 102 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGG 102 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCC
Confidence 35799999999999965 57899999988643 2344567999999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCcee
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~ 744 (933)
+|.+++.. ..+++..+..++.|++.|++|||+ .+++||||+|+||++++++.++|+|||++........ .
T Consensus 103 ~L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~ 172 (292)
T cd06657 103 ALTDIVTH------TRMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R 172 (292)
T ss_pred cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc-c
Confidence 99998743 357899999999999999999998 8999999999999999999999999998875543221 1
Q ss_pred ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCC
Q 002346 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLD 824 (933)
Q Consensus 745 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~ 824 (933)
.....|++.|+|||++.+..++.++||||+|+++|||++|+.||........ ...... ..+..+. .+.
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~------~~~~~~~-~~~-- 240 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRD------NLPPKLK-NLH-- 240 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh------hCCcccC-Ccc--
Confidence 2335688999999999888899999999999999999999999975432211 111111 1111110 000
Q ss_pred hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 825 EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 825 ~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+.+++.+|++.+|.+||++.++++
T Consensus 241 ----~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 241 ----KVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ----cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 11234678999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=298.39 Aligned_cols=257 Identities=16% Similarity=0.210 Sum_probs=183.4
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC----CcEEEEEEeccccCCch-h--------HHHHHHHHHHHHhcCCCcceeEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNK-G--------LSEFQAEIAVLTKVRHRHLVALLG 646 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~-~--------~~~~~~E~~~l~~l~h~niv~l~~ 646 (933)
.++|++.+.||+|+||.||+|...+ +..+|+|+......... + ......+...+..+.|++++++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 4689999999999999999997644 34566665432211100 0 011223344556678999999999
Q ss_pred EeeeCc----eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC
Q 002346 647 YCINGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (933)
Q Consensus 647 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~ 722 (933)
++.... ..++++|++. .++.+.+.. ....++..+..++.|+++|++|||+ ++|+||||||+|||++.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~ 161 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKR-----IKCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDG 161 (294)
T ss_pred eeeEecCCceEEEEEEehhc-cCHHHHHHh-----hccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcC
Confidence 876543 3367788763 466666543 1335788899999999999999998 89999999999999999
Q ss_pred CCcEEEecccccccCCCCCce------eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh
Q 002346 723 DMRAKVADFGLVKNAPDGKYS------VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR 796 (933)
Q Consensus 723 ~~~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~ 796 (933)
++.++|+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~ 241 (294)
T PHA02882 162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN 241 (294)
T ss_pred CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence 999999999999865322111 11234699999999999999999999999999999999999999986532211
Q ss_pred -hHH--HHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 797 -AHL--VTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 797 -~~~--~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
... ..+...........+ .....+.+++..|++.+|++||+++++++.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 242 LIHAAKCDFIKRLHEGKIKIK--------------NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHhHHHHHHHhhhhhhccC--------------CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 111 111111111110000 1124577999999999999999999999865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=308.41 Aligned_cols=273 Identities=25% Similarity=0.360 Sum_probs=202.6
Q ss_pred CccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------ceeE
Q 002346 583 FSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------SERL 655 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~ 655 (933)
|...+.||+||||.||+|+ ...|+.||||.+.... .....+...+|++++++++|+|||++.+.-.+. ....
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 4456789999999999997 6789999999998764 445567889999999999999999999876543 3568
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec--CCC--cEEEecc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG--DDM--RAKVADF 731 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~--~~kl~Df 731 (933)
+|||||.+|+|...+.+... ...+++.+.+.++.+++.||.|||+ ++||||||||.||++- ++| ..||+||
T Consensus 94 lvmEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred EEEeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecc
Confidence 99999999999999977433 3459999999999999999999998 9999999999999983 333 4899999
Q ss_pred cccccCCCCCceeecccccccCcccccccC-CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAA-TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
|.|+...++. .....+||+.|.+||.+. .+.|+..+|.|||||++||.+||..||..........-+.|........
T Consensus 169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 9999888765 456789999999999998 4889999999999999999999999997654432211122222111111
Q ss_pred C---------CCCcccCCCCCCC-hhhHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHhhhh
Q 002346 811 E---------NIPKAIDPNLNLD-EETIESIYRVAELAGHCTAREPQQRP--DMGHAVNVLGPLV 863 (933)
Q Consensus 811 ~---------~~~~~~d~~l~~~-~~~~~~~~~~~~li~~cl~~~P~~RP--s~~evl~~L~~~~ 863 (933)
+ .-+-.....++.. .........+-..+..++..+|++|- ...+....+..++
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 0 0000011112111 11223334455667777888888887 5555544444443
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=297.96 Aligned_cols=260 Identities=23% Similarity=0.286 Sum_probs=193.9
Q ss_pred CccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeC--ceeEEEE
Q 002346 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCING--SERLLVY 658 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~ 658 (933)
|++.+.||+|+||.||+|.. .+++.||+|+++....+.. .....+|+.++.++. |+||+++++++.++ +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 56788999999999999954 4689999999876532222 234457888999885 99999999999887 8899999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||++ ++|.+++... ...+++.+++.++.|++.||+|||+ .+++||||||+||+++. +.+||+|||+++...
T Consensus 80 e~~~-~~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~ 150 (282)
T cd07831 80 ELMD-MNLYELIKGR----KRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIY 150 (282)
T ss_pred ecCC-ccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccc
Confidence 9996 5888887542 2468999999999999999999998 89999999999999999 999999999988654
Q ss_pred CCCceeecccccccCcccccccC-CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc--------
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAA-TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-------- 809 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-------- 809 (933)
.... .....++..|+|||++. ++.++.++||||+||++|||++|+.||....+.+. ..+.......
T Consensus 151 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 225 (282)
T cd07831 151 SKPP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVLGTPDAEVLKK 225 (282)
T ss_pred cCCC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHcCCCCHHHHHh
Confidence 3321 12346789999999764 45678899999999999999999999976543221 1111111100
Q ss_pred ---cCCCCcccCCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 ---KENIPKAIDPNLNLD--EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ---~~~~~~~~d~~l~~~--~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......+....... .........+.+++.+|++.+|++||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred hcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000000000000 001123467889999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=321.79 Aligned_cols=283 Identities=23% Similarity=0.332 Sum_probs=222.2
Q ss_pred HHHHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeee
Q 002346 573 IEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650 (933)
Q Consensus 573 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 650 (933)
...++.-.++|.++++||+|+||.|..++. ..++.||.|++.+-.+- .....-|..|-.+|..-+.+=||++...|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 445566678999999999999999999965 46889999999874332 3334678899999999999999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
..+.|+|||||+||+|...+.. +.++++.-++-++..|+-||.-+|+ .|+|||||||+|||+|..|++||+|
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk-----~~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLAD 218 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSK-----FDRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLAD 218 (1317)
T ss_pred ccceEEEEecccCchHHHHHhh-----cCCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeecc
Confidence 9999999999999999999965 3468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccCcccccccC----C-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAA----T-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 805 (933)
||.+.....+..-.....+|||.|++||++. + +.|++.+|.||+||++|||+.|..||+.. .++.-+.+
T Consensus 219 FGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad------slveTY~K 292 (1317)
T KOG0612|consen 219 FGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD------SLVETYGK 292 (1317)
T ss_pred chhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH------HHHHHHHH
Confidence 9988766655545556679999999999884 2 57899999999999999999999999753 34455555
Q ss_pred HhhccCC--CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH----------HHhhhhhhcCCCC
Q 002346 806 VLISKEN--IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD---MGHAVN----------VLGPLVEQWKPAT 870 (933)
Q Consensus 806 ~~~~~~~--~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs---~~evl~----------~L~~~~~~~~~~~ 870 (933)
+...+.. +|+.+ +...+..++|.+.+. +|+.|.. +.++.. .+++...++.|..
T Consensus 293 Im~hk~~l~FP~~~-----------~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPev 360 (1317)
T KOG0612|consen 293 IMNHKESLSFPDET-----------DVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPEV 360 (1317)
T ss_pred HhchhhhcCCCccc-----------ccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCcC
Confidence 5544322 22211 122445677877665 6888877 777654 2333344455555
Q ss_pred cCCCCCCcccc
Q 002346 871 REDEDGYGIDL 881 (933)
Q Consensus 871 ~~~~~~~~~~~ 881 (933)
....|.++++.
T Consensus 361 ssd~DTsnFd~ 371 (1317)
T KOG0612|consen 361 SSDDDTSNFDV 371 (1317)
T ss_pred CCCCccccccc
Confidence 55666666533
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=292.20 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=189.5
Q ss_pred CccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHH-HhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVL-TKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.. .+++.||+|.++..... ......+..|..++ ...+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999955 46899999998765322 22233455555544 445899999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
++|.+++.. ...+++..+..++.|++.||.|||+ .+++||||+|+||++++++.+||+|||+++....
T Consensus 82 ~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 149 (260)
T cd05611 82 GDCASLIKT-----LGGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---- 149 (260)
T ss_pred CCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc----
Confidence 999999865 2458899999999999999999999 8999999999999999999999999999875433
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
.....|++.|+|||.+.+..++.++||||||+++|||++|..||........ ...........+..+..
T Consensus 150 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~~~---- 218 (260)
T cd05611 150 -NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV------FDNILSRRINWPEEVKE---- 218 (260)
T ss_pred -cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcccCCCCcccc----
Confidence 2234688999999999888889999999999999999999999976433211 11111111111111111
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
.....+.+++.+|++.+|++||++.++.+.+
T Consensus 219 -----~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 219 -----FCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred -----cCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 1124577999999999999999876555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=295.06 Aligned_cols=243 Identities=23% Similarity=0.360 Sum_probs=187.0
Q ss_pred ccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchh-HHHHHHHH---HHHHhcCCCcceeEEeEeeeCceeEEEEeecC
Q 002346 588 ILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKG-LSEFQAEI---AVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 588 ~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
.||+|+||.||+|.. .+++.||+|.+......... ...+..|. +.++...||+|+++++++..++..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999954 46899999998765332211 22233443 34444579999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 742 (933)
+++|.+++.. ...+++.++..++.|+++|++|||+ .+|+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~-----~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~- 151 (278)
T cd05606 81 GGDLHYHLSQ-----HGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK- 151 (278)
T ss_pred CCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC-
Confidence 9999998854 2468999999999999999999998 899999999999999999999999999987554322
Q ss_pred eeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCC
Q 002346 743 SVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821 (933)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 821 (933)
.....|+..|+|||++.++ .++.++||||+|+++|||++|+.||........... ..........++. .
T Consensus 152 --~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~----~- 221 (278)
T cd05606 152 --PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMAVELPD----S- 221 (278)
T ss_pred --CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH---HHHhhccCCCCCC----c-
Confidence 1234689999999998754 689999999999999999999999976533222111 1111111111111 1
Q ss_pred CCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 822 NLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 822 ~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
....+.+++.+|+..+|.+|| ++.++++
T Consensus 222 --------~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 222 --------FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --------CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 123577999999999999999 8999875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=302.57 Aligned_cols=266 Identities=22% Similarity=0.356 Sum_probs=198.8
Q ss_pred HHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee-CceeE
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERL 655 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~ 655 (933)
.++++|++.+.||+|+||.||+|. ..+++.||+|++..........+.+.+|++++++++||||+++++++.. +...+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 467899999999999999999995 4579999999987654344455778899999999999999999998865 55788
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+ +++|.+++.. .++++..+..++.|+++||+|||+ .+|+||||+|+||++++++.++|+|||.+.
T Consensus 87 lv~e~~-~~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~ 156 (328)
T cd07856 87 FVTELL-GTDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR 156 (328)
T ss_pred EEeehh-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence 999998 5689888753 457888899999999999999999 899999999999999999999999999987
Q ss_pred cCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHH-HH--------HHHH
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHL-VT--------WFRR 805 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~-~~--------~~~~ 805 (933)
..... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||........... .. +...
T Consensus 157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (328)
T cd07856 157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT 232 (328)
T ss_pred ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 54321 123467889999998765 5689999999999999999999999976533211100 00 0000
Q ss_pred Hhhcc-CCCCcccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 806 VLISK-ENIPKAID--PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 806 ~~~~~-~~~~~~~d--~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..... ..+...+. ...............+.+++.+|++.+|++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~ 287 (328)
T cd07856 233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA 287 (328)
T ss_pred ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00000 00000000 000000000112246789999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=302.59 Aligned_cols=258 Identities=21% Similarity=0.332 Sum_probs=194.5
Q ss_pred CccccC--CCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRG--GFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
..||+| +||+||++.. .+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 457777 8999999965 5799999999886654555567899999999999999999999999999999999999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
++|.+++.... ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.++++||+.+.........
T Consensus 84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~ 157 (328)
T cd08226 84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK 157 (328)
T ss_pred CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence 99999986632 2358899999999999999999998 89999999999999999999999999865422211100
Q ss_pred e------ecccccccCcccccccCCC--CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC-
Q 002346 744 V------ETRLAGTFGYLAPEYAATG--RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP- 814 (933)
Q Consensus 744 ~------~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 814 (933)
. .....++..|+|||++.+. .++.++|||||||++|||++|+.||........ ..... ......+
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~----~~~~~~~~ 231 (328)
T cd08226 158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKL----KGPPYSPL 231 (328)
T ss_pred ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHh----cCCCCCCc
Confidence 0 0112356679999998763 478999999999999999999999976432111 11100 0000000
Q ss_pred ----------------------------------cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 ----------------------------------KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ----------------------------------~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+..+. ..........+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 232 DITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR-TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred cccccchhhhhhccchhhhhcccccchhcccccccccccccc-chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 00000111 1112234457889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=275.01 Aligned_cols=260 Identities=22% Similarity=0.372 Sum_probs=201.2
Q ss_pred HHHHHHHhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee
Q 002346 573 IEVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (933)
Q Consensus 573 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 650 (933)
++++..+++ +.||+|+|+.|-.+ .+.+|.+||||++.+. ....+.+..+|++++.+. .|+||+++++||++
T Consensus 75 F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd 147 (463)
T KOG0607|consen 75 FEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFED 147 (463)
T ss_pred HHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc
Confidence 455555543 67999999999887 6778999999999876 345567899999999999 49999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC---cEE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAK 727 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~k 727 (933)
+...|||||.|.||+|..+++++ ..+++.++.++.++|+.||.+||. +||.|||+||+|||-.... -+|
T Consensus 148 d~~FYLVfEKm~GGplLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 148 DTRFYLVFEKMRGGPLLSHIQKR-----KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred cceEEEEEecccCchHHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCcee
Confidence 99999999999999999999772 558999999999999999999999 9999999999999986543 489
Q ss_pred EecccccccCCCC------CceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCch-
Q 002346 728 VADFGLVKNAPDG------KYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDD- 795 (933)
Q Consensus 728 l~DfGla~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~- 795 (933)
|+||.+....... ....-...+|+..|||||+.. ...|+.++|.|||||++|-|+.|.+||.+.-..+
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 9999886532211 111123468999999999762 2358889999999999999999999997643211
Q ss_pred --------hhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHH-HHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 796 --------RAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESI-YRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 796 --------~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~-~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..-....+..+......+ .+.+|..+ .+..+++...+..++.+|.++.+++.
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeF----------PdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEF----------PDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcC----------ChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 111111222222222222 23344433 44568999999999999999999876
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=305.19 Aligned_cols=263 Identities=22% Similarity=0.347 Sum_probs=194.6
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------ 651 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------ 651 (933)
+.++|.+.+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 13 LPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 357899999999999999999964 5789999999876543344456788999999999999999999998654
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
...++|+||+. .+|.+++. ..+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+||
T Consensus 93 ~~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~df 161 (342)
T cd07879 93 QDFYLVMPYMQ-TDLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDF 161 (342)
T ss_pred ceEEEEecccc-cCHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeC
Confidence 34689999995 46766541 358899999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH------
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR------ 804 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~------ 804 (933)
|+++..... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||................
T Consensus 162 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 237 (342)
T cd07879 162 GLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPE 237 (342)
T ss_pred CCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHH
Confidence 998754332 123467889999999866 468899999999999999999999998653322111100000
Q ss_pred --HHhhccCCCCcccC--CCCCCCh---hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 --RVLISKENIPKAID--PNLNLDE---ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 --~~~~~~~~~~~~~d--~~l~~~~---~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... .......+. +...... ........+.+++.+|++.||++||+++++++
T Consensus 238 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~ 296 (342)
T cd07879 238 FVQKLE-DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE 296 (342)
T ss_pred HHHHhc-ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0000 000000000 0000000 00011235779999999999999999999986
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=302.60 Aligned_cols=269 Identities=24% Similarity=0.369 Sum_probs=200.4
Q ss_pred HHHHHHHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC
Q 002346 573 IEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (933)
Q Consensus 573 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 651 (933)
...+..++++|++.+.||+|+||.||+|. ..+++.||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 34566778999999999999999999995 45789999999976533334456788999999999999999999988643
Q ss_pred ------ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 652 ------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 652 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
...+++++++ +++|.+++.. ..+++..+..++.|+++|++|||+ .+|+||||||+||++++++.
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~ 158 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCE 158 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCC
Confidence 3467888887 7899888743 358999999999999999999999 89999999999999999999
Q ss_pred EEEecccccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
+||+|||+++..... .....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||......... .....
T Consensus 159 ~kl~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~ 232 (345)
T cd07877 159 LKILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL--KLILR 232 (345)
T ss_pred EEEeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHH
Confidence 999999998754332 233568899999998765 56788999999999999999999999654332111 11000
Q ss_pred HHhhccCCCCccc------------C--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 RVLISKENIPKAI------------D--PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ~~~~~~~~~~~~~------------d--~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
........+...+ + +..............+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 233 LVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred HhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000000000000 0 000000000011235779999999999999999999986
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.79 Aligned_cols=264 Identities=26% Similarity=0.356 Sum_probs=201.7
Q ss_pred CCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc-----eeE
Q 002346 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-----ERL 655 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~ 655 (933)
+|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 5888999999999999999664 5899999998765433455678999999999999999999999988765 789
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||++ ++|.+++.. ..++++..++.++.|+++||+|||+ .+|+||||||+||+++.++.++|+|||++.
T Consensus 81 lv~e~~~-~~l~~~l~~-----~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~ 151 (330)
T cd07834 81 IVTELME-TDLHKVIKS-----PQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLAR 151 (330)
T ss_pred EEecchh-hhHHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence 9999997 588888854 2378999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCc--eeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-c-
Q 002346 736 NAPDGKY--SVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-K- 810 (933)
Q Consensus 736 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~- 810 (933)
....... .......+++.|+|||++.+. .++.++||||||+++|+|++|+.||......+... .+...... .
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~ 228 (330)
T cd07834 152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSE 228 (330)
T ss_pred eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCCh
Confidence 6654331 112334678999999999877 78999999999999999999999997654322111 11110000 0
Q ss_pred --------CCCCcccC---CC--CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 --------ENIPKAID---PN--LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 --------~~~~~~~d---~~--l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......+. .. .............+.+++.+||+.+|++||++.++++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 288 (330)
T cd07834 229 EDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA 288 (330)
T ss_pred hHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 00000000 00 0000000112345789999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=298.32 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=202.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 657 (933)
++|.+.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++ ||||+++++++..++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4688999999999999999965 4799999999876432 2334567889999999998 99999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+++|+||+|+||+++.++.++++|||++...
T Consensus 81 ~e~~~~~~L~~~l~~-----~~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~ 152 (280)
T cd05581 81 LEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152 (280)
T ss_pred EcCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence 999999999999965 2369999999999999999999998 89999999999999999999999999998755
Q ss_pred CCCCc-------------------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH
Q 002346 738 PDGKY-------------------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH 798 (933)
Q Consensus 738 ~~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~ 798 (933)
..... .......|+..|+|||+.....++.++||||||++++++++|+.||.......
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--- 229 (280)
T cd05581 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL--- 229 (280)
T ss_pred CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---
Confidence 43221 11223467899999999988889999999999999999999999997653211
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM----GHAVN 857 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~----~evl~ 857 (933)
.+.........++..+ ...+.+++.+|++.+|++||++ .++++
T Consensus 230 ---~~~~~~~~~~~~~~~~-------------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 230 ---TFQKILKLEYSFPPNF-------------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ---HHHHHHhcCCCCCCcc-------------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 1111111111122111 2357799999999999999999 77764
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=322.12 Aligned_cols=263 Identities=28% Similarity=0.477 Sum_probs=209.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC--------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC
Q 002346 581 DNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 651 (933)
++..+.+.||+|.||.|++|... ....||||.++..... .+.+.+..|+++|+.+ +|+||+.++|+|..+
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 44455679999999999999542 1457999999877644 7788999999999999 699999999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhcc---------cCCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWH---------DHGY--TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
+..++|+||+..|+|.++++..+ .... ..++..+.+.++.|||.|++||++ .++||||+.++|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEe
Confidence 99999999999999999998755 1111 238999999999999999999999 899999999999999
Q ss_pred cCCCcEEEecccccccCCCCCceeeccccc--ccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhh
Q 002346 721 GDDMRAKVADFGLVKNAPDGKYSVETRLAG--TFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~ 797 (933)
+++..+||+|||+|+...+..+.....-.| ...|||||.+....|+.|+|||||||++||++| |..|+.+.....
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~-- 529 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE-- 529 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH--
Confidence 999999999999999777665554333233 446999999999999999999999999999999 778886532111
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.+..+.+. ...+.. ...+ ..++.++++.||+.+|++||++.++++.++..+.
T Consensus 530 ~l~~~l~~----G~r~~~--------P~~c---~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~ 581 (609)
T KOG0200|consen 530 ELLEFLKE----GNRMEQ--------PEHC---SDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ 581 (609)
T ss_pred HHHHHHhc----CCCCCC--------CCCC---CHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence 22222211 111111 1111 2467799999999999999999999999988543
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=292.51 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=196.4
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 589 LGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 589 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
||+|+||.||++... +|+.||+|++..... .....+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999765 499999999876532 224467889999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc----
Q 002346 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY---- 742 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~---- 742 (933)
.+++... ..+++..+..++.|+++||+|||+ .+++||||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 152 (265)
T cd05579 81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN 152 (265)
T ss_pred HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence 9999652 368999999999999999999998 8999999999999999999999999999875443211
Q ss_pred ---eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 743 ---SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 743 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.......++..|+|||......++.++||||||+++||+++|+.||....+... ...........+...
T Consensus 153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~~-- 224 (265)
T cd05579 153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI------FQNILNGKIEWPEDV-- 224 (265)
T ss_pred cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCCcCCCccc--
Confidence 122345688899999999888899999999999999999999999976543211 111111111111110
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
.....+.+++.+|++.+|++||++.++.+.|
T Consensus 225 ---------~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 225 ---------EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred ---------cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 0124577999999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=295.35 Aligned_cols=263 Identities=23% Similarity=0.325 Sum_probs=202.0
Q ss_pred CccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeec
Q 002346 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
|++.+.||+|++|.||++.. .+++.+|+|++............+.+|++++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56778999999999999965 47899999998776544445678889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
++ +|.+++... ...+++.++..++.|+++|++|||+ .+|+|+||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~-~l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~ 152 (283)
T cd05118 81 DT-DLYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV 152 (283)
T ss_pred CC-CHHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence 65 888888552 1468999999999999999999998 899999999999999999999999999987665433
Q ss_pred ceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-cC-CCCcccC
Q 002346 742 YSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-KE-NIPKAID 818 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~d 818 (933)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||......+.. ......... .. ......+
T Consensus 153 -~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 153 -RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred -ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchh
Confidence 122334678899999998766 7899999999999999999999999765432211 101010000 00 0000000
Q ss_pred ------------CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 ------------PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ------------~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..............++.+++.+|++.+|.+||++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 000000111223456889999999999999999999986
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-32 Score=294.66 Aligned_cols=264 Identities=26% Similarity=0.348 Sum_probs=197.3
Q ss_pred CccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc---CCCcceeEEeEeeeCce-----
Q 002346 583 FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCINGSE----- 653 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----- 653 (933)
|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 567889999999999999765 489999999976543333345677788777666 59999999999987776
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.+++|||+. ++|.+++.... ...+++..++.++.|+++||+|||+ .+++|+||+|+||+++.++.+||+|||+
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~ 153 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGL 153 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCc
Confidence 899999996 58988886522 2358999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-cCC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-KEN 812 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 812 (933)
+........ .....++..|+|||++.+..++.++|||||||++|||++|+.||......+ ....+....... ...
T Consensus 154 ~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 229 (287)
T cd07838 154 ARIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEE 229 (287)
T ss_pred ceeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHh
Confidence 876544321 123357889999999998889999999999999999999999987644322 111111111000 000
Q ss_pred CC-------cccCCCCC--CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IP-------KAIDPNLN--LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~-------~~~d~~l~--~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+ ..+..... ......+....+.+++.+|++.||++||++.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred cCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 00 00000000 00111123356679999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=302.41 Aligned_cols=268 Identities=26% Similarity=0.331 Sum_probs=196.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-------
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------- 651 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 651 (933)
.++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+++++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 47899999999999999999965 4689999999876543333345678999999999999999999987543
Q ss_pred -ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 652 -SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 652 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
...++||||+. +++...+... ...+++.++..++.|+++||+|||+ .+|+||||||+||++++++.+||+|
T Consensus 87 ~~~~~lv~~~~~-~~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~d 158 (311)
T cd07866 87 RGSVYMVTPYMD-HDLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIAD 158 (311)
T ss_pred CceEEEEEecCC-cCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECc
Confidence 34689999996 4777776441 2468999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCce----------eecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHH
Q 002346 731 FGLVKNAPDGKYS----------VETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHL 799 (933)
Q Consensus 731 fGla~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~ 799 (933)
||+++........ ..+...|++.|+|||++.+. .++.++||||||+++|||++|++||...........
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~ 238 (311)
T cd07866 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHL 238 (311)
T ss_pred CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 9998754332211 11234578899999987654 578999999999999999999999976544322111
Q ss_pred HHHHHHHhhcc-------CCCCccc----CCCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 800 VTWFRRVLISK-------ENIPKAI----DPNLNLDE--ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 800 ~~~~~~~~~~~-------~~~~~~~----d~~l~~~~--~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ........ ..++... ........ ........+.+++.+|++.+|++||++.|++.
T Consensus 239 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 239 I--FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred H--HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 1 11000000 0001000 00000000 00111246789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=296.28 Aligned_cols=247 Identities=25% Similarity=0.389 Sum_probs=195.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
+.|+..+.||+|+||.||+|.. .+++.||+|.+..... ......++.+|+++++.++|+|++++++++......++||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 3467778899999999999965 4688999998865322 3344567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+. |++.+.+... ..++++.++..++.|++.|++|||+ .+++||||||+||+++.++.++|+|||++....
T Consensus 95 e~~~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 166 (308)
T cd06634 95 EYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (308)
T ss_pred EccC-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeec
Confidence 9996 6888777431 2458899999999999999999998 899999999999999999999999999987554
Q ss_pred CCCceeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
.. ....|++.|+|||++. .+.++.++|||||||++|||++|+.||......... .... ....+.
T Consensus 167 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~--~~~~~~ 233 (308)
T cd06634 167 PA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIA--QNESPA 233 (308)
T ss_pred Cc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HHHh--hcCCCC
Confidence 32 2346889999999874 356788999999999999999999998654321111 1111 111111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... ......+.+++.+||+.+|++||++.++++
T Consensus 234 ~~~---------~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~ 266 (308)
T cd06634 234 LQS---------GHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (308)
T ss_pred cCc---------ccccHHHHHHHHHHhhCCcccCCCHHHHhh
Confidence 111 112245779999999999999999999987
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=299.48 Aligned_cols=264 Identities=20% Similarity=0.266 Sum_probs=195.1
Q ss_pred cCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
+.+.+|.|+++.||++.. +++.||||++..........+.+.+|+++++.++|+||+++++++...+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 445556666666666655 7999999999876445566788999999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc--
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-- 742 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-- 742 (933)
+|.+++.... ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||.+........
T Consensus 85 ~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~ 158 (314)
T cd08216 85 SCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ 158 (314)
T ss_pred CHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence 9999997532 2358899999999999999999998 8999999999999999999999999998864432211
Q ss_pred ----eeecccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh---ccC--
Q 002346 743 ----SVETRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI---SKE-- 811 (933)
Q Consensus 743 ----~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~---~~~-- 811 (933)
.......++..|+|||++.. ..++.++|||||||++|||++|+.||....... ........... ...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~ 236 (314)
T cd08216 159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTY 236 (314)
T ss_pred cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCch
Confidence 01123457788999999865 358899999999999999999999997643211 11111100000 000
Q ss_pred -----CCCc----ccCCCCC---CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 -----NIPK----AIDPNLN---LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 -----~~~~----~~d~~l~---~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... ..++... ...........+.+++.+||+.+|++||++.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 0000 0000000 00111222346789999999999999999999987
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-32 Score=297.88 Aligned_cols=267 Identities=23% Similarity=0.328 Sum_probs=192.7
Q ss_pred CCccCCccccCCCeEEEEEEeC-C--CcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC----ce
Q 002346 582 NFSEANILGRGGFGVVYGGELP-D--GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING----SE 653 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~ 653 (933)
+|++.+.||+|+||.||++... . +..||+|++..........+.+.+|+.+++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788899999999999999653 3 77999999875433333456788999999999 599999999875432 45
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++++||+. ++|.+++.. ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~ 151 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-----GQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGL 151 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence 688899885 689988854 2568999999999999999999998 8999999999999999999999999999
Q ss_pred cccCCCCCce---eecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHH---------
Q 002346 734 VKNAPDGKYS---VETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV--------- 800 (933)
Q Consensus 734 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~--------- 800 (933)
++........ ......|++.|+|||++.+ ..++.++||||+|+++|+|++|+.||............
T Consensus 152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 9865432211 1233578999999998765 46889999999999999999999999764321110000
Q ss_pred HHHHHHhhccC-CCCcccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 801 TWFRRVLISKE-NIPKAID--PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 801 ~~~~~~~~~~~-~~~~~~d--~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+......... .....+. +..............+.+++.+|++.+|++||++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0000000 000000000011245779999999999999999999875
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=293.00 Aligned_cols=245 Identities=25% Similarity=0.406 Sum_probs=194.3
Q ss_pred CccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 583 FSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
|...+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+++++.++|||++++++++.++...++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999965 4688999999875432 233456788999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+. |++.+++... ..++++.++..++.|++.|++|||+ .+++||||+|+||+++.++.+||+|||++......
T Consensus 103 ~~-~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~ 174 (313)
T cd06633 103 CL-GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174 (313)
T ss_pred CC-CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence 95 6787777541 2468999999999999999999998 89999999999999999999999999988643321
Q ss_pred CceeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 741 KYSVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
....|+..|+|||++. .+.++.++|||||||++|||++|+.||......... . .... ...+...
T Consensus 175 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~---~---~~~~--~~~~~~~ 241 (313)
T cd06633 175 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---Y---HIAQ--NDSPTLQ 241 (313)
T ss_pred -----CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH---H---HHHh--cCCCCCC
Confidence 2346889999999874 456888999999999999999999998765322211 1 1111 1111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+.. ...+.+++.+|++.+|.+||++.++++
T Consensus 242 ~~~~---------~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 242 SNEW---------TDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred cccc---------CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111 134778999999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-32 Score=302.21 Aligned_cols=259 Identities=23% Similarity=0.353 Sum_probs=198.6
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce----
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE---- 653 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 653 (933)
+.++|++.+.||+|+||.||+|... +++.||+|++............+.+|+.++++++||||+++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4678999999999999999999664 68899999987653334445678889999999999999999998766554
Q ss_pred --eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 654 --RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 654 --~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
.++|+||+ +++|.+++.. ..+++.++..++.|+++|++|||+ .+|+||||||+||++++++.+||+||
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~df 162 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDF 162 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccc
Confidence 89999999 6799998854 468999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
|++...... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......... ..+....
T Consensus 163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~--- 232 (343)
T cd07851 163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLV--- 232 (343)
T ss_pred ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhc---
Confidence 998865432 223467889999998865 36789999999999999999999999754332111 1110000
Q ss_pred CCCCccc----------------CCCC--CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 ENIPKAI----------------DPNL--NLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 ~~~~~~~----------------d~~l--~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...++.+ .... ............+.+++.+|++.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 0000000 0000 000000112356789999999999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-32 Score=292.82 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=193.8
Q ss_pred cCCccCCccccCCCeEEEEEEeCC-CcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|...+ ++.||||+++.... .....++..|+.++.+.. ||||+++++++..+...++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 568889999999999999997754 89999999876532 233456677887777774 999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+. +++.+.+... ..++++..+..++.|+++|++|||+ .++|+||||+|+||++++++.+||+|||++....
T Consensus 94 e~~~-~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 94 ELMS-TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred eccC-cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 9984 5777766441 2368999999999999999999996 2589999999999999999999999999987654
Q ss_pred CCCceeecccccccCcccccccCCCC----CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGR----VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
.... .....+++.|+|||++.+.. ++.++||||||+++|||++|+.||...... . .......... .+
T Consensus 167 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~----~~~~~~~~~~--~~ 237 (296)
T cd06618 167 DSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-F----EVLTKILQEE--PP 237 (296)
T ss_pred CCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-H----HHHHHHhcCC--CC
Confidence 3221 12335788999999986553 788999999999999999999999653211 1 1111111111 11
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. +.... ....++.+++.+|++.+|++||++.++++
T Consensus 238 ~-~~~~~-------~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 272 (296)
T cd06618 238 S-LPPNE-------GFSPDFCSFVDLCLTKDHRKRPKYRELLQ 272 (296)
T ss_pred C-CCCCC-------CCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1 11000 12245789999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=298.62 Aligned_cols=266 Identities=23% Similarity=0.316 Sum_probs=195.8
Q ss_pred hcCCcc-CCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCch------------hHHHHHHHHHHHHhcCCCcceeEE
Q 002346 580 TDNFSE-ANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK------------GLSEFQAEIAVLTKVRHRHLVALL 645 (933)
Q Consensus 580 ~~~~~~-~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------------~~~~~~~E~~~l~~l~h~niv~l~ 645 (933)
.++|.. .+.||+|+||.||+|.. .+++.||||++........ ....+.+|++++++++|+||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 456654 57799999999999964 4789999999875432210 012577899999999999999999
Q ss_pred eEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 646 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
+++..++..++||||++ |+|.+++.. ...+++.....++.|+++||+|||+ .+|+||||+|+||+++.++.
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~-----~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~ 157 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDR-----KIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGI 157 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCC
Confidence 99999999999999996 699998854 2458899999999999999999998 89999999999999999999
Q ss_pred EEEecccccccCCCCC-------------ceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCC
Q 002346 726 AKVADFGLVKNAPDGK-------------YSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDT 791 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~ 791 (933)
++|+|||++....... ........+++.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~ 237 (335)
T PTZ00024 158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE 237 (335)
T ss_pred EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999987554111 0111223568899999998764 4689999999999999999999999765
Q ss_pred CCchhhHHHHHHHHHhhcc--CCCCccc--------CCCCCC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 792 MPDDRAHLVTWFRRVLISK--ENIPKAI--------DPNLNL--DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 792 ~~~~~~~~~~~~~~~~~~~--~~~~~~~--------d~~l~~--~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+.+. ...+....... ..++... ...... ..........+.+++.+|++.+|++||+++|++.
T Consensus 238 ~~~~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 238 NEIDQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CHHHH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 43221 11111111000 0011100 000000 0000111345779999999999999999999986
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.5e-32 Score=303.83 Aligned_cols=261 Identities=25% Similarity=0.412 Sum_probs=212.9
Q ss_pred ecHHHHHHHhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEe
Q 002346 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYC 648 (933)
Q Consensus 571 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 648 (933)
..++.+..-++.|++.+.||+|.+|.||++ ..++++.+|+|+.... .+..++...|..+++.. .|||++.++|++
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~---~d~deEiE~eynil~~~~~hpnv~~fyg~~ 85 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT---EDEEEEIELEYNMLKKYSHHPNVATFYGAF 85 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC---ccccHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 345555556788999999999999999999 4568999999988765 33346788899999888 699999999998
Q ss_pred ee-----CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 649 IN-----GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 649 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
.. +++.|||||||.+|+..+.++... ...+.|..+..|++++++|+.|||. ..++|||||-.|||++.+
T Consensus 86 ~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e 159 (953)
T KOG0587|consen 86 IKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTEN 159 (953)
T ss_pred EEecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEecc
Confidence 63 678999999999999999998754 4679999999999999999999998 899999999999999999
Q ss_pred CcEEEecccccccCCCCCceeecccccccCcccccccCCC-----CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH
Q 002346 724 MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG-----RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH 798 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~ 798 (933)
+.||++|||++....... .......|||.|||||++... .|+..+|+||||++..||.-|.+|+.+..|....
T Consensus 160 ~~VKLvDFGvSaQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL- 237 (953)
T KOG0587|consen 160 AEVKLVDFGVSAQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL- 237 (953)
T ss_pred CcEEEeeeeeeeeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-
Confidence 999999999988765433 223446899999999998533 4677899999999999999999999887664321
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..++..-.|.+. .......++.++|..|+.+|.++||++.++++
T Consensus 238 ------------F~IpRNPPPkLk---rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 238 ------------FLIPRNPPPKLK---RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ------------ccCCCCCCcccc---chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 112222223332 23345567889999999999999999998875
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=290.28 Aligned_cols=264 Identities=24% Similarity=0.357 Sum_probs=197.1
Q ss_pred CccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEEEee
Q 002346 583 FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
|++.+.||+|+||.||+|... +++.||+|++...... .......+|+..+.+++ |+||+++++++..++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 567889999999999999764 5789999998765322 22334567999999998 99999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+ +|+|.+++.... ...+++.++..++.|+++||+|||+ ++++|+||+|+||++++++.++|+|||++......
T Consensus 80 ~-~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~ 152 (283)
T cd07830 80 M-EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR 152 (283)
T ss_pred C-CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCC
Confidence 9 889999886522 2468999999999999999999998 89999999999999999999999999998765432
Q ss_pred CceeecccccccCcccccccC-CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHH-H---------HHHHHhhc
Q 002346 741 KYSVETRLAGTFGYLAPEYAA-TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV-T---------WFRRVLIS 809 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~-~---------~~~~~~~~ 809 (933)
.. .....|+..|+|||++. ...++.++|+||||+++|||++|+.||......+..... . |......
T Consensus 153 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 229 (283)
T cd07830 153 PP--YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKL- 229 (283)
T ss_pred CC--cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhh-
Confidence 21 23346888999999874 445789999999999999999999999765432221100 0 0000000
Q ss_pred cCCCCcccCCCCCC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAIDPNLNL--DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d~~l~~--~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......+...... ..........+.+++.+|++.+|++||++.|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 230 ASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 00000011000000 0000011356889999999999999999999976
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=298.78 Aligned_cols=264 Identities=23% Similarity=0.352 Sum_probs=192.6
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-------
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------- 651 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------- 651 (933)
..+|++.+.||.|+||.||+|.. .+|+.||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~--~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD--PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC--CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 36899999999999999999954 568999999986653 34457788999999999999999999776543
Q ss_pred -------ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec-CC
Q 002346 652 -------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DD 723 (933)
Q Consensus 652 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~~ 723 (933)
...++||||++ ++|.+++.. ..+++..++.++.|+++|++|||+ .+|+||||||+||+++ ++
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~ 151 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTED 151 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence 35789999996 589888743 458899999999999999999998 8999999999999997 45
Q ss_pred CcEEEecccccccCCCCCce--eecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHH
Q 002346 724 MRAKVADFGLVKNAPDGKYS--VETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV 800 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~ 800 (933)
+.+|++|||++......... ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||....+......
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~- 230 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQL- 230 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-
Confidence 67899999998754322111 1122357889999997654 5678899999999999999999999976543221111
Q ss_pred HHHHHHhhcc--------CCCCccc-----CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 801 TWFRRVLISK--------ENIPKAI-----DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 801 ~~~~~~~~~~--------~~~~~~~-----d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......... ...+... .+.............++.+++.+|++.+|++||++.++++
T Consensus 231 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 231 -ILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred -HHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 000000000 0000000 0000000000012245779999999999999999999986
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=289.90 Aligned_cols=262 Identities=26% Similarity=0.359 Sum_probs=199.6
Q ss_pred CccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeec
Q 002346 583 FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
|+..+.||+|+||.||+|... +++.||+|++..........+.+..|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 566788999999999999664 5899999999876433444567889999999999999999999999999999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
+ ++|.+++.... ..+++.++..++.|+++||+|||+ .+|+||||+|+||++++++.+||+|||.++......
T Consensus 81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 152 (282)
T cd07829 81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL 152 (282)
T ss_pred C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence 7 59999996521 468999999999999999999999 899999999999999999999999999987654432
Q ss_pred ceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc--------CC
Q 002346 742 YSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--------EN 812 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--------~~ 812 (933)
. ......++..|+|||++.+. .++.++||||||+++|||++|+.||......+. ...+....... ..
T Consensus 153 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 153 R-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQ---LFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred c-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH---HHHHHHHhCCCcHHHHHhhcc
Confidence 1 12233567889999998766 789999999999999999999999976432211 11111100000 00
Q ss_pred C---CcccCCCCCCC---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 I---PKAIDPNLNLD---EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~---~~~~d~~l~~~---~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+ ...+ +..... .........+.+++.+|++.+|++||++.+++.
T Consensus 229 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 229 LPDYKPTF-PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccc-cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0 0000 000000 000111346889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=283.80 Aligned_cols=238 Identities=28% Similarity=0.407 Sum_probs=193.8
Q ss_pred cccCCCeEEEEEEeC-CCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCCh
Q 002346 589 LGRGGFGVVYGGELP-DGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL 666 (933)
Q Consensus 589 lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL 666 (933)
||+|+||.||++... +++.||+|.+...... ......+..|+.++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999654 5899999998765432 23466889999999999999999999999999999999999999999
Q ss_pred hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeec
Q 002346 667 AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746 (933)
Q Consensus 667 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~ 746 (933)
.+++.. ...+++..+..++.|+++|+.|||+ .+++|+||+|+||+++.++.++|+|||++........ ...
T Consensus 81 ~~~l~~-----~~~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (250)
T cd05123 81 FSHLSK-----EGRFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTN 151 (250)
T ss_pred HHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCCC-ccc
Confidence 999965 2358999999999999999999998 8999999999999999999999999999876544321 223
Q ss_pred ccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChh
Q 002346 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEE 826 (933)
Q Consensus 747 ~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~ 826 (933)
...|+..|+|||...+...+.++|+||||+++||+++|+.||..... .. ...........++..+
T Consensus 152 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~---~~~~~~~~~~~~~~~~--------- 216 (250)
T cd05123 152 TFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KE---IYEKILKDPLRFPEFL--------- 216 (250)
T ss_pred CCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HH---HHHHHhcCCCCCCCCC---------
Confidence 45688999999999888889999999999999999999999965432 11 1122222111222211
Q ss_pred hHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 002346 827 TIESIYRVAELAGHCTAREPQQRPDMGH 854 (933)
Q Consensus 827 ~~~~~~~~~~li~~cl~~~P~~RPs~~e 854 (933)
...+.+++.+|+..||++||++.+
T Consensus 217 ----~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 217 ----SPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ----CHHHHHHHHHHhcCCHhhCCCccc
Confidence 235679999999999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=247.96 Aligned_cols=265 Identities=23% Similarity=0.313 Sum_probs=197.6
Q ss_pred CCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+|.-.++||+|.||+||||+ ..+++.||+|+++.+..++.......+|+.+++.++|.|||++++....+....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45567889999999999994 45689999999998876666667889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
|+ .+|..+... -.+.++.+.+..++.|+++|+.++|+ +.+.|||+||+|.+++.+|+.|++|||+++.++-.
T Consensus 83 cd-qdlkkyfds----lng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgip 154 (292)
T KOG0662|consen 83 CD-QDLKKYFDS----LNGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP 154 (292)
T ss_pred hh-HHHHHHHHh----cCCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence 94 477777643 34678999999999999999999999 89999999999999999999999999999977654
Q ss_pred CceeecccccccCcccccccCCCC-CCCccchHhHHHHHHHHHcCCCC-CCCCCCchhhHHHHHHHHHh-hccCCCCcc-
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGR-VTTKIDVYAFGVVLMETITGRKA-LDDTMPDDRAHLVTWFRRVL-ISKENIPKA- 816 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~elltG~~p-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~- 816 (933)
-.. ...-+-|..|.+|.++.+.+ |+...|+||.||++.|+....+| |.+...++. +...++..- ..++.++.+
T Consensus 155 vrc-ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq--lkrif~~lg~p~ed~wps~t 231 (292)
T KOG0662|consen 155 VRC-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEDQWPSMT 231 (292)
T ss_pred eEe-eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH--HHHHHHHhCCCccccCCccc
Confidence 322 22335689999999987764 78899999999999999985544 444332222 222222111 111222211
Q ss_pred --cC----CCCCCChh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 --ID----PNLNLDEE----TIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 --~d----~~l~~~~~----~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
-| |....... .......=.+++++.+.-+|.+|.+++++++
T Consensus 232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 11 00110000 0111122357788888889999999998876
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=285.90 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=195.6
Q ss_pred CCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccc---cCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 582 NFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESN---TMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+|.+.+.||+|+||.||++... .+..+++|.++.. ........++.+|+.+++.++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999553 3445566655432 22233345677899999999999999999999988899999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++..... ....+++.+++.++.|+++|++|||+ .+++|+||||+||+++. +.++|+|||++...
T Consensus 81 ~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~ 155 (260)
T cd08222 81 TEYCEGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL 155 (260)
T ss_pred EEeCCCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeec
Confidence 999999999999865322 23579999999999999999999998 89999999999999975 56999999998765
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......|++.|+|||+..+..++.++|+||||+++|+|++|+.||..... ......... ...+. +
T Consensus 156 ~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~~~~~~--~~~~~-~ 225 (260)
T cd08222 156 MGSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVVLRIVE--GPTPS-L 225 (260)
T ss_pred CCCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHHHHHHc--CCCCC-C
Confidence 43322 22335688999999999888889999999999999999999999965321 111111111 11111 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+ ......+.+++.+|++.+|++||++.++++
T Consensus 226 ~---------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 226 P---------ETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred c---------chhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 122246779999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-31 Score=316.53 Aligned_cols=147 Identities=32% Similarity=0.472 Sum_probs=131.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|.+.+.||+|+||.||+|... +++.||||+++.... .......+.+|+.++..++||||+++++++......++||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67899999999999999999654 689999999976432 2334567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
||+.+++|.+++.. ...+++..++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~-----~~~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI-----YGYFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999999965 2458899999999999999999998 899999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-32 Score=281.73 Aligned_cols=260 Identities=25% Similarity=0.406 Sum_probs=198.4
Q ss_pred HhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCC-----chhHHHHHHHHHHHHhcCCCcceeEEeEeee-C
Q 002346 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMG-----NKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-G 651 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~ 651 (933)
+.++|-.+++||+|||+.|||| ++...+.||||+-.....- ....+...+|.++-+.|.||.||++|+|+.- .
T Consensus 461 Ln~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDt 540 (775)
T KOG1151|consen 461 LNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDT 540 (775)
T ss_pred hHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecc
Confidence 4568889999999999999999 6777889999986543211 1123457889999999999999999999875 4
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec---CCCcEEE
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKV 728 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl 728 (933)
+..+-|.|||+|-+|+-||+. ...+++.+++.|+.||+.||.||.+. +.+|||-|+||.|||+- .-|.+||
T Consensus 541 dsFCTVLEYceGNDLDFYLKQ-----hklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 541 DSFCTVLEYCEGNDLDFYLKQ-----HKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred ccceeeeeecCCCchhHHHHh-----hhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEe
Confidence 567899999999999999976 25689999999999999999999974 57999999999999995 3478999
Q ss_pred ecccccccCCCCCce------eecccccccCcccccccC----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH
Q 002346 729 ADFGLVKNAPDGKYS------VETRLAGTFGYLAPEYAA----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH 798 (933)
Q Consensus 729 ~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~ 798 (933)
.|||+++...++.+. .+...+||..|++||.+- ..+.+.|+||||.||++|+.+.|+.||...... .+
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ--Qd 692 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ--QD 692 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH--HH
Confidence 999999976654432 234568999999999773 235789999999999999999999999764322 22
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.... .++... .+ .+.+.. ....+...+|++|++.--++|.+..++..
T Consensus 693 ILqeN-TIlkAt-EV--qFP~KP-------vVsseAkaFIRRCLaYRKeDR~DV~qLA~ 740 (775)
T KOG1151|consen 693 ILQEN-TILKAT-EV--QFPPKP-------VVSSEAKAFIRRCLAYRKEDRIDVQQLAC 740 (775)
T ss_pred HHhhh-chhcce-ec--cCCCCC-------ccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence 22111 111111 01 111111 11235668999999999999988777653
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-32 Score=288.62 Aligned_cols=245 Identities=22% Similarity=0.392 Sum_probs=201.4
Q ss_pred CCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 586 ANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
.++||.|-||+||-| ..++|+.||||++.+.....+....+.+|+++++++.||.||.+-.-|+..+..++|||.+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 478999999999999 4568999999999998888888889999999999999999999999999999999999999 56
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC---CcEEEecccccccCCCCC
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~DfGla~~~~~~~ 741 (933)
+..+.+-.. ..+.+++....-++.||+.||.|||. ++|+|+|+||+|||+.+. -.+||||||.|+..+...
T Consensus 648 DMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks 721 (888)
T KOG4236|consen 648 DMLEMILSS---EKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS 721 (888)
T ss_pred hHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence 777766542 23569999999999999999999998 999999999999999754 369999999999887644
Q ss_pred ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCC
Q 002346 742 YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l 821 (933)
.....+|||.|.|||++....|...-|+||.||++|--+.|..||....+ +-+.++. .. +
T Consensus 722 --FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-----IndQIQN----Aa---------F 781 (888)
T KOG4236|consen 722 --FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-----INDQIQN----AA---------F 781 (888)
T ss_pred --hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-----hhHHhhc----cc---------c
Confidence 33457999999999999999999999999999999999999999975321 1111111 10 0
Q ss_pred CCChhhHHHH-HHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 822 NLDEETIESI-YRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 822 ~~~~~~~~~~-~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
-....+|.++ .+.+++|...++..-.+|.+..+.+.
T Consensus 782 MyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls 818 (888)
T KOG4236|consen 782 MYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS 818 (888)
T ss_pred ccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence 1122233333 24568999999999999999887654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-33 Score=295.25 Aligned_cols=365 Identities=21% Similarity=0.280 Sum_probs=293.9
Q ss_pred CCCCCccccceEeCC---------------CCCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCc-C
Q 002346 50 SSTGYCEWTGINCDN---------------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANA-T 113 (933)
Q Consensus 50 ~~~~~C~w~gv~c~~---------------~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l-~ 113 (933)
+.++.|.-.=..|+. ...+..|++++|.|..+-+..|.++++|+++++.+|.++. ||.|+.. .
T Consensus 47 pa~c~c~~~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt~-IP~f~~~sg 125 (873)
T KOG4194|consen 47 PATCPCNTRLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELTR-IPRFGHESG 125 (873)
T ss_pred CCcCCCCceeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhhh-ccccccccc
Confidence 344556555566653 2367889999999998888899999999999999999994 5656554 5
Q ss_pred cCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEE
Q 002346 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLR 193 (933)
Q Consensus 114 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 193 (933)
+|+.|+|.+|.|+++....+..++.|+.||||.|.|+. .--..|..-.++++|+|++|.|+..-...|..+.+|..|.
T Consensus 126 hl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~--i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlk 203 (873)
T KOG4194|consen 126 HLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISE--IPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLK 203 (873)
T ss_pred ceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhc--ccCCCCCCCCCceEEeeccccccccccccccccchheeee
Confidence 69999999999999999999999999999999999988 2234667778999999999999999999999999999999
Q ss_pred ccCCcCCCCCCccccc-cccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCccc
Q 002346 194 LSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLT 271 (933)
Q Consensus 194 L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~ 271 (933)
|++|+++...+..|.+ ++|+.|+|+.|.+...-.. .|.++++|+.|.|..|.+...-.. |..+.++++|+|+.|++.
T Consensus 204 LsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~l-tFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~ 282 (873)
T KOG4194|consen 204 LSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGL-TFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQ 282 (873)
T ss_pred cccCcccccCHHHhhhcchhhhhhccccceeeehhh-hhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhh
Confidence 9999999444445552 7899999999998755222 477899999999999999876653 889999999999999999
Q ss_pred ccCcccccCCCCCCEEEccCccCccCCCCCC---CCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccC
Q 002346 272 GVVPASVISLPALLNISLQNNKLQGPYPLFP---SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348 (933)
Q Consensus 272 ~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~---~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (933)
..--.++.+++.|+.|+||+|.+...-+..+ .+|++|+|++|+|....++.+.. ...+..
T Consensus 283 ~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~-----------------L~~Le~ 345 (873)
T KOG4194|consen 283 AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRV-----------------LSQLEE 345 (873)
T ss_pred hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHH-----------------HHHhhh
Confidence 8888889999999999999999987666533 48999999999998876543221 111222
Q ss_pred CCCCCCCCCCCCc-cccCCCceeEEEccCccccCcCch---hhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccC
Q 002346 349 SWEGNNACDGWPF-VTCSQGRIITINLANKLLAGNISP---AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSN 424 (933)
Q Consensus 349 ~~~~~~~~~~~p~-~~~~l~~L~~L~Ls~N~l~g~~p~---~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~ 424 (933)
+..+.|.+..+.+ .+..+.+|+.|||.+|.|++.|-+ .|.+|++|+.|+|.+|+|..+--.+|..|++|++|||.+
T Consensus 346 LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~ 425 (873)
T KOG4194|consen 346 LNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGD 425 (873)
T ss_pred hcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCC
Confidence 2223333333332 345578999999999999988764 688999999999999999966667999999999999999
Q ss_pred CcCcccCCCCC
Q 002346 425 NNLSGKVPDFG 435 (933)
Q Consensus 425 N~l~g~~p~~~ 435 (933)
|.+-..-|...
T Consensus 426 NaiaSIq~nAF 436 (873)
T KOG4194|consen 426 NAIASIQPNAF 436 (873)
T ss_pred Ccceeeccccc
Confidence 99988877644
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=253.76 Aligned_cols=209 Identities=27% Similarity=0.399 Sum_probs=172.4
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCce
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSE 653 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 653 (933)
++...++...+..||+|++|.|-+.+ ..+|+..|||++.... ..+..++..+|+.+..+. .+|.+|.+||.......
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 34444555567789999999998874 4689999999998764 455567788888875554 79999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++.||.| .-+|+.+-.+.-.. ...+++...-+||..|.+||.|||+ +..+||||+||+|||++.+|++|+||||+
T Consensus 120 vwIcME~M-~tSldkfy~~v~~~-g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGI 195 (282)
T KOG0984|consen 120 VWICMELM-DTSLDKFYRKVLKK-GGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGI 195 (282)
T ss_pred EEEeHHHh-hhhHHHHHHHHHhc-CCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccc
Confidence 99999999 45887776553333 3679999999999999999999999 48999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCC----CCCCCccchHhHHHHHHHHHcCCCCCCCC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAAT----GRVTTKIDVYAFGVVLMETITGRKALDDT 791 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~Dv~SlG~~l~elltG~~p~~~~ 791 (933)
+....+.- ..+--.|...|||||.+.. ..|+-|+||||||+++.||.+++.||+..
T Consensus 196 sG~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 196 SGYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred ceeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 87665432 1233478899999998853 36889999999999999999999999864
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=286.67 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=202.2
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCc-EEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGT-KIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.+++.+..||-||||.|=.++..... .+|+|.+++... +.++.+....|-.+|...+.|.||++|-.|.+....|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45556778999999999998775433 389998877543 4455677889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
|-|-||.|+..+++ .+.++..+..-++..+++|++|||+ ++||+||+||+|.++|.+|.+||.|||.|+...
T Consensus 500 EaClGGElWTiLrd-----Rg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~ 571 (732)
T KOG0614|consen 500 EACLGGELWTILRD-----RGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG 571 (732)
T ss_pred HhhcCchhhhhhhh-----cCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhc
Confidence 99999999999966 3568899999999999999999999 999999999999999999999999999999887
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.+.. +..++|||.|.|||++.....+.++|.||||+++|||++|.+||....++....+.- .. + +.-.+|..+
T Consensus 572 ~g~K--TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL--kG-i-d~i~~Pr~I- 644 (732)
T KOG0614|consen 572 SGRK--TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL--KG-I-DKIEFPRRI- 644 (732)
T ss_pred cCCc--eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH--hh-h-hhhhccccc-
Confidence 7653 456799999999999999999999999999999999999999999887765433321 10 0 011112111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs 851 (933)
.....+++++....+|.+|..
T Consensus 645 ------------~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 645 ------------TKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred ------------chhHHHHHHHHHhcCcHhhhc
Confidence 134568999999999999985
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=293.84 Aligned_cols=244 Identities=26% Similarity=0.367 Sum_probs=196.9
Q ss_pred HhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
.++.|.....+|.|+|+.|-.+ ...+++..+||++.+.. .+-.+|+.++... +||||+++.+.+.++.+.|+
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence 4678888899999999999887 55678899999997762 2345677666666 79999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe-cCCCcEEEecccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVK 735 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill-~~~~~~kl~DfGla~ 735 (933)
|||.+.++-+.+.+.. .+....++..|+.+++.|+.|||+ +||||||+||+|||+ ++.++++|+|||.++
T Consensus 394 v~e~l~g~ell~ri~~------~~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRS------KPEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred eehhccccHHHHHHHh------cchhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhh
Confidence 9999999988888755 222337888899999999999999 999999999999999 589999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
..... ....+-|..|.|||++....|++++|+||||++||+|++|+.||.....+ ..+ ..++. .+...+
T Consensus 465 ~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei---~~~i~--~~~~s~ 533 (612)
T KOG0603|consen 465 ELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEI---HTRIQ--MPKFSE 533 (612)
T ss_pred hCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHH---HHhhc--CCcccc
Confidence 77664 12234578999999999999999999999999999999999999875433 111 11111 111111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
......++|+.+||+.||.+||+|.++.. ++|.
T Consensus 534 -------------~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~------h~w~ 566 (612)
T KOG0603|consen 534 -------------CVSDEAKDLLQQLLQVDPALRLGADEIGA------HPWF 566 (612)
T ss_pred -------------ccCHHHHHHHHHhccCChhhCcChhhhcc------Ccch
Confidence 11235679999999999999999999976 6676
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-32 Score=264.74 Aligned_cols=268 Identities=23% Similarity=0.362 Sum_probs=199.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--------C
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--------G 651 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 651 (933)
..|.-..+||+|.||.||+|+. ..|+.||+|++-.+......-....+|++++..++|+|++.+++.|.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 3455567899999999999954 467889998765443233333567899999999999999999988753 2
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
...|+||++|+. +|.-.|... ...++..++.+++.++..||.|+|+ ..|+|||+||.|+||+.++.+||+||
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADF 168 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADF 168 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeecc
Confidence 457999999965 888887441 2568999999999999999999998 89999999999999999999999999
Q ss_pred cccccCCCCCcee---ecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 732 GLVKNAPDGKYSV---ETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 732 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
|+++.+....... .+..+-|..|.+||.+.+ ..|+++.|||..||++.||+||.+-+.+.......++....-...
T Consensus 169 Glar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~ 248 (376)
T KOG0669|consen 169 GLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSI 248 (376)
T ss_pred ccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccC
Confidence 9997554332211 244567999999998865 468999999999999999999999988776655544444322211
Q ss_pred hccCCCCcccC---------CCCCCChhh--HHHHH------HHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 ISKENIPKAID---------PNLNLDEET--IESIY------RVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ~~~~~~~~~~d---------~~l~~~~~~--~~~~~------~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ++.+|.... +.+...... .+... +.++++..++..||.+|+++++++.
T Consensus 249 t-kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 249 T-KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred C-cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 1 111222110 001111110 11111 4678999999999999999999986
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-32 Score=274.86 Aligned_cols=243 Identities=26% Similarity=0.384 Sum_probs=195.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCch-hHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 657 (933)
.+|..+.+||+|+||.|..|.. .+.+.+|||+++++..-+. ..+--+.|-+++... +-|.++++..+++..+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 4677889999999999999954 3567899999988754322 223345566677666 578999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+.||+|--++++ .+.+-+..+.-+|.+||-||-+||+ ++||+||+|.+||++|.+|++||+|||+.+..
T Consensus 429 MEyvnGGDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred EEEecCchhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999998876 3567788899999999999999999 99999999999999999999999999999855
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
-.+.. .+..++|||.|+|||++..++|+..+|.|||||+||||+.|++||++..+++ .++.+....-..++.+
T Consensus 501 i~~~~-TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e------lF~aI~ehnvsyPKsl 573 (683)
T KOG0696|consen 501 IFDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE------LFQAIMEHNVSYPKSL 573 (683)
T ss_pred ccCCc-ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHHccCcCcccc
Confidence 44332 2345799999999999999999999999999999999999999998754322 2333333333333322
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs 851 (933)
..+.+.+....+.+.|.+|..
T Consensus 574 -------------SkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 574 -------------SKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred -------------cHHHHHHHHHHhhcCCccccC
Confidence 245667888899999999973
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=272.70 Aligned_cols=263 Identities=23% Similarity=0.330 Sum_probs=202.7
Q ss_pred HHhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-C-C----cceeEEeEeee
Q 002346 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-H-R----HLVALLGYCIN 650 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~ 650 (933)
..+.+|.+...+|+|+||.|-+. +...+..||||+++.- ....+...-|+++++++. + | -+|++.+|+..
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy 162 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY 162 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence 34789999999999999999998 4445899999998754 334566788999999993 2 2 47888899999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC--------
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-------- 722 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-------- 722 (933)
.++.++|+|.+ |-++.+++.. ++..+++...+..|++|+++++++||+ .+++|-|+||+|||+.+
T Consensus 163 rghiCivfell-G~S~~dFlk~---N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 163 RGHICIVFELL-GLSTFDFLKE---NNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred cCceEEEEecc-ChhHHHHhcc---CCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEec
Confidence 99999999998 6799999954 556789999999999999999999999 89999999999999842
Q ss_pred ------------CCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCC
Q 002346 723 ------------DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDD 790 (933)
Q Consensus 723 ------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~ 790 (933)
+..+||+|||.|....... ...+.|..|.|||++.+-.++.++||||+||+|+|++||..-|+.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 2459999999998655433 345778999999999999999999999999999999999999986
Q ss_pred CCCchhhHHHHHHHHHhhcc----------------CC--CC---------cccCCCCCCC---hhhHHHHHHHHHHHHH
Q 002346 791 TMPDDRAHLVTWFRRVLISK----------------EN--IP---------KAIDPNLNLD---EETIESIYRVAELAGH 840 (933)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~----------------~~--~~---------~~~d~~l~~~---~~~~~~~~~~~~li~~ 840 (933)
....+ ++ ..+.+++... +. ++ ...++..+.. .....+...+.+|+++
T Consensus 312 Hen~E--HL-aMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~ 388 (415)
T KOG0671|consen 312 HENLE--HL-AMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR 388 (415)
T ss_pred CCcHH--HH-HHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence 54222 22 1222222100 00 00 0011111100 0122345678999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 002346 841 CTAREPQQRPDMGHAVN 857 (933)
Q Consensus 841 cl~~~P~~RPs~~evl~ 857 (933)
|+..||.+|+|+.|++.
T Consensus 389 mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 389 MLEFDPARRITLREALS 405 (415)
T ss_pred HHccCccccccHHHHhc
Confidence 99999999999999986
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-31 Score=275.41 Aligned_cols=221 Identities=20% Similarity=0.248 Sum_probs=175.7
Q ss_pred CCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCChhhHh
Q 002346 592 GGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL 670 (933)
Q Consensus 592 G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 670 (933)
|.||.||++. ..+++.||+|++.... .+.+|...+....||||+++++++......++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 8999999994 4578999999987652 2344555556667999999999999999999999999999999998
Q ss_pred hhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeeccccc
Q 002346 671 FEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750 (933)
Q Consensus 671 ~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g 750 (933)
... ..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.++++|||.+....... ....+
T Consensus 77 ~~~-----~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~ 144 (237)
T cd05576 77 SKF-----LNIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAV 144 (237)
T ss_pred HHh-----cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCc
Confidence 652 358999999999999999999998 899999999999999999999999999876544321 22356
Q ss_pred ccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHH
Q 002346 751 TFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIES 830 (933)
Q Consensus 751 t~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~ 830 (933)
+..|+|||++....++.++||||+|+++|||++|+.|+........ ......++. . .
T Consensus 145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------~~~~~~~~~----~---------~ 201 (237)
T cd05576 145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------THTTLNIPE----W---------V 201 (237)
T ss_pred CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------cccccCCcc----c---------C
Confidence 7789999999888899999999999999999999988754211000 000001111 1 1
Q ss_pred HHHHHHHHHHcccCCCCCCCCHHH
Q 002346 831 IYRVAELAGHCTAREPQQRPDMGH 854 (933)
Q Consensus 831 ~~~~~~li~~cl~~~P~~RPs~~e 854 (933)
...+.+++.+|++.||++||++.+
T Consensus 202 ~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 202 SEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CHHHHHHHHHHccCCHHHhcCCCc
Confidence 235779999999999999999743
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=289.70 Aligned_cols=268 Identities=21% Similarity=0.279 Sum_probs=183.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-----------------CCCcEEEEEEeccccCCc------------hhHHHHHHHH
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-----------------PDGTKIAVKRMESNTMGN------------KGLSEFQAEI 630 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~E~ 630 (933)
.++|++.++||+|+||.||+|.. .+++.||||++....... ...+.+..|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 56899999999999999999953 245689999986542110 0112344577
Q ss_pred HHHHhcCCCcc-----eeEEeEeee--------CceeEEEEeecCCCChhhHhhhcccC-------------------CC
Q 002346 631 AVLTKVRHRHL-----VALLGYCIN--------GSERLLVYEYMPRGTLAQHLFEWHDH-------------------GY 678 (933)
Q Consensus 631 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~ 678 (933)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++..... ..
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77888876554 677787753 35679999999999999998752110 11
Q ss_pred CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeecccccccCccccc
Q 002346 679 TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758 (933)
Q Consensus 679 ~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE 758 (933)
..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++....+.........+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 235788899999999999999998 89999999999999999999999999999755433222122234588999999
Q ss_pred ccCCCC--------------------C--CCccchHhHHHHHHHHHcCCC-CCCCCCCch------hhHHHHHHHHHhhc
Q 002346 759 YAATGR--------------------V--TTKIDVYAFGVVLMETITGRK-ALDDTMPDD------RAHLVTWFRRVLIS 809 (933)
Q Consensus 759 ~~~~~~--------------------~--~~~~Dv~SlG~~l~elltG~~-p~~~~~~~~------~~~~~~~~~~~~~~ 809 (933)
.+.... + ..+.||||+||++|||++|.. |+....... ..++..|... ...
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~-~~~ 459 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY-KGQ 459 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh-ccc
Confidence 875332 1 134799999999999999985 665321110 1111122111 000
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHHHhhhhhhcCC
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREP---QQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P---~~RPs~~evl~~L~~~~~~~~~ 868 (933)
...+. .+|. ......+++.+++..+| .+|+|++|+++ ++|..
T Consensus 460 ~~~~~-~~d~----------~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~------Hp~f~ 504 (507)
T PLN03224 460 KYDFS-LLDR----------NKEAGWDLACKLITKRDQANRGRLSVGQALS------HRFFL 504 (507)
T ss_pred CCCcc-cccc----------cChHHHHHHHHHhccCCCCcccCCCHHHHhC------CCCcC
Confidence 00000 0110 11346689999999766 68999999986 67664
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-30 Score=290.17 Aligned_cols=244 Identities=28% Similarity=0.427 Sum_probs=188.9
Q ss_pred cCCccccCCCe-EEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEeecC
Q 002346 585 EANILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 585 ~~~~lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
..+.+|.|+.| .||+|.. +|+.||||++-.+ ..+..++|+..++.- +|||||++++.-.++...|++.|.|
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred cHHHcccCCCCcEEEEEee-CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 34568999987 7899998 7899999988543 345678999999998 6999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---C--CcEEEecccccccC
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---D--MRAKVADFGLVKNA 737 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~--~~~kl~DfGla~~~ 737 (933)
..+|.+++... ........-...+.+..|++.||+|||+ .+|||||+||+||||+. + .+++|+|||+++..
T Consensus 586 ~~sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 586 ACSLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hhhHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 56999999763 1111111114457789999999999999 89999999999999975 3 47999999999987
Q ss_pred CCCCcee--ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcC-CCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 738 PDGKYSV--ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG-RKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 738 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
..+.... .....||.+|+|||++....-+.++||||+||++|+.++| .+||.+....+. -++.....+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~~L~ 733 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNYTLV 733 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcccee
Confidence 7665433 3456899999999999988888999999999999999997 799986533211 1111122111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..- + .. +. +..++|.+|++++|..||++.+|+.
T Consensus 734 ~L~-~----~~---d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 734 HLE-P----LP---DC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred eec-c----Cc---hH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111 0 01 11 5669999999999999999999975
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=298.15 Aligned_cols=268 Identities=22% Similarity=0.246 Sum_probs=172.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-C----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeE------e
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-D----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY------C 648 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~ 648 (933)
.++|.+.+.||+|+||.||+|... + +..||||++..... .+.+..| .+....+.+++.++.. +
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 568999999999999999999664 4 68999998764321 1111111 1112222222222211 2
Q ss_pred eeCceeEEEEeecCCCChhhHhhhcccC---------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCC
Q 002346 649 INGSERLLVYEYMPRGTLAQHLFEWHDH---------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL 713 (933)
Q Consensus 649 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 713 (933)
..+...++||||+.+++|.+++...... .........+..++.|+++||+|||+ ++|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcC
Confidence 4567889999999999999998652100 00112234466899999999999998 89999999
Q ss_pred CCCcEEecC-CCcEEEecccccccCCCCCceeecccccccCcccccccCCC----------------------CCCCccc
Q 002346 714 KPSNILIGD-DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG----------------------RVTTKID 770 (933)
Q Consensus 714 k~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 770 (933)
||+|||++. ++.+||+|||+++....+.........|++.|+|||.+... .+..++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986654443444556899999999965321 2345679
Q ss_pred hHhHHHHHHHHHcCCCCCCCCCCc-------hhhHHHHHHHHHhhccCCCCcccCCCCCCChhh-HHHHHHHHHHHHHcc
Q 002346 771 VYAFGVVLMETITGRKALDDTMPD-------DRAHLVTWFRRVLISKENIPKAIDPNLNLDEET-IESIYRVAELAGHCT 842 (933)
Q Consensus 771 v~SlG~~l~elltG~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~-~~~~~~~~~li~~cl 842 (933)
||||||++|||+++..+++..... ...+...|..... ....+.+...... ........+++.+|+
T Consensus 362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~d~~~~~~~dLi~~mL 434 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE-------PRASPDLRRGFEVLDLDGGAGWELLKSMM 434 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc-------cccchhhhhhhhhccccchHHHHHHHHHc
Confidence 999999999999987665421100 0001111111100 0000000000000 000123458999999
Q ss_pred cCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 843 AREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 843 ~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
+.||++|||+.|+++ ++|...
T Consensus 435 ~~dP~kR~ta~e~L~------Hpff~~ 455 (566)
T PLN03225 435 RFKGRQRISAKAALA------HPYFDR 455 (566)
T ss_pred cCCcccCCCHHHHhC------CcCcCC
Confidence 999999999999987 677654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-30 Score=256.87 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=200.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 657 (933)
.+|..+++||+|+|+.|..+++ ++.+.||+|+++++-... +..+..+.|-.+..+. +||.+|-+..++..+...++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 5788999999999999999965 467889999998875443 4467788898888887 799999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
.||+.||+|--++++ ...++++.++-+..+|.-||.|||+ +|||.||+|.+|||+|..|++|+.|+|+.+.-
T Consensus 330 ieyv~ggdlmfhmqr-----qrklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQR-----QRKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred EEEecCcceeeehhh-----hhcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence 999999999777755 3569999999999999999999999 99999999999999999999999999998854
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCc-hhhHHHHH-HHHHhhccCCCCc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD-DRAHLVTW-FRRVLISKENIPK 815 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~-~~~~~~~~-~~~~~~~~~~~~~ 815 (933)
-... ..+..++|||.|.|||.+.+..|....|.|++||+++||+.|+.||+-...+ ......++ ++-++.....+|+
T Consensus 402 l~~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr 480 (593)
T KOG0695|consen 402 LGPG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR 480 (593)
T ss_pred CCCC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc
Confidence 3322 2345679999999999999999999999999999999999999999843211 11111222 2333333344444
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP 850 (933)
.+. .+...+++.-+++||.+|.
T Consensus 481 sls-------------vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 SLS-------------VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred eee-------------hhhHHHHHHhhcCCcHHhc
Confidence 332 2344788889999999986
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=293.54 Aligned_cols=315 Identities=24% Similarity=0.351 Sum_probs=254.3
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceecccccccc--CCCCCcccCCCCCCEEE
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFT--SVPTGCFDGLTNLQVLS 143 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~ 143 (933)
.+++.|.|...+|. .+|.+++.+.+|++|.+++|++..+.-.+..|+.|+.+++..|++. +||++ +-.+..|.+||
T Consensus 32 t~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~~vhGELs~Lp~LRsv~~R~N~LKnsGiP~d-iF~l~dLt~lD 109 (1255)
T KOG0444|consen 32 TQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLISVHGELSDLPRLRSVIVRDNNLKNSGIPTD-IFRLKDLTILD 109 (1255)
T ss_pred hheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhHhhhhhhccchhhHHHhhhccccccCCCCch-hcccccceeee
Confidence 47999999999998 8999999999999999999999987778999999999999999998 68887 55799999999
Q ss_pred ccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccC
Q 002346 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL 222 (933)
Q Consensus 144 Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~ 222 (933)
||+|++.. .|..+.+-+++-+|+||+|+|..+....|.+|+.|-+||||+|++. .+|..+-. ..|+.|.|++|.+
T Consensus 110 LShNqL~E---vP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL 185 (1255)
T KOG0444|consen 110 LSHNQLRE---VPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPL 185 (1255)
T ss_pred cchhhhhh---cchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChh
Confidence 99999998 8999999999999999999998887778899999999999999998 77777655 6799999999988
Q ss_pred CcccccccccCCccCcEEEecCCcc--CCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC-
Q 002346 223 GLSGTLDVLSGMTQLRQVWLHKNQF--TGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP- 299 (933)
Q Consensus 223 ~~~~~~~~l~~l~~L~~L~L~~N~l--~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p- 299 (933)
..... ..+-.+++|+.|++++.+- ...++++.++.+|..+|||.|.|. .+|+.+.++++|+.|+||+|+++..--
T Consensus 186 ~hfQL-rQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~iteL~~~ 263 (1255)
T KOG0444|consen 186 NHFQL-RQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKITELNMT 263 (1255)
T ss_pred hHHHH-hcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCceeeeecc
Confidence 65433 2355678899999998764 446668999999999999999999 999999999999999999999985322
Q ss_pred -CCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCcc
Q 002346 300 -LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL 378 (933)
Q Consensus 300 -~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~ 378 (933)
..+.+++.|.||.|.++. +|..++.+++|+.|++.+|+
T Consensus 264 ~~~W~~lEtLNlSrNQLt~-----------------------------------------LP~avcKL~kL~kLy~n~Nk 302 (1255)
T KOG0444|consen 264 EGEWENLETLNLSRNQLTV-----------------------------------------LPDAVCKLTKLTKLYANNNK 302 (1255)
T ss_pred HHHHhhhhhhccccchhcc-----------------------------------------chHHHhhhHHHHHHHhccCc
Confidence 235688999999998854 45555555666666666555
Q ss_pred ccC-cCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCccc
Q 002346 379 LAG-NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430 (933)
Q Consensus 379 l~g-~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~ 430 (933)
++- .||..||.|..|+.+..++|+|. .+|+.++.+.+|+.|.|++|.|-..
T Consensus 303 L~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLiTL 354 (1255)
T KOG0444|consen 303 LTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLITL 354 (1255)
T ss_pred ccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhcccccceeec
Confidence 542 25555666666666666666555 5566666666666666666655543
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=262.60 Aligned_cols=239 Identities=29% Similarity=0.445 Sum_probs=192.0
Q ss_pred CCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCChhhHhh
Q 002346 593 GFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLF 671 (933)
Q Consensus 593 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 671 (933)
+||.||+|... +++.||+|++........ .+.+.+|++.+++++|+||+++++++......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999765 589999999876543221 6789999999999999999999999999999999999999999999986
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeecccccc
Q 002346 672 EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751 (933)
Q Consensus 672 ~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt 751 (933)
.. ..+++..++.++.+++++++|||+ .+++|+||+|+||++++++.++|+|||.+....... ......++
T Consensus 80 ~~-----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~ 149 (244)
T smart00220 80 KR-----GRLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGT 149 (244)
T ss_pred hc-----cCCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCC
Confidence 52 228899999999999999999999 899999999999999999999999999988665432 22345688
Q ss_pred cCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHH
Q 002346 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESI 831 (933)
Q Consensus 752 ~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~ 831 (933)
..|++||......++.++|||++|+++|++++|..||..... ......+.. ........ .. ....
T Consensus 150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~--~~~~~~~~~---~~~~~~~~---~~-------~~~~ 214 (244)
T smart00220 150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQ--LLELFKKIG---KPKPPFPP---PE-------WKIS 214 (244)
T ss_pred cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHh---ccCCCCcc---cc-------ccCC
Confidence 899999999888899999999999999999999999976321 111111111 11110000 00 0022
Q ss_pred HHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 832 YRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 832 ~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.++.+++.+|+..+|++||++.++++
T Consensus 215 ~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 215 PEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHHccCCchhccCHHHHhh
Confidence 46789999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.1e-31 Score=254.44 Aligned_cols=267 Identities=21% Similarity=0.334 Sum_probs=197.3
Q ss_pred ccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----ceeEEE
Q 002346 584 SEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SERLLV 657 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~lv 657 (933)
+..+.||-|+||.||.+.. .+|+.||.|++..-...-...+++.+|++++...+|.|++..++...-. .+.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999844 5799999999876544445567899999999999999999988876533 356788
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
+|.| ..+|...+-. ...++-..+.-+++||++||.|||+ .+|.||||||.|.|++.+...||+|||+++.-
T Consensus 136 TELm-QSDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARve 206 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTW 206 (449)
T ss_pred HHHH-Hhhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEeccccccccc
Confidence 8888 4577776633 3668888999999999999999999 89999999999999999999999999999976
Q ss_pred CCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHH---------HHHHh
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW---------FRRVL 807 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~---------~~~~~ 807 (933)
..++....+.-+-|..|.|||.+++. .|+.+.||||.||++.||+.++.-|....|-...+++.. ++...
T Consensus 207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 65554445555678899999999875 689999999999999999999988887666444333211 11111
Q ss_pred hccC--CCCccc-CCCCC---CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 808 ISKE--NIPKAI-DPNLN---LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 808 ~~~~--~~~~~~-d~~l~---~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
+... -++... .|.+. .-....+.-.+...+...++..||++|.+.++.+..+
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~ 344 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR 344 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence 0000 000000 01110 0000111122345777889999999999999887654
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-31 Score=281.36 Aligned_cols=342 Identities=19% Similarity=0.216 Sum_probs=254.2
Q ss_pred CCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEE
Q 002346 65 SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143 (933)
Q Consensus 65 ~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 143 (933)
..+++.+++..|.|+ .+|...+...+|+.|+|.+|.|+.+-. ++.-++.|+.||||.|.|+.++...|..-.++++|+
T Consensus 101 l~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~ 179 (873)
T KOG4194|consen 101 LPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLN 179 (873)
T ss_pred CCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEe
Confidence 457888888888887 677777777778888888888887665 688888888888888888888888888888888888
Q ss_pred ccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccC
Q 002346 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL 222 (933)
Q Consensus 144 Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~ 222 (933)
|++|+|+. .-...|.++.+|..|.|++|+++...+..|.+|++|+.|+|..|+|.-.---.|.. .+++.|.|..|.+
T Consensus 180 La~N~It~--l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I 257 (873)
T KOG4194|consen 180 LASNRITT--LETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDI 257 (873)
T ss_pred eccccccc--cccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCc
Confidence 88888887 45578888888888888888888888888888888888888888886221333332 5677788887776
Q ss_pred CcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCC
Q 002346 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF 301 (933)
Q Consensus 223 ~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 301 (933)
.--. ..+|-++.+++.|+|..|++...-. .+.++++|+.|+||+|.|....++++.-.++|++|+|++|+++...+..
T Consensus 258 ~kL~-DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~s 336 (873)
T KOG4194|consen 258 SKLD-DGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGS 336 (873)
T ss_pred cccc-CcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhH
Confidence 5222 2356677888888888888876554 3677888888888888888777777777788888888888887655543
Q ss_pred ---CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCC---CccccCCCceeEEEcc
Q 002346 302 ---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGW---PFVTCSQGRIITINLA 375 (933)
Q Consensus 302 ---~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~---p~~~~~l~~L~~L~Ls 375 (933)
++.|+.|.|++|++..+....+. +....-.+++..|.....+ ...+..++.|+.|.|.
T Consensus 337 f~~L~~Le~LnLs~Nsi~~l~e~af~----------------~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~ 400 (873)
T KOG4194|consen 337 FRVLSQLEELNLSHNSIDHLAEGAFV----------------GLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLT 400 (873)
T ss_pred HHHHHHhhhhcccccchHHHHhhHHH----------------HhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeec
Confidence 35667777777777554322111 0111112233333322111 2234457899999999
Q ss_pred CccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcC
Q 002346 376 NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427 (933)
Q Consensus 376 ~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l 427 (933)
+|+|..+.-..|.++..||.|||.+|-|..+-|.+|..| .|+.|-+..-.|
T Consensus 401 gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 401 GNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred CceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 999997666799999999999999999998999999999 899988876554
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=268.46 Aligned_cols=208 Identities=26% Similarity=0.411 Sum_probs=176.3
Q ss_pred cCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.-|..++.||-|+||+|..++ .++...||.|.+++... ...+....+.|..||..-..+-||++|..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 346678999999999999994 44567889999887643 3345667889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc--
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-- 736 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~-- 736 (933)
||++||++-..|.+ .+-+.+.-++-++.++..|+++.|. .|+|||||||+|||||.+|++||.|||+..-
T Consensus 709 dYIPGGDmMSLLIr-----mgIFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR 780 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR-----MGIFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 780 (1034)
T ss_pred eccCCccHHHHHHH-----hccCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccce
Confidence 99999999999866 3568888899999999999999998 8999999999999999999999999999642
Q ss_pred -------CCCCCce--------------------------------eecccccccCcccccccCCCCCCCccchHhHHHH
Q 002346 737 -------APDGKYS--------------------------------VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVV 777 (933)
Q Consensus 737 -------~~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~ 777 (933)
+..++.. .....+||+.|+|||++....|+.-+|.||.||+
T Consensus 781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi 860 (1034)
T KOG0608|consen 781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI 860 (1034)
T ss_pred eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence 2111100 0012469999999999999999999999999999
Q ss_pred HHHHHcCCCCCCCCCCchh
Q 002346 778 LMETITGRKALDDTMPDDR 796 (933)
Q Consensus 778 l~elltG~~p~~~~~~~~~ 796 (933)
||||+.|+.||....+.+.
T Consensus 861 l~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 861 LYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHHHhhCCCCccCCCCCcc
Confidence 9999999999988776543
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-31 Score=286.62 Aligned_cols=319 Identities=24% Similarity=0.280 Sum_probs=276.4
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccc--cccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEE
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNI--AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l--~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~ 143 (933)
..+..|.+++|+|. .+-.+++.|+.|+.+++..|++ +|+++.+..+..|+.||||+|+++..|.+ +...+++-+|+
T Consensus 55 qkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~EvP~~-LE~AKn~iVLN 132 (1255)
T KOG0444|consen 55 QKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLREVPTN-LEYAKNSIVLN 132 (1255)
T ss_pred hhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhccccccCCCCchhcccccceeeecchhhhhhcchh-hhhhcCcEEEE
Confidence 36888999999998 6777899999999999999998 56777999999999999999999999987 88899999999
Q ss_pred ccCCCCCCCCCCCc-cccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccc-cccccchhhccccc
Q 002346 144 LSDNPNLAPWPFPN-ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF-AKSDIQNLWMNDQQ 221 (933)
Q Consensus 144 Ls~N~~~~~~~~p~-~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~-~~~~l~~l~l~~n~ 221 (933)
||+|+|.. +|. -+.+|+.|-.|+||+|++... |..+..|..|++|+|++|.+.-.--..+ +..+|+.|.+++.+
T Consensus 133 LS~N~Iet---IPn~lfinLtDLLfLDLS~NrLe~L-PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~Tq 208 (1255)
T KOG0444|consen 133 LSYNNIET---IPNSLFINLTDLLFLDLSNNRLEML-PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQ 208 (1255)
T ss_pred cccCcccc---CCchHHHhhHhHhhhccccchhhhc-CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhccccc
Confidence 99999998 565 568999999999999999776 6678889999999999998863111111 12568899999999
Q ss_pred CCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCC
Q 002346 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF 301 (933)
Q Consensus 222 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~ 301 (933)
.++...+..+.++.+|..+|||.|.|...+..+..+.+|+.|+||+|+|+ .+........+|+.|+||+|+++..+...
T Consensus 209 RTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt~LP~av 287 (1255)
T KOG0444|consen 209 RTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLTVLPDAV 287 (1255)
T ss_pred chhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhccchHHH
Confidence 99999999999999999999999999988778999999999999999999 77777788899999999999999544332
Q ss_pred --CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccc
Q 002346 302 --PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL 379 (933)
Q Consensus 302 --~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l 379 (933)
+++|+.|.+.+|++.. .+||+-++.+.+|+.+..++|.+
T Consensus 288 cKL~kL~kLy~n~NkL~F---------------------------------------eGiPSGIGKL~~Levf~aanN~L 328 (1255)
T KOG0444|consen 288 CKLTKLTKLYANNNKLTF---------------------------------------EGIPSGIGKLIQLEVFHAANNKL 328 (1255)
T ss_pred hhhHHHHHHHhccCcccc---------------------------------------cCCccchhhhhhhHHHHhhcccc
Confidence 4567788888887743 46899999999999999999998
Q ss_pred cCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCC
Q 002346 380 AGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 380 ~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p 432 (933)
. ..|..+..+..|+.|.|++|+|. ++|+++.-|+.|++|||..|+=---+|
T Consensus 329 E-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPP 379 (1255)
T KOG0444|consen 329 E-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPP 379 (1255)
T ss_pred c-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCC
Confidence 7 78999999999999999999999 999999999999999999996443344
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-32 Score=275.94 Aligned_cols=371 Identities=22% Similarity=0.357 Sum_probs=280.6
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 146 (933)
.++.|++.+|++. ++|++++.+..++.|+.++|.+...++.++.+.+|+.|+++.|.+..++++ ++.+-.|+.|+..+
T Consensus 69 ~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls~lp~~i~s~~~l~~l~~s~n~~~el~~~-i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLSELPEQIGSLISLVKLDCSSNELKELPDS-IGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHhhccHHHhhhhhhhhhhccccceeecCch-HHHHhhhhhhhccc
Confidence 5788999999998 889999999999999999999998888999999999999999999999887 78889999999999
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCCcc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLS 225 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~~ 225 (933)
|++.. +|..+.++.+|..|++.+|++....|+.+. ++.|++||...|-++ ++|+.++. .+|..|++..|.+..-
T Consensus 147 N~i~s---lp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l 221 (565)
T KOG0472|consen 147 NQISS---LPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFL 221 (565)
T ss_pred ccccc---CchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccC
Confidence 99988 899999999999999999999888777666 999999999999997 88888876 5788888988887643
Q ss_pred cccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCC-
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS- 303 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~- 303 (933)
+.|.++..|++|+++.|+++-.+.+ ..++.+|.+|||.+|+++ ..|+.++-+.+|+.||+|+|.+++.++....
T Consensus 222 ---Pef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~Lp~sLgnl 297 (565)
T KOG0472|consen 222 ---PEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSLPYSLGNL 297 (565)
T ss_pred ---CCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccCCcccccc
Confidence 4677888888888888888866655 558888888888888888 8888888888888888888888876554322
Q ss_pred CccEEeccCCcCCCCCCCC--------------------------------CCCCCch-------hhhhHhhh-------
Q 002346 304 KVQKVSLDHNNFCKNSSDA--------------------------------GKPCDPQ-------VTTLLQIA------- 337 (933)
Q Consensus 304 ~l~~L~l~~n~~~~~~~~~--------------------------------~~~~~~~-------~~~~~~~~------- 337 (933)
.++.|.+.+|.+..+.-++ ..+.... .+..++..
T Consensus 298 hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~V 377 (565)
T KOG0472|consen 298 HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLV 377 (565)
T ss_pred eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccC
Confidence 5666777777763211100 0000000 00000000
Q ss_pred ---------------------------cccCCCc-cccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcC
Q 002346 338 ---------------------------GDMGYPA-ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN 389 (933)
Q Consensus 338 ---------------------------~~~~~~~-~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 389 (933)
..+...+ ........+|..+-+|..++.+++|..|+|++|-+. .+|.+++.
T Consensus 378 PdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~ 456 (565)
T KOG0472|consen 378 PDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGS 456 (565)
T ss_pred CHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhh
Confidence 0000000 001122235666666777777888888888877776 57777888
Q ss_pred cccCCeEecccCccc----------------------CCCCc-ccCCCCCcCEEeccCCcCcccCCCCCCCccccc--CC
Q 002346 390 LTSLKNLYLQQNNLT----------------------GPIPD-GLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTV--SP 444 (933)
Q Consensus 390 l~~L~~L~L~~N~l~----------------------g~~p~-~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~--~~ 444 (933)
+-.|+.|||+.|+|. |.++. .+.+|.+|..|||.+|.|...+|.+++...+.. +.
T Consensus 457 lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq~IPp~LgnmtnL~hLeL~ 536 (565)
T KOG0472|consen 457 LVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQQIPPILGNMTNLRHLELD 536 (565)
T ss_pred hhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchhhCChhhccccceeEEEec
Confidence 877888888777653 24444 488999999999999999999999987666654 47
Q ss_pred CCCCc
Q 002346 445 GNPFI 449 (933)
Q Consensus 445 ~n~~~ 449 (933)
||||.
T Consensus 537 gNpfr 541 (565)
T KOG0472|consen 537 GNPFR 541 (565)
T ss_pred CCccC
Confidence 99985
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=256.33 Aligned_cols=132 Identities=27% Similarity=0.398 Sum_probs=113.9
Q ss_pred cCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-----C---CcceeEEeEeee-
Q 002346 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-----H---RHLVALLGYCIN- 650 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~~- 650 (933)
.+|-+.++||.|.|++||.+ +..+.+.||+|+.+.. ....+....|++++++++ | .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 78999999999999999999 6677889999998754 334466789999999994 2 479999999874
Q ss_pred ---CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec
Q 002346 651 ---GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721 (933)
Q Consensus 651 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 721 (933)
+.+.++|+|++ |.+|..+|.... .+-++...+.+|++||+.||.|||.. .+|||-||||+|||+.
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~---YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSN---YRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC 222 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhC---CCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence 56899999999 889999997644 35588999999999999999999984 7999999999999984
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=234.31 Aligned_cols=258 Identities=21% Similarity=0.353 Sum_probs=194.5
Q ss_pred hcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCc--eeE
Q 002346 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS--ERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~ 655 (933)
.++|++.+++|+|-|+.||.| ...+.++++||++++- ..+.+.+|+.+++.|+ ||||+++++...+.. ...
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 368899999999999999999 5568899999999754 3468999999999996 999999999987754 456
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-CcEEEeccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLV 734 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfGla 734 (933)
+|+||+.+.+..... +.++...+..++.+++.||.|||+ .||.|||+||.|+++|.. ...+|+|+|+|
T Consensus 112 LiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLA 180 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLA 180 (338)
T ss_pred hHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchH
Confidence 999999988877665 558888899999999999999999 899999999999999854 56999999999
Q ss_pred ccCCCCCceeecccccccCcccccccC-CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC--
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAA-TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE-- 811 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 811 (933)
..+.++... .-.+.+..|.-||.+- -..|+..-|+|||||++..|+..+.||....... ..++.. .+++-..+
T Consensus 181 EFYHp~~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~-DQLVkI-akVLGt~el~ 256 (338)
T KOG0668|consen 181 EFYHPGKEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY-DQLVKI-AKVLGTDELY 256 (338)
T ss_pred hhcCCCcee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCH-HHHHHH-HHHhChHHHH
Confidence 988765432 2235567788999874 4568889999999999999999999997654321 112211 11110000
Q ss_pred ----CCCcccCCCCC--------------CChhhHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 ----NIPKAIDPNLN--------------LDEETIE-SIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ----~~~~~~d~~l~--------------~~~~~~~-~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...-.+||.+. ...+... ...+..+++.+.+..|-++|||+.|++.
T Consensus 257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 00001122111 0001111 1246779999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-29 Score=272.20 Aligned_cols=252 Identities=27% Similarity=0.391 Sum_probs=205.4
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|.....+|.|+||.|||++ ...++..|||+++... .....-.++|+-+++..+|||||.++|.+...+..|++|
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 4678889999999999999994 4578999999998774 344567889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
|||.+|+|.+.-+. .+++++.++..+.++..+|++|||+ .+-+|||||-.||++++.|.+|++|||.+..+.
T Consensus 92 EycgggslQdiy~~-----TgplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqit 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHV-----TGPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQIT 163 (829)
T ss_pred EecCCCcccceeee-----cccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhh
Confidence 99999999887654 4789999999999999999999999 888999999999999999999999999987665
Q ss_pred CCCceeecccccccCccccccc---CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYA---ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
..- .....+.||+.|||||+. ..+.|..++|||++|++..|+-.-++|..+..++....+.. .....-+.
T Consensus 164 ati-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT------kS~~qpp~ 236 (829)
T KOG0576|consen 164 ATI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT------KSGFQPPT 236 (829)
T ss_pred hhh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh------ccCCCCCc
Confidence 422 233457899999999976 45678999999999999999998888887766654433221 11111122
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAV 856 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl 856 (933)
.-|+ ......+-++++.|+.++|++||+++.++
T Consensus 237 lkDk--------~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 237 LKDK--------TKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred ccCC--------ccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 2221 22234566999999999999999988654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=261.94 Aligned_cols=199 Identities=21% Similarity=0.339 Sum_probs=171.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCch------hHHHHHHHHHHHHhcC---CCcceeEEeEee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK------GLSEFQAEIAVLTKVR---HRHLVALLGYCI 649 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~---h~niv~l~~~~~ 649 (933)
..+|...+.+|.|+||.|+.+.. ++...|+||.+.++..-.+ ..-..-.|+++|+.++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 35689999999999999999954 4567899998877653211 1223567999999997 999999999999
Q ss_pred eCceeEEEEeec-CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 650 NGSERLLVYEYM-PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 650 ~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
+++.+|++||.. ++.+|.+++.. .+.+++.++..|++||+.|+++||+ ++|||||||-+||.++.+|-+||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~-----kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~kl 711 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF-----KPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKL 711 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc-----cCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEE
Confidence 999999999976 45789999855 3568999999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCC
Q 002346 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALD 789 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~ 789 (933)
+|||.|.....+.. ..++||..|+|||++.+.+| ...-|||++|+++|.++....||.
T Consensus 712 idfgsaa~~ksgpf---d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 712 IDFGSAAYTKSGPF---DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred eeccchhhhcCCCc---ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 99999887766543 34689999999999998887 566899999999999999888885
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=240.51 Aligned_cols=263 Identities=22% Similarity=0.307 Sum_probs=196.0
Q ss_pred cCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------ce
Q 002346 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------SE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 653 (933)
.+|.-++.+|.|.- .|..+ +.-.+++||+|++..........++..+|..++..++|+||++++.++.-. .+
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 56777888999988 55555 445789999999877765566778899999999999999999999998643 46
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.|+|||+| ..+|.+.++. .++-+++..|..|++.|++|||+ .+|+|||+||+||++..+..+||.|||+
T Consensus 96 ~y~v~e~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGL 164 (369)
T ss_pred HHHHHHhh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchh
Confidence 69999999 5699988853 36678899999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh----------------h
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR----------------A 797 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~----------------~ 797 (933)
|+..... ...+.++.|..|.|||++.+..+.+.+||||+||++.||++|+.-|.+..--+. .
T Consensus 165 ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 165 ARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred hcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 9865543 345667889999999999888899999999999999999999988864321110 0
Q ss_pred HHHHHHHHHhhc-----cCCCCcccCC-CCCCCh-hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 798 HLVTWFRRVLIS-----KENIPKAIDP-NLNLDE-ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 798 ~~~~~~~~~~~~-----~~~~~~~~d~-~l~~~~-~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+....+..... .....+.+.. .+.... .+.-......+++.+||-.+|++|-+++++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000100000000 0111111111 111000 01111223458999999999999999999986
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-26 Score=235.92 Aligned_cols=211 Identities=35% Similarity=0.554 Sum_probs=182.4
Q ss_pred cccCCCeEEEEEEeCC-CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCChh
Q 002346 589 LGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667 (933)
Q Consensus 589 lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~ 667 (933)
||+|++|.||++...+ ++.+++|++....... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999997744 8999999988663221 3568999999999999999999999999989999999999999999
Q ss_pred hHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-CCcEEEecccccccCCCCCceeec
Q 002346 668 QHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAPDGKYSVET 746 (933)
Q Consensus 668 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~~~~~~~~~ 746 (933)
+++.... ..+++..+..++.+++++++|||+ .+++|+||+|.||+++. ++.++|+|||.+........ ...
T Consensus 80 ~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~ 151 (215)
T cd00180 80 DLLKENE----GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLK 151 (215)
T ss_pred HHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhh
Confidence 9986521 358899999999999999999999 89999999999999999 89999999999886654321 122
Q ss_pred ccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCCh
Q 002346 747 RLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDE 825 (933)
Q Consensus 747 ~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~ 825 (933)
...+...|++||..... .++.++|+|++|++++++
T Consensus 152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------- 187 (215)
T cd00180 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------- 187 (215)
T ss_pred cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence 34678899999999877 888999999999999999
Q ss_pred hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 826 ETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 826 ~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
..+.+++.+|++.+|++||++.++++.
T Consensus 188 ------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 246689999999999999999999863
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-27 Score=251.37 Aligned_cols=276 Identities=20% Similarity=0.284 Sum_probs=211.5
Q ss_pred eecHHHHHHHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC------CCcce
Q 002346 570 AISIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR------HRHLV 642 (933)
Q Consensus 570 ~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv 642 (933)
.+.+..-+.+..+|.+....|+|-|++|.+|. ...|..||||++.... .-.+.=..|+++|++|+ --|++
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE---~M~KtGl~EleiLkKL~~AD~Edk~Hcl 497 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE---VMHKTGLKELEILKKLNDADPEDKFHCL 497 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch---HHhhhhhHHHHHHHHhhccCchhhhHHH
Confidence 44555567778999999999999999999994 4468899999998652 23455678999999995 34899
Q ss_pred eEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC
Q 002346 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (933)
Q Consensus 643 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~ 722 (933)
+++-.|....++|||+|-+ .-+|.+.|+.+-. ...+....+..++.|+.-||.+|.. .+|+|.||||+|||+++
T Consensus 498 rl~r~F~hknHLClVFE~L-slNLRevLKKyG~--nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE 571 (752)
T KOG0670|consen 498 RLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGR--NVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNE 571 (752)
T ss_pred HHHHHhhhcceeEEEehhh-hchHHHHHHHhCc--ccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEecc
Confidence 9999999999999999987 5799999987533 2458888999999999999999998 89999999999999987
Q ss_pred CC-cEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHH
Q 002346 723 DM-RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 723 ~~-~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~ 801 (933)
.. .+||||||.|........ +.+.-+..|.|||++.+-.|+...|+||.||+||||+||+.-|.+.....+..+.-
T Consensus 572 ~k~iLKLCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~m 648 (752)
T KOG0670|consen 572 SKNILKLCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFM 648 (752)
T ss_pred CcceeeeccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHH
Confidence 54 689999999987765432 33445667999999999999999999999999999999999998765443322211
Q ss_pred HHHH----HhhccCCC-Cccc--------------------------CC------CC----CCChhhHHHHHHHHHHHHH
Q 002346 802 WFRR----VLISKENI-PKAI--------------------------DP------NL----NLDEETIESIYRVAELAGH 840 (933)
Q Consensus 802 ~~~~----~~~~~~~~-~~~~--------------------------d~------~l----~~~~~~~~~~~~~~~li~~ 840 (933)
-... .+..++.+ ...| .| .+ ....+....+..+.+|+..
T Consensus 649 e~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdk 728 (752)
T KOG0670|consen 649 ELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDK 728 (752)
T ss_pred HhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHH
Confidence 0000 00000000 0011 11 00 1233445667788999999
Q ss_pred cccCCCCCCCCHHHHHH
Q 002346 841 CTAREPQQRPDMGHAVN 857 (933)
Q Consensus 841 cl~~~P~~RPs~~evl~ 857 (933)
|+..||++|.+..++++
T Consensus 729 ml~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 729 MLILDPEKRITVNQALK 745 (752)
T ss_pred HhccChhhcCCHHHHhc
Confidence 99999999999999875
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.4e-27 Score=226.98 Aligned_cols=254 Identities=22% Similarity=0.345 Sum_probs=189.2
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeE-eeeCceeE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGY-CINGSERL 655 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~ 655 (933)
..+.|.+.+.+|+|.||.+-.+.. .+.+.+++|.++.. ....++|.+|..---.| .|.||+.-|+. |+..+.+.
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p---~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP---QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc---hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 457789999999999999999954 46789999998875 33457999998775556 59999988865 45667778
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec-C-CCcEEEecccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-D-DMRAKVADFGL 733 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~-~~~~kl~DfGl 733 (933)
+++||++.|+|.+-+.. ..+.+....+++.|++.|+.|||+ +.+||||||.+|||+- . ..++|++|||+
T Consensus 99 F~qE~aP~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~ 169 (378)
T KOG1345|consen 99 FVQEFAPRGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGL 169 (378)
T ss_pred EeeccCccchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeeccc
Confidence 99999999999988844 336788889999999999999999 9999999999999993 3 34799999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCC-----CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATG-----RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
.+..+..- ....-+..|.|||..... ...+.+|||.||+++|.++||..||+...- ....++.|......
T Consensus 170 t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~-~d~~Y~~~~~w~~r 244 (378)
T KOG1345|consen 170 TRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASI-MDKPYWEWEQWLKR 244 (378)
T ss_pred ccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhc-cCchHHHHHHHhcc
Confidence 87554321 112235578999977433 245679999999999999999999985433 23344555443322
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
....+|+.+.+- ..+.+++.++-+..+|++|=...++.++.
T Consensus 245 k~~~~P~~F~~f----------s~~a~r~Fkk~lt~~~~drcki~~~kk~r 285 (378)
T KOG1345|consen 245 KNPALPKKFNPF----------SEKALRLFKKSLTPRFKDRCKIWTAKKMR 285 (378)
T ss_pred cCccCchhhccc----------CHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence 222333333221 13566788889999999996666665554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-29 Score=259.71 Aligned_cols=349 Identities=23% Similarity=0.271 Sum_probs=282.5
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 146 (933)
.+..++.++|++. .+|++++.+.+|+.|++++|.+...+++++.+..|..|+..+|+++++|++ +.++.+|..|++.+
T Consensus 92 ~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~el~~~i~~~~~l~dl~~~~N~i~slp~~-~~~~~~l~~l~~~~ 169 (565)
T KOG0472|consen 92 ALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELKELPDSIGRLLDLEDLDATNNQISSLPED-MVNLSKLSKLDLEG 169 (565)
T ss_pred HHHHhhcccchHh-hccHHHhhhhhhhhhhccccceeecCchHHHHhhhhhhhccccccccCchH-HHHHHHHHHhhccc
Confidence 4567889999998 899999999999999999999999999999999999999999999999987 77899999999999
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~ 226 (933)
|+++. +|+..-+++.|++|++..|-+ +.+|..++.+.+|+.|+|.+|++. .+|+-=+.+.|.+|++..|++....
T Consensus 170 n~l~~---l~~~~i~m~~L~~ld~~~N~L-~tlP~~lg~l~~L~~LyL~~Nki~-~lPef~gcs~L~Elh~g~N~i~~lp 244 (565)
T KOG0472|consen 170 NKLKA---LPENHIAMKRLKHLDCNSNLL-ETLPPELGGLESLELLYLRRNKIR-FLPEFPGCSLLKELHVGENQIEMLP 244 (565)
T ss_pred cchhh---CCHHHHHHHHHHhcccchhhh-hcCChhhcchhhhHHHHhhhcccc-cCCCCCccHHHHHHHhcccHHHhhH
Confidence 99998 777777799999999999887 556888999999999999999998 8885445578999999999886432
Q ss_pred ccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccC---------
Q 002346 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP--------- 297 (933)
Q Consensus 227 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~--------- 297 (933)
...+..+++|..|||..|+++..+.++.-+.+|..||+|+|.|+ .+|.+++++ .|+.|-+.+|++...
T Consensus 245 -ae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT 321 (565)
T KOG0472|consen 245 -AEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGT 321 (565)
T ss_pred -HHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccH
Confidence 23456789999999999999998888999999999999999999 788899999 999999999998521
Q ss_pred -----------------------------CCCCCC------C--------------------------ccEEeccCCcCC
Q 002346 298 -----------------------------YPLFPS------K--------------------------VQKVSLDHNNFC 316 (933)
Q Consensus 298 -----------------------------~p~~~~------~--------------------------l~~L~l~~n~~~ 316 (933)
++...+ + +..++++.|.++
T Consensus 322 ~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~ 401 (565)
T KOG0472|consen 322 QEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLC 401 (565)
T ss_pred HHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHh
Confidence 000000 1 234667777776
Q ss_pred CCCCCCCCCCCchhhhhH--------hhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCcccc--------
Q 002346 317 KNSSDAGKPCDPQVTTLL--------QIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA-------- 380 (933)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~-------- 380 (933)
..+.+.... ....+.+ .++..+.....+..+-..||++..+|.+.+.+..|+.||+|+|++.
T Consensus 402 elPk~L~~l--kelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~ 479 (565)
T KOG0472|consen 402 ELPKRLVEL--KELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFRMLPECLYE 479 (565)
T ss_pred hhhhhhHHH--HHHHHHHHhhcCccccchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccccchHHHhh
Confidence 554321110 0011111 1122223333444555678999999999999999999999877554
Q ss_pred ---------------CcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCc
Q 002346 381 ---------------GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (933)
Q Consensus 381 ---------------g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 428 (933)
..-|..+.+|.+|..|||.+|.|. .||+.+++|.+|++|++++|+|.
T Consensus 480 lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 480 LQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred HHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 223344889999999999999999 99999999999999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-26 Score=235.00 Aligned_cols=200 Identities=33% Similarity=0.471 Sum_probs=172.2
Q ss_pred CccCCccccCCCeEEEEEEeCC-CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeec
Q 002346 583 FSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
|.+.+.||+|++|.||++...+ ++.+|+|.+...... ...+.+.+|++.++.++|+|++++++++......++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 5667899999999999997754 899999999865322 24678999999999999999999999999889999999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
++++|.+++.... ..+++..+..++.++++++.+||+ .+++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~ 152 (225)
T smart00221 80 EGGDLFDYLRKKG----GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL 152 (225)
T ss_pred CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence 9999999996521 117899999999999999999998 899999999999999999999999999988665542
Q ss_pred ceeecccccccCccccccc-CCCCCCCccchHhHHHHHHHHHcCCCCCCC
Q 002346 742 YSVETRLAGTFGYLAPEYA-ATGRVTTKIDVYAFGVVLMETITGRKALDD 790 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~~l~elltG~~p~~~ 790 (933)
........++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 153 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 153 AALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 1122334678899999998 667788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=239.40 Aligned_cols=269 Identities=23% Similarity=0.357 Sum_probs=198.8
Q ss_pred HHHHHHhcCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEe
Q 002346 574 EVLRQVTDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYC 648 (933)
Q Consensus 574 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 648 (933)
+.+..+.+.|..+++||+|.|++||++... ..+.||+|.+..... ..+..+|+++|..+ .+.||+++.+++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhh
Confidence 345566788999999999999999999442 467899999876532 35789999999999 599999999999
Q ss_pred eeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-CCcEE
Q 002346 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAK 727 (933)
Q Consensus 649 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~k 727 (933)
...++..+|+||++..+-.++... ++..++..+++.+..||+|+|. .|||||||||+|+|.+. .+.-.
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCce
Confidence 999999999999999999988844 7788999999999999999998 99999999999999985 46789
Q ss_pred EecccccccCCC-------------------C---------------Cce---------eecccccccCcccccccCC-C
Q 002346 728 VADFGLVKNAPD-------------------G---------------KYS---------VETRLAGTFGYLAPEYAAT-G 763 (933)
Q Consensus 728 l~DfGla~~~~~-------------------~---------------~~~---------~~~~~~gt~~y~aPE~~~~-~ 763 (933)
|.|||+|..... + .+. .....+||+||.|||++.. +
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 999999872100 0 000 0112469999999998854 5
Q ss_pred CCCCccchHhHHHHHHHHHcCCCCCCCCCCchh--hHHHHHH-----HHHhhccCC--CCc---------------ccC-
Q 002346 764 RVTTKIDVYAFGVVLMETITGRKALDDTMPDDR--AHLVTWF-----RRVLISKEN--IPK---------------AID- 818 (933)
Q Consensus 764 ~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~--~~~~~~~-----~~~~~~~~~--~~~---------------~~d- 818 (933)
..+.++||||.||+++-+++++.||.....+.. ..++..+ ++.....+. +.+ .++
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~ 333 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHI 333 (418)
T ss_pred CcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccCh
Confidence 678899999999999999999999986543211 1222111 111111111 000 000
Q ss_pred CCCCC------Chhh--HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNL------DEET--IESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~------~~~~--~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+.. .... ......+.+++.+|++.+|.+|-+++++++
T Consensus 334 ~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 334 ESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred hhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 00000 0001 111235679999999999999999999986
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.1e-25 Score=255.18 Aligned_cols=261 Identities=26% Similarity=0.391 Sum_probs=203.6
Q ss_pred EEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCC
Q 002346 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (933)
Q Consensus 68 v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 147 (933)
-..|+|++++|+ .+|+.+. ++|+.|++++|+|+.++ .+ +++|++|+|++|+|+.+|.. .++|+.|+|++|
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~LP-~l--p~~Lk~LdLs~N~LtsLP~l----p~sL~~L~Ls~N 272 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLP-AL--PPELRTLEVSGNQLTSLPVL----PPGLLELSIFSN 272 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCCCC-CC--CCCCcEEEecCCccCcccCc----ccccceeeccCC
Confidence 467899999998 7888776 48999999999999754 32 58899999999999998752 578999999999
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccc
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~ 227 (933)
.+.. +|.. .++|+.|+|++|+++.. |. .+++|+.|+|++|+|+ .+|..
T Consensus 273 ~L~~---Lp~l---p~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~-~Lp~l--------------------- 320 (788)
T PRK15387 273 PLTH---LPAL---PSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLA-SLPAL--------------------- 320 (788)
T ss_pred chhh---hhhc---hhhcCEEECcCCccccc-cc---cccccceeECCCCccc-cCCCC---------------------
Confidence 9887 5543 25788999999999765 44 2478999999999998 46642
Q ss_pred cccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccE
Q 002346 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQK 307 (933)
Q Consensus 228 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 307 (933)
..+|+.|++++|+|++.+ .+ ..+|+.|+|++|+|+ .+|.. .++|+.|++++|+|++ +|..++.|+.
T Consensus 321 ------p~~L~~L~Ls~N~L~~LP-~l--p~~Lq~LdLS~N~Ls-~LP~l---p~~L~~L~Ls~N~L~~-LP~l~~~L~~ 386 (788)
T PRK15387 321 ------PSELCKLWAYNNQLTSLP-TL--PSGLQELSVSDNQLA-SLPTL---PSELYKLWAYNNRLTS-LPALPSGLKE 386 (788)
T ss_pred ------cccccccccccCcccccc-cc--ccccceEecCCCccC-CCCCC---Ccccceehhhcccccc-Ccccccccce
Confidence 235677788888887643 32 247888888888888 45543 2467778888888885 5666778888
Q ss_pred EeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhh
Q 002346 308 VSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAY 387 (933)
Q Consensus 308 L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 387 (933)
|+|++|.|.+.+ .. .++|+.|+|++|+|++ +|..+
T Consensus 387 LdLs~N~Lt~LP-----------------------------------------~l---~s~L~~LdLS~N~Lss-IP~l~ 421 (788)
T PRK15387 387 LIVSGNRLTSLP-----------------------------------------VL---PSELKELMVSGNRLTS-LPMLP 421 (788)
T ss_pred EEecCCcccCCC-----------------------------------------Cc---ccCCCEEEccCCcCCC-CCcch
Confidence 888888875432 11 1468889999999985 67543
Q ss_pred cCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC
Q 002346 388 ANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (933)
Q Consensus 388 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 433 (933)
.+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|.
T Consensus 422 ---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 422 ---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred ---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 46788999999998 8999999999999999999999998875
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-25 Score=213.79 Aligned_cols=247 Identities=23% Similarity=0.409 Sum_probs=197.0
Q ss_pred cCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
...+|.+...|..|+|++ .|..+++|++.....+....++|..|.-.++-..||||..++|.|.......++..||+.|
T Consensus 194 l~tkl~e~hsgelwrgrw-qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g 272 (448)
T KOG0195|consen 194 LITKLAESHSGELWRGRW-QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG 272 (448)
T ss_pred hhhhhccCCCcccccccc-cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence 345788999999999999 5778889998887777777789999999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeE-ecCCCCCcEEecCCCcEEEe--cccccccCCCCC
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFI-HRDLKPSNILIGDDMRAKVA--DFGLVKNAPDGK 741 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv-H~Dik~~Nill~~~~~~kl~--DfGla~~~~~~~ 741 (933)
+|+..++.. ....++-.++.+++.++|+|++|||+. .+++ ---+..+.|++|++.+++|+ |--++...
T Consensus 273 slynvlhe~---t~vvvd~sqav~faldiargmaflhsl--ep~ipr~~lns~hvmidedltarismad~kfsfqe---- 343 (448)
T KOG0195|consen 273 SLYNVLHEQ---TSVVVDHSQAVRFALDIARGMAFLHSL--EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---- 343 (448)
T ss_pred HHHHHHhcC---ccEEEecchHHHHHHHHHhhHHHHhhc--chhhhhhhcccceEEecchhhhheecccceeeeec----
Confidence 999999763 335678889999999999999999996 4555 34688999999999988875 22221111
Q ss_pred ceeecccccccCcccccccCCCCC---CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 742 YSVETRLAGTFGYLAPEYAATGRV---TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 742 ~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
....=.|.||+||.+...+. -+++|+|||++++|||.|+..||.+-.+++....+. -+.++-.+.
T Consensus 344 ----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--------leglrv~ip 411 (448)
T KOG0195|consen 344 ----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--------LEGLRVHIP 411 (448)
T ss_pred ----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--------hccccccCC
Confidence 11233688999999876543 357999999999999999999999887765432221 223333344
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
|.+. ..+.+++.-|+..||.+||.+..++-+||++
T Consensus 412 pgis---------~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 412 PGIS---------RHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred CCcc---------HHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 4333 3467899999999999999999999999875
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-26 Score=231.72 Aligned_cols=366 Identities=22% Similarity=0.252 Sum_probs=267.9
Q ss_pred CCCCccc---cceEeCCC----------CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCc
Q 002346 51 STGYCEW---TGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQ 116 (933)
Q Consensus 51 ~~~~C~w---~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~ 116 (933)
..+.|+- .-|+|+.. ...+.|+|..|+|+.+.+.+|+.+++|+.|||++|+|+.+-| +|.++.+|.
T Consensus 39 ~pC~Cs~~~g~~VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~ 118 (498)
T KOG4237|consen 39 APCTCSDVEGGIVDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLL 118 (498)
T ss_pred CCcccCCCCCceEEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhh
Confidence 3444554 33777642 478999999999998888999999999999999999999999 899999998
Q ss_pred eecccc-ccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEcc
Q 002346 117 DIYLDN-NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (933)
Q Consensus 117 ~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 195 (933)
.|-+.+ |+|+.++.+.|++|..|+.|.+.-|++.- .....|..+++|..|.+..|.+..+--..|..+..++.+.+.
T Consensus 119 ~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~C--ir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA 196 (498)
T KOG4237|consen 119 SLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINC--IRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLA 196 (498)
T ss_pred HHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcc--hhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhh
Confidence 888776 99999999999999999999999999988 567899999999999999999977766689999999999999
Q ss_pred CCcCCC------------CCCcccc-----------c------------cccchh---hcccccCCcccccccccCCccC
Q 002346 196 YNNFTG------------SLPASFA-----------K------------SDIQNL---WMNDQQLGLSGTLDVLSGMTQL 237 (933)
Q Consensus 196 ~N~l~~------------~~p~~~~-----------~------------~~l~~l---~l~~n~~~~~~~~~~l~~l~~L 237 (933)
.|.+-. ..|..++ . ..++.+ ....+.........-|.++++|
T Consensus 197 ~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L 276 (498)
T KOG4237|consen 197 QNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNL 276 (498)
T ss_pred cCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccc
Confidence 998321 1121111 1 011111 2222334444445568899999
Q ss_pred cEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCC---CccEEeccCC
Q 002346 238 RQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS---KVQKVSLDHN 313 (933)
Q Consensus 238 ~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~---~l~~L~l~~n 313 (933)
+.|+|++|+++++-+ .|.++.+++.|.|..|+|.......|.++..|+.|+|.+|+++...|..+. .|..|.|-.|
T Consensus 277 ~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N 356 (498)
T KOG4237|consen 277 RKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN 356 (498)
T ss_pred eEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccC
Confidence 999999999999776 489999999999999999977788899999999999999999988887654 5667788888
Q ss_pred cCCCC-------------CCCCCCCCCchhhhhHhhhc--------ccCCCccccCCCC----------------CCCCC
Q 002346 314 NFCKN-------------SSDAGKPCDPQVTTLLQIAG--------DMGYPAILSDSWE----------------GNNAC 356 (933)
Q Consensus 314 ~~~~~-------------~~~~~~~~~~~~~~~~~~~~--------~~~~~~~l~~~~~----------------~~~~~ 356 (933)
.|.-+ ......+|... ..+-+++. ..+.++.....-+ .|+.+
T Consensus 357 p~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p-~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~l 435 (498)
T KOG4237|consen 357 PFNCNCRLAWLGEWLRKKSVVGNPRCQSP-GFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLL 435 (498)
T ss_pred cccCccchHHHHHHHhhCCCCCCCCCCCC-chhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccch
Confidence 77321 11111222211 11111110 0001111110000 13334
Q ss_pred CCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCC
Q 002346 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425 (933)
Q Consensus 357 ~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N 425 (933)
+.+|.-+- ...++|++.+|.++ .+|.+ .+.+| .+||++|+++..--..|.+|.+|.+|-||+|
T Consensus 436 k~lp~~iP--~d~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 436 KLLPRGIP--VDVTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hhcCCCCC--chhHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 44443332 24667888899888 46666 67788 8999999998666778899999999999887
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.2e-23 Score=207.82 Aligned_cols=264 Identities=19% Similarity=0.275 Sum_probs=205.8
Q ss_pred hcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 657 (933)
.-.|+++++||+|.||+++.| .+-+++.||||.-+... ...++..|.+..+.| ..+.|...|.|..++.+-.||
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccC----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 357899999999999999999 56789999999654332 234678888888888 589999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-----CcEEEeccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-----MRAKVADFG 732 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-----~~~kl~DfG 732 (933)
+|.+ |.+|.+... -+...++.+++..||.|++.-++|+|+ +.+|.|||||+|+||..- ..+.|+|||
T Consensus 103 idLL-GPSLEDLFD----~CgR~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFG 174 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFD----LCGRRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFG 174 (449)
T ss_pred hhhh-CcCHHHHHH----HhcCcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEecc
Confidence 9998 889988773 234779999999999999999999999 999999999999999643 358999999
Q ss_pred ccccCCCCCc------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH
Q 002346 733 LVKNAPDGKY------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 733 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+|+.+.+... .......||.+||+-....+.+.+.+.|+-|+|-++++.+.|..||.+--....... ..++
T Consensus 175 mAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~k---YeKI 251 (449)
T KOG1165|consen 175 MAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEK---YEKI 251 (449)
T ss_pred chhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHH---HHHh
Confidence 9998776543 334457899999999999999999999999999999999999999987543322211 1111
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
-..+. ..+....+...+.++...+.-.-..+-.+-|+++-+...+.++++..
T Consensus 252 Ge~Kr--------~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~ 303 (449)
T KOG1165|consen 252 GETKR--------STPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRL 303 (449)
T ss_pred ccccc--------cCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhc
Confidence 11010 01112223334556667776677778889999988887777776653
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-24 Score=265.61 Aligned_cols=194 Identities=19% Similarity=0.223 Sum_probs=138.0
Q ss_pred cCC-CcceeEEeEe-------eeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC
Q 002346 636 VRH-RHLVALLGYC-------INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707 (933)
Q Consensus 636 l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ 707 (933)
++| +||+++++++ .+.+..+.++||+ +++|.+++... ...+++.+++.++.||++||+|||+ ++
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~g 100 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHS---QG 100 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHh---CC
Confidence 445 5788888877 2234567788987 66999999541 2559999999999999999999998 89
Q ss_pred eEecCCCCCcEEecC-------------------CCcEEEecccccccCCCCCc---------------eeecccccccC
Q 002346 708 FIHRDLKPSNILIGD-------------------DMRAKVADFGLVKNAPDGKY---------------SVETRLAGTFG 753 (933)
Q Consensus 708 ivH~Dik~~Nill~~-------------------~~~~kl~DfGla~~~~~~~~---------------~~~~~~~gt~~ 753 (933)
|+||||||+||||+. ++.+|++|||+++....... .......||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 999999999999954 44566667776653211000 00112468899
Q ss_pred cccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHH
Q 002346 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYR 833 (933)
Q Consensus 754 y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~ 833 (933)
|+|||++.+..++.++|||||||++|||++|..|+.... ......... ..+ +.. ......
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~----~~~~~~~~~------~~~----~~~------~~~~~~ 240 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS----RTMSSLRHR------VLP----PQI------LLNWPK 240 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH----HHHHHHHHh------hcC----hhh------hhcCHH
Confidence 999999999999999999999999999999988764311 111111100 011 100 011223
Q ss_pred HHHHHHHcccCCCCCCCCHHHHHH
Q 002346 834 VAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 834 ~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...++.+||+++|.+||+|.|+++
T Consensus 241 ~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 241 EASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHHHhCCCChhhCcChHHHhh
Confidence 457888999999999999999976
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=5e-23 Score=205.35 Aligned_cols=170 Identities=24% Similarity=0.267 Sum_probs=126.0
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++... ...+++.+++.|+.|+++||+|||+ ++ ||+||+++.++.+|+ ||+++......
T Consensus 1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-- 63 (176)
T smart00750 1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-- 63 (176)
T ss_pred CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc--
Confidence 6899998652 2469999999999999999999998 44 999999999999999 99987654422
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~ 823 (933)
..|++.|+|||++.+..++.++|||||||++|||+||+.||....... ..+..+..... .. ++.-..
T Consensus 64 ----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~~~-------~~-~~~~~~ 130 (176)
T smart00750 64 ----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNGMP-------AD-DPRDRS 130 (176)
T ss_pred ----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHHhc-------cC-Cccccc
Confidence 268999999999999999999999999999999999999997543211 11111111110 00 000000
Q ss_pred ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 824 ~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
..........+.+++.+|++.+|++||++.|+++.+....
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 1111111125889999999999999999999999876553
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-22 Score=219.67 Aligned_cols=261 Identities=21% Similarity=0.265 Sum_probs=194.7
Q ss_pred CCccCCccccCCCeEEEEEEeCCC--cEEEEEEeccccCCchhHHHHHHHHHHHHhcCC----CcceeEEeEe-eeCcee
Q 002346 582 NFSEANILGRGGFGVVYGGELPDG--TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH----RHLVALLGYC-INGSER 654 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~ 654 (933)
+|.+.+.||+|+||.||.+..... ..+|+|.......... ..+..|+.++..+.. +++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 799999999999999999965443 4788887665422211 267888888888863 6899999998 477788
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-----CcEEEe
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-----MRAKVA 729 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-----~~~kl~ 729 (933)
++||+.+ |.+|.+...... ...++..+...|+.|++.+|+++|+ .|++||||||.|+++... ..+.|.
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~ll 169 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLL 169 (322)
T ss_pred EEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEE
Confidence 9999988 889999875532 4679999999999999999999999 999999999999999754 469999
Q ss_pred cccccc--cCCCCCce------e-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhh-HH
Q 002346 730 DFGLVK--NAPDGKYS------V-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA-HL 799 (933)
Q Consensus 730 DfGla~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~-~~ 799 (933)
|||+++ ........ . .....||.+|+++....+.+.+++.|+||++.++.|+..|..||......... ..
T Consensus 170 DfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~ 249 (322)
T KOG1164|consen 170 DFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF 249 (322)
T ss_pred ecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence 999998 32221110 1 12356999999999999999999999999999999999999999664332221 11
Q ss_pred HHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 800 VTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
........ ... . .... ...+.++...+-..+...+|.+..+...++.+...-
T Consensus 250 ~~~~~~~~-----~~~-----~--~~~~---~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~ 301 (322)
T KOG1164|consen 250 EKDPRKLL-----TDR-----F--GDLK---PEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE 301 (322)
T ss_pred HHHhhhhc-----ccc-----c--cCCC---hHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence 11111100 000 0 0111 123455666666689999999999999988776554
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=223.69 Aligned_cols=170 Identities=26% Similarity=0.225 Sum_probs=131.4
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEeC--CCcEEEEEEeccccC---CchhHHHHHHHHHHHHhcCCCcceeEEeEeee
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGELP--DGTKIAVKRMESNTM---GNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 650 (933)
...+.++|.+.+.||+|+||+||+|... +++.||||++..... .....+.|.+|++++++++|+|+++.+..+
T Consensus 13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-- 90 (365)
T PRK09188 13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-- 90 (365)
T ss_pred cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence 3456688999999999999999999653 577889998753311 223456799999999999999998533322
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCC-CCCcEEecCCCcEEEe
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL-KPSNILIGDDMRAKVA 729 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-k~~Nill~~~~~~kl~ 729 (933)
+..++||||+++++|.. +.. . . ...++.++++||+|||+ ++|+|||| ||+|||++.++.+||+
T Consensus 91 -~~~~LVmE~~~G~~L~~-~~~---~--~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLi 154 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHL-ARP---H--G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVI 154 (365)
T ss_pred -CCcEEEEEccCCCCHHH-hCc---c--c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEE
Confidence 45799999999999963 211 0 1 14678899999999999 89999999 9999999999999999
Q ss_pred cccccccCCCCCcee-------ecccccccCcccccccCCC
Q 002346 730 DFGLVKNAPDGKYSV-------ETRLAGTFGYLAPEYAATG 763 (933)
Q Consensus 730 DfGla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~ 763 (933)
|||+|+......... -+...+++.|+|||++...
T Consensus 155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 999998655432111 1345788999999998644
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=195.17 Aligned_cols=262 Identities=21% Similarity=0.283 Sum_probs=202.2
Q ss_pred HhcCCccCCccccCCCeEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLL 656 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 656 (933)
+..+|.++++||.|+||.+|.| ...+|+.||+|+-..... ..++..|.++...++ ...|..+..|..++..-.+
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl 88 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL 88 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence 3578999999999999999999 667899999997654432 246788999999996 4688888888888888899
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC---CcEEEecccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADFGL 733 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~DfGl 733 (933)
|||.+ |.+|.+...-. ...++..+++-++-|++.-++|+|. +++|||||||+|+|+.-+ ..+.++|||+
T Consensus 89 VMdLL-GPsLEdLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL 160 (341)
T KOG1163|consen 89 VMDLL-GPSLEDLFNFC----SRRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL 160 (341)
T ss_pred eeecc-CccHHHHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccc
Confidence 99988 88999887542 3568999999999999999999998 999999999999999643 4589999999
Q ss_pred cccCCCCCc------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 734 VKNAPDGKY------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 734 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
|+.+.+... .......||.+|++-....+.+.+...|+-|+|.++.++-.|..||++-.+.....-.+ ++.
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE---kI~ 237 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE---KIS 237 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH---HHH
Confidence 997665432 22345789999999998888888999999999999999999999999765443322222 111
Q ss_pred hccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
..+-..+ ...-+.-.+.++.-.+..|-..--++-|+..-+-+.+.-+.
T Consensus 238 EkK~s~~--------ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 238 EKKMSTP--------IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HhhcCCC--------HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1111111 01122223456677788888888889998877777665554
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=236.16 Aligned_cols=247 Identities=22% Similarity=0.328 Sum_probs=201.0
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
.+++.|++.+|+|+. +|. ..++|++|+|++|+|+.+++ + .++|+.|+|++|.|+.++.. .++|+.|+|+
T Consensus 222 ~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~LtsLP~-l--p~sL~~L~Ls~N~L~~Lp~l----p~~L~~L~Ls 290 (788)
T PRK15387 222 AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTSLPV-L--PPGLLELSIFSNPLTHLPAL----PSGLCKLWIF 290 (788)
T ss_pred cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCcccC-c--ccccceeeccCCchhhhhhc----hhhcCEEECc
Confidence 368999999999984 664 35899999999999997643 2 46899999999999988752 3679999999
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~ 225 (933)
+|+++. +|.. +++|+.|+|++|+|++. |.. ..+|+.|++++|+|+ .+|..
T Consensus 291 ~N~Lt~---LP~~---p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~-~LP~l------------------- 340 (788)
T PRK15387 291 GNQLTS---LPVL---PPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLT-SLPTL------------------- 340 (788)
T ss_pred CCcccc---cccc---ccccceeECCCCccccC-CCC---cccccccccccCccc-ccccc-------------------
Confidence 999987 5543 47899999999999875 442 246889999999998 57642
Q ss_pred cccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCc
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 305 (933)
..+|+.|+|++|+|+++++. ..+|+.|++++|+|+ .+|... ++|+.|+|++|+|++ +|..+++|
T Consensus 341 --------p~~Lq~LdLS~N~Ls~LP~l---p~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt~-LP~l~s~L 404 (788)
T PRK15387 341 --------PSGLQELSVSDNQLASLPTL---PSELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLTS-LPVLPSEL 404 (788)
T ss_pred --------ccccceEecCCCccCCCCCC---Ccccceehhhccccc-cCcccc---cccceEEecCCcccC-CCCcccCC
Confidence 24789999999999975542 357888999999999 577643 578999999999996 66677899
Q ss_pred cEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCch
Q 002346 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385 (933)
Q Consensus 306 ~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 385 (933)
+.|++++|.|..+ |.. ..+|+.|+|++|+|+ .+|.
T Consensus 405 ~~LdLS~N~LssI-----------------------------------------P~l---~~~L~~L~Ls~NqLt-~LP~ 439 (788)
T PRK15387 405 KELMVSGNRLTSL-----------------------------------------PML---PSGLLSLSVYRNQLT-RLPE 439 (788)
T ss_pred CEEEccCCcCCCC-----------------------------------------Ccc---hhhhhhhhhccCccc-ccCh
Confidence 9999999998653 221 135788999999998 6899
Q ss_pred hhcCcccCCeEecccCcccCCCCcccCCC
Q 002346 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKL 414 (933)
Q Consensus 386 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 414 (933)
.|+++++|+.|+|++|+|+|.+|..+..+
T Consensus 440 sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 440 SLIHLSSETTVNLEGNPLSERTLQALREI 468 (788)
T ss_pred HHhhccCCCeEECCCCCCCchHHHHHHHH
Confidence 99999999999999999999988877543
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-21 Score=231.45 Aligned_cols=247 Identities=21% Similarity=0.331 Sum_probs=156.2
Q ss_pred ccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeec
Q 002346 91 QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170 (933)
Q Consensus 91 ~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L 170 (933)
+...|+++++.++.++..+. ++|+.|+|++|+|+.+|...+ ++|++|+|++|+++. +|..+. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~LtsLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~---~nL~~L~Ls~N~Lts---LP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLTTIPACIP--EQITTLILDNNELKSLPENLQ---GNIKTLYANSNQLTS---IPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcCcCCcccc--cCCcEEEecCCCCCcCChhhc---cCCCEEECCCCcccc---CChhhh--ccccEEEC
Confidence 44566666666664433332 356666666666666655432 356666666666554 444332 35666666
Q ss_pred cCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCC
Q 002346 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250 (933)
Q Consensus 171 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 250 (933)
++|++.. +|..+. .+|++|+|++|+|+ .+|..+ .++|+.|+|++|+|++.
T Consensus 249 s~N~L~~-LP~~l~--s~L~~L~Ls~N~L~-~LP~~l--------------------------~~sL~~L~Ls~N~Lt~L 298 (754)
T PRK15370 249 SINRITE-LPERLP--SALQSLDLFHNKIS-CLPENL--------------------------PEELRYLSVYDNSIRTL 298 (754)
T ss_pred cCCccCc-CChhHh--CCCCEEECcCCccC-cccccc--------------------------CCCCcEEECCCCccccC
Confidence 6666653 344443 35666666666665 455432 24678888888888765
Q ss_pred CCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchh
Q 002346 251 IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQV 330 (933)
Q Consensus 251 ~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~ 330 (933)
++.+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|.+++.+..++.+|+.|+|++|+|..+
T Consensus 299 P~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~LP~~l~~sL~~L~Ls~N~L~~L------------ 361 (754)
T PRK15370 299 PAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTSLPASLPPELQVLDVSKNQITVL------------ 361 (754)
T ss_pred cccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCccccCChhhcCcccEEECCCCCCCcC------------
Confidence 54443 46778888888887 4555443 5778888888888765444556788888888877432
Q ss_pred hhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcc
Q 002346 331 TTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410 (933)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 410 (933)
|..+. ++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..
T Consensus 362 -----------------------------P~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~s 406 (754)
T PRK15370 362 -----------------------------PETLP--PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPES 406 (754)
T ss_pred -----------------------------Chhhc--CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchh
Confidence 22221 46888899998888 4666654 36888889999888 55654
Q ss_pred cC----CCCCcCEEeccCCcCcc
Q 002346 411 LT----KLASLQNLDVSNNNLSG 429 (933)
Q Consensus 411 ~~----~l~~L~~l~ls~N~l~g 429 (933)
+. .++.+..|+|.+|+|+.
T Consensus 407 l~~~~~~~~~l~~L~L~~Npls~ 429 (754)
T PRK15370 407 LPHFRGEGPQPTRIIVEYNPFSE 429 (754)
T ss_pred HHHHhhcCCCccEEEeeCCCccH
Confidence 43 35778888999988873
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.2e-24 Score=242.83 Aligned_cols=373 Identities=24% Similarity=0.287 Sum_probs=234.7
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 146 (933)
++.+|++++|.+. ..|..|..+.+|+.|+++.|.|...+.+..++.+|++|+|.+|.+..+|.+ +..+++|+.||+|+
T Consensus 46 ~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~~vp~s~~~~~~l~~lnL~~n~l~~lP~~-~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIRSVPSSCSNMRNLQYLNLKNNRLQSLPAS-ISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccc-cCCchhhhHHHHhhcccchhhHhhCchhhhhhhcchhheeccchhhcCchh-HHhhhcccccccch
Confidence 3889999998886 788899999999999999999997776899999999999999999998876 89999999999999
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCc-------------------ccCCCCChhhcCCCCCCEEEccCCcCCCCCCccc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNA-------------------NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n-------------------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 207 (933)
|++.. +|..+..++.+..+..++| .+.+.++..+..++. .|+|++|.+. ..--..
T Consensus 124 N~f~~---~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~~dls~ 197 (1081)
T KOG0618|consen 124 NHFGP---IPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-VLDLSN 197 (1081)
T ss_pred hccCC---CchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-hhhhhh
Confidence 99876 6666666665555555555 444444444444444 4666666665 211111
Q ss_pred cccccchhhcccccCCccc-----------------ccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcc
Q 002346 208 AKSDIQNLWMNDQQLGLSG-----------------TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQL 270 (933)
Q Consensus 208 ~~~~l~~l~l~~n~~~~~~-----------------~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l 270 (933)
...++.+....|++.... ....-.--.+|+++++++|++++.+..+..+.+|+.|++.+|+|
T Consensus 198 -~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~lp~wi~~~~nle~l~~n~N~l 276 (1081)
T KOG0618|consen 198 -LANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNLPEWIGACANLEALNANHNRL 276 (1081)
T ss_pred -ccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhcchHHHHhcccceEecccchhH
Confidence 112333333333322100 00000112456666666666666664466666677777777766
Q ss_pred cccCcccccCCCCCCEEEccCccCccCCCCC--CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhc--------cc
Q 002346 271 TGVVPASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG--------DM 340 (933)
Q Consensus 271 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~--------~~ 340 (933)
+ .+|..+..+++|+.|++.+|.+.-..|.. ...|+.|+|..|+|...+.....-......++-.... +.
T Consensus 277 ~-~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e 355 (1081)
T KOG0618|consen 277 V-ALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEE 355 (1081)
T ss_pred H-hhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccccccccc
Confidence 5 66666666666666666666666544432 3578899999999977654322211111111110000 01
Q ss_pred CCCccccC-CCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccC--------------
Q 002346 341 GYPAILSD-SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG-------------- 405 (933)
Q Consensus 341 ~~~~~l~~-~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g-------------- 405 (933)
.....+.. ++.+|.+....=..+-...+|+.|+|++|+|.......+.++..|+.|+||+|+|+.
T Consensus 356 ~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL 435 (1081)
T KOG0618|consen 356 NNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTL 435 (1081)
T ss_pred hhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHH
Confidence 11112222 223344444433445566778888888887774444567777777777777777651
Q ss_pred --------CCCcccCCCCCcCEEeccCCcCccc-CCCCC--CCcccccCCCCCCcC
Q 002346 406 --------PIPDGLTKLASLQNLDVSNNNLSGK-VPDFG--SNVKFTVSPGNPFIG 450 (933)
Q Consensus 406 --------~~p~~~~~l~~L~~l~ls~N~l~g~-~p~~~--~~~~~~~~~~n~~~~ 450 (933)
.+| ++..++.|+++|||.|+|+.. +|... ..++-..+.||+|..
T Consensus 436 ~ahsN~l~~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~~l~ 490 (1081)
T KOG0618|consen 436 RAHSNQLLSFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNTRLV 490 (1081)
T ss_pred hhcCCceeech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCcccc
Confidence 455 677888999999999999754 33322 345555677888743
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.6e-22 Score=231.83 Aligned_cols=202 Identities=24% Similarity=0.371 Sum_probs=138.8
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 146 (933)
+.+.|++++++++ .+|..+. ++|+.|+|++|+|+.+++.+. .+|++|+|++|+|+.+|... .++|+.|+|++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~LtsLP~~l~--~nL~~L~Ls~N~LtsLP~~l---~~~L~~L~Ls~ 250 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELKSLPENLQ--GNIKTLYANSNQLTSIPATL---PDTIQEMELSI 250 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCcCChhhc--cCCCEEECCCCccccCChhh---hccccEEECcC
Confidence 4788999999998 5777664 589999999999997655554 58999999999999988653 25799999999
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~ 226 (933)
|++.. +|..+. ++|+.|+|++|+|.. +|..+. ++|++|+|++|+|+ .+|..+.
T Consensus 251 N~L~~---LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt-~LP~~lp------------------ 303 (754)
T PRK15370 251 NRITE---LPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIR-TLPAHLP------------------ 303 (754)
T ss_pred CccCc---CChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccc-cCcccch------------------
Confidence 99986 677664 589999999999985 576654 58999999999999 5776543
Q ss_pred ccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCcc
Q 002346 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQ 306 (933)
Q Consensus 227 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 306 (933)
++|+.|++++|+++..++.+. ++|+.|++++|.|+ .+|..+. ++|+.|+|++|+|+..+...+..|+
T Consensus 304 --------~sL~~L~Ls~N~Lt~LP~~l~--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~L~~LP~~lp~~L~ 370 (754)
T PRK15370 304 --------SGITHLNVQSNSLTALPETLP--PGLKTLEAGENALT-SLPASLP--PELQVLDVSKNQITVLPETLPPTIT 370 (754)
T ss_pred --------hhHHHHHhcCCccccCCcccc--ccceeccccCCccc-cCChhhc--CcccEEECCCCCCCcCChhhcCCcC
Confidence 234445555555554332221 34555555555555 2444332 4555555555555532222334555
Q ss_pred EEeccCCcCC
Q 002346 307 KVSLDHNNFC 316 (933)
Q Consensus 307 ~L~l~~n~~~ 316 (933)
.|+|++|+|.
T Consensus 371 ~LdLs~N~Lt 380 (754)
T PRK15370 371 TLDVSRNALT 380 (754)
T ss_pred EEECCCCcCC
Confidence 5555555553
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-20 Score=204.08 Aligned_cols=261 Identities=26% Similarity=0.425 Sum_probs=199.6
Q ss_pred CccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCch-hHHHHHHHHHHHHhcCCC-cceeEEeEeeeCceeEEEEee
Q 002346 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRHR-HLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~ 660 (933)
|.+.+.||.|+||.||++... ..+++|.+........ ....+.+|+.+++.+.|+ +++++++++......++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999775 8899999987754443 577899999999999988 799999999777778999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEEecccccccCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAPD 739 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~~ 739 (933)
+.++++.+++...... ..+.......++.|++.+++|+|+ .+++|||+||+||+++..+ .++++|||.++....
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~ 154 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPD 154 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCC
Confidence 9999999776542111 368899999999999999999999 8999999999999999988 799999999885544
Q ss_pred CCce-----eecccccccCcccccccCC---CCCCCccchHhHHHHHHHHHcCCCCCCCCCCc-hhhHHHHHHHHHhhcc
Q 002346 740 GKYS-----VETRLAGTFGYLAPEYAAT---GRVTTKIDVYAFGVVLMETITGRKALDDTMPD-DRAHLVTWFRRVLISK 810 (933)
Q Consensus 740 ~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~-~~~~~~~~~~~~~~~~ 810 (933)
.... ......|+..|+|||.+.+ ..+....|+||+|++++++++|..||...... ........+... .
T Consensus 155 ~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---~ 231 (384)
T COG0515 155 PGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL---P 231 (384)
T ss_pred CCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc---C
Confidence 3322 2355689999999999987 57889999999999999999999997654321 011111111111 1
Q ss_pred CC-CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 811 EN-IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 811 ~~-~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
.. .......... ......+.+++..|+..+|..|.++.+....
T Consensus 232 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 232 TPSLASPLSPSNP-----ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CcccccccCcccc-----chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 11 1111111100 2223456789999999999999998887764
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.1e-22 Score=231.81 Aligned_cols=261 Identities=20% Similarity=0.261 Sum_probs=191.1
Q ss_pred ccCCccccCCCeEEEEEE-eCCCcEEEEEEecc---ccCCch-hHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 584 SEANILGRGGFGVVYGGE-LPDGTKIAVKRMES---NTMGNK-GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~---~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
...+++|.|++|.|+... ....+.++.|.+.. ...+.. ....+..|+.+-..++|||++..+..+.+.....-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 346789999999887773 33444455554431 111222 2223677888888899999998888777766666669
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
|||++ +|..++.. ...+...++..++.|+.+|++|+|+ .||.|||+|++|++++.+|.+||+|||.+....
T Consensus 401 E~~~~-Dlf~~~~~-----~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~ 471 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-----NGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFR 471 (601)
T ss_pred hcccH-HHHHHHhc-----ccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeec
Confidence 99999 99999855 1357888899999999999999999 899999999999999999999999999886443
Q ss_pred CCC---ceeecccccccCcccccccCCCCCCC-ccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 739 DGK---YSVETRLAGTFGYLAPEYAATGRVTT-KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 739 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~-~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
.+. .......+|+..|+|||.+.+.+|.+ ..||||.|++++.|++|+.||......+..... . . ..
T Consensus 472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~----~----~--~~ 541 (601)
T KOG0590|consen 472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT----N----N--YS 541 (601)
T ss_pred cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh----h----c--cc
Confidence 322 24456788999999999999999865 699999999999999999999765443332100 0 0 00
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
..................+...++.++++.+|.+|-++++|++ ++|...
T Consensus 542 ~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~------d~W~~~ 590 (601)
T KOG0590|consen 542 DQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN------DEWIRS 590 (601)
T ss_pred cccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh------ChHhhh
Confidence 0000000111112233456778999999999999999999987 667643
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.84 E-value=9.4e-20 Score=230.57 Aligned_cols=330 Identities=16% Similarity=0.202 Sum_probs=189.6
Q ss_pred CCEEEEEecCC------CCccccCccccCCc-ccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCC
Q 002346 66 NRVTTISLAKS------GLSGTLSPEISSLT-QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTN 138 (933)
Q Consensus 66 ~~v~~L~l~~~------~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 138 (933)
.+++.|.+..+ ++...+|..+..++ +|+.|++.+|.+...++.| .+.+|++|+|.+|++..++.+ +..+++
T Consensus 558 ~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~~lP~~f-~~~~L~~L~L~~s~l~~L~~~-~~~l~~ 635 (1153)
T PLN03210 558 RNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLRCMPSNF-RPENLVKLQMQGSKLEKLWDG-VHSLTG 635 (1153)
T ss_pred ccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCCCCCCcC-CccCCcEEECcCccccccccc-cccCCC
Confidence 35666666544 23345666666654 5888888887776554455 467788888888888777654 567788
Q ss_pred CCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcc
Q 002346 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMN 218 (933)
Q Consensus 139 L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~ 218 (933)
|+.|+|++|.... .+| .+..+++|+.|+|++|.....+|..++++++|+.|+|++|..-+.+|..+...+|+.|.+.
T Consensus 636 Lk~L~Ls~~~~l~--~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Ls 712 (1153)
T PLN03210 636 LRNIDLRGSKNLK--EIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLS 712 (1153)
T ss_pred CCEEECCCCCCcC--cCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCC
Confidence 8888887765444 244 4777788888888877766777778888888888888876544577776655667777777
Q ss_pred cccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCccc-------ccCcccccCCCCCCEEEccC
Q 002346 219 DQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT-------GVVPASVISLPALLNISLQN 291 (933)
Q Consensus 219 ~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~-------~~~p~~l~~l~~L~~L~Ls~ 291 (933)
+|..... .+ ....+|+.|+|++|.++..+..+ .+++|+.|++.++... ...+..+...++|+.|+|++
T Consensus 713 gc~~L~~--~p--~~~~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~ 787 (1153)
T PLN03210 713 GCSRLKS--FP--DISTNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSD 787 (1153)
T ss_pred CCCCccc--cc--cccCCcCeeecCCCccccccccc-cccccccccccccchhhccccccccchhhhhccccchheeCCC
Confidence 7643211 11 11356777777777776543322 3444444444432211 01111111223444555555
Q ss_pred ccCccCCCCC---CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCc
Q 002346 292 NKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368 (933)
Q Consensus 292 N~l~~~~p~~---~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~ 368 (933)
|...+.+|.. +.+|+.|++++|......+.. ...+..-.+.+.+|..+..+|.. .++
T Consensus 788 n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~-----------------~~L~sL~~L~Ls~c~~L~~~p~~---~~n 847 (1153)
T PLN03210 788 IPSLVELPSSIQNLHKLEHLEIENCINLETLPTG-----------------INLESLESLDLSGCSRLRTFPDI---STN 847 (1153)
T ss_pred CCCccccChhhhCCCCCCEEECCCCCCcCeeCCC-----------------CCccccCEEECCCCCcccccccc---ccc
Confidence 4444444432 223444444443211110000 00000111122222333333332 246
Q ss_pred eeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCc
Q 002346 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNN 426 (933)
Q Consensus 369 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~ 426 (933)
|+.|+|++|.++ .+|.++..+++|+.|+|++|+-...+|..+..++.|+.++++++.
T Consensus 848 L~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 848 ISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 777788888776 477778888888888887744333577777777888888877763
|
syringae 6; Provisional |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=188.12 Aligned_cols=142 Identities=18% Similarity=0.206 Sum_probs=110.2
Q ss_pred CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchh-------H-----------------HHHHHHHHHHHhcCCCcc
Q 002346 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKG-------L-----------------SEFQAEIAVLTKVRHRHL 641 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------~-----------------~~~~~E~~~l~~l~h~ni 641 (933)
...||+|+||.||+|...+|+.||||+++....+... . .....|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4679999999999998778999999999765322111 1 122459999999988776
Q ss_pred eeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCeEecCCCCCcEEe
Q 002346 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL-HSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 642 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH~Dik~~Nill 720 (933)
.....+.. ...++||||++++++...... ..++++.++..++.|++.+|+|+ |+ .+|+||||||+||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli 151 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLY 151 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEE
Confidence 44433322 223899999998877655322 24688999999999999999999 67 899999999999999
Q ss_pred cCCCcEEEecccccccCC
Q 002346 721 GDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~~~ 738 (933)
+ ++.++|+|||+|....
T Consensus 152 ~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 152 H-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred E-CCcEEEEEccccccCC
Confidence 8 4789999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=8e-21 Score=191.08 Aligned_cols=175 Identities=14% Similarity=0.155 Sum_probs=136.7
Q ss_pred HHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCch-hHHH------HHHHHHHHHhcCCCcceeEEeEee
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK-GLSE------FQAEIAVLTKVRHRHLVALLGYCI 649 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~~l~~l~h~niv~l~~~~~ 649 (933)
..+..+|++.+++|.|+||.||.++. ++..+|+|++........ .... +.+|+..+.++.|++|..+.+++.
T Consensus 27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 45578999999999999999999876 577899999976543222 1222 689999999999999999998865
Q ss_pred eC--------ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec
Q 002346 650 NG--------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721 (933)
Q Consensus 650 ~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 721 (933)
.. ...++||||++|.+|.++.. ++. ....+++.++..+|+ .+++|||+||+||+++
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~ 169 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVS 169 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEe
Confidence 33 35789999999999987741 222 246699999999998 8999999999999999
Q ss_pred CCCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHH
Q 002346 722 DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETI 782 (933)
Q Consensus 722 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ell 782 (933)
+++ ++|+|||.......... ...+.....+..++|+|+||+++..+.
T Consensus 170 ~~g-i~liDfg~~~~~~e~~a-------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 170 KNG-LRIIDLSGKRCTAQRKA-------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCC-EEEEECCCcccccchhh-------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 988 99999998765432211 011344456677999999999987654
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.3e-19 Score=229.21 Aligned_cols=305 Identities=17% Similarity=0.183 Sum_probs=228.6
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceecccccc-ccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNN-FTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~L 144 (933)
..++.|.+.++.+. .+|..| ...+|+.|+|++|.|......+..+++|++|+|++|. +..+|. +..+++|+.|+|
T Consensus 589 ~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~--ls~l~~Le~L~L 664 (1153)
T PLN03210 589 PKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLEKLWDGVHSLTGLRNIDLRGSKNLKEIPD--LSMATNLETLKL 664 (1153)
T ss_pred cccEEEEecCCCCC-CCCCcC-CccCCcEEECcCccccccccccccCCCCCEEECCCCCCcCcCCc--cccCCcccEEEe
Confidence 36888999998886 677776 5789999999999998765678889999999999865 666653 788999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCc
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~ 224 (933)
++|.... .+|..+.++++|+.|++++|...+.+|..+ ++++|++|+|++|...+.+|... .+|++|++.+|.+..
T Consensus 665 ~~c~~L~--~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~--~nL~~L~L~~n~i~~ 739 (1153)
T PLN03210 665 SDCSSLV--ELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDIS--TNISWLDLDETAIEE 739 (1153)
T ss_pred cCCCCcc--ccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCcccccccc--CCcCeeecCCCcccc
Confidence 9987665 588999999999999999887666777766 78999999999987766777543 457888888887643
Q ss_pred ccccccccCCccCcEEEecCCccCCC-------CCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCcc
Q 002346 225 SGTLDVLSGMTQLRQVWLHKNQFTGP-------IPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 225 ~~~~~~l~~l~~L~~L~L~~N~l~~~-------~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
. +....+++|+.|++.++..... .+. ....++|+.|+|++|...+.+|.+++++++|+.|+|++|...+
T Consensus 740 l---P~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~ 816 (1153)
T PLN03210 740 F---PSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLE 816 (1153)
T ss_pred c---cccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcC
Confidence 2 2222467788888776432211 111 2334678888888888777888888888888888888876555
Q ss_pred CCCCC--CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEc
Q 002346 297 PYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINL 374 (933)
Q Consensus 297 ~~p~~--~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~L 374 (933)
.+|.. +.+|+.|+|++|..-...+. .+..+..+...++.+..+|..+..+++|+.|+|
T Consensus 817 ~LP~~~~L~sL~~L~Ls~c~~L~~~p~--------------------~~~nL~~L~Ls~n~i~~iP~si~~l~~L~~L~L 876 (1153)
T PLN03210 817 TLPTGINLESLESLDLSGCSRLRTFPD--------------------ISTNISDLNLSRTGIEEVPWWIEKFSNLSFLDM 876 (1153)
T ss_pred eeCCCCCccccCEEECCCCCccccccc--------------------cccccCEeECCCCCCccChHHHhcCCCCCEEEC
Confidence 55543 46788888887654222111 112233333445566789999999999999999
Q ss_pred cCccccCcCchhhcCcccCCeEecccCc
Q 002346 375 ANKLLAGNISPAYANLTSLKNLYLQQNN 402 (933)
Q Consensus 375 s~N~l~g~~p~~~~~l~~L~~L~L~~N~ 402 (933)
++|+-...+|..+..|++|+.|++++|.
T Consensus 877 ~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 877 NGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCCCCcCccCcccccccCCCeeecCCCc
Confidence 9965555688899999999999999885
|
syringae 6; Provisional |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-19 Score=178.14 Aligned_cols=189 Identities=17% Similarity=0.113 Sum_probs=142.0
Q ss_pred ccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC--chhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEEEee
Q 002346 584 SEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
.+...|++|+||+||.+.. .+.+++.+.+.....- ......|.+|+++|+++. |+++++++++ ...+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998876 7888888877655331 112235889999999995 5889999886 346899999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCC-CCCcEEecCCCcEEEecccccccCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL-KPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di-k~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
++|.+|.+.+.. ....++.|++++++++|+ +||+|||| ||+|||++.++.++|+|||+|.....
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~ 144 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNP 144 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCC
Confidence 999998654311 113578899999999999 89999999 79999999999999999999985543
Q ss_pred CCce----e--------ecccccccCcccccccCCC-CCC-CccchHhHHHHHHHHHcCCCCCCCCC
Q 002346 740 GKYS----V--------ETRLAGTFGYLAPEYAATG-RVT-TKIDVYAFGVVLMETITGRKALDDTM 792 (933)
Q Consensus 740 ~~~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~~Dv~SlG~~l~elltG~~p~~~~~ 792 (933)
.... . ......++.|++|+...-- ..+ ...+.++-|+.+|.++||+.+.....
T Consensus 145 ~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 145 RARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 2210 0 1112357778888744221 223 46788899999999999998876543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-21 Score=219.14 Aligned_cols=305 Identities=25% Similarity=0.303 Sum_probs=213.6
Q ss_pred EEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCC
Q 002346 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (933)
Q Consensus 68 v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 147 (933)
++.|+++.|-+-...-+.+..-.+|+.|++++|++...+-.+..+.+|+.|+++.|.|..+|. ...++.+|++|.|.+|
T Consensus 23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~~vp~-s~~~~~~l~~lnL~~n 101 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIRSVPS-SCSNMRNLQYLNLKNN 101 (1081)
T ss_pred HHhhhccccccccCchHHhhheeeeEEeeccccccccCCchhhhHHHHhhcccchhhHhhCch-hhhhhhcchhheeccc
Confidence 666677766654322233344445777777777776544467777777777777777777773 3667777777777777
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccc
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~ 227 (933)
++.. +|..+..+++|+.|+++.|++ +.+|..+..++.++.+..++|.....++.. .++.+++..|.+.....
T Consensus 102 ~l~~---lP~~~~~lknl~~LdlS~N~f-~~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~----~ik~~~l~~n~l~~~~~ 173 (1081)
T KOG0618|consen 102 RLQS---LPASISELKNLQYLDLSFNHF-GPIPLVIEVLTAEEELAASNNEKIQRLGQT----SIKKLDLRLNVLGGSFL 173 (1081)
T ss_pred hhhc---CchhHHhhhcccccccchhcc-CCCchhHHhhhHHHHHhhhcchhhhhhccc----cchhhhhhhhhcccchh
Confidence 7766 677777777777777777776 455777777777777777777322233332 24555555555443332
Q ss_pred cccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCC-CCCcc
Q 002346 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF-PSKVQ 306 (933)
Q Consensus 228 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~ 306 (933)
.+ +..++. .|+|..|.+. .-++..+.+|+.|....|++... .-..++|+.|+.++|.++...+.+ +.+++
T Consensus 174 ~~-i~~l~~--~ldLr~N~~~--~~dls~~~~l~~l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~ 244 (1081)
T KOG0618|consen 174 ID-IYNLTH--QLDLRYNEME--VLDLSNLANLEVLHCERNQLSEL----EISGPSLTALYADHNPLTTLDVHPVPLNLQ 244 (1081)
T ss_pred cc-hhhhhe--eeecccchhh--hhhhhhccchhhhhhhhcccceE----EecCcchheeeeccCcceeeccccccccce
Confidence 22 222333 4888888887 44677788888888888888732 223467888888888888555543 56788
Q ss_pred EEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchh
Q 002346 307 KVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPA 386 (933)
Q Consensus 307 ~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~ 386 (933)
.+++++|+|++ +|++++.+.+|+.|+.++|+|+ .+|..
T Consensus 245 ~~dis~n~l~~-----------------------------------------lp~wi~~~~nle~l~~n~N~l~-~lp~r 282 (1081)
T KOG0618|consen 245 YLDISHNNLSN-----------------------------------------LPEWIGACANLEALNANHNRLV-ALPLR 282 (1081)
T ss_pred eeecchhhhhc-----------------------------------------chHHHHhcccceEecccchhHH-hhHHH
Confidence 88888888854 5778888888999999999885 68888
Q ss_pred hcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC
Q 002346 387 YANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (933)
Q Consensus 387 ~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 433 (933)
+..+++|++|++..|++. -+|+.+..++.|++|+|..|+|...++.
T Consensus 283 i~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~ 328 (1081)
T KOG0618|consen 283 ISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDN 328 (1081)
T ss_pred HhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchH
Confidence 888888999999989888 7788888888889999998888766653
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.5e-21 Score=197.67 Aligned_cols=301 Identities=21% Similarity=0.264 Sum_probs=197.4
Q ss_pred ceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCC
Q 002346 59 GINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLT 137 (933)
Q Consensus 59 gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 137 (933)
+.+|.+.. =..++.++.+|+ .+|..+- ...++++|..|+|+.++| +|+.+++|+.||||+|+|+.|.+++|.+++
T Consensus 40 pC~Cs~~~-g~~VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~ 115 (498)
T KOG4237|consen 40 PCTCSDVE-GGIVDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLA 115 (498)
T ss_pred CcccCCCC-CceEEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhH
Confidence 45555433 356788999998 5665443 357889999999999888 899999999999999999999999999999
Q ss_pred CCCEEEccC-CCCCCCCCCC-ccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCc-cccc-cccc
Q 002346 138 NLQVLSLSD-NPNLAPWPFP-NELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQ 213 (933)
Q Consensus 138 ~L~~L~Ls~-N~~~~~~~~p-~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~-~~~~-~~l~ 213 (933)
+|..|-+.+ |+|+. +| ..|.+|..|+.|.+.-|++.-...+.|..+++|..|.|..|.+. +++. +|.. ..++
T Consensus 116 ~l~~Lvlyg~NkI~~---l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~ 191 (498)
T KOG4237|consen 116 SLLSLVLYGNNKITD---LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIK 191 (498)
T ss_pred hhhHHHhhcCCchhh---hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccc
Confidence 988887766 88888 45 58899999999999999999999999999999999999999998 6665 4433 2344
Q ss_pred hhhcccccCC------c-----ccccccccCCccCcEEEecCCccCCCCCC-CCC-CCCCC-EEEccCCcccccCc-ccc
Q 002346 214 NLWMNDQQLG------L-----SGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSK-CESLF-DLSLRDNQLTGVVP-ASV 278 (933)
Q Consensus 214 ~l~l~~n~~~------~-----~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~-~~~L~-~L~L~~N~l~~~~p-~~l 278 (933)
.+++..|... . ......+++.....-..|..+++....+. |.. +.++. .+....+... .-| ..|
T Consensus 192 tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~-~cP~~cf 270 (498)
T KOG4237|consen 192 TLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDS-ICPAKCF 270 (498)
T ss_pred hHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCC-cChHHHH
Confidence 4444444311 0 00001222233333333333333332221 111 11111 1111122222 333 345
Q ss_pred cCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCC
Q 002346 279 ISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG 358 (933)
Q Consensus 279 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 358 (933)
..+++|+.|+|++|+++++-+
T Consensus 271 ~~L~~L~~lnlsnN~i~~i~~----------------------------------------------------------- 291 (498)
T KOG4237|consen 271 KKLPNLRKLNLSNNKITRIED----------------------------------------------------------- 291 (498)
T ss_pred hhcccceEeccCCCccchhhh-----------------------------------------------------------
Confidence 566666666666666664322
Q ss_pred CCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcc
Q 002346 359 WPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429 (933)
Q Consensus 359 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g 429 (933)
.++..+.+|++|.|..|+|...--..|.++..|+.|+|++|+|+-.-|.+|..+.+|..|+|-.|++..
T Consensus 292 --~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~C 360 (498)
T KOG4237|consen 292 --GAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNC 360 (498)
T ss_pred --hhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccC
Confidence 122333455666666666655555567777777777777777776677777777777777777777754
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.8e-19 Score=178.11 Aligned_cols=143 Identities=20% Similarity=0.246 Sum_probs=112.5
Q ss_pred CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchh------------------------HHHHHHHHHHHHhcCCCcc
Q 002346 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKG------------------------LSEFQAEIAVLTKVRHRHL 641 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~~l~~l~h~ni 641 (933)
...||+|+||.||+|...+|+.||||+++........ ...+..|.+.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 5689999999999998778999999998865321100 1234678999999999987
Q ss_pred eeEEeEeeeCceeEEEEeecCCCChhhH-hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 642 VALLGYCINGSERLLVYEYMPRGTLAQH-LFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 642 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
.....+... ..++||||++++++... +.. ..++..+...++.|++.++.++|+ ..+|+||||||+||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll 151 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILY 151 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEE
Confidence 554444332 24899999998865443 322 357788999999999999999997 3699999999999999
Q ss_pred cCCCcEEEecccccccCCC
Q 002346 721 GDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~~~~ 739 (933)
+ ++.++|+|||++.....
T Consensus 152 ~-~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 152 H-DGKPYIIDVSQAVELDH 169 (190)
T ss_pred E-CCCEEEEEcccceecCC
Confidence 9 88999999999886544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.3e-20 Score=206.42 Aligned_cols=227 Identities=24% Similarity=0.348 Sum_probs=181.9
Q ss_pred ccccCCCeEEEEEE----eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEEEeecC
Q 002346 588 ILGRGGFGVVYGGE----LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 588 ~lg~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
.+|+|.||.|+.++ ...|.-+|.|++++.............|..++...+ ||.+|++...++.+...+++.+|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999763 234778899988876544443446677888999996 9999999999999999999999999
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~ 742 (933)
+|.|...+.. ...+++.....+...++-|++++|+ .+|+|||+|++||+++.+|++++.|||+++..-+...
T Consensus 81 gg~lft~l~~-----~~~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~ 152 (612)
T KOG0603|consen 81 GGDLFTRLSK-----EVMFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI 152 (612)
T ss_pred cchhhhcccc-----CCchHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence 9999988854 3557778888888899999999999 8999999999999999999999999999986654332
Q ss_pred eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCC
Q 002346 743 SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLN 822 (933)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 822 (933)
. +||..|||||++. ....++|.||||++++||+||..||.. +....++..+...+..+
T Consensus 153 ~-----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----------~~~~~Il~~~~~~p~~l----- 210 (612)
T KOG0603|consen 153 A-----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----------DTMKRILKAELEMPREL----- 210 (612)
T ss_pred c-----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----------HHHHHHhhhccCCchhh-----
Confidence 2 8999999999998 567789999999999999999999975 11222333233333222
Q ss_pred CChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 823 LDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 823 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
.....+++..++..+|..|...
T Consensus 211 --------~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 211 --------SAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred --------hHHHHHHHHHHHhhCHHHHhcc
Confidence 2334578888999999999855
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-19 Score=188.15 Aligned_cols=237 Identities=22% Similarity=0.331 Sum_probs=151.9
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCC----------CcceeEEeEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRH----------RHLVALLGYCI 649 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~~ 649 (933)
.+...+.||.|+|+.||.+.. .+|+++|||++..... +....+++++|.-....+.+ -.++..++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 345678899999999999955 5699999998765542 33457788888766655432 22222222211
Q ss_pred ---------eC---c-----eeEEEEeecCCCChhhHhhhccc--CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEe
Q 002346 650 ---------NG---S-----ERLLVYEYMPRGTLAQHLFEWHD--HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIH 710 (933)
Q Consensus 650 ---------~~---~-----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 710 (933)
.. . ..+++|+-+ .++|.+++..... .....+....+..+..|+++.+++||+ .|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceEe
Confidence 11 1 226778877 5688877532111 112234455667788999999999999 99999
Q ss_pred cCCCCCcEEecCCCcEEEecccccccCCCCCceeecccccccCcccccccCC--------CCCCCccchHhHHHHHHHHH
Q 002346 711 RDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT--------GRVTTKIDVYAFGVVLMETI 782 (933)
Q Consensus 711 ~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~~l~ell 782 (933)
+||+|+|++++.+|.++|+||+......... .. ...+..|.+||.... -.++.+.|.|++|+++|.|+
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---~~-~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---RC-SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---EG-GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---ec-cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 9999999999999999999999877554321 11 344578999997643 24788999999999999999
Q ss_pred cCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCC
Q 002346 783 TGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQR 849 (933)
Q Consensus 783 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~R 849 (933)
+|+.||+...+...... .+. .+.+..+.+..+|..+++.+|++|
T Consensus 245 C~~lPf~~~~~~~~~~~----------------~f~-------~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 245 CGRLPFGLSSPEADPEW----------------DFS-------RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HSS-STCCCGGGSTSGG----------------GGT-------TSS---HHHHHHHHHHT-SSGGGS
T ss_pred HccCCCCCCCccccccc----------------cch-------hcCCcCHHHHHHHHHHccCCcccC
Confidence 99999986543221100 111 111445678899999999999988
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.5e-20 Score=211.33 Aligned_cols=250 Identities=19% Similarity=0.226 Sum_probs=176.4
Q ss_pred CCccCCccccCCCeEEEEEEeCCCcEEEEEEecccc--CCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNT--MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.|...+.||.+.|=.|.+|+.++|. |+||++-+.. .+-+...+-..|++ ...++|||.+++.-+-......|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 4666788999999999999987887 8999986653 22223333344444 555689999998887766777788888
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc--C
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--A 737 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~--~ 737 (933)
|.. -+|++.+.. .+-+...+.+-|+.|++.|+..+|. .+|+|||||.+|||++.-.=+.|+||..-+. .
T Consensus 102 yvk-hnLyDRlST-----RPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYL 172 (1431)
T KOG1240|consen 102 YVK-HNLYDRLST-----RPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYL 172 (1431)
T ss_pred HHh-hhhhhhhcc-----chHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccC
Confidence 884 589988854 2336777888899999999999999 8999999999999999999999999986552 2
Q ss_pred CCCCceeeccc----ccccCcccccccCCC-----------CCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHH
Q 002346 738 PDGKYSVETRL----AGTFGYLAPEYAATG-----------RVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 738 ~~~~~~~~~~~----~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~ 801 (933)
+.+.....+.+ ..-.+|.|||.+... ..+++.||||+||++.||++ |+++|.-. .+..
T Consensus 173 PeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------QL~a 246 (1431)
T KOG1240|consen 173 PEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------QLLA 246 (1431)
T ss_pred CCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------HHHh
Confidence 22221111111 223579999977431 15678999999999999998 57777532 1111
Q ss_pred HHHHH-hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 802 WFRRV-LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 802 ~~~~~-~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
+.... ...+..+.++-|. .+..++..|++.||++|.++++.++.-++
T Consensus 247 Yr~~~~~~~e~~Le~Ied~-------------~~Rnlil~Mi~rdPs~RlSAedyL~~yrG 294 (1431)
T KOG1240|consen 247 YRSGNADDPEQLLEKIEDV-------------SLRNLILSMIQRDPSKRLSAEDYLQKYRG 294 (1431)
T ss_pred HhccCccCHHHHHHhCcCc-------------cHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence 11110 0000001111111 35689999999999999999999987443
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-19 Score=183.74 Aligned_cols=197 Identities=26% Similarity=0.309 Sum_probs=139.4
Q ss_pred CCCcceeEEeEeee---------------------------CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHH
Q 002346 637 RHRHLVALLGYCIN---------------------------GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689 (933)
Q Consensus 637 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i 689 (933)
+|||||++.++|.+ +...|+||...+ .+|.+++.. ...+...+.-|
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~------~~~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT------RHRSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc------CCCchHHHHHH
Confidence 59999999887643 234588998774 599999965 34566778889
Q ss_pred HHHHHHHHHHhhhccCCCeEecCCCCCcEEec--CCC--cEEEecccccccCCCCC-----ceeecccccccCccccccc
Q 002346 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIG--DDM--RAKVADFGLVKNAPDGK-----YSVETRLAGTFGYLAPEYA 760 (933)
Q Consensus 690 ~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~--~~kl~DfGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~ 760 (933)
+.|+++|+.|||. +||.|||+|++|||+. +|+ ...|+|||++--..... ........|...-||||+.
T Consensus 347 laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ 423 (598)
T KOG4158|consen 347 LAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA 423 (598)
T ss_pred HHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence 9999999999998 9999999999999993 444 47899999865322211 1112334688889999988
Q ss_pred CCCC------CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHH
Q 002346 761 ATGR------VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRV 834 (933)
Q Consensus 761 ~~~~------~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~ 834 (933)
...+ --.|+|.|+.|.+.||+++...||+...+... +...+... .-..+++.+.+ .+
T Consensus 424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L-~~r~Yqe~---qLPalp~~vpp-------------~~ 486 (598)
T KOG4158|consen 424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL-DTRTYQES---QLPALPSRVPP-------------VA 486 (598)
T ss_pred hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee-chhhhhhh---hCCCCcccCCh-------------HH
Confidence 5432 23589999999999999999999987432211 11111111 11223333322 35
Q ss_pred HHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 835 AELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 835 ~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.+++...++.||.+|++..-+...|.
T Consensus 487 rqlV~~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 487 RQLVFDLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHHHHHHhcCCccccCCccHHHhHHH
Confidence 58999999999999998876666554
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.8e-21 Score=174.38 Aligned_cols=178 Identities=25% Similarity=0.355 Sum_probs=149.1
Q ss_pred cCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEE
Q 002346 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263 (933)
Q Consensus 184 ~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L 263 (933)
.++.+.+.|.|++|+++ .+|..++. +.+|+.|++++|+++..+++++.+++|+.|
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~------------------------l~nlevln~~nnqie~lp~~issl~klr~l 84 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAE------------------------LKNLEVLNLSNNQIEELPTSISSLPKLRIL 84 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHH------------------------hhhhhhhhcccchhhhcChhhhhchhhhhe
Confidence 35677888999999998 77777665 899999999999999999999999999999
Q ss_pred EccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCC
Q 002346 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343 (933)
Q Consensus 264 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (933)
+++-|++. ..|..|+.++.|+.|||++|++...
T Consensus 85 nvgmnrl~-~lprgfgs~p~levldltynnl~e~---------------------------------------------- 117 (264)
T KOG0617|consen 85 NVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNEN---------------------------------------------- 117 (264)
T ss_pred ecchhhhh-cCccccCCCchhhhhhccccccccc----------------------------------------------
Confidence 99999999 8999999999999999999998731
Q ss_pred ccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEecc
Q 002346 344 AILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423 (933)
Q Consensus 344 ~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls 423 (933)
.+|+.+..++.|+.|+|+.|.+. .+|+.+++|++|+.|.+.+|.+. .+|.+++.|..|+.|.++
T Consensus 118 --------------~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiq 181 (264)
T KOG0617|consen 118 --------------SLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQ 181 (264)
T ss_pred --------------cCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcc
Confidence 23555556677888888888887 68888999999999999999998 889999999999999999
Q ss_pred CCcCcccCCCCCCCc-----ccccCCCCCCc
Q 002346 424 NNNLSGKVPDFGSNV-----KFTVSPGNPFI 449 (933)
Q Consensus 424 ~N~l~g~~p~~~~~~-----~~~~~~~n~~~ 449 (933)
+|+|+-.+|++++.- +....+.|||.
T Consensus 182 gnrl~vlppel~~l~l~~~k~v~r~E~NPwv 212 (264)
T KOG0617|consen 182 GNRLTVLPPELANLDLVGNKQVMRMEENPWV 212 (264)
T ss_pred cceeeecChhhhhhhhhhhHHHHhhhhCCCC
Confidence 999998888876422 22345688884
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.9e-20 Score=170.46 Aligned_cols=164 Identities=35% Similarity=0.511 Sum_probs=139.4
Q ss_pred CCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCC
Q 002346 107 PSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186 (933)
Q Consensus 107 p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 186 (933)
|.+.++.+.+.|.||+|+++.+|+. +..+.+|+.|++++|+++. +|..++.+++|+.|++.-|++.- .|..|+.+
T Consensus 27 ~gLf~~s~ITrLtLSHNKl~~vppn-ia~l~nlevln~~nnqie~---lp~~issl~klr~lnvgmnrl~~-lprgfgs~ 101 (264)
T KOG0617|consen 27 PGLFNMSNITRLTLSHNKLTVVPPN-IAELKNLEVLNLSNNQIEE---LPTSISSLPKLRILNVGMNRLNI-LPRGFGSF 101 (264)
T ss_pred ccccchhhhhhhhcccCceeecCCc-HHHhhhhhhhhcccchhhh---cChhhhhchhhhheecchhhhhc-CccccCCC
Confidence 4455666677777777777777776 7777888888888888777 78888899999999999888854 48999999
Q ss_pred CCCCEEEccCCcCCC-CCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEc
Q 002346 187 SNLQNLRLSYNNFTG-SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSL 265 (933)
Q Consensus 187 ~~L~~L~L~~N~l~~-~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L 265 (933)
+.|+.|||.+|++.. .+|..|+. ++.|+.|+|++|.+.-.+|+++.+++|+.|.+
T Consensus 102 p~levldltynnl~e~~lpgnff~------------------------m~tlralyl~dndfe~lp~dvg~lt~lqil~l 157 (264)
T KOG0617|consen 102 PALEVLDLTYNNLNENSLPGNFFY------------------------MTTLRALYLGDNDFEILPPDVGKLTNLQILSL 157 (264)
T ss_pred chhhhhhccccccccccCCcchhH------------------------HHHHHHHHhcCCCcccCChhhhhhcceeEEee
Confidence 999999999999874 56877765 88899999999999999999999999999999
Q ss_pred cCCcccccCcccccCCCCCCEEEccCccCccCCCC
Q 002346 266 RDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300 (933)
Q Consensus 266 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 300 (933)
.+|.+- .+|..++.++.|++|.+.+|+++-.+|.
T Consensus 158 rdndll-~lpkeig~lt~lrelhiqgnrl~vlppe 191 (264)
T KOG0617|consen 158 RDNDLL-SLPKEIGDLTRLRELHIQGNRLTVLPPE 191 (264)
T ss_pred ccCchh-hCcHHHHHHHHHHHHhcccceeeecChh
Confidence 999998 8999999999999999999999966653
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=4.1e-18 Score=187.80 Aligned_cols=215 Identities=23% Similarity=0.398 Sum_probs=161.5
Q ss_pred HHhcCCCcceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCe-Eec
Q 002346 633 LTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF-IHR 711 (933)
Q Consensus 633 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i-vH~ 711 (933)
|+.+.|.|+.+++|.+.++...+.|.+||..|+|.+.+.. ....++|.....+++++++|++|+|+ .+| .|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~----~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg 73 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN----EDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHG 73 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc----cccCccHHHHHHHHHHHHHHHHHHhc---Ccceeee
Confidence 3567899999999999999999999999999999999965 23568999999999999999999998 344 899
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCC-CceeecccccccCcccccccCCC-------CCCCccchHhHHHHHHHHHc
Q 002346 712 DLKPSNILIGDDMRAKVADFGLVKNAPDG-KYSVETRLAGTFGYLAPEYAATG-------RVTTKIDVYAFGVVLMETIT 783 (933)
Q Consensus 712 Dik~~Nill~~~~~~kl~DfGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~Dv~SlG~~l~ellt 783 (933)
.++++|.++|....+|++|||+....... .........-..-|.|||.+... ..+.+.||||||++++|+++
T Consensus 74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~ 153 (484)
T KOG1023|consen 74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF 153 (484)
T ss_pred eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence 99999999999999999999997755421 11111112234579999988653 14678999999999999999
Q ss_pred CCCCCCCCCCchh-hHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 784 GRKALDDTMPDDR-AHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 784 G~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.+.||+....... ..++.++.. .....+.|.+.... +...++..++..||..+|.+||+++++-..++.+
T Consensus 154 r~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~ 224 (484)
T KOG1023|consen 154 RSGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI 224 (484)
T ss_pred ccCccccccccCChHHHHHHHHh------cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence 9999987432221 222222211 11222233332111 2223678999999999999999999998877665
Q ss_pred h
Q 002346 863 V 863 (933)
Q Consensus 863 ~ 863 (933)
.
T Consensus 225 ~ 225 (484)
T KOG1023|consen 225 N 225 (484)
T ss_pred c
Confidence 4
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1e-17 Score=168.72 Aligned_cols=135 Identities=19% Similarity=0.253 Sum_probs=105.3
Q ss_pred CccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-----CCCcceeEEeEeeeCc---e-
Q 002346 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-----RHRHLVALLGYCINGS---E- 653 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~- 653 (933)
+...+.||+|+||.||. ...++.. +||++.... ....+.+.+|+.+++.+ .||||++++|++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~--~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRG--DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccc--cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34567899999999996 4444444 799887643 23456799999999999 5799999999998763 3
Q ss_pred eEEEEee--cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHH-HHhhhccCCCeEecCCCCCcEEecC----CCcE
Q 002346 654 RLLVYEY--MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV-EYLHSLAQQSFIHRDLKPSNILIGD----DMRA 726 (933)
Q Consensus 654 ~~lv~e~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l-~~LH~~~~~~ivH~Dik~~Nill~~----~~~~ 726 (933)
..+|+|| +.+++|.+++.+ ..+++. ..++.+++.++ +|||+ ++|+||||||+|||++. ++.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~------~~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~ 148 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQ------CRYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIP 148 (210)
T ss_pred EEEEecCCCCcchhHHHHHHc------ccccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcE
Confidence 3378999 557999999954 224444 35677888777 99999 89999999999999974 3479
Q ss_pred EEeccc
Q 002346 727 KVADFG 732 (933)
Q Consensus 727 kl~DfG 732 (933)
+|+||+
T Consensus 149 ~LiDg~ 154 (210)
T PRK10345 149 VVCDNI 154 (210)
T ss_pred EEEECC
Confidence 999954
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-19 Score=197.73 Aligned_cols=280 Identities=22% Similarity=0.256 Sum_probs=149.0
Q ss_pred EEEecCCCCc-cccCccccCCcccceeeccccccccc----CC-CccCcCcCceeccccccccCCC------CCcccCCC
Q 002346 70 TISLAKSGLS-GTLSPEISSLTQLETLSFQMNNIAGA----IP-SLANATSLQDIYLDNNNFTSVP------TGCFDGLT 137 (933)
Q Consensus 70 ~L~l~~~~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~~~~------~~~~~~l~ 137 (933)
.|+|..+.++ ......+..+..|+.|+++++.++.. ++ .+...++|++|+++++.+...+ ...+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 3566666665 23344555666677777777777432 22 3555666777777777665311 12344566
Q ss_pred CCCEEEccCCCCCCCCCCCccccCCcc---CCeeeccCcccCC----CCChhhcCC-CCCCEEEccCCcCCCCCCccccc
Q 002346 138 NLQVLSLSDNPNLAPWPFPNELTKSTS---LTTLYMDNANIFG----LIPDFFDSF-SNLQNLRLSYNNFTGSLPASFAK 209 (933)
Q Consensus 138 ~L~~L~Ls~N~~~~~~~~p~~~~~l~~---L~~L~L~~n~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~~p~~~~~ 209 (933)
+|+.|+|++|.+.. ..+..+..+.. |++|++++|++.. .+...+..+ ++|+.|+|++|.+++.....+..
T Consensus 82 ~L~~L~l~~~~~~~--~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 82 GLQELDLSDNALGP--DGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred ceeEEEccCCCCCh--hHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 66666666666553 23333333333 6666666666552 222334444 56666666666665422222111
Q ss_pred cccchhhcccccCCcccccccccCCccCcEEEecCCccCCCC-----CCCCCCCCCCEEEccCCccccc----CcccccC
Q 002346 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-----PDLSKCESLFDLSLRDNQLTGV----VPASVIS 280 (933)
Q Consensus 210 ~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~-----~~~~~~~~L~~L~L~~N~l~~~----~p~~l~~ 280 (933)
.+..+++|+.|+|++|.+++.. ..+..+++|+.|+|++|.+++. ++..+..
T Consensus 160 --------------------~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~ 219 (319)
T cd00116 160 --------------------ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLAS 219 (319)
T ss_pred --------------------HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcc
Confidence 1233455666666666665311 1133445666666666665432 2233444
Q ss_pred CCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCC
Q 002346 281 LPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360 (933)
Q Consensus 281 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p 360 (933)
+++|++|++++|.+++... ..+. ..++
T Consensus 220 ~~~L~~L~ls~n~l~~~~~----------------------------------~~l~-------------------~~~~ 246 (319)
T cd00116 220 LKSLEVLNLGDNNLTDAGA----------------------------------AALA-------------------SALL 246 (319)
T ss_pred cCCCCEEecCCCcCchHHH----------------------------------HHHH-------------------HHHh
Confidence 5556666666665553100 0000 0000
Q ss_pred ccccCCCceeEEEccCcccc----CcCchhhcCcccCCeEecccCcccCC----CCcccCCC-CCcCEEeccCCcC
Q 002346 361 FVTCSQGRIITINLANKLLA----GNISPAYANLTSLKNLYLQQNNLTGP----IPDGLTKL-ASLQNLDVSNNNL 427 (933)
Q Consensus 361 ~~~~~l~~L~~L~Ls~N~l~----g~~p~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l-~~L~~l~ls~N~l 427 (933)
...+.|+.|++++|.++ ..+...+..+++|++|++++|+++.. +...+... +.|+.+|+.+|++
T Consensus 247 ---~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 247 ---SPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred ---ccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 01246777777777775 22445566667777778877777743 44445445 6777777777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=4.8e-17 Score=168.31 Aligned_cols=145 Identities=17% Similarity=0.157 Sum_probs=112.9
Q ss_pred cCCccCCccccCCCeEEEEEE--eCCCcEEEEEEeccccCCch----------------------hHHHHHHHHHHHHhc
Q 002346 581 DNFSEANILGRGGFGVVYGGE--LPDGTKIAVKRMESNTMGNK----------------------GLSEFQAEIAVLTKV 636 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~~----------------------~~~~~~~E~~~l~~l 636 (933)
.-|.+.+.||+|+||.||+|. ..+|+.||+|+++....... ....+.+|+..+.++
T Consensus 28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L 107 (237)
T smart00090 28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL 107 (237)
T ss_pred chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 357889999999999999997 56899999999875421100 113467899999999
Q ss_pred CCC--cceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-eEecCC
Q 002346 637 RHR--HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS-FIHRDL 713 (933)
Q Consensus 637 ~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-ivH~Di 713 (933)
.+. .+.+++++ ...++||||+++++|...... .......+...++.|++.++++||+ .+ |+||||
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Di 175 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-----DVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDL 175 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-----cCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCC
Confidence 753 34455543 234899999999888765422 1345566778999999999999998 88 999999
Q ss_pred CCCcEEecCCCcEEEecccccccCC
Q 002346 714 KPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 714 k~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+||+++ ++.++|+|||.+....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 8899999999887543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.3e-17 Score=192.93 Aligned_cols=196 Identities=23% Similarity=0.316 Sum_probs=156.5
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC---CCcceeEEeEeeeCc
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGYCINGS 652 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~ 652 (933)
.+.-.+.|.+.+.||+|+||.||+|...+|+.||+|+=+... .. +|.-=.+++.+|+ -+.|..+..++...+
T Consensus 693 ~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~-~W----EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 693 FEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPN-PW----EFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred eeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCC-ce----eeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 344467899999999999999999988789999999766542 11 2323334455555 234555555566667
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec-------CCCc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-------DDMR 725 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-------~~~~ 725 (933)
..++|+||.+.|+|.+++.. .+..+|.-++.++.|+++.+++||. .+||||||||+|++|. +...
T Consensus 768 ~S~lv~ey~~~Gtlld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~ 839 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKG 839 (974)
T ss_pred cceeeeeccccccHHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccc
Confidence 77999999999999999963 4568999999999999999999999 8999999999999994 2346
Q ss_pred EEEecccccccC---CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCC
Q 002346 726 AKVADFGLVKNA---PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRK 786 (933)
Q Consensus 726 ~kl~DfGla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~ 786 (933)
++|+|||.+... +++ ......++|-.+-.+|...+..+++.+|.|.++.+++-|+.|++
T Consensus 840 l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 840 LYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred eEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999988633 333 23345678889999999999999999999999999999999973
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=162.14 Aligned_cols=146 Identities=21% Similarity=0.195 Sum_probs=113.4
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCc--------------------hhHHHHHHHHHHHHh
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN--------------------KGLSEFQAEIAVLTK 635 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~~l~~ 635 (933)
+......|.+.+.||+|+||.||++..++|+.||||++....... .....+..|..++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 333344588889999999999999988889999999876542110 011236788999999
Q ss_pred cCCC--cceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCC
Q 002346 636 VRHR--HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL 713 (933)
Q Consensus 636 l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 713 (933)
+.|+ .+++.++. ...++||||+++++|...... .....++.++++++.++|+ .+|+||||
T Consensus 90 l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl 151 (198)
T cd05144 90 LYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYK---HGIIHGDL 151 (198)
T ss_pred HHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHH---CCCCcCCC
Confidence 9877 44555543 345899999999998765421 2346788999999999999 89999999
Q ss_pred CCCcEEecCCCcEEEecccccccCCC
Q 002346 714 KPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 714 k~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
||+||++++++.++|+|||++.....
T Consensus 152 ~p~Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 152 SEFNILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcccEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999999865443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.8e-16 Score=162.96 Aligned_cols=136 Identities=21% Similarity=0.350 Sum_probs=114.8
Q ss_pred CccccCCCeEEEEEEeCCCcEEEEEEeccccCCch------hHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK------GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+.||+|++|.||+|.. +|..|++|+......... ...++.+|+.++..++|++|+....++......++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 778899998664432211 234678899999999999998887777777888999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
++|++|.+++.. ..+ ++..++.+++.+++++|+ .+++|||++|+||+++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~--------~~~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINS--------NGM-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHh--------ccH-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999854 112 788999999999999998 8999999999999999 78899999998764
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-18 Score=192.17 Aligned_cols=260 Identities=22% Similarity=0.215 Sum_probs=167.1
Q ss_pred eeeccccccccc-CC-CccCcCcCceeccccccccCC----CCCcccCCCCCCEEEccCCCCCC--C--CCCCccccCCc
Q 002346 94 TLSFQMNNIAGA-IP-SLANATSLQDIYLDNNNFTSV----PTGCFDGLTNLQVLSLSDNPNLA--P--WPFPNELTKST 163 (933)
Q Consensus 94 ~L~l~~N~l~~~-~p-~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~~~~--~--~~~p~~~~~l~ 163 (933)
.|+|..+.+++. .. -+..+.+|++|+|++|.++.. ....+...++|+.|++++|.+.. . ..++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 467777777632 22 456667788888888888532 12235566778888888876652 0 01234556677
Q ss_pred cCCeeeccCcccCCCCChhhcCCCC---CCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCC-ccCcE
Q 002346 164 SLTTLYMDNANIFGLIPDFFDSFSN---LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM-TQLRQ 239 (933)
Q Consensus 164 ~L~~L~L~~n~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l-~~L~~ 239 (933)
+|+.|++++|.+.+..+..+..+.+ |++|++++|++++.....+. ..+..+ ++|+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~--------------------~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA--------------------KGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH--------------------HHHHhCCCCceE
Confidence 7777777777776655666655554 77777777777632111111 012234 67777
Q ss_pred EEecCCccCCCCC-----CCCCCCCCCEEEccCCccccc----CcccccCCCCCCEEEccCccCccCCCCCCCCccEEec
Q 002346 240 VWLHKNQFTGPIP-----DLSKCESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSL 310 (933)
Q Consensus 240 L~L~~N~l~~~~~-----~~~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l 310 (933)
|+|++|.+++... .+..+.+|+.|+|++|.+++. ++..+..+++|++|+|++|.+++...
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~----------- 210 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA----------- 210 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH-----------
Confidence 7777777774221 245566777777777777632 33344555677777777776653211
Q ss_pred cCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcC-
Q 002346 311 DHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN- 389 (933)
Q Consensus 311 ~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~- 389 (933)
+.++..+..+++|+.|++++|.+++.....+..
T Consensus 211 ----------------------------------------------~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~ 244 (319)
T cd00116 211 ----------------------------------------------SALAETLASLKSLEVLNLGDNNLTDAGAAALASA 244 (319)
T ss_pred ----------------------------------------------HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHH
Confidence 112233455688999999999998754444432
Q ss_pred ----cccCCeEecccCccc----CCCCcccCCCCCcCEEeccCCcCccc
Q 002346 390 ----LTSLKNLYLQQNNLT----GPIPDGLTKLASLQNLDVSNNNLSGK 430 (933)
Q Consensus 390 ----l~~L~~L~L~~N~l~----g~~p~~~~~l~~L~~l~ls~N~l~g~ 430 (933)
.+.|+.|++++|+++ ..+...+..+++|+++++++|.++..
T Consensus 245 ~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~ 293 (319)
T cd00116 245 LLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEE 293 (319)
T ss_pred HhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHH
Confidence 379999999999997 24566777789999999999999854
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.2e-16 Score=160.79 Aligned_cols=133 Identities=23% Similarity=0.383 Sum_probs=108.4
Q ss_pred ccccCCCeEEEEEEeCCCcEEEEEEeccccCCc------hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeec
Q 002346 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN------KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 588 ~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
.||+|+||.||+|.+ ++..|++|+........ ....++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999986 67899999865432211 12356788999999999887666555566667779999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
+|++|.+++... .. .++.+++++++++|+ .+++|||++|+||+++ ++.++++|||++...
T Consensus 80 ~g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEG-----ND-------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhc-----HH-------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999887431 10 789999999999999 8999999999999999 889999999987653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.68 E-value=6e-17 Score=186.22 Aligned_cols=213 Identities=28% Similarity=0.443 Sum_probs=147.8
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.+|..++.|..|+||.||.++.+ ..+.+|.| +.+... +.+- ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc--cccccCCccee-----------------
Confidence 57888999999999999999654 46778884 433211 1110 22222344333
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+-...++. .++++.. ++.+++|+|+ .+|+|||+||+|.+|+.-|++|+.|||+.+....
T Consensus 136 ----gDc~tllk~-----~g~lPvd--------mvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ----GDCATLLKN-----IGPLPVD--------MVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ----chhhhhccc-----CCCCcch--------hhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 344444422 1334332 2779999999 9999999999999999999999999998763211
Q ss_pred C--------C------ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH
Q 002346 740 G--------K------YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 740 ~--------~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 805 (933)
. . .......+|||.|+|||++....|...+|.|++|+++||.+.|..||++..+++. +..
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel------fg~ 269 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL------FGQ 269 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH------Hhh
Confidence 1 0 0112335899999999999999999999999999999999999999998766543 222
Q ss_pred HhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 002346 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAV 856 (933)
Q Consensus 806 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl 856 (933)
.+.....+++. |..+. .+.++++.++++.+|..|--....+
T Consensus 270 visd~i~wpE~-dea~p---------~Ea~dli~~LL~qnp~~Rlgt~ga~ 310 (1205)
T KOG0606|consen 270 VISDDIEWPEE-DEALP---------PEAQDLIEQLLRQNPLCRLGTGGAL 310 (1205)
T ss_pred hhhhhcccccc-CcCCC---------HHHHHHHHHHHHhChHhhcccchhh
Confidence 22223333333 32222 4677899999999999997444433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.2e-16 Score=182.45 Aligned_cols=142 Identities=23% Similarity=0.313 Sum_probs=114.2
Q ss_pred HHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC------chhHHHHHHHHHHHHhcCCCcceeEEeEeeeC
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG------NKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 651 (933)
.....|...+.||+|+||.||+|.+.. ..+++|+....... ....+++.+|+++++.++|++++..+.++...
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~-~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLG-RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecC-ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 334455678999999999999998744 44555443221111 11235688999999999999999888888777
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
...++||||+++++|.+++. ....++.+++++++|||+ .+|+||||||+||++ +++.++|+||
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEEeC
Confidence 78899999999999999883 356789999999999999 899999999999999 6789999999
Q ss_pred cccccC
Q 002346 732 GLVKNA 737 (933)
Q Consensus 732 Gla~~~ 737 (933)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.7e-17 Score=176.17 Aligned_cols=174 Identities=27% Similarity=0.397 Sum_probs=129.3
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..|+.|++|+..+|.+|+.+... ....++.....++.|++.|+.| ++.+|||+||.||+...+..+||.|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFg 401 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFG 401 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhh
Confidence 56899999999999999975333 3457888999999999999999 488999999999999999999999999
Q ss_pred ccccCCCCC-----ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 733 LVKNAPDGK-----YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 733 la~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
+........ ....+..+||..||+||.+.+..|+.|+||||||++++|+++ +|... .+.......+
T Consensus 402 l~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~--~er~~t~~d~---- 472 (516)
T KOG1033|consen 402 LVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQ--FERIATLTDI---- 472 (516)
T ss_pred heeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccH--HHHHHhhhhh----
Confidence 987665544 334566789999999999999999999999999999999997 22211 1111111111
Q ss_pred hccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 002346 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGH 854 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~e 854 (933)
..+.++. ... .....=..++.+++.+.|.+||++.+
T Consensus 473 -r~g~ip~----~~~------~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 473 -RDGIIPP----EFL------QDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -hcCCCCh----HHh------hcCcHHHHHHHHhcCCCcccCchHHH
Confidence 1222221 111 11112247889999999999994433
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.1e-14 Score=146.67 Aligned_cols=139 Identities=19% Similarity=0.229 Sum_probs=100.4
Q ss_pred CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHH----------------------HHHHHHHHhcCCC--cc
Q 002346 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEF----------------------QAEIAVLTKVRHR--HL 641 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~----------------------~~E~~~l~~l~h~--ni 641 (933)
.+.||+|+||.||+|...+++.||||++............+ ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 56799999999999988789999999987643222111111 3566666666443 34
Q ss_pred eeEEeEeeeCceeEEEEeecCCCChhhH-hhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 642 VALLGYCINGSERLLVYEYMPRGTLAQH-LFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 642 v~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
.+.+++ ...++||||++++.+... +... ... .++..++.+++.++.++|. .++|+||||||+||++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili 148 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILV 148 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEE
Confidence 455543 235899999998654322 2110 011 5678899999999999997 3799999999999999
Q ss_pred cCCCcEEEecccccccCC
Q 002346 721 GDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~~~ 738 (933)
+ ++.++++|||.+....
T Consensus 149 ~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 149 D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred E-CCcEEEEECccccccc
Confidence 9 8999999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=139.43 Aligned_cols=135 Identities=21% Similarity=0.222 Sum_probs=113.9
Q ss_pred cCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCC--CcceeEEeEeeeCceeEEEEeecC
Q 002346 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVALLGYCINGSERLLVYEYMP 662 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~ 662 (933)
+.+.||+|.++.||++... +..+++|....... ...+.+|+..+..++| .++++++++...++..+++|||++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~-~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~ 76 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK-DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE 76 (155)
T ss_pred cceecccccccceEEEEec-CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence 4578999999999999874 47899998865532 4678999999999976 589999998888788999999998
Q ss_pred CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 663 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
++.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.++.
T Consensus 77 g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 77 GETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 8766433 4566778899999999999985445799999999999999989999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.57 E-value=2.3e-14 Score=148.80 Aligned_cols=138 Identities=18% Similarity=0.210 Sum_probs=107.0
Q ss_pred CCccc-cCCCeEEEEEEeCCCcEEEEEEeccccC-----------CchhHHHHHHHHHHHHhcCCCcc--eeEEeEeeeC
Q 002346 586 ANILG-RGGFGVVYGGELPDGTKIAVKRMESNTM-----------GNKGLSEFQAEIAVLTKVRHRHL--VALLGYCING 651 (933)
Q Consensus 586 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~ 651 (933)
...|| .||.|+||++.. .+..++||.+..... +.....++.+|+.++..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45687 899999999987 478899998854221 11234578899999999998775 6777765432
Q ss_pred c----eeEEEEeecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcE
Q 002346 652 S----ERLLVYEYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (933)
Q Consensus 652 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 726 (933)
. ..++||||+++ .+|.+++.. .+++.. .+.++++++++||+ .||+||||||+|||++.++.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~------~~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v 181 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQE------APLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKF 181 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhc------CCCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCE
Confidence 2 22599999997 689888744 234443 35789999999999 999999999999999999999
Q ss_pred EEecccccccC
Q 002346 727 KVADFGLVKNA 737 (933)
Q Consensus 727 kl~DfGla~~~ 737 (933)
+|+|||.+...
T Consensus 182 ~LIDfg~~~~~ 192 (239)
T PRK01723 182 WLIDFDRGELR 192 (239)
T ss_pred EEEECCCcccC
Confidence 99999987643
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.54 E-value=9.2e-16 Score=178.20 Aligned_cols=257 Identities=21% Similarity=0.292 Sum_probs=189.5
Q ss_pred cCCccCCccccCCCeEEEEEEeC--CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP--DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv 657 (933)
..|.+.+.||+|+|+.|-..... ....+|+|.+...............|..+-..+. |+|++.+++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34667778999999999887443 3445677766555433344455566888877776 99999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhh-hccCCCeEecCCCCCcEEecCCC-cEEEecccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH-SLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVK 735 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~ 735 (933)
.+|.+++++.+.+.. .. ....+....-.+..|+..++.|+| . .++.||||||+|.+++..+ ..+++|||+|.
T Consensus 100 ~~~s~g~~~f~~i~~-~~--~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At 173 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PD--STGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLAT 173 (601)
T ss_pred cCccccccccccccc-CC--ccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhc
Confidence 999999999988831 11 113455566778999999999999 6 8999999999999999999 99999999998
Q ss_pred cCCC--CCceeeccccc-ccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 736 NAPD--GKYSVETRLAG-TFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 736 ~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
.+.. +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++.....+ .....|.... .
T Consensus 174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~~----~ 248 (601)
T KOG0590|consen 174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSNK----G 248 (601)
T ss_pred cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeecccc----c
Confidence 6655 44444455678 9999999998874 45678999999999999999999998764433 1222222111 0
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.........+. ....++..+++..+|..|.+..++..
T Consensus 249 ~~~~~~~~~~~---------~~~~~~l~k~l~~~~~~r~s~~~~~~ 285 (601)
T KOG0590|consen 249 RFTQLPWNSIS---------DQAHDLLHKILKENPSNRLSIEELKL 285 (601)
T ss_pred ccccCccccCC---------hhhhhcccccccCCchhccccccccc
Confidence 00001111111 23457788888899999999888764
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.52 E-value=3.8e-14 Score=167.56 Aligned_cols=158 Identities=25% Similarity=0.422 Sum_probs=109.5
Q ss_pred cCCccchHHHHHHHHHhcCCCC-CCCCCCCC-CCCccccceEeCCC-----CCEEEEEecCCCCccccCccccCCcccce
Q 002346 22 TTSLGDDGSVMLKLAQSLQNLP-SDWSSTSS-TGYCEWTGINCDNS-----NRVTTISLAKSGLSGTLSPEISSLTQLET 94 (933)
Q Consensus 22 ~~~~~~d~~~l~~~~~~~~~~~-~~w~~~~~-~~~C~w~gv~c~~~-----~~v~~L~l~~~~l~~~~~~~~~~l~~L~~ 94 (933)
+.+..+|.+||+.+|+++.... .+|..++- ...|.|.||.|... ..|+.|+|++++++|.+|..|+.+++|+.
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~~~W~g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~ 446 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLRFGWNGDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS 446 (623)
T ss_pred cccCchHHHHHHHHHHhcCCcccCCCCCCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCE
Confidence 3456689999999999997543 36754210 01137999999631 24788888888888888888888888888
Q ss_pred eecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCc
Q 002346 95 LSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173 (933)
Q Consensus 95 L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n 173 (933)
|+|++|.|+|.+| .+..+++|+.|+|++|+|++ .+|..++++++|+.|+|++|
T Consensus 447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg--------------------------~iP~~l~~L~~L~~L~Ls~N 500 (623)
T PLN03150 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNG--------------------------SIPESLGQLTSLRILNLNGN 500 (623)
T ss_pred EECCCCcccCcCChHHhCCCCCCEEECCCCCCCC--------------------------CCchHHhcCCCCCEEECcCC
Confidence 8888888887776 56666666666665555554 35556666666666666666
Q ss_pred ccCCCCChhhcCC-CCCCEEEccCCcCCCCCCc
Q 002346 174 NIFGLIPDFFDSF-SNLQNLRLSYNNFTGSLPA 205 (933)
Q Consensus 174 ~l~~~~p~~~~~l-~~L~~L~L~~N~l~~~~p~ 205 (933)
+++|.+|..++.+ .++..+++.+|...+..|.
T Consensus 501 ~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~ 533 (623)
T PLN03150 501 SLSGRVPAALGGRLLHRASFNFTDNAGLCGIPG 533 (623)
T ss_pred cccccCChHHhhccccCceEEecCCccccCCCC
Confidence 7777777776653 4667888888876655553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.1e-12 Score=148.18 Aligned_cols=148 Identities=24% Similarity=0.286 Sum_probs=103.5
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCch--------------------------------------h
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK--------------------------------------G 622 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~ 622 (933)
..|. .+.||.|++|.||+|++++|+.||||+.+......- .
T Consensus 118 ~~fd-~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFE-EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCC-CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 3444 368999999999999999999999999876421000 0
Q ss_pred HHHHHHHHHHHHhcC----CCcceeEEeEe-eeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHH-H
Q 002346 623 LSEFQAEIAVLTKVR----HRHLVALLGYC-INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-G 696 (933)
Q Consensus 623 ~~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~ 696 (933)
.-+|.+|++.+.+++ |.+-+.+-..+ ......++||||++|++|.++.... .. .. .+..++..+++ .
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~-~~---~~---~~~~ia~~~~~~~ 269 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD-EA---GL---DRKALAENLARSF 269 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH-hc---CC---CHHHHHHHHHHHH
Confidence 013556666666662 32223322222 2234578999999999998876431 11 12 23456676666 4
Q ss_pred HHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 697 l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
+..+|. .|++|+|++|.||++++++.++++|||++.....
T Consensus 270 l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 270 LNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 678887 8999999999999999999999999999876543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.40 E-value=6.5e-13 Score=157.09 Aligned_cols=76 Identities=37% Similarity=0.587 Sum_probs=67.7
Q ss_pred CCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCC
Q 002346 359 WPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434 (933)
Q Consensus 359 ~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~ 434 (933)
+|..++.+++|+.|+|++|++.|.+|..++.+++|+.|+|++|+|+|.+|..+.+|++|+.|+|++|+|+|.+|..
T Consensus 434 ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 509 (623)
T PLN03150 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA 509 (623)
T ss_pred CCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChH
Confidence 4556777888999999999999999999999999999999999999999999999999999999999999999863
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.38 E-value=3e-14 Score=153.60 Aligned_cols=213 Identities=21% Similarity=0.346 Sum_probs=157.3
Q ss_pred eccccccccCCCCCccc-CCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccC
Q 002346 118 IYLDNNNFTSVPTGCFD-GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSY 196 (933)
Q Consensus 118 L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 196 (933)
|.|++-++...|...+. .+..-...||+.|++.. +|..+..+-.|+.|.|+.|.+. .+|..+.++..|.+|||+.
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~e---lp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~ 130 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSE---LPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSS 130 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhcccccccc---CchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhcc
Confidence 44555555555544433 34555677888888877 7888888888888888888874 4588888999999999999
Q ss_pred CcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcc
Q 002346 197 NNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPA 276 (933)
Q Consensus 197 N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~ 276 (933)
|+++ .+|..++. + -|+.|-+++|+++..++.++.+.+|..||.+.|.+. .+|.
T Consensus 131 NqlS-~lp~~lC~------------------------l-pLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~-slps 183 (722)
T KOG0532|consen 131 NQLS-HLPDGLCD------------------------L-PLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQ-SLPS 183 (722)
T ss_pred chhh-cCChhhhc------------------------C-cceeEEEecCccccCCcccccchhHHHhhhhhhhhh-hchH
Confidence 9998 88877764 2 488888888888888888888888888888888888 7888
Q ss_pred cccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCC
Q 002346 277 SVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC 356 (933)
Q Consensus 277 ~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 356 (933)
.++++.+|+.|.+..|.+...
T Consensus 184 ql~~l~slr~l~vrRn~l~~l----------------------------------------------------------- 204 (722)
T KOG0532|consen 184 QLGYLTSLRDLNVRRNHLEDL----------------------------------------------------------- 204 (722)
T ss_pred HhhhHHHHHHHHHhhhhhhhC-----------------------------------------------------------
Confidence 888888888888888887642
Q ss_pred CCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCC---cCEEeccCCc
Q 002346 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS---LQNLDVSNNN 426 (933)
Q Consensus 357 ~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~---L~~l~ls~N~ 426 (933)
|.+++ .-.|..||+|.|+++ .||..|.+|+.|++|-|.+|-|. ..|..++..-. .++|+..-.+
T Consensus 205 ---p~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~kGkVHIFKyL~~qA~q 271 (722)
T KOG0532|consen 205 ---PEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICEKGKVHIFKYLSTQACQ 271 (722)
T ss_pred ---CHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHHHhccceeeeeeecchhcc
Confidence 33333 225667777777776 57777888888888888888877 66666654333 3566665554
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.6e-12 Score=131.47 Aligned_cols=204 Identities=22% Similarity=0.312 Sum_probs=140.5
Q ss_pred HHHHhcCCCcceeEEeEeeeC-----ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccC
Q 002346 631 AVLTKVRHRHLVALLGYCING-----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705 (933)
Q Consensus 631 ~~l~~l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~ 705 (933)
.-+-++-|.|||++..|+.+. .+..++.|||+-|++.++|++.+.. ...+......+++.||..||.|||+ |.
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~-~~a~~~~~wkkw~tqIlsal~yLhs-~~ 196 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN-QKALFQKAWKKWCTQILSALSYLHS-CD 196 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh-hhhhhHHHHHHHHHHHHhhhhhhhc-cC
Confidence 345556799999999887543 3567899999999999999885544 4667888888999999999999998 67
Q ss_pred CCeEecCCCCCcEEecCCCcEEEecccccccCC---CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHH
Q 002346 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP---DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETI 782 (933)
Q Consensus 706 ~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ell 782 (933)
.+|+|+++.-+-|++..++-+|+.----..... .........-.|-++|.|||+-.....+-++|||+||....||.
T Consensus 197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 899999999999999999988874211100000 00001112234678999999887777888999999999999999
Q ss_pred cCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 783 TGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 783 tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+..--..... ....-.. +...... ....+. ..++..|++..|..||+|.+++.
T Consensus 277 ilEiq~tnseS-~~~~ee~-ia~~i~~-------len~lq------------r~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSES-KVEVEEN-IANVIIG-------LENGLQ------------RGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCcc-eeehhhh-hhhheee-------ccCccc------------cCcCcccccCCCCCCcchhhhhc
Confidence 88743211110 0000000 0111110 001111 25788999999999999998653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.9e-12 Score=143.13 Aligned_cols=250 Identities=23% Similarity=0.251 Sum_probs=180.7
Q ss_pred cCCccCCcccc--CCCeEEEEEEe---CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGR--GGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~ 654 (933)
..|.+.+.+|. |.+|.||.+.. .++..+|+|+-+..........+=.+|+...+.+ .|++.++.+..+..++..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34667788999 99999999854 5788999997444332233233345666666667 499999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHH----HHHHhhhccCCCeEecCCCCCcEEecCC-CcEEEe
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR----GVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVA 729 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~ 729 (933)
++-.|++ +.+|.++.+... .-++....+.+..+..+ |+.++|+ ..++|-|+||.||++..+ ...++.
T Consensus 194 fiqtE~~-~~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~ 265 (524)
T KOG0601|consen 194 FIQTELC-GESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLT 265 (524)
T ss_pred eeeeccc-cchhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecC
Confidence 9999998 578888876521 23566777778888888 9999999 899999999999999999 889999
Q ss_pred cccccccCCCCCce----eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH
Q 002346 730 DFGLVKNAPDGKYS----VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 730 DfGla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 805 (933)
|||+.....++... ......|...|++||... +.++.++|+|++|.++.+..++..+...... ..|.+-
T Consensus 266 df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~------~~W~~~ 338 (524)
T KOG0601|consen 266 DFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN------SSWSQL 338 (524)
T ss_pred CcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC------CCcccc
Confidence 99999877765522 223346888999999876 6788999999999999999998765533200 011110
Q ss_pred HhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 806 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....++ .+++.....++...+..+++.+|..|++.+.+..
T Consensus 339 ---r~~~ip---------~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 339 ---RQGYIP---------LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ---ccccCc---------hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 000011 1111111223445888999999999998877654
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.34 E-value=3.8e-14 Score=152.78 Aligned_cols=196 Identities=23% Similarity=0.323 Sum_probs=153.2
Q ss_pred EEecCCCCcccc-CccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCC
Q 002346 71 ISLAKSGLSGTL-SPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149 (933)
Q Consensus 71 L~l~~~~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~ 149 (933)
|.|++..+.... +.+=-.+..-...||+.|++..++..+..+-.|..|.|+.|.|..++.. +.++..|.+|||+.|++
T Consensus 55 l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~elp~~~~~f~~Le~liLy~n~~r~ip~~-i~~L~~lt~l~ls~Nql 133 (722)
T KOG0532|consen 55 LLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFSELPEEACAFVSLESLILYHNCIRTIPEA-ICNLEALTFLDLSSNQL 133 (722)
T ss_pred cccccchhhcCCCccccccccchhhhhccccccccCchHHHHHHHHHHHHHHhccceecchh-hhhhhHHHHhhhccchh
Confidence 455555554211 1111456677778888888886655777777788888888888887765 77888888888888888
Q ss_pred CCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccc
Q 002346 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLD 229 (933)
Q Consensus 150 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~ 229 (933)
.. +|..+..|+ |+.|-+++|+++. +|+.++.+..|..||.+.|.+. .+|..++
T Consensus 134 S~---lp~~lC~lp-Lkvli~sNNkl~~-lp~~ig~~~tl~~ld~s~nei~-slpsql~--------------------- 186 (722)
T KOG0532|consen 134 SH---LPDGLCDLP-LKVLIVSNNKLTS-LPEEIGLLPTLAHLDVSKNEIQ-SLPSQLG--------------------- 186 (722)
T ss_pred hc---CChhhhcCc-ceeEEEecCcccc-CCcccccchhHHHhhhhhhhhh-hchHHhh---------------------
Confidence 77 677777765 8888888888844 4777888888888888888887 7776654
Q ss_pred cccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC
Q 002346 230 VLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (933)
Q Consensus 230 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 299 (933)
++.+|+.|.+..|++...++++. .-.|..||+|.|++. .+|-.|.+|..|++|-|.+|.|+.++.
T Consensus 187 ---~l~slr~l~vrRn~l~~lp~El~-~LpLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqSPPA 251 (722)
T KOG0532|consen 187 ---YLTSLRDLNVRRNHLEDLPEELC-SLPLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQSPPA 251 (722)
T ss_pred ---hHHHHHHHHHhhhhhhhCCHHHh-CCceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCCChH
Confidence 48899999999999999888887 556889999999999 899999999999999999999996443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.6e-12 Score=147.41 Aligned_cols=63 Identities=32% Similarity=0.528 Sum_probs=37.5
Q ss_pred ceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC
Q 002346 368 RIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (933)
Q Consensus 368 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 433 (933)
++..|.+.+|++.. ++..++.++.|++|++++|+++ .++. +..+.+|+.|++++|.++..+|.
T Consensus 233 ~l~~l~l~~n~~~~-~~~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 233 NLSGLELSNNKLED-LPESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cccccccCCceeee-ccchhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchh
Confidence 33334444444432 2455666666777777777776 4444 66677777777777777766664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=1.8e-12 Score=146.95 Aligned_cols=196 Identities=29% Similarity=0.432 Sum_probs=108.6
Q ss_pred eeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCC-CCCEEEccCCCCCCCCCCCccccCCccCCeeeccC
Q 002346 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLT-NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172 (933)
Q Consensus 94 ~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~ 172 (933)
.|+++.|.+...+..+..++.++.|++.+|.++.+++. ...++ +|+.|++++|++.. +|..+..+++|+.|++++
T Consensus 97 ~l~~~~~~~~~~~~~~~~~~~l~~L~l~~n~i~~i~~~-~~~~~~nL~~L~l~~N~i~~---l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPL-IGLLKSNLKELDLSDNKIES---LPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred eeeccccccccCchhhhcccceeEEecCCcccccCccc-cccchhhcccccccccchhh---hhhhhhccccccccccCC
Confidence 45555555544444444555666666666666665553 33332 56666666666555 445566666666666666
Q ss_pred cccCCCCChhhcCCCCCCEEEccCCcCCCCCCcccccc-ccchhhcccccCCcccccccccCCccCcEEEecCCccCCCC
Q 002346 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS-DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (933)
Q Consensus 173 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 251 (933)
|++... |...+.+++|+.|++++|+++ .+|...... .+.++.+..|.+ ...+..+..++++..|.+.+|++...+
T Consensus 173 N~l~~l-~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~--~~~~~~~~~~~~l~~l~l~~n~~~~~~ 248 (394)
T COG4886 173 NDLSDL-PKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSI--IELLSSLSNLKNLSGLELSNNKLEDLP 248 (394)
T ss_pred chhhhh-hhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcc--eecchhhhhcccccccccCCceeeecc
Confidence 666544 333335566666666666666 555543221 133333333320 001112334566666666777666554
Q ss_pred CCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC
Q 002346 252 PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (933)
Q Consensus 252 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 299 (933)
..+..+++|+.|++++|+++ .++. +..+.+|+.|++++|.+....|
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~ 294 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALP 294 (394)
T ss_pred chhccccccceecccccccc-cccc-ccccCccCEEeccCccccccch
Confidence 45666666777777777776 3333 6666677777777777665544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.29 E-value=3.7e-12 Score=145.03 Aligned_cols=151 Identities=21% Similarity=0.258 Sum_probs=98.6
Q ss_pred HHHhcCCccCCccccCCCeEEEEEEeCC-CcEEEEEEeccccCC---------------------------c-----hhH
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMG---------------------------N-----KGL 623 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~---------------------------~-----~~~ 623 (933)
..+...|+. +.||.|++|.||+|.+++ |+.||||+.++.... . +..
T Consensus 116 ~~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~ 194 (537)
T PRK04750 116 EEWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFE 194 (537)
T ss_pred HHHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHH
Confidence 344566776 899999999999999887 999999999764210 0 001
Q ss_pred ------HHHHHHHHHHHhcC----CCcceeEEeEeee-CceeEEEEeecCCCChhhHhhhcccCCC--CCCCHHHHHHHH
Q 002346 624 ------SEFQAEIAVLTKVR----HRHLVALLGYCIN-GSERLLVYEYMPRGTLAQHLFEWHDHGY--TPLTWKQRVTIA 690 (933)
Q Consensus 624 ------~~~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~ 690 (933)
-+|.+|+..+.+++ +...+.+-..+.+ ....++||||++|+.+.+.-.- ...+. ..+....+..++
T Consensus 195 ~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l-~~~g~d~~~la~~~v~~~~ 273 (537)
T PRK04750 195 KTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL-RAAGTDMKLLAERGVEVFF 273 (537)
T ss_pred HHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH-HhcCCCHHHHHHHHHHHHH
Confidence 12455665555553 3333333333322 3566899999999999874211 11110 122233333333
Q ss_pred HHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC----cEEEecccccccCCC
Q 002346 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVADFGLVKNAPD 739 (933)
Q Consensus 691 ~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~DfGla~~~~~ 739 (933)
.|+ .. .|++|+|+||.||+++.++ .++++|||++.....
T Consensus 274 ~Qi-------f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 274 TQV-------FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HHH-------Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 333 33 7999999999999999888 999999999886654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.3e-10 Score=114.81 Aligned_cols=139 Identities=15% Similarity=0.166 Sum_probs=100.6
Q ss_pred CCccccCCCeEEEEEEeCC-------CcEEEEEEeccccCC----------c----------hhHHHH----HHHHHHHH
Q 002346 586 ANILGRGGFGVVYGGELPD-------GTKIAVKRMESNTMG----------N----------KGLSEF----QAEIAVLT 634 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~----------~----------~~~~~~----~~E~~~l~ 634 (933)
...||.|--+.||.|...+ +..+|||+.+..... + ...+.+ .+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3568999999999996543 579999977543210 0 012223 38999999
Q ss_pred hcCC--CcceeEEeEeeeCceeEEEEeecCCCChhh-HhhhcccCCCCCCCHHHHHHHHHHHHHHHHHh-hhccCCCeEe
Q 002346 635 KVRH--RHLVALLGYCINGSERLLVYEYMPRGTLAQ-HLFEWHDHGYTPLTWKQRVTIALDVARGVEYL-HSLAQQSFIH 710 (933)
Q Consensus 635 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-H~~~~~~ivH 710 (933)
++.. -++.+++++ ...++||||+.+..+.. .+.+ ..++..+...+..+++.++.++ |. .+|||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~---~glVH 148 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVH 148 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 9953 466677765 45689999997654432 2322 2345566778889999999999 77 89999
Q ss_pred cCCCCCcEEecCCCcEEEecccccccCC
Q 002346 711 RDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 711 ~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++.||+++ ++.+.|+|||.+....
T Consensus 149 GDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 149 ADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999999997 4679999999877554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=3.4e-11 Score=119.05 Aligned_cols=130 Identities=20% Similarity=0.143 Sum_probs=96.0
Q ss_pred CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcce-eEEeEeeeCceeEEEEeecCCC
Q 002346 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV-ALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~g 664 (933)
++.|+.|.++.||++.. .++.|++|....... ....+..|+.+++.+.+.+++ +++.+. ....++||||+++.
T Consensus 3 ~~~l~~G~~~~vy~~~~-~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV-ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEE-CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 46789999999999987 478899998765421 123567899999998655544 455443 33458999999998
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA--QQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
++.+.- .....++.+++++++.||+.. ..+++|+|++|.||+++ ++.++++|||.+.
T Consensus 77 ~l~~~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred cccccc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 775430 011345789999999999831 12369999999999999 6689999999865
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.21 E-value=3.9e-10 Score=125.82 Aligned_cols=167 Identities=17% Similarity=0.215 Sum_probs=127.4
Q ss_pred EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCC
Q 002346 601 ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP 680 (933)
Q Consensus 601 ~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 680 (933)
+..++.+|.|+..+.... .......+-++.++.++||||+++++.++.++..|+|+|-+. .|..++.+
T Consensus 33 ~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~-------- 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE-------- 100 (690)
T ss_pred eeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH--------
Confidence 455788899988876532 334556778889999999999999999999999999999874 57777754
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeecccccccCccccccc
Q 002346 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760 (933)
Q Consensus 681 l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~ 760 (933)
+........+.||+.||.+||+ ..+++|++|..+.|+++..|+.||++|-++........ ......---.|..|+.+
T Consensus 101 l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~ 177 (690)
T KOG1243|consen 101 LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEI 177 (690)
T ss_pred hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhc
Confidence 3456777789999999999997 38999999999999999999999999988764432211 00011111245566654
Q ss_pred CCCCCCCccchHhHHHHHHHHHcC
Q 002346 761 ATGRVTTKIDVYAFGVVLMETITG 784 (933)
Q Consensus 761 ~~~~~~~~~Dv~SlG~~l~elltG 784 (933)
.... -..|.|.||++++|++.|
T Consensus 178 ~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 178 DPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred Cccc--cchhhhhHHHHHHHHhCc
Confidence 3322 346999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.18 E-value=3e-10 Score=107.56 Aligned_cols=134 Identities=25% Similarity=0.348 Sum_probs=103.7
Q ss_pred CccccCCCeEEEEEEeCCCcEEEEEEeccccCCch------hHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK------GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
..+++|+-+.+|.+.+. |.++++|.-.+...-.. ...+-.+|++++.+++--.|...+-+..+.....++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 46899999999999774 44577775433322211 134567899999999766666666666777888999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
++|..|.+.+... ...++..+-+-+.-||. .+|||+|+.++||++..+. +.++|||++...
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 9999999898541 35677888888899998 9999999999999997765 999999998743
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.17 E-value=6.3e-12 Score=125.24 Aligned_cols=134 Identities=25% Similarity=0.261 Sum_probs=101.6
Q ss_pred CCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccC
Q 002346 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDH 312 (933)
Q Consensus 233 ~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~ 312 (933)
.++.|++|||++|.|+..-.++.-.++++.|++|+|.|.. +- .+..+++|+.||||+|.++..
T Consensus 282 TWq~LtelDLS~N~I~~iDESvKL~Pkir~L~lS~N~i~~-v~-nLa~L~~L~~LDLS~N~Ls~~--------------- 344 (490)
T KOG1259|consen 282 TWQELTELDLSGNLITQIDESVKLAPKLRRLILSQNRIRT-VQ-NLAELPQLQLLDLSGNLLAEC--------------- 344 (490)
T ss_pred hHhhhhhccccccchhhhhhhhhhccceeEEeccccceee-eh-hhhhcccceEeecccchhHhh---------------
Confidence 3567888888888888776677777888888888888873 32 377788888888888887732
Q ss_pred CcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCccc
Q 002346 313 NNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTS 392 (933)
Q Consensus 313 n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 392 (933)
-++-..+.++++|+|+.|.|.. -..++.|-+
T Consensus 345 -----------------------------------------------~Gwh~KLGNIKtL~La~N~iE~--LSGL~KLYS 375 (490)
T KOG1259|consen 345 -----------------------------------------------VGWHLKLGNIKTLKLAQNKIET--LSGLRKLYS 375 (490)
T ss_pred -----------------------------------------------hhhHhhhcCEeeeehhhhhHhh--hhhhHhhhh
Confidence 1223345678888888887752 234677788
Q ss_pred CCeEecccCcccCCC-CcccCCCCCcCEEeccCCcCcccCC
Q 002346 393 LKNLYLQQNNLTGPI-PDGLTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 393 L~~L~L~~N~l~g~~-p~~~~~l~~L~~l~ls~N~l~g~~p 432 (933)
|..||+++|+|.... -..+++||-|+++.|.+|+|.+.+.
T Consensus 376 LvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 376 LVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred heeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 999999999998432 3578999999999999999998765
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.13 E-value=2.5e-11 Score=140.61 Aligned_cols=251 Identities=24% Similarity=0.272 Sum_probs=171.7
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.+.+.+.+.+-.|.++.++.+.- ..|...+.|+......-. ...+...++-.+.-..+||-++....-+......++|
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 35667778899999999998743 234444555443332111 1122333333333334567777666655667788999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
++|..+++|...++. .+..+..-.......+..+.+|||+ ..+.|||++|.|.+...+++.++.|||.....
T Consensus 883 ~~~~~~~~~~Skl~~-----~~~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHN-----SGCLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hHHhccCCchhhhhc-----CCCcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence 999999999999866 2345666667777888899999998 66999999999999999999999999843211
Q ss_pred CC---------------------C---------CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCC
Q 002346 738 PD---------------------G---------KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKA 787 (933)
Q Consensus 738 ~~---------------------~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p 787 (933)
.. . +........||+.|.|||...+......+|.|++|+.++|.++|.+|
T Consensus 955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen 955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence 10 0 00112235699999999999999999999999999999999999999
Q ss_pred CCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 002346 788 LDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGH 854 (933)
Q Consensus 788 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~e 854 (933)
|....++... +.+......++ ........+..+++...+..+|.+|-.|..
T Consensus 1035 ~na~tpq~~f------~ni~~~~~~~p----------~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~ 1085 (1205)
T KOG0606|consen 1035 FNAETPQQIF------ENILNRDIPWP----------EGPEEGSYEAQDLINRLLTEEPTQRLGAKG 1085 (1205)
T ss_pred CCCcchhhhh------hccccCCCCCC----------CCccccChhhhhhhhhhhccCchhccCccc
Confidence 9887664331 11111111111 111122234568888899999999987763
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.12 E-value=3.3e-11 Score=116.62 Aligned_cols=86 Identities=28% Similarity=0.400 Sum_probs=18.1
Q ss_pred ccCcCcCceeccccccccCCCCCccc-CCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCC
Q 002346 109 LANATSLQDIYLDNNNFTSVPTGCFD-GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187 (933)
Q Consensus 109 ~~~l~~L~~L~Ls~N~l~~~~~~~~~-~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 187 (933)
+.+..++++|+|.+|.|+.|.. ++ .+.+|+.|+|++|.+.. + +.+..++.|+.|++++|+|+...+.....++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~Ie~--L~~~l~~L~~L~Ls~N~I~~---l-~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp 88 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTIEN--LGATLDKLEVLDLSNNQITK---L-EGLPGLPRLKTLDLSNNRISSISEGLDKNLP 88 (175)
T ss_dssp ---------------------S----TT-TT--EEE-TTS--S------TT----TT--EEE--SS---S-CHHHHHH-T
T ss_pred cccccccccccccccccccccc--hhhhhcCCCEEECCCCCCcc---c-cCccChhhhhhcccCCCCCCccccchHHhCC
Confidence 4444455666666666655432 33 35556666666665555 2 2344555556666666665544222223456
Q ss_pred CCCEEEccCCcCC
Q 002346 188 NLQNLRLSYNNFT 200 (933)
Q Consensus 188 ~L~~L~L~~N~l~ 200 (933)
+|++|+|++|+|.
T Consensus 89 ~L~~L~L~~N~I~ 101 (175)
T PF14580_consen 89 NLQELYLSNNKIS 101 (175)
T ss_dssp T--EEE-TTS---
T ss_pred cCCEEECcCCcCC
Confidence 6666666666665
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-11 Score=122.91 Aligned_cols=185 Identities=23% Similarity=0.287 Sum_probs=128.3
Q ss_pred CccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCC----C-------------------cccCCCCC
Q 002346 83 SPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPT----G-------------------CFDGLTNL 139 (933)
Q Consensus 83 ~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~----~-------------------~~~~l~~L 139 (933)
|-.+.-+.+|..+.++.+.-..+..-...-+.|++|.+.+..++..+. . .......|
T Consensus 207 ~f~l~~f~~l~~~~~s~~~~~~i~~~~~~kptl~t~~v~~s~~~~~~~l~pe~~~~D~~~~E~~t~~G~~~~~~dTWq~L 286 (490)
T KOG1259|consen 207 SFNLNAFRNLKTLKFSALSTENIVDIELLKPTLQTICVHNTTIQDVPSLLPETILADPSGSEPSTSNGSALVSADTWQEL 286 (490)
T ss_pred ccchHHhhhhheeeeeccchhheeceeecCchhheeeeecccccccccccchhhhcCccCCCCCccCCceEEecchHhhh
Confidence 334445566666666665433222111122556666666655543211 0 01123468
Q ss_pred CEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhccc
Q 002346 140 QVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMND 219 (933)
Q Consensus 140 ~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~ 219 (933)
++||||+|.|+. +.++..-++.++.|++++|.|... ..+..+++|+.||||+|.++ .+-.+=.
T Consensus 287 telDLS~N~I~~---iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~----------- 349 (490)
T KOG1259|consen 287 TELDLSGNLITQ---IDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHL----------- 349 (490)
T ss_pred hhccccccchhh---hhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHh-----------
Confidence 999999998887 778888889999999999998766 44888999999999999988 4444322
Q ss_pred ccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccC-cccccCCCCCCEEEccCccCccCC
Q 002346 220 QQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVV-PASVISLPALLNISLQNNKLQGPY 298 (933)
Q Consensus 220 n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~ 298 (933)
.+-+++.|.|++|.+.. ...+..+-+|..||+++|+|.... -..++++|.|+.|.|.+|++.+.+
T Consensus 350 -------------KLGNIKtL~La~N~iE~-LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 350 -------------KLGNIKTLKLAQNKIET-LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred -------------hhcCEeeeehhhhhHhh-hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 26788999999998874 334667778889999999997532 357889999999999999988653
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.8e-11 Score=116.20 Aligned_cols=109 Identities=27% Similarity=0.356 Sum_probs=40.3
Q ss_pred ccCCcccceeecccccccccCCCcc-CcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccc-cCCc
Q 002346 86 ISSLTQLETLSFQMNNIAGAIPSLA-NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNEL-TKST 163 (933)
Q Consensus 86 ~~~l~~L~~L~l~~N~l~~~~p~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~-~~l~ 163 (933)
+.+...+++|+|++|.|+.+ ..++ .+.+|+.|+|++|.|+.+.. +..+++|++|+|++|+++. +...+ ..++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I-e~L~~~l~~L~~L~Ls~N~I~~l~~--l~~L~~L~~L~L~~N~I~~---i~~~l~~~lp 88 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI-ENLGATLDKLEVLDLSNNQITKLEG--LPGLPRLKTLDLSNNRISS---ISEGLDKNLP 88 (175)
T ss_dssp ----------------------S--TT-TT--EEE-TTS--S--TT------TT--EEE--SS---S----CHHHHHH-T
T ss_pred cccccccccccccccccccc-cchhhhhcCCCEEECCCCCCccccC--ccChhhhhhcccCCCCCCc---cccchHHhCC
Confidence 44555678888888888854 4455 57788888888888888763 7778888888888888887 44444 3678
Q ss_pred cCCeeeccCcccCCCC-ChhhcCCCCCCEEEccCCcCC
Q 002346 164 SLTTLYMDNANIFGLI-PDFFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 164 ~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 200 (933)
+|++|+|++|+|...- -..+..+++|+.|+|.+|.++
T Consensus 89 ~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 89 NLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp T--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred cCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 8888888888886542 255677888999999999887
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.11 E-value=6e-10 Score=115.49 Aligned_cols=143 Identities=20% Similarity=0.287 Sum_probs=111.4
Q ss_pred CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCC--CcceeEEeEeeeCc---eeEEEEee
Q 002346 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVALLGYCINGS---ERLLVYEY 660 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~ 660 (933)
.+.|+.|.++.||++...+|+.+++|........ ....++..|+++++.+++ ..+.+++.+..... ..++||||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~ 81 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER 81 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence 3678999999999998866789999987654321 234578999999999975 44677787776542 56899999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc------------------------------------
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA------------------------------------ 704 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------------ 704 (933)
++|.++.+.+.. ..++..++..++.++++++++||+..
T Consensus 82 i~G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (223)
T cd05154 82 VDGRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP 155 (223)
T ss_pred eCCEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence 999888776521 24677788888899999999998521
Q ss_pred -----------------CCCeEecCCCCCcEEecC--CCcEEEecccccc
Q 002346 705 -----------------QQSFIHRDLKPSNILIGD--DMRAKVADFGLVK 735 (933)
Q Consensus 705 -----------------~~~ivH~Dik~~Nill~~--~~~~kl~DfGla~ 735 (933)
...++|+|+.+.||+++. ++.+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 256799999999999998 6678999999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.8e-10 Score=103.52 Aligned_cols=145 Identities=21% Similarity=0.234 Sum_probs=107.9
Q ss_pred cCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC------chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG------NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
....|-||+-+.|+++.+ .|+.+.||.-.....- .-..++..+|++.+.+++--.|.-..-++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 467899999999999998 6888888854333221 122456788999999987555554444555555667899
Q ss_pred eecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC---cEEEeccccc
Q 002346 659 EYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKVADFGLV 734 (933)
Q Consensus 659 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~DfGla 734 (933)
||+++ .++.+++..... .+........++..|-+.+.-||. .+|||+|+..+||++..++ .+.++|||++
T Consensus 90 E~~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EeccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecch
Confidence 99976 588888876332 222333337889999999999998 8999999999999997665 3689999997
Q ss_pred cc
Q 002346 735 KN 736 (933)
Q Consensus 735 ~~ 736 (933)
..
T Consensus 164 ~~ 165 (229)
T KOG3087|consen 164 SV 165 (229)
T ss_pred hc
Confidence 53
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-11 Score=130.01 Aligned_cols=65 Identities=25% Similarity=0.239 Sum_probs=31.9
Q ss_pred CcCcCceeccccccccCCCC-CcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCccc
Q 002346 111 NATSLQDIYLDNNNFTSVPT-GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI 175 (933)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l 175 (933)
++.+|+.+.|.+..+..++. .....|++++.||||.|-+....++-.-...|++|+.|+|+.|++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl 184 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRL 184 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccc
Confidence 45556666666655554332 233445555555555554444323333334444555555555444
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.5e-10 Score=128.25 Aligned_cols=248 Identities=18% Similarity=0.187 Sum_probs=174.7
Q ss_pred HHHhcCCccCCccccCCCeEEEEEEe--CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCce
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGGEL--PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSE 653 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 653 (933)
.....+|..+..||.|.|+.|++... .++..|++|.+............-..|+.+...+ .|.+++..+..+..-+.
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34456888999999999999999843 4678899998877654433333335566666666 58899988877777777
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-CcEEEeccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFG 732 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfG 732 (933)
.|+=-||++++++...+.- ...++...++++..|++.++.++|+ ..++|+|+||+||++..+ +..+++|||
T Consensus 341 ~~ip~e~~~~~s~~l~~~~-----~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~ 412 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSSLRSVT-----SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFG 412 (524)
T ss_pred ccCchhhhcCcchhhhhHH-----HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccc
Confidence 8899999999998877622 2457778899999999999999998 899999999999999886 788999999
Q ss_pred ccccCCCCCceeecccccccCcc--cccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYL--APEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
.+...... .....+.-++. +++......+-.+.|+||||..+.|.++|..--.... .|... ..
T Consensus 413 ~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~--------~~~~i---~~ 477 (524)
T KOG0601|consen 413 CWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV--------QSLTI---RS 477 (524)
T ss_pred ccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCcccc--------cceee---ec
Confidence 88642211 11112233444 4555555677889999999999999999874322211 01100 01
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
+.++ ... . .. ..+..+.+.+..+++..||.+.++...
T Consensus 478 ~~~p-----~~~---~--~~-~~~q~~~kv~~~~~~~~~~l~~~l~~~ 514 (524)
T KOG0601|consen 478 GDTP-----NLP---G--LK-LQLQVLLKVMINPDRKRRPSAVELSLH 514 (524)
T ss_pred cccc-----CCC---c--hH-HhhhhhhhhhcCCccccchhhhhhccc
Confidence 1111 111 0 01 235567778889999999998877653
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.04 E-value=3e-11 Score=127.12 Aligned_cols=209 Identities=19% Similarity=0.144 Sum_probs=135.0
Q ss_pred cCCcccceeecccccccccCC--CccCcCcCceeccccccccCC--CCCcccCCCCCCEEEccCCCCCCCCCCCccccCC
Q 002346 87 SSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSV--PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKS 162 (933)
Q Consensus 87 ~~l~~L~~L~l~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l 162 (933)
.++.+|++..|.+..+..... ....+++++.||||+|-|... .......|++|+.|+|+.|++...+. -..-..+
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~-s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFIS-SNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcc-ccchhhh
Confidence 468889999998887764432 467789999999999998853 23345679999999999999876321 1122467
Q ss_pred ccCCeeeccCcccCCC-CChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCCcccccccccCCccCcEE
Q 002346 163 TSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240 (933)
Q Consensus 163 ~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L 240 (933)
+.|+.|.|+.|.|+-. +-.....+|+|+.|+|..|..-+.-.....- ..|++|+|++|++...........++.|..|
T Consensus 197 ~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~L 276 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQL 276 (505)
T ss_pred hhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhh
Confidence 8899999999998733 2333456899999999999622121111111 3466666776666666665666666777777
Q ss_pred EecCCccCCCC-CC------CCCCCCCCEEEccCCccccc-CcccccCCCCCCEEEccCccCcc
Q 002346 241 WLHKNQFTGPI-PD------LSKCESLFDLSLRDNQLTGV-VPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 241 ~L~~N~l~~~~-~~------~~~~~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
+++.+.+..+- |+ ...+++|++|+++.|++..- .-..+..+++|+.|.+..|.|+.
T Consensus 277 nls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 277 NLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred hccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 77777665421 22 23456677777777766411 11234445566666666666653
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=5.7e-11 Score=134.76 Aligned_cols=175 Identities=29% Similarity=0.338 Sum_probs=116.4
Q ss_pred cCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCC
Q 002346 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLT 166 (933)
Q Consensus 87 ~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~ 166 (933)
..+..++.+++..|.|..+...+..+.+|..|++.+|+|..+... +..+++|++|+|++|.|... ..+..++.|+
T Consensus 69 ~~l~~l~~l~l~~n~i~~~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~~~L~~L~ls~N~I~~i----~~l~~l~~L~ 143 (414)
T KOG0531|consen 69 ESLTSLKELNLRQNLIAKILNHLSKLKSLEALDLYDNKIEKIENL-LSSLVNLQVLDLSFNKITKL----EGLSTLTLLK 143 (414)
T ss_pred HHhHhHHhhccchhhhhhhhcccccccceeeeeccccchhhcccc-hhhhhcchheeccccccccc----cchhhccchh
Confidence 456777788888888886555688888999999999999887654 67788999999999988872 4567777799
Q ss_pred eeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCc
Q 002346 167 TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246 (933)
Q Consensus 167 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~ 246 (933)
.|++++|.|+.. ..+..++.|+.+++++|++. .+.... +..+.+|+.+++.+|.
T Consensus 144 ~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~-~ie~~~-----------------------~~~~~~l~~l~l~~n~ 197 (414)
T KOG0531|consen 144 ELNLSGNLISDI--SGLESLKSLKLLDLSYNRIV-DIENDE-----------------------LSELISLEELDLGGNS 197 (414)
T ss_pred hheeccCcchhc--cCCccchhhhcccCCcchhh-hhhhhh-----------------------hhhccchHHHhccCCc
Confidence 999999988776 55666889999999999988 343310 0124556666666665
Q ss_pred cCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCC--CCEEEccCccCc
Q 002346 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA--LLNISLQNNKLQ 295 (933)
Q Consensus 247 l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~ 295 (933)
+.. +..+..+..+..+++..|.++..-+ +..+.. |+.+++++|++.
T Consensus 198 i~~-i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~ 245 (414)
T KOG0531|consen 198 IRE-IEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS 245 (414)
T ss_pred hhc-ccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc
Confidence 552 2223333444444666666652211 111222 555555555554
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.6e-11 Score=125.76 Aligned_cols=39 Identities=26% Similarity=0.394 Sum_probs=24.1
Q ss_pred cccCCeEecccCcccC----CCCcccCCCCCcCEEeccCCcCc
Q 002346 390 LTSLKNLYLQQNNLTG----PIPDGLTKLASLQNLDVSNNNLS 428 (933)
Q Consensus 390 l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~ 428 (933)
.++|+.|.|.+|.++. .+-..+...+.|..|+|++|.|.
T Consensus 269 ~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 269 APSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred CCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 4566666666666653 23334455677777777777774
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3e-11 Score=123.88 Aligned_cols=125 Identities=14% Similarity=0.152 Sum_probs=66.3
Q ss_pred cCCccCCeeeccCcccCCCCCh----hhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCc
Q 002346 160 TKSTSLTTLYMDNANIFGLIPD----FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT 235 (933)
Q Consensus 160 ~~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~ 235 (933)
..+++|++|+||.|-|.-.-+. .+.++..|++|.|.+|.+. ......-...|.+|..+ .....-+
T Consensus 89 ~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg-~~ag~~l~~al~~l~~~----------kk~~~~~ 157 (382)
T KOG1909|consen 89 LGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLG-PEAGGRLGRALFELAVN----------KKAASKP 157 (382)
T ss_pred hcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCC-hhHHHHHHHHHHHHHHH----------hccCCCc
Confidence 3344555555555554332222 2345566666666666664 22111111112222200 1122346
Q ss_pred cCcEEEecCCccCCCCC-----CCCCCCCCCEEEccCCccccc----CcccccCCCCCCEEEccCccCc
Q 002346 236 QLRQVWLHKNQFTGPIP-----DLSKCESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQ 295 (933)
Q Consensus 236 ~L~~L~L~~N~l~~~~~-----~~~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 295 (933)
.|+++..++|++..... .|...+.|+.+.++.|.|... +...|..+++|+.|||.+|-|+
T Consensus 158 ~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft 226 (382)
T KOG1909|consen 158 KLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFT 226 (382)
T ss_pred ceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhh
Confidence 77888888887765433 155567777777777776521 2345566777777777777776
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=3.7e-08 Score=103.69 Aligned_cols=273 Identities=15% Similarity=0.161 Sum_probs=167.4
Q ss_pred cCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeE------eee-CceeEE
Q 002346 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGY------CIN-GSERLL 656 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~-~~~~~l 656 (933)
..+.||+|+.+.+|-.- .-...+.|+........ -...+..|... .||-+-.-+.| .-+ +....+
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~-----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAA-----QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchH-----HHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 45779999999999642 11223557666543211 12223444444 46644331221 111 223567
Q ss_pred EEeecCCC-ChhhHhh-hcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 657 VYEYMPRG-TLAQHLF-EWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 657 v~e~~~~g-sL~~~l~-~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
.|+.+.+. -...++. +.++......+|...+++++.+|.+.+.||. .|.+-+|+.++|+|+.+++.+.+.|-..-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence 88877663 2222222 1234455678999999999999999999999 89999999999999999999999986543
Q ss_pred ccCCCCCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcC-CCCCCCCCC-----c-hhhHHHH-
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITG-RKALDDTMP-----D-DRAHLVT- 801 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG-~~p~~~~~~-----~-~~~~~~~- 801 (933)
....++ ...-..+|.+.|.+||.-. +-.-+...|.|.+|+++++++.| ++||.+-.. . .+.++..
T Consensus 165 qi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 333222 2233457999999999664 23456789999999999999987 899975321 1 1111110
Q ss_pred -HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccC--CCCCCCCHHHHHHHHhhhhhhcCCCCcCCCC
Q 002346 802 -WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAR--EPQQRPDMGHAVNVLGPLVEQWKPATREDED 875 (933)
Q Consensus 802 -~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~--~P~~RPs~~evl~~L~~~~~~~~~~~~~~~~ 875 (933)
+........+..+......+ .-....+..+..+|+.. .+.-||+++..+..|..+.+++.++.....+
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~------~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C~v~a~H 313 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPL------SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKCTVSAMH 313 (637)
T ss_pred eeeechhccCCCCCCCCCCCh------hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhhhhcccc
Confidence 00000000111111000000 01112344566677764 3678999999999999988888776665444
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.92 E-value=1.3e-10 Score=131.86 Aligned_cols=214 Identities=21% Similarity=0.243 Sum_probs=151.9
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 146 (933)
.+..++++.|.+. .+-..+..+++|+.|++.+|+|..+...+..+.+|++|+|++|.|+.+.. +..++.|+.|++++
T Consensus 73 ~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~~~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~ 149 (414)
T KOG0531|consen 73 SLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIENLLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSG 149 (414)
T ss_pred hHHhhccchhhhh-hhhcccccccceeeeeccccchhhcccchhhhhcchheeccccccccccc--hhhccchhhheecc
Confidence 3455567777776 34455888999999999999999766668889999999999999998875 67788899999999
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCC-hhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~ 225 (933)
|.|.. ...+..+++|+.+++++|.+...-+ . ...+.+|+.+++.+|.+. .+...
T Consensus 150 N~i~~----~~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~-~i~~~------------------- 204 (414)
T KOG0531|consen 150 NLISD----ISGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR-EIEGL------------------- 204 (414)
T ss_pred Ccchh----ccCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh-cccch-------------------
Confidence 99988 2456669999999999999987755 3 578899999999999997 33211
Q ss_pred cccccccCCccCcEEEecCCccCCCCCCCCCCC--CCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC-CCC
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCE--SLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFP 302 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~--~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~ 302 (933)
..+..+..+++..|.++..-+ +..+. .|+.+++++|.+. .++..+..+.++..|++.+|++...-. ...
T Consensus 205 ------~~~~~l~~~~l~~n~i~~~~~-l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~~~~~~~ 276 (414)
T KOG0531|consen 205 ------DLLKKLVLLSLLDNKISKLEG-LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNLEGLERL 276 (414)
T ss_pred ------HHHHHHHHhhcccccceeccC-cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccccccccc
Confidence 113344444666666653222 22222 3677777777776 444556666777777777777765322 223
Q ss_pred CCccEEeccCCcCC
Q 002346 303 SKVQKVSLDHNNFC 316 (933)
Q Consensus 303 ~~l~~L~l~~n~~~ 316 (933)
..+..+.+..|.+.
T Consensus 277 ~~~~~~~~~~~~~~ 290 (414)
T KOG0531|consen 277 PKLSELWLNDNKLA 290 (414)
T ss_pred chHHHhccCcchhc
Confidence 34455555555554
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.87 E-value=2.2e-08 Score=98.83 Aligned_cols=128 Identities=22% Similarity=0.306 Sum_probs=84.2
Q ss_pred EEEEEEeCCCcEEEEEEeccccCC------------------------chhHHHHHHHHHHHHhcCCC--cceeEEeEee
Q 002346 596 VVYGGELPDGTKIAVKRMESNTMG------------------------NKGLSEFQAEIAVLTKVRHR--HLVALLGYCI 649 (933)
Q Consensus 596 ~Vy~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~ 649 (933)
.||.|...+|..+|||..+....+ .......++|.+.|.++..- ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489998889999999977553210 01134567899999999755 566776553
Q ss_pred eCceeEEEEeecC--CCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHH-hhhccCCCeEecCCCCCcEEecCCCcE
Q 002346 650 NGSERLLVYEYMP--RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY-LHSLAQQSFIHRDLKPSNILIGDDMRA 726 (933)
Q Consensus 650 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~-LH~~~~~~ivH~Dik~~Nill~~~~~~ 726 (933)
...+||||++ |..+.... . ..++......++.++++.+.. +|. .||+|+|+.+.||+++++ .+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~-~------~~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~ 145 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLK-D------VDLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KV 145 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHH-H------CGGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CE
T ss_pred ---CCEEEEEecCCCccchhhHH-h------ccccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eE
Confidence 3479999998 54554433 2 111134456678888886666 466 899999999999999888 99
Q ss_pred EEecccccccCC
Q 002346 727 KVADFGLVKNAP 738 (933)
Q Consensus 727 kl~DfGla~~~~ 738 (933)
.|+|||.+....
T Consensus 146 ~iIDf~qav~~~ 157 (188)
T PF01163_consen 146 YIIDFGQAVDSS 157 (188)
T ss_dssp EE--GTTEEETT
T ss_pred EEEecCcceecC
Confidence 999999877554
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.4e-08 Score=103.68 Aligned_cols=142 Identities=15% Similarity=0.162 Sum_probs=101.8
Q ss_pred CccccCCCeEEEEEEeCCCcEEEEEEeccccCCc---------hhHHHHHHHHHHHHhcCCCc--ceeEEeEeee-----
Q 002346 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN---------KGLSEFQAEIAVLTKVRHRH--LVALLGYCIN----- 650 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~----- 650 (933)
+.+-.-....|+++.+ +|+.|.||+........ .....+.+|...+.++...+ .++++++...
T Consensus 28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 4444444556777776 67899999774432110 01124789999988885333 3445555543
Q ss_pred CceeEEEEeecCCC-ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-------
Q 002346 651 GSERLLVYEYMPRG-TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD------- 722 (933)
Q Consensus 651 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~------- 722 (933)
....++|||++++. +|.+++.... ..+.+...+..++.++++.++.||+ .||+|+|++++|||++.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~ 180 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREE 180 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCC
Confidence 23568999999885 8998885421 1345567788999999999999999 99999999999999975
Q ss_pred CCcEEEecccccc
Q 002346 723 DMRAKVADFGLVK 735 (933)
Q Consensus 723 ~~~~kl~DfGla~ 735 (933)
+..+.++||+.+.
T Consensus 181 ~~~~~LIDl~r~~ 193 (268)
T PRK15123 181 DLKLSVIDLHRAQ 193 (268)
T ss_pred CceEEEEECCccc
Confidence 4689999999775
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.2e-07 Score=102.64 Aligned_cols=169 Identities=18% Similarity=0.259 Sum_probs=126.8
Q ss_pred eEEEEE-EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEee----eCceeEEEEeecCC-CChhh
Q 002346 595 GVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI----NGSERLLVYEYMPR-GTLAQ 668 (933)
Q Consensus 595 g~Vy~~-~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~ 668 (933)
.+.||+ ...||..|++|+++...... ...-..-+++++++.|.|||++.+++. .+...++||+|.++ ++|.+
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d 367 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD 367 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence 578998 34589999999995432211 112234578899999999999998876 34567899999876 67877
Q ss_pred Hhhhccc----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 669 HLFEWHD----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 669 ~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
.-+.... ......+++..|.++.|+..||.++|+ .|+.-+-+.+++|+++.+.+++|+..|......
T Consensus 368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~ 444 (655)
T KOG3741|consen 368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ 444 (655)
T ss_pred HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence 6544221 122357889999999999999999999 899999999999999999999999888765444
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRK 786 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~ 786 (933)
.+.. |-+ .-..+-|.=.||.+++.|.||..
T Consensus 445 ~d~~---------------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 445 EDPT---------------EPL---ESQQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCCC---------------cch---hHHhhhhHHHHHHHHHHHhhccc
Confidence 3220 111 11235688899999999999964
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.9e-09 Score=83.96 Aligned_cols=60 Identities=38% Similarity=0.597 Sum_probs=44.0
Q ss_pred cccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCC
Q 002346 90 TQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149 (933)
Q Consensus 90 ~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~ 149 (933)
++|++|++++|+|+.+++ .|.++++|++|++++|.|+.+++.+|.++++|++|+|++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 457777777777776666 677777777777777777777777777777777777777753
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.1e-09 Score=83.29 Aligned_cols=61 Identities=38% Similarity=0.562 Sum_probs=57.2
Q ss_pred CceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcC
Q 002346 367 GRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427 (933)
Q Consensus 367 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l 427 (933)
++|+.|+|++|+++...+..|.++++|++|+|++|+++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4799999999999987778999999999999999999988889999999999999999986
|
... |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.8e-09 Score=126.83 Aligned_cols=298 Identities=20% Similarity=0.204 Sum_probs=151.3
Q ss_pred CCcccceeecccccccccCCCccCcCcCceecccccc--ccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccC
Q 002346 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNN--FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165 (933)
Q Consensus 88 ~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~--l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L 165 (933)
+....+...+.+|.+..+.-+. ..++|++|-+..|. +..++...|..++.|++|||++|.-.+ .+|..++.|-+|
T Consensus 521 ~~~~~rr~s~~~~~~~~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~--~LP~~I~~Li~L 597 (889)
T KOG4658|consen 521 SWNSVRRMSLMNNKIEHIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLS--KLPSSIGELVHL 597 (889)
T ss_pred chhheeEEEEeccchhhccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccC--cCChHHhhhhhh
Confidence 3456677777777665433322 23367777777775 667777777778888888888765444 577788888888
Q ss_pred CeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCcccc-ccccchhhcccccCC-cccccccccCCccCcEEEec
Q 002346 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA-KSDIQNLWMNDQQLG-LSGTLDVLSGMTQLRQVWLH 243 (933)
Q Consensus 166 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~-~~~l~~l~l~~n~~~-~~~~~~~l~~l~~L~~L~L~ 243 (933)
++|+|+...+. .+|..+++|..|.+|++..+.-...+|.... -.+|++|.+...... .......+..+.+|+.|...
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 88888877776 4477788888888888877765545544443 234444443332210 11111223334444444443
Q ss_pred CCccCCCCCCCCCCCCCC----EEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCC
Q 002346 244 KNQFTGPIPDLSKCESLF----DLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNS 319 (933)
Q Consensus 244 ~N~l~~~~~~~~~~~~L~----~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~ 319 (933)
.... .....+..+..|. .+.+..+... ..+..+..+.+|+.|.+.++......-........++ .
T Consensus 677 ~~s~-~~~e~l~~~~~L~~~~~~l~~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~----~----- 745 (889)
T KOG4658|consen 677 ISSV-LLLEDLLGMTRLRSLLQSLSIEGCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLL----C----- 745 (889)
T ss_pred cchh-HhHhhhhhhHHHHHHhHhhhhcccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhh----h-----
Confidence 3322 1111122222211 2222222222 3445556666666666666665532221111111110 0
Q ss_pred CCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecc
Q 002346 320 SDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQ 399 (933)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~ 399 (933)
...+.... ..+...-..+.+.-..++|+.|.+..+.....+.+....+..++.+-+.
T Consensus 746 ----------f~~l~~~~-------------~~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~~k~~~~l~~~i~~ 802 (889)
T KOG4658|consen 746 ----------FPNLSKVS-------------ILNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPKLKALLELKELILP 802 (889)
T ss_pred ----------HHHHHHHH-------------hhccccccccchhhccCcccEEEEecccccccCCCHHHHhhhcccEEec
Confidence 00000000 0000001112222334677777777776666666666666666666666
Q ss_pred cCcccCC-CCcccCCCCCcCEEecc
Q 002346 400 QNNLTGP-IPDGLTKLASLQNLDVS 423 (933)
Q Consensus 400 ~N~l~g~-~p~~~~~l~~L~~l~ls 423 (933)
.+.+.+. .-...+.++++..+.++
T Consensus 803 f~~~~~l~~~~~l~~l~~i~~~~l~ 827 (889)
T KOG4658|consen 803 FNKLEGLRMLCSLGGLPQLYWLPLS 827 (889)
T ss_pred ccccccceeeecCCCCceeEecccC
Confidence 6666654 23344444444444443
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.72 E-value=8.5e-08 Score=96.63 Aligned_cols=137 Identities=20% Similarity=0.201 Sum_probs=98.0
Q ss_pred CccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC--------------------chhHHHHHHHHHHHHhcCCC--c
Q 002346 583 FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG--------------------NKGLSEFQAEIAVLTKVRHR--H 640 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------------------~~~~~~~~~E~~~l~~l~h~--n 640 (933)
..+++.||.|--+.||.|..+.|.++|||.-+....+ .......++|.++|.+|.-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 4567899999999999999999999999954332111 11234567899999999644 7
Q ss_pred ceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 641 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
|.+.+++ +...+||||++|-.|...- ++.+....|+..|++-+..+-. .||||+|+.+-||++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV 235 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILV 235 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEE
Confidence 7777775 3457999999886664332 1222333344444444444434 799999999999999
Q ss_pred cCCCcEEEeccccccc
Q 002346 721 GDDMRAKVADFGLVKN 736 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~ 736 (933)
+++|.+.++||--+..
T Consensus 236 ~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 236 TEDGDIVVIDWPQAVP 251 (304)
T ss_pred ecCCCEEEEeCccccc
Confidence 9999999999975543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=8.7e-07 Score=87.73 Aligned_cols=140 Identities=21% Similarity=0.181 Sum_probs=103.3
Q ss_pred cccCCCeEEEEEEeCCCcEEEEEEecccc-CC---chhHHHHHHHHHHHHhcCC--CcceeEEeEeee--C--ceeEEEE
Q 002346 589 LGRGGFGVVYGGELPDGTKIAVKRMESNT-MG---NKGLSEFQAEIAVLTKVRH--RHLVALLGYCIN--G--SERLLVY 658 (933)
Q Consensus 589 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~---~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~--~--~~~~lv~ 658 (933)
-|+||.+-|++... +|..+-+|+-.... .+ +-....|.+|+..+.++.. -.+.+++.+... + -.-+||+
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 37799999999887 45578888765211 01 3356789999999999953 235555522211 1 2357999
Q ss_pred eecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc--EEEecccccc
Q 002346 659 EYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR--AKVADFGLVK 735 (933)
Q Consensus 659 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--~kl~DfGla~ 735 (933)
|-+++ .+|.+++.+. ...+.+...+..++.+++++++-||+ .++.|+|+.+.||+++.++. ++++||.-++
T Consensus 105 e~L~g~~~L~~~l~~~---~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQH---AVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcC---CcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 6898888541 22356778888999999999999999 99999999999999986666 9999998665
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.56 E-value=6e-08 Score=117.48 Aligned_cols=104 Identities=24% Similarity=0.266 Sum_probs=53.8
Q ss_pred ccceeeccccc--ccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCe
Q 002346 91 QLETLSFQMNN--IAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (933)
Q Consensus 91 ~L~~L~l~~N~--l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~ 167 (933)
.|++|-+..|. +..+.. .|..++.|++|||++|.=-+-.|..+++|-+|++|+|++..+.. +|..+.+|+.|.+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~~---LP~~l~~Lk~L~~ 622 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGISH---LPSGLGNLKKLIY 622 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCccc---cchHHHHHHhhhe
Confidence 45555555554 222222 24555556666665543222222335555556666666555554 5556666666666
Q ss_pred eeccCcccCCCCChhhcCCCCCCEEEccCC
Q 002346 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYN 197 (933)
Q Consensus 168 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 197 (933)
|++..+.-...+|..+..|++|++|.|..-
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s 652 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRS 652 (889)
T ss_pred eccccccccccccchhhhcccccEEEeecc
Confidence 666555544444555555566665555443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.51 E-value=2.1e-08 Score=100.62 Aligned_cols=183 Identities=19% Similarity=0.190 Sum_probs=81.0
Q ss_pred CEEEEEecCCCCcc--ccCccccCCcccceeecccccccccCCCc-cCcCcCceeccccccccC-CCCCcccCCCCCCEE
Q 002346 67 RVTTISLAKSGLSG--TLSPEISSLTQLETLSFQMNNIAGAIPSL-ANATSLQDIYLDNNNFTS-VPTGCFDGLTNLQVL 142 (933)
Q Consensus 67 ~v~~L~l~~~~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~p~~-~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L 142 (933)
+|..+||.+|.|+. .+..-+.+++.|+.|+|+.|++...|.++ ..+.+|++|-|.+..+.- -....+..++.+++|
T Consensus 72 ~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vtel 151 (418)
T KOG2982|consen 72 DVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVTEL 151 (418)
T ss_pred hhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhhhh
Confidence 45555665555542 22223445666666666666665544443 345556666665555541 122234445555555
Q ss_pred EccCCCCCCCCCCCcccc-CCccCCeeeccCcccCCC--CChhhcCCCCCCEEEccCCcCCCCCCccc--cccccchhhc
Q 002346 143 SLSDNPNLAPWPFPNELT-KSTSLTTLYMDNANIFGL--IPDFFDSFSNLQNLRLSYNNFTGSLPASF--AKSDIQNLWM 217 (933)
Q Consensus 143 ~Ls~N~~~~~~~~p~~~~-~l~~L~~L~L~~n~l~~~--~p~~~~~l~~L~~L~L~~N~l~~~~p~~~--~~~~l~~l~l 217 (933)
.+|.|.+.....-..... .-+.++.|++..|....- +...-.-++++..+.+..|.+...-...= ..+.+..|.|
T Consensus 152 HmS~N~~rq~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fpnv~sv~v~e~PlK~~s~ek~se~~p~~~~LnL 231 (418)
T KOG2982|consen 152 HMSDNSLRQLNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFPNVNSVFVCEGPLKTESSEKGSEPFPSLSCLNL 231 (418)
T ss_pred hhccchhhhhccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcccchheeeecCcccchhhcccCCCCCcchhhhh
Confidence 555553211000000000 011222222222211000 00001124556666666665552211110 0123345566
Q ss_pred ccccCCcccccccccCCccCcEEEecCCccCC
Q 002346 218 NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (933)
Q Consensus 218 ~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 249 (933)
..+++......+++.+++.|..|.+++|.|..
T Consensus 232 ~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d 263 (418)
T KOG2982|consen 232 GANNIDSWASVDALNGFPQLVDLRVSENPLSD 263 (418)
T ss_pred cccccccHHHHHHHcCCchhheeeccCCcccc
Confidence 66666666666666666666666666666554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.1e-06 Score=89.30 Aligned_cols=107 Identities=27% Similarity=0.342 Sum_probs=84.2
Q ss_pred HHHHHHHHHHHHhcCCC--cceeEEeEeeeC----ceeEEEEeecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHH
Q 002346 623 LSEFQAEIAVLTKVRHR--HLVALLGYCING----SERLLVYEYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695 (933)
Q Consensus 623 ~~~~~~E~~~l~~l~h~--niv~l~~~~~~~----~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~ 695 (933)
..+..+|...+..+... .+.+.+++.... ...++|+|++++ .+|.+++.... ..+......++.++++
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~ 129 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR 129 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence 35678888888888533 345666666542 245899999987 48999886521 2556678899999999
Q ss_pred HHHHhhhccCCCeEecCCCCCcEEecCCC---cEEEecccccccC
Q 002346 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKVADFGLVKNA 737 (933)
Q Consensus 696 ~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~DfGla~~~ 737 (933)
.++-||+ .||+|+|+++.|||++.+. .+.++||+-++..
T Consensus 130 ~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 130 LIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 9999999 9999999999999999887 8999999976643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=3.7e-09 Score=117.67 Aligned_cols=131 Identities=27% Similarity=0.212 Sum_probs=89.1
Q ss_pred CccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCC
Q 002346 234 MTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHN 313 (933)
Q Consensus 234 l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n 313 (933)
.-.|...+.+.|.|.-.-.++.-++.|+.|+|++|+++.. +.+..+++|++|||++|.|+-..-..+.
T Consensus 163 Wn~L~~a~fsyN~L~~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~---------- 230 (1096)
T KOG1859|consen 163 WNKLATASFSYNRLVLMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMV---------- 230 (1096)
T ss_pred hhhHhhhhcchhhHHhHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchh----------
Confidence 3467888888888887666777788888999999998844 3788888899999999888743211110
Q ss_pred cCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccC
Q 002346 314 NFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSL 393 (933)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L 393 (933)
--+|+.|+|.+|.++. -..+.+|++|
T Consensus 231 ----------------------------------------------------gc~L~~L~lrnN~l~t--L~gie~LksL 256 (1096)
T KOG1859|consen 231 ----------------------------------------------------GCKLQLLNLRNNALTT--LRGIENLKSL 256 (1096)
T ss_pred ----------------------------------------------------hhhheeeeecccHHHh--hhhHHhhhhh
Confidence 0135666666666552 2346777777
Q ss_pred CeEecccCcccCCC-CcccCCCCCcCEEeccCCcCccc
Q 002346 394 KNLYLQQNNLTGPI-PDGLTKLASLQNLDVSNNNLSGK 430 (933)
Q Consensus 394 ~~L~L~~N~l~g~~-p~~~~~l~~L~~l~ls~N~l~g~ 430 (933)
+-|||+.|-|.+.- -..++.|..|..|+|.+|+|...
T Consensus 257 ~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~ 294 (1096)
T KOG1859|consen 257 YGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA 294 (1096)
T ss_pred hccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence 77788877776532 12355566777888888877643
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.46 E-value=6.3e-07 Score=101.84 Aligned_cols=149 Identities=21% Similarity=0.288 Sum_probs=97.6
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC---------------------------c-hhH--------
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG---------------------------N-KGL-------- 623 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------------~-~~~-------- 623 (933)
...|. .+.|+.++-|.||+|++++|+.||||+.++.... . ...
T Consensus 125 F~eF~-~~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~ 203 (517)
T COG0661 125 FSEFE-PEPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR 203 (517)
T ss_pred HHHcC-CCchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence 34444 3789999999999999999999999988664210 0 001
Q ss_pred --HHHHHHHHHHHhcC-----CCcceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHH
Q 002346 624 --SEFQAEIAVLTKVR-----HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696 (933)
Q Consensus 624 --~~~~~E~~~l~~l~-----h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~ 696 (933)
-++.+|...+.+++ .+.|.-..=|........++|||++|..+.+...-. ..+ ++ +..++..++++
T Consensus 204 ~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~-~~g---~d---~k~ia~~~~~~ 276 (517)
T COG0661 204 EELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK-SAG---ID---RKELAELLVRA 276 (517)
T ss_pred HHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH-hcC---CC---HHHHHHHHHHH
Confidence 12455666666652 233322222222345678999999999998874321 122 33 33344444443
Q ss_pred H-HHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 697 V-EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 697 l-~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
. ..+= ..|+.|.|..|.||+++.+|.+.+.|||+.....+
T Consensus 277 f~~q~~---~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 277 FLRQLL---RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHH---hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2 1121 26999999999999999999999999999876654
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.43 E-value=9.5e-08 Score=107.61 Aligned_cols=150 Identities=21% Similarity=0.283 Sum_probs=100.2
Q ss_pred HHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC------ceee--cccccccCcccccccCC
Q 002346 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK------YSVE--TRLAGTFGYLAPEYAAT 762 (933)
Q Consensus 691 ~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~------~~~~--~~~~gt~~y~aPE~~~~ 762 (933)
.+++.|+.|+|. +.++||++|.|++|.++.++..||+.|+.+....... +... .-..-...|.|||++..
T Consensus 106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 345589999998 5899999999999999999999999999866443311 1110 11224467999999999
Q ss_pred CCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHc
Q 002346 763 GRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHC 841 (933)
Q Consensus 763 ~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~c 841 (933)
...+.++|+||+|+++|.+.. |+.-+........... ... ..+... .....+...++.+-+.++
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~----~~~---~~~~~~--------~~~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF----SRN---LLNAGA--------FGYSNNLPSELRESLKKL 248 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh----hhc---cccccc--------ccccccCcHHHHHHHHHH
Confidence 888999999999999999994 4444433211111000 000 000000 001122235677888889
Q ss_pred ccCCCCCCCCHHHHHH
Q 002346 842 TAREPQQRPDMGHAVN 857 (933)
Q Consensus 842 l~~~P~~RPs~~evl~ 857 (933)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999998777654
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.6e-06 Score=82.47 Aligned_cols=155 Identities=23% Similarity=0.279 Sum_probs=104.9
Q ss_pred ecHHHHHHHhcCCccCCcccc---CCCeEEEEEEeCCCcEEEEEEeccccCCch----------------------hHHH
Q 002346 571 ISIEVLRQVTDNFSEANILGR---GGFGVVYGGELPDGTKIAVKRMESNTMGNK----------------------GLSE 625 (933)
Q Consensus 571 ~~~~~l~~~~~~~~~~~~lg~---G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~----------------------~~~~ 625 (933)
.+.+.+..+.++..+....|. |--+.||+|...++..||||+++.....-+ ....
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 456777777777777666554 555699999887899999998865432110 0122
Q ss_pred HHHHHHHHHhcC--CCcceeEEeEeeeCceeEEEEeecCCCCh-hhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhh
Q 002346 626 FQAEIAVLTKVR--HRHLVALLGYCINGSERLLVYEYMPRGTL-AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702 (933)
Q Consensus 626 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~ 702 (933)
...|+.-|.++. +-.+.+.+++. +-.|||||+..... .-.|.+ .++...+...+..++++.+.-|-.
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~ 184 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK 184 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH
Confidence 356777777773 45566666654 33799999965311 112211 223333566777777777776654
Q ss_pred ccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 703 ~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
..++||+|+..-|||+. ++.+.|+|||-|....
T Consensus 185 --~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 185 --EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred --hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 37999999999999999 8899999999876544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=7.2e-06 Score=84.46 Aligned_cols=141 Identities=16% Similarity=0.206 Sum_probs=85.8
Q ss_pred CccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCc--ceeEEeEeeeCceeEEEEeecCCC
Q 002346 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH--LVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
..||+|..+.||+. .+..+++|..+... ...+..+|.++++.+..-. +.+.+++....+...+|||+++|.
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCc
Confidence 57899999999984 25568889876432 2345688999999986433 567788887777788999999886
Q ss_pred C-hhhHh------------------hhcccCCCCCCCHHHHHH-HHH----------HHHH-HHHHhhhc-cCCCeEecC
Q 002346 665 T-LAQHL------------------FEWHDHGYTPLTWKQRVT-IAL----------DVAR-GVEYLHSL-AQQSFIHRD 712 (933)
Q Consensus 665 s-L~~~l------------------~~~~~~~~~~l~~~~~~~-i~~----------~i~~-~l~~LH~~-~~~~ivH~D 712 (933)
+ +...+ .+.+.............. +-. .+.+ ...+|... ....++|+|
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD 159 (226)
T TIGR02172 80 RSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD 159 (226)
T ss_pred cchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence 3 21111 111111000111111100 000 0001 11222211 134678999
Q ss_pred CCCCcEEecCCCcEEEecccccc
Q 002346 713 LKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 713 ik~~Nill~~~~~~kl~DfGla~ 735 (933)
+.|.||++++++ +.|+||+.+.
T Consensus 160 ~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 160 FQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CCCCcEEEcCCC-cEEEechhcC
Confidence 999999999888 9999999764
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 933 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 8e-48 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-46 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 9e-41 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 7e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-32 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-32 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-30 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-23 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 8e-23 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-22 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-21 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 3e-21 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 5e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-21 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 6e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 8e-21 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-21 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-21 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-20 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-20 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-20 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-20 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 8e-20 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 8e-20 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-19 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-19 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-19 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-19 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-19 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-19 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-19 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-19 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-19 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-19 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-19 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-19 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-19 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-19 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-19 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-19 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 6e-19 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-19 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-19 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-19 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-19 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 9e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 9e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-19 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 9e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-18 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-18 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-18 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-18 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-18 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 1e-18 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 1e-18 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-18 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-18 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-18 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-18 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-18 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 4e-18 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 4e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-18 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 7e-18 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-18 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-18 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-18 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 7e-18 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-18 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-18 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 8e-18 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 8e-18 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-18 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-17 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-17 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-17 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 3e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 4e-17 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 5e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-17 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-17 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-17 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 7e-17 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-17 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-17 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 8e-17 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-17 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 1e-16 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-16 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-16 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-16 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-16 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-16 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-16 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-16 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 3e-16 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-16 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-16 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-16 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-16 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-16 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-16 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-16 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-16 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-16 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-16 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-16 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-16 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 5e-16 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-16 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-16 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-16 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-16 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-16 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 6e-16 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-16 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-16 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-16 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-16 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-16 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-16 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-16 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-16 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-16 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-16 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-16 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-15 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-15 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 1e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-15 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-15 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-15 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-15 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 7e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-15 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-15 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-15 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 3e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-15 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 8e-05 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 4e-15 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 4e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 5e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 5e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 7e-15 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-15 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-15 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 1e-14 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-14 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-14 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-14 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-14 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-14 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-14 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-14 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-14 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 5e-14 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 6e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-13 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-13 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-13 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-13 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-13 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-13 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-13 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-13 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-13 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-13 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 6e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-13 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-13 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-12 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-12 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-12 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-12 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-12 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 3e-12 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-12 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-12 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-12 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 4e-12 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-12 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-12 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-12 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-12 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-12 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-12 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 5e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 5e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-12 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-10 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 1e-08 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-12 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 6e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 6e-12 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-12 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 6e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 6e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 8e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 8e-12 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 9e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 1e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 1e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-11 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-11 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-11 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-11 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-11 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-11 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 4e-11 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-11 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-11 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 5e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 5e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 5e-11 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 6e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 6e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 6e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 6e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 6e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-11 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 6e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-11 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 7e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 7e-11 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 7e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 8e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-11 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 9e-11 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-10 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-10 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-10 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-10 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-10 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-10 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 1e-10 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-10 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-10 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-10 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-10 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-10 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-10 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-10 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-10 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-10 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-10 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-10 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 3e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 3e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-10 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 4e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 5e-10 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-10 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 6e-10 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 6e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-10 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-10 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 6e-10 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-10 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-10 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 9e-10 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 9e-10 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 9e-10 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 9e-10 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-09 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-09 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-09 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-09 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-09 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-09 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-09 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-09 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-09 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-09 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-09 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-09 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-09 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-09 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-09 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-09 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-09 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-09 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-09 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-09 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-09 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-09 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-09 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-09 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-09 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-09 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-09 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-09 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-09 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-09 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-09 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-09 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-09 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-09 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-09 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-09 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-09 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-09 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-09 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-09 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-09 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-09 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 4e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-09 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-09 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-09 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 4e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-09 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 5e-09 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 5e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-09 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-09 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 6e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 6e-09 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 6e-09 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-09 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-09 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-09 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 6e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-09 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 7e-09 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 7e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-09 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-09 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-09 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 8e-09 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-09 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 8e-09 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-09 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-09 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 9e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 9e-09 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-09 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-09 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-08 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 1e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-08 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-08 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 1e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-08 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-08 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-08 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-08 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 1e-08 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-08 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 2e-08 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-08 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-08 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-08 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-08 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 3e-08 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-08 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-08 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-08 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-08 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-08 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-08 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-08 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-08 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-08 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 4e-08 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 4e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 4e-08 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-08 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-08 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-08 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 5e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 5e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-08 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-08 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-08 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-08 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-08 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 5e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 6e-08 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 6e-08 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 6e-08 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-08 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 6e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-08 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 6e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 6e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-08 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-08 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 8e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-08 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 8e-08 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 8e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-08 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 9e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 9e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 9e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-08 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-07 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-07 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-07 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 1e-07 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-07 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-07 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-07 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-07 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-07 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-07 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-07 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-07 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 3e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 3e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-07 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 4e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-07 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 4e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 4e-07 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 4e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-07 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-07 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 8e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 8e-07 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-07 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 9e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-07 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 9e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-06 | ||
| 3m18_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 2e-06 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-06 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-06 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-06 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-06 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 3e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-06 | ||
| 3m19_A | 251 | Crystal Structure Of Variable Lymphocyte Receptor V | 4e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-06 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 5e-06 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 5e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 5e-06 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-06 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-06 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-06 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-06 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-06 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-06 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-06 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-06 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-06 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-06 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 8e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 9e-06 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 9e-06 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-06 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-06 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 9e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 9e-06 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-05 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-05 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-05 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-05 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-05 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-05 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 1e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 1e-05 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-05 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 4e-05 | ||
| 2o6r_A | 177 | Structural Diversity Of The Hagfish Variable Lympho | 4e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-05 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-05 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 4e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 4e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-05 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-05 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-05 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 5e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 6e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 6e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 7e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-05 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 7e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 7e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 8e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 8e-05 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 8e-05 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 8e-05 | ||
| 3v44_A | 407 | Crystal Structure Of The N-Terminal Fragment Of Zeb | 8e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 9e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-05 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 9e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 1e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-04 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-04 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-04 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 1e-04 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 1e-04 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 1e-04 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-04 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 2e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-04 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-04 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3M18|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R2.1 In Complex With Hen Egg Lysozyme Length = 251 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3M19|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor Vlra.R5.1 Length = 251 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2O6R|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B61 Length = 177 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3V44|A Chain A, Crystal Structure Of The N-Terminal Fragment Of Zebrafish Tlr5 Length = 407 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 393 bits (1012), Expect = e-130
Identities = 109/313 (34%), Positives = 175/313 (55%), Gaps = 9/313 (2%)
Query: 548 SELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTK 607
S+ + + +S +L + + + L + T+NF ++G G FG VY G L DG K
Sbjct: 6 SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
+A+KR ++G+ EF+ EI L+ RH HLV+L+G+C +E +L+Y+YM G L
Sbjct: 66 VALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 668 QHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727
+HL+ D ++W+QR+ I + ARG+ YLH+ ++ IHRD+K NIL+ ++ K
Sbjct: 124 RHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPK 179
Query: 728 VADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRK 786
+ DFG+ K + + + T + GT GY+ PEY GR+T K DVY+FGVVL E + R
Sbjct: 180 ITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 787 ALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREP 846
A+ ++P + +L W + + + +DPNL D+ ES+ + + A C A
Sbjct: 240 AIVQSLPREMVNLAEWA-VESHNNGQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSS 297
Query: 847 QQRPDMGHAVNVL 859
+ RP MG + L
Sbjct: 298 EDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 387 bits (996), Expect = e-128
Identities = 102/301 (33%), Positives = 158/301 (52%), Gaps = 20/301 (6%)
Query: 572 SIEVLRQVTDNFSE------ANILGRGGFGVVYGGELPDGTKIAVKRMES--NTMGNKGL 623
S L+ VT+NF E N +G GGFGVVY G + + T +AVK++ + + +
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELK 74
Query: 624 SEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTW 683
+F EI V+ K +H +LV LLG+ +G + LVY YMP G+L L G PL+W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSW 132
Query: 684 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743
R IA A G+ +LH + IHRD+K +NIL+ + AK++DFGL + + +
Sbjct: 133 HMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 744 -VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW 802
+ +R+ GT Y+APE G +T K D+Y+FGVVL+E ITG A+D+ L+
Sbjct: 190 VMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDI 246
Query: 803 FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862
+ ++ I ID +N + S+ + +A C + +RPD+ +L +
Sbjct: 247 KEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 863 V 863
Sbjct: 305 T 305
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 380 bits (979), Expect = e-125
Identities = 125/325 (38%), Positives = 185/325 (56%), Gaps = 13/325 (4%)
Query: 557 DVSDRHLFEG--GNVAI-SIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRM 613
DV E G + S+ L+ +DNFS NILGRGGFG VY G L DGT +AVKR+
Sbjct: 3 DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62
Query: 614 ESN-TMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFE 672
+ T G + +FQ E+ +++ HR+L+ L G+C+ +ERLLVY YM G++A L E
Sbjct: 63 KEERTQGGE--LQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRE 120
Query: 673 WHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
PL W +R IAL ARG+ YLH IHRD+K +NIL+ ++ A V DFG
Sbjct: 121 -RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFG 179
Query: 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTM 792
L K V T + GT G++APEY +TG+ + K DV+ +GV+L+E ITG++A D
Sbjct: 180 LAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
Query: 793 P--DDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
DD L+ W + L+ ++ + +D +L + + E + ++ ++A CT P +RP
Sbjct: 240 LANDDDVMLLDWVKG-LLKEKKLEALVDVDLQGNYKDEE-VEQLIQVALLCTQSSPMERP 297
Query: 851 DMGHAVNVL--GPLVEQWKPATRED 873
M V +L L E+W+ +E+
Sbjct: 298 KMSEVVRMLEGDGLAERWEEWQKEE 322
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 8e-78
Identities = 72/339 (21%), Positives = 130/339 (38%), Gaps = 43/339 (12%)
Query: 548 SELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTK 607
H SSG V + E L + + RG FG V+ +
Sbjct: 3 HHHHHHSSG------------VDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEY 49
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ERLLVYEYMPR 663
+AVK +K + + E+ L ++H +++ +G G+ + L+ + +
Sbjct: 50 VAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEK 106
Query: 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS-------LAQQSFIHRDLKPS 716
G+L+ L + ++W + IA +ARG+ YLH + + HRD+K
Sbjct: 107 GSLSDFL---KAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSK 160
Query: 717 NILIGDDMRAKVADFGLVKNAPDGKYSVET-RLAGTFGYLAPEYAATG-----RVTTKID 770
N+L+ +++ A +ADFGL GK + +T GT Y+APE +ID
Sbjct: 161 NVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRID 220
Query: 771 VYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL----ISKENIPKAIDPNLNLDEE 826
+YA G+VL E + A D + + + + + + K P L +
Sbjct: 221 MYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQ 280
Query: 827 TIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
+ + E C + + R G + +
Sbjct: 281 KHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL 319
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 242 bits (620), Expect = 2e-68
Identities = 97/429 (22%), Positives = 171/429 (39%), Gaps = 81/429 (18%)
Query: 21 TTTSLGDDGSVMLKLAQSL--QNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGL 78
+ SL + ++ L +NL DWSS + C + G+ C + +VT+I L+ L
Sbjct: 6 PSQSLYREIHQLISFKDVLPDKNLLPDWSSNKN--PCTFDGVTCRDD-KVTSIDLSSKPL 62
Query: 79 S---GTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV--PTGCF 133
+ +S + SLT LE+L ++I G++ + SL + L N+ +
Sbjct: 63 NVGFSAVSSSLLSLTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSL 122
Query: 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD---FFDSFSNLQ 190
+ L+ L++S N P K SL L + +I G D L+
Sbjct: 123 GSCSGLKFLNVSSNTLDFPGKVS-GGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELK 181
Query: 191 NLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250
+L +S N +G + +S L + + N F+
Sbjct: 182 HLAISGNKISGDVD--------------------------VSRCVNLEFLDVSSNNFSTG 215
Query: 251 IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVS 309
IP L C +L L + N+L+G ++ + L +++ +N+ GP P P +Q +S
Sbjct: 216 IPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLPLKSLQYLS 275
Query: 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
L N F G+ + D G C +
Sbjct: 276 LAENKF------TGE---------------------IPDFLSGA----------CDT--L 296
Query: 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP-DGLTKLASLQNLDVSNNNLS 428
++L+ G + P + + + L++L L NN +G +P D L K+ L+ LD+S N S
Sbjct: 297 TGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFS 356
Query: 429 GKVPDFGSN 437
G++P+ +N
Sbjct: 357 GELPESLTN 365
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-61
Identities = 105/385 (27%), Positives = 156/385 (40%), Gaps = 66/385 (17%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+ + + + ++ + LSG S IS+ T+L+ L+ N G IP SLQ + L N
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-LPLKSLQYLSLAEN 279
Query: 124 NFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-D 181
FT +P L L LS N + P + L +L + + N G +P D
Sbjct: 280 KFTGEIPDFLSGACDTLTGLDLSGN-HFYG-AVPPFFGSCSLLESLALSSNNFSGELPMD 337
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG-------- 233
L+ L LS+N F+G LP S NL + L LS SG
Sbjct: 338 TLLKMRGLKVLDLSFNEFSGELPESLT-----NLSASLLTLDLSSNN--FSGPILPNLCQ 390
Query: 234 --MTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
L++++L N FTG IP LS C L L L N L+G +P+S+ SL L ++ L
Sbjct: 391 NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLW 450
Query: 291 NNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
N L+G P ++ + LD N+ G+ +
Sbjct: 451 LNMLEGEIPQELMYVKTLETLILDFNDL------TGE---------------------IP 483
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
N C+ + I+L+N L G I L +L L L N+ +G I
Sbjct: 484 SGL-SN----------CTN--LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNI 530
Query: 408 PDGLTKLASLQNLDVSNNNLSGKVP 432
P L SL LD++ N +G +P
Sbjct: 531 PAELGDCRSLIWLDLNTNLFNGTIP 555
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 6e-57
Identities = 82/385 (21%), Positives = 150/385 (38%), Gaps = 64/385 (16%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEI---SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYL 120
N + + L+ + +SG +L+ L+ N I+G + ++ +L+ + +
Sbjct: 149 KLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD-VSRCVNLEFLDV 207
Query: 121 DNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+NNF+ +P + LQ L +S N L+ F ++ T L L + + G I
Sbjct: 208 SSNNFSTGIPF--LGDCSALQHLDISGN-KLS-GDFSRAISTCTELKLLNISSNQFVGPI 263
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
P +LQ L L+ N FTG +P + + L
Sbjct: 264 PPL--PLKSLQYLSLAENKFTGEIPDFLSGA-----------------------CDTLTG 298
Query: 240 VWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQGP 297
+ L N F G +P C L L+L N +G +P + + L + L N+ G
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358
Query: 298 YPLF----PSKVQKVSLDHNNFCKN-SSDAGKPCDPQVTTLL----QIAGDMGYPAILSD 348
P + + + L NNF + + + L G + P L
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI--PPTL-- 414
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408
+ +++++L+ L+G I + +L+ L++L L N L G IP
Sbjct: 415 ---------------SNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIP 459
Query: 409 DGLTKLASLQNLDVSNNNLSGKVPD 433
L + +L+ L + N+L+G++P
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPS 484
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 208 bits (533), Expect = 8e-57
Identities = 87/373 (23%), Positives = 153/373 (41%), Gaps = 27/373 (7%)
Query: 69 TTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGAIP-SLANAT-SLQDIYLDNNNF 125
+++L+ + SG L + + + L+ L N +G +P SL N + SL + L +NNF
Sbjct: 321 ESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNF 380
Query: 126 T-SVPTG-CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ + C + LQ L L +N P L+ + L +L++ + G IP
Sbjct: 381 SGPILPNLCQNPKNTLQELYLQNN-GFT-GKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTL-DVLSGMTQLRQVW 241
S S L++L+L N G +P ++ L ++ L +G + LS T L +
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL--TGEIPSGLSNCTNLNWIS 496
Query: 242 LHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300
L N+ TG IP + + E+L L L +N +G +PA + +L+ + L N G P
Sbjct: 497 LSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIP- 555
Query: 301 FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
K S + + G +
Sbjct: 556 ------------AAMFKQSGKIAA--NFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRS 601
Query: 361 FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420
N+ +++ G+ SP + N S+ L + N L+G IP + + L L
Sbjct: 602 EQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFIL 661
Query: 421 DVSNNNLSGKVPD 433
++ +N++SG +PD
Sbjct: 662 NLGHNDISGSIPD 674
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 3e-56
Identities = 101/410 (24%), Positives = 170/410 (41%), Gaps = 63/410 (15%)
Query: 37 QSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLS 96
SL+ L D S+ S +G + D + ++++ + +SG + +S LE L
Sbjct: 151 NSLEVL--DLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLD 206
Query: 97 FQMNNIAGAIPSLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPF 155
NN + IP L + ++LQ + + N + T L++L++S N P
Sbjct: 207 VSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAIS-TCTELKLLNISSN-QFV-GPI 263
Query: 156 PNELTKSTSLTTLYMDNANIFGLIPD-FFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQ 213
P SL L + G IPD + L L LS N+F G++P F S ++
Sbjct: 264 PPL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLE 321
Query: 214 NLWMNDQQLGLSGTL--DVLSGMTQLRQVWLHKNQFTGPIPD-LSKC-ESLFDLSLRDNQ 269
+L ++ SG L D L M L+ + L N+F+G +P+ L+ SL L L N
Sbjct: 322 SLALSSNNF--SGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNN 379
Query: 270 LTGVVPASV--ISLPALLNISLQNNKLQGPYPLFP---SKVQKVSLDHNNFCKNSSDAGK 324
+G + ++ L + LQNN G P S++ + L N
Sbjct: 380 FSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFN----------- 428
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384
++G + P+ L ++ + L +L G I
Sbjct: 429 ----------YLSGTI--PSSLGSL-----------------SKLRDLKLWLNMLEGEIP 459
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434
+ +L+ L L N+LTG IP GL+ +L + +SNN L+G++P +
Sbjct: 460 QELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 2e-55
Identities = 82/380 (21%), Positives = 140/380 (36%), Gaps = 61/380 (16%)
Query: 69 TTISLAKSGLSGTLS-PEISSLTQLETLSFQMNNIAGAIPS----LANATSLQDIYLDNN 123
++++ + L L LE L N+I+GA L+ + + N
Sbjct: 129 KFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGN 188
Query: 124 NFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
+ V NL+ L +S N N + P L ++L L + + G
Sbjct: 189 KISGDVDVS---RCVNLEFLDVSSN-NFST-GIP-FLGDCSALQHLDISGNKLSGDFSRA 242
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL--DVLSGMTQLRQV 240
+ + L+ L +S N F G +P KS +Q L + + + +G + + L +
Sbjct: 243 ISTCTELKLLNISSNQFVGPIPPLPLKS-LQYLSLAENKF--TGEIPDFLSGACDTLTGL 299
Query: 241 WLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQGPY 298
L N F G +P C L L+L N +G +P + + L + L N+ G
Sbjct: 300 DLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGEL 359
Query: 299 PLF----PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNN 354
P + + + L NNF G IL + +
Sbjct: 360 PESLTNLSASLLTLDLSSNNFS------GP--------------------ILPNLCQ--- 390
Query: 355 ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414
+ + + L N G I P +N + L +L+L N L+G IP L L
Sbjct: 391 ---------NPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSL 441
Query: 415 ASLQNLDVSNNNLSGKVPDF 434
+ L++L + N L G++P
Sbjct: 442 SKLRDLKLWLNMLEGEIPQE 461
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-55
Identities = 85/385 (22%), Positives = 155/385 (40%), Gaps = 28/385 (7%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLT-QLETLSFQMNNIAGAIPS---LANATSLQDIY 119
+ + L+ + SG L +++L+ L TL NN +G I +LQ++Y
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400
Query: 120 LDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
L NN FT +P + L L LS N L+ P+ L + L L + + G
Sbjct: 401 LQNNGFTGKIPPT-LSNCSELVSLHLSFN-YLS-GTIPSSLGSLSKLRDLKLWLNMLEGE 457
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTL-DVLSGMTQ 236
IP L+ L L +N+ TG +P+ + +++ + +++ +L +G + + +
Sbjct: 458 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL--TGEIPKWIGRLEN 515
Query: 237 LRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
L + L N F+G IP L C SL L L N G +PA++ + N +
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKI----AANFIA 571
Query: 296 GPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
G ++ H + + + +
Sbjct: 572 GKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNP---------CNIT--SRVY 620
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
+ G ++ ++++ +L+G I ++ L L L N+++G IPD + L
Sbjct: 621 GGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLR 680
Query: 416 SLQNLDVSNNNLSGKVPDFGSNVKF 440
L LD+S+N L G++P S +
Sbjct: 681 GLNILDLSSNKLDGRIPQAMSALTM 705
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 6e-53
Identities = 94/383 (24%), Positives = 157/383 (40%), Gaps = 61/383 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122
+ + ++ + S + P + + L+ L N ++G +++ T L+ + + +
Sbjct: 198 RCVNLEFLDVSSNNFSTGI-PFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISS 256
Query: 123 NNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT-KSTSLTTLYMDNANIFGLIP 180
N F +P L +LQ LSL++N P+ L+ +LT L + + +G +P
Sbjct: 257 NQFVGPIPPL---PLKSLQYLSLAEN-KFT-GEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
FF S S L++L LS NNF+G LP L M L+ +
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDT-----------------------LLKMRGLKVL 348
Query: 241 WLHKNQFTGPIPD-LSKC-ESLFDLSLRDNQLTGVVPASV--ISLPALLNISLQNNKLQG 296
L N+F+G +P+ L+ SL L L N +G + ++ L + LQNN G
Sbjct: 349 DLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTG 408
Query: 297 PYPLFP---SKVQKVSLDHNNFCKNSSDAGK--PCDPQVTTLLQIAGDMGYPAILSDSWE 351
P S++ + L N +G ++ L + L
Sbjct: 409 KIPPTLSNCSELVSLHLSFNYL------SGTIPSSLGSLSKLRDL--------KLW---- 450
Query: 352 GNNACDG-WPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
N +G P + T+ L L G I +N T+L + L N LTG IP
Sbjct: 451 -LNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKW 509
Query: 411 LTKLASLQNLDVSNNNLSGKVPD 433
+ +L +L L +SNN+ SG +P
Sbjct: 510 IGRLENLAILKLSNNSFSGNIPA 532
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 8e-49
Identities = 88/395 (22%), Positives = 144/395 (36%), Gaps = 74/395 (18%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLD 121
+ ++++ + G + P L L+ LS N G IP +L + L
Sbjct: 245 TCTELKLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302
Query: 122 NNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNE-LTKSTSLTTLYMDNANIFGLI 179
N+F +VP F + L+ L+LS N N + P + L K L L + G +
Sbjct: 303 GNHFYGAVPP-FFGSCSLLESLALSSN-NFSG-ELPMDTLLKMRGLKVLDLSFNEFSGEL 359
Query: 180 PD-FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWM-----NDQQLGLSGTL-DVLS 232
P+ + ++L L LS NNF+G + + ++ L N G +G + LS
Sbjct: 360 PESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNN----GFTGKIPPTLS 415
Query: 233 GMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
++L + L N +G IP L L DL L N L G +P ++ + L + L
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 292 NKLQGPYPLFP------SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI 345
N L G P + + +SL +N
Sbjct: 476 NDLTGE---IPSGLSNCTNLNWISLSNNR------------------------------- 501
Query: 346 LSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG 405
L+ P + + L+N +GNI + SL L L N G
Sbjct: 502 LTGEI---------PKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNG 552
Query: 406 PIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKF 440
IP + K + ++ N ++GK + N
Sbjct: 553 TIPAAMFKQS----GKIAANFIAGKRYVYIKNDGM 583
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 9e-49
Identities = 81/394 (20%), Positives = 139/394 (35%), Gaps = 81/394 (20%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122
N + + ++ L+ + LSGT+ + SL++L L +N + G IP L +L+ + LD
Sbjct: 416 NCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDF 475
Query: 123 NNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
N+ T +P+ TNL +SLS+N L P + + +L L + N + G IP
Sbjct: 476 NDLTGEIPS-GLSNCTNLNWISLSNN-RLTG-EIPKWIGRLENLAILKLSNNSFSGNIPA 532
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+L L L+ N F G++PA+
Sbjct: 533 ELGDCRSLIWLDLNTNLFNGTIPAAMF-----KQSGK----------------------- 564
Query: 242 LHKNQFTGPIP-DLSKCESLFDLSLRDN--QLTGVVPASVISLPALLNISLQNNKLQGPY 298
+ N G + + N + G+ + L ++ + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 299 PLFPSKVQKVS---LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
+ + +N G + P +
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLS---------------------GYI--PKEIGS------- 654
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
+ +NL + ++G+I +L L L L N L G IP ++ L
Sbjct: 655 --------MPY--LFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALT 704
Query: 416 SLQNLDVSNNNLSGKVPDFGSNVKFTVS--PGNP 447
L +D+SNNNLSG +P+ G F + NP
Sbjct: 705 MLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNP 738
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 224 bits (573), Expect = 1e-66
Identities = 82/283 (28%), Positives = 135/283 (47%), Gaps = 24/283 (8%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G G FG V+ E G+ +AVK + + ++EF E+A++ ++RH ++V +G
Sbjct: 43 EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGY-TPLTWKQRVTIALDVARGVEYLHSLAQ 705
+V EY+ RG+L + L H G L ++R+++A DVA+G+ YLH+
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLL---HKSGAREQLDERRRLSMAYDVAKGMNYLHNRN- 157
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV 765
+HR+LK N+L+ KV DFGL + S AGT ++APE
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSS-KSAAGTPEWMAPEVLRDEPS 216
Query: 766 TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDE 825
K DVY+FGV+L E T ++ + P V + + L IP+ ++P +
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE----IPRNLNPQV---- 268
Query: 826 ETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868
A + C EP +RP +++L PL++ P
Sbjct: 269 ---------AAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 215 bits (550), Expect = 2e-63
Identities = 82/338 (24%), Positives = 136/338 (40%), Gaps = 45/338 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
++GRG FGVV + +A+K++ES + F E+ L++V H +
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESESE----RKAFIVELRQLSRVNHPN 62
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP-LTWKQRVTIALDVARGVEY 699
+V L G C+N LV EY G+L L H P T ++ L ++GV Y
Sbjct: 63 IVKLYGACLN--PVCLVMEYAEGGSLYNVL---HGAEPLPYYTAAHAMSWCLQCSQGVAY 117
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMR-AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
LHS+ ++ IHRDLKP N+L+ K+ DFG + + T G+ ++APE
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPE 173
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN---IPK 815
+ K DV+++G++L E IT R P D + + + K
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFRIMWAVHNGTRPPLIK 227
Query: 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPATREDED 875
+ + L C +++P QRP M V ++ L+ + A +
Sbjct: 228 NLPKPI-------------ESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274
Query: 876 GYGIDLHMSLPQALQRWQANEGTSTMFGDVSSSYSQSH 913
L ++ + F + +S H
Sbjct: 275 PCQHSLPPGEDGRVEPYV-------DFAEFYRLWSVDH 305
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-62
Identities = 59/285 (20%), Positives = 106/285 (37%), Gaps = 35/285 (12%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
L G ++ G G I VK ++ + +F E L H +++ +LG
Sbjct: 16 TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 647 YCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
C + + +MP G+L L H+ + Q V ALD+ARG+ +LH+L
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKFALDMARGMAFLHTL- 130
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE---YAA 761
+ L +++I +DM A+++ + ++APE
Sbjct: 131 EPLIPRHALNSRSVMIDEDMTARISMADV------KFSFQSPGRMYAPAWVAPEALQKKP 184
Query: 762 TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF-RRVLISKENIPKAIDPN 820
D+++F V+L E +T D + V R IP I P+
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP-----TIPPGISPH 239
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
+ ++L C +P +RP V +L + ++
Sbjct: 240 V-------------SKLMKICMNEDPAKRPKFDMIVPILEKMQDK 271
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (534), Expect = 1e-61
Identities = 74/283 (26%), Positives = 115/283 (40%), Gaps = 37/283 (13%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
I+G GGFG VY G ++AVK + + ++ + + E + ++H +++AL
Sbjct: 13 EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
G C+ LV E+ G L + L + V A+ +ARG+ YLH A
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL---SGK---RIPPDILVNWAVQIARGMNYLHDEA 125
Query: 705 QQSFIHRDLKPSNILIGDDMR--------AKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
IHRDLK SNILI + K+ DFGL + AG + ++A
Sbjct: 126 IVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMA 182
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816
PE + DV+++GV+L E +TG A+ V + L IP
Sbjct: 183 PEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP----IPST 238
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
A+L C +P RP + ++ L
Sbjct: 239 CPEPF-------------AKLMEDCWNPDPHSRPSFTNILDQL 268
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 3e-61
Identities = 72/328 (21%), Positives = 121/328 (36%), Gaps = 52/328 (15%)
Query: 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAV--LTKVR 637
DN ++GRG +G VY G L D +AVK F E + + +
Sbjct: 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR-----QNFINEKNIYRVPLME 65
Query: 638 HRHLVALLGYCINGS-----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
H ++ + + E LLV EY P G+L ++L W +A
Sbjct: 66 HDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHS 119
Query: 693 VARGVEYLHS------LAQQSFIHRDLKPSNILIGDDMRAKVADFGL-------VKNAPD 739
V RG+ YLH+ + + HRDL N+L+ +D ++DFGL P
Sbjct: 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPG 179
Query: 740 GKYSVETRLAGTFGYLAPEYA-------ATGRVTTKIDVYAFGVVLMETITGRKAL--DD 790
+ + GT Y+APE ++D+YA G++ E L +
Sbjct: 180 EEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239
Query: 791 TMPDDRAHLVTWFR--------RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCT 842
++P+ + T +VL+S+E + + S+ E C
Sbjct: 240 SVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSL---KETIEDCW 296
Query: 843 AREPQQRPDMGHAVNVLGPLVEQWKPAT 870
++ + R A + L+ W+
Sbjct: 297 DQDAEARLTAQXAEERMAELMMIWERNK 324
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 6e-61
Identities = 76/294 (25%), Positives = 129/294 (43%), Gaps = 43/294 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRM-----ESNTMGNKGLSEFQAEIAVLT 634
+ +G+GGFG+V+ G + D + +A+K + E T + EFQ E+ +++
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
+ H ++V L G N +V E++P G L L D P+ W ++ + LD+A
Sbjct: 79 NLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRL---LDKA-HPIKWSVKLRLMLDIA 132
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILI-----GDDMRAKVADFGLVKNAPDGKYSVETRLA 749
G+EY+ + +HRDL+ NI + + AKVADFGL + + + L
Sbjct: 133 LGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSV----SGLL 187
Query: 750 GTFGYLAPE--YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807
G F ++APE A T K D Y+F ++L +TG D+ + + +
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIR 243
Query: 808 ISKE--NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
IP+ P L + C + +P++RP + V L
Sbjct: 244 EEGLRPTIPEDCPPRL-------------RNVIELCWSGDPKKRPHFSYIVKEL 284
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 9e-61
Identities = 72/295 (24%), Positives = 111/295 (37%), Gaps = 43/295 (14%)
Query: 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+LG+G FG G + +K + + F E+ V+ + H +++ +
Sbjct: 16 EVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFI 73
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G + EY+ GTL + + W QRV+ A D+A G+ YLHS
Sbjct: 74 GVLYKDKRLNFITEYIKGGTLRGII---KSMD-SQYPWSQRVSFAKDIASGMAYLHS--- 126
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-------------LAGTF 752
+ IHRDL N L+ ++ VADFGL + D K E + G
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 753 GYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP--DDRAHLVTWFRRVLISK 810
++APE K+DV++FG+VL E I A D +P D V F
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY--- 243
Query: 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
P P+ + C +P++RP + L L
Sbjct: 244 --CPPNCPPSF-------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 1e-60
Identities = 56/286 (19%), Positives = 107/286 (37%), Gaps = 40/286 (13%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
++G+G FG VY G G +A++ ++ L F+ E+ + RH ++V +G
Sbjct: 39 ELIGKGRFGQVYHGRW-HGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
C++ ++ TL + D L + IA ++ +G+ YLH+ +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVV---RDAK-IVLDVNKTRQIAQEIVKGMGYLHA---K 149
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVK----NAPDGKYSVETRLAGTFGYLAPE---- 758
+H+DLK N+ D+ + + DFGL + G +LAPE
Sbjct: 150 GILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQ 208
Query: 759 -----YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813
+ DV+A G + E + + + +S+ +
Sbjct: 209 LSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGM 268
Query: 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
K I +++ C A E ++RP +++L
Sbjct: 269 GKEI-----------------SDILLFCWAFEQEERPTFTKLMDML 297
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 3e-60
Identities = 73/276 (26%), Positives = 122/276 (44%), Gaps = 29/276 (10%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G G FG VY G+ G +AVK + + L F+ E+ VL K RH +++ +GY
Sbjct: 32 IGSGSFGTVYKGKW-HGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 649 INGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
+L +V ++ +L HL H T K+ + IA ARG++YLH+ +S
Sbjct: 90 TA--PQLAIVTQWCEGSSLYHHL---HASE-TKFEMKKLIDIARQTARGMDYLHA---KS 140
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFGYLAPE---YAATG 763
IHRDLK +NI + +D K+ DFGL + +L+G+ ++APE +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 764 RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823
+ + DVYAFG+VL E +TG+ + D+ + + + +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM-- 258
Query: 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
L C ++ +RP + +
Sbjct: 259 -----------KRLMAECLKKKRDERPSFPRILAEI 283
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-58
Identities = 72/302 (23%), Positives = 132/302 (43%), Gaps = 19/302 (6%)
Query: 27 DDGSVMLKLAQSLQNLP--SDWSSTSSTGYCEWTGINCD---NSNRVTTISLAKSGLSGT 81
D +L++ + L N S W T+ W G+ CD + RV + L+ L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 82 --LSPEISSLTQLETLSFQ-MNNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGL 136
+ +++L L L +NN+ G IP ++A T L +Y+ + N + ++P +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF-LSQI 124
Query: 137 TNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL-QNLRLS 195
L L S N L+ P ++ +L + D I G IPD + SFS L ++ +S
Sbjct: 125 KTLVTLDFSYN-ALSG-TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-DVLSGMTQLRQVWLHKNQFTGPIPDL 254
N TG +P +FA ++ + ++ L G + +++ L KN + +
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDLSRNML--EGDASVLFGSDKNTQKIHLAKNSLAFDLGKV 240
Query: 255 SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP--SKVQKVSLDH 312
++L L LR+N++ G +P + L L ++++ N L G P + + +
Sbjct: 241 GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYAN 300
Query: 313 NN 314
N
Sbjct: 301 NK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 5e-47
Identities = 76/343 (22%), Positives = 128/343 (37%), Gaps = 70/343 (20%)
Query: 108 SLANATSLQD----IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKST 163
L N T+L N + V + L LS P+P P+ L
Sbjct: 17 DLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLP 76
Query: 164 SLTTLYMDNAN-IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
L LY+ N + G IP + L L +++ N +G++P
Sbjct: 77 YLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDF---------------- 120
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISL 281
LS + L + N +G +P +S +L ++ N+++G +P S S
Sbjct: 121 --------LSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSF 172
Query: 282 PALLN-ISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340
L +++ N+L G P ++L + +N + GD
Sbjct: 173 SKLFTSMTISRNRLTGK---IPPTFANLNLAFVDLSRN----------------MLEGDA 213
Query: 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQ 400
+ G++ I+LA LA ++ +L L L+
Sbjct: 214 --SVLF-----GSDK------------NTQKIHLAKNSLAFDL-GKVGLSKNLNGLDLRN 253
Query: 401 NNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVS 443
N + G +P GLT+L L +L+VS NNL G++P G+ +F VS
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVS 296
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 44/121 (36%), Positives = 60/121 (49%), Gaps = 9/121 (7%)
Query: 326 CDPQ-VTTLLQIAGDMGYPAILSDSWEGNNACDG-WPFVTCSQ----GRIITINLANKLL 379
C+PQ LLQI D+G P LS + C+ W V C R+ ++L+ L
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 380 AG--NISPAYANLTSLKNLYLQ-QNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGS 436
I + ANL L LY+ NNL GPIP + KL L L +++ N+SG +PDF S
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLS 122
Query: 437 N 437
Sbjct: 123 Q 123
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 1e-15
Identities = 29/142 (20%), Positives = 55/142 (38%), Gaps = 8/142 (5%)
Query: 65 SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNN 123
S T+++++++ L+G + P ++L L + N + G + + Q I+L N
Sbjct: 173 SKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 124 NFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
+ + NL L L +N + P LT+ L +L + N+ G IP
Sbjct: 232 SLAFDLGK--VGLSKNLNGLDLRNN-RIYG-TLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 183 FDSFSNLQNLRLSYNNFTGSLP 204
+ + N P
Sbjct: 288 G-NLQRFDVSAYANNKCLCGSP 308
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 2e-52
Identities = 68/342 (19%), Positives = 119/342 (34%), Gaps = 47/342 (13%)
Query: 553 QSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKR 612
+S D+ ++ G + + V R + +G+G +G V+ G+ G K+AVK
Sbjct: 9 ESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKV 67
Query: 613 MESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER----LLVYEYMPRGTLAQ 668
+ + + EI +RH +++ + I G+ L+ +Y G+L
Sbjct: 68 FFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD 124
Query: 669 HLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF-----IHRDLKPSNILIGDD 723
+L L K + +A G+ +LH+ + HRDLK NIL+ +
Sbjct: 125 YL---KST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN 178
Query: 724 MRAKVADFGLVKNAPDGKYSVE---TRLAGTFGYLAPE------YAATGRVTTKIDVYAF 774
+AD GL V+ GT Y+ PE + D+Y+F
Sbjct: 179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSF 238
Query: 775 GVVLMETITGRKALD---------DTMPDDRAHLVTWFRRVLISKE--NIPKAIDPNLNL 823
G++L E + + V I K + P +
Sbjct: 239 GLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSD--- 295
Query: 824 DEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
E + ++ +L C A P R L + E
Sbjct: 296 -----ECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 4e-51
Identities = 64/320 (20%), Positives = 113/320 (35%), Gaps = 53/320 (16%)
Query: 575 VLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAE--IAV 632
+ R V + + +G+G +G V+ G G +AVK S + + E +
Sbjct: 2 MQRTVARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS-----RDEKSWFRETELYN 55
Query: 633 LTKVRHRHLVALLGYCINGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT 688
+RH +++ + + + L+ Y G+L +L L +
Sbjct: 56 TVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLT---TLDTVSCLR 109
Query: 689 IALDVARGVEYLHSLAQQSF-----IHRDLKPSNILIGDDMRAKVADFGL---VKNAPDG 740
I L +A G+ +LH + HRDLK NIL+ + + +AD GL + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169
Query: 741 KYSVETRLAGTFGYLAPE------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD 794
GT Y+APE ++D++AFG+VL E R + + D
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVAR-RMVSNGIVED 228
Query: 795 DR--------AHLVTWFRRVLISKEN----IPKAIDPNLNLDEETIESIYRVAELAGHCT 842
+ R ++ + IP + L +A+L C
Sbjct: 229 YKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTS--------LAKLMKECW 280
Query: 843 AREPQQRPDMGHAVNVLGPL 862
+ P R L +
Sbjct: 281 YQNPSARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-48
Identities = 65/307 (21%), Positives = 113/307 (36%), Gaps = 45/307 (14%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAE--IAVLTKVRHRHLVAL 644
+G+G FG V+ G+ G ++AVK S + E I +RH +++
Sbjct: 48 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGF 101
Query: 645 LGYCINGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+ + + LV +Y G+L +L + + +T + + +AL A G+ +L
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYL---NRY---TVTVEGMIKLALSTASGLAHL 155
Query: 701 HSLAQQS-----FIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYSVETRLAGTF 752
H + HRDLK NIL+ + +AD GL +A D GT
Sbjct: 156 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 215
Query: 753 GYLAPE------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD--------DRAH 798
Y+APE + D+YA G+V E R ++ D +
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLPYYDLVPSD 274
Query: 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858
R ++ ++ + I E++ +A++ C R
Sbjct: 275 PSVEEMRKVVCEQKLRPNIPNRWQSC----EALRVMAKIMRECWYANGAARLTALRIKKT 330
Query: 859 LGPLVEQ 865
L L +Q
Sbjct: 331 LSQLSQQ 337
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 5e-47
Identities = 62/200 (31%), Positives = 92/200 (46%), Gaps = 16/200 (8%)
Query: 589 LGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+GRG FG V+ G L D T +AVK ++F E +L + H ++V L+G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C +V E + G L G L K + + D A G+EYL S +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL---RTEG-ARLRVKTLLQMVGDAAAGMEYLES---KC 233
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY----LAPEYAATG 763
IHRDL N L+ + K++DFG+ + DG Y G APE G
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY---AASGGLRQVPVKWTAPEALNYG 290
Query: 764 RVTTKIDVYAFGVVLMETIT 783
R +++ DV++FG++L ET +
Sbjct: 291 RYSSESDVWSFGILLWETFS 310
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 1e-45
Identities = 73/410 (17%), Positives = 132/410 (32%), Gaps = 83/410 (20%)
Query: 67 RVTTISLAKSGLSGTLSPEISSLTQLETL---------SFQMNNIAGAIP-SLANATSLQ 116
++ L + + S + L + L S + ++ S L+
Sbjct: 273 QLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLE 332
Query: 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN----PNLAPWPFPNELTKSTSLTTLYMDN 172
+ +++N+ + + F GL NL+ LSLS++ L F + + L L +
Sbjct: 333 HLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVS--LAHSPLHILNLTK 390
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
I + D F +L+ L L N L
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ-----------------------EWR 427
Query: 233 GMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGV--VPASVISLPALLNISL 289
G+ + +++L N++ + + SL L LR L V P+ L L + L
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDL 487
Query: 290 QNNKLQG-PYPLFPS--KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL 346
NN + + K++ + L HNN L
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNN-------------------------------L 516
Query: 347 SDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGP 406
+ W+ N F+ + +NL + + +L LK + L NNL
Sbjct: 517 ARLWKHANPGGPIYFLK-GLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575
Query: 407 IPDGLTKLASLQNLDVSNNNLSGKVPD-FGSNVK----FTVSPGNPFIGT 451
SL++L++ N ++ FG + + NPF T
Sbjct: 576 PASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMR-FNPFDCT 624
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 5e-42
Identities = 65/389 (16%), Positives = 125/389 (32%), Gaps = 83/389 (21%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT 126
+T ++L + L + + +QL +L N I+ P L+ + L +N +
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
+ F TNL L L N ++ N K +L TL + + +
Sbjct: 87 QLSDKTFAFCTNLTELHLMSN-SIQ-KIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQL 144
Query: 187 SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
NLQ L LS N + + L+++ L NQ
Sbjct: 145 ENLQELLLSNNKIQALKSEELD----------------------IFANSSLKKLELSSNQ 182
Query: 247 FTGPIPD-LSKCESLFDLSLRDNQLTGVVPASV---ISLPALLNISLQNNKLQGPYP--- 299
P LF L L + QL + + ++ ++ N+SL N++L
Sbjct: 183 IKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTF 242
Query: 300 --LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD 357
L + + + L +NN +D+
Sbjct: 243 LGLKWTNLTMLDLSYNNLNVVGNDS----------------------------------- 267
Query: 358 GWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQN---------NLTGPIP 408
F Q + L + S + L +++ L L+++ +L
Sbjct: 268 ---FAWLPQ--LEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDD 322
Query: 409 DGLTKLASLQNLDVSNNNLSGKVPDFGSN 437
L L++L++ +N++ G + +
Sbjct: 323 FSFQWLKCLEHLNMEDNDIPGIKSNMFTG 351
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-41
Identities = 56/372 (15%), Positives = 117/372 (31%), Gaps = 82/372 (22%)
Query: 89 LTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
T + L+ N + + + L + + N + + L L+VL+L N
Sbjct: 24 PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHN 83
Query: 148 P--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205
L+ T+LT L++ + +I + + F NL L LS+N + +
Sbjct: 84 ELSQLS----DKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLG 139
Query: 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD---LSKCESLFD 262
+ + L+++ L N+ + + SL
Sbjct: 140 TQ------------------------VQLENLQELLLSNNKIQALKSEELDIFANSSLKK 175
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP------LFPSKVQKVSLDHNNFC 316
L L NQ+ P ++ L + L N +L L + ++ +SL ++
Sbjct: 176 LELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLS 235
Query: 317 KNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLAN 376
S+ F+ + ++L+
Sbjct: 236 TTSNTT--------------------------------------FLGLKWTNLTMLDLSY 257
Query: 377 KLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGS 436
L + ++A L L+ +L+ NN+ L L +++ L++ + + S
Sbjct: 258 NNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSI----S 313
Query: 437 NVKFTVSPGNPF 448
F
Sbjct: 314 LASLPKIDDFSF 325
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-41
Identities = 69/399 (17%), Positives = 125/399 (31%), Gaps = 72/399 (18%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEIS---SLTQLETLSFQMNNIAGAIPSL---ANATSLQ 116
R+ + L L +L+ ++ + T + LS + ++ + T+L
Sbjct: 192 HAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLT 251
Query: 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN---- 172
+ L NN V F L L+ L N N+ F + L ++ L +
Sbjct: 252 MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYN-NIQ-HLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 173 -----ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSG 226
A++ + F L++L + N+ G F +++ L +++ L
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 227 -TLDVLSGM--TQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-L 281
T + + + L + L KN+ + D S L L L N++ + L
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 429
Query: 282 PALLNISLQNNKLQGPYP-LFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG 338
+ I L NK F +Q++ L
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL----------------------- 466
Query: 339 DMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYL 398
D P + ++L+N +A L L+ L L
Sbjct: 467 ---------------KNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDL 511
Query: 399 QQNNLT--------GPIPDGLTKLASLQNLDVSNNNLSG 429
Q NNL G L L+ L L++ +N
Sbjct: 512 QHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDE 550
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-41
Identities = 78/394 (19%), Positives = 129/394 (32%), Gaps = 56/394 (14%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSL--TQLETLSFQMNNIAGAIP-SLANATSLQDI 118
+ + L+ + + S E+ + L+ L N I P L +
Sbjct: 141 QVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGL 200
Query: 119 YLDNNNFTSVPT---GCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNA 173
+L+N T T+++ LSLS++ + F K T+LT L +
Sbjct: 201 FLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLG--LKWTNLTMLDLSYN 258
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
N+ + D F L+ L YNN S + N+ + L L + S
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSL--HGLFNV----RYLNLKRSFTKQS- 311
Query: 234 MTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+ + L L++ DN + G+ L L +SL N+
Sbjct: 312 --------ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 293 KLQGPYP-------LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI 345
L S + ++L N K SDA + L D+G
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWL-GHLEVL-----DLG---- 413
Query: 346 LSDSWEGNN---ACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNN 402
N G + I I L+ ++A + SL+ L L++
Sbjct: 414 ------LNEIGQELTGQEWRGLEN--IFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
Query: 403 LTG--PIPDGLTKLASLQNLDVSNNNLSGKVPDF 434
L P L +L LD+SNNN++ D
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDM 499
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 5e-40
Identities = 65/374 (17%), Positives = 113/374 (30%), Gaps = 81/374 (21%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS 127
++L + LS + T L L N+I +L + L +N +S
Sbjct: 76 KVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSS 135
Query: 128 VPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
G L NLQ L LS+N L ++ ++SL L + + I P F +
Sbjct: 136 TKLGTQVQLENLQELLLSNNKIQALKSEEL--DIFANSSLKKLELSSNQIKEFSPGCFHA 193
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
L L L+ SL T +R + L +
Sbjct: 194 IGRLFGLFLNNVQLGPSLTEKLCLE---------------------LANTSIRNLSLSNS 232
Query: 246 QFTGPIPDL---SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP 302
Q + K +L L L N L V S LP L L+ N +Q
Sbjct: 233 QLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ------- 285
Query: 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFV 362
L ++ + + +
Sbjct: 286 ------HLFSHSLHGLFN-------------------------VRYLNLKRS-------- 306
Query: 363 TCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422
+++ L ++ L L++L ++ N++ G + T L +L+ L +
Sbjct: 307 ------FTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 423 SNNNLSGKVPDFGS 436
SN+ S + +
Sbjct: 361 SNSFTSLRTLTNET 374
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 1e-38
Identities = 58/293 (19%), Positives = 104/293 (35%), Gaps = 30/293 (10%)
Query: 36 AQSLQNLPS------DWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSL 89
+ L + S TS T ++ +S + ++L K+ +S S S L
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP-LHILNLTKNKISKIESDAFSWL 404
Query: 90 TQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
LE L +N I + ++ +IYL N + + F + +LQ L L
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRV 464
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
P+ +LT L + N NI + D + L+ L L +NN
Sbjct: 465 ALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN--------- 515
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLR 266
+ LW + G + L G++ L + L N F + L + L
Sbjct: 516 ----LARLWKHANPGGP---IYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLG 568
Query: 267 DNQLTGVVPASVISLPALLNISLQNNKLQGPYP----LFPSKVQKVSLDHNNF 315
N L + + + +L +++LQ N + + ++ + N F
Sbjct: 569 LNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPF 621
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-30
Identities = 57/382 (14%), Positives = 107/382 (28%), Gaps = 83/382 (21%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNI------AGAIPSLANATSLQDIYLDN 122
+++ + + G S + L L+ LS + SLA+ + L + L
Sbjct: 332 EHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAH-SPLHILNLTK 390
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N + + + F L +L+VL L N + E ++ +Y+ L +
Sbjct: 391 NKISKIESDAFSWLGHLEVLDLGLN-EIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNS 449
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWL 242
F +LQ L L + + + L + L
Sbjct: 450 FALVPSLQRLMLRRVALKN----------------------VDSSPSPFQPLRNLTILDL 487
Query: 243 HKNQFTGPIPD-LSKCESLFDLSLRDNQLT--------GVVPASVISLPALLNISLQNNK 293
N D L E L L L+ N L G + L L ++L++N
Sbjct: 488 SNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNG 547
Query: 294 LQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
P +F +++ + L NN +
Sbjct: 548 FDEIPVEVFKDLFELKIIDLGLNNLNTLPASV---------------------------- 579
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA-NLTSLKNLYLQQNNLTGPIPD 409
F + ++NL L+ + +L L ++ N
Sbjct: 580 ----------FNNQV--SLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCES 627
Query: 410 GLTKLASLQNLDVSNNNLSGKV 431
+ + + LS
Sbjct: 628 IAWFVNWINETHTNIPELSSHY 649
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-29
Identities = 48/336 (14%), Positives = 94/336 (27%), Gaps = 98/336 (29%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
S + + T VP TN+ VL+L+ N
Sbjct: 4 VSHEVADCSHLKLTQVPDDLP---TNITVLNLTHN------------------------- 35
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
+ L F +S L +L + +N + P
Sbjct: 36 -QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELC------------------------Q 70
Query: 233 GMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ L+ + L N+ + + C +L +L L N + + + L+ + L +
Sbjct: 71 KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 292 NKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348
N L +Q++ L +N L
Sbjct: 131 NGLSSTKLGTQVQLENLQELLLSNNKI---------------QALKSEE----------- 164
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408
+ + + L++ + + + L L+L L +
Sbjct: 165 ------------LDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLT 212
Query: 409 DGLT---KLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
+ L S++NL +SN+ LS +K+T
Sbjct: 213 EKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWT 248
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 2e-19
Identities = 43/275 (15%), Positives = 86/275 (31%), Gaps = 91/275 (33%)
Query: 162 STSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQ 221
+ S + + +PD D +N+ L L++N A+F
Sbjct: 3 TVSHEVADCSHLKLTQ-VPD--DLPTNITVLNLTHNQLRRLPAANF-------------- 45
Query: 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS 280
+ +QL + + N + P+ K L L+L+ N+L+ + +
Sbjct: 46 ----------TRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 281 LPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340
L + L +N +Q + +N F K +
Sbjct: 96 CTNLTELHLMSNSIQ-------------KIKNNPFVKQKN-------------------- 122
Query: 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQ 400
+IT++L++ L+ L +L+ L L
Sbjct: 123 ----------------------------LITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154
Query: 401 NNLTGPIPDGLT--KLASLQNLDVSNNNLSGKVPD 433
N + + L +SL+ L++S+N + P
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPG 189
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 3e-45
Identities = 57/392 (14%), Positives = 115/392 (29%), Gaps = 60/392 (15%)
Query: 58 TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQD 117
++ + + + ++ + + NNI ++ T L+
Sbjct: 151 DYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQ 210
Query: 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
Y+ N+ F + N + + LT + + N
Sbjct: 211 FYMGNSPFVAENICEAWENENSEYAQQYKT-------EDLKWDNLKDLTDVEVYNCPNLT 263
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTG---------SLPASFAKSDIQNLWMNDQQLGLSGTL 228
+P F + +Q + ++ N +L + IQ +++ L
Sbjct: 264 KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVE 323
Query: 229 DVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNIS 288
L M +L + NQ G +P L L+L NQ+T + + N+S
Sbjct: 324 TSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLS 383
Query: 289 LQNNKLQG-PYPLFPSKV---QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
+NKL+ P V + +N P DP + +
Sbjct: 384 FAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINV-------- 435
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404
+INL+N ++ ++ + L ++ L N LT
Sbjct: 436 -------------------------SSINLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
Query: 405 G-------PIPDGLTKLASLQNLDVSNNNLSG 429
+ L ++D+ N L+
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 2e-41
Identities = 54/429 (12%), Positives = 122/429 (28%), Gaps = 83/429 (19%)
Query: 22 TTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWT------------GINCDNSNRVT 69
T D + ++ +L + W G++ +++ RVT
Sbjct: 25 TAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLNSNGRVT 84
Query: 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI-----PSLANATSLQDIYLDNNN 124
+SL G SG + I LT+LE L+ + ++ S + +
Sbjct: 85 GLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMH 144
Query: 125 FT--SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
+ V + ++L ++ +P + T + + NI +
Sbjct: 145 YQKTFVDYDPREDFSDLIKDCINSDPQQ--KSIKKSSRITLKDTQIGQLSNNITF-VSKA 201
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDV-LSGMTQLRQVW 241
+ L+ + + F ++ N + T D+ + L V
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWEN------ENSEYAQQYKTEDLKWDNLKDLTDVE 255
Query: 242 LHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300
++ +P L + +++ N+ AL + +
Sbjct: 256 VYNCPNLTKLPTFLKALPEMQLINVACNRGISG-EQLKDDWQALADAPVGEK-------- 306
Query: 301 FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
+Q + + +NN + +
Sbjct: 307 ----IQIIYIGYNNL----------------KTFPVETSLQ------------------- 327
Query: 361 FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420
+ + + L G + PA+ + L +L L N +T + ++NL
Sbjct: 328 --KMKK--LGMLECLYNQLEGKL-PAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENL 382
Query: 421 DVSNNNLSG 429
++N L
Sbjct: 383 SFAHNKLKY 391
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 7e-39
Identities = 45/371 (12%), Positives = 93/371 (25%), Gaps = 98/371 (26%)
Query: 79 SGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTN 138
+ + + + +L L N + G +P+ + L + L N T +P
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQ 378
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN-------ANIFGLIPDFFDSFSNLQN 191
++ LS + N L P + + ++ + F + N+ +
Sbjct: 379 VENLSFAHN-KLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 192 LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-- 249
+ LS N + F S + L + L N T
Sbjct: 438 INLSNNQISKFPKELF------------------------STGSPLSSINLMGNMLTEIP 473
Query: 250 ------PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS 303
+ L + LR N+LT L + L
Sbjct: 474 KNSLKDENENFKNTYLLTSIDLRFNKLT--------KLSD----DFRATTLP-------- 513
Query: 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363
+ + L +N+F + + N
Sbjct: 514 YLVGIDLSYNSF---------------SKFPTQPLNSSTLKGFGIR---NQ--------- 546
Query: 364 CSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423
+ SL L + N++ + + + ++ LD+
Sbjct: 547 --------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-VNEKI--TPNISVLDIK 595
Query: 424 NNNLSGKVPDF 434
+N +
Sbjct: 596 DNPNISIDLSY 606
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-33
Identities = 39/233 (16%), Positives = 80/233 (34%), Gaps = 23/233 (9%)
Query: 83 SPEISSLTQLETLSFQMNNIAGAI--------PSLANATSLQDIYLDNNNFTSVPTGCFD 134
+ S++ + + F N I P+ ++ I L NN + P F
Sbjct: 395 IFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFS 454
Query: 135 GLTNLQVLSLSDN-----PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSN 188
+ L ++L N P + + LT++ + + L DF +
Sbjct: 455 TGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPY 514
Query: 189 LQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLG----LSGTL-DVLSGMTQLRQVWL 242
L + LSYN+F+ P S ++ + +Q+ + ++ L Q+ +
Sbjct: 515 LVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQI 573
Query: 243 HKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
N + + ++ L ++DN + + V L +K Q
Sbjct: 574 GSNDIRK-VNE-KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 43/349 (12%), Positives = 90/349 (25%), Gaps = 79/349 (22%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+LT + +++ A I + +L++I+ N G + + N
Sbjct: 11 ALTDDAIVPIKLSRTAEYIK---DYLALKEIWDALNG----KNWSQQGFGTQPGANWNFN 63
Query: 148 PNLAPW--PFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205
L W L + +T L ++ G +PD + L+ L L + +
Sbjct: 64 KELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERL 123
Query: 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD---LSKCESLFD 262
K +S Q + + D L
Sbjct: 124 FGPKG--------------------ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIK 163
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP-SKVQKVSLDHNNFCKNSS 320
+ + + S I +N + + +K+++ + ++ F
Sbjct: 164 DCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPF----- 218
Query: 321 DAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA 380
N C+ W N
Sbjct: 219 ------------------------------VAENICEAWE----------NENSEYAQQY 238
Query: 381 GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
+ NL L ++ + +P L L +Q ++V+ N
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 6e-16
Identities = 39/306 (12%), Positives = 79/306 (25%), Gaps = 73/306 (23%)
Query: 155 FPNELTKSTSLTTLYMDNANIFGLIPDF---FDSFSNLQNLRLSYNNFTGSLPASFAKSD 211
N LT + A I D+ + + L S F A++ +
Sbjct: 8 KDNALTDDAIVPIKLSRTA---EYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNK 64
Query: 212 IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQL 270
++W Q G+S L+ ++ + L +G +PD + + L L+L +
Sbjct: 65 ELDMWGA--QPGVS-----LNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGE 117
Query: 271 TG----VVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPC 326
P + + + Q + + + L + +
Sbjct: 118 KVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKK 177
Query: 327 DPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPA 386
++T I + + +S A
Sbjct: 178 SSRITLKDT-----------------------------------QIGQLSNNITF-VSKA 201
Query: 387 YANLTSLKNLYLQQNNLTGP-------------------IPDGLTKLASLQNLDVSNNNL 427
LT L+ Y+ + L L +++V N
Sbjct: 202 VMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN 261
Query: 428 SGKVPD 433
K+P
Sbjct: 262 LTKLPT 267
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 1e-12
Identities = 22/101 (21%), Positives = 37/101 (36%), Gaps = 8/101 (7%)
Query: 349 SWEGNNACDGW---PFVTC-SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404
+W N D W P V+ S GR+ ++L +G + A LT L+ L L +
Sbjct: 59 NWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEK 118
Query: 405 GP----IPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
P G++ S + + D+ F+
Sbjct: 119 VNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFS 159
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 1e-06
Identities = 8/56 (14%), Positives = 23/56 (41%), Gaps = 7/56 (12%)
Query: 389 NLTSLKNLYLQQNNLTG-------PIPDGLTKLASLQNLDVSNNNLSGKVPDFGSN 437
+++ + + N + P+ K ++ ++++SNN +S + S
Sbjct: 400 SVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 6e-06
Identities = 8/50 (16%), Positives = 15/50 (30%), Gaps = 1/50 (2%)
Query: 389 NLTSLKNLYLQQNNLTG-PIPDGLTKLASLQNLDVSNNNLSGKVPDFGSN 437
++NL N L P ++ + +D S N +
Sbjct: 375 FTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDP 424
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G G FG+V+ G + K+A+K + M + +F E V+ K+ H LV L G
Sbjct: 14 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPKLVQLYG 70
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
C+ + LV E+M G L+ +L + + + LDV G+ YL +
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYL---RTQRGL-FAAETLLGMCLDVCEGMAYL---EEA 123
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPEYAATGR 764
IHRDL N L+G++ KV+DFG+ + D +Y + F +PE + R
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY--TSSTGTKFPVKWASPEVFSFSR 181
Query: 765 VTTKIDVYAFGVVLMETIT-GRK 786
++K DV++FGV++ E + G+
Sbjct: 182 YSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 4e-44
Identities = 66/207 (31%), Positives = 102/207 (49%), Gaps = 21/207 (10%)
Query: 587 NILGRGGFGVVYGGELPDG-TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+ LG G +G VY G +AVK ++ +TM + EF E AV+ +++H +LV LL
Sbjct: 19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHPNLVQLL 75
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C ++ E+M G L +L + ++ + +A ++ +EYL +
Sbjct: 76 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYL---EK 129
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL-----APEYA 760
++FIHRDL N L+G++ KVADFGL + Y+ A APE
Sbjct: 130 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-----AHAGAKFPIKWTAPESL 184
Query: 761 ATGRVTTKIDVYAFGVVLMETIT-GRK 786
A + + K DV+AFGV+L E T G
Sbjct: 185 AYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 6e-44
Identities = 63/202 (31%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 588 ILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G FGVV G+ +AVK ++ +M EF E + K+ H LV G
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMKLSHPKLVKFYGV 71
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
C +V EY+ G L +L HG L Q + + DV G+ +L
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL---RSHGKG-LEPSQLLEMCYDVCEGMAFL---ESHQ 124
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPEYAATGRV 765
FIHRDL N L+ D+ KV+DFG+ + D +Y + + F APE +
Sbjct: 125 FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY--VSSVGTKFPVKWSAPEVFHYFKY 182
Query: 766 TTKIDVYAFGVVLMETIT-GRK 786
++K DV+AFG+++ E + G+
Sbjct: 183 SSKSDVWAFGILMWEVFSLGKM 204
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 7e-44
Identities = 63/198 (31%), Positives = 100/198 (50%), Gaps = 10/198 (5%)
Query: 587 NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+ LG G +G VY G +AVK ++ +TM + EF E AV+ +++H +LV LL
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLL 282
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C ++ E+M G L +L + ++ + +A ++ +EYL
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEYLEK--- 336
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV 765
++FIHR+L N L+G++ KVADFGL + Y+ + APE A +
Sbjct: 337 KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 396
Query: 766 TTKIDVYAFGVVLMETIT 783
+ K DV+AFGV+L E T
Sbjct: 397 SIKSDVWAFGVLLWEIAT 414
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 8e-44
Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 15/203 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G FGVV G+ +A+K ++ +M EF E V+ + H LV L G
Sbjct: 30 KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEKLVQLYG 86
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
C ++ EYM G L +L + + +Q + + DV +EYL +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYL---REMRHR-FQTQQLLEMCKDVCEAMEYL---ESK 139
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPEYAATGR 764
F+HRDL N L+ D KV+DFGL + D +Y + + F PE +
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY--TSSVGSKFPVRWSPPEVLMYSK 197
Query: 765 VTTKIDVYAFGVVLMETIT-GRK 786
++K D++AFGV++ E + G+
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKM 220
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 9e-44
Identities = 63/201 (31%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G FG V+ G TK+AVK ++ +M F AE ++ +++H+ LV L
Sbjct: 19 ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQRLVRLYA 75
Query: 647 YCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
++ ++ EYM G+L L LT + + +A +A G+ ++
Sbjct: 76 VV---TQEPIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPEYAAT 762
++++IHRDL+ +NIL+ D + K+ADFGL + D +Y R F APE
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--TAREGAKFPIKWTAPEAINY 184
Query: 763 GRVTTKIDVYAFGVVLMETIT 783
G T K DV++FG++L E +T
Sbjct: 185 GTFTIKSDVWSFGILLTEIVT 205
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-43
Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
+LG+G FG V +L K+AVK ++++ + + + EF E A + + H H+
Sbjct: 29 RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88
Query: 643 ALLGYCINGSER------LLVYEYMPRGTLAQHL-FEWHDHGYTPLTWKQRVTIALDVAR 695
L+G + + +++ +M G L L L + V +D+A
Sbjct: 89 KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
G+EYL + ++FIHRDL N ++ +DM VADFGL + YS + G L
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI----YSGDYYRQGCASKL 201
Query: 756 -----APEYAATGRVTTKIDVYAFGVVLMETIT 783
A E A T DV+AFGV + E +T
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-43
Identities = 69/381 (18%), Positives = 127/381 (33%), Gaps = 39/381 (10%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS 127
+ L++ + SL+ L TL N I + + +SLQ + N S
Sbjct: 55 QVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLAS 114
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
+ L L+ L+++ N + + P + T+L L + + I +
Sbjct: 115 LENFPIGHLKTLKELNVAHN-LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLH 173
Query: 188 NLQN----LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
+ L LS N P +F + + L + + L+ + G+ L L
Sbjct: 174 QMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLV 233
Query: 244 KNQFTG----PIPDLSKCESLFDLSLRDNQLT------GVVPASVISLPALLNISLQNNK 293
+F D S E L +L++ + +L + L + + SL +
Sbjct: 234 LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVT 293
Query: 294 LQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
++ + Q + L + F K + T +G
Sbjct: 294 IERVKDFSYNFGWQHLELVNCKF--GQFPTLKLKSLKRLTFTSN--------------KG 337
Query: 353 NNACDGWPFVTCSQGRIITINLANKL-LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
NA + V + ++ N L G S + TSLK L L N + +
Sbjct: 338 GNA---FSEVDLPSLEFLDLSR-NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNF 392
Query: 412 TKLASLQNLDVSNNNLSGKVP 432
L L++LD ++NL
Sbjct: 393 LGLEQLEHLDFQHSNLKQMSE 413
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-39
Identities = 60/384 (15%), Positives = 118/384 (30%), Gaps = 44/384 (11%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFT 126
+ ++ L+ + I L L+ L+ N I +N T+L+ + L +N
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 127 SVPTGCFDGLTNLQV----LSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFG-LI 179
S+ L + + L LS NP + P F K L L + N ++
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-----KEIRLHKLTLRNNFDSLNVM 217
Query: 180 PDFFDSFSNLQNLRLSYNNFTG---------SLPASFAKSDIQNLWMNDQQLGLSGTLDV 230
+ L+ RL F S I+ + L +D+
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
+ +T + L + D S L L + + + L +L ++
Sbjct: 278 FNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPT---LKLKSLKRLTFT 333
Query: 291 NNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349
+NK + ++ + L N + D T+L + LS
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGL--SFKGCCSQSDFGTTSLKYL--------DLS-- 381
Query: 350 WEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIP 408
N ++ ++ + L + +L +L L + +
Sbjct: 382 ---FNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFN 438
Query: 409 DGLTKLASLQNLDVSNNNLSGKVP 432
L+SL+ L ++ N+
Sbjct: 439 GIFNGLSSLEVLKMAGNSFQENFL 462
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 7e-37
Identities = 69/406 (16%), Positives = 122/406 (30%), Gaps = 69/406 (16%)
Query: 67 RVTTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAG-------AIPSLANATSLQDI 118
R+ ++L + S + I L LE + +L +L
Sbjct: 201 RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIE 260
Query: 119 YLD---NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI 175
+ + F+ LTN+ SL F + L + N
Sbjct: 261 EFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY----NFGWQHLELVN-CK 315
Query: 176 FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-DVLSGM 234
FG P +L+ L + N + S ++ L ++ L G G
Sbjct: 316 FGQFP--TLKLKSLKRLTFTSNKGGNAFSEVDLPS-LEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 235 TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQNNK 293
T L+ + L N + E L L + + L + SV SL L+ + + +
Sbjct: 373 TSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432
Query: 294 LQGPYP-LFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
+ + +F S ++ + + N+F + P L
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSF----QENFLPDIFTELRNLT--------------- 473
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
++L+ L A+ +L+SL+ L + NN
Sbjct: 474 --------------------FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 411 LTKLASLQNLDVSNNNLSGKVPD-----FGSNVKFTVSPGNPFIGT 451
L SLQ LD S N++ S ++ N F T
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT-QNDFACT 558
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-35
Identities = 67/387 (17%), Positives = 125/387 (32%), Gaps = 62/387 (16%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLE----TLSFQMNNIAGAIPSLANATSLQDIY 119
N + + L+ + + ++ L Q+ +L +N + P L +
Sbjct: 147 NLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLT 206
Query: 120 LDNNNFT-SVPTGCFDGLTNLQVLSLSDN----PNLAPWPFPNELTKSTSLTTLYMD--- 171
L NN + +V C GL L+V L + L +LT
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231
I D F+ +N+ + L S+ Q+L + + + G TL +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYN-FGWQHLELVNCKFGQFPTLKLK 325
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT--GVVPASVISLPALLNISL 289
S L+++ N+ SL L L N L+ G S +L + L
Sbjct: 326 S----LKRLTFTSNKGGNAFS-EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380
Query: 290 QNNKLQGPYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
N + F +++ + H+N L
Sbjct: 381 SFNGVITMSSNFLGLEQLEHLDFQHSN-------------------------------LK 409
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
+ F++ +I +++++ + + L+SL+ L + N+
Sbjct: 410 QMS------EFSVFLSLRN--LIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENF 461
Query: 408 -PDGLTKLASLQNLDVSNNNLSGKVPD 433
PD T+L +L LD+S L P
Sbjct: 462 LPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-33
Identities = 60/377 (15%), Positives = 113/377 (29%), Gaps = 77/377 (20%)
Query: 65 SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNN 123
+ L+ + L S S +L+ L I + + + L + L N
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM-DNANIFGLIPDF 182
S+ G F GL++LQ L + NLA + +L L + N +P++
Sbjct: 87 PIQSLALGAFSGLSSLQKLVAVET-NLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWL 242
F + +NL++L LS N + + + + L LS
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDL--RVLHQMPLLNLSLDLSL---------------- 186
Query: 243 HKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP 302
N P K L L+LR+N + V + I L ++
Sbjct: 187 --NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ-------GLAGLEVH------- 230
Query: 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFV 362
L F + +A +G +
Sbjct: 231 ------RLVLGEFR------------------------NEGNLEKFD---KSALEGLCNL 257
Query: 363 TCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422
T + R+ ++ +I + LT++ + L + + Q+L++
Sbjct: 258 TIEEFRLAYLDY----YLDDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLEL 311
Query: 423 SNNNLSGKVPDFGSNVK 439
N ++K
Sbjct: 312 VNCKFGQFPTLKLKSLK 328
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-33
Identities = 55/393 (13%), Positives = 101/393 (25%), Gaps = 93/393 (23%)
Query: 68 VTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFT 126
+ LA ++ + LT + + S I + + Q + L N F
Sbjct: 259 IEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFG 317
Query: 127 SVPTGC-------------------FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167
PT L +L+ L LS N +TSL
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227
L + + + +F L++L ++N S
Sbjct: 378 LDLSFNGVITMSSNFL-GLEQLEHLDFQHSNLKQMSEFSV-------------------- 416
Query: 228 LDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALL 285
+ L + + + SL L + N + + L L
Sbjct: 417 ---FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 473
Query: 286 NISLQNNKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGY 342
+ L +L+ F S +Q +++ HNNF + K + L
Sbjct: 474 FLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL-NSLQVL--------- 523
Query: 343 PAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANL-TSLKNLYLQQN 401
+ + + + + +SL L L QN
Sbjct: 524 ------------------------------DYSLNHIMTSKKQELQHFPSSLAFLNLTQN 553
Query: 402 NLTG--PIPDGLTKLASLQNLDVSNNNLSGKVP 432
+ L + + L V + P
Sbjct: 554 DFACTCEHQSFLQWIKDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-32
Identities = 55/374 (14%), Positives = 110/374 (29%), Gaps = 65/374 (17%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTS------VPTGC 132
+ P +L L+ + N + + + L+ L F +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 133 FDGLTNLQVLSLSDN-PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQN 191
+GL NL + + + T++++ + + I + + Q+
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSY--NFGWQH 308
Query: 192 LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ--FTG 249
L L F ++ L + G + + + L + L +N F G
Sbjct: 309 LELVNCKFGQFPTLKL--KSLKRLTFTSNKGGNAFSE---VDLPSLEFLDLSRNGLSFKG 363
Query: 250 PIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLF--PSK 304
SL L L N + + ++ + L L ++ Q++ L+ + +F
Sbjct: 364 CCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRN 422
Query: 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC 364
+ + + H + + F
Sbjct: 423 LIYLDISHTHTRVAFNGI--------------------------------------FNGL 444
Query: 365 SQGRIITINLANKLLAGNISPAY-ANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423
S + + +A N P L +L L L Q L P L+SLQ L++S
Sbjct: 445 SS--LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMS 502
Query: 424 NNNLSGKVPDFGSN 437
+NN
Sbjct: 503 HNNFFSLDTFPYKC 516
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 42/213 (19%), Positives = 71/213 (33%), Gaps = 12/213 (5%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPS-LANATSLQDI 118
N ++ + S L + SL L L + A +SL+ +
Sbjct: 391 NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 450
Query: 119 YLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
+ N+F + F L NL L LS L P +SL L M + N F
Sbjct: 451 KMAGNSFQENFLPDIFTELRNLTFLDLSQC-QLE-QLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK--SDIQNLWMNDQQLGLSGTLDV---LS 232
L + ++LQ L S N+ S S + L + + T + L
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQND--FACTCEHQSFLQ 566
Query: 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSL 265
+ RQ+ + + P + + L++
Sbjct: 567 WIKDQRQLLVEVERMECATPSDKQGMPVLSLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-25
Identities = 53/316 (16%), Positives = 104/316 (32%), Gaps = 40/316 (12%)
Query: 132 CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQN 191
C + + N+ + N P P S L + + L F SF LQ
Sbjct: 3 CVEVVPNITYQCMELNFYKIPDNLP------FSTKNLDLSFNPLRHLGSYSFFSFPELQV 56
Query: 192 LRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQLRQVWLHKNQFTG 249
L LS ++ S + L + + L+ L SG++ L+++ +
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLA--LGAFSGLSSLQKLVAVETNLAS 114
Query: 250 PIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQGPYP-----LFP 302
+ ++L +L++ N + S L L ++ L +NK+Q Y L
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174
Query: 303 SKVQKVSLD--HNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
+ +SLD N A K + ++ L + + +
Sbjct: 175 MPLLNLSLDLSLNPMNFIQPGAFK--EIRLHKL-----TLRNNFDSLNVMKTC------- 220
Query: 361 FVTCSQGRIITINLANKLLAGNIS-PAYANLTSLKNLYLQQNNLT------GPIPDGLTK 413
+ + + L GN+ + L L NL +++ L I D
Sbjct: 221 IQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNC 280
Query: 414 LASLQNLDVSNNNLSG 429
L ++ + + + +
Sbjct: 281 LTNVSSFSLVSVTIER 296
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 3e-15
Identities = 37/241 (15%), Positives = 69/241 (28%), Gaps = 51/241 (21%)
Query: 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQ 269
+ N+ +L D L + + L N L L L +
Sbjct: 6 VVPNITYQCMELNFYKIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 270 LTGVVPASVISLPALLNISLQNNKLQG-PYPLF--PSKVQKVSLDHNNFCKNSSDAGKPC 326
+ + + SL L + L N +Q F S +QK+ N +
Sbjct: 64 IQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFP---- 119
Query: 327 DPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISP 385
+ +N+A N + + +
Sbjct: 120 ----------------------------------IGHLK--TLKELNVAHNLIQSFKLPE 143
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQN----LDVSNNNLSGKVPDFGSNVKFT 441
++NLT+L++L L N + L L + LD+S N ++ P ++
Sbjct: 144 YFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLH 203
Query: 442 V 442
Sbjct: 204 K 204
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 71/204 (34%), Positives = 107/204 (52%), Gaps = 21/204 (10%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G+G FG V G+ G K+AVK ++++ F AE +V+T++RH +LV LLG
Sbjct: 27 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLG 81
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ L +V EYM +G+L +L G + L + +LDV +EYL
Sbjct: 82 VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYL---EG 135
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPEYAATG 763
+F+HRDL N+L+ +D AKV+DFGL K A T+ G APE
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----S--STQDTGKLPVKWTAPEALREK 189
Query: 764 RVTTKIDVYAFGVVLMETIT-GRK 786
+ +TK DV++FG++L E + GR
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRV 213
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 3e-43
Identities = 65/206 (31%), Positives = 103/206 (50%), Gaps = 18/206 (8%)
Query: 587 NILGRGGFGVVYGGE---LPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG+G FG V L D T AVK+++ +T + L +F+ EI +L ++H ++
Sbjct: 16 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNI 73
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
V G C + R L+ EY+P G+L +L H + + + + +G+EY
Sbjct: 74 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKER-IDHIKLLQYTSQICKGMEY 129
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF--GYLAP 757
L + + +IHRDL NIL+ ++ R K+ DFGL K P K + + G + AP
Sbjct: 130 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAP 186
Query: 758 EYAATGRVTTKIDVYAFGVVLMETIT 783
E + + DV++FGVVL E T
Sbjct: 187 ESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 4e-43
Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 44/285 (15%)
Query: 587 NILGRGGFGVVYGGE---LPDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG+G FG V L D T AVK+++ +T + L +F+ EI +L ++H ++
Sbjct: 47 QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE--EHLRDFEREIEILKSLQHDNI 104
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
V G C + R L+ EY+P G+L +L H + + + + +G+EY
Sbjct: 105 VKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKER-IDHIKLLQYTSQICKGMEY 160
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF--GYLAP 757
L + + +IHRDL NIL+ ++ R K+ DFGL K P K + + G + AP
Sbjct: 161 LGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAP 217
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817
E + + DV++FGVVL E T + + + N
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI-----------GNDK--- 263
Query: 818 DPNLNLDE--ETIESIYR----------VAELAGHCTAREPQQRP 850
+ + E +++ R + + C QRP
Sbjct: 264 QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP 308
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 4e-43
Identities = 68/198 (34%), Positives = 106/198 (53%), Gaps = 16/198 (8%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+G+G FG V G+ G K+AVK ++++ F AE +V+T++RH +LV LLG
Sbjct: 199 QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLG 253
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ L +V EYM +G+L +L G + L + +LDV +EYL
Sbjct: 254 VIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEG--- 307
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV 765
+F+HRDL N+L+ +D AKV+DFGL K A + +L + APE +
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLP--VKWTAPEALREKKF 363
Query: 766 TTKIDVYAFGVVLMETIT 783
+TK DV++FG++L E +
Sbjct: 364 STKSDVWSFGILLWEIYS 381
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 4e-43
Identities = 66/212 (31%), Positives = 100/212 (47%), Gaps = 22/212 (10%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
ILG G FG V G L K+AVK M+ + + + EF +E A + H +++
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 643 ALLGYC-----INGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
LLG C + +++ +M G L +L + G + + + +D+A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL- 755
+EYL + ++F+HRDL N ++ DDM VADFGL K YS + G +
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI----YSGDYYRQGRIAKMP 212
Query: 756 ----APEYAATGRVTTKIDVYAFGVVLMETIT 783
A E A T+K DV+AFGV + E T
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 7e-43
Identities = 67/197 (34%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG+G FG V+ G T++A+K ++ TM + F E V+ K+RH LV L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 246
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ +V EYM +G+L L L Q V +A +A G+ Y+
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---M 299
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVT 766
+++HRDL+ +NIL+G+++ KVADFGL + D +Y+ + APE A GR T
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359
Query: 767 TKIDVYAFGVVLMETIT 783
K DV++FG++L E T
Sbjct: 360 IKSDVWSFGILLTELTT 376
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 7e-43
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 24/213 (11%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG+G FG+VY G T++A+K + + EF E +V+ + H
Sbjct: 31 RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHH 89
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL-----FEWHDHGYTPLTWKQRVTIALDVAR 695
+V LLG G L++ E M RG L +L ++ P + + + +A ++A
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
G+ YL F+HRDL N ++ +D K+ DFG+ ++ + Y G G L
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR----KGGKGLL 202
Query: 756 -----APEYAATGRVTTKIDVYAFGVVLMETIT 783
+PE G TT DV++FGVVL E T
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 2e-42
Identities = 68/220 (30%), Positives = 107/220 (48%), Gaps = 33/220 (15%)
Query: 589 LGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V E TK+AVK ++S+ K LS+ +E+ ++ + +H+
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHK 135
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVT 688
+++ LLG C ++ EY +G L ++L + + L+ K V+
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRL 748
A VARG+EYL A + IHRDL N+L+ +D K+ADFGL ++ + ++
Sbjct: 196 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDYYK 248
Query: 749 AGTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
T G L APE T + DV++FGV+L E T
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 2e-42
Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 14/199 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG G FG V+ TK+AVK M+ +M + F AE V+ ++H LV L
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHA 250
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
++ E+M +G+L L + + + + +A G+ ++ Q+
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFL---KSDEGSKQPLPKLIDFSAQIAEGMAFI---EQR 303
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPEYAATGR 764
++IHRDL+ +NIL+ + K+ADFGL + D +Y R F APE G
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY--TAREGAKFPIKWTAPEAINFGS 361
Query: 765 VTTKIDVYAFGVVLMETIT 783
T K DV++FG++LME +T
Sbjct: 362 FTIKSDVWSFGILLMEIVT 380
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 62/222 (27%), Positives = 105/222 (47%), Gaps = 33/222 (14%)
Query: 587 NILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-R 637
LG G FG V E +AVK ++ + K LS+ +E+ ++ + +
Sbjct: 41 KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGK 99
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQR 686
H++++ LLG C ++ EY +G L ++L ++ + +T+K
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746
V+ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL ++ +++
Sbjct: 160 VSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLARDI----NNIDY 212
Query: 747 RLAGTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
T G L APE T + DV++FGV++ E T
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 31/217 (14%)
Query: 589 LGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FG V+ E + +AVK ++ T+ +FQ E +LT ++H H+V
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIV 80
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVTIAL 691
G C +G ++V+EYM G L + L L Q + IA
Sbjct: 81 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
+A G+ YL A Q F+HRDL N L+G ++ K+ DFG+ ++ Y R G
Sbjct: 141 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YR-VGG 193
Query: 752 FGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
L PE + TT+ DV++FGV+L E T
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 4e-42
Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 587 NILGRGGFGVVYGGELP-----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG G FG V G ++AVK ++ + G +++ + EI +L + H ++
Sbjct: 27 RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENI 85
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
V G C L+ E++P G+L ++L + + KQ++ A+ + +G++Y
Sbjct: 86 VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNK-INLKQQLKYAVQICKGMDY 141
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF--GYLAP 757
L S + ++HRDL N+L+ + + K+ DFGL K K + + AP
Sbjct: 142 LGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198
Query: 758 EYAATGRVTTKIDVYAFGVVLMETIT 783
E + DV++FGV L E +T
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 5e-42
Identities = 69/218 (31%), Positives = 98/218 (44%), Gaps = 30/218 (13%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG V+ E + +AVK ++ + +FQ E +LT ++H+H
Sbjct: 47 WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE--SARQDFQREAELLTMLQHQH 104
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL----------FEWHDHGYTPLTWKQRVTIA 690
+V G C G L+V+EYM G L + L D PL Q + +A
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
VA G+ YL A F+HRDL N L+G + K+ DFG+ ++ Y R G
Sbjct: 165 SQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YR-VG 217
Query: 751 TFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
L PE + TT+ DV++FGVVL E T
Sbjct: 218 GRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 6e-42
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 33/222 (14%)
Query: 587 NILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-R 637
LG G FG V E + +AVK ++ + K LS+ +E+ ++ + +
Sbjct: 87 KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGK 145
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQR 686
H++++ LLG C ++ EY +G L ++L ++ + +T+K
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746
V+ +ARG+EY LA Q IHRDL N+L+ ++ K+ADFGL ++ +++
Sbjct: 206 VSCTYQLARGMEY---LASQKCIHRDLAARNVLVTENNVMKIADFGLARDI----NNIDY 258
Query: 747 RLAGTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
T G L APE T + DV++FGV++ E T
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-42
Identities = 57/207 (27%), Positives = 95/207 (45%), Gaps = 15/207 (7%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
I+G G G V G L +A+K +++ + +F +E +++ + H +++
Sbjct: 55 KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT-ERQRRDFLSEASIMGQFDHPNII 113
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G G ++V EYM G+L L H T Q V + V G+ YL
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFL---RTHDGQ-FTIMQLVGMLRGVGAGMRYL-- 167
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL--APEYA 760
+ ++HRDL N+L+ ++ KV+DFGL + D + T G APE
Sbjct: 168 -SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 761 ATGRVTTKIDVYAFGVVLMETIT-GRK 786
A ++ DV++FGVV+ E + G +
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 7e-42
Identities = 69/217 (31%), Positives = 103/217 (47%), Gaps = 31/217 (14%)
Query: 587 NILGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLV 642
+++G G FG V + A+KRM+ +F E+ VL K+ H +++
Sbjct: 31 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNII 89
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVTIAL 691
LLG C + L EY P G L L F + + L+ +Q + A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
DVARG++YL +Q+ FIHRDL NIL+G++ AK+ADFGL + + V T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGL---SRGQEVYV----KKT 199
Query: 752 FGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
G L A E TT DV+++GV+L E ++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 67/207 (32%), Positives = 101/207 (48%), Gaps = 20/207 (9%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G+G FGVVY GE D + A+K + T + + F E ++ + H +++
Sbjct: 27 RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVL 85
Query: 643 ALLGYCINGSERLL-VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
AL+G + + YM G L Q + T K ++ L VARG+EYL
Sbjct: 86 ALIGIMLPPEGLPHVLLPYMCHGDLLQFI---RSPQRN-PTVKDLISFGLQVARGMEYL- 140
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL-----A 756
A+Q F+HRDL N ++ + KVADFGL ++ D +Y + L A
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREY--YSVQQHRHARLPVKWTA 196
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETIT 783
E T R TTK DV++FGV+L E +T
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLT 223
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 1e-41
Identities = 67/197 (34%), Positives = 102/197 (51%), Gaps = 10/197 (5%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
LG+G FG V+ G T++A+K ++ TM + F E V+ K+RH LV L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEKLVQLYA 329
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ +V EYM +G+L L L Q V +A +A G+ Y+
Sbjct: 330 VV-SEEPIYIVTEYMSKGSLLDFL---KGETGKYLRLPQLVDMAAQIASGMAYVER---M 382
Query: 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVT 766
+++HRDL+ +NIL+G+++ KVADFGL + D +Y+ + APE A GR T
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442
Query: 767 TKIDVYAFGVVLMETIT 783
K DV++FG++L E T
Sbjct: 443 IKSDVWSFGILLTELTT 459
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 1e-41
Identities = 57/207 (27%), Positives = 99/207 (47%), Gaps = 16/207 (7%)
Query: 588 ILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G G FG VY G L +A+K +++ K +F E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNII 109
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G +++ EYM G L + L + + Q V + +A G++YL
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFL---REKDGE-FSVLQLVGMLRGIAAGMKYL-- 163
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPEYA 760
A +++HRDL NIL+ ++ KV+DFGL + D + T G APE
Sbjct: 164 -ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 761 ATGRVTTKIDVYAFGVVLMETIT-GRK 786
+ + T+ DV++FG+V+ E +T G +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 2e-41
Identities = 61/227 (26%), Positives = 97/227 (42%), Gaps = 38/227 (16%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG V T +AVK ++ N L + +E VL +V H H
Sbjct: 29 KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS-PSELRDLLSEFNVLKQVNHPH 87
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL-------------------FEWHDHGYTPL 681
++ L G C LL+ EY G+L L L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741
T ++ A +++G++Y LA+ +HRDL NIL+ + + K++DFGL ++
Sbjct: 148 TMGDLISFAWQISQGMQY---LAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV---- 200
Query: 742 YSVETRLAGTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
Y ++ + + G + A E TT+ DV++FGV+L E +T
Sbjct: 201 YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 247
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 2e-41
Identities = 76/291 (26%), Positives = 112/291 (38%), Gaps = 58/291 (19%)
Query: 587 NILGRGGFGVVYGGEL---PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
LG G FG V DGT AVK ++++ G + S ++ EI +L + H H+
Sbjct: 37 RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHI 95
Query: 642 VALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+ G C + LV EY+P G+L +L H + Q + A + G+ Y
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRH---SIGLAQLLLFAQQICEGMAY 149
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYL-- 755
LH+ Q +IHRDL N+L+ +D K+ DFGL K P+G Y V G
Sbjct: 150 LHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRED-----GDSPV 201
Query: 756 ---APEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKE 811
APE + DV++FGV L E +T + +
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQ--------- 252
Query: 812 NIPKAIDPNLNLDE--ETIESIYR----------VAELAGHCTAREPQQRP 850
+ + E +E R V L +C E RP
Sbjct: 253 -------GQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRP 296
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-41
Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 587 NILGRGGFGVVYGGELPDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++G G FG V G L +K +A+K ++ K +F E +++ + H +++
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT-EKQRRDFLGEASIMGQFDHPNII 109
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G ++V EYM G+L L H T Q V + +A G++YL
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFL---RKHDAQ-FTVIQLVGMLRGIASGMKYL-- 163
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL--APEYA 760
+ ++HRDL NILI ++ KV+DFGL + D + T G +PE
Sbjct: 164 -SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 761 ATGRVTTKIDVYAFGVVLMETIT-GRK 786
A + T+ DV+++G+VL E ++ G +
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 32/221 (14%)
Query: 587 NILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LGRG FG V + +AVK ++ + +E+ +L + H
Sbjct: 33 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHL 91
Query: 640 HLVALLGYC-INGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRV 687
++V LLG C G +++ E+ G L+ +L D LT + +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
+ VA+G+E+L A + IHRDL NIL+ + K+ DFGL ++ Y
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI----YKDPDY 204
Query: 748 LAGTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
+ L APE T + DV++FGV+L E +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 5e-41
Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 24/213 (11%)
Query: 587 NILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG VY G++ P ++AVK + + +F E +++K H++
Sbjct: 36 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQN 94
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG--YTPLTWKQRVTIALDVARGVE 698
+V +G + R ++ E M G L L E + L + +A D+A G +
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 699 YLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
Y L + FIHRD+ N L+ G AK+ DFG+ ++ Y R G L
Sbjct: 155 Y---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YR-KGGCAML 207
Query: 756 -----APEYAATGRVTTKIDVYAFGVVLMETIT 783
PE G T+K D ++FGV+L E +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 9e-41
Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 15/205 (7%)
Query: 588 ILGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVAL 644
LG G FG V G +AVK +++ E AE V+ ++ + ++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+G C +LV E G L ++L + + H + K + + V+ G++YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYLQQ-NRH----VKDKNIIELVHQVSMGMKYL---E 134
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF--GYLAPEYAAT 762
+ +F+HRDL N+L+ AK++DFGL K + + + G + + APE
Sbjct: 135 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194
Query: 763 GRVTTKIDVYAFGVVLMETIT-GRK 786
+ ++K DV++FGV++ E + G+K
Sbjct: 195 YKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 9e-41
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 35/221 (15%)
Query: 587 NILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V K+AVK ++S +E+ +++ + +H
Sbjct: 52 KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAH-ADEKEALMSELKIMSHLGQHE 110
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL---------FEWHDHGYTPLTWKQRVTIA 690
++V LLG C +G L++ EY G L L + + + + +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKYSVETR 747
VA+G+ +L A ++ IHRD+ N+L+ + AK+ DFGL + N D Y V+
Sbjct: 171 SQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN--DSNYIVKGN 225
Query: 748 LAGTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
L APE T + DV+++G++L E +
Sbjct: 226 -----ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 9e-41
Identities = 54/222 (24%), Positives = 88/222 (39%), Gaps = 33/222 (14%)
Query: 587 NILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
LG G FG V +AVK ++ + +E+ VL+ + H
Sbjct: 29 KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHM 87
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL-------------FEWHDHGYTPLTWKQR 686
++V LLG C G L++ EY G L L + L +
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746
++ + VA+G+ +L A ++ IHRDL NIL+ K+ DFGL ++ +
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI----KNDSN 200
Query: 747 RLAGTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
+ L APE T + DV+++G+ L E +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-40
Identities = 56/227 (24%), Positives = 94/227 (41%), Gaps = 38/227 (16%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHR 639
+LG G FG V ++AVK ++ + +E+ ++T++ H
Sbjct: 51 KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHE 109
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHL------------------FEWHDHGYTPL 681
++V LLG C L++EY G L +L + L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741
T++ + A VA+G+E+L +S +HRDL N+L+ K+ DFGL ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI---- 222
Query: 742 YSVETRLAGTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
S + L APE G T K DV+++G++L E +
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-40
Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 16/207 (7%)
Query: 588 ILGRGGFGVVYGGEL--PDG--TKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLV 642
LG G FGVV GE P G +AVK ++ + + + + +F E+ + + HR+L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
L G + +V E P G+L L H A+ VA G+ YL S
Sbjct: 85 RLYGVVL-TPPMKMVTELAPLGSLLDRL---RKHQGH-FLLGTLSRYAVQVAEGMGYLES 139
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPEYA 760
+ FIHRDL N+L+ K+ DFGL++ P + + APE
Sbjct: 140 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 196
Query: 761 ATGRVTTKIDVYAFGVVLMETIT-GRK 786
T + D + FGV L E T G++
Sbjct: 197 KTRTFSHASDTWMFGVTLWEMFTYGQE 223
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 2e-40
Identities = 69/227 (30%), Positives = 105/227 (46%), Gaps = 38/227 (16%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+G G FG V+ P T +AVK ++ ++FQ E A++ + + +
Sbjct: 53 RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPN 111
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL-------------------FEWHDHGYTPL 681
+V LLG C G L++EYM G L + L G PL
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741
+ +++ IA VA G+ Y L+++ F+HRDL N L+G++M K+ADFGL +N
Sbjct: 172 SCAEQLCIARQVAAGMAY---LSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI---- 224
Query: 742 YSVETRLAGTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
YS + A + PE R TT+ DV+A+GVVL E +
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-40
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 587 NILGRGGFGVVYGGEL-PDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
+LG G FG VY G P+G +A+K + T K E E V+ V + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHV 79
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
LLG C+ S L+ + MP G L ++ +H + + + + +A+G+ YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYV---REHKDN-IGSQYLLNWCVQIAKGMNYL- 133
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT---FGYLAPE 758
+ +HRDL N+L+ K+ DFGL K + E G ++A E
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALE 189
Query: 759 YAATGRVTTKIDVYAFGVVLMETIT-GRK 786
T + DV+++GV + E +T G K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 51/219 (23%), Positives = 89/219 (40%), Gaps = 30/219 (13%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG FG VY G L +A+K ++ EF+ E + +++H +
Sbjct: 15 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPN 73
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQRVTI 689
+V LLG +++ Y G L + L + + L V +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
+A G+EYL + +H+DL N+L+ D + K++D GL + Y+ +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV----YAADYYKL 186
Query: 750 GTFGYL-----APEYAATGRVTTKIDVYAFGVVLMETIT 783
L APE G+ + D++++GVVL E +
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-40
Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 24/213 (11%)
Query: 587 NILGRGGFGVVYGGELPDG------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
LG G FG VY G++ ++AVK + + +F E +++K H++
Sbjct: 77 RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCS-EQDELDFLMEALIISKFNHQN 135
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFE--WHDHGYTPLTWKQRVTIALDVARGVE 698
+V +G + R ++ E M G L L E + L + +A D+A G +
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 699 YLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
Y L + FIHRD+ N L+ G AK+ DFG+ ++ Y R G L
Sbjct: 196 Y---LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YR-KGGCAML 248
Query: 756 -----APEYAATGRVTTKIDVYAFGVVLMETIT 783
PE G T+K D ++FGV+L E +
Sbjct: 249 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 5e-40
Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 16/205 (7%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++GRG FG VY G L D AVK + T +S+F E ++ H +++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVL 89
Query: 643 ALLGYCINGSE-RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+LLG C+ L+V YM G L + H T K + L VA+G++YL
Sbjct: 90 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETH---NPTVKDLIGFGLQVAKGMKYL- 144
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTF--GYLAPE 758
A + F+HRDL N ++ + KVADFGL ++ D + YSV + ++A E
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 759 YAATGRVTTKIDVYAFGVVLMETIT 783
T + TTK DV++FGV+L E +T
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMT 227
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 9e-40
Identities = 67/409 (16%), Positives = 142/409 (34%), Gaps = 61/409 (14%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEIS--SLTQLETLSFQMNNI----AGAIPSLANATS 114
+S +++ + + + ++ L +F+ + L S
Sbjct: 197 GAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE-MS 255
Query: 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174
++ I L + F ++ + F + LQ L L+ +L+ P+ L ++L L +
Sbjct: 256 VESINLQKHYFFNISSNTFHCFSGLQELDLTAT-HLSE--LPSGLVGLSTLKKLVLSANK 312
Query: 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK--SDIQNLWMNDQQLGLSG-TLDVL 231
L +F +L +L + N L + +++ L ++ + S L
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 232 SGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISL 289
++ L+ + L N+ + +C L L L +L S L L ++L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 290 QNNKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL 346
++ L LF +Q ++L N+F K + L
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK--------------------TNSL 472
Query: 347 SDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGP 406
GR+ + L+ L+ A+ +L + ++ L N LT
Sbjct: 473 QTL-----------------GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSS 515
Query: 407 IPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK----FTVSPGNPFIGT 451
+ L+ L + L++++N++S +P + + NP T
Sbjct: 516 SIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLR-QNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-38
Identities = 66/383 (17%), Positives = 129/383 (33%), Gaps = 52/383 (13%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYL 120
+ +R+ T+ L + L +S L+ L F I+ L N +L+ +YL
Sbjct: 77 FQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYL 136
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD-NANIFGLI 179
+N+ +S+ L+VL +N + +++ T L ++ N N I
Sbjct: 137 GSNHISSIKLPKGFPTEKLKVLDFQNN-AIHYLS-KEDMSSLQQATNLSLNLNGNDIAGI 194
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMND----QQLGLSGTLDVLSGMT 235
+ Q+L + S IQ+LW+ +S +
Sbjct: 195 EPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM 254
Query: 236 QLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
+ + L K+ F + L +L L L+ + P+ ++ L L + L NK
Sbjct: 255 SVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLSTLKKLVLSANKF 313
Query: 295 QGPYPLFPS---KVQKVSLDHNNF-CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
+ + S + +S+ N + + + + L D+ +
Sbjct: 314 ENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENL-ENLREL-----DLSH-------- 359
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
++ I T + N L NL+ L++L L N +
Sbjct: 360 --DD--------------IETSDCCNLQLR--------NLSHLQSLNLSYNEPLSLKTEA 395
Query: 411 LTKLASLQNLDVSNNNLSGKVPD 433
+ L+ LD++ L K
Sbjct: 396 FKECPQLELLDLAFTRLKVKDAQ 418
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 4e-37
Identities = 68/380 (17%), Positives = 133/380 (35%), Gaps = 57/380 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLD- 121
N + ++ L + +S P+ +L+ L FQ N I +++ ++ L+
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 122 -NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
N+ + G FD Q L+ NL + + SL ++ + + P
Sbjct: 187 NGNDIAGIEPGAFDSA-VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISP 245
Query: 181 DFFDSFS--NLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
F+ +++++ L + F +F S +Q L + L S L G++ L
Sbjct: 246 AVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL--SELPSGLVGLSTL 303
Query: 238 RQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQ 295
+++ L N+F S SL LS++ N + + L L + L ++ ++
Sbjct: 304 KKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIE 363
Query: 296 GPYPLFPS-----KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
+Q ++L +N ++A
Sbjct: 364 TSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEA---------------------------- 395
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPD 409
F C Q + ++LA L + + NL LK L L + L
Sbjct: 396 ----------FKECPQ--LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQ 443
Query: 410 GLTKLASLQNLDVSNNNLSG 429
L +LQ+L++ N+
Sbjct: 444 LFDGLPALQHLNLQGNHFPK 463
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 6e-36
Identities = 61/409 (14%), Positives = 122/409 (29%), Gaps = 46/409 (11%)
Query: 47 SSTSSTGYCEWTGINCDNSNR------------VTTISLAKSGLSGTLSPEISSLTQLET 94
+S+ + + N + + + L + S L L
Sbjct: 2 TSSDQKCIEKEVNKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTF 61
Query: 95 LSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPW 153
L I + + L + L N + G L+ L ++
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQT-GISSI 120
Query: 154 PFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDI 212
L +L +LY+ + +I + L+ L N +
Sbjct: 121 D-FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQA 179
Query: 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP---DLSKCESLFDLSLRDNQ 269
NL +N ++G + + Q I S +SL+ + D
Sbjct: 180 TNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMD 239
Query: 270 LTGVVPASVISLPA--LLNISLQNNKLQGPYP-LFP--SKVQKVSLDHNNFCKNSSDAGK 324
+ PA L + +I+LQ + F S +Q++ L + + +G
Sbjct: 240 DEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL--SELPSGL 297
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQ-GRIITINLA-NKLLAGN 382
+ L +LS N + ++ S + +++ N
Sbjct: 298 VGLSTLKKL-----------VLS-----ANKFENLCQISASNFPSLTHLSIKGNTKRLEL 341
Query: 383 ISPAYANLTSLKNLYLQQNNLT--GPIPDGLTKLASLQNLDVSNNNLSG 429
+ NL +L+ L L +++ L L+ LQ+L++S N
Sbjct: 342 GTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLS 390
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 66/400 (16%), Positives = 128/400 (32%), Gaps = 71/400 (17%)
Query: 53 GYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLT-------QLETLSFQMNNIAGA 105
G + + T SL +IS +E+++ Q +
Sbjct: 210 GGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNI 269
Query: 106 IP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTS 164
+ + LQ++ L + + +P+G GL+ L+ L LS N + S
Sbjct: 270 SSNTFHCFSGLQELDLTATHLSELPSG-LVGLSTLKKLVLSAN-KFENLC-QISASNFPS 326
Query: 165 LTTLYM-DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLG 223
LT L + N L ++ NL+ L LS+++ S + ++ +L Q L
Sbjct: 327 LTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHL----QSLN 382
Query: 224 LSG------TLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVP 275
LS + QL + L + L L+L + L
Sbjct: 383 LSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442
Query: 276 ASVISLPALLNISLQNNKLQGPYPLFP------SKVQKVSLDHNNFCKNSSDAGKPCDPQ 329
LPAL +++LQ N +++ + L + A
Sbjct: 443 QLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHA------- 495
Query: 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN 389
F + + ++L++ L + A ++
Sbjct: 496 -------------------------------FTSLKM--MNHVDLSHNRLTSSSIEALSH 522
Query: 390 LTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
L + L L N+++ +P L L+ + +++ N L
Sbjct: 523 LKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 48/386 (12%), Positives = 104/386 (26%), Gaps = 66/386 (17%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYL 120
N+ T + GL+ + + + E L F N + + + +L + L
Sbjct: 10 EKEVNK--TYNCENLGLN-EIPGTLPNS--TECLEFSFNVLPTIQNTTFSRLINLTFLDL 64
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
+ F L L L+ NP +A +L L+ I +
Sbjct: 65 TRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSG----PKALKHLFFIQTGISSI 120
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
+ L++L L N+ + +L+
Sbjct: 121 DFIPLHNQKTLESLYLGSNHISSIKLPKG------------------------FPTEKLK 156
Query: 239 QVWLHKNQFTGPIPD----LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
+ N + L + +L L+L N + G+ +++ +
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIAGI-EPGAFDSAVFQSLNFGGTQN 214
Query: 295 QGPYP-----LFPSKVQKVSLDHNNFCKNSSDA-GKPCDPQVTTLLQIAGDMGYPAILSD 348
+ + + + S C+ V ++ ++ +
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESI-----NLQKHYFFNI 269
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
S + ++L L + L++LK L L N
Sbjct: 270 S----------SNTFHCFSGLQELDLTATHL--SELPSGLVGLSTLKKLVLSANKFENLC 317
Query: 408 PDGLTKLASLQNLDVSNNNLSGKVPD 433
+ SL +L + N ++
Sbjct: 318 QISASNFPSLTHLSIKGNTKRLELGT 343
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 9e-34
Identities = 61/382 (15%), Positives = 126/382 (32%), Gaps = 58/382 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLE--TLSFQMNNIAGAIPSLANATSLQDIYLD 121
+ ++ + + + ++SSL Q +L+ N+IAG P ++ Q +
Sbjct: 151 PTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFG 210
Query: 122 NNNFT--SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+ +L + + D + P E S+ ++ + F +
Sbjct: 211 GTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNIS 270
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQL 237
+ F FS LQ L L+ + + LP+ S ++ L ++ + L S L
Sbjct: 271 SNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQ--ISASNFPSL 327
Query: 238 RQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLT--GVVPASVISLPALLNISLQNNK 293
+ + N + L E+L +L L + + + +L L +++L N+
Sbjct: 328 THLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNE 387
Query: 294 LQGPYPLFPSKV---QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
+ + + L + S
Sbjct: 388 PLSLKTEAFKECPQLELLDLAFTRLKV---------------------------KDAQSP 420
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI--- 407
N + +NL++ LL + + L +L++L LQ N+
Sbjct: 421 FQNLH------------LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQK 468
Query: 408 PDGLTKLASLQNLDVSNNNLSG 429
+ L L L+ L +S +LS
Sbjct: 469 TNSLQTLGRLEILVLSFCDLSS 490
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-33
Identities = 62/393 (15%), Positives = 118/393 (30%), Gaps = 72/393 (18%)
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
V +I+L K S + L+ L +++ L ++L+ + L N F
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANKF 313
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI--FGLIPDFF 183
++ +L LS+ N L +L L + + +I
Sbjct: 314 ENLCQISASNFPSLTHLSIKGN-TKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWL 242
+ S+LQ+L LSYN +F + ++ L + +L + + L+ + L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 243 HKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVV---PASVISLPALLNISLQNNKLQG-P 297
+ +L L+L+ N S+ +L L + L L
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSID 492
Query: 298 YPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
F + V L HN +S +A
Sbjct: 493 QHAFTSLKMMNHVDLSHNRLTSSSIEA--------------------------------- 519
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG---------- 405
I +NLA+ ++ + L+ + + L+QN L
Sbjct: 520 -----LSHLKG---IYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEW 571
Query: 406 --------PIPDGLT--KLASLQNLDVSNNNLS 428
+ L+ + +S+ LS
Sbjct: 572 YKENMQKLEDTEDTLCENPPLLRGVRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 1e-14
Identities = 36/327 (11%), Positives = 68/327 (20%), Gaps = 118/327 (36%)
Query: 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
+N +P + + L S N +
Sbjct: 17 YNCENLGLNEIPGTLP---NSTECLEFSFN--------------------------VLPT 47
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ F NL L L+ +F +L
Sbjct: 48 IQNTTFSRLINLTFLDLTRCQIYWIHEDTF------------------------QSQHRL 83
Query: 238 RQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
+ L N LS ++L L ++ + + + L
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL------------ 131
Query: 297 PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC 356
+ + L N+ G P
Sbjct: 132 ---------ESLYLGSNHISSIKLPKGFPT------------------------------ 152
Query: 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYL--QQNNLTGPIPDGLTKL 414
++ ++ N + ++L NL L N++ G I G
Sbjct: 153 ----------EKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDS 201
Query: 415 ASLQNLDVSNNNLSGKVPDFGSNVKFT 441
A Q+L+ + N
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQ 228
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 3e-07
Identities = 19/143 (13%), Positives = 48/143 (33%), Gaps = 18/143 (12%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS-LANATSLQDIYLDN 122
R+ + L+ LS +SL + + N + + L++ + + L +
Sbjct: 474 TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLAS 532
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNP-----NLAPWPFPNELTKSTSLTTLYMDNANIFG 177
N+ + + L+ + ++L NP + + L + +
Sbjct: 533 NHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYF-----------LEWYKENMQKLED 581
Query: 178 LIPDFFDSFSNLQNLRLSYNNFT 200
++ L+ +RLS +
Sbjct: 582 TEDTLCENPPLLRGVRLSDVTLS 604
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 65/207 (31%), Positives = 93/207 (44%), Gaps = 20/207 (9%)
Query: 587 NILGRGGFGVVYGGE---LPDGTKI--AVKRM-ESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ LG+G FG V L D T AVK++ S + +FQ EI +L +
Sbjct: 29 SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDF 85
Query: 641 LVALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
+V G + LV EY+P G L L H L + + + + +G+E
Sbjct: 86 IVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRAR-LDASRLLLYSSQICKGME 141
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYLA 756
YL S + +HRDL NIL+ + K+ADFGL K P K Y V + A
Sbjct: 142 YLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETIT 783
PE + + + DV++FGVVL E T
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 2e-39
Identities = 57/412 (13%), Positives = 110/412 (26%), Gaps = 94/412 (22%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI----------PSLANATSLQDI 118
T + L L + L +L++L+ N A +Q
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 119 YLDNNNFTSVPT-GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
Y+ NN P + L +L N + + LT L +D I
Sbjct: 554 YMGYNNLEEFPASASLQKMVKLGLLDCVHN-KVR---HLEAFGTNVKLTDLKLDYNQIEE 609
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS-----------G 226
+ DF ++ L S+N +P F + + + S
Sbjct: 610 IPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVM----GSVDFSYNKIGSEGRNIS 664
Query: 227 TLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLT-------GVVPASV 278
V L N+ + + + + L +N +T +
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
Query: 279 ISLPALLNISLQNNKLQG-PYPLFPSK---VQKVSLDHNNFCKNSSDAGKPCDPQVTTLL 334
+ L I L+ NKL + + + + +N F ++
Sbjct: 725 KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCF---------------SSF- 768
Query: 335 QIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGN-----ISPAYA 388
P + ++ + + GN
Sbjct: 769 -------------------------PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGIT 803
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL-SGKVPDFGSNVK 439
SL L + N++ + + L L LD+++N S V ++
Sbjct: 804 TCPSLIQLQIGSNDIRK-VDEKL--TPQLYILDIADNPNISIDVTSVCPYIE 852
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 1e-38
Identities = 78/444 (17%), Positives = 138/444 (31%), Gaps = 79/444 (17%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLA 74
+ + + L Q L D + E I +R++
Sbjct: 374 DMSEERKHRIRMHYKKMFLDYDQRLNLS--DLLQDAINRNPEMKPI--KKDSRISLKDTQ 429
Query: 75 KSGLS---GTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTG 131
L+ +S I LT+L+ + F + ++ +D D
Sbjct: 430 IGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAV----DWEDANSDYAKQYENEEL 485
Query: 132 CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL---------IPDF 182
+ L +L + L + PN+ P+ L L +L + + D
Sbjct: 486 SWSNLKDLTDVELYNCPNM--TQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADD 543
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG----TLDVLSGMTQLR 238
D+ +Q + YNN PAS + + L L L+ +L
Sbjct: 544 EDTGPKIQIFYMGYNNLE-EFPASASLQKMVKL----GLLDCVHNKVRHLEAFGTNVKLT 598
Query: 239 QVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPA-SVISLPALLNISLQNNKLQ 295
+ L NQ IP+ + + + L N+L + + S+ + ++ NK+
Sbjct: 599 DLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIG 657
Query: 296 G-PYPLFPS-------KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
+ S V+L +N K ++ ++T+ ILS
Sbjct: 658 SEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATG-SPISTI-----------ILS 705
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
NN + +I + Y N L + L+ N LT +
Sbjct: 706 -----NN-------------LMTSIP---ENSLKPKDGNYKNTYLLTTIDLRFNKLTS-L 743
Query: 408 PDGL--TKLASLQNLDVSNNNLSG 429
D T L L N+DVS N S
Sbjct: 744 SDDFRATTLPYLSNMDVSYNCFSS 767
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 148 bits (374), Expect = 1e-36
Identities = 66/425 (15%), Positives = 120/425 (28%), Gaps = 81/425 (19%)
Query: 40 QNLPSDWSSTSSTGYCEW---TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLS 96
+W+ + W G++ DN+ RVT +SLA G G + I LT+L+ LS
Sbjct: 296 TIHSLNWNF--NKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLS 353
Query: 97 FQMNNIAGAIPSLANATSLQDIY--LDNNNFTSVPTGCFDGLTNLQVLSLSDN-----PN 149
F ++ + + D+ + D L + L + P
Sbjct: 354 FGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPE 413
Query: 150 LAPWPFPNELTKSTSLTTLYMDNA-NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA 208
+ P + + SL + N N I + LQ + + + FT A
Sbjct: 414 MKPIKKDSRI----SLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIA--- 466
Query: 209 KSDIQNLWMNDQQLGLSGTL-DVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLR 266
+ N S + L V L+ +PD L L L++
Sbjct: 467 ---VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIA 523
Query: 267 DNQLTGV---------VPASVISLPALLNISLQNNKLQG--PYPLFP--SKVQKVSLDHN 313
N+ + + P + + N L+ K+ + HN
Sbjct: 524 CNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHN 583
Query: 314 NFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITIN 373
L A G N ++ +
Sbjct: 584 KV---------------RHL---------EAF------GTNV------------KLTDLK 601
Query: 374 LANKLLAGNISPAYANLTSLKNLYLQQNNLTG-PIPDGLTKLASLQNLDVSNNNLSGKVP 432
L + A ++ L N L P + + ++D S N + +
Sbjct: 602 LDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGR 661
Query: 433 DFGSN 437
+ +
Sbjct: 662 NISCS 666
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-30
Identities = 44/235 (18%), Positives = 77/235 (32%), Gaps = 33/235 (14%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSL------ANATSLQDIYLDNNNFTSVPTGCFDGLTN 138
S+ + ++ F N I ++ + + L N PT F +
Sbjct: 639 NAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSP 698
Query: 139 LQVLSLSDN-----PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSNLQNL 192
+ + LS+N P + P + LTT+ + + L DF + L N+
Sbjct: 699 ISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNM 758
Query: 193 RLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDV------------LSGMTQLRQV 240
+SYN F+ S P S L + G+ D ++ L Q+
Sbjct: 759 DVSYNCFS-SFPTQPLNS--SQL----KAFGIRHQRDAEGNRILRQWPTGITTCPSLIQL 811
Query: 241 WLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
+ N + + L+ L + DN + SV L +K Q
Sbjct: 812 QIGSNDIRK-VDE-KLTPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQ 864
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 99.2 bits (247), Expect = 2e-21
Identities = 45/359 (12%), Positives = 100/359 (27%), Gaps = 63/359 (17%)
Query: 88 SLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
LT+ + Q+ A I A + + N + S G + + + +
Sbjct: 250 KLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWRYYS---GTINNTIHSLNWNFNK 306
Query: 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS 206
++ +L + +T L + G +PD + L+ L ++ T S
Sbjct: 307 ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLF 366
Query: 207 FAKSDIQNLWMNDQQL------GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCE-S 259
+ ++ + + D ++ L Q +++N PI S+
Sbjct: 367 GDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLK 426
Query: 260 LFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNS 319
+ N++T + ++ L L I N+ + + D+ +N
Sbjct: 427 DTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI--AVDWEDANSDYAKQYENE 483
Query: 320 SDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL 379
+ + + + L N
Sbjct: 484 ELS--------------------------------------WSNLKD--LTDVELYNCPN 503
Query: 380 AGNISPAYANLTSLKNLYLQQNNLTGP---------IPDGLTKLASLQNLDVSNNNLSG 429
+ +L L++L + N + D +Q + NNL
Sbjct: 504 MTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE 562
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 9e-20
Identities = 31/218 (14%), Positives = 71/218 (32%), Gaps = 25/218 (11%)
Query: 58 TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNI--------AGAIPSL 109
++ +T++L+ + + + ++ + + T+ N + +
Sbjct: 665 CSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNY 724
Query: 110 ANATSLQDIYLDNNNFTSVPTG-CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168
N L I L N TS+ L L + +S N + FP + S+ L
Sbjct: 725 KNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYN-CFSS--FPTQPLNSSQLKAF 781
Query: 169 Y------MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
+ I P + +L L++ N+ + + L + D
Sbjct: 782 GIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKLTPQ-LYILDIADNPN 839
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL 260
+S + + + L ++ D+ C++L
Sbjct: 840 -ISIDVTSVCPYIEAGMYVLLYDK----TQDIRGCDAL 872
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-39
Identities = 51/206 (24%), Positives = 85/206 (41%), Gaps = 18/206 (8%)
Query: 588 ILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+G G FG V+ G +A+K ++ T + +F E + + H H+V
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVK 80
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+G + ++ E G L L + L + A ++ + YL
Sbjct: 81 LIGVIT-ENPVWIIMELCTLGELRSFLQV-RKY---SLDLASLILYAYQLSTALAYL--- 132
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF--GYLAPEYAA 761
+ F+HRD+ N+L+ + K+ DFGL + D Y G ++APE
Sbjct: 133 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESIN 190
Query: 762 TGRVTTKIDVYAFGVVLMETIT-GRK 786
R T+ DV+ FGV + E + G K
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 20/207 (9%)
Query: 588 ILGRGGFGVVYGGEL--PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
ILG G FG VY G G KI AVK + + +F +E ++ + H H+V
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCT-LDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+G ++ E P G L +L + + L V +L + + + YL
Sbjct: 78 LIGIIEEEP-TWIIMELYPYGELGHYL---ERNKNS-LKVLTLVLYSLQICKAMAYL--- 129
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT---FGYLAPEYA 760
+ +HRD+ NIL+ K+ DFGL + D Y + + T +++PE
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESI 186
Query: 761 ATGRVTTKIDVYAFGVVLMETIT-GRK 786
R TT DV+ F V + E ++ G++
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-39
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 589 LGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG V G +A+K ++ T E E ++ ++ + ++V L+
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C +LV E G L + L + + V+ G++YL +
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFL---VGKREE-IPVSNVAELLHQVSMGMKYL---EE 128
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF--GYLAPEYAATG 763
++F+HRDL N+L+ + AK++DFGL K R AG + + APE
Sbjct: 129 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188
Query: 764 RVTTKIDVYAFGVVLMETIT-GRK 786
+ +++ DV+++GV + E ++ G+K
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-38
Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 587 NILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLV 642
++GRG FG VY G L D AVK + T +S+F E ++ H +++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEVSQFLTEGIIMKDFSHPNVL 153
Query: 643 ALLGYCINGSE-RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+LLG C+ L+V YM G L + + + T K + L VA+G+++L
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHN-PTVKDLIGFGLQVAKGMKFL- 208
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL-----A 756
A + F+HRDL N ++ + KVADFGL ++ D ++ ++ T L A
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF--DSVHNKTGAKLPVKWMA 264
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETIT 783
E T + TTK DV++FGV+L E +T
Sbjct: 265 LESLQTQKFTTKSDVWSFGVLLWELMT 291
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 1e-38
Identities = 54/209 (25%), Positives = 95/209 (45%), Gaps = 20/209 (9%)
Query: 587 NILGRGGFGVVYGGELPDG-----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
+LG G FG V+ G + +K +E + G + + + + H H+
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHI 77
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
V LLG C GS LV +Y+P G+L H+ H L + + + +A+G+ YL
Sbjct: 78 VRLLGLCP-GSSLQLVTQYLPLGSLLDHV---RQHRGA-LGPQLLLNWGVQIAKGMYYL- 131
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT---FGYLAPE 758
+ +HR+L N+L+ + +VADFG+ P + + ++A E
Sbjct: 132 --EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK--QLLYSEAKTPIKWMALE 187
Query: 759 YAATGRVTTKIDVYAFGVVLMETIT-GRK 786
G+ T + DV+++GV + E +T G +
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-38
Identities = 67/365 (18%), Positives = 141/365 (38%), Gaps = 66/365 (18%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTS 127
L K+ ++ L + L +A I + T+L+ + L+ N T
Sbjct: 24 GIRAVLQKASVTDV--VTQEELESITKLVVAGEKVAS-IQGIEYLTNLEYLNLNGNQITD 80
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
+ L L L + N + + L T+L LY++ NI + P + +
Sbjct: 81 ISP--LSNLVKLTNLYIGTN-KITD---ISALQNLTNLRELYLNEDNISDISP--LANLT 132
Query: 188 NLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
+ +L L N+ S + + + + L + + ++ + ++ +T L + L+ NQ
Sbjct: 133 KMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKV---KDVTPIANLTDLYSLSLNYNQ 188
Query: 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKV 305
I L+ SL + NQ+T + P V ++ L ++ + NNK+ PL S++
Sbjct: 189 IED-ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQL 245
Query: 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS 365
+ + N Q++ + ++ +
Sbjct: 246 TWLEIGTN---------------QISDI--------------NAVKDLT----------- 265
Query: 366 QGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSN 424
++ +N+ N++ +IS NL+ L +L+L N L + + L +L L +S
Sbjct: 266 --KLKMLNVGSNQI--SDISVL-NNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQ 320
Query: 425 NNLSG 429
N+++
Sbjct: 321 NHITD 325
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 1e-37
Identities = 68/361 (18%), Positives = 140/361 (38%), Gaps = 84/361 (23%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV 128
++L + ++ +S+L +L L N I I +L N T+L+++YL+ +N + +
Sbjct: 69 EYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKITD-ISALQNLTNLRELYLNEDNISDI 125
Query: 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188
LT + L+L N NL+ + L+ T L L + + + + P + ++
Sbjct: 126 S--PLANLTKMYSLNLGANHNLS---DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTD 178
Query: 189 LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248
L +L L+YN + L+ +T L + NQ T
Sbjct: 179 LYSLSLNYNQIED--------------------------ISPLASLTSLHYFTAYVNQIT 212
Query: 249 GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQK 307
I ++ L L + +N++T + P + +L L + + N++ + +K++
Sbjct: 213 D-ITPVANMTRLNSLKIGNNKITDLSPLA--NLSQLTWLEIGTNQISDINAVKDLTKLKM 269
Query: 308 VSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQG 367
+++ N Q++ + + LS
Sbjct: 270 LNVGSN---------------QISDISVLNN-------LS-------------------- 287
Query: 368 RIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
++ ++ L N L LT+L L+L QN++T P L L+ + + D +N +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVI 345
Query: 428 S 428
Sbjct: 346 K 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-33
Identities = 52/254 (20%), Positives = 99/254 (38%), Gaps = 30/254 (11%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N + ++ I +++LT++ +L+ N+ + L+N T L + + +
Sbjct: 118 NEDNISDI------------SPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTES 165
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
V LT+L LSL+ N +++P L TSL I + P
Sbjct: 166 KVKDVTP--IANLTDLYSLSLNYNQIEDISP------LASLTSLHYFTAYVNQITDITP- 216
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+ + L +L++ N T P + + L + Q+ ++ + +T+L+ +
Sbjct: 217 -VANMTRLNSLKIGNNKITDLSPLANLSQ-LTWLEIGTNQIS---DINAVKDLTKLKMLN 271
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF 301
+ NQ + I L+ L L L +NQL + L L + L N + PL
Sbjct: 272 VGSNQISD-ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA 330
Query: 302 P-SKVQKVSLDHNN 314
SK+ +
Sbjct: 331 SLSKMDSADFANQV 344
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-31
Identities = 60/341 (17%), Positives = 125/341 (36%), Gaps = 66/341 (19%)
Query: 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--N 149
TL+ I I A+ L + T V T + L ++ L ++ +
Sbjct: 2 AATLATLPAPI-NQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58
Query: 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK 209
+ + T+L L ++ I + P + L NL + N T + A
Sbjct: 59 IQG------IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-DISALQNL 109
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ 269
++++ L++N+ + + L+ +T++ + L N + LS L L++ +++
Sbjct: 110 TNLRELYLNEDNI---SDISPLANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESK 166
Query: 270 LTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDP 328
+ V P + +L L ++SL N+++ PL + + + N
Sbjct: 167 VKDVTPIA--NLTDLYSLSLNYNQIEDISPLASLTSLHYFTAYVN--------------- 209
Query: 329 QVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA 388
Q+T + P ++ + I NK+ A
Sbjct: 210 QITDIT-------------------------PVANMTRLNSLKIG-NNKI---TDLSPLA 240
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
NL+ L L + N ++ + + L L+ L+V +N +S
Sbjct: 241 NLSQLTWLEIGTNQISD--INAVKDLTKLKMLNVGSNQISD 279
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 46/211 (21%), Positives = 84/211 (39%), Gaps = 30/211 (14%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
++V + I++LT L +LS N I I LA+ TSL N
Sbjct: 163 TESKVKDV------------TPIANLTDLYSLSLNYNQIED-ISPLASLTSLHYFTAYVN 209
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
T + +T L L + +N +L+P L + LT L + I +
Sbjct: 210 QITDITP--VANMTRLNSLKIGNNKITDLSP------LANLSQLTWLEIGTNQISDINA- 260
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
+ L+ L + N + + S + +L++N+ QLG + ++V+ G+T L +
Sbjct: 261 -VKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLG-NEDMEVIGGLTNLTTL 316
Query: 241 WLHKNQFTGPIPDLSKCESLFDLSLRDNQLT 271
+L +N T I L+ + + +
Sbjct: 317 FLSQNHITD-IRPLASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 5e-08
Identities = 26/190 (13%), Positives = 62/190 (32%), Gaps = 49/190 (25%)
Query: 251 IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKVS 309
I + L+ +T VV L ++ + + K+ + + + ++ ++
Sbjct: 15 IFPDADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVASIQGIEYLTNLEYLN 72
Query: 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
L+ N Q+T + P + +
Sbjct: 73 LNGN---------------QITDIS-------------------------PLSNLVK--L 90
Query: 370 ITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
+ + + A NLT+L+ LYL ++N++ P L L + +L++ N+
Sbjct: 91 TNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNLS 146
Query: 430 KVPDFGSNVK 439
+ +
Sbjct: 147 DLSPLSNMTG 156
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-05
Identities = 15/52 (28%), Positives = 24/52 (46%), Gaps = 3/52 (5%)
Query: 388 ANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
AN+T L +L + N +T P L L+ L L++ N +S + K
Sbjct: 218 ANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS-DINAVKDLTK 266
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-38
Identities = 71/260 (27%), Positives = 109/260 (41%), Gaps = 37/260 (14%)
Query: 545 GVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGE-LP 603
G H SSG + F+G V I + ++ LG GGF V E L
Sbjct: 2 GSSHHHHHHSSG--RENLYFQGHMVIIDNK-------HYLFIQKLGEGGFSYVDLVEGLH 52
Query: 604 DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERLLVYE 659
DG A+KR+ + + E Q E + H +++ L+ YC+ E L+
Sbjct: 53 DGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110
Query: 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719
+ RGTL + D G LT Q + + L + RG+E +H+ + + HRDLKP+NIL
Sbjct: 111 FFKRGTLWNEIERLKDKG-NFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNIL 166
Query: 720 IGDDMRAKVADFGLVKNAPDGKYSVETRLA--------GTFGYLAPE------YAATGRV 765
+GD+ + + D G + A L T Y APE + +
Sbjct: 167 LGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV---I 223
Query: 766 TTKIDVYAFGVVLMETITGR 785
+ DV++ G VL + G
Sbjct: 224 DERTDVWSLGCVLYAMMFGE 243
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-38
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 587 NILGRGGFGVVYGGEL-PDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
+LG G FG VY G P+G +A+K + T K E E V+ V + H+
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHV 79
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
LLG C+ S L+ + MP G L ++ +H + + + + +A+G+ YL
Sbjct: 80 CRLLGICL-TSTVQLITQLMPFGCLLDYV---REHKDN-IGSQYLLNWCVQIAKGMNYL- 133
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT---FGYLAPE 758
+ +HRDL N+L+ K+ DFGL K + E G ++A E
Sbjct: 134 --EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALE 189
Query: 759 YAATGRVTTKIDVYAFGVVLMETIT-GRK 786
T + DV+++GV + E +T G K
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 60/269 (22%), Positives = 104/269 (38%), Gaps = 32/269 (11%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+GRG F VY G + ++A ++ + F+ E +L ++H ++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 647 YCINGSE---RLLVY-EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
+ + +++ E M GTL +L + + K + + +G+++LH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT 147
Query: 703 LAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA 761
IHRDLK NI I G K+ D GL S + GT ++APE
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMYE 203
Query: 762 TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821
+DVYAFG+ ++E T + +RRV + P + D
Sbjct: 204 EK-YDESVDVYAFGMCMLEMATSEYPYSECQN-----AAQIYRRV--TSGVKPASFDKVA 255
Query: 822 NLDEETIESIYRVAELAGHCTAREPQQRP 850
+ V E+ C + +R
Sbjct: 256 IPE---------VKEIIEGCIRQNKDERY 275
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 2e-37
Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 15/204 (7%)
Query: 589 LGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
LG G FG V G +A+K ++ T E E ++ ++ + ++V L+
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
G C +LV E G L + L + + + V+ G++YL +
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYL---EE 454
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY--LAPEYAATG 763
++F+HR+L N+L+ + AK++DFGL K R AG + APE
Sbjct: 455 KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 514
Query: 764 RVTTKIDVYAFGVVLMETIT-GRK 786
+ +++ DV+++GV + E ++ G+K
Sbjct: 515 KFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 3e-37
Identities = 67/384 (17%), Positives = 121/384 (31%), Gaps = 37/384 (9%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122
N NR + S L L+ S ++ L N ++ LA T L+ + L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N + L+ L+ L L++N + EL S+ TL+ N N +
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNN-YV------QELLVGPSIETLHAAN-NNISRVS-- 115
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+N+ L+ N T S +Q L + ++ ++ + L +
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPL 300
L N + L L L N+L + S + ISL+NNKL L
Sbjct: 176 LQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKAL 233
Query: 301 FP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTL---------LQIAGDMGYPAILSDSW 350
++ L N F + + +V T+ Q + P +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGH--- 290
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLA------GNISPAYANLTSLKNLYLQQNNLT 404
G C+ P + + + LL+ + N + + +
Sbjct: 291 YGAYCCEDLPAPFADRLIALK-RKEHALLSGQGSETERLECERENQARQREIDALKEQYR 349
Query: 405 GPIPDGLTKLASLQNLDVSNNNLS 428
I + + L+ L
Sbjct: 350 TVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-33
Identities = 55/377 (14%), Positives = 119/377 (31%), Gaps = 35/377 (9%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV 128
+ L+ + LS + +++ T+LE L+ N + L + ++L+ + L+NN +
Sbjct: 37 KELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQEL 95
Query: 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188
+++ L ++N N++ +Y+ N I L S
Sbjct: 96 LV-----GPSIETLHAANN-NISRVSCSR----GQGKKNIYLANNKITMLRDLDEGCRSR 145
Query: 189 LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG----TLDVLSGMTQLRQVWLHK 244
+Q L L N ++ + + L + L L + +L+ + L
Sbjct: 146 VQYLDLKLNEID-TVNFAELAASSDTL----EHLNLQYNFIYDVKGQVVFAKLKTLDLSS 200
Query: 245 NQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLFP 302
N+ P+ + +SLR+N+L ++ ++ L + L+ N F
Sbjct: 201 NKLAFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFS 259
Query: 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE----------- 351
+ ++ K + + C PA +D
Sbjct: 260 KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLS 319
Query: 352 -GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
+ + +Q R I+ + I + L ++ L + +G
Sbjct: 320 GQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNG 379
Query: 411 LTKLASLQNLDVSNNNL 427
A L
Sbjct: 380 RRAHAELDGTLQQAVGQ 396
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 6e-20
Identities = 31/228 (13%), Positives = 64/228 (28%), Gaps = 12/228 (5%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+L+TL N +A P +A + I L NN + NL+
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKA-LRFSQNLEHFD 243
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYN---NFT 200
L N + +K+ + T+ + L + + +
Sbjct: 244 LRGNG-FHCGTLRDFFSKNQRVQTV--AKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLP 300
Query: 201 GSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS-GMTQLRQVWLHKNQFTGPIPDL-SKCE 258
+ + Q + L+ + R++ K Q+ I + + +
Sbjct: 301 APFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQ 360
Query: 259 SLFDLSLRDNQLTGVVP---ASVISLPALLNISLQNNKLQGPYPLFPS 303
+ L + L V + L L ++ +LQ
Sbjct: 361 AKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSP 408
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 43/262 (16%), Positives = 96/262 (36%), Gaps = 55/262 (20%)
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQ 236
I + + + + +++ ++ +L + +++ L ++ L +S L+ T+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA--ADLAPFTK 59
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L + L N DL +L L L +N + ++ P++ + NN +
Sbjct: 60 LELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 297 -PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
+ + L +N ++T L
Sbjct: 114 VSCSRGQG-KKNIYLANN---------------KITMLR--------------------- 136
Query: 356 CDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414
+ R+ ++L N++ N + A+ +L++L LQ N + + +
Sbjct: 137 ----DLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-F 190
Query: 415 ASLQNLDVSNNNLSGKVPDFGS 436
A L+ LD+S+N L+ P+F S
Sbjct: 191 AKLKTLDLSSNKLAFMGPEFQS 212
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 18/154 (11%), Positives = 34/154 (22%), Gaps = 3/154 (1%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+ LS Q + N ++I + +V L
Sbjct: 311 KRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKK 370
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
L N L L + S LQ LR +
Sbjct: 371 -ALDE-QVSNGRRAHAELDGTLQQAVGQIEL-QHATEEQSPLQLLRAIVKRYEEMYVEQQ 427
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+ + + Q + + + + +L
Sbjct: 428 SVQNNAIRDWDMYQHKETQLAEENARLKKLNGEA 461
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-37
Identities = 44/223 (19%), Positives = 86/223 (38%), Gaps = 44/223 (19%)
Query: 588 ILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
LG+G F ++ G T++ +K ++ F ++++K+ H+
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFFEAASMMSKLSHK 72
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
HLV G C+ G E +LV E++ G+L +L + + ++ +A +A + +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYL---KKNK-NCINILWKLEVAKQLAAAMHF 128
Query: 700 LHSLAQQSFIHRDLKPSNILI--------GDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
L + + IH ++ NIL+ G+ K++D G+
Sbjct: 129 ---LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI--------- 176
Query: 752 FGY------LAPEYAATGRV-TTKIDVYAFGVVLMETIT-GRK 786
+ PE + D ++FG L E + G K
Sbjct: 177 --LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 4e-37
Identities = 61/279 (21%), Positives = 114/279 (40%), Gaps = 54/279 (19%)
Query: 589 LGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVAL 644
LG GG VY E D K+A+K + + + F+ E+ +++ H+++V++
Sbjct: 19 LGGGGMSTVYLAE--DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+ LV EY+ TL++++ HG PL+ + + G+++ H
Sbjct: 77 IDVDEEDDCYYLVMEYIEGPTLSEYI---ESHG--PLSVDTAINFTNQILDGIKHAH--- 128
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR 764
+HRD+KP NILI + K+ DFG+ K + + + GT Y +PE A
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188
Query: 765 VTTKIDVYAFGVVLMETITGR-------------KALDDTMPDDRAHLVTWFRRVLISKE 811
D+Y+ G+VL E + G K + D++P+ + +
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR----------K 238
Query: 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
+IP+++ + T ++ R
Sbjct: 239 DIPQSLS-----------------NVILRATEKDKANRY 260
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-36
Identities = 51/204 (25%), Positives = 86/204 (42%), Gaps = 14/204 (6%)
Query: 588 ILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA 643
+G G FG V+ G +A+K ++ T + +F E + + H H+V
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVK 455
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
L+G + ++ E G L L L + A ++ + YL S
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQV-RKF---SLDLASLILYAYQLSTALAYLES- 509
Query: 704 AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG 763
+ F+HRD+ N+L+ + K+ DFGL + D Y ++ ++APE
Sbjct: 510 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567
Query: 764 RVTTKIDVYAFGVVLMETIT-GRK 786
R T+ DV+ FGV + E + G K
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVK 591
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 2e-36
Identities = 84/375 (22%), Positives = 145/375 (38%), Gaps = 49/375 (13%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTS 127
L K+ ++ T+S + L Q+ TL I I + +L I NN T
Sbjct: 26 KMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTD 82
Query: 128 VPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+ LT L + +++N ++ P L T+LT L + N I + P +
Sbjct: 83 ITP--LKNLTKLVDILMNNNQIADITP------LANLTNLTGLTLFNNQITDIDP--LKN 132
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+NL L LS N + + A + +Q L +Q L L+ +T L ++ + N
Sbjct: 133 LTNLNRLELSSNTIS-DISALSGLTSLQQLSFGNQVTDLKP----LANLTTLERLDISSN 187
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SK 304
+ + I L+K +L L +NQ++ + P L L +SL N+L+ L +
Sbjct: 188 KVSD-ISVLAKLTNLESLIATNNQISDITPLG--ILTNLDELSLNGNQLKDIGTLASLTN 244
Query: 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC 364
+ + L +N + +G ++T L L N + P
Sbjct: 245 LTDLDLANNQISNLAPLSGL---TKLTEL-----------KLG----ANQISNISPLAGL 286
Query: 365 SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSN 424
+ + + L L +NL +L L L NN++ P ++ L LQ L N
Sbjct: 287 TA--LTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYN 340
Query: 425 NNLSGKVPDFGSNVK 439
N +S V +
Sbjct: 341 NKVSD-VSSLANLTN 354
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-36
Identities = 86/374 (22%), Positives = 151/374 (40%), Gaps = 50/374 (13%)
Query: 60 INCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIY 119
++ + ++VTT+ + G+ + L L ++F N + I L N T L DI
Sbjct: 40 VSQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTD-ITPLKNLTKLVDIL 96
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFG 177
++NN + LTNL L+L +N ++ P L T+L L + + I
Sbjct: 97 MNNNQIADITP--LANLTNLTGLTLFNNQITDIDP------LKNLTNLNRLELSSNTISD 148
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQ 236
+ ++LQ L N T P A + ++ L ++ ++ + VL+ +T
Sbjct: 149 ISA--LSGLTSLQQLSFG-NQVTDLKP--LANLTTLERLDISSNKV---SDISVLAKLTN 200
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L + NQ + I L +L +LSL NQL + + SL L ++ L NN++
Sbjct: 201 LESLIATNNQISD-ITPLGILTNLDELSLNGNQLKDIGTLA--SLTNLTDLDLANNQISN 257
Query: 297 PYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
PL +K+ ++ L N S AG +T L N
Sbjct: 258 LAPLSGLTKLTELKLGANQISNISPLAGL---TALTNL---------------ELNENQL 299
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
D P + + L ++ +ISP ++LT L+ L+ N ++ L L
Sbjct: 300 EDISPISNLKN--LTYLTLYFNNIS-DISP-VSSLTKLQRLFFYNNKVSD--VSSLANLT 353
Query: 416 SLQNLDVSNNNLSG 429
++ L +N +S
Sbjct: 354 NINWLSAGHNQISD 367
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-35
Identities = 72/357 (20%), Positives = 137/357 (38%), Gaps = 64/357 (17%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+++LT L L+ N I I L N T+L + L +N + + GLT+LQ LS
Sbjct: 106 TPLANLTNLTGLTLFNNQITD-IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLS 162
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
+ L T+L L + + + + +NL++L + N +
Sbjct: 163 FGNQVT-----DLKPLANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDIT 215
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
P + + L +N QL + L+ +T L + L NQ + + LS L +L
Sbjct: 216 PLGILTN-LDELSLNGNQLK---DIGTLASLTNLTDLDLANNQISN-LAPLSGLTKLTEL 270
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDA 322
L NQ++ + P + L AL N+ L N+L+ P+ + ++L N
Sbjct: 271 KLGANQISNISPLA--GLTALTNLELNENQLEDISPISNLKNLTYLTLYFN--------- 319
Query: 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382
++ + P + ++ + + NK+ +
Sbjct: 320 ------NISDIS-------------------------PVSSLTKLQRLFFY-NNKV---S 344
Query: 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
+ ANLT++ L N ++ P L L + L +++ + ++ +NV
Sbjct: 345 DVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVS 399
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-33
Identities = 68/379 (17%), Positives = 132/379 (34%), Gaps = 69/379 (18%)
Query: 64 NSNRVTTIS-------LAKSGLSGTLS--PEISSLTQLETLSFQMNNIAGAIPSLANATS 114
+SN ++ IS L + ++ +++LT LE L N ++ I LA T+
Sbjct: 142 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSD-ISVLAKLTN 200
Query: 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174
L+ + NN + + LTNL LSL+ N L L T+LT L + N
Sbjct: 201 LESLIATNNQISDIT--PLGILTNLDELSLNGN-QLK---DIGTLASLTNLTDLDLANNQ 254
Query: 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234
I L P + L L+L N + ++ + + NL +N+ QL + +S +
Sbjct: 255 ISNLAP--LSGLTKLTELKLGANQIS-NISPLAGLTALTNLELNENQL---EDISPISNL 308
Query: 235 TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
L + L+ N + I +S L L +N+++ V + +L + +S +N++
Sbjct: 309 KNLTYLTLYFNNISD-ISPVSSLTKLQRLFFYNNKVSDVSSLA--NLTNINWLSAGHNQI 365
Query: 295 QGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353
PL +++ ++ L+ + + ++
Sbjct: 366 SDLTPLANLTRITQLGLNDQAWTNAPVNYKAN-----VSIPN------------------ 402
Query: 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTK 413
+ + IS + S + N + +
Sbjct: 403 ---------------TVKNVTGALIAPATIS----DGGSYTEPDITWNLPSY-TNEVSYT 442
Query: 414 LASLQNLDVSNNNLSGKVP 432
+ + SG V
Sbjct: 443 FSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-32
Identities = 82/374 (21%), Positives = 141/374 (37%), Gaps = 70/374 (18%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+S LT L+ LSF N + + LAN T+L+ + + +N + + LTNL+ L
Sbjct: 150 SALSGLTSLQQLSFG-NQVTD-LKPLANLTTLERLDISSNKVSDISV--LAKLTNLESLI 205
Query: 144 LSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG 201
++N ++ P L T+L L ++ + + S +NL +L L+ N +
Sbjct: 206 ATNNQISDITP------LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISN 257
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLF 261
P S + L + Q+ + L+G+T L + L++NQ I +S ++L
Sbjct: 258 LAPLSGLTK-LTELKLGANQIS---NISPLAGLTALTNLELNENQLED-ISPISNLKNLT 312
Query: 262 DLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKVSLDHNNFCKNSS 320
L+L N ++ + P S SL L + NNK+ L + + +S HN
Sbjct: 313 YLTLYFNNISDISPVS--SLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHN------- 363
Query: 321 DAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA 380
Q++ L +A L+ RI + L ++
Sbjct: 364 --------QISDLTPLAN-------LT--------------------RITQLGLNDQAWT 388
Query: 381 GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS--GKVP-DFGSN 437
N Y S+ N P ++ S D++ N S +V F
Sbjct: 389 -NAPVNYKANVSIPNTVKNVTGALIA-PATISDGGSYTEPDITWNLPSYTNEVSYTFSQP 446
Query: 438 VKFTVSPGNPFIGT 451
V F GT
Sbjct: 447 VTIGKGTTT-FSGT 459
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 9e-32
Identities = 78/347 (22%), Positives = 140/347 (40%), Gaps = 67/347 (19%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+ +LT L L N I+ I +L+ TSLQ + N P LT L+ L
Sbjct: 128 DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGNQVTDLKP---LANLTTLERLD 183
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
+S N ++ + L K T+L +L N I + P +NL L L+ N
Sbjct: 184 ISSN-KVS---DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD-- 235
Query: 204 PASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFD 262
+ A +++ +L + + Q+ L LSG+T+L ++ L NQ + I L+ +L +
Sbjct: 236 IGTLASLTNLTDLDLANNQIS---NLAPLSGLTKLTELKLGANQISN-ISPLAGLTALTN 291
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKVSLDHNNFCKNSSD 321
L L +NQL + P S +L L ++L N + P+ +K+Q++ +N
Sbjct: 292 LELNENQLEDISPIS--NLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNN-------- 341
Query: 322 AGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLA 380
+V+ + +A L++ I ++ N++
Sbjct: 342 -------KVSDVSSLAN-------LTN--------------------INWLSAGHNQI-- 365
Query: 381 GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
+++P ANLT + L L T + + S+ N +
Sbjct: 366 SDLTP-LANLTRITQLGLNDQAWTNAPVNYKANV-SIPNTVKNVTGA 410
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-20
Identities = 58/313 (18%), Positives = 101/313 (32%), Gaps = 85/313 (27%)
Query: 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG 177
+ + T L L +L + +TTL D I
Sbjct: 7 TITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQ-TDLDQ---VTTLQADRLGIKS 60
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ D + +NL + S N T + L +T+L
Sbjct: 61 I--DGVEYLNNLTQINFSNNQLTD--------------------------ITPLKNLTKL 92
Query: 238 RQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
+ ++ NQ I L+ +L L+L +NQ+T + P +L L + L +N +
Sbjct: 93 VDILMNNNQIAD-ITPLANLTNLTGLTLFNNQITDIDPLK--NLTNLNRLELSSNTISDI 149
Query: 298 YPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNAC 356
L + +Q++S GN
Sbjct: 150 SALSGLTSLQQLSF-----------------------------------------GNQVT 168
Query: 357 DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS 416
D P + + I+ +NK+ +IS A LT+L++L N ++ P L L +
Sbjct: 169 DLKPLANLTTLERLDIS-SNKV--SDISV-LAKLTNLESLIATNNQISDITP--LGILTN 222
Query: 417 LQNLDVSNNNLSG 429
L L ++ N L
Sbjct: 223 LDELSLNGNQLKD 235
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 4e-04
Identities = 9/62 (14%), Positives = 17/62 (27%), Gaps = 3/62 (4%)
Query: 367 GRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNN 426
G + + + I L L + N+T + T L + L
Sbjct: 1 GPLGSATITQDTPINQIFTD-TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 427 LS 428
+
Sbjct: 58 IK 59
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-36
Identities = 61/385 (15%), Positives = 116/385 (30%), Gaps = 45/385 (11%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFT 126
+ ++ L+ S I L L+ L+ N I +N T+L + L N
Sbjct: 107 ENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQ 166
Query: 127 SVPTGCFDGLTNL----QVLSLSDNP--NLAPWPFPNELTKSTSLTTLYM-DNANIFGLI 179
++ L L +S NP + F + L L + N N ++
Sbjct: 167 TITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAF-----QGIKLHELTLRGNFNSSNIM 221
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLP-ASFAKSDIQNL-WMNDQQLGLSG------TLDVL 231
+ + L RL F F S ++ L + + L+ +
Sbjct: 222 KTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKF 281
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ + + L + D+ K LS+ QL LP L +++L
Sbjct: 282 HCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLSIIRCQLKQFPTLD---LPFLKSLTLTM 337
Query: 292 NKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKP-CDPQVTTLLQIAGDMGYPAILSDS 349
NK + + + L N + + + L D+ + + S
Sbjct: 338 NKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL-----DLSFNGAIIMS 392
Query: 350 WEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIP 408
F+ + + ++ + L A+ +L L L + N
Sbjct: 393 AN---------FMGLEE--LQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 409 DGLTKLASLQNLDVSNNNLSGKVPD 433
L SL L ++ N+
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 5e-36
Identities = 61/378 (16%), Positives = 119/378 (31%), Gaps = 40/378 (10%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS 127
+ L++ + L L L N I P S + TSL+++ S
Sbjct: 59 QWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
+ + L L+ L+++ N + P + T+L + + I + +
Sbjct: 119 LESFPIGQLITLKKLNVAHN-FIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 188 NLQN----LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
L +S N +F + L + + L + L L
Sbjct: 178 ENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLI 237
Query: 244 KNQFTG----PIPDLSKCESLFDLSLRD-----NQLTGVVPASVISLPALLNISLQNNKL 294
+F I + S E L D+++ + L + +SL +
Sbjct: 238 LGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI 297
Query: 295 QGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353
+ + K Q +S+ + + P + +L L+ N
Sbjct: 298 KYLEDVPKHFKWQSLSIIRCQLKQFPTLD----LPFLKSL-----------TLT----MN 338
Query: 354 NACDGWPFVTCSQGRIITINLA-NKL-LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
+ V + ++L+ N L +G S + SL++L L N +
Sbjct: 339 KGSISFKKVALPS--LSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANF 395
Query: 412 TKLASLQNLDVSNNNLSG 429
L LQ+LD ++ L
Sbjct: 396 MGLEELQHLDFQHSTLKR 413
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-34
Identities = 63/386 (16%), Positives = 117/386 (30%), Gaps = 45/386 (11%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+ N + TI+ L + +L +N I L ++ L N
Sbjct: 161 SYNYIQTIT------VNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214
Query: 124 NF-TSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELT----KSTSLTTLYMDNANIF 176
+++ C L L V L + ++ + N F
Sbjct: 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDF 274
Query: 177 GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQ 236
F +N+ + L+ + L Q+L + QL +
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIK-YLEDVPKHFKWQSLSIIRCQL----KQFPTLDLPF 329
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASV--ISLPALLNISLQNNKL 294
L+ + L N+ + SL L L N L+ S + +L ++ L N
Sbjct: 330 LKSLTLTMNKGSI-SFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA 388
Query: 295 QGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
F ++Q + H+ + + + ++ L +S
Sbjct: 389 IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL-----------DIS----- 432
Query: 353 NNACDGWP---FVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408
F+ + + T+ +A N +S +AN T+L L L + L
Sbjct: 433 YTNTKIDFDGIFLGLTS--LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISW 490
Query: 409 DGLTKLASLQNLDVSNNNLSGKVPDF 434
L LQ L++S+NNL
Sbjct: 491 GVFDTLHRLQLLNMSHNNLLFLDSSH 516
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 5e-33
Identities = 62/407 (15%), Positives = 118/407 (28%), Gaps = 67/407 (16%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAG--AIPSLANAT---- 113
++ ++L + S + + +L L + + +
Sbjct: 199 QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGL 258
Query: 114 ---SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170
++ + L N S F L N+ +SL+ ++ + ++ K +L +
Sbjct: 259 CDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV-SIK---YLEDVPKHFKWQSLSI 314
Query: 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL-GLSGTLD 229
+ L++L L+ N + S S + L ++ L
Sbjct: 315 IRCQLKQFP---TLDLPFLKSLTLTMNKGSISFKKVALPS-LSYLDLSRNALSFSGCCSY 370
Query: 230 VLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNIS 288
G LR + L N + E L L + + L V S SL LL +
Sbjct: 371 SDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLD 430
Query: 289 LQNNKLQGPYP-LFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI 345
+ + + +F + + + + N+F D TT L
Sbjct: 431 ISYTNTKIDFDGIFLGLTSLNTLKMAGNSF----KDNTLSNVFANTTNLT---------- 476
Query: 346 LSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG 405
++L+ L + L L+ L + NNL
Sbjct: 477 -------------------------FLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLF 511
Query: 406 PIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK----FTVSPGNPF 448
+L SL LD S N + K F ++ N
Sbjct: 512 LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLT-NNSV 557
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-32
Identities = 53/437 (12%), Positives = 112/437 (25%), Gaps = 90/437 (20%)
Query: 9 SICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPS----DWSSTSSTGYCEWTGINCDN 64
I ++L +L + + + LQNL
Sbjct: 195 FIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSI 254
Query: 65 -----SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIY 119
+ L + + L + +S +I + + Q +
Sbjct: 255 MEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY-LEDVPKHFKWQSLS 313
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+ P L L+ L+L+ N + SL+ L + +
Sbjct: 314 IIRCQLKQFP---TLDLPFLKSLTLTMNKGSISFKK----VALPSLSYLDLSRNALSFSG 366
Query: 180 PDFFDSF--SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ ++L++L LS+N + A+F G+ +L
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANF------------------------MGLEEL 401
Query: 238 RQVWLHKNQFTGPIP--DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
+ + + E L L + + L +L + + N +
Sbjct: 402 QHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFK 461
Query: 296 G--PYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
+F + + + L + S ++ L
Sbjct: 462 DNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTL-HRLQLL------------------ 502
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
N+++ L S Y L SL L N +
Sbjct: 503 ---------------------NMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
Query: 412 TKLASLQNLDVSNNNLS 428
SL +++NN+++
Sbjct: 542 HFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 9e-31
Identities = 65/384 (16%), Positives = 115/384 (29%), Gaps = 64/384 (16%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIY 119
C T LS + +I S + + N + S +N + LQ +
Sbjct: 6 PCIEVVPNITYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSELQWLD 62
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFG 177
L ++ + GL +L L L+ NP + +P F TSL L +
Sbjct: 63 LSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG----LTSLENLVAVETKLAS 118
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTG-SLPASFAKSDIQNLWMNDQQLGLSG---------T 227
L L+ L +++N LPA F S++ NL + LS
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYF--SNLTNL----VHVDLSYNYIQTITVND 172
Query: 228 LDVLSGMTQLRQV-WLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVIS-LPALL 285
L L Q+ + N + L +L+LR N + + + + L L
Sbjct: 173 LQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLH 232
Query: 286 NISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI 345
L + + L + + CD + + Y
Sbjct: 233 VHRLILGEFKDERNL-------EIFEPSIM-------EGLCDVTIDEF-----RLTYTND 273
Query: 346 LSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLT 404
SD + ++LA + ++L + + L
Sbjct: 274 FSDD----------IVKFHCLANVSAMSLAGVSI---KYLEDVPKHFKWQSLSIIRCQLK 320
Query: 405 GPIPDGLTKLASLQNLDVSNNNLS 428
L L++L ++ N S
Sbjct: 321 QFPTLDLP---FLKSLTLTMNKGS 341
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-30
Identities = 68/390 (17%), Positives = 123/390 (31%), Gaps = 63/390 (16%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT 126
I L+ + L S S+ ++L+ L I + L ++ L N
Sbjct: 34 TKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQ 93
Query: 127 SVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGL-IPDFF 183
S G F GLT+L+ L + +L +P +L L + + I +P +F
Sbjct: 94 SFSPGSFSGLTSLENLVAVETKLASLESFPIGQ----LITLKKLNVAHNFIHSCKLPAYF 149
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
+ +NL ++ LSYN ++ + L +S
Sbjct: 150 SNLTNLVHVDLSYNYIQTITVNDL--QFLRENPQVNLSLDMSL----------------- 190
Query: 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNNKLQGPYP--- 299
N + L +L+LR N + + + + L L L + +
Sbjct: 191 -NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEI 249
Query: 300 --------LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
L + + L + N + V+ + L+
Sbjct: 250 FEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCL-ANVSAM-----------SLA---- 293
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
G + + + ++I +L +L LK+L L N + I
Sbjct: 294 GVSIKYLEDVPKHFKWQSLSII-RCQL--KQFPTL--DLPFLKSLTLTMNKGS--ISFKK 346
Query: 412 TKLASLQNLDVSNNNLSGKVPDFGSNVKFT 441
L SL LD+S N LS S++
Sbjct: 347 VALPSLSYLDLSRNALSFSGCCSYSDLGTN 376
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-25
Identities = 46/345 (13%), Positives = 106/345 (30%), Gaps = 44/345 (12%)
Query: 104 GAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTK 161
G++ + + VP ++ + + LS NP L + F N ++
Sbjct: 2 GSLNPCIEVVPNITYQCMDQKLSKVPDDIP---SSTKNIDLSFNPLKILKSYSFSN-FSE 57
Query: 162 STSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQ 221
L L + I + + +L NL L+ N P SF S + +L +
Sbjct: 58 ---LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSF--SGLTSL----EN 108
Query: 222 LGLSGTL------DVLSGMTQLRQVWLHKNQFTG-PIPD-LSKCESLFDLSLRDNQLTGV 273
L T + + L+++ + N +P S +L + L N + +
Sbjct: 109 LVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTI 168
Query: 274 VPASVISL----PALLNISLQNNKLQG--PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD 327
+ L L++ + N + K+ +++L N ++ +
Sbjct: 169 TVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGNFN-SSNIMKTCLQN 227
Query: 328 PQVTTLLQIAGDMGYPAILSDSWEGNN---ACDGWPFVTCSQGRIITINLANKLLAGNIS 384
+ + ++ ++ + I L +
Sbjct: 228 LAGLHVHR---------LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDI 278
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
+ L ++ + L ++ + + K Q+L + L
Sbjct: 279 VKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQLKQ 321
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 2e-10
Identities = 37/269 (13%), Positives = 70/269 (26%), Gaps = 91/269 (33%)
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
+PD D S+ +N+ LS+N SF S ++L+
Sbjct: 26 VPD--DIPSSTKNIDLSFNPLKILKSYSF------------------------SNFSELQ 59
Query: 239 QVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
+ L + + L +L L N + P S L +L
Sbjct: 60 WLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSL------------- 106
Query: 298 YPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD 357
+ + S + L ++
Sbjct: 107 --------ENLVAVETKLASLESFPIGQL-ITLKKL-----------NVAH--------- 137
Query: 358 GWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL--- 414
N + + + ++NLT+L ++ L N + + L L
Sbjct: 138 ------------------NFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLREN 179
Query: 415 -ASLQNLDVSNNNLSGKVPDFGSNVKFTV 442
+LD+S N + +K
Sbjct: 180 PQVNLSLDMSLNPIDFIQDQAFQGIKLHE 208
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-36
Identities = 66/267 (24%), Positives = 99/267 (37%), Gaps = 32/267 (11%)
Query: 589 LGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVAL 644
+GRGG G VY E D +A+K M + Q E +++ H+V +
Sbjct: 42 VGRGGMGDVYEAE--DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
+ + + + LA L G PL + V I + ++ H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAML---RRQG--PLAPPRAVAIVRQIGSALDAAH--- 151
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR 764
HRD+KP NIL+ D A + DFG+ D K + GT Y+APE +
Sbjct: 152 AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211
Query: 765 VTTKIDVYAFGVVLMETITGRKALD-DTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNL 823
T + D+YA VL E +TG D + AH+ R + IP A D
Sbjct: 212 ATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFD----- 266
Query: 824 DEETIESIYRVAELAGHCTAREPQQRP 850
+ A+ P+ R
Sbjct: 267 ------------AVIARGMAKNPEDRY 281
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 74/304 (24%), Positives = 117/304 (38%), Gaps = 45/304 (14%)
Query: 589 LGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVAL 644
LG GG V+ D +AVK + ++ + F+ E + H +VA+
Sbjct: 20 LGFGGMSEVHLAR--DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 645 LGY-CINGSERLLVY---EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
L Y EY+ TL + H G P+T K+ + + D + + +
Sbjct: 78 YDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEG--PMTPKRAIEVIADACQALNFS 132
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR---LAGTFGYLAP 757
H Q IHRD+KP+NI+I KV DFG+ + D SV T+ + GT YL+P
Sbjct: 133 H---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV-TQTAAVIGTAQYLSP 188
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA--HLVTWFRRVLISKENIPK 815
E A V + DVY+ G VL E +TG P A H+ +E+
Sbjct: 189 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----------REDPIP 238
Query: 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP----DMGHAVNVLGPLVEQWKPATR 871
+ L + + + A+ P+ R +M + + P
Sbjct: 239 PSARHEGLSAD-------LDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVL 291
Query: 872 EDED 875
D +
Sbjct: 292 TDAE 295
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-34
Identities = 61/366 (16%), Positives = 127/366 (34%), Gaps = 68/366 (18%)
Query: 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSV 128
+ + E +L + ++F+ + + +P+ L + ++ + L++ +
Sbjct: 26 VHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI 84
Query: 129 PTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
T F +Q L + N L P F N LT L ++ ++ L F +
Sbjct: 85 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN----VPLLTVLVLERNDLSSLPRGIFHNT 140
Query: 187 SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
L L +S NN + D T L+ + L N+
Sbjct: 141 PKLTTLSMSNNNLE-RIED-----------------------DTFQATTSLQNLQLSSNR 176
Query: 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQ 306
T + LS SLF ++ N L+ ++ A+ + +N + ++
Sbjct: 177 LTH-VD-LSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELT 229
Query: 307 KVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGY---PAILSDSWEGNNACDGWPFVT 363
+ L HNN + P + + D+ Y I+ +
Sbjct: 230 ILKLQHNNL--TDTAWLLNY-PGLVEV-----DLSYNELEKIMYHPFVKMQ--------- 272
Query: 364 CSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422
R+ + ++ N+L ++ + +LK L L N+L + + L+NL +
Sbjct: 273 ----RLERLYISNNRL--VALNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYL 325
Query: 423 SNNNLS 428
+N++
Sbjct: 326 DHNSIV 331
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-34
Identities = 78/371 (21%), Positives = 139/371 (37%), Gaps = 71/371 (19%)
Query: 66 NRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDN 122
N ++ S + L + S Q+E L+ I I + A A ++Q +Y+
Sbjct: 45 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N +P F + L VL L N +L+ P + LTTL M N N+ + D
Sbjct: 103 NAIRYLPPHVFQNVPLLTVLVLERN-DLSSLP-RGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG-TLDVLSGMTQLRQVW 241
F + ++LQNL+LS N T S I +L +S L L+ + ++
Sbjct: 161 FQATTSLQNLQLSSNRLT-----HVDLSLIPSL----FHANVSYNLLSTLAIPIAVEELD 211
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPL 300
N + L L L+ N LT A +++ P L+ + L N+L+ Y
Sbjct: 212 ASHNSINV-VRGPV-NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP 267
Query: 301 FP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG 358
F +++++ + +N ++ L
Sbjct: 268 FVKMQRLERLYISNN---------------RLVAL------------------------- 287
Query: 359 WPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASL 417
+ ++L+ N LL ++ L+NLYL N++ + +L
Sbjct: 288 -NLYGQPIPTLKVLDLSHNHLL--HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTL 341
Query: 418 QNLDVSNNNLS 428
+NL +S+N+
Sbjct: 342 KNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 9e-27
Identities = 51/262 (19%), Positives = 100/262 (38%), Gaps = 31/262 (11%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIY 119
D+ +V ++L + + + ++ L N I +P N L +
Sbjct: 66 DSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLV 123
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFG 177
L+ N+ +S+P G F L LS+S+N + F +TSL L + + N
Sbjct: 124 LERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQA----TTSLQNLQLSS-NRLT 178
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT-LDVLSGM-- 234
+ +L + +SYN + +L + ++L S ++V+ G
Sbjct: 179 HVD--LSLIPSLFHANVSYNLLS-TLAIPI------AV----EELDASHNSINVVRGPVN 225
Query: 235 TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
+L + L N T L L ++ L N+L ++ + + L + + NN+L
Sbjct: 226 VELTILKLQHNNLT-DTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL 284
Query: 295 QGPYPLFP--SKVQKVSLDHNN 314
++ + L HN+
Sbjct: 285 VALNLYGQPIPTLKVLDLSHNH 306
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-23
Identities = 53/325 (16%), Positives = 102/325 (31%), Gaps = 59/325 (18%)
Query: 108 SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167
+L D+++D L N ++++ ++ + P L +
Sbjct: 16 NLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNS-TMRKLP-AALLDSFRQVEL 73
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227
L +++ I + F +Q L + +N LP
Sbjct: 74 LNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPP---------------------- 110
Query: 228 LDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALL 285
V + L + L +N + +P L LS+ +N L + + + +L
Sbjct: 111 -HVFQNVPLLTVLVLERNDLSS-LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQ 168
Query: 286 NISLQNNKLQG-PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
N+ L +N+L L PS + ++ +N V L
Sbjct: 169 NLQLSSNRLTHVDLSLIPS-LFHANVSYNLLST------LAIPIAVEEL----------- 210
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNL 403
S +N+ + + + + L N L + N L + L N L
Sbjct: 211 DAS-----HNSINVVRGPVNVE--LTILKLQHNNLTD---TAWLLNYPGLVEVDLSYNEL 260
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
+ K+ L+ L +SNN L
Sbjct: 261 EKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 2e-22
Identities = 39/252 (15%), Positives = 81/252 (32%), Gaps = 53/252 (21%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+SNR+T + L S + L + N ++ +LA +++++ +N
Sbjct: 173 SSNRLTHVDL-------------SLIPSLFHANVSYNLLS----TLAIPIAVEELDASHN 215
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ V L +L L N NL + L + + + ++ F
Sbjct: 216 SINVVRGPVN---VELTILKLQHN-NLTDTAWLLNYP---GLVEVDLSYNELEKIMYHPF 268
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
L+ L +S N +L + L+ + L
Sbjct: 269 VKMQRLERLYISNNRLV-ALNLYG------------------------QPIPTLKVLDLS 303
Query: 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP 302
N + + + L +L L N + + S + L N++L +N
Sbjct: 304 HNHLLHVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHNDWDCNSLRALF 360
Query: 303 SKVQKVSLDHNN 314
V + ++D +
Sbjct: 361 RNVARPAVDDAD 372
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 5e-14
Identities = 37/324 (11%), Positives = 87/324 (26%), Gaps = 91/324 (28%)
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
+ + + + + + F E + + N+ + L
Sbjct: 6 RQPEYKCIDSNLQYDCV-FYDVHIDMQTQDVYFGF--EDITLNNQKIVTFKNSTMRKLPA 62
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
DSF ++ L L+ + + ++++
Sbjct: 63 ALLDSFRQVELLNLNDLQIE-EIDT-----------------------YAFAYAHTIQKL 98
Query: 241 WLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPY 298
++ N +P L L L N L+ + + P L
Sbjct: 99 YMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL-------------- 143
Query: 299 PLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG 358
+S+ +NN + D + + L LS +N
Sbjct: 144 -------TTLSMSNNNLERIEDDTFQAT-TSLQNL-----------QLS-----SN---- 175
Query: 359 WPFVTCSQGRIITI------NLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLT 412
R+ + +L + ++ N+ A +++ L N++ + +
Sbjct: 176 ---------RLTHVDLSLIPSLFHANVSYNLLSTLAIPIAVEELDASHNSINV-VRGPV- 224
Query: 413 KLASLQNLDVSNNNLSGKVPDFGS 436
L L + +NNL+ +
Sbjct: 225 -NVELTILKLQHNNLT-DTAWLLN 246
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 6e-34
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 24/214 (11%)
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRH 640
+F ++LG G G + + D +AVKR+ + S E+ +L + H +
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP-----ECFSFADREVQLLRESDEHPN 79
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
++ + + + E TL Q E D + + +T+ G+ +L
Sbjct: 80 VIRYFCTEKDRQFQYIAIELCA-ATL-QEYVEQKDFAHLG---LEPITLLQQTTSGLAHL 134
Query: 701 HSLAQQSFIHRDLKPSNILIGD-----DMRAKVADFGLVKNAPDGKYSVETR--LAGTFG 753
HSL + +HRDLKP NILI ++A ++DFGL K G++S R + GT G
Sbjct: 135 HSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 754 YLAPEY---AATGRVTTKIDVYAFGVVLMETITG 784
++APE T +D+++ G V I+
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-34
Identities = 64/368 (17%), Positives = 118/368 (32%), Gaps = 42/368 (11%)
Query: 86 ISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
SL+ L TL N I + + +SLQ + N S+ L L+ L++
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQN----LRLSYNNFT 200
+ N + + P + T+L L + + I + + L LS N
Sbjct: 132 AHN-LIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN 190
Query: 201 GSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-------PIPD 253
P +F + + L + + L+ + G+ L L +F
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 254 LSKCESLFDLSLRDNQLTGV---VPASVISLPALLNISLQNNKLQG-PYPLFPSKVQKVS 309
L +L R L + L + + SL + ++ + Q +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
L + F + + + L + V
Sbjct: 311 LVNCKFGQFPTLK----LKSLKRL-----TFTSNKGGNAF----------SEVDLPSLE- 350
Query: 370 ITINLA-NKL-LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
++L+ N L G S + TSLK L L N + + L L++LD ++NL
Sbjct: 351 -FLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNL 408
Query: 428 SGKVPDFG 435
++ +F
Sbjct: 409 K-QMSEFS 415
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-33
Identities = 61/386 (15%), Positives = 121/386 (31%), Gaps = 48/386 (12%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA--GAIPSLANATSLQDIYLDNNNFT 126
+ ++ L+ + I L L+ L+ N I +N T+L+ + L +N
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 127 SVPTGCFDGLTNLQV----LSLSDNP--NLAPWPFPNELTKSTSLTTLYM-DNANIFGLI 179
S+ L + + L LS NP + P F K L L + +N + ++
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-----KEIRLHKLTLRNNFDSLNVM 217
Query: 180 PDFFDSFSNLQNLRLSYNNFTG---------SLPASFAKSDIQNLWMNDQQLGLSGTLDV 230
+ L+ RL F S I+ + L +D+
Sbjct: 218 KTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
+ +T + L + D S L L + + + L +L ++
Sbjct: 278 FNCLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQF---PTLKLKSLKRLTFT 333
Query: 291 NNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349
+NK + ++ + L N + D T+L + LS
Sbjct: 334 SNKGGNAFSEVDLPSLEFLDLSRNGL--SFKGCCSQSDFGTTSLKYL--------DLS-- 381
Query: 350 WEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYA--NLTSLKNLYLQQNNLTGP 406
N ++ ++ + L +S +L +L L + +
Sbjct: 382 ---FNGVITMSSNFLGLEQLEHLDFQHSNL--KQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 407 IPDGLTKLASLQNLDVSNNNLSGKVP 432
L+SL+ L ++ N+
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFL 462
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 3e-30
Identities = 68/372 (18%), Positives = 125/372 (33%), Gaps = 46/372 (12%)
Query: 90 TQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+ L N + + S + LQ + L ++ G + L++L L L+ N
Sbjct: 28 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86
Query: 148 P--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT-GSLP 204
P +LA + +SL L N+ L L+ L +++N LP
Sbjct: 87 PIQSLA----LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 205 ASFAK-SDIQNLWMNDQQLG--LSGTLDVLSGMTQLRQVW-LHKNQFTGPIPDLSKCESL 260
F+ +++++L ++ ++ L VL M L L N P K L
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 261 FDLSLRDNQLTGVVPASVIS-LPAL------LNISLQNNKLQGPYPLFPSKVQKVSLDHN 313
L+LR+N + V + I L L L L+ + ++++
Sbjct: 203 HKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEF 262
Query: 314 NFCKNSSDAGKPCDP---------------QVTTLLQIAGDMGYPAILSDSWEGNNACDG 358
D + + + + G N
Sbjct: 263 RLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG----WQHLELVNCKFGQ 318
Query: 359 WPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT--GPIPDGLTKLAS 416
+P + + +T +NK + + +L SL+ L L +N L+ G S
Sbjct: 319 FPTLKLKSLKRLTFT-SNKG---GNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTS 374
Query: 417 LQNLDVSNNNLS 428
L+ LD+S N +
Sbjct: 375 LKYLDLSFNGVI 386
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 73/385 (18%), Positives = 131/385 (34%), Gaps = 42/385 (10%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLE----TLSFQMNNIAGAIPSLANATSLQDI 118
N + + L+ + + ++ L Q+ +L +N + P L +
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKL 205
Query: 119 YLDNNNFT-SVPTGCFDGLTNLQVLSLS-----DNPNLAPWPFPNELTKSTSLTTLYMDN 172
L NN + +V C GL L+V L + NL + + L +LT
Sbjct: 206 TLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD-KSALEGLCNLTIEEFRL 264
Query: 173 ANIFGLIPDFFDSFSNLQNLR---LSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLD 229
A + + D D F+ L N+ L S+ Q+L + + + G TL
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG-WQHLELVNCKFGQFPTL- 322
Query: 230 VLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT--GVVPASVISLPALLNI 287
+ L+++ N+ SL L L N L+ G S +L +
Sbjct: 323 ---KLKSLKRLTFTSNKGGN-AFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 288 SLQNNKLQGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCD-PQVTTLLQIAGDMGYPA 344
L N + F +++ + H+N K S+ + L D+ +
Sbjct: 379 DLSFNGVITMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYL-----DISHTH 432
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNL 403
+G + + +A N + + L +L L L Q L
Sbjct: 433 TRVAFNG---IFNGLS-------SLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL 482
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
P L+SLQ L++++N L
Sbjct: 483 EQLSPTAFNSLSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-27
Identities = 48/251 (19%), Positives = 94/251 (37%), Gaps = 21/251 (8%)
Query: 76 SGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDG 135
++ + S + L P+L SL+ + +N + +
Sbjct: 290 VSVTIERVKDFSYNFGWQHLELVNCKFGQ-FPTL-KLKSLKRLTFTSNKGGNAFS--EVD 345
Query: 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195
L +L+ L LS N +TSL L + N + F L++L
Sbjct: 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSF-NGVITMSSNFLGLEQLEHLDFQ 404
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL------DVLSGMTQLRQVWLHKNQFTG 249
++N + ++NL L +S T + +G++ L + + N F
Sbjct: 405 HSNLK-QMSEFSVFLSLRNL----IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 459
Query: 250 PIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP--SK 304
++ +L L L QL + P + SL +L +++ +N+L+ P +F +
Sbjct: 460 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTS 519
Query: 305 VQKVSLDHNNF 315
+QK+ L N +
Sbjct: 520 LQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 9e-25
Identities = 48/213 (22%), Positives = 87/213 (40%), Gaps = 36/213 (16%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYL 120
+ + + L+ +G+ T+S L QLE L FQ +N+ + +L + +
Sbjct: 370 FGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
+ + G F+GL++L+VL ++ N + P+ T+ +LT L + + L P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGN-SFQENFLPDIFTELRNLTFLDLSQCQLEQLSP 487
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
F+S S+LQ L ++ N S+P + +T L+++
Sbjct: 488 TAFNSLSSLQVLNMASNQLK-SVPD-----------------------GIFDRLTSLQKI 523
Query: 241 WLHKNQFTGPIPDLSKCESLFDLS--LRDNQLT 271
WLH N + C + LS L N
Sbjct: 524 WLHTNPWDCS------CPRIDYLSRWLNKNSQK 550
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 34/256 (13%), Positives = 63/256 (24%), Gaps = 72/256 (28%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+ +NL LS+N SF +L+ + L +
Sbjct: 27 PFSTKNLDLSFNPLRHLGSYSF------------------------FSFPELQVLDLSRC 62
Query: 246 QFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP- 302
+ L L L N + + + L +L + L
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 303 -SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361
++++++ HN P S+
Sbjct: 123 LKTLKELNVAHNLI----------------------QSFKLPEYFSNL------------ 148
Query: 362 VTCSQGRIITINLANKLLAGNISPAYANLTSLKN----LYLQQNNLTGPIPDGLTKLASL 417
+ ++L++ + L + L L N + I G K L
Sbjct: 149 -----TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRL 202
Query: 418 QNLDVSNNNLSGKVPD 433
L + NN S V
Sbjct: 203 HKLTLRNNFDSLNVMK 218
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 8e-34
Identities = 69/290 (23%), Positives = 116/290 (40%), Gaps = 56/290 (19%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+F E ++G GGFG V+ DG +KR++ N + + E+ L K+ H
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHV 64
Query: 640 HLVALLGYCINGSERL----------------LVYEYMPRGTLAQHLFEWHDHGYTPLTW 683
++V G + E+ +GTL Q + L
Sbjct: 65 NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI---EKRRGEKLDK 121
Query: 684 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKY 742
+ + + +GV+Y+HS + I+RDLKPSNI + D + K+ DFGLV + DGK
Sbjct: 122 VLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 178
Query: 743 SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW 802
TR GT Y++PE ++ ++D+YA G++L E + + + T
Sbjct: 179 ---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT-----AFETSKFFT- 229
Query: 803 FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
+ I D L +++P+ RP+
Sbjct: 230 ----DLRDGIISDIFDKKEK-------------TLLQKLLSKKPEDRPNT 262
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-33
Identities = 56/275 (20%), Positives = 102/275 (37%), Gaps = 32/275 (11%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ + +G G FG DG + +K + + M +K E + E+AVL ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V +V +Y G L + + + Q + + + +++
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI---NAQKGVLFQEDQILDWFVQICLALKH 140
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
+H + +HRD+K NI + D ++ DFG+ + + + GT YL+PE
Sbjct: 141 VHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEI 196
Query: 760 AATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN---IPKA 816
K D++A G VL E T + A + +LV I + +
Sbjct: 197 CENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVL-----KIISGSFPPVSLH 248
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
+L L R P+ RP
Sbjct: 249 YSYDLR-------------SLVSQLFKRNPRDRPS 270
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 68/295 (23%), Positives = 106/295 (35%), Gaps = 50/295 (16%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+F LGRGGFGVV+ D A+KR+ + E+ L K+ H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHP 63
Query: 640 HLVALLGYCI---------NGSERLLVY---EYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
+V + S ++ +Y + + L + +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCL 121
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-----------N 736
I L +A VE+LHS + +HRDLKPSNI D KV DFGLV
Sbjct: 122 HIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL 178
Query: 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR 796
P Y+ T GT Y++PE + K+D+++ G++L E + M +R
Sbjct: 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ER 233
Query: 797 AHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
+T + P E + + P +RP+
Sbjct: 234 VRTLT-----DVRNLKFPP--LFTQKYPCE--------YVMVQDMLSPSPMERPE 273
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-33
Identities = 43/366 (11%), Positives = 88/366 (24%), Gaps = 50/366 (13%)
Query: 524 EVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNF 583
E G+ ++ + GY + + + ++ +L Q
Sbjct: 5 EAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQGERKL 64
Query: 584 SEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHL 641
L G VV+ ++ A+K ++ E ++
Sbjct: 65 KLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESP 124
Query: 642 VALLGYC--------------------------INGSERLLVYEYMPRGTLAQ--HLFEW 673
+ LL+ L ++
Sbjct: 125 EEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDF 183
Query: 674 HDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ + R L S + +H P N+ I D R + D
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 734 VKNAPDGKYSVETRLAGTFGYLAPEY--AATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
+ + + Y E+ A+T T ++ + G+ +
Sbjct: 241 LWKVGTRGPAS----SVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
P + +W R L A L + V L G + ++R
Sbjct: 297 TPGIKG---SWKRPSLRVPGTDSLAFGSCTPLPDF-------VKTLIGRFLNFDRRRRLL 346
Query: 852 MGHAVN 857
A+
Sbjct: 347 PLEAME 352
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-33
Identities = 67/275 (24%), Positives = 96/275 (34%), Gaps = 39/275 (14%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RH 638
+F + LG G +G V+ DG AVKR S G K + AE+ KV +H
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQH 116
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
V L G L E +L QH W L Q D +
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALA 171
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFGYLA 756
+LHS Q +H D+KP+NI +G R K+ DFGL+ E G Y+A
Sbjct: 172 HLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMA 224
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR-RVLISKENIPK 815
PE G T DV++ G+ ++E + +P W + R
Sbjct: 225 PE-LLQGSYGTAADVFSLGLTILEVACNME-----LPHGGE---GWQQLRQGYLPPEFTA 275
Query: 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
+ L + +P+ R
Sbjct: 276 GLSSELR-------------SVLVMMLEPDPKLRA 297
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 1e-32
Identities = 59/281 (20%), Positives = 105/281 (37%), Gaps = 42/281 (14%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVAL 644
+G GG V+ A+K + N+ L ++ EIA L K++ ++ L
Sbjct: 34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
Y I +V E L L + +R + ++ V +H
Sbjct: 94 YDYEITDQYIYMVMECG-NIDLNSWL---KKKK--SIDPWERKSYWKNMLEAVHTIH--- 144
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPE----- 758
Q +H DLKP+N LI D K+ DFG+ PD V+ GT Y+ PE
Sbjct: 145 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 759 ------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLISKE 811
+ +++ K DV++ G +L G+ P + ++ ++
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISKLHAIIDPNH 257
Query: 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
I P+ +++ + + C R+P+QR +
Sbjct: 258 EIE---FPD-IPEKDLQDVLKC-------CLKRDPKQRISI 287
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-32
Identities = 64/244 (26%), Positives = 114/244 (46%), Gaps = 23/244 (9%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
++F LG+G FG VY E +A+K + + G+ + E+ + + +RH
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+++ L GY + + R+ L+ EY P GT+ + L + + ++ T ++A +
Sbjct: 69 PNILRLYGY-FHDATRVYLILEYAPLGTVYRELQK-----LSKFDEQRTATYITELANAL 122
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
Y HS + IHRD+KP N+L+G K+ADFG +AP + L GT YL P
Sbjct: 123 SYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR--TD-LCGTLDYLPP 176
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLISKENIPKA 816
E K+D+++ GV+ E + G+ P + + T ++R+ + P
Sbjct: 177 EMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQET-YKRISRVEFTFPDF 229
Query: 817 IDPN 820
+
Sbjct: 230 VTEG 233
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 2e-32
Identities = 78/371 (21%), Positives = 139/371 (37%), Gaps = 71/371 (19%)
Query: 66 NRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDN 122
N ++ S + L + S Q+E L+ I I + A A ++Q +Y+
Sbjct: 51 NNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 108
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N +P F + L VL L N +L+ P + LTTL M N N+ + D
Sbjct: 109 NAIRYLPPHVFQNVPLLTVLVLERN-DLSSLP-RGIFHNTPKLTTLSMSNNNLERIEDDT 166
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG-TLDVLSGMTQLRQVW 241
F + ++LQNL+LS N T S I +L +S L L+ + ++
Sbjct: 167 FQATTSLQNLQLSSNRLT-----HVDLSLIPSL----FHANVSYNLLSTLAIPIAVEELD 217
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPL 300
N + L L L+ N LT A +++ P L+ + L N+L+ Y
Sbjct: 218 ASHNSINV-VRGPV-NVELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHP 273
Query: 301 FP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDG 358
F +++++ + +N ++ L
Sbjct: 274 FVKMQRLERLYISNN---------------RLVAL------------------------- 293
Query: 359 WPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASL 417
+ ++L+ N LL ++ L+NLYL N++ + +L
Sbjct: 294 -NLYGQPIPTLKVLDLSHNHLL--HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTL 347
Query: 418 QNLDVSNNNLS 428
+NL +S+N+
Sbjct: 348 KNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-26
Identities = 58/338 (17%), Positives = 105/338 (31%), Gaps = 84/338 (24%)
Query: 95 LSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAP 152
+ Q ++ + + + + N+ +P D +++L+L+D +
Sbjct: 34 IDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDT 92
Query: 153 WPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDI 212
+ F + ++ LYM I L P F + L L L N+ + SLP
Sbjct: 93 YAFAY----AHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPR------- 140
Query: 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQL 270
+ +L + + N I D SL +L L N+L
Sbjct: 141 ----------------GIFHNTPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRL 183
Query: 271 TGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQV 330
T V S+ +P+L + ++ N L V+++ HN+ ++
Sbjct: 184 T-HVDLSL--IPSLFHANVSYNLLSTLAIP--IAVEELDASHNSINVVRGPVN----VEL 234
Query: 331 TTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANL 390
T L L +N + N
Sbjct: 235 TIL-----------KLQ-----HN-------------NLTDT------------AWLLNY 253
Query: 391 TSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L + L N L + K+ L+ L +SNN L
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 291
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 105 bits (262), Expect = 2e-23
Identities = 52/370 (14%), Positives = 106/370 (28%), Gaps = 57/370 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+SNR+T + L S + L + N ++ +LA +++++ +N
Sbjct: 179 SSNRLTHVDL-------------SLIPSLFHANVSYNLLS----TLAIPIAVEELDASHN 221
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ V L +L L N NL L L + + + ++ F
Sbjct: 222 SINVVRGPVN---VELTILKLQHN-NLTD---TAWLLNYPGLVEVDLSYNELEKIMYHPF 274
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
L+ L +S N +L + L+ + L
Sbjct: 275 VKMQRLERLYISNNRLV-ALNLYG------------------------QPIPTLKVLDLS 309
Query: 244 KNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP 302
N + + + L +L L N + + + + L N++L +N
Sbjct: 310 HNHLLHVERNQPQFDRLENLYLDHNSIVTLKLS---THHTLKNLTLSHNDWDCNSLRALF 366
Query: 303 SKVQKVSLDHNNF---CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE-GNNACDG 358
V + ++D + + G C L + + + C
Sbjct: 367 RNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCSA 426
Query: 359 WPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQ 418
+ Q I + A + L+ Q N L L +
Sbjct: 427 TDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQEQLLQGLHAEI 486
Query: 419 NLDVSNNNLS 428
+ ++ L
Sbjct: 487 DTNLRRYRLP 496
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 7e-09
Identities = 40/248 (16%), Positives = 84/248 (33%), Gaps = 58/248 (23%)
Query: 193 RLSYNNFTGSLPASFAKSDIQ------NLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
+ YN S++Q ++ ++ Q + + ++ + + V +
Sbjct: 4 QQRYNVKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDIT-LNNQKIVTFKNST 62
Query: 247 FTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP- 302
+P L + L+L D Q+ + + + + + N ++ P +F
Sbjct: 63 MRK-LPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQN 121
Query: 303 -SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361
+ + L+ N+ + L I +
Sbjct: 122 VPLLTVLVLERNDL----------------SSLP-------RGIFHN------------- 145
Query: 362 VTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420
++ T++++N L I + TSL+NL L N LT + L + SL +
Sbjct: 146 ----TPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDLSL--IPSLFHA 197
Query: 421 DVSNNNLS 428
+VS N LS
Sbjct: 198 NVSYNLLS 205
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-32
Identities = 72/311 (23%), Positives = 111/311 (35%), Gaps = 56/311 (18%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+ + + ILG G G V G +AVKRM + EI +LT+
Sbjct: 11 QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTES 65
Query: 637 -RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFE--WHDHGYTPLTWKQRVTIALDV 693
H +++ + E L + D +++ +
Sbjct: 66 DDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQI 124
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILI-------------GDDMRAKVADFGLVKNAPDG 740
A GV +LHSL IHRDLKP NIL+ +++R ++DFGL K G
Sbjct: 125 ASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 741 KYSVETRL---AGTFGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGRKALDD 790
+ S T L +GT G+ APE R+T ID+++ G V ++ K
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK---- 237
Query: 791 TMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELA----GHCTAREP 846
P F + NI + I +LDE + A +P
Sbjct: 238 -HP---------FGDKYSRESNIIRGI---FSLDEMKCLHDRSLIAEATDLISQMIDHDP 284
Query: 847 QQRPDMGHAVN 857
+RP +
Sbjct: 285 LKRPTAMKVLR 295
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-32
Identities = 62/266 (23%), Positives = 100/266 (37%), Gaps = 41/266 (15%)
Query: 552 SQSSGDVSDRHLFEGGNVAI---SIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTK 607
S D+ F G V + + V R L GGF VY + + G +
Sbjct: 6 SLGGASGRDQSDFVGQTVELGELRLRVRRV----------LAEGGFAFVYEAQDVGSGRE 55
Query: 608 IAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSER-------LLVYE 659
A+KR+ SN + E+ + K+ H ++V G E L+
Sbjct: 56 YALKRLLSNEE--EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLT 113
Query: 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719
+ +G L + L + G PL+ + I R V+++H + IHRDLK N+L
Sbjct: 114 ELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLL 170
Query: 720 IGDDMRAKVADFGLVKNA---PDGKYSVETRLA--------GTFGYLAPE---YAATGRV 765
+ + K+ DFG PD +S + R T Y PE + +
Sbjct: 171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI 230
Query: 766 TTKIDVYAFGVVLMETITGRKALDDT 791
K D++A G +L + +D
Sbjct: 231 GEKQDIWALGCILYLLCFRQHPFEDG 256
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-32
Identities = 59/281 (20%), Positives = 105/281 (37%), Gaps = 42/281 (14%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVAL 644
+G GG V+ A+K + N+ L ++ EIA L K++ ++ L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
Y I +V E L L + +R + ++ V +H
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKK--SIDPWERKSYWKNMLEAVHTIH--- 125
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPE----- 758
Q +H DLKP+N LI D K+ DFG+ PD V+ GT Y+ PE
Sbjct: 126 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 759 ------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLISKE 811
+ +++ K DV++ G +L G+ P + ++ ++
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISKLHAIIDPNH 238
Query: 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
I P+ +++ + + C R+P+QR +
Sbjct: 239 EIE---FPD-IPEKDLQDVLKC-------CLKRDPKQRISI 268
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 5e-32
Identities = 53/263 (20%), Positives = 106/263 (40%), Gaps = 33/263 (12%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVK--------------RMESNTMGNKGLSE-FQAEIAVL 633
L +G F + E D A+K + ++ + K + F+ E+ ++
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 634 TKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL---FEWHDHGYTPLTWKQRVTIA 690
T +++ + + G N E ++YEYM ++ + F + + + I
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
V Y+H+ +++ HRD+KPSNIL+ + R K++DFG + D K ++ G
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK--IKG-SRG 212
Query: 751 TFGYLAPEYAATGRVT--TKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVL 807
T+ ++ PE+ + K+D+++ G+ L +P + LV F +
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV------VPFSLKISLVELFNNIR 266
Query: 808 ISKENIPKAIDPNLNLDEETIES 830
P + L +
Sbjct: 267 TKNIEYPLDRNHFLYPLTNKKST 289
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-32
Identities = 68/299 (22%), Positives = 110/299 (36%), Gaps = 55/299 (18%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+F E +LG+G FG V D A+K++ + LS +E+ +L + H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNH 61
Query: 639 RHLVALLG-YCINGSERL------------LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ 685
+++V + + + EY GTL + + + W+
Sbjct: 62 QYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR- 120
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN--------- 736
+ + + Y+HS Q IHRDLKP NI I + K+ DFGL KN
Sbjct: 121 ---LFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174
Query: 737 ----APDGKYSVETRLAGTFGYLAPE-YAATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
G T GT Y+A E TG KID+Y+ G++ E I
Sbjct: 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST---- 230
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
+R ++ +++ P D N E ++ +P +RP
Sbjct: 231 -GMERVNI---LKKLRSVSIEFPPDFDDNKMKVE---------KKIIRLLIDHDPNKRP 276
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 53/283 (18%), Positives = 98/283 (34%), Gaps = 39/283 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+++ +G G +G DG + K ++ +M +E+ +L +++H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 640 HLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
++V I+ + L V EY G LA + + L + + + + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLAL 124
Query: 698 EYLHSLAQQSF--IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
+ H + +HRDLKP+N+ + K+ DFGL + +T GT Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYM 183
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGRKALD-DTMPDDRAHLVTWFRRVLISK---- 810
+PE K D+++ G +L E + + L K
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE------------LAGKIREG 231
Query: 811 --ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
IP LN E+ + RP
Sbjct: 232 KFRRIPYRYSDELN-------------EIITRMLNLKDYHRPS 261
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 66/378 (17%), Positives = 129/378 (34%), Gaps = 60/378 (15%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDI 118
C+ S + + + + I + T+ L N I + A+ L+++
Sbjct: 6 RCECSAQDRAVLCHRKRFV-AVPEGIPTETR--LLDLGKNRIK-TLNQDEFASFPHLEEL 61
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
L+ N ++V G F+ L NL+ L L N L P T ++LT L + I L
Sbjct: 62 ELNENIVSAVEPGAFNNLFNLRTLGLRSN-RLKLIP-LGVFTGLSNLTKLDISENKIVIL 119
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQ 236
+ F NL++L + N+ + +F+ + ++ L + L T + LS +
Sbjct: 120 LDYMFQDLYNLKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPT-EALSHLHG 177
Query: 237 LRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
L + L I D + L L + + + + L ++S+ + L
Sbjct: 178 LIVLRLRHLNINA-IRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNL 236
Query: 295 QG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
PY ++ ++L +N ++ + L
Sbjct: 237 TAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHEL-LRLQEI-----------QLVG--- 281
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDG 410
+L + P A+ L L+ L + N LT
Sbjct: 282 ------------------------GQL--AVVEPYAFRGLNYLRVLNVSGNQLTTLEESV 315
Query: 411 LTKLASLQNLDVSNNNLS 428
+ +L+ L + +N L+
Sbjct: 316 FHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 1e-09
Identities = 35/255 (13%), Positives = 73/255 (28%), Gaps = 74/255 (29%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+ + L L N +L D + L ++ L++N
Sbjct: 31 PTETRLLDLGKNRIK-TLNQ-----------------------DEFASFPHLEELELNEN 66
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP 302
+ + + +L L LR N+L + L L + + NK+ +F
Sbjct: 67 IVSA-VEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 303 --SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
++ + + N + + + A G
Sbjct: 126 DLYNLKSLEVGDN---------------DLVYI------------------SHRAFSGLN 152
Query: 361 FVTCSQGRIITINLA-NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQ 418
+ + L L +I A ++L L L L+ N+ +L L+
Sbjct: 153 -------SLEQLTLEKCNL--TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLK 203
Query: 419 NLDVSNNNLSGKVPD 433
L++S+ +
Sbjct: 204 VLEISHWPYLDTMTP 218
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-31
Identities = 58/281 (20%), Positives = 104/281 (37%), Gaps = 42/281 (14%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVAL 644
+G GG V+ A+K + N+ L ++ EIA L K++ ++ L
Sbjct: 62 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
Y I +V E L L + +R + ++ V +H
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKK--SIDPWERKSYWKNMLEAVHTIH--- 172
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVETRLAGTFGYLAPE----- 758
Q +H DLKP+N LI D K+ DFG+ PD V+ G Y+ PE
Sbjct: 173 QHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 759 ------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLISKE 811
+ +++ K DV++ G +L G+ P + ++ ++
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQIINQISKLHAIIDPNH 285
Query: 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
I P+ +++ + + C R+P+QR +
Sbjct: 286 EIEF---PD-IPEKDLQDVLKC-------CLKRDPKQRISI 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-31
Identities = 56/274 (20%), Positives = 96/274 (35%), Gaps = 18/274 (6%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122
N NR + S L L+ S ++ L N ++ LA T L+ + L +
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSS 67
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N + L+ L+ L L++N + EL S+ TL+ N N +
Sbjct: 68 NVLYETLD--LESLSTLRTLDLNNN-YV------QELLVGPSIETLHAAN-NNISRVS-- 115
Query: 183 FDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
+N+ L+ N T S +Q L + ++ ++ + L +
Sbjct: 116 CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN 175
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPL 300
L N + L L L N+L + S + ISL+NNKL L
Sbjct: 176 LQYNFIYD-VKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLIEKAL 233
Query: 301 FP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTL 333
++ L N F + + +V T+
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTV 267
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-31
Identities = 40/248 (16%), Positives = 89/248 (35%), Gaps = 23/248 (9%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
+++ T+LE L+ N + L + ++L+ + L+NN + +++ L
Sbjct: 53 DLAPFTKLELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQELLV-----GPSIETLHA 106
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
++N N++ +Y+ N I L S +Q L L N ++
Sbjct: 107 ANN-NISRVSCSR----GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID-TVN 160
Query: 205 ASFAKSDIQNLWMNDQQLGLSG----TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL 260
+ + L + L L + +L+ + L N+ P+ +
Sbjct: 161 FAELAASSDTL----EHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGV 216
Query: 261 FDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG--PYPLFPSKVQKVSLDHNNFCKN 318
+SLR+N+L ++ ++ L + L+ N F + ++ K
Sbjct: 217 TWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKL 275
Query: 319 SSDAGKPC 326
+ + C
Sbjct: 276 TGQNEEEC 283
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 8e-30
Identities = 44/330 (13%), Positives = 103/330 (31%), Gaps = 86/330 (26%)
Query: 105 AIPSL-ANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKST 163
AI + N + + +++ N++ L LS N L+ +L T
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGN-PLSQIS-AADLAPFT 58
Query: 164 SLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLG 223
L L + + ++ + +S S L+ L L+ N
Sbjct: 59 KLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ----------------------- 93
Query: 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA 283
L + + N + + S+ + ++ L +N++T +
Sbjct: 94 ------ELLVGPSIETLHAANNNISR-VS-CSRGQGKKNIYLANNKITMLRDLDEGCRSR 145
Query: 284 LLNISLQNNKLQG-PYPLFPS---KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGD 339
+ + L+ N++ + + ++ ++L +N + +
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYN---------------FIYDV------ 184
Query: 340 MGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYL 398
G ++ T++L+ NKL + P + + + + L
Sbjct: 185 -----------------KGQVVFA----KLKTLDLSSNKLA--FMGPEFQSAAGVTWISL 221
Query: 399 QQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ N L I L +L++ D+ N
Sbjct: 222 RNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 4e-25
Identities = 44/240 (18%), Positives = 76/240 (31%), Gaps = 34/240 (14%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
E+ +ETL NNI+ + ++IYL NN T + + +Q L L
Sbjct: 94 ELLVGPSIETLHAANNNIS-RVSCSRG-QGKKNIYLANNKITMLRDLDEGCRSRVQYLDL 151
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
N + F S +L L + I+ + F+ L+ L LS N +
Sbjct: 152 KLN-EIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA-FMG 207
Query: 205 ASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFD 262
F + + + + + +L + L L L N F C +L D
Sbjct: 208 PEFQSAAGVTWISLRNNKLVLIEKAL---RFSQNLEHFDLRGNGFH--------CGTLRD 256
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDA 322
++ ++ V +V L L + +C A
Sbjct: 257 FFSKNQRVQTVAKQTVKKLTGQNEEECTVPTL---------------GHYGAYCCEDLPA 301
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 43/262 (16%), Positives = 95/262 (36%), Gaps = 55/262 (20%)
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQ 236
I + + + + +++ ++ +L + +++ L ++ L +S L+ T+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISA--ADLAPFTK 59
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L + L N DL +L L L +N + ++ P++ + NN +
Sbjct: 60 LELLNLSSNVLYE-TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR 113
Query: 297 -PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
+ + L +N ++T L +
Sbjct: 114 VSCSRGQG-KKNIYLANN---------------KITML------------------RDLD 139
Query: 356 CDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414
R+ ++L N++ N + A+ +L++L LQ N + +
Sbjct: 140 EGCRS-------RVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQ-VVF 190
Query: 415 ASLQNLDVSNNNLSGKVPDFGS 436
A L+ LD+S+N L+ P+F S
Sbjct: 191 AKLKTLDLSSNKLAFMGPEFQS 212
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 22/124 (17%), Positives = 37/124 (29%), Gaps = 5/124 (4%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+L+TL N +A P +A + I L NN + NL+
Sbjct: 185 KGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKA-LRFSQNLEHFD 243
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
L N + +K+ + T+ + + + L L
Sbjct: 244 LRGNG-FHCGTLRDFFSKNQRVQTVAK---QTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 204 PASF 207
PA F
Sbjct: 300 PAPF 303
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 14/69 (20%), Positives = 27/69 (39%), Gaps = 1/69 (1%)
Query: 371 TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430
+ + L ++ + ++K L L N L+ L L+ L++S+N L +
Sbjct: 14 IEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY-E 72
Query: 431 VPDFGSNVK 439
D S
Sbjct: 73 TLDLESLST 81
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-31
Identities = 53/273 (19%), Positives = 94/273 (34%), Gaps = 58/273 (21%)
Query: 589 LGRGGFGVVYGGE---LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+ GG G +Y + +G + +K + ++ + + AE L +V H +V +
Sbjct: 88 IAHGGLGWIYLALDRNV-NGRPVVLKGL-VHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 646 GYCINGSERL--------LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+ +V EY+ +L + + L + + L++ +
Sbjct: 146 NF---VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPAL 195
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
YLHS ++ DLKP NI++ ++ + K+ D G V L GT G+ AP
Sbjct: 196 SYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAP 246
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817
E T D+Y G L + D +P+
Sbjct: 247 EI-VRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPED- 287
Query: 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
DP L + L +P+QR
Sbjct: 288 DPVLKTYDS-------YGRLLRRAIDPDPRQRF 313
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-31
Identities = 68/308 (22%), Positives = 131/308 (42%), Gaps = 30/308 (9%)
Query: 550 LHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKI 608
+ QS G A+ ++ NF +GRG F VY L DG +
Sbjct: 1 MDEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPV 60
Query: 609 AVKRME-SNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLA 667
A+K+++ + M K ++ EI +L ++ H +++ I +E +V E G L+
Sbjct: 61 ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLS 120
Query: 668 QHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727
+ + + + + + + +E++HS + +HRD+KP+N+ I K
Sbjct: 121 RMIKHFKKQK-RLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVK 176
Query: 728 VADFGLVKNAPDGKYSVETRLAGTF-G---YLAPEYAATGRVTTKIDVYAFGVVLMETIT 783
+ D GL + +S +T A + G Y++PE K D+++ G +L E
Sbjct: 177 LGDLGLGR-----FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAA 231
Query: 784 GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTA 843
+ D+ +L + ++ I + + P P+ + EE + +L C
Sbjct: 232 LQSPFY----GDKMNLYSLCKK--IEQCDYPPL--PSDHYSEE-------LRQLVNMCIN 276
Query: 844 REPQQRPD 851
+P++RPD
Sbjct: 277 PDPEKRPD 284
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 5e-31
Identities = 61/247 (24%), Positives = 107/247 (43%), Gaps = 43/247 (17%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG+GGF + + A K + + + E EI++ + H+H+V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GV 697
+ ++ + +V E R +L + K+R + AR G
Sbjct: 83 F-FEDNDFVFVVLELCRRRSLLELH-------------KRRKALTEPEARYYLRQIVLGC 128
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRLA---GTFG 753
+YLH IHRDLK N+ + +D+ K+ DFGL K DG+ R GT
Sbjct: 129 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPN 180
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813
Y+APE + + ++DV++ G ++ + G+ P + + L + R+ ++ +I
Sbjct: 181 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYLRIKKNEYSI 234
Query: 814 PKAIDPN 820
PK I+P
Sbjct: 235 PKHINPV 241
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 7e-31
Identities = 62/248 (25%), Positives = 96/248 (38%), Gaps = 26/248 (10%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
Q + LG GGFG V G ++A+K+ + K + EI ++ K+
Sbjct: 11 QTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKL 69
Query: 637 RHRHLVALL------GYCINGSERLLVYEYMPRGTLAQHLFEWHDHG-YTPLTWKQRVTI 689
H ++V+ LL EY G L ++L + L T+
Sbjct: 70 NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGLKEGPIRTL 126
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVET 746
D++ + YLH + IHRDLKP NI++ + K+ D G K G+
Sbjct: 127 LSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTE 182
Query: 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806
+ GT YLAPE + T +D ++FG + E ITG P +
Sbjct: 183 FV-GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF------RPFLPNWQPVQWHGK 235
Query: 807 LISKENIP 814
+ K N
Sbjct: 236 VREKSNEH 243
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 125 bits (314), Expect = 8e-31
Identities = 43/329 (13%), Positives = 83/329 (25%), Gaps = 68/329 (20%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVK--------------RMESNTMGNKGLSEFQAEIAV 632
+LG+ + G V +M+ + + L + +
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 633 LTKVRHRHLVALL--------------GYCINGSERLLVYEYMPRGTLAQHLFEWHDHG- 677
+R L+ + R +Y M + L H
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS 203
Query: 678 -YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736
+ L R+ + L V R + LH +H L+P +I++ + F +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260
Query: 737 APDGKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDT 791
S R A +T D + G+ +
Sbjct: 261 DGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------ 314
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD 851
+P+ + + S +NIP+ V L + R
Sbjct: 315 LPNTDDAALGGSEWIFRSCKNIPQP-----------------VRALLEGFLRYPKEDRLL 357
Query: 852 MGHAV-----NVLGPLVEQWKPATREDED 875
A+ L + P + D +
Sbjct: 358 PLQAMETPEYEQLRTELSAALPLYQTDGE 386
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-31
Identities = 65/333 (19%), Positives = 112/333 (33%), Gaps = 29/333 (8%)
Query: 105 AIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTS 164
+P L + + L N+ + F L +LQ L + N +S
Sbjct: 24 QVPELP--AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQ-TPGLVIRNNTFRGLSS 80
Query: 165 LTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS-LPA-SFAK-SDIQNLWMNDQQ 221
L L +D L F+ +NL+ L L+ N G+ L F + ++ L + D
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISL 281
+ M + + L N+ S CE + + T ++ L
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVK------SICEEDLL-NFQGKHFT------LLRL 187
Query: 282 PALLNISLQNNKLQGPYPLFPSK---VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG 338
++ + L P K + + L N F S A + D T +Q
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGF--KESMAKRFFDAIAGTKIQSLI 245
Query: 339 DMGYPAILSDSWEGNNAC-DGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNL 396
+ S N D + F + T +L+ + + +++ T L+ L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQL 304
Query: 397 YLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
L QN + I D L L L++S N L
Sbjct: 305 TLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG 336
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-30
Identities = 77/364 (21%), Positives = 116/364 (31%), Gaps = 76/364 (20%)
Query: 87 SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
S L L+ L + I + +SL + LD N F + TG F+GL NL+VL+L
Sbjct: 51 SRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTL 110
Query: 145 SDNPNLAPWPFPNEL-TKSTSLTTLYMDNANIFGLIPD-FFDSFSNLQNLRLSYNNFTGS 202
+ NL TSL L + + NI + P FF + L L++N
Sbjct: 111 TQC-NLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSI 169
Query: 203 LPASFAK-----------SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT--- 248
S I MN+ LG T + + L N F
Sbjct: 170 CEEDLLNFQGKHFTLLRLSSITLQDMNEYWLG-WEKCGNPFKNTSITTLDLSGNGFKESM 228
Query: 249 -GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQK 307
D + L L ++ G S N +G L S V+
Sbjct: 229 AKRFFDAIAGTKIQSLILSNSYNMGS------SFGHTNFKDPDNFTFKG---LEASGVKT 279
Query: 308 VSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQG 367
L + ++ L + + +
Sbjct: 280 CDLSKS---------------KIFAL------------------LKSVFSHFTDLE---- 302
Query: 368 RIITINLA-NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSN 424
+ LA N++ I A+ LT L L L QN L I + L L+ LD+S
Sbjct: 303 ---QLTLAQNEI--NKIDDNAFWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSY 356
Query: 425 NNLS 428
N++
Sbjct: 357 NHIR 360
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 43/226 (19%), Positives = 78/226 (34%), Gaps = 21/226 (9%)
Query: 88 SLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTN---LQVLS 143
L+ + + + TS+ + L N F F +Q L
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245
Query: 144 LSDNPNLAPWPFPNELTK----------STSLTTLYMDNANIFGLIPDFFDSFSNLQNLR 193
LS++ N+ ++ + T + + IF L+ F F++L+ L
Sbjct: 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLT 305
Query: 194 LSYNNFTGSLPA-SFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251
L+ N + +F + + L ++ LG S + + +L + L N +
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIRA-L 362
Query: 252 PD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
D +L +L+L NQL V L +L I L N
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWD 408
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 70.2 bits (172), Expect = 1e-12
Identities = 31/141 (21%), Positives = 56/141 (39%), Gaps = 33/141 (23%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIY 119
+ + ++LA++ ++ + LT L L+ N + G+I S N L+ +
Sbjct: 296 SHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLD 353
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
L N+ ++ F GL NL+ L+L N L + +
Sbjct: 354 LSYNHIRALGDQSFLGLPNLKELALDTN----------------QLKS-----------V 386
Query: 180 PD-FFDSFSNLQNLRLSYNNF 199
PD FD ++LQ + L N +
Sbjct: 387 PDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 16/63 (25%), Positives = 26/63 (41%), Gaps = 3/63 (4%)
Query: 371 TINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
+ + + I + L+SL L L N + G LA+L+ L ++ NL
Sbjct: 58 FLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQ-LETGAFNGLANLEVLTLTQCNLD 116
Query: 429 GKV 431
G V
Sbjct: 117 GAV 119
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 62/242 (25%), Positives = 95/242 (39%), Gaps = 25/242 (10%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIY 119
C N + T S + GL + I + +Q + N I+ +P S +L ++
Sbjct: 8 CYNEPK-VTTSCPQQGLQ-AVPVGIPAASQ--RIFLHGNRIS-HVPAASFRACRNLTILW 62
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
L +N + F GL L+ L LSDN L P L TL++D + L
Sbjct: 63 LHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVD-PATFHGLGRLHTLHLDRCGLQELG 121
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPA-SFAKSDIQNLWMNDQQLGLSG------TLDVLS 232
P F + LQ L L N +LP +F D+ NL L L G
Sbjct: 122 PGLFRGLAALQYLYLQDNALQ-ALPDDTF--RDLGNL----THLFLHGNRISSVPERAFR 174
Query: 233 GMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
G+ L ++ LH+N+ + L L L N L+ + ++ L AL + L
Sbjct: 175 GLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLN 233
Query: 291 NN 292
+N
Sbjct: 234 DN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 59/324 (18%), Positives = 91/324 (28%), Gaps = 127/324 (39%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ Q I+L N + VP F NL +L L N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSN------------------------- 66
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
+ + F + L+ L LS N S+
Sbjct: 67 -VLARIDAAAFTGLALLEQLDLSDNAQLRSVDP-----------------------ATFH 102
Query: 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
G+ +L + L + L G L AL + LQ+N
Sbjct: 103 GLGRLHTLHLDRCGLQ---------------ELGPGLFRG--------LAALQYLYLQDN 139
Query: 293 KLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349
LQ P F + + L N +++++
Sbjct: 140 ALQALPDDTFRDLGNLTHLFLHGN---------------RISSV---------------- 168
Query: 350 WEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISP-AYANLTSLKNLYLQQNNLT 404
A G +L LL N + P A+ +L L LYL NNL+
Sbjct: 169 --PERAFRGLH------------SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
Query: 405 GPIPDG-LTKLASLQNLDVSNNNL 427
+P L L +LQ L +++N
Sbjct: 215 A-LPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 8e-06
Identities = 32/175 (18%), Positives = 58/175 (33%), Gaps = 54/175 (30%)
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP--SKVQKVSLDHNNFCKNS 319
+ L N+++ V AS + L + L +N L F + ++++ L N
Sbjct: 37 IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA----- 91
Query: 320 SDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL 379
Q+ ++ ++ G L L
Sbjct: 92 ---------------QLR------SVDPATFHG------------------LGRLHTLHL 112
Query: 380 AGN----ISP-AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
+ P + L +L+ LYLQ N L +PD L +L +L + N +S
Sbjct: 113 DRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 18/56 (32%), Positives = 23/56 (41%), Gaps = 7/56 (12%)
Query: 379 LAGN----ISP-AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
L GN + A+ L SL L L QN + + L L L + NNLS
Sbjct: 160 LHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 21/91 (23%), Positives = 32/91 (35%), Gaps = 13/91 (14%)
Query: 356 CDGWP--FVTCSQGRIITI------NLANKLLAGN----ISP-AYANLTSLKNLYLQQNN 402
C P +C Q + + L GN + ++ +L L+L N
Sbjct: 8 CYNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNV 67
Query: 403 LTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
L T LA L+ LD+S+N V
Sbjct: 68 LARIDAAAFTGLALLEQLDLSDNAQLRSVDP 98
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 11/44 (25%), Positives = 23/44 (52%), Gaps = 2/44 (4%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
+ +L +L +L+L N ++ +P+ L SL L + N ++
Sbjct: 148 TFRDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA 190
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-30
Identities = 63/400 (15%), Positives = 125/400 (31%), Gaps = 52/400 (13%)
Query: 55 CEWTGINCDNSNR-----------VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA 103
C + G + L+ + + + L QL+ L
Sbjct: 2 CSFDGRIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 104 GAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTK 161
I + N +L+ + L ++ + F GL +L L L
Sbjct: 62 LTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRN 121
Query: 162 STSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLPASFA---KSDIQNLWM 217
+LT L + I L + F ++L+++ S N + +
Sbjct: 122 LKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSL 181
Query: 218 NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCE-SLFDLSLRDNQLTGVVPA 276
L ++D M R + L D+S ++ N ++
Sbjct: 182 AANSLYSRVSVDWGKCMNPFRNMVLEIL-------DVSGNGWTVDITGNFSNAISKSQAF 234
Query: 277 SVISLPALLNISLQNNKLQGP-----YPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVT 331
S+I ++ + ++ P L S V+ + L H +S + +
Sbjct: 235 SLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL-KDLK 293
Query: 332 TLLQIAGDMGY---PAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA 388
L ++ Y I +++ G + + +NL+ LL S +
Sbjct: 294 VL-----NLAYNKINKIADEAFYGLD-------------NLQVLNLSYNLLGELYSSNFY 335
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L + + LQ+N++ L LQ LD+ +N L+
Sbjct: 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-28
Identities = 63/376 (16%), Positives = 117/376 (31%), Gaps = 81/376 (21%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNI----AGAIPSLANATSLQDI 118
N V + +S + + + + F +NI LA +S++ +
Sbjct: 213 GNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLAR-SSVRHL 271
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNANIF 176
L + S+ + F+ L +L+VL+L+ N +A +L L + +
Sbjct: 272 DLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIAD----EAFYGLDNLQVLNLSYNLLG 327
Query: 177 GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQ 236
L F + + L N+ + + +
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIA-IIQD-----------------------QTFKFLEK 363
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L+ + L N T + S+ D+ L N+L + + I L N+L+
Sbjct: 364 LQTLDLRDNALT----TIHFIPSIPDIFLSGNKLVTLPKIN----LTANLIHLSENRLEN 415
Query: 297 -PYPLFP---SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
F +Q + L+ N F S D +P + L L
Sbjct: 416 LDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQL-----------FLG----- 459
Query: 353 NNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLT 412
N L + L+ L+ LYL N L P +
Sbjct: 460 EN------------------MLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501
Query: 413 KLASLQNLDVSNNNLS 428
L +L+ L +++N L+
Sbjct: 502 HLTALRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-25
Identities = 58/292 (19%), Positives = 98/292 (33%), Gaps = 43/292 (14%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLD 121
+ + T + S + L + ++ S L+ + L
Sbjct: 248 GFHNIKDPD------QNTFAGLARS--SVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLA 298
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
N + F GL NLQVL+LS N L F + + + +I +
Sbjct: 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYG----LPKVAYIDLQKNHIAIIQ 354
Query: 180 PDFFDSFSNLQNLRLSYNNFT-----GSLPASFAK----SDIQNLWMNDQQLGLSGT--- 227
F LQ L L N T S+P F + + + + LS
Sbjct: 355 DQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLE 414
Query: 228 ----LDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASV--- 278
L L + L+ + L++N+F+ D S+ SL L L +N L +
Sbjct: 415 NLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWD 474
Query: 279 --ISLPALLNISLQNNKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKP 325
L L + L +N L P +F + ++ +SL+ N S +
Sbjct: 475 VFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPA 526
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-25
Identities = 46/259 (17%), Positives = 82/259 (31%), Gaps = 21/259 (8%)
Query: 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNF 125
+ ++LA + ++ L L+ L+ N + + + I L N+
Sbjct: 291 DLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHI 350
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+ F L LQ L L DN + S+ +++ + L
Sbjct: 351 AIIQDQTFKFLEKLQTLDLRDNAL-------TTIHFIPSIPDIFLSGNKLVTLPKINL-- 401
Query: 186 FSNLQNLRLSYNNFTGSLPASFAK--SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH 243
+ LS N F +Q L +N + S L Q++L
Sbjct: 402 --TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLG 459
Query: 244 KNQFTGPIPD------LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG- 296
+N L L L N L + P L AL +SL +N+L
Sbjct: 460 ENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL 519
Query: 297 PYPLFPSKVQKVSLDHNNF 315
+ P+ ++ + + N
Sbjct: 520 SHNDLPANLEILDISRNQL 538
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-19
Identities = 51/257 (19%), Positives = 92/257 (35%), Gaps = 38/257 (14%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDN 122
+V I L K+ ++ + + L +L+TL + N + ++ S+ DI+L
Sbjct: 336 GLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT----TIHFIPSIPDIFLSG 390
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
N ++P ++ LS+N NL F + L L ++
Sbjct: 391 NKLVTLPKINL----TANLIHLSENRLENLDILYFLLRVP---HLQILILNQNRFSSCSG 443
Query: 181 D-FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
D +L+ L L N + DV G++ L+
Sbjct: 444 DQTPSENPSLEQLFLGENMLQLAWETEL-------------------CWDVFEGLSHLQV 484
Query: 240 VWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPY 298
++L+ N P S +L LSL N+LT + + L + + N+L P
Sbjct: 485 LYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQLLAPN 542
Query: 299 PLFPSKVQKVSLDHNNF 315
P + + + HN F
Sbjct: 543 PDVFVSLSVLDITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 1e-14
Identities = 46/213 (21%), Positives = 81/213 (38%), Gaps = 15/213 (7%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNF-----TSVPTGCFDGLTN 138
+ + L+ L N + + SL+ ++L N T + F+GL++
Sbjct: 422 LLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSH 481
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198
LQVL L+ N L P P + T+L L +++ + L + +NL+ L +S N
Sbjct: 482 LQVLYLNHN-YLNSLP-PGVFSHLTALRGLSLNSNRLTVLSHNDL--PANLEILDISRNQ 537
Query: 199 FTGSLPASFAKSDIQNLWMN--DQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSK 256
P F + ++ N + LS ++ L+ PD
Sbjct: 538 LLAPNPDVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPP--ADIYCVYPDSFS 595
Query: 257 CESLFDLSLRDNQLTGVVPASVISLPALLNISL 289
SLF LS V+ + SL + ++L
Sbjct: 596 GVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTL 628
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 31/211 (14%), Positives = 63/211 (29%), Gaps = 46/211 (21%)
Query: 230 VLSGMTQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNI 287
V + ++ L N E L L L + +LP L +
Sbjct: 19 VPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRIL 78
Query: 288 SLQNNKLQG-PYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
L ++K+ F + ++ L
Sbjct: 79 DLGSSKIYFLHPDAFQGLFHLFELRLYFCG------------------------------ 108
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNL 403
LSD+ + + ++L+ N++ + + P++ L SLK++ N +
Sbjct: 109 -LSDAVLKDGYFRNLK-------ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQI 160
Query: 404 TGPIPDGLTKLA--SLQNLDVSNNNLSGKVP 432
L L +L ++ N+L +V
Sbjct: 161 FLVCEHELEPLQGKTLSFFSLAANSLYSRVS 191
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 8/45 (17%), Positives = 15/45 (33%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
L + + L L N + L LQ L++ + +
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 5e-04
Identities = 26/156 (16%), Positives = 49/156 (31%), Gaps = 20/156 (12%)
Query: 67 RVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
+ + L + L+ +L P + S LT L LS N + + +L+ + + N
Sbjct: 481 HLQVLYLNHNYLN-SLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPANLEILDISRNQL 538
Query: 126 TSVPTGCFDGLTNLQVLSLSDNP--------------NLAPWPFPNELTKSTSLTTLYMD 171
+ D +L VL ++ N N +
Sbjct: 539 LAPNP---DVFVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFS 595
Query: 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
++F L + D L++L+ S F
Sbjct: 596 GVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLF 631
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-30
Identities = 51/347 (14%), Positives = 111/347 (31%), Gaps = 49/347 (14%)
Query: 86 ISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+ + L+ L + + I I + + SL+ + L +N+ +S+ + F L++L+ L+
Sbjct: 46 LRACANLQVLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGS 202
L N + T+L TL + N F I F ++L L + + +
Sbjct: 105 LMGN-PYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-N 162
Query: 203 LPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLF 261
+ L + + + LH ++ + S+
Sbjct: 163 YQS-----------------------QSLKSIRDIHHLTLHLSESAFLLEIFADILSSVR 199
Query: 262 DLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSD 321
L LRD L + + + + L +F +
Sbjct: 200 YLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS-------------VLTDESFNELLKL 246
Query: 322 AGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAG 381
+ D + + ++ V R + ++ L
Sbjct: 247 LRYILELSEVEFD----DCTLNGLGDFNPSESDVVSELGKVETVTIRRL--HIPQFYLFY 300
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
++S Y+ L +K + ++ + + L SL+ LD+S N +
Sbjct: 301 DLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV 347
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-30
Identities = 59/369 (15%), Positives = 130/369 (35%), Gaps = 31/369 (8%)
Query: 69 TTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIA--GAIPSLANATSLQDIYLDNNN- 124
+ L+ + LS +LS L+ L+ L+ N G N T+LQ + + N
Sbjct: 77 EHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 125 FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFD 184
F+ + F GLT+L L + +L + L + L + + L+ F D
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKAL-SLRNYQ-SQSLKSIRDIHHLTLHLSESAFLLEIFAD 193
Query: 185 SFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK 244
S+++ L L N + ++ + G T + + + +L + L
Sbjct: 194 ILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILEL 253
Query: 245 NQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS- 303
++ C ++ V + + + + L S
Sbjct: 254 SEVE-----FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSL 308
Query: 304 --KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361
KV++++++++ + + L D+ ++ + + + WP
Sbjct: 309 LEKVKRITVENSKVFLVPCSFSQHL-KSLEFL-----DLSENLMVEEYLKNSACKGAWPS 362
Query: 362 VTCSQGRIITINLA-NKLLA-GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQN 419
+ T+ L+ N L + L +L +L + +N P+PD ++
Sbjct: 363 LQ-------TLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRF 414
Query: 420 LDVSNNNLS 428
L++S+ +
Sbjct: 415 LNLSSTGIR 423
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 51/364 (14%), Positives = 119/364 (32%), Gaps = 49/364 (13%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTN 138
++ +LT L+TL I A TSL ++ + + + + + +
Sbjct: 114 GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198
+ L+L + + + +S+ L + + N+ ++
Sbjct: 174 IHHLTLHLSES--AFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFR 231
Query: 199 FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSK-- 256
+ SF +++ L +L + T + ++ + +L K
Sbjct: 232 GSVLTDESF--NELLKLLRYILEL----SEVEFDDCTLNGLGDFNPSESDV-VSELGKVE 284
Query: 257 CESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLF--PSKVQKVSLDHN 313
++ L + L + L + I+++N+K+ P ++ + L N
Sbjct: 285 TVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSEN 344
Query: 314 NF----CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS-----WEGNNACDGWPFVTC 364
KNS+ G P + TL +LS + +
Sbjct: 345 LMVEEYLKNSACKGAW--PSLQTL-----------VLSQNHLRSMQKTGEILLTLK---- 387
Query: 365 SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSN 424
+ +++++ + + ++ L L + + + +L+ LDVSN
Sbjct: 388 ---NLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRV-VKTCI--PQTLEVLDVSN 440
Query: 425 NNLS 428
NNL
Sbjct: 441 NNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 45/237 (18%), Positives = 92/237 (38%), Gaps = 15/237 (6%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLD 121
+ + + + + L LS S L +++ ++ + + + +P + SL+ + L
Sbjct: 284 ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV-FLVPCSFSQHLKSLEFLDLS 342
Query: 122 NNNFTSVP---TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
N + C +LQ L LS N + L +LT+L + N F
Sbjct: 343 ENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISR-NTFHP 401
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
+PD ++ L LS + ++ ++ L +++ L + +L+
Sbjct: 402 MPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQT-LEVLDVSNNNLD-----SFSLFLPRLQ 454
Query: 239 QVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
++++ +N+ +PD S L + + NQL V L +L I L N
Sbjct: 455 ELYISRNKLKT-LPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 9e-25
Identities = 62/396 (15%), Positives = 122/396 (30%), Gaps = 59/396 (14%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYL 120
N + T+ + + + LT L L + ++ SL + + + L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANI--- 175
+ + D L++++ L L D P P S+ + L + +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPV-DEVSSPMKKLAFRGSVLTDE 238
Query: 176 -FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSD------------IQNLWMNDQQL 222
F + L + G + ++SD I+ L + L
Sbjct: 239 SFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYL 298
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVV---PASV 278
+ V S + +++++ + ++ P +SL L L +N + A
Sbjct: 299 FYDLS-TVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACK 357
Query: 279 ISLPALLNISLQNNKLQ----GPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTL 333
+ P+L + L N L+ L + + + N F P ++ L
Sbjct: 358 GAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWP--EKMRFL 415
Query: 334 LQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN-ISPAYANLTS 392
LS I L ++ N + L
Sbjct: 416 -----------NLS----STG------IRVVKTC--IPQTLEVLDVSNNNLDSFSLFLPR 452
Query: 393 LKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L+ LY+ +N L +PD + L + +S N L
Sbjct: 453 LQELYISRNKLKT-LPDA-SLFPVLLVMKISRNQLK 486
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-24
Identities = 39/343 (11%), Positives = 97/343 (28%), Gaps = 98/343 (28%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+L L + +++ + + +++ +++ + + L ++ +++ ++
Sbjct: 262 TLNGLGDFNPSESDVVSELGKV-ETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
+F + F +L+ L LS N +
Sbjct: 321 --------------------------KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNS 354
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT---GPIPDLSKCESLFDLS 264
A L+ + L +N L ++L L
Sbjct: 355 A---------------------CKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLD 393
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGK 324
+ N +P S + ++L + ++ P ++ + + +NN S
Sbjct: 394 ISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFL-- 450
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384
P++ L +S N ++ T+
Sbjct: 451 ---PRLQEL-----------YIS-----RN-------------KLKTL------------ 466
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
P + L + + +N L +L SLQ + + N
Sbjct: 467 PDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-09
Identities = 44/314 (14%), Positives = 86/314 (27%), Gaps = 119/314 (37%)
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+ +FTS+P+G ++ L LS N I +
Sbjct: 12 GRSRSFTSIPSGLT---AAMKSLDLSFN--------------------------KITYIG 42
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
+ +NLQ L L + ++ D + L
Sbjct: 43 HGDLRACANLQVLILKSSRIN-TIEG-----------------------DAFYSLGSLE- 77
Query: 240 VWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ--GP 297
L L DN L+ + + L +L ++L N Q G
Sbjct: 78 ----------------------HLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGV 115
Query: 298 YPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
LFP + +Q + + + + + D T L
Sbjct: 116 TSLFPNLTNLQTLRIGNV----ETFSEIRRIDFAGLTSLN-------------------- 151
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
+ + L S + ++ + +L L + + L+
Sbjct: 152 ---------------ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILS 196
Query: 416 SLQNLDVSNNNLSG 429
S++ L++ + NL+
Sbjct: 197 SVRYLELRDTNLAR 210
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-04
Identities = 16/66 (24%), Positives = 28/66 (42%), Gaps = 5/66 (7%)
Query: 371 TINLA-NKLLAGNISP-AYANLTSLKNLYLQQNNLTG-PIPDGLTKLASLQNLDVSNNNL 427
++L+ N L ++S + L+SLK L L N + L +LQ L + N
Sbjct: 78 HLDLSDNHL--SSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 428 SGKVPD 433
++
Sbjct: 136 FSEIRR 141
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 73/315 (23%), Positives = 122/315 (38%), Gaps = 64/315 (20%)
Query: 589 LGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG+GGF + + A K + + + E EI++ + H+H+V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GV 697
+ ++ + +V E R +L + K+R + AR G
Sbjct: 109 F-FEDNDFVFVVLELCRRRSLLELH-------------KRRKALTEPEARYYLRQIVLGC 154
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL-VKNAPDGKYSVETRLA---GTFG 753
+YLH IHRDLK N+ + +D+ K+ DFGL K DG+ R GT
Sbjct: 155 QYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE-----RKKVLCGTPN 206
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813
Y+APE + + ++DV++ G ++ + G+ P + + L + R+ ++ +I
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYLRIKKNEYSI 260
Query: 814 PKAIDPN--------LNLDEE---TIESI---------YRVAELAGHCTAREPQ-QRPDM 852
PK I+P L D TI + Y A L C P+
Sbjct: 261 PKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPS 320
Query: 853 GHAVNVLGPLVEQWK 867
+ PL K
Sbjct: 321 SLDPSNRKPLTVLNK 335
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 22/237 (9%)
Query: 589 LGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG+G F VY + G ++A+K ++ M G+ + Q E+ + +++H ++ L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 647 YCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
Y S + LV E G + ++L + P + + + G+ YLHS
Sbjct: 79 Y-FEDSNYVYLVLEMCHNGEMNRYL---KNRV-KPFSENEARHFMHQIITGMLYLHS--- 130
Query: 706 QSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYSVETRLAGTFGYLAPEYAATG 763
+HRDL SN+L+ +M K+ADFGL P K T L GT Y++PE A
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK--HYT-LCGTPNYISPEIATRS 187
Query: 764 RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
+ DV++ G + + GR P D + +V+++ +P +
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGR------PPFDTDTVKNTLNKVVLADYEMPSFLSIE 238
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 68/243 (27%), Positives = 115/243 (47%), Gaps = 23/243 (9%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
D+F LG+G FG VY E + +A+K + + + +G+ + EI + + +RH
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
+++ + Y + +R+ L+ E+ PRG L + L + HG ++ T ++A +
Sbjct: 74 PNILRMYNY-FHDRKRIYLMLEFAPRGELYKELQK---HG--RFDEQRSATFMEELADAL 127
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
Y H + IHRD+KP N+L+G K+ADFG +AP + T + GT YL P
Sbjct: 128 HYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR--RRT-MCGTLDYLPP 181
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLISKENIPKA 816
E K+D++ GV+ E + G P D +H T RR++ P
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGM------PPFDSPSHTET-HRRIVNVDLKFPPF 234
Query: 817 IDP 819
+
Sbjct: 235 LSD 237
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 4e-30
Identities = 51/224 (22%), Positives = 88/224 (39%), Gaps = 25/224 (11%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+ ++ILG+G V+ G G A+K + + + + E VL K+
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKL 64
Query: 637 RHRHLVALLGYCINGSERL--LVYEYMPRGTLAQHLFEWHDHGYT-PLTWKQRVTIALDV 693
H+++V L + R L+ E+ P G+L L + L + + + DV
Sbjct: 65 NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDV 121
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIG----DDMRAKVADFGLVKNAPDGKYSVETRLA 749
G+ +L +HR++KP NI+ K+ DFG + D + V L
Sbjct: 122 VGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LY 176
Query: 750 GTFGYLAPEYAATGRVTT--------KIDVYAFGVVLMETITGR 785
GT YL P+ + +D+++ GV TG
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 41/313 (13%), Positives = 85/313 (27%), Gaps = 55/313 (17%)
Query: 546 VPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGG-ELPD 604
SE ++ + L+ G L + +LG+ +
Sbjct: 38 TTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQET 97
Query: 605 GTKIAVKRMESNTMGNKGLSE--------------------------FQAEIAVLTKVRH 638
G V + F ++ +
Sbjct: 98 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157
Query: 639 RHLVALLGYCINGSERLLVYEYM-PRGTLAQHLFEWHDHG--YTPLTWKQRVTIALDVAR 695
+ ++ + + + Y + L H + L R+ + L V R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
+ LH +H L+P +I++ + F + DG + + G+
Sbjct: 218 LLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGAR---VVSSVSRGFE 269
Query: 756 APEYAAT-----------GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804
PE A +T D +A G+V+ +P + +
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD------LPITKDAALGGSE 323
Query: 805 RVLISKENIPKAI 817
+ S +NIP+ +
Sbjct: 324 WIFRSCKNIPQPV 336
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 52/245 (21%), Positives = 94/245 (38%), Gaps = 20/245 (8%)
Query: 87 SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
L+ L N I I ++ SL+ + L N +++ + F L++L L+L
Sbjct: 73 QRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131
Query: 145 SDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202
NP L + LTK L + F + L+ L + ++
Sbjct: 132 LGNPYKTLGETSLFSHLTKLQILRVGN--MDTFTKIQRKDFAGLTFLEELEIDASDLQSY 189
Query: 203 LPASFAK-SDIQNLWMNDQQLGL--SGTLDVLSGMT--QLRQVWLHKNQFT----GPIPD 253
P S ++ +L ++ +Q L +DV S + +LR L F+ G
Sbjct: 190 EPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNS 249
Query: 254 LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFPS--KVQKVSL 310
L K + ++ + D L V + + LL + N+L+ P +F +QK+ L
Sbjct: 250 LIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWL 308
Query: 311 DHNNF 315
N +
Sbjct: 309 HTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 52/321 (16%), Positives = 100/321 (31%), Gaps = 65/321 (20%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+++ + L NN T + NLQ L L+ N + + + SL L +
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSN-GINTIE-EDSFSSLGSLEHLDLSY 109
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
+ L +F S+L L L N + +L + + S
Sbjct: 110 NYLSNLSSSWFKPLSSLTFLNLLGNPYK-TLGET----------------------SLFS 146
Query: 233 GMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
+T+L+ + + I + L +L + + L P S+ S+ + ++ L
Sbjct: 147 HLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 291 NNKLQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
+ S V+ + L + + L +
Sbjct: 207 MKQHILLLEIFVDVTSSVECLELRDTDLDTF----------HFSEL---------STGET 247
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
+S + R + I L + ++ L L +N L +
Sbjct: 248 NS-----------LIKKFTFRNVKITD-ESLFQ--VMKLLNQISGLLELEFSRNQLKS-V 292
Query: 408 PDG-LTKLASLQNLDVSNNNL 427
PDG +L SLQ + + N
Sbjct: 293 PDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 22/242 (9%)
Query: 90 TQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+++L N I I + L +LQ + L +N ++ F L +L+ L LS N
Sbjct: 52 EAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYN 110
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD-FFDSFSNLQNLRLSYNNFTGSLPA- 205
L+ + +SLT L + L F + LQ LR+ + +
Sbjct: 111 -YLSNLS-SSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 206 SFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFD 262
FA + ++ L ++ L S L + + + LH Q + + + S+
Sbjct: 169 DFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHIL-LLEIFVDVTSSVEC 226
Query: 263 LSLRDNQLTG--------VVPASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVSLDH 312
L LRD L S+I N+ + + L L S + ++
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSR 286
Query: 313 NN 314
N
Sbjct: 287 NQ 288
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 2e-22
Identities = 37/211 (17%), Positives = 62/211 (29%), Gaps = 44/211 (20%)
Query: 87 SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
S LT+L+ L + I A T L+++ +D ++ S + N+ L L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
L F D S+++ L L +
Sbjct: 206 HMKQ----------------HILLL----------EIFVDVTSSVECLELRDTDLD---- 235
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
+ +L +G + L R V + + L++ L +L
Sbjct: 236 -----------TFHFSEL-STGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELE 283
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
NQL V L +L I L N
Sbjct: 284 FSRNQLKSVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 32/200 (16%), Positives = 59/200 (29%), Gaps = 46/200 (23%)
Query: 235 TQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
++ + L N+ T DL +C +L L L N + + S SL +L ++ L N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNY 111
Query: 294 LQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
L F S + ++L N TL + + +
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGN---------------PYKTLGETSLFSHLTKLQILRV 156
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPD 409
I +A LT L+ L + ++L
Sbjct: 157 -----------------------GNMDTFT-KIQRKDFAGLTFLEELEIDASDLQS-YEP 191
Query: 410 G-LTKLASLQNLDVSNNNLS 428
L + ++ +L +
Sbjct: 192 KSLKSIQNVSHLILHMKQHI 211
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 5e-29
Identities = 58/262 (22%), Positives = 109/262 (41%), Gaps = 17/262 (6%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIY 119
C SN+ + + + GLS + I S T+ L+ NNI I + + L+ +
Sbjct: 50 CSCSNQFSKVVCTRRGLS-EVPQGIPSNTR--YLNLMENNIQ-MIQADTFRHLHHLEVLQ 105
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
L N+ + G F+GL +L L L DN L P + L L++ N I +
Sbjct: 106 LGRNSIRQIEVGAFNGLASLNTLELFDN-WLTVIP-SGAFEYLSKLRELWLRNNPIESIP 163
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
F+ +L L L + +F +++ L + + + L+ + L
Sbjct: 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNI---KDMPNLTPLVGL 220
Query: 238 RQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
++ + N F P SL L + ++Q++ + + L +L+ ++L +N L
Sbjct: 221 EELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS 280
Query: 297 -PYPLFPS--KVQKVSLDHNNF 315
P+ LF + ++ L HN +
Sbjct: 281 LPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 54/324 (16%), Positives = 100/324 (30%), Gaps = 86/324 (26%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+ + VP G +N + L+L +N N+ + L L +
Sbjct: 55 QFSKVVCTRRGLSEVPQGIP---SNTRYLNLMEN-NIQMIQ-ADTFRHLHHLEVLQLGRN 109
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
+I + F+ ++L L L N T +P+
Sbjct: 110 SIRQIEVGAFNGLASLNTLELFDNWLT-VIPS-----------------------GAFEY 145
Query: 234 MTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRD-NQLTGVVPASVISLPALLNISLQ 290
+++LR++WL N IP ++ SL L L + +L + + L L ++L
Sbjct: 146 LSKLRELWLRNNPIES-IPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLG 204
Query: 291 NNKLQGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348
++ P ++++ + N+F +
Sbjct: 205 MCNIKDM-PNLTPLVGLEELEMSGNHF---------------PEI--------------- 233
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISP-AYANLTSLKNLYLQQNNL 403
+ G +L + + I A+ L SL L L NNL
Sbjct: 234 ---RPGSFHGLS------------SLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNL 278
Query: 404 TGPIPDGLTKLASLQNLDVSNNNL 427
+ D T L L L + +N
Sbjct: 279 SSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 43/209 (20%), Positives = 77/209 (36%), Gaps = 19/209 (9%)
Query: 235 TQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
+ R + L +N L L L N + + + L +L + L +N
Sbjct: 75 SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNW 134
Query: 294 LQG-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLL--------QIAGDM-- 340
L P F SK++++ L +N S A P + L I+
Sbjct: 135 LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV-PSLMRLDLGELKKLEYISEGAFE 193
Query: 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQ 399
G + + N D + ++ N I P ++ L+SLK L++
Sbjct: 194 GLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMS-GNHF--PEIRPGSFHGLSSLKKLWVM 250
Query: 400 QNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ ++ + LASL L++++NNLS
Sbjct: 251 NSQVSLIERNAFDGLASLVELNLAHNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 21/86 (24%), Positives = 35/86 (40%), Gaps = 14/86 (16%)
Query: 356 CDGWPF-VTCSQGRIITI------NLANKLLAGN----ISP-AYANLTSLKNLYLQQNNL 403
C V C++ + + N L N I + +L L+ L L +N++
Sbjct: 52 CSNQFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 404 TGPIPDG-LTKLASLQNLDVSNNNLS 428
I G LASL L++ +N L+
Sbjct: 112 RQ-IEVGAFNGLASLNTLELFDNWLT 136
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 8e-04
Identities = 14/61 (22%), Positives = 27/61 (44%), Gaps = 5/61 (8%)
Query: 376 NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLSGKVPD 433
N + +I A+ + SL L L + I +G L +L+ L++ N+ +P+
Sbjct: 157 NPI--ESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPN 213
Query: 434 F 434
Sbjct: 214 L 214
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 6e-29
Identities = 51/221 (23%), Positives = 88/221 (39%), Gaps = 25/221 (11%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ ++ILG+G V+ G G A+K + + + + E VL K+ H+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHK 67
Query: 640 HLVALLGYCINGSERL--LVYEYMPRGTLAQHLFEWHDHGYT-PLTWKQRVTIALDVARG 696
++V L + R L+ E+ P G+L L + L + + + DV G
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL---EEPSNAYGLPESEFLIVLRDVVGG 124
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIG----DDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ +L +HR++KP NI+ K+ DFG + D + V L GT
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTE 179
Query: 753 GYLAPEYAATGRVTT--------KIDVYAFGVVLMETITGR 785
YL P+ + +D+++ GV TG
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 52/212 (24%), Positives = 77/212 (36%), Gaps = 32/212 (15%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
S +L+ L I I A + + L + L N S+ G F GL++LQ L
Sbjct: 49 FSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107
Query: 145 SDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLI-PDFFDSFSNLQNLRLSYNNFTG 201
+ +L +P +L L + + I P++F + +NL++L LS N
Sbjct: 108 VETNLASLENFPI----GHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ- 162
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR-QVWLHKNQFTGPIPDLSKCESL 260
S+ L VL M L + L N P K L
Sbjct: 163 SIYC--------------------TDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRL 202
Query: 261 FDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+L+L NQL V L +L I L N
Sbjct: 203 KELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 44/211 (20%), Positives = 74/211 (35%), Gaps = 14/211 (6%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
S +++ L N + + F LQVL LS + + L+TL +
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRC-EIQTIE-DGAYQSLSHLSTLILTG 85
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQNLWMNDQQLGLSGTLDV 230
I L F S+LQ L N SL ++ L + + +
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 231 LSGMTQLRQVWLHKNQFT----GPIPDLSKCESL-FDLSLRDNQLTGVVPASVISLPALL 285
S +T L + L N+ + L + L L L N + + L
Sbjct: 145 FSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLK 203
Query: 286 NISLQNNKLQG-PYPLF--PSKVQKVSLDHN 313
++L N+L+ P +F + +QK+ L N
Sbjct: 204 ELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 26/90 (28%), Positives = 33/90 (36%), Gaps = 28/90 (31%)
Query: 87 SSLTQLETLSFQMNNI----AGAIPSLANAT------------------------SLQDI 118
S+LT LE L N I + L L+++
Sbjct: 146 SNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKEL 205
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
LD N SVP G FD LT+LQ + L NP
Sbjct: 206 ALDTNQLKSVPDGIFDRLTSLQKIWLHTNP 235
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 48.4 bits (116), Expect = 4e-06
Identities = 34/206 (16%), Positives = 60/206 (29%), Gaps = 55/206 (26%)
Query: 235 TQLRQVWLHKNQFTGPIP--DLSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQN 291
+ + L N + L L L ++ + L L + L
Sbjct: 28 FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTG 85
Query: 292 NKLQG-PYPLF--PSKVQKVSLDHNNFCKNSSDA-GKPCDPQVTTLLQIAGDMGYPAILS 347
N +Q F S +QK+ N + G + L
Sbjct: 86 NPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHL--KTLKEL-------------- 129
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
+N I + L ++NLT+L++L L N + I
Sbjct: 130 --NVAHN-------------LIQSFKLPE---------YFSNLTNLEHLDLSSNKIQS-I 164
Query: 408 P----DGLTKLASLQ-NLDVSNNNLS 428
L ++ L +LD+S N ++
Sbjct: 165 YCTDLRVLHQMPLLNLSLDLSLNPMN 190
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-28
Identities = 73/247 (29%), Positives = 113/247 (45%), Gaps = 15/247 (6%)
Query: 577 RQVT-DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVL 633
+ VT + F + +LG+GGFG V ++ K+ A K++E KG + E +L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 634 TKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
KV R +V+L Y + L LV M G L H+ + G + V A +
Sbjct: 239 EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHI---YHMGQAGFPEARAVFYAAE 294
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ G+E LH + ++RDLKP NIL+ D +++D GL + P+G+ +++ R GT
Sbjct: 295 ICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-TIKGR-VGTV 349
Query: 753 GYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812
GY+APE R T D +A G +L E I G+ + R V E
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ--RKKKIKREEVERLVKEVPEE 407
Query: 813 IPKAIDP 819
+ P
Sbjct: 408 YSERFSP 414
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 45/277 (16%), Positives = 84/277 (30%), Gaps = 35/277 (12%)
Query: 580 TDNFSEANILGRGGFGVVY------GGELPDGTKIAVKRMESNTMGNKGLSEFQA---EI 630
+ ++LG G F VY + + K +K + EF +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP-----WEFYIGTQLM 118
Query: 631 AVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
L + + + +LV E GTL + + + + ++ A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA-----------KVADFGL---VKN 736
+ + +E +H IH D+KP N ++G+ + D G +K
Sbjct: 179 MRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR 796
P G T T G+ E + +ID + + + G +
Sbjct: 236 FPKGTIF--TAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNEGGE 292
Query: 797 AHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYR 833
FRR L + + LN+ +
Sbjct: 293 CKPEGLFRR-LPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 68/256 (26%), Positives = 103/256 (40%), Gaps = 28/256 (10%)
Query: 577 RQVT-DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVL 633
+ + D F + +LGRGGFG V+ ++ K+ A K++ KG E +L
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 634 TKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALD 692
KV R +V+L Y L LV M G + H++ +
Sbjct: 240 AKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVD---------EDNPGFQEP 289
Query: 693 VAR--------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSV 744
A G+E+LH ++ I+RDLKP N+L+ DD +++D GL G+
Sbjct: 290 RAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804
+ AGT G++APE +D +A GV L E I R + +
Sbjct: 347 KGY-AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL--KQ 403
Query: 805 RVLISKENIPKAIDPN 820
RVL P P
Sbjct: 404 RVLEQAVTYPDKFSPA 419
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ F +LG G F V+ + G A+K ++ + S + EIAVL K++
Sbjct: 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRD--SSLENEIAVLKKIK 64
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
H ++V L + + LV + + G LF+ + G T K + V
Sbjct: 65 HENIVTLEDIYESTTHYYLVMQLVSGG----ELFDRILERGV--YTEKDASLVIQQVLSA 118
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
V+YLH +HRDLKP N+L ++ + + DFGL K +G + GT G
Sbjct: 119 VKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPG 172
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVL 778
Y+APE A + +D ++ GV+
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 64/360 (17%), Positives = 116/360 (32%), Gaps = 51/360 (14%)
Query: 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP 129
+ A + T + L L +L ++I + + T L + +NN T++
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTGIEKLTGLTKLICTSNNITTLD 80
Query: 130 TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL 189
TNL L+ N L T T LT L D + L L
Sbjct: 81 ---LSQNTNLTYLACDSN-KLTNLDV----TPLTKLTYLNCDTNKLTKLD---VSQNPLL 129
Query: 190 QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249
L + N T + S + L + + T ++ TQL + N+ T
Sbjct: 130 TYLNCARNTLT-EIDVSHNTQ-LTELDCHLNKK---ITKLDVTPQTQLTTLDCSFNKITE 184
Query: 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKV 308
D+S+ + L L+ N +T + + L + +NKL + P +++
Sbjct: 185 --LDVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-IDVTPLTQLTYF 238
Query: 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
N T L D+ + L+ +Q
Sbjct: 239 DCSVNPL---------------TEL-----DVSTLSKLTTLHCIQTDLLEIDLTHNTQLI 278
Query: 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
K+ +++ + T L L Q +T + L++ L L ++N L+
Sbjct: 279 YFQAEGCRKIKELDVT----HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 5e-26
Identities = 58/369 (15%), Positives = 113/369 (30%), Gaps = 51/369 (13%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
++S T L L+ N + + + T L + D N T + L L+
Sbjct: 80 DLSQNTNLTYLACDSNKLT-NLD-VTPLTKLTYLNCDTNKLTKLD---VSQNPLLTYLNC 134
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
+ N L ++ +T LT L + + L L S+N T L
Sbjct: 135 ARN-TLTEID----VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD 186
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
S K + L + + LD L+ QL + N+ T D++ L
Sbjct: 187 VSQNKL-LNRLNCDTNNIT---KLD-LNQNIQLTFLDCSSNKLTEI--DVTPLTQLTYFD 239
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGK 324
N LT + V +L L + L +++ +
Sbjct: 240 CSVNPLTEL---DVSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCR---------- 286
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNI 383
++ L D+ + L + ++ + L +L ++
Sbjct: 287 ----KIKEL-----DVTHNTQLYLLDCQAAGITELDLSQNPK--LVYLYLNNTELTELDV 335
Query: 384 SPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVS 443
S + T LK+L ++ + K+ +L N + + +N T++
Sbjct: 336 S----HNTKLKSLSCVNAHIQD-FSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIA 389
Query: 444 PGNPFIGTN 452
+
Sbjct: 390 VSPDLLDQF 398
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 42/260 (16%), Positives = 82/260 (31%), Gaps = 28/260 (10%)
Query: 64 NSNRVTTISLAKSGLSGTL--------SPEISSLTQLETLSFQMNNIAGAIPSLANATSL 115
+ N++T + ++++ L L +++ QL L N + I + T L
Sbjct: 178 SFNKITELDVSQNKLLNRLNCDTNNITKLDLNQNIQLTFLDCSSNKLT-EID-VTPLTQL 235
Query: 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI 175
N T + L+ L L +L LT +T L +
Sbjct: 236 TYFDCSVNPLTELDVS---TLSKLTTLHCIQT-DLLEID----LTHNTQLIYFQAEGCRK 287
Query: 176 FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT 235
+ + L L T L S + L++N+ +L LD +S T
Sbjct: 288 IKELD--VTHNTQLYLLDCQAAGIT-ELDLSQNPK-LVYLYLNNTEL---TELD-VSHNT 339
Query: 236 QLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
+L+ + + K +L + + Q + ++ + + +S
Sbjct: 340 KLKSLSCVNAHIQD-FSSVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQF 398
Query: 296 G-PYPLFPSKVQKVSLDHNN 314
G P + P N
Sbjct: 399 GNPMNIEPGDGGVYDQATNT 418
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 4e-17
Identities = 57/333 (17%), Positives = 100/333 (30%), Gaps = 74/333 (22%)
Query: 98 QMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPF 155
Q + P N S + ++ + L L L ++ ++
Sbjct: 7 QTQSFNDWFPD-DNFASEVAAAFEMQATDTIS---EEQLATLTSLDCHNSSITDM----- 57
Query: 156 PNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNL 215
+ K T LT L + NI L +NL L N T +L + + L
Sbjct: 58 -TGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLT-NLDVTPLTK-LTYL 111
Query: 216 WMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVP 275
+ +L T +S L + +N T D+S L +L N+ +
Sbjct: 112 NCDTNKL----TKLDVSQNPLLTYLNCARNTLT--EIDVSHNTQLTELDCHLNKKITKLD 165
Query: 276 ASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQ 335
V L + NK+ + +++ D N +T L
Sbjct: 166 --VTPQTQLTTLDCSFNKITELDVSQNKLLNRLNCDTN---------------NITKL-- 206
Query: 336 IAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKN 395
D+ L+ F+ CS ++ I++ LT L
Sbjct: 207 ---DLNQNIQLT-------------FLDCSSNKLTEIDV-------------TPLTQLTY 237
Query: 396 LYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
N LT + ++ L+ L L +L
Sbjct: 238 FDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-14
Identities = 43/261 (16%), Positives = 86/261 (32%), Gaps = 43/261 (16%)
Query: 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTL 228
+ PD N + + + S + + + +L ++ + +
Sbjct: 6 GQTQSFNDWFPD-----DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT---DM 57
Query: 229 DVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNIS 288
+ +T L ++ N T DLS+ +L L+ N+LT + V L L ++
Sbjct: 58 TGIEKLTGLTKLICTSNNITTL--DLSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLN 112
Query: 289 LQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348
NKL + ++ N T + ++ +
Sbjct: 113 CDTNKLTKLDVSQNPLLTYLNCARNTL----------------TEIDVSH---NTQLTEL 153
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
N +Q + T++ + NK+ ++S L L NN+T +
Sbjct: 154 DCHLNKKITKLDVTPQTQ--LTTLDCSFNKITELDVS----QNKLLNRLNCDTNNITK-L 206
Query: 408 PDGLTKLASLQNLDVSNNNLS 428
L + L LD S+N L+
Sbjct: 207 D--LNQNIQLTFLDCSSNKLT 225
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 55/260 (21%), Positives = 95/260 (36%), Gaps = 43/260 (16%)
Query: 90 TQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
L Q N+I+ + L + L NN + + F L LQ L +S N
Sbjct: 54 PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL--PA 205
+L P L +SL L + + I + F N+ + + N S P
Sbjct: 113 -HLV--EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPG 167
Query: 206 SFAKSDIQNLWMND--------------QQLGLSG------TLDVLSGMTQLRQVWLHKN 245
+F + L +++ +L L L+ L ++L ++ L N
Sbjct: 168 AFDGLKLNYLRISEAKLTGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHN 227
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ-------- 295
Q I + LS +L +L L +N+L+ VPA + L L + L N +
Sbjct: 228 QIRM-IENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVNDFC 285
Query: 296 -GPYPLFPSKVQKVSLDHNN 314
+ + + +SL +N
Sbjct: 286 PVGFGVKRAYYNGISLFNNP 305
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-25
Identities = 56/246 (22%), Positives = 88/246 (35%), Gaps = 38/246 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANA-TSLQDIYLDN 122
+N+++ I S L +L+ L N++ IP N +SL ++ + +
Sbjct: 86 VNNKISKIH------EKAFS----PLRKLQKLYISKNHLV-EIP--PNLPSSLVELRIHD 132
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N VP G F GL N+ + + NP L F L L + A + G IP
Sbjct: 133 NRIRKVPKGVFSGLRNMNCIEMGGNP-LENSGFEPGAFDGLKLNYLRISEAKLTG-IPK- 189
Query: 183 FDSFSNLQNLRLSYNNFTGSLPA-SFAKSDIQNLWMNDQQLGLSG------TLDVLSGMT 235
D L L L +N ++ L +LGL LS +
Sbjct: 190 -DLPETLNELHLDHNKIQ-AIELEDL--LRYSKL----YRLGLGHNQIRMIENGSLSFLP 241
Query: 236 QLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPAS------VISLPALLNISL 289
LR++ L N+ + L + L + L N +T V + ISL
Sbjct: 242 TLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNITKVGVNDFCPVGFGVKRAYYNGISL 301
Query: 290 QNNKLQ 295
NN +
Sbjct: 302 FNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 1e-19
Identities = 41/243 (16%), Positives = 68/243 (27%), Gaps = 55/243 (22%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA-GAIPSLA-NATSLQDIYLD 121
+ NR+ + G S L + + N + A + L + +
Sbjct: 131 HDNRIRKVP------KGVFS----GLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRIS 180
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
T +P L L L N + + L L + + I +
Sbjct: 181 EAKLTGIPKDLP---ETLNELHLDHNKIQAIELEDLLR----YSKLYRLGLGHNQIRMIE 233
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
L+ L L N + +PA + L+
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPAGL------------------------PDLKLLQV 268
Query: 240 VWLHKNQFT-------GPIPDLSKCESLFDLSLRDNQLT--GVVPASVISLPALLNISLQ 290
V+LH N T P+ K +SL +N + V PA+ + L I
Sbjct: 269 VYLHTNNITKVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFG 328
Query: 291 NNK 293
N K
Sbjct: 329 NYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/326 (16%), Positives = 94/326 (28%), Gaps = 107/326 (32%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
L+ + + +VP + +L L +N
Sbjct: 34 HLRVVQCSDLGLKAVPKEIS---PDTTLLDLQNN-------------------------- 64
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
+I L D F +L L L N + + S
Sbjct: 65 DISELRKDDFKGLQHLYALVLVNNKIS-KIHE-----------------------KAFSP 100
Query: 234 MTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
+ +L+++++ KN P+L SL +L + DN++ V L + I + N
Sbjct: 101 LRKLQKLYISKNHLVEIPPNLPS--SLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNP 158
Query: 294 LQ----GPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349
L+ P K+ + + D P+ L +
Sbjct: 159 LENSGFEPGAFDGLKLNYLRISEAKLTGIPKDL-----PETLNELHLDH----------- 202
Query: 350 WEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAY-ANLTSLKNLYLQQNNLTGPIP 408
NK+ I + L L L N + I
Sbjct: 203 --------------------------NKI--QAIELEDLLRYSKLYRLGLGHNQIRM-IE 233
Query: 409 DG-LTKLASLQNLDVSNNNLSGKVPD 433
+G L+ L +L+ L + NN LS +VP
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPA 258
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 41/305 (13%), Positives = 78/305 (25%), Gaps = 104/305 (34%)
Query: 131 GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ 190
G+ +L L + + P L + + + +P + +
Sbjct: 8 ETTSGIPDLDSLPPTYSAMC-----PFGC--HCHLRVVQCSDLGLKA-VPK--EISPDTT 57
Query: 191 NLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250
L L N+ + L D G+ L
Sbjct: 58 LLDLQNNDIS-ELRK-----------------------DDFKGLQHLYA----------- 82
Query: 251 IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFPSKVQKVS 309
L L +N+++ + + L L + + N L P L S + ++
Sbjct: 83 ------------LVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVEIPPNLPSS-LVELR 129
Query: 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRI 369
+ N K + + G +
Sbjct: 130 IHDNRIRK---------------------------VPKGVFSGLR-------------NM 149
Query: 370 ITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
I + N L P + L L + + LTG IP L +L L + +N +
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG-IPKDL--PETLNELHLDHNKIQ 206
Query: 429 GKVPD 433
+
Sbjct: 207 -AIEL 210
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-28
Identities = 63/360 (17%), Positives = 120/360 (33%), Gaps = 83/360 (23%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV 128
++ + + L+ L SL L + + ++ P L + + + NN +
Sbjct: 94 ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPPLL------EYLGVSNNQLEKL 146
Query: 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188
P + L+++ + +N +L P+ SL + N N +P+ +
Sbjct: 147 PE--LQNSSFLKIIDVDNN-SLKK--LPDLPP---SLEFIAAGN-NQLEELPELQ-NLPF 196
Query: 189 LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248
L + N+ LP ++++ + L L L + L ++ N
Sbjct: 197 LTAIYADNNSLK-KLPDLPLS--LESIVAGNNILE---ELPELQNLPFLTTIYADNNLLK 250
Query: 249 GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV 308
+PDL SL L++RDN LT + P SL L + L P + +
Sbjct: 251 T-LPDL--PPSLEALNVRDNYLTDL-PELPQSLTFLDVSENIFSGL----SELPPNLYYL 302
Query: 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
+ N ++ +L CD P
Sbjct: 303 NASSN---------------EIRSL----------------------CDLPP-------S 318
Query: 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ +N++N L + L+ L N+L +P+ +L+ L V N L
Sbjct: 319 LEELNVSNNKLI-ELPA---LPPRLERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 67/344 (19%), Positives = 119/344 (34%), Gaps = 62/344 (18%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
LE ++ N + +P L N L IY DNN+ +P D +L+ + +
Sbjct: 170 DLPPSLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSLKKLP----DLPLSLESIVAGN 224
Query: 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS 206
N L EL LTT+Y DN N+ +PD +L+ L + N T LP
Sbjct: 225 N-ILE---ELPELQNLPFLTTIYADN-NLLKTLPD---LPPSLEALNVRDNYLT-DLPEL 275
Query: 207 FAKSDIQNLWMNDQQL-GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSL 265
+ L +++ GLS L + N+ + DL SL +L++
Sbjct: 276 PQS--LTFLDVSENIFSGLSELP------PNLYYLNASSNEIRS-LCDL--PPSLEELNV 324
Query: 266 RDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKP 325
+N+L +PA P L + N L P P ++++ +++N
Sbjct: 325 SNNKLI-ELPAL---PPRLERLIASFNHLAE-VPELPQNLKQLHVEYN------------ 367
Query: 326 CDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNIS 384
+ P I S E V + +++ N L
Sbjct: 368 ---PLREF---------PDIPE-SVEDLRMNSHLAEVPELPQNLKQLHVETNPLR--EFP 412
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
S+++L + + P L++ +++
Sbjct: 413 DI---PESVEDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 69/373 (18%), Positives = 123/373 (32%), Gaps = 72/373 (19%)
Query: 69 TTISLAKSGLSGTLSPEISSL-------------TQLETLSFQMNNIAGAIPSLANATSL 115
T A S P Q L + ++P L L
Sbjct: 37 TEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL-SSLPELP--PHL 93
Query: 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI 175
+ + N+ T +P L +L V + + L+ P L L + N N
Sbjct: 94 ESLVASCNSLTELPEL-PQSLKSLLVDNNNLK-ALSDLP--------PLLEYLGVSN-NQ 142
Query: 176 FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT 235
+P+ + S L+ + + N+ LP ++ + + QL L L +
Sbjct: 143 LEKLPELQN-SSFLKIIDVDNNSLK-KLPDLPPS--LEFIAAGNNQLE---ELPELQNLP 195
Query: 236 QLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
L ++ N +PDL SL + +N L + +LP L I NN L+
Sbjct: 196 FLTAIYADNNSLKK-LPDL--PLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK 250
Query: 296 GPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
P P ++ +++ N P PQ T L + N
Sbjct: 251 T-LPDLPPSLEALNVRDNYLTDL------PELPQSLTFLDV---------------SENI 288
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
G + + + +N ++ + ++ SL+ L + N L +P +L
Sbjct: 289 FSGLSELPPN---LYYLNASSNEIR-SLCD---LPPSLEELNVSNNKLIE-LPALPPRL- 339
Query: 416 SLQNLDVSNNNLS 428
+ L S N+L+
Sbjct: 340 --ERLIASFNHLA 350
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 59/363 (16%), Positives = 106/363 (29%), Gaps = 72/363 (19%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIP--------------SLANATSLQDIYLDNNNFT 126
+ E ++ + P ++ L+N +
Sbjct: 25 EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS 84
Query: 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
S+P + +L+ L S N +L P SL + + L P
Sbjct: 85 SLP----ELPPHLESLVASCN-SLT--ELPELPQSLKSLLVDNNNLKALSDLPP------ 131
Query: 187 SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
L+ L +S N LP S ++ + +++ L + L + NQ
Sbjct: 132 -LLEYLGVSNNQLE-KLPELQNSSFLKIIDVDNNSLK-----KLPDLPPSLEFIAAGNNQ 184
Query: 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF-PSKV 305
+P+L L + +N L + +L +I NN L+ L +
Sbjct: 185 LEE-LPELQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGNNILEELPELQNLPFL 239
Query: 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS 365
+ D+N + TL + L +N P + S
Sbjct: 240 TTIYADNN---------------LLKTLPDLPPS------LEALNVRDNYLTDLPELPQS 278
Query: 366 QGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425
+ L+ +L L N + + D SL+ L+VSNN
Sbjct: 279 LTFLDVSENIFSGLS-------ELPPNLYYLNASSNEIRS-LCDLPP---SLEELNVSNN 327
Query: 426 NLS 428
L
Sbjct: 328 KLI 330
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 64/361 (17%), Positives = 118/361 (32%), Gaps = 86/361 (23%)
Query: 82 LSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140
++P S T L+ +N+ +P N S + Y + + +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
V L D + L ++N + +P+ +L++L S N+ T
Sbjct: 62 VSRLRDCLD-------------RQAHELELNNLGL-SSLPE---LPPHLESLVASCNSLT 104
Query: 201 GSLPASFAKSDIQNLWMNDQQLGLSGT-LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES 259
LP +++L + L L L + + NQ +P+L
Sbjct: 105 -ELPELPQS--LKSL----LVDNNNLKALSDL--PPLLEYLGVSNNQLEK-LPELQNSSF 154
Query: 260 LFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKN 318
L + + +N L +P P+L I+ NN+L+ L + + D+N
Sbjct: 155 LKIIDVDNNSLK-KLPDL---PPSLEFIAAGNNQLEELPELQNLPFLTAIYADNN----- 205
Query: 319 SSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL 378
+ L P + + +I N +
Sbjct: 206 ----------SLKKL---------PDLP--------------------LSLESIVAGNNI 226
Query: 379 LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNV 438
L P NL L +Y N L +PD SL+ L+V +N L+ +P+ ++
Sbjct: 227 L--EELPELQNLPFLTTIYADNNLLKT-LPDLPP---SLEALNVRDNYLT-DLPELPQSL 279
Query: 439 K 439
Sbjct: 280 T 280
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-21
Identities = 50/264 (18%), Positives = 84/264 (31%), Gaps = 51/264 (19%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
LE++ N + +P L N L IY DNN ++P D +L+ L++
Sbjct: 211 PDLPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLKTLP----DLPPSLEALNVR 265
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-------------DFFDSFSNLQNL 192
DN P T L + + L P D +L+ L
Sbjct: 266 DNYLTD---LPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEEL 322
Query: 193 RLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP 252
+S N LPA + ++ L + L +V L+Q+ + N P
Sbjct: 323 NVSNNKLI-ELPALPPR--LERLIASFNHLA-----EVPELPQNLKQLHVEYNPLRE-FP 373
Query: 253 DL-----------------SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
D+ ++L L + N L P S+ L + + ++
Sbjct: 374 DIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVV 429
Query: 296 GPYPLFPSKVQKVSLDHNNFCKNS 319
PY K+ D +
Sbjct: 430 DPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-19
Identities = 39/214 (18%), Positives = 74/214 (34%), Gaps = 32/214 (14%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140
L SLT L+ + + L +L + +N S+ D +L+
Sbjct: 271 DLPELPQSLTFLDVSENIFSGL----SELP--PNLYYLNASSNEIRSLC----DLPPSLE 320
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
L++S+N L P + L L N +P+ NL+ L + YN
Sbjct: 321 ELNVSNN-KLIE--LPALPPR---LERLIASF-NHLAEVPE---LPQNLKQLHVEYNPLR 370
Query: 201 GSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL 260
P +++L MN + L+Q+ + N PD+ ES+
Sbjct: 371 -EFPDIP--ESVEDLRMNSHLAEVPELP------QNLKQLHVETNPLRE-FPDIP--ESV 418
Query: 261 FDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
DL + ++ + + L + +++
Sbjct: 419 EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHH 452
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 70/308 (22%), Positives = 127/308 (41%), Gaps = 44/308 (14%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
++ +G+G G VY ++ G ++A+++M K EI V+ + ++
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKK--ELIINEILVMRENKN 76
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V L + G E +V EY+ G+L + E T + Q + + + +E
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALE 130
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
+LHS IHRD+K NIL+G D K+ DFG + T + GT ++APE
Sbjct: 131 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPE 186
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL--ISKENIPKA 816
K+D+++ G++ +E I G + P R L I+ P+
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----------LRALYLIATNGTPEL 236
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----------MGHAVNVLGPLVEQ 865
+P L + + R C + ++R + ++ L PL+
Sbjct: 237 QNPE-KLSAIFRDFLNR-------CLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAA 288
Query: 866 WKPATRED 873
K AT+ +
Sbjct: 289 AKEATKNN 296
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-28
Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 27/219 (12%)
Query: 87 SSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
L LE L N+I I + +L + L +N T++P G F L+ L+ L L
Sbjct: 85 KHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWL 143
Query: 145 SDNP--NLAPWPFPNELTKSTSLTTLYMDNAN-IFGLIPDFFDSFSNLQNLRLSYNNFTG 201
+NP ++ + F + SL L + + + F+ SNL+ L L+ N
Sbjct: 144 RNNPIESIPSYAF----NRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTL------DVLSGMTQLRQVWLHKNQFTGPIPD-- 253
+P + + L +L LSG G+ L+++W+ ++Q I
Sbjct: 199 EIPN-L--TPLIKL----DELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNA 250
Query: 254 LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+SL +++L N LT + L L I L +N
Sbjct: 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 46/212 (21%), Positives = 84/212 (39%), Gaps = 19/212 (8%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
T+ + + L N + F L +L++L LS N ++ +L TL + +
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRN-HIRTIE-IGAFNGLANLNTLELFD 121
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG------ 226
+ + F S L+ L L N +F + I +L ++L L
Sbjct: 122 NRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAF--NRIPSL----RRLDLGELKRLSY 175
Query: 227 -TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALL 285
+ G++ LR + L IP+L+ L +L L N L+ + P S L L
Sbjct: 176 ISEGAFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQ 234
Query: 286 NISLQNNKLQG-PYPLFP--SKVQKVSLDHNN 314
+ + +++Q F + +++L HNN
Sbjct: 235 KLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 1e-19
Identities = 33/139 (23%), Positives = 58/139 (41%), Gaps = 17/139 (12%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDN 122
R++ IS G L+ L L+ M N+ IP+L L ++ L
Sbjct: 168 GELKRLSYIS------EGAFE----GLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSG 216
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
N+ +++ G F GL +LQ L + + + F N SL + + + N+ L
Sbjct: 217 NHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDN----LQSLVEINLAHNNLTLLPH 272
Query: 181 DFFDSFSNLQNLRLSYNNF 199
D F +L+ + L +N +
Sbjct: 273 DLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 2e-17
Identities = 57/325 (17%), Positives = 107/325 (32%), Gaps = 88/325 (27%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+ N VP G TN ++L+L +N
Sbjct: 44 QFSKVICVRKNLREVPDGIS---TNTRLLNLHEN-------------------------- 74
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVL 231
I + + F +L+ L+LS N+ +F +++ L + D +L +
Sbjct: 75 QIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPN--GAF 132
Query: 232 SGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRD-NQLTGVVPASVISLPALLNIS 288
+++L+++WL N IP ++ SL L L + +L+ + + L L ++
Sbjct: 133 VYLSKLKELWLRNNPIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLN 191
Query: 289 LQNNKLQG-PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
L L+ P K+ ++ L N+ + +
Sbjct: 192 LAMCNLREIPNLTPLIKLDELDLSGNHL---------------SAI-------------- 222
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISP-AYANLTSLKNLYLQQNN 402
+ G +L + + I A+ NL SL + L NN
Sbjct: 223 ----RPGSFQGLM------------HLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNN 266
Query: 403 LTGPIPDGLTKLASLQNLDVSNNNL 427
LT D T L L+ + + +N
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 3e-08
Identities = 45/210 (21%), Positives = 69/210 (32%), Gaps = 45/210 (21%)
Query: 235 TQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
T R + LH+NQ + L L L N + + + L L + L +N+
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123
Query: 294 LQG-PYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
L P F SK++++ L +N S A P + L L +
Sbjct: 124 LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI-PSLRRLD-----------LGE-- 169
Query: 351 EGNNACDGWPFVTCSQGRIITI------NLAN--KL-LAGN-IS--PAYANLTSLKNLYL 398
R+ I L+N L LA + P L L L L
Sbjct: 170 --LK-------------RLSYISEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDL 214
Query: 399 QQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
N+L+ P L LQ L + + +
Sbjct: 215 SGNHLSAIRPGSFQGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 3e-04
Identities = 18/85 (21%), Positives = 34/85 (40%), Gaps = 12/85 (14%)
Query: 356 CDG-WPFVTCSQGRIITI------NLANKLLAGN----ISP-AYANLTSLKNLYLQQNNL 403
C + V C + + + N L N I ++ +L L+ L L +N++
Sbjct: 41 CSNQFSKVICVRKNLREVPDGISTNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
LA+L L++ +N L+
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLT 125
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 10/43 (23%), Positives = 24/43 (55%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
++ L L+ L++ Q+ + + L SL +++++NNL+
Sbjct: 226 SFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 15/61 (24%), Positives = 31/61 (50%), Gaps = 5/61 (8%)
Query: 376 NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLSGKVPD 433
N + +I A+ + SL+ L L + I +G L++L+ L+++ NL ++P+
Sbjct: 146 NPI--ESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN 202
Query: 434 F 434
Sbjct: 203 L 203
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 75/334 (22%), Positives = 129/334 (38%), Gaps = 57/334 (17%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G+G F V + G ++A+K ++ + L + E+ ++ + H ++V L
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS 707
L+ EY G + +L HG + K+ + + V+Y H Q+
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVA---HGR--MKEKEARSKFRQIVSAVQYCH---QKR 134
Query: 708 FIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE------YAA 761
+HRDLK N+L+ DM K+ADFG G ++ G Y APE Y
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK-LDA-FCGAPPYAAPELFQGKKYDG 192
Query: 762 TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNL 821
++DV++ GV+L ++G +P D +L RVL K IP + +
Sbjct: 193 -----PEVDVWSLGVILYTLVSGS------LPFDGQNLKELRERVLRGKYRIPFYMSTD- 240
Query: 822 NLDEETIESIYRVAELAGHCTAREPQQRPDM-----------GHAVNVLGPLVEQWKPAT 870
L P +R + GH + L P VE +
Sbjct: 241 ------------CENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDIS 288
Query: 871 RED----EDGYGIDLHMSLPQALQRWQANEGTST 900
+ G G + ++L + + +E T+T
Sbjct: 289 DQKRIDIMVGMGYSQEE-IQESLSKMKYDEITAT 321
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 1e-27
Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLG 646
+LG+G +G+VY G +L + +IA+K + ++ EIA+ ++H+++V LG
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLG 86
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVT--IALDVARGVEYLHSLA 704
+ E +P G+L+ L + PL ++ + G++YLH
Sbjct: 87 SFSENGFIKIFMEQVPGGSLSALL----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD-- 140
Query: 705 QQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE---YA 760
+HRD+K N+LI K++DFG K ET GT Y+APE
Sbjct: 141 -NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKG 198
Query: 761 ATGRVTTKIDVYAFGVVLMETITGR 785
G D+++ G ++E TG+
Sbjct: 199 PRGY-GKAADIWSLGCTIIEMATGK 222
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 69/283 (24%), Positives = 119/283 (42%), Gaps = 30/283 (10%)
Query: 581 DNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
D++ ++G G VV P K+A+KR+ + E EI +++ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN-LEKCQTSMDELLKEIQAMSQCHHP 73
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLA---QHLFEWHDHGYTPLTWKQRVTIALDVARG 696
++V+ + E LV + + G++ +H+ +H L TI +V G
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPDGKYSVETRLAGTF 752
+EYLH IHRD+K NIL+G+D ++ADFG L + V GT
Sbjct: 134 LEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 753 GYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811
++APE R K D+++FG+ +E TG P +VL+
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP----------MKVLM--- 237
Query: 812 NIPKAIDPNLNLDEETIESIYRVA----ELAGHCTAREPQQRP 850
+ P+L + E + + ++ C ++P++RP
Sbjct: 238 LTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 52/260 (20%), Positives = 100/260 (38%), Gaps = 24/260 (9%)
Query: 69 TTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTS 127
T+ L + +S +SP + L +LE L N + +P +LQ++ + N T
Sbjct: 79 HTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPEKM-PKTLQELRVHENEITK 135
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
V F+GL + V+ L NP + L+ + + + NI IP
Sbjct: 136 VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQ--GLPP 192
Query: 188 NLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLSGTLDVLSGMTQLRQVWLHKN 245
+L L L N T AS +++ L ++ + + L+ LR++ L+ N
Sbjct: 193 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN--GSLANTPHLRELHLNNN 250
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGV------VPASVISLPALLNISLQNNKLQGPYP 299
+ L+ + + + L +N ++ + P + +SL +N +Q +
Sbjct: 251 KLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ-YWE 309
Query: 300 LFP------SKVQKVSLDHN 313
+ P V L +
Sbjct: 310 IQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 6e-27
Identities = 67/383 (17%), Positives = 116/383 (30%), Gaps = 119/383 (31%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDI 118
C R + + GL + ++ T L Q N I I N +L +
Sbjct: 28 RCQCHLR--VVQCSDLGLE-KVPKDLPPDTA--LLDLQNNKIT-EIKDGDFKNLKNLHTL 81
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
L NN + + G F L L+ L LS N L
Sbjct: 82 ILINNKISKISPGAFAPLVKLERLYLSKN----------------QLKE----------- 114
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
+P+ LQ LR+ N T + V +G+ Q+
Sbjct: 115 LPE--KMPKTLQELRVHENEIT-KVRK-----------------------SVFNGLNQMI 148
Query: 239 QVWLHKNQFT-GPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
V L N I + + L + + D +T +P + P+L + L NK+
Sbjct: 149 VVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKIT 205
Query: 296 G-PYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
+ + K+ L N ++ +
Sbjct: 206 KVDAASLKGLNNLAKLGLSFN---------------SISAV------------------D 232
Query: 353 NNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTG------ 405
N + P + ++L NKL+ + A+ ++ +YL NN++
Sbjct: 233 NGSLANTP-------HLRELHLNNNKLVK--VPGGLADHKYIQVVYLHNNNISAIGSNDF 283
Query: 406 PIPDGLTKLASLQNLDVSNNNLS 428
P TK AS + + +N +
Sbjct: 284 CPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 45/228 (19%), Positives = 80/228 (35%), Gaps = 40/228 (17%)
Query: 89 LTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTS--VPTGCFDGLTNLQVLSL 144
L+ L N I + + + L N S + G F G+ L + +
Sbjct: 120 PKTLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRI 178
Query: 145 SDN-----PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNF 199
+D P P SLT L++D I + +NL L LS+N+
Sbjct: 179 ADTNITTIPQGLP----------PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSI 228
Query: 200 TGSLPASFAKSDIQNLWMNDQQLGLSGTL-----DVLSGMTQLRQVWLHKNQFT------ 248
+ S ++ +L ++L L+ L+ ++ V+LH N +
Sbjct: 229 SAVDNGSL--ANTPHL----RELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSND 282
Query: 249 -GPIPDLSKCESLFDLSLRDNQL--TGVVPASVISLPALLNISLQNNK 293
P +K S +SL N + + P++ + + L N K
Sbjct: 283 FCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 2e-09
Identities = 24/141 (17%), Positives = 46/141 (32%), Gaps = 42/141 (29%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS-LANATSLQDIYLDN 122
+ N ++ + +G+L+ + L L N + +P LA+ +Q +YL N
Sbjct: 224 SFNSISAVD------NGSLA----NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 272
Query: 123 NNFTSVPTGCF------DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIF 176
NN +++ + F + +SL NP + W
Sbjct: 273 NNISAIGSNDFCPPGYNTKKASYSGVSLFSNP-VQYWEIQ-------------------- 311
Query: 177 GLIPDFFDSFSNLQNLRLSYN 197
P F ++L
Sbjct: 312 ---PSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 4e-04
Identities = 9/48 (18%), Positives = 20/48 (41%), Gaps = 3/48 (6%)
Query: 388 ANLTSLKNLYLQQNNLT-GPIPDG-LTKLASLQNLDVSNNNLSGKVPD 433
L + + L N L I +G + L + +++ N++ +P
Sbjct: 142 NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ 188
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-27
Identities = 53/280 (18%), Positives = 98/280 (35%), Gaps = 45/280 (16%)
Query: 55 CEWTGINCDNSN----------RVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIA 103
C T I C++ T + L + L +L + LTQL LS N ++
Sbjct: 7 CSGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSSNGLS 65
Query: 104 -GAIPSLANA--TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT 160
S ++ TSL+ + L N ++ + F GL L+ L + NL +
Sbjct: 66 FKGCCSQSDFGTTSLKYLDLSFNGVITMSSN-FLGLEQLEHLDFQHS-NLKQMSEFSVFL 123
Query: 161 KSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQ 220
+L L + + + F+ S+L+ L+++ N+F +
Sbjct: 124 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLP--------------- 168
Query: 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKC-ESLFDLSLRDNQLTGVVPASVI 279
D+ + + L + L + Q P SL L++ N +
Sbjct: 169 --------DIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYK 220
Query: 280 SLPALLNISLQNNKLQG-PYPLF---PSKVQKVSLDHNNF 315
L +L + N + PS + ++L N+F
Sbjct: 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 39/221 (17%), Positives = 68/221 (30%), Gaps = 57/221 (25%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIPS---LANATSLQDIYLDNNNFTSVPTGCFDGLT 137
T+S L QLE L FQ +N+ + + +L + + + + G F+GL+
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNL-KQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 150
Query: 138 NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYN 197
+L+VL ++ N + PD F NL L LS
Sbjct: 151 SLEVLKMAGNSFQENFL-------------------------PDIFTELRNLTFLDLSQC 185
Query: 198 NFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LS 255
L + ++ L+ + + N F +
Sbjct: 186 QLE-QLSP-----------------------TAFNSLSSLQVLNMSHNNFFS-LDTFPYK 220
Query: 256 KCESLFDLSLRDNQLTGVVPASVISLP-ALLNISLQNNKLQ 295
SL L N + + P +L ++L N
Sbjct: 221 CLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 57/323 (17%), Positives = 103/323 (31%), Gaps = 77/323 (23%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
S +I ++ TSVPTG ++ L L N
Sbjct: 8 SGTEIRCNSKGLTSVPTGIP---SSATRLELESN-------------------------- 38
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
+ L FD + L L LS N + S + G
Sbjct: 39 KLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQS----------------------DFG 76
Query: 234 MTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVIS-LPALLNISLQNN 292
T L+ + L N + E L L + + L + SV L L+ + + +
Sbjct: 77 TTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 293 KLQG-PYPLFP--SKVQKVSLDHNNFCKN-SSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348
+ +F S ++ + + N+F +N D +T L D+ +
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTEL-RNLTFL-----DLSQCQLEQL 190
Query: 349 SWEGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISP-AYANLTSLKNLYLQQNNLTGP 406
S A + + +N++ N ++ Y L SL+ L N++
Sbjct: 191 S---PTAFNSLS-------SLQVLNMSHNNFF--SLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 407 IPDGLTKL-ASLQNLDVSNNNLS 428
L +SL L+++ N+ +
Sbjct: 239 KKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 16/61 (26%), Positives = 26/61 (42%), Gaps = 3/61 (4%)
Query: 376 NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434
N L + TSLK L L N + + L L++LD ++NL ++ +F
Sbjct: 62 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEF 119
Query: 435 G 435
Sbjct: 120 S 120
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 6e-04
Identities = 24/177 (13%), Positives = 52/177 (29%), Gaps = 47/177 (26%)
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQG---PYPLFP--SKVQKVSLDHNNFCK 317
L L N+L + L L +SL +N L + ++ + L N
Sbjct: 33 LELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG--- 89
Query: 318 NSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANK 377
++ ++ + F+ Q + +
Sbjct: 90 ---------------VITMSSN---------------------FLGLEQLEHLDFQ-HSN 112
Query: 378 LLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLSGKVPD 433
L + + +L +L L + + +G L+SL+ L ++ N+
Sbjct: 113 LKQMSEFSVFLSLRNLIYLDISHTHTRV-AFNGIFNGLSSLEVLKMAGNSFQENFLP 168
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 56/216 (25%), Positives = 87/216 (40%), Gaps = 26/216 (12%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE------FQAE 629
+ + D + + LG G G V E K+A+K + E + E
Sbjct: 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65
Query: 630 IAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVT 688
I +L K+ H ++ + + + + +V E M G LF+ + L
Sbjct: 66 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGG----ELFDKVVGNKR--LKEATCKL 118
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVE 745
+ V+YLH IHRDLKP N+L+ +D K+ DFG K + S+
Sbjct: 119 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLM 173
Query: 746 TRLAGTFGYLAPE---YAATGRVTTKIDVYAFGVVL 778
L GT YLAPE T +D ++ GV+L
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 52/228 (22%), Positives = 82/228 (35%), Gaps = 31/228 (13%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-R 637
T F E +G G FG V+ + DG A+KR + G+ E+ + +
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H H+V L+ EY G+LA + E + + + + L V RG+
Sbjct: 70 HSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISE-NYRIMSYFKEAELKDLLLQVGRGL 128
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDD-------------------MRAKVADFGLVKNAP 738
Y+HS S +H D+KPSNI I + K+ D G V
Sbjct: 129 RYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 739 DGKYSVETRLAGTFGYLAPE-YAATGRVTTKIDVYAFGVVLMETITGR 785
+ G +LA E K D++A + ++
Sbjct: 186 SPQVEE-----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-27
Identities = 70/307 (22%), Positives = 122/307 (39%), Gaps = 27/307 (8%)
Query: 523 PEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVT-D 581
V + K V + L + F ++E+ +T +
Sbjct: 130 EHVQGHLVKKQVPPDLFQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVELNIHLTMN 189
Query: 582 NFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV--- 636
+FS I+GRGGFG VYG D K+ A+K ++ +G + E +L+ V
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDVA 694
+V + Y + ++L + + M G L HL HG + + A ++
Sbjct: 250 DCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFS---EADMRFYAAEII 302
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFG 753
G+E++H+ ++RDLKP+NIL+ + +++D GL + K GT G
Sbjct: 303 LGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHG 355
Query: 754 YLAPEYAATGRVTTK-IDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812
Y+APE G D ++ G +L + + G D+ + R L
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMAVE 412
Query: 813 IPKAIDP 819
+P + P
Sbjct: 413 LPDSFSP 419
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 8e-27
Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 27/217 (12%)
Query: 578 QVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVK-------RMESNTMGNKGLSEFQAE 629
+N+ ILGRG VV P + AVK S + E
Sbjct: 14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKE 73
Query: 630 IAVLTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRV 687
+ +L KV H +++ L + LV++ M +G LF++ + L+ K+
Sbjct: 74 VDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKG----ELFDYLTEKVT--LSEKETR 127
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
I + + LH + +HRDLKP NIL+ DDM K+ DFG G
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLRE 182
Query: 748 LAGTFGYLAPE------YAATGRVTTKIDVYAFGVVL 778
+ GT YLAPE ++D+++ GV++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 8e-27
Identities = 55/216 (25%), Positives = 87/216 (40%), Gaps = 26/216 (12%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSE------FQAE 629
+ + D + + LG G G V E K+A++ + E + E
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETE 190
Query: 630 IAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVT 688
I +L K+ H ++ + + + + +V E M G L F+ + L
Sbjct: 191 IEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKR--LKEATCKL 243
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVE 745
+ V+YLH IHRDLKP N+L+ +D K+ DFG K + S+
Sbjct: 244 YFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLM 298
Query: 746 TRLAGTFGYLAPE---YAATGRVTTKIDVYAFGVVL 778
L GT YLAPE T +D ++ GV+L
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 56/210 (26%), Positives = 85/210 (40%), Gaps = 27/210 (12%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ ++ +LG+G FG V + + AVK + + NK S E+ +L K+
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
H +++ L + S +V E G LF+ + I V G
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGG----ELFDEIIKRKR--FSEHDAARIIKQVFSG 133
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
+ Y+H + +HRDLKP NIL+ D K+ DFGL GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAY 188
Query: 754 YLAPE-----YAATGRVTTKIDVYAFGVVL 778
Y+APE Y K DV++ GV+L
Sbjct: 189 YIAPEVLRGTY------DEKCDVWSAGVIL 212
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-26
Identities = 53/328 (16%), Positives = 103/328 (31%), Gaps = 33/328 (10%)
Query: 561 RHLFEGGNVAISIEVLRQVTDN---FSEANILGRG--GFGVVYGG-ELPDGTKIAVKRME 614
H + + + + ++G+G V P G + V+R+
Sbjct: 2 AHHHHHHMENLYFQGMSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN 61
Query: 615 SNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWH 674
N+ ++ Q E+ V H ++V I +E +V +M G+ + L H
Sbjct: 62 LEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSA-KDLICTH 120
Query: 675 DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG-- 732
+ I V + ++Y+H ++HR +K S+ILI D + ++
Sbjct: 121 FMD--GMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 733 --LVKNAP--DGKYSVETRLAGTFGYLAPEYAATGRV--TTKIDVYAFGVVLMETITGRK 786
++ + + +L+PE K D+Y+ G+ E G
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235
Query: 787 ALDDTMPDDRAHLVTWFRRVL--ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAR 844
D ++L +P +D + EE S R +G +
Sbjct: 236 PFKDMPA----------TQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSL 285
Query: 845 EPQQRPDMGHAVNVLGPLVEQWKPATRE 872
P + P
Sbjct: 286 TTSTPRPSNGDSPSH-PYHRTFSPHFHH 312
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 61/302 (20%), Positives = 120/302 (39%), Gaps = 44/302 (14%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+G G G+V E G ++AVK M+ + E+ ++ +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRR--ELLFNEVVIMRDYQH 101
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V + + G E ++ E++ G L + + L +Q T+ V + +
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALA 155
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLH+ Q IHRD+K +IL+ D R K++DFG ++ L GT ++APE
Sbjct: 156 YLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS-LVGTPYWMAPE 211
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL--ISKENIPKA 816
+ T++D+++ G++++E + G P + + + PK
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----------VQAMKRLRDSPPPKL 261
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----------MGHAVNVLGPLVEQ 865
+ + + + + R R+PQ+R L PL++
Sbjct: 262 KNSH-KVSPVLRDFLER-------MLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQL 313
Query: 866 WK 867
++
Sbjct: 314 YR 315
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 70/317 (22%), Positives = 121/317 (38%), Gaps = 50/317 (15%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+ F LG G +G VY G +A+K++ L E EI+++ +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQEIIKEISIMQQCDS 83
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
H+V G ++ +V EY G+++ + + LT + TI +G+E
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRN---KTLTEDEIATILQSTLKGLE 139
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLH IHRD+K NIL+ + AK+ADFG+ D T + GT ++APE
Sbjct: 140 YLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPE 195
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL--ISKENIPKA 816
D+++ G+ +E G+ D P R + I P
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----------MRAIFMIPTNPPPTF 245
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----------MGHAVNVLGPLVEQ 865
P + + + + C + P+QR V++L L+ +
Sbjct: 246 RKPE-LWSDNFTDFVKQ-------CLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINE 297
Query: 866 WK------PATREDEDG 876
+++ E+G
Sbjct: 298 AMDVKLKRQESQQREEG 314
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 16/206 (7%)
Query: 578 QVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+ +DN+ LG+G F VV G + A K + + + + + + E + K+
Sbjct: 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVAR 695
+H ++V L S LV++ + G LFE + + +
Sbjct: 63 QHPNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREF--YSEADASHCIQQILE 116
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
+ Y HS +HR+LKP N+L+ K+ADFGL D + AGT
Sbjct: 117 SIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTP 171
Query: 753 GYLAPEYAATGRVTTKIDVYAFGVVL 778
GYL+PE + +D++A GV+L
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-26
Identities = 56/240 (23%), Positives = 98/240 (40%), Gaps = 23/240 (9%)
Query: 549 ELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTK 607
EL Q + + + + ++ + LG G GVV+ P G
Sbjct: 8 ELDEQQRKRLEAFLTQKQKVGELKDDDFEKI-------SELGAGNGGVVFKVSHKPSGLV 60
Query: 608 IAVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGT 665
+A K +E + E+ VL + ++V G + E + E+M G+
Sbjct: 61 MARKLIHLEIKPAIRNQI---IRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 117
Query: 666 LAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725
L Q L + + +++ V +G+ YL + +HRD+KPSNIL+
Sbjct: 118 LDQVL-----KKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGE 170
Query: 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
K+ DFG+ D S+ GT Y++PE + + D+++ G+ L+E GR
Sbjct: 171 IKLCDFGVSGQLID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 53/204 (25%), Positives = 84/204 (41%), Gaps = 15/204 (7%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+++ + LG G +G V + + A+K + ++ S+ E+AVL +
Sbjct: 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD 94
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H +++ L + + LV E G L + I V GV
Sbjct: 95 HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIH---RMK--FNEVDAAVIIKQVLSGV 149
Query: 698 EYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
YLH + +HRDLKP N+L+ D K+ DFGL + K GT Y
Sbjct: 150 TYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK--KMKERLGTAYY 204
Query: 755 LAPEYAATGRVTTKIDVYAFGVVL 778
+APE + K DV++ GV+L
Sbjct: 205 IAPE-VLRKKYDEKCDVWSIGVIL 227
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 74/313 (23%), Positives = 132/313 (42%), Gaps = 49/313 (15%)
Query: 580 TDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+ F++ +G+G FG V+ G + +A+K ++ ++ + + Q EI VL++
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDS 79
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++ G + ++ ++ EY+ G+ L E PL Q TI ++ +G++
Sbjct: 80 PYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLE-----PGPLDETQIATILREILKGLD 133
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLHS + IHRD+K +N+L+ + K+ADFG+ D + T GT ++APE
Sbjct: 134 YLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPE 189
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818
+K D+++ G+ +E G + P +VL IPK
Sbjct: 190 VIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----------MKVLF---LIPKNNP 236
Query: 819 PNL--NLDEETIESIYRVAELAGHCTAREPQQRP------------DMGHAVNVLGPLVE 864
P L N + E + C +EP RP + L L++
Sbjct: 237 PTLEGNYSKPLKEFVEA-------CLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELID 289
Query: 865 ---QWKPATREDE 874
+WK D+
Sbjct: 290 RYKRWKAEQSHDD 302
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-26
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 22/207 (10%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V D + LG G FGVV+ E G K + + +K + EI+++ ++
Sbjct: 49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQLH 106
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW---HDHGYTPLTWKQRVTIALDVA 694
H L+ L + E +L+ E++ G LF+ D+ + + +
Sbjct: 107 HPKLINLHDAFEDKYEMVLILEFLSGG----ELFDRIAAEDYKMSE---AEVINYMRQAC 159
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGL-VKNAPDGKYSVETRLAGT 751
G++++H S +H D+KP NI+ K+ DFGL K PD V T
Sbjct: 160 EGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTAT 213
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVL 778
+ APE V D++A GV+
Sbjct: 214 AEFAAPEIVDREPVGFYTDMWAIGVLG 240
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 55/223 (24%), Positives = 91/223 (40%), Gaps = 20/223 (8%)
Query: 565 EGGNVAISIEVLRQVTDNFSEA----NILGRGGFGVVY-GGELPDGTKIAVKRMESNTMG 619
G + E + + FS+ LG+G F VV G + A K + + +
Sbjct: 9 GGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS 68
Query: 620 NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGY 678
+ + + E + K++H ++V L S LV++ + G LFE +
Sbjct: 69 ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG----ELFEDIVAREF 124
Query: 679 TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVK 735
+ + + Y HS +HR+LKP N+L+ K+ADFGL
Sbjct: 125 --YSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI 179
Query: 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVL 778
D + AGT GYL+PE + +D++A GV+L
Sbjct: 180 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 4e-26
Identities = 52/219 (23%), Positives = 95/219 (43%), Gaps = 25/219 (11%)
Query: 573 IEVLRQ--VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVK----RMESNTMGNKGLSE 625
+E +Q V D + LG G F +V E G + A K R + E
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 626 FQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWK 684
+ E+++L +V H +++ L N ++ +L+ E + G LF++ L+ +
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGG----ELFDFLAQKES--LSEE 115
Query: 685 QRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGL-VKNAPD 739
+ + + GV YLH+ + H DLKP NI++ K+ DFGL +
Sbjct: 116 EATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVL 778
++ + GT ++APE + + D+++ GV+
Sbjct: 173 VEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 4e-26
Identities = 62/312 (19%), Positives = 108/312 (34%), Gaps = 50/312 (16%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEF-QAEIAVLT 634
R+ + +GRG FG V+ + G + AVK++ L F E+
Sbjct: 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACA 105
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
+ +V L G G + E + G+L Q + + L + +
Sbjct: 106 GLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ-----MGCLPEDRALYYLGQAL 160
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFGLVKNAPDGKYSVETR----LA 749
G+EYLH+ + +H D+K N+L+ D RA + DFG +
Sbjct: 161 EGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL-- 807
GT ++APE K+D+++ +++ + G +
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR----------GPLCLK 267
Query: 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD----MGH---AVNVLG 860
I+ E P P + T ++I +EP R A+ +G
Sbjct: 268 IASEPPPIREIPP-SCAPLTAQAIQE-------GLRKEPVHRASAMELRRKVGKALQEVG 319
Query: 861 PLVEQWKPATRE 872
L WK +E
Sbjct: 320 GLKSPWKGEYKE 331
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 4e-26
Identities = 51/211 (24%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLS----EFQAEIAVL 633
V D++ LG G F +V + G + A K ++ + + E + E+ +L
Sbjct: 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 634 TKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALD 692
++RH +++ L N ++ +L+ E + G LF++ + LT +
Sbjct: 63 REIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKES--LTEDEATQFLKQ 116
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGL-VKNAPDGKYSVETR 747
+ GV YLHS + H DLKP NI++ + R K+ DFG+ K ++
Sbjct: 117 ILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--- 170
Query: 748 LAGTFGYLAPEYAATGRVTTKIDVYAFGVVL 778
+ GT ++APE + + D+++ GV+
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 201
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 70/299 (23%), Positives = 111/299 (37%), Gaps = 42/299 (14%)
Query: 567 GNVAISIEVLRQVT-DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLS 624
G + IS E T ++ + +GRG +G V P G +AVKR+ S K
Sbjct: 7 GKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQK 65
Query: 625 EFQAEIAVLTK-VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTW 683
+ ++ V+ + ++V G + + E M + + + +
Sbjct: 66 QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPE 124
Query: 684 KQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPD 739
+ I L + + +L IHRD+KPSNIL+ K+ DFG LV
Sbjct: 125 EILGKITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---- 178
Query: 740 GKYSV-ETRLAGTFGYLAPE----YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD 794
S+ +TR AG Y+APE A+ + DV++ G+ L E TGR
Sbjct: 179 ---SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS- 234
Query: 795 DRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELA---GHCTAREPQQRP 850
L + K P L+ EE S C ++ +RP
Sbjct: 235 --------VFDQL---TQVVKGDPPQLSNSEEREFS----PSFINFVNLCLTKDESKRP 278
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 68/323 (21%), Positives = 116/323 (35%), Gaps = 67/323 (20%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
+ + LG G FG VY G A K +E+ + L ++ EI +L H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDYIVEIEILATCDH 75
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V LLG + + ++ E+ P G + + LT Q + + +
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIM----LELDRGLTEPQIQVVCRQMLEALN 131
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG----- 753
+LHS + IHRDLK N+L+ + ++ADFG V + T
Sbjct: 132 FLHS---KRIIHRDLKAGNVLMTLEGDIRLADFG-----------VSAKNLKTLQKRDSF 177
Query: 754 -----YLAPEYAATGRVT-----TKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF 803
++APE + K D+++ G+ L+E + P
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP---------- 227
Query: 804 RRVL--ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD---------- 851
RVL I+K + P + P+ E + + + P+ RP
Sbjct: 228 MRVLLKIAKSDPPTLLTPS-KWSVEFRDFLKI-------ALDKNPETRPSAAQLLEHPFV 279
Query: 852 -MGHAVNVLGPLVEQWKPATRED 873
+ L LV + K E+
Sbjct: 280 SSITSNKALRELVAEAKAEVMEE 302
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 58/274 (21%), Positives = 111/274 (40%), Gaps = 27/274 (9%)
Query: 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTS 127
I+ KS ++ T + L + TLS + I + +L + L +N T
Sbjct: 21 AIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQITD 77
Query: 128 VPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+ LT + L LS NP N++ + S+ TL + + I + P
Sbjct: 78 LA--PLKNLTKITELELSGNPLKNVSA------IAGLQSIKTLDLTSTQITDVTP--LAG 127
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
SNLQ L L N T ++ +++Q L + + Q+ L L+ +++L + N
Sbjct: 128 LSNLQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQV---SDLTPLANLSKLTTLKADDN 183
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305
+ + I L+ +L ++ L++NQ++ V P + + L ++L N + + + +
Sbjct: 184 KISD-ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNL 240
Query: 306 QKVSLDHNNF-----CKNSSDAGKPCDPQVTTLL 334
++ SD G P +T L
Sbjct: 241 VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNL 274
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 48/232 (20%), Positives = 97/232 (41%), Gaps = 21/232 (9%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+L ++ +N+ + A+ + + T++ L NL L L
Sbjct: 15 DPALANAIKIAAGKSNVTD-TVTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELK 71
Query: 146 DNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
DN +LAP L T +T L + + + +++ L L+ T +
Sbjct: 72 DNQITDLAP------LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQIT-DV 122
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
S++Q L+++ Q+ + L+G+T L+ + + Q + + L+ L L
Sbjct: 123 TPLAGLSNLQVLYLDLNQI---TNISPLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTL 178
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNN 314
DN+++ + P + SLP L+ + L+NN++ PL S + V+L +
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQT 228
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-22
Identities = 49/232 (21%), Positives = 92/232 (39%), Gaps = 16/232 (6%)
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
+ +TT+S +G++ T+ + L L L + N I + L N T + ++ L N
Sbjct: 41 DGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPL 97
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+V GL +++ L L+ P L+ L LY+D I + P
Sbjct: 98 KNVSA--IAGLQSIKTLDLTSTQITDVTPLAG-LSN---LQVLYLDLNQITNISP--LAG 149
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+NLQ L + + L S + L +D ++ + L+ + L +V L N
Sbjct: 150 LTNLQYLSIGNAQVS-DLTPLANLSKLTTLKADDNKIS---DISPLASLPNLIEVHLKNN 205
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
Q + + L+ +LF ++L + +T +L + + P
Sbjct: 206 QISD-VSPLANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSGAPIAP 256
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 6e-15
Identities = 57/345 (16%), Positives = 112/345 (32%), Gaps = 106/345 (30%)
Query: 106 IPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165
I + I +N T T L + LS +
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGT----------------GV 53
Query: 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225
TT+ + +NL L L N T D+ L
Sbjct: 54 TTI------------EGVQYLNNLIGLELKDNQIT----------DLAPL---------- 81
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALL 285
+T++ ++ L N + ++ +S+ L L Q+T V P + L L
Sbjct: 82 ------KNLTKITELELSGNPLKN-VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQ 132
Query: 286 NISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
+ L N++ PL + +Q +S+ + QV+ L +A
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNA---------------QVSDLTPLAN------ 171
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404
LS ++ T+ + ++ +ISP A+L +L ++L+ N ++
Sbjct: 172 -LS--------------------KLTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS 208
Query: 405 GPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFI 449
P L ++L + ++N ++ + + +N+ P
Sbjct: 209 DVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVVKGPSG 251
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 48/259 (18%), Positives = 94/259 (36%), Gaps = 58/259 (22%)
Query: 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231
I + PD + +N + +N T ++ + I L + T++ +
Sbjct: 6 PTAINVIFPD--PALANAIKIAAGKSNVTDTVTQADLDG-ITTLSAFGTGVT---TIEGV 59
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ L + L NQ T + L + +L L N L V + L ++ + L +
Sbjct: 60 QYLNNLIGLELKDNQITD-LAPLKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTS 116
Query: 292 NKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
++ PL S +Q + LD N Q+T + +AG L+
Sbjct: 117 TQITDVTPLAGLSNLQVLYLDLN---------------QITNISPLAG-------LT--- 151
Query: 351 EGNNACDGWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409
+ +++ ++ +++P ANL+ L L N ++ I
Sbjct: 152 -----------------NLQYLSIGNAQV--SDLTP-LANLSKLTTLKADDNKISD-IS- 189
Query: 410 GLTKLASLQNLDVSNNNLS 428
L L +L + + NN +S
Sbjct: 190 PLASLPNLIEVHLKNNQIS 208
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 26/141 (18%), Positives = 51/141 (36%), Gaps = 24/141 (17%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+ N+++ IS ++SL L + + N I+ + LAN ++L + L N
Sbjct: 181 DDNKISDIS------------PLASLPNLIEVHLKNNQISD-VSPLANTSNLFIVTLTNQ 227
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
T+ P + L V+ +AP + T Y + L
Sbjct: 228 TITNQPVFYNNNLVVPNVVKGPSGAPIAPATISDNGT--------YASPNLTWNLTSFIN 279
Query: 184 D---SFSNLQNLRLSYNNFTG 201
+ +F+ + + F+G
Sbjct: 280 NVSYTFNQSVTFKNTTVPFSG 300
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 8e-26
Identities = 72/315 (22%), Positives = 121/315 (38%), Gaps = 52/315 (16%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVR 637
FS+ +G G FG VY ++ + +A+K+M S N+ + E+ L K+R
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H + + G + LV EY G+ + L E H PL + + +G+
Sbjct: 113 HPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHK---KPLQEVEIAAVTHGALQGL 167
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
YLHS + IHRD+K NIL+ + K+ DFG + GT ++AP
Sbjct: 168 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAP 219
Query: 758 EYAATGRVTT---KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL--ISKEN 812
E K+DV++ G+ +E + L + L I++
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----------MSALYHIAQNE 269
Query: 813 IPKAIDPNLNLD-EETIESIYRVAELAGHCTAREPQQRPD-----------MGHAVNVLG 860
P + + ++S C + PQ RP V+
Sbjct: 270 SPALQSGHWSEYFRNFVDS----------CLQKIPQDRPTSEVLLKHRFVLRERPPTVIM 319
Query: 861 PLVEQWKPATREDED 875
L+++ K A RE ++
Sbjct: 320 DLIQRTKDAVRELDN 334
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-26
Identities = 63/259 (24%), Positives = 103/259 (39%), Gaps = 50/259 (19%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA------------------- 628
+G+G +GVV D T A+K + + + +
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 629 -----EIAVLTKVRHRHLVALLGYCI----NGSERLLVYEYMPRGTLAQHLFEWHDHGYT 679
EIA+L K+ H ++V L + N +V+E + +G + E
Sbjct: 81 EQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPV----MEVPTLK-- 132
Query: 680 PLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739
PL+ Q D+ +G+EYLH Q IHRD+KPSN+L+G+D K+ADFG+
Sbjct: 133 PLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189
Query: 740 GKYSVETRLAGTFGYLAPEYAATGRVT---TKIDVYAFGVVLMETITGRKALDDTMPDDR 796
+ GT ++APE + R +DV+A GV L + G+ P
Sbjct: 190 SDALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ------CPFMD 242
Query: 797 AHLVTWFRRVLISKENIPK 815
++ ++ P
Sbjct: 243 ERIMCLHSKIKSQALEFPD 261
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 9e-26
Identities = 49/211 (23%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLS----EFQAEIAVL 633
V D + LG G F +V E G + A K ++ E + E+++L
Sbjct: 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSIL 69
Query: 634 TKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALD 692
+V H +++ L N ++ +L+ E + G LF++ L+ ++ +
Sbjct: 70 RQVLHHNVITLHDVYENRTDVVLILELVSGG----ELFDFLAQKES--LSEEEATSFIKQ 123
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGL-VKNAPDGKYSVETR 747
+ GV YLH+ + H DLKP NI++ K+ DFGL + ++
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--- 177
Query: 748 LAGTFGYLAPEYAATGRVTTKIDVYAFGVVL 778
+ GT ++APE + + D+++ GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 208
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-25
Identities = 56/205 (27%), Positives = 85/205 (41%), Gaps = 17/205 (8%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ ++ +LG+G FG V + + AVK + + NK S E+ +L K+
Sbjct: 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD 79
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
H +++ L + S +V E G LF+ + I V G
Sbjct: 80 HPNIMKLFEILEDSSSFYIVGELYTGGE----LFDEIIKRKR--FSEHDAARIIKQVFSG 133
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
+ Y+H + +HRDLKP NIL+ D K+ DFGL GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAY 188
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVL 778
Y+APE G K DV++ GV+L
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVIL 212
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 43/251 (17%), Positives = 89/251 (35%), Gaps = 28/251 (11%)
Query: 60 INCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDI 118
+ + L L + L+ L+ ++ + +P ++ L+ +
Sbjct: 75 LEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETL 132
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNL-------APWPFPNELTKSTSLTTLYMD 171
L N ++P L L+ LS+ P L A E +L +L ++
Sbjct: 133 TLARNPLRALPAS-IASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191
Query: 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG----- 226
I L P + NL++L++ + + +L + + L ++L L G
Sbjct: 192 WTGIRSL-PASIANLQNLKSLKIRNSPLS-ALGPAIHH--LPKL----EELDLRGCTALR 243
Query: 227 TL-DVLSGMTQLRQVWL-HKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPA 283
+ G L+++ L + +P + + L L LR +P+ + LPA
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPA 302
Query: 284 LLNISLQNNKL 294
I + +
Sbjct: 303 NCIILVPPHLQ 313
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 44/226 (19%), Positives = 83/226 (36%), Gaps = 19/226 (8%)
Query: 82 LSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDG-LTNLQ 140
L P L+Q + N + AN+ + Q + D
Sbjct: 25 LRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRV 84
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
L L L FP++ + + L + +D A + L PD F+ L+ L L+ N
Sbjct: 85 ALELRSV-PLPQ--FPDQAFRLSHLQHMTIDAAGLMEL-PDTMQQFAGLETLTLARNPLR 140
Query: 201 GSLPASFAK-SDIQNLWMNDQ--------QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251
+LPAS A + ++ L + L + G+ L+ + L
Sbjct: 141 -ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLP 199
Query: 252 PDLSKCESLFDLSLRDNQLTGVVPASVISLPAL--LNISLQNNKLQ 295
++ ++L L +R++ L+ + ++ LP L L++ L+
Sbjct: 200 ASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLR-GCTALR 243
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 40/231 (17%), Positives = 77/231 (33%), Gaps = 26/231 (11%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATS--LQDIYLDNNNFTSVPTGCFDGLTN 138
+ ++ + + + L +AT + L + P F L++
Sbjct: 47 HSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLPQFPDQAFR-LSH 105
Query: 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN 198
LQ +++ L P+ + + L TL + N +P S + L+ L +
Sbjct: 106 LQHMTIDAA-GLME--LPDTMQQFAGLETLTLAR-NPLRALPASIASLNRLRELSIRACP 161
Query: 199 FTGSLPASFAKSDI-------QNLWMNDQQLGLSGTL-----DVLSGMTQLRQVWLHKNQ 246
LP A +D NL Q L L T ++ + L+ + + +
Sbjct: 162 ELTELPEPLASTDASGEHQGLVNL----QSLRLEWTGIRSLPASIANLQNLKSLKIRNSP 217
Query: 247 FTGPIPDLSKCESLFDLSLRD-NQLTGVVPASVISLPALLNISLQN-NKLQ 295
+ P + L +L LR L P L + L++ + L
Sbjct: 218 LSALGPAIHHLPKLEELDLRGCTALRN-YPPIFGGRAPLKRLILKDCSNLL 267
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-10
Identities = 29/168 (17%), Positives = 56/168 (33%), Gaps = 22/168 (13%)
Query: 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195
+ + L + L P+ + L++ Y + N + +S +N Q +
Sbjct: 11 SSGRENLYFQGSTALR--PYHDVLSQ---WQRHYNADRNRWHSAWRQANS-NNPQIETRT 64
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-----DVLSGMTQLRQVWLHKNQFTGP 250
+ + L L D ++ L+ + +
Sbjct: 65 GRALK-ATADLLEDATQPGR----VALELRSVPLPQFPDQAFRLSHLQHMTIDAAGLME- 118
Query: 251 IPD-LSKCESLFDLSLRDNQLTGVVPASVISLPAL--LNISLQNNKLQ 295
+PD + + L L+L N L +PAS+ SL L L+I +L
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIR-ACPELT 164
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 11/45 (24%), Positives = 21/45 (46%), Gaps = 1/45 (2%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
NL +LK+L ++ + L+ + + L L+ LD+ P
Sbjct: 204 NLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNYPP 247
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 10/58 (17%), Positives = 22/58 (37%), Gaps = 1/58 (1%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGN 446
L+ L L +N L +P + L L+ L + ++P+ ++ +
Sbjct: 125 QFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQG 181
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 3e-05
Identities = 13/65 (20%), Positives = 28/65 (43%), Gaps = 2/65 (3%)
Query: 364 CSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423
+Q + + L + L L+ L+++ + L +PD + + A L+ L ++
Sbjct: 78 ATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGLETLTLA 135
Query: 424 NNNLS 428
N L
Sbjct: 136 RNPLR 140
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 9/45 (20%), Positives = 17/45 (37%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
+L L+ L L+ P A L+ L + + + +P
Sbjct: 227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPL 271
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 12/47 (25%), Positives = 26/47 (55%), Gaps = 1/47 (2%)
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ S + L +L++L L+ + +P + L +L++L + N+ LS
Sbjct: 174 DASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSPLS 219
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 2e-04
Identities = 10/45 (22%), Positives = 19/45 (42%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
LK L L+ + +P + +L L+ LD+ ++P
Sbjct: 251 GRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-25
Identities = 60/272 (22%), Positives = 100/272 (36%), Gaps = 42/272 (15%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140
+L L +L S + ++ P+L + L +++ N TS+P LQ
Sbjct: 95 SLPVLPPGLLELSIFSNPLTHL----PALP--SGLCKLWIFGNQLTSLP----VLPPGLQ 144
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
LS+SDN + P + L L+ N N +P S LQ L +S N
Sbjct: 145 ELSVSDNQLAS---LPALPS---ELCKLWAYN-NQLTSLPM---LPSGLQELSVSDNQLA 194
Query: 201 GSLPASFAKSDIQNLWMNDQQL----GLSGTLDVL-----------SGMTQLRQVWLHKN 245
SLP ++ + LW + +L L L L ++L+++ + N
Sbjct: 195 -SLPTLPSE--LYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPVLPSELKELMVSGN 251
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305
+ T +P L L LS+ NQLT +P S+I L + ++L+ N L ++
Sbjct: 252 RLTS-LPML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREI 307
Query: 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIA 337
+ L A
Sbjct: 308 TSAPGYSGPIIRFDMAGASAPRETRALHLAAA 339
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-23
Identities = 71/377 (18%), Positives = 141/377 (37%), Gaps = 84/377 (22%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYL 120
C N+ +++ +SGL+ TL + + TL NN+ ++P+ L+ + +
Sbjct: 36 ACLNNG-NAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLT-SLPA--LPPELRTLEV 88
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
N TS+P GL L + S +L P + L L++ N +P
Sbjct: 89 SGNQLTSLPVL-PPGLLELSIFSNPLT-HLPALP--------SGLCKLWIFG-NQLTSLP 137
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
LQ L +S N SLPA ++ + LW + QL + + L+++
Sbjct: 138 V---LPPGLQELSVSDNQLA-SLPALPSE--LCKLWAYNNQLT-----SLPMLPSGLQEL 186
Query: 241 WLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300
+ NQ +P L L+ L +N+LT +PA L + + N+L P+
Sbjct: 187 SVSDNQLAS-LPTLP--SELYKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPV 238
Query: 301 FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360
PS+++++ + N ++T+L P +
Sbjct: 239 LPSELKELMVSGN---------------RLTSL---------PMLP-------------- 260
Query: 361 FVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420
++++++ L + + +L+S + L+ N L+ L ++ S
Sbjct: 261 ------SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGY 313
Query: 421 DVSNNNLSGKVPDFGSN 437
S + + +
Sbjct: 314 --SGPIIRFDMAGASAP 328
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 83.4 bits (206), Expect = 1e-16
Identities = 68/340 (20%), Positives = 117/340 (34%), Gaps = 97/340 (28%)
Query: 98 QMNNIAGAIPSLANA--TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPF 155
+ A + + + + + T++P ++ L + DN
Sbjct: 23 ESRGRAAVVQKMRACLNNGNAVLNVGESGLTTLPDC---LPAHITTLVIPDN-------- 71
Query: 156 PNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNL 215
+LT+L P L+ L +S N T SLP + L
Sbjct: 72 --------NLTSL-----------PA---LPPELRTLEVSGNQLT-SLPVLP--PGLLEL 106
Query: 216 WMNDQQLGLSGT-LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVV 274
T L L + L ++W+ NQ T +P L L +LS+ DNQL +
Sbjct: 107 ----SIFSNPLTHLPAL--PSGLCKLWIFGNQLTS-LPVL--PPGLQELSVSDNQLA-SL 156
Query: 275 PASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLL 334
PA L + NN+L P+ PS +Q++S+ N Q+ +L
Sbjct: 157 PA---LPSELCKLWAYNNQLTS-LPMLPSGLQELSVSDN---------------QLASL- 196
Query: 335 QIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITI-----NLANKLLAGN-ISPAYA 388
P + S + R+ ++ L +++GN ++
Sbjct: 197 --------PTLPS----------ELYKLWAYNNRLTSLPALPSGLKELIVSGNRLTSLPV 238
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ LK L + N LT +P + L +L V N L+
Sbjct: 239 LPSELKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLT 274
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 50.3 bits (120), Expect = 3e-06
Identities = 34/191 (17%), Positives = 58/191 (30%), Gaps = 15/191 (7%)
Query: 87 SSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ L +LS N + +P SL + +S + L+ N + +T+ S
Sbjct: 258 MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGP 316
Query: 146 DN-PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSL 203
++A P E ++ A P D + F N +++ F L
Sbjct: 317 IIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWHMFGQEDNAD-AFSLFLDRL 375
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
+ +S L L+ LR N F S CE
Sbjct: 376 SETENFIKDAGFKAQ-----ISSWLAQLAEDEALRA-----NTFAMATEATSSCEDRVTF 425
Query: 264 SLRDNQLTGVV 274
L + +V
Sbjct: 426 FLHQMKNVQLV 436
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-25
Identities = 59/226 (26%), Positives = 104/226 (46%), Gaps = 27/226 (11%)
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQ 627
++++V + + + + LG G F VY + +A+K ++ + G++
Sbjct: 1 MALDVKSRA-KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGIN-RT 58
Query: 628 A--EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ 685
A EI +L ++ H +++ LL + S LV+++M L + LT
Sbjct: 59 ALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETD-LEVII----KDNSLVLTPSH 113
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS 743
L +G+EYLH +HRDLKP+N+L+ ++ K+ADFGL +P+ Y+
Sbjct: 114 IKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYT 170
Query: 744 --VETRLAGTFGYLAPE--YAATGRVTTKIDVYAFGVVLMETITGR 785
V TR Y APE + A +D++A G +L E +
Sbjct: 171 HQVVTRW-----YRAPELLFGAR-MYGVGVDMWAVGCILAELLLRV 210
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME------SNTMGNKGLSEFQAE 629
++ + +++GRG VV G + AVK ME S + + E
Sbjct: 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRE 149
Query: 630 IAVLTKVR-HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRV 687
+L +V H H++ L+ + S LV++ M +G L F++ + L+ K+
Sbjct: 150 THILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVA--LSEKETR 203
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
+I + V +LH+ + +HRDLKP NIL+ D+M+ +++DFG + G+
Sbjct: 204 SIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE--KLRE 258
Query: 748 LAGTFGYLAPE------YAATGRVTTKIDVYAFGVVL 778
L GT GYLAPE ++D++A GV+L
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 3e-25
Identities = 59/251 (23%), Positives = 100/251 (39%), Gaps = 24/251 (9%)
Query: 537 GNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEA----NILGRG 592
+ ++G + L+ QS V+ ++ + D S+ + LGRG
Sbjct: 5 HHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRG 64
Query: 593 GFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651
+VY + A+K ++ + EI VL ++ H +++ L
Sbjct: 65 ATSIVYRCKQKGTQKPYALKVLKKT----VDKKIVRTEIGVLLRLSHPNIIKLKEIFETP 120
Query: 652 SERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIH 710
+E LV E + G LF+ + GY + + + V YLH +H
Sbjct: 121 TEISLVLELVTGG----ELFDRIVEKGY--YSERDAADAVKQILEAVAYLHE---NGIVH 171
Query: 711 RDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTT 767
RDLKP N+L D K+ADFGL K + + GT GY APE
Sbjct: 172 RDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPEILRGCAYGP 229
Query: 768 KIDVYAFGVVL 778
++D+++ G++
Sbjct: 230 EVDMWSVGIIT 240
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 25/217 (11%)
Query: 575 VLRQ--VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLS----EFQ 627
V RQ V D + LG G F VV E G + A K ++ + + +
Sbjct: 3 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 62
Query: 628 AEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQR 686
E+++L +++H +++ L N ++ +L+ E + G LF++ + LT ++
Sbjct: 63 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGG----ELFDFLAEKES--LTEEEA 116
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGL-VKNAPDGK 741
+ GV YLHSL H DLKP NI++ R K+ DFGL K +
Sbjct: 117 TEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE 173
Query: 742 YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVL 778
+ + GT ++APE + + D+++ GV+
Sbjct: 174 FKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVIT 207
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 57/214 (26%), Positives = 89/214 (41%), Gaps = 22/214 (10%)
Query: 575 VLRQVTDNFSEA----NILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSE-FQA 628
++ T FS+ +LG+G FG V + G + AVK + + K E
Sbjct: 16 FVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLR 75
Query: 629 EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRV 687
E+ +L ++ H +++ L + + LV E G L F+ +
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKR--FSEVDAA 129
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSV 744
I V G+ Y+H +HRDLKP N+L+ D ++ DFGL + K
Sbjct: 130 RIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK--K 184
Query: 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVL 778
GT Y+APE G K DV++ GV+L
Sbjct: 185 MKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVIL 217
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 52/224 (23%), Positives = 98/224 (43%), Gaps = 39/224 (17%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + +G G +G V+ +A+K R++ + +G+ A EI +L +
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD---EGVP-SSALREICLLKE 57
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
++H+++V L + + LV+E+ + L ++ D L + + + +
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYF----DSCNGDLDPEIVKSFLFQLLK 112
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
G+ + HS ++ +HRDLKP N+LI + K+A+FGL P YS V T
Sbjct: 113 GLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLW--- 166
Query: 752 FGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGRKAL 788
Y P+ Y +T ID+++ G + E + L
Sbjct: 167 --YRPPDVLFGAKLY------STSIDMWSAGCIFAELANAGRPL 202
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 58/217 (26%), Positives = 89/217 (41%), Gaps = 22/217 (10%)
Query: 574 EVLRQVTDNFSE-----ANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQ 627
+ Q +NF+ + LGRG F VV G + A K ++ G +E
Sbjct: 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEIL 76
Query: 628 AEIAVLTKVRHR-HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQ 685
EIAVL + ++ L N SE +L+ EY G + F ++
Sbjct: 77 HEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSLCLPELAEMVSEND 132
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGL-VKNAPDGK 741
+ + + GV YLH + +H DLKP NIL+ K+ DFG+ K +
Sbjct: 133 VIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189
Query: 742 YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVL 778
+ GT YLAPE +TT D++ G++
Sbjct: 190 LRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIA 223
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 54/205 (26%), Positives = 84/205 (40%), Gaps = 31/205 (15%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA----EIAVLTKVRHR--HL 641
LG GGFG VY G + D +A+K +E + + + G E+ +L KV +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARGVEYL 700
+ LL + +L+ E P Q LF++ + G L + + V V +
Sbjct: 111 IRLLDWFERPDSFVLILER-PEP--VQDLFDFITERG--ALQEELARSFFWQVLEAVRHC 165
Query: 701 HSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE- 758
H+ +HRD+K NILI + K+ DFG D Y+ GT Y PE
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD---FDGTRVYSPPEW 219
Query: 759 -----YAATGRVTTKIDVYAFGVVL 778
Y V++ G++L
Sbjct: 220 IRYHRYHG-----RSAAVWSLGILL 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 8e-25
Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 578 QVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+ T+ + LG+G F VV ++ G + A + + + + + + E + +
Sbjct: 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVAR 695
+H ++V L L+++ + G LFE Y + +
Sbjct: 68 KHPNIVRLHDSISEEGHHYLIFDLVTGG----ELFEDIVAREY--YSEADASHCIQQILE 121
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTF 752
V + H +HR+LKP N+L+ K+ADFGL + + AGT
Sbjct: 122 AVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTP 177
Query: 753 GYLAPEYAATGRVTTKIDVYAFGVVL 778
GYL+PE +D++A GV+L
Sbjct: 178 GYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 9e-25
Identities = 65/308 (21%), Positives = 115/308 (37%), Gaps = 43/308 (13%)
Query: 552 SQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAV 610
S SSG + G I ++ +G G G V+ G IAV
Sbjct: 3 SGSSGKQTGYLTIGGQRYQAEI-------NDLENLGEMGSGTCGQVWKMRFRKTGHVIAV 55
Query: 611 KRMESNTMGNKGLSEFQAEIAVLTK-VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQH 669
K+M + + ++ V+ K ++V G I ++ + E M
Sbjct: 56 KQMRRSG-NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAE--- 111
Query: 670 LFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729
+ G P+ + + + + + + YL + IHRD+KPSNIL+ + + K+
Sbjct: 112 KLKKRMQG--PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLC 167
Query: 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPE-----YAATGRVTTKIDVYAFGVVLMETITG 784
DFG+ D K + R AG Y+APE + DV++ G+ L+E TG
Sbjct: 168 DFGISGRLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATG 225
Query: 785 RKALDDTMPDDRAHLVTWFRRVL--ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCT 842
+ + D VL + +E P ++ + + C
Sbjct: 226 QFPYKNCKTD---------FEVLTKVLQEEPPLL-PGHMGFSGDFQSFV-------KDCL 268
Query: 843 AREPQQRP 850
++ ++RP
Sbjct: 269 TKDHRKRP 276
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-24
Identities = 45/207 (21%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
+++ + + A LGRG FG+V+ E K ++ + EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVA 694
RHR+++ L + E ++++E++ + FE + + L ++ V+ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFE-LNEREIVSYVHQVC 112
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGL-VKNAPDGKYSVETRLAGT 751
+++LHS + H D++P NI+ K+ +FG + P + + L
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTA 166
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVL 778
Y APE V+T D+++ G ++
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLV 193
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 50/205 (24%), Positives = 83/205 (40%), Gaps = 19/205 (9%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ ++ N +GRG +G V + + A K++ + + + F+ EI ++ +
Sbjct: 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV--EDVDRFKQEIEIMKSLD 64
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARG 696
H +++ L + ++ LV E G LFE I DV
Sbjct: 65 HPNIIRLYETFEDNTDIYLVMELCTGG----ELFERVVHKRV--FRESDAARIMKDVLSA 118
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
V Y H + HRDLKP N L D K+ DFGL GK + GT
Sbjct: 119 VAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK--MMRTKVGTPY 173
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVL 778
Y++P+ G + D ++ GV++
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMM 197
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 42/198 (21%), Positives = 77/198 (38%), Gaps = 12/198 (6%)
Query: 588 ILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQA---EIAVLTKVRHRHLVA 643
++G+G F VV G + AVK ++ + + E ++ ++H H+V
Sbjct: 31 VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL 703
LL + +V+E+M L + + + + + Y H
Sbjct: 91 LLETYSSDGMLYMVFEFMDGADLCFEIVK-RADAGFVYSEAVASHYMRQILEALRYCHD- 148
Query: 704 AQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+ IHRD+KP +L+ + K+ FG+ + R GT ++APE
Sbjct: 149 --NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFMAPEVV 205
Query: 761 ATGRVTTKIDVYAFGVVL 778
+DV+ GV+L
Sbjct: 206 KREPYGKPVDVWGCGVIL 223
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 21/215 (9%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK-VRH 638
D+ LGRG +GVV +P G +AVKR+ + T+ ++ ++ + + V
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRA-TVNSQEQKRLLMDLDISMRTVDC 65
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
V G + + E M +L + + D G + IA+ + + +E
Sbjct: 66 PFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKG-QTIPEDILGKIAVSIVKALE 123
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG----LVKNAPDGKYSVETRLAGTFGY 754
+LHS + S IHRD+KPSN+LI + K+ DFG LV + + AG Y
Sbjct: 124 HLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD------VAKDIDAGCKPY 175
Query: 755 LAPE----YAATGRVTTKIDVYAFGVVLMETITGR 785
+APE + K D+++ G+ ++E R
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 58/209 (27%), Positives = 85/209 (40%), Gaps = 36/209 (17%)
Query: 90 TQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ L Q N + + A L T L+ +YL++N ++P G F L NL+ L ++
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRL---TKLRLLYLNDNKLQTLPAGIFKELKNLETLWVT 93
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205
DN L P + +L L +D + L P FDS + L L L YN SLP
Sbjct: 94 DN-KLQALP-IGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPK 150
Query: 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDL 263
V +T L+++ L+ NQ +P+ K L L
Sbjct: 151 -----------------------GVFDKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTL 186
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNN 292
L +NQL V + SL L + LQ N
Sbjct: 187 KLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 7e-19
Identities = 45/158 (28%), Positives = 66/158 (41%), Gaps = 14/158 (8%)
Query: 69 TTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNF 125
+ L + L TL I L LETL N + A+P +L ++ LD N
Sbjct: 64 RLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQL 121
Query: 126 TSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
S+P FD LT L LSL N +L F K TSL L + N + + F
Sbjct: 122 KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVF----DKLTSLKELRLYNNQLKRVPEGAF 177
Query: 184 DSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQNLWMND 219
D + L+ L+L N +P +F ++ L + +
Sbjct: 178 DKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQE 214
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-18
Identities = 49/211 (23%), Positives = 80/211 (37%), Gaps = 64/211 (30%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ + L +N +S+P+ F LT L++L L+DN L TL
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDN----------------KLQTLP--- 77
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
F NL+ L ++ N +LP V
Sbjct: 78 -------AGIFKELKNLETLWVTDNKLQ-ALPI-----------------------GVFD 106
Query: 233 GMTQLRQVWLHKNQFTGPIPD-----LSKCESLFDLSLRDNQLTGVVPASVI-SLPALLN 286
+ L ++ L +NQ +P L+K L LSL N+L +P V L +L
Sbjct: 107 QLVNLAELRLDRNQLKS-LPPRVFDSLTK---LTYLSLGYNELQ-SLPKGVFDKLTSLKE 161
Query: 287 ISLQNNKLQG-PYPLFP--SKVQKVSLDHNN 314
+ L NN+L+ P F ++++ + LD+N
Sbjct: 162 LRLYNNQLKRVPEGAFDKLTELKTLKLDNNQ 192
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 24/63 (38%), Positives = 32/63 (50%), Gaps = 3/63 (4%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
LT L+ L N + +P A T L+ + LDNN VP G FD L L++L L
Sbjct: 155 KLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQ 213
Query: 146 DNP 148
+NP
Sbjct: 214 ENP 216
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 52/247 (21%), Positives = 87/247 (35%), Gaps = 74/247 (29%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
++ + L L N + SLP+ +T+LR ++L+ N
Sbjct: 36 PADTKKLDLQSNKLS-SLPSK-----------------------AFHRLTKLRLLYLNDN 71
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQNNKLQG-PYPLF 301
+ +P + ++L L + DN+L +P V L L + L N+L+ P +F
Sbjct: 72 KLQT-LPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVF 129
Query: 302 PS--KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGW 359
S K+ +SL +N ++ +L P D
Sbjct: 130 DSLTKLTYLSLGYN---------------ELQSL---------PK---------GVFDK- 155
Query: 360 PFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQ 418
+ + L N L A+ LT LK L L N L +P+G L L+
Sbjct: 156 ------LTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLK 208
Query: 419 NLDVSNN 425
L + N
Sbjct: 209 MLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 37/171 (21%), Positives = 60/171 (35%), Gaps = 47/171 (27%)
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP--SKVQKVSLDHNNFCKNS 319
L L+ N+L+ + + L L + L +NKLQ P +F ++ + + N +
Sbjct: 42 LDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKL--QA 99
Query: 320 SDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL 379
G L+ L N+L
Sbjct: 100 LPIGVFDQLVNLAELR----------LDR---------------------------NQLK 122
Query: 380 AGNISP-AYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNLS 428
+ + P + +LT L L L N L +P G+ KL SL+ L + NN L
Sbjct: 123 S--LPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTSLKELRLYNNQLK 170
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 40/221 (18%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTKV 636
+ + + +G G +GVVY + G +A+K R+++ G A EI++L ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG----IPSTAIREISLLKEL 76
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H ++V+L+ I+ L LV+E+M + L + L D T L Q + R
Sbjct: 77 HHPNIVSLID-VIHSERCLTLVFEFMEKD-LKKVL----DENKTGLQDSQIKIYLYQLLR 130
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
GV + H +HRDLKP N+LI D K+ADFGL P Y+ V T
Sbjct: 131 GVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW--- 184
Query: 752 FGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
Y AP+ Y +T +D+++ G + E ITG+
Sbjct: 185 --YRAPDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 29/217 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
++F ILG G F V ++ A+K +E + + + E V++++ H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
V L + E+L Y G L +++ ++ + R
Sbjct: 90 PFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-------------RKIGSFDETCTRFY 135
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-L 748
+EYLH IHRDLKP NIL+ +DM ++ DFG K
Sbjct: 136 TAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
GT Y++PE D++A G ++ + + G
Sbjct: 193 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 56/251 (22%), Positives = 97/251 (38%), Gaps = 41/251 (16%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVALL 645
LG G +G V + AVK ++ + E EI +L ++RH++++ L+
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 646 GYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-------- 695
N ++ +V EY G Q + + R + A
Sbjct: 73 DVLYNEEKQKMYMVMEYCVCGM--QEMLDSVPEK--------RFPV--CQAHGYFCQLID 120
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA---GTF 752
G+EYLHS Q +H+D+KP N+L+ K++ G+ A ++ + G+
Sbjct: 121 GLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVA-EALH-PFAADDTCRTSQGSP 175
Query: 753 GYLAPEYAATGRV--TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810
+ PE A K+D+++ GV L TG P + ++ F +
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL------YPFEGDNIYKLFENIGKGS 229
Query: 811 ENIPKAIDPNL 821
IP P L
Sbjct: 230 YAIPGDCGPPL 240
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-24
Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 582 NFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
S+ ILG G FG V+ E G K+A K + T G K E + EI+V+ ++ H +
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKII--KTRGMKDKEEVKNEISVMNQLDHAN 147
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVARGVEY 699
L+ L + ++ +LV EY+ G LF+ D Y LT + + G+ +
Sbjct: 148 LIQLYDAFESKNDIVLVMEYVDGG----ELFDRIIDESYN-LTELDTILFMKQICEGIRH 202
Query: 700 LHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGL-VKNAPDGKYSVETRLAGTFGYLA 756
+H +H DLKP NIL D + K+ DFGL + P K V GT +LA
Sbjct: 203 MHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLA 256
Query: 757 PEYAATGRVTTKIDVYAFGVVL 778
PE V+ D+++ GV+
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIA 278
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 48/246 (19%), Positives = 77/246 (31%), Gaps = 39/246 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLT--QLETLSFQMNNIAGAIPSLAN-----ATSLQ 116
+ + ++L ++GT P + T L L+ + + A LA L+
Sbjct: 93 GISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLK 152
Query: 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKS--TSLTTLYMDNAN 174
+ + + + L L LSDNP L + L +L L + NA
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 175 ---IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231
G+ + LQ L LS+N+ + A
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPS-----------------------C 249
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+QL + L L L L L N+L S LP + N+SL+
Sbjct: 250 DWPSQLNSLNLSFTGLKQVPKGLPA--KLSVLDLSYNRLDRNP--SPDELPQVGNLSLKG 305
Query: 292 NKLQGP 297
N
Sbjct: 306 NPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 55/304 (18%), Positives = 87/304 (28%), Gaps = 53/304 (17%)
Query: 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA--GAIPSLANA 112
C ++ D S+ + A L G LE L +++ A G + +
Sbjct: 15 CNFSDPKPDWSSAFNCLGAADVELYG-------GGRSLEYLLKRVDTEADLGQFTDIIKS 67
Query: 113 TSLQDIYLDNNNFTSVPTGC---FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169
SL+ + + S G++ LQ L+L + P P L L
Sbjct: 68 LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127
Query: 170 MDNANIFGLIPDFFDSFS----------------------------NLQNLRLSYNNFTG 201
+ N + + L L LS N G
Sbjct: 128 LRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 202 SLPASFAK-----SDIQNLWMNDQQL-GLSGTL-DVLSGMTQLRQVWLHKNQFTGPIPDL 254
A +Q L + + + SG + + QL+ + L N
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
Query: 255 --SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFPSKVQKVSLD 311
L L+L L V L + L N+L P P +V +SL
Sbjct: 248 SCDWPSQLNSLNLSFTGLKQVPKG---LPAKLSVLDLSYNRLDRNPSPDELPQVGNLSLK 304
Query: 312 HNNF 315
N F
Sbjct: 305 GNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 4e-15
Identities = 56/320 (17%), Positives = 94/320 (29%), Gaps = 60/320 (18%)
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD- 181
N + + G +L+ L + F ++ KS SL L + A I I
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFT-DIIKSLSLKRLTVRAARIPSRILFG 87
Query: 182 --FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
S LQ L L TG+ P ++ +L + + L ++
Sbjct: 88 ALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN-----------LRNVS---- 132
Query: 240 VWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299
W ++ + + K L LS+ V PAL + L +N G
Sbjct: 133 -WATRDAWLAELQQWLK-PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG 190
Query: 300 LFPSKVQKV--SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD 357
L + +L + +
Sbjct: 191 LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARV---------------------- 228
Query: 358 GWPFVTCSQGRIITINLA-NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS 416
++ ++L+ N L +P+ + L +L L L +P GL A
Sbjct: 229 ----------QLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGL--PAK 275
Query: 417 LQNLDVSNNNLSGKVPDFGS 436
L LD+S N L P
Sbjct: 276 LSVLDLSYNRLDR-NPSPDE 294
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 44/272 (16%), Positives = 89/272 (32%), Gaps = 38/272 (13%)
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
N PD+ +F+ L + SL + D + + LS
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVD-----TEADLGQFTDIIKSLS- 69
Query: 234 MTQLRQVWLHKNQFTGPIPD----LSKCESLFDLSLRDNQLTGVVPASVISL--PALLNI 287
L+++ + + I + L +L+L + ++TG P ++ P L +
Sbjct: 70 ---LKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNIL 126
Query: 288 SLQNNKLQGPYPLFPS-------KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340
+L+N ++ +S+ + S + + P ++TL D+
Sbjct: 127 NLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVF-PALSTL-----DL 180
Query: 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLAN---KLLAGNISPAYANLTSLKNLY 397
L + + C + + L N + +G S A L+ L
Sbjct: 181 SDNPELGERGLISALCPLKF------PTLQVLALRNAGMETPSGVCSALAAARVQLQGLD 234
Query: 398 LQQNNLTG-PIPDGLTKLASLQNLDVSNNNLS 428
L N+L + L +L++S L
Sbjct: 235 LSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK 266
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 23/113 (20%), Positives = 42/113 (37%), Gaps = 8/113 (7%)
Query: 14 VLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISL 73
VL L + S + LQ L D S S +CD +++ +++L
Sbjct: 205 VLALRNAGMETPSGVCSALAAARVQLQGL--DLSHNSLRDAAG--APSCDWPSQLNSLNL 260
Query: 74 AKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFT 126
+ +GL + + + +L L N + PS + ++ L N F
Sbjct: 261 SFTGLK-QVPKGLPA--KLSVLDLSYNRLDR-NPSPDELPQVGNLSLKGNPFL 309
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 579 VTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V D++ LG G FGVV+ E G A K + + +K + EI ++ +R
Sbjct: 155 VLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVLR 212
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H LV L + +E +++YE+M G L + + + H+ ++ + V V +G+
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK----MSEDEAVEYMRQVCKGL 268
Query: 698 EYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGL-VKNAPDGKYSVETRLAGTFGY 754
++H +++H DLKP NI+ K+ DFGL P V GT +
Sbjct: 269 CHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEF 322
Query: 755 LAPEYAATGRVTTKIDVYAFGVVL 778
APE A V D+++ GV+
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLS 346
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 75/272 (27%), Positives = 117/272 (43%), Gaps = 56/272 (20%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG G FG V GE G K+AVK + + + + + EI L RH H++ L
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVE 698
++ +V EY+ G L ++ + RV AR V+
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYICK-----------HGRVEE--MEARRLFQQILSAVD 125
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y H +HRDLKP N+L+ M AK+ADFGL DG++ + T G+ Y APE
Sbjct: 126 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS-CGSPNYAAPE 180
Query: 759 ------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812
YA ++D+++ GV+L + G +P D H+ T F+++
Sbjct: 181 VISGRLYAG-----PEVDIWSCGVILYALLCGT------LPFDDEHVPTLFKKIRGGVFY 229
Query: 813 IPKAIDPN--------LNLDEE---TIESIYR 833
IP+ ++ + L +D TI+ I
Sbjct: 230 IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE 261
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-24
Identities = 63/258 (24%), Positives = 105/258 (40%), Gaps = 42/258 (16%)
Query: 547 PSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDG 605
PS S D R ++++ ++G G FGVVY +L G
Sbjct: 20 PSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSG 79
Query: 606 TKIAVKRMESNTMGNKGLSEFQA-EIAVLTKVRHRHLVALLGYCINGSERL------LVY 658
+A+K++ + F+ E+ ++ K+ H ++V L + + E+ LV
Sbjct: 80 ELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVL 132
Query: 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNI 718
+Y+P T+ + + L + R + Y+HS HRD+KP N+
Sbjct: 133 DYVPE-TVYRVA-RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNL 187
Query: 719 LIGDDMRA-KVADFGLVKNAPDGKYSVE---TRLAGTFGYLAPE-------YAATGRVTT 767
L+ D K+ DFG K G+ +V +R Y APE Y T+
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY-----YRAPELIFGATDY------TS 236
Query: 768 KIDVYAFGVVLMETITGR 785
IDV++ G VL E + G+
Sbjct: 237 SIDVWSAGCVLAELLLGQ 254
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 31/266 (11%), Positives = 69/266 (25%), Gaps = 56/266 (21%)
Query: 589 LGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKG-LSEFQAEIAVLTKVRHRHLVAL 644
G + D ++A+ ++ + L E + L+++ + +
Sbjct: 39 HGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV 96
Query: 645 LGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA 704
L + L+V E++ G+L + D +P + +A + H
Sbjct: 97 LDVVHTRAGGLVVAEWIRGGSLQEVA----DTSPSP---VGAIRAMQSLAAAADAAH--- 146
Query: 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR 764
+ PS + + D +A +
Sbjct: 147 RAGVALSIDHPSRVRVSIDGDVVLAY---------------------PATMPDANPQD-- 183
Query: 765 VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLD 824
D+ G L + R L + R + P ID ++
Sbjct: 184 -----DIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAGQPIEPADIDRDIPFQ 235
Query: 825 EETIESIYRVAELAGHCTAREPQQRP 850
++ +A + R
Sbjct: 236 ---------ISAVAARSVQGDGGIRS 252
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 57/243 (23%)
Query: 569 VAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQA 628
+A + Q ++ ++G G FGVV+ +L + ++A+K++ + F+
Sbjct: 28 LASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KRFKN 80
Query: 629 -EIAVLTKVRHRHLVALLGYCINGSERL------LVYEYMPRGTLAQHLFEWHDHGYTPL 681
E+ ++ V+H ++V L + + ++ LV EY+P T+ + H
Sbjct: 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRAS----RH----- 130
Query: 682 TWKQRVTIALD--------VARGVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFG 732
K + T+ + + R + Y+HS+ HRD+KP N+L+ K+ DFG
Sbjct: 131 YAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFG 187
Query: 733 LVKNAPDGKYSVE---TRLAGTFGYLAPE-------YAATGRVTTKIDVYAFGVVLMETI 782
K G+ +V +R Y APE Y TT ID+++ G V+ E +
Sbjct: 188 SAKILIAGEPNVSYICSRY-----YRAPELIFGATNY------TTNIDIWSTGCVMAELM 236
Query: 783 TGR 785
G+
Sbjct: 237 QGQ 239
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 3e-24
Identities = 41/186 (22%), Positives = 67/186 (36%), Gaps = 17/186 (9%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
++L N + T L L+L L TL + +
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD----GTLPVLGTLDLSH 86
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQLGLSGTL-- 228
N +P + L L +S+N T SLP ++Q L++ +L TL
Sbjct: 87 -NQLQSLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNEL---KTLPP 141
Query: 229 DVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286
+L+ +L ++ L N T +P L+ E+L L L++N L +P L
Sbjct: 142 GLLTPTPKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPF 199
Query: 287 ISLQNN 292
L N
Sbjct: 200 AFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-23
Identities = 57/213 (26%), Positives = 90/213 (42%), Gaps = 19/213 (8%)
Query: 108 SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167
++ S ++ D N T++P + +L LS+N L + L T LT
Sbjct: 5 EVSKVASHLEVNCDKRNLTALPPDLP---KDTTILHLSEN-LLYTFS-LATLMPYTRLTQ 59
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQL-GLS 225
L +D A + L + L L LS+N SLP + L ++ +L L
Sbjct: 60 LNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLP 116
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVI-SLP 282
L L G+ +L++++L N+ +P L+ L LSL +N LT +PA ++ L
Sbjct: 117 --LGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLE 172
Query: 283 ALLNISLQNNKLQG-PYPLFPS-KVQKVSLDHN 313
L + LQ N L P F S + L N
Sbjct: 173 NLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 37/138 (26%), Positives = 56/138 (40%), Gaps = 6/138 (4%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSL-ANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVL 142
+L L TL N + ++P L +L + + N TS+P G GL LQ L
Sbjct: 71 QVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQEL 129
Query: 143 SLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202
L N L P P LT + L L + N N+ L + NL L L N+ +
Sbjct: 130 YLKGN-ELKTLP-PGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 203 LPAS-FAKSDIQNLWMND 219
+P F + +++
Sbjct: 187 IPKGFFGSHLLPFAFLHG 204
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 6e-13
Identities = 51/244 (20%), Positives = 84/244 (34%), Gaps = 53/244 (21%)
Query: 187 SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
++ + N T +LP D L +++ L + +L L T+L Q+ L + +
Sbjct: 10 ASHLEVNCDKRNLT-ALPPDLP-KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAE 66
Query: 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLF--PS 303
T + L L L NQL +P +LPAL + + N+L P
Sbjct: 67 LTK-LQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363
++Q++ L N ++ TL P P +
Sbjct: 125 ELQELYLKGN---------------ELKTL---------PP---------GLLTPTPKLE 151
Query: 364 CSQGRIITINLA-NKLLAGNISP-AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLD 421
++LA N L + L +L L LQ+N+L IP G L
Sbjct: 152 -------KLSLANNNLTE--LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAF 201
Query: 422 VSNN 425
+ N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 18/64 (28%), Positives = 28/64 (43%), Gaps = 4/64 (6%)
Query: 87 SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
+ +LE LS NN+ +P+ L +L + L N+ ++P G F L L
Sbjct: 145 TPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFG-SHLLPFAFL 202
Query: 145 SDNP 148
NP
Sbjct: 203 HGNP 206
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 42/203 (20%), Positives = 64/203 (31%), Gaps = 57/203 (28%)
Query: 235 TQLRQVWLHKNQFTG-PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
+ L +N + L L L+L +LT + +LP L + L +N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVDG-TLPVLGTLDLSHNQ 88
Query: 294 LQGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
LQ L + + + N ++T+L P
Sbjct: 89 LQSLPLLGQTLPALTVLDVSFN---------------RLTSL---------PL------- 117
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGN----ISP-AYANLTSLKNLYLQQNNLTGP 406
A G L L GN + P L+ L L NNLT
Sbjct: 118 --GALRGLG------------ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE- 162
Query: 407 IPDGL-TKLASLQNLDVSNNNLS 428
+P GL L +L L + N+L
Sbjct: 163 LPAGLLNGLENLDTLLLQENSLY 185
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 39/204 (19%), Positives = 71/204 (34%), Gaps = 56/204 (27%)
Query: 232 SGMTQLRQVWLHKNQFTG-P--IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNIS 288
S + +V K T P +P + L L +N L A+++ L ++
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLP-----KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 289 LQNNKLQGPYPLFP--SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL 346
L +L + + + L HN Q+ +L
Sbjct: 62 LDRAELTKL-QVDGTLPVLGTLDLSHN---------------QLQSL------------- 92
Query: 347 SDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP-AYANLTSLKNLYLQQNNLTG 405
P + + + ++++ L ++ A L L+ LYL+ N L
Sbjct: 93 -------------PLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELKT 138
Query: 406 PIPDGL-TKLASLQNLDVSNNNLS 428
+P GL T L+ L ++NNNL+
Sbjct: 139 -LPPGLLTPTPKLEKLSLANNNLT 161
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 57/214 (26%), Positives = 87/214 (40%), Gaps = 47/214 (21%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA----EIAVLTKVR----HR 639
LG+GGFG V+ G L D ++A+K + N + E+A+L KV H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR---- 695
++ LL + +LV E Q LF++ +T K + +R
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA---QDLFDY-------ITEKGPLG--EGPSRCFFG 146
Query: 696 ----GVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
+++ HS + +HRD+K NILI AK+ DFG D Y+ G
Sbjct: 147 QVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD---FDG 200
Query: 751 TFGYLAPE------YAATGRVTTKIDVYAFGVVL 778
T Y PE Y A V++ G++L
Sbjct: 201 TRVYSPPEWISRHQYHA-----LPATVWSLGILL 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 9e-24
Identities = 53/257 (20%), Positives = 87/257 (33%), Gaps = 49/257 (19%)
Query: 568 NVAISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEF 626
N+ L ++ + +G+G +GVV E A+K M N + +
Sbjct: 13 NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72
Query: 627 QA---EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTL----------------- 666
+ E+ ++ K+ H ++ L + LV E G L
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 667 ------------------AQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ + + K I + + YLH+ Q
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGI 189
Query: 709 IHRDLKPSNILIGDDMRA--KVADFGL---VKNAPDGKYSVETRLAGTFGYLAPE--YAA 761
HRD+KP N L + K+ DFGL +G+Y T AGT ++APE
Sbjct: 190 CHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTT 249
Query: 762 TGRVTTKIDVYAFGVVL 778
K D ++ GV+L
Sbjct: 250 NESYGPKCDAWSAGVLL 266
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 1e-23
Identities = 60/222 (27%), Positives = 91/222 (40%), Gaps = 41/222 (18%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + + +G G +GVV+ G +A+K + + A EI +L +
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPV----IKKIALREIRMLKQ 58
Query: 636 VRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
++H +LV LL RL LV+EY T+ L + + G K +I
Sbjct: 59 LKHPNLVNLLE-VFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVK---SITWQTL 112
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAG 750
+ V + H + IHRD+KP NILI K+ DFG + P Y V TR
Sbjct: 113 QAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRW-- 167
Query: 751 TFGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
Y +PE Y +DV+A G V E ++G
Sbjct: 168 ---YRSPELLVGDTQY------GPPVDVWAIGCVFAELLSGV 200
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-23
Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 30/223 (13%)
Query: 575 VLRQVTDNFSEA----NILGRGGFGVVYGG-ELPDGTKIAVK-----------RMESNTM 618
+R+ E+ LG G +G V E ++ A+K + N
Sbjct: 26 YVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKN 85
Query: 619 GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY 678
K E EI++L + H +++ L + LV E+ G L + +
Sbjct: 86 IEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN---RHK 142
Query: 679 TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVK 735
I + G+ YLH + +HRD+KP NIL+ + K+ DFGL
Sbjct: 143 --FDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSS 197
Query: 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVL 778
GT Y+APE + K DV++ GV++
Sbjct: 198 FFSKDY--KLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIM 237
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 41/181 (22%), Positives = 68/181 (37%), Gaps = 16/181 (8%)
Query: 611 KRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL 670
+ + + +I + ++ V L + + + L +
Sbjct: 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM 152
Query: 671 FEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730
+ I + +A VE+LHS + +HRDLKPSNI D KV D
Sbjct: 153 NR--RCSLEDREHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD 207
Query: 731 FGLVK-----------NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLM 779
FGLV P Y+ T GT Y++PE + K+D+++ G++L
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267
Query: 780 E 780
E
Sbjct: 268 E 268
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 51/208 (24%), Positives = 86/208 (41%), Gaps = 23/208 (11%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK- 635
Q TD + +G G + V + AVK + +K + EI +L +
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII------DKSKRDPTEEIEILLRY 72
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVTIALDVA 694
+H +++ L +G +V E M G L + + + ++ + +
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGG----ELLDKILRQKF--FSEREASAVLFTIT 126
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
+ VEYLH+ Q +HRDLKPSNIL G+ ++ DFG K + T
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCY 182
Query: 751 TFGYLAPEYAATGRVTTKIDVYAFGVVL 778
T ++APE D+++ GV+L
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLL 210
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 12/204 (5%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ D F LG G FG V+ E G + +K + + + + +AEI VL +
Sbjct: 20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP-MEQIEAEIEVLKSLD 78
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H +++ + + +V E G L + + G L+ + + +
Sbjct: 79 HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA-LSEGYVAELMKQMMNAL 137
Query: 698 EYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
Y HS Q +H+DLKP NIL K+ DFGL + + T AGT Y
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE--HSTNAAGTALY 192
Query: 755 LAPEYAATGRVTTKIDVYAFGVVL 778
+APE VT K D+++ GVV+
Sbjct: 193 MAPE-VFKRDVTFKCDIWSAGVVM 215
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 58/232 (25%), Positives = 91/232 (39%), Gaps = 38/232 (16%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTM-GNKGLSEFQAEIA 631
E R+ D F + G+G FG V G E G +A+K++ + N+ L +
Sbjct: 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI----MQ 71
Query: 632 VLTKVRHRHLVALLGYCINGSER-------LLVYEYMPRGTLAQHLFEWHDHGYTPLTWK 684
L + H ++V L Y ER +V EY+P TL + +
Sbjct: 72 DLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCC-RNYYRRQVAPPPI 129
Query: 685 QRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYS 743
+ R + LH + HRD+KP N+L+ D K+ DFG K + +
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN 188
Query: 744 VE---TRLAGTFGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
V +R Y APE Y TT +D+++ G + E + G
Sbjct: 189 VAYICSRY-----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 99.9 bits (250), Expect = 3e-23
Identities = 61/221 (27%), Positives = 101/221 (45%), Gaps = 40/221 (18%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTKV 636
+ + +G G +GVVY + G A+K R+E +G+ EI++L ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKED---EGIP-STTIREISILKEL 57
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+H ++V L I+ +RL LV+E++ + L + L D L + L +
Sbjct: 58 KHSNIVKLYD-VIHTKKRLVLVFEHLDQD-LKKLL----DVCEGGLESVTAKSFLLQLLN 111
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
G+ Y H + +HRDLKP N+LI + K+ADFGL P KY+ + T
Sbjct: 112 GIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW--- 165
Query: 752 FGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
Y AP+ Y +T ID+++ G + E + G
Sbjct: 166 --YRAPDVLMGSKKY------STTIDIWSVGCIFAEMVNGT 198
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-23
Identities = 69/247 (27%), Positives = 110/247 (44%), Gaps = 45/247 (18%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG G FG V G+ G K+AVK + + + + + EI L RH H++ L
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVE 698
S+ +V EY+ G L ++ + R+ +R GV+
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYICK-----------NGRLDE--KESRRLFQQILSGVD 130
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y H +HRDLKP N+L+ M AK+ADFGL DG++ + T G+ Y APE
Sbjct: 131 YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF-LRTS-CGSPNYAAPE 185
Query: 759 ------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812
YA ++D+++ GV+L + G +P D H+ T F+++
Sbjct: 186 VISGRLYAG-----PEVDIWSSGVILYALLCGT------LPFDDDHVPTLFKKICDGIFY 234
Query: 813 IPKAIDP 819
P+ ++P
Sbjct: 235 TPQYLNP 241
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-23
Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + + + LG G + VY G+ +A+K R+E +G A E+++L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE----EGAP-CTAIREVSLLKD 56
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
++H ++V L LV+EY+ + L Q+L D + + R
Sbjct: 57 LKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL----DDCGNIINMHNVKLFLFQLLR 111
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
G+ Y H Q +HRDLKP N+LI + K+ADFGL K+ P Y V T
Sbjct: 112 GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLW--- 165
Query: 752 FGYLAPE--YAATGRVTTKIDVYAFGVVLMETITGR 785
Y P+ +T +T+ID++ G + E TGR
Sbjct: 166 --YRPPDILLGST-DYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 6e-23
Identities = 59/225 (26%), Positives = 97/225 (43%), Gaps = 43/225 (19%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
F + LG G + VY G G +A+K +++S +G A EI+++ +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE----EGTP-STAIREISLMKE 59
Query: 636 VRHRHLVALLGYCINGSERL-LVYEYMP---RGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
++H ++V L I+ +L LV+E+M + + G K
Sbjct: 60 LKHENIVRLYD-VIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK---YFQW 115
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETR 747
+ +G+ + H +HRDLKP N+LI + K+ DFGL P +S V T
Sbjct: 116 QLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTL 172
Query: 748 LAGTFGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
Y AP+ Y +T ID+++ G +L E ITG+
Sbjct: 173 W-----YRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 99 bits (250), Expect = 7e-23
Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 39/221 (17%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + ++G G +G+V G +A+K + K A EI +L +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVK----KIAMREIKLLKQ 80
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+RH +LV LL C LV+E++ T+ L E +G + +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQ---KYLFQIIN 135
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL--VKNAPDGKYS--VETRLAGT 751
G+ + HS + IHRD+KP NIL+ K+ DFG AP Y V TR
Sbjct: 136 GIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRW--- 189
Query: 752 FGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
Y APE Y +DV+A G ++ E G
Sbjct: 190 --YRAPELLVGDVKY------GKAVDVWAIGCLVTEMFMGE 222
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 7e-23
Identities = 38/212 (17%), Positives = 84/212 (39%), Gaps = 20/212 (9%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ + + + ++ + S+ I +N++ SV L N+ L L+
Sbjct: 20 DDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLN 76
Query: 146 DNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
N ++ P L +L L++D + L L++L L +N + +
Sbjct: 77 GNKLTDIKP------LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGIS-DI 127
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
+++L++ + ++ + VLS +T+L + L NQ + I L+ L +L
Sbjct: 128 NGLVHLPQLESLYLGNNKI---TDITVLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNL 183
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
L N ++ + + L L + L + +
Sbjct: 184 YLSKNHISDLRA--LAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 45/240 (18%), Positives = 82/240 (34%), Gaps = 42/240 (17%)
Query: 60 INCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIY 119
+ + N + I S + ++ I L + L N + I LAN +L ++
Sbjct: 40 VTQNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLT-DIKPLANLKNLGWLF 96
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFG 177
LD N + + L L+ LSL N ++ L L +LY+ N I
Sbjct: 97 LDENKVKDLSS--LKDLKKLKSLSLEHNGISDING------LVHLPQLESLYLGNNKITD 148
Query: 178 LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ + L L L N + + L+G+T+L
Sbjct: 149 I--TVLSRLTKLDTLSLEDNQIS--------------------------DIVPLAGLTKL 180
Query: 238 RQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
+ ++L KN + + L+ ++L L L + +L + + L P
Sbjct: 181 QNLYLSKNHISD-LRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTP 239
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 3e-12
Identities = 46/312 (14%), Positives = 98/312 (31%), Gaps = 82/312 (26%)
Query: 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIF 176
+ + + D +L ++ NEL + + +N++I
Sbjct: 6 ETITVPTPIKQIFS--DDAFAETIKDNLKKK-SVTDAVTQNELNS---IDQIIANNSDIK 59
Query: 177 GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQ 236
+ N+ L L+ N T DI+ L + +
Sbjct: 60 SV--QGIQYLPNVTKLFLNGNKLT----------DIKPL----------------ANLKN 91
Query: 237 LRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L ++L +N+ + L + L LSL N ++ + LP L ++ L NNK+
Sbjct: 92 LGWLFLDENKVKD-LSSLKDLKKLKSLSLEHNGISDINGLV--HLPQLESLYLGNNKITD 148
Query: 297 PYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNA 355
L +K+ +SL+ N Q++ +
Sbjct: 149 ITVLSRLTKLDTLSLEDN---------------QISDI---------------------- 171
Query: 356 CDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415
P ++ + + L+ ++ ++ A L +L L L + + L
Sbjct: 172 ---VPLAGLTK--LQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLV 224
Query: 416 SLQNLDVSNNNL 427
+ ++ +L
Sbjct: 225 VPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 2e-09
Identities = 44/264 (16%), Positives = 86/264 (32%), Gaps = 78/264 (29%)
Query: 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225
+ I + D D+F+ L + T
Sbjct: 5 SETITVPTPIKQIFSD--DAFAETIKDNLKKKSVT------------------------- 37
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALL 285
+ + + Q+ + + + + ++ L L N+LT + P + +L L
Sbjct: 38 -DAVTQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDIKPLA--NLKNLG 93
Query: 286 NISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPA 344
+ L NK++ L K++ +SL+HN ++ +
Sbjct: 94 WLFLDENKVKDLSSLKDLKKLKSLSLEHN---------------GISDI----------- 127
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404
V Q + ++ L N + +I+ + LT L L L+ N ++
Sbjct: 128 --------------NGLVHLPQ--LESLYLGNNKIT-DITVL-SRLTKLDTLSLEDNQIS 169
Query: 405 GPIPDGLTKLASLQNLDVSNNNLS 428
L L LQNL +S N++S
Sbjct: 170 DI--VPLAGLTKLQNLYLSKNHIS 191
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 16/97 (16%), Positives = 36/97 (37%), Gaps = 13/97 (13%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N+++ I ++ LT+L+ L N+I+ + +LA +L + L +
Sbjct: 164 EDNQISDIV------------PLAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQ 210
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT 160
+ P L + +D + P ++
Sbjct: 211 ECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD 247
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 1e-22
Identities = 49/207 (23%), Positives = 82/207 (39%), Gaps = 26/207 (12%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALL 645
+LG G V L + AVK +E + S E+ +L + + HR+++ L+
Sbjct: 20 VLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLELI 77
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ LV+E M G++ H+ H + + + DVA +++LH+
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSILSHI---HKRRH--FNELEASVVVQDVASALDFLHN--- 129
Query: 706 QSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETR------LAGTFGYLA 756
+ HRDLKP NIL K+ DF L G+ Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189
Query: 757 PE-----YAATGRVTTKIDVYAFGVVL 778
PE + D+++ GV+L
Sbjct: 190 PEVVEAFSEEASIYDKRCDLWSLGVIL 216
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 37/209 (17%), Positives = 68/209 (32%), Gaps = 30/209 (14%)
Query: 87 SSLTQLETLSFQMNNI-AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ + +F ++ + + + + NN T LT L+ L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 146 DNPNLAPWPFPNELTKS-TSLTTLYMDNANI-FGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
N L E+T SL L + ++ + +L +L +S N T ++
Sbjct: 357 MN-QLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
+++ + LH N+ + K E+L +L
Sbjct: 416 FRCL--------------------------PPRIKVLDLHSNKIKSIPKQVVKLEALQEL 449
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNN 292
++ NQL V L +L I L N
Sbjct: 450 NVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 57/373 (15%), Positives = 116/373 (31%), Gaps = 49/373 (13%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSLSD 146
+LE L N + I +L+ + L N F ++P F ++ L+ L LS
Sbjct: 67 FNQELEYLDLSHNKLV-KISC-HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLST 124
Query: 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS 206
+L + L + + + L T
Sbjct: 125 T-HLEKSSV-LPIAHLNISKVLLVLGETYGEKED--PEGLQDFNTESLHIVFPTNKEFHF 180
Query: 207 FAK-----------SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP----I 251
S+I+ + +++ L L +L + L+ + T I
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240
Query: 252 PDLSKCESLFDLSLRDNQLTGVVPASVI-----SLPALLNISLQNNKLQGPYP---LFPS 303
L +++ S+ + +L G + SL AL + ++ P S
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300
Query: 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363
+ + + C +++ L + D + C +
Sbjct: 301 NMNIKNFTVSGTRMVHM----LCPSKISPFLHL--DFSNNLLTDTV---FENCGHLTELE 351
Query: 364 CSQGRIITINLANKLLA--GNISPAYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNL 420
T+ L L I+ + SL+ L + QN+++ G + SL +L
Sbjct: 352 -------TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404
Query: 421 DVSNNNLSGKVPD 433
++S+N L+ +
Sbjct: 405 NMSSNILTDTIFR 417
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 55/360 (15%), Positives = 107/360 (29%), Gaps = 56/360 (15%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
I SL++L L N I + L+ + L +N + NL+ L
Sbjct: 41 ILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNKLVKIS---CHPTVNLKHLD 96
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQN-LRLSYNNFTGS 202
LS N P E + L L + ++ + + L L
Sbjct: 97 LSFNA-FDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKE 155
Query: 203 LPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR------QVWLHKNQFTGPIPDLSK 256
P + ++L + + +S T + L N+ + + L+K
Sbjct: 156 DPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAK 215
Query: 257 CE--------SLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV 308
+ +L ++ N ++ ++ + S+ N KLQG
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
Query: 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
SL + + SD + Y + + + T S R
Sbjct: 274 SLKALSIHQVVSD-----------VFGFPQSYIYEIFSNMNIKN---------FTVSGTR 313
Query: 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
++ + + ++ +L N LT + + L L+ L + N L
Sbjct: 314 MVHM------------LCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 1e-20
Identities = 47/325 (14%), Positives = 112/325 (34%), Gaps = 17/325 (5%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ + N + + T L+ L++L +S N + + + L L + +
Sbjct: 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHN-RIQYLD-ISVFKFNQELEYLDLSH 78
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP--ASFAK-SDIQNLWMNDQQLGLSGTLD 229
N I NL++L LS+N F +LP F S ++ L ++ L ++
Sbjct: 79 -NKLVKIS--CHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL-EKSSVL 133
Query: 230 VLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISL 289
++ + +V L + G D + SL T ++ + +L
Sbjct: 134 PIAHLNIS-KVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANL 192
Query: 290 QNNKLQG-PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI--- 345
+ + ++ S + K S+ + + ++I + + +
Sbjct: 193 ELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYF 252
Query: 346 -LSDSWEGNNACDGWPFVTCSQGRIITI-NLANKLLAGNISPAYANLTSLKNLYLQQNNL 403
+S+ + + + ++I + + + S Y +++ +
Sbjct: 253 SISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT 312
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
+K++ +LD SNN L+
Sbjct: 313 RMVHMLCPSKISPFLHLDFSNNLLT 337
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 1e-17
Identities = 55/396 (13%), Positives = 117/396 (29%), Gaps = 58/396 (14%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLAN--ATSLQDI 118
N +++ + L+ + L + I+ L + L L + SL +
Sbjct: 112 GNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIV 171
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNP---------NLAPWPFPNELTKSTSLTTLY 169
+ N F + + NL++ ++ ++ N + +L +
Sbjct: 172 FPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIE 231
Query: 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS--------DIQNLWMNDQQ 221
+ ++ + + +S G L I + +
Sbjct: 232 TTWNSFIRILQ--LVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFG 289
Query: 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISL 281
S ++ S M + + + SK L +N LT V + L
Sbjct: 290 FPQSYIYEIFSNMNIKN-FTVSGTRMV-HMLCPSKISPFLHLDFSNNLLTDTVFENCGHL 347
Query: 282 PALLNISLQNNKLQGPYPLF-----PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQI 336
L + LQ N+L+ + +Q++ + N+ + + +L
Sbjct: 348 TELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL--- 404
Query: 337 AGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISPAYANLTS 392
+M + + + + L N I L +
Sbjct: 405 --NMSSNILTDTIFRC-----------------LPPRIKVLDLHSNKIKSIPKQVVKLEA 445
Query: 393 LKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNL 427
L+ L + N L +PDG +L SLQ + + N
Sbjct: 446 LQELNVASNQLKS-VPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 37/189 (19%), Positives = 68/189 (35%), Gaps = 31/189 (16%)
Query: 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLD 121
+ + + + L+ T+ LT+LETL L
Sbjct: 320 PSKISPFLHLDFSNNLLTDTVFENCGHLTELETL-----------------------ILQ 356
Query: 122 NNNFTSVP--TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
N + + +LQ L +S N +++ + + + SL +L M + + I
Sbjct: 357 MNQLKELSKIAEMTTQMKSLQQLDISQN-SVSYDEKKGDCSWTKSLLSLNMSSNILTDTI 415
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238
++ L L N S+P K +Q L + QL S + +T L+
Sbjct: 416 FRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQ 471
Query: 239 QVWLHKNQF 247
++WLH N +
Sbjct: 472 KIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 29/144 (20%), Positives = 55/144 (38%), Gaps = 11/144 (7%)
Query: 61 NCDNSNRVTTISLAKSGLSGTLSPEIS---SLTQLETLSFQMNNIAGAIPSLA--NATSL 115
NC + + T+ L + L LS + L+ L N+++ SL
Sbjct: 343 NCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401
Query: 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI 175
+ + +N T C ++VL L N + P ++ K +L L + + +
Sbjct: 402 LSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIKS---IPKQVVKLEALQELNVASNQL 456
Query: 176 FGLIPDFFDSFSNLQNLRLSYNNF 199
+ FD ++LQ + L N +
Sbjct: 457 KSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 34/218 (15%)
Query: 589 LGRGGFGVVYGG---ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+GRG +G VY + D A+K++E + E IA+L +++H ++++L
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84
Query: 646 GYCINGSERL--LVYEYMP---RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
++ ++R L+++Y + H + L ++ + G+ YL
Sbjct: 85 KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRA----KVADFGL--VKNAPDGKYSVETRLAGTFGY 754
H+ +HRDLKP+NIL+ + K+AD G + N+P + + TF Y
Sbjct: 145 HA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201
Query: 755 LAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
APE Y T ID++A G + E +T
Sbjct: 202 RAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 68/247 (27%), Positives = 109/247 (44%), Gaps = 46/247 (18%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRHRHLVALLG 646
LG G FG V K+A+K + + + + EI+ L +RH H++ L
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVE 698
++ ++V EY LF D+ + K+R+T D R +E
Sbjct: 77 VITTPTDIVMVIEYA-----GGELF---DY----IVEKKRMTE--DEGRRFFQQIICAIE 122
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y H +HRDLKP N+L+ D++ K+ADFGL DG + ++T G+ Y APE
Sbjct: 123 YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKT-SCGSPNYAAPE 177
Query: 759 ------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812
YA ++DV++ G+VL + GR +P D + F++V
Sbjct: 178 VINGKLYAG-----PEVDVWSCGIVLYVMLVGR------LPFDDEFIPNLFKKVNSCVYV 226
Query: 813 IPKAIDP 819
+P + P
Sbjct: 227 MPDFLSP 233
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 3e-22
Identities = 58/223 (26%), Positives = 85/223 (38%), Gaps = 34/223 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
D+F ++GRG F V ++ ++ A+K M M +G F+ E VL
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
R + L + L LV EY G L L K I ++AR
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLS------------KFGERIPAEMARFY 167
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
++ +H L ++HRD+KP NIL+ ++ADFG
Sbjct: 168 LAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV 224
Query: 750 GTFGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
GT YL+PE TG + D +A GV E G+
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 3e-22
Identities = 72/300 (24%), Positives = 115/300 (38%), Gaps = 50/300 (16%)
Query: 571 ISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAE 629
I + LR F ++G G +G VY G + G A+K M+ + E + E
Sbjct: 14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQE 70
Query: 630 IAVLTKV-RHRHLVALLGYCINGSERL------LVYEYMPRGTLAQHLFEWHDHGYTPLT 682
I +L K HR++ G I + LV E+ G++ L + L
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV-TDLIKNTKGN--TLK 127
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ I ++ RG+ +LH IHRD+K N+L+ ++ K+ DFG+ +
Sbjct: 128 EEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV---SAQLDR 181
Query: 743 SVETR--LAGTFGYLAPEYAATGRVT-----TKIDVYAFGVVLMETITGRKALDDTMPDD 795
+V R GT ++APE A K D+++ G+ +E G L D P
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP-- 239
Query: 796 RAHLVTWFRRVL--ISKENIPKAIDPNLNLD-EETIESIYRVAELAGHCTAREPQQRPDM 852
R L I + P+ + + IES C + QRP
Sbjct: 240 --------MRALFLIPRNPAPRLKSKKWSKKFQSFIES----------CLVKNHSQRPAT 281
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 46/196 (23%), Positives = 75/196 (38%), Gaps = 19/196 (9%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALL 645
LG G F + AVK + + + Q EI L H ++V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLH 72
Query: 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQ 705
+ LV E + G L + + + + + + I + V ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKK---KKH--FSETEASYIMRKLVSAVSHMHD--- 124
Query: 706 QSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT 762
+HRDLKP N+L D++ K+ DFG + P ++T T Y APE
Sbjct: 125 VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP-CFTLHYAAPELLNQ 183
Query: 763 GRVTTKIDVYAFGVVL 778
D+++ GV+L
Sbjct: 184 NGYDESCDLWSLGVIL 199
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-22
Identities = 57/254 (22%), Positives = 97/254 (38%), Gaps = 36/254 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
D+F +G+G FG V + D K+ A+K M + + E+ ++ + H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
LV L Y E + +V + + G L HL +Q V + +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHL-------------QQNVHFKEETVKLF 120
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
++YL + Q IHRD+KP NIL+ + + DF + P T +A
Sbjct: 121 ICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI--TTMA 175
Query: 750 GTFGYLAPEYAATGRV---TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806
GT Y+APE ++ + + +D ++ GV E + GR+ +
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEI---VHTF 232
Query: 807 LISKENIPKAIDPN 820
+ P A
Sbjct: 233 ETTVVTYPSAWSQE 246
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 4e-22
Identities = 54/220 (24%), Positives = 83/220 (37%), Gaps = 33/220 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
+++ ++GRG FG V K+ A+K + M + S F E ++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
+V L Y L +V EYMP G L + + AR
Sbjct: 129 PWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM--------------SNYDVPEKWARFY 173
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
++ +HS+ FIHRD+KP N+L+ K+ADFG
Sbjct: 174 TAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV 230
Query: 750 GTFGYLAPE----YAATGRVTTKIDVYAFGVVLMETITGR 785
GT Y++PE G + D ++ GV L E + G
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-22
Identities = 56/222 (25%), Positives = 91/222 (40%), Gaps = 34/222 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
++F ++GRG FG V +L + K+ A+K + M + + F+ E VL
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
+ + L Y L LV +Y G L L K + ++AR
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLS------------KFEDRLPEEMARFY 180
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRL 748
++ +H L ++HRD+KP NIL+ + ++ADFG DG
Sbjct: 181 LAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSV-A 236
Query: 749 AGTFGYLAPE-----YAATGRVTTKIDVYAFGVVLMETITGR 785
GT Y++PE GR + D ++ GV + E + G
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 9e-22
Identities = 63/360 (17%), Positives = 118/360 (32%), Gaps = 42/360 (11%)
Query: 90 TQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ + LS N+I I L + L+ + L +N S+ F +L+ L +S
Sbjct: 52 PRTKALSLSQNSISELRMPDISFL---SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVS 108
Query: 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD--FFDSFSNLQNLRLSYNNFTGSL 203
N L SL L + N F ++P F + + L L LS F
Sbjct: 109 HN-RLQNISC----CPMASLRHLDLSF-NDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLD 162
Query: 204 PASFAKSDIQNLWMNDQQLGLS-GTLDVLSGM-TQLRQVWLHKNQFTGPIPDLSKCESLF 261
A + + ++ + G + L T + + H N ++S +L
Sbjct: 163 LLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVN-ALG 221
Query: 262 DLSLRDNQLTGVVPASVISL-------PALLNISLQNNKLQGPY------PLFPSKVQKV 308
L L + +L +++ P LLN++LQ+ + +P V+ +
Sbjct: 222 HLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYL 281
Query: 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
++ + + L I + L + +
Sbjct: 282 NIYNLTITERIDREEFTYSETALKSLMIE-HVKNQVFLFSK---EALYSVFAEMNIKM-- 335
Query: 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
++I+ + + +S L QN T + G + L LQ L + N L
Sbjct: 336 -LSISDTPFIHMVCPP----SPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 3e-17
Identities = 58/393 (14%), Positives = 111/393 (28%), Gaps = 91/393 (23%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSLSD 146
LE L N + I SL+ + L N+F +P F LT L L LS
Sbjct: 98 FNQDLEYLDVSHNRLQ-NISC-CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSA 155
Query: 147 N------------------------PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
++ + +T++ L ++F +
Sbjct: 156 AKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQ--V 213
Query: 183 FDSFSNLQNLRLSYNN--------FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234
S + L +L+LS L + N+ + + ++ +
Sbjct: 214 NMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFF 273
Query: 235 --TQLRQVWLHKNQFTGPIP------DLSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286
+ + ++ T I + +SL +++ A +
Sbjct: 274 WPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNI 333
Query: 287 ISLQNNKLQG---PYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343
L + P PS ++ N
Sbjct: 334 KMLSISDTPFIHMVCPPSPSSFTFLNFTQN------------------------------ 363
Query: 344 AILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA--GNISPAYANLTSLKNLYLQQN 401
+ +DS C + T+ L L ++ N++SL+ L + N
Sbjct: 364 -VFTDSVFQG--CSTLKRLQ-------TLILQRNGLKNFFKVALMTKNMSSLETLDVSLN 413
Query: 402 NLTGPIPDGLTKL-ASLQNLDVSNNNLSGKVPD 433
+L D S+ L++S+N L+G V
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR 446
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 83.0 bits (205), Expect = 2e-16
Identities = 34/213 (15%), Positives = 65/213 (30%), Gaps = 38/213 (17%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
S ++ +++ I + + +S + N FT L LQ L L
Sbjct: 326 SVFAEMNIKMLSISDT-PFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
N L N+ +L +
Sbjct: 385 QRN----------------GLKNF-----------FKVALMTKNMSSLETLDVSLNSLNS 417
Query: 205 ASFAK-----SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES 259
++ + I L ++ L L +++ + LH N+ D++ ++
Sbjct: 418 HAYDRTCAWAESILVLNLSSNML-TGSVFRCLP--PKVKVLDLHNNRIMSIPKDVTHLQA 474
Query: 260 LFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
L +L++ NQL V L +L I L +N
Sbjct: 475 LQELNVASNQLKSVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 8e-16
Identities = 61/353 (17%), Positives = 114/353 (32%), Gaps = 58/353 (16%)
Query: 91 QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV--LSLSDNP 148
L+ +S+ + + N T L ++ N+ F+ + L +LQ+ + L+D
Sbjct: 175 LLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDEN 234
Query: 149 NLAPWPFPNELTKSTSLTTLYMDNANIF--GLIPDF-FDSFSNLQNLRLSYNNFTGSLPA 205
F +ELT+ +L + + + + F F ++ L + T +
Sbjct: 235 CQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDR 294
Query: 206 SFAKSD--------IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-PIPDLSK 256
I+++ V + M L + +
Sbjct: 295 EEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM---LSISDTPFIHMVCPPS 351
Query: 257 CESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFC 316
S L+ N T V +L L + LQ N L+ + + SL+ +
Sbjct: 352 PSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVS 411
Query: 317 KNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA- 375
NS ++ + W I+ +NL+
Sbjct: 412 LNSLNSH----------------------------AYDRTCAWA------ESILVLNLSS 437
Query: 376 NKLLAGNISPAYANLT-SLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
N L + L +K L L N + IP +T L +LQ L+V++N L
Sbjct: 438 NMLTGS----VFRCLPPKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQL 485
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 22/60 (36%), Positives = 35/60 (58%), Gaps = 2/60 (3%)
Query: 90 TQLETLSFQMNNIAGAIPS-LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
+++ L N I +IP + + +LQ++ + +N SVP G FD LT+LQ + L DNP
Sbjct: 450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 9e-22
Identities = 79/328 (24%), Positives = 125/328 (38%), Gaps = 38/328 (11%)
Query: 506 YKFIARRKH--RKFGRVKNPEVGNEMNKNGVTGGNGTNGYNGVPSELHSQSSGDVSDRHL 563
FI R R + E E + +G + SG SD
Sbjct: 71 NTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSG 130
Query: 564 FEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNK 621
E V+++ R + F +LG+G FG V + + A+K ++ +
Sbjct: 131 AEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKD 190
Query: 622 GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTP 680
++ E VL RH L AL Y +RL V EY G L HL
Sbjct: 191 EVAHTLTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANGGELFFHL---------- 239
Query: 681 LTWKQRVTI---------ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731
R + ++ ++YLHS +++ ++RDLK N+++ D K+ DF
Sbjct: 240 ----SRERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDF 293
Query: 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDT 791
GL K +++T GT YLAPE +D + GVV+ E + GR +
Sbjct: 294 GLCKEGIKDGATMKT-FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN- 351
Query: 792 MPDDRAHLVTWFRRVLISKENIPKAIDP 819
D L F +L+ + P+ + P
Sbjct: 352 --QDHEKL---FELILMEEIRFPRTLGP 374
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 99.7 bits (248), Expect = 9e-22
Identities = 52/287 (18%), Positives = 94/287 (32%), Gaps = 51/287 (17%)
Query: 34 KLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLE 93
++ + + S W +W NR +SL + + Q
Sbjct: 21 TISGTYADYFSAWD--------KWEKQALPGENRNEAVSL----------LKECLINQFS 62
Query: 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPW 153
L N++ ++P + + + N S+P + +L+ L DN L+
Sbjct: 63 ELQLNRLNLS-SLPD-NLPPQITVLEITQNALISLP----ELPASLEYLDACDN-RLST- 114
Query: 154 PFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQ 213
P SL L +DN N ++P+ + L+ + N T LP
Sbjct: 115 -LPELPA---SLKHLDVDN-NQLTMLPE---LPALLEYINADNNQLT-MLPEL-----PT 160
Query: 214 NLWMNDQQLGLSG-TLDVL-SGMTQLRQVWLHKNQFTG-P--IPDLSKCESL-FDLSLRD 267
+L + L + L L L + + N P E R+
Sbjct: 161 SL----EVLSVRNNQLTFLPELPESLEALDVSTNLLESLPAVPVRNHHSEETEIFFRCRE 216
Query: 268 NQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNN 314
N++T +P +++SL I L++N L S+ H
Sbjct: 217 NRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGP 262
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 95.4 bits (237), Expect = 2e-20
Identities = 45/268 (16%), Positives = 83/268 (30%), Gaps = 40/268 (14%)
Query: 60 INCDNSNRVTTISLAKSGLSGTLSPEI----SSLTQLETLSFQMNNIAGAIPSLANATSL 115
I +N + + + + N +
Sbjct: 3 IMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE-CLINQF 61
Query: 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI 175
++ L+ N +S+P + VL ++ N L P SL L + N
Sbjct: 62 SELQLNRLNLSSLPDNLP---PQITVLEITQN-ALI--SLPELP---ASLEYLDACD-NR 111
Query: 176 FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT-LDVL-SG 233
+P + ++L++L + N T LP L + + L +L
Sbjct: 112 LSTLP---ELPASLKHLDVDNNQLT-MLPEL-----PALL----EYINADNNQLTMLPEL 158
Query: 234 MTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLN----ISL 289
T L + + NQ T +P+L ESL L + N L +PA +
Sbjct: 159 PTSLEVLSVRNNQLTF-LPELP--ESLEALDVSTNLLES-LPAVPVRNHHSEETEIFFRC 214
Query: 290 QNNKLQG-PYPLF-PSKVQKVSLDHNNF 315
+ N++ P + + L+ N
Sbjct: 215 RENRITHIPENILSLDPTCTIILEDNPL 242
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 85.4 bits (211), Expect = 3e-17
Identities = 57/344 (16%), Positives = 108/344 (31%), Gaps = 88/344 (25%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
+S + T+S + A + N S+ C + L L
Sbjct: 12 SLSQNSFYNTISGTYADYFSAWDKW---EKQALPGENRNEAVSLLKECL--INQFSELQL 66
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
+ NL+ P+ L +T L + N +P+ ++L+ L N + +LP
Sbjct: 67 NRL-NLSS--LPDNLPPQ--ITVLEITQ-NALISLPE---LPASLEYLDACDNRLS-TLP 116
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
L+ + + NQ T +P+L L ++
Sbjct: 117 ELP---------------------------ASLKHLDVDNNQLTM-LPEL--PALLEYIN 146
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGK 324
+NQLT ++P SL L S++NN+L P P ++ + + N
Sbjct: 147 ADNNQLT-MLPELPTSLEVL---SVRNNQLTFL-PELPESLEALDVSTN----------- 190
Query: 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384
+ +L PA+ S+ I + +I
Sbjct: 191 ----LLESL---------PAVPVR-------------NHHSEETEIFFRCRENRIT-HIP 223
Query: 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+L + L+ N L+ I + L++ + + S
Sbjct: 224 ENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 4e-16
Identities = 45/239 (18%), Positives = 89/239 (37%), Gaps = 41/239 (17%)
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
N+ + + L + LS +L + Q+ L N + ++P L SL+ + +N
Sbjct: 59 NQFSELQLNRLNLS-SLPDNL--PPQITVLEITQNAL-ISLPELP--ASLEYLDACDNRL 112
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
+++P + +L+ L + +N L P L + DN N ++P+
Sbjct: 113 STLP----ELPASLKHLDVDNN-QLTM--LPELPA---LLEYINADN-NQLTMLPE---L 158
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-----DVLSGMTQLRQV 240
++L+ L + N T LP ++L + L +S L V +
Sbjct: 159 PTSLEVLSVRNNQLT-FLPEL-----PESL----EALDVSTNLLESLPAVPVRNHHSEET 208
Query: 241 ----WLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
+N+ T IP+ + + + L DN L+ + S+ A +
Sbjct: 209 EIFFRCRENRITH-IPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYF 266
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 79.6 bits (196), Expect = 2e-15
Identities = 47/297 (15%), Positives = 98/297 (32%), Gaps = 67/297 (22%)
Query: 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195
+L S + + + + K + L+ + + L+L+
Sbjct: 10 NFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLN 67
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLS 255
N + SLP + I L + L + L + N+ + +P+L
Sbjct: 68 RLNLS-SLPDNLPPQ-ITVLEITQNALI-----SLPELPASLEYLDACDNRLST-LPEL- 118
Query: 256 KCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNF 315
SL L + +NQLT ++P L + + NN+L P P+ ++ +S+ +N
Sbjct: 119 -PASLKHLDVDNNQLT-MLPELPALLEYI---NADNNQLTM-LPELPTSLEVLSVRNN-- 170
Query: 316 CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLA 375
Q+T L P + + ++++
Sbjct: 171 -------------QLTFL---------PELP--------------------ESLEALDVS 188
Query: 376 NKLLAGNISPAYANLTSLKN----LYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
LL ++ + ++N +T IP+ + L + + +N LS
Sbjct: 189 TNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPLS 243
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 9e-22
Identities = 48/200 (24%), Positives = 78/200 (39%), Gaps = 25/200 (12%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALL 645
+LG G G V G K A+K + + + E+ + H+V +L
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHHWQASGGPHIVCIL 88
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
N L++ E M G L + E D +T ++ I D+ +++LH
Sbjct: 89 DVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTE---REAAEIMRDIGTAIQFLH 145
Query: 702 SLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
S + HRD+KP N+L D K+ DFG K T Y+APE
Sbjct: 146 S---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL---QTPCYTPYYVAPE 199
Query: 759 YAATGRVTTKIDVYAFGVVL 778
+ D+++ GV++
Sbjct: 200 VLGPEKYDKSCDMWSLGVIM 219
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 2e-21
Identities = 57/233 (24%), Positives = 93/233 (39%), Gaps = 51/233 (21%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVLTK 635
+ + +G+G FG V+ G K+A+K ME+ G A EI +L
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP----ITALREIKILQL 72
Query: 636 VRHRHLVALLGYCINGSERL--------LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
++H ++V L+ C + LV+++ LA L + T +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL----SNVLVKFTLSEIK 127
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL------VKNAPDGK 741
+ + G+ Y+H +HRD+K +N+LI D K+ADFGL KN+ +
Sbjct: 128 RVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184
Query: 742 YS--VETRLAGTFGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGR 785
Y+ V T Y PE Y ID++ G ++ E T
Sbjct: 185 YTNRVVTLW-----YRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 2e-21
Identities = 53/243 (21%), Positives = 85/243 (34%), Gaps = 45/243 (18%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G +G V +AVK ++ + EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEY 699
G+ + L EY G L + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA-GTFGYLAPE 758
LH HRD+KP N+L+ + K++DFGL GT Y+APE
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177
Query: 759 ------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLISKE 811
+ A +DV++ G+VL + G +P D + + K
Sbjct: 178 LLKRREFHA-----EPVDVWSCGIVLTAMLAGE------LPWDQPSDSCQEYSDWKEKKT 226
Query: 812 NIP 814
+
Sbjct: 227 YLN 229
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 3e-21
Identities = 54/211 (25%), Positives = 82/211 (38%), Gaps = 43/211 (20%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQA------EIAVLTKVRHRHL 641
LG G FG V+ ++ VK ++ + E EIA+L++V H ++
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR------ 695
+ +L N LV E G LF + + R+ +A
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG---LDLFAF-------IDRHPRLDE--PLASYIFRQL 139
Query: 696 --GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
V YL + IHRD+K NI+I +D K+ DFG GK T GT
Sbjct: 140 VSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL-FYT-FCGTIE 194
Query: 754 YLAPE------YAATGRVTTKIDVYAFGVVL 778
Y APE Y ++++++ GV L
Sbjct: 195 YCAPEVLMGNPYRG-----PELEMWSLGVTL 220
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.9 bits (243), Expect = 3e-21
Identities = 55/272 (20%), Positives = 95/272 (34%), Gaps = 44/272 (16%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
+ + + + ++ + S+ I +N++ SV L N+ L L+
Sbjct: 17 DDAFAETIKDNLKKKSVTD-AVTQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLN 73
Query: 146 DNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
N ++ P LT +L L++D I L L++L L +N +
Sbjct: 74 GNKLTDIKP------LTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGIS--- 122
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
DI L + QL ++L N+ T I LS+ L L
Sbjct: 123 -------DINGL----------------VHLPQLESLYLGNNKITD-ITVLSRLTKLDTL 158
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDA 322
SL DNQ++ +VP + L L N+ L N + L + + L +
Sbjct: 159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDLRALAGLKNLDVLELFSQECLNKPINH 216
Query: 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNN 354
T+ G + P I+SD +
Sbjct: 217 QSNL-VVPNTVKNTDGSLVTPEIISDDGDYEK 247
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.9 bits (186), Expect = 3e-14
Identities = 47/314 (14%), Positives = 103/314 (32%), Gaps = 82/314 (26%)
Query: 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174
+ + + + D +L ++ NEL + + +N++
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKK-SVTDAVTQNELNS---IDQIIANNSD 54
Query: 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234
I + N+ L L+ N T DI+ L + +
Sbjct: 55 IKSV--QGIQYLPNVTKLFLNGNKLT----------DIKPL----------------TNL 86
Query: 235 TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
L ++L +N+ + L + L LSL N ++ + ++ LP L ++ L NNK+
Sbjct: 87 KNLGWLFLDENKIKD-LSSLKDLKKLKSLSLEHNGISDING--LVHLPQLESLYLGNNKI 143
Query: 295 QGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353
L +K+ +SL+ N Q++ ++ +AG
Sbjct: 144 TDITVLSRLTKLDTLSLEDN---------------QISDIVPLAG--------------- 173
Query: 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTK 413
++ + L+ ++ ++ A L +L L L + +
Sbjct: 174 ------------LTKLQNLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSN 219
Query: 414 LASLQNLDVSNNNL 427
L + ++ +L
Sbjct: 220 LVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 66.3 bits (161), Expect = 3e-11
Identities = 28/138 (20%), Positives = 49/138 (35%), Gaps = 23/138 (16%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N ++ I+ + L QLE+L N I I L+ T L + L++N
Sbjct: 117 EHNGISDIN------------GLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDN 163
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
+ + GLT LQ L LS N +L L +L L + + +
Sbjct: 164 QISDIV--PLAGLTKLQNLYLSKNHISDLRA------LAGLKNLDVLELFSQECLNKPIN 215
Query: 182 FFDSFSNLQNLRLSYNNF 199
+ ++ + +
Sbjct: 216 HQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 62.4 bits (151), Expect = 5e-10
Identities = 46/265 (17%), Positives = 87/265 (32%), Gaps = 78/265 (29%)
Query: 165 LTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224
+ + I + PD D+F+ L + T
Sbjct: 1 MGETITVSTPIKQIFPD--DAFAETIKDNLKKKSVT------------------------ 34
Query: 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPAL 284
+ + + Q+ + + + + ++ L L N+LT + P + +L L
Sbjct: 35 --DAVTQNELNSIDQIIANNSDIKS-VQGIQYLPNVTKLFLNGNKLTDIKPLT--NLKNL 89
Query: 285 LNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343
+ L NK++ L K++ +SL+HN +
Sbjct: 90 GWLFLDENKIKDLSSLKDLKKLKSLSLEHNGISDIN------------------------ 125
Query: 344 AILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403
V Q + ++ L N + +I+ + LT L L L+ N +
Sbjct: 126 ----------------GLVHLPQ--LESLYLGNNKIT-DITV-LSRLTKLDTLSLEDNQI 165
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
+ I L L LQNL +S N++S
Sbjct: 166 SD-IV-PLAGLTKLQNLYLSKNHIS 188
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 20/139 (14%), Positives = 48/139 (34%), Gaps = 22/139 (15%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N+++ I ++ LT+L+ L N+I+ + +LA +L + L +
Sbjct: 161 EDNQISDIV------------PLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQ 207
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ P L + +D + P ++ + N+ +P+F
Sbjct: 208 ECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGD---------YEKPNVKWHLPEFT 258
Query: 184 DSFSNLQNLRLSYNNFTGS 202
+ S + ++
Sbjct: 259 NEVSFIFYQPVTIGKAKAR 277
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 5e-21
Identities = 53/221 (23%), Positives = 92/221 (41%), Gaps = 29/221 (13%)
Query: 581 DNFSEANILGRGGFGVVY-GGELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVL-- 633
+ +G G +G VY + G +A+K R+ + G GL E+A+L
Sbjct: 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLP-ISTVREVALLRR 67
Query: 634 -TKVRHRHLVALL----GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
H ++V L+ + ++ LV+E++ + L +L L +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYL---DKAPPPGLPAETIK 123
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYS--V 744
+ RG+++LH+ +HRDLKP NIL+ K+ADFGL + + + V
Sbjct: 124 DLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 745 ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
T Y APE T +D+++ G + E +
Sbjct: 181 VTLW-----YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 94.5 bits (235), Expect = 7e-21
Identities = 30/189 (15%), Positives = 69/189 (36%), Gaps = 9/189 (4%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ ++ + G F G +L+ + +S N L + + L + ++
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIE-ADVFSNLPKLHEIRIEK 88
Query: 173 AN-IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL--D 229
AN + + P+ F + NLQ L +S LP +Q + ++ Q T+ +
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERN 147
Query: 230 VLSGMT-QLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286
G++ + +WL+KN I + + + +N L + +
Sbjct: 148 SFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206
Query: 287 ISLQNNKLQ 295
+ + ++
Sbjct: 207 LDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 1e-20
Identities = 53/313 (16%), Positives = 102/313 (32%), Gaps = 30/313 (9%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLD 121
++ I G S LE + N++ I + N L +I ++
Sbjct: 38 VLTKLRVIQ------KGAFS----GFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 87
Query: 122 N-NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM-DNANIFGLI 179
NN + F L NLQ L +S+ + P S L + DN NI +
Sbjct: 88 KANNLLYINPEAFQNLPNLQYLLISNT-GIKHLP-DVHKIHSLQKVLLDIQDNINIHTIE 145
Query: 180 PDFFDSFS-NLQNLRLSYNNFTGSLPASFAKSDIQNL-WMNDQQL-GLSGTLDVLSGMTQ 236
+ F S L L+ N ++F + + L ++ L L DV G +
Sbjct: 146 RNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPN--DVFHGASG 203
Query: 237 LRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294
+ + + + +P L + L S L + L AL+ SL
Sbjct: 204 PVILDISRTRIH-SLPSYGLENLKKLRARST--YNLKKLPTLE--KLVALMEASLTYPSH 258
Query: 295 QGPYPLFPSKVQKVSL--DHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352
+ + ++ ++ + + + + + + ++ +
Sbjct: 259 CCAFANWRRQISELHPICNKSILRQEVDYMTQARGQRSSLAEDNESSYSRGFDMTYTEFD 318
Query: 353 NNACDGWPFVTCS 365
+ C+ VTCS
Sbjct: 319 YDLCNEVVDVTCS 331
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 55/245 (22%), Positives = 88/245 (35%), Gaps = 49/245 (20%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
LG G +G V +AVK ++ + EI + + H ++V G+
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEY 699
G+ + L EY G L + + A+ GV Y
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRIEP-----------DIGMPE--PDAQRFFHQLMAGVVY 120
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA---GTFGYLA 756
LH HRD+KP N+L+ + K++DFGL + E L GT Y+A
Sbjct: 121 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYN--NRERLLNKMCGTLPYVA 175
Query: 757 PE------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP-DDRAHLVTWFRRVLIS 809
PE + A +DV++ G+VL + G +P D + +
Sbjct: 176 PELLKRREFHA-----EPVDVWSCGIVLTAMLAGE------LPWDQPSDSCQEYSDWKEK 224
Query: 810 KENIP 814
K +
Sbjct: 225 KTYLN 229
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 1e-20
Identities = 52/259 (20%), Positives = 101/259 (38%), Gaps = 46/259 (17%)
Query: 548 SELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVY-GGELPDGT 606
+ H G + + G + + D + LG G +G VY +
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATSI-DRYRRITKLGEGTYGEVYKAIDTVTNE 60
Query: 607 KIAVK--RMESNTMGNKGLSEFQA--EIAVLTKVRHRHLVALLGYCINGSERLLVYEYMP 662
+A+K R+E G A E+++L +++HR+++ L + L++EY
Sbjct: 61 TVAIKRIRLEHEEEG----VPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE 116
Query: 663 RGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-- 720
L +++ D ++ + + + GV + HS + +HRDLKP N+L+
Sbjct: 117 N-DLKKYM----DKN-PDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSV 167
Query: 721 ---GDDMRAKVADFGL--VKNAPDGKYS--VETRLAGTFGYLAPE-------YAATGRVT 766
+ K+ DFGL P +++ + T Y PE Y +
Sbjct: 168 SDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW-----YRPPEILLGSRHY------S 216
Query: 767 TKIDVYAFGVVLMETITGR 785
T +D+++ + E +
Sbjct: 217 TSVDIWSIACIWAEMLMKT 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-20
Identities = 45/250 (18%), Positives = 83/250 (33%), Gaps = 37/250 (14%)
Query: 56 EWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANAT 113
+ + I P + TQ TL ++ IPS +N
Sbjct: 12 QEEDFRVTC-KDIQRI------------PSLPPSTQ--TLKLIETHLR-TIPSHAFSNLP 55
Query: 114 SLQDIYLDNNN-FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
++ IY+ + + + F L+ + + + + NL P+ L + L L + N
Sbjct: 56 NISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYID-PDALKELPLLKFLGIFN 114
Query: 173 ANIFGLIPD--FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL-- 228
+ PD S L ++ N + S+P + Q L L L
Sbjct: 115 -TGLKMFPDLTKVYSTDIFFILEITDNPYMTSIPVN----AFQGLCNETLTLKLYNNGFT 169
Query: 229 ----DVLSGMTQLRQVWLHKNQFTGPIPD--LSKCES-LFDLSLRDNQLTGVVPASVISL 281
+G T+L V+L+KN++ I S L + +T + + L
Sbjct: 170 SVQGYAFNG-TKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHL 228
Query: 282 PALLNISLQN 291
L+ +
Sbjct: 229 KELIARNTWT 238
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 2e-19
Identities = 34/219 (15%), Positives = 70/219 (31%), Gaps = 24/219 (10%)
Query: 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149
Q E +I IPSL S Q + L + ++P+ F L N+ + +S +
Sbjct: 11 HQEEDFRVTCKDIQ-RIPSLP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVT 67
Query: 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPASFA 208
L + + +T + + N I D L+ L + P
Sbjct: 68 LQQLE-SHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 209 KSDIQNLWM-----NDQQLGLSGTLDVLSGMT-QLRQVWLHKNQFTGPIPD----LSKCE 258
++ N + + G+ + + L+ N FT + +K
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPV--NAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTK-- 180
Query: 259 SLFDLSLRDNQLTGVVPASVIS-LPALLNI-SLQNNKLQ 295
L + L N+ V+ + + ++ + +
Sbjct: 181 -LDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 42/341 (12%), Positives = 83/341 (24%), Gaps = 140/341 (41%)
Query: 104 GAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKST 163
G +D + + +P+ + Q L L +
Sbjct: 2 GCSSPPCECHQEEDFRVTCKDIQRIPSL----PPSTQTLKLIETH--------------- 42
Query: 164 SLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLG 223
L T+ F + N+ + +S + L +
Sbjct: 43 -LRTIP----------SHAFSNLPNISRIYVSIDVTLQQLES------------------ 73
Query: 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA 283
++++ + + LT + P ++ LP
Sbjct: 74 -----HSFYNLSKVTHIEIRNT----------------------RNLTYIDPDALKELPL 106
Query: 284 LLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343
L + + N L+ ++ + +L+I
Sbjct: 107 LKFLGIFNTGLK-------------MFPDLTKVYST---------DIFFILEI------- 137
Query: 344 AILSDSWEGNNACDGWPFVTCSQGRIITI------NLANKL----LAGN-IS--PAYA-N 389
N + +I L N+ L N + YA N
Sbjct: 138 -------TDNP-------------YMTSIPVNAFQGLCNETLTLKLYNNGFTSVQGYAFN 177
Query: 390 LTSLKNLYLQQNNLTGPIPDG-LTKLAS-LQNLDVSNNNLS 428
T L +YL +N I + S LDVS +++
Sbjct: 178 GTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 14/89 (15%), Positives = 32/89 (35%), Gaps = 7/89 (7%)
Query: 65 SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANA---TSLQDIYLD 121
N T+ L +G + ++ + T+L+ + N I A + + +
Sbjct: 155 CNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVS 213
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNPNL 150
+ T++P+ + L L + L
Sbjct: 214 QTSVTALPSKGLEHLKELIARN---TWTL 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 3e-20
Identities = 48/227 (21%), Positives = 84/227 (37%), Gaps = 33/227 (14%)
Query: 578 QVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQA--------- 628
+ ++ + G +G V G +G +A+KR+ + + ++
Sbjct: 19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78
Query: 629 EIAVLTKVRHRHLVALLGYCINGSERL-----LVYEYMPRGT-LAQHLFEWHDHGYTPLT 682
EI +L H +++ L ++ E LV E M T LAQ + ++
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQVI----HDQRIVIS 132
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
+ + G+ LH +HRDL P NIL+ D+ + DF L +
Sbjct: 133 PQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN 189
Query: 743 S---VETRLAGTFGYLAPEY-AATGRVTTKIDVYAFGVVLMETITGR 785
V R Y APE T +D+++ G V+ E +
Sbjct: 190 KTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 63/252 (25%), Positives = 95/252 (37%), Gaps = 38/252 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
D F LG G FG V + + A+K ++ + K + E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
LV L + + L +V EY+ G + HL ++ + AR
Sbjct: 101 PFLVKLE-FSFKDNSNLYMVMEYVAGGEMFSHL-------------RRIGRFSEPHARFY 146
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
EYLHSL I+RDLKP N+LI +V DFG K ++ L
Sbjct: 147 AAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT----LC 199
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809
GT LAPE + +D +A GV++ E G D + + +++
Sbjct: 200 GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA---DQPIQI---YEKIVSG 253
Query: 810 KENIPKAIDPNL 821
K P +L
Sbjct: 254 KVRFPSHFSSDL 265
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 6e-20
Identities = 59/252 (23%), Positives = 105/252 (41%), Gaps = 40/252 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
+F LG G FG V+ + A+K ++ + K + E +L+ V H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI-ALDVAR- 695
++ + ++++ ++ +Y+ G L L ++ VA+
Sbjct: 66 PFIIRMW-GTFQDAQQIFMIMDYIEGGELFSLL--------------RKSQRFPNPVAKF 110
Query: 696 -------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRL 748
+EYLHS I+RDLKP NIL+ + K+ DFG K PD Y+ L
Sbjct: 111 YAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT----L 163
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808
GT Y+APE +T ID ++FG+++ E + G D + + ++L
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD---SNTMKT---YEKILN 217
Query: 809 SKENIPKAIDPN 820
++ P + +
Sbjct: 218 AELRFPPFFNED 229
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 7e-20
Identities = 63/218 (28%), Positives = 91/218 (41%), Gaps = 19/218 (8%)
Query: 38 SLQNLPSDWSSTSSTGYCEWTGI----NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLE 93
Q P D + + + + + N + I S + I L +
Sbjct: 9 IKQIFPDDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDI--KSVQGIQYLPNVR 66
Query: 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPW 153
L+ N + I +L T+L + L N S+P G FD LTNL+ L L +N L
Sbjct: 67 YLALGGNKLH-DISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVEN-QLQSL 124
Query: 154 PFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SD 211
P K T+LT L + + + L FD +NL L LSYN SLP F K +
Sbjct: 125 P-DGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQ 182
Query: 212 IQNLWMNDQQLGLS---GTLDVLSGMTQLRQVWLHKNQ 246
+++L + QL S G D L T L+ +WLH N
Sbjct: 183 LKDLRLYQNQLK-SVPDGVFDRL---TSLQYIWLHDNP 216
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 35/187 (18%), Positives = 62/187 (33%), Gaps = 39/187 (20%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
L + T T + L ++ + +++ + ++ L +
Sbjct: 19 AETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ----YLPNVRYLALGG 72
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
+ + +NL L L+ N SLP V
Sbjct: 73 NKLHDI--SALKELTNLTYLILTGNQLQ-SLPN-----------------------GVFD 106
Query: 233 GMTQLRQVWLHKNQFT---GPIPDLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNIS 288
+T L+++ L +NQ + D K +L L+L NQL +P V L L +
Sbjct: 107 KLTNLKELVLVENQLQSLPDGVFD--KLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELD 163
Query: 289 LQNNKLQ 295
L N+LQ
Sbjct: 164 LSYNQLQ 170
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 3e-09
Identities = 39/199 (19%), Positives = 67/199 (33%), Gaps = 43/199 (21%)
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180
P F L ++ NEL S+ + +N++I +
Sbjct: 6 STPIKQIFPDDAFAETIKAN---LKKK-SVTDAVTQNELN---SIDQIIANNSDIKSVQG 58
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV 240
N++ L L N + L +T L +
Sbjct: 59 --IQYLPNVRYLALGGNKLH-DIS-------------------------ALKELTNLTYL 90
Query: 241 WLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQNNKLQG- 296
L NQ +P+ K +L +L L +NQL +P V L L ++L +N+LQ
Sbjct: 91 ILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSL 148
Query: 297 PYPLFPS--KVQKVSLDHN 313
P +F + ++ L +N
Sbjct: 149 PKGVFDKLTNLTELDLSYN 167
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 1e-19
Identities = 43/215 (20%), Positives = 72/215 (33%), Gaps = 60/215 (27%)
Query: 90 TQLETLSFQMNNIAGAIPS---LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
+ L NN++ + + T+L + L +N+ + + F + NL+ L LS
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97
Query: 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS 206
N L TL F L+ L L N+ +
Sbjct: 98 NH----------------LHTLD----------EFLFSDLQALEVLLLYNNHIV-VVDR- 129
Query: 207 FAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT----GPIPDLSKCESLFD 262
+ M QL++++L +NQ + I D +K L
Sbjct: 130 ----------------------NAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLML 167
Query: 263 LSLRDNQLTGVVPASVISLPAL--LNISLQNNKLQ 295
L L N+L + + LPA + L NN L+
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 31/151 (20%), Positives = 54/151 (35%), Gaps = 17/151 (11%)
Query: 81 TLSPEI--SSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGL 136
L E + LT L +L N++ I S A +L+ + L +N+ ++ F L
Sbjct: 53 RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDL 111
Query: 137 TNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLR- 193
L+VL L +N + F + + L LY+ I + + L L
Sbjct: 112 QALEVLLLYNNHIVVVDRNAFED-M---AQLQKLYLSQNQISRFPVELIKDGNKLPKLML 167
Query: 194 --LSYNNFTGSLPASFA---KSDIQNLWMND 219
LS N L++++
Sbjct: 168 LDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 7e-11
Identities = 29/176 (16%), Positives = 51/176 (28%), Gaps = 55/176 (31%)
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
+VP + +L LS N L P LT L +L + + ++ +
Sbjct: 27 KQQLPNVPQSLP---SYTALLDLSHNNLSRLRAEWTPTRLTN---LHSLLLSHNHLNFIS 80
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239
+ F NL+ L LS N+ +L + S + L
Sbjct: 81 SEAFVPVPNLRYLDLSSNHLH-TLDE-----------------------FLFSDLQALEV 116
Query: 240 VWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
L L +N + V + + L + L N++
Sbjct: 117 -----------------------LLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 29/134 (21%), Positives = 43/134 (32%), Gaps = 29/134 (21%)
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
S L LS+NN + L A + + +T L + L N
Sbjct: 38 PSYTALLDLSHNNLS-RLRAEWT----------------------PTRLTNLHSLLLSHN 74
Query: 246 QFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLFP 302
I +L L L N L + L AL + L NN + F
Sbjct: 75 HLNF-ISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFE 133
Query: 303 --SKVQKVSLDHNN 314
+++QK+ L N
Sbjct: 134 DMAQLQKLYLSQNQ 147
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 15/68 (22%), Positives = 21/68 (30%), Gaps = 6/68 (8%)
Query: 87 SSLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV- 141
+ QL+ L N I I L + L +N +P L
Sbjct: 133 EDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKN 192
Query: 142 -LSLSDNP 148
L L +NP
Sbjct: 193 GLYLHNNP 200
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 11/44 (25%), Positives = 24/44 (54%), Gaps = 2/44 (4%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
A+ + +L+ L L N+L + + + L +L+ L + NN++
Sbjct: 83 AFVPVPNLRYLDLSSNHLHT-LDEFLFSDLQALEVLLLYNNHIV 125
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.9 bits (101), Expect = 4e-04
Identities = 12/42 (28%), Positives = 22/42 (52%), Gaps = 2/42 (4%)
Query: 388 ANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
++L +L+ L L N++ + +A LQ L +S N +S
Sbjct: 109 SDLQALEVLLLYNNHIVV-VDRNAFEDMAQLQKLYLSQNQIS 149
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 16/47 (34%), Positives = 24/47 (51%), Gaps = 5/47 (10%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDG----LTKLASLQNLDVSNNNLS 428
A+ ++ L+ LYL QN ++ P KL L LD+S+N L
Sbjct: 131 AFEDMAQLQKLYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLK 176
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 16/54 (29%), Positives = 25/54 (46%), Gaps = 2/54 (3%)
Query: 376 NKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLS 428
N L LT+L +L L N+L I + +L+ LD+S+N+L
Sbjct: 49 NNLSRLRAEWTPTRLTNLHSLLLSHNHLNF-ISSEAFVPVPNLRYLDLSSNHLH 101
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 90.4 bits (224), Expect = 2e-19
Identities = 54/272 (19%), Positives = 85/272 (31%), Gaps = 84/272 (30%)
Query: 587 NILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAE----------- 629
LGRG FG V + +AVK ++ + +E
Sbjct: 28 KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHL 86
Query: 630 -----IAVLTKVRHRHLVALLGYCING-------SERLLVYEY----------------- 660
+ TK +V ++ +C G S+R Y
Sbjct: 87 NVVNLLGACTKPGGPLMV-IVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145
Query: 661 ------------------------MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
+ + D LT + + + VA+G
Sbjct: 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKG 205
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL- 755
+E+L A + IHRDL NIL+ + K+ DFGL ++ V L
Sbjct: 206 MEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV----RKGDARLP 258
Query: 756 ----APEYAATGRVTTKIDVYAFGVVLMETIT 783
APE T + DV++FGV+L E +
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 36/182 (19%), Positives = 61/182 (33%), Gaps = 53/182 (29%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
++ +I L+ N +P G F L+ + LS+N ++ L
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNN----------------QISELA--- 72
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
PD F +L +L L N T LP +
Sbjct: 73 -------PDAFQGLRSLNSLVLYGNKIT-ELPK-----------------------SLFE 101
Query: 233 GMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
G+ L+ + L+ N+ + +L LSL DN+L + + L A+ + L
Sbjct: 102 GLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160
Query: 291 NN 292
N
Sbjct: 161 QN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 6e-12
Identities = 29/139 (20%), Positives = 46/139 (33%), Gaps = 32/139 (23%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPS--LANATSLQDIY 119
++ I L+ + +S L+P+ L L +L N I +P SLQ +
Sbjct: 53 SPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLL 110
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179
L+ N + F L NL +LSL DN + +
Sbjct: 111 LNANKINCLRVDAFQDLHNLNLLSLYDN--------------------------KLQTIA 144
Query: 180 PDFFDSFSNLQNLRLSYNN 198
F +Q + L N
Sbjct: 145 KGTFSPLRAIQTMHL-AQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 16/63 (25%), Positives = 27/63 (42%), Gaps = 3/63 (4%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
L L+ L N I + A + +L + L +N ++ G F L +Q + L+
Sbjct: 102 GLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLA 160
Query: 146 DNP 148
NP
Sbjct: 161 QNP 163
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 11/41 (26%), Positives = 17/41 (41%), Gaps = 2/41 (4%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNLS 428
L SL+ L L N + + L +L L + +N L
Sbjct: 102 GLFSLQLLLLNANKINC-LRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 16/44 (36%), Positives = 24/44 (54%), Gaps = 2/44 (4%)
Query: 386 AYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNLS 428
A+ L SL +L L N +T +P L L SLQ L ++ N ++
Sbjct: 75 AFQGLRSLNSLVLYGNKITE-LPKSLFEGLFSLQLLLLNANKIN 117
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 57/261 (21%), Positives = 99/261 (37%), Gaps = 80/261 (30%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA---EIAVLT 634
+ +S LG G FG+V ++ G + A+K++ L + + E+ ++
Sbjct: 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV---------LQDPRYKNRELDIMK 55
Query: 635 KVRHRHLVALLGYCINGSERL--------------------------------------L 656
+ H +++ L+ Y + +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL------DVARGVEYLHSLAQQSFIH 710
+ EY+P TL + L + + + + + L + R V ++HSL H
Sbjct: 116 IMEYVP-DTLHKVL-------KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICH 164
Query: 711 RDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVE---TRLAGTFGYLAPE--YAATGR 764
RD+KP N+L+ D K+ DFG K + SV +R Y APE AT
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGAT-E 218
Query: 765 VTTKIDVYAFGVVLMETITGR 785
T ID+++ G V E I G+
Sbjct: 219 YTPSIDLWSIGCVFGELILGK 239
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 32/212 (15%), Positives = 71/212 (33%), Gaps = 38/212 (17%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
S+ ++ A + A SL I L N N T + TG + N++ L++++
Sbjct: 20 STFKAYLNGLLGQSSTA--NITEAQMNSLTYITLANINVTDL-TG-IEYAHNIKDLTINN 75
Query: 147 NP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
N P ++ ++L L + ++ ++L L +S++ S
Sbjct: 76 IHATNYNP------ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS-- 127
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264
L ++ + ++ + L N I L L L+
Sbjct: 128 ----------------------ILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLN 165
Query: 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
++ + + + P L + + + G
Sbjct: 166 IQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 29/208 (13%), Positives = 64/208 (30%), Gaps = 55/208 (26%)
Query: 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF 125
N +T I+LA ++ L+ I ++ L+ + ++ ++L+ + + +
Sbjct: 44 NSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIHATN-YNPISGLSNLERLRIMGKDV 100
Query: 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDS 185
TS GLT+L +L +S + I ++
Sbjct: 101 TSDKIPNLSGLTSLTLLDISHS--------------------------AHDDSILTKINT 134
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+ ++ LSYN +DI L + +L+ + + +
Sbjct: 135 LPKVNSIDLSYNGAI---------TDIMP----------------LKTLPELKSLNIQFD 169
Query: 246 QFTGPIPDLSKCESLFDLSLRDNQLTGV 273
+ L L + G
Sbjct: 170 GVHD-YRGIEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 32/214 (14%), Positives = 64/214 (29%), Gaps = 50/214 (23%)
Query: 220 QQLGLSGTLDV-LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASV 278
LG S T ++ + M L + L T + + ++ DL++ + T P S
Sbjct: 28 GLLGQSSTANITEAQMNSLTYITLANINVTD-LTGIEYAHNIKDLTINNIHATNYNPIS- 85
Query: 279 ISLPALLNISLQNNKLQ--GPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQ 335
L L + + + L + + + + H+
Sbjct: 86 -GLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSA--------------------- 123
Query: 336 IAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKN 395
DS T + + +I+L+ +I P L LK+
Sbjct: 124 ----------HDDS-------ILTKINTLPK--VNSIDLSYNGAITDIMP-LKTLPELKS 163
Query: 396 LYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429
L +Q + + + L L + + G
Sbjct: 164 LNIQFDGVHDYRG--IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 3e-06
Identities = 13/56 (23%), Positives = 27/56 (48%), Gaps = 1/56 (1%)
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSN 437
N +P + L++L+ L + ++T L+ L SL LD+S++ + +
Sbjct: 80 NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 4e-05
Identities = 12/72 (16%), Positives = 27/72 (37%)
Query: 371 TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430
+ + K + + P + LTSL L + + I + L + ++D+S N
Sbjct: 92 RLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITD 151
Query: 431 VPDFGSNVKFTV 442
+ + +
Sbjct: 152 IMPLKTLPELKS 163
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 4e-19
Identities = 65/251 (25%), Positives = 97/251 (38%), Gaps = 37/251 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKVRH 638
++F +LG+G FG V + A+K + + ++ E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 639 RHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR-- 695
L AL Y +RL V EY G L HL + + AR
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGELFFHL-------------SRERVFTEERARFY 110
Query: 696 ------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-L 748
+EYLHS ++RD+K N+++ D K+ DFGL K +
Sbjct: 111 GAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTF 165
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808
GT YLAPE +D + GVV+ E + GR + D L F +L+
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN---QDHERL---FELILM 219
Query: 809 SKENIPKAIDP 819
+ P+ + P
Sbjct: 220 EEIRFPRTLSP 230
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 4e-19
Identities = 63/246 (25%), Positives = 96/246 (39%), Gaps = 45/246 (18%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGY 647
+G G FGV +AVK +E ++ + Q EI +RH ++V
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV---QREIINHRSLRHPNIVRFKEV 84
Query: 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEY 699
+ + ++ EY G L+E + R + D AR GV Y
Sbjct: 85 ILTPTHLAIIMEYASGG----ELYER-------ICNAGRFSE--DEARFFFQQLLSGVSY 131
Query: 700 LHSLAQQSFIHRDLKPSNILI--GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
HS HRDLK N L+ R K+ DFG K++ ++ + GT Y+AP
Sbjct: 132 CHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV-GTPAYIAP 186
Query: 758 E------YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811
E Y DV++ GV L + G +D P++ +R+L K
Sbjct: 187 EVLLRQEYDG-----KIADVWSCGVTLYVMLVGAYPFED--PEEPRDYRKTIQRILSVKY 239
Query: 812 NIPKAI 817
+IP I
Sbjct: 240 SIPDDI 245
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 5e-19
Identities = 56/236 (23%), Positives = 95/236 (40%), Gaps = 45/236 (19%)
Query: 571 ISIEVLRQ---VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEF 626
S+E+ V + +G G G+V + +A+K++ S N+
Sbjct: 12 YSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPFQNQTH--- 67
Query: 627 QA-----EIAVLTKVRHRHLVALL------GYCINGSERLLVYEYMP---RGTLAQHLFE 672
A E+ ++ V H++++ LL + +V E M + L
Sbjct: 68 -AKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL-- 124
Query: 673 WHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732
H+ + L ++ + G+++LHS IHRDLKPSNI++ D K+ DFG
Sbjct: 125 DHER-MSYLLYQ--------MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172
Query: 733 LVKNAPDGKYS---VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
L + A V TR Y APE +D+++ G ++ E I G
Sbjct: 173 LARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 8e-19
Identities = 64/253 (25%), Positives = 108/253 (42%), Gaps = 37/253 (14%)
Query: 581 DNFSEANILGRGGFGVVY---GGELPDGTKI-AVKRMESNTMGNKGLSEFQAEIAVLTKV 636
F +LG+G FG V+ D ++ A+K ++ T+ + + E +L +V
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 637 RHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +V L Y +L L+ +++ G L L + V + +
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRL-------------SKEVMFTEEDVK 129
Query: 696 --------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR 747
+++LHSL I+RDLKP NIL+ ++ K+ DFGL K + D + +
Sbjct: 130 FYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS- 185
Query: 748 LAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807
GT Y+APE T D ++FGV++ E +TG DR +L
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG---KDRKET---MTMIL 239
Query: 808 ISKENIPKAIDPN 820
+K +P+ + P
Sbjct: 240 KAKLGMPQFLSPE 252
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-19
Identities = 46/200 (23%), Positives = 82/200 (41%), Gaps = 24/200 (12%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALL 645
+LG G G V K A+K ++ + + E+ + + + H+V ++
Sbjct: 69 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIV 121
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
N L+V E + G L + + D +T ++ I + ++YLH
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE---REASEIMKSIGEAIQYLH 178
Query: 702 SLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
S + HRD+KP N+L + K+ DFG K S+ T T Y+APE
Sbjct: 179 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-SLTTP-CYTPYYVAPE 233
Query: 759 YAATGRVTTKIDVYAFGVVL 778
+ D+++ GV++
Sbjct: 234 VLGPEKYDKSCDMWSLGVIM 253
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 1e-18
Identities = 53/192 (27%), Positives = 72/192 (37%), Gaps = 34/192 (17%)
Query: 105 AIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKS 162
++PS A+ L L + ++ F GLT L L+L N L
Sbjct: 28 SVPSGIPADTEKL---DLQSTGLATLSDATFRGLTKLTWLNLDYN-QLQTLS-AGVFDDL 82
Query: 163 TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
T L TL + N + L FD + L L L N SLP+
Sbjct: 83 TELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLK-SLPS----------------- 124
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVIS 280
G D L T+L+++ L+ NQ IP K +L LSL NQL V +
Sbjct: 125 ---GVFDRL---TKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDR 177
Query: 281 LPALLNISLQNN 292
L L I+L N
Sbjct: 178 LGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 48/166 (28%), Positives = 67/166 (40%), Gaps = 37/166 (22%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
LT+L L+ N + AG L T L + L NN S+P G FD LT L L
Sbjct: 57 GLTKLTWLNLDYNQLQTLSAGVFDDL---TELGTLGLANNQLASLPLGVFDHLTQLDKLY 113
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
L N+L L FD + L+ LRL+ N S+
Sbjct: 114 LGG----------NQLKS----------------LPSGVFDRLTKLKELRLNTNQLQ-SI 146
Query: 204 PAS-FAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247
PA F K +++Q L ++ QL S + +L+ + L NQF
Sbjct: 147 PAGAFDKLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGNQF 191
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 13/112 (11%)
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT----GPIPDLSKCESLFDLSL 265
+D + L + L + + G+T+L + L NQ G DL++ L L L
Sbjct: 35 ADTEKLDLQSTGLA-TLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTE---LGTLGL 90
Query: 266 RDNQLTGVVPASV-ISLPALLNISLQNNKLQG-PYPLFPS--KVQKVSLDHN 313
+NQL +P V L L + L N+L+ P +F K++++ L+ N
Sbjct: 91 ANNQLA-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTN 141
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 40/174 (22%), Positives = 59/174 (33%), Gaps = 55/174 (31%)
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQG-PYPLF--PSKVQKVSLDHNNFCKNS 319
L L+ L + A+ L L ++L N+LQ +F +++ + L +N
Sbjct: 40 LDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANN------ 93
Query: 320 SDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL 379
Q+ +L P + D L L
Sbjct: 94 ---------QLASL---------PLGVFDH---------------------LTQLDKLYL 114
Query: 380 AGN----ISP-AYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNL 427
GN + + LT LK L L N L IP G KL +LQ L +S N L
Sbjct: 115 GGNQLKSLPSGVFDRLTKLKELRLNTNQLQS-IPAGAFDKLTNLQTLSLSTNQL 167
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 1e-18
Identities = 54/222 (24%), Positives = 92/222 (41%), Gaps = 33/222 (14%)
Query: 581 DNFSEANILGRGGFGVVYGG--ELPDGTKIAVK--RMESNTMGNKGLSEFQA--EIAVL- 633
+ +G G +G V+ G +A+K R+++ G E+AVL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG----MPLSTIREVAVLR 66
Query: 634 --TKVRHRHLVALL----GYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR 686
H ++V L + +L LV+E++ + L +L + +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYL---DKVPEPGVPTETI 122
Query: 687 VTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVET 746
+ + RG+++LHS +HRDLKP NIL+ + K+ADFGL + YS +
Sbjct: 123 KDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR-----IYSFQM 174
Query: 747 RLAG---TFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
L T Y APE T +D+++ G + E +
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 86.8 bits (215), Expect = 6e-18
Identities = 58/260 (22%), Positives = 101/260 (38%), Gaps = 39/260 (15%)
Query: 544 NGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQ---VTDNFSEANILGRGGFGVVYGG 600
G ++ + + N S+EV V + +G G G+V
Sbjct: 22 QGFDKQVDVSYIAKHYNMSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAA 81
Query: 601 -ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIAVLTKVRHRHLVALL------GYC 648
+ +A+K++ S N+ A E+ ++ V H+++++LL
Sbjct: 82 YDAVLDRNVAIKKL-SRPFQNQTH----AKRAYRELVLMKCVNHKNIISLLNVFTPQKTL 136
Query: 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708
+ LV E M L Q + L ++ + + G+++LHS
Sbjct: 137 EEFQDVYLVMELMD-ANLCQVI-------QMELDHERMSYLLYQMLCGIKHLHSA---GI 185
Query: 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY---SVETRLAGTFGYLAPEYAATGRV 765
IHRDLKPSNI++ D K+ DFGL + A V TR Y APE
Sbjct: 186 IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGY 240
Query: 766 TTKIDVYAFGVVLMETITGR 785
+D+++ G ++ E + +
Sbjct: 241 KENVDIWSVGCIMGEMVRHK 260
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 9e-18
Identities = 40/211 (18%), Positives = 64/211 (30%), Gaps = 43/211 (20%)
Query: 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
L + ++ + S + +Q+ DN+N S+ TNL+ L LS
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHLS 71
Query: 146 DNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203
N +L+P L T L L ++ + L + L L L N
Sbjct: 72 HNQISDLSP------LKDLTKLEELSVNRNRLKNLNG---IPSACLSRLFLDNNELR--- 119
Query: 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDL 263
D L + L + + N+ I L L L
Sbjct: 120 -----------------------DTDSLIHLKNLEILSIRNNKLKS-IVMLGFLSKLEVL 155
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKL 294
L N++T + L + I L K
Sbjct: 156 DLHGNEITNTGG--LTRLKKVNWIDLTGQKC 184
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 37/239 (15%), Positives = 81/239 (33%), Gaps = 53/239 (22%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
VT + L+ ++ + +NI ++ + T+L++++L +N
Sbjct: 27 GKQSVTDLV------------SQKELSGVQNFNGDNSNIQ-SLAGMQFFTNLKELHLSHN 73
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
+ + LT L+ LS++ N NL S L+ L++DN +
Sbjct: 74 QISDLSP--LKDLTKLEELSVNRNRLKNLNG-------IPSACLSRLFLDNNELRDTDS- 123
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
NL+ L + N ++ +L +++L +
Sbjct: 124 -LIHLKNLEILSIRNNKLK--------------------------SIVMLGFLSKLEVLD 156
Query: 242 LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL 300
LH N+ T L++ + + + L + L + + + PY +
Sbjct: 157 LHGNEITN-TGGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPYYI 214
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 32/266 (12%), Positives = 75/266 (28%), Gaps = 77/266 (28%)
Query: 163 TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
+ + ++ L+ S +QN +N + +
Sbjct: 19 ANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ----------SLAGM------- 59
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLP 282
T L+++ L NQ + + L L +LS+ N+L + + I
Sbjct: 60 ---------QFFTNLKELHLSHNQISD-LSPLKDLTKLEELSVNRNRLKNL---NGIPSA 106
Query: 283 ALLNISLQNNKLQGPYPLFP-SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMG 341
L + L NN+L+ L ++ +S+ +N ++ +++ +
Sbjct: 107 CLSRLFLDNNELRDTDSLIHLKNLEILSIRNN---------------KLKSIVMLGF--- 148
Query: 342 YPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQN 401
LS ++ ++L + N L + + L
Sbjct: 149 ----LS--------------------KLEVLDLHGNEIT-NTGG-LTRLKKVNWIDLTGQ 182
Query: 402 NLTGPIPDGLTKLASLQNLDVSNNNL 427
+L + +
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRW 208
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 5e-08
Identities = 38/258 (14%), Positives = 77/258 (29%), Gaps = 77/258 (29%)
Query: 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDV 230
I + PD +N L + T D+ +
Sbjct: 5 RPTPINQVFPD--PGLANAVKQNLGKQSVT----------DLVSQ--------------- 37
Query: 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
++ ++ + + + +L +L L NQ++ + P L L +S+
Sbjct: 38 -KELSGVQNFNGDNSNIQS-LAGMQFFTNLKELHLSHNQISDLSPLK--DLTKLEELSVN 93
Query: 291 NNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
N+L+ + + + ++ LD+N
Sbjct: 94 RNRLKNLNGIPSACLSRLFLDNNELRDTD------------------------------- 122
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
+ I++I NKL +I L+ L+ L L N +T G
Sbjct: 123 ---------SLIHLKNLEILSIR-NNKL--KSIVM-LGFLSKLEVLDLHGNEITN--TGG 167
Query: 411 LTKLASLQNLDVSNNNLS 428
LT+L + +D++
Sbjct: 168 LTRLKKVNWIDLTGQKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 4e-04
Identities = 21/138 (15%), Positives = 40/138 (28%), Gaps = 18/138 (13%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+N++ +I + L++LE L N I L + I L
Sbjct: 136 RNNKLKSIV------------MLGFLSKLEVLDLHGNEIT-NTGGLTRLKKVNWIDLTGQ 182
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ P L + D ++ P ++ S + + +
Sbjct: 183 KCVNEPVKYQPELYITNTVKDPDGRWIS----PYYISNGGSYVDGCV-LWELPVYTDEVS 237
Query: 184 DSFSNLQNLRLSYNNFTG 201
FS N+ + F G
Sbjct: 238 YKFSEYINVGETEAIFDG 255
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 2e-17
Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 22/244 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
+F+ +LG+G FG V E ++ AVK ++ + + + E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
L L C +RL V EY+ G L +H V A ++A G
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGG----DLM-YHIQQVGRFKEPHAVFYAAEIAIG 454
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+ +L S + I+RDLK N+++ + K+ADFG+ K + V T+ GT Y+
Sbjct: 455 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYI 509
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815
APE A +D +AFGV+L E + G+ + +D L F+ ++ PK
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDEL---FQSIMEHNVAYPK 563
Query: 816 AIDP 819
++
Sbjct: 564 SMSK 567
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-17
Identities = 65/293 (22%), Positives = 115/293 (39%), Gaps = 42/293 (14%)
Query: 547 PSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVT-DNFSEANILGRGGFGVVYGGELPDG 605
L+ Q + E N S + + +F ++GRG + V L
Sbjct: 17 TENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKT 76
Query: 606 TKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERL-LVYEYM 661
+I A++ ++ ++ + Q E V + H LV L C RL V EY+
Sbjct: 77 DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH-SCFQTESRLFFVIEYV 135
Query: 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEYLHSLAQQSFIHRDL 713
G L H+ +++ + + AR + YLH + I+RDL
Sbjct: 136 NGGDLMFHM-------------QRQRKLPEEHARFYSAEISLALNYLHE---RGIIYRDL 179
Query: 714 KPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYLAPEYAATGRVTTKIDVY 772
K N+L+ + K+ D+G+ K + T GT Y+APE +D +
Sbjct: 180 KLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWW 237
Query: 773 AFGVVLMETITGR------KALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819
A GV++ E + GR + D+ + +L F+ +L + IP+++
Sbjct: 238 ALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---FQVILEKQIRIPRSLSV 287
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-17
Identities = 51/223 (22%), Positives = 99/223 (44%), Gaps = 37/223 (16%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIA 631
++ + +G G +G V + G K+A+K++ S ++ A E+
Sbjct: 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL-SRPFQSEIF----AKRAYRELL 75
Query: 632 VLTKVRHRHLVALL------GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQ 685
+L ++H +++ LL N + LV +M L + + + ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM-------GLKFSEEK 127
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YS 743
+ + +G++Y+HS +HRDLKP N+ + +D K+ DFGL ++A Y
Sbjct: 128 IQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY- 183
Query: 744 VETRLAGTFGYLAPEYA-ATGRVTTKIDVYAFGVVLMETITGR 785
V TR Y APE + +D+++ G ++ E +TG+
Sbjct: 184 VVTRW-----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 5e-17
Identities = 37/196 (18%), Positives = 63/196 (32%), Gaps = 44/196 (22%)
Query: 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLA---N 111
CE T ++C ++ ++ I + L N + +
Sbjct: 11 CEGTTVDC-SNQKLNKI---PEHIP----------QYTAELRLNNNEFT-VLEATGIFKK 55
Query: 112 ATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171
L+ I NN T + G F+G + + + L+ N L SL TL +
Sbjct: 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN-RLENVQ-HKMFKGLESLKTLMLR 113
Query: 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231
+ I + D F S+++ L L N T ++ G D L
Sbjct: 114 SNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAP--------------------GAFDTL 152
Query: 232 SGMTQLRQVWLHKNQF 247
++ L L N F
Sbjct: 153 HSLSTL---NLLANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 32/173 (18%), Positives = 57/173 (32%), Gaps = 31/173 (17%)
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPD 181
N +P L L++N K L + N I +
Sbjct: 20 NQKLNKIPEHIP---QYTAELRLNNN-EFTVLEATGIFKKLPQLRKINFSNNKITDIEEG 75
Query: 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVW 241
F+ S + + L+ N ++ + G+ L+ +
Sbjct: 76 AFEGASGVNEILLTSNRLE-NVQHK-----------------------MFKGLESLKTLM 111
Query: 242 LHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
L N+ T + + S+ LSL DNQ+T V P + +L +L ++L N
Sbjct: 112 LRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 5e-04
Identities = 13/46 (28%), Positives = 24/46 (52%), Gaps = 3/46 (6%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNLSGKVPD 433
L SLK L L+ N +T + + L+S++ L + +N ++ V
Sbjct: 103 GLESLKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQIT-TVAP 146
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 61/255 (23%), Positives = 102/255 (40%), Gaps = 39/255 (15%)
Query: 581 DNFSEANILGRGGFGVVY---GGELPDGTKI-AVK--RMESNTMGNKGLSEFQAEIAVLT 634
+ F +LG+GG+G V+ + KI A+K + K + +AE +L
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 635 KVRHRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDV 693
+V+H +V L+ Y +L L+ EY+ G L L ++ D
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQL-------------EREGIFMEDT 122
Query: 694 AR--------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE 745
A + +LH I+RDLKP NI++ K+ DFGL K +
Sbjct: 123 ACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179
Query: 746 TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805
T GT Y+APE +D ++ G ++ + +TG ++R +
Sbjct: 180 T-FCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG---ENRKKT---IDK 232
Query: 806 VLISKENIPKAIDPN 820
+L K N+P +
Sbjct: 233 ILKCKLNLPPYLTQE 247
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 41/258 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
+F ++GRG + V L +I A+K ++ ++ + Q E V +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR- 695
H LV L C RL V EY+ G L H+ +++ + + AR
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHM-------------QRQRKLPEEHARF 114
Query: 696 -------GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR- 747
+ YLH + I+RDLK N+L+ + K+ D+G+ K + T
Sbjct: 115 YSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTST 169
Query: 748 LAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR------KALDDTMPDDRAHLVT 801
GT Y+APE +D +A GV++ E + GR + D+ + +L
Sbjct: 170 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL-- 227
Query: 802 WFRRVLISKENIPKAIDP 819
F+ +L + IP+++
Sbjct: 228 -FQVILEKQIRIPRSLSV 244
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-16
Identities = 64/289 (22%), Positives = 103/289 (35%), Gaps = 39/289 (13%)
Query: 545 GVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVT-DNFSEANILGRGGFGVVYGGELP 603
G+ + + + +F ++G+G FG V
Sbjct: 1 GISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHK 60
Query: 604 DGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTK-VRHRHLVALLGYCINGSERL-LVYE 659
AVK ++ + K +E VL K V+H LV L + +++L V +
Sbjct: 61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKLYFVLD 119
Query: 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEYLHSLAQQSFIHR 711
Y+ G L HL ++ AR + YLHSL + ++R
Sbjct: 120 YINGGELFYHL-------------QRERCFLEPRARFYAAEIASALGYLHSL---NIVYR 163
Query: 712 DLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYLAPEYAATGRVTTKID 770
DLKP NIL+ + DFGL K + +++ T GT YLAPE +D
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVD 221
Query: 771 VYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819
+ G VL E + G + A + + +L + I
Sbjct: 222 WWCLGAVLYEMLYGLPPFYS---RNTAEM---YDNILNKPLQLKPNITN 264
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 2e-16
Identities = 60/244 (24%), Positives = 99/244 (40%), Gaps = 22/244 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
DNF +LG+G FG V + + + AVK ++ + + + E +L+
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H L L C +RL V E++ G L +H + A ++
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGG----DLM-FHIQKSRRFDEARARFYAAEIISA 136
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+ +LH + I+RDLK N+L+ + K+ADFG+ K V T GT Y+
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYI 191
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815
APE +D +A GV+L E + G + ++ L F +L + P
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA---ENEDDL---FEAILNDEVVYPT 245
Query: 816 AIDP 819
+
Sbjct: 246 WLHE 249
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-16
Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 22/244 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
+F+ +LG+G FG V E ++ AVK ++ + + + E VL +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
L L C +RL V EY+ G L +H V A ++A G
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGG----DLM-YHIQQVGRFKEPHAVFYAAEIAIG 133
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+ +L S + I+RDLK N+++ + K+ADFG+ K + V T+ GT Y+
Sbjct: 134 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYI 188
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815
APE A +D +AFGV+L E + G+ + +D L F+ ++ PK
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG---EDEDEL---FQSIMEHNVAYPK 242
Query: 816 AIDP 819
++
Sbjct: 243 SMSK 246
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-16
Identities = 66/301 (21%), Positives = 112/301 (37%), Gaps = 37/301 (12%)
Query: 537 GNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGV 596
G + G G ++ ++ +H N+ E + +NF +LG G +G
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGI--ENFELLKVLGTGAYGK 69
Query: 597 VY---GGELPDGTKI-AVK--RMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650
V+ D K+ A+K + + K + E VL +R + L Y
Sbjct: 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 129
Query: 651 GSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR--------GVEYLH 701
+L L+ +Y+ G L HL QR + +E+LH
Sbjct: 130 TETKLHLILDYINGGELFTHL-------------SQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA 761
L I+RD+K NIL+ + + DFGL K + GT Y+AP+
Sbjct: 177 KL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 233
Query: 762 TGRV--TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819
G +D ++ GV++ E +TG + + RR+L S+ P+ +
Sbjct: 234 GGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEPPYPQEMSA 291
Query: 820 N 820
Sbjct: 292 L 292
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 4e-16
Identities = 61/244 (25%), Positives = 103/244 (42%), Gaps = 22/244 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKI-AVKRME-SNTMGNKGLSEFQAEIAVLTKV-R 637
++F +LG+G FG V+ E + A+K ++ + + + E VL+
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 638 HRHLVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H L + E L V EY+ G L H+ L + A ++ G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDL--SRATFYAAEIILG 130
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETR-LAGTFGYL 755
+++LHS ++RDLK NIL+ D K+ADFG+ K + +T GT Y+
Sbjct: 131 LQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYI 185
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815
APE + +D ++FGV+L E + G+ D L F + + P+
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEEL---FHSIRMDNPFYPR 239
Query: 816 AIDP 819
++
Sbjct: 240 WLEK 243
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-16
Identities = 57/239 (23%), Positives = 97/239 (40%), Gaps = 64/239 (26%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-------- 628
V ++ + +G G +G+V + + ++A+K+ +S F+
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK----------ISPFEHQTYCQRTL 73
Query: 629 -EIAVLTKVRHRHLVALLGYCINGSERL-----LVYEYMP----RGTLAQHLFEWHDHG- 677
EI +L + RH +++ + + +V + M + QHL DH
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN--DHIC 131
Query: 678 ---YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734
Y L RG++Y+HS + +HRDLKPSN+L+ K+ DFGL
Sbjct: 132 YFLYQIL-------------RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
Query: 735 KNAPDGKYS-------VETRLAGTFGYLAPEYA-ATGRVTTKIDVYAFGVVLMETITGR 785
+ A V TR Y APE + T ID+++ G +L E ++ R
Sbjct: 176 RVADPDHDHTGFLTEYVATR-----WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-15
Identities = 57/247 (23%), Positives = 89/247 (36%), Gaps = 65/247 (26%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA---- 628
++ ++ +F ++LG G +GVV P G +A+K+ + F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK----------IEPFDKPLFA 53
Query: 629 -----EIAVLTKVRHRHLVALLGYCINGSERL-----LVYEYMP----RGTLAQHLFEWH 674
EI +L +H +++ + S ++ E M R Q L + H
Sbjct: 54 LRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDH 113
Query: 675 DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734
Q R V+ LH + IHRDLKPSN+LI + KV DFGL
Sbjct: 114 ---------IQ--YFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLA 159
Query: 735 KNAPDGKYSVETRLAGTFG---------YLAPE-------YAATGRVTTKIDVYAFGVVL 778
+ + G Y APE Y + +DV++ G +L
Sbjct: 160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCIL 213
Query: 779 METITGR 785
E R
Sbjct: 214 AELFLRR 220
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 48/230 (20%), Positives = 90/230 (39%), Gaps = 52/230 (22%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIAV 632
D++ LGRG + V+ + + K+ VK L + EI +
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKI----------LKPVKKKKIKREIKI 83
Query: 633 LTKVR-HRHLVALLGYCINGSER--LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
L +R +++ L + R LV+E++ Q Y LT
Sbjct: 84 LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQL--------YQTLTDYDIRFY 135
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA-KVADFGLVK-NAPDGKYSVE-- 745
++ + ++Y HS +HRD+KP N++I + R ++ D+GL + P +Y+V
Sbjct: 136 MYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVA 192
Query: 746 TRLAGTFGYLAPE-------YAATGRVTTKIDVYAFGVVLMETITGRKAL 788
+R + PE Y +D+++ G +L I ++
Sbjct: 193 SRY-----FKGPELLVDYQMY------DYSLDMWSLGCMLASMIFRKEPF 231
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 52/231 (22%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-------- 628
+V + + + +G G +G V + G ++AVK K FQ+
Sbjct: 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK---------KLSRPFQSIIHAKRTY 76
Query: 629 -EIAVLTKVRHRHLVALL------GYCINGSERLLVYEYMP----RGTLAQHLFEWHDHG 677
E+ +L ++H +++ LL ++ LV M Q L + H
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDH-VQ 135
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
+ + + RG++Y+HS IHRDLKPSN+ + +D K+ DFGL ++
Sbjct: 136 F----------LIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182
Query: 738 PDGK--YSVETRLAGTFGYLAPEYA-ATGRVTTKIDVYAFGVVLMETITGR 785
D Y V TR Y APE +D+++ G ++ E +TGR
Sbjct: 183 ADEMTGY-VATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 38/167 (22%), Positives = 65/167 (38%), Gaps = 22/167 (13%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALL 645
+LG G G V K A+K ++ + + E+ + + + H+V ++
Sbjct: 25 VLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIV 77
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
N L+V E + G L + + G T ++ I + ++YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 702 SLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVE 745
S + HRD+KP N+L + K+ DFG K KY
Sbjct: 135 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKS 178
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 77.5 bits (191), Expect = 5e-15
Identities = 49/254 (19%), Positives = 91/254 (35%), Gaps = 49/254 (19%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIA 631
V DN+ +++GRG +G VY + +A+K++ + + EI
Sbjct: 23 HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLID----CKRILREIT 77
Query: 632 VLTKVRHRHLVALLGYCINGSERL-----LVYEYMPRGT-LAQHLFEWHDHGYTPLTWKQ 685
+L +++ +++ L I +V E + L + LT +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA--DSDLKKLF-----KTPIFLTEEH 130
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKY 742
TI ++ G ++H IHRDLKP+N L+ D KV DFGL + + D
Sbjct: 131 IKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 743 SVETRLAGTFGYLAP-------EYAAT------------GRVTTKIDVYAFGVVLMETIT 783
+ G + T T ID+++ G + E +
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 784 GRKALDDTMPDDRA 797
++ + +
Sbjct: 248 MLQSHINDPTNRFP 261
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 6e-15
Identities = 57/233 (24%), Positives = 101/233 (43%), Gaps = 39/233 (16%)
Query: 571 ISIEVLRQ---VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEF 626
EV + V + + +G G +G V + G K+A+K++ ++
Sbjct: 12 YRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKL-YRPFQSELF--- 67
Query: 627 QA-----EIAVLTKVRHRHLVALL------GYCINGSERLLVYEYMPRGTLAQHLFEWHD 675
A E+ +L +RH +++ LL + ++ LV +M L + +
Sbjct: 68 -AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLM----- 120
Query: 676 HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
+ L + + + +G+ Y+H+ IHRDLKP N+ + +D K+ DFGL +
Sbjct: 121 -KHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176
Query: 736 NAPDGK--YSVETRLAGTFGYLAPEYA-ATGRVTTKIDVYAFGVVLMETITGR 785
A Y V TR Y APE R T +D+++ G ++ E ITG+
Sbjct: 177 QADSEMTGY-VVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 76.8 bits (189), Expect = 9e-15
Identities = 54/259 (20%), Positives = 90/259 (34%), Gaps = 54/259 (20%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA-----EIA 631
Q+ D + +++G G +G V + + +A+K++ + EIA
Sbjct: 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKI-LRVFEDLID----CKRILREIA 104
Query: 632 VLTKVRHRHLVALLGYCINGSERL-----LVYEYMPRGT-LAQHLFEWHDHGYTPLTWKQ 685
+L ++ H H+V +L I +V E + + LT
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA--DSDFKKLF-----RTPVYLTELH 157
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL---VKNAPDGKY 742
T+ ++ GV+Y+HS +HRDLKP+N L+ D KV DFGL V +G
Sbjct: 158 IKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 743 SVETRLAGTFGYLAP------------EYAAT------------GRVTTKIDVYAFGVVL 778
+ L + T T IDV++ G +
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 779 METITGRKALDDTMPDDRA 797
E + K D
Sbjct: 275 AELLNMIKENVAYHADRGP 293
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 74.2 bits (183), Expect = 2e-14
Identities = 52/237 (21%), Positives = 93/237 (39%), Gaps = 53/237 (22%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRM--ESNTMGNKGLSEFQAEIAVLTK 635
+ + + LG GG G+V+ + ++A+K++ L E I ++ +
Sbjct: 9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALRE----IKIIRR 64
Query: 636 VRHRHLVALL--------------GYCINGSERLLVYEYMP----RGTLAQHLFEWHDHG 677
+ H ++V + G + +V EYM L E H
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH--- 121
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKN 736
+ L RG++Y+HS + +HRDLKP+N+ I +D+ K+ DFGL +
Sbjct: 122 ------ARLFMYQL--LRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARI 170
Query: 737 APDGKYS-------VETRLAGTFGYLAPE-YAATGRVTTKIDVYAFGVVLMETITGR 785
+ T+ Y +P + T ID++A G + E +TG+
Sbjct: 171 MDPHYSHKGHLSEGLVTKW-----YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 43/181 (23%), Positives = 64/181 (35%), Gaps = 52/181 (28%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
T+ Q +YL +N T + G FD L NL+ L L N L
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSN----------------QLGA----- 78
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
L FDS + L L L N T LP+ D L
Sbjct: 79 -----LPVGVFDSLTQLTVLDLGTNQLT-VLPS--------------------AVFDRL- 111
Query: 233 GMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
L+++++ N+ T +P + + L L+L NQL + + L +L + L
Sbjct: 112 --VHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 292 N 292
N
Sbjct: 169 N 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-12
Identities = 34/116 (29%), Positives = 48/116 (41%), Gaps = 13/116 (11%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
SL L+ L N + G SL L + L N T +P+ FD L +L+ L
Sbjct: 62 SLINLKELYLGSNQLGALPVGVFDSLTQ---LTVLDLGTNQLTVLPSAVFDRLVHLKELF 118
Query: 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSNLQNLRLSYNN 198
+ N P + + T LT L +D N IP FD S+L + L + N
Sbjct: 119 MCCNKLTE---LPRGIERLTHLTHLALDQ-NQLKSIPHGAFDRLSSLTHAYL-FGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 8e-07
Identities = 20/62 (32%), Positives = 28/62 (45%), Gaps = 2/62 (3%)
Query: 88 SLTQLETLSFQMNNIAGAIPS-LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
L L+ L N + +P + T L + LD N S+P G FD L++L L
Sbjct: 110 RLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG 168
Query: 147 NP 148
NP
Sbjct: 169 NP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 8e-04
Identities = 15/44 (34%), Positives = 23/44 (52%), Gaps = 2/44 (4%)
Query: 390 LTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433
L LK L++ N LT +P G+ +L L +L + N L +P
Sbjct: 111 LVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLK-SIPH 152
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 9e-14
Identities = 62/246 (25%), Positives = 101/246 (41%), Gaps = 53/246 (21%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQA---- 628
V R V + LG+G +G+V+ + G +AVK++ + N A
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTD----AQRTF 56
Query: 629 -EIAVLTKVR-HRHLVALLGYCI--NGSERLLVYEYMP----RGTLAQHLFEWHDHGYTP 680
EI +LT++ H ++V LL N + LV++YM A L H
Sbjct: 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVH------ 110
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740
KQ + + + ++YLHS +HRD+KPSNIL+ + KVADFGL ++ +
Sbjct: 111 ---KQ--YVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162
Query: 741 KYSVETRLAGTFGYLAP---------EYAAT------------GRVTTKIDVYAFGVVLM 779
+ +Y AT + T ID+++ G +L
Sbjct: 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG 222
Query: 780 ETITGR 785
E + G+
Sbjct: 223 EILCGK 228
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 30/199 (15%), Positives = 61/199 (30%), Gaps = 40/199 (20%)
Query: 589 LGRGGFGVVYGGE---------LPDGTKIAVK--------RMESNTMGNKGLSEFQAEIA 631
R G++Y P K ++K E N +
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 632 VLTKVRHRHLVALLGYCINGSE-RLLVYEYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTI 689
L + +G+ ++ + R LV +P G Q + L+ + + +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLV---LPSLGRSLQSALDVSPKH--VLSERSVLQV 164
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV--ADFGLVKNAPDGKYSVETR 747
A + +E+LH ++H ++ NI + + +++V A +G V
Sbjct: 165 ACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 748 ------LAGTFGYLAPEYA 760
G E+
Sbjct: 222 EGSRSPHEGD-----LEFI 235
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 3e-13
Identities = 29/166 (17%), Positives = 57/166 (34%), Gaps = 25/166 (15%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G+GGFG +Y ++ + + E+ + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 649 IN------------GSERLLVYEY----MPR-GTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
G Y M R G+ Q ++E + + K + ++L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK---RFSRKTVLQLSL 159
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV--ADFGLVK 735
+ +EY+H ++H D+K SN+L+ +V D+GL
Sbjct: 160 RILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 45/177 (25%), Positives = 78/177 (44%), Gaps = 23/177 (12%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLG 646
+G G FG +Y G + G ++A+K +E + L E + ++ + +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIK-LECVKTKHPQL---HIESKIYKMMQGGVGIPTIRW 72
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
G ++V E + G + LF + ++ T + +A + +EY+HS +
Sbjct: 73 CGAEGDYNVMVMELL--GPSLEDLFNFCSRKFSLKT---VLLLADQMISRIEYIHS---K 124
Query: 707 SFIHRDLKPSNILIGDDMRAK---VADFGLVK---NAPDGK---YSVETRLAGTFGY 754
+FIHRD+KP N L+G + + DFGL K +A + Y L GT Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 70.3 bits (171), Expect = 5e-13
Identities = 34/214 (15%), Positives = 62/214 (28%), Gaps = 54/214 (25%)
Query: 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVK--RMESNTMGN----KGLSEFQAEIAVL 633
T+ +G G FG V+ D T +A+K +E + N K E EI +
Sbjct: 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 634 TKV---------RHRHLVALLGYCI-------------------NGSERL---------- 655
++ R + L GS
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 656 -LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714
+V E+ G L + + +I + + + + F HRDL
Sbjct: 138 FIVLEFEFGGID---LEQMRTK---LSSLATAKSILHQLTASLAVAEASLR--FEHRDLH 189
Query: 715 PSNILIGDDMRAKVADFGLVKNAPDGKYSVETRL 748
N+L+ K+ K++ ++ +
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSI 223
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 42/179 (23%), Positives = 71/179 (39%), Gaps = 25/179 (13%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLG 646
+G G FGV++ G L + ++A+K E L + E + + +
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIK-FEPRRSDAPQLRD---EYRTYKLLAGCTGIPNVYY 73
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ G +LV + + G + L + ++ T A + V+ +H +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKT---VAMAAKQMLARVQSIHE---K 125
Query: 707 SFIHRDLKPSNILIGDDMRAK-----VADFGLVKNAPDGK------YSVETRLAGTFGY 754
S ++RD+KP N LIG V DFG+VK D Y + L+GT Y
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 2e-12
Identities = 28/182 (15%), Positives = 58/182 (31%), Gaps = 8/182 (4%)
Query: 14 VLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISL 73
+LL+ L + +++ + + + + + + V + L
Sbjct: 389 ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHL 448
Query: 74 AKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCF 133
A L T+ + L + L N + P+LA L+ + +N +V
Sbjct: 449 AHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG--V 504
Query: 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN---ANIFGLIPDFFDSFSNLQ 190
L LQ L L +N L L L L + G+ + ++
Sbjct: 505 ANLPRLQELLLCNN-RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVS 563
Query: 191 NL 192
++
Sbjct: 564 SI 565
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 1e-09
Identities = 53/322 (16%), Positives = 96/322 (29%), Gaps = 22/322 (6%)
Query: 4 KKPQVSICAVVLLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCD 63
+ V C V + +V ++ L + S +
Sbjct: 240 EPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHV 299
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
+ SL T + + + A L L
Sbjct: 300 WLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLFRCELSVE 359
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
T + + + LQ L + L LT + L L +F
Sbjct: 360 KSTVLQSE-LESCKELQELEPENKWCL--------LTIILLMRALDPLLYEKETL--QYF 408
Query: 184 DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG----TLDVLSGMTQLRQ 239
+ + +R +Y + S S ++ + + + L L+ L L + +
Sbjct: 409 STLKAVDPMRAAYLDDLRS-KFLLENSVLKMEYADVRVLHLAHKDLTVLCHLEQLLLVTH 467
Query: 240 VWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299
+ L N+ P L+ L L DN L V V +LP L + L NN+LQ
Sbjct: 468 LDLSHNRLRALPPALAALRCLEVLQASDNALENV--DGVANLPRLQELLLCNNRLQQSAA 525
Query: 300 LFP----SKVQKVSLDHNNFCK 317
+ P ++ ++L N+ C+
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQ 547
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 58.6 bits (141), Expect = 6e-09
Identities = 37/227 (16%), Positives = 70/227 (30%), Gaps = 21/227 (9%)
Query: 202 SLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLF 261
+ P+ D+ +NDQ L + +G ++ L K++ D + E LF
Sbjct: 294 NRPSHVWLCDLPAASLNDQ-LPQHTFRVIWTGSDSQKECVLLKDRPECWCRDSATDEQLF 352
Query: 262 DLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSD 321
L + T V+ + + S L + +N L + + +
Sbjct: 353 RCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKET------- 404
Query: 322 AGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAG 381
+ + + + ++LA+K L
Sbjct: 405 ---------LQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT- 454
Query: 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
+ L + +L L N L +P L L L+ L S+N L
Sbjct: 455 VL-CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE 499
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 8e-07
Identities = 54/403 (13%), Positives = 105/403 (26%), Gaps = 86/403 (21%)
Query: 50 SSTGYCEW--TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI- 106
S+ Y W + +S ++ LS S ++ +++ TL ++ ++
Sbjct: 227 SAWFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSRPLTVGSRMGTLLLMVDEAPLSVE 286
Query: 107 ---------PSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPN 157
PS L L++ + G + + L P +
Sbjct: 287 WRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLL---KDRPECWCR 343
Query: 158 ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWM 217
+ L + + ++ +S LQ L ++ + L
Sbjct: 344 DSATDEQLFRCEL-SVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRA--LDPLLY 400
Query: 218 NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPAS 277
+ L TL + M L + + L L LT
Sbjct: 401 EKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLT-----V 455
Query: 278 VISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIA 337
+ L LL V + L HN ++ L
Sbjct: 456 LCHLEQLLL------------------VTHLDLSHN---------------RLRALPPAL 482
Query: 338 GDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLY 397
+ +L S +N + ++ ++ NL L+ L
Sbjct: 483 AALRCLEVLQAS---DN-------------ALENVD--------GVA----NLPRLQELL 514
Query: 398 LQQNNLTG-PIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
L N L L L L++ N+L + +
Sbjct: 515 LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLA 556
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 49/182 (26%), Positives = 66/182 (36%), Gaps = 53/182 (29%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ L+ N+ S+P G FD LT+L L L N L +L
Sbjct: 28 AQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGN----------------KLQSLP--- 68
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
F+ ++L L LS N SLP +G D L
Sbjct: 69 -------NGVFNKLTSLTYLNLSTNQLQ-SLP--------------------NGVFDKL- 99
Query: 233 GMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
TQL+++ L+ NQ +PD K L DL L NQL V L +L I L
Sbjct: 100 --TQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLH 156
Query: 291 NN 292
+N
Sbjct: 157 DN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 8e-09
Identities = 32/120 (26%), Positives = 51/120 (42%), Gaps = 21/120 (17%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNI----AGAIPSLANATSLQD 117
D +T + L + L +L + + LT L L+ N + G L T L++
Sbjct: 49 DELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKL---TQLKE 104
Query: 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
+ L+ N S+P G FD LT L+ L L N P+ F TSL +++ +
Sbjct: 105 LALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGV---FDR----LTSLQYIWLHD 157
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 3e-07
Identities = 27/65 (41%), Positives = 34/65 (52%), Gaps = 7/65 (10%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
LTQL+ L+ N + G L T L+D+ L N SVP G FD LT+LQ +
Sbjct: 98 KLTQLKELALNTNQLQSLPDGVFDKL---TQLKDLRLYQNQLKSVPDGVFDRLTSLQYIW 154
Query: 144 LSDNP 148
L DNP
Sbjct: 155 LHDNP 159
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-12
Identities = 27/151 (17%), Positives = 46/151 (30%), Gaps = 33/151 (21%)
Query: 100 NNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN--PNLAPWPFPN 157
I NA +++ L + L + SDN L +P
Sbjct: 7 ELIE-QAAQYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKLDGFP--- 61
Query: 158 ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWM 217
L TL ++N I + + +L L L+ N+ + L
Sbjct: 62 ---LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS-------------LVEL-- 103
Query: 218 NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248
G LD L+ + L + + +N T
Sbjct: 104 --------GDLDPLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-10
Identities = 24/99 (24%), Positives = 40/99 (40%), Gaps = 6/99 (6%)
Query: 78 LSGTLSPEI----SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCF 133
L G P I ++L Q + + F N I + L+ + ++NN + G
Sbjct: 26 LRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLD 84
Query: 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
L +L L L++N +L + L SLT L +
Sbjct: 85 QALPDLTELILTNN-SLVELGDLDPLASLKSLTYLCILR 122
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 3e-05
Identities = 20/137 (14%), Positives = 43/137 (31%), Gaps = 22/137 (16%)
Query: 192 LRLSYNNFTGSLPASFAKSDIQNLW--MNDQQLGLSGTL-----DVLSGMTQLRQVWLHK 244
++L+ + D++L L G ++ + + Q +
Sbjct: 2 VKLTAELIE----------QAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSD 51
Query: 245 NQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP---YPLF 301
N+ + L L + +N++ + +LP L + L NN L PL
Sbjct: 52 NEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLA 110
Query: 302 P-SKVQKVSLDHNNFCK 317
+ + + N
Sbjct: 111 SLKSLTYLCILRNPVTN 127
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 7e-12
Identities = 40/197 (20%), Positives = 70/197 (35%), Gaps = 39/197 (19%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGL-SEFQ-----AEIAVLTKVRHRHL 641
+G GGFG++Y K A ++ N L SE + A+ + K R
Sbjct: 45 IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104
Query: 642 VALLG-----YC-----INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
+ LG S R +V E + G Q + + + + +
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGT----FKKSTVLQLGI 158
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV--ADFGLVKNAPDG------KYS 743
+ +EY+H ++H D+K +N+L+G +V AD+GL + +
Sbjct: 159 RMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQEN 215
Query: 744 VETRLAGTFGYLAPEYA 760
GT E+
Sbjct: 216 PRKGHNGT-----IEFT 227
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 8e-12
Identities = 44/171 (25%), Positives = 71/171 (41%), Gaps = 20/171 (11%)
Query: 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEI 630
S+ VL V NF +G G FG + G+ L +A+K +E L E
Sbjct: 1 SMGVLM-VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRAPQLHL---EY 55
Query: 631 AVLTKVRH-RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
++ + + + G +V E + G + LF+ D + K + I
Sbjct: 56 RFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLFDLCDR---TFSLKTVLMI 110
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK-----VADFGLVK 735
A+ + +EY+HS ++ I+RD+KP N LIG + DF L K
Sbjct: 111 AIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 45/218 (20%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVRHR----- 639
++G+G FG VV + +A+K + + ++ QA EI +L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHR-----QAAEEIRILEHLRKQDKDNT 158
Query: 640 -HLVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQRVTIA 690
+++ +L C+ +E L+ +L+E + + + A
Sbjct: 159 MNVIHMLENFTFRNHICM-------TFEL-----LSMNLYELIKKNKFQGFSLPLVRKFA 206
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA--KVADFGLVKNAPDGKYS-VETR 747
+ + ++ LH IH DLKP NIL+ R+ KV DFG Y+ +++R
Sbjct: 207 HSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSR 263
Query: 748 LAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
F Y APE R ID+++ G +L E +TG
Sbjct: 264 ----F-YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 65.4 bits (159), Expect = 4e-11
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 17/152 (11%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLG 646
+G G FG +Y G + ++A+K +E+ + L E + ++ + +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIK-LENVKTKHPQL---LYESKIYRILQGGTGIPNVRW 70
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ + G +LV + + G + LF + L+ K + +A + VE++HS +
Sbjct: 71 FGVEGDYNVLVMDLL--GPSLEDLFNFCSR---KLSLKTVLMLADQMINRVEFVHS---K 122
Query: 707 SFIHRDLKPSNILIGDDMRAK---VADFGLVK 735
SF+HRD+KP N L+G RA + DFGL K
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 5e-11
Identities = 49/224 (21%), Positives = 95/224 (42%), Gaps = 53/224 (23%)
Query: 587 NILGRGGFG-VVYGGELPDGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTKVRHR----- 639
+++G+G FG VV + + +A+K +++ N+ E + +L +
Sbjct: 60 SLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMK 115
Query: 640 -HLVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQRVTIA 690
++V L + C+ V+E L+ +L++ + + ++ A
Sbjct: 116 YYIVHLKRHFMFRNHLCL-------VFEM-----LSYNLYDLLRNTNFRGVSLNLTRKFA 163
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA--KVADFGLVKNAPDGKYS-VETR 747
+ + +L + + S IH DLKP NIL+ + R+ K+ DFG Y +++R
Sbjct: 164 QQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSR 222
Query: 748 LAGTFGYLAPE------YAATGRVTTKIDVYAFGVVLMETITGR 785
F Y +PE Y ID+++ G +L+E TG
Sbjct: 223 ----F-YRSPEVLLGMPY------DLAIDMWSLGCILVEMHTGE 255
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 9e-11
Identities = 50/249 (20%), Positives = 95/249 (38%), Gaps = 61/249 (24%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESNTMGNKGLSEFQA--EIAVLTKVR------- 637
LG G F V ++ + T +A+K + + + + A EI +L +V
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-----AAEDEIKLLQRVNDADNTKE 80
Query: 638 ----HRHLVALLGY----CINGSERLLVYEYMPRGTLAQHLFEW-HDHGYTPLTWKQRVT 688
H++ LL + NG ++V+E L ++L + + +
Sbjct: 81 DSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEHRGIPLIYVKQ 135
Query: 689 IALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA------KVADFGLVKNAPDGKY 742
I+ + G++Y+H + IH D+KP N+L+ K+AD G +
Sbjct: 136 ISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 743 S-VETRLAGTFGYLAPE------YAATGRVTTKIDVYAFGVVLMETITGRKAL-----DD 790
+ ++TR Y +PE + D+++ ++ E ITG L
Sbjct: 194 NSIQTRE-----YRSPEVLLGAPW------GCGADIWSTACLIFELITG-DFLFEPDEGH 241
Query: 791 TMPDDRAHL 799
+ D H+
Sbjct: 242 SYTKDDDHI 250
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 37/192 (19%), Positives = 67/192 (34%), Gaps = 31/192 (16%)
Query: 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFT 126
+ TTI A S + ++E L + I +L+ + + + L NN
Sbjct: 3 KATTIKDAIRIFEERKSVVATEAEKVE-LHGMIPPIEKMDATLSTLKACKHLALSTNNIE 61
Query: 127 SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSF 186
+ + G+ NL++LSL N + N + +L L++ I L +
Sbjct: 62 KI-SS-LSGMENLRILSLGRN-LIK--KIENLDAVADTLEELWISYNQIASL--SGIEKL 114
Query: 187 SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246
NL+ L +S N I N G +D L+ + +L + L N
Sbjct: 115 VNLRVLYMSNNK-------------ITNW----------GEIDKLAALDKLEDLLLAGNP 151
Query: 247 FTGPIPDLSKCE 258
+ +
Sbjct: 152 LYNDYKENNATS 163
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 70/396 (17%), Positives = 121/396 (30%), Gaps = 97/396 (24%)
Query: 90 TQLETLSFQMNNI----AGAIPS-LANATSLQDIYLDNNNFTSVP-----TGCFDGLTNL 139
+++ LS Q + G + S L +LQ+++L +N G D L
Sbjct: 85 CKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRL 144
Query: 140 QVLSLSDNP-------NLAPWPFPNELTKSTSLTTLYMDNANIFG------LIPDFFDSF 186
+ L L LA L L + N N L DS
Sbjct: 145 EKLQLEYCSLSAASCEPLAS-----VLRAKPDFKELTVSN-NDINEAGVRVLCQGLKDSP 198
Query: 187 SNLQNLRLSYNNFTGSLPASFAK-----SDIQNLWMNDQQLGLSGTLD----VLSGMTQL 237
L+ L+L T + ++ L + +LG G + +L ++L
Sbjct: 199 CQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRL 258
Query: 238 RQVWLHKNQFTGP-----IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
R +W+ + T L ESL +LSL N+L L L
Sbjct: 259 RTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG---DEGARLLCETL--LEPGC 313
Query: 293 KLQGPYPLFPSKVQKVSLDHNNF----CKNSSDAGKPCDPQVTTLL----QIAGDMGYPA 344
+L+ + + +F C + S + L ++ D G
Sbjct: 314 QLE-----------SLWVKSCSFTAACCSHFSSVLAQN-RFLLELQISNNRL-EDAGVRE 360
Query: 345 ILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL----AGNISPAYANLTSLKNLYLQQ 400
+ C G + + LA+ + +++ SL+ L L
Sbjct: 361 L----------CQGLGQPGSV---LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSN 407
Query: 401 NNLTGPIPDGLTKLA--------SLQNLDVSNNNLS 428
N L G+ +L L+ L + + S
Sbjct: 408 NCLG---DAGILQLVESVRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 2e-10
Identities = 68/435 (15%), Positives = 142/435 (32%), Gaps = 95/435 (21%)
Query: 64 NSNRVTTISLAKSGLSGT-LSPEISSLTQLETLSFQMNNI----AGAIPS-LANATSLQD 117
+ + + ++ + LS + + L Q + + + I S L +L +
Sbjct: 2 SLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 60
Query: 118 IYLDNNNFTSVPTGC---FDGL----TNLQVLSLSDNP-------NLAPWPFPNELTKST 163
+ L +N G GL +Q LSL + L+ L
Sbjct: 61 LNLRSNELG--DVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSS-----TLRTLP 113
Query: 164 SLTTLYMDNANI-----FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-----SDIQ 213
+L L++ + + L D L+ L+L Y + + + A D +
Sbjct: 114 TLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFK 173
Query: 214 NLWMNDQQLGLSGTLDVLSG----MTQLRQVWLHKNQFTGP-----IPDLSKCESLFDLS 264
L +++ + +G + G QL + L T ++ SL +L+
Sbjct: 174 ELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELA 233
Query: 265 LRDNQLT--GVV---PASVISLPALLNISLQNNKL--QGPYPLFP-----SKVQKVSLDH 312
L N+L G+ P + L + + + +G L ++++SL
Sbjct: 234 LGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAG 293
Query: 313 NNF----CKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
N + + Q+ +L + C + V
Sbjct: 294 NELGDEGARLLCETLLEPGCQLESLW-----------VKSCSFTAACCSHFSSVLAQNRF 342
Query: 369 IITINLAN--------KLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS---- 416
++ + ++N + L + + L+ L+L +++ + LA+
Sbjct: 343 LLELQISNNRLEDAGVRELCQGLG---QPGSVLRVLWLADCDVS---DSSCSSLAATLLA 396
Query: 417 ---LQNLDVSNNNLS 428
L+ LD+SNN L
Sbjct: 397 NHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 5e-08
Identities = 55/341 (16%), Positives = 109/341 (31%), Gaps = 85/341 (24%)
Query: 15 LLLLQLTTTSLGDDG----SVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTT 70
L LQL SL + +L+ + L + + G D+ ++
Sbjct: 144 LEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEA 203
Query: 71 ISLAKSGLS----GTLSPEISSLTQLETLSFQMNNI--AGAIPSLANA-----TSLQDIY 119
+ L G++ L ++S L L+ N + G L + L+ ++
Sbjct: 204 LKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMA-ELCPGLLHPSSRLRTLW 262
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG-- 177
+ T+ GC L L SL L + N G
Sbjct: 263 IWECGITAK--GC-------GDLCRV-------------LRAKESLKELSLAG-NELGDE 299
Query: 178 ----LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-----SDIQNLWMNDQQLGLSGTL 228
L + L++L + +FT + + F+ + L +++ +L +G
Sbjct: 300 GARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVR 359
Query: 229 DVLSGM----TQLRQVWLHKNQFTGPIPD--------LSKCESLFDLSLRDNQLT--GVV 274
++ G+ + LR +WL + L SL +L L +N L G++
Sbjct: 360 ELCQGLGQPGSVLRVLWLADCDVS---DSSCSSLAATLLANHSLRELDLSNNCLGDAGIL 416
Query: 275 PASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNF 315
L S++ ++++ L +
Sbjct: 417 ---------QLVESVRQPG---------CLLEQLVLYDIYW 439
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 24/92 (26%), Positives = 38/92 (41%), Gaps = 15/92 (16%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
L L L + N + I A A+ +Q++ L N + F GL L+ L+L
Sbjct: 52 RLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLY 110
Query: 146 DN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
DN + F + L SLT+L + +
Sbjct: 111 DNQISCVMPGS---FEH-L---NSLTSLNLAS 135
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 30/147 (20%), Positives = 52/147 (35%), Gaps = 40/147 (27%)
Query: 106 IPSLANATSLQDIYLDNNNFTSV-PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTS 164
IP ++ L++N + G F L +L L L N +LT
Sbjct: 27 IP-----LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRN----------QLTG--- 68
Query: 165 LTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA-SFAK-SDIQNLWMNDQQL 222
+ P+ F+ S++Q L+L N + F ++ L + D Q+
Sbjct: 69 -------------IEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114
Query: 223 G--LSGTLDVLSGMTQLRQVWLHKNQF 247
+ G+ + L L + L N F
Sbjct: 115 SCVMPGSFEHL---NSLTSLNLASNPF 138
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 5e-08
Identities = 16/65 (24%), Positives = 27/65 (41%), Gaps = 7/65 (10%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+ ++ L N I L L+ + L +N + V G F+ L +L L+
Sbjct: 76 GASHIQELQLGENKIKEISNKMFLGL---HQLKTLNLYDNQISCVMPGSFEHLNSLTSLN 132
Query: 144 LSDNP 148
L+ NP
Sbjct: 133 LASNP 137
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 40/138 (28%), Positives = 56/138 (40%), Gaps = 34/138 (24%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+S + L++N S+P G FD LT L LSLS N++
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQ----------NQIQS----------- 66
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQLGL--SGTL 228
L FD + L L L N SLP F K + ++ L ++ QL G
Sbjct: 67 -----LPDGVFDKLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIF 120
Query: 229 DVLSGMTQLRQVWLHKNQ 246
D L T L+++WLH N
Sbjct: 121 DRL---TSLQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 31/94 (32%), Positives = 39/94 (41%), Gaps = 19/94 (20%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
LTQL LS N I G L T L +YL N S+P G FD LT L+ L+
Sbjct: 50 KLTQLTKLSLSQNQIQSLPDGVFDKL---TKLTILYLHENKLQSLPNGVFDKLTQLKELA 106
Query: 144 LSDN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
L N P+ F TSL +++
Sbjct: 107 LDTNQLKSVPDGI---FDR----LTSLQKIWLHT 133
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 2e-08
Identities = 36/132 (27%), Positives = 52/132 (39%), Gaps = 27/132 (20%)
Query: 163 TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
+S T L +++ + L FD + L L LS N SLP
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQ-SLPD----------------- 69
Query: 223 GLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASVIS 280
G D L T+L ++LH+N+ +P+ K L +L+L NQL V
Sbjct: 70 ---GVFDKL---TKLTILYLHENKLQS-LPNGVFDKLTQLKELALDTNQLKSVPDGIFDR 122
Query: 281 LPALLNISLQNN 292
L +L I L N
Sbjct: 123 LTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 24/63 (38%), Positives = 34/63 (53%), Gaps = 3/63 (4%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLA--NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
LT+L L N + ++P+ T L+++ LD N SVP G FD LT+LQ + L
Sbjct: 74 KLTKLTILYLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLH 132
Query: 146 DNP 148
NP
Sbjct: 133 TNP 135
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 34/167 (20%), Positives = 55/167 (32%), Gaps = 59/167 (35%)
Query: 106 IPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165
IP + ++YLD N FT VP +L ++ LS+N ++
Sbjct: 29 IP-----RDVTELYLDGNQFTLVP-KELSNYKHLTLIDLSNN----------RIST---- 68
Query: 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225
L F + + L L LSYN +P
Sbjct: 69 ------------LSNQSFSNMTQLLTLILSYNRLR-CIPPR------------------- 96
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQL 270
G+ LR + LH N + +P+ + +L L++ N L
Sbjct: 97 ----TFDGLKSLRLLSLHGNDISV-VPEGAFNDLSALSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 35/156 (22%), Positives = 55/156 (35%), Gaps = 41/156 (26%)
Query: 55 CEWTGINCDNSNR--------VTTISLAKSGLSGTLSP-EISSLTQLETLSFQMNNIAGA 105
C T + C N L G TL P E+S+ L + N I+
Sbjct: 10 CLDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRIS-T 68
Query: 106 IPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKST 163
+ + +N T L + L N +P FDGL +L++LSL N++
Sbjct: 69 LSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHG----------NDI-SV- 116
Query: 164 SLTTLYMDNANIFGLIPD-FFDSFSNLQNLRLSYNN 198
+P+ F+ S L +L + N
Sbjct: 117 ---------------VPEGAFNDLSALSHLAI-GAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 30/89 (33%), Positives = 46/89 (51%), Gaps = 5/89 (5%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLA--NATSLQDIY 119
N +T I L+ + +S TLS + S++TQL TL N + IP SL+ +
Sbjct: 51 SNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRLR-CIPPRTFDGLKSLRLLS 108
Query: 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
L N+ + VP G F+ L+ L L++ NP
Sbjct: 109 LHGNDISVVPEGAFNDLSALSHLAIGANP 137
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 17/46 (36%), Positives = 23/46 (50%), Gaps = 3/46 (6%)
Query: 389 NLTSLKNLYLQQNNLTGPIPDGLT-KLASLQNLDVSNNNLSGKVPD 433
N+T L L L N L IP L SL+ L + N++S VP+
Sbjct: 76 NMTQLLTLILSYNRLRC-IPPRTFDGLKSLRLLSLHGNDIS-VVPE 119
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 19/102 (18%), Positives = 32/102 (31%), Gaps = 4/102 (3%)
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNE-LTKSTSLTTLYMDNANIFGLIP 180
+ G NL L + + +L L L L + + + + P
Sbjct: 17 RDGALDSLHH-LPGAENLTELYIENQQHL--QHLELRDLRGLGELRNLTIVKSGLRFVAP 73
Query: 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQL 222
D F L L LS+N + +Q L ++ L
Sbjct: 74 DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 60.9 bits (147), Expect = 6e-10
Identities = 17/121 (14%), Positives = 34/121 (28%), Gaps = 18/121 (14%)
Query: 55 CEW-TGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLAN 111
+G+ C + ++ + L L + + L
Sbjct: 7 PHGSSGLRCTRDGALDSL------------HHLPGAENLTELYIENQQHLQHLELRDLRG 54
Query: 112 ATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171
L+++ + + V F L L+LS N L + + SL L +
Sbjct: 55 LGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFN-ALE--SLSWKTVQGLSLQELVLS 111
Query: 172 N 172
Sbjct: 112 G 112
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 6e-05
Identities = 19/117 (16%), Positives = 34/117 (29%), Gaps = 25/117 (21%)
Query: 156 PNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSNLQNLRLSYNNFTGSLPASFAKSDIQN 214
+ L + +LT LY++N + L+NL + + +
Sbjct: 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAP--------- 73
Query: 215 LWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT 271
D +L ++ L N + SL +L L N L
Sbjct: 74 --------------DAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.1 bits (106), Expect = 7e-05
Identities = 20/99 (20%), Positives = 39/99 (39%), Gaps = 4/99 (4%)
Query: 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVVPASV 278
+ G +L L G L ++++ Q + L L +L++ + L V P +
Sbjct: 17 RDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAF 76
Query: 279 ISLPALLNISLQNNKLQG--PYPLFPSKVQKVSLDHNNF 315
P L ++L N L+ + +Q++ L N
Sbjct: 77 HFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 19/110 (17%), Positives = 32/110 (29%), Gaps = 16/110 (14%)
Query: 355 ACDGWPFVTCSQGRIITI--------NLANKLLAGN-----ISP-AYANLTSLKNLYLQQ 400
G + C++ + NL + + L L+NL + +
Sbjct: 6 CPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 401 NNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSP--GNPF 448
+ L PD L L++S N L + GNP
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPL 115
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 8e-10
Identities = 44/255 (17%), Positives = 79/255 (30%), Gaps = 54/255 (21%)
Query: 92 LETLSFQMNNI--AGAIP---SLANATSLQDIYLDNNNFTSVPTGC---FDGL---TNLQ 140
+E S +++ I L S+++I L N + + +L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIG--TEAARWLSENIASKKDLE 63
Query: 141 VLSLSDNPNLAPWPFPNE--------LTKSTSLTTLYMDNANIFG-----LIPDFFDSFS 187
+ SD E L K L T+ + + N FG + DF +
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSD-NAFGPTAQEPLIDFLSKHT 122
Query: 188 NLQNLRLSYNNFT--------------GSLPASFAKSDIQNLWMNDQQLGLSGTL---DV 230
L++L L N + ++++ +L
Sbjct: 123 PLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKT 182
Query: 231 LSGMTQLRQVWLHKNQFT-----GPIPD-LSKCESLFDLSLRDNQLT--GVVP-ASVI-S 280
L V + +N + + L+ C+ L L L+DN T G A + S
Sbjct: 183 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKS 242
Query: 281 LPALLNISLQNNKLQ 295
P L + L + L
Sbjct: 243 WPNLRELGLNDCLLS 257
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 47/299 (15%), Positives = 87/299 (29%), Gaps = 64/299 (21%)
Query: 18 LQLTTTSLGDDGSV----MLKLAQSLQNLPSDWSSTSSTGYCEWTGINCD-------NSN 66
+ L+ ++G + + + + L+ ++S + +
Sbjct: 37 IVLSGNTIGTEAARWLSENIASKKDLEIA--EFSDIFTGRVKDEIPEALRLLLQALLKCP 94
Query: 67 RVTTISLAKSGLSGT----LSPEISSLTQLETLSFQMNNI--AGAIPSLANATSLQDIYL 120
++ T+ L+ + T L +S T LE L N + +A A L
Sbjct: 95 KLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGA-KIARA-------L 146
Query: 121 DNNNFTSVPTGCFDGLTNLQVLSLSDN-------PNLAPWPFPNELTKSTSLTTLYMDNA 173
L+ + N A L T+ M
Sbjct: 147 QELAVNKKAKNA----PPLRSIICGRNRLENGSMKEWA-----KTFQSHRLLHTVKMVQN 197
Query: 174 NIF-----GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-----SDIQNLWMNDQQLG 223
I L+ + L+ L L N FT ++ A +++ L +ND L
Sbjct: 198 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
Query: 224 LSGTLDVLSGM-----TQLRQVWLHKNQFTGP-IPDL-----SKCESLFDLSLRDNQLT 271
G V+ L+ + L N+ + L K L L L N+ +
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 54/330 (16%), Positives = 96/330 (29%), Gaps = 80/330 (24%)
Query: 136 LTN--LQVLSLSDNPNLAP---WPFPNELTKSTSLTTLYMDNANIFG-----LIPDFFDS 185
+ ++ SL + + L + S+ + + N G + + S
Sbjct: 1 MARFSIEGKSLKLD-AITTEDEKSVFAVLLEDDSVKEIVLSG-NTIGTEAARWLSENIAS 58
Query: 186 FSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245
+L+ S + FTG + + L L L +L V L N
Sbjct: 59 KKDLEIAEFS-DIFTGRVKDEIPE-------------ALRLLLQALLKCPKLHTVRLSDN 104
Query: 246 QFTGPI------PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299
F GP LSK L L L +N L P + + L N K + P
Sbjct: 105 AF-GPTAQEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARALQELAVNKKAKNAPP 160
Query: 300 LFPSKVQKVSLDHNNF----CKNSSDAGKPCDPQVTTLL----QIAGDMGYPAILSDSWE 351
L + + N K + + + T+ I G +L +
Sbjct: 161 L-----RSIICGRNRLENGSMKEWAKTFQSH-RLLHTVKMVQNGI-RPEGIEHLLLEGLA 213
Query: 352 GNNACDGWPFVTCSQGRIITINLA-NKLL---AGNISPAYANLTSLKNLYLQQNNLTGPI 407
+ ++L N + ++ A + +L+ L L L+
Sbjct: 214 YCQE-------------LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS--- 257
Query: 408 PDGLTKLA---------SLQNLDVSNNNLS 428
G + LQ L + N +
Sbjct: 258 ARGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-09
Identities = 23/110 (20%), Positives = 37/110 (33%), Gaps = 3/110 (2%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDN 122
V + L + + + LE LS + ++ +L L+ + L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSE 80
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
N + L NL L+LS N L L K L +L + N
Sbjct: 81 NRIFGGLDMLAEKLPNLTHLNLSGN-KLKDISTLEPLKKLECLKSLDLFN 129
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 2e-08
Identities = 28/141 (19%), Positives = 51/141 (36%), Gaps = 32/141 (22%)
Query: 111 NATSLQDIYLDNNNFTSVPT-GCFDGLTNLQVLSLSDN--PNLAPWPFPNELTKSTSLTT 167
+++++ LDN G NL+ LSL + +++ L K L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN------LPKLPKLKK 75
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227
L + IFG + + NL +L LS N ++++ T
Sbjct: 76 LELSENRIFGGLDMLAEKLPNLTHLNLSGNK-------------LKDI----------ST 112
Query: 228 LDVLSGMTQLRQVWLHKNQFT 248
L+ L + L+ + L + T
Sbjct: 113 LEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 6e-06
Identities = 17/86 (19%), Positives = 37/86 (43%), Gaps = 1/86 (1%)
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ 269
+ ++ L +++ + + + L + L + +L K L L L +N+
Sbjct: 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLIS-VSNLPKLPKLKKLELSENR 82
Query: 270 LTGVVPASVISLPALLNISLQNNKLQ 295
+ G + LP L +++L NKL+
Sbjct: 83 IFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Length = 130 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 5e-09
Identities = 12/36 (33%), Positives = 17/36 (47%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148
++ L NN T++P G D L L+ L NP
Sbjct: 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANP 66
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 6e-09
Identities = 28/156 (17%), Positives = 50/156 (32%), Gaps = 38/156 (24%)
Query: 99 MNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSLSDN-----PNLAP 152
M + ++++ LDN+ G D L+ LS + NL
Sbjct: 3 MGRRIHLELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSIANLP- 61
Query: 153 WPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDI 212
K L L + + + G + + NL +L LS N I
Sbjct: 62 --------KLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNK-------------I 100
Query: 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248
++L T++ L + L+ + L + T
Sbjct: 101 KDL----------STIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-08
Identities = 27/132 (20%), Positives = 49/132 (37%), Gaps = 5/132 (3%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDN 122
+ V + L S + + +LE LS + +I +L L+ + L +
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPKLNKLKKLELSD 73
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N + + NL L+LS N + L K +L +L + N + D+
Sbjct: 74 NRVSGGLEVLAEKCPNLTHLNLSGN-KIKDLSTIEPLKKLENLKSLDLFN-CEVTNLNDY 131
Query: 183 FDS-FSNLQNLR 193
++ F L L
Sbjct: 132 RENVFKLLPQLT 143
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 3e-06
Identities = 21/114 (18%), Positives = 46/114 (40%), Gaps = 5/114 (4%)
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ 269
SD++ L +++ + + +L + T I +L K L L L DN+
Sbjct: 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS-IANLPKLNKLKKLELSDNR 75
Query: 270 LTGVVPASVISLPALLNISLQNNKLQGPYPLFP----SKVQKVSLDHNNFCKNS 319
++G + P L +++L NK++ + P ++ + L + +
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLN 129
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 48/239 (20%), Positives = 78/239 (32%), Gaps = 67/239 (28%)
Query: 588 ILGRGGFG-VVYGGELPDGTKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHR-----H 640
+G G FG V+ + + AVK + + E +L K+++ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNN 97
Query: 641 LVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQRVTIALD 692
+V G C+ ++E L L+E + Y + ++
Sbjct: 98 IVKYHGKFMYYDHMCL-------IFE-----PLGPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 693 VARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT- 751
+ + + YL + S H DLKP NIL+ D K T+ G
Sbjct: 146 ILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 752 ---FG-----------------YLAPE------YAATGRVTTKIDVYAFGVVLMETITG 784
FG Y APE + D+++FG VL E TG
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGW------DVSSDMWSFGCVLAELYTG 255
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 23/65 (35%), Positives = 31/65 (47%), Gaps = 7/65 (10%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
LTQL L N + AG L T L + L++N S+P G FD L +L +
Sbjct: 52 RLTQLTRLDLDNNQLTVLPAGVFDKL---TQLTQLSLNDNQLKSIPRGAFDNLKSLTHIW 108
Query: 144 LSDNP 148
L +NP
Sbjct: 109 LLNNP 113
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 33/92 (35%), Positives = 40/92 (43%), Gaps = 19/92 (20%)
Query: 90 TQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
T + L N I G L T L + LDNN T +P G FD LT L LSL+
Sbjct: 30 TTTQVLYLYDNQITKLEPGVFDRL---TQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLN 86
Query: 146 DN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
DN P A F N SLT +++ N
Sbjct: 87 DNQLKSIPRGA---FDN----LKSLTHIWLLN 111
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 42/137 (30%), Positives = 51/137 (37%), Gaps = 39/137 (28%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
S + + SVPTG T QVL L DN ++TK
Sbjct: 10 SGTTVDCSGKSLASVPTGI---PTTTQVLYLYDN----------QITK------------ 44
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQLGLS---GTL 228
L P FD + L L L N T LPA F K + + L +ND QL S G
Sbjct: 45 ----LEPGVFDRLTQLTRLDLDNNQLT-VLPAGVFDKLTQLTQLSLNDNQLK-SIPRGAF 98
Query: 229 DVLSGMTQLRQVWLHKN 245
D L L +WL N
Sbjct: 99 DNL---KSLTHIWLLNN 112
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 21/65 (32%), Positives = 31/65 (47%), Gaps = 7/65 (10%)
Query: 88 SLTQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
L L+ L F N + G L T L + L++N+ S+P G FD L +L +
Sbjct: 55 HLVNLQQLYFNSNKLTAIPTGVFDKL---TQLTQLDLNDNHLKSIPRGAFDNLKSLTHIY 111
Query: 144 LSDNP 148
L +NP
Sbjct: 112 LYNNP 116
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 33/92 (35%), Positives = 42/92 (45%), Gaps = 19/92 (20%)
Query: 90 TQLETLSFQMNNI----AGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145
T + L N I G L N LQ +Y ++N T++PTG FD LT L L L+
Sbjct: 33 TDKQRLWLNNNQITKLEPGVFDHLVN---LQQLYFNSNKLTAIPTGVFDKLTQLTQLDLN 89
Query: 146 DN-----PNLAPWPFPNELTKSTSLTTLYMDN 172
DN P A F N SLT +Y+ N
Sbjct: 90 DNHLKSIPRGA---FDN----LKSLTHIYLYN 114
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 2e-05
Identities = 36/137 (26%), Positives = 51/137 (37%), Gaps = 39/137 (28%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+ N SVP G T+ Q L L++N ++TK
Sbjct: 13 DQTLVNCQNIRLASVPAGI---PTDKQRLWLNNN----------QITK------------ 47
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQLGLS---GTL 228
L P FD NLQ L + N T ++P F K + + L +ND L S G
Sbjct: 48 ----LEPGVFDHLVNLQQLYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLK-SIPRGAF 101
Query: 229 DVLSGMTQLRQVWLHKN 245
D L L ++L+ N
Sbjct: 102 DNL---KSLTHIYLYNN 115
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 46/232 (19%), Positives = 77/232 (33%), Gaps = 67/232 (28%)
Query: 629 EIAVLTKVR--------HRHLVALLGY----CINGSERLLVYEYMPRGTLAQHLFEWHDH 676
EI +L VR +V LL +NG+ +V+E + L + + + +
Sbjct: 83 EIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQ 141
Query: 677 GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD------------- 723
G K+ I V +G++YLH+ + IH D+KP NIL+ +
Sbjct: 142 GLPLPCVKK---IIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATE 196
Query: 724 ----------------------------MRAKVADFGLVKNAPDGK----YSVETRLAGT 751
+ K A+ VK A G + T T
Sbjct: 197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQT 256
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALD----DTMPDDRAHL 799
Y + E T D+++ + E TG + + D H+
Sbjct: 257 RQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHI 308
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 6e-07
Identities = 49/240 (20%), Positives = 79/240 (32%), Gaps = 73/240 (30%)
Query: 588 ILGRGGFGVVYGG--ELPDGTKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHR----- 639
LG G FG V +++A+K + + E I VL K++ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81
Query: 640 -HLVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQRVTIA 690
V + + CI +E L ++ FE+ ++ + P +A
Sbjct: 82 FLCVLMSDWFNFHGHMCI-------AFE-----LLGKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA-------------------KVADF 731
+ + +LH H DLKP NIL + +VADF
Sbjct: 130 YQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 732 GLVKNAPDGKYS-VETRLAGTFGYLAPE------YAATGRVTTKIDVYAFGVVLMETITG 784
G + + V TR Y PE + DV++ G +L E G
Sbjct: 187 GSATFDHEHHTTIVATR----H-YRPPEVILELGW------AQPCDVWSIGCILFEYYRG 235
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 8e-06
Identities = 59/248 (23%), Positives = 86/248 (34%), Gaps = 89/248 (35%)
Query: 588 ILGRGGFG-VV------YGGELPDGTKIAVKRMESN-TMGNKGLSEFQAEIAVLTKVRHR 639
LG G FG VV GG +AVK +++ SE I VL +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRH-----VAVKIVKNVDRYCEAARSE----IQVLEHLNTT 71
Query: 640 ------HLVALLGY-------CINGSERLLVYEYMPRGTLAQHLFEWH-DHGYTPLTWKQ 685
V +L + CI V+E L +++ ++G+ P
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICI-------VFE-----LLGLSTYDFIKENGFLPFRLDH 119
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA------------------- 726
+A + + V +LHS H DLKP NIL
Sbjct: 120 IRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDI 176
Query: 727 KVADFGLVKNA-PDGKYS---VETRLAGTFGYLAPE------YAATGRVTTKIDVYAFGV 776
KV DFG +A D ++ V TR Y APE + + DV++ G
Sbjct: 177 KVVDFG---SATYDDEHHSTLVSTR----H-YRAPEVILALGW------SQPCDVWSIGC 222
Query: 777 VLMETITG 784
+L+E G
Sbjct: 223 ILIEYYLG 230
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 9e-06
Identities = 42/313 (13%), Positives = 89/313 (28%), Gaps = 42/313 (13%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLA 74
L+ +++ + + K A +L+ S + +N ++ + L+
Sbjct: 222 LVSVKVGDFEILELVGF-FKAAANLEEF--CGGSLNEDIGMPEKYMNLVFPRKLCRLGLS 278
Query: 75 KSGLSGTLSPEISSLTQLETLSFQMNNI--AGAIPSLANATSLQDIYLDN----NNFTSV 128
G + + Q+ L + + +L+ + N +
Sbjct: 279 YMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVL 337
Query: 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNEL----------TKSTSLTTLYMDNANI--F 176
C L+ L + + L L + + ++I
Sbjct: 338 AQYC----KQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNE 393
Query: 177 GLIPDFFDSFSNLQNLRLSY----NNFT--------GSLPASFAKSDIQNLWMNDQQLGL 224
L NL + RL T SL K ++ L
Sbjct: 394 SLES-IGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTD 452
Query: 225 SGTLDVLSGMTQLRQVWLHKNQFT--GPIPDLSKCESLFDLSLRDNQLTGV-VPASVISL 281
G + +R + L + G + C +L L +R + + A+V L
Sbjct: 453 LGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKL 512
Query: 282 PALLNISLQNNKL 294
P+L + +Q +
Sbjct: 513 PSLRYLWVQGYRA 525
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 51/461 (11%), Positives = 120/461 (26%), Gaps = 95/461 (20%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQ--SLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTIS 72
L + + D L A+ L+ L D + TT
Sbjct: 114 LKSVHFRRMIVSDLDLDRLAKARADDLETL------------------KLDKCSGFTTDG 155
Query: 73 LAKSGLSGTLSPEISSLTQLETLSFQMNNI----AGAIPSLA-NATSLQDIYLDNNNFTS 127
L ++ +++TL + ++ + LA + TSL+ + F
Sbjct: 156 LLS---------IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAK 206
Query: 128 VPTGC----FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL----- 178
+ +L + + D L F ++
Sbjct: 207 ISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNL 266
Query: 179 ------------------IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS--DIQNLWMN 218
+P F + ++ L L Y + + +++ L
Sbjct: 267 VFPRKLCRLGLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETR 326
Query: 219 DQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT--GVVPA 276
+ +G G + QL+++ + + + + ++ G++ A
Sbjct: 327 N-VIGDRGLEVLAQYCKQLKRL------------RIERGADEQGMEDEEGLVSQRGLI-A 372
Query: 277 SVISLPALLNISLQNNKL--QGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLL 334
L +++ + + + + + P D V +LL
Sbjct: 373 LAQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLL 432
Query: 335 QIAGDMGYPAILSDSWEGNNACD-GWPFVTCSQGRIITINLANKLL--AGNISPAYANLT 391
+ + D G ++ + + L G +
Sbjct: 433 IGCKKL---RRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEG-LMEFSRGCP 488
Query: 392 SLKNLYLQQNNLTGPIPDGLTKLA----SLQNLDVSNNNLS 428
+L+ L ++ + + SL+ L V S
Sbjct: 489 NLQKLEMRGCCFS---ERAIAAAVTKLPSLRYLWVQGYRAS 526
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 4e-05
Identities = 83/549 (15%), Positives = 146/549 (26%), Gaps = 186/549 (33%)
Query: 368 RIITI------NLANKLLAGNISPAYANL-TSLKNLYLQQNNLTGPIPDGLTKLASLQNL 420
R+ + K + + Y L + +K Q P +T++ Q
Sbjct: 66 RLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQ--------PSMMTRMYIEQR- 116
Query: 421 DVSNNNLSGKVPDFGSNVKFTVSPGNPFI-----------GTNVDTTPGGAGTPGSKPSG 469
+ L F K+ VS P++ NV G G
Sbjct: 117 ----DRLYNDNQVF---AKYNVSRLQPYLKLRQALLELRPAKNV-LIDGVLG-------- 160
Query: 470 PSGSPAASSKSKLSVGTIVAIVV----VVVIFIAVVFFVVYKFIARRKHRKFGRVKNPEV 525
SG K+ + V V +F++ +PE
Sbjct: 161 -SG------KTWV-----ALDVCLSYKVQCKMDFKIFWL-----------NLKNCNSPET 197
Query: 526 GNEMNKN--GVTGGNGTNGYNGVPSELHSQSSGDVSDRHLFEGGNVAISIEVLRQVTDNF 583
EM + N T+ + + S R L + + VL V +
Sbjct: 198 VLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQN-- 255
Query: 584 SEANILGRGGFGVVYGGELPDGTKIAV-KRMESNT--MGNKGLSEFQAE--IAVLTKVRH 638
A F + KI + R + T + + + LT
Sbjct: 256 --AKAW--NAFNL--------SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTP--- 300
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLF-------EWHDHGYTPLTWKQ----RV 687
+ +LL ++ + L PR L + D T WK ++
Sbjct: 301 DEVKSLLLKYLDCRPQDL-----PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
Query: 688 TIALDVARGVEYLHS-LAQQSFIHRDLK--PSNILI----------------GDDMRAKV 728
T ++ + + L ++ F L P + I + K+
Sbjct: 356 TTIIESS--LNVLEPAEYRKMF--DRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL 411
Query: 729 ADFGLV-KNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKA 787
+ LV K + S+ +Y + L + A
Sbjct: 412 HKYSLVEKQPKESTISIP------------------------SIY---LELKVKLENEYA 444
Query: 788 LDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN----LNLDEETIESIYRVAELAGHCTA 843
L H R ++ NIPK D + LD+ Y + + H
Sbjct: 445 L---------H------RSIVDHYNIPKTFDSDDLIPPYLDQ------YFYSHIGHHLKN 483
Query: 844 REPQQRPDM 852
E +R +
Sbjct: 484 IEHPERMTL 492
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 6e-05
Identities = 37/244 (15%), Positives = 74/244 (30%), Gaps = 56/244 (22%)
Query: 64 NSNRVTTISLAKSGLSG----TLSPEISSLTQLETLSFQMNNI--AGAIPSLA-----NA 112
+ + ++LA L TL P + L Q+N++ L +
Sbjct: 99 GRHALDEVNLASCQLDPAGLRTLLP---VFLRARKLGLQLNSLGPEACK-DLRDLLLHDQ 154
Query: 113 TSLQDIYLDNNNFTSVPTGC---FDGL---TNLQVLSLSDNP-------NLAPWPFPNEL 159
+ + L NN T+ G +GL T++ LSL LA +L
Sbjct: 155 CQITTLRLSNNPLTAA--GVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA-----AQL 207
Query: 160 TKSTSLTTLYMDNANI--FG--LIPDFFDSFSNLQNLRLSYNNFTGS--------LPASF 207
++ L L + + +L+ L L +N + A+
Sbjct: 208 DRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLRDLGGAAE 267
Query: 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRD 267
+ + + ++ +LS + + W + + L L D
Sbjct: 268 GGARVVVSLTEGTAVSEYWSV-ILSEVQRNLNSWDRAR--------VQRHLELLLRDLED 318
Query: 268 NQLT 271
++
Sbjct: 319 SRGA 322
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-04
Identities = 43/306 (14%), Positives = 88/306 (28%), Gaps = 83/306 (27%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLA 74
+ L L+ L +L ++L +P +T + L
Sbjct: 82 VTSLNLSGNFLSYKS--SDELVKTLAAIPF----------------------TITVLDLG 117
Query: 75 KSGLSGTLSPEISSL-----TQLETLSFQMNNI--AGAIPSLANA-----TSLQDIYLDN 122
+ S S E + +L+ + N++ + L ++ + L
Sbjct: 118 WNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSD-ELIQILAAIPANVNSLNLRG 176
Query: 123 NNFTSVPTGCF---DGL----TNLQVLSLSDNP-------NLAPWPFPNELTKS--TSLT 166
NN S C L ++ L LS N LA + S +
Sbjct: 177 NNLAS--KNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA------YIFSSIPNHVV 228
Query: 167 TLYMDNANI----FGLIPDFFDSFSNLQNLRLSYNNF---TGSLPASFAK-----SDIQN 214
+L + + + DS +LQ + L Y+ + + I
Sbjct: 229 SLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIIL 288
Query: 215 LWMNDQQLGLSGTLDVLSGMTQ----LRQVWLHKNQFTG------PIPDLSKCESLFDLS 264
+ N +++ S ++ + + + + L I DL+ + L +
Sbjct: 289 VDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRESI 348
Query: 265 LRDNQL 270
L
Sbjct: 349 QTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 3e-04
Identities = 48/311 (15%), Positives = 102/311 (32%), Gaps = 72/311 (23%)
Query: 159 LTKSTSLTTLYMDNANI-----FGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA----- 208
+ +T+L + N+ LI F ++ +++ +L LS N+
Sbjct: 18 TSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAA 77
Query: 209 -KSDIQNLWMNDQQLGLSGTLDVLSGM----TQLRQVWLHKNQFTGP-IPDLSK-----C 257
+++ +L ++ L + +++ + + + L N F+ + +
Sbjct: 78 IPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 258 ESLFDLSLRDNQLTGVVPASVISL-PALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNF- 315
S+ L+LR N L S L L I P+ V ++L NN
Sbjct: 138 ASITSLNLRGNDLG---IKSSDELIQILAAI--------------PANVNSLNLRGNNLA 180
Query: 316 ---CKNSSDAGKPCDPQVTTL-L---QIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
C + VT+L L + G Y L+ +
Sbjct: 181 SKNCAELAKFLASIPASVTSLDLSANLL-GLKSYAE-LAYIFSSIPN------------H 226
Query: 369 IITINLANKLL----AGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLAS-------L 417
++++NL L N+ +L L+ +YL + + + L + +
Sbjct: 227 VVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKI 286
Query: 418 QNLDVSNNNLS 428
+D + +
Sbjct: 287 ILVDKNGKEIH 297
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 42.6 bits (100), Expect = 6e-04
Identities = 41/281 (14%), Positives = 83/281 (29%), Gaps = 51/281 (18%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLA 74
L ++L + DD + +A+S +N + + +T LA
Sbjct: 107 LEEIRLKRMVVTDDC--LELIAKSFKNF---------------KVLVLSSCEGFSTDGLA 149
Query: 75 KSG----------LSGTLSPEIS---------SLTQLETLSFQM--NNI-AGAIPSLA-N 111
L + ++S + T L +L+ + + A+ L
Sbjct: 150 AIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR 209
Query: 112 ATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT----KSTSLTT 167
+L+ + L+ L+ L + L+ L
Sbjct: 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRC 269
Query: 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK--SDIQNLWMNDQQLGLS 225
L + +P + S L L LSY +Q LW+ D + +
Sbjct: 270 LSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLD-YIEDA 328
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLR 266
G + S LR++ + ++ + +L + L
Sbjct: 329 GLEVLASTCKDLRELRVFPSEPF----VMEPNVALTEQGLV 365
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 933 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 100.0 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 100.0 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 100.0 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 100.0 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 100.0 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 100.0 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 100.0 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 100.0 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 100.0 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 100.0 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.98 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.98 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.97 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.97 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 99.97 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.97 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 99.97 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 99.97 | |
| 4g8a_A | 635 | TOLL-like receptor 4; leucine rich repeat MD-2 rel | 99.97 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 99.97 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 99.96 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.96 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 99.96 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.96 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.96 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 99.96 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.96 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.95 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.95 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.95 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 99.95 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 99.95 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 99.94 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 99.94 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.94 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 99.94 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 99.94 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 99.94 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 99.93 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.93 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 99.93 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 99.92 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 99.91 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.9 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 99.9 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 99.9 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.9 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.89 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.89 | |
| 4glp_A | 310 | Monocyte differentiation antigen CD14; alpha beta | 99.88 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.88 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 99.88 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 99.87 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 99.87 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.87 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.87 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.87 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 99.87 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.85 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 99.85 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 99.84 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 99.84 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 99.83 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.83 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.82 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.81 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.81 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.81 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 99.8 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 99.79 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 99.79 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.79 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.79 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.78 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 99.78 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.77 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 99.77 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.75 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 99.75 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.75 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.75 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 99.75 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.74 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 99.74 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 99.73 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 99.72 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.71 | |
| 4b8c_D | 727 | Glucose-repressible alcohol dehydrogenase transcr | 99.71 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 99.7 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.67 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 99.66 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.64 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.63 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.6 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.59 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 99.57 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.57 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 99.56 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 99.56 | |
| 3sb4_A | 329 | Hypothetical leucine rich repeat protein; LRR, rig | 99.54 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 99.5 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.5 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.47 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 99.46 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 99.43 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.39 | |
| 4fdw_A | 401 | Leucine rich hypothetical protein; putative cell s | 99.39 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 99.38 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.24 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.24 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 99.21 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 99.19 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.18 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 99.13 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.11 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.99 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.92 | |
| 4fs7_A | 394 | Uncharacterized protein; leucine-rich repeats, pro | 98.91 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.86 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.84 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 98.79 | |
| 4gt6_A | 394 | Cell surface protein; leucine rich repeats, putati | 98.79 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.59 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.51 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 3rw6_A | 267 | Nuclear RNA export factor 1; retroviral constituti | 98.33 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.32 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.3 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.29 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.27 | |
| 1io0_A | 185 | Tropomodulin; LRR protein, right-handed super-heli | 98.26 | |
| 4h09_A | 379 | Hypothetical leucine rich repeat protein; two LRR_ | 98.09 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.08 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.9 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.78 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.74 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.62 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.53 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.39 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.32 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.28 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 97.2 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.16 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 97.09 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.99 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.97 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.85 | |
| 1pgv_A | 197 | TMD-1, tropomodulin TMD-1; structural genomics, PS | 96.84 | |
| 3e4g_A | 176 | ATP synthase subunit S, mitochondrial; leucine-ric | 96.71 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.63 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.47 | |
| 3rfe_A | 130 | Platelet glycoprotein IB beta chain; platelet surf | 96.39 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.38 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.32 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.79 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.42 | |
| 2k1k_A | 38 | Ephrin type-A receptor 1; EPHA1, receptor tyrosine | 90.94 | |
| 2ks1_B | 44 | Epidermal growth factor receptor; ERBB1, ERBB2, tr | 88.6 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.34 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 88.03 | |
| 2l2t_A | 44 | Receptor tyrosine-protein kinase ERBB-4; transmemb | 87.68 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 86.56 | |
| 2jwa_A | 44 | Receptor tyrosine-protein kinase ERBB-2; transmemb | 84.63 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 83.54 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=442.45 Aligned_cols=264 Identities=25% Similarity=0.427 Sum_probs=208.4
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
+++.+.+.||+|+||+||+|.+. ..||||+++....+....++|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS--SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC--CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 56788899999999999999874 369999998766666777899999999999999999999998865 568999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
|++|+|.++++.. ..+++|.++..|+.|||+||+|||+ ++||||||||+|||+++++.+||+|||+|+.....
T Consensus 113 ~~gGsL~~~l~~~----~~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 113 CEGSSLYKHLHVQ----ETKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp CSSCBHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred CCCCCHHHHHhhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 9999999999652 2469999999999999999999999 89999999999999999999999999999865533
Q ss_pred C-ceeecccccccCcccccccCC---CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 741 K-YSVETRLAGTFGYLAPEYAAT---GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 741 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
. .......+||+.|||||++.+ +.|+.++|||||||++|||+||+.||......... . .........+.
T Consensus 186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~--~----~~~~~~~~~p~- 258 (307)
T 3omv_A 186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQI--I----FMVGRGYASPD- 258 (307)
T ss_dssp --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--H----HHHHTTCCCCC-
T ss_pred CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHH--H----HHHhcCCCCCC-
Confidence 2 223345689999999999853 46899999999999999999999999865432211 1 11111111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
+. .+. .+....+.+++.+||+.||++||||+||++.|+.+.+.+.
T Consensus 259 ~~-~~~-----~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lp 303 (307)
T 3omv_A 259 LS-KLY-----KNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLP 303 (307)
T ss_dssp ST-TSC-----TTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCC
T ss_pred cc-ccc-----ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCC
Confidence 00 000 1122467799999999999999999999999988866554
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-52 Score=443.60 Aligned_cols=261 Identities=30% Similarity=0.484 Sum_probs=213.1
Q ss_pred cCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
++|.+.+.||+|+||.||+|.+. +++.||||+++.. +....++|.+|+++|++++|||||+++|+|.+++..
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 57888999999999999999753 4788999999764 455678899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcc--------cCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcE
Q 002346 655 LLVYEYMPRGTLAQHLFEWH--------DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRA 726 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~ 726 (933)
++|||||++|+|.++|+... ......++|.+++.|+.|||+||+|||+ ++||||||||+|||+++++.+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~ 167 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLV 167 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcE
Confidence 99999999999999997632 1223569999999999999999999999 899999999999999999999
Q ss_pred EEecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHH
Q 002346 727 KVADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 727 kl~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 804 (933)
||+|||+|+......... .....||++|||||++.++.|+.++|||||||++|||+| |+.||......+ +..
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~--- 241 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE--- 241 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH---
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH---
Confidence 999999998665443332 334579999999999999999999999999999999999 899998754322 222
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.+.. +..+. .++.. ..++.+++.+||+.||++||+++|+++.|+++.+
T Consensus 242 ~i~~--~~~~~-~p~~~---------~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~ 289 (299)
T 4asz_A 242 CITQ--GRVLQ-RPRTC---------PQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAK 289 (299)
T ss_dssp HHHH--TCCCC-CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHc--CCCCC-CCccc---------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 1111 11111 11111 2357799999999999999999999999988754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=447.59 Aligned_cols=261 Identities=30% Similarity=0.475 Sum_probs=207.3
Q ss_pred cCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
++|.+.+.||+|+||.||+|.+. +++.||||+++.. +....++|.+|+++|++++|||||+++|+|.++...
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 56778899999999999999764 4789999999764 455678899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccC----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDH----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM 724 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 724 (933)
++|||||++|+|.++++..... ...+++|.+++.|+.|||+||+|||+ ++||||||||+|||+++++
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~ 195 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGL 195 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTT
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCC
Confidence 9999999999999999764221 23469999999999999999999999 8999999999999999999
Q ss_pred cEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHH
Q 002346 725 RAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTW 802 (933)
Q Consensus 725 ~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~ 802 (933)
.+||+|||+|+....... ...+...||+.|||||++.+..|+.++|||||||++|||+| |+.||......+ ...
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~- 271 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AID- 271 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHH-
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHH-
Confidence 999999999986654332 33345689999999999999999999999999999999999 899998654322 222
Q ss_pred HHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 803 FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 803 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.+.. ....+ .++.. ..++.+++.+||+.||++||||+||++.|+.+.+
T Consensus 272 --~i~~-g~~~~--~p~~~---------~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~ 319 (329)
T 4aoj_A 272 --CITQ-GRELE--RPRAC---------PPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQ 319 (329)
T ss_dssp --HHHH-TCCCC--CCTTC---------CHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --HHHc-CCCCC--Ccccc---------cHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhh
Confidence 1111 11111 11111 2357799999999999999999999999988754
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=441.76 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=209.8
Q ss_pred cCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.++++.+.||+|+||+||+|.+ .+++.||||+++... .....++|.+|+.++++++|||||+++|+|.+++..
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 3566778999999999999976 256889999997653 344567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
++|||||++|+|.++|+..... ....++|.++..|+.|||+||+|||+ ++||||||||+|||++++
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGG
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCC
Confidence 9999999999999999753211 12469999999999999999999999 899999999999999999
Q ss_pred CcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHH
Q 002346 724 MRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~ 801 (933)
+.+||+|||+|+....... ...+...||++|||||++.++.|+.++|||||||++|||+| |+.||......+ +..
T Consensus 182 ~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~ 258 (308)
T 4gt4_A 182 LNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVE 258 (308)
T ss_dssp GCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHH
T ss_pred CCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHH
Confidence 9999999999986544332 23345689999999999999999999999999999999999 899998754322 222
Q ss_pred HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
.+ .. . ..+. ..+. ....+.+++.+||+.||++||+|+||++.|+.
T Consensus 259 ~i---~~-~-~~~~-~p~~---------~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a 303 (308)
T 4gt4_A 259 MI---RN-R-QVLP-CPDD---------CPAWVYALMIECWNEFPSRRPRFKDIHSRLRA 303 (308)
T ss_dssp HH---HT-T-CCCC-CCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred HH---Hc-C-CCCC-Cccc---------chHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence 11 11 1 1111 1111 12457799999999999999999999999865
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-52 Score=448.97 Aligned_cols=252 Identities=21% Similarity=0.375 Sum_probs=206.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++++.||+|+||+||+|.. .+|+.||||++..........+.|.+|++++++++|||||++++++.+++..|+|||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 6899999999999999999954 579999999998876666777899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
||+||+|.+++... ....+++.+++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 104 y~~gg~L~~~i~~~---~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 177 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ---KGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS 177 (350)
T ss_dssp CCTTCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred CCCCCcHHHHHHHc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence 99999999999652 23568999999999999999999999 8999999999999999999999999999986653
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.. ......+||+.|||||++.+..|+.++|||||||++|||+||+.||......+ .+..+... ..+. +..
T Consensus 178 ~~-~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~--~~~~-~~~ 247 (350)
T 4b9d_A 178 TV-ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN------LVLKIISG--SFPP-VSL 247 (350)
T ss_dssp HH-HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHT--CCCC-CCT
T ss_pred Cc-ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH------HHHHHHcC--CCCC-CCc
Confidence 22 12344689999999999999999999999999999999999999998653221 12222221 1111 111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+ ..++.+++.+||+.||++|||++|+++
T Consensus 248 ~~---------s~~~~~li~~~L~~dP~~R~s~~e~l~ 276 (350)
T 4b9d_A 248 HY---------SYDLRSLVSQLFKRNPRDRPSVNSILE 276 (350)
T ss_dssp TS---------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred cC---------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 11 135779999999999999999999976
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=439.21 Aligned_cols=254 Identities=22% Similarity=0.380 Sum_probs=210.7
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+.|++.+.||+|+||.||+|.. .+|+.||||++..... ...+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--SSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 5699999999999999999955 5799999999976532 334578999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
||++|+|.+++.. ..+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 152 y~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 222 (346)
T 4fih_A 152 FLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 222 (346)
T ss_dssp CCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence 9999999999965 458999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... .....+||+.|||||++.+..|+.++||||+||++|||++|+.||....+.+ ... .+.... + +
T Consensus 223 ~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~---~i~~~~---~----~ 288 (346)
T 4fih_A 223 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMK---MIRDNL---P----P 288 (346)
T ss_dssp SSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH---HHHHSS---C----C
T ss_pred CCC-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHH---HHHcCC---C----C
Confidence 332 2345789999999999999999999999999999999999999997653322 111 111111 0 1
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.+.. ......++.+++.+||+.||++|||++|+++ ++|..
T Consensus 289 ~~~~---~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~------Hp~~~ 328 (346)
T 4fih_A 289 RLKN---LHKVSPSLKGFLDRLLVRDPAQRATAAELLK------HPFLA 328 (346)
T ss_dssp CCSC---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT------CGGGG
T ss_pred CCCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc------CHhhc
Confidence 1110 0011245779999999999999999999976 67764
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=435.23 Aligned_cols=261 Identities=20% Similarity=0.331 Sum_probs=216.4
Q ss_pred cCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||+||+|. ..+|+.||||++.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999995 46799999999976532 2344678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||++||+|.+++.. .+.+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 112 Ey~~gG~L~~~i~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~ 183 (311)
T 4aw0_A 112 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 183 (311)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence 99999999999976 2569999999999999999999999 899999999999999999999999999999765
Q ss_pred CCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... .......+||+.|||||++.+..|+.++||||+||++|||+||+.||...... . .+..+......+++.+
T Consensus 184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~---~~~~i~~~~~~~p~~~ 257 (311)
T 4aw0_A 184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---L---IFAKIIKLEYDFPEKF 257 (311)
T ss_dssp TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H---HHHHHHHTCCCCCTTC
T ss_pred CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---H---HHHHHHcCCCCCCccc
Confidence 432 23345678999999999999999999999999999999999999999764322 1 2223333333333221
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
. .++.+++.+||+.||++||+++|+...-+-..++|+.
T Consensus 258 ----s---------~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~ 295 (311)
T 4aw0_A 258 ----F---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 295 (311)
T ss_dssp ----C---------HHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred ----C---------HHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcC
Confidence 1 3567999999999999999999975433323467764
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=423.93 Aligned_cols=251 Identities=24% Similarity=0.386 Sum_probs=204.0
Q ss_pred ccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee----CceeEEEE
Q 002346 584 SEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERLLVY 658 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 658 (933)
+..+.||+|+||.||+|.. .+++.||+|++..........++|.+|++++++++|||||++++++.+ +...|+||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 5567899999999999954 568999999998776666677889999999999999999999999865 34578999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEecCCCCCcEEecC-CCcEEEecccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGD-DMRAKVADFGLVK 735 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dik~~Nill~~-~~~~kl~DfGla~ 735 (933)
|||++|+|.+++.+ ...+++.++..++.||++||+|||+ ++ ||||||||+|||++. ++.+||+|||+|+
T Consensus 109 Ey~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 99999999999976 2569999999999999999999998 66 999999999999984 7999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
...... ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||........ + ...+. ....+.
T Consensus 181 ~~~~~~---~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~---~~~i~--~~~~~~ 249 (290)
T 3fpq_A 181 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---YRRVT--SGVKPA 249 (290)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---HHHHT--TTCCCG
T ss_pred eCCCCc---cCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--H---HHHHH--cCCCCC
Confidence 654322 234689999999998864 699999999999999999999999975433211 1 11211 111122
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.++.... .++.+++.+||+.||++|||++|+++ ++|..
T Consensus 250 ~~~~~~~---------~~~~~li~~~L~~dP~~R~s~~e~l~------Hp~~~ 287 (290)
T 3fpq_A 250 SFDKVAI---------PEVKEIIEGCIRQNKDERYSIKDLLN------HAFFQ 287 (290)
T ss_dssp GGGGCCC---------HHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGC
T ss_pred CCCccCC---------HHHHHHHHHHccCChhHCcCHHHHhc------Ccccc
Confidence 2222211 35779999999999999999999986 66654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=431.54 Aligned_cols=254 Identities=20% Similarity=0.296 Sum_probs=207.2
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+.|++.++||+|+||.||+|.. .+|+.||||+++.... +.+|+.++++++|||||++++++.+++..|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 4678889999999999999964 5799999999976532 2479999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEEecccccccCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVKNAP 738 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~~~~ 738 (933)
||+||+|.++++. .+.+++.++..++.||+.||+|||+ ++||||||||+|||++.++ ++||+|||+|+...
T Consensus 131 y~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~ 202 (336)
T 4g3f_A 131 LLEGGSLGQLIKQ-----MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ 202 (336)
T ss_dssp CCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred ccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence 9999999999976 2569999999999999999999999 8999999999999999988 69999999998765
Q ss_pred CCCce----eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 739 DGKYS----VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 739 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
..... .....+||+.|||||++.+..|+.++|||||||++|||+||++||.......... .+.......
T Consensus 203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~~~~~- 275 (336)
T 4g3f_A 203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL------KIASEPPPI- 275 (336)
T ss_dssp -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH------HHHHSCCGG-
T ss_pred CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHHcCCCCc-
Confidence 43221 1233579999999999999999999999999999999999999998755433221 111111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
..+.+.+. ..+.+++.+||+.||++|||+.|+++.|..++..
T Consensus 276 ~~~~~~~s---------~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~ 317 (336)
T 4g3f_A 276 REIPPSCA---------PLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE 317 (336)
T ss_dssp GGSCTTSC---------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred hhcCccCC---------HHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence 11222222 4577999999999999999999999988776544
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-50 Score=430.77 Aligned_cols=269 Identities=23% Similarity=0.327 Sum_probs=204.4
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc----eeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 655 (933)
.++|.+.+.||+|+||+||+|.+ +|+.||||++.... .....+.+|+..+.+++|||||+++++|.+++ ..+
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 35678889999999999999988 68999999986542 22223345666677889999999999998653 579
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeEecCCCCCcEEecCCCcEEEec
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA-----QQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
+|||||++|+|.++++. .+++|.++.+++.|+++||+|||+.+ ..+||||||||+|||++.++.+||+|
T Consensus 78 lV~Ey~~~gsL~~~l~~------~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D 151 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred EEecCCCCCcHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence 99999999999999976 45899999999999999999999731 24999999999999999999999999
Q ss_pred ccccccCCCCCcee---ecccccccCcccccccCCC------CCCCccchHhHHHHHHHHHcCCCCCCCCCCch------
Q 002346 731 FGLVKNAPDGKYSV---ETRLAGTFGYLAPEYAATG------RVTTKIDVYAFGVVLMETITGRKALDDTMPDD------ 795 (933)
Q Consensus 731 fGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~------ 795 (933)
||+|+......... ....+||+.|||||++.+. .++.++|||||||++|||+||+.||.......
T Consensus 152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~ 231 (303)
T 3hmm_A 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc
Confidence 99998655433222 2346899999999998654 46789999999999999999987764322110
Q ss_pred ---hhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 796 ---RAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 796 ---~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.... ........ ...++|.++......+....+.+++.+||+.||++||||+||++.|+++.+
T Consensus 232 ~~~~~~~-~~~~~~~~-----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~ 297 (303)
T 3hmm_A 232 VPSDPSV-EEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCSSCCH-HHHHHHHT-----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccccchH-HHHHHHHh-----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence 0011 11111111 112233333223334556678899999999999999999999999988764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=417.90 Aligned_cols=247 Identities=26% Similarity=0.415 Sum_probs=193.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||+||+|.. .+|+.||||++.+.... ....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5899999999999999999964 57999999999765433 334578999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+ +|+|.+++.. ..++++.++..++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 93 Ey~-~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 163 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-----RDKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT 163 (275)
T ss_dssp ECC-CEEHHHHHHH-----SCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred eCC-CCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence 999 6899999965 2569999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...... ..+..+......++..+
T Consensus 164 ~~~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~~~~i~~~~~~~p~~~ 235 (275)
T 3hyh_A 164 DGN--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VLFKNISNGVYTLPKFL 235 (275)
T ss_dssp -------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHHTCCCCCTTS
T ss_pred CCC--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HHHHHHHcCCCCCCCCC
Confidence 432 2344689999999999988776 57999999999999999999999764321 12222232222222221
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. .++.+++.+||+.||++|||++|+++
T Consensus 236 ----s---------~~~~~li~~~L~~dP~~R~s~~eil~ 262 (275)
T 3hyh_A 236 ----S---------PGAAGLIKRMLIVNPLNRISIHEIMQ 262 (275)
T ss_dssp ----C---------HHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ----C---------HHHHHHHHHHccCChhHCcCHHHHHc
Confidence 1 35679999999999999999999987
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=440.04 Aligned_cols=253 Identities=21% Similarity=0.367 Sum_probs=210.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+.|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.+|++++|||||++++++.+++..|+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTT--CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccc--hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 5799999999999999999955 579999999997653 2334678999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
||+||+|.+++.. ..+++.++..|+.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+....
T Consensus 229 y~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~ 299 (423)
T 4fie_A 229 FLEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 299 (423)
T ss_dssp CCTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred CCCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence 9999999999965 458999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc-cC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA-ID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~d 818 (933)
... .....+||+.|||||++.+..|+.++|||||||++|||++|+.||....+.+. .. .+.... .+.. ..
T Consensus 300 ~~~-~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~---~i~~~~--~~~~~~~ 370 (423)
T 4fie_A 300 EVP-RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MK---MIRDNL--PPRLKNL 370 (423)
T ss_dssp SCC-CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HH---HHHHSC--CCCCSCT
T ss_pred CCc-cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HH---HHHcCC--CCCCccc
Confidence 332 23456899999999999999999999999999999999999999976543221 11 111111 0000 00
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
..+ ..++.+|+.+||+.||++|||++|+++ ++|..
T Consensus 371 ~~~---------s~~~~dli~~~L~~dP~~R~ta~ell~------Hp~~~ 405 (423)
T 4fie_A 371 HKV---------SPSLKGFLDRLLVRDPAQRATAAELLK------HPFLA 405 (423)
T ss_dssp TSS---------CHHHHHHHHHHSCSSTTTSCCHHHHTT------CGGGG
T ss_pred ccC---------CHHHHHHHHHHcCCChhHCcCHHHHhc------CHHhc
Confidence 111 135779999999999999999999976 67764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=428.42 Aligned_cols=254 Identities=24% Similarity=0.351 Sum_probs=203.0
Q ss_pred cCCccCCccccCCCeEEEEEEe----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
++|++.+.||+|+||+||+|+. ..++.||||++++.........++.+|++++++++|||||++++++.+++..|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5799999999999999999964 247899999998765444445578999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||++||+|.+++.+ .+.+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 104 vmEy~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~ 175 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK-----EVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175 (304)
T ss_dssp EECCCTTCEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred EEEcCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence 9999999999999976 2569999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
...... .....+||+.|||||++.+..|+.++||||+||++|||+||+.||......+ .+..+.......+..
T Consensus 176 ~~~~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~~~~i~~~~~~~p~~ 248 (304)
T 3ubd_A 176 SIDHEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------TMTMILKAKLGMPQF 248 (304)
T ss_dssp -----C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCTT
T ss_pred ccCCCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------HHHHHHcCCCCCCCc
Confidence 544322 2345689999999999999999999999999999999999999998653322 122233323222222
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHHHhhhhhhcCC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM-----GHAVNVLGPLVEQWKP 868 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~-----~evl~~L~~~~~~~~~ 868 (933)
++ .++.+++.+||+.||++||++ +|+++ ++|..
T Consensus 249 ~s-------------~~~~~li~~~L~~dP~~R~ta~~~~~~eil~------Hp~f~ 286 (304)
T 3ubd_A 249 LS-------------PEAQSLLRMLFKRNPANRLGAGPDGVEEIKR------HSFFS 286 (304)
T ss_dssp SC-------------HHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT------SGGGT
T ss_pred CC-------------HHHHHHHHHHcccCHHHCCCCCcCCHHHHHc------Ccccc
Confidence 21 357799999999999999985 45543 66764
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-49 Score=432.53 Aligned_cols=273 Identities=25% Similarity=0.392 Sum_probs=218.6
Q ss_pred cHHHHHHHhcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCC-CcceeE
Q 002346 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVAL 644 (933)
Q Consensus 572 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l 644 (933)
+.+..+.-.++|++.+.||+|+||.||+|.+. .++.||||++.... .....++|.+|+++|.+++| ||||++
T Consensus 55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 34444455689999999999999999999653 24689999997653 34456789999999999965 899999
Q ss_pred EeEeeeC-ceeEEEEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecC
Q 002346 645 LGYCING-SERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRD 712 (933)
Q Consensus 645 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~D 712 (933)
+|+|.+. ...++|||||++|+|.++|+..... ....++|.++..++.|||+||+|||+ ++|||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCc
Confidence 9999764 5689999999999999999763321 12458999999999999999999999 8999999
Q ss_pred CCCCcEEecCCCcEEEecccccccCCCCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCC
Q 002346 713 LKPSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDD 790 (933)
Q Consensus 713 ik~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~ 790 (933)
|||+|||+++++.+||+|||+|+...... ....+...||+.|||||++.++.|+.++|||||||++|||+| |+.||..
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~ 290 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 290 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999999765443 334456789999999999999999999999999999999998 8999986
Q ss_pred CCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 791 TMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
...... +.. .+...... . ..... ..++.+++.+||+.||++|||++|+++.|+.+++.
T Consensus 291 ~~~~~~--~~~----~i~~g~~~-~-~p~~~---------~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~ 348 (353)
T 4ase_A 291 VKIDEE--FCR----RLKEGTRM-R-APDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 348 (353)
T ss_dssp CCCSHH--HHH----HHHHTCCC-C-CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCHHHH--HHH----HHHcCCCC-C-CCccC---------CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence 543221 111 11111111 1 11111 13577999999999999999999999999888754
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=405.53 Aligned_cols=251 Identities=25% Similarity=0.384 Sum_probs=190.7
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc-------
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------- 652 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------- 652 (933)
++|++++.||+|+||+||+|.. .+|+.||||+++... .....+++.+|++++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 4699999999999999999964 579999999997653 3445678999999999999999999999987543
Q ss_pred -----eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEE
Q 002346 653 -----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (933)
Q Consensus 653 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~k 727 (933)
..|+|||||++|+|.+++.... .....++..++.++.||++||+|||+ ++||||||||+|||++.++.+|
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vK 158 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVK 158 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEE
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEE
Confidence 3689999999999999997522 22346778899999999999999999 8999999999999999999999
Q ss_pred EecccccccCCCCCce-----------eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh
Q 002346 728 VADFGLVKNAPDGKYS-----------VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR 796 (933)
Q Consensus 728 l~DfGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~ 796 (933)
|+|||+|+........ ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||... .+.
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~--~~~ 233 (299)
T 4g31_A 159 VGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQ--MER 233 (299)
T ss_dssp ECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSH--HHH
T ss_pred EccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCc--cHH
Confidence 9999999865543211 1234579999999999999999999999999999999996 77532 111
Q ss_pred hHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 797 AHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+.... ....+ ...........+++.+||+.||++|||+.|+++
T Consensus 234 ---~~~~~~~~--~~~~p----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 279 (299)
T 4g31_A 234 ---VRTLTDVR--NLKFP----------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE 279 (299)
T ss_dssp ---HHHHHHHH--TTCCC----------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HHHHHHHh--cCCCC----------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11111111 11111 122223345668999999999999999999976
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=448.90 Aligned_cols=415 Identities=21% Similarity=0.276 Sum_probs=317.8
Q ss_pred CCccchHHHHHHHHHhcCCCCCCCCCCC---CCC--Cccc------------cceEeCCCCCEEEEEecCCCCccccCcc
Q 002346 23 TSLGDDGSVMLKLAQSLQNLPSDWSSTS---STG--YCEW------------TGINCDNSNRVTTISLAKSGLSGTLSPE 85 (933)
Q Consensus 23 ~~~~~d~~~l~~~~~~~~~~~~~w~~~~---~~~--~C~w------------~gv~c~~~~~v~~L~l~~~~l~~~~~~~ 85 (933)
+...+|+.||++||+++.+. +|+... ..+ +|.| .||+|+..++|+.|+|++++|+|.+|++
T Consensus 265 ~~~~~d~~ALl~~k~~l~~~--~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~~~~V~~L~Ls~~~L~G~ip~~ 342 (876)
T 4ecn_A 265 AEYIKDYKALKAIWEALDGK--NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDA 342 (876)
T ss_dssp CHHHHHHHHHHHHHHHTTGG--GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECTTSCEEEEECTTTCCEEEECGG
T ss_pred ccchHHHHHHHHHHHHcCCC--CCCcCCCcccccCCccccccccccccccCcCceEecCCCCEEEEECccCCCCCcCchH
Confidence 34457999999999999664 786543 223 4999 9999998899999999999999999999
Q ss_pred ccCCcccceeec-cccccccc-----------------------------------------------------------
Q 002346 86 ISSLTQLETLSF-QMNNIAGA----------------------------------------------------------- 105 (933)
Q Consensus 86 ~~~l~~L~~L~l-~~N~l~~~----------------------------------------------------------- 105 (933)
|++|++|++|+| ++|.++|.
T Consensus 343 l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i~~~~~ 422 (876)
T 4ecn_A 343 IGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSR 422 (876)
T ss_dssp GGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCCCCCCC
T ss_pred HhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCccccccccccc
Confidence 999999999999 77765443
Q ss_pred -----------------CC-CccCcCcCceeccccccccC------------------CCCCccc--CCCCCCEEEccCC
Q 002346 106 -----------------IP-SLANATSLQDIYLDNNNFTS------------------VPTGCFD--GLTNLQVLSLSDN 147 (933)
Q Consensus 106 -----------------~p-~~~~l~~L~~L~Ls~N~l~~------------------~~~~~~~--~l~~L~~L~Ls~N 147 (933)
+| .|.++++|++|+|++|+|++ +|.. ++ ++++|++|+|++|
T Consensus 423 l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~-l~f~~L~~L~~L~Ls~N 501 (876)
T 4ecn_A 423 ISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEE-LSWSNLKDLTDVELYNC 501 (876)
T ss_dssp CCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSC-CCGGGCTTCCEEEEESC
T ss_pred cchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChh-hhhccCCCCCEEECcCC
Confidence 55 78889999999999999998 6655 55 9999999999999
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcc-cCC-CCChhhcCCC-------CCCEEEccCCcCCCCCCc--cccc-cccchh
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNAN-IFG-LIPDFFDSFS-------NLQNLRLSYNNFTGSLPA--SFAK-SDIQNL 215 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~-l~~-~~p~~~~~l~-------~L~~L~L~~N~l~~~~p~--~~~~-~~l~~l 215 (933)
++.+ .+|..+.++++|+.|+|++|+ +++ .+|..++.++ +|++|+|++|+++ .+|. .+.. .+|+.|
T Consensus 502 ~l~~--~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L 578 (876)
T 4ecn_A 502 PNMT--QLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLL 578 (876)
T ss_dssp TTCC--SCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEE
T ss_pred CCCc--cChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEE
Confidence 9888 688999999999999999998 888 7888776665 9999999999999 8888 7766 579999
Q ss_pred hcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCC-CCEEEccCCcccccCcccccCCCC--CCEEEccCc
Q 002346 216 WMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES-LFDLSLRDNQLTGVVPASVISLPA--LLNISLQNN 292 (933)
Q Consensus 216 ~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~-L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls~N 292 (933)
++++|.+. .++.+..+++|+.|+|++|+++..++.+..+++ |+.|+|++|+|+ .+|..+..++. |+.|+|++|
T Consensus 579 ~Ls~N~l~---~lp~~~~L~~L~~L~Ls~N~l~~lp~~l~~l~~~L~~L~Ls~N~L~-~lp~~~~~~~~~~L~~L~Ls~N 654 (876)
T 4ecn_A 579 DCVHNKVR---HLEAFGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYN 654 (876)
T ss_dssp ECTTSCCC---BCCCCCTTSEESEEECCSSCCSCCCTTSCEECTTCCEEECCSSCCC-SCCSCCCTTCSSCEEEEECCSS
T ss_pred ECCCCCcc---cchhhcCCCcceEEECcCCccccchHHHhhccccCCEEECcCCCCC-cCchhhhccccCCCCEEECcCC
Confidence 99999887 333788899999999999999965557888988 999999999999 78888877754 999999999
Q ss_pred cCccCCCCCC--------CCccEEeccCCcCCCCCCCCCCCC-Cch-----hhhhHhhhcccCC-C-------ccccCCC
Q 002346 293 KLQGPYPLFP--------SKVQKVSLDHNNFCKNSSDAGKPC-DPQ-----VTTLLQIAGDMGY-P-------AILSDSW 350 (933)
Q Consensus 293 ~l~~~~p~~~--------~~l~~L~l~~n~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~-~-------~~l~~~~ 350 (933)
+++|.+|.++ .+|+.|+|++|++...+...+..+ ..+ ...+..++..... . ..++.+.
T Consensus 655 ~l~g~ip~l~~~l~~~~~~~L~~L~Ls~N~L~~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~ 734 (876)
T 4ecn_A 655 KIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTID 734 (876)
T ss_dssp CTTTTSSSCSSCTTTCCCCCEEEEECCSSCCCSCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEE
T ss_pred cCCCccccchhhhccccCCCcCEEEccCCcCCccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEE
Confidence 9998777543 267888888888875443211000 000 0000011111100 0 0333333
Q ss_pred CCCCCCCCCCcccc--CCCceeEEEccCccccCcCchhhcCcccCCeEeccc------CcccCCCCcccCCCCCcCEEec
Q 002346 351 EGNNACDGWPFVTC--SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQ------NNLTGPIPDGLTKLASLQNLDV 422 (933)
Q Consensus 351 ~~~~~~~~~p~~~~--~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~------N~l~g~~p~~~~~l~~L~~l~l 422 (933)
..+|.+..+|..+. .+++|+.|+|++|++++ +|..++++++|+.|+|++ |++.+.+|..|..+++|+.|+|
T Consensus 735 Ls~N~L~~lp~~l~~~~l~~L~~L~Ls~N~L~~-lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~L 813 (876)
T 4ecn_A 735 LRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813 (876)
T ss_dssp CCSSCCCCCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEEC
T ss_pred CCCCCCccchHHhhhccCCCcCEEEeCCCCCCc-cchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEEC
Confidence 33445557888776 78888888888888887 777788888888888865 7777788888888888888888
Q ss_pred cCCcCcccCCC-CCCCcccccCCCCCCc
Q 002346 423 SNNNLSGKVPD-FGSNVKFTVSPGNPFI 449 (933)
Q Consensus 423 s~N~l~g~~p~-~~~~~~~~~~~~n~~~ 449 (933)
++|+| +.+|. +...++...+.+|++.
T Consensus 814 s~N~L-~~Ip~~l~~~L~~LdLs~N~l~ 840 (876)
T 4ecn_A 814 GSNDI-RKVDEKLTPQLYILDIADNPNI 840 (876)
T ss_dssp CSSCC-CBCCSCCCSSSCEEECCSCTTC
T ss_pred CCCCC-CccCHhhcCCCCEEECCCCCCC
Confidence 88888 55554 4455555556677664
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=410.20 Aligned_cols=269 Identities=23% Similarity=0.337 Sum_probs=208.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee------Cc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------GS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 652 (933)
.++|++++.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|++++|||||++++++.. .+
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 46899999999999999999954 679999999998766555667789999999999999999999998764 35
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..|+|||||+ |+|.+++.. ...+++.++..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-----~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFG 203 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-----SQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFG 203 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEEeCCC-CCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecc
Confidence 7899999995 789999854 3579999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCC---ceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 733 LVKNAPDGK---YSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 733 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
+|+...... .......+||+.|+|||++.+. .++.++||||+||++|||++|++||......+.. ..+....
T Consensus 204 la~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l---~~I~~~~- 279 (398)
T 4b99_A 204 MARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQL---QLIMMVL- 279 (398)
T ss_dssp TCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHH---HHHHHHH-
T ss_pred eeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhc-
Confidence 998654322 1223457899999999998765 5699999999999999999999999875432221 1111111
Q ss_pred ccCCCCcc----------------cCCCCCCChh--hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 809 SKENIPKA----------------IDPNLNLDEE--TIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 809 ~~~~~~~~----------------~d~~l~~~~~--~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
+..+.. +.+....... ......++.+|+.+||+.||++|||++|+++ ++|...
T Consensus 280 --g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~------Hp~f~~ 350 (398)
T 4b99_A 280 --GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR------HPFLAK 350 (398)
T ss_dssp --CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT------SGGGTT
T ss_pred --CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc------CHhhCc
Confidence 111100 0000000000 0011245779999999999999999999876 777654
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=442.80 Aligned_cols=417 Identities=21% Similarity=0.274 Sum_probs=320.0
Q ss_pred ccchHHHHHHHHHhcCCCCC-----------CCCCCCCCCCccc---cceEeCCCCCEEEEEecCCCCccccCccccCCc
Q 002346 25 LGDDGSVMLKLAQSLQNLPS-----------DWSSTSSTGYCEW---TGINCDNSNRVTTISLAKSGLSGTLSPEISSLT 90 (933)
Q Consensus 25 ~~~d~~~l~~~~~~~~~~~~-----------~w~~~~~~~~C~w---~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~ 90 (933)
...|+.||.+++.++.+..+ +|. .+.++|.| .||+|+..++|+.|+|++++++|.+|++|++|+
T Consensus 28 ~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~--~~~~~c~w~~~~GV~C~~~~~V~~L~L~~~~l~g~lp~~l~~L~ 105 (636)
T 4eco_A 28 YIKDYLALKEIWDALNGKNWSQQGFGTQPGANWN--FNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLT 105 (636)
T ss_dssp HHHHHHHHHHHHHHTTGGGCCCCC------CCCC--CSSCGGGTTCCTTEEECTTCCEEEEECTTSCCEEEECGGGGGCT
T ss_pred HHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCC--CCCCcccccCCCCeEEcCCCCEEEEEecCcccCCcCChHHhcCc
Confidence 34699999999999866421 454 46789999 999998889999999999999999999999999
Q ss_pred ccceeecccc----------------------------------------------------------------------
Q 002346 91 QLETLSFQMN---------------------------------------------------------------------- 100 (933)
Q Consensus 91 ~L~~L~l~~N---------------------------------------------------------------------- 100 (933)
+|++|+|++|
T Consensus 106 ~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~l~~ 185 (636)
T 4eco_A 106 ELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKD 185 (636)
T ss_dssp TCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCCCCT
T ss_pred cceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccchhh
Confidence 9999999988
Q ss_pred --------cccccCCCccCcCcCceeccccccccC------------------CCCCccc--CCCCCCEEEccCCCCCCC
Q 002346 101 --------NIAGAIPSLANATSLQDIYLDNNNFTS------------------VPTGCFD--GLTNLQVLSLSDNPNLAP 152 (933)
Q Consensus 101 --------~l~~~~p~~~~l~~L~~L~Ls~N~l~~------------------~~~~~~~--~l~~L~~L~Ls~N~~~~~ 152 (933)
+++|+++.++++++|++|+|++|+|++ +|. .++ ++++|++|+|++|++.+
T Consensus 186 l~l~~~~n~l~~ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~- 263 (636)
T 4eco_A 186 TQIGQLSNNITFVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLT- 263 (636)
T ss_dssp TTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCS-
T ss_pred hhhccccCCCccCCHHHhcccCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCc-
Confidence 445633379999999999999999999 555 477 99999999999999888
Q ss_pred CCCCccccCCccCCeeeccCcc-cCC-CCChhhcCC------CCCCEEEccCCcCCCCCCc--cccc-cccchhhccccc
Q 002346 153 WPFPNELTKSTSLTTLYMDNAN-IFG-LIPDFFDSF------SNLQNLRLSYNNFTGSLPA--SFAK-SDIQNLWMNDQQ 221 (933)
Q Consensus 153 ~~~p~~~~~l~~L~~L~L~~n~-l~~-~~p~~~~~l------~~L~~L~L~~N~l~~~~p~--~~~~-~~l~~l~l~~n~ 221 (933)
.+|..++++++|++|+|++|+ +++ .+|..++.+ ++|++|+|++|+++ .+|. .+.. ..|++|++++|.
T Consensus 264 -~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~ 341 (636)
T 4eco_A 264 -KLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQ 341 (636)
T ss_dssp -SCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCC
T ss_pred -cChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCc
Confidence 688999999999999999998 888 788888776 88999999999988 8887 6765 578888888887
Q ss_pred CCcccccccccCCccCcEEEecCCccCCCCCCCCCCCC-CCEEEccCCcccccCcccccCCC--CCCEEEccCccCccCC
Q 002346 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES-LFDLSLRDNQLTGVVPASVISLP--ALLNISLQNNKLQGPY 298 (933)
Q Consensus 222 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~-L~~L~L~~N~l~~~~p~~l~~l~--~L~~L~Ls~N~l~~~~ 298 (933)
+. |.++.+..+++|+.|+|++|+++..+..+..+++ |+.|+|++|+++ .+|..+..++ +|+.|+|++|.+++.+
T Consensus 342 l~--g~ip~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~~L~~L~Ls~N~l~-~lp~~~~~~~l~~L~~L~Ls~N~l~~~~ 418 (636)
T 4eco_A 342 LE--GKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSAIDFSYNEIGSVD 418 (636)
T ss_dssp CE--EECCCCEEEEEESEEECCSSEEEECCTTSEEECTTCCEEECCSSCCS-SCCSCCCTTCSSCEEEEECCSSCTTTTT
T ss_pred Cc--cchhhhCCCCCCCEEECCCCccccccHhhhhhcccCcEEEccCCcCc-ccchhhhhcccCccCEEECcCCcCCCcc
Confidence 75 2223677778888888888888855556777777 888888888887 6777776654 7888888888888776
Q ss_pred CCCCC----------CccEEeccCCcCCCCCCCCCCCCC-ch-----hhhhHhhhcccCC--------CccccCCCCCCC
Q 002346 299 PLFPS----------KVQKVSLDHNNFCKNSSDAGKPCD-PQ-----VTTLLQIAGDMGY--------PAILSDSWEGNN 354 (933)
Q Consensus 299 p~~~~----------~l~~L~l~~n~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~--------~~~l~~~~~~~~ 354 (933)
|..+. +|+.|+|++|++...+...+..+. .+ ...+..++..... ...++.+...+|
T Consensus 419 p~~l~~~~~~~~~~~~L~~L~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N 498 (636)
T 4eco_A 419 GKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFN 498 (636)
T ss_dssp TCSSCTTCSSCCCCCCEEEEECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSS
T ss_pred hhhhcccccccccCCCCCEEECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCC
Confidence 65433 677777777777654432111000 00 0000011110000 003433334445
Q ss_pred CCCCCCcccc--CCCceeEEEccCccccCcCchhhcCcccCCeEec------ccCcccCCCCcccCCCCCcCEEeccCCc
Q 002346 355 ACDGWPFVTC--SQGRIITINLANKLLAGNISPAYANLTSLKNLYL------QQNNLTGPIPDGLTKLASLQNLDVSNNN 426 (933)
Q Consensus 355 ~~~~~p~~~~--~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L------~~N~l~g~~p~~~~~l~~L~~l~ls~N~ 426 (933)
.+..+|..+. .+++|+.|+|++|++++ +|..++++++|+.|+| ++|++.+.+|..+..+++|+.|+|++|+
T Consensus 499 ~l~~lp~~~~~~~l~~L~~L~Ls~N~l~~-ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 577 (636)
T 4eco_A 499 KLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSND 577 (636)
T ss_dssp CCCBCCGGGSTTTCTTCCEEECCSSCCSS-CCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSC
T ss_pred cCCccChhhhhccCCCcCEEECCCCCCCC-cChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCc
Confidence 5558998887 89999999999999998 8999999999999999 5688888999999999999999999999
Q ss_pred CcccCCC-CCCCcccccCCCCCCcCCC
Q 002346 427 LSGKVPD-FGSNVKFTVSPGNPFIGTN 452 (933)
Q Consensus 427 l~g~~p~-~~~~~~~~~~~~n~~~~~~ 452 (933)
| +.+|. +...++...+.+|++.|..
T Consensus 578 l-~~ip~~~~~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 578 I-RKVNEKITPNISVLDIKDNPNISID 603 (636)
T ss_dssp C-CBCCSCCCTTCCEEECCSCTTCEEE
T ss_pred C-CccCHhHhCcCCEEECcCCCCcccc
Confidence 9 55554 5566666677888887644
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=403.57 Aligned_cols=204 Identities=25% Similarity=0.400 Sum_probs=174.3
Q ss_pred HHHHHHhcCCccCCccccCCCeEEEEEEe----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEe
Q 002346 574 EVLRQVTDNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYC 648 (933)
Q Consensus 574 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~ 648 (933)
+.+..+.++|++.+.||+|+||+||+|.. ..++.||+|++.... ...++.+|+++++.+ +|||||++++++
T Consensus 14 ~~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~ 89 (361)
T 4f9c_A 14 EAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCF 89 (361)
T ss_dssp HHSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEE
T ss_pred HhcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence 34445678999999999999999999954 247889999986542 245788999999998 699999999999
Q ss_pred eeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-CcEE
Q 002346 649 INGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAK 727 (933)
Q Consensus 649 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~k 727 (933)
.+.+..|+||||+++|+|.+++. .+++.++..++.|++.||+|||+ ++||||||||+|||++.+ +.+|
T Consensus 90 ~~~~~~~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~k 158 (361)
T 4f9c_A 90 RKNDHVVIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYA 158 (361)
T ss_dssp EETTEEEEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEE
T ss_pred EECCEEEEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEE
Confidence 99999999999999999999983 48999999999999999999999 899999999999999877 7999
Q ss_pred EecccccccCCCCCc---------------------------eeecccccccCcccccccCCC-CCCCccchHhHHHHHH
Q 002346 728 VADFGLVKNAPDGKY---------------------------SVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLM 779 (933)
Q Consensus 728 l~DfGla~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~ 779 (933)
|+|||+|+...+... ...+..+||+.|+|||++.+. .|+.++||||+||++|
T Consensus 159 l~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ 238 (361)
T 4f9c_A 159 LVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFL 238 (361)
T ss_dssp ECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHH
T ss_pred ECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHH
Confidence 999999985543211 112345799999999998765 5899999999999999
Q ss_pred HHHcCCCCCCCCC
Q 002346 780 ETITGRKALDDTM 792 (933)
Q Consensus 780 elltG~~p~~~~~ 792 (933)
||++|+.||....
T Consensus 239 ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 239 SLLSGRYPFYKAS 251 (361)
T ss_dssp HHHHTCSSSSCCS
T ss_pred HHHHCCCCCCCCC
Confidence 9999999997654
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=440.03 Aligned_cols=407 Identities=24% Similarity=0.372 Sum_probs=253.9
Q ss_pred hccCCccchHHHHHHHHHhcCCC--CCCCCCCCCCCCccccceEeCCCCCEEEEEecCCCCccc---cC-----------
Q 002346 20 LTTTSLGDDGSVMLKLAQSLQNL--PSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGT---LS----------- 83 (933)
Q Consensus 20 ~~~~~~~~d~~~l~~~~~~~~~~--~~~w~~~~~~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~---~~----------- 83 (933)
+++.+.++|++||++||+++.+. .++|. .+++||.|.||+|+ .++|+.|+|+++++.|. +|
T Consensus 5 ~~~~~~~~~~~all~~k~~~~~~~~l~~W~--~~~~~C~w~gv~C~-~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~ 81 (768)
T 3rgz_A 5 SPSQSLYREIHQLISFKDVLPDKNLLPDWS--SNKNPCTFDGVTCR-DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES 81 (768)
T ss_dssp ---CCHHHHHHHHHHHHTTCSCTTSSTTCC--TTSCGGGSTTEEEE-TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred ccccCCHHHHHHHHHHHhhCCCcccccCCC--CCCCCcCCcceEEC-CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence 44445678999999999999754 35675 46789999999998 78999999999999886 44
Q ss_pred ------------ccccCCcccceeecccccccccCC---CccCcCcCceeccccccccCCCCCcc-cCCCCCCEEEccCC
Q 002346 84 ------------PEISSLTQLETLSFQMNNIAGAIP---SLANATSLQDIYLDNNNFTSVPTGCF-DGLTNLQVLSLSDN 147 (933)
Q Consensus 84 ------------~~~~~l~~L~~L~l~~N~l~~~~p---~~~~l~~L~~L~Ls~N~l~~~~~~~~-~~l~~L~~L~Ls~N 147 (933)
..|+.+++|++|+|++|.++|.+| .++++++|++|+|++|.+++..+..+ .++++|++|+|++|
T Consensus 82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n 161 (768)
T 3rgz_A 82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN 161 (768)
T ss_dssp EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence 467788999999999999988665 57888888888888888876544333 56666666666666
Q ss_pred CCCCCCC-----------------------CCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCC
Q 002346 148 PNLAPWP-----------------------FPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204 (933)
Q Consensus 148 ~~~~~~~-----------------------~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 204 (933)
++.+..+ -...+.++++|++|+|++|++.+.+|. ++.+++|++|+|++|++++.+|
T Consensus 162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~-l~~l~~L~~L~Ls~n~l~~~~~ 240 (768)
T 3rgz_A 162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFS 240 (768)
T ss_dssp CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCSCCCB-CTTCCSCCEEECCSSCCCSCHH
T ss_pred ccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCCCCcc-cccCCCCCEEECcCCcCCCccc
Confidence 6543100 001125667777777777777777666 7777777777777777777777
Q ss_pred ccccc-cccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCC-CCC-CCCCCEEEccCCcccccCcccccCC
Q 002346 205 ASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSK-CESLFDLSLRDNQLTGVVPASVISL 281 (933)
Q Consensus 205 ~~~~~-~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~-~~~L~~L~L~~N~l~~~~p~~l~~l 281 (933)
..+.. .+|++|++.+|.+... .+.. .+++|++|+|++|++++.+|. +.. +++|++|+|++|++++.+|..|..+
T Consensus 241 ~~l~~l~~L~~L~Ls~n~l~~~--~~~~-~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l 317 (768)
T 3rgz_A 241 RAISTCTELKLLNISSNQFVGP--IPPL-PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317 (768)
T ss_dssp HHTTTCSSCCEEECCSSCCEES--CCCC-CCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGC
T ss_pred HHHhcCCCCCEEECCCCcccCc--cCcc-ccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcC
Confidence 76655 5677777777765422 2222 456666666666666655543 333 3666666666666666666666666
Q ss_pred CCCCEEEccCccCccCCCC----CCCCccEEeccCCcCCCCCCCCCCCCCchhhhhH--------hhhcccC---CCccc
Q 002346 282 PALLNISLQNNKLQGPYPL----FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLL--------QIAGDMG---YPAIL 346 (933)
Q Consensus 282 ~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~---~~~~l 346 (933)
++|++|+|++|.++|.+|. ...+|+.|+|++|.+.+..+.....+......+. .++.... .+..-
T Consensus 318 ~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~ 397 (768)
T 3rgz_A 318 SLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQ 397 (768)
T ss_dssp TTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCC
T ss_pred CCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCcc
Confidence 6666666666666655552 1345566666666555433221100000000000 0000000 01111
Q ss_pred cCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCc
Q 002346 347 SDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNN 426 (933)
Q Consensus 347 ~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~ 426 (933)
...+.+|...+.+|..++.+++|+.|+|++|++++.+|..|+++++|+.|+|++|+++|.+|..+..+++|++|++++|+
T Consensus 398 ~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~ 477 (768)
T 3rgz_A 398 ELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFND 477 (768)
T ss_dssp EEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred EEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCCcccCcCCHHHcCCCCceEEEecCCc
Confidence 22333444444566666666666666666666666666666666666666666666666666666666666666666666
Q ss_pred CcccCCC
Q 002346 427 LSGKVPD 433 (933)
Q Consensus 427 l~g~~p~ 433 (933)
++|.+|.
T Consensus 478 l~~~~p~ 484 (768)
T 3rgz_A 478 LTGEIPS 484 (768)
T ss_dssp CCSCCCG
T ss_pred ccCcCCH
Confidence 6666553
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-44 Score=415.17 Aligned_cols=250 Identities=22% Similarity=0.363 Sum_probs=202.2
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHH---HHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEF---QAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
++|++.+.||+|+||.||+|.. .+|+.||||++.+..... .....+ ..++.+++.++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 6899999999999999999954 579999999997653221 122233 34466777789999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||++||+|.+++.. .+.+++..++.++.||+.||+|||+ ++||||||||+|||++.+|++||+|||+|+
T Consensus 269 lVmEy~~GGdL~~~l~~-----~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~ 340 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 340 (689)
T ss_dssp EEECCCCSCBHHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceee
Confidence 99999999999999976 2569999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
...... ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||......+.. ............++
T Consensus 341 ~~~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i~~~i~~~~~~~p 414 (689)
T 3v5w_A 341 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTMAVELP 414 (689)
T ss_dssp ECSSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HHHHHHHHCCCCCC
T ss_pred ecCCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHhhcCCCCCCC
Confidence 765432 244689999999999965 57999999999999999999999999764333222 22223333333333
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
..++ .++.+++.+||+.||++|++ ++|+.+
T Consensus 415 ~~~S-------------~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~ 449 (689)
T 3v5w_A 415 DSFS-------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 449 (689)
T ss_dssp TTSC-------------HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred ccCC-------------HHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence 2221 35679999999999999998 577654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=389.20 Aligned_cols=286 Identities=37% Similarity=0.696 Sum_probs=238.2
Q ss_pred cHHHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC
Q 002346 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (933)
Q Consensus 572 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 651 (933)
+..++..++++|++.+.||+|+||.||+|...+++.||||++... .....+.+.+|+.+++.++||||+++++++.++
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 107 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLIGFCDER 107 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSC--CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEeccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence 334455677899999999999999999999888999999998765 344567899999999999999999999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
+..++||||+++|+|.+++.... .....+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Df 183 (321)
T 2qkw_B 108 NEMILIYKYMENGNLKRHLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDF 183 (321)
T ss_dssp TCCEEEEECCTTCBTGGGSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCC
T ss_pred CeEEEEEEcCCCCcHHHHHhccC-CCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeec
Confidence 99999999999999999996532 223469999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 732 GLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 732 Gla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
|+++...... ........||+.|+|||++.+..++.++||||||+++|||++|+.||....+.+......|..... ..
T Consensus 184 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 262 (321)
T 2qkw_B 184 GISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NN 262 (321)
T ss_dssp TTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH-TT
T ss_pred ccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc-cc
Confidence 9998654322 222334568999999999988899999999999999999999999998876665555555554432 23
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
..+...+++.+. .....+....+.+++.+||+.||++||+++|+++.|+.+.+.
T Consensus 263 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~ 316 (321)
T 2qkw_B 263 GQLEQIVDPNLA-DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316 (321)
T ss_dssp TCCCSSSSSSCT-TCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred ccHHHhcChhhc-cccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence 445555665544 233456677899999999999999999999999999987643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=411.17 Aligned_cols=258 Identities=23% Similarity=0.359 Sum_probs=213.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ....+.+.+|+.+|+.++|||||++++++.++...|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 36899999999999999999954 579999999997652 344578899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC--CcEEEeccccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD--MRAKVADFGLVKN 736 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~--~~~kl~DfGla~~ 736 (933)
|||+||+|.+++... ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus 234 E~~~gg~L~~~i~~~----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~ 306 (573)
T 3uto_A 234 EFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 306 (573)
T ss_dssp ECCCCCBHHHHHTCT----TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred eecCCCcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence 999999999998541 2469999999999999999999999 899999999999999854 8999999999998
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
...... ....+||+.|||||++.+..|+.++||||+||++|||++|+.||......+. +..+.......+..
T Consensus 307 ~~~~~~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~ 378 (573)
T 3uto_A 307 LDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWNMDDS 378 (573)
T ss_dssp CCTTSE--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTTCCCCCSG
T ss_pred ccCCCc--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH------HHHHHhCCCCCCcc
Confidence 765432 2345899999999999999999999999999999999999999986543221 22222222222222
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
..+.+. ..+.+|+.+||+.||++||+++|+++ ++|...
T Consensus 379 ~~~~~s---------~~~~dli~~~L~~dp~~R~t~~e~l~------Hpw~~~ 416 (573)
T 3uto_A 379 AFSGIS---------EDGKDFIRKLLLADPNTRMTIHQALE------HPWLTP 416 (573)
T ss_dssp GGTTSC---------HHHHHHHHTTSCSSGGGSCCHHHHHH------STTTSC
T ss_pred cccCCC---------HHHHHHHHHHccCChhHCcCHHHHhc------CcCcCC
Confidence 212222 35779999999999999999999986 677653
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=388.34 Aligned_cols=293 Identities=40% Similarity=0.692 Sum_probs=238.7
Q ss_pred CCceeecHHHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEE
Q 002346 566 GGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645 (933)
Q Consensus 566 ~~~~~~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~ 645 (933)
+....++..++....++|++.+.||+|+||.||+|...+|+.||||++..... ......+.+|+++++.++||||++++
T Consensus 15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERT-QGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccC-chHHHHHHHHHHHHHhccCCCccceE
Confidence 34567888999999999999999999999999999888899999999976532 22234689999999999999999999
Q ss_pred eEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 646 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
+++..+...++||||+++|+|.+++.... ....++++..+..++.|++.||+|||+.+..+|+||||||+||+++.++.
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~ 172 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence 99999999999999999999999997632 23356999999999999999999999922229999999999999999999
Q ss_pred EEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCC--CchhhHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTM--PDDRAHLVTWF 803 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~--~~~~~~~~~~~ 803 (933)
+||+|||+++..............||+.|+|||++.+..++.++||||||+++|||++|+.||+... .........|.
T Consensus 173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 252 (326)
T 3uim_A 173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252 (326)
T ss_dssp EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence 9999999998776555455556679999999999988889999999999999999999999996311 11222333444
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.... .........+..+. .....+....+.+++.+|++.||++||+++|+++.|++.
T Consensus 253 ~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~ 309 (326)
T 3uim_A 253 KGLL-KEKKLEALVDVDLQ-GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309 (326)
T ss_dssp TTTT-SSCCSTTSSCTTCT-TSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred HHHh-hchhhhhhcChhhc-cccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence 3322 23344455555444 334566778899999999999999999999999999753
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=375.78 Aligned_cols=266 Identities=30% Similarity=0.493 Sum_probs=208.2
Q ss_pred HhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
..++|++.+.||+|+||.||+|.. +|+.||||++..........+++.+|++++++++||||+++++++......++||
T Consensus 35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 113 (309)
T 3p86_A 35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT 113 (309)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence 357899999999999999999987 6899999999877666666788999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||+++|+|.+++.... ....+++..++.++.|+++||+|||+ ++ |+||||||+||+++.++.+||+|||+++.
T Consensus 114 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 114 EYLSRGSLYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp ECCTTCBHHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred ecCCCCcHHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999996521 11348999999999999999999998 78 99999999999999999999999999975
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....+... ...... ......++
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~---~~~~~~-~~~~~~~~-- 261 (309)
T 3p86_A 189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV---VAAVGF-KCKRLEIP-- 261 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH---HHHHHH-SCCCCCCC--
T ss_pred ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh-cCCCCCCC--
Confidence 44322 123345799999999999999999999999999999999999999986543221 111110 11111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
..+ ...+.+++.+||+.+|++||+++++++.|+.+++...+
T Consensus 262 --~~~---------~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p 302 (309)
T 3p86_A 262 --RNL---------NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP 302 (309)
T ss_dssp --TTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred --ccC---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence 111 13577999999999999999999999999998876554
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=422.88 Aligned_cols=382 Identities=28% Similarity=0.385 Sum_probs=286.9
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCC-C-ccCcCcCceeccccccccCCCCCcccCCC-CCCEEE
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-S-LANATSLQDIYLDNNNFTSVPTGCFDGLT-NLQVLS 143 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~ 143 (933)
.++.|+|++|.+++.+|..|+.+++|++|+|++|.++|.+| . +..+++|++|+|++|.+++..+..+..++ +|++|+
T Consensus 295 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~ 374 (768)
T 3rgz_A 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLD 374 (768)
T ss_dssp TCSEEECCSSEEEECCCGGGGGCTTCCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEE
T ss_pred cCCEEECcCCcCCCccchHHhcCCCccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEE
Confidence 45555555555555555555556666666666666655554 2 55556666666666666544444455554 566666
Q ss_pred ccCCCCCCCCCCCccccC--CccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccc
Q 002346 144 LSDNPNLAPWPFPNELTK--STSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQ 220 (933)
Q Consensus 144 Ls~N~~~~~~~~p~~~~~--l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n 220 (933)
|++|++.+ .+|..+.. +++|++|++++|++.+.+|..|+.+++|++|+|++|++++.+|..+.. ..|++|++.+|
T Consensus 375 Ls~N~l~~--~~~~~~~~~~~~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n 452 (768)
T 3rgz_A 375 LSSNNFSG--PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLN 452 (768)
T ss_dssp CCSSEEEE--ECCTTTTCSTTCCCCEEECCSSEEEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred ccCCCcCC--CcChhhhhcccCCccEEECCCCccccccCHHHhcCCCCCEEECcCCcccCcccHHHhcCCCCCEEECCCC
Confidence 66665554 34555554 677888888888888888888999999999999999999888888876 57888999988
Q ss_pred cCCcccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC
Q 002346 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (933)
Q Consensus 221 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 299 (933)
.+.... ...+..+++|+.|+|++|++++.+|. +..+++|+.|+|++|++++.+|.+++.+++|+.|+|++|+++|.+|
T Consensus 453 ~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 531 (768)
T 3rgz_A 453 MLEGEI-PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIP 531 (768)
T ss_dssp CCCSCC-CGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSCCEEECC
T ss_pred cccCcC-CHHHcCCCCceEEEecCCcccCcCCHHHhcCCCCCEEEccCCccCCcCChHHhcCCCCCEEECCCCcccCcCC
Confidence 876332 34577889999999999999988774 8899999999999999999999999999999999999999999888
Q ss_pred CC---CCCccEEeccCCcCCCCCCCCCCCCCchh------------------------------------hhhHh-----
Q 002346 300 LF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQV------------------------------------TTLLQ----- 335 (933)
Q Consensus 300 ~~---~~~l~~L~l~~n~~~~~~~~~~~~~~~~~------------------------------------~~~~~----- 335 (933)
.. ..+|+.|+|++|++.+..+.....+.... ..+..
T Consensus 532 ~~l~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 611 (768)
T 3rgz_A 532 AELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRN 611 (768)
T ss_dssp GGGGGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTC
T ss_pred HHHcCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhcccccc
Confidence 64 45789999999999876654322110000 00000
Q ss_pred ------------hhcccC-CCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCc
Q 002346 336 ------------IAGDMG-YPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNN 402 (933)
Q Consensus 336 ------------~~~~~~-~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~ 402 (933)
++..+. .......++++|+..+.+|..+++++.|+.|+|++|+++|.+|..|++|++|++|||++|+
T Consensus 612 ~~~l~~~~~~g~~~~~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~ 691 (768)
T 3rgz_A 612 PCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691 (768)
T ss_dssp CSCTTSCEEEEECCCSCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred ccccccceecccCchhhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence 000011 1122345678889999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCcccCCCCCcCEEeccCCcCcccCCCCCCCcccc--cCCCCCCcCC
Q 002346 403 LTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFT--VSPGNPFIGT 451 (933)
Q Consensus 403 l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~--~~~~n~~~~~ 451 (933)
++|.+|..+..+++|++|||++|+|+|.||+.++...+. ...|||..|.
T Consensus 692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg 742 (768)
T 3rgz_A 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742 (768)
T ss_dssp CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEES
T ss_pred ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcC
Confidence 999999999999999999999999999999876544443 4568887774
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=372.80 Aligned_cols=255 Identities=24% Similarity=0.402 Sum_probs=214.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+++.+|+++++.++||||+++++++...+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 36899999999999999999965 68999999999877666666788999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... ..+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 94 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 165 (328)
T 3fe3_A 94 EYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFT 165 (328)
T ss_dssp CCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS
T ss_pred ECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecC
Confidence 999999999999662 458999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCCCCCC-CccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVT-TKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... ......||+.|+|||++.+..+. .++||||+||++|||++|+.||....... ............+..+
T Consensus 166 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~~p~~~ 237 (328)
T 3fe3_A 166 VGG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------LRERVLRGKYRIPFYM 237 (328)
T ss_dssp SSC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCTTS
T ss_pred CCC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCCCCC
Confidence 432 23456899999999999887765 79999999999999999999998653221 1222222222222211
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
...+.+++.+|++.||.+|||++|+++ ++|...
T Consensus 238 -------------s~~~~~li~~~L~~dP~~R~t~~eil~------h~~~~~ 270 (328)
T 3fe3_A 238 -------------STDCENLLKRFLVLNPIKRGTLEQIMK------DRWINA 270 (328)
T ss_dssp -------------CHHHHHHHHHHCCSSTTTSCCHHHHTT------CTTTTT
T ss_pred -------------CHHHHHHHHHHCCCChhHCcCHHHHhc------CHhhcC
Confidence 135679999999999999999999986 666643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=365.24 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=207.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccc--ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46899999999999999999964 679999999987653 333567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 97 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167 (297)
T ss_dssp ECCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred ECCCCCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999999965 358999999999999999999999 899999999999999999999999999988665
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....+...... ... ....... ..
T Consensus 168 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---~~~--~~~~~~~--~~ 239 (297)
T 3fxz_A 168 PEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IAT--NGTPELQ--NP 239 (297)
T ss_dssp STTC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HHH--HCSCCCS--CG
T ss_pred Cccc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHh--CCCCCCC--Cc
Confidence 4332 23446799999999999999999999999999999999999999976543222111 111 1011100 00
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......+.+++.+||+.||++||+++|+++
T Consensus 240 ---------~~~~~~~~~li~~~l~~dp~~Rps~~ell~ 269 (297)
T 3fxz_A 240 ---------EKLSAIFRDFLNRCLEMDVEKRGSAKELLQ 269 (297)
T ss_dssp ---------GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---------cccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 111235779999999999999999999986
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=372.92 Aligned_cols=266 Identities=25% Similarity=0.383 Sum_probs=209.5
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc----eeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 655 (933)
.++|++.+.||+|+||.||+|.. .++.||||++... ......+.+|+.++++++|||||++++++..+. ..+
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhhchhhheecccCceEEEEEEE-CCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 36899999999999999999987 4899999999754 233456677999999999999999999998743 469
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC----------CeEecCCCCCcEEecCCCc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ----------SFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~----------~ivH~Dik~~Nill~~~~~ 725 (933)
+||||+++|+|.+++.. ..+++.+++.++.|+++||+|||+ . +|+||||||+||+++.++.
T Consensus 99 lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~ 169 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKA------NVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLT 169 (322)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCC
T ss_pred EEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCe
Confidence 99999999999999965 458999999999999999999998 6 9999999999999999999
Q ss_pred EEEecccccccCCCCCce-eecccccccCcccccccCC-----CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhh--
Q 002346 726 AKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA-- 797 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~-- 797 (933)
+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 170 ~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~ 249 (322)
T 3soc_A 170 ACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249 (322)
T ss_dssp EEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT
T ss_pred EEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch
Confidence 999999999765543322 2334679999999999876 35667899999999999999999999764332111
Q ss_pred --------HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 798 --------HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 798 --------~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
....+...... . ...+.+...........++.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~ 318 (322)
T 3soc_A 250 EEEIGQHPSLEDMQEVVVH-K-----KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR 318 (322)
T ss_dssp HHHHCSSCCHHHHHHHHTT-S-----CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred hhhhccCCchhhhhhhhhc-c-----cCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 11111111111 1 1112222111223445668899999999999999999999999998754
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-41 Score=367.24 Aligned_cols=260 Identities=27% Similarity=0.434 Sum_probs=212.9
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|.+.+.||+|+||.||+|.. .+++.||+|++... .....+.|.+|++++++++||||+++++++.++...++||
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 86 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFIT 86 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEE
Confidence 36789999999999999999965 56899999988654 4556788999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 87 e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 159 (310)
T 3s95_A 87 EYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMV 159 (310)
T ss_dssp ECCTTCBHHHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecc
Confidence 999999999999652 2468999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCcee-------------ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhh---HHHHH
Q 002346 739 DGKYSV-------------ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA---HLVTW 802 (933)
Q Consensus 739 ~~~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~---~~~~~ 802 (933)
...... .....||+.|+|||++.+..++.++||||||+++|||++|..|+....+.... .....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~ 239 (310)
T 3s95_A 160 DEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGF 239 (310)
T ss_dssp --------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHH
T ss_pred cccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcc
Confidence 432211 11457999999999999999999999999999999999999998765432211 11111
Q ss_pred HHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 803 FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 803 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
... ..+. ... ..+.+++.+|++.||++||++.++++.|+.+.....
T Consensus 240 ~~~------~~~~----~~~---------~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~ 285 (310)
T 3s95_A 240 LDR------YCPP----NCP---------PSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285 (310)
T ss_dssp HHH------TCCT----TCC---------TTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred ccc------cCCC----CCC---------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence 110 0111 111 246789999999999999999999999998876543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-41 Score=362.85 Aligned_cols=263 Identities=21% Similarity=0.376 Sum_probs=208.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 46899999999999999999964 5789999999865432 334467899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++... .++++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~ 161 (294)
T 4eqm_A 90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL 161 (294)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence 9999999999999652 468999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-cCCCCcc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-KENIPKA 816 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 816 (933)
............||+.|+|||.+.+..++.++||||||+++|||++|+.||........ ....... .......
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~~~~~~~ 235 (294)
T 4eqm_A 162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI------AIKHIQDSVPNVTTD 235 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH------HHHHHSSCCCCHHHH
T ss_pred ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhhccCCCcchh
Confidence 55443334456799999999999998999999999999999999999999976543211 1111111 1111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhhhhh
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRP-DMGHAVNVLGPLVEQ 865 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~ 865 (933)
+.+.+ ...+.+++.+|++.||++|| +++++.+.|+.+...
T Consensus 236 ~~~~~---------~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 236 VRKDI---------PQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp SCTTS---------CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred cccCC---------CHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 11112 24577999999999999999 899999888776543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=372.72 Aligned_cols=264 Identities=27% Similarity=0.443 Sum_probs=214.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe--------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 650 (933)
.++|++.+.||+|+||.||+|.. .++..||||+++... .....+++.+|+.+++++ +||||+++++++..
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 46899999999999999999964 245679999997653 345567899999999999 89999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
++..++||||+++|+|.+++...... ....+++.+++.++.||++||+|||+ ++|+||||||+|||
T Consensus 159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl 235 (370)
T 2psq_A 159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 235 (370)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence 99999999999999999999763311 12458999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~ 797 (933)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+.
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~- 314 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL- 314 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-
T ss_pred ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence 99999999999999986654332 22233467889999999998999999999999999999999 9999976543322
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
...+ . ... ....... ....+.+++.+||+.+|++||++.|+++.|+.++..
T Consensus 315 --~~~~---~--~~~-~~~~~~~---------~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~ 365 (370)
T 2psq_A 315 --FKLL---K--EGH-RMDKPAN---------CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365 (370)
T ss_dssp --HHHH---H--TTC-CCCCCTT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --HHHH---h--cCC-CCCCCCC---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence 1111 1 111 1111111 123577999999999999999999999999988654
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=361.04 Aligned_cols=285 Identities=35% Similarity=0.602 Sum_probs=230.5
Q ss_pred ceeecHHHHHHHhcCCccC------CccccCCCeEEEEEEeCCCcEEEEEEeccccC--CchhHHHHHHHHHHHHhcCCC
Q 002346 568 NVAISIEVLRQVTDNFSEA------NILGRGGFGVVYGGELPDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRHR 639 (933)
Q Consensus 568 ~~~~~~~~l~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h~ 639 (933)
...|+++++..++++|... +.||+|+||.||+|.. +++.||||++..... .....+.+.+|+.++++++||
T Consensus 12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 90 (307)
T 2nru_A 12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHE 90 (307)
T ss_dssp CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCT
T ss_pred CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCC
Confidence 3568899999999999887 8999999999999987 689999999875431 234467899999999999999
Q ss_pred cceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 640 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
||+++++++.+++..++||||+++++|.+++..... ..++++..++.++.|+++||+|||+ ++|+||||||+||+
T Consensus 91 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil 165 (307)
T 2nru_A 91 NLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL 165 (307)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred CeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence 999999999999999999999999999999965322 3569999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH 798 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~ 798 (933)
++.++.+||+|||+++....... .......||+.|+|||.+.+ .++.++||||||+++|||++|+.||.........
T Consensus 166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~- 243 (307)
T 2nru_A 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL- 243 (307)
T ss_dssp ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT-
T ss_pred EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHH-
Confidence 99999999999999986654322 22344679999999998864 5899999999999999999999999865432211
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
..+..........+...+++.+. .........+.+++.+|++.+|++||++.++++.|+++.
T Consensus 244 -~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~ 305 (307)
T 2nru_A 244 -LDIKEEIEDEEKTIEDYIDKKMN--DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT 305 (307)
T ss_dssp -THHHHHHHTTSCCHHHHSCSSCS--CCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred -HHHHHHhhhhhhhhhhhcccccc--ccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence 11222222222223333443332 233455677889999999999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-41 Score=376.59 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=209.7
Q ss_pred HHHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC
Q 002346 574 EVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (933)
Q Consensus 574 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 651 (933)
..++...++|++.+.||+|+||.||+|.. .+++.||+|++.+... .....+.+.+|+.+++.++|||||++++++.++
T Consensus 62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~ 141 (410)
T 3v8s_A 62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 141 (410)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence 44455578999999999999999999965 4689999999876321 112234588999999999999999999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
...++||||+++|+|.+++.. ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+||
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~------~~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DF 212 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSN------YDVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADF 212 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred CEEEEEEeCCCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEecc
Confidence 999999999999999999965 358999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccCcccccccCCCC----CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR----VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
|+++.............+||+.|+|||++.+.. ++.++|||||||++|||++|+.||........ +..+.
T Consensus 213 G~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~ 286 (410)
T 3v8s_A 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIM 286 (410)
T ss_dssp TTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHH
T ss_pred ceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH------HHHHH
Confidence 999877655544445678999999999997654 88999999999999999999999986533221 11111
Q ss_pred hcc--CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 002346 808 ISK--ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQ--RPDMGHAVN 857 (933)
Q Consensus 808 ~~~--~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~evl~ 857 (933)
... ...+. +..+. ..+.+++.+|++.+|.+ ||+++|+++
T Consensus 287 ~~~~~~~~p~--~~~~s---------~~~~~li~~lL~~~~~rlgR~~~~ei~~ 329 (410)
T 3v8s_A 287 NHKNSLTFPD--DNDIS---------KEAKNLICAFLTDREVRLGRNGVEEIKR 329 (410)
T ss_dssp THHHHCCCCT--TCCCC---------HHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred hccccccCCC--ccccc---------HHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence 111 11111 11111 35779999999999988 999999986
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=353.86 Aligned_cols=257 Identities=28% Similarity=0.441 Sum_probs=214.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|+..++..||||++..... ..+++.+|++++.+++||||+++++++.++...++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM---SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC---cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 468999999999999999999988888999999976532 34679999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 156 (268)
T 3sxs_A 84 YISNGCLLNYLRSH----GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD 156 (268)
T ss_dssp CCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred ccCCCcHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence 99999999999662 2458999999999999999999999 8999999999999999999999999999987766
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........||+.|+|||.+.+..++.++||||||+++|||++ |+.||......... ....... . ...
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~~-~---~~~ 226 (268)
T 3sxs_A 157 DQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------LKVSQGH-R---LYR 226 (268)
T ss_dssp TCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHTTC-C---CCC
T ss_pred hhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------HHHHcCC-C---CCC
Confidence 55444455567888999999988889999999999999999999 99999765432211 1111111 0 011
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
+.. ....+.+++.+|++.+|++||++.++++.|+.+.+
T Consensus 227 ~~~--------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (268)
T 3sxs_A 227 PHL--------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE 264 (268)
T ss_dssp CTT--------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred CCc--------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence 111 01357799999999999999999999999988754
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-41 Score=356.66 Aligned_cols=257 Identities=27% Similarity=0.463 Sum_probs=213.2
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.++...++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhhceeeheecCCCccEEEEEEecCCCeEEEEEeccccc---CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 367899999999999999999888899999999986532 24679999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 86 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp CCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred eCCCCcHHHHHHhc----CcccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999652 2468999999999999999999999 8999999999999999999999999999986655
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........|++.|+|||++.+..++.++||||+|+++|||++ |+.||........ . ...... ......
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~---~---~~~~~~---~~~~~~ 229 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---V---EDISTG---FRLYKP 229 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H---HHHHTT---CCCCCC
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHH---H---HHHhcC---ccCCCC
Confidence 43333344567889999999998899999999999999999999 9999976533221 1 111111 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
... ...+.+++.+|++.+|++||++.++++.|+++.+
T Consensus 230 ~~~---------~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~ 266 (269)
T 4hcu_A 230 RLA---------STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 266 (269)
T ss_dssp TTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CcC---------CHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence 111 1357799999999999999999999999988764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-40 Score=366.59 Aligned_cols=259 Identities=22% Similarity=0.355 Sum_probs=211.3
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc----hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
+.++|++.+.||+|+||.||+|.. .+|+.||+|++....... ...+.+.+|+.++++++||||+++++++.++..
T Consensus 10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~ 89 (361)
T 2yab_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD 89 (361)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence 457899999999999999999965 469999999998754322 235789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC----cEEEe
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVA 729 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~ 729 (933)
.++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~ 161 (361)
T 2yab_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (361)
T ss_dssp EEEEEECCCSCBHHHHHTT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEE
Confidence 9999999999999999954 2569999999999999999999999 8999999999999998877 79999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+...
T Consensus 162 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~~~~i~~~ 233 (361)
T 2yab_A 162 DFGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TLANITAV 233 (361)
T ss_dssp CCSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------HHHHHHTT
T ss_pred ecCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhc
Confidence 999998765532 2234579999999999998899999999999999999999999997653221 11222221
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....+....+ .....+.+++.+||+.||++||++.|+++ ++|..
T Consensus 234 ~~~~~~~~~~---------~~s~~~~~li~~~L~~dP~~R~t~~e~l~------hp~~~ 277 (361)
T 2yab_A 234 SYDFDEEFFS---------QTSELAKDFIRKLLVKETRKRLTIQEALR------HPWIT 277 (361)
T ss_dssp CCCCCHHHHT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHT------STTTS
T ss_pred CCCCCchhcc---------CCCHHHHHHHHHHCCCChhHCcCHHHHhc------CcCcC
Confidence 1111111111 11245779999999999999999999986 56654
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=375.95 Aligned_cols=256 Identities=20% Similarity=0.336 Sum_probs=210.1
Q ss_pred HHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
.+.++|++.+.||+|+||.||+|. ..+|+.||+|++..........+.+.+|+.+++.++|||||++++++.+++..++
T Consensus 8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l 87 (444)
T 3soa_A 8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL 87 (444)
T ss_dssp HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence 456789999999999999999995 4679999999998776555667789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec---CCCcEEEecccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKVADFGL 733 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl~DfGl 733 (933)
||||+++|+|.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+|||++ .++.+||+|||+
T Consensus 88 v~E~~~gg~L~~~i~~-----~~~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~ 159 (444)
T 3soa_A 88 IFDLVTGGELFEDIVA-----REYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGL 159 (444)
T ss_dssp EECCCBCCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSS
T ss_pred EEEeCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCce
Confidence 9999999999999966 2568999999999999999999999 8999999999999998 467899999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
++....... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...... .. ...........
T Consensus 160 a~~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~---~~~i~~~~~~~ 232 (444)
T 3soa_A 160 AIEVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RL---YQQIKAGAYDF 232 (444)
T ss_dssp CBCCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HH---HHHHHHTCCCC
T ss_pred eEEecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HH---HHHHHhCCCCC
Confidence 986654332 224468999999999999889999999999999999999999999764322 11 12222222222
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+....+.+ ...+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~~~~---------s~~~~~li~~~L~~dP~~Rpta~e~L~ 267 (444)
T 3soa_A 233 PSPEWDTV---------TPEAKDLINKMLTINPSKRITAAEALK 267 (444)
T ss_dssp CTTTTTTS---------CHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CccccccC---------CHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 11111111 235779999999999999999999987
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=363.51 Aligned_cols=260 Identities=26% Similarity=0.412 Sum_probs=210.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|++.+.||+|+||.||+|... .+..||||++.... .....++|.+|+.++++++||||+++++++.++...+
T Consensus 48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 126 (325)
T 3kul_A 48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM 126 (325)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence 468999999999999999999763 35569999997653 4455678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 127 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 199 (325)
T 3kul_A 127 IVTEYMENGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSR 199 (325)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEeeCCCCCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccc
Confidence 999999999999999642 2469999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCce--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 736 NAPDGKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 736 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
........ ......+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+. .. .... ...
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~---~~---~~~~-~~~ 272 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDV---IS---SVEE-GYR 272 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---HH---HHHT-TCC
T ss_pred ccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHH---HH---HHHc-CCC
Confidence 76543221 2233456788999999998899999999999999999999 9999976543221 11 1111 111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.+ ..... ...+.+++.+||+.||++||++.++++.|+.+...
T Consensus 273 ~~--~~~~~---------~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~ 314 (325)
T 3kul_A 273 LP--APMGC---------PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS 314 (325)
T ss_dssp CC--CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred CC--CCCCc---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence 11 11111 24577999999999999999999999999988654
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=362.48 Aligned_cols=260 Identities=22% Similarity=0.368 Sum_probs=212.6
Q ss_pred eecHHHHHHHhcC----------CccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCC
Q 002346 570 AISIEVLRQVTDN----------FSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638 (933)
Q Consensus 570 ~~~~~~l~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h 638 (933)
.++.++++.+++. |...+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.++++++|
T Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCSHHHHHHHHHHHTTCCC
T ss_pred cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc--hhHHHHHHHHHHHHHhCCC
Confidence 4667777777664 777889999999999999765 79999999987653 3445789999999999999
Q ss_pred CcceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcE
Q 002346 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNI 718 (933)
Q Consensus 639 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Ni 718 (933)
|||+++++++..++..++||||+++++|.+++.. ..+++.++..++.|+++||+|||+ .+|+||||||+||
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NI 172 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSI 172 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHE
Confidence 9999999999999999999999999999999854 458999999999999999999999 8999999999999
Q ss_pred EecCCCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH
Q 002346 719 LIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH 798 (933)
Q Consensus 719 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~ 798 (933)
+++.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 173 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~--- 248 (321)
T 2c30_A 173 LLTLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--- 248 (321)
T ss_dssp EECTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---
T ss_pred EECCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---
Confidence 999999999999999886654322 2344679999999999999999999999999999999999999997653321
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....+ .... . +.+.. .......+.+++.+||+.||++||++.|+++
T Consensus 249 ~~~~~---~~~~--~-----~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 294 (321)
T 2c30_A 249 AMKRL---RDSP--P-----PKLKN---SHKVSPVLRDFLERMLVRDPQERATAQELLD 294 (321)
T ss_dssp HHHHH---HHSS--C-----CCCTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHH---hcCC--C-----CCcCc---cccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 1111 0 11110 0111235779999999999999999999986
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-40 Score=364.50 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=206.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+|+.||+|++++... .......+.+|+.+++.++||||+++++++...+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 6899999999999999999965 4699999999976532 2334678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 85 E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 156 (337)
T 1o6l_A 85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence 99999999999965 2468999999999999999999999 899999999999999999999999999998643
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+......++..
T Consensus 157 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~p~~-- 227 (337)
T 1o6l_A 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEIRFPRT-- 227 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCTT--
T ss_pred cCCC-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------HHHHHHcCCCCCCCC--
Confidence 3221 2344689999999999999999999999999999999999999997643221 122222222222221
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
+ ..++.+++.+||+.||++|| +++|+++
T Consensus 228 --~---------s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~ 260 (337)
T 1o6l_A 228 --L---------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp --S---------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred --C---------CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence 1 13577999999999999999 8888876
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=363.12 Aligned_cols=266 Identities=18% Similarity=0.213 Sum_probs=214.7
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+.+++++ +||||+++++++..+...++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 46899999999999999999964 6799999999875432 23688999999999 999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc-----EEEeccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR-----AKVADFG 732 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-----~kl~DfG 732 (933)
|||+ +++|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++. +||+|||
T Consensus 84 ~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg 155 (330)
T 2izr_A 84 LELL-GPSLEDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFA 155 (330)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred EEeC-CCCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence 9999 99999999752 2569999999999999999999999 89999999999999999887 9999999
Q ss_pred ccccCCCCCce------eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH
Q 002346 733 LVKNAPDGKYS------VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 733 la~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+...
T Consensus 156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~ 235 (330)
T 2izr_A 156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT 235 (330)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence 99865443221 124568999999999999999999999999999999999999999876544333322222111
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
.... . .+... .... ++.+++..|++.+|.+||+++++++.|+++.+.....
T Consensus 236 ~~~~-~-~~~~~---------~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~ 286 (330)
T 2izr_A 236 KRAT-P-IEVLC---------ENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM 286 (330)
T ss_dssp HHHS-C-HHHHT---------TTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred hccC-C-HHHHh---------ccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence 1100 0 00000 0011 6889999999999999999999999999888766443
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=367.12 Aligned_cols=255 Identities=23% Similarity=0.374 Sum_probs=209.9
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
.+.++|++.+.||+|+||.||+|.. .+|+.||+|++..........+.+.+|+.++++++||||+++++++.++...++
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~l 105 (362)
T 2bdw_A 26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL 105 (362)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 4467899999999999999999955 468999999998776566667889999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC---cEEEecccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKVADFGL 733 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~DfGl 733 (933)
||||+++|+|.+++.. ...+++.++..++.||++||+|||+ ++|+||||||+||+++.++ .+||+|||+
T Consensus 106 v~e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~ 177 (362)
T 2bdw_A 106 VFDLVTGGELFEDIVA-----REFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGL 177 (362)
T ss_dssp EECCCCSCBHHHHHTT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEecCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence 9999999999999854 2468999999999999999999999 8999999999999998654 599999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .+. ..........
T Consensus 178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~---~~i~~~~~~~ 249 (362)
T 2bdw_A 178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLY---AQIKAGAYDY 249 (362)
T ss_dssp CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHTCCCC
T ss_pred ceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHH---HHHHhCCCCC
Confidence 98665432 223468999999999999889999999999999999999999999764321 111 1222211111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.... ......+.+++.+||+.||++||++.|+++
T Consensus 250 ~~~~~---------~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 284 (362)
T 2bdw_A 250 PSPEW---------DTVTPEAKSLIDSMLTVNPKKRITADQALK 284 (362)
T ss_dssp CTTGG---------GGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred Ccccc---------cCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11100 011245779999999999999999999976
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=362.14 Aligned_cols=292 Identities=26% Similarity=0.424 Sum_probs=211.9
Q ss_pred CCccchHHHHHHHHHhcCCCC--CCCCCCCCCCCcc--ccceEeCCC---CCEEEEEecCCCCcc--ccCccccCCcccc
Q 002346 23 TSLGDDGSVMLKLAQSLQNLP--SDWSSTSSTGYCE--WTGINCDNS---NRVTTISLAKSGLSG--TLSPEISSLTQLE 93 (933)
Q Consensus 23 ~~~~~d~~~l~~~~~~~~~~~--~~w~~~~~~~~C~--w~gv~c~~~---~~v~~L~l~~~~l~~--~~~~~~~~l~~L~ 93 (933)
.|.++|++||++||+++.+.. .+|.. +.+||. |.||+|+.. ++|+.|+|++++++| .+|..|+.+++|+
T Consensus 2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~--~~~~C~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~~l~~l~~L~ 79 (313)
T 1ogq_A 2 LCNPQDKQALLQIKKDLGNPTTLSSWLP--TTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCCT--TSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHhcCCcccccCCCC--CCCCCcCCCcceEeCCCCCCceEEEEECCCCCccCCcccChhHhCCCCCC
Confidence 477889999999999997532 46753 567888 999999864 799999999999999 8999999999999
Q ss_pred eeeccc-ccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeecc
Q 002346 94 TLSFQM-NNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (933)
Q Consensus 94 ~L~l~~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~ 171 (933)
+|+|++ |.+.+.+| .|.++++|++|+|++|++++..+..|.++++|++|+|++|.+
T Consensus 80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l---------------------- 137 (313)
T 1ogq_A 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNAL---------------------- 137 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEE----------------------
T ss_pred eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCcc----------------------
Confidence 999994 89988777 677788888888888777754444455555555555555554
Q ss_pred CcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCc-cCcEEEecCCccCCC
Q 002346 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT-QLRQVWLHKNQFTGP 250 (933)
Q Consensus 172 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~-~L~~L~L~~N~l~~~ 250 (933)
.+.+|..|..+++|++|+|++|++++.+|..+.. ++ +|+.|+|++|++++.
T Consensus 138 ----~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~l~~------------------------l~~~L~~L~L~~N~l~~~ 189 (313)
T 1ogq_A 138 ----SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS------------------------FSKLFTSMTISRNRLTGK 189 (313)
T ss_dssp ----ESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGC------------------------CCTTCCEEECCSSEEEEE
T ss_pred ----CCcCChHHhcCCCCCeEECcCCcccCcCCHHHhh------------------------hhhcCcEEECcCCeeecc
Confidence 4444455555555555555555555445544332 33 455555555555544
Q ss_pred CCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCch
Q 002346 251 IPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (933)
Q Consensus 251 ~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~ 329 (933)
+|. +..+. |+.|+|++|++++.+|..|..+++|+.|+|++|++++.+|.
T Consensus 190 ~~~~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~----------------------------- 239 (313)
T 1ogq_A 190 IPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK----------------------------- 239 (313)
T ss_dssp CCGGGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-----------------------------
T ss_pred CChHHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-----------------------------
Confidence 442 44444 77777777777777788888888888888888887754331
Q ss_pred hhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCc
Q 002346 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (933)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 409 (933)
+..+++|+.|+|++|++++.+|..|..+++|+.|+|++|+++|.+|.
T Consensus 240 ---------------------------------~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~ 286 (313)
T 1ogq_A 240 ---------------------------------VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286 (313)
T ss_dssp ---------------------------------CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC
T ss_pred ---------------------------------ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCcccccCCC
Confidence 22346777888888888888888888889999999999999988887
Q ss_pred ccCCCCCcCEEeccCCc-Cccc
Q 002346 410 GLTKLASLQNLDVSNNN-LSGK 430 (933)
Q Consensus 410 ~~~~l~~L~~l~ls~N~-l~g~ 430 (933)
. ..+++|+.+++++|+ ++|.
T Consensus 287 ~-~~l~~L~~l~l~~N~~lc~~ 307 (313)
T 1ogq_A 287 G-GNLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp S-TTGGGSCGGGTCSSSEEEST
T ss_pred C-ccccccChHHhcCCCCccCC
Confidence 6 788888888888887 6664
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-40 Score=358.55 Aligned_cols=262 Identities=25% Similarity=0.409 Sum_probs=205.7
Q ss_pred HhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHh--cCCCcceeEEeEeee----Cc
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK--VRHRHLVALLGYCIN----GS 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~ 652 (933)
+.++|++.+.||+|+||.||+|.. +++.||||++... ....+.+|.+++.. ++||||+++++++.. ..
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 457899999999999999999987 7999999998653 23566677777766 799999999998754 34
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hccCCCeEecCCCCCcEEecCCC
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH--------SLAQQSFIHRDLKPSNILIGDDM 724 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dik~~Nill~~~~ 724 (933)
..++||||+++|+|.++++. ..+++..++.++.|+++||+||| + ++|+||||||+|||++.++
T Consensus 80 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~ 150 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNG 150 (301)
T ss_dssp EEEEEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTS
T ss_pred eeEEehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCC
Confidence 57899999999999999954 46899999999999999999999 6 8999999999999999999
Q ss_pred cEEEecccccccCCCCCcee---ecccccccCcccccccCCC------CCCCccchHhHHHHHHHHHcC----------C
Q 002346 725 RAKVADFGLVKNAPDGKYSV---ETRLAGTFGYLAPEYAATG------RVTTKIDVYAFGVVLMETITG----------R 785 (933)
Q Consensus 725 ~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~~l~elltG----------~ 785 (933)
.+||+|||+++......... .....||+.|+|||++.+. .++.++|||||||++|||++| +
T Consensus 151 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~ 230 (301)
T 3q4u_A 151 QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230 (301)
T ss_dssp CEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCC
T ss_pred CEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccc
Confidence 99999999997554433222 2334799999999999876 456799999999999999999 8
Q ss_pred CCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 786 KALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 786 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.||....+..... .. ......... ..+.+............+.+++.+||+.||++||++.++++.|+++
T Consensus 231 ~pf~~~~~~~~~~-~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i 300 (301)
T 3q4u_A 231 PPFYDVVPNDPSF-ED-MRKVVCVDQ-----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300 (301)
T ss_dssp CTTTTTSCSSCCH-HH-HHHHHTTSC-----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred ccccccCCCCcch-hh-hhHHHhccC-----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence 8887654332211 11 111111111 1112221222334566788999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-40 Score=355.50 Aligned_cols=258 Identities=26% Similarity=0.415 Sum_probs=210.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|+..++..||+|++..... ..+++.+|++++.+++||||+++++++.++...++|||
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 23 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCC---CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 468999999999999999999988888999999986532 24679999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 100 YMANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CCTTCBHHHHHHCG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred ccCCCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999652 2458999999999999999999999 8999999999999999999999999999986655
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........||+.|+|||++.+..++.++||||||+++|||++ |+.||......... ...... ......
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~------~~~~~~---~~~~~~ 243 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA------EHIAQG---LRLYRP 243 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------HHHHTT---CCCCCC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHH------HHHhcc---cCCCCC
Confidence 43333334567888999999998899999999999999999998 99999765432211 111111 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
... ...+.+++.+||+.+|++||++.++++.|++++++
T Consensus 244 ~~~---------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~ 281 (283)
T 3gen_A 244 HLA---------SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE 281 (283)
T ss_dssp TTC---------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcC---------CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence 111 13577999999999999999999999999887643
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-40 Score=358.38 Aligned_cols=273 Identities=25% Similarity=0.355 Sum_probs=208.0
Q ss_pred HhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
+.++|++.+.||+|+||.||+|...+|+.||+|++..........+.+.+|++++++++||||+++++++.++...++||
T Consensus 19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 35789999999999999999998888999999999876544555678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||++ ++|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 99 e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 170 (311)
T 3niz_A 99 EFME-KDLKKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFG 170 (311)
T ss_dssp ECCS-EEHHHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred cCCC-CCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence 9997 5888888542 2458999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc--CCCCc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--ENIPK 815 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~ 815 (933)
.... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.... +....... ..++.
T Consensus 171 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~ 246 (311)
T 3niz_A 171 IPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQ 246 (311)
T ss_dssp SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGG
T ss_pred CCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhh
Confidence 3322 2234578999999999876 5689999999999999999999999987554332211 11111100 00000
Q ss_pred cc------CCCCC-CChhhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 816 AI------DPNLN-LDEETI-----ESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 816 ~~------d~~l~-~~~~~~-----~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
.- ..... ...... ....++.+++.+||+.||++|||++|+++ ++|...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~ 306 (311)
T 3niz_A 247 VQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN------HPYFKD 306 (311)
T ss_dssp GTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT------SGGGTT
T ss_pred hhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc------Cccccc
Confidence 00 00000 000000 11245779999999999999999999986 666653
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=363.32 Aligned_cols=258 Identities=22% Similarity=0.350 Sum_probs=205.3
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 46899999999999999999965 4799999999875532 233467899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 85 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 156 (323)
T 3tki_A 85 EYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFR 156 (323)
T ss_dssp ECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECE
T ss_pred EcCCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceec
Confidence 99999999999854 2469999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCc-eeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 739 DGKY-SVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 739 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
.... .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....+. .......
T Consensus 157 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~----~~~~~~~-- 229 (323)
T 3tki_A 157 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTYLN-- 229 (323)
T ss_dssp ETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHH----TTCTTST--
T ss_pred cCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHh----cccccCC--
Confidence 3221 22345689999999999987765 7899999999999999999999986543222 111111 1111100
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
+ .......+.+++.+||+.||++||++.|+++ ++|..
T Consensus 230 --~-------~~~~~~~~~~li~~~L~~dP~~R~t~~eil~------h~~~~ 266 (323)
T 3tki_A 230 --P-------WKKIDSAPLALLHKILVENPSARITIPDIKK------DRWYN 266 (323)
T ss_dssp --T-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT------CTTTT
T ss_pred --c-------cccCCHHHHHHHHHHccCChhhCcCHHHHhh------Chhhc
Confidence 0 0011235678999999999999999999976 66654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-40 Score=359.04 Aligned_cols=252 Identities=19% Similarity=0.293 Sum_probs=207.5
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+.++|++.+.||+|+||.||+|.. .+++.||+|.+... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 357899999999999999999965 46889999998754 33456789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC--CCcEEEecccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD--DMRAKVADFGLVK 735 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~--~~~~kl~DfGla~ 735 (933)
|||+++|+|.+++.. ....+++.+++.++.|+++||+|||+ ++|+||||||+||+++. ++.+||+|||+++
T Consensus 80 ~e~~~g~~L~~~l~~----~~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~ 152 (321)
T 1tki_A 80 FEFISGLDIFERINT----SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTS----SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EEeCCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence 999999999999954 12468999999999999999999999 89999999999999987 7899999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ............+.
T Consensus 153 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~~~~i~~~~~~~~~ 224 (321)
T 1tki_A 153 QLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTFDE 224 (321)
T ss_dssp ECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCCCCH
T ss_pred ECCCCCc--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHHcCCCCCCh
Confidence 7765432 234579999999999998889999999999999999999999997653321 11222221211111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+ ....++.+++.+|++.||++||++.|+++
T Consensus 225 ~~~~---------~~s~~~~~li~~~L~~dp~~Rpt~~e~l~ 257 (321)
T 1tki_A 225 EAFK---------EISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHT---------TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhhc---------cCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1001 11246789999999999999999999987
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=372.23 Aligned_cols=260 Identities=28% Similarity=0.438 Sum_probs=211.8
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|.+.+.||+|+||.||+|... +++.||||+++... .....++|.+|++++++++||||+++++++..++..++||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 191 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVM 191 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS-CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEE
Confidence 467889999999999999999775 78999999987542 3444567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 192 e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~ 264 (377)
T 3cbl_A 192 ELVQGGDFLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEA 264 (377)
T ss_dssp ECCTTCBHHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECT
T ss_pred EcCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecC
Confidence 999999999999652 2458999999999999999999999 899999999999999999999999999998655
Q ss_pred CCCceee-cccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 739 DGKYSVE-TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 739 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
....... ....+++.|+|||++.++.++.++|||||||++|||++ |+.||........ ... .......+
T Consensus 265 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~~~----~~~~~~~~-- 335 (377)
T 3cbl_A 265 DGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---REF----VEKGGRLP-- 335 (377)
T ss_dssp TSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---HHH----HHTTCCCC--
T ss_pred CCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH----HHcCCCCC--
Confidence 4332222 12345778999999998899999999999999999998 9999976533221 111 11111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
..... ...+.+++.+||+.||++||+++++++.|+.+.+.
T Consensus 336 ~~~~~---------~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~ 375 (377)
T 3cbl_A 336 CPELC---------PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375 (377)
T ss_dssp CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC---------CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence 11111 13577999999999999999999999999987653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=357.87 Aligned_cols=259 Identities=22% Similarity=0.365 Sum_probs=210.6
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc----hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
+.++|++.+.||+|+||.||+|.. .+|+.||+|++....... ...+.+.+|+.++++++||||+++++++.++..
T Consensus 9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 88 (326)
T 2y0a_A 9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 88 (326)
T ss_dssp HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 346799999999999999999965 468999999987654321 236789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC----cEEEe
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVA 729 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~ 729 (933)
.++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++ .+||+
T Consensus 89 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 160 (326)
T 2y0a_A 89 VILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 160 (326)
T ss_dssp EEEEEECCCSCBHHHHHTT-----SSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCCCHHHHHHh-----cCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEE
Confidence 9999999999999999954 2568999999999999999999999 8999999999999999887 89999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ......
T Consensus 161 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~---~~~~~~ 232 (326)
T 2y0a_A 161 DFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---L---ANVSAV 232 (326)
T ss_dssp CCTTCEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---H---HHHHHT
T ss_pred ECCCCeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---H---HHHHhc
Confidence 9999987654322 2345799999999999988999999999999999999999999976532211 1 111111
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....+....+ .....+.+++.+||+.||++||++.|+++ ++|..
T Consensus 233 ~~~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~ 276 (326)
T 2y0a_A 233 NYEFEDEYFS---------NTSALAKDFIRRLLVKDPKKRMTIQDSLQ------HPWIK 276 (326)
T ss_dssp CCCCCHHHHT---------TSCHHHHHHHHHHSCSSGGGSCCHHHHHH------STTTS
T ss_pred CCCcCccccc---------cCCHHHHHHHHHHccCChhhCCCHHHHhc------CCCcc
Confidence 1111111111 11245779999999999999999999987 66654
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=371.25 Aligned_cols=274 Identities=25% Similarity=0.386 Sum_probs=217.6
Q ss_pred ecHHHHHHHhcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCccee
Q 002346 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVA 643 (933)
Q Consensus 571 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 643 (933)
+.....+...++|++.+.||+|+||.||+|.+ .+++.||||++.... .....+.+.+|++++.++ +||||++
T Consensus 12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceee
Confidence 34555666788999999999999999999963 356899999997653 344567899999999999 7999999
Q ss_pred EEeEeeeCc-eeEEEEeecCCCChhhHhhhcccCC---------------------------------------------
Q 002346 644 LLGYCINGS-ERLLVYEYMPRGTLAQHLFEWHDHG--------------------------------------------- 677 (933)
Q Consensus 644 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~--------------------------------------------- 677 (933)
+++++.+.+ ..++||||+++|+|.+++.......
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 999998755 4899999999999999997643210
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCC
Q 002346 678 ----------------YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK 741 (933)
Q Consensus 678 ----------------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~ 741 (933)
...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 1228999999999999999999999 899999999999999999999999999998654332
Q ss_pred -ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 742 -YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 742 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
........||+.|+|||++.+..++.++||||||+++|||++ |+.||......... .. ........ ....
T Consensus 248 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~----~~~~~~~~--~~~~ 319 (359)
T 3vhe_A 248 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CR----RLKEGTRM--RAPD 319 (359)
T ss_dssp TCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HH----HHHHTCCC--CCCT
T ss_pred cchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH--HH----HHHcCCCC--CCCC
Confidence 233445678999999999998999999999999999999998 99999765433221 11 11111110 0111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.. ...+.+++.+|++.||++||+++|+++.|+.+++.
T Consensus 320 ~~---------~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~ 356 (359)
T 3vhe_A 320 YT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356 (359)
T ss_dssp TC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC---------CHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence 11 13577999999999999999999999999988754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=375.14 Aligned_cols=263 Identities=19% Similarity=0.308 Sum_probs=211.9
Q ss_pred cHHHHHHHhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEee
Q 002346 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (933)
Q Consensus 572 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 649 (933)
...+++...++|++.++||+|+||.||+|... +++.||+|++.+... .......+.+|+.++..++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34455566789999999999999999999764 578999999976321 1122345889999999999999999999999
Q ss_pred eCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEe
Q 002346 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (933)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 729 (933)
+++..++||||+++|+|.+++... ...+++..++.++.|++.||+|||+ .+||||||||+|||++.++.+||+
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~ 217 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA 217 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEecCCCCcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence 999999999999999999999652 2469999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
|||+++.............+||+.|+|||++. .+.++.++|||||||++|||++|+.||......+.. .
T Consensus 218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~------~ 291 (437)
T 4aw2_A 218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------G 291 (437)
T ss_dssp CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------H
T ss_pred chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH------H
Confidence 99999877655544455578999999999986 567899999999999999999999999865432221 1
Q ss_pred HHhhc--cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 002346 805 RVLIS--KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQ--RPDMGHAVN 857 (933)
Q Consensus 805 ~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~--RPs~~evl~ 857 (933)
.+... ...++... +.+ ...+.+++.+|+..+|++ ||+++|+++
T Consensus 292 ~i~~~~~~~~~p~~~-~~~---------s~~~~dLi~~lL~~~~~r~~r~~~~eil~ 338 (437)
T 4aw2_A 292 KIMNHKERFQFPTQV-TDV---------SENAKDLIRRLICSREHRLGQNGIEDFKK 338 (437)
T ss_dssp HHHTHHHHCCCCSSC-CCS---------CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred hhhhccccccCCccc-ccC---------CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence 11111 11122111 011 135779999999988888 999999986
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=364.20 Aligned_cols=257 Identities=21% Similarity=0.327 Sum_probs=206.6
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC---CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM---GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.++||||+++++++.+++..+
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46899999999999999999954 5799999999865421 1224578999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc---EEEeccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AKVADFG 732 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfG 732 (933)
+||||+++++|.+++...... ...+++..++.++.|+++||+|||+ ++|+||||||+||+++.++. +||+|||
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred EEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 999999999999888653222 2468999999999999999999999 89999999999999987654 9999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.... . .. ..........
T Consensus 179 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~-~~---~~~i~~~~~~ 250 (351)
T 3c0i_A 179 VAIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK---E-RL---FEGIIKGKYK 250 (351)
T ss_dssp TCEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH---H-HH---HHHHHHTCCC
T ss_pred ceeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH---H-HH---HHHHHcCCCC
Confidence 9987655332 2344579999999999999899999999999999999999999997632 1 11 1122211111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......+ .....+.+++.+||+.||++||++.|+++
T Consensus 251 ~~~~~~~---------~~s~~~~~li~~~L~~dP~~R~s~~e~l~ 286 (351)
T 3c0i_A 251 MNPRQWS---------HISESAKDLVRRMLMLDPAERITVYEALN 286 (351)
T ss_dssp CCHHHHT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCccccc---------cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1100001 11246789999999999999999999986
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=368.45 Aligned_cols=260 Identities=26% Similarity=0.435 Sum_probs=201.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|++.+.||+|+||.||+|... ++..||||+++... .....++|.+|+.++++++||||+++++++.++...+
T Consensus 44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 122 (373)
T 2qol_A 44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM 122 (373)
T ss_dssp GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence 368999999999999999999764 57789999997653 4455678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 123 lv~e~~~~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~ 195 (373)
T 2qol_A 123 IVTEYMENGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGR 195 (373)
T ss_dssp EEEECCTTCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----
T ss_pred EEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCcccc
Confidence 999999999999999652 2468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcee--ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 736 NAPDGKYSV--ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 736 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
......... .....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ... .... ...
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~---~i~~-~~~ 268 (373)
T 2qol_A 196 VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIK---AVDE-GYR 268 (373)
T ss_dssp ------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHH---HHHT-TEE
T ss_pred ccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHc-CCC
Confidence 665432211 122345778999999998999999999999999999998 999997654322 111 1111 111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.+. .. .....+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 269 ~~~--~~---------~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 310 (373)
T 2qol_A 269 LPP--PM---------DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310 (373)
T ss_dssp CCC--CT---------TCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred CCC--Cc---------cccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence 110 00 1124578999999999999999999999999988754
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-40 Score=379.65 Aligned_cols=259 Identities=26% Similarity=0.454 Sum_probs=212.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|...++..||||+++... ...++|.+|+.++++++|||||++++++. .+..++|||
T Consensus 187 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 187 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS---BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC---ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 56889999999999999999998888999999998653 34678999999999999999999999986 567899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.++++... ...+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 263 ~~~~g~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 336 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIED 336 (454)
T ss_dssp CCTTCBHHHHHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCC
T ss_pred ecCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCC
Confidence 999999999996522 1358899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........+++.|+|||++..+.++.++|||||||++|||+| |+.||......+ ....+.. ....+. .
T Consensus 337 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~----~~~~~~--~ 407 (454)
T 1qcf_A 337 NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALER----GYRMPR--P 407 (454)
T ss_dssp HHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHHHH----TCCCCC--C
T ss_pred CceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----CCCCCC--C
Confidence 33222333456789999999998899999999999999999999 999997653322 1111111 111110 1
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
.. ....+.+++.+||+.||++||++.++++.|+.+....
T Consensus 408 ~~---------~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~ 446 (454)
T 1qcf_A 408 EN---------CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT 446 (454)
T ss_dssp TT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred CC---------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence 11 1245779999999999999999999999998875443
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-40 Score=366.99 Aligned_cols=251 Identities=23% Similarity=0.387 Sum_probs=201.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
.++|++.+.||+|+||.||+|+. .+++.||+|++++.... ....+.+.+|..++.++ +|||||++++++.+++..++
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 36899999999999999999965 46889999999875432 22345688999999887 89999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 131 V~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~ 202 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202 (396)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeee
Confidence 99999999999999762 468999999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh---hHHHHHHHHHhhccCCC
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR---AHLVTWFRRVLISKENI 813 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~ 813 (933)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ................+
T Consensus 203 ~~~~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~ 281 (396)
T 4dc2_A 203 GLRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI 281 (396)
T ss_dssp CCCTT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC
T ss_pred cccCC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC
Confidence 33222 223456899999999999999999999999999999999999999975322111 11111222222222222
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
+..+ . ..+.+++.+||+.||++||++
T Consensus 282 p~~~----s---------~~~~~li~~lL~~dP~~R~~~ 307 (396)
T 4dc2_A 282 PRSL----S---------VKAASVLKSFLNKDPKERLGC 307 (396)
T ss_dssp CTTS----C---------HHHHHHHHHHTCSCTTTSTTC
T ss_pred CCcC----C---------HHHHHHHHHHhcCCHhHcCCC
Confidence 2221 1 357799999999999999996
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=367.71 Aligned_cols=250 Identities=24% Similarity=0.368 Sum_probs=202.2
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++++... .....+.+.+|..+++.+ +||||+++++++.+.+..++
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 47899999999999999999965 4689999999976532 233456788999999998 79999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 102 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~ 173 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE 173 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceee
Confidence 99999999999999662 468999999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ .+..+.......+..
T Consensus 174 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~~~p~~ 246 (353)
T 3txo_A 174 GICNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD------LFEAILNDEVVYPTW 246 (353)
T ss_dssp SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCTT
T ss_pred cccCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH------HHHHHHcCCCCCCCC
Confidence 43322 22345689999999999998889999999999999999999999997653321 122223222222221
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM------GHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~------~evl~ 857 (933)
+ ...+.+++.+|++.||++||++ .|+++
T Consensus 247 ----~---------~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~ 280 (353)
T 3txo_A 247 ----L---------HEDATGILKSFMTKNPTMRLGSLTQGGEHAILR 280 (353)
T ss_dssp ----S---------CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred ----C---------CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence 1 1356799999999999999998 66654
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.59 Aligned_cols=272 Identities=21% Similarity=0.288 Sum_probs=207.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999965 468999999998776555666889999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++ ++.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~-~l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9975 666666431 2569999999999999999999999 8999999999999999999999999999986643
Q ss_pred CCceeecccccccCcccccccCCCC-CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc-CCCCccc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGR-VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK-ENIPKAI 817 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 817 (933)
... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||....... ..+........... ...+...
T Consensus 154 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~ 231 (292)
T 3o0g_A 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQLKRIFRLLGTPTEEQWPSMT 231 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHH-HHHHHHHHHHCCCCTTTCTTGG
T ss_pred ccc-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhhhhhhc
Confidence 322 223457899999999987765 7999999999999999999998875543221 11111111111000 0000000
Q ss_pred -----------CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 818 -----------DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 818 -----------d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
................+.+++.+|++.||++|||++|+++ ++|..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~ 287 (292)
T 3o0g_A 232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ------HPYFS 287 (292)
T ss_dssp GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGT
T ss_pred ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc------Ccccc
Confidence 0000000001112345779999999999999999999986 66654
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-40 Score=364.86 Aligned_cols=270 Identities=31% Similarity=0.500 Sum_probs=214.6
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEee
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 649 (933)
+....++|++.+.||+|+||.||+|... +++.||||+++... .....+.|.+|+.++++++||||+++++++.
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3445689999999999999999999763 35899999998653 3445678999999999999999999999999
Q ss_pred eCceeEEEEeecCCCChhhHhhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEe
Q 002346 650 NGSERLLVYEYMPRGTLAQHLFEWHDH-------------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIH 710 (933)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 710 (933)
+++..++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ ++|+|
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH 197 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 197 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeec
Confidence 999999999999999999999763211 12569999999999999999999999 89999
Q ss_pred cCCCCCcEEecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCC
Q 002346 711 RDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKAL 788 (933)
Q Consensus 711 ~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~ 788 (933)
|||||+||+++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||
T Consensus 198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 99999999999999999999999975543221 22234578999999999988899999999999999999999 99999
Q ss_pred CCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 789 DDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
......+ .. .... ...... ..... ...+.+++.+||+.||++||++.++++.|+++.+.+.
T Consensus 278 ~~~~~~~---~~---~~~~--~~~~~~-~~~~~---------~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~ 338 (343)
T 1luf_A 278 YGMAHEE---VI---YYVR--DGNILA-CPENC---------PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338 (343)
T ss_dssp TTSCHHH---HH---HHHH--TTCCCC-CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred CCCChHH---HH---HHHh--CCCcCC-CCCCC---------CHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence 7653221 11 1111 111111 11111 1357799999999999999999999999998876554
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=349.74 Aligned_cols=255 Identities=23% Similarity=0.363 Sum_probs=209.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. +++.||||++..........++|.+|+.++++++||||+++++++.+. ...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI 87 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEE-CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence 36799999999999999999988 589999999988766666678899999999999999999999999876 778999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEecCCCCCcEEecCCCcEEEecccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
|||+++|+|.+++... ....+++.+++.++.|+++||+|||+ ++ |+||||||+||+++.++.++|+|||++.
T Consensus 88 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~ 161 (271)
T 3kmu_A 88 THWMPYGSLYNVLHEG---TNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKF 161 (271)
T ss_dssp EECCTTCBHHHHHHSC---SSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred ecccCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEecccee
Confidence 9999999999999652 22368999999999999999999998 77 9999999999999999999999999876
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCC---ccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTT---KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
.... ....||+.|+|||.+.+..++. ++||||||+++|||++|+.||........ ...... . .
T Consensus 162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~~~~-~-~ 227 (271)
T 3kmu_A 162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI------GMKVAL-E-G 227 (271)
T ss_dssp TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH------HHHHHH-S-C
T ss_pred eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH------HHHHHh-c-C
Confidence 4332 2347899999999998765544 89999999999999999999976533221 111111 1 1
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
....+.... ...+.+++.+||+.||++||+++++++.|+.+.+
T Consensus 228 ~~~~~~~~~---------~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~ 270 (271)
T 3kmu_A 228 LRPTIPPGI---------SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270 (271)
T ss_dssp CCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred CCCCCCCCC---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 111111111 1357799999999999999999999999988753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=376.59 Aligned_cols=262 Identities=30% Similarity=0.484 Sum_probs=207.2
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|...++..||||+++.... ..++|.+|++++++++||||+++++++.+ +..++|||
T Consensus 183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 467889999999999999999988888899999986532 34689999999999999999999999876 67899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 259 ~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 999999999996521 2458999999999999999999999 8999999999999999999999999999987655
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........+++.|+|||++..+.++.++||||||+++|||++ |+.||......+. .. .... .... ...
T Consensus 333 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~---~i~~-~~~~--~~~ 403 (452)
T 1fmk_A 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LD---QVER-GYRM--PCP 403 (452)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH---HHHT-TCCC--CCC
T ss_pred CceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHc-CCCC--CCC
Confidence 43333344567889999999998899999999999999999999 9999976533221 11 1111 1111 111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
+. ....+.+++.+||+.+|++||+++++++.|+.+.....+.
T Consensus 404 ~~---------~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~~ 445 (452)
T 1fmk_A 404 PE---------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ 445 (452)
T ss_dssp TT---------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred CC---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCcc
Confidence 11 1245779999999999999999999999998876554443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=365.08 Aligned_cols=266 Identities=30% Similarity=0.432 Sum_probs=215.6
Q ss_pred hcCCccCCccccCCCeEEEEEEe--------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 650 (933)
.++|.+.+.||+|+||.||+|.. ..+..||||++.... .....+++.+|+++++++ +||||+++++++..
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 47899999999999999999964 234679999997653 445567899999999999 89999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
++..++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ ++|+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEE
Confidence 99999999999999999999764321 12459999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~ 797 (933)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~-- 301 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 301 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence 99999999999999986654322 22334567899999999999999999999999999999999 999997653221
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
... .... ... ....... ...+.+++.+||+.+|++||++.|+++.|+.+.....
T Consensus 302 -~~~---~~~~-~~~--~~~~~~~---------~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~ 355 (382)
T 3tt0_A 302 -LFK---LLKE-GHR--MDKPSNC---------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTS 355 (382)
T ss_dssp -HHH---HHHT-TCC--CCCCSSC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSC
T ss_pred -HHH---HHHc-CCC--CCCCccC---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence 111 1111 111 1111111 1357899999999999999999999999999875543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=379.94 Aligned_cols=257 Identities=28% Similarity=0.434 Sum_probs=213.4
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|... ++..||||+++... ...++|.+|+.++++++|||||+++++|..+...++||
T Consensus 219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~ 295 (495)
T 1opk_A 219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295 (495)
T ss_dssp GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc---cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEE
Confidence 467889999999999999999765 48899999997653 24578999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... ....+++..++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 296 E~~~~g~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 369 (495)
T 1opk_A 296 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369 (495)
T ss_dssp ECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred EccCCCCHHHHHHhc---CcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceecc
Confidence 999999999999752 23568999999999999999999999 899999999999999999999999999998776
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
...........+++.|+|||++....++.++|||||||++|||++ |+.||........ ...+ ...... ..
T Consensus 370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~---~~~~----~~~~~~--~~ 440 (495)
T 1opk_A 370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV---YELL----EKDYRM--ER 440 (495)
T ss_dssp TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH---HHHH----HTTCCC--CC
T ss_pred CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH---HHHH----HcCCCC--CC
Confidence 554444445567889999999998899999999999999999999 9999976543322 1111 111111 11
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
.... ...+.+++.+||+.||++||++.++++.|+.+.
T Consensus 441 ~~~~---------~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~ 477 (495)
T 1opk_A 441 PEGC---------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 477 (495)
T ss_dssp CTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred CCCC---------CHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence 1111 245779999999999999999999999998764
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-40 Score=356.55 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=206.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 6799999999999999999965 4799999999976532 1234577889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 86 e~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~ 157 (318)
T 1fot_A 86 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 157 (318)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eCCCCCCHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecC
Confidence 99999999999965 2468999999999999999999998 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.......+..
T Consensus 158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~~i~~~~~~~p~~-- 225 (318)
T 1fot_A 158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAELRFPPF-- 225 (318)
T ss_dssp SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCCCCCCTT--
T ss_pred Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCCCC--
Confidence 42 234589999999999999999999999999999999999999997643221 122223222222221
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
+. .++.+++.+|++.||++|| +++++++
T Consensus 226 --~~---------~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~ 258 (318)
T 1fot_A 226 --FN---------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 258 (318)
T ss_dssp --SC---------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CC---------HHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence 11 3577999999999999999 7888875
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=350.89 Aligned_cols=260 Identities=24% Similarity=0.381 Sum_probs=199.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|++.+.||+|+||.||+|... .+..||+|++.... .....+.+.+|+.++++++||||+++++++. ++..+
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 91 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 91 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence 468999999999999999999653 24579999987643 3445678999999999999999999999984 56789
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 92 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 164 (281)
T 1mp8_A 92 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 164 (281)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECcccccc
Confidence 999999999999999652 2468999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
..............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+ .. ...
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~---~~~i---~~-~~~-- 235 (281)
T 1mp8_A 165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGRI---EN-GER-- 235 (281)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH---HHHH---HT-TCC--
T ss_pred ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH---HHHH---Hc-CCC--
Confidence 765544333344567889999999988899999999999999999997 9999986543322 1111 11 111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
..+.+.. ...+.+++.+|++.||++||++.++++.|+.++++.
T Consensus 236 ~~~~~~~---------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~ 278 (281)
T 1mp8_A 236 LPMPPNC---------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 278 (281)
T ss_dssp CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCCCC---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111 245779999999999999999999999999887543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=355.96 Aligned_cols=266 Identities=25% Similarity=0.432 Sum_probs=206.6
Q ss_pred hcCCccCCccccCCCeEEEEEEe-----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--c
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--S 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~ 652 (933)
.++|++.+.||+|+||.||+|.+ .+++.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (295)
T 3ugc_A 9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 86 (295)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 46899999999999999999973 36889999999765 345567899999999999999999999998653 4
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||+++|+|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 87 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg 159 (295)
T 3ugc_A 87 NLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 159 (295)
T ss_dssp SCEEEEECCTTCBHHHHHHHC----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred ceEEEEEeCCCCCHHHHHHhc----ccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCc
Confidence 589999999999999999762 2358999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCc--eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCc---------hhhHHHH
Q 002346 733 LVKNAPDGKY--SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD---------DRAHLVT 801 (933)
Q Consensus 733 la~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~---------~~~~~~~ 801 (933)
+++....... .......|++.|+|||.+.+..++.++||||||+++|||+||..|+...... .......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T 3ugc_A 160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239 (295)
T ss_dssp SCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHH
T ss_pred ccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHH
Confidence 9986654322 1223345778899999999899999999999999999999999998643110 0001111
Q ss_pred HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
............+ .... ....+.+++.+||+.||++||+++|+++.|+.+.+.
T Consensus 240 ~~~~~~~~~~~~~--~~~~---------~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~ 292 (295)
T 3ugc_A 240 HLIELLKNNGRLP--RPDG---------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDN 292 (295)
T ss_dssp HHHHHHHTTCCCC--CCTT---------CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred HHHHHHhccCcCC--CCcC---------cCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence 1111111111111 1111 124678999999999999999999999999988654
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=356.00 Aligned_cols=264 Identities=27% Similarity=0.403 Sum_probs=215.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
.++|.+.+.||+|+||.||+|.. .+++.||||++.... .....+++.+|+.++++++||||+++++++.+++.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 22 RKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred hhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 57899999999999999999964 345889999997653 44556789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCC
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDH-------------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 714 (933)
.++||||+++++|.+++...... ....+++.+++.++.|+++||+|||+ ++|+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccc
Confidence 99999999999999999763321 12348999999999999999999999 899999999
Q ss_pred CCcEEecCCCcEEEecccccccCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCC
Q 002346 715 PSNILIGDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTM 792 (933)
Q Consensus 715 ~~Nill~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~ 792 (933)
|+||+++.++.+||+|||+++........ ......|++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999866544322 2234467889999999988889999999999999999999 999998754
Q ss_pred CchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 793 PDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 793 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
..... ..+ .. . . ........ ...+.+++.+|++.||++||+++++++.|++++..
T Consensus 258 ~~~~~---~~~---~~-~-~-~~~~~~~~---------~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~ 312 (314)
T 2ivs_A 258 PERLF---NLL---KT-G-H-RMERPDNC---------SEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK 312 (314)
T ss_dssp GGGHH---HHH---HT-T-C-CCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHH---HHh---hc-C-C-cCCCCccC---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence 43221 111 11 1 1 11111111 24578999999999999999999999999988754
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=352.52 Aligned_cols=250 Identities=26% Similarity=0.408 Sum_probs=197.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc------------------------hhHHHHHHHHHHHHh
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN------------------------KGLSEFQAEIAVLTK 635 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~~l~~ 635 (933)
++|++.+.||+|+||.||+|.. .+++.||||++....... ...+++.+|++++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 6899999999999999999954 578999999987653211 123568999999999
Q ss_pred cCCCcceeEEeEeee--CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCC
Q 002346 636 VRHRHLVALLGYCIN--GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDL 713 (933)
Q Consensus 636 l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Di 713 (933)
++||||+++++++.+ +...++||||+++++|.+++.. .++++.+++.++.|+++||+|||+ ++|+||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dl 163 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDI 163 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCC
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCC
Confidence 999999999999986 5688999999999999887532 569999999999999999999999 89999999
Q ss_pred CCCcEEecCCCcEEEecccccccCCCCCceeecccccccCcccccccCCCC---CCCccchHhHHHHHHHHHcCCCCCCC
Q 002346 714 KPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGR---VTTKIDVYAFGVVLMETITGRKALDD 790 (933)
Q Consensus 714 k~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~~l~elltG~~p~~~ 790 (933)
||+||+++.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||..
T Consensus 164 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~ 242 (298)
T 2zv2_A 164 KPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD 242 (298)
T ss_dssp CGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999987654332 234457999999999997655 47889999999999999999999976
Q ss_pred CCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 791 TMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... . ............+. .+.+ ...+.+++.+||+.||++||++.|+++
T Consensus 243 ~~~~---~---~~~~~~~~~~~~~~--~~~~---------~~~l~~li~~~l~~dp~~R~s~~e~l~ 292 (298)
T 2zv2_A 243 ERIM---C---LHSKIKSQALEFPD--QPDI---------AEDLKDLITRMLDKNPESRIVVPEIKL 292 (298)
T ss_dssp SSHH---H---HHHHHHHCCCCCCS--SSCC---------CHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ccHH---H---HHHHHhcccCCCCC--cccc---------CHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence 4321 1 11111111111111 1111 135779999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=351.01 Aligned_cols=266 Identities=18% Similarity=0.223 Sum_probs=214.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++..... .+.+.+|+.+++.+ +|+|++++++++..+...++|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 84 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 84 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence 46899999999999999999964 6799999999865432 24578899999999 799999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc-----EEEeccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR-----AKVADFG 732 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-----~kl~DfG 732 (933)
|||+ +++|.+++... ..++++.+++.++.|+++||+|||+ ++|+||||||+||+++.++. +||+|||
T Consensus 85 ~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 9999 99999999652 2458999999999999999999998 89999999999999987776 9999999
Q ss_pred ccccCCCCCc------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH
Q 002346 733 LVKNAPDGKY------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 733 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 9986654322 1234467999999999999999999999999999999999999999875543332222222211
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.. ....+. +.+. ....+.+++.+|++.+|++||+++++++.|+++.+....
T Consensus 237 ~~-~~~~~~-~~~~---------~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~ 287 (298)
T 1csn_A 237 KQ-STPLRE-LCAG---------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 287 (298)
T ss_dssp HH-HSCHHH-HTTT---------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cc-CccHHH-HHhh---------CcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCC
Confidence 11 011000 1111 124678999999999999999999999999999876654
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=348.73 Aligned_cols=253 Identities=28% Similarity=0.469 Sum_probs=195.3
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC--chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .++.||||++...... ....+.+.+|+++++.++||||+++++++..++..++|
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV 84 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEE-TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred hhheeeeeeeccCCCeEEEEEEE-cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence 36789999999999999999987 5899999998765322 23457899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC---eEecCCCCCcEEecC--------CCcE
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS---FIHRDLKPSNILIGD--------DMRA 726 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~---ivH~Dik~~Nill~~--------~~~~ 726 (933)
|||+++++|.+++.. ..+++..++.++.|+++||+|||+ ++ |+||||||+||+++. ++.+
T Consensus 85 ~e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~ 155 (271)
T 3dtc_A 85 MEFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155 (271)
T ss_dssp EECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred EEcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcce
Confidence 999999999999853 468999999999999999999999 66 999999999999986 7789
Q ss_pred EEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH
Q 002346 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 727 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
||+|||+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ...
T Consensus 156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~ 226 (271)
T 3dtc_A 156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA------YGV 226 (271)
T ss_dssp EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH------HHH
T ss_pred EEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------Hhh
Confidence 999999998654432 22457999999999999889999999999999999999999999765322111 111
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
.. ........... ...+.+++.+|++.+|++||++.|+++.|+.+
T Consensus 227 ~~--~~~~~~~~~~~---------~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l 271 (271)
T 3dtc_A 227 AM--NKLALPIPSTC---------PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271 (271)
T ss_dssp HT--SCCCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred hc--CCCCCCCCccc---------CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence 11 11111111111 13578999999999999999999999998753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=355.83 Aligned_cols=250 Identities=24% Similarity=0.389 Sum_probs=202.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 657 (933)
++|++.+.||+|+||.||+|.. .+++.||+|++.+.... ....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 5799999999999999999965 46899999999876433 34456788999999988 899999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++|+|.+++... ..+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 9999999999999652 458999999999999999999999 89999999999999999999999999999864
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh---hHHHHHHHHHhhccCCCC
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR---AHLVTWFRRVLISKENIP 814 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~ 814 (933)
.... .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ................++
T Consensus 161 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p 239 (345)
T 3a8x_A 161 LRPG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239 (345)
T ss_dssp CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC
T ss_pred cCCC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC
Confidence 3322 123456899999999999999999999999999999999999999975322110 111111222222222222
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
. .+ ...+.+++.+||+.||++||++
T Consensus 240 ~----~~---------s~~~~~li~~lL~~dP~~R~~~ 264 (345)
T 3a8x_A 240 R----SL---------SVKAASVLKSFLNKDPKERLGC 264 (345)
T ss_dssp T----TS---------CHHHHHHHHHHTCSSTTTSTTC
T ss_pred C----CC---------CHHHHHHHHHHhcCCHhHCCCC
Confidence 1 11 1357799999999999999996
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=361.00 Aligned_cols=251 Identities=23% Similarity=0.361 Sum_probs=205.7
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.+++.++|||||++++++.+....++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 6799999999999999999965 4688999999876432 2344678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+.+|+|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++...
T Consensus 95 e~~~gg~L~~~l~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ-----NVHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp CCCTTEEHHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred ecCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 99999999999965 2569999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceeecccccccCcccccccCC---CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAAT---GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..............+ .......+.
T Consensus 167 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~---~~~~~~~p~ 241 (384)
T 4fr4_A 167 RET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF---ETTVVTYPS 241 (384)
T ss_dssp TTC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH---HHCCCCCCT
T ss_pred CCC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH---hhcccCCCC
Confidence 432 2345689999999999864 45899999999999999999999999865443333322222 111212221
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-MGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-~~evl~ 857 (933)
. + ...+.+++.+||+.||++||+ ++++.+
T Consensus 242 ~----~---------s~~~~~li~~lL~~dP~~R~s~~~~l~~ 271 (384)
T 4fr4_A 242 A----W---------SQEMVSLLKKLLEPNPDQRFSQLSDVQN 271 (384)
T ss_dssp T----S---------CHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred c----C---------CHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence 1 1 135779999999999999998 666553
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=358.22 Aligned_cols=265 Identities=28% Similarity=0.458 Sum_probs=197.8
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCC----cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee-
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER- 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~- 654 (933)
.++|++.+.||+|+||.||+|..... ..||||++..........+++.+|++++++++||||+++++++......
T Consensus 22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (323)
T 3qup_A 22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG 101 (323)
T ss_dssp ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence 46899999999999999999976433 2799999987655566678999999999999999999999999876655
Q ss_pred -----EEEEeecCCCChhhHhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 655 -----LLVYEYMPRGTLAQHLFEWHDH-GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 655 -----~lv~e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||
T Consensus 102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl 178 (323)
T 3qup_A 102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCV 178 (323)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEE
T ss_pred CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEE
Confidence 8999999999999999763322 12368999999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHH
Q 002346 729 ADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 729 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......... . ..
T Consensus 179 ~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---~---~~ 252 (323)
T 3qup_A 179 ADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---N---YL 252 (323)
T ss_dssp CCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H---HH
T ss_pred eeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---H---HH
Confidence 99999986544332 12233467889999999998899999999999999999999 89999865433221 1 11
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.. .... ...+.. ...+.+++.+||+.||++||++.++++.|++++..
T Consensus 253 ~~-~~~~--~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 253 IG-GNRL--KQPPEC---------MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp HT-TCCC--CCCTTC---------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hc-CCCC--CCCCcc---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 11 1111 111111 13578999999999999999999999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-40 Score=354.15 Aligned_cols=265 Identities=25% Similarity=0.377 Sum_probs=202.6
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|++.+.||+|+||.||+|...+|+.||+|++..........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999888899999999976654444457889999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++ +|.+++... ...+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++.....
T Consensus 82 ~~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 153 (288)
T 1ob3_A 82 LDQ-DLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (288)
T ss_dssp CSE-EHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred cCC-CHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence 975 999988542 2468999999999999999999999 89999999999999999999999999999865432
Q ss_pred CceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc--CCCCc--
Q 002346 741 KYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--ENIPK-- 815 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-- 815 (933)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. +.... ...... ...+.
T Consensus 154 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~ 229 (288)
T 1ob3_A 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIF-RILGTPNSKNWPNVT 229 (288)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH-HHHCCCCTTTSTTGG
T ss_pred cc-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHH-HHHCCCChhhchhhh
Confidence 21 2234578999999999865 4589999999999999999999999976533221 11111 111100 00000
Q ss_pred ---ccCCCCCC------ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 ---AIDPNLNL------DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ---~~d~~l~~------~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+++.+.. ..........+.+++.+||+.||++||+++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 280 (288)
T 1ob3_A 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (288)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 01111100 0000112245779999999999999999999986
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-40 Score=365.72 Aligned_cols=264 Identities=24% Similarity=0.396 Sum_probs=210.5
Q ss_pred hcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
.++|++.+.||+|+||.||+|.+. +++.||||+++... ......++.+|+.++++++|||||++++++..+..
T Consensus 70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 148 (367)
T 3l9p_A 70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 148 (367)
T ss_dssp GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 468999999999999999999742 46789999997542 34456689999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC---cEEE
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKV 728 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl 728 (933)
.++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++ .+||
T Consensus 149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEE
Confidence 99999999999999999764321 12458999999999999999999999 8999999999999999555 5999
Q ss_pred ecccccccCCCCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHH
Q 002346 729 ADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 729 ~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||....... ... ..
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~---~i 299 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE---FV 299 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH---HH
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HH
Confidence 9999997432211 112234568999999999988899999999999999999998 999997653322 111 11
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.. .... ...... ...+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 300 ~~-~~~~--~~~~~~---------~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~ 346 (367)
T 3l9p_A 300 TS-GGRM--DPPKNC---------PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346 (367)
T ss_dssp HT-TCCC--CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred Hc-CCCC--CCCccC---------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence 11 1110 011111 13577999999999999999999999999887654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-39 Score=351.78 Aligned_cols=273 Identities=19% Similarity=0.286 Sum_probs=211.8
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc--eeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS--ERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 656 (933)
.++|++.+.||+|+||.||+|... +++.||||++..... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence 467999999999999999999654 589999999976532 334678899999999999999999999988655 7799
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe----cCCCcEEEeccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFG 732 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~DfG 732 (933)
||||+++++|.+++..... ...+++.+++.++.|+++||+|||+ ++|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp EEECCTTCBHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred EEeCCCCCCHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 9999999999999976322 2348999999999999999999999 899999999999999 788889999999
Q ss_pred ccccCCCCCceeecccccccCcccccccC--------CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAA--------TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
+++....... .....||+.|+|||++. +..++.++|||||||++|||++|+.||......... ...+.
T Consensus 162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~ 237 (319)
T 4euu_A 162 AARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMY 237 (319)
T ss_dssp TCEECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHH
T ss_pred CceecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHH
Confidence 9987655432 23457999999999885 567899999999999999999999999754332211 11122
Q ss_pred HHhhccC-CCCcc----------cCCCCCC-ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 805 RVLISKE-NIPKA----------IDPNLNL-DEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 805 ~~~~~~~-~~~~~----------~d~~l~~-~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
....... ..... ....+.. ..........+.+++.+||+.||++||+++|+++...+.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~ 307 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI 307 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence 2221111 00000 0011110 122345556788999999999999999999999877554
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=358.92 Aligned_cols=257 Identities=19% Similarity=0.292 Sum_probs=208.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... ......+.+|+.++++++||||+++++++.++...++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 47899999999999999999955 478999999987652 334567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC--CCcEEEeccccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD--DMRAKVADFGLVKN 736 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~--~~~~kl~DfGla~~ 736 (933)
||+++|+|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||+++.
T Consensus 128 E~~~gg~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~ 200 (387)
T 1kob_A 128 EFLSGGELFDRIAAE----DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200 (387)
T ss_dssp ECCCCCBHHHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCCcHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEeccccee
Confidence 999999999998541 2468999999999999999999999 89999999999999974 57799999999987
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
...... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... .. ..........+..
T Consensus 201 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~---~~i~~~~~~~~~~ 272 (387)
T 1kob_A 201 LNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TL---QNVKRCDWEFDED 272 (387)
T ss_dssp CCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HH---HHHHHCCCCCCSS
T ss_pred cCCCcc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HH---HHHHhCCCCCCcc
Confidence 655432 233479999999999999999999999999999999999999998643221 11 1111111111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....+ ..++.+++.+||+.||++||++.|+++ ++|..
T Consensus 273 ~~~~~---------s~~~~~li~~~L~~dP~~Rpt~~ell~------hp~~~ 309 (387)
T 1kob_A 273 AFSSV---------SPEAKDFIKNLLQKEPRKRLTVHDALE------HPWLK 309 (387)
T ss_dssp TTTTS---------CHHHHHHHHTTSCSSGGGSCCHHHHHT------STTTS
T ss_pred ccccC---------CHHHHHHHHHHcCCChhHCcCHHHHhh------Ccccc
Confidence 11111 235779999999999999999999986 56654
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=347.04 Aligned_cols=257 Identities=27% Similarity=0.459 Sum_probs=212.3
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|...+++.||+|++..... ..+++.+|++++++++||||+++++++.+++..++|||
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTB---CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 367899999999999999999888889999999986532 24689999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++.....
T Consensus 84 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 156 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 156 (267)
T ss_dssp CCTTCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCCCCcHHHHHhhC----cccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccc
Confidence 99999999999652 2458999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........|++.|+|||++.+..++.++||||||+++|||++ |+.||....... .. ...... ......
T Consensus 157 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~i~~~---~~~~~~ 227 (267)
T 3t9t_A 157 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VV---EDISTG---FRLYKP 227 (267)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHTT---CCCCCC
T ss_pred ccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HH---HHHhcC---CcCCCC
Confidence 33222334567889999999988889999999999999999999 899997643221 11 111111 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
... ...+.+++.+|++.+|++||+++++++.|+++.+
T Consensus 228 ~~~---------~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~ 264 (267)
T 3t9t_A 228 RLA---------STHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264 (267)
T ss_dssp TTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ccC---------cHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 111 1357799999999999999999999999988764
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-39 Score=360.31 Aligned_cols=246 Identities=26% Similarity=0.355 Sum_probs=206.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 6799999999999999999965 4799999999976532 2234678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 121 e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~ 192 (350)
T 1rdq_E 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceecc
Confidence 999999999999762 458999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+......++.
T Consensus 193 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~~~~i~~~~~~~p~--- 259 (350)
T 1rdq_E 193 GR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGKVRFPS--- 259 (350)
T ss_dssp SC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCT---
T ss_pred CC----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH------HHHHHHcCCCCCCC---
Confidence 43 234579999999999999999999999999999999999999997653221 12222222222221
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
.+ ...+.+++.+||+.||++||+ ++++++
T Consensus 260 -~~---------~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~ 293 (350)
T 1rdq_E 260 -HF---------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp -TC---------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred -CC---------CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence 11 135779999999999999998 777765
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=351.17 Aligned_cols=262 Identities=28% Similarity=0.503 Sum_probs=199.6
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|... ..||||++..........+.|.+|+.++++++||||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 468999999999999999999863 3699999987766666778899999999999999999999965 4566899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceecccccc
Confidence 99999999999542 2568999999999999999999999 8999999999999999999999999999975543
Q ss_pred CC-ceeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 740 GK-YSVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 740 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
.. ........||+.|+|||++. +..++.++||||||+++|||++|+.||......+. ....... .....
T Consensus 173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-----~~~~~ 245 (289)
T 3og7_A 173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGR-----GSLSP 245 (289)
T ss_dssp -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHH-----TSCCC
T ss_pred ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhcc-----cccCc
Confidence 21 12223457999999999986 56788899999999999999999999976543221 1111111 11111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.... + .......+.+++.+|++.+|++||++.++++.|+++.+
T Consensus 246 ~~~~-~-----~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~ 288 (289)
T 3og7_A 246 DLSK-V-----RSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR 288 (289)
T ss_dssp CTTS-S-----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred chhh-c-----cccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence 1110 0 00112467899999999999999999999999988753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=362.34 Aligned_cols=250 Identities=25% Similarity=0.423 Sum_probs=205.4
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERL 655 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~ 655 (933)
..++|.+.+.||+|+||.||+|.. .+|+.||+|++++... .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~ 94 (345)
T 1xjd_A 15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF 94 (345)
T ss_dssp -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence 457899999999999999999966 4689999999976532 123456788999999887 8999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++... ..+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 95 lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 95 FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 999999999999999652 458999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
....... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ...+.......+.
T Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~---~~~i~~~~~~~p~ 239 (345)
T 1xjd_A 167 ENMLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---L---FHSIRMDNPFYPR 239 (345)
T ss_dssp CCCCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHHCCCCCCT
T ss_pred hcccCCC-cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---H---HHHHHhCCCCCCc
Confidence 6443221 2345689999999999999999999999999999999999999997653321 1 2222222222221
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMG-HAV 856 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~-evl 856 (933)
. + ...+.+++.+||+.||++||++. +++
T Consensus 240 ~----~---------s~~~~~li~~lL~~dp~~R~~~~~~i~ 268 (345)
T 1xjd_A 240 W----L---------EKEAKDLLVKLFVREPEKRLGVRGDIR 268 (345)
T ss_dssp T----S---------CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred c----c---------CHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence 1 1 13577999999999999999997 554
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=358.96 Aligned_cols=252 Identities=22% Similarity=0.328 Sum_probs=200.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCC--CcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--RHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||++...+++.||||++..........+.+.+|+.++.+++| |||+++++++..+...++|
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 46799999999999999999988889999999998766566667889999999999976 9999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
||+ .+++|.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+|||++ ++.+||+|||+++..
T Consensus 88 ~e~-~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 88 MEC-GNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 157 (343)
T ss_dssp ECC-CSEEHHHHHHH-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred EeC-CCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence 995 58899999976 2568999999999999999999999 8999999999999997 678999999999866
Q ss_pred CCCCce-eecccccccCcccccccCC-----------CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH
Q 002346 738 PDGKYS-VETRLAGTFGYLAPEYAAT-----------GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 738 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 805 (933)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ ....
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~ 232 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLHA 232 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHHH
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH-----HHHH
Confidence 543322 2345679999999999854 6788999999999999999999999976433211 1111
Q ss_pred HhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 806 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..... ....++... ...+.+++.+||+.||++||++.|+++
T Consensus 233 ~~~~~--~~~~~~~~~---------~~~l~~li~~~L~~dp~~Rpt~~e~l~ 273 (343)
T 3dbq_A 233 IIDPN--HEIEFPDIP---------EKDLQDVLKCCLKRDPKQRISIPELLA 273 (343)
T ss_dssp HHCTT--SCCCCCCCS---------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhcCC--cccCCcccC---------CHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence 11111 111111111 135779999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=348.54 Aligned_cols=260 Identities=27% Similarity=0.440 Sum_probs=212.9
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|...+++.||||++.... ...+.+.+|++++++++||||+++++++. .+..++|||
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc---ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 46899999999999999999998888899999997653 23568999999999999999999999986 456899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+||++++++.+||+|||++.....
T Consensus 88 ~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 999999999996421 1358999999999999999999999 8999999999999999999999999999987765
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+ .. ..... . ......
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~---~~~~~-~--~~~~~~ 232 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VI---QNLER-G--YRMVRP 232 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH---HHHHT-T--CCCCCC
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HH---HHHhc-c--cCCCCc
Confidence 54444445567889999999988889999999999999999999 899997643321 11 11111 1 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
... ...+.+++.+|++.+|++||++.++++.|+.+.....
T Consensus 233 ~~~---------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~ 272 (279)
T 1qpc_A 233 DNC---------PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272 (279)
T ss_dssp TTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred ccc---------cHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhcc
Confidence 111 2467899999999999999999999999998876544
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=364.76 Aligned_cols=276 Identities=16% Similarity=0.221 Sum_probs=207.3
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC------CcEEEEEEeccccCCch---------hHHHHHHHHHHHHhcCCCcceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNK---------GLSEFQAEIAVLTKVRHRHLVAL 644 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l 644 (933)
.++|++.+.||+|+||.||+|.... ++.||||++........ ....+..|+..+..++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 4689999999999999999997654 47899999876531100 01223455666777889999999
Q ss_pred EeEeeeC----ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 645 LGYCING----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 645 ~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
++++... ...++||||+ +++|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||+
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill 185 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLL 185 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEE
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEE
Confidence 9998764 4579999999 99999999652 2569999999999999999999999 899999999999999
Q ss_pred c--CCCcEEEecccccccCCCCCcee------ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCC
Q 002346 721 G--DDMRAKVADFGLVKNAPDGKYSV------ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTM 792 (933)
Q Consensus 721 ~--~~~~~kl~DfGla~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~ 792 (933)
+ .++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||+||+.||....
T Consensus 186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 9 88999999999997654322111 123459999999999999999999999999999999999999998543
Q ss_pred CchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCCCc
Q 002346 793 PDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPATR 871 (933)
Q Consensus 793 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~ 871 (933)
..... ..+..... ...++..+++.+... ....++.+++..|++.+|++||+++++++.|+.+++.......
T Consensus 266 ~~~~~--~~~~~~~~--~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~ 336 (364)
T 3op5_A 266 KDPKY--VRDSKIRY--RENIASLMDKCFPAA----NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD 336 (364)
T ss_dssp TCHHH--HHHHHHHH--HHCHHHHHHHHSCTT----CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred cCHHH--HHHHHHHh--hhhHHHHHHHhcccc----cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence 32211 11111111 111111111111100 1124678999999999999999999999999999887655433
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=365.25 Aligned_cols=262 Identities=23% Similarity=0.322 Sum_probs=209.2
Q ss_pred cHHHHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEee
Q 002346 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (933)
Q Consensus 572 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 649 (933)
...+.+...++|++.+.||+|+||.||++.. .+|+.||+|++.+... .....+.+.+|+.++..++||||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 3445555678999999999999999999966 4799999999975422 1223456889999999999999999999999
Q ss_pred eCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEe
Q 002346 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (933)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 729 (933)
+.+..|+||||+++|+|.+++... ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~----~~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~ 204 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF----GERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLA 204 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEe
Confidence 999999999999999999999652 1368999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccCcccccccC-------CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHH
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA-------TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW 802 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~ 802 (933)
|||+++.............+||+.|+|||++. ...++.++|||||||++|||++|+.||......+.
T Consensus 205 DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------ 278 (412)
T 2vd5_A 205 DFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAET------ 278 (412)
T ss_dssp CCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------
T ss_pred echhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHH------
Confidence 99999877655443444568999999999986 45789999999999999999999999976543221
Q ss_pred HHHHhhc--cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 002346 803 FRRVLIS--KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQR---PDMGHAVN 857 (933)
Q Consensus 803 ~~~~~~~--~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~R---Ps~~evl~ 857 (933)
+..+... ....+. .+..+ ..++.+++.+||+ +|++| |+++|+++
T Consensus 279 ~~~i~~~~~~~~~p~-~~~~~---------s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~ 327 (412)
T 2vd5_A 279 YGKIVHYKEHLSLPL-VDEGV---------PEEARDFIQRLLC-PPETRLGRGGAGDFRT 327 (412)
T ss_dssp HHHHHTHHHHCCCC-----CC---------CHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred HHHHHhcccCcCCCc-cccCC---------CHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence 1111111 111111 11112 1357799999999 99998 58888865
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-39 Score=349.68 Aligned_cols=260 Identities=27% Similarity=0.433 Sum_probs=216.6
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
..++|++.+.||+|+||.||+|... ++..||+|++... ....+++.+|+.++++++||||+++++++.++...++|
T Consensus 11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v 87 (288)
T 3kfa_A 11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 87 (288)
T ss_dssp CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC---STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence 3578999999999999999999664 5889999999754 33467899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~ 161 (288)
T 3kfa_A 88 TEFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLM 161 (288)
T ss_dssp EECCTTEEHHHHHHHC---CTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred EEcCCCCcHHHHHHhc---ccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceec
Confidence 9999999999999652 23568999999999999999999999 89999999999999999999999999999877
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
............|++.|+|||++.+..++.++||||||+++|||++ |+.||......... ..+.. . ....
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~---~~~~~----~--~~~~ 232 (288)
T 3kfa_A 162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEK----D--YRME 232 (288)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHHT----T--CCCC
T ss_pred cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHhc----c--CCCC
Confidence 6655555555678899999999998899999999999999999999 99999765433221 11111 1 1111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
..... ...+.+++.+|++.||++||++.++++.|+.+...
T Consensus 233 ~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~ 272 (288)
T 3kfa_A 233 RPEGC---------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272 (288)
T ss_dssp CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCCC---------CHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence 11111 14578999999999999999999999999887654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=359.19 Aligned_cols=250 Identities=25% Similarity=0.406 Sum_probs=195.6
Q ss_pred hcCCccCCccccCCCeEEEEEEe----CCCcEEEEEEeccccCC--chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
.++|++.+.||+|+||.||++.. .+++.||+|+++..... ......+.+|+.++++++||||+++++++..++.
T Consensus 16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 95 (327)
T 3a62_A 16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK 95 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence 46899999999999999999975 47899999999865321 2334668899999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++++|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 167 (327)
T 3a62_A 96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGL 167 (327)
T ss_dssp EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence 99999999999999999652 458999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ....+......+
T Consensus 168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~~~~i~~~~~~~ 240 (327)
T 3a62_A 168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK------TIDKILKCKLNL 240 (327)
T ss_dssp C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHTCCCC
T ss_pred ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH------HHHHHHhCCCCC
Confidence 87543322 12334679999999999998899999999999999999999999997653221 112222222222
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
+. .+ ...+.+++.+||+.||++|| ++.|+++
T Consensus 241 p~----~~---------~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~ 276 (327)
T 3a62_A 241 PP----YL---------TQEARDLLKKLLKRNAASRLGAGPGDAGEVQA 276 (327)
T ss_dssp CT----TS---------CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred CC----CC---------CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence 21 11 13577999999999999999 6677765
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=353.76 Aligned_cols=265 Identities=24% Similarity=0.394 Sum_probs=214.7
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 652 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++++ +||||+++++++..++
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 46899999999999999999964 357899999997653 334567899999999999 9999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDH-------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
..++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ ++|+||||||+||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEE
Confidence 999999999999999999763211 12358999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~ 797 (933)
++.++.+||+|||+++....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~- 256 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH-
Confidence 99999999999999986654432 22334567889999999988899999999999999999999 9999976543222
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
....... . ......... ...+.+++.+|++.||++||++.|+++.|++++..
T Consensus 257 -~~~~~~~----~--~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~ 308 (313)
T 1t46_A 257 -FYKMIKE----G--FRMLSPEHA---------PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (313)
T ss_dssp -HHHHHHH----T--CCCCCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -HHHHhcc----C--CCCCCcccC---------CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence 1111111 1 111111111 24578999999999999999999999999987654
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-39 Score=356.85 Aligned_cols=257 Identities=25% Similarity=0.379 Sum_probs=194.0
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+.++|++.+.||+|+||.||+|... +++.||||++.... ..+.+.+|+.++++++||||+++++++..+...++|
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 4678999999999999999999664 58899999997542 235788999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---CCcEEEeccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVADFGLV 734 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGla 734 (933)
|||+++|+|.+++.. ...+++.+++.++.|+++||+|||+ .+|+||||||+||+++. ++.+||+|||++
T Consensus 127 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 127 LELVTGGELFDRIVE-----KGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198 (349)
T ss_dssp ECCCCSCBHHHHHTT-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred EEeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence 999999999999954 2458999999999999999999999 89999999999999975 889999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
+...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ . ............
T Consensus 199 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~~i~~~~~~~~ 271 (349)
T 2w4o_A 199 KIVEHQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---FRRILNCEYYFI 271 (349)
T ss_dssp ----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---HHHHHTTCCCCC
T ss_pred cccCccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---HHHHHhCCCccC
Confidence 8654322 22345799999999999998999999999999999999999999976543221 1 112222111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
....+. ....+.+++.+|++.||++||++.|+++ ++|...
T Consensus 272 ~~~~~~---------~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~~ 311 (349)
T 2w4o_A 272 SPWWDE---------VSLNAKDLVRKLIVLDPKKRLTTFQALQ------HPWVTG 311 (349)
T ss_dssp TTTTTT---------SCHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTTS
T ss_pred Cchhhh---------CCHHHHHHHHHHccCChhhCcCHHHHhc------CcccCC
Confidence 111111 1245779999999999999999999987 667653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-39 Score=344.71 Aligned_cols=254 Identities=23% Similarity=0.380 Sum_probs=209.5
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++++++..+...++|
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 357899999999999999999965 5689999999987766666678899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc---EEEeccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AKVADFGLV 734 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfGla 734 (933)
|||+++++|.+++... ..+++.++..++.|++.||+|||+ .+|+||||||+||+++.++. +||+|||++
T Consensus 84 ~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~ 155 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155 (284)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceee
Confidence 9999999999988652 458999999999999999999999 89999999999999987655 999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||....... ... .........+
T Consensus 156 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~---~~~~~~~~~~ 227 (284)
T 3kk8_A 156 IEVNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYA---QIKAGAYDYP 227 (284)
T ss_dssp EECCSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---HHHHTCCCCC
T ss_pred EEcccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHH---HHHhccccCC
Confidence 86654332 234579999999999999999999999999999999999999997653221 111 1111111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...... ....+.+++.+|++.||++||+++|+++
T Consensus 228 ~~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (284)
T 3kk8_A 228 SPEWDT---------VTPEAKSLIDSMLTVNPKKRITADQALK 261 (284)
T ss_dssp TTTTTT---------SCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred chhhcc---------cCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 111011 1135779999999999999999999986
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-39 Score=355.94 Aligned_cols=253 Identities=23% Similarity=0.377 Sum_probs=201.2
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc-----
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----- 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----- 652 (933)
..++|++.+.||+|+||.||+|... +|+.||||++.... .....+.+.+|+.++++++||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 3468999999999999999999664 79999999997653 3445678999999999999999999999986543
Q ss_pred ----------------------------------------------------eeEEEEeecCCCChhhHhhhcccCCCCC
Q 002346 653 ----------------------------------------------------ERLLVYEYMPRGTLAQHLFEWHDHGYTP 680 (933)
Q Consensus 653 ----------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~ 680 (933)
..++||||+++++|.+++.... ....
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~ 160 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLED 160 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGG
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--Cccc
Confidence 2789999999999999997632 2345
Q ss_pred CCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc-----------eeecccc
Q 002346 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY-----------SVETRLA 749 (933)
Q Consensus 681 l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~-----------~~~~~~~ 749 (933)
.++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++....... .......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV 237 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC
T ss_pred hhhHHHHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccC
Confidence 6788899999999999999999 8999999999999999999999999999987654321 1223457
Q ss_pred cccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHH
Q 002346 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIE 829 (933)
Q Consensus 750 gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~ 829 (933)
||+.|+|||++.+..++.++||||||+++|||++|..|+.. .... ..... .... ......
T Consensus 238 gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~---~~~~~--~~~~----------~~~~~~ 297 (332)
T 3qd2_B 238 GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRI---ITDVR--NLKF----------PLLFTQ 297 (332)
T ss_dssp -CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHH---HHHHH--TTCC----------CHHHHH
T ss_pred CCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHH---HHHhh--ccCC----------Cccccc
Confidence 99999999999998999999999999999999998765421 1111 11111 1111 122233
Q ss_pred HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 830 SIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 830 ~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....+.+++.+||+.||++||+++|+++
T Consensus 298 ~~~~~~~li~~~l~~~p~~Rps~~~~l~ 325 (332)
T 3qd2_B 298 KYPQEHMMVQDMLSPSPTERPEATDIIE 325 (332)
T ss_dssp HCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred CChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence 3456789999999999999999999987
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-39 Score=344.88 Aligned_cols=255 Identities=29% Similarity=0.547 Sum_probs=204.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchh-----HHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKG-----LSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
.++|++.+.||+|+||.||+|.. .+++.||+|++......... .+++.+|+.++++++||||+++++++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 96 (287)
T 4f0f_A 18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP- 96 (287)
T ss_dssp STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence 36789999999999999999965 57899999998765432221 268999999999999999999999986655
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEecCCCCCcEEecCCCc-----E
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGDDMR-----A 726 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dik~~Nill~~~~~-----~ 726 (933)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++ |+||||||+||+++.++. +
T Consensus 97 -~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 97 -RMVMEFVPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp -EEEEECCTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred -eEEEEecCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeE
Confidence 7999999999999988552 2569999999999999999999998 78 999999999999988776 9
Q ss_pred EEecccccccCCCCCceeecccccccCccccccc--CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 727 KVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA--ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 727 kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
||+|||+++..... .....||+.|+|||++ ....++.++||||||+++|||++|+.||........... .
T Consensus 169 kl~Dfg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~-~--- 240 (287)
T 4f0f_A 169 KVADFGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI-N--- 240 (287)
T ss_dssp EECCCTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH-H---
T ss_pred EeCCCCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH-H---
Confidence 99999999854432 2346799999999998 445678999999999999999999999986544332111 1
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
... .......+.... ...+.+++.+||+.||++||+++|+++.|+++
T Consensus 241 ~~~--~~~~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l 287 (287)
T 4f0f_A 241 MIR--EEGLRPTIPEDC---------PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287 (287)
T ss_dssp HHH--HSCCCCCCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred HHh--ccCCCCCCCccc---------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence 111 111111122111 24578999999999999999999999998753
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-39 Score=350.65 Aligned_cols=247 Identities=26% Similarity=0.336 Sum_probs=197.9
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.++||+|+||+||+|... +|+.||||++...........++..|+..+.++ +||||+++++++.+++..++|
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv 135 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ 135 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence 468999999999999999999664 799999999876654555555666777766666 899999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+ +++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+|||++.++.+||+|||+++..
T Consensus 136 ~e~~-~~~L~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~ 207 (311)
T 3p1a_A 136 TELC-GPSLQQHCEAW----GASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL 207 (311)
T ss_dssp EECC-CCBHHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred Eecc-CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence 9999 77999998663 2469999999999999999999999 89999999999999999999999999998866
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
.... ......||+.|+|||++.+ .++.++|||||||++|||++|+.|+.... . + .... ....+..+
T Consensus 208 ~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~-----~-~~~~--~~~~~~~~ 273 (311)
T 3p1a_A 208 GTAG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---G-----W-QQLR--QGYLPPEF 273 (311)
T ss_dssp C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---H-----H-HHHT--TTCCCHHH
T ss_pred ccCC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---H-----H-HHHh--ccCCCccc
Confidence 5432 2334579999999998875 79999999999999999999987765321 1 1 1111 11111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... ....+.+++.+|++.||++||+++|+++
T Consensus 274 ~~~---------~~~~l~~li~~~L~~dP~~Rpt~~ell~ 304 (311)
T 3p1a_A 274 TAG---------LSSELRSVLVMMLEPDPKLRATAEALLA 304 (311)
T ss_dssp HTT---------SCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ccC---------CCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 111 2246789999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-39 Score=349.80 Aligned_cols=259 Identities=31% Similarity=0.519 Sum_probs=202.3
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|++.+.||+|+||.||+|.. .++.||||++... ...+.|.+|++++++++||||+++++++.+ ..++||||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~ 80 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY 80 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred hHeeeeeEeecCCCceEEEEEE-CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence 5788999999999999999987 5789999998643 345789999999999999999999998863 47899999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc-EEEecccccccCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR-AKVADFGLVKNAPD 739 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~-~kl~DfGla~~~~~ 739 (933)
+++|+|.+++.... ....+++..++.++.|+++||+|||+...++|+||||||+||+++.++. +||+|||++.....
T Consensus 81 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 81 AEGGSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp CTTCBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred CCCCCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 99999999996521 1235789999999999999999999854468999999999999998886 79999999875543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
. .....||+.|+|||++.+..++.++||||||+++|||++|+.||......... ..+. .. ....+. ...
T Consensus 159 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~--~~--~~~~~~-~~~ 227 (307)
T 2eva_A 159 H----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA--VH--NGTRPP-LIK 227 (307)
T ss_dssp ----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHH--HH--TTCCCC-CBT
T ss_pred c----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHH--Hh--cCCCCC-ccc
Confidence 2 12346999999999999989999999999999999999999999764332211 1111 11 111111 111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.+ ...+.+++.+|++.||++||+++++++.|+.+...+..
T Consensus 228 ~~---------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~ 267 (307)
T 2eva_A 228 NL---------PKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG 267 (307)
T ss_dssp TC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred cc---------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence 11 13577999999999999999999999999988765543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=350.12 Aligned_cols=263 Identities=22% Similarity=0.314 Sum_probs=202.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++..++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47899999999999999999965 47899999999765432 33457899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++... .++++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 184 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASAT 184 (309)
T ss_dssp EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence 9999999999999752 468999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
............|++.|+|||++.+..++.++||||||+++|||++|+.||...... . ...........+...
T Consensus 185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~----~~~~~~~~~~~~~~~ 257 (309)
T 2h34_A 185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---V----MGAHINQAIPRPSTV 257 (309)
T ss_dssp ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---H----HHHHHHSCCCCGGGT
T ss_pred cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---H----HHHHhccCCCCcccc
Confidence 554333334567999999999999889999999999999999999999999764221 1 111121111111222
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhhhhhc
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRP-DMGHAVNVLGPLVEQW 866 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-s~~evl~~L~~~~~~~ 866 (933)
.+.+. ..+.+++.+||+.||++|| +++++++.|+.++...
T Consensus 258 ~~~~~---------~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~ 298 (309)
T 2h34_A 258 RPGIP---------VAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA 298 (309)
T ss_dssp STTCC---------THHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred CCCCC---------HHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence 22222 3577999999999999999 9999999998775443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=353.79 Aligned_cols=264 Identities=27% Similarity=0.439 Sum_probs=210.4
Q ss_pred CccCCccccCCCeEEEEEEe-----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--CceeE
Q 002346 583 FSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERL 655 (933)
Q Consensus 583 ~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~ 655 (933)
|++.+.||+|+||.||++.+ .+++.||||++.... .....+.+.+|++++++++||||+++++++.+ ....+
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 111 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ 111 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence 38899999999999998854 268899999998653 44556789999999999999999999999987 46789
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 112 lv~e~~~~~~L~~~l~~------~~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 182 (318)
T 3lxp_A 112 LVMEYVPLGSLRDYLPR------HSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAK 182 (318)
T ss_dssp EEECCCTTCBHHHHGGG------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred EEEecccCCcHHHHHhh------CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccc
Confidence 99999999999999965 348999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCce--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCc---------hhhHHHHHHH
Q 002346 736 NAPDGKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD---------DRAHLVTWFR 804 (933)
Q Consensus 736 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~---------~~~~~~~~~~ 804 (933)
........ ......|++.|+|||++.+..++.++||||||+++|||++|+.||...... ....... ..
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~ 261 (318)
T 3lxp_A 183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LT 261 (318)
T ss_dssp ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH-HH
T ss_pred cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH-HH
Confidence 76654322 233456888999999999888999999999999999999999998753211 0111111 11
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
........ ...... ....+.+++.+||+.||++||++.|+++.|+.+.+.+..
T Consensus 262 ~~~~~~~~--~~~~~~---------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~ 314 (318)
T 3lxp_A 262 ELLERGER--LPRPDK---------CPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314 (318)
T ss_dssp HHHHTTCC--CCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred HHHhcccC--CCCCcc---------ccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence 11111111 111111 124678999999999999999999999999998877654
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-39 Score=355.63 Aligned_cols=258 Identities=26% Similarity=0.433 Sum_probs=201.3
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCc----EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.++|++.+.||+|+||.||+|.. .+++ +||+|.+.... .....++|.+|+.++++++||||++++++|..+. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~ 91 (327)
T 3poz_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence 36799999999999999999964 3444 35888876542 3445678999999999999999999999998754 7
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+.+|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 92 ~~v~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a 164 (327)
T 3poz_A 92 QLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEEECCTTCBHHHHHHHS----TTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHH
T ss_pred EEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcce
Confidence 7899999999999999762 2468999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 735 KNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 735 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+....... .......||+.|+|||++.+..++.++|||||||++|||+| |+.||........... ......
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-------~~~~~~ 237 (327)
T 3poz_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-------LEKGER 237 (327)
T ss_dssp HHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-------HHTTCC
T ss_pred eEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-------HHcCCC
Confidence 86544322 22234467889999999999999999999999999999999 9999987544332111 111111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.+ ..+. ....+.+++.+||+.+|++||++.++++.|+.+..
T Consensus 238 ~~--~~~~---------~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~ 278 (327)
T 3poz_A 238 LP--QPPI---------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC--CCTT---------BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred CC--CCcc---------CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 11 1111 12357799999999999999999999999988764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=357.30 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=201.8
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|.+.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999964 67899999998754321 222457899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+ +|+|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 89 E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~ 159 (336)
T 3h4j_B 89 EYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT 159 (336)
T ss_dssp CCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred ECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence 999 78999988652 468999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
.... .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... .........+
T Consensus 160 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~----------~~i~~~~~~~ 227 (336)
T 3h4j_B 160 DGNF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF----------KKVNSCVYVM 227 (336)
T ss_dssp TSBT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB----------CCCCSSCCCC
T ss_pred CCcc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH----------HHHHcCCCCC
Confidence 4332 234579999999999988776 68999999999999999999999764322110 0000000001
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... ....+.+++.+|++.||.+|||++|+++
T Consensus 228 p~~---------~s~~~~~li~~~L~~dP~~Rpt~~eil~ 258 (336)
T 3h4j_B 228 PDF---------LSPGAQSLIRRMIVADPMQRITIQEIRR 258 (336)
T ss_dssp CTT---------SCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred ccc---------CCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 111 1235779999999999999999999976
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=368.26 Aligned_cols=252 Identities=30% Similarity=0.454 Sum_probs=206.5
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc-eeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-ERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .|+.||||+++... ..+.|.+|+.++++++|||||++++++.... ..++||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred hHHeEEEeeecCcCCeeEEEEEe-cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 46789999999999999999988 48899999997653 3468999999999999999999999987665 789999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... +...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++...
T Consensus 267 e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp ECCTTCBHHHHHHHH---CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred EecCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 999999999999763 22347999999999999999999999 899999999999999999999999999998544
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... ....+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.. . .... .... ..
T Consensus 341 ~~~----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~---~---~i~~-~~~~--~~ 407 (450)
T 1k9a_A 341 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---P---RVEK-GYKM--DA 407 (450)
T ss_dssp ----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH---H---HHHT-TCCC--CC
T ss_pred ccc----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H---HHHc-CCCC--CC
Confidence 321 22367889999999999999999999999999999998 99999865443221 1 1111 1111 11
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.... ...+.+++.+||+.||++||++.++++.|+.+..
T Consensus 408 p~~~---------~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~ 445 (450)
T 1k9a_A 408 PDGC---------PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT 445 (450)
T ss_dssp CTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence 1111 2457799999999999999999999999988754
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=363.49 Aligned_cols=275 Identities=17% Similarity=0.257 Sum_probs=209.9
Q ss_pred hcCCccCCccccC--CCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 580 TDNFSEANILGRG--GFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
.++|++.+.||+| +||.||+|... +|+.||||++..........+.+.+|+.+++.++|||||++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3689999999999 99999999664 79999999998776666667889999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++|+|.+++.... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||.+..
T Consensus 104 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp EEECCTTCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred EEEccCCCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 999999999999997632 2458999999999999999999999 8999999999999999999999999998864
Q ss_pred CCCCCc------eeecccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 737 APDGKY------SVETRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 737 ~~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... ........
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~ 255 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVP 255 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCC
Confidence 432211 11123478999999999987 578999999999999999999999997654332211 00000000
Q ss_pred ---cc-----CC-------------CCcccC--------CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 809 ---SK-----EN-------------IPKAID--------PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 809 ---~~-----~~-------------~~~~~d--------~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
.. .. ..+.+. ...............+.+++.+||+.||++||+++|+++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~-- 333 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLN-- 333 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTT--
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhc--
Confidence 00 00 000000 000000011122345789999999999999999999986
Q ss_pred hhhhhhcCC
Q 002346 860 GPLVEQWKP 868 (933)
Q Consensus 860 ~~~~~~~~~ 868 (933)
++|..
T Consensus 334 ----hp~f~ 338 (389)
T 3gni_B 334 ----HSFFK 338 (389)
T ss_dssp ----SGGGG
T ss_pred ----CHHHH
Confidence 56654
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=353.26 Aligned_cols=278 Identities=22% Similarity=0.283 Sum_probs=207.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|++++++++||||+++++++..++..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 36899999999999999999966 45899999999776555555678899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++.. ...+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 82 e~~~~~~l~~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 153 (311)
T 4agu_A 82 EYCDHTVLHELDRY-----QRGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLT 153 (311)
T ss_dssp ECCSEEHHHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EeCCCchHHHHHhh-----hcCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhcc
Confidence 99999999988754 2558999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH--------HHhhc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR--------RVLIS 809 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~--------~~~~~ 809 (933)
.... ......||+.|+|||++.+ ..++.++||||+|+++|||++|+.||......+......... .....
T Consensus 154 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (311)
T 4agu_A 154 GPSD-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST 232 (311)
T ss_dssp -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred Cccc-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence 3322 2234578999999999865 578999999999999999999999998754433221111000 00000
Q ss_pred cCCCCc--ccCCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCCCcC
Q 002346 810 KENIPK--AIDPNLNLD--EETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPATRE 872 (933)
Q Consensus 810 ~~~~~~--~~d~~l~~~--~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~~~~ 872 (933)
...... ..++.-... .........+.+++.+||+.||++|||++|+++ ++|....++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~~~~~ 293 (311)
T 4agu_A 233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH------HPYFENIRE 293 (311)
T ss_dssp CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT------SGGGTTCC-
T ss_pred ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc------ChHHHhccC
Confidence 000000 000000000 000112345789999999999999999999986 677665443
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=357.61 Aligned_cols=266 Identities=24% Similarity=0.410 Sum_probs=209.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 652 (933)
.++|++.+.||+|+||.||+|.. .++..||||++.... .....+.+.+|+.+++++ +||||+++++++..++
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 122 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 122 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence 57899999999999999999974 246689999997543 334457899999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccC------------------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCC
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDH------------------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 714 (933)
..++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ ++|+|||||
T Consensus 123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dik 199 (344)
T 1rjb_A 123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 199 (344)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCC
Confidence 999999999999999999763211 11348999999999999999999999 899999999
Q ss_pred CCcEEecCCCcEEEecccccccCCCCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCC
Q 002346 715 PSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTM 792 (933)
Q Consensus 715 ~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~ 792 (933)
|+||+++.++.+||+|||++....... ........||+.|+|||.+.+..++.++||||||+++|||+| |+.||....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999998554332 223345578899999999988899999999999999999998 999997754
Q ss_pred CchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 793 PDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 793 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
.... ... ..... ......... ...+.+++.+||+.||++||++.++++.|+.+....
T Consensus 280 ~~~~--~~~----~~~~~--~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~ 336 (344)
T 1rjb_A 280 VDAN--FYK----LIQNG--FKMDQPFYA---------TEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA 336 (344)
T ss_dssp CSHH--HHH----HHHTT--CCCCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred cHHH--HHH----HHhcC--CCCCCCCCC---------CHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence 3322 111 11111 111111111 245779999999999999999999999998876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-39 Score=361.05 Aligned_cols=207 Identities=28% Similarity=0.455 Sum_probs=168.4
Q ss_pred HHHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCc--
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS-- 652 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-- 652 (933)
..+.++|++.+.||+|+||.||+|. ..+|+.||||++..........+++.+|+.++.++. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~ 84 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR 84 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence 3456899999999999999999995 457999999999766555566778899999999997 999999999997544
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+|||++.++.+||+|||
T Consensus 85 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG 154 (388)
T 3oz6_A 85 DVYLVFDYME-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFG 154 (388)
T ss_dssp CEEEEEECCS-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred EEEEEecccC-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCc
Confidence 6899999997 699999865 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCC--------------------CceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCC
Q 002346 733 LVKNAPDG--------------------KYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDT 791 (933)
Q Consensus 733 la~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~ 791 (933)
+++..... .....+..+||+.|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 155 ~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~ 234 (388)
T 3oz6_A 155 LSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGS 234 (388)
T ss_dssp TCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99865321 1112244689999999999876 67899999999999999999999999875
Q ss_pred CC
Q 002346 792 MP 793 (933)
Q Consensus 792 ~~ 793 (933)
..
T Consensus 235 ~~ 236 (388)
T 3oz6_A 235 ST 236 (388)
T ss_dssp SH
T ss_pred CH
Confidence 43
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=353.71 Aligned_cols=274 Identities=24% Similarity=0.403 Sum_probs=208.0
Q ss_pred HHHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc--CCCcceeEEeEeee
Q 002346 573 IEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV--RHRHLVALLGYCIN 650 (933)
Q Consensus 573 ~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~ 650 (933)
......+.++|++.+.||+|+||.||+|.. .++.||||++... ....+.+|.+++..+ +||||+++++++..
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~ 102 (337)
T 3mdy_A 29 LLVQRTIAKQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIK 102 (337)
T ss_dssp HHHHTTHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred cccccccccceEEEeEeecCCCeEEEEEEE-CCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence 344456678999999999999999999987 4899999998643 224555666666555 89999999999987
Q ss_pred C----ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeEecCCCCCcEEec
Q 002346 651 G----SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA-----QQSFIHRDLKPSNILIG 721 (933)
Q Consensus 651 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dik~~Nill~ 721 (933)
. ...++||||+++|+|.+++.. ..+++.+++.++.|++.||+|||+.+ ..+|+||||||+||+++
T Consensus 103 ~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~ 176 (337)
T 3mdy_A 103 GTGSWTQLYLITDYHENGSLYDYLKS------TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176 (337)
T ss_dssp SCGGGCEEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEEC
T ss_pred CCCCCCceEEEEeccCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEEC
Confidence 7 688999999999999999965 45899999999999999999999810 12999999999999999
Q ss_pred CCCcEEEecccccccCCCCCcee---ecccccccCcccccccCCCCCCCc------cchHhHHHHHHHHHcC--------
Q 002346 722 DDMRAKVADFGLVKNAPDGKYSV---ETRLAGTFGYLAPEYAATGRVTTK------IDVYAFGVVLMETITG-------- 784 (933)
Q Consensus 722 ~~~~~kl~DfGla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~Dv~SlG~~l~elltG-------- 784 (933)
.++.+||+|||+++......... .....||+.|+|||++.+..++.+ +|||||||++|||+||
T Consensus 177 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~ 256 (337)
T 3mdy_A 177 KNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256 (337)
T ss_dssp TTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC
T ss_pred CCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc
Confidence 99999999999997655433221 124579999999999987766654 9999999999999999
Q ss_pred --CCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 785 --RKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 785 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
+.||....+.... ... ...... ... ..+.+...........++.+++.+||+.||++||++.++++.|+.+
T Consensus 257 ~~~~p~~~~~~~~~~-~~~-~~~~~~-~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l 329 (337)
T 3mdy_A 257 EYQLPYHDLVPSDPS-YED-MREIVC-IKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM 329 (337)
T ss_dssp CCCCTTTTTSCSSCC-HHH-HHHHHT-TSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred cccccHhhhcCCCCc-hhh-hHHHHh-hhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence 6676554332211 111 111111 111 1122221222335566788999999999999999999999999988
Q ss_pred hhh
Q 002346 863 VEQ 865 (933)
Q Consensus 863 ~~~ 865 (933)
.+.
T Consensus 330 ~~~ 332 (337)
T 3mdy_A 330 SES 332 (337)
T ss_dssp HHT
T ss_pred Hhh
Confidence 654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=349.40 Aligned_cols=259 Identities=22% Similarity=0.359 Sum_probs=210.8
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc----hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
+.++|++.+.||+|+||.||+|.. .+|+.||||++....... ...+++.+|+.++++++||||+++++++.++..
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 357899999999999999999965 468999999997654322 136789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC----cEEEe
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVA 729 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~ 729 (933)
.++||||+++++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++ .+||+
T Consensus 90 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~ 161 (321)
T 2a2a_A 90 VVLILELVSGGELFDFLAQ-----KESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLI 161 (321)
T ss_dssp EEEEECCCCSCBHHHHHHT-----CSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEEC
T ss_pred EEEEEEcCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEc
Confidence 9999999999999999965 2468999999999999999999999 8999999999999999888 79999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||......+. .......
T Consensus 162 Dfg~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i~~~ 233 (321)
T 2a2a_A 162 DFGLAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANITSV 233 (321)
T ss_dssp CCTTCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHTT
T ss_pred cCccceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhc
Confidence 9999987654322 2345799999999999989999999999999999999999999976432211 1111111
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....+..+.+ .....+.+++.+|++.||++||++.|+++ ++|..
T Consensus 234 ~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~e~l~------hp~~~ 277 (321)
T 2a2a_A 234 SYDFDEEFFS---------HTSELAKDFIRKLLVKETRKRLTIQEALR------HPWIT 277 (321)
T ss_dssp CCCCCHHHHT---------TCCHHHHHHHHTTSCSSTTTSCCHHHHHH------STTTS
T ss_pred ccccChhhhc---------ccCHHHHHHHHHHcCCChhhCcCHHHHhc------Ccccc
Confidence 1111111111 11245779999999999999999999987 56654
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=358.64 Aligned_cols=250 Identities=24% Similarity=0.361 Sum_probs=205.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
.++|++.+.||+|+||.||+|... +++.||+|++.+... .....+.+..|..++..+ +||+|+++++++.+.+..++
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 478999999999999999999664 578999999976532 223456788999999988 79999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 99 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~ 170 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170 (353)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence 99999999999999652 458999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
...... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....... ....+.......+..
T Consensus 171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~~~p~~ 243 (353)
T 2i0e_A 171 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------LFQSIMEHNVAYPKS 243 (353)
T ss_dssp CCCTTC-CBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCTT
T ss_pred cccCCc-ccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH------HHHHHHhCCCCCCCC
Confidence 433221 2345689999999999999999999999999999999999999997643221 222233222222221
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM-----GHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~-----~evl~ 857 (933)
+ ..++.+++.+||+.||++||++ +++++
T Consensus 244 ----~---------s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~ 276 (353)
T 2i0e_A 244 ----M---------SKEAVAICKGLMTKHPGKRLGCGPEGERDIKE 276 (353)
T ss_dssp ----S---------CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred ----C---------CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 1 1357799999999999999964 55554
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=348.57 Aligned_cols=270 Identities=21% Similarity=0.335 Sum_probs=205.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+++.+|+.++++++||||+++++++..++..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 36799999999999999999964 5799999999976432 344567899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++..... ....+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 111 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~ 186 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFF 186 (310)
T ss_dssp EECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC------
T ss_pred EecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeee
Confidence 999999999999975332 23568999999999999999999999 89999999999999999999999999998865
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ....... ....+...
T Consensus 187 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~--~~~~~~~~ 259 (310)
T 2wqm_A 187 SSKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY----SLCKKIE--QCDYPPLP 259 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH----HHHHHHH--TTCSCCCC
T ss_pred cCCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH----HHHHHhh--cccCCCCc
Confidence 44321 22345789999999999988999999999999999999999999975432211 1111111 11111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
.... ...+.+++.+||+.||++||++.++++.|+++...+.+.
T Consensus 260 ~~~~---------~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~ 302 (310)
T 2wqm_A 260 SDHY---------SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302 (310)
T ss_dssp TTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred cccc---------CHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence 1111 135779999999999999999999999999998777654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-39 Score=354.42 Aligned_cols=255 Identities=25% Similarity=0.368 Sum_probs=196.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce----
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE---- 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 653 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 47899999999999999999964 67899999999875432 3445689999999999999999999999876543
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++++|.+++.. ..++++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 162 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 162 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred cEEEEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence 4999999999999999965 2468999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc--eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 734 VKNAPDGKY--SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 734 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
++....... .......||+.|+|||++.+..++.++||||||+++|||++|+.||....+... .........
T Consensus 163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~------~~~~~~~~~ 236 (311)
T 3ork_A 163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 236 (311)
T ss_dssp C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC
T ss_pred cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHhcCCC
Confidence 986544322 122345799999999999988999999999999999999999999976543221 111111111
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+....+. ....+.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~~~~~---------~~~~l~~li~~~l~~dP~~R~~~~~~l~ 273 (311)
T 3ork_A 237 IPPSARHEG---------LSADLDAVVLKALAKNPENRYQTAAEMR 273 (311)
T ss_dssp CCHHHHSTT---------CCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred CCcccccCC---------CCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence 111111111 1245779999999999999997776654
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-39 Score=353.31 Aligned_cols=269 Identities=22% Similarity=0.339 Sum_probs=191.9
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 46799999999999999999965 468999999997653 2333467889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccC-CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 659 EYMPRGTLAQHLFEWHDH-GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
||++ |+|.+++...... ....+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~ 158 (317)
T 2pmi_A 83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158 (317)
T ss_dssp ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence 9997 6999998763321 22458999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh-ccCC-CC
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI-SKEN-IP 814 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~-~~~~-~~ 814 (933)
..... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. ...+..... .... .+
T Consensus 159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~ 234 (317)
T 2pmi_A 159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQ---LKLIFDIMGTPNESLWP 234 (317)
T ss_dssp TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCCTTTCG
T ss_pred CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH---HHHHHHHhCCCChhHhh
Confidence 43221 1234578999999999876 4689999999999999999999999986543222 111111110 0000 00
Q ss_pred c-----ccCCCCC----CChh-------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 K-----AIDPNLN----LDEE-------TIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~-----~~d~~l~----~~~~-------~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ...+.+. .... .......+.+++.+||+.||++||+++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~ 293 (317)
T 2pmi_A 235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH 293 (317)
T ss_dssp GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence 0 0000000 0000 0011246789999999999999999999976
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=353.10 Aligned_cols=260 Identities=20% Similarity=0.299 Sum_probs=186.5
Q ss_pred cCCcc---CCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeE
Q 002346 581 DNFSE---ANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~---~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~ 655 (933)
++|++ .+.||+|+||.||+|.. .+++.||||++... ....+.+|+.+++.+. ||||+++++++.++...+
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 34554 37899999999999965 46899999998643 3467889999999997 999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC---cEEEeccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAKVADFG 732 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~kl~DfG 732 (933)
+||||+++|+|.+++.. ...+++.++..++.|+++||+|||+ ++|+||||||+||+++.++ .+||+|||
T Consensus 83 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg 154 (325)
T 3kn6_A 83 LVMELLNGGELFERIKK-----KKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFG 154 (325)
T ss_dssp EEECCCCSCBHHHHHHH-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCT
T ss_pred EEEEccCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccc
Confidence 99999999999999976 2569999999999999999999999 8999999999999998765 89999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh-hHHHHHHHHHhhccC
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR-AHLVTWFRRVLISKE 811 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~-~~~~~~~~~~~~~~~ 811 (933)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...............
T Consensus 155 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 155 FARLKPPDNQ-PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp TCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred cceecCCCCC-cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 9986654332 22345789999999999999999999999999999999999999976433211 111122222222111
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
..+ .........++.+++.+||+.||++||+++|+++ ++|...
T Consensus 234 ~~~---------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~------h~w~~~ 276 (325)
T 3kn6_A 234 SFE---------GEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY------NEWLQD 276 (325)
T ss_dssp CCC---------SHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT------CGGGCT
T ss_pred CCC---------cccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc------Chhhcc
Confidence 111 1111122356789999999999999999999875 677653
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=354.97 Aligned_cols=257 Identities=24% Similarity=0.445 Sum_probs=203.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcE----EEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
++|++.+.||+|+||.||+|.. .+++. ||+|.+.... .......+.+|+.++++++||||+++++++. +...+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 5789999999999999999965 34543 7888775442 2333456789999999999999999999986 56688
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 91 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~ 163 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQH----RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVAD 163 (325)
T ss_dssp EEEECCTTCBSHHHHHSS----GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGG
T ss_pred EEEEeCCCCCHHHHHHHc----cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCccc
Confidence 999999999999999652 2468899999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 736 NAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 736 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
........ ......|++.|+|||++.+..++.++||||||+++|||++ |+.||........... +.. ......
T Consensus 164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~--~~~~~~ 238 (325)
T 3kex_A 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL---LEK--GERLAQ 238 (325)
T ss_dssp GSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH---HHT--TCBCCC
T ss_pred ccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH---HHc--CCCCCC
Confidence 76544322 2344568889999999998999999999999999999999 9999987544332211 111 011112
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
+...++ .+.+++.+||+.||++||++.++++.|+.+..
T Consensus 239 ~~~~~~-------------~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~ 276 (325)
T 3kex_A 239 PQICTI-------------DVYMVMVKCWMIDENIRPTFKELANEFTRMAR 276 (325)
T ss_dssp CTTBCT-------------TTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred CCcCcH-------------HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 222222 24589999999999999999999999988754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-39 Score=348.08 Aligned_cols=263 Identities=25% Similarity=0.435 Sum_probs=207.0
Q ss_pred cCCccCCccccCCCeEEEEEE-----eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC--ce
Q 002346 581 DNFSEANILGRGGFGVVYGGE-----LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING--SE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~ 653 (933)
++|++.+.||+|+||.||+|. ..+++.||||++.... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 568899999999999999997 3468999999998653 344567899999999999999999999999876 66
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++++|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~ 172 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKN----KNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGL 172 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred EEEEEEeCCCCcHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccc
Confidence 89999999999999999652 2458999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc--eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCC---------chhhHHHHH
Q 002346 734 VKNAPDGKY--SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP---------DDRAHLVTW 802 (933)
Q Consensus 734 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~---------~~~~~~~~~ 802 (933)
+........ .......||..|+|||++.+..++.++||||||+++|||++|+.|+..... .........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 252 (302)
T 4e5w_A 173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRL 252 (302)
T ss_dssp CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHH
T ss_pred cccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHH
Confidence 987655432 223445788899999999988999999999999999999999988643210 011111111
Q ss_pred HHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 803 FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 803 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
. ........ ....+.. ...+.+++.+||+.||++||++.++++.|+.++
T Consensus 253 ~-~~~~~~~~--~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll 301 (302)
T 4e5w_A 253 V-NTLKEGKR--LPCPPNC---------PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301 (302)
T ss_dssp H-HHHHTTCC--CCCCTTC---------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred H-HHHhccCC--CCCCCCC---------CHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence 1 11111111 1111111 245789999999999999999999999998875
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=357.38 Aligned_cols=264 Identities=25% Similarity=0.311 Sum_probs=204.1
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC---CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM---GNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 651 (933)
+..+.++|++.+.||+|+||.||+|.. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++.++
T Consensus 21 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 100 (345)
T 3hko_A 21 LLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE 100 (345)
T ss_dssp HHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC
Confidence 356678999999999999999999955 5788999999875431 345567899999999999999999999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCC-----------------------------------CCCCCHHHHHHHHHHHHHH
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHG-----------------------------------YTPLTWKQRVTIALDVARG 696 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~-----------------------------------~~~l~~~~~~~i~~~i~~~ 696 (933)
+..++||||+++|+|.+++....... ...+++..++.++.|+++|
T Consensus 101 ~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 180 (345)
T 3hko_A 101 QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180 (345)
T ss_dssp SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHH
T ss_pred CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence 99999999999999999985321110 1234678889999999999
Q ss_pred HHHhhhccCCCeEecCCCCCcEEecCCC--cEEEecccccccCCC---CCceeecccccccCcccccccCC--CCCCCcc
Q 002346 697 VEYLHSLAQQSFIHRDLKPSNILIGDDM--RAKVADFGLVKNAPD---GKYSVETRLAGTFGYLAPEYAAT--GRVTTKI 769 (933)
Q Consensus 697 l~~LH~~~~~~ivH~Dik~~Nill~~~~--~~kl~DfGla~~~~~---~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~ 769 (933)
|+|||+ .+|+||||||+||+++.++ .+||+|||+++.... ..........||+.|+|||++.+ ..++.++
T Consensus 181 l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~ 257 (345)
T 3hko_A 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257 (345)
T ss_dssp HHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred HHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence 999999 8999999999999998776 899999999985432 22222345679999999999865 6789999
Q ss_pred chHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCC
Q 002346 770 DVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQR 849 (933)
Q Consensus 770 Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~R 849 (933)
||||||+++|||++|+.||......+. ...........+.. ........+.+++.+|++.+|++|
T Consensus 258 DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R 322 (345)
T 3hko_A 258 DAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKLCFENP---------NYNVLSPLARDLLSNLLNRNVDER 322 (345)
T ss_dssp HHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCTTSG---------GGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred HHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhcccccCCc---------ccccCCHHHHHHHHHHcCCChhHC
Confidence 999999999999999999976543221 11222211111111 001112457799999999999999
Q ss_pred CCHHHHHH
Q 002346 850 PDMGHAVN 857 (933)
Q Consensus 850 Ps~~evl~ 857 (933)
|++.++++
T Consensus 323 ps~~~~l~ 330 (345)
T 3hko_A 323 FDAMRALQ 330 (345)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHhc
Confidence 99999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-39 Score=352.50 Aligned_cols=266 Identities=27% Similarity=0.447 Sum_probs=213.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe--------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL--------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 650 (933)
.++|++.+.||+|+||.||+|.. .++..||||++.... .....+++.+|+.+++++ +||||+++++++..
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 112 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 112 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence 47899999999999999999965 356789999997653 345567899999999999 89999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
.+..++||||+++|+|.+++...... ....+++.+++.++.|+++||+|||+ ++|+||||||+||+
T Consensus 113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL 189 (334)
T ss_dssp SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEE
T ss_pred CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEE
Confidence 99999999999999999999763221 12348999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~ 797 (933)
++.++.+||+|||+++........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-- 267 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-- 267 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH--
Confidence 999999999999999876554322 2234467889999999988889999999999999999999 999997653222
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
....+.. ... ....... ...+.+++.+||+.+|++||++.|+++.|+.+.....
T Consensus 268 -~~~~~~~----~~~--~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~ 321 (334)
T 2pvf_A 268 -LFKLLKE----GHR--MDKPANC---------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT 321 (334)
T ss_dssp -HHHHHHH----TCC--CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred -HHHHHhc----CCC--CCCCccC---------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence 1111111 110 0111111 1357799999999999999999999999999876544
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=359.10 Aligned_cols=266 Identities=22% Similarity=0.290 Sum_probs=207.8
Q ss_pred cHHHHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-----CCcceeEE
Q 002346 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-----HRHLVALL 645 (933)
Q Consensus 572 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~ 645 (933)
++.....+.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+..|+.+++.++ ||||++++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~ 102 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYH 102 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeeccc
Confidence 3334445578999999999999999999965 57899999998743 344567888999999996 99999999
Q ss_pred eEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---
Q 002346 646 GYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD--- 722 (933)
Q Consensus 646 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~--- 722 (933)
+++...+..++||||+ +++|.+++.... ...+++.+++.++.|++.||+|||+ ++|+||||||+|||++.
T Consensus 103 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 103 GKFMYYDHMCLIFEPL-GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp EEEEETTEEEEEECCC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTC
T ss_pred ceeeECCeeEEEEcCC-CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccc
Confidence 9999999999999999 999999997622 2458999999999999999999999 89999999999999975
Q ss_pred ----------------------CCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHH
Q 002346 723 ----------------------DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLME 780 (933)
Q Consensus 723 ----------------------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~e 780 (933)
++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++||
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 251 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH----GSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC----CSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCCCC----cCccCcccccCcHHHcCCCCCCccchHHHHHHHHH
Confidence 7899999999998654422 34579999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc-------------cc--------CCCCCCChhh------------
Q 002346 781 TITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK-------------AI--------DPNLNLDEET------------ 827 (933)
Q Consensus 781 lltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~--------d~~l~~~~~~------------ 827 (933)
|++|+.||......+.... +.... ...+. .+ .+........
T Consensus 252 ll~g~~pf~~~~~~~~~~~---~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 325 (360)
T 3llt_A 252 LYTGSLLFRTHEHMEHLAM---MESII---QPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK 325 (360)
T ss_dssp HHHSSCSCCCSSHHHHHHH---HHHHT---CCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred HHHCCCCCCCCcHHHHHHH---HHHhc---CCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence 9999999986543222111 11111 00000 00 0000000000
Q ss_pred HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 828 IESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 828 ~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......+.+++.+||+.||++|||++|+++
T Consensus 326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~ 355 (360)
T 3llt_A 326 IIKHELFCDFLYSILQIDPTLRPSPAELLK 355 (360)
T ss_dssp HCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 001145779999999999999999999975
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-39 Score=357.47 Aligned_cols=271 Identities=24% Similarity=0.393 Sum_probs=202.4
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHH--HHhcCCCcceeEEeEeee-----Cc
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAV--LTKVRHRHLVALLGYCIN-----GS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~-----~~ 652 (933)
.++|++.+.||+|+||.||+|.. +++.||||++.... ...+..|.++ +..++||||+++++++.. ..
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 85 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM 85 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence 36899999999999999999977 78999999986542 2344445444 445899999999986542 33
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC---------CeEecCCCCCcEEecCC
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ---------SFIHRDLKPSNILIGDD 723 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~---------~ivH~Dik~~Nill~~~ 723 (933)
..++||||+++|+|.+++.. ...++..++.++.|+++||+|||+ . +|+||||||+|||++.+
T Consensus 86 ~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~ 156 (336)
T 3g2f_A 86 EYLLVMEYYPNGSLXKYLSL------HTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKND 156 (336)
T ss_dssp EEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTT
T ss_pred eEEEEEecCCCCcHHHHHhh------cccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCC
Confidence 66899999999999999965 345899999999999999999998 6 99999999999999999
Q ss_pred CcEEEecccccccCCCCC-------ceeecccccccCcccccccCC-------CCCCCccchHhHHHHHHHHHcCCCCCC
Q 002346 724 MRAKVADFGLVKNAPDGK-------YSVETRLAGTFGYLAPEYAAT-------GRVTTKIDVYAFGVVLMETITGRKALD 789 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~~l~elltG~~p~~ 789 (933)
+.+||+|||+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 157 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~ 236 (336)
T 3g2f_A 157 GTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236 (336)
T ss_dssp SCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGS
T ss_pred CcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCC
Confidence 999999999998654322 111234579999999999976 456779999999999999999987775
Q ss_pred CCCCchhh--H---------HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 790 DTMPDDRA--H---------LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 790 ~~~~~~~~--~---------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
........ . .......... .......+..... ........+.+++.+||+.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~ 312 (336)
T 3g2f_A 237 PGESVPEYQMAFQTEVGNHPTFEDMQVLVS-REKQRPKFPEAWK---ENSLAVRSLKETIEDCWDQDAEARLTAQXAEER 312 (336)
T ss_dssp TTSCCCCCCCTTHHHHCSSCCHHHHHHHHT-TSCCCCCCCTTCC---CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CccchhHHHHhhhcccCCCchHHHHHhhhc-ccccCCCCCcccc---cccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence 43221100 0 0001111111 1111111222111 112344568899999999999999999999999
Q ss_pred HhhhhhhcCCC
Q 002346 859 LGPLVEQWKPA 869 (933)
Q Consensus 859 L~~~~~~~~~~ 869 (933)
|+++++.|...
T Consensus 313 L~~ll~~~~~~ 323 (336)
T 3g2f_A 313 MAELMMIWERN 323 (336)
T ss_dssp HHHHHHCCCC-
T ss_pred HHHHHHHHHhc
Confidence 99999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=347.75 Aligned_cols=253 Identities=22% Similarity=0.389 Sum_probs=204.4
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CC-------cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DG-------TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING 651 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~ 651 (933)
.++|.+.+.||+|+||.||+|... ++ ..||+|++... .....+.+.+|+.++++++||||+++++++..+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 84 (289)
T 4fvq_A 7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG 84 (289)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG--GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT
T ss_pred hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC
Confidence 468999999999999999999543 23 57999998765 344567899999999999999999999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc------
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR------ 725 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~------ 725 (933)
+..++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.
T Consensus 85 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 85 DENILVQEFVKFGSLDTYLKKN----KNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp TCCEEEEECCTTCBHHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred CCCEEEEECCCCCCHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCccccccc
Confidence 9999999999999999999762 2348999999999999999999999 89999999999999998887
Q ss_pred --EEEecccccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHH
Q 002346 726 --AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW 802 (933)
Q Consensus 726 --~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~ 802 (933)
+||+|||++...... ....|++.|+|||++.+ ..++.++||||||+++|||++|..|+........ ...
T Consensus 158 ~~~kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~--~~~- 229 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR--KLQ- 229 (289)
T ss_dssp CEEEECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH--HHH-
T ss_pred ceeeeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH--HHH-
Confidence 999999998755432 23468999999999987 6789999999999999999996655544332211 111
Q ss_pred HHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 803 FRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 803 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
........+...++ .+.+++.+||+.||++||++.++++.|+++..+
T Consensus 230 ---~~~~~~~~~~~~~~-------------~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p 276 (289)
T 4fvq_A 230 ---FYEDRHQLPAPKAA-------------ELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP 276 (289)
T ss_dssp ---HHHTTCCCCCCSSC-------------TTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred ---HhhccCCCCCCCCH-------------HHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 11112222222222 356899999999999999999999999887644
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=379.38 Aligned_cols=261 Identities=30% Similarity=0.489 Sum_probs=212.3
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|.+.++..||||+++.... ..++|.+|+++|++++|||||++++++.+ ...++|||
T Consensus 266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 266 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC---CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 467889999999999999999988888999999986532 34689999999999999999999999876 67899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++.... ...+++.+++.|+.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++....
T Consensus 342 ~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 999999999996522 2458999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
..........++..|+|||++..+.++.++|||||||++|||++ |+.||......+ ... .... .... ...
T Consensus 416 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~---~i~~-~~~~--~~~ 486 (535)
T 2h8h_A 416 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD---QVER-GYRM--PCP 486 (535)
T ss_dssp HHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHH---HHHT-TCCC--CCC
T ss_pred CceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH---HHHc-CCCC--CCC
Confidence 33222233457789999999998899999999999999999999 899997653322 111 1111 1111 111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
... ...+.+++.+||+.||++||+++++++.|+.+.....+
T Consensus 487 ~~~---------~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~ 527 (535)
T 2h8h_A 487 PEC---------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 527 (535)
T ss_dssp TTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred CCC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence 111 23577999999999999999999999999887654444
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-39 Score=349.49 Aligned_cols=268 Identities=29% Similarity=0.426 Sum_probs=204.1
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc--
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-- 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 652 (933)
..++|.+.+.||+|+||.||+|... .++.||||++..........+.+.+|+.++++++||||+++++++.+..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 111 (313)
T 3brb_A 32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ 111 (313)
T ss_dssp CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence 3578999999999999999999653 3458999999877656666788999999999999999999999998755
Q ss_pred ---eeEEEEeecCCCChhhHhhhccc-CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 653 ---ERLLVYEYMPRGTLAQHLFEWHD-HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 653 ---~~~lv~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
..++||||+++++|.+++..... .....+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||
T Consensus 112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl 188 (313)
T 3brb_A 112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCV 188 (313)
T ss_dssp ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEE
T ss_pred CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEE
Confidence 34899999999999999854322 233569999999999999999999998 89999999999999999999999
Q ss_pred ecccccccCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHH
Q 002346 729 ADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 729 ~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+|||+++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |+.||......... . ..
T Consensus 189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---~---~~ 262 (313)
T 3brb_A 189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY---D---YL 262 (313)
T ss_dssp CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---H---HH
T ss_pred eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH---H---HH
Confidence 999999865543321 2233467889999999998899999999999999999999 88898765433221 1 11
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
.. . .. ....... ...+.+++.+|++.+|++||++.++++.|+.+.+...
T Consensus 263 ~~-~-~~-~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp 311 (313)
T 3brb_A 263 LH-G-HR-LKQPEDC---------LDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311 (313)
T ss_dssp HT-T-CC-CCCBTTC---------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred Hc-C-CC-CCCCccc---------cHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence 11 1 11 1111111 1357899999999999999999999999998876543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=352.48 Aligned_cols=273 Identities=24% Similarity=0.368 Sum_probs=215.8
Q ss_pred cHHHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHh--cCCCcceeEEeEee
Q 002346 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK--VRHRHLVALLGYCI 649 (933)
Q Consensus 572 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~ 649 (933)
+......+.++|++.+.||+|+||.||+|.. +|+.||||++... ..+.+.+|++++.. ++||||+++++++.
T Consensus 33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~ 106 (342)
T 1b6c_B 33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADN 106 (342)
T ss_dssp CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence 3445567788999999999999999999987 6899999998643 34678889999888 68999999999998
Q ss_pred eCc----eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhh--------hccCCCeEecCCCCCc
Q 002346 650 NGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH--------SLAQQSFIHRDLKPSN 717 (933)
Q Consensus 650 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--------~~~~~~ivH~Dik~~N 717 (933)
... ..++||||+++|+|.+++.. ..+++.+++.++.|+++||+||| + ++|+||||||+|
T Consensus 107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~N 177 (342)
T 1b6c_B 107 KDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKN 177 (342)
T ss_dssp CCCSSCCCEEEEECCCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGG
T ss_pred ccCCccceeEEEEeecCCCcHHHHHhc------cCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHH
Confidence 775 78999999999999999965 35899999999999999999999 6 899999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCce---eecccccccCcccccccCCC------CCCCccchHhHHHHHHHHHcC----
Q 002346 718 ILIGDDMRAKVADFGLVKNAPDGKYS---VETRLAGTFGYLAPEYAATG------RVTTKIDVYAFGVVLMETITG---- 784 (933)
Q Consensus 718 ill~~~~~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~~l~elltG---- 784 (933)
|+++.++.+||+|||+++........ ......||+.|+|||++.+. .++.++||||||+++|||+||
T Consensus 178 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~ 257 (342)
T 1b6c_B 178 ILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG 257 (342)
T ss_dssp EEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBT
T ss_pred EEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcC
Confidence 99999999999999999765443322 12345799999999998765 334789999999999999999
Q ss_pred ------CCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 002346 785 ------RKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858 (933)
Q Consensus 785 ------~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~ 858 (933)
+.||....+... ....+..... .. ...+.+.......+....+.+++.+||+.||++||++.++++.
T Consensus 258 ~~~~~~~~p~~~~~~~~~-~~~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 258 GIHEDYQLPYYDLVPSDP-SVEEMRKVVC--EQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TBCCCCCCTTTTTSCSSC-CHHHHHHHHT--TS----CCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CcccccccCccccCcCcc-cHHHHHHHHH--HH----HhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 778876433221 1111122111 11 1122222111233556678899999999999999999999999
Q ss_pred Hhhhhhhc
Q 002346 859 LGPLVEQW 866 (933)
Q Consensus 859 L~~~~~~~ 866 (933)
|+.+.++.
T Consensus 331 L~~i~~~~ 338 (342)
T 1b6c_B 331 LSQLSQQE 338 (342)
T ss_dssp HHHHHHTT
T ss_pred HHHHHHHh
Confidence 99887654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-39 Score=351.67 Aligned_cols=264 Identities=22% Similarity=0.328 Sum_probs=210.4
Q ss_pred HHHHhcCCccC-CccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc
Q 002346 576 LRQVTDNFSEA-NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (933)
Q Consensus 576 l~~~~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 652 (933)
.+.+.++|.+. +.||+|+||.||+|.. .+++.||+|++...........++.+|+.++..+ +||||+++++++....
T Consensus 23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~ 102 (327)
T 3lm5_A 23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS 102 (327)
T ss_dssp HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence 45667788887 8999999999999965 4699999999987765566678899999999999 5799999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---CCcEEEe
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVA 729 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~ 729 (933)
..++||||+++|+|.+++.. .....+++.+++.++.|++.||+|||+ ++|+||||||+||+++. ++.+||+
T Consensus 103 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~ 176 (327)
T 3lm5_A 103 EIILILEYAAGGEIFSLCLP---ELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176 (327)
T ss_dssp EEEEEEECCTTEEGGGGGSS---CC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred eEEEEEEecCCCcHHHHHHH---hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEe
Confidence 99999999999999999854 223569999999999999999999999 89999999999999998 7899999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .. .....
T Consensus 177 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~---~i~~~ 248 (327)
T 3lm5_A 177 DFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET---YL---NISQV 248 (327)
T ss_dssp CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH---HHHHT
T ss_pred eCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---HH---HHHhc
Confidence 999998765432 12345799999999999999999999999999999999999999976533221 11 11111
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....+....+.. ...+.+++.+||+.||++||+++++++ ++|..
T Consensus 249 ~~~~~~~~~~~~---------~~~~~~li~~~L~~dP~~Rpt~~~ll~------h~~~~ 292 (327)
T 3lm5_A 249 NVDYSEETFSSV---------SQLATDFIQSLLVKNPEKRPTAEICLS------HSWLQ 292 (327)
T ss_dssp CCCCCTTTTTTS---------CHHHHHHHHHHSCSSGGGSCCHHHHTT------CGGGC
T ss_pred ccccCchhhccc---------CHHHHHHHHHHcCCChhhCcCHHHHhC------CHhhc
Confidence 111111111111 235779999999999999999999976 56654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=367.29 Aligned_cols=195 Identities=28% Similarity=0.392 Sum_probs=157.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----ce
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 653 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++..........+++.+|+.++++++|||||++++++... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~ 131 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE 131 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence 47899999999999999999954 5789999999977655556678899999999999999999999998543 56
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.|+||||+ +++|.+++.. ...+++..++.++.||++||+|||+ .+||||||||+|||++.++.+||+|||+
T Consensus 132 ~~lv~e~~-~~~L~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGl 202 (458)
T 3rp9_A 132 LYVVLEIA-DSDFKKLFRT-----PVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGL 202 (458)
T ss_dssp EEEEECCC-SEEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecc-ccchhhhccc-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeeccccc
Confidence 89999998 5799998854 2569999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc--------------------------eeecccccccCccccccc-CCCCCCCccchHhHHHHHHHHHc
Q 002346 734 VKNAPDGKY--------------------------SVETRLAGTFGYLAPEYA-ATGRVTTKIDVYAFGVVLMETIT 783 (933)
Q Consensus 734 a~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~~l~ellt 783 (933)
++....... ...+..+||+.|+|||++ ....++.++|||||||++|||++
T Consensus 203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 986542211 122446789999999976 55679999999999999999999
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=343.39 Aligned_cols=254 Identities=24% Similarity=0.357 Sum_probs=200.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|.+.+.||+|+||.||++.. .+++.||+|++.... .....+.+.+|++++++++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG-CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc-cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 46899999999999999999965 568999999987664 3344678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe---cCCCcEEEecccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVK 735 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla~ 735 (933)
||+++|+|.+++...... ...+++..++.++.|+++||+|||+ ++|+||||||+||++ +.++.+||+|||++.
T Consensus 100 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~ 175 (285)
T 3is5_A 100 ETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175 (285)
T ss_dssp CCCSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCC
T ss_pred EeCCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecce
Confidence 999999999998653222 2569999999999999999999999 899999999999999 456789999999997
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
...... ......||+.|+|||++. +.++.++||||||+++|||++|+.||........ . ............
T Consensus 176 ~~~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~---~---~~~~~~~~~~~~ 246 (285)
T 3is5_A 176 LFKSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV---Q---QKATYKEPNYAV 246 (285)
T ss_dssp C------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---H---HHHHHCCCCCCC
T ss_pred ecCCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH---H---hhhccCCccccc
Confidence 654432 223457999999999886 5789999999999999999999999976533221 1 111111111111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. .. ....+.+++.+|++.||++||++.|+++
T Consensus 247 ~~-~~---------~~~~~~~li~~~L~~dP~~Rps~~e~l~ 278 (285)
T 3is5_A 247 EC-RP---------LTPQAVDLLKQMLTKDPERRPSAAQVLH 278 (285)
T ss_dssp ---CC---------CCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred cc-Cc---------CCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00 00 1135779999999999999999999986
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-39 Score=350.90 Aligned_cols=274 Identities=23% Similarity=0.320 Sum_probs=203.3
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC---chhHHHHHHHHHHHHhcC---CCcceeEEeEeee
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG---NKGLSEFQAEIAVLTKVR---HRHLVALLGYCIN 650 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 650 (933)
.+.++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 3467999999999999999999965 57899999998754321 122346677877777764 9999999999987
Q ss_pred Cc-----eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 651 GS-----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 651 ~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
.. ..++||||+. ++|.+++... ....+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~ 158 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKA---PPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGT 158 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTC---CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCC
Confidence 54 5789999996 6999999652 22449999999999999999999999 89999999999999999999
Q ss_pred EEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 805 (933)
+||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +......
T Consensus 159 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~ 234 (308)
T 3g33_A 159 VKLADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQ--LGKIFDL 234 (308)
T ss_dssp EEECSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHH--HHHHHHH
T ss_pred EEEeeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHH
Confidence 9999999998654332 23456899999999999989999999999999999999999999976543222 1111111
Q ss_pred Hhh-ccCCCCccc-------CCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 806 VLI-SKENIPKAI-------DPNLNLD--EETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 806 ~~~-~~~~~~~~~-------d~~l~~~--~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
... ....++... .+..... ....+....+.+++.+||+.||++|||+.|+++ ++|..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------h~~~~ 301 (308)
T 3g33_A 235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ------HSYLH 301 (308)
T ss_dssp HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT------STTC-
T ss_pred hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc------Ccccc
Confidence 100 011111100 0000000 000112246789999999999999999999986 66664
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-39 Score=357.27 Aligned_cols=252 Identities=23% Similarity=0.308 Sum_probs=194.2
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||++... +++.||||++..... ..+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 95 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM 95 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT---SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc---ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence 468999999999999999999654 789999999976532 2357889999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc--EEEeccccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR--AKVADFGLVKN 736 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--~kl~DfGla~~ 736 (933)
||+++|+|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++. +||+|||+++.
T Consensus 96 e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~ 167 (361)
T 3uc3_A 96 EYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKS 167 (361)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred EeCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence 99999999999965 2458999999999999999999999 89999999999999987765 99999999874
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCc-cchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTK-IDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
..... ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||........ ...............+.
T Consensus 168 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~--~~~~~~~~~~~~~~~~~ 243 (361)
T 3uc3_A 168 SVLHS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRD--YRKTIQRILSVKYSIPD 243 (361)
T ss_dssp ---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCC--HHHHHHHHHTTCCCCCT
T ss_pred ccccC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhcCCCCCCC
Confidence 33222 2234579999999999988777655 8999999999999999999986543221 12222222222222211
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ..+ ...+.+++.+||+.||++||++.|+++
T Consensus 244 ~--~~~---------s~~~~~li~~~L~~dP~~Rps~~ell~ 274 (361)
T 3uc3_A 244 D--IRI---------SPECCHLISRIFVADPATRISIPEIKT 274 (361)
T ss_dssp T--SCC---------CHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred c--CCC---------CHHHHHHHHHHccCChhHCcCHHHHHh
Confidence 1 011 135779999999999999999999986
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=355.97 Aligned_cols=246 Identities=24% Similarity=0.344 Sum_probs=196.7
Q ss_pred CCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 586 ANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
.+.||+|+||.||+|.. .+|+.||+|++.... ....+++.+|++++++++||||+++++++.+.+..++||||++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 57899999999999964 579999999997652 345678999999999999999999999999999999999999999
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe--cCCCcEEEecccccccCCCCCc
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI--GDDMRAKVADFGLVKNAPDGKY 742 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill--~~~~~~kl~DfGla~~~~~~~~ 742 (933)
+|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 172 ~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 172 ELFDRIIDE----SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EEHHHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred cHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 999998652 2458999999999999999999999 899999999999999 6778999999999987654332
Q ss_pred eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCC
Q 002346 743 SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLN 822 (933)
Q Consensus 743 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~ 822 (933)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ...+.......+....+.
T Consensus 245 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~~~~~~~~~~~-- 314 (373)
T 2x4f_A 245 --LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET------LNNILACRWDLEDEEFQD-- 314 (373)
T ss_dssp --CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCCSCSGGGTT--
T ss_pred --cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhccCCCChhhhcc--
Confidence 2335799999999999988999999999999999999999999976532211 112222111111111111
Q ss_pred CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 823 LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 823 ~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...++.+++.+||+.||++||++.|+++
T Consensus 315 -------~~~~~~~li~~~L~~dp~~Rps~~e~l~ 342 (373)
T 2x4f_A 315 -------ISEEAKEFISKLLIKEKSWRISASEALK 342 (373)
T ss_dssp -------SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred -------CCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 1246789999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=344.37 Aligned_cols=260 Identities=23% Similarity=0.344 Sum_probs=207.3
Q ss_pred hcCCccCC-ccccCCCeEEEEEEe---CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEAN-ILGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|.+.+ .||+|+||.||+|.. .+++.||||++..........+++.+|+.+++.++||||+++++++ ..+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 46788887 999999999999943 3468899999987654555578899999999999999999999999 567789
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 94 lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp EEEECCTTEEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred EEEEeCCCCCHHHHHHh-----CcCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 99999999999999966 2458999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCcee--ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 736 NAPDGKYSV--ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 736 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
......... .....|++.|+|||.+.+..++.++||||||+++|||++ |+.||....... ....+ . ...
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~---~--~~~ 237 (291)
T 1xbb_A 166 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAML---E--KGE 237 (291)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH---H--TTC
T ss_pred eeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH---H--cCC
Confidence 765443322 223456789999999988889999999999999999999 999998654322 11111 1 111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
.+ ...... ...+.+++.+||+.||++||++.++++.|+.+....
T Consensus 238 ~~-~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 281 (291)
T 1xbb_A 238 RM-GCPAGC---------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 281 (291)
T ss_dssp CC-CCCTTC---------CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred CC-CCCCCC---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence 11 111111 245789999999999999999999999999886543
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=342.25 Aligned_cols=261 Identities=23% Similarity=0.363 Sum_probs=211.5
Q ss_pred cCCccCC-ccccCCCeEEEEEEeC---CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEAN-ILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
++|.+.+ .||+|+||.||+|... ++..||||+++... .....+++.+|++++++++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 5666766 9999999999999643 57889999998653 345567899999999999999999999999 5567899
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++++|.+++.. ....+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||+++.
T Consensus 87 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 159 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVG----KREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 159 (287)
T ss_dssp EEECCTTEEHHHHHTT----CTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCCHHHHHHh----CCccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceee
Confidence 9999999999999954 12568999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCcee--ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 737 APDGKYSV--ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 737 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
........ .....||+.|+|||++.+..++.++||||||+++|||++ |+.||......+. ...+ .. ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~i---~~--~~~ 231 (287)
T 1u59_A 160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFI---EQ--GKR 231 (287)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHHH---HT--TCC
T ss_pred eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHH---hc--CCc
Confidence 65433222 223457899999999988889999999999999999999 9999976543221 1111 11 111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
..+++.. ...+.+++.+|++.+|++||++.++++.|+.+......
T Consensus 232 -~~~~~~~---------~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~ 276 (287)
T 1u59_A 232 -MECPPEC---------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 276 (287)
T ss_dssp -CCCCTTC---------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred -CCCCCCc---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence 1111111 24677999999999999999999999999998776554
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.81 Aligned_cols=264 Identities=22% Similarity=0.331 Sum_probs=201.8
Q ss_pred hcCCccC-CccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 580 TDNFSEA-NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 580 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
.+.|++. +.||+|+||.||+|.. .+++.||||++.... ....+.+.+|++++.++ +||||+++++++.+++..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4678875 7899999999999964 579999999997652 34467899999999985 79999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc---EEEecccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AKVADFGL 733 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~DfGl 733 (933)
||||+++++|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++. +||+|||+
T Consensus 89 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~ 160 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDL 160 (316)
T ss_dssp EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTC
T ss_pred EEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccC
Confidence 99999999999999762 468999999999999999999999 89999999999999998776 99999999
Q ss_pred cccCCCCCc------eeecccccccCcccccccCC-----CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh------
Q 002346 734 VKNAPDGKY------SVETRLAGTFGYLAPEYAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR------ 796 (933)
Q Consensus 734 a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~------ 796 (933)
+........ .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 240 (316)
T 2ac3_A 161 GSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGE 240 (316)
T ss_dssp CC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----
T ss_pred ccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccc
Confidence 875432211 11123469999999999865 5688999999999999999999999986543210
Q ss_pred ---hHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 797 ---AHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 797 ---~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.................+..... .....+.+++.+||+.||++||+++|+++ ++|..
T Consensus 241 ~~~~~~~~~~~~i~~~~~~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~ 300 (316)
T 2ac3_A 241 ACPACQNMLFESIQEGKYEFPDKDWA---------HISCAAKDLISKLLVRDAKQRLSAAQVLQ------HPWVQ 300 (316)
T ss_dssp CCHHHHHHHHHHHHHCCCCCCHHHHT---------TSCHHHHHHHHHHSCSSTTTSCCHHHHHH------STTCC
T ss_pred cchhHHHHHHHHHhccCcccCchhcc---------cCCHHHHHHHHHHhhCChhhCCCHHHHhc------Chhhc
Confidence 00011111222111111110000 11245789999999999999999999987 66664
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-39 Score=344.81 Aligned_cols=258 Identities=24% Similarity=0.381 Sum_probs=205.5
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|.+.+.||+|+||.||+|...+ +..||+|++.... .....+++.+|+.++++++||||+++++++.+ +..+
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 88 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW 88 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence 4689999999999999999996532 3469999987653 34456789999999999999999999999865 4568
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++.
T Consensus 89 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 161 (281)
T 3cc6_A 89 IIMELYPYGELGHYLERN----KNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSR 161 (281)
T ss_dssp EEEECCTTCBHHHHHHHH----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGG
T ss_pred EEEecCCCCCHHHHHHhc----cccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCc
Confidence 999999999999999652 2458999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
..............+++.|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..+.. ....+
T Consensus 162 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~---~~~~~----~~~~~ 234 (281)
T 3cc6_A 162 YIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI---GVLEK----GDRLP 234 (281)
T ss_dssp CC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH---HHHHH----TCCCC
T ss_pred ccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH---HHHhc----CCCCC
Confidence 765544333344567889999999988899999999999999999998 99999765433221 11111 11111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
..... ...+.+++.+|++.+|++||++.|+++.|+.+.+
T Consensus 235 --~~~~~---------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~ 273 (281)
T 3cc6_A 235 --KPDLC---------PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQ 273 (281)
T ss_dssp --CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --CCCCC---------CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHH
Confidence 01111 1357799999999999999999999999988754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-38 Score=357.71 Aligned_cols=252 Identities=21% Similarity=0.330 Sum_probs=200.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC--CCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR--HRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|...+++.||||++..........+.+.+|+.++.+++ ||||+++++++..++..++|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 3569999999999999999998878999999999876555666788999999999996 59999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|| +.+++|.+++.. ...+++.+++.++.||++||+|||+ ++|+||||||+|||++ ++.+||+|||+++..
T Consensus 135 ~E-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM 204 (390)
T ss_dssp EE-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred Ee-cCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence 99 568899999976 2468899999999999999999998 8999999999999995 588999999999866
Q ss_pred CCCCce-eecccccccCcccccccCC-----------CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH
Q 002346 738 PDGKYS-VETRLAGTFGYLAPEYAAT-----------GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805 (933)
Q Consensus 738 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~ 805 (933)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....... ..+..
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~-----~~~~~ 279 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHA 279 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH-----HHHHH
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH-----HHHHH
Confidence 543322 2345679999999999864 468899999999999999999999997643221 11122
Q ss_pred HhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 806 ~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....... ..++... ...+.+++.+||+.||++||++.|+++
T Consensus 280 ~~~~~~~--~~~~~~~---------~~~~~~li~~~L~~dP~~Rps~~ell~ 320 (390)
T 2zmd_A 280 IIDPNHE--IEFPDIP---------EKDLQDVLKCCLKRDPKQRISIPELLA 320 (390)
T ss_dssp HHCTTSC--CCCCCCS---------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HhCcccc--CCCCccc---------hHHHHHHHHHHcccChhhCCCHHHHhh
Confidence 2211111 1111111 135779999999999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-39 Score=352.26 Aligned_cols=252 Identities=23% Similarity=0.357 Sum_probs=201.7
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
+.++|++.+.||+|+||.||++.. .+|+.||||++..... .+.+|++++.++ +||||+++++++.++...++
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 467899999999999999999965 4689999999976532 245788888888 79999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC----CcEEEeccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD----MRAKVADFG 732 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~----~~~kl~DfG 732 (933)
||||+++|+|.+++.. ...+++.++..++.||+.||+|||+ ++|+||||||+||++.++ +.+||+|||
T Consensus 94 v~E~~~gg~L~~~i~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg 165 (342)
T 2qr7_A 94 VTELMKGGELLDKILR-----QKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG 165 (342)
T ss_dssp EECCCCSCBHHHHHHT-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCT
T ss_pred EEeCCCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECC
Confidence 9999999999999965 2468999999999999999999999 899999999999998543 359999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.. ........
T Consensus 166 ~a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~---~i~~~~~~ 241 (342)
T 2qr7_A 166 FAKQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILA---RIGSGKFS 241 (342)
T ss_dssp TCEECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHH---HHHHCCCC
T ss_pred CcccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHH---HHccCCcc
Confidence 9986554322 2234579999999999988889999999999999999999999998643333222222 22222222
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+....+.+ ...+.+++.+||+.||++||++.++++
T Consensus 242 ~~~~~~~~~---------s~~~~~li~~~L~~dP~~R~t~~~il~ 277 (342)
T 2qr7_A 242 LSGGYWNSV---------SDTAKDLVSKMLHVDPHQRLTAALVLR 277 (342)
T ss_dssp CCSTTTTTS---------CHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred cCccccccC---------CHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 211111111 235779999999999999999999876
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=352.22 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=207.0
Q ss_pred HHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCc------hhHHHHHHHHHHHHhcCCCcceeEEeEeee
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN------KGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 650 (933)
...++|++.+.||+|+||.||+|. ..+++.||||++....... ...+.+.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence 456789999999999999999995 4678999999998754221 134467889999999999999999999999
Q ss_pred CceeEEEEeecCCC-ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEe
Q 002346 651 GSERLLVYEYMPRG-TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (933)
Q Consensus 651 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 729 (933)
.+..++||||+.+| +|.+++.. ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+
T Consensus 101 ~~~~~lv~e~~~~g~~l~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~ 172 (335)
T 3dls_A 101 QGFFQLVMEKHGSGLDLFAFIDR-----HPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLI 172 (335)
T ss_dssp SSEEEEEEECCTTSCBHHHHHHT-----CCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEEC
T ss_pred CCEEEEEEEeCCCCccHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEe
Confidence 99999999999777 99999965 2469999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
|||+++....... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||...... ..
T Consensus 173 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------------~~ 238 (335)
T 3dls_A 173 DFGSAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET------------VE 238 (335)
T ss_dssp CCTTCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG------------TT
T ss_pred ecccceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH------------Hh
Confidence 9999987655432 234579999999999988776 78999999999999999999999652110 00
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
.....+.. . ...+.+++.+||+.||++||+++++++ ++|...
T Consensus 239 ~~~~~~~~----~---------~~~l~~li~~~L~~dP~~Rps~~ell~------hp~~~~ 280 (335)
T 3dls_A 239 AAIHPPYL----V---------SKELMSLVSGLLQPVPERRTTLEKLVT------DPWVTQ 280 (335)
T ss_dssp TCCCCSSC----C---------CHHHHHHHHHHTCSSGGGSCCHHHHHH------CTTTTC
T ss_pred hccCCCcc----c---------CHHHHHHHHHHccCChhhCcCHHHHhc------CccccC
Confidence 01111111 1 135779999999999999999999987 666643
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=340.30 Aligned_cols=251 Identities=22% Similarity=0.312 Sum_probs=205.0
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+.++|++.+.||+|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++.++...++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF--VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhc--cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEE
Confidence 457899999999999999999965 457899999987653 33467899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe---cCCCcEEEeccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLV 734 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla 734 (933)
|||+++++|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~ 156 (277)
T 3f3z_A 85 MELCTGGELFERVVH-----KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156 (277)
T ss_dssp EECCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EeccCCCcHHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccc
Confidence 999999999999865 2458999999999999999999999 899999999999999 78899999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
........ .....||+.|+|||++.+ .++.++||||||+++|||++|+.||........ ...........+
T Consensus 157 ~~~~~~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~ 227 (277)
T 3f3z_A 157 ARFKPGKM--MRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV------MLKIREGTFTFP 227 (277)
T ss_dssp EECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCCC
T ss_pred eeccCccc--hhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhCCCCCC
Confidence 86654332 234579999999999865 489999999999999999999999976532211 111122111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..... .....+.+++.+|++.||++||++.++++
T Consensus 228 ~~~~~---------~~~~~~~~li~~~l~~dp~~R~s~~~~l~ 261 (277)
T 3f3z_A 228 EKDWL---------NVSPQAESLIRRLLTKSPKQRITSLQALE 261 (277)
T ss_dssp HHHHT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred chhhh---------cCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11000 11246789999999999999999999976
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=354.39 Aligned_cols=259 Identities=23% Similarity=0.359 Sum_probs=197.7
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------c
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------S 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 652 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+++.+|+.+++.++||||+++++++... .
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 47899999999999999999965 5799999999976654555567899999999999999999999999765 3
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg 173 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 173 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeee
Confidence 469999999 8899999865 458999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc-
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK- 810 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 810 (933)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+.. ..+.......
T Consensus 174 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l---~~i~~~~g~~~ 246 (367)
T 1cm8_A 174 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL---KEIMKVTGTPP 246 (367)
T ss_dssp TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCC
T ss_pred cccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCC
Confidence 99875432 234578999999999876 67999999999999999999999999865432211 1111100000
Q ss_pred ----------------CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 ----------------ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 ----------------~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..++..-...+ ..........+.+++.+|++.||++|||++|+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~ 307 (367)
T 1cm8_A 247 AEFVQRLQSDEAKNYMKGLPELEKKDF--ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 307 (367)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCG--GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHhhhHHHHHHHHhCCCCCCCCH--HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence 00000000000 0000111245779999999999999999999987
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-39 Score=366.97 Aligned_cols=248 Identities=28% Similarity=0.440 Sum_probs=206.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|.+.+.||+|+||.||+|.. .+|+.||||++...... ......+.+|+.+++.++||||+++++++...+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 5799999999999999999965 47999999999765321 234568999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...
T Consensus 96 E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 96 EYVSGGELFDYICK-----NGRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp ECCSSEEHHHHTTS-----SSSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred eCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 99999999999954 2569999999999999999999998 899999999999999999999999999998765
Q ss_pred CCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
.... .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....... ....+.......+..
T Consensus 168 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~------~~~~i~~~~~~~p~~- 238 (476)
T 2y94_A 168 DGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT------LFKKICDGIFYTPQY- 238 (476)
T ss_dssp TTCC--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH------HHHHHHTTCCCCCTT-
T ss_pred cccc--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH------HHHHHhcCCcCCCcc-
Confidence 5332 234579999999999988765 689999999999999999999998654321 122222211111111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+ ...+.+++.+||+.||++||++.|+++
T Consensus 239 ---~---------s~~~~~Li~~~L~~dP~~Rpt~~eil~ 266 (476)
T 2y94_A 239 ---L---------NPSVISLLKHMLQVDPMKRATIKDIRE 266 (476)
T ss_dssp ---C---------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred ---C---------CHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence 1 135779999999999999999999987
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=352.40 Aligned_cols=248 Identities=25% Similarity=0.396 Sum_probs=202.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.+.|+..+.||+|+||.||+|.. .+++.||||++..... .....+++.+|++++++++||||+++++++..+...++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35689999999999999999964 6799999999976532 233457899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+. |+|.+++... ..++++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 133 ~e~~~-g~l~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 204 (348)
T 1u5q_A 133 MEYCL-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 204 (348)
T ss_dssp EECCS-EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred EecCC-CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence 99996 6888888542 2568999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCceeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
... ....||+.|+|||++. .+.++.++|||||||++|||++|+.||........ ....... ..+
T Consensus 205 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~------~~~~~~~--~~~ 271 (348)
T 1u5q_A 205 APA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN--ESP 271 (348)
T ss_dssp SSB-----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS--CCC
T ss_pred CCC-----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHHhc--CCC
Confidence 432 2357999999999884 56789999999999999999999999976532211 1111111 111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....... ...+.+++.+||+.+|++||+++++++
T Consensus 272 ~~~~~~~---------~~~l~~li~~~l~~dP~~Rps~~~ll~ 305 (348)
T 1u5q_A 272 ALQSGHW---------SEYFRNFVDSCLQKIPQDRPTSEVLLK 305 (348)
T ss_dssp CCCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCCC---------CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1111111 135779999999999999999999986
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=372.29 Aligned_cols=255 Identities=27% Similarity=0.432 Sum_probs=208.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+|+.||+|++.+... .......+.+|+.+++.++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 46799999999999999999965 4799999999976532 223456789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++|+|.+++... +...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 263 mEy~~gg~L~~~l~~~---~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~ 336 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM---GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHV 336 (576)
T ss_dssp ECCCCSCBHHHHHHSS---SSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEcCCCCcHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceec
Confidence 9999999999999652 22458999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ............++.
T Consensus 337 ~~~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~i~~~~~~~p~-- 410 (576)
T 2acx_A 337 PEGQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERLVKEVPEEYSE-- 410 (576)
T ss_dssp CTTCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHHHHHCCCCCCT--
T ss_pred ccCcc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHHhhcccccCCc--
Confidence 55432 234589999999999999899999999999999999999999998754322111 111222221222221
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
.+. ..+.+++.+||+.||++|| +++|+++
T Consensus 411 --~~s---------~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~ 444 (576)
T 2acx_A 411 --RFS---------PQARSLCSQLLCKDPAERLGCRGGSAREVKE 444 (576)
T ss_dssp --TSC---------HHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred --cCC---------HHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence 111 3577999999999999999 6778765
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=359.19 Aligned_cols=250 Identities=25% Similarity=0.358 Sum_probs=195.2
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHH-HHhcCCCcceeEEeEeeeCceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAV-LTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
.++|++.+.||+|+||.||+|+. .+++.||+|++.+.... ......+.+|..+ ++.++||||+++++++.+.+..|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 36799999999999999999965 46889999999876432 2334566777776 567899999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++|+|.+++.. ...+++..++.++.||+.||+|||+ ++|+||||||+|||++.++++||+|||+++.
T Consensus 117 v~E~~~gg~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~ 188 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR-----ERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188 (373)
T ss_dssp EEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred EEeCCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence 9999999999999965 2458899999999999999999999 8999999999999999999999999999985
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+ ....+......++
T Consensus 189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~------~~~~i~~~~~~~~-- 259 (373)
T 2r5t_A 189 NIEHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------MYDNILNKPLQLK-- 259 (373)
T ss_dssp GBCCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH------HHHHHHHSCCCCC--
T ss_pred cccCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH------HHHHHHhcccCCC--
Confidence 43222 12345689999999999999999999999999999999999999997643221 1222222222221
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.+. ..+.+++.+||+.||++||++.+.++
T Consensus 260 --~~~~---------~~~~~li~~lL~~dp~~R~~~~~~~~ 289 (373)
T 2r5t_A 260 --PNIT---------NSARHLLEGLLQKDRTKRLGAKDDFM 289 (373)
T ss_dssp --SSSC---------HHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred --CCCC---------HHHHHHHHHHcccCHHhCCCCCCCHH
Confidence 1221 35779999999999999999864433
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=342.62 Aligned_cols=268 Identities=20% Similarity=0.294 Sum_probs=206.8
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEe-eeCceeE
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC-INGSERL 655 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~ 655 (933)
.+.++|++.+.||+|+||.||+|.. .+++.||||++...... +++.+|+.+++.++|++++..++++ ..+...+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV 81 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceE
Confidence 4568899999999999999999964 67899999987654322 3588999999999988877776665 5677889
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe---cCCCcEEEeccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFG 732 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfG 732 (933)
+||||+ +++|.+++... ...+++.+++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||
T Consensus 82 lv~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg 153 (296)
T 4hgt_A 82 MVMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFG 153 (296)
T ss_dssp EEEECC-CCBHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred EEEEcc-CCCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCc
Confidence 999999 99999999642 2469999999999999999999999 899999999999999 788999999999
Q ss_pred ccccCCCCCc------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH
Q 002346 733 LVKNAPDGKY------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 733 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+++....... .......||+.|+|||.+.+..++.++|||||||++|||++|+.||..................
T Consensus 154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 233 (296)
T 4hgt_A 154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 233 (296)
T ss_dssp TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence 9986554332 1223467999999999999999999999999999999999999999875443222222111111
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.... . ...+...+ ...+.+++.+|++.+|++||+++++++.|+++.+....
T Consensus 234 ~~~~-~-~~~~~~~~---------~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~ 284 (296)
T 4hgt_A 234 KMST-P-IEVLCKGY---------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHHS-C-HHHHTTTS---------CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred cccc-h-hhhhhccC---------CHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence 1100 0 00000111 24678999999999999999999999999998876553
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=370.10 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=206.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|.+.+.||+|+||.||+|.. .+|+.||+|++.+.... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 263 (543)
T 3c4z_A 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV 263 (543)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence 36899999999999999999966 46999999999765322 23457889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++|+|.+++.... .....+++..++.++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 264 mE~~~gg~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~ 339 (543)
T 3c4z_A 264 MTIMNGGDIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339 (543)
T ss_dssp ECCCTTCBHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEeccCCCHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence 99999999999986632 223569999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||........ ...............+.
T Consensus 340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~i~~~~~~~p~-- 414 (543)
T 3c4z_A 340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQRVLEQAVTYPD-- 414 (543)
T ss_dssp CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHHHHHCCCCCCT--
T ss_pred cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHHHhhcccCCCc--
Confidence 54432 22345899999999999999999999999999999999999999986533211 11222233322222221
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
.+ ...+.+++.+||+.||++||++
T Consensus 415 --~~---------s~~~~~li~~lL~~dP~~R~~~ 438 (543)
T 3c4z_A 415 --KF---------SPASKDFCEALLQKDPEKRLGF 438 (543)
T ss_dssp --TS---------CHHHHHHHHHHSCSSGGGSCCC
T ss_pred --cc---------CHHHHHHHHHhccCCHhHCCCC
Confidence 11 1357799999999999999976
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-39 Score=352.13 Aligned_cols=276 Identities=25% Similarity=0.378 Sum_probs=218.5
Q ss_pred ecHHHHHHHhcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCccee
Q 002346 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVA 643 (933)
Q Consensus 571 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~ 643 (933)
+.........++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.++.++ +||||++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~ 95 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVN 95 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeee
Confidence 34445555678999999999999999999963 356899999997653 344567899999999999 7999999
Q ss_pred EEeEeeeCc-eeEEEEeecCCCChhhHhhhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEec
Q 002346 644 LLGYCINGS-ERLLVYEYMPRGTLAQHLFEWHDHG-----------YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHR 711 (933)
Q Consensus 644 l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~ 711 (933)
+++++...+ ..++||||+++++|.+++....... ...+++.+++.++.|+++||+|||+ ++|+||
T Consensus 96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~ 172 (316)
T 2xir_A 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHR 172 (316)
T ss_dssp EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCS
T ss_pred EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccc
Confidence 999987754 5899999999999999997632210 1238999999999999999999999 899999
Q ss_pred CCCCCcEEecCCCcEEEecccccccCCCCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCC
Q 002346 712 DLKPSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALD 789 (933)
Q Consensus 712 Dik~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~ 789 (933)
||||+||+++.++.+||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|||+| |+.||.
T Consensus 173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 252 (316)
T ss_dssp CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence 999999999999999999999998654433 233345678999999999998899999999999999999998 999997
Q ss_pred CCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 790 DTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 790 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
....... ....+ .. .... ...... ...+.+++.+||+.+|++||++.|+++.|+.+++...
T Consensus 253 ~~~~~~~--~~~~~---~~-~~~~--~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 313 (316)
T 2xir_A 253 GVKIDEE--FCRRL---KE-GTRM--RAPDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 313 (316)
T ss_dssp TCCCSHH--HHHHH---HH-TCCC--CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred ccchhHH--HHHHh---cc-CccC--CCCCCC---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence 6543221 11111 11 1110 011111 1357799999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-38 Score=340.43 Aligned_cols=249 Identities=25% Similarity=0.392 Sum_probs=202.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee----CceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~ 655 (933)
..|.+.+.||+|+||.||+|.. .++..||+|++..........+.+.+|+.++++++||||+++++++.. +...+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 105 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence 3477888999999999999955 568899999998776666677889999999999999999999998865 45679
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEecCCCCCcEEec-CCCcEEEeccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIG-DDMRAKVADFG 732 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dik~~Nill~-~~~~~kl~DfG 732 (933)
+||||+++++|.+++... ..+++..++.++.|+++||+|||+ .+ |+||||||+||+++ .++.+||+|||
T Consensus 106 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg 177 (290)
T 1t4h_A 106 LVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLG 177 (290)
T ss_dssp EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred EEEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence 999999999999999652 468999999999999999999998 67 99999999999998 78999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
++....... .....||+.|+|||++. +.++.++||||||+++|||++|+.||........ . ..... ...
T Consensus 178 ~~~~~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~---~~~~~--~~~ 246 (290)
T 1t4h_A 178 LATLKRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---YRRVT--SGV 246 (290)
T ss_dssp GGGGCCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---HHHHT--TTC
T ss_pred Ccccccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--H---HHHHh--ccC
Confidence 997654432 23457999999999886 5689999999999999999999999976433221 1 11111 111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+..++... ...+.+++.+||+.||++||+++|+++
T Consensus 247 ~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~ell~ 282 (290)
T 1t4h_A 247 KPASFDKVA---------IPEVKEIIEGCIRQNKDERYSIKDLLN 282 (290)
T ss_dssp CCGGGGGCC---------CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CccccCCCC---------CHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 111222111 135789999999999999999999986
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=350.60 Aligned_cols=269 Identities=26% Similarity=0.433 Sum_probs=215.1
Q ss_pred HHHhcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 650 (933)
+...++|++.+.||+|+||.||+|... +++.||||++.... ......++.+|+.++++++||||+++++++.+
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 345678999999999999999999653 37889999997553 34456679999999999999999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHD-----HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
+...++||||+++|+|.+++..... ....++++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~ 176 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT 176 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCC
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCe
Confidence 9999999999999999999975321 112457999999999999999999999 89999999999999999999
Q ss_pred EEEecccccccCCCCCce-eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYS-VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWF 803 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~ 803 (933)
+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++ |+.||....... ..
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~--- 250 (322)
T 1p4o_A 177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ---VL--- 250 (322)
T ss_dssp EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH---HH---
T ss_pred EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH---HH---
Confidence 999999998755433221 2233467889999999998899999999999999999999 888987643221 11
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
..... ..... .... ....+.+++.+|++.+|++||++.|+++.|+++++.+.
T Consensus 251 ~~~~~--~~~~~-~~~~---------~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~ 302 (322)
T 1p4o_A 251 RFVME--GGLLD-KPDN---------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGF 302 (322)
T ss_dssp HHHHT--TCCCC-CCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTH
T ss_pred HHHHc--CCcCC-CCCC---------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCC
Confidence 11111 11111 1111 12357799999999999999999999999998876544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-39 Score=344.90 Aligned_cols=255 Identities=19% Similarity=0.305 Sum_probs=205.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--CceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~l 656 (933)
.++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+.+|+.++++++||||+++++++.. +...++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999965 478999999998776566667889999999999999999999998854 567899
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC-----eEecCCCCCcEEecCCCcEEEecc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS-----FIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~-----ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
||||+++++|.+++..... ....+++.+++.++.|+++||+|||+ .+ |+||||||+||+++.++.+||+||
T Consensus 85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df 160 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 160 (279)
T ss_dssp EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence 9999999999999976332 23458999999999999999999998 66 999999999999999999999999
Q ss_pred cccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
|+++....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.||...... .... .... .
T Consensus 161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~---~i~~--~ 231 (279)
T 2w5a_A 161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG---KIRE--G 231 (279)
T ss_dssp CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH---HHHH--T
T ss_pred chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHH---HHhh--c
Confidence 99986654322 123357899999999999889999999999999999999999999865322 1111 1111 1
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+ .+.... ...+.+++.+||+.+|++||++.|+++
T Consensus 232 ~~~-~~~~~~---------~~~l~~li~~~l~~~p~~Rps~~~ll~ 267 (279)
T 2w5a_A 232 KFR-RIPYRY---------SDELNEIITRMLNLKDYHRPSVEEILE 267 (279)
T ss_dssp CCC-CCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccc-cCCccc---------CHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 111 111111 245779999999999999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=343.27 Aligned_cols=248 Identities=26% Similarity=0.480 Sum_probs=202.2
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.++++++||||+++++++.+....++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 46899999999999999999954 56789999998654322 22356789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++... ..+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 88 ~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~ 159 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHA 159 (279)
T ss_dssp ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccC
Confidence 9999999999999662 458999999999999999999998 89999999999999999999999999998654
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
.... .....|++.|+|||.+.+..++.++||||||+++|||++|+.||........ . ..........+..+
T Consensus 160 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~---~~~~~~~~~~~~~~ 230 (279)
T 3fdn_A 160 PSSR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---Y---KRISRVEFTFPDFV 230 (279)
T ss_dssp -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H---HHHHHTCCCCCTTS
T ss_pred Cccc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---H---HHHHhCCCCCCCcC
Confidence 4322 2345799999999999998999999999999999999999999976432221 1 11111111222111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+.+++.+|++.+|++||++.|+++
T Consensus 231 -------------~~~~~~li~~~l~~~p~~Rps~~e~l~ 257 (279)
T 3fdn_A 231 -------------TEGARDLISRLLKHNPSQRPMLREVLE 257 (279)
T ss_dssp -------------CHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred -------------CHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 135679999999999999999999997
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-38 Score=342.43 Aligned_cols=267 Identities=20% Similarity=0.293 Sum_probs=210.2
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEe-eeCceeEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC-INGSERLL 656 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~l 656 (933)
+.++|++.+.||+|+||.||+|.. .+++.||||++..... .+++.+|+.+++.++|++++..++++ ..+...++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 357899999999999999999964 6899999999875532 24689999999999988877666655 56677899
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe---cCCCcEEEecccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGL 733 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGl 733 (933)
||||+ +++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||++ +.++.+||+|||+
T Consensus 83 v~e~~-~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 154 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGL 154 (296)
T ss_dssp EEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEEec-CCCHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence 99999 99999999642 2469999999999999999999999 899999999999999 4888999999999
Q ss_pred cccCCCCCce------eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 734 VKNAPDGKYS------VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 734 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||..............+....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 3uzp_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccc
Confidence 9865543321 1234679999999999999999999999999999999999999998654322222221111111
Q ss_pred hccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
... . ...+.+.. ...+.+++.+||+.||++||+++++++.|+.+......
T Consensus 235 ~~~-~-~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~ 284 (296)
T 3uzp_A 235 MST-P-IEVLCKGY---------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 284 (296)
T ss_dssp HHS-C-HHHHTTTS---------CHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cCC-c-hHHHHhhC---------CHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence 100 0 00011111 14578999999999999999999999999998776654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=354.60 Aligned_cols=256 Identities=16% Similarity=0.200 Sum_probs=207.5
Q ss_pred hcCCccCCccccCCCeEEEEE------EeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC---CCcceeEEeEeee
Q 002346 580 TDNFSEANILGRGGFGVVYGG------ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGYCIN 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~------~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~ 650 (933)
.++|.+.+.||+|+||.||+| ...+++.||||++... ...++.+|+++++.++ |+||+++++++..
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~ 138 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA-----NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLF 138 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC-----CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC-----ChhHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence 478999999999999999999 3557899999998754 2457888888888886 9999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC--------
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-------- 722 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-------- 722 (933)
++..++||||+++|+|.+++..........+++.+++.|+.|+++||+|||+ ++||||||||+|||++.
T Consensus 139 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 139 QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC---
T ss_pred CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCcccc
Confidence 9999999999999999999976544445679999999999999999999999 89999999999999998
Q ss_pred ---CCcEEEecccccccCC-CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhH
Q 002346 723 ---DMRAKVADFGLVKNAP-DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAH 798 (933)
Q Consensus 723 ---~~~~kl~DfGla~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~ 798 (933)
++.+||+|||+++... ...........||+.|+|||++.+..++.++|||||||++|||+||+.||........
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~-- 293 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC-- 293 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE--
T ss_pred ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce--
Confidence 8999999999997543 1222334556899999999999999999999999999999999999999964322110
Q ss_pred HHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHhhhhhhc
Q 002346 799 LVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQR-PDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 799 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~R-Ps~~evl~~L~~~~~~~ 866 (933)
.+...+. ... ....+.+++..|++.+|.+| |+++++.+.|++..++.
T Consensus 294 -------------~~~~~~~-~~~-------~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~ 341 (365)
T 3e7e_A 294 -------------KPEGLFR-RLP-------HLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH 341 (365)
T ss_dssp -------------EECSCCT-TCS-------SHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred -------------eechhcc-ccC-------cHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence 0011111 111 12345689999999999998 57888888888876653
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-39 Score=353.55 Aligned_cols=272 Identities=19% Similarity=0.283 Sum_probs=198.1
Q ss_pred HhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
..++|++.+.||+|+||.||+|. ..+++.||||++..........+.+.+|+.++++++||||+++++++.++...++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 35789999999999999999995 45789999999987654455566788999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe-----cCCCcEEEeccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI-----GDDMRAKVADFG 732 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill-----~~~~~~kl~DfG 732 (933)
|||++ |+|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||++ +.++.+||+|||
T Consensus 112 ~e~~~-~~L~~~~~~-----~~~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDK-----NPDVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EECCS-EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EecCC-CCHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 99997 599999965 2458999999999999999999999 899999999999999 455569999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc-
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK- 810 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 810 (933)
+++....... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+...........
T Consensus 183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~ 259 (329)
T 3gbz_A 183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPDD 259 (329)
T ss_dssp HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCT
T ss_pred CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCch
Confidence 9986543321 22345789999999998764 48999999999999999999999997654322 1222111111000
Q ss_pred CCCCccc--------CCCCCCChh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 811 ENIPKAI--------DPNLNLDEE----TIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 811 ~~~~~~~--------d~~l~~~~~----~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
...+... .+....... ......++.+++.+||+.||++||+++|+++ ++|..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~ 323 (329)
T 3gbz_A 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE------HPYFS 323 (329)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT------SGGGS
T ss_pred hhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC------CcccC
Confidence 0000000 000000000 0002246789999999999999999999986 66664
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=360.43 Aligned_cols=200 Identities=27% Similarity=0.379 Sum_probs=169.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----ce
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 653 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++..........+++.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 47899999999999999999954 5688999999987654555678899999999999999999999999766 57
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.|+||||++ ++|.+++.. ...+++..++.++.||++||+|||+ .+|+||||||+|||++.++.+||+|||+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~-----~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGl 175 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT-----PIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGL 175 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEecCC-cCHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence 899999995 699999864 2569999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCce---------------------eecccccccCccccccc-CCCCCCCccchHhHHHHHHHHHcCCCCC
Q 002346 734 VKNAPDGKYS---------------------VETRLAGTFGYLAPEYA-ATGRVTTKIDVYAFGVVLMETITGRKAL 788 (933)
Q Consensus 734 a~~~~~~~~~---------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Dv~SlG~~l~elltG~~p~ 788 (933)
++........ ..+..+||+.|+|||++ ....++.++||||+||++|||++|..||
T Consensus 176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9866443211 12456899999999986 5667999999999999999999865444
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-39 Score=355.49 Aligned_cols=267 Identities=16% Similarity=0.226 Sum_probs=199.9
Q ss_pred hcCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCc---------hhHHHHHHHHHHHHhcCCCcceeEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGN---------KGLSEFQAEIAVLTKVRHRHLVALLG 646 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~ 646 (933)
.++|++.+.||+|+||.||+|... ++..||||++....... .....+.+|+..++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 467999999999999999999764 57889999987653211 01234678889999999999999999
Q ss_pred Eeee----CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC
Q 002346 647 YCIN----GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD 722 (933)
Q Consensus 647 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~ 722 (933)
++.. ....++||||+ +++|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGY 186 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEES
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEcc
Confidence 9987 67889999999 99999999652 369999999999999999999999 89999999999999998
Q ss_pred CC--cEEEecccccccCCCCCc------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCc
Q 002346 723 DM--RAKVADFGLVKNAPDGKY------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD 794 (933)
Q Consensus 723 ~~--~~kl~DfGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~ 794 (933)
++ .+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 266 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD 266 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence 87 999999999986543221 1113457999999999999889999999999999999999999999653222
Q ss_pred hhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 795 DRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 795 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
... ......... ..++..+...... ......+.+++.+||+.||++||+++++++.|+.+.
T Consensus 267 ~~~-~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~ 327 (345)
T 2v62_A 267 PVA-VQTAKTNLL---DELPQSVLKWAPS----GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG 327 (345)
T ss_dssp HHH-HHHHHHHHH---HTTTHHHHHHSCT----TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred cHH-HHHHHHhhc---ccccHHHHhhccc----cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence 211 111111111 1111111000000 011246889999999999999999999999998764
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-38 Score=350.17 Aligned_cols=266 Identities=28% Similarity=0.377 Sum_probs=208.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEee--eCce
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI--NGSE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 653 (933)
++|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|++++++++||||+++++++. +...
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 6889999999999999999973 46889999999765 3455678999999999999999999999886 4566
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++++|.+++.... ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 173 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGL 173 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred EEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccc
Confidence 889999999999999996522 358999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCce--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh--------hHHHHHH
Q 002346 734 VKNAPDGKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR--------AHLVTWF 803 (933)
Q Consensus 734 a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~--------~~~~~~~ 803 (933)
++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.||........ .......
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T 3lxl_A 174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL 253 (327)
T ss_dssp CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence 9876544322 22345688899999999888899999999999999999999999864321100 0000111
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
........ .....+. ....+.+++.+|++.||++||++.|+++.|+.+....
T Consensus 254 ~~~~~~~~--~~~~~~~---------~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~ 305 (327)
T 3lxl_A 254 LELLEEGQ--RLPAPPA---------CPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGS 305 (327)
T ss_dssp HHHHHTTC--CCCCCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred HHHhhccc--CCCCCCc---------ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence 11111111 1111111 1245789999999999999999999999998875444
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-38 Score=347.63 Aligned_cols=260 Identities=25% Similarity=0.427 Sum_probs=203.9
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC-----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD-----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.++|++.+.||+|+||.||+|.... +..||||++.... ......++.+|+.++++++||||+++++++...+..
T Consensus 43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 121 (333)
T 1mqb_A 43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 121 (333)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence 3578888999999999999996532 2469999997653 344567899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 122 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 194 (333)
T 1mqb_A 122 MIITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLS 194 (333)
T ss_dssp EEEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEeCCCCCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcc
Confidence 9999999999999999652 2468999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCce--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 735 KNAPDGKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 735 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
+........ ......+++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ... .... ..
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~---~~~~-~~ 267 (333)
T 1mqb_A 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMK---AIND-GF 267 (333)
T ss_dssp ----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHT-TC
T ss_pred hhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHH---HHHC-CC
Confidence 865543211 1223356789999999998899999999999999999999 999997653321 111 1111 11
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
..+ .... ....+.+++.+||+.+|++||++.++++.|+.+...
T Consensus 268 ~~~--~~~~---------~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 310 (333)
T 1mqb_A 268 RLP--TPMD---------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 310 (333)
T ss_dssp CCC--CCTT---------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred cCC--Cccc---------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111 1111 124577999999999999999999999999988654
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=366.72 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=199.0
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------c
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------S 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 652 (933)
.++|++.+.||+|+||.||+|. ..+++.||||++..........+++.+|+.+++.++|||||++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 5789999999999999999995 45789999999987654556678899999999999999999999998654 4
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||+++ +|.+.+. ..+++.++..++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||
T Consensus 141 ~~~lv~E~~~~-~l~~~~~-------~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG 209 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 209 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred eEEEEEeCCCC-CHHHHHh-------hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEE
Confidence 57999999965 5766663 248999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH-------
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR------- 805 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~------- 805 (933)
+++...... ..+...||+.|+|||++.+..++.++||||+||++|||++|+.||......+.. ...+..
T Consensus 210 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~--~~i~~~lg~p~~~ 285 (464)
T 3ttj_A 210 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW--NKVIEQLGTPCPE 285 (464)
T ss_dssp CC-----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHH
T ss_pred eeeecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCCCCHH
Confidence 998665432 234568999999999999999999999999999999999999999765432211 111110
Q ss_pred -----------HhhccCC-----CCcccCCC-CC-CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 806 -----------VLISKEN-----IPKAIDPN-LN-LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 806 -----------~~~~~~~-----~~~~~d~~-l~-~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....... ++..+... .. ...........+.+++.+||+.||++|||++|+++
T Consensus 286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 355 (464)
T 3ttj_A 286 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 355 (464)
T ss_dssp HHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000 00000000 00 01111222456889999999999999999999987
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=362.82 Aligned_cols=265 Identities=21% Similarity=0.286 Sum_probs=210.7
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCC-CcceeEEeEeeeCceeEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLGYCINGSERLL 656 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~l 656 (933)
+.++|++.+.||+|+||.||+|.. .+++.||||++...... .++.+|+++++.++| ++|+.+..++...+..++
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 357899999999999999999964 67999999987755322 357899999999976 566666677778888999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe---cCCCcEEEecccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGL 733 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGl 733 (933)
||||+ +++|.+++... ...+++.+++.|+.||+.||+|||+ ++||||||||+|||+ +.++.+||+|||+
T Consensus 81 vme~~-g~sL~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGl 152 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC----SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGL 152 (483)
T ss_dssp EEECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred EEECC-CCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCc
Confidence 99999 99999999642 2469999999999999999999999 899999999999999 6889999999999
Q ss_pred cccCCCCCce------eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 734 VKNAPDGKYS------VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 734 a~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
++........ ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 9866543321 1235689999999999999999999999999999999999999998765443333222222211
Q ss_pred hccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
.. ..+. .+.. ....++.+++.+||+.+|++||++.++++.|+.+....
T Consensus 233 ~~-~~~~-~l~~---------~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~ 280 (483)
T 3sv0_A 233 VA-TSIE-ALCR---------GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIRE 280 (483)
T ss_dssp HH-SCHH-HHHT---------TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred cc-ccHH-HHhc---------CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHc
Confidence 10 0000 0001 11246889999999999999999999999999987653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=358.94 Aligned_cols=276 Identities=19% Similarity=0.283 Sum_probs=214.1
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc--eeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS--ERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~l 656 (933)
.++|++.+.||+|+||.||+|... +|+.||||++..... ....+.+.+|++++++++||||+++++++.... ..++
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l 86 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL 86 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence 467999999999999999999654 589999999976532 334678889999999999999999999998755 7799
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe----cCCCcEEEeccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDMRAKVADFG 732 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~~~kl~DfG 732 (933)
||||+++|+|.+++..... ...+++.+++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||
T Consensus 87 v~e~~~~g~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 87 IMEFCPCGSLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp EECCCTTEEHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred EEecCCCCCHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 9999999999999966322 2348999999999999999999999 899999999999999 788889999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCC--------CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAAT--------GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ...+.
T Consensus 162 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~ 237 (396)
T 4eut_A 162 AARELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMY 237 (396)
T ss_dssp GCEECCCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHH
T ss_pred CceEccCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHH
Confidence 9987654332 234579999999998864 56788999999999999999999999754322111 11122
Q ss_pred HHhhccC-CCCcc----------cCCCCC-CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 805 RVLISKE-NIPKA----------IDPNLN-LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 805 ~~~~~~~-~~~~~----------~d~~l~-~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
....... ..... ....+. ...........+.+++.+||+.||++||++.|+++.++.+++.
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~ 310 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR 310 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence 2221111 00000 000111 0112245556788999999999999999999999999888764
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-39 Score=355.93 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=204.0
Q ss_pred cCCccCCccccCCCeEEEEEEe----CCCcEEEEEEeccccC--CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCce
Q 002346 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~ 653 (933)
++|++.+.||+|+||.||+|.. .+++.||||+++.... .....+.+.+|+++++++ +||||+++++++..+..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 6899999999999999999976 4789999999876432 122345678899999999 69999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+++|+|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||+
T Consensus 134 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~ 205 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 205 (355)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred EEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCC
Confidence 99999999999999999752 458999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
++..............||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ............
T Consensus 206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~ 283 (355)
T 1vzo_A 206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKSEP 283 (355)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHHCCC
T ss_pred CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhccCC
Confidence 98665443333345679999999999975 34789999999999999999999999754332221 122222222222
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
..+. .+ ...+.+++.+||+.||++|| +++|+++
T Consensus 284 ~~~~----~~---------~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~ 321 (355)
T 1vzo_A 284 PYPQ----EM---------SALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 321 (355)
T ss_dssp CCCT----TS---------CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCc----cc---------CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHc
Confidence 2211 11 13567999999999999999 8888876
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=356.37 Aligned_cols=251 Identities=23% Similarity=0.311 Sum_probs=191.5
Q ss_pred hcCCccC-CccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHh-cCCCcceeEEeEeee----Cc
Q 002346 580 TDNFSEA-NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK-VRHRHLVALLGYCIN----GS 652 (933)
Q Consensus 580 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~ 652 (933)
.++|.+. +.||+|+||.||++.. .+|+.||||++... ..+.+|+.++.+ .+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3567666 7899999999999955 47899999998643 457788888754 489999999999875 56
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---CCcEEEe
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVA 729 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~ 729 (933)
..++||||+++|+|.+++... +...+++.+++.|+.||++||+|||+ ++|+||||||+|||++. ++.+||+
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~ 206 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 206 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEEC
T ss_pred EEEEEEEeCCCCcHHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEE
Confidence 789999999999999999652 22469999999999999999999999 89999999999999997 7899999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhh-HHHHHHHHHhh
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA-HLVTWFRRVLI 808 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~-~~~~~~~~~~~ 808 (933)
|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .... ....
T Consensus 207 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~i~~ 281 (400)
T 1nxk_A 207 DFGFAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT---RIRM 281 (400)
T ss_dssp CCTTCEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH---HHHH
T ss_pred ecccccccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH---HHHc
Confidence 999998655322 223467899999999999999999999999999999999999999865432210 1111 1111
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.....+...... ...++.+++.+||+.||++||++.|+++
T Consensus 282 ~~~~~~~~~~~~---------~s~~~~~li~~~L~~dP~~Rpt~~eil~ 321 (400)
T 1nxk_A 282 GQYEFPNPEWSE---------VSEEVKMLIRNLLKTEPTQRMTITEFMN 321 (400)
T ss_dssp TCCCCCTTTTTT---------SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CcccCCCccccc---------CCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 111111111011 1245789999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=355.06 Aligned_cols=268 Identities=13% Similarity=0.226 Sum_probs=209.4
Q ss_pred hcCCccCCccccCCCeEEEEEEeC---------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCccee-------
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP---------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA------- 643 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~------- 643 (933)
.++|++.+.||+|+||.||+|... +++.||||++... +.+.+|+.++++++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 368999999999999999999765 3789999998754 36889999999999999998
Q ss_pred --------EEeEeee-CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCC
Q 002346 644 --------LLGYCIN-GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (933)
Q Consensus 644 --------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 714 (933)
+++++.. +...++||||+ +++|.+++.... ...+++.+++.++.|+++||+|||+ ++|+|||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dik 186 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVT 186 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCC
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCC
Confidence 6777766 67889999999 999999997631 2569999999999999999999999 899999999
Q ss_pred CCcEEecCCC--cEEEecccccccCCCCCce------eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCC
Q 002346 715 PSNILIGDDM--RAKVADFGLVKNAPDGKYS------VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRK 786 (933)
Q Consensus 715 ~~Nill~~~~--~~kl~DfGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~ 786 (933)
|+||+++.++ .+||+|||+++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 8999999999865432211 1133579999999999999899999999999999999999999
Q ss_pred CCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 787 ALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 787 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
||....+... ............. ....+..... ......+.+++.+|++.||++||+++++++.|+++.+.+
T Consensus 267 pf~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~ 338 (352)
T 2jii_A 267 PWTNCLPNTE-DIMKQKQKFVDKP---GPFVGPCGHW----IRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL 338 (352)
T ss_dssp TTGGGTTCHH-HHHHHHHHHHHSC---CCEECTTSCE----ECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred CcccCCcCHH-HHHHHHHhccCCh---hhhhhhcccc----CCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence 9986543222 2222222211111 1111111000 001145789999999999999999999999999998776
Q ss_pred CCC
Q 002346 867 KPA 869 (933)
Q Consensus 867 ~~~ 869 (933)
...
T Consensus 339 ~~~ 341 (352)
T 2jii_A 339 RVS 341 (352)
T ss_dssp TCC
T ss_pred CCC
Confidence 543
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=354.57 Aligned_cols=261 Identities=29% Similarity=0.459 Sum_probs=198.4
Q ss_pred CCccCCccccCCCeEEEEEEeC--CC--cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee-CceeEE
Q 002346 582 NFSEANILGRGGFGVVYGGELP--DG--TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERLL 656 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~l 656 (933)
.|++.+.||+|+||.||+|... ++ ..||||.+.... .....++|.+|+.++++++||||+++++++.. ++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4677889999999999999653 22 368999887542 34557889999999999999999999998754 557899
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++|+|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 169 v~e~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~ 241 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARD 241 (373)
T ss_dssp EEECCTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEECCCCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccc
Confidence 99999999999999641 2458899999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCce---eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 737 APDGKYS---VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 737 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
....... ......|++.|+|||++.+..++.++||||||+++|||+| |.+||......+... . ..... .
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~---~---~~~~~-~ 314 (373)
T 3c1x_A 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---Y---LLQGR-R 314 (373)
T ss_dssp ----------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH---H---HHTTC-C
T ss_pred ccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH---H---HHcCC-C
Confidence 5433211 1233467889999999998999999999999999999999 667776554332211 1 11111 1
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
. ...... ...+.+++.+||+.+|++||++.|+++.|+.+...+..
T Consensus 315 ~--~~p~~~---------~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~ 359 (373)
T 3c1x_A 315 L--LQPEYC---------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 359 (373)
T ss_dssp C--CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred C--CCCCCC---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence 0 011111 13577999999999999999999999999999877664
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=342.45 Aligned_cols=262 Identities=29% Similarity=0.428 Sum_probs=205.6
Q ss_pred cCCccCCccccCCCeEEEEEEeCC----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEee-eCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI-NGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~ 655 (933)
.+|++.+.||+|+||.||+|...+ +..||+|.+.... .....+.+.+|+.++++++||||+++++++. .+...+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 468889999999999999996532 2368999987643 3455678999999999999999999999865 456789
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 104 ~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~ 176 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLAR 176 (298)
T ss_dssp EEEECCTTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred EEEeCCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccc
Confidence 999999999999999641 2458999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCc---eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcC-CCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 736 NAPDGKY---SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITG-RKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 736 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
....... .......||+.|+|||.+.+..++.++||||||+++|||++| .+||......+.. . .......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~---~---~~~~~~~ 250 (298)
T 3f66_A 177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---V---YLLQGRR 250 (298)
T ss_dssp CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHH---H---HHHTTCC
T ss_pred cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHH---H---HHhcCCC
Confidence 6554332 122345678899999999988999999999999999999995 5555543322211 1 1111111
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....... ...+.+++.+|++.+|++||++.|+++.|+.+...+..
T Consensus 251 ---~~~~~~~---------~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~ 295 (298)
T 3f66_A 251 ---LLQPEYC---------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 295 (298)
T ss_dssp ---CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred ---CCCCccC---------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence 1111111 13577999999999999999999999999998876654
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-38 Score=358.47 Aligned_cols=260 Identities=23% Similarity=0.349 Sum_probs=196.6
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC------chhHHHHHHHHHHHHhcCCCcceeEEeEeee
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG------NKGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 650 (933)
.+.++|.+.+.||+|+||.||+|.. .+++.||||++...... ......+.+|+.++++++||||+++++++.
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~- 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD- 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence 4578999999999999999999954 56899999998765321 112235889999999999999999999975
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC---cEE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM---RAK 727 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~---~~k 727 (933)
.+..++||||+++|+|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++.++ .+|
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~k 282 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 282 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS-----SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEE
T ss_pred cCceEEEEEcCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEE
Confidence 4567999999999999998854 3569999999999999999999999 8999999999999997544 599
Q ss_pred EecccccccCCCCCceeecccccccCcccccccCC---CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT---GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 728 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ +...+
T Consensus 283 l~DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i- 357 (419)
T 3i6u_A 283 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI- 357 (419)
T ss_dssp ECCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH-
T ss_pred EeecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH-
Confidence 99999998765432 2344679999999999853 5788899999999999999999999976433221 11111
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
........... .......+.+++.+||+.||++||+++|+++ ++|..
T Consensus 358 --~~~~~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~------hp~~~ 404 (419)
T 3i6u_A 358 --TSGKYNFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR------HPWLQ 404 (419)
T ss_dssp --HTTCCCCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGC
T ss_pred --hcCCCCCCchh---------hcccCHHHHHHHHHHccCChhHCcCHHHHhC------CcccC
Confidence 11111110000 0111246789999999999999999999987 66664
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=369.16 Aligned_cols=256 Identities=25% Similarity=0.389 Sum_probs=200.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 46899999999999999999954 5789999999976532 233456788999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++|+|.+++.. ...+++..+..++.|+++||+|||+ .++|+||||||+|||++.++.+||+|||+++..
T Consensus 227 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~ 299 (446)
T 4ejn_A 227 MEYANGGELFFHLSR-----ERVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEG 299 (446)
T ss_dssp ECCCSSCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTT
T ss_pred EeeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceec
Confidence 999999999999965 2468999999999999999999996 268999999999999999999999999999864
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... + ..........++..+
T Consensus 300 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~---~~~i~~~~~~~p~~~ 372 (446)
T 4ejn_A 300 IKDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---L---FELILMEEIRFPRTL 372 (446)
T ss_dssp CC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHHCCCCCCTTS
T ss_pred cCCCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---H---HHHHHhCCCCCCccC
Confidence 43322 2344689999999999999999999999999999999999999997653221 1 122222222222211
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHhhhhhhcCC
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~~~~~ 868 (933)
. ..+.+++.+||+.||++|| +++|+++ ++|..
T Consensus 373 ----~---------~~~~~li~~~L~~dP~~R~~~~~~t~~ell~------hp~f~ 409 (446)
T 4ejn_A 373 ----G---------PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ------HRFFA 409 (446)
T ss_dssp ----C---------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT------SGGGT
T ss_pred ----C---------HHHHHHHHHHcccCHHHhCCCCCCCHHHHHh------Ccccc
Confidence 1 3577999999999999999 9999876 56654
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-38 Score=338.95 Aligned_cols=254 Identities=22% Similarity=0.384 Sum_probs=204.5
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCc----hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
+.++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+.++++++||||+++++++.++..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 3467999999999999999999664 68999999987654322 236789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC----cEEEe
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVA 729 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~ 729 (933)
.++||||+++++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++ .+||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~ 154 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAE-----KESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLI 154 (283)
T ss_dssp EEEEEECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEeecCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEE
Confidence 9999999999999999965 2468999999999999999999999 8999999999999998877 89999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||++........ .....|++.|+|||++.+..++.++||||||+++|||++|+.||........ .......
T Consensus 155 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~ 226 (283)
T 3bhy_A 155 DFGIAHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET------LTNISAV 226 (283)
T ss_dssp CCTTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTT
T ss_pred ecccceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH------HHHhHhc
Confidence 9999986654321 2345789999999999988999999999999999999999999976532211 1111111
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....+....+ .....+.+++.+|++.||++||+++|+++
T Consensus 227 ~~~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~~~l~ 265 (283)
T 3bhy_A 227 NYDFDEEYFS---------NTSELAKDFIRRLLVKDPKRRMTIAQSLE 265 (283)
T ss_dssp CCCCCHHHHT---------TCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred ccCCcchhcc---------cCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence 1111111101 11245779999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=351.68 Aligned_cols=265 Identities=24% Similarity=0.392 Sum_probs=212.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-C-----CcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-D-----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 652 (933)
.++|++.+.||+|+||.||+|... . +..||+|.+.... .....+.+.+|+.+++++ +||||+++++++..++
T Consensus 45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 123 (333)
T 2i1m_A 45 RNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGG 123 (333)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence 478999999999999999999653 2 3489999997653 344567899999999999 8999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccC---------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDH---------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ ++|+||||||+||+++.+
T Consensus 124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGG
T ss_pred ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCC
Confidence 999999999999999999753210 12458999999999999999999999 899999999999999999
Q ss_pred CcEEEecccccccCCCCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHH
Q 002346 724 MRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~ 801 (933)
+.+||+|||+++...... ........||+.|+|||.+.+..++.++||||||+++|||+| |+.||........ ...
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~~~ 278 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK--FYK 278 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH--HHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH--HHH
Confidence 999999999998554332 222344567889999999988899999999999999999999 9999976543322 111
Q ss_pred HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.... ... ....... ...+.+++.+||+.||.+||++.|+++.|+.+...
T Consensus 279 ~~~~----~~~--~~~~~~~---------~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~ 327 (333)
T 2i1m_A 279 LVKD----GYQ--MAQPAFA---------PKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE 327 (333)
T ss_dssp HHHH----TCC--CCCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHhc----CCC--CCCCCCC---------CHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence 1111 111 0011111 13577999999999999999999999999887654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=351.20 Aligned_cols=267 Identities=22% Similarity=0.349 Sum_probs=202.9
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.+|+.++++++||||+++++++.+....++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 46899999999999999999965 45899999998776555555677899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++.. ...+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...
T Consensus 104 e~~~~~~l~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 104 EFVDHTILDDLELF-----PNGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLA 175 (331)
T ss_dssp ECCSEEHHHHHHHS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred ecCCcchHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence 99999999887643 2458999999999999999999999 899999999999999999999999999997654
Q ss_pred CCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHH----------Hh
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR----------VL 807 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~----------~~ 807 (933)
.... ......|++.|+|||++.+. .++.++|||||||++|||++|+.||......+.. ...... ..
T Consensus 176 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~ 252 (331)
T 4aaa_A 176 APGE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL--YHIMMCLGNLIPRHQELF 252 (331)
T ss_dssp ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHCSCCHHHHHHH
T ss_pred CCcc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHH--HHHHHHhCCCChhhhhHh
Confidence 4322 22345789999999998765 7899999999999999999999999765432221 111100 00
Q ss_pred hccCCCCcccCCCCCCC----hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 ISKENIPKAIDPNLNLD----EETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~----~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...........+..... .........+.+++.+||+.||++||+++|+++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~ 306 (331)
T 4aaa_A 253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306 (331)
T ss_dssp HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 00000000001111100 001122356889999999999999999999986
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-38 Score=366.01 Aligned_cols=253 Identities=24% Similarity=0.351 Sum_probs=200.9
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+.++|++.+.||+|+||.||+|.. .+++.||+|++............+.+|+.+++.++|||||++++++.+....++|
T Consensus 35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 114 (494)
T 3lij_A 35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV 114 (494)
T ss_dssp HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 356799999999999999999965 4789999999987654455567899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC---CcEEEeccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADFGLV 734 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~DfGla 734 (933)
|||+++|+|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+|||++.+ +.+||+|||++
T Consensus 115 ~e~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a 186 (494)
T 3lij_A 115 MECYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186 (494)
T ss_dssp EECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCC
Confidence 9999999999988652 468999999999999999999999 899999999999999764 45999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
+...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||......+. ...........+
T Consensus 187 ~~~~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~------~~~i~~~~~~~~ 257 (494)
T 3lij_A 187 AVFENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI------LRKVEKGKYTFD 257 (494)
T ss_dssp EECBTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCCCC
T ss_pred eECCCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCCC
Confidence 8665432 233457999999999886 5699999999999999999999999986543221 122222121111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....+. ....+.+++.+||+.+|++|||+.|+++
T Consensus 258 ~~~~~~---------~s~~~~~li~~~L~~dp~~R~s~~e~l~ 291 (494)
T 3lij_A 258 SPEWKN---------VSEGAKDLIKQMLQFDSQRRISAQQALE 291 (494)
T ss_dssp SGGGTT---------SCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred chhccc---------CCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence 111111 1245779999999999999999999986
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-38 Score=347.81 Aligned_cols=258 Identities=26% Similarity=0.435 Sum_probs=200.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcE----EEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTK----IAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.++|++.+.||+|+||.||+|.. .+++. ||+|.+.... .....+++.+|+.++++++||||+++++++..+. .
T Consensus 14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~ 91 (327)
T 3lzb_A 14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 91 (327)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-E
T ss_pred HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-c
Confidence 36799999999999999999964 34543 5777776442 3455688999999999999999999999998755 7
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++|+||+.+|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~v~~~~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a 164 (327)
T 3lzb_A 92 QLITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLA 164 (327)
T ss_dssp EEEECCCSSCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-
T ss_pred eEEEEecCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcce
Confidence 8899999999999999662 2458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 735 KNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 735 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+....... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||.......... . ......
T Consensus 165 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---~----~~~~~~ 237 (327)
T 3lzb_A 165 KLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---I----LEKGER 237 (327)
T ss_dssp ---------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---H----HHTTCC
T ss_pred eEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---H----HHcCCC
Confidence 86543322 12233457889999999999999999999999999999999 999998754433211 1 111111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.+ ..+. ....+.+++.+||+.||++||++.|+++.|+.+..
T Consensus 238 ~~--~~~~---------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~ 278 (327)
T 3lzb_A 238 LP--QPPI---------CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR 278 (327)
T ss_dssp CC--CCTT---------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred CC--CCcc---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 11 1111 11357799999999999999999999999988763
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-38 Score=339.33 Aligned_cols=251 Identities=24% Similarity=0.434 Sum_probs=184.3
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+++.+|+.++++++||||+++++++.+....++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 46799999999999999999965 57999999998754321 22357899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++... ..++++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~ 162 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQL 162 (278)
T ss_dssp EECCTTEEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence 9999999999999652 2568999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||........ .......... .
T Consensus 163 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~----~ 231 (278)
T 3cok_A 163 KMPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNT------LNKVVLADYE----M 231 (278)
T ss_dssp C-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------CCSSCCC----C
T ss_pred cCCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHH------HHHHhhcccC----C
Confidence 53221 12335789999999999988899999999999999999999999976533211 0011100000 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... ....+.+++.+|++.||++||+++++++
T Consensus 232 ~~~---------~~~~~~~li~~~l~~dp~~Rps~~~~l~ 262 (278)
T 3cok_A 232 PSF---------LSIEAKDLIHQLLRRNPADRLSLSSVLD 262 (278)
T ss_dssp CTT---------SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred ccc---------cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence 111 1235779999999999999999999986
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-39 Score=351.02 Aligned_cols=270 Identities=23% Similarity=0.355 Sum_probs=199.2
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|... +++.||||++..... ......+.+|+.++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 57999999999999999999654 789999999875431 1112245679999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|++ |+|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 152 (324)
T 3mtl_A 81 YLD-KDLKQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSI 152 (324)
T ss_dssp CCS-EEHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--
T ss_pred ccc-cCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccC
Confidence 996 6999988652 2468999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc--cCCCCcc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS--KENIPKA 816 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 816 (933)
... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ...+...... ...++..
T Consensus 153 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~~~~~~~~~~~ 228 (324)
T 3mtl_A 153 PTK-TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ---LHFIFRILGTPTEETWPGI 228 (324)
T ss_dssp -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCCCCTTTSTTG
T ss_pred Ccc-ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCChHhchhh
Confidence 322 2234578999999999876 5689999999999999999999999987543322 2222221110 0111111
Q ss_pred cC---------CCCCCC---hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 817 ID---------PNLNLD---EETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 817 ~d---------~~l~~~---~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
.. +..... .........+.+++.+||+.||++|||++|+++ ++|...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~ 287 (324)
T 3mtl_A 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK------HPFFLS 287 (324)
T ss_dssp GGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT------SGGGGG
T ss_pred hcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc------Chhhhh
Confidence 00 000000 000011245779999999999999999999986 677653
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=339.50 Aligned_cols=262 Identities=27% Similarity=0.407 Sum_probs=206.9
Q ss_pred CCccCCccccCCCeEEEEEEeC-C---CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee-EE
Q 002346 582 NFSEANILGRGGFGVVYGGELP-D---GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER-LL 656 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~l 656 (933)
.|...+.||+|+||.||+|... + +..||+|++.... .....+.+.+|+.++++++||||+++++++.+.+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4566789999999999999642 2 2379999987643 345567899999999999999999999999876655 89
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+.+|+|.+++.. ....+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 101 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~ 173 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRS----PQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARD 173 (298)
T ss_dssp EECCCTTCBHHHHHHC----TTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCT
T ss_pred EEecccCCCHHHHHhc----cccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCccc
Confidence 9999999999999965 12568999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCc---eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 737 APDGKY---SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 737 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
...... .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+....... ....... . ....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~---~-~~~~ 247 (298)
T 3pls_A 174 ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFLA---Q-GRRL 247 (298)
T ss_dssp TTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHHH---T-TCCC
T ss_pred ccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHhh---c-CCCC
Confidence 544321 12234568899999999999999999999999999999999666654432221 1111111 1 1111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
+ ..... ...+.+++.+|++.+|++||++.++++.|++++..+..
T Consensus 248 ~--~~~~~---------~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~ 291 (298)
T 3pls_A 248 P--QPEYC---------PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG 291 (298)
T ss_dssp C--CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred C--CCccc---------hHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence 0 11111 13577999999999999999999999999999877654
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=384.54 Aligned_cols=394 Identities=19% Similarity=0.149 Sum_probs=270.2
Q ss_pred ccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccC-C-CccCcCcCceeccccccccCCCCCc
Q 002346 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI-P-SLANATSLQDIYLDNNNFTSVPTGC 132 (933)
Q Consensus 55 C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~-p-~~~~l~~L~~L~Ls~N~l~~~~~~~ 132 (933)
|.|..|.+ -..+++.|+|++|.+++..+..|.++++|++|+|++|.+.+.+ | .|.++++|++|+|++|.|+++.+..
T Consensus 14 ~~L~~vP~-lp~~l~~LdLs~N~i~~i~~~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~~ 92 (844)
T 3j0a_A 14 CNLTQVPQ-VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDA 92 (844)
T ss_dssp CCSSCCCS-SCTTCCEEEEESCCCCEECSSSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTTS
T ss_pred CCCCCCCC-CCCCcCEEECCCCcCCccChhHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHhH
Confidence 45777776 5578999999999999988999999999999999999766655 5 7999999999999999999998889
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCC-hhhcCCCCCCEEEccCCcCCCCCCccccc--
Q 002346 133 FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPASFAK-- 209 (933)
Q Consensus 133 ~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-- 209 (933)
|+++++|++|+|++|.+.+..+-...+.++++|++|+|++|.+.+..+ ..|+++++|++|+|++|++++..|..+..
T Consensus 93 ~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~~~~~~~l~~l~ 172 (844)
T 3j0a_A 93 FQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQ 172 (844)
T ss_dssp SCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCCCCCSGGGHHHH
T ss_pred ccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCCeeCHHHccccc
Confidence 999999999999999998732222348999999999999999988765 67899999999999999998777766643
Q ss_pred -cc------------------------------cchhhcccccCCccc--------------------------------
Q 002346 210 -SD------------------------------IQNLWMNDQQLGLSG-------------------------------- 226 (933)
Q Consensus 210 -~~------------------------------l~~l~l~~n~~~~~~-------------------------------- 226 (933)
.+ |+.|++++|.+....
T Consensus 173 ~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~l~~~~l~~L~l~~~~~~~~~~~~~l 252 (844)
T 3j0a_A 173 GKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI 252 (844)
T ss_dssp HCSSCCCEECCSBSCCCCCCCCCSSSCTTTTCCBSEEBCSSCCSSTTTTSGGGGTSCSCCBSEEECCSSCCBCSSSCSSS
T ss_pred CCccceEECCCCccccccccchhhcCCccccCceeEEecCCCcCchhHHHHHHhhcCcccccceeccccccccccccccc
Confidence 22 444555544322100
Q ss_pred -----------------------------ccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCcc
Q 002346 227 -----------------------------TLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPA 276 (933)
Q Consensus 227 -----------------------------~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~ 276 (933)
....+..+++|+.|+|++|++++..+ .+..+++|+.|+|++|++++..|.
T Consensus 253 ~~~~~~~f~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 332 (844)
T 3j0a_A 253 KDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSS 332 (844)
T ss_dssp TTGGGTTTTTTTTSCCCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEECTTTTTTCSSCCEEEEESCCCSCCCSC
T ss_pred CCCChhhhhccccCCccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCChHHhcCCCCCCEEECCCCCCCccCHH
Confidence 01123445555566666666555544 355566666666666666655566
Q ss_pred cccCCCCCCEEEccCccCccCCCCC---CCCccEEeccCCcCCCCCCCCC-------------CCCCc------------
Q 002346 277 SVISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAG-------------KPCDP------------ 328 (933)
Q Consensus 277 ~l~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~l~~n~~~~~~~~~~-------------~~~~~------------ 328 (933)
.|..+++|+.|+|++|.+++..+.. ..+|+.|+|++|.+.+...-.. .|...
T Consensus 333 ~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~ 412 (844)
T 3j0a_A 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENR 412 (844)
T ss_dssp SCSSCTTCCEEECCSCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCC
T ss_pred HhcCCCCCCEEECCCCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCc
Confidence 6666666666666666665554432 3356666666666554321000 00000
Q ss_pred -----------hhhhhHhh--h----------cccCCCcccc-CCCCCCCCC-----CCCCccccCCCceeEEEccCccc
Q 002346 329 -----------QVTTLLQI--A----------GDMGYPAILS-DSWEGNNAC-----DGWPFVTCSQGRIITINLANKLL 379 (933)
Q Consensus 329 -----------~~~~~~~~--~----------~~~~~~~~l~-~~~~~~~~~-----~~~p~~~~~l~~L~~L~Ls~N~l 379 (933)
....+..+ . ........++ +++.+|... +..|..+..+++|+.|+|++|++
T Consensus 413 l~~l~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l 492 (844)
T 3j0a_A 413 LENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYL 492 (844)
T ss_dssp CCSSTTHHHHTTCTTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHH
T ss_pred cccCchhhhhhcCCccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcc
Confidence 00000000 0 0000001111 112222222 23345567788999999999999
Q ss_pred cCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCCCCCcccccCCCCCCcCC
Q 002346 380 AGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGT 451 (933)
Q Consensus 380 ~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n~~~~~ 451 (933)
++.+|..|.++++|+.|+|++|+|++..|..+. ++|+.|||++|+|++.+|.....+....+.+|||.|.
T Consensus 493 ~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~ 562 (844)
T 3j0a_A 493 NSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICE 562 (844)
T ss_dssp TTCCTTSSSSCCSCSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCS
T ss_pred cccChhHccchhhhheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccc
Confidence 988888899999999999999999977777666 7899999999999999998766666667789999984
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-38 Score=342.02 Aligned_cols=249 Identities=24% Similarity=0.360 Sum_probs=202.4
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
..++|++.+.||+|+||.||+|... +++.||+|++...........++.+|+..+..+ +||||+++++++.+++..++
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 4578999999999999999999664 799999999987655555677899999999999 99999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-------------
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD------------- 723 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~------------- 723 (933)
||||+++++|.+++...... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.+
T Consensus 89 v~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~ 164 (289)
T 1x8b_A 89 QNEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDED 164 (289)
T ss_dssp EEECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC---------------
T ss_pred EEEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccc
Confidence 99999999999999763221 2568999999999999999999999 899999999999999844
Q ss_pred ------CcEEEecccccccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchh
Q 002346 724 ------MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDR 796 (933)
Q Consensus 724 ------~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~ 796 (933)
..+||+|||.+....... ...||+.|+|||++.+. .++.++||||||+++|||++|++++.... .
T Consensus 165 ~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~ 236 (289)
T 1x8b_A 165 DWASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---Q 236 (289)
T ss_dssp -----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---H
T ss_pred cccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---H
Confidence 479999999998765432 23589999999999765 56789999999999999999997764321 1
Q ss_pred hHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 797 AHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. .... ....+. +...+. ..+.+++.+||+.||++||++.|+++
T Consensus 237 --~----~~~~--~~~~~~-~~~~~~---------~~~~~li~~~l~~dp~~Rps~~~ll~ 279 (289)
T 1x8b_A 237 --W----HEIR--QGRLPR-IPQVLS---------QEFTELLKVMIHPDPERRPSAMALVK 279 (289)
T ss_dssp --H----HHHH--TTCCCC-CSSCCC---------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --H----HHHH--cCCCCC-CCcccC---------HHHHHHHHHHhCCCcccCCCHHHHhh
Confidence 1 1111 111111 111111 35779999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=375.31 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=201.6
Q ss_pred CccccCCCeEEEEEEe---CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.+ ..++.||||+++.........++|.+|++++++++|||||++++++.. +..++||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 346789999998765555667899999999999999999999999864 567899999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCc-
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY- 742 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~- 742 (933)
|+|.+++.. ...+++.+++.|+.||+.||+|||+ ++||||||||+|||++.++.+||+|||+++.......
T Consensus 454 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~ 525 (635)
T 4fl3_A 454 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 525 (635)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred CCHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence 999999965 2468999999999999999999999 8999999999999999999999999999987654332
Q ss_pred -eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 743 -SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 743 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+. .. .... ... ......
T Consensus 526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~---~i~~-~~~--~~~p~~ 596 (635)
T 4fl3_A 526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV---TA---MLEK-GER--MGCPAG 596 (635)
T ss_dssp ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HH---HHHT-TCC--CCCCTT
T ss_pred cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHHc-CCC--CCCCCC
Confidence 22233457889999999998899999999999999999998 9999976543221 11 1111 111 111111
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
. ..++.+++.+||+.||++||+++++++.|+++...
T Consensus 597 ~---------~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~ 632 (635)
T 4fl3_A 597 C---------PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 632 (635)
T ss_dssp C---------CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred C---------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1 24678999999999999999999999999887543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-38 Score=364.71 Aligned_cols=253 Identities=25% Similarity=0.352 Sum_probs=205.2
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+.++|++.+.||+|+||.||+|.. .+++.||||++............+.+|+.++++++||||+++++++.+....++|
T Consensus 20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 99 (486)
T 3mwu_A 20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV 99 (486)
T ss_dssp HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence 457899999999999999999965 4789999999976544445567899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec---CCCcEEEeccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKVADFGLV 734 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl~DfGla 734 (933)
|||+++|+|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++ .++.+||+|||++
T Consensus 100 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a 171 (486)
T 3mwu_A 100 GELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171 (486)
T ss_dssp ECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCT
T ss_pred EEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcC
Confidence 9999999999998652 468999999999999999999999 8999999999999995 4567999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
+...... ......||+.|+|||++.+ .++.++||||+||++|+|++|+.||......+ . ...+........
T Consensus 172 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~---~~~i~~~~~~~~ 242 (486)
T 3mwu_A 172 TCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---I---LKRVETGKYAFD 242 (486)
T ss_dssp TTBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---HHHHHHTCCCSC
T ss_pred eECCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCCCCCC
Confidence 8665432 2234579999999999875 59999999999999999999999997653322 1 112221111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. ........+.+++.+||+.+|++|||+.|+++
T Consensus 243 ~~---------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~ 276 (486)
T 3mwu_A 243 LP---------QWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276 (486)
T ss_dssp SG---------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred Cc---------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 00 00111245779999999999999999999987
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=347.37 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=209.3
Q ss_pred cHHHHHHHhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCC------chhHHHHHHHHHHHHhc-CCCccee
Q 002346 572 SIEVLRQVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMG------NKGLSEFQAEIAVLTKV-RHRHLVA 643 (933)
Q Consensus 572 ~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l-~h~niv~ 643 (933)
.......+.++|++.+.||+|+||.||+|... +|+.||||++...... ....+.+.+|+.+++++ +||||++
T Consensus 85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~ 164 (365)
T 2y7j_A 85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIIT 164 (365)
T ss_dssp HHHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCC
T ss_pred cchhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 34555667789999999999999999999764 7999999998765321 12245788999999999 7999999
Q ss_pred EEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC
Q 002346 644 LLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD 723 (933)
Q Consensus 644 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~ 723 (933)
+++++......++||||+++++|.+++.. ...+++..+..++.|++.||+|||+ .+|+||||||+||+++.+
T Consensus 165 ~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~ 236 (365)
T 2y7j_A 165 LIDSYESSSFMFLVFDLMRKGELFDYLTE-----KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDN 236 (365)
T ss_dssp EEEEEEBSSEEEEEECCCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTT
T ss_pred EEEEEeeCCEEEEEEEeCCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCC
Confidence 99999999999999999999999999965 2468999999999999999999999 899999999999999999
Q ss_pred CcEEEecccccccCCCCCceeecccccccCcccccccCC------CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhh
Q 002346 724 MRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT------GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA 797 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~ 797 (933)
+.+||+|||++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......
T Consensus 237 ~~ikl~DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-- 312 (365)
T 2y7j_A 237 MQIRLSDFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-- 312 (365)
T ss_dssp CCEEECCCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred CCEEEEecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--
Confidence 9999999999987654332 234679999999998853 358899999999999999999999997643211
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.. .............. .......+.+++.+|++.||++||++.|+++
T Consensus 313 -~~---~~i~~~~~~~~~~~---------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~ 359 (365)
T 2y7j_A 313 -ML---RMIMEGQYQFSSPE---------WDDRSSTVKDLISRLLQVDPEARLTAEQALQ 359 (365)
T ss_dssp -HH---HHHHHTCCCCCHHH---------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred -HH---HHHHhCCCCCCCcc---------cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 11 11111111111000 0011245789999999999999999999987
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-38 Score=372.29 Aligned_cols=260 Identities=22% Similarity=0.345 Sum_probs=204.4
Q ss_pred CCccCC-ccccCCCeEEEEEEeC---CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 582 NFSEAN-ILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 582 ~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
++.+.+ .||+|+||.||+|... ++..||||+++... .....++|.+|++++++++|||||++++++.. +..++|
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv 413 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 413 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEE
Confidence 344444 7999999999999653 46689999998653 34456889999999999999999999999976 568999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++|+|.+++... ...+++.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus 414 ~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 414 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp EECCTTCBHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred EEeCCCCcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 9999999999999542 3569999999999999999999999 89999999999999999999999999999876
Q ss_pred CCCCcee--ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 738 PDGKYSV--ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 738 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
....... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||......+. .. .+.. ...
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~---~i~~-~~~-- 557 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MA---FIEQ-GKR-- 557 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HH---HHHT-TCC--
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HH---HHHc-CCC--
Confidence 5433211 122346689999999998999999999999999999998 9999987544322 11 1111 111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....+.. ...+.+++.+||+.+|++||++.++++.|+.+......
T Consensus 558 ~~~p~~~---------~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~ 602 (613)
T 2ozo_A 558 MECPPEC---------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS 602 (613)
T ss_dssp CCCCTTC---------CHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred CCCCCcC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence 1111111 24678999999999999999999999999987655543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-38 Score=340.97 Aligned_cols=251 Identities=25% Similarity=0.405 Sum_probs=203.3
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+.++|.+.+.||+|+||.||++.. .+|+.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 457899999999999999999965 479999999997653 22346789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe---cCCCcEEEeccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLV 734 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGla 734 (933)
|||+++++|.+++... ..+++.+++.++.|++.||+|||+ .+|+||||||+||++ +.++.+||+|||++
T Consensus 85 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~ 156 (304)
T 2jam_A 85 MQLVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156 (304)
T ss_dssp ECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTT
T ss_pred EEcCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcc
Confidence 9999999999998652 458999999999999999999999 899999999999999 78899999999998
Q ss_pred ccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
+...... .....|++.|+|||++.+..++.++||||||+++|||++|+.||....... . ...........+
T Consensus 157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~---~~~i~~~~~~~~ 227 (304)
T 2jam_A 157 KMEQNGI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---L---FEKIKEGYYEFE 227 (304)
T ss_dssp CCCCCBT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---H---HHHHHHCCCCCC
T ss_pred eecCCCc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---H---HHHHHcCCCCCC
Confidence 7544321 233468999999999999999999999999999999999999997653221 1 112222111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....+.+ ...+.+++.+|++.||++||++.|+++
T Consensus 228 ~~~~~~~---------~~~~~~li~~~l~~dp~~Rps~~~~l~ 261 (304)
T 2jam_A 228 SPFWDDI---------SESAKDFICHLLEKDPNERYTCEKALS 261 (304)
T ss_dssp TTTTTTS---------CHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred ccccccC---------CHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence 1111111 245779999999999999999999986
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-38 Score=341.65 Aligned_cols=250 Identities=23% Similarity=0.396 Sum_probs=206.9
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|.+.+.||+|+||.||++... +++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 468999999999999999999654 688999999876543 234567889999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 165 (294)
T 2rku_A 94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 165 (294)
T ss_dssp EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence 9999999999988652 468999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ...........+..
T Consensus 166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~~~~~- 237 (294)
T 2rku_A 166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNEYSIPKH- 237 (294)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTCCCCCTT-
T ss_pred ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhhccCCCccc-
Confidence 53322 22345799999999999988899999999999999999999999976532211 11112212112111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ...+.+++.+|++.||++||+++|+++
T Consensus 238 ---~---------~~~~~~li~~~l~~~p~~Rps~~~ll~ 265 (294)
T 2rku_A 238 ---I---------NPVAASLIQKMLQTDPTARPTINELLN 265 (294)
T ss_dssp ---S---------CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---c---------CHHHHHHHHHHcccChhhCcCHHHHhh
Confidence 1 135779999999999999999999986
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-38 Score=340.64 Aligned_cols=249 Identities=25% Similarity=0.455 Sum_probs=207.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.+.|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTT-CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccc-cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 36789999999999999999954 578999999997654 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++.. .++++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 100 e~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 170 (303)
T 3a7i_A 100 EYLGGGSALDLLEP------GPLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLT 170 (303)
T ss_dssp ECCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECB
T ss_pred EeCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecC
Confidence 99999999999854 468999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... ......|++.|+|||++.+..++.++||||||+++|||++|+.||........ ...+ .. .. +..+.
T Consensus 171 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~~~---~~--~~-~~~~~ 240 (303)
T 3a7i_A 171 DTQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---LFLI---PK--NN-PPTLE 240 (303)
T ss_dssp TTBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHH---HH--SC-CCCCC
T ss_pred cccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH---HHHh---hc--CC-CCCCc
Confidence 4322 22345799999999999999999999999999999999999999976533221 1111 11 11 11111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... ..+.+++.+||+.+|++||++.++++
T Consensus 241 ~~~~---------~~l~~li~~~l~~dp~~Rps~~~ll~ 270 (303)
T 3a7i_A 241 GNYS---------KPLKEFVEACLNKEPSFRPTAKELLK 270 (303)
T ss_dssp SSCC---------HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred cccC---------HHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111 35779999999999999999999986
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=348.19 Aligned_cols=263 Identities=27% Similarity=0.394 Sum_probs=204.7
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee----Ccee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSER 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~ 654 (933)
.++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 105 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA 105 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence 47899999999999999999965 67999999998654 34556789999999999999999999999873 3477
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++|+|.+++..... ....+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 106 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~ 181 (317)
T 2buj_A 106 WLLLPFFKRGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSM 181 (317)
T ss_dssp EEEEECCTTCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSC
T ss_pred EEEEEeCCCCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcc
Confidence 899999999999999976433 23679999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCce--------eecccccccCcccccccCCCC---CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHH
Q 002346 735 KNAPDGKYS--------VETRLAGTFGYLAPEYAATGR---VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF 803 (933)
Q Consensus 735 ~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~ 803 (933)
......... ......||+.|+|||++.... ++.++||||||+++|||++|+.||........ ....
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~-- 258 (317)
T 2buj_A 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-SVAL-- 258 (317)
T ss_dssp EESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-CHHH--
T ss_pred hhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-hhhH--
Confidence 755421110 012245799999999987554 68999999999999999999999953211110 0111
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
........+. .+.. ...+.+++.+||+.||++||++.++++.|+.+..
T Consensus 259 --~~~~~~~~~~--~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~ 306 (317)
T 2buj_A 259 --AVQNQLSIPQ--SPRH---------SSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306 (317)
T ss_dssp --HHHCC--CCC--CTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred --HhhccCCCCc--cccC---------CHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence 1111111110 1111 1357899999999999999999999999987643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=334.57 Aligned_cols=254 Identities=22% Similarity=0.336 Sum_probs=205.7
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
..++|++.+.||+|+||.||+|.. .+++.||||++..... ....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence 347899999999999999999965 4789999999876532 34457899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 84 ~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 155 (276)
T 2yex_A 84 LEYCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155 (276)
T ss_dssp EECCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEecCCCcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCcccc
Confidence 999999999999854 2468999999999999999999999 89999999999999999999999999998765
Q ss_pred CCCCc-eeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 738 PDGKY-SVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 738 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
..... .......|++.|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....+. .......
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~----~~~~~~~- 229 (276)
T 2yex_A 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK----EKKTYLN- 229 (276)
T ss_dssp EETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH----TTCTTST-
T ss_pred CCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh----hcccccC-
Confidence 43221 12234579999999999987665 7899999999999999999999986543221 111111 1111110
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+ .......+.+++.+|++.||++||+++|+++
T Consensus 230 ---~-------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (276)
T 2yex_A 230 ---P-------WKKIDSAPLALLHKILVENPSARITIPDIKK 261 (276)
T ss_dssp ---T-------GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ---c-------hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence 0 0011235779999999999999999999976
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=351.47 Aligned_cols=202 Identities=26% Similarity=0.408 Sum_probs=177.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 110 (360)
T 3eqc_A 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 110 (360)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence 46899999999999999999965 478999999987653 3455678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++... ..+++..+..++.|++.||+|||+. ++|+||||||+||+++.++.+||+|||++....
T Consensus 111 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 183 (360)
T 3eqc_A 111 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 183 (360)
T ss_dssp CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred ECCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999999662 4589999999999999999999981 389999999999999999999999999986442
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTM 792 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~ 792 (933)
.. ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 184 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 234 (360)
T 3eqc_A 184 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 234 (360)
T ss_dssp HH---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred cc---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1234579999999999999999999999999999999999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=346.99 Aligned_cols=268 Identities=23% Similarity=0.328 Sum_probs=206.2
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--------C
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--------G 651 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 651 (933)
++|++.+.||+|+||.||+|.. .+|+.||||++............+.+|+.+++.++||||+++++++.. .
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 6899999999999999999965 579999999997765555555688899999999999999999999876 3
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
+..++||||++ ++|.+.+... ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+||
T Consensus 97 ~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Df 168 (351)
T 3mi9_A 97 GSIYLVFDFCE-HDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 168 (351)
T ss_dssp CEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccC-CCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccc
Confidence 46899999997 4887777542 2458999999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCC---ceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 732 GLVKNAPDGK---YSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 732 Gla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
|+++...... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........... +....
T Consensus 169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~---i~~~~ 245 (351)
T 3mi9_A 169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL---ISQLC 245 (351)
T ss_dssp TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHH
T ss_pred hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHh
Confidence 9998654322 122234578999999998875 4589999999999999999999999987543322211 11111
Q ss_pred hccCCCCcccCCCC-------------CCChhhHHH------HHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 808 ISKENIPKAIDPNL-------------NLDEETIES------IYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 808 ~~~~~~~~~~d~~l-------------~~~~~~~~~------~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
...+....+.. .......+. ...+.+++.+||+.||++||+++|+++ ++|..
T Consensus 246 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~ 316 (351)
T 3mi9_A 246 ---GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN------HDFFW 316 (351)
T ss_dssp ---CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGG
T ss_pred ---CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC------CCCcC
Confidence 11111000000 000000111 234779999999999999999999987 67764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-38 Score=343.67 Aligned_cols=267 Identities=25% Similarity=0.424 Sum_probs=210.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-----CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc--
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-----PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS-- 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-- 652 (933)
.++|++.+.||+|+||.||++.. .+++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 117 (326)
T 2w1i_A 40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 117 (326)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence 46789999999999999999973 46899999999764 3455678999999999999999999999987644
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||+++++|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 118 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg 190 (326)
T 2w1i_A 118 NLKLIMEYLPYGSLRDYLQKH----KERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190 (326)
T ss_dssp CCEEEECCCTTCBHHHHHHHS----TTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCT
T ss_pred ceEEEEECCCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCc
Confidence 679999999999999999662 2458999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCcee--ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCc---------hhhHHHH
Q 002346 733 LVKNAPDGKYSV--ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD---------DRAHLVT 801 (933)
Q Consensus 733 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~---------~~~~~~~ 801 (933)
+++......... .....++..|+|||.+.+..++.++||||||+++|||+||+.|+...... .......
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (326)
T 2w1i_A 191 LTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 270 (326)
T ss_dssp TCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHH
T ss_pred chhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHH
Confidence 998765443221 23345778899999998888999999999999999999999988642100 0001111
Q ss_pred HHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 802 WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 802 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
............+ .... ....+.+++.+||+.+|++||++.|+++.|+.+.+++
T Consensus 271 ~~~~~~~~~~~~~--~~~~---------~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l 324 (326)
T 2w1i_A 271 HLIELLKNNGRLP--RPDG---------CPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324 (326)
T ss_dssp HHHHHHHTTCCCC--CCTT---------CCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred HHHHHhhcCCCCC--CCCc---------ccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence 1111111111111 1111 1245789999999999999999999999999887653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=338.02 Aligned_cols=253 Identities=31% Similarity=0.452 Sum_probs=199.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-ceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-SERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. +|+.||||++.... ..+.+.+|+.++++++||||+++++++.+. +..++||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~ 94 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred hhhceEEeEEecCCCceEEEEEE-cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence 46899999999999999999987 58999999987542 356899999999999999999999997654 4789999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 95 e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 168 (278)
T 1byg_A 95 EYMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 168 (278)
T ss_dssp CCCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred ecCCCCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeecccccccc
Confidence 9999999999996521 1347899999999999999999999 899999999999999999999999999987554
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+. .. ... .. .....
T Consensus 169 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~---~~---~~~--~~-~~~~~ 235 (278)
T 1byg_A 169 STQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP---RVE--KG-YKMDA 235 (278)
T ss_dssp -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---HH---HHT--TT-CCCCC
T ss_pred ccc----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH---HHh--cC-CCCCC
Confidence 322 22367889999999988899999999999999999998 9999976543221 11 111 11 11111
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.... ...+.+++.+|++.||++||++.++++.|+.+...
T Consensus 236 ~~~~---------~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~ 274 (278)
T 1byg_A 236 PDGC---------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274 (278)
T ss_dssp CTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred cccC---------CHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence 1111 24577999999999999999999999999887643
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=345.46 Aligned_cols=263 Identities=29% Similarity=0.478 Sum_probs=206.1
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEE--EEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKI--AVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
++|++.+.||+|+||.||+|.. .++..+ |+|++.... .....+.+.+|+++++++ +||||+++++++.+++..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 103 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 103 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence 6789999999999999999965 456644 999887542 334456799999999999 89999999999999999999
Q ss_pred EEeecCCCChhhHhhhccc-----------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 657 VYEYMPRGTLAQHLFEWHD-----------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
||||+++++|.+++..... .....+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.
T Consensus 104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~ 180 (327)
T 1fvr_A 104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 180 (327)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence 9999999999999976320 123469999999999999999999999 89999999999999999999
Q ss_pred EEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~ 804 (933)
+||+|||+++..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... ...
T Consensus 181 ~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~~ 252 (327)
T 1fvr_A 181 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LYE 252 (327)
T ss_dssp EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHH
T ss_pred EEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HHH
Confidence 999999998743321 11223457889999999988889999999999999999998 999997653221 111
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcC
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~ 867 (933)
.... .... ..... ....+.+++.+|++.+|++||+++++++.|+.+.+...
T Consensus 253 ~~~~-~~~~--~~~~~---------~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~ 303 (327)
T 1fvr_A 253 KLPQ-GYRL--EKPLN---------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 303 (327)
T ss_dssp HGGG-TCCC--CCCTT---------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred Hhhc-CCCC--CCCCC---------CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence 1111 1100 01111 12357899999999999999999999999998876543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=347.84 Aligned_cols=250 Identities=23% Similarity=0.395 Sum_probs=207.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|.+.+.||+|+||.||++.. .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 46899999999999999999965 4588999999876533 234567899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++..
T Consensus 120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 191 (335)
T 2owb_A 120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV 191 (335)
T ss_dssp ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence 9999999999998652 468999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. ..........++..
T Consensus 192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~~~- 263 (335)
T 2owb_A 192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLRIKKNEYSIPKH- 263 (335)
T ss_dssp CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCCCCTT-
T ss_pred ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHHHhcCCCCCCcc-
Confidence 53322 22345799999999999988899999999999999999999999976432211 11111112222211
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+ ...+.+++.+||+.||++||+++|+++
T Consensus 264 ---~---------~~~~~~li~~~l~~dp~~Rps~~ell~ 291 (335)
T 2owb_A 264 ---I---------NPVAASLIQKMLQTDPTARPTINELLN 291 (335)
T ss_dssp ---S---------CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred ---C---------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 1 135678999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=340.33 Aligned_cols=251 Identities=27% Similarity=0.471 Sum_probs=205.5
Q ss_pred HHhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee------
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------ 650 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------ 650 (933)
....+|++.+.||+|+||.||+|... +++.||+|++.... +.+.+|++++++++||||+++++++..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (284)
T 2a19_B 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPE 81 (284)
T ss_dssp HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC--
T ss_pred hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcc
Confidence 45678999999999999999999764 79999999987542 357789999999999999999998854
Q ss_pred ----------CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe
Q 002346 651 ----------GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI 720 (933)
Q Consensus 651 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill 720 (933)
....++||||+++++|.+++.... ...+++..++.++.|+++||+|||+ ++|+||||||+||++
T Consensus 82 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~ 155 (284)
T 2a19_B 82 TSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFL 155 (284)
T ss_dssp -------CCEEEEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEE
T ss_pred cccccccccCcceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEE
Confidence 445789999999999999997632 2468999999999999999999999 899999999999999
Q ss_pred cCCCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHH
Q 002346 721 GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV 800 (933)
Q Consensus 721 ~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~ 800 (933)
+.++.+||+|||++........ .....|++.|+|||++.+..++.++||||||+++|||++|..|+... .
T Consensus 156 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~--- 225 (284)
T 2a19_B 156 VDTKQVKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S--- 225 (284)
T ss_dssp EETTEEEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H---
T ss_pred cCCCCEEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H---
Confidence 9999999999999987654332 23457999999999999889999999999999999999999876421 1
Q ss_pred HHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 801 TWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 801 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
....... ...++..+ . ..+.+++.+|++.||++||++.|+++.|+.+.+.
T Consensus 226 ~~~~~~~--~~~~~~~~----~---------~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 226 KFFTDLR--DGIISDIF----D---------KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHHH--TTCCCTTS----C---------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHHhh--cccccccC----C---------HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 1111111 11122111 1 3467999999999999999999999999876543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=363.23 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=202.5
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-----------hhHHHHHHHHHHHHhcCCCcceeEEe
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-----------KGLSEFQAEIAVLTKVRHRHLVALLG 646 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~~l~~l~h~niv~l~~ 646 (933)
+.++|++.+.||+|+||.||+|.. .+++.||||++....... ...+.+.+|+.++++++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 468899999999999999999965 468899999997654321 34578999999999999999999999
Q ss_pred EeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC--
Q 002346 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-- 724 (933)
Q Consensus 647 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-- 724 (933)
++.++...++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~ 185 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSL 185 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCC
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCC
Confidence 999999999999999999999998652 458999999999999999999999 8999999999999998776
Q ss_pred -cEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHH
Q 002346 725 -RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF 803 (933)
Q Consensus 725 -~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~ 803 (933)
.+||+|||+++...... ......||+.|+|||++. +.++.++||||+||++|+|++|+.||....... . .
T Consensus 186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~---~ 256 (504)
T 3q5i_A 186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---I---I 256 (504)
T ss_dssp SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---H---H
T ss_pred ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---H---H
Confidence 69999999998765432 223457999999999987 569999999999999999999999998654322 1 1
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+.......+....+ .....+.+++.+|++.||.+|||++|+++
T Consensus 257 ~~i~~~~~~~~~~~~~---------~~s~~~~~li~~~L~~dp~~R~t~~e~l~ 301 (504)
T 3q5i_A 257 KKVEKGKYYFDFNDWK---------NISDEAKELIKLMLTYDYNKRCTAEEALN 301 (504)
T ss_dssp HHHHHCCCCCCHHHHT---------TSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHcCCCCCCccccC---------CCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 2222211111100001 11245789999999999999999999986
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-38 Score=344.61 Aligned_cols=264 Identities=25% Similarity=0.400 Sum_probs=206.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++.... ......++.+|+.++++++||||+++++++.....
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP 107 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence 47899999999999999999973 357789999997542 34456789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---CCcEEE
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKV 728 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl 728 (933)
.++||||+++++|.+++...... ....+++.+++.++.|+++||+|||+ ++|+||||||+||+++. +..+||
T Consensus 108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl 184 (327)
T 2yfx_A 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKI 184 (327)
T ss_dssp CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEE
Confidence 99999999999999999764321 12458999999999999999999999 89999999999999984 446999
Q ss_pred ecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHH
Q 002346 729 ADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 729 ~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+|||+++....... .......|++.|+|||++.+..++.++||||||+++|||+| |+.||....... ... ..
T Consensus 185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~---~~ 258 (327)
T 2yfx_A 185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLE---FV 258 (327)
T ss_dssp CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHH---HH
T ss_pred CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHH---HH
Confidence 99999875433221 22234568899999999988899999999999999999998 999997653221 111 11
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.. .. .. ...... ...+.+++.+||+.||++||++.++++.|+.+...
T Consensus 259 ~~-~~-~~-~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~ 305 (327)
T 2yfx_A 259 TS-GG-RM-DPPKNC---------PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305 (327)
T ss_dssp HT-TC-CC-CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred hc-CC-CC-CCCCCC---------CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence 11 11 10 111111 13577999999999999999999999999887543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=351.27 Aligned_cols=261 Identities=24% Similarity=0.388 Sum_probs=186.3
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------c
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------S 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~ 652 (933)
.++|++.+.||+|+||.||+|. ..+|+.||||++..........+++.+|+.+++.++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 4789999999999999999995 46799999999976654555677899999999999999999999998654 5
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG 177 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFG 177 (367)
T ss_dssp CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecc
Confidence 679999999 7899998854 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
+++..... .....||+.|+|||++.+ ..++.++||||+||++|||++|+.||......+. ...+........
T Consensus 178 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~---l~~i~~~~g~p~ 250 (367)
T 2fst_X 178 LARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ---LKLILRLVGTPG 250 (367)
T ss_dssp -----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHCSCC
T ss_pred cccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence 99865432 234579999999999876 6789999999999999999999999976543222 111111110000
Q ss_pred -----CCC--------cccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 -----NIP--------KAID--PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 -----~~~--------~~~d--~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+. ..+. +..............+.+++.+||+.||++||++.|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~ 311 (367)
T 2fst_X 251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 311 (367)
T ss_dssp HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence 000 0000 000000000011245789999999999999999999986
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-38 Score=356.21 Aligned_cols=276 Identities=23% Similarity=0.336 Sum_probs=188.3
Q ss_pred HhcCCcc-CCccccCCCeEEEEEEeC---CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--Cc
Q 002346 579 VTDNFSE-ANILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GS 652 (933)
Q Consensus 579 ~~~~~~~-~~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~ 652 (933)
+.+.|++ .++||+|+||.||+|... +++.||||++..... ...+.+|+.++++++|||||++++++.. +.
T Consensus 18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 93 (405)
T 3rgf_A 18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADR 93 (405)
T ss_dssp HHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred hhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence 3456776 568999999999999754 578999999976532 2468899999999999999999999954 67
Q ss_pred eeEEEEeecCCCChhhHhhhccc----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe----cCCC
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHD----HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----GDDM 724 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill----~~~~ 724 (933)
..++||||++ ++|.+++..... .....+++..++.++.|++.||+|||+ ++|+||||||+|||+ +.++
T Consensus 94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTT
T ss_pred eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCC
Confidence 8899999996 588888754221 112359999999999999999999999 899999999999999 7788
Q ss_pred cEEEecccccccCCCCCc--eeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCch------
Q 002346 725 RAKVADFGLVKNAPDGKY--SVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDD------ 795 (933)
Q Consensus 725 ~~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~------ 795 (933)
.+||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 999999999986543221 222446899999999998774 58999999999999999999999997643311
Q ss_pred -hhHHHHHHHHHhhccC-CCCcccC-C-------CCCC----ChhhHH--------HHHHHHHHHHHcccCCCCCCCCHH
Q 002346 796 -RAHLVTWFRRVLISKE-NIPKAID-P-------NLNL----DEETIE--------SIYRVAELAGHCTAREPQQRPDMG 853 (933)
Q Consensus 796 -~~~~~~~~~~~~~~~~-~~~~~~d-~-------~l~~----~~~~~~--------~~~~~~~li~~cl~~~P~~RPs~~ 853 (933)
...+...+...-.... .+..... + .+.. ...... ....+.+++.+||+.||++|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 1111111111100000 0000000 0 0000 000000 023567999999999999999999
Q ss_pred HHHHHHhhhhhhcCC
Q 002346 854 HAVNVLGPLVEQWKP 868 (933)
Q Consensus 854 evl~~L~~~~~~~~~ 868 (933)
|+++ ++|..
T Consensus 330 e~L~------hp~f~ 338 (405)
T 3rgf_A 330 QAMQ------DPYFL 338 (405)
T ss_dssp HHHT------SGGGT
T ss_pred HHhc------Chhhc
Confidence 9987 67764
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=338.85 Aligned_cols=247 Identities=26% Similarity=0.452 Sum_probs=204.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++.++...++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 6799999999999999999965 46889999998654321 223567999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++....
T Consensus 94 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~ 165 (284)
T 2vgo_A 94 EFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAP 165 (284)
T ss_dssp CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECS
T ss_pred EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCc
Confidence 999999999999662 458999999999999999999998 899999999999999999999999999987654
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... .....|++.|+|||++.+..++.++||||||+++|||++|+.||........ ...........+
T Consensus 166 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~~~---- 232 (284)
T 2vgo_A 166 SLR---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET------HRRIVNVDLKFP---- 232 (284)
T ss_dssp SSC---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTCCCCC----
T ss_pred ccc---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH------HHHHhccccCCC----
Confidence 322 2345789999999999998999999999999999999999999976432211 112221111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.+ ...+.+++.+|++.||++||++.++++
T Consensus 233 ~~~---------~~~~~~li~~~l~~~p~~Rps~~~ll~ 262 (284)
T 2vgo_A 233 PFL---------SDGSKDLISKLLRYHPPQRLPLKGVME 262 (284)
T ss_dssp TTS---------CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CcC---------CHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence 111 135779999999999999999999986
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-38 Score=339.30 Aligned_cols=255 Identities=24% Similarity=0.339 Sum_probs=190.2
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+.++...++.++||||+++++++.+++..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 57899999999999999999965 57999999999876444444445556666688889999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
||++ |+|.+++...... ...+++..++.++.|++.||+|||+ + +|+||||||+||+++.++.+||+|||+++..
T Consensus 86 e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp ECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred ehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 9996 5998887653222 3579999999999999999999998 6 9999999999999999999999999999865
Q ss_pred CCCCceeecccccccCccccccc----CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYA----ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
..... .....||+.|+|||++ .+..++.++||||+|+++|||++|+.||........ ... .... ...
T Consensus 161 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~----~~~~--~~~ 231 (290)
T 3fme_A 161 VDDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QLK----QVVE--EPS 231 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HHH----HHHH--SCC
T ss_pred ccccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HHH----HHhc--cCC
Confidence 54322 2334799999999996 556789999999999999999999999975432211 111 1111 111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+....... ...+.+++.+|++.||++||+++|+++
T Consensus 232 ~~~~~~~~---------~~~~~~li~~~l~~~p~~Rpt~~e~l~ 266 (290)
T 3fme_A 232 PQLPADKF---------SAEFVDFTSQCLKKNSKERPTYPELMQ 266 (290)
T ss_dssp CCCCTTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCcccccC---------CHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence 11111111 235789999999999999999999976
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-37 Score=359.98 Aligned_cols=342 Identities=19% Similarity=0.225 Sum_probs=268.0
Q ss_pred CCccccc--eEeCCC---------CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC--CccCcCcCceec
Q 002346 53 GYCEWTG--INCDNS---------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIY 119 (933)
Q Consensus 53 ~~C~w~g--v~c~~~---------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--~~~~l~~L~~L~ 119 (933)
..|.|.+ |.|++. .+++.|+|++|++++..|..|+.+++|++|+|++|.+.+.++ .|.++++|++|+
T Consensus 6 ~~c~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~ 85 (455)
T 3v47_A 6 SECSVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILK 85 (455)
T ss_dssp -CCEEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEE
T ss_pred ceeEEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEe
Confidence 3465555 888753 479999999999999889999999999999999999986654 699999999999
Q ss_pred cccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChh-hcCCCCCCEEEccCCc
Q 002346 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF-FDSFSNLQNLRLSYNN 198 (933)
Q Consensus 120 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-~~~l~~L~~L~L~~N~ 198 (933)
|++|+++++++..|+++++|++|+|++|++.+..+....+..+++|++|+|++|++.+..|.. |..+++|++|+|++|+
T Consensus 86 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~ 165 (455)
T 3v47_A 86 LDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNK 165 (455)
T ss_dssp CTTCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCC
T ss_pred CCCCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCc
Confidence 999999999998999999999999999999872222234899999999999999999998876 8999999999999999
Q ss_pred CCCCCCccccc---cccchhhcccccCCcccccc-------cccCCccCcEEEecCCccCCCCCC-C-------------
Q 002346 199 FTGSLPASFAK---SDIQNLWMNDQQLGLSGTLD-------VLSGMTQLRQVWLHKNQFTGPIPD-L------------- 254 (933)
Q Consensus 199 l~~~~p~~~~~---~~l~~l~l~~n~~~~~~~~~-------~l~~l~~L~~L~L~~N~l~~~~~~-~------------- 254 (933)
+++..|..+.. ..++.|++..|.+....... .+..+++|+.|+|++|++++..+. +
T Consensus 166 l~~~~~~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~ 245 (455)
T 3v47_A 166 VKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245 (455)
T ss_dssp BSCCCTTTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEE
T ss_pred ccccChhhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEe
Confidence 99888888765 56778888888776543321 233457888888888887653331 1
Q ss_pred ------------------------C--CCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCC---CCc
Q 002346 255 ------------------------S--KCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP---SKV 305 (933)
Q Consensus 255 ------------------------~--~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~---~~l 305 (933)
. ..++|+.|+|++|++++.+|..+..+++|++|+|++|++++..|..+ .+|
T Consensus 246 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L 325 (455)
T 3v47_A 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHL 325 (455)
T ss_dssp CTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTC
T ss_pred eccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhcccCCCCCEEECCCCcccccChhHhcCcccC
Confidence 1 12467777777777776677777777777777777777776655432 466
Q ss_pred cEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCch
Q 002346 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385 (933)
Q Consensus 306 ~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 385 (933)
+.|+|++|.+.+. .|..+..+++|+.|+|++|++++..|.
T Consensus 326 ~~L~Ls~N~l~~~----------------------------------------~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 365 (455)
T 3v47_A 326 LKLNLSQNFLGSI----------------------------------------DSRMFENLDKLEVLDLSYNHIRALGDQ 365 (455)
T ss_dssp CEEECCSSCCCEE----------------------------------------CGGGGTTCTTCCEEECCSSCCCEECTT
T ss_pred CEEECCCCccCCc----------------------------------------ChhHhcCcccCCEEECCCCcccccChh
Confidence 6777777766432 244566778888888888888888888
Q ss_pred hhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCC
Q 002346 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434 (933)
Q Consensus 386 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~ 434 (933)
.|.++++|++|+|++|+|++..+..|..+++|+.|++++|++++.+|..
T Consensus 366 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~ 414 (455)
T 3v47_A 366 SFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRI 414 (455)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCCcc
Confidence 8888888888888888888766667788888888888888888888753
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=358.60 Aligned_cols=244 Identities=15% Similarity=0.183 Sum_probs=191.2
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHH---HHHHhcCCCcceeEE-------eE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEI---AVLTKVRHRHLVALL-------GY 647 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~~ 647 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+ +.+++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46789999999999999999975 5699999999975432 334567899999 455555899999998 55
Q ss_pred eeeCc-----------------eeEEEEeecCCCChhhHhhhcccC--CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCe
Q 002346 648 CINGS-----------------ERLLVYEYMPRGTLAQHLFEWHDH--GYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708 (933)
Q Consensus 648 ~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 708 (933)
+..++ ..++||||+ +|+|.+++...... ....+++..++.|+.||++||+|||+ ++|
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 55443 278999999 68999999763211 11345568899999999999999999 899
Q ss_pred EecCCCCCcEEecCCCcEEEecccccccCCCCCceeecccccccCcccccccCCC-----------CCCCccchHhHHHH
Q 002346 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG-----------RVTTKIDVYAFGVV 777 (933)
Q Consensus 709 vH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Dv~SlG~~ 777 (933)
+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 9999999999999999999999999986433 2344578 999999999877 89999999999999
Q ss_pred HHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 002346 778 LMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID--PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHA 855 (933)
Q Consensus 778 l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d--~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~ev 855 (933)
+|||++|+.||......... ..... +.+ ...+.+++.+||+.||++||++.|+
T Consensus 303 l~elltg~~Pf~~~~~~~~~----------------~~~~~~~~~~---------~~~~~~li~~~L~~dp~~Rpt~~e~ 357 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGGS----------------EWIFRSCKNI---------PQPVRALLEGFLRYPKEDRLLPLQA 357 (377)
T ss_dssp HHHHHHSSCCC------CCS----------------GGGGSSCCCC---------CHHHHHHHHHHTCSSGGGCCCHHHH
T ss_pred HHHHHHCCCCCcccccccch----------------hhhhhhccCC---------CHHHHHHHHHHcCCCchhCCCHHHH
Confidence 99999999999754321110 00111 111 1357799999999999999999999
Q ss_pred HH
Q 002346 856 VN 857 (933)
Q Consensus 856 l~ 857 (933)
++
T Consensus 358 l~ 359 (377)
T 3byv_A 358 ME 359 (377)
T ss_dssp HT
T ss_pred hh
Confidence 86
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=332.61 Aligned_cols=249 Identities=27% Similarity=0.431 Sum_probs=197.1
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|... +|+.||||++..... .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 368999999999999999999764 799999999875432 223456899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++...
T Consensus 90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~ 161 (276)
T 2h6d_A 90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161 (276)
T ss_dssp EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence 9999999999999652 458999999999999999999999 89999999999999999999999999999866
Q ss_pred CCCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
..... .....|++.|+|||.+.+..+ +.++||||||+++|||++|+.||...... ... ..........+..
T Consensus 162 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~---~~~~~~~~~~~~~ 233 (276)
T 2h6d_A 162 SDGEF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLF---KKIRGGVFYIPEY 233 (276)
T ss_dssp CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHH---HHHHHCCCCCCTT
T ss_pred CCCcc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHH---HHhhcCcccCchh
Confidence 54322 234578999999999987765 68999999999999999999999764321 111 1111111111111
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+ ...+.+++.+|++.||++||++.|+++
T Consensus 234 ----~---------~~~l~~li~~~l~~~p~~Rps~~~~l~ 261 (276)
T 2h6d_A 234 ----L---------NRSVATLLMHMLQVDPLKRATIKDIRE 261 (276)
T ss_dssp ----S---------CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----c---------CHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 1 135779999999999999999999987
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=363.70 Aligned_cols=253 Identities=23% Similarity=0.359 Sum_probs=206.5
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
+.++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.++++++||||+++++++.+....++
T Consensus 24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 357899999999999999999965 47999999999765432 3456789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe---cCCCcEEEecccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGL 733 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill---~~~~~~kl~DfGl 733 (933)
||||+.+|+|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+||++ +.++.+||+|||+
T Consensus 104 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 175 (484)
T 3nyv_A 104 VGEVYTGGELFDEIIS-----RKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGL 175 (484)
T ss_dssp EECCCCSCBHHHHHHT-----CSCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTH
T ss_pred EEecCCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeee
Confidence 9999999999999865 2568999999999999999999999 899999999999999 5678999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
++....... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||......+ .. ..+.......
T Consensus 176 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~---~~i~~~~~~~ 246 (484)
T 3nyv_A 176 STHFEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---IL---KKVEKGKYTF 246 (484)
T ss_dssp HHHBCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCCCC
T ss_pred eEEcccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HH---HHHHcCCCCC
Confidence 987654332 234579999999999865 69999999999999999999999998653322 11 1222111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.. ........+.+++.+||+.+|++|||+.|+++
T Consensus 247 ~~~---------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~ 281 (484)
T 3nyv_A 247 ELP---------QWKKVSESAKDLIRKMLTYVPSMRISARDALD 281 (484)
T ss_dssp CSG---------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCc---------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence 100 00111245779999999999999999999986
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-38 Score=375.93 Aligned_cols=245 Identities=25% Similarity=0.367 Sum_probs=204.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++++... .....+.+..|..++..+ +||+|+++++++.+.+..|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 47899999999999999999965 4688999999976432 233456788999999988 79999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++|+|.+++... ..+++.+++.++.||+.||+|||+ ++||||||||+|||++.++++||+|||+++.
T Consensus 420 V~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~ 491 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491 (674)
T ss_dssp EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred EEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeec
Confidence 99999999999999762 468999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ..+..+......++..
T Consensus 492 ~~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~------~~~~~i~~~~~~~p~~ 564 (674)
T 3pfq_A 492 NIWDGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED------ELFQSIMEHNVAYPKS 564 (674)
T ss_dssp CCCTTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHHHHSSCCCCCTT
T ss_pred cccCCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH------HHHHHHHhCCCCCCcc
Confidence 443322 234568999999999999999999999999999999999999999864322 1223333323222221
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~ 852 (933)
+ ..++.+++.+||+.||++||++
T Consensus 565 ----~---------s~~~~~li~~lL~~dP~~R~~~ 587 (674)
T 3pfq_A 565 ----M---------SKEAVAICKGLMTKHPGKRLGC 587 (674)
T ss_dssp ----S---------CHHHHHHHHHHSCSSSTTCTTC
T ss_pred ----C---------CHHHHHHHHHHccCCHHHCCCC
Confidence 1 1357799999999999999997
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=345.63 Aligned_cols=265 Identities=24% Similarity=0.396 Sum_probs=187.8
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
..++|++.+.||+|+||.||+|.. .+++.||||++.... .....+++.+|+.++++++||||+++++++...+..++|
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 91 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLV 91 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhh-cchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEE
Confidence 357899999999999999999965 478999999987653 233456789999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccC---CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDH---GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
|||+++++|.+++...... ....+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~ 168 (303)
T 2vwi_A 92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVS 168 (303)
T ss_dssp EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHH
T ss_pred ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccch
Confidence 9999999999998653211 23568999999999999999999999 89999999999999999999999999998
Q ss_pred ccCCCCCc----eeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 735 KNAPDGKY----SVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 735 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||........... .....
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~ 243 (303)
T 2vwi_A 169 AFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-----TLQND 243 (303)
T ss_dssp HHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-----HHTSS
T ss_pred heeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-----HhccC
Confidence 76543321 11234579999999999865 5689999999999999999999999987544322110 11111
Q ss_pred cCCCCccc-CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAI-DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~-d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
........ ++... . .....+.+++.+||+.||++||++.++++
T Consensus 244 ~~~~~~~~~~~~~~-~----~~~~~~~~li~~~l~~dp~~Rps~~~ll~ 287 (303)
T 2vwi_A 244 PPSLETGVQDKEML-K----KYGKSFRKMISLCLQKDPEKRPTAAELLR 287 (303)
T ss_dssp CCCTTC-----CCC-C----CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred CCccccccccchhh-h----hhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence 11111100 01110 0 11235779999999999999999999986
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-37 Score=346.41 Aligned_cols=262 Identities=22% Similarity=0.349 Sum_probs=201.7
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----ce
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 653 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++.... .....+.+.+|++++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 46899999999999999999954 578899999997542 344457899999999999999999999998754 36
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||++ |+|.+++.. ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 105 ~~iv~e~~~-~~L~~~l~~------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 174 (364)
T 3qyz_A 105 VYIVQDLME-TDLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGL 174 (364)
T ss_dssp EEEEEECCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred EEEEEcccC-cCHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcc
Confidence 799999996 599999865 458999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCcee--ecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 734 VKNAPDGKYSV--ETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 734 a~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
++......... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... .......
T Consensus 175 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~~ 251 (364)
T 3qyz_A 175 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSP 251 (364)
T ss_dssp CEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCSC
T ss_pred eEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCCC
Confidence 98665432211 234589999999998654 45899999999999999999999999876443322111 1100000
Q ss_pred C-----------------CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 E-----------------NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 ~-----------------~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ..+. ................+.+++.+||+.||++||++.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~ 313 (364)
T 3qyz_A 252 SQEDLNCIINLKARNYLLSLPH--KNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 313 (364)
T ss_dssp CHHHHHTCCCHHHHHHHHTSCC--CCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CHHHHHHhhhhhHHHHHHhcCC--ccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0 0000 0000000000111245789999999999999999999986
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-37 Score=336.55 Aligned_cols=259 Identities=26% Similarity=0.440 Sum_probs=198.1
Q ss_pred hcCCccCCccccCCCeEEEEEEeC--CCc--EEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP--DGT--KIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~--~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.++|++.+.||+|+||.||+|... +++ .||||+++.... .....+++.+|+.++++++||||+++++++..+. .
T Consensus 17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~ 95 (291)
T 1u46_A 17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M 95 (291)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence 368999999999999999999642 333 689999876533 2345678999999999999999999999998755 8
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||++
T Consensus 96 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~ 168 (291)
T 1u46_A 96 KMVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLM 168 (291)
T ss_dssp EEEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred eeeEecccCCCHHHHHHhc----cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccc
Confidence 8999999999999999752 1458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCce--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 735 KNAPDGKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 735 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
......... ......+++.|+|||++.+..++.++||||||+++|||++ |+.||....... . .........
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~---~~~~~~~~~ 242 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---I---LHKIDKEGE 242 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---HHHHHTSCC
T ss_pred ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---H---HHHHHccCC
Confidence 876544322 2234567889999999988889999999999999999999 999997653321 1 112111111
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
..+ .... ....+.+++.+|++.+|++||++.++++.|+++.
T Consensus 243 ~~~--~~~~---------~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~ 283 (291)
T 1u46_A 243 RLP--RPED---------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283 (291)
T ss_dssp CCC--CCTT---------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred CCC--CCcC---------cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence 111 1111 1245789999999999999999999999998764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-37 Score=345.01 Aligned_cols=263 Identities=21% Similarity=0.292 Sum_probs=195.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc------
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 652 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++..........+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999954 57899999999876545556678999999999999999999999997654
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||++ ++|.+++. ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg 172 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFG 172 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred ceEEEEEcCC-CCHHHHHh-------hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEee
Confidence 7899999996 57888874 348899999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH--------
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR-------- 804 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~-------- 804 (933)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+. +...+.
T Consensus 173 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~ 248 (371)
T 2xrw_A 173 LARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPE 248 (371)
T ss_dssp C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHH
T ss_pred ccccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence 998654322 22345799999999999998999999999999999999999999976533211 100000
Q ss_pred ----------HHhhccCCCC-----cccCCC-CC-CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 ----------RVLISKENIP-----KAIDPN-LN-LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ----------~~~~~~~~~~-----~~~d~~-l~-~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......... ..+... .. ...........+.+++.+||+.||++|||++|+++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 318 (371)
T 2xrw_A 249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 318 (371)
T ss_dssp HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence 0000000000 000000 00 01112233567889999999999999999999987
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-37 Score=346.27 Aligned_cols=262 Identities=21% Similarity=0.331 Sum_probs=201.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee----
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER---- 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---- 654 (933)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+++.+|+.+++.++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 57899999999999999999954 5799999999987655555678899999999999999999999999876654
Q ss_pred --EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 655 --LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 655 --~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
++||||++ ++|.+++. ..+++.++..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-------MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEEcccc-ccHHHHhh-------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 99999996 68888773 348999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+. +.... ... +
T Consensus 190 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~-~~~---~ 259 (371)
T 4exu_A 190 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ--LTQIL-KVT---G 259 (371)
T ss_dssp CC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH-HHH---C
T ss_pred cccccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHH-HHh---C
Confidence 99855432 234578999999999877 6789999999999999999999999986532221 11111 100 0
Q ss_pred CCCcc----------------cCCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 812 NIPKA----------------IDPNLNLD--EETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 812 ~~~~~----------------~d~~l~~~--~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
..+.. +....... .........+.+++.+||+.||++||+++|+++ ++|..
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~f~ 328 (371)
T 4exu_A 260 VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT------HPFFE 328 (371)
T ss_dssp CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT------SGGGT
T ss_pred CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc------Ccccc
Confidence 00000 00000000 000111346789999999999999999999986 66654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.12 Aligned_cols=252 Identities=22% Similarity=0.385 Sum_probs=198.1
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
.|.....||+|+||.||+|.. .+++.||||++... .....+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 100 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ 100 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECC--CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCC--chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence 455566899999999999964 57899999998765 234457899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-CCcEEEecccccccCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVADFGLVKNAPD 739 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~DfGla~~~~~ 739 (933)
+++++|.+++... .....+++..+..++.|+++||+|||+ ++|+||||||+||+++. ++.+||+|||++.....
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 101 VPGGSLSALLRSK--WGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp CSEEEHHHHHHHT--TCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCCCCHHHHHHhh--ccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 9999999999762 223457899999999999999999999 89999999999999987 89999999999986654
Q ss_pred CCceeecccccccCcccccccCCCC--CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGR--VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... ......|++.|+|||++.+.. ++.++||||||+++|||++|+.||......... . +.......... +
T Consensus 176 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~--~~~~~~~~~~~----~ 247 (295)
T 2clq_A 176 INP-CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-M--FKVGMFKVHPE----I 247 (295)
T ss_dssp ------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-H--HHHHHHCCCCC----C
T ss_pred CCC-cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-H--Hhhcccccccc----c
Confidence 321 223457999999999987643 789999999999999999999999754322111 1 11111111111 1
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... ...+.+++.+||+.||++||++.++++
T Consensus 248 ~~~~---------~~~~~~li~~~l~~dp~~Rps~~~ll~ 278 (295)
T 2clq_A 248 PESM---------SAEAKAFILKCFEPDPDKRACANDLLV 278 (295)
T ss_dssp CTTS---------CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred cccC---------CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1111 135779999999999999999999986
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=343.28 Aligned_cols=268 Identities=24% Similarity=0.298 Sum_probs=197.5
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCc---hhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGN---KGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
..++|++.+.||+|+||.||+|... +|+.||||++....... ...+.+.+|+.++++++||||+++++++.+....
T Consensus 8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCC
T ss_pred HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCce
Confidence 4578999999999999999999764 68999999997643221 1124688999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++ +|.+++.. ....+++.++..++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++
T Consensus 88 ~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 159 (346)
T 1ua2_A 88 SLVFDFMET-DLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLA 159 (346)
T ss_dssp EEEEECCSE-EHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGG
T ss_pred EEEEEcCCC-CHHHHHHh----cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccc
Confidence 999999975 89888854 12468899999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-cCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-KEN 812 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~ 812 (933)
+...... .......||+.|+|||++.+. .++.++|||||||++|||++|.+||......+ .+...+...... ...
T Consensus 160 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~--~~~~i~~~~~~~~~~~ 236 (346)
T 1ua2_A 160 KSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQ 236 (346)
T ss_dssp STTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTT
T ss_pred eeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHcCCCChhh
Confidence 8664432 223345789999999998654 58899999999999999999999987653322 122211111100 011
Q ss_pred CCcccC--CCCCC---Chhh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAID--PNLNL---DEET-----IESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d--~~l~~---~~~~-----~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
++.... ..... .... ......+.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 237 WPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred hhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 111000 00000 0000 112246889999999999999999999987
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.78 Aligned_cols=255 Identities=24% Similarity=0.342 Sum_probs=198.1
Q ss_pred HHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC------chhHHHHHHHHHHHHhcCCCcceeEEeEeee
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG------NKGLSEFQAEIAVLTKVRHRHLVALLGYCIN 650 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~ 650 (933)
.+.++|++.+.||+|+||.||+|.. .+++.||||++...... ......+.+|++++++++||||+++++++..
T Consensus 7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES
T ss_pred hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC
Confidence 3567899999999999999999965 56899999998764321 1223468899999999999999999999876
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc---EE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AK 727 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~k 727 (933)
+. .++||||+++++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++. +|
T Consensus 87 ~~-~~lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~k 157 (322)
T 2ycf_A 87 ED-YYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIK 157 (322)
T ss_dssp SS-EEEEEECCTTEETHHHHST-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEE
T ss_pred Cc-eEEEEecCCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEE
Confidence 54 8999999999999999854 3568999999999999999999999 89999999999999987664 99
Q ss_pred EecccccccCCCCCceeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 728 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
|+|||+++...... ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ +...+.
T Consensus 158 l~Dfg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~ 233 (322)
T 2ycf_A 158 ITDFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT 233 (322)
T ss_dssp ECCCTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH
T ss_pred EccCccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH
Confidence 99999998765432 123457999999999873 56789999999999999999999999976543221 111111
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.......... .......+.+++.+|++.||++||+++++++
T Consensus 234 ---~~~~~~~~~~---------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~ 274 (322)
T 2ycf_A 234 ---SGKYNFIPEV---------WAEVSEKALDLVKKLLVVDPKARFTTEEALR 274 (322)
T ss_dssp ---HTCCCCCHHH---------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred ---hCccccCchh---------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence 1111110000 0111246789999999999999999999986
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-37 Score=353.46 Aligned_cols=200 Identities=22% Similarity=0.306 Sum_probs=173.9
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc------CCCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV------RHRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~ 652 (933)
..+|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.+++.+ +|+||+++++++....
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 172 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN 172 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence 46899999999999999999954 56899999999754 33456788888888887 5779999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc--EEEec
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR--AKVAD 730 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~--~kl~D 730 (933)
..++||||+. ++|.+++.... ...+++..++.++.||++||+|||+ ++|+||||||+|||++.++. +||+|
T Consensus 173 ~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~D 245 (429)
T 3kvw_A 173 HICMTFELLS-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVID 245 (429)
T ss_dssp EEEEEECCCC-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECC
T ss_pred eEEEEEeccC-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEee
Confidence 9999999995 69999986622 2458999999999999999999999 89999999999999999987 99999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCC
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP 793 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~ 793 (933)
||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 246 FG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~ 304 (429)
T 3kvw_A 246 FGSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE 304 (429)
T ss_dssp CTTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence 9999765432 2345799999999999999999999999999999999999999986543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=353.40 Aligned_cols=264 Identities=21% Similarity=0.269 Sum_probs=202.8
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC--------CCcceeEEeEee-
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR--------HRHLVALLGYCI- 649 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~- 649 (933)
.++|++.+.||+|+||.||+|. ..+++.||||++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~ 112 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI 112 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence 4789999999999999999995 457899999999754 344578899999999995 788999999987
Q ss_pred ---eCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEecCCCCCcEEecCCC-
Q 002346 650 ---NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDM- 724 (933)
Q Consensus 650 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dik~~Nill~~~~- 724 (933)
.+...++||||+ +++|.+++... ....+++.+++.++.||++||+|||+ + +|+||||||+|||++.++
T Consensus 113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~---~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 113 SGVNGTHICMVFEVL-GHHLLKWIIKS---NYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EETTEEEEEEEECCC-CCBHHHHHHHT---TTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHH
T ss_pred cCCCCceEEEEEecc-CccHHHHHHhc---ccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccch
Confidence 556789999999 67777777542 22568999999999999999999998 7 999999999999999775
Q ss_pred ------------------------------------------------cEEEecccccccCCCCCceeecccccccCccc
Q 002346 725 ------------------------------------------------RAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756 (933)
Q Consensus 725 ------------------------------------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~a 756 (933)
.+||+|||+++..... .....||+.|+|
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~a 261 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRS 261 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCC
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccC
Confidence 7999999999866432 234579999999
Q ss_pred ccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc-----------ccCC------
Q 002346 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK-----------AIDP------ 819 (933)
Q Consensus 757 PE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~d~------ 819 (933)
||++.+..++.++|||||||++|||++|+.||......................+..+. .+..
T Consensus 262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 341 (397)
T 1wak_A 262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH 341 (397)
T ss_dssp HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence 99999989999999999999999999999999865433211111111111110111100 0000
Q ss_pred --CCC-C---------ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 820 --NLN-L---------DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 820 --~l~-~---------~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... . ..........+.+++.+||+.||++||+++|+++
T Consensus 342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 391 (397)
T 1wak_A 342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391 (397)
T ss_dssp CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence 000 0 0112345567889999999999999999999986
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-37 Score=344.56 Aligned_cols=258 Identities=24% Similarity=0.317 Sum_probs=189.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEee--------
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCI-------- 649 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~-------- 649 (933)
..+|++.+.||+|+||.||+|.. .+++.||||++... .....+.+.+|+.++.++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 35899999999999999999965 57899999998654 3455678999999999996 999999999984
Q ss_pred eCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEecCCCCCcEEecCCCcEE
Q 002346 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIGDDMRAK 727 (933)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dik~~Nill~~~~~~k 727 (933)
.....++||||+. |+|.+++..... ..++++.+++.++.|++.||+|||+ .+ |+||||||+||+++.++.+|
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~k 178 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIK 178 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEE
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEE
Confidence 3445789999995 799999865332 2469999999999999999999998 77 99999999999999999999
Q ss_pred EecccccccCCCCCcee-----------ecccccccCccccccc---CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCC
Q 002346 728 VADFGLVKNAPDGKYSV-----------ETRLAGTFGYLAPEYA---ATGRVTTKIDVYAFGVVLMETITGRKALDDTMP 793 (933)
Q Consensus 728 l~DfGla~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~ 793 (933)
|+|||+++......... .....||+.|+|||++ .+..++.++||||||+++|||++|+.||.....
T Consensus 179 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 179 LCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp BCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 99999998665432111 1134689999999998 566789999999999999999999999975322
Q ss_pred chhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 794 DDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
.. .... ....+ ..... ...+.+++.+||+.||++||++.|+++.|+.+....
T Consensus 259 ~~------~~~~----~~~~~--~~~~~---------~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~ 310 (337)
T 3ll6_A 259 LR------IVNG----KYSIP--PHDTQ---------YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR 310 (337)
T ss_dssp -----------------CCCC--TTCCS---------SGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred HH------hhcC----cccCC--ccccc---------chHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence 11 0000 00000 00001 123668999999999999999999999998886543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=345.34 Aligned_cols=260 Identities=20% Similarity=0.350 Sum_probs=201.8
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|.... .||+|++..........+.+.+|+.++++++||||+++++++.+....++|||
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e 109 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITS 109 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECB
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEee
Confidence 5789999999999999999998743 59999998765444555678899999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++ ++.+||+|||+++....
T Consensus 110 ~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 110 LCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred cccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999541 2468999999999999999999999 8999999999999998 67999999999875432
Q ss_pred CC----ceeecccccccCcccccccCC---------CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH
Q 002346 740 GK----YSVETRLAGTFGYLAPEYAAT---------GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 740 ~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
.. ........|++.|+|||++.. ..++.++||||||+++|||++|+.||........ . ...
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---~---~~~ 255 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI---I---WQM 255 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHH---H---HHH
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---H---HHh
Confidence 11 111233468999999999864 3578899999999999999999999976533211 1 111
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
. ....+........ ..+.+++.+||+.+|++||++.++++.|+.+.+..
T Consensus 256 ~--~~~~~~~~~~~~~---------~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~ 304 (319)
T 2y4i_B 256 G--TGMKPNLSQIGMG---------KEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304 (319)
T ss_dssp H--TTCCCCCCCSSCC---------TTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred c--cCCCCCCCcCCCC---------HHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence 1 1111111111111 24779999999999999999999999998876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=340.94 Aligned_cols=262 Identities=18% Similarity=0.266 Sum_probs=202.5
Q ss_pred cCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeee--CceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCIN--GSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 656 (933)
++|++.+.||+|+||.||+|. ..+++.||||++... ..+.+.+|+.++++++ ||||+++++++.. ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc-----chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 689999999999999999995 467999999998643 2467999999999997 9999999999987 667899
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEEecccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVK 735 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~ 735 (933)
||||+++++|.+++. .+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++ .+||+|||+++
T Consensus 111 v~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~ 179 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179 (330)
T ss_dssp EEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence 999999999999983 38899999999999999999999 8999999999999999777 89999999998
Q ss_pred cCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH--------
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV-------- 806 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~-------- 806 (933)
....... .....|++.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+.......
T Consensus 180 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~ 256 (330)
T 3nsz_A 180 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDY 256 (330)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHH
T ss_pred EcCCCCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhH
Confidence 6654332 234578999999999876 6789999999999999999999999965443211 111111000
Q ss_pred -hhccCCCCc------------ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 807 -LISKENIPK------------AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 807 -~~~~~~~~~------------~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
......... ....... ..........+.+++.+||+.||++|||++|+++ ++|..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~------hp~f~ 324 (330)
T 3nsz_A 257 IDKYNIELDPRFNDILGRHSRKRWERFVH-SENQHLVSPEALDFLDKLLRYDHQSRLTAREAME------HPYFY 324 (330)
T ss_dssp HHHTTCCCCTHHHHHHCCCCCCCGGGGCC-TTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT------SGGGT
T ss_pred HHHhccccccchhhhhhhccccchhhhcc-ccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc------CccHh
Confidence 000000000 0000000 0011112356789999999999999999999986 66664
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-37 Score=332.38 Aligned_cols=257 Identities=26% Similarity=0.436 Sum_probs=197.0
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee-------
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------- 650 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------- 650 (933)
..++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++||||+++++++.+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence 457899999999999999999965 57999999998653 3456789999999999999999999998865
Q ss_pred ------CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC
Q 002346 651 ------GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM 724 (933)
Q Consensus 651 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~ 724 (933)
....++||||+++++|.+++... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~ 153 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESR 153 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTS
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCC
Confidence 45678999999999999999652 2457889999999999999999999 8999999999999999999
Q ss_pred cEEEecccccccCCCCC-------------ceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCC
Q 002346 725 RAKVADFGLVKNAPDGK-------------YSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDD 790 (933)
Q Consensus 725 ~~kl~DfGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~ 790 (933)
.+||+|||+++...... ........|++.|+|||++.+. .++.++||||||+++|||++ ||..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 99999999988654321 1112345789999999998754 68999999999999999998 4432
Q ss_pred CCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 791 TMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 791 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
. .+. ..............+..++.. ....+.+++.+|++.||++||++.++++ ++|..
T Consensus 231 ~--~~~---~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~li~~~l~~dp~~Rps~~~ll~------h~~~~ 288 (303)
T 1zy4_A 231 G--MER---VNILKKLRSVSIEFPPDFDDN---------KMKVEKKIIRLLIDHDPNKRPGARTLLN------SGWLP 288 (303)
T ss_dssp H--HHH---HHHHHHHHSTTCCCCTTCCTT---------TSHHHHHHHHHHTCSSGGGSCCHHHHHH------SSCSC
T ss_pred c--hhH---HHHHHhccccccccCcccccc---------chHHHHHHHHHHHhcCcccCcCHHHHhC------CCCcC
Confidence 1 111 112222222122222222211 1235779999999999999999999987 66664
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-37 Score=338.49 Aligned_cols=272 Identities=23% Similarity=0.337 Sum_probs=205.0
Q ss_pred HhcCCccCCccccCCCeEEEEEEe--CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc---CCCcceeEEeEee----
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL--PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCI---- 649 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---- 649 (933)
+.++|++.+.||+|+||.||+|.. .+|+.||+|++............+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 457899999999999999999976 4688999999876543333334566777777766 8999999999987
Q ss_pred -eCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 650 -NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 650 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
.....++||||++ |+|.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl 161 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL 161 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence 4567899999997 69999996632 2458999999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
+|||+++...... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+. +.. +.....
T Consensus 162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~-i~~~~~ 236 (326)
T 1blx_A 162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ--LGK-ILDVIG 236 (326)
T ss_dssp CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHH-HHHHHC
T ss_pred ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHH-HHHHcC
Confidence 9999987654322 22345789999999999988999999999999999999999999986543221 111 111110
Q ss_pred --ccCCCCccc-------CCCC--CCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 809 --SKENIPKAI-------DPNL--NLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 809 --~~~~~~~~~-------d~~l--~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....++... .... ............+.+++.+||+.||++||++.|+++ ++|..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~~~ 301 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS------HPYFQ 301 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGT
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc------Ccccc
Confidence 000111000 0000 000000112245779999999999999999999986 66654
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-37 Score=330.35 Aligned_cols=256 Identities=24% Similarity=0.335 Sum_probs=207.5
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
.....++|++.+.||+|+||.||+|... +++.||+|++..........+.+.+|+.++++++||||+++++++......
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 96 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSF 96 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeE
Confidence 4556789999999999999999999664 789999999987655556678899999999999999999999999999999
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC---CcEEEecc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD---MRAKVADF 731 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~---~~~kl~Df 731 (933)
++||||+++++|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++.+ +.+||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Df 168 (287)
T 2wei_A 97 YIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDF 168 (287)
T ss_dssp EEEECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECST
T ss_pred EEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEecc
Confidence 9999999999999988652 458999999999999999999999 899999999999999764 46999999
Q ss_pred cccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 732 GLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 732 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
|++........ .....|++.|+|||.+.+ .++.++||||||+++|||++|+.||......+ .. ........
T Consensus 169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~---~~~~~~~~ 239 (287)
T 2wei_A 169 GLSTCFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---IL---KRVETGKY 239 (287)
T ss_dssp TGGGTBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---HHHHHCCC
T ss_pred CcceeecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HH---HHHHcCCC
Confidence 99986554321 223468999999998875 58999999999999999999999997653221 11 11111111
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
........ .....+.+++.+|++.+|++||++.|+++
T Consensus 240 ~~~~~~~~---------~~~~~~~~li~~~l~~dp~~Rps~~ell~ 276 (287)
T 2wei_A 240 AFDLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLE 276 (287)
T ss_dssp CCCSGGGT---------TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCchhhh---------hcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence 11100001 11245779999999999999999999987
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-37 Score=367.65 Aligned_cols=382 Identities=19% Similarity=0.177 Sum_probs=270.2
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|++++..+..|.++++|++|+|++|.|++++| .|.++++|++|+|++|.++++++..|+++++|++|+|
T Consensus 32 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 111 (606)
T 3vq2_A 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVA 111 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEEC
T ss_pred CCcCEEECCCCCcCEeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEc
Confidence 579999999999998888899999999999999999999888 7999999999999999999998899999999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCC-CCChhhcCCCCCCEEEccCCcCCCCCCcccccc-------------
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG-LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS------------- 210 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~------------- 210 (933)
++|.+.. ..+..++++++|++|+|++|.+.+ .+|..|+++++|++|+|++|++++..|..+...
T Consensus 112 ~~n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~ 189 (606)
T 3vq2_A 112 VETKLAS--LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMS 189 (606)
T ss_dssp TTSCCCC--SSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECT
T ss_pred cCCcccc--ccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeecc
Confidence 9999988 344779999999999999999987 569999999999999999999997766655431
Q ss_pred ---------------ccchhhcccccCCc---------------------------------------------------
Q 002346 211 ---------------DIQNLWMNDQQLGL--------------------------------------------------- 224 (933)
Q Consensus 211 ---------------~l~~l~l~~n~~~~--------------------------------------------------- 224 (933)
.|+.|++.+|.+..
T Consensus 190 ~n~l~~~~~~~~~~~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 269 (606)
T 3vq2_A 190 LNPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLT 269 (606)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEEC
T ss_pred CCCcceeCcccccCceeeeeeccCCccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheecc
Confidence 23444444443210
Q ss_pred -----ccc----------------------cccccCCccCcEEEecCCccCCCCC---------------------CCCC
Q 002346 225 -----SGT----------------------LDVLSGMTQLRQVWLHKNQFTGPIP---------------------DLSK 256 (933)
Q Consensus 225 -----~~~----------------------~~~l~~l~~L~~L~L~~N~l~~~~~---------------------~~~~ 256 (933)
.+. .+.+..+++|+.|++++|+++ .+| .+..
T Consensus 270 ~~~~~~~~~~~~~~l~~L~~L~l~~~~~~~l~~l~~~~~L~~L~l~~n~l~-~lp~~~l~~L~~L~l~~n~~~~~~~~~~ 348 (606)
T 3vq2_A 270 YTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLK-QFPTLDLPFLKSLTLTMNKGSISFKKVA 348 (606)
T ss_dssp CCTTCCGGGGSCGGGTTCSEEEEESCCCCCCCCCCTTCCCSEEEEESCCCS-SCCCCCCSSCCEEEEESCSSCEECCCCC
T ss_pred ccccccccccccccCCCCCEEEecCccchhhhhccccccCCEEEcccccCc-ccccCCCCccceeeccCCcCccchhhcc
Confidence 000 002233344555555555542 222 2345
Q ss_pred CCCCCEEEccCCccccc--CcccccCCCCCCEEEccCccCccCCCCC--CCCccEEeccCCcCCCCCC-CCCCCCCchhh
Q 002346 257 CESLFDLSLRDNQLTGV--VPASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVSLDHNNFCKNSS-DAGKPCDPQVT 331 (933)
Q Consensus 257 ~~~L~~L~L~~N~l~~~--~p~~l~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~l~~n~~~~~~~-~~~~~~~~~~~ 331 (933)
+++|+.|+|++|++++. +|..+..+++|++|+|++|.+++..+.+ ..+|+.|++++|++.+..+ ..+..+. ...
T Consensus 349 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~-~L~ 427 (606)
T 3vq2_A 349 LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAIIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLE-KLL 427 (606)
T ss_dssp CTTCCEEECCSSCEEEEEECCHHHHCCSCCCEEECCSCSEEEECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCT-TCC
T ss_pred CCCCCEEECcCCccCCCcchhhhhccCCcccEeECCCCccccchhhccCCCCCCeeECCCCccCCccChhhhhccc-cCC
Confidence 67777888888877755 3667777777777777777776644322 3466777777777666543 1111110 000
Q ss_pred hh-------H-hhhcccCCCcccc-CCCCCCCCCC-CCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccC
Q 002346 332 TL-------L-QIAGDMGYPAILS-DSWEGNNACD-GWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQN 401 (933)
Q Consensus 332 ~~-------~-~~~~~~~~~~~l~-~~~~~~~~~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N 401 (933)
.+ . ..+..+.....++ ..+.+|...+ .+|..+..+++|+.|+|++|++++.+|..|+++++|+.|+|++|
T Consensus 428 ~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 507 (606)
T 3vq2_A 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHN 507 (606)
T ss_dssp EEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCC
Confidence 00 0 0011111222222 2334444444 36778888888888888888888888888888888888888888
Q ss_pred cccCCCCcccCCCCCcCEEeccCCcCcccCCCCCC---CcccccCCCCCCcCC
Q 002346 402 NLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGS---NVKFTVSPGNPFIGT 451 (933)
Q Consensus 402 ~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~---~~~~~~~~~n~~~~~ 451 (933)
++++.+|..|..+++|+.|+|++|+|+..++.+.. .++...+.+|||.|.
T Consensus 508 ~l~~~~~~~~~~l~~L~~L~l~~N~l~~~p~~~~~l~~~L~~l~l~~N~~~c~ 560 (606)
T 3vq2_A 508 NLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVACI 560 (606)
T ss_dssp CCSCEEGGGTTTCTTCCEEECTTSCCCCEESCGGGSCTTCCEEECCSCCCCCS
T ss_pred cCCCcCHHHccCCCcCCEEECCCCcCcccCHhHhhhcccCcEEEccCCCcccC
Confidence 88888888888888888888888888865554432 234445678888763
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-37 Score=345.76 Aligned_cols=266 Identities=22% Similarity=0.317 Sum_probs=197.2
Q ss_pred HHHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC----
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING---- 651 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---- 651 (933)
+...++|++.+.||+|+||.||+|. ..+|+.||||++..... ...+|+++++.++|||||++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 76 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEE 76 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc------hHHHHHHHHHHcCCCCccchhheeeecCccc
Confidence 3456789999999999999999995 46799999999875422 234799999999999999999998543
Q ss_pred ----------------------------------ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHH
Q 002346 652 ----------------------------------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697 (933)
Q Consensus 652 ----------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l 697 (933)
...++||||++ |+|.+.+...... ...+++..++.++.|+++||
T Consensus 77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHH
Confidence 33789999997 5888888653332 35799999999999999999
Q ss_pred HHhhhccCCCeEecCCCCCcEEec-CCCcEEEecccccccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHH
Q 002346 698 EYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFG 775 (933)
Q Consensus 698 ~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG 775 (933)
+|||+ .+|+||||||+||+++ .++.+||+|||+++....... .....||+.|+|||++.+. .++.++||||+|
T Consensus 155 ~~LH~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG 229 (383)
T 3eb0_A 155 GFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIG 229 (383)
T ss_dssp HHHHT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred HHHHH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence 99998 8999999999999998 688999999999986654332 2345789999999988764 589999999999
Q ss_pred HHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh--------hccCCCCcccCCCCCCChh----hHHHHHHHHHHHHHccc
Q 002346 776 VVLMETITGRKALDDTMPDDRAHLVTWFRRVL--------ISKENIPKAIDPNLNLDEE----TIESIYRVAELAGHCTA 843 (933)
Q Consensus 776 ~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~d~~l~~~~~----~~~~~~~~~~li~~cl~ 843 (933)
|++|||++|+.||......+. +...+...- .......+..-+....... .......+.+++.+||+
T Consensus 230 ~il~ell~g~~pf~~~~~~~~--~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 307 (383)
T 3eb0_A 230 CVFGELILGKPLFSGETSIDQ--LVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307 (383)
T ss_dssp HHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCC
T ss_pred HHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHcc
Confidence 999999999999987543222 111111000 0000000000011110000 00122457899999999
Q ss_pred CCCCCCCCHHHHHH
Q 002346 844 REPQQRPDMGHAVN 857 (933)
Q Consensus 844 ~~P~~RPs~~evl~ 857 (933)
.||++|||+.|+++
T Consensus 308 ~dP~~R~t~~e~l~ 321 (383)
T 3eb0_A 308 YEPDLRINPYEAMA 321 (383)
T ss_dssp SSGGGSCCHHHHHT
T ss_pred CChhhCCCHHHHhc
Confidence 99999999999986
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-37 Score=347.57 Aligned_cols=279 Identities=19% Similarity=0.270 Sum_probs=204.8
Q ss_pred ecHHHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC---------chhHHHHHHHHHHHHhcCCCcc
Q 002346 571 ISIEVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG---------NKGLSEFQAEIAVLTKVRHRHL 641 (933)
Q Consensus 571 ~~~~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------~~~~~~~~~E~~~l~~l~h~ni 641 (933)
....++..+.++|++.+.||+|+||.||+|...+|+.||||++...... ....+.+.+|+.++++++||||
T Consensus 12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i 91 (362)
T 3pg1_A 12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI 91 (362)
T ss_dssp HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence 3467788899999999999999999999998888999999998764322 1224789999999999999999
Q ss_pred eeEEeEeee-----CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCC
Q 002346 642 VALLGYCIN-----GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716 (933)
Q Consensus 642 v~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~ 716 (933)
+++++++.. ....++||||++ |+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+
T Consensus 92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~ 163 (362)
T 3pg1_A 92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPG 163 (362)
T ss_dssp CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGG
T ss_pred cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChH
Confidence 999999854 336799999997 6888888641 2468999999999999999999999 89999999999
Q ss_pred cEEecCCCcEEEecccccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCch
Q 002346 717 NILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDD 795 (933)
Q Consensus 717 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~ 795 (933)
||+++.++.+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+
T Consensus 164 NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 241 (362)
T 3pg1_A 164 NILLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241 (362)
T ss_dssp GEEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HEEEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999997544322 2234578999999999876 678999999999999999999999998654322
Q ss_pred hhHHHHHHHHHhhcc--------------CCCCcccCCCCCCC--hhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 002346 796 RAHLVTWFRRVLISK--------------ENIPKAIDPNLNLD--EETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859 (933)
Q Consensus 796 ~~~~~~~~~~~~~~~--------------~~~~~~~d~~l~~~--~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L 859 (933)
... ... ...... ..+........... .........+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~--~i~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~-- 316 (362)
T 3pg1_A 242 QLN--KIV-EVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR-- 316 (362)
T ss_dssp HHH--HHH-HHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT--
T ss_pred HHH--HHH-HHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc--
Confidence 111 111 000000 00000000000000 000111245789999999999999999999986
Q ss_pred hhhhhhcCC
Q 002346 860 GPLVEQWKP 868 (933)
Q Consensus 860 ~~~~~~~~~ 868 (933)
++|..
T Consensus 317 ----hp~f~ 321 (362)
T 3pg1_A 317 ----HPYFE 321 (362)
T ss_dssp ----SGGGT
T ss_pred ----Cchhh
Confidence 66654
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=338.87 Aligned_cols=254 Identities=24% Similarity=0.399 Sum_probs=197.7
Q ss_pred HHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee----
Q 002346 577 RQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN---- 650 (933)
Q Consensus 577 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---- 650 (933)
....++|++.+.||+|+||.||+|.. .+++.||||++.... ...+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG---DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc---ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34467899999999999999999965 578999999987543 2346889999999999 79999999999976
Q ss_pred --CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 651 --GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 651 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
....++||||+++++|.+++.... ...+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl 170 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKL 170 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEE
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEE
Confidence 467899999999999999997632 2468999999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHH
Q 002346 729 ADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF 803 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~ 803 (933)
+|||++....... .......|++.|+|||++. +..++.++||||||+++|||++|+.||......... .
T Consensus 171 ~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~-- 244 (326)
T 2x7f_A 171 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL---F-- 244 (326)
T ss_dssp CCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H--
T ss_pred eeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH---H--
Confidence 9999987654322 1223457999999999986 567899999999999999999999999765432211 1
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... ....+........ ..+.+++.+||+.||++||+++++++
T Consensus 245 -~~~--~~~~~~~~~~~~~---------~~l~~li~~~l~~dp~~Rps~~~ll~ 286 (326)
T 2x7f_A 245 -LIP--RNPAPRLKSKKWS---------KKFQSFIESCLVKNHSQRPATEQLMK 286 (326)
T ss_dssp -HHH--HSCCCCCSCSCSC---------HHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred -Hhh--cCccccCCccccC---------HHHHHHHHHHhccChhhCCCHHHHhh
Confidence 111 1111111111111 35779999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-37 Score=332.22 Aligned_cols=254 Identities=26% Similarity=0.364 Sum_probs=204.6
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-------chhHHHHHHHHHHHHhcC-CCcceeEEeEee
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-------NKGLSEFQAEIAVLTKVR-HRHLVALLGYCI 649 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~ 649 (933)
..++|++.+.||+|+||.||+|.. .+|+.||||++...... ....+.+.+|+.+++++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 457899999999999999999965 46899999998765311 123467889999999995 999999999999
Q ss_pred eCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEe
Q 002346 650 NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (933)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 729 (933)
.+...++||||+++++|.+++.. ...+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEEC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEe
Confidence 99999999999999999999965 2468999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccCcccccccC------CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHH
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAA------TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF 803 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~ 803 (933)
|||++........ .....|++.|+|||++. ...++.++||||||+++|||++|+.||....... ..
T Consensus 167 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~--- 238 (298)
T 1phk_A 167 DFGFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---ML--- 238 (298)
T ss_dssp CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH---
T ss_pred cccchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HH---
Confidence 9999986654322 23457899999999884 4568899999999999999999999997643221 11
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..........+. +. .......+.+++.+|++.||++||++.|+++
T Consensus 239 ~~~~~~~~~~~~---~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (298)
T 1phk_A 239 RMIMSGNYQFGS---PE------WDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 283 (298)
T ss_dssp HHHHHTCCCCCT---TT------GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhcCCcccCc---cc------ccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence 111111111110 00 0112245789999999999999999999976
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-37 Score=340.11 Aligned_cols=271 Identities=23% Similarity=0.330 Sum_probs=203.5
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----c
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----S 652 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~ 652 (933)
+.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......++.+|+.++++++||||+++++++... .
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 357899999999999999999965 468999999996542 344566788999999999999999999998754 6
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
..++||||++ ++|.+++.. ..+++.++..++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 157 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFG 157 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecc
Confidence 7899999996 699999865 468999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCce---------eecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHH
Q 002346 733 LVKNAPDGKYS---------VETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTW 802 (933)
Q Consensus 733 la~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~ 802 (933)
+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......... ..
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~ 234 (353)
T 2b9h_A 158 LARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQL---LL 234 (353)
T ss_dssp TCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HH
T ss_pred cccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HH
Confidence 99865432211 1223578999999998754 67899999999999999999999999865432211 11
Q ss_pred HHHHhhccC--CCCccc------------C--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 803 FRRVLISKE--NIPKAI------------D--PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 803 ~~~~~~~~~--~~~~~~------------d--~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
+........ .....+ . +..............+.+++.+||+.||++||+++|+++ ++|
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~------hp~ 308 (353)
T 2b9h_A 235 IFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE------HPY 308 (353)
T ss_dssp HHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGG
T ss_pred HHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc------Ccc
Confidence 111110000 000000 0 000000000112345779999999999999999999986 666
Q ss_pred CCC
Q 002346 867 KPA 869 (933)
Q Consensus 867 ~~~ 869 (933)
...
T Consensus 309 ~~~ 311 (353)
T 2b9h_A 309 LQT 311 (353)
T ss_dssp GTT
T ss_pred ccc
Confidence 543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=333.06 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=199.5
Q ss_pred HHhcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 578 QVTDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 578 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
...++|++.+.||+|+||.||+|... +|+.||+|++.... ..+++.+|+.++++++||||+++++++......++
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 101 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWI 101 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEE
Confidence 44678999999999999999999654 68999999987642 23678999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++++|.+++... ...+++.+++.++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++..
T Consensus 102 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 174 (314)
T 3com_A 102 VMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQ 174 (314)
T ss_dssp EEECCTTEEHHHHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EeecCCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchh
Confidence 99999999999998641 2568999999999999999999999 8999999999999999999999999999976
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
...... ......|++.|+|||++.+..++.++||||||+++|||++|+.||......... . .... ...+.
T Consensus 175 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~---~~~~--~~~~~- 244 (314)
T 3com_A 175 LTDTMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI---F---MIPT--NPPPT- 244 (314)
T ss_dssp CBTTBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---H---HHHH--SCCCC-
T ss_pred hhhhcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH---H---HHhc--CCCcc-
Confidence 544321 223457899999999999889999999999999999999999999765332111 1 1111 10000
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.. .......+.+++.+|++.||++||++.++++
T Consensus 245 ----~~~---~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~ 278 (314)
T 3com_A 245 ----FRK---PELWSDNFTDFVKQCLVKSPEQRATATQLLQ 278 (314)
T ss_dssp ----CSS---GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred ----cCC---cccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 000 0011245779999999999999999999976
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-37 Score=335.39 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=198.2
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+++.+|+.+++.++||||+++++++..++..++||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 95 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI 95 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCC--CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence 578999999999999999999664 5899999998765 3445678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++++|.+++... ...+++.+++.++.|+++||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 96 e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 96 EFCPGGAVDAIMLEL----DRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL 168 (302)
T ss_dssp ECCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred EeCCCCcHHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence 999999999998652 2458999999999999999999999 899999999999999999999999999875322
Q ss_pred CCCceeecccccccCccccccc-----CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYA-----ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
... .......|++.|+|||++ ....++.++||||||+++|||++|+.||........ ....... ..
T Consensus 169 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~--~~ 239 (302)
T 2j7t_A 169 KTL-QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKS--DP 239 (302)
T ss_dssp HHH-HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS--CC
T ss_pred ccc-cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH------HHHHhcc--CC
Confidence 111 112234789999999988 466789999999999999999999999976543211 1111111 11
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.... .......+.+++.+|++.||++||+++++++
T Consensus 240 ~~~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 275 (302)
T 2j7t_A 240 PTLLT--------PSKWSVEFRDFLKIALDKNPETRPSAAQLLE 275 (302)
T ss_dssp CCCSS--------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred cccCC--------ccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 11100 0111245779999999999999999999976
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-37 Score=367.74 Aligned_cols=260 Identities=24% Similarity=0.396 Sum_probs=206.6
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC----CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCcee
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSER 654 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 654 (933)
..++|++.+.||+|+||.||+|... .+..||||++.... .....+.|.+|+.++++++||||+++++++. ++..
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 465 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 465 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence 3578999999999999999999653 25679999987542 3445678999999999999999999999985 4568
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
++||||+++|+|.+++... ...+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||++
T Consensus 466 ~lv~E~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a 538 (656)
T 2j0j_A 466 WIIMELCTLGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS 538 (656)
T ss_dssp EEEEECCTTCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred EEEEEcCCCCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCC
Confidence 9999999999999999652 2458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
+..............|++.|+|||++.+..++.++||||||+++|||++ |+.||......+ ....+ .. ....
T Consensus 539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i---~~-~~~~ 611 (656)
T 2j0j_A 539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI---EN-GERL 611 (656)
T ss_dssp CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HH-TCCC
T ss_pred eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH---Hc-CCCC
Confidence 8765544333344567889999999988899999999999999999997 999997653322 11111 11 1111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.+.+.. ...+.+++.+||+.||++||++.++++.|+.+++.
T Consensus 612 --~~~~~~---------~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~ 652 (656)
T 2j0j_A 612 --PMPPNC---------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652 (656)
T ss_dssp --CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --CCCccc---------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence 111111 13577999999999999999999999999988654
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-37 Score=339.64 Aligned_cols=258 Identities=21% Similarity=0.347 Sum_probs=198.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce-----
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE----- 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----- 653 (933)
.++|.+.+.||+|+||.||+|.. .+|+.||||++..........+++.+|+.+++.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 102 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 102 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence 46899999999999999999965 579999999998765455556789999999999999999999999987653
Q ss_pred -eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 654 -RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 654 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
.++||||++ ++|.+++. ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||
T Consensus 103 ~~~lv~e~~~-~~l~~~~~-------~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg 171 (353)
T 3coi_A 103 DFYLVMPFMQ-TDLQKIMG-------LKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFG 171 (353)
T ss_dssp CCEEEEECCS-EEGGGTTT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred eEEEEecccc-CCHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecc
Confidence 499999996 68888773 348999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc-
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK- 810 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 810 (933)
+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||......+. ...+.......
T Consensus 172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~i~~~~~~~~ 244 (353)
T 3coi_A 172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ---LTQILKVTGVPG 244 (353)
T ss_dssp CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHH---HHHHHHHHCBCC
T ss_pred cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHhCCCC
Confidence 99865432 234578999999999876 6789999999999999999999999986543221 11111100000
Q ss_pred ----------------CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 ----------------ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 ----------------~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..++....+.+. .........+.+++.+|++.||++||+++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~ 305 (353)
T 3coi_A 245 TEFVQKLNDKAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQALT 305 (353)
T ss_dssp HHHHTTCSCHHHHHHHHTSCBCSSCCTT--TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred HHHHHHHhhHHHHHHHHhCcCCCCccHH--HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 000000000000 000112346789999999999999999999986
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-37 Score=340.87 Aligned_cols=267 Identities=20% Similarity=0.318 Sum_probs=206.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCch---------------hHHHHHHHHHHHHhcCCCcceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK---------------GLSEFQAEIAVLTKVRHRHLVAL 644 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~---------------~~~~~~~E~~~l~~l~h~niv~l 644 (933)
.++|++.+.||+|+||.||+|.. +++.||||++........ ..+.+.+|+.++++++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46899999999999999999988 999999999876532211 12789999999999999999999
Q ss_pred EeEeeeCceeEEEEeecCCCChhhHhhhc---ccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec
Q 002346 645 LGYCINGSERLLVYEYMPRGTLAQHLFEW---HDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG 721 (933)
Q Consensus 645 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~ 721 (933)
++++.+.+..++||||+++++|.+++... .......+++..++.++.|+++||+|||+ .++|+||||||+||+++
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~ 186 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMD 186 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEEC
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEc
Confidence 99999999999999999999999983211 11223679999999999999999999996 37999999999999999
Q ss_pred CCCcEEEecccccccCCCCCceeecccccccCcccccccCCC-CCCC-ccchHhHHHHHHHHHcCCCCCCCCCCchhhHH
Q 002346 722 DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTT-KIDVYAFGVVLMETITGRKALDDTMPDDRAHL 799 (933)
Q Consensus 722 ~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~ 799 (933)
.++.+||+|||++...... ......|++.|+|||++.+. .++. ++||||||+++|||++|+.||....... ..
T Consensus 187 ~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~ 261 (348)
T 2pml_X 187 KNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--EL 261 (348)
T ss_dssp TTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HH
T ss_pred CCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HH
Confidence 9999999999999865443 23456799999999999877 6666 9999999999999999999998654321 11
Q ss_pred HHHHHHHhhccCCCCcccC----CCCCC--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 800 VTWFRRVLISKENIPKAID----PNLNL--DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 800 ~~~~~~~~~~~~~~~~~~d----~~l~~--~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...........+.... +.... ..........+.+++.+||+.||++||+++|+++
T Consensus 262 ---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 262 ---FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp ---HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred ---HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 1122211111111100 00000 0000112346789999999999999999999986
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-37 Score=333.90 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=198.7
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC--chhHHHHHHHHHHHHhcCCCcceeEEeEee--eCce
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG--NKGLSEFQAEIAVLTKVRHRHLVALLGYCI--NGSE 653 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~ 653 (933)
+.++|++.+.||+|+||.||++.. .+++.||+|++...... ....+.+.+|+.++++++||||+++++++. +...
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence 457899999999999999999965 46899999999765321 234578999999999999999999999984 4557
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||++++ |.+++.... ...+++.+++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~ 155 (305)
T 2wtk_C 83 MYMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGV 155 (305)
T ss_dssp EEEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccc
Confidence 89999999876 777775522 3568999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCC-ceeecccccccCcccccccCCCC--CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc
Q 002346 734 VKNAPDGK-YSVETRLAGTFGYLAPEYAATGR--VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK 810 (933)
Q Consensus 734 a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~ 810 (933)
+....... ........|++.|+|||++.+.. ++.++||||||+++|||++|+.||....... .........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~i~~~~ 229 (305)
T 2wtk_C 156 AEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK------LFENIGKGS 229 (305)
T ss_dssp CEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCC
T ss_pred ccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH------HHHHHhcCC
Confidence 98654322 22233457999999999987643 4779999999999999999999997643211 111222111
Q ss_pred CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 811 ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 811 ~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..++. .. ...+.+++.+|++.||++||+++|+++
T Consensus 230 ~~~~~----~~---------~~~l~~li~~~l~~dp~~Rps~~~ll~ 263 (305)
T 2wtk_C 230 YAIPG----DC---------GPPLSDLLKGMLEYEPAKRFSIRQIRQ 263 (305)
T ss_dssp CCCCS----SS---------CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCC----cc---------CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 11111 11 135779999999999999999999987
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=350.41 Aligned_cols=255 Identities=12% Similarity=0.095 Sum_probs=183.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhc--CCCcceeEE-------eEee
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV--RHRHLVALL-------GYCI 649 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~~ 649 (933)
.+|++.+.||+|+||.||+|.. .+|+.||||++..... .....+.+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4588999999999999999965 5789999999987653 234456778886555555 699988755 3443
Q ss_pred eC-----------------ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHH------HHHHHHHHHHHHHhhhccCC
Q 002346 650 NG-----------------SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQR------VTIALDVARGVEYLHSLAQQ 706 (933)
Q Consensus 650 ~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~l~~LH~~~~~ 706 (933)
.. ...++||||++ |+|.+++.... ..+.+..+ ..++.||++||+|||+ +
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~ 213 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQS---K 213 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence 22 34799999998 89999997632 23455556 7888999999999999 8
Q ss_pred CeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeecccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcC
Q 002346 707 SFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITG 784 (933)
Q Consensus 707 ~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG 784 (933)
+|+||||||+|||++.++.+||+|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|||++|
T Consensus 214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg 289 (371)
T 3q60_A 214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL 289 (371)
T ss_dssp TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence 9999999999999999999999999999866432 113467799999999987 6799999999999999999999
Q ss_pred CCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 785 RKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 785 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+.||....+..... ................. ........+.+++.+||+.||++||++.++++
T Consensus 290 ~~Pf~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~ 352 (371)
T 3q60_A 290 FLPFGLVTPGIKGS---------WKRPSLRVPGTDSLAFG-SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352 (371)
T ss_dssp SCSTTBCCTTCTTC---------CCBCCTTSCCCCSCCCT-TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred CCCCCCcCcccccc---------hhhhhhhhccccccchh-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 99998764322110 00000000000011000 00112246789999999999999999999975
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.85 Aligned_cols=253 Identities=22% Similarity=0.322 Sum_probs=199.4
Q ss_pred HhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC--CCcceeEEeEeeeCceeEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR--HRHLVALLGYCINGSERLL 656 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~l 656 (933)
..++|++.+.||+|+||.||++...+++.||||++..........+.+.+|++++.+++ ||||+++++++..+...++
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~l 105 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 105 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEE
Confidence 35789999999999999999998888999999999876555666788999999999997 5999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||| +.+++|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+||++++ +.+||+|||+++.
T Consensus 106 v~e-~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~ 175 (313)
T 3cek_A 106 VME-CGNIDLNSWLKK-----KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQ 175 (313)
T ss_dssp EEC-CCSEEHHHHHHH-----CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred EEe-cCCCcHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeecccccc
Confidence 999 558899999975 2468999999999999999999999 89999999999999964 8999999999986
Q ss_pred CCCCCce-eecccccccCcccccccCC-----------CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 737 APDGKYS-VETRLAGTFGYLAPEYAAT-----------GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 737 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
....... ......|++.|+|||++.+ ..++.++||||||+++|||++|+.||........ ...
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~-----~~~ 250 (313)
T 3cek_A 176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS-----KLH 250 (313)
T ss_dssp --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-----HHH
T ss_pred ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH-----HHH
Confidence 5543221 2234579999999999865 4688899999999999999999999976533211 111
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...... ....+.... ...+.+++.+||+.||++||++.|+++
T Consensus 251 ~~~~~~--~~~~~~~~~---------~~~l~~li~~~l~~dp~~Rps~~ell~ 292 (313)
T 3cek_A 251 AIIDPN--HEIEFPDIP---------EKDLQDVLKCCLKRDPKQRISIPELLA 292 (313)
T ss_dssp HHHCTT--SCCCCCCCS---------CHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHhcc--cccCCcccc---------hHHHHHHHHHHccCCcccCcCHHHHhc
Confidence 111111 111111111 135779999999999999999999986
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-37 Score=346.58 Aligned_cols=262 Identities=24% Similarity=0.335 Sum_probs=194.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------ce
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------SE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~ 653 (933)
.+|++.+.||+|+||.||+|.. .+|+.||||++.... ..+.+|+++++.++|||||++++++... ..
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCccee
Confidence 4688999999999999999976 469999999986542 1234799999999999999999998542 23
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-CcEEEeccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-MRAKVADFG 732 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-~~~kl~DfG 732 (933)
.++||||+++ ++.+.+..... ....+++..++.++.||++||+|||+ ++|+||||||+|||++.+ +.+||+|||
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG 202 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 202 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccch
Confidence 5799999975 77776654222 23579999999999999999999998 899999999999999965 578999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH-----
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV----- 806 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~----- 806 (933)
+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||......+ .+...+...
T Consensus 203 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 203 SAKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTR 278 (420)
T ss_dssp TCEECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCH
T ss_pred hhhhcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence 9986654332 2345789999999998764 78999999999999999999999998754322 222222110
Q ss_pred ---hhccCCCCcccCCCCCCChh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 807 ---LISKENIPKAIDPNLNLDEE----TIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 807 ---~~~~~~~~~~~d~~l~~~~~----~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
........+...+.+..... ......++.+++.+||+.||++||++.|+++
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~ 336 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 336 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence 00011111111111110000 0011246789999999999999999999986
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-37 Score=340.71 Aligned_cols=278 Identities=21% Similarity=0.289 Sum_probs=194.4
Q ss_pred HHHHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc
Q 002346 574 EVLRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS 652 (933)
Q Consensus 574 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~ 652 (933)
+......++|++.+.||+|+||.||+|.. .+|+.||||++.... ....++.+|++.++.++||||+++++++....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~ 92 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP---RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLG 92 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT---TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc---cccHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence 34456678999999999999999999965 568999999986543 22346678888899999999999999986543
Q ss_pred e-------eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhh--hccCCCeEecCCCCCcEEecC-
Q 002346 653 E-------RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH--SLAQQSFIHRDLKPSNILIGD- 722 (933)
Q Consensus 653 ~-------~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH--~~~~~~ivH~Dik~~Nill~~- 722 (933)
. .++||||+++ +|.+.+..... ....+++..+..++.|++.|++||| + ++|+||||||+|||++.
T Consensus 93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~ 167 (360)
T 3e3p_A 93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYR-RQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEA 167 (360)
T ss_dssp SSCTTCEEEEEEEECCSC-BHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETT
T ss_pred cccccceeEEEEeecccc-cHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCC
Confidence 3 7899999975 66655543222 2356899999999999999999999 7 89999999999999997
Q ss_pred CCcEEEecccccccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHH
Q 002346 723 DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT 801 (933)
Q Consensus 723 ~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~ 801 (933)
++.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........ +..
T Consensus 168 ~~~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~--~~~ 243 (360)
T 3e3p_A 168 DGTLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ--LHE 243 (360)
T ss_dssp TTEEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHH
T ss_pred CCcEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH--HHH
Confidence 89999999999986654332 2345789999999998654 489999999999999999999999987543222 111
Q ss_pred HHHHHhh----------ccCCCCcccC-CCCC----CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 802 WFRRVLI----------SKENIPKAID-PNLN----LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 802 ~~~~~~~----------~~~~~~~~~d-~~l~----~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
....... .........+ .... ...........+.+++.+||+.||++||++.|+++ ++|
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~------hp~ 317 (360)
T 3e3p_A 244 IVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC------HPY 317 (360)
T ss_dssp HHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT------SGG
T ss_pred HHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc------Ccc
Confidence 1111000 0000000000 0000 00000112356889999999999999999999986 666
Q ss_pred CCC
Q 002346 867 KPA 869 (933)
Q Consensus 867 ~~~ 869 (933)
...
T Consensus 318 f~~ 320 (360)
T 3e3p_A 318 FDE 320 (360)
T ss_dssp GGG
T ss_pred ccc
Confidence 543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-37 Score=337.45 Aligned_cols=258 Identities=23% Similarity=0.361 Sum_probs=203.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe--CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCc------ceeEEeEeeeC
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL--PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH------LVALLGYCING 651 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 651 (933)
.++|++.+.||+|+||.||+|.. .+++.||||+++.. ....+.+.+|+.+++.++|++ ++++++++...
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~ 89 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH 89 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC
Confidence 46899999999999999999964 46889999998753 344577899999999997654 99999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---------
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD--------- 722 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~--------- 722 (933)
+..++||||+ +++|.+++... +..++++.+++.++.|+++||+|||+ ++|+||||||+||+++.
T Consensus 90 ~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~ 162 (339)
T 1z57_A 90 GHICIVFELL-GLSTYDFIKEN---GFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNP 162 (339)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC-
T ss_pred CcEEEEEcCC-CCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCC
Confidence 9999999999 89999999652 23468999999999999999999999 89999999999999987
Q ss_pred ----------CCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCC
Q 002346 723 ----------DMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTM 792 (933)
Q Consensus 723 ----------~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~ 792 (933)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 238 (339)
T 1z57_A 163 KIKRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD 238 (339)
T ss_dssp ---CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred ccccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 668999999999865432 234579999999999999899999999999999999999999998654
Q ss_pred CchhhHHHHHHHHHhhccCCCCccc----------C-C--CCC------------------CChhhHHHHHHHHHHHHHc
Q 002346 793 PDDRAHLVTWFRRVLISKENIPKAI----------D-P--NLN------------------LDEETIESIYRVAELAGHC 841 (933)
Q Consensus 793 ~~~~~~~~~~~~~~~~~~~~~~~~~----------d-~--~l~------------------~~~~~~~~~~~~~~li~~c 841 (933)
..+.... +..... ..+..+ . . ... ...........+.+++.+|
T Consensus 239 ~~~~~~~---~~~~~~---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 312 (339)
T 1z57_A 239 SKEHLAM---MERILG---PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312 (339)
T ss_dssp HHHHHHH---HHHHHC---SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred hHHHHHH---HHHHhC---CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHH
Confidence 3322111 111110 000000 0 0 000 0001113345688999999
Q ss_pred ccCCCCCCCCHHHHHH
Q 002346 842 TAREPQQRPDMGHAVN 857 (933)
Q Consensus 842 l~~~P~~RPs~~evl~ 857 (933)
|+.||++||+++|+++
T Consensus 313 L~~dP~~Rpt~~ell~ 328 (339)
T 1z57_A 313 LEYDPAKRITLREALK 328 (339)
T ss_dssp TCSSTTTSCCHHHHTT
T ss_pred hCcCcccccCHHHHhc
Confidence 9999999999999976
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-36 Score=339.24 Aligned_cols=203 Identities=23% Similarity=0.305 Sum_probs=173.2
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CC-----cceeEEeEeeeC
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HR-----HLVALLGYCING 651 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~ 651 (933)
+.++|++.+.||+|+||.||+|.. .+++.||||++... .....++.+|+.+++.++ |+ +|+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 357899999999999999999954 46889999999753 334567888999998885 55 499999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec--CCCcEEEe
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVA 729 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~~~kl~ 729 (933)
...++||||++ ++|.+++.... ...+++..+..++.|++.||+|||+. ..+|+||||||+|||++ .++.+||+
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~ 203 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred CceEEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence 99999999995 59999997632 24589999999999999999999941 27999999999999994 57889999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCC
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMP 793 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~ 793 (933)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999876542 2345799999999999999999999999999999999999999986543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-37 Score=335.12 Aligned_cols=264 Identities=22% Similarity=0.346 Sum_probs=193.1
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEee---------
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI--------- 649 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------- 649 (933)
.++|++.+.||+|+||.||+|... +++.||+|++... .....+++.+|++++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 478999999999999999999664 5899999998755 3455678999999999999999999999873
Q ss_pred -----eCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec-CC
Q 002346 650 -----NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DD 723 (933)
Q Consensus 650 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~~ 723 (933)
+....++||||++ |+|.+++.. .++++..++.++.|+++||+|||+ ++|+||||||+||+++ ++
T Consensus 88 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~ 157 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTED 157 (320)
T ss_dssp ---CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTT
T ss_pred cccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCC
Confidence 3467899999997 699999854 468999999999999999999999 8999999999999997 56
Q ss_pred CcEEEecccccccCCCCCc--eeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHH
Q 002346 724 MRAKVADFGLVKNAPDGKY--SVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV 800 (933)
Q Consensus 724 ~~~kl~DfGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~ 800 (933)
+.+||+|||+++....... .......|++.|+|||.+.+ ..++.++||||||+++|||++|+.||..........
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~-- 235 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ-- 235 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--
Confidence 7999999999986543221 11233467999999998765 678999999999999999999999998654322111
Q ss_pred HHHHHHhh--------ccCCCCccc-----CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 801 TWFRRVLI--------SKENIPKAI-----DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 801 ~~~~~~~~--------~~~~~~~~~-----d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
........ ....++..+ .+.............++.+++.+|++.||++||+++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 305 (320)
T 2i6l_A 236 LILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS 305 (320)
T ss_dssp HHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred HHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence 11100000 000000000 0000000000112346789999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-36 Score=343.41 Aligned_cols=268 Identities=21% Similarity=0.320 Sum_probs=197.5
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc------e
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------E 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~ 653 (933)
..+|++.+.||+|+||.||+|....+..||+|++..... ...+|+++++.++||||+++++++.... .
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 357999999999999999999887777799998865421 2247999999999999999999986543 3
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec-CCCcEEEeccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFG 732 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~~kl~DfG 732 (933)
.++||||+++ ++.+.+..... ....+++..++.++.|+++||+|||+ ++|+||||||+|||++ .++.+||+|||
T Consensus 113 ~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 113 LNLVLEYVPE-TVYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp EEEEEECCSE-EHHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEeeccCc-cHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 7899999976 44444432221 13569999999999999999999999 8999999999999999 79999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh----
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL---- 807 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~---- 807 (933)
+++....... .....||+.|+|||++.+. .++.++||||+||++|||++|+.||......+. +...+...-
T Consensus 188 ~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 188 SAKILIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ--LVEIIKVLGTPSR 263 (394)
T ss_dssp TCEECCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHHHCCCCH
T ss_pred CcccccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCH
Confidence 9987654332 2345789999999998654 589999999999999999999999987543222 111111100
Q ss_pred -----hccCCCCcccCCCCCCChh----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 808 -----ISKENIPKAIDPNLNLDEE----TIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 808 -----~~~~~~~~~~d~~l~~~~~----~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
.........+ +....... ......++.+++.+||+.||++||++.|+++ ++|...
T Consensus 264 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~------hp~f~~ 327 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKF-PQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC------HPFFDE 327 (394)
T ss_dssp HHHHHHCGGGSSSCC-CCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT------SGGGST
T ss_pred HHHHhhChhhhhhcc-ccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc------Chhhhh
Confidence 0000000000 01000000 0012246789999999999999999999986 666543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=343.12 Aligned_cols=270 Identities=19% Similarity=0.294 Sum_probs=202.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-----------CCcceeEEeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-----------HRHLVALLGY 647 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~ 647 (933)
.++|++.+.||+|+||.||+|.. .+++.||||++... ....+.+.+|+.++++++ ||||++++++
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~ 94 (373)
T 1q8y_A 18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 94 (373)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence 36899999999999999999964 57899999999754 334567889999999886 8999999999
Q ss_pred eeeCc----eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEecCCCCCcEEec-
Q 002346 648 CINGS----ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIG- 721 (933)
Q Consensus 648 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dik~~Nill~- 721 (933)
+...+ ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+ + +|+||||||+|||++
T Consensus 95 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~ 167 (373)
T 1q8y_A 95 FNHKGPNGVHVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEI 167 (373)
T ss_dssp EEEEETTEEEEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEE
T ss_pred hhccCCCCceEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEec
Confidence 87654 789999999 899999997632 2458999999999999999999998 7 999999999999994
Q ss_pred -----CCCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh
Q 002346 722 -----DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR 796 (933)
Q Consensus 722 -----~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~ 796 (933)
..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus 168 ~~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 243 (373)
T 1q8y_A 168 VDSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY 243 (373)
T ss_dssp EETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred cCCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence 4458999999999866432 2335789999999999988999999999999999999999999986532211
Q ss_pred hHHHHHHHHHhhccCCCCc--------------------ccCC-CCC--------CChhhHHHHHHHHHHHHHcccCCCC
Q 002346 797 AHLVTWFRRVLISKENIPK--------------------AIDP-NLN--------LDEETIESIYRVAELAGHCTAREPQ 847 (933)
Q Consensus 797 ~~~~~~~~~~~~~~~~~~~--------------------~~d~-~l~--------~~~~~~~~~~~~~~li~~cl~~~P~ 847 (933)
..............+..+. .+.. ... ...........+.+++.+||+.||+
T Consensus 244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 323 (373)
T 1q8y_A 244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 323 (373)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence 1011111111110111111 0000 000 0011234556788999999999999
Q ss_pred CCCCHHHHHHHHhhhhhhcCCC
Q 002346 848 QRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 848 ~RPs~~evl~~L~~~~~~~~~~ 869 (933)
+||+++|+++ ++|...
T Consensus 324 ~Rpt~~ell~------hp~f~~ 339 (373)
T 1q8y_A 324 KRADAGGLVN------HPWLKD 339 (373)
T ss_dssp TCBCHHHHHT------CGGGTT
T ss_pred ccCCHHHHhh------Chhhhc
Confidence 9999999986 666653
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-37 Score=339.05 Aligned_cols=247 Identities=23% Similarity=0.372 Sum_probs=200.8
Q ss_pred HHHHHhcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCc----hhHHHHHHHHHHHHhcC--CCcceeEEeE
Q 002346 575 VLRQVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVR--HRHLVALLGY 647 (933)
Q Consensus 575 ~l~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~ 647 (933)
..+...++|++.+.||+|+||.||+|. ..+++.||||++....... ...+.+.+|+.++++++ |+||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 344557889999999999999999995 4678999999997654322 12345778999999996 5999999999
Q ss_pred eeeCceeEEEEeecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec-CCCc
Q 002346 648 CINGSERLLVYEYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DDMR 725 (933)
Q Consensus 648 ~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~~ 725 (933)
+..++..++|||++.+ ++|.+++.. ...+++..++.++.|+++||+|||+ .+|+||||||+||+++ +++.
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~ 188 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGE 188 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTE
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCC
Confidence 9999999999999976 899999965 2468999999999999999999999 8999999999999999 7899
Q ss_pred EEEecccccccCCCCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
+||+|||+++...... .....||+.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 189 ~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------------ 253 (320)
T 3a99_A 189 LKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------ 253 (320)
T ss_dssp EEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------------
Confidence 9999999998765432 234579999999999877665 688999999999999999999996421
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
......... ...+. .++.+++.+||+.||++||+++|+++
T Consensus 254 ~~~~~~~~~----~~~~~---------~~~~~li~~~l~~dp~~Rps~~~ll~ 293 (320)
T 3a99_A 254 EIIRGQVFF----RQRVS---------SECQHLIRWCLALRPSDRPTFEEIQN 293 (320)
T ss_dssp HHHHCCCCC----SSCCC---------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hhhcccccc----cccCC---------HHHHHHHHHHccCChhhCcCHHHHhc
Confidence 011111111 11111 35779999999999999999999986
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-37 Score=336.91 Aligned_cols=258 Identities=23% Similarity=0.338 Sum_probs=180.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHH-HHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIA-VLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ......++..|+. +++.++||||+++++++..++..++|
T Consensus 21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv 99 (327)
T 3aln_A 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC 99 (327)
T ss_dssp SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence 36889999999999999999966 478999999997653 2333455666666 67778999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
|||+++ +|.+++..........+++..+..++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||+++.
T Consensus 100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 999974 88888764333334678999999999999999999998 6 999999999999999999999999999986
Q ss_pred CCCCCceeecccccccCccccccc----CCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYA----ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
..... ......||+.|+|||++ .+..++.++||||||+++|||++|+.||........ ...... ...
T Consensus 176 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~~~~--~~~ 246 (327)
T 3aln_A 176 LVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLTQVV--KGD 246 (327)
T ss_dssp --------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCC--CSC
T ss_pred ccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHHHHh--cCC
Confidence 54432 12334799999999998 456789999999999999999999999975422100 000000 010
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+ .+.... .......+.+++.+||+.||++||++.++++
T Consensus 247 ~~-~~~~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 285 (327)
T 3aln_A 247 PP-QLSNSE-----EREFSPSFINFVNLCLTKDESKRPKYKELLK 285 (327)
T ss_dssp CC-CCCCCS-----SCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CC-CCCCcc-----cccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence 01 111000 0011246789999999999999999999976
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-36 Score=334.25 Aligned_cols=253 Identities=24% Similarity=0.312 Sum_probs=171.9
Q ss_pred HhcCCccCC-ccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee----Cc
Q 002346 579 VTDNFSEAN-ILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GS 652 (933)
Q Consensus 579 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~ 652 (933)
+.++|.+.+ .||+|+||.||+|... +|+.||||++... . .........++.++||||+++++++.. +.
T Consensus 26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 457888855 6999999999999654 7999999998653 1 122222334566799999999999876 45
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---CCcEEEe
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVA 729 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~ 729 (933)
..++||||+++|+|.+++... ....+++.+++.++.|+++||+|||+ ++|+||||||+||+++. ++.+||+
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQER---GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred eEEEEEeccCCCCHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEe
Confidence 578999999999999999652 22469999999999999999999999 89999999999999986 4559999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||+++...... .....||+.|+|||++.+..++.++||||||+++|||++|+.||........... ........
T Consensus 174 Dfg~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~~~~ 248 (336)
T 3fhr_A 174 DFGFAKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRIRLG 248 (336)
T ss_dssp CCTTCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred ccccceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhhhcc
Confidence 999998654322 2345789999999999888899999999999999999999999976533221100 00011111
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
....+..... .....+.+++.+|++.||++||+++|+++
T Consensus 249 ~~~~~~~~~~---------~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 287 (336)
T 3fhr_A 249 QYGFPNPEWS---------EVSEDAKQLIRLLLKTDPTERLTITQFMN 287 (336)
T ss_dssp --CCCTTTST---------TCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred ccccCchhhc---------cCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence 1111110001 11245779999999999999999999987
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-36 Score=354.36 Aligned_cols=370 Identities=19% Similarity=0.252 Sum_probs=275.2
Q ss_pred CccccceEeCCC------------CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceecc
Q 002346 54 YCEWTGINCDNS------------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYL 120 (933)
Q Consensus 54 ~C~w~gv~c~~~------------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~L 120 (933)
.|.|.|+ |+.. ..++.|+|++|++++..|..|..+++|++|+|++|+|++.+| .|.++++|++|+|
T Consensus 3 ~C~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L 81 (549)
T 2z81_A 3 SCDASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDL 81 (549)
T ss_dssp EECTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEC
T ss_pred cCCCCce-EECCCCccccccccCCCCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhccccccCCEEEC
Confidence 4899998 8632 379999999999999889999999999999999999999987 7999999999999
Q ss_pred ccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCC-ChhhcCCCCCCEEEccCCcC
Q 002346 121 DNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI-PDFFDSFSNLQNLRLSYNNF 199 (933)
Q Consensus 121 s~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~L~~N~l 199 (933)
++|+++++++..|+++++|++|+|++|++... ..|..+.++++|++|++++|++.+.+ +..|..+++|++|+|++|++
T Consensus 82 s~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l 160 (549)
T 2z81_A 82 SDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTL-GVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSL 160 (549)
T ss_dssp TTSCCCSCCHHHHTTCTTCCEEECTTCCCSSS-CSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTC
T ss_pred CCCccCccCHHHhccCCCCcEEECCCCccccc-chhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCcc
Confidence 99999999999999999999999999999862 25678999999999999999854444 46899999999999999999
Q ss_pred CCCCCccccc-------------------------cccchhhcccccCCcccc--ccc----------------------
Q 002346 200 TGSLPASFAK-------------------------SDIQNLWMNDQQLGLSGT--LDV---------------------- 230 (933)
Q Consensus 200 ~~~~p~~~~~-------------------------~~l~~l~l~~n~~~~~~~--~~~---------------------- 230 (933)
++.+|..+.. .+|++|++++|.+..... ...
T Consensus 161 ~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~ 240 (549)
T 2z81_A 161 RNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESF 240 (549)
T ss_dssp CEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESCEEEHHHH
T ss_pred cccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceeccccccchhHH
Confidence 9888877653 245555555555443110 000
Q ss_pred ------cc-----------------------------------------------------------CCccCcEEEecCC
Q 002346 231 ------LS-----------------------------------------------------------GMTQLRQVWLHKN 245 (933)
Q Consensus 231 ------l~-----------------------------------------------------------~l~~L~~L~L~~N 245 (933)
+. .+++|+.|++++|
T Consensus 241 ~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~~L~l~~n 320 (549)
T 2z81_A 241 NELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENS 320 (549)
T ss_dssp HHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCCEEEEESS
T ss_pred HHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccceEEEeccC
Confidence 00 0123444455555
Q ss_pred ccCCCCCCC-CCCCCCCEEEccCCcccccCcc---cccCCCCCCEEEccCccCccCC-----CCCCCCccEEeccCCcCC
Q 002346 246 QFTGPIPDL-SKCESLFDLSLRDNQLTGVVPA---SVISLPALLNISLQNNKLQGPY-----PLFPSKVQKVSLDHNNFC 316 (933)
Q Consensus 246 ~l~~~~~~~-~~~~~L~~L~L~~N~l~~~~p~---~l~~l~~L~~L~Ls~N~l~~~~-----p~~~~~l~~L~l~~n~~~ 316 (933)
+++..+..+ ..+++|+.|+|++|++++.+|. .+..+++|+.|+|++|++++.. .....+|+.|+|++|+|.
T Consensus 321 ~l~~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~ 400 (549)
T 2z81_A 321 KVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH 400 (549)
T ss_dssp CCCCCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHHHHHHGGGCTTCCEEECTTCCCC
T ss_pred ccccCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCcccccccchhhhhcCCCCCEEECCCCCCc
Confidence 544333233 4688999999999999987653 4778899999999999997643 234568999999999887
Q ss_pred CCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeE
Q 002346 317 KNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNL 396 (933)
Q Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L 396 (933)
..+... .....++.+...++.+..+|..+. ++|+.|+|++|++++.+ +++++|+.|
T Consensus 401 ~lp~~~------------------~~~~~L~~L~Ls~N~l~~l~~~~~--~~L~~L~Ls~N~l~~~~----~~l~~L~~L 456 (549)
T 2z81_A 401 PMPDSC------------------QWPEKMRFLNLSSTGIRVVKTCIP--QTLEVLDVSNNNLDSFS----LFLPRLQEL 456 (549)
T ss_dssp CCCSCC------------------CCCTTCCEEECTTSCCSCCCTTSC--TTCSEEECCSSCCSCCC----CCCTTCCEE
T ss_pred cCChhh------------------cccccccEEECCCCCcccccchhc--CCceEEECCCCChhhhc----ccCChhcEE
Confidence 543321 122233333334444555665442 57888899988888743 578888889
Q ss_pred ecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC-CC--CCcccccCCCCCCcCC
Q 002346 397 YLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD-FG--SNVKFTVSPGNPFIGT 451 (933)
Q Consensus 397 ~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~--~~~~~~~~~~n~~~~~ 451 (933)
+|++|+|+ .+|. ...+++|++|+|++|+|++.+|. +. ..++...+.+|||.|.
T Consensus 457 ~Ls~N~l~-~ip~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 512 (549)
T 2z81_A 457 YISRNKLK-TLPD-ASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 512 (549)
T ss_dssp ECCSSCCS-SCCC-GGGCTTCCEEECCSSCCCCCCTTGGGGCTTCCEEECCSSCBCCC
T ss_pred ECCCCccC-cCCC-cccCccCCEEecCCCccCCcCHHHHhcCcccCEEEecCCCccCC
Confidence 99999888 6776 46788888999999988888876 33 2334445678888663
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-37 Score=334.05 Aligned_cols=252 Identities=25% Similarity=0.408 Sum_probs=194.5
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc----hhHHHHHHHHHHHHhc----CCCcceeEEe
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKV----RHRHLVALLG 646 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l----~h~niv~l~~ 646 (933)
.+...++|++.+.||+|+||.||+|.. .+++.||||++....... .....+.+|+.++.++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 345568899999999999999999965 578999999997653221 1233466799999998 8999999999
Q ss_pred EeeeCceeEEEEee-cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec-CCC
Q 002346 647 YCINGSERLLVYEY-MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG-DDM 724 (933)
Q Consensus 647 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~-~~~ 724 (933)
++...+..++|||| +.+++|.+++... ..+++.+++.++.|+++||+|||+ ++|+||||||+||+++ .++
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~ 177 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRG 177 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTT
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCC
Confidence 99999999999999 7899999999762 458999999999999999999999 8999999999999999 889
Q ss_pred cEEEecccccccCCCCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHH
Q 002346 725 RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF 803 (933)
Q Consensus 725 ~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~ 803 (933)
.+||+|||+++...... .....|++.|+|||++.+..+ +.++||||||+++|||++|+.||....
T Consensus 178 ~~kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~----------- 243 (312)
T 2iwi_A 178 CAKLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----------- 243 (312)
T ss_dssp EEEECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----------
T ss_pred eEEEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----------
Confidence 99999999998765432 234579999999999876666 458999999999999999999996421
Q ss_pred HHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 804 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
........++ ... ...+.+++.+|++.+|++||+++|+++ ++|...
T Consensus 244 -~~~~~~~~~~----~~~---------~~~~~~li~~~l~~~p~~Rps~~e~l~------~~~~~~ 289 (312)
T 2iwi_A 244 -EILEAELHFP----AHV---------SPDCCALIRRCLAPKPSSRPSLEEILL------DPWMQT 289 (312)
T ss_dssp -HHHHTCCCCC----TTS---------CHHHHHHHHHHTCSSTTTSCCHHHHHH------STTTCC
T ss_pred -HHhhhccCCc----ccC---------CHHHHHHHHHHccCChhhCcCHHHHhc------ChhhcC
Confidence 0111111111 111 135779999999999999999999987 566543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-35 Score=330.27 Aligned_cols=263 Identities=21% Similarity=0.307 Sum_probs=203.7
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CC-cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCc------ceeEEeEeeeC
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DG-TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH------LVALLGYCING 651 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~ 651 (933)
.++|++.+.||+|+||.||+|... ++ +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++...
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~ 94 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH 94 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC
Confidence 478999999999999999999653 44 78999999753 344567889999999997766 89999999999
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEe-----------
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILI----------- 720 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill----------- 720 (933)
+..++||||+ ++++.+++... ....+++.+++.++.|+++||+|||+ ++|+||||||+|||+
T Consensus 95 ~~~~lv~e~~-~~~l~~~l~~~---~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~ 167 (355)
T 2eu9_A 95 GHMCIAFELL-GKNTFEFLKEN---NFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNE 167 (355)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT---TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECC
T ss_pred CeEEEEEecc-CCChHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccc
Confidence 9999999999 67888887552 22468999999999999999999998 899999999999999
Q ss_pred --------cCCCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCC
Q 002346 721 --------GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTM 792 (933)
Q Consensus 721 --------~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~ 792 (933)
+.++.+||+|||+++...... ....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 168 HKSCEEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp C-CCCEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 567899999999998654322 34579999999999999999999999999999999999999998654
Q ss_pred CchhhHHHHHHHHHhhccCCCCccc-----------CCC--CCC------------------ChhhHHHHHHHHHHHHHc
Q 002346 793 PDDRAHLVTWFRRVLISKENIPKAI-----------DPN--LNL------------------DEETIESIYRVAELAGHC 841 (933)
Q Consensus 793 ~~~~~~~~~~~~~~~~~~~~~~~~~-----------d~~--l~~------------------~~~~~~~~~~~~~li~~c 841 (933)
..+.. ..+.... ...+..+ ... ... ..........+.+++.+|
T Consensus 244 ~~~~~---~~~~~~~---~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 317 (355)
T 2eu9_A 244 NREHL---VMMEKIL---GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317 (355)
T ss_dssp HHHHH---HHHHHHH---CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHH
T ss_pred HHHHH---HHHHHHc---CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHH
Confidence 32221 1111111 0011000 000 000 000112234688999999
Q ss_pred ccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 842 TAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 842 l~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
|+.||++||+++|+++ ++|..
T Consensus 318 L~~dP~~Rpt~~e~l~------hp~f~ 338 (355)
T 2eu9_A 318 LEFDPAQRITLAEALL------HPFFA 338 (355)
T ss_dssp TCSSTTTSCCHHHHTT------SGGGG
T ss_pred hcCChhhCcCHHHHhc------Chhhc
Confidence 9999999999999975 66654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-36 Score=342.21 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=188.3
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+.|.+.+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +|||||++++++.++...++|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 445667889999999998776668999999998653 235678999999987 89999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCC--CCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC-------------C
Q 002346 660 YMPRGTLAQHLFEWHDHGY--TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD-------------M 724 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~-------------~ 724 (933)
|+. |+|.+++........ ...++..++.++.||+.||+|||+ ++|+||||||+|||++.+ +
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~ 165 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENL 165 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCce
Confidence 995 699999976322110 112344567899999999999999 899999999999999754 4
Q ss_pred cEEEecccccccCCCCCce---eecccccccCcccccccCC-------CCCCCccchHhHHHHHHHHHc-CCCCCCCCCC
Q 002346 725 RAKVADFGLVKNAPDGKYS---VETRLAGTFGYLAPEYAAT-------GRVTTKIDVYAFGVVLMETIT-GRKALDDTMP 793 (933)
Q Consensus 725 ~~kl~DfGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~ 793 (933)
.+||+|||+++........ ......||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 8999999999876554322 1234579999999999865 578999999999999999999 9999976433
Q ss_pred chhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 794 DDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 794 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... . ........+.. + .........++.+++.+|++.||++||++.++++
T Consensus 246 ~~~----~----i~~~~~~~~~~--~----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~ 295 (434)
T 2rio_A 246 RES----N----IIRGIFSLDEM--K----CLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR 295 (434)
T ss_dssp HHH----H----HHHTCCCCCCC--T----TCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred hHH----H----HhcCCCCcccc--c----ccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence 221 1 11111111111 0 1112334467889999999999999999999986
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-35 Score=352.00 Aligned_cols=357 Identities=16% Similarity=0.155 Sum_probs=214.8
Q ss_pred ccceEeCC----------CCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccc
Q 002346 57 WTGINCDN----------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNF 125 (933)
Q Consensus 57 w~gv~c~~----------~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l 125 (933)
+.-+.|.+ ...++.|+|++|.|++..|.+|+.+++|++|+|++|.++++.| .|.++++|++|+|++|++
T Consensus 14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l 93 (606)
T 3t6q_A 14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANPL 93 (606)
T ss_dssp TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCSEECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCC
T ss_pred CceEECCCCCcccCcCCCCCcCcEEEccCCccCcCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCcc
Confidence 45688864 2478999999999998888899999999999999999998887 789999999999999999
Q ss_pred cCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCc
Q 002346 126 TSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205 (933)
Q Consensus 126 ~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 205 (933)
+++++..|+++++|++|+|++|++.. ..|..+.++++|++|+|++|++.+..+..+..+++|++|+|++|++++..|.
T Consensus 94 ~~~~~~~~~~l~~L~~L~L~~n~i~~--l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 171 (606)
T 3t6q_A 94 IFMAETALSGPKALKHLFFIQTGISS--IDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKE 171 (606)
T ss_dssp SEECTTTTSSCTTCCEEECTTSCCSC--GGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCEECHH
T ss_pred cccChhhhcccccccEeeccccCccc--CCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccccChh
Confidence 99888889999999999999998887 2356677888888888888888775444444477777777777777755555
Q ss_pred cccc-cccc--hhhcccccCCccccc------------------------------------------------ccccCC
Q 002346 206 SFAK-SDIQ--NLWMNDQQLGLSGTL------------------------------------------------DVLSGM 234 (933)
Q Consensus 206 ~~~~-~~l~--~l~l~~n~~~~~~~~------------------------------------------------~~l~~l 234 (933)
.+.. ..++ .|++++|.+...... ..+.++
T Consensus 172 ~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~~~~~i~~~~~~~l 251 (606)
T 3t6q_A 172 DMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGL 251 (606)
T ss_dssp HHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTSCCCCCCGGGGGGG
T ss_pred hhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccccccccChhHhchh
Confidence 5544 2344 455555544321110 001111
Q ss_pred c--cCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCC---CCCccEE
Q 002346 235 T--QLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---PSKVQKV 308 (933)
Q Consensus 235 ~--~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L 308 (933)
. +|+.|++++|.+++..+. +..+++|+.|+|++|+++ .+|..+..+++|++|++++|++++..|.. ..+|+.|
T Consensus 252 ~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 330 (606)
T 3t6q_A 252 CEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHL 330 (606)
T ss_dssp GGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGGGGCGGGCTTCSEE
T ss_pred hcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCchhhhhccCcCCEE
Confidence 1 455555555555555543 555555666666655555 45555555555566666655555544422 2355555
Q ss_pred eccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccC-CCCCCCCCCCC--CccccCCCceeEEEccCccccCcCch
Q 002346 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD-SWEGNNACDGW--PFVTCSQGRIITINLANKLLAGNISP 385 (933)
Q Consensus 309 ~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-~~~~~~~~~~~--p~~~~~l~~L~~L~Ls~N~l~g~~p~ 385 (933)
++++|.+.+..+... +.....++. ++.+|...+.. |..+..+++|+.|+|++|++.+..|.
T Consensus 331 ~l~~n~~~~~~~~~~----------------~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~ 394 (606)
T 3t6q_A 331 SIKGNTKRLELGTGC----------------LENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTE 394 (606)
T ss_dssp ECCSCSSCCBCCSST----------------TTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTT
T ss_pred ECCCCCcccccchhh----------------hhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHH
Confidence 555555543221110 000111111 11222221111 33444455555555555555554455
Q ss_pred hhcCcccCCeEecccCcccCCCCcc-cCCCCCcCEEeccCCcCcccCC
Q 002346 386 AYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 386 ~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~g~~p 432 (933)
.|+.+++|+.|+|++|++++..|.. +..+++|+.|++++|.+++.+|
T Consensus 395 ~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~ 442 (606)
T 3t6q_A 395 AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSE 442 (606)
T ss_dssp TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCT
T ss_pred HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCH
Confidence 5555555555555555555444332 4455555555555555554444
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-35 Score=325.14 Aligned_cols=253 Identities=22% Similarity=0.361 Sum_probs=181.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+..+..+++.++||||+++++++..++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 36789999999999999999966 47899999999876433333444555666788889999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCC-CeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ-SFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~-~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
||+ ++.+..+... . ...+++..++.++.|+++||+|||+ . +|+||||||+||+++.++.+||+|||++...
T Consensus 104 e~~-~~~~~~l~~~-~---~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR-M---QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175 (318)
T ss_dssp CCC-SEEHHHHHHH-H---TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred ecc-CCcHHHHHHH-h---ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence 999 4555544432 1 2568999999999999999999998 5 9999999999999999999999999998765
Q ss_pred CCCCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
.... ......|++.|+|||++. ...++.++||||||+++|||++|+.||........ . .........
T Consensus 176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~---~~~~~~~~~- 247 (318)
T 2dyl_A 176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--V---LTKVLQEEP- 247 (318)
T ss_dssp -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--H---HHHHHHSCC-
T ss_pred cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--H---HHHHhccCC-
Confidence 4432 223457999999999984 45688999999999999999999999976432211 1 111121111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+..... ....+.+++.+||+.||.+||+++++++
T Consensus 248 --~~~~~~~~-------~~~~l~~li~~~l~~dp~~Rps~~~ll~ 283 (318)
T 2dyl_A 248 --PLLPGHMG-------FSGDFQSFVKDCLTKDHRKRPKYNKLLE 283 (318)
T ss_dssp --CCCCSSSC-------CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred --CCCCccCC-------CCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence 11110000 1135779999999999999999999986
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-35 Score=340.57 Aligned_cols=317 Identities=19% Similarity=0.219 Sum_probs=250.2
Q ss_pred CCCCCc--cccceEeCCC----------CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCc
Q 002346 50 SSTGYC--EWTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQ 116 (933)
Q Consensus 50 ~~~~~C--~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~ 116 (933)
+..|.| .|..|.|... ..++.|+|++|+|++..+..|..+++|++|+|++|.|+++.| .|.++++|+
T Consensus 4 p~~C~C~~~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~ 83 (477)
T 2id5_A 4 PPRCECSAQDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLR 83 (477)
T ss_dssp STTCEEETTTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCC
T ss_pred cCCCeECCCCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCC
Confidence 344556 3678888642 367888888888887777788888888888888888888776 788888888
Q ss_pred eeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccC
Q 002346 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSY 196 (933)
Q Consensus 117 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~ 196 (933)
+|+|++|+++.++...|.++++|++|+|++|++.. ..|..+..+++|++|+|++|.+.+..+..|..+++|++|+|++
T Consensus 84 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~ 161 (477)
T 2id5_A 84 TLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVI--LLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEK 161 (477)
T ss_dssp EEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCE--ECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEES
T ss_pred EEECCCCcCCccCcccccCCCCCCEEECCCCcccc--CChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCC
Confidence 88888888888888888888888888888888877 4567788888888888888888888888888888888888888
Q ss_pred CcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCc
Q 002346 197 NNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVP 275 (933)
Q Consensus 197 N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p 275 (933)
|++++..+..+ ..+++|+.|+|++|.+++..+ .+..+++|+.|+|++|.+.+.+|
T Consensus 162 n~l~~~~~~~l------------------------~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~~~~ 217 (477)
T 2id5_A 162 CNLTSIPTEAL------------------------SHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMT 217 (477)
T ss_dssp CCCSSCCHHHH------------------------TTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCCEEC
T ss_pred CcCcccChhHh------------------------cccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCccccccC
Confidence 88874333333 347888888888888887666 47788888888888888777777
Q ss_pred ccccCCCCCCEEEccCccCccCCC---CCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCC
Q 002346 276 ASVISLPALLNISLQNNKLQGPYP---LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG 352 (933)
Q Consensus 276 ~~l~~l~~L~~L~Ls~N~l~~~~p---~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 352 (933)
..+....+|+.|+|++|++++..+ ....+|+.|+|++|.+.+..
T Consensus 218 ~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~--------------------------------- 264 (477)
T 2id5_A 218 PNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIE--------------------------------- 264 (477)
T ss_dssp TTTTTTCCCSEEEEESSCCCSCCHHHHTTCTTCCEEECCSSCCCEEC---------------------------------
T ss_pred cccccCccccEEECcCCcccccCHHHhcCccccCeeECCCCcCCccC---------------------------------
Confidence 777777788888888888885443 23457888888888775532
Q ss_pred CCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCC
Q 002346 353 NNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 353 ~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p 432 (933)
+..+..+++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+..+
T Consensus 265 -------~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c~c~ 337 (477)
T 2id5_A 265 -------GSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLACDCR 337 (477)
T ss_dssp -------TTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEECSGG
T ss_pred -------hhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccCccc
Confidence 2345567889999999999998888899999999999999999997777788889999999999999887644
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-35 Score=349.20 Aligned_cols=380 Identities=18% Similarity=0.195 Sum_probs=242.5
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|.+++..|..|+.+++|++|+|++|.|++..+ .+.++++|++|+|++|.+++++...+..+++|++|+|
T Consensus 81 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 160 (606)
T 3t6q_A 81 HRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDF 160 (606)
T ss_dssp TTCCEEECTTCCCSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEEC
T ss_pred cccCeeeCCCCcccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEc
Confidence 478888999988888888888888888888888888888755 7888888888888888888876555666888888888
Q ss_pred cCCCCCCCCCCCccccCCccCC----------------------------------------------------------
Q 002346 145 SDNPNLAPWPFPNELTKSTSLT---------------------------------------------------------- 166 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~---------------------------------------------------------- 166 (933)
++|++.. ..|..+..+++|+
T Consensus 161 ~~n~l~~--~~~~~~~~l~~L~~l~L~l~~n~l~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~~~l~~l~~~~~~~~ 238 (606)
T 3t6q_A 161 QNNAIHY--LSKEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDM 238 (606)
T ss_dssp CSSCCCE--ECHHHHHTTTTCCSEEEECTTCCCCEECTTTTTTCEEEEEECTTCSCHHHHHHHTTTCEEEEEECCCCTTS
T ss_pred ccCcccc--cChhhhhhhcccceeEEecCCCccCccChhHhhhccccccccCCchhHHHHhhhccccchhheechhhccc
Confidence 8887765 2334444444444
Q ss_pred -------------------eeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCCccc
Q 002346 167 -------------------TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSG 226 (933)
Q Consensus 167 -------------------~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~~~ 226 (933)
.|++++|++.+..+..|+.+++|++|+|++|+++ .+|..+.. ..|++|++.+|.+....
T Consensus 239 ~~~~i~~~~~~~l~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~-~lp~~l~~l~~L~~L~l~~n~l~~~~ 317 (606)
T 3t6q_A 239 DDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC 317 (606)
T ss_dssp CCCCCCGGGGGGGGGSEEEEEECTTCCCSSCCTTTTTTCTTCSEEECTTSCCS-CCCSSCCSCTTCCEEECTTCCCSBGG
T ss_pred cccccChhHhchhhcCceeEEEeecCccCccCHHHhccccCCCEEeccCCccC-CCChhhcccccCCEEECccCCcCcCc
Confidence 3444444444444555677788888888888887 77777655 56777888877765332
Q ss_pred ccccccCCccCcEEEecCCccCCCCCC--CCCCCCCCEEEccCCcccccC--cccccCCCCCCEEEccCccCccCCCCC-
Q 002346 227 TLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRDNQLTGVV--PASVISLPALLNISLQNNKLQGPYPLF- 301 (933)
Q Consensus 227 ~~~~l~~l~~L~~L~L~~N~l~~~~~~--~~~~~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~~- 301 (933)
...+..+++|+.|++++|.+.+.++. +..+++|+.|++++|++++.. |..+..+++|++|++++|++++..|..
T Consensus 318 -~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~ 396 (606)
T 3t6q_A 318 -QISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAF 396 (606)
T ss_dssp -GGCGGGCTTCSEEECCSCSSCCBCCSSTTTTCTTCCEEECCSSCCCEEEESTTTTTTCTTCCEEECCSCSCEEECTTTT
T ss_pred -hhhhhccCcCCEEECCCCCcccccchhhhhccCcCCEEECCCCccccccCcchhcccCCCCCEEECCCCcCCcCCHHHh
Confidence 23455566666666666666654442 566666666666666666544 555666666666666666666555433
Q ss_pred --CCCccEEeccCCcCCCCCCCC-CCCCCchhhhh-------Hh-hhcccCCCccc-cCCCCCCCCCC---CCCccccCC
Q 002346 302 --PSKVQKVSLDHNNFCKNSSDA-GKPCDPQVTTL-------LQ-IAGDMGYPAIL-SDSWEGNNACD---GWPFVTCSQ 366 (933)
Q Consensus 302 --~~~l~~L~l~~n~~~~~~~~~-~~~~~~~~~~~-------~~-~~~~~~~~~~l-~~~~~~~~~~~---~~p~~~~~l 366 (933)
..+|+.|++++|.+.+..+.. +..+ .....+ .. .+..+.....+ ...+.+|...+ ..+..+..+
T Consensus 397 ~~l~~L~~L~l~~n~l~~~~~~~~~~~l-~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~l 475 (606)
T 3t6q_A 397 KECPQLELLDLAFTRLKVKDAQSPFQNL-HLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTL 475 (606)
T ss_dssp TTCTTCSEEECTTCCEECCTTCCTTTTC-TTCCEEECTTCCCBTTCTTTTTTCTTCCEEECTTCBCGGGEECSSCGGGGC
T ss_pred cCCccCCeEECCCCcCCCcccchhhhCc-ccCCEEECCCCccCCcCHHHHhCCCCCCEEECCCCCCCccccccchhhccC
Confidence 235566666666665443221 1100 000000 00 00011111122 22334444433 223456777
Q ss_pred CceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCCC---CCcccccC
Q 002346 367 GRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG---SNVKFTVS 443 (933)
Q Consensus 367 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~---~~~~~~~~ 443 (933)
++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..+.+++.| +|++++|++++.+|... ..++...+
T Consensus 476 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~L-~L~L~~N~l~~~~~~~~~~l~~L~~L~l 554 (606)
T 3t6q_A 476 GRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNLASNHISIILPSLLPILSQQRTINL 554 (606)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCGGGGGGGTTCCSC-EEECCSSCCCCCCGGGHHHHHTSSEEEC
T ss_pred CCccEEECCCCccCccChhhhccccCCCEEECCCCccCcCChhHhCccccc-EEECcCCcccccCHhhcccCCCCCEEeC
Confidence 788888888888887777778888888888888888887777788888888 88888888887776532 23344456
Q ss_pred CCCCCcCC
Q 002346 444 PGNPFIGT 451 (933)
Q Consensus 444 ~~n~~~~~ 451 (933)
.+|||.|.
T Consensus 555 ~~N~~~c~ 562 (606)
T 3t6q_A 555 RQNPLDCT 562 (606)
T ss_dssp TTCCEECS
T ss_pred CCCCcccc
Confidence 78888663
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=338.28 Aligned_cols=249 Identities=25% Similarity=0.404 Sum_probs=186.8
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~ 658 (933)
..+|.+.+.||+|+||+||.....+++.||||++..... ..+.+|+++++++ +|||||++++++.+....++||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 356888999999999997665556899999999875432 2356899999999 7999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-----CCcEEEecccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-----DMRAKVADFGL 733 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-----~~~~kl~DfGl 733 (933)
||+. |+|.+++.... ....+.+++.++.||++||+|||+ ++|+||||||+||+++. ...+||+|||+
T Consensus 98 E~~~-g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp ECCS-EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred ECCC-CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 9995 69999996522 234445677899999999999999 89999999999999953 33688999999
Q ss_pred cccCCCCCc--eeecccccccCcccccccC---CCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHh
Q 002346 734 VKNAPDGKY--SVETRLAGTFGYLAPEYAA---TGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 734 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
++....... .......||+.|+|||++. ...++.++|||||||++|||++ |+.||........ ...
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~--------~~~ 241 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA--------NIL 241 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH--------HHH
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH--------HHH
Confidence 986654321 2234467999999999997 4567889999999999999999 8899865432211 011
Q ss_pred hccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 808 ISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 808 ~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...... ....+ .......+.+++.+||+.||++||++.|+++
T Consensus 242 ~~~~~~-~~~~~-------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~ 283 (432)
T 3p23_A 242 LGACSL-DCLHP-------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK 283 (432)
T ss_dssp TTCCCC-TTSCT-------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hccCCc-cccCc-------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence 111111 11111 1122344679999999999999999999985
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=341.57 Aligned_cols=359 Identities=20% Similarity=0.193 Sum_probs=247.6
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|++++..+..|..+++|++|+|++|+|+++.| .|.++++|++|+|++|+|+.+|.. .+++|++|+|
T Consensus 52 ~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 128 (562)
T 3a79_B 52 PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC---PMASLRHLDL 128 (562)
T ss_dssp TTCCEEECCSSCCCCCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC---CCTTCSEEEC
T ss_pred CCcCEEECCCCCccccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc---ccccCCEEEC
Confidence 578999999999998888899999999999999999999887 789999999999999999988876 7999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCC--CEEEccCCcC--CCCCCcccccc----------
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL--QNLRLSYNNF--TGSLPASFAKS---------- 210 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~~---------- 210 (933)
++|++... ++|..++++++|++|+|++|++.+. .+..+++| ++|+|++|++ ++..|..+...
T Consensus 129 s~N~l~~l-~~p~~~~~l~~L~~L~L~~n~l~~~---~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 204 (562)
T 3a79_B 129 SFNDFDVL-PVCKEFGNLTKLTFLGLSAAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFH 204 (562)
T ss_dssp CSSCCSBC-CCCGGGGGCTTCCEEEEECSBCCTT---TTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEEC
T ss_pred CCCCcccc-CchHhhcccCcccEEecCCCccccC---chhhhhhceeeEEEeecccccccccCcccccccCcceEEEEec
Confidence 99998862 3468899999999999999999874 34445555 9999999999 77778777652
Q ss_pred -----------------ccchhhcccccCC---ccccccccc---------------------------CCccCcEEEec
Q 002346 211 -----------------DIQNLWMNDQQLG---LSGTLDVLS---------------------------GMTQLRQVWLH 243 (933)
Q Consensus 211 -----------------~l~~l~l~~n~~~---~~~~~~~l~---------------------------~l~~L~~L~L~ 243 (933)
.|+.+++..|... ..+..+.+. ..++|++|+++
T Consensus 205 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~ 284 (562)
T 3a79_B 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIY 284 (562)
T ss_dssp SSSCCCCCCEEEESSEEEEEEEEEECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEE
T ss_pred CccchhhhhhhcccccceEEEecccccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEe
Confidence 2333333333100 000000000 12367777777
Q ss_pred CCccCCCCCC-C-----CCCC--------------------------CCCEEEccCCcccccCcccccCCCCCCEEEccC
Q 002346 244 KNQFTGPIPD-L-----SKCE--------------------------SLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291 (933)
Q Consensus 244 ~N~l~~~~~~-~-----~~~~--------------------------~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 291 (933)
+|+++|.+|. + ..++ +|+.|++++|++.... ....+++|++|++++
T Consensus 285 ~n~l~~~ip~~~~~~~~~~L~~L~~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~l~~ 362 (562)
T 3a79_B 285 NLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV--CPPSPSSFTFLNFTQ 362 (562)
T ss_dssp EEEECSCCCCCCCCCCSCSCCEEEEEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC--CCSSCCCCCEEECCS
T ss_pred ccEeeccccchhhhcccccchheehhhcccceeecChhhhhhhhccCcceEEEccCCCccccc--CccCCCCceEEECCC
Confidence 7777765553 2 2222 2344444444433111 014566677777777
Q ss_pred ccCccCCCCC---CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccc-cCCCCCCCCCCCCCcc-ccCC
Q 002346 292 NKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL-SDSWEGNNACDGWPFV-TCSQ 366 (933)
Q Consensus 292 N~l~~~~p~~---~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~~~p~~-~~~l 366 (933)
|++++.+|.. ..+|+.|+|++|++.+... ++..+.....+ ..++.+|...+.+|.. +..+
T Consensus 363 n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~---------------~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l 427 (562)
T 3a79_B 363 NVFTDSVFQGCSTLKRLQTLILQRNGLKNFFK---------------VALMTKNMSSLETLDVSLNSLNSHAYDRTCAWA 427 (562)
T ss_dssp SCCCTTTTTTCCSCSSCCEEECCSSCCCBTTH---------------HHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCC
T ss_pred CccccchhhhhcccCCCCEEECCCCCcCCccc---------------chhhhcCCCCCCEEECCCCcCCCccChhhhcCc
Confidence 7777655543 2456677777776654321 11111111222 2233444444435554 6678
Q ss_pred CceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC-CCC--CcccccC
Q 002346 367 GRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD-FGS--NVKFTVS 443 (933)
Q Consensus 367 ~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~--~~~~~~~ 443 (933)
++|+.|+|++|++++.+|..+. ++|+.|+|++|+|+ .+|..+..+++|++|+|++|+|++.++. +.. .++...+
T Consensus 428 ~~L~~L~l~~n~l~~~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~l 504 (562)
T 3a79_B 428 ESILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWL 504 (562)
T ss_dssp TTCCEEECCSSCCCGGGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCCCCCTTSTTTCTTCCCEEC
T ss_pred ccCCEEECCCCCCCcchhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCCCCCHHHHhcCCCCCEEEe
Confidence 9999999999999988887665 79999999999999 8888888999999999999999976555 443 3334456
Q ss_pred CCCCCcCC
Q 002346 444 PGNPFIGT 451 (933)
Q Consensus 444 ~~n~~~~~ 451 (933)
.+|||.|.
T Consensus 505 ~~N~~~c~ 512 (562)
T 3a79_B 505 HDNPWDCT 512 (562)
T ss_dssp CSCCBCCC
T ss_pred cCCCcCCC
Confidence 78999763
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=354.66 Aligned_cols=340 Identities=17% Similarity=0.222 Sum_probs=285.5
Q ss_pred CCEEEEEecCCCCccc-----------------cCcccc--CCcccceeecccccccccCC-CccCcCcCceecccccc-
Q 002346 66 NRVTTISLAKSGLSGT-----------------LSPEIS--SLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN- 124 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~-----------------~~~~~~--~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~- 124 (933)
.+++.|+|++|.|+|. +|..++ ++++|++|+|++|.+.+.+| .|.++++|++|+|++|+
T Consensus 206 ~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~ 285 (636)
T 4eco_A 206 TKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRG 285 (636)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTCTT
T ss_pred cCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCCCC
Confidence 5899999999999996 999999 99999999999999999988 89999999999999998
Q ss_pred ccC-CCCCcccCC------CCCCEEEccCCCCCCCCCCCc--cccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEcc
Q 002346 125 FTS-VPTGCFDGL------TNLQVLSLSDNPNLAPWPFPN--ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (933)
Q Consensus 125 l~~-~~~~~~~~l------~~L~~L~Ls~N~~~~~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 195 (933)
+++ ..+..++.+ ++|++|+|++|++.. +|. .++++++|++|+|++|++.|.+| .|+.+++|++|+|+
T Consensus 286 l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~~---ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~ 361 (636)
T 4eco_A 286 ISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKT---FPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA 361 (636)
T ss_dssp SCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCSS---CCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECC
T ss_pred CccccchHHHHhhhccccCCCCCEEECCCCcCCc---cCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECC
Confidence 987 334446665 999999999999985 888 99999999999999999998999 99999999999999
Q ss_pred CCcCCCCCCccccc-cc-cchhhcccccCCcccccccccCC--ccCcEEEecCCccCCCCCC-CC-------CCCCCCEE
Q 002346 196 YNNFTGSLPASFAK-SD-IQNLWMNDQQLGLSGTLDVLSGM--TQLRQVWLHKNQFTGPIPD-LS-------KCESLFDL 263 (933)
Q Consensus 196 ~N~l~~~~p~~~~~-~~-l~~l~l~~n~~~~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~-~~-------~~~~L~~L 263 (933)
+|+++ .+|..+.. .. |++|++++|.+.. .+..+..+ ++|+.|+|++|++++.+|. +. .+.+|+.|
T Consensus 362 ~N~l~-~lp~~l~~l~~~L~~L~Ls~N~l~~--lp~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~~~~~~~~~~~L~~L 438 (636)
T 4eco_A 362 YNQIT-EIPANFCGFTEQVENLSFAHNKLKY--IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSI 438 (636)
T ss_dssp SSEEE-ECCTTSEEECTTCCEEECCSSCCSS--CCSCCCTTCSSCEEEEECCSSCTTTTTTCSSCTTCSSCCCCCCEEEE
T ss_pred CCccc-cccHhhhhhcccCcEEEccCCcCcc--cchhhhhcccCccCEEECcCCcCCCcchhhhcccccccccCCCCCEE
Confidence 99999 89988877 46 9999999999872 23445544 4899999999999998774 66 77899999
Q ss_pred EccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCC----------CccEEeccCCcCCCCCCCCCCCCCchhhhh
Q 002346 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPS----------KVQKVSLDHNNFCKNSSDAGKPCDPQVTTL 333 (933)
Q Consensus 264 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~----------~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~ 333 (933)
+|++|+++...+..+..+++|+.|+|++|+++...+.... +|+.|+|++|++..++.....
T Consensus 439 ~Ls~N~l~~lp~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~--------- 509 (636)
T 4eco_A 439 NLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRA--------- 509 (636)
T ss_dssp ECCSSCCCSCCTHHHHTTCCCSEEECCSSCCSBCCSSSSEETTEECTTGGGCCEEECCSSCCCBCCGGGST---------
T ss_pred ECcCCccCcCCHHHHccCCCCCEEECCCCCCCCcCHHHhccccccccccCCccEEECcCCcCCccChhhhh---------
Confidence 9999999944344456799999999999999944443332 899999999999854322110
Q ss_pred HhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEc------cCccccCcCchhhcCcccCCeEecccCcccCCC
Q 002346 334 LQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINL------ANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407 (933)
Q Consensus 334 ~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~L------s~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~ 407 (933)
...+..-..++.+|... .+|..+..+++|+.|+| ++|++.+.+|..|+++++|+.|+|++|+| +.+
T Consensus 510 ------~~l~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~Ls~N~~ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l-~~i 581 (636)
T 4eco_A 510 ------TTLPYLVGIDLSYNSFS-KFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKV 581 (636)
T ss_dssp ------TTCTTCCEEECCSSCCS-SCCCGGGGCSSCCEEECCSCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CBC
T ss_pred ------ccCCCcCEEECCCCCCC-CcChhhhcCCCCCEEECCCCcccccCcccccChHHHhcCCCCCEEECCCCcC-Ccc
Confidence 01222223344555554 49999999999999999 56889999999999999999999999999 699
Q ss_pred CcccCCCCCcCEEeccCCcCcccC
Q 002346 408 PDGLTKLASLQNLDVSNNNLSGKV 431 (933)
Q Consensus 408 p~~~~~l~~L~~l~ls~N~l~g~~ 431 (933)
|..+. ++|+.|||++|++...-
T Consensus 582 p~~~~--~~L~~L~Ls~N~l~~~~ 603 (636)
T 4eco_A 582 NEKIT--PNISVLDIKDNPNISID 603 (636)
T ss_dssp CSCCC--TTCCEEECCSCTTCEEE
T ss_pred CHhHh--CcCCEEECcCCCCcccc
Confidence 98876 89999999999887543
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-35 Score=346.01 Aligned_cols=369 Identities=17% Similarity=0.167 Sum_probs=252.9
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
..++.|+|++|++++..+.+|..+++|++|+|++|+|+++.+ .|.++++|++|+|++|.++.+++..|+++++|++|+|
T Consensus 28 ~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 107 (570)
T 2z63_A 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 107 (570)
T ss_dssp SSCCEEECCSCCCCEECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEEC
T ss_pred ccccEEEccCCccCccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccc
Confidence 468889999999988778888999999999999999988877 6888999999999999999888888999999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCC-CCChhhcCCCCCCEEEccCCcCCCCCCccccc-ccc----chhhcc
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG-LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDI----QNLWMN 218 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l----~~l~l~ 218 (933)
++|++.. ..+..++++++|++|+|++|.+.+ .+|..|+++++|++|++++|++++..|..+.. ..+ ..|++.
T Consensus 108 ~~n~l~~--l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~ 185 (570)
T 2z63_A 108 VETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 185 (570)
T ss_dssp TTSCCCC--STTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred ccccccc--CCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccC
Confidence 9998887 222358888889999999888877 46888888888888888888887655555443 122 233443
Q ss_pred cccCCccc------------------------------------------------------------------------
Q 002346 219 DQQLGLSG------------------------------------------------------------------------ 226 (933)
Q Consensus 219 ~n~~~~~~------------------------------------------------------------------------ 226 (933)
.|.+....
T Consensus 186 ~n~l~~~~~~~~~~~~L~~L~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~ 265 (570)
T 2z63_A 186 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265 (570)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEE
T ss_pred CCCceecCHHHhccCcceeEecccccccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhh
Confidence 33322110
Q ss_pred --------ccccccCCccCcEEEecCCccCCCCCCCCC------------------------------------------
Q 002346 227 --------TLDVLSGMTQLRQVWLHKNQFTGPIPDLSK------------------------------------------ 256 (933)
Q Consensus 227 --------~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~------------------------------------------ 256 (933)
....+..+++|+.|++++|.+++.++.+..
T Consensus 266 ~~~~~~~~~~~~~~~l~~L~~L~l~~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~ 345 (570)
T 2z63_A 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345 (570)
T ss_dssp ETTEEESCSTTTTGGGTTCSEEEEESCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCB
T ss_pred cchhhhhhchhhhcCcCcccEEEecCccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCcccccccccc
Confidence 012244456677777777776654433333
Q ss_pred CCCCCEEEccCCcccccC--cccccCCCCCCEEEccCccCccCCCC--CCCCccEEeccCCcCCCCCCCCCCCCCchhhh
Q 002346 257 CESLFDLSLRDNQLTGVV--PASVISLPALLNISLQNNKLQGPYPL--FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTT 332 (933)
Q Consensus 257 ~~~L~~L~L~~N~l~~~~--p~~l~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~ 332 (933)
+++|+.|++++|++++.. |..+..+++|++|++++|.+++..+. ...+|+.|++++|.+.+..+...
T Consensus 346 ~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~--------- 416 (570)
T 2z63_A 346 LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV--------- 416 (570)
T ss_dssp CTTCCEEECCSSCCBEEEEEEHHHHTCSCCCEEECCSCSEEEEEEEEETCTTCCEEECTTSEEESCTTSCT---------
T ss_pred CCCCCEEeCcCCccCccccccccccccCccCEEECCCCccccccccccccCCCCEEEccCCccccccchhh---------
Confidence 344444444444444322 34444445555555555554443322 12345555555555544322100
Q ss_pred hHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCcccc-CcCchhhcCcccCCeEecccCcccCCCCccc
Q 002346 333 LLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA-GNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411 (933)
Q Consensus 333 ~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~-g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 411 (933)
....+..-..++.+|...+..|..+..+++|+.|+|++|.+. +.+|..|+.+++|+.|+|++|++++..|..|
T Consensus 417 ------~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~ 490 (570)
T 2z63_A 417 ------FLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAF 490 (570)
T ss_dssp ------TTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTT
T ss_pred ------hhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhh
Confidence 001122223345566666677888888899999999999987 6788889999999999999999998889899
Q ss_pred CCCCCcCEEeccCCcCcccCCCC-CC--CcccccCCCCCCcCC
Q 002346 412 TKLASLQNLDVSNNNLSGKVPDF-GS--NVKFTVSPGNPFIGT 451 (933)
Q Consensus 412 ~~l~~L~~l~ls~N~l~g~~p~~-~~--~~~~~~~~~n~~~~~ 451 (933)
..+++|++|++++|+|++.+|.. .. .++...+.+|||.|.
T Consensus 491 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~ 533 (570)
T 2z63_A 491 NSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS 533 (570)
T ss_dssp TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred hcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence 99999999999999999888753 32 334445678888653
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=348.55 Aligned_cols=371 Identities=17% Similarity=0.171 Sum_probs=254.4
Q ss_pred CccccceEeCC----------CCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceecccc
Q 002346 54 YCEWTGINCDN----------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDN 122 (933)
Q Consensus 54 ~C~w~gv~c~~----------~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~ 122 (933)
.|.+..|.|.. ..+++.|+|++|++++..+..|+.+++|++|+|++|.+++.+| .|.++++|++|+|++
T Consensus 3 ~~~~~~~~cs~~~L~~ip~~~~~~l~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~ 82 (680)
T 1ziw_A 3 TVSHEVADCSHLKLTQVPDDLPTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQH 82 (680)
T ss_dssp -CBSSEEECCSSCCSSCCSCSCTTCSEEECCSSCCCCCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCS
T ss_pred eeECCeeECCCCCccccccccCCCCcEEECCCCCCCCcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCC
Confidence 45566677753 2479999999999998888889999999999999999999888 689999999999999
Q ss_pred ccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCC
Q 002346 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202 (933)
Q Consensus 123 N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 202 (933)
|+++.+++..|+++++|++|+|++|++.. ..|..+.++++|++|+|++|.+.+..|..++.+++|++|+|++|++++.
T Consensus 83 n~l~~l~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~ 160 (680)
T 1ziw_A 83 NELSQLSDKTFAFCTNLTELHLMSNSIQK--IKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQAL 160 (680)
T ss_dssp SCCCCCCTTTTTTCTTCSEEECCSSCCCC--CCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCCB
T ss_pred CccCccChhhhccCCCCCEEECCCCccCc--cChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCccccc
Confidence 99999999899999999999999999987 4557899999999999999999999999999999999999999999977
Q ss_pred CCccccc---cccchhhcccccCCccccc--------------------------------------------------c
Q 002346 203 LPASFAK---SDIQNLWMNDQQLGLSGTL--------------------------------------------------D 229 (933)
Q Consensus 203 ~p~~~~~---~~l~~l~l~~n~~~~~~~~--------------------------------------------------~ 229 (933)
.+..+.. ..|++|++..|.+...... .
T Consensus 161 ~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~~~l~~~~~~~~~~~l~~~~L~~L~L~~n~l~~~~~~ 240 (680)
T 1ziw_A 161 KSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240 (680)
T ss_dssp CHHHHGGGTTCEESEEECTTCCCCCBCTTGGGGSSEECEEECTTCCCHHHHHHHHHHHHTTSCCCEEECTTSCCCEECTT
T ss_pred CHHHhhccccccccEEECCCCcccccChhhhhhhhhhhhhhccccccChhhHHHHHHHhhhccccEEEccCCcccccChh
Confidence 6665542 5788888888876533211 0
Q ss_pred cccCCc--cCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccC-----CCC-
Q 002346 230 VLSGMT--QLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP-----YPL- 300 (933)
Q Consensus 230 ~l~~l~--~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~-----~p~- 300 (933)
.+.+++ +|+.|+|++|++++.++. +..+++|+.|+|++|++++..|..|..+++|+.|++++|...+. +|.
T Consensus 241 ~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~~~~~~~~~~~~lp~i 320 (680)
T 1ziw_A 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKI 320 (680)
T ss_dssp TTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEEECTTCBCCC------CCEE
T ss_pred HhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEEeccchhhhccccccccccc
Confidence 122222 255555555555554432 45555555555555555555555555555555555554433321 111
Q ss_pred ------CCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhc--------------ccCCCccccCCCCCCCCCCCCC
Q 002346 301 ------FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAG--------------DMGYPAILSDSWEGNNACDGWP 360 (933)
Q Consensus 301 ------~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~l~~~~~~~~~~~~~p 360 (933)
...+|+.|++++|.+.+..+..+..+.... . +.+.. .......-...+.+|...+..|
T Consensus 321 ~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~-~-L~Ls~n~~~~~~l~~~~f~~~~~~~L~~L~L~~n~l~~~~~ 398 (680)
T 1ziw_A 321 DDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLK-Y-LSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIES 398 (680)
T ss_dssp CTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCC-E-EECTTCBSCCCEECTTTTGGGTTSCCCEEECTTSCCCEECT
T ss_pred ChhhcccCCCCCEEECCCCccCCCChhHhccccCCc-E-EECCCCchhhhhcchhhhcccccCcCceEECCCCCCCeECh
Confidence 124677777777877776554333221000 0 00000 0000111222344555555567
Q ss_pred ccccCCCceeEEEccCccccCcCc-hhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCc
Q 002346 361 FVTCSQGRIITINLANKLLAGNIS-PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (933)
Q Consensus 361 ~~~~~l~~L~~L~Ls~N~l~g~~p-~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 428 (933)
..+..+++|+.|+|++|.+.+.+| ..|.++++|++|+|++|++.+..+..|..+++|+.|++++|.++
T Consensus 399 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~l~~n~l~ 467 (680)
T 1ziw_A 399 DAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALK 467 (680)
T ss_dssp TTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEECTTSCCB
T ss_pred hhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccchhcccccc
Confidence 777778888888888888877666 57777888888888888777666666666666666666666654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-35 Score=347.60 Aligned_cols=271 Identities=24% Similarity=0.372 Sum_probs=202.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee------Cc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------GS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~ 652 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... .....+++.+|++++++++||||+++++++.. ++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 36899999999999999999965 568999999987652 45556789999999999999999999998765 66
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc---EEEe
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR---AKVA 729 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~---~kl~ 729 (933)
..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+ .+|+||||||+||+++.++. +||+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred eEEEEEEeCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEc
Confidence 7799999999999999997632 22458899999999999999999999 89999999999999997765 9999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh--
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL-- 807 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~-- 807 (933)
|||++........ .....||+.|+|||++.+..++.++||||||+++|||++|+.||...... ..|.....
T Consensus 167 DFG~a~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~ 239 (676)
T 3qa8_A 167 DLGYAKELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREK 239 (676)
T ss_dssp SCCCCCBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC--
T ss_pred ccccccccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcc
Confidence 9999987654332 24467999999999999999999999999999999999999999754211 01100000
Q ss_pred -----hccCCCCc--ccCCCCC-CChhhHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHhhhh
Q 002346 808 -----ISKENIPK--AIDPNLN-LDEETIESIYRVAELAGHCTAREPQQRPDMGH-----AVNVLGPLV 863 (933)
Q Consensus 808 -----~~~~~~~~--~~d~~l~-~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~e-----vl~~L~~~~ 863 (933)
........ .+...+. ...........+.+++.+|++.||++||++++ ..+.++.+.
T Consensus 240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL 308 (676)
T 3qa8_A 240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL 308 (676)
T ss_dssp ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence 00000000 0001111 01112224456889999999999999999987 444454443
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-35 Score=354.74 Aligned_cols=338 Identities=18% Similarity=0.216 Sum_probs=282.0
Q ss_pred CCEEEEEecCCCCcc-----------------ccCcccc--CCcccceeecccccccccCC-CccCcCcCceecccccc-
Q 002346 66 NRVTTISLAKSGLSG-----------------TLSPEIS--SLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN- 124 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~-----------------~~~~~~~--~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~- 124 (933)
.+++.|+|++|.|+| .+|+.++ ++++|++|+|++|.+.+.+| .|.++++|++|+|++|+
T Consensus 448 ~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~ 527 (876)
T 4ecn_A 448 TKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRG 527 (876)
T ss_dssp TTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTCTT
T ss_pred CCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCCCC
Confidence 579999999999998 4999988 99999999999999999988 79999999999999998
Q ss_pred ccC--CCCC------cccCCCCCCEEEccCCCCCCCCCCCc--cccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEc
Q 002346 125 FTS--VPTG------CFDGLTNLQVLSLSDNPNLAPWPFPN--ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRL 194 (933)
Q Consensus 125 l~~--~~~~------~~~~l~~L~~L~Ls~N~~~~~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 194 (933)
|++ +|.. .+..+++|++|+|++|++.. +|. .+.++++|+.|+|++|++. .+| .|+.+++|+.|+|
T Consensus 528 lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~~---ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~L 602 (876)
T 4ecn_A 528 ISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE---FPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKL 602 (876)
T ss_dssp SCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCCB---CCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEEC
T ss_pred cccccchHHHHhhhhcccccCCccEEEeeCCcCCc---cCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEEC
Confidence 886 4432 23445599999999999995 888 9999999999999999998 778 8999999999999
Q ss_pred cCCcCCCCCCccccc-cc-cchhhcccccCCcccccccccCCc--cCcEEEecCCccCCCCCCCC------CCCCCCEEE
Q 002346 195 SYNNFTGSLPASFAK-SD-IQNLWMNDQQLGLSGTLDVLSGMT--QLRQVWLHKNQFTGPIPDLS------KCESLFDLS 264 (933)
Q Consensus 195 ~~N~l~~~~p~~~~~-~~-l~~l~l~~n~~~~~~~~~~l~~l~--~L~~L~L~~N~l~~~~~~~~------~~~~L~~L~ 264 (933)
++|+++ .+|..+.. .. |+.|++++|.+. ..+..+..++ +|+.|+|++|++++.+|.+. .+.+|+.|+
T Consensus 603 s~N~l~-~lp~~l~~l~~~L~~L~Ls~N~L~--~lp~~~~~~~~~~L~~L~Ls~N~l~g~ip~l~~~l~~~~~~~L~~L~ 679 (876)
T 4ecn_A 603 DYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK--YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVT 679 (876)
T ss_dssp CSSCCS-CCCTTSCEECTTCCEEECCSSCCC--SCCSCCCTTCSSCEEEEECCSSCTTTTSSSCSSCTTTCCCCCEEEEE
T ss_pred cCCccc-cchHHHhhccccCCEEECcCCCCC--cCchhhhccccCCCCEEECcCCcCCCccccchhhhccccCCCcCEEE
Confidence 999999 89988876 45 999999999987 2234455554 49999999999999887544 456899999
Q ss_pred ccCCcccccCcccc-cCCCCCCEEEccCccCccCCCCCCC----------CccEEeccCCcCCCCCCCCCCCCCchhhhh
Q 002346 265 LRDNQLTGVVPASV-ISLPALLNISLQNNKLQGPYPLFPS----------KVQKVSLDHNNFCKNSSDAGKPCDPQVTTL 333 (933)
Q Consensus 265 L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p~~~~----------~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~ 333 (933)
|++|+|+ .+|..+ ..+++|+.|+|++|+++...+.... +|+.|+|++|+|..++....
T Consensus 680 Ls~N~L~-~lp~~~~~~l~~L~~L~Ls~N~L~~ip~~~~~~~~~~l~nl~~L~~L~Ls~N~L~~lp~~l~---------- 748 (876)
T 4ecn_A 680 LSYNEIQ-KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFR---------- 748 (876)
T ss_dssp CCSSCCC-SCCHHHHHTTCCCSEEECCSCCCSCCCTTSSSCTTSCCTTGGGCCEEECCSSCCCCCCGGGS----------
T ss_pred ccCCcCC-ccCHHHHccCCCCCEEECCCCcCCccChHHhccccccccccCCccEEECCCCCCccchHHhh----------
Confidence 9999999 666655 4899999999999999944443332 79999999999975432210
Q ss_pred HhhhcccCCCcccc-CCCCCCCCCCCCCccccCCCceeEEEccC------ccccCcCchhhcCcccCCeEecccCcccCC
Q 002346 334 LQIAGDMGYPAILS-DSWEGNNACDGWPFVTCSQGRIITINLAN------KLLAGNISPAYANLTSLKNLYLQQNNLTGP 406 (933)
Q Consensus 334 ~~~~~~~~~~~~l~-~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~------N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ 406 (933)
......++ +++.+|. +..+|..+..+++|+.|+|++ |++.+.+|..|+++++|+.|+|++|+| +.
T Consensus 749 ------~~~l~~L~~L~Ls~N~-L~~lp~~l~~L~~L~~L~Ls~N~~ls~N~l~~~ip~~l~~L~~L~~L~Ls~N~L-~~ 820 (876)
T 4ecn_A 749 ------ATTLPYLSNMDVSYNC-FSSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDI-RK 820 (876)
T ss_dssp ------TTTCTTCCEEECCSSC-CSSCCCGGGGCTTCCEEECCCCBCTTCCBCCCCCCTTGGGCSSCCEEECCSSCC-CB
T ss_pred ------hccCCCcCEEEeCCCC-CCccchhhhcCCCCCEEECCCCCCcccccccccChHHHhcCCCCCEEECCCCCC-Cc
Confidence 00122233 3444444 445999999999999999976 889999999999999999999999999 79
Q ss_pred CCcccCCCCCcCEEeccCCcCcccCC
Q 002346 407 IPDGLTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 407 ~p~~~~~l~~L~~l~ls~N~l~g~~p 432 (933)
+|..+. ++|+.|||++|++....+
T Consensus 821 Ip~~l~--~~L~~LdLs~N~l~~i~~ 844 (876)
T 4ecn_A 821 VDEKLT--PQLYILDIADNPNISIDV 844 (876)
T ss_dssp CCSCCC--SSSCEEECCSCTTCEEEC
T ss_pred cCHhhc--CCCCEEECCCCCCCccCh
Confidence 999876 699999999999976554
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-34 Score=346.71 Aligned_cols=367 Identities=19% Similarity=0.171 Sum_probs=289.0
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
..++.|+|++|+|++..+.+|.++++|++|+|++|+|++++| +|.++++|++|+|++|+|+++++..|.++++|++|+|
T Consensus 52 ~~~~~LdLs~N~i~~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~L 131 (635)
T 4g8a_A 52 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVA 131 (635)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEEC
T ss_pred cCCCEEEeeCCCCCCCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEEC
Confidence 479999999999998888899999999999999999999988 7999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCC-CChhhcCCCCCCEEEccCCcCCCCCCcccccc-------------
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS------------- 210 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~------------- 210 (933)
++|+++. ..+..|+++++|++|+|++|.+.+. +|..++.+++|++|+|++|+|++..|..+...
T Consensus 132 s~N~l~~--l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls 209 (635)
T 4g8a_A 132 VETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLS 209 (635)
T ss_dssp TTSCCCC--STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECT
T ss_pred CCCcCCC--CChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcc
Confidence 9999998 3456799999999999999999764 68899999999999999999987666554320
Q ss_pred ---------------ccchhhcccccC-----------------------------------------------------
Q 002346 211 ---------------DIQNLWMNDQQL----------------------------------------------------- 222 (933)
Q Consensus 211 ---------------~l~~l~l~~n~~----------------------------------------------------- 222 (933)
.+..+.+..|..
T Consensus 210 ~n~l~~i~~~~~~~~~~~~l~l~~n~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~ 289 (635)
T 4g8a_A 210 LNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 289 (635)
T ss_dssp TCCCCEECTTTTTTCEEEEEEEESCCSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEE
T ss_pred cCcccccCcccccchhhhhhhhhcccccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhh
Confidence 000111111100
Q ss_pred ---------------------------------------------------Ccc------------------cccccccC
Q 002346 223 ---------------------------------------------------GLS------------------GTLDVLSG 233 (933)
Q Consensus 223 ---------------------------------------------------~~~------------------~~~~~l~~ 233 (933)
... ........
T Consensus 290 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~ 369 (635)
T 4g8a_A 290 YLDYYLDGIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 369 (635)
T ss_dssp CCCSCEEECTTTTGGGTTCSEEEEESCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCB
T ss_pred hhcccccchhhhhhhhcccccccccccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCccccc
Confidence 000 00001123
Q ss_pred CccCcEEEecCCccCCCC--C-CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCC----CCCCcc
Q 002346 234 MTQLRQVWLHKNQFTGPI--P-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL----FPSKVQ 306 (933)
Q Consensus 234 l~~L~~L~L~~N~l~~~~--~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~ 306 (933)
+++|+.|++++|.+.... + .+..+.+|+.|+++.|.+. .++..+..+++|+.+++++|.+....+. ....++
T Consensus 370 l~~L~~L~ls~n~l~~~~~~~~~~~~~~~L~~L~~~~~~~~-~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~ 448 (635)
T 4g8a_A 370 LPSLEFLDLSRNGLSFKGCCSQSDFGTISLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLI 448 (635)
T ss_dssp CTTCCEEECCSSCCBEEEECCHHHHSCSCCCEEECCSCSEE-EECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCC
T ss_pred ccccccchhhccccccccccccchhhhhhhhhhhccccccc-cccccccccccccchhhhhccccccccccccccccccc
Confidence 567888888888876422 2 2567788999999999888 4566788889999999998888776553 235788
Q ss_pred EEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCC-CCCccccCCCceeEEEccCccccCcCch
Q 002346 307 KVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD-GWPFVTCSQGRIITINLANKLLAGNISP 385 (933)
Q Consensus 307 ~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 385 (933)
.++++.|.+.+..+..... ........+.+|+... ..|..+..+++|+.|+|++|+|++.+|.
T Consensus 449 ~l~ls~n~l~~~~~~~~~~----------------~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~ 512 (635)
T 4g8a_A 449 YLDISHTHTRVAFNGIFNG----------------LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 512 (635)
T ss_dssp EEECTTSCCEECCTTTTTT----------------CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTT
T ss_pred ccccccccccccccccccc----------------chhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChH
Confidence 8999999887765443221 1122233445555443 4678889999999999999999999999
Q ss_pred hhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCCC----CCcccccCCCCCCcCC
Q 002346 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG----SNVKFTVSPGNPFIGT 451 (933)
Q Consensus 386 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~----~~~~~~~~~~n~~~~~ 451 (933)
.|+++++|+.|+|++|+|++..|..|..+++|++|||++|+|++.+|... ..++...+.+|||.|.
T Consensus 513 ~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~ 582 (635)
T 4g8a_A 513 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 582 (635)
T ss_dssp TTTTCTTCCEEECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCS
T ss_pred HHcCCCCCCEEECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCccc
Confidence 99999999999999999999999999999999999999999999998643 2345556789999884
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-35 Score=315.15 Aligned_cols=234 Identities=12% Similarity=0.106 Sum_probs=185.0
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|... +++.||||++...... ....+++.+|+.++.+++||||+++++++.+++..|+|
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 109 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV 109 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence 467999999999999999999664 5899999999876433 34467899999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++.. . ....++..|+.|+++||+|||+ ++|+||||||+||+++.++.+||+++|
T Consensus 110 ~e~~~g~~L~~~l~~------~-~~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 110 AEWIRGGSLQEVADT------S-PSPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EECCCEEEHHHHHTT------C-CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EEecCCCCHHHHHhc------C-CChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 999999999999843 2 3556788999999999999999 899999999999999999999997443
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
|++ .++.++|||||||++|||+||+.||............ ..........+..+
T Consensus 175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~~~~~~~~~~~ 228 (286)
T 3uqc_A 175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDTAGQPIEPADI 228 (286)
T ss_dssp ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCTTSCBCCHHHH
T ss_pred ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHhccCCCChhhc
Confidence 333 3688999999999999999999999875432210000 00000000000011
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.+ .....+.+++.+||+.||++| |+.|+++.|+.+..
T Consensus 229 ~~---------~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~ 265 (286)
T 3uqc_A 229 DR---------DIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA 265 (286)
T ss_dssp CT---------TSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred cc---------CCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence 11 122457899999999999999 99999999988753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-35 Score=353.20 Aligned_cols=241 Identities=22% Similarity=0.358 Sum_probs=194.9
Q ss_pred hcCCccCCccccCCCeEEEEEEeC--CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce----
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP--DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE---- 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---- 653 (933)
.++|++.+.||+|+||.||+|... +|+.||||++.... .......+.+|+.++++++|||||++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 157 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP 157 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence 478999999999999999999764 68999999987542 34456788999999999999999999999987655
Q ss_pred -eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 654 -RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 654 -~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
.|+||||+++++|.+++. ..+++.+++.++.||++||+|||+ ++||||||||+|||++.+ .+||+|||
T Consensus 158 ~~~lv~E~~~g~~L~~~~~-------~~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG 226 (681)
T 2pzi_A 158 VGYIVMEYVGGQSLKRSKG-------QKLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLG 226 (681)
T ss_dssp EEEEEEECCCCEECC-----------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCT
T ss_pred eeEEEEEeCCCCcHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecc
Confidence 699999999999988773 258999999999999999999999 899999999999999886 89999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+++..... ....||+.|+|||++.++ ++.++|||||||++|||++|..||...... .
T Consensus 227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------------~ 283 (681)
T 2pzi_A 227 AVSRINSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----------------G 283 (681)
T ss_dssp TCEETTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----------------S
T ss_pred cchhcccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc-----------------c
Confidence 99876543 345799999999998765 488999999999999999999887642110 0
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHhhhh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-MGHAVNVLGPLV 863 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-~~evl~~L~~~~ 863 (933)
++ ...........+.+++.+||+.||++||+ ++++.+.|..+.
T Consensus 284 ~~--------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 284 LP--------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp CC--------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cc--------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 11 01111222346789999999999999995 666666666554
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-34 Score=342.95 Aligned_cols=359 Identities=16% Similarity=0.099 Sum_probs=243.0
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|++++..|.+|+++++|++|+|++|.|++.+| .|.++++|++|+|++|.++++++..|+++++|++|+|
T Consensus 56 ~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L 135 (606)
T 3vq2_A 56 SELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNV 135 (606)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEECTTSCCCCSSSSCCTTCTTCCEEEC
T ss_pred ccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEEccCCccccccccccCCCCCCCEEeC
Confidence 579999999999998889999999999999999999999977 8999999999999999999999888999999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCC-------------------------------------
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS------------------------------------- 187 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~------------------------------------- 187 (933)
++|.+... .+|..++++++|++|+|++|++.+..|..|+.++
T Consensus 136 ~~n~l~~~-~lp~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~n 214 (606)
T 3vq2_A 136 AHNFIHSC-KLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGIKLHELTLRGN 214 (606)
T ss_dssp CSSCCCCC-CCCGGGGTCTTCCEEECCSSCCCEECTTTTHHHHHCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred CCCcccce-echHhHhhcCCCCEEEccCCcceecChhhhhhhhccccccceeeccCCCcceeCcccccCceeeeeeccCC
Confidence 99998752 3689999999999999999998887665443332
Q ss_pred --------------------------------------------------------------------------------
Q 002346 188 -------------------------------------------------------------------------------- 187 (933)
Q Consensus 188 -------------------------------------------------------------------------------- 187 (933)
T Consensus 215 ~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~l~~L~~L~l~~ 294 (606)
T 3vq2_A 215 FNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAG 294 (606)
T ss_dssp CSCHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCGGGGTTGGGSEEEEEEECCCTTCCGGGGSCGGGTTCSEEEEES
T ss_pred ccchhHHHHHhccccccccccccccccccCCcccccChHHhhhhhhccHhheeccccccccccccccccCCCCCEEEecC
Confidence
Q ss_pred -------------CCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCC---C
Q 002346 188 -------------NLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP---I 251 (933)
Q Consensus 188 -------------~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~---~ 251 (933)
+|++|++++|++ +.+|.. ....|++|++.+|...... .+..+++|+.|+|++|++++. +
T Consensus 295 ~~~~~l~~l~~~~~L~~L~l~~n~l-~~lp~~-~l~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~ls~n~l~~~~~~~ 369 (606)
T 3vq2_A 295 VSIKYLEDVPKHFKWQSLSIIRCQL-KQFPTL-DLPFLKSLTLTMNKGSISF---KKVALPSLSYLDLSRNALSFSGCCS 369 (606)
T ss_dssp CCCCCCCCCCTTCCCSEEEEESCCC-SSCCCC-CCSSCCEEEEESCSSCEEC---CCCCCTTCCEEECCSSCEEEEEECC
T ss_pred ccchhhhhccccccCCEEEcccccC-cccccC-CCCccceeeccCCcCccch---hhccCCCCCEEECcCCccCCCcchh
Confidence 223333333333 233311 1122333333333111110 233455555555555555544 1
Q ss_pred CCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC-C---CCCCccEEeccCCcCCCCCCCCCCCCC
Q 002346 252 PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-L---FPSKVQKVSLDHNNFCKNSSDAGKPCD 327 (933)
Q Consensus 252 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~---~~~~l~~L~l~~n~~~~~~~~~~~~~~ 327 (933)
..+..+++|+.|+|++|++++ +|..+..+++|+.|++++|++++..| . ...+|+.|++++|.+.+..+.....+.
T Consensus 370 ~~~~~~~~L~~L~L~~n~l~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~ 448 (606)
T 3vq2_A 370 YSDLGTNSLRHLDLSFNGAII-MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLT 448 (606)
T ss_dssp HHHHCCSCCCEEECCSCSEEE-ECCCCTTCTTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCT
T ss_pred hhhccCCcccEeECCCCcccc-chhhccCCCCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCC
Confidence 224445555555555555552 34445555555555555555554443 1 123445555555555443332221110
Q ss_pred c-h-----hhhhHh--hhcccCCCccc-cCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEec
Q 002346 328 P-Q-----VTTLLQ--IAGDMGYPAIL-SDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYL 398 (933)
Q Consensus 328 ~-~-----~~~~~~--~~~~~~~~~~l-~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 398 (933)
. + ...+.. ++..+.....+ ..++.+|...+..|..+..+++|+.|+|++|++++.+|..|+++++|+.|+|
T Consensus 449 ~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l 528 (606)
T 3vq2_A 449 SLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDC 528 (606)
T ss_dssp TCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEEC
T ss_pred CCCEEECCCCcCCCcchHHhhccCCCCCEEECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEEC
Confidence 0 0 000000 11122222233 3455667777777888999999999999999999999999999999999999
Q ss_pred ccCcccCCCCcccCCCC-CcCEEeccCCcCcccCC
Q 002346 399 QQNNLTGPIPDGLTKLA-SLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 399 ~~N~l~g~~p~~~~~l~-~L~~l~ls~N~l~g~~p 432 (933)
++|+|+ .+|..+..++ +|++|++++|++.+..+
T Consensus 529 ~~N~l~-~~p~~~~~l~~~L~~l~l~~N~~~c~c~ 562 (606)
T 3vq2_A 529 SFNRIE-TSKGILQHFPKSLAFFNLTNNSVACICE 562 (606)
T ss_dssp TTSCCC-CEESCGGGSCTTCCEEECCSCCCCCSST
T ss_pred CCCcCc-ccCHhHhhhcccCcEEEccCCCcccCCc
Confidence 999999 7888899997 59999999999998776
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=331.84 Aligned_cols=322 Identities=20% Similarity=0.229 Sum_probs=280.8
Q ss_pred ceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCC
Q 002346 59 GINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLT 137 (933)
Q Consensus 59 gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 137 (933)
+..|... .+.++.++++++ .+|..+. ++|++|+|++|+|+++.+ .|.++++|++|+|++|.++++.+..|.+++
T Consensus 6 ~C~C~~~--~~~v~c~~~~l~-~ip~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~ 80 (477)
T 2id5_A 6 RCECSAQ--DRAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLF 80 (477)
T ss_dssp TCEEETT--TTEEECCSCCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCT
T ss_pred CCeECCC--CCEEEeCCCCcC-cCCCCCC--CCCcEEECCCCccceECHhHccCCCCCCEEECCCCccCEeChhhhhCCc
Confidence 4556543 357899999998 6776654 689999999999999887 899999999999999999999999999999
Q ss_pred CCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhc
Q 002346 138 NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWM 217 (933)
Q Consensus 138 ~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l 217 (933)
+|++|+|++|++.. ..+..|.++++|++|+|++|++.+..+..|..+++|++|+|++|++++..|..|.
T Consensus 81 ~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--------- 149 (477)
T 2id5_A 81 NLRTLGLRSNRLKL--IPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFS--------- 149 (477)
T ss_dssp TCCEEECCSSCCCS--CCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSST---------
T ss_pred cCCEEECCCCcCCc--cCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhcc---------
Confidence 99999999999988 3345689999999999999999999999999999999999999999976676654
Q ss_pred ccccCCcccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCcc
Q 002346 218 NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 218 ~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
++++|+.|+|++|++++.++. +..+++|+.|+|++|++.+..+..|..+++|+.|+|++|.+.+
T Consensus 150 ---------------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~~~~~~ 214 (477)
T 2id5_A 150 ---------------GLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLD 214 (477)
T ss_dssp ---------------TCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCEECTTCSCSCTTCCEEEEECCTTCC
T ss_pred ---------------CCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcEeChhhcccCcccceeeCCCCcccc
Confidence 489999999999999987764 8899999999999999999888899999999999999999887
Q ss_pred CCCCC---CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEE
Q 002346 297 PYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITIN 373 (933)
Q Consensus 297 ~~p~~---~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~ 373 (933)
.+|.. ..+|+.|+|++|++...+ +..+..+++|+.|+
T Consensus 215 ~~~~~~~~~~~L~~L~l~~n~l~~~~----------------------------------------~~~~~~l~~L~~L~ 254 (477)
T 2id5_A 215 TMTPNCLYGLNLTSLSITHCNLTAVP----------------------------------------YLAVRHLVYLRFLN 254 (477)
T ss_dssp EECTTTTTTCCCSEEEEESSCCCSCC----------------------------------------HHHHTTCTTCCEEE
T ss_pred ccCcccccCccccEEECcCCcccccC----------------------------------------HHHhcCccccCeeE
Confidence 76643 238999999999885432 13466789999999
Q ss_pred ccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCCC---CCcccccCCCCCCcC
Q 002346 374 LANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFG---SNVKFTVSPGNPFIG 450 (933)
Q Consensus 374 Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~---~~~~~~~~~~n~~~~ 450 (933)
|++|.+++..+..|.++++|+.|+|++|++++..|..|..+++|+.|+|++|+|++..+... ..++...+.+|||.|
T Consensus 255 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~c 334 (477)
T 2id5_A 255 LSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLAC 334 (477)
T ss_dssp CCSSCCCEECTTSCTTCTTCCEEECCSSCCSEECTTTBTTCTTCCEEECCSSCCSCCCGGGBSCGGGCCEEECCSSCEEC
T ss_pred CCCCcCCccChhhccccccCCEEECCCCccceECHHHhcCcccCCEEECCCCcCceeCHhHcCCCcccCEEEccCCCccC
Confidence 99999999888899999999999999999999999999999999999999999998877532 234445678999977
Q ss_pred C
Q 002346 451 T 451 (933)
Q Consensus 451 ~ 451 (933)
.
T Consensus 335 ~ 335 (477)
T 2id5_A 335 D 335 (477)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-34 Score=329.28 Aligned_cols=360 Identities=17% Similarity=0.170 Sum_probs=290.4
Q ss_pred EEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceecccccccc-CCCCCcccCCCCCCEEEccC
Q 002346 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 69 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~ 146 (933)
+.++.++++++ .+|. + .++|++|+|++|.|++.+| .|.++++|++|+|++|.+. .+++..|.++++|++|+|++
T Consensus 13 ~~~~c~~~~l~-~lp~-l--~~~l~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls~ 88 (455)
T 3v47_A 13 YNAICINRGLH-QVPE-L--PAHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88 (455)
T ss_dssp TEEECCSSCCS-SCCC-C--CTTCCEEECCSSCCCEECTTTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECTT
T ss_pred cccCcCCCCcc-cCCC-C--CCccCEEEecCCccCcCChhHhccCccccEEECcCCcccceECcccccccccCCEEeCCC
Confidence 46889999998 5665 3 3799999999999999877 7999999999999999997 67788899999999999999
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCChh--hcCCCCCCEEEccCCcCCCCCCcc-ccc-cccchhhcccccC
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF--FDSFSNLQNLRLSYNNFTGSLPAS-FAK-SDIQNLWMNDQQL 222 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~--~~~l~~L~~L~L~~N~l~~~~p~~-~~~-~~l~~l~l~~n~~ 222 (933)
|++.. ..|..+.++++|++|+|++|++++.++.. |..+++|++|+|++|++++..|.. +.. ..|++|++++|.+
T Consensus 89 n~l~~--~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l 166 (455)
T 3v47_A 89 NQFLQ--LETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166 (455)
T ss_dssp CTTCE--ECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCB
T ss_pred CccCc--cChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCcc
Confidence 99988 56889999999999999999999866655 999999999999999999887877 443 6799999999987
Q ss_pred CcccccccccCC--ccCcEEEecCCccCCCCCC---------CCCCCCCCEEEccCCcccccCcccccCC---CCCCEEE
Q 002346 223 GLSGTLDVLSGM--TQLRQVWLHKNQFTGPIPD---------LSKCESLFDLSLRDNQLTGVVPASVISL---PALLNIS 288 (933)
Q Consensus 223 ~~~~~~~~l~~l--~~L~~L~L~~N~l~~~~~~---------~~~~~~L~~L~L~~N~l~~~~p~~l~~l---~~L~~L~ 288 (933)
..... ..+..+ .+|+.|++++|.+.+..+. +..+++|+.|+|++|++++.+|..+..+ ++|+.|+
T Consensus 167 ~~~~~-~~l~~l~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~L~~L~ 245 (455)
T 3v47_A 167 KSICE-EDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLI 245 (455)
T ss_dssp SCCCT-TTSGGGTTCEEEEEECTTCBCTTCSTTCTTHHHHCCTTTTCEEEEEECTTSCCCHHHHHHHHHHTTTCCEEEEE
T ss_pred cccCh-hhhhccccccccccccccCcccccchhhccccccccccccceeeeEecCCCcccccchhhhhccccccceeeEe
Confidence 64433 233333 6899999999999886653 3466889999999999998888877654 7888888
Q ss_pred ccCccCccCCCCC---------------CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCC
Q 002346 289 LQNNKLQGPYPLF---------------PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353 (933)
Q Consensus 289 Ls~N~l~~~~p~~---------------~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 353 (933)
+++|.+.+..... ..+++.|++++|++.+..+..+.. .+..-..++.+|
T Consensus 246 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~----------------l~~L~~L~Ls~n 309 (455)
T 3v47_A 246 LSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSH----------------FTDLEQLTLAQN 309 (455)
T ss_dssp CTTCTTTSCCTTCCSSCCCCTTTTGGGTTSCCCEEECCSSCCCEECTTTTTT----------------CTTCCEEECTTS
T ss_pred eccccccccccchhhhccCcccccccccccCceEEEecCccccccchhhccc----------------CCCCCEEECCCC
Confidence 8888666532110 146888888888887765443221 111222344555
Q ss_pred CCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC
Q 002346 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (933)
Q Consensus 354 ~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 433 (933)
...+..|..+..+++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..|..+++|++|+|++|+|++.++.
T Consensus 310 ~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~ 389 (455)
T 3v47_A 310 EINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDG 389 (455)
T ss_dssp CCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTT
T ss_pred cccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEECCCCcccccChhhccccccccEEECCCCccccCCHh
Confidence 55556677888999999999999999998899999999999999999999999999999999999999999999987775
Q ss_pred CC---CCcccccCCCCCCcCC
Q 002346 434 FG---SNVKFTVSPGNPFIGT 451 (933)
Q Consensus 434 ~~---~~~~~~~~~~n~~~~~ 451 (933)
.. ..++...+.+|||.|.
T Consensus 390 ~~~~l~~L~~L~l~~N~l~~~ 410 (455)
T 3v47_A 390 IFDRLTSLQKIWLHTNPWDCS 410 (455)
T ss_dssp TTTTCTTCCEEECCSSCBCCC
T ss_pred HhccCCcccEEEccCCCcccC
Confidence 42 3444556788998764
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-33 Score=339.58 Aligned_cols=369 Identities=21% Similarity=0.229 Sum_probs=291.8
Q ss_pred CCEEEEEecCCCCccccCccccCCcc--cceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEE
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQ--LETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVL 142 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~--L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 142 (933)
..++.|++++|.+++..|..+..++. |++|+|++|.+++.+| .|..+++|++|+|++|+++++++..|.++++|++|
T Consensus 222 ~~L~~L~L~~n~l~~~~~~~~~~l~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 301 (680)
T 1ziw_A 222 TSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301 (680)
T ss_dssp SCCCEEECTTSCCCEECTTTTGGGGGSCCCEEECTTSCCCEECTTTTTTCTTCCEEECCSCCBSEECTTTTTTCTTCCEE
T ss_pred ccccEEEccCCcccccChhHhhccCcCCCCEEECCCCCcCccCcccccCcccccEeeCCCCccCccChhhhcCCCCccEE
Confidence 46889999999999998999988866 9999999999999887 79999999999999999999999899999999999
Q ss_pred EccCCCCCCCC---CCCc----cccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCC-Cc-ccc---cc
Q 002346 143 SLSDNPNLAPW---PFPN----ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL-PA-SFA---KS 210 (933)
Q Consensus 143 ~Ls~N~~~~~~---~~p~----~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~-~~~---~~ 210 (933)
+|++|...... .+|. .+..+++|++|++++|++.+..+..|..+++|++|+|++|.+++.. +. .|. ..
T Consensus 302 ~L~~~~~~~~~~~~~lp~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~~~~~~l~~~~f~~~~~~ 381 (680)
T 1ziw_A 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHS 381 (680)
T ss_dssp ECTTCBCCC------CCEECTTTTTTCTTCCEEECCSCCBCCCCTTTTTTCTTCCEEECTTCBSCCCEECTTTTGGGTTS
T ss_pred eccchhhhcccccccccccChhhcccCCCCCEEECCCCccCCCChhHhccccCCcEEECCCCchhhhhcchhhhcccccC
Confidence 99987654311 2343 7888999999999999999999999999999999999999865422 22 222 24
Q ss_pred ccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC--CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEE
Q 002346 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP--DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNIS 288 (933)
Q Consensus 211 ~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~--~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 288 (933)
.++.|++.+|.+.... ...+..+++|+.|+|++|++++.++ .+.++++|+.|+|++|++.+..+..|..+++|+.|+
T Consensus 382 ~L~~L~L~~n~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~L~~L~ 460 (680)
T 1ziw_A 382 PLHILNLTKNKISKIE-SDAFSWLGHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLM 460 (680)
T ss_dssp CCCEEECTTSCCCEEC-TTTTTTCTTCCEEECCSSCCEEECCSGGGTTCTTCCEEECCSCSEEECCTTTTTTCTTCCEEE
T ss_pred cCceEECCCCCCCeEC-hhhhhCCCCCCEEeCCCCcCccccCcccccCcccccEEecCCCCcceeChhhhhcCcccccch
Confidence 6888899988876433 3567788999999999999987655 488889999999999999888888888889999999
Q ss_pred ccCccCc--cCCCCC---CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCC----CC
Q 002346 289 LQNNKLQ--GPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD----GW 359 (933)
Q Consensus 289 Ls~N~l~--~~~p~~---~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~----~~ 359 (933)
+++|.++ +.+|.. ..+|+.|+|++|++.+..+..+..+ ...-..++.+|...+ .+
T Consensus 461 l~~n~l~~~~~~p~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l----------------~~L~~L~Ls~N~l~~~~~~~~ 524 (680)
T 1ziw_A 461 LRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGL----------------EKLEILDLQHNNLARLWKHAN 524 (680)
T ss_dssp CTTSCCBCTTCSSCTTTTCTTCCEEECCSSCCCCCCTTTTTTC----------------TTCCEEECCSSCCGGGGSTTS
T ss_pred hccccccccccCCcccccCCCCCEEECCCCCCCcCChhhhccc----------------cccCEEeCCCCCccccchhhc
Confidence 9999887 445543 3578889999998887655432211 111122233333321 11
Q ss_pred ----CccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCC-
Q 002346 360 ----PFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF- 434 (933)
Q Consensus 360 ----p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~- 434 (933)
+..+..+++|+.|+|++|+++...+..|.++++|+.|+|++|+|++..+..|..+++|+.|+|++|+|++.+|..
T Consensus 525 ~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 604 (680)
T 1ziw_A 525 PGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVF 604 (680)
T ss_dssp TTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHH
T ss_pred cCCcchhhcCCCCCCEEECCCCCCCCCCHHHcccccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHh
Confidence 223678899999999999999655567999999999999999999777778899999999999999999988752
Q ss_pred ---CCCcccccCCCCCCcCC
Q 002346 435 ---GSNVKFTVSPGNPFIGT 451 (933)
Q Consensus 435 ---~~~~~~~~~~~n~~~~~ 451 (933)
...++...+.+|||.|.
T Consensus 605 ~~~~~~L~~l~l~~N~~~c~ 624 (680)
T 1ziw_A 605 GPAFRNLTELDMRFNPFDCT 624 (680)
T ss_dssp HHHHTTCSEEECTTCCCCBC
T ss_pred cccccccCEEEccCCCcccC
Confidence 23455566789999885
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-34 Score=327.15 Aligned_cols=246 Identities=15% Similarity=0.160 Sum_probs=182.1
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEecccc-CCchhHHHHHHHHHHHHhcCC-Cccee-------------
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNT-MGNKGLSEFQAEIAVLTKVRH-RHLVA------------- 643 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h-~niv~------------- 643 (933)
..+|...+.||+|+||.||+|. ..+|+.||||++.... ......+.|.+|+.+++.++| +|...
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 3457788999999999999996 5679999999987432 223346789999999999977 22111
Q ss_pred --------EEeEeee-----CceeEEEEeecCCCChhhHhhhcc--cCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCe
Q 002346 644 --------LLGYCIN-----GSERLLVYEYMPRGTLAQHLFEWH--DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSF 708 (933)
Q Consensus 644 --------l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~i 708 (933)
+..++.. ....+++|+++ +++|.+++.... ......+++..++.++.|+++||+|||+ ++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGL 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTE
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 1111111 12356777765 789999885321 1223568899999999999999999999 899
Q ss_pred EecCCCCCcEEecCCCcEEEecccccccCCCCCceeecccccccCccccccc----------CCCCCCCccchHhHHHHH
Q 002346 709 IHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA----------ATGRVTTKIDVYAFGVVL 778 (933)
Q Consensus 709 vH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Dv~SlG~~l 778 (933)
+||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil 307 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI 307 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence 99999999999999999999999998865432 344578 999999998 556688999999999999
Q ss_pred HHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 779 METITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 779 ~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
|||++|+.||........ ....+...... ...+.+++.+||+.||++||++.++++
T Consensus 308 ~elltg~~Pf~~~~~~~~----------------~~~~~~~~~~~-------~~~~~~li~~~l~~dP~~Rpt~~~~l~ 363 (413)
T 3dzo_A 308 YWIWCADLPNTDDAALGG----------------SEWIFRSCKNI-------PQPVRALLEGFLRYPKEDRLLPLQAME 363 (413)
T ss_dssp HHHHHSSCCCCTTGGGSC----------------SGGGGSSCCCC-------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HHHHHCCCCCCCcchhhh----------------HHHHHhhcccC-------CHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 999999999976432211 11111111111 145789999999999999999888764
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=307.00 Aligned_cols=230 Identities=21% Similarity=0.288 Sum_probs=178.3
Q ss_pred hcCCccC-CccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHH-HhcCCCcceeEEeEeee----Cc
Q 002346 580 TDNFSEA-NILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVL-TKVRHRHLVALLGYCIN----GS 652 (933)
Q Consensus 580 ~~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~ 652 (933)
.++|.+. +.||+|+||.||+|.. .+++.||+|++... ..+.+|+.++ +..+||||+++++++.. +.
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3567776 7899999999999955 57899999998643 4677888887 55589999999999876 67
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---CCcEEEe
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVA 729 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~ 729 (933)
..++||||+++|+|.+++... ....+++.+++.++.|++.||+|||+ ++|+||||||+||+++. ++.+||+
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred eEEEEEeecCCCcHHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 789999999999999999762 22469999999999999999999999 89999999999999998 7889999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||++.... +..++.++|||||||++|||++|+.||........ .
T Consensus 163 Dfg~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~----------~-- 207 (299)
T 3m2w_A 163 DFGFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI----------S-- 207 (299)
T ss_dssp CCTTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------------------
T ss_pred ccccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh----------h--
Confidence 999886432 24567899999999999999999999976432110 0
Q ss_pred cCCCCcccCCCCCCChh-hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAIDPNLNLDEE-TIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~-~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
................. .......+.+++.+|++.||++||++.|+++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~ 256 (299)
T 3m2w_A 208 PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 256 (299)
T ss_dssp CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence 00000000011110110 0112356789999999999999999999986
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-33 Score=331.47 Aligned_cols=313 Identities=19% Similarity=0.200 Sum_probs=233.7
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCC-CCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|.+++..|.+|+.+++|++|+|++|.|+.+++. .+++|++|+|++|++++++ +..|+++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~Ls~N~l~~l~~p~~~~~l~~L~~L~L 153 (562)
T 3a79_B 76 SELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQNISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGL 153 (562)
T ss_dssp TTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCCEECSC--CCTTCSEEECCSSCCSBCCCCGGGGGCTTCCEEEE
T ss_pred CCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCCccCcc--ccccCCEEECCCCCccccCchHhhcccCcccEEec
Confidence 5799999999999998899999999999999999999965545 8999999999999999987 478999999999999
Q ss_pred cCCCCCCCCCCCccccCCccC--CeeeccCccc--CCCCChhhcCCC---------------------------------
Q 002346 145 SDNPNLAPWPFPNELTKSTSL--TTLYMDNANI--FGLIPDFFDSFS--------------------------------- 187 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L--~~L~L~~n~l--~~~~p~~~~~l~--------------------------------- 187 (933)
++|++.. ..+..+++| +.|++++|++ ++..|..|..+.
T Consensus 154 ~~n~l~~-----~~~~~l~~L~L~~L~L~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l 228 (562)
T 3a79_B 154 SAAKFRQ-----LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNI 228 (562)
T ss_dssp ECSBCCT-----TTTGGGTTSCEEEEEEEESSCCCCSSSCCEEEECCEEEEEEEECSSSCCCCCCEEEESSEEEEEEEEE
T ss_pred CCCcccc-----CchhhhhhceeeEEEeecccccccccCcccccccCcceEEEEecCccchhhhhhhcccccceEEEecc
Confidence 9999876 245555666 9999999999 788777776644
Q ss_pred ------------------------------------------------CCCEEEccCCcCCCCCCccccc----------
Q 002346 188 ------------------------------------------------NLQNLRLSYNNFTGSLPASFAK---------- 209 (933)
Q Consensus 188 ------------------------------------------------~L~~L~L~~N~l~~~~p~~~~~---------- 209 (933)
+|++|++++|+++|.+|..+..
T Consensus 229 ~~n~~~~~~l~~~~~~l~~l~~L~~L~L~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~ip~~~~~~~~~~L~~L~ 308 (562)
T 3a79_B 229 KLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLM 308 (562)
T ss_dssp ECCSTTHHHHHHHHHHHHSCSSCEEEEEEEEEECHHHHHHHHHHHTTSSEEEEEEEEEEECSCCCCCCCCCCSCSCCEEE
T ss_pred cccccccchHHHHHHHHhccCcceEEEecCCcCcHHHHHHHHHhhhcccccEEEEeccEeeccccchhhhcccccchhee
Confidence 6777777777777777776521
Q ss_pred ----------------------cccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEcc
Q 002346 210 ----------------------SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLR 266 (933)
Q Consensus 210 ----------------------~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~ 266 (933)
..+++|++++|.+.... ....+++|++|+|++|++++.+| .+..+++|+.|+|+
T Consensus 309 ~~~~~~~~~~~p~~~~~~~~~~~~L~~L~l~~n~~~~~~---~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~ 385 (562)
T 3a79_B 309 IEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMV---CPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQ 385 (562)
T ss_dssp EEEEEECCCSSCHHHHHHHHHTCCCSEEEEESSCCCCCC---CCSSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECC
T ss_pred hhhcccceeecChhhhhhhhccCcceEEEccCCCccccc---CccCCCCceEEECCCCccccchhhhhcccCCCCEEECC
Confidence 12334444444332111 11455666666666666666444 36666666666666
Q ss_pred CCcccc--cCcccccCCCCCCEEEccCccCccCCCCC----CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhccc
Q 002346 267 DNQLTG--VVPASVISLPALLNISLQNNKLQGPYPLF----PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDM 340 (933)
Q Consensus 267 ~N~l~~--~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~----~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~ 340 (933)
+|++++ .+|..+..+++|++|+|++|++++.+|.. ..+|+.|+|++|++.+
T Consensus 386 ~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~L~~L~l~~n~l~~----------------------- 442 (562)
T 3a79_B 386 RNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG----------------------- 442 (562)
T ss_dssp SSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTTCCEEECCSSCCCG-----------------------
T ss_pred CCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCcccCCEEECCCCCCCc-----------------------
Confidence 666664 22455666666666666666666644321 2456666666666643
Q ss_pred CCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcc-cCCCCCcCE
Q 002346 341 GYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQN 419 (933)
Q Consensus 341 ~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~ 419 (933)
.+|..+. ++|+.|+|++|+++ .+|..+.++++|+.|+|++|+|+ .+|.. +..+++|+.
T Consensus 443 -----------------~~~~~l~--~~L~~L~L~~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~ 501 (562)
T 3a79_B 443 -----------------SVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQY 501 (562)
T ss_dssp -----------------GGGSSCC--TTCSEEECCSSCCC-CCCTTTTSSCCCSEEECCSSCCC-CCCTTSTTTCTTCCC
T ss_pred -----------------chhhhhc--CcCCEEECCCCcCc-ccChhhcCCCCCCEEECCCCCCC-CCCHHHHhcCCCCCE
Confidence 2222222 68999999999999 68888889999999999999999 66666 999999999
Q ss_pred EeccCCcCcccCC
Q 002346 420 LDVSNNNLSGKVP 432 (933)
Q Consensus 420 l~ls~N~l~g~~p 432 (933)
|++++|++++..|
T Consensus 502 L~l~~N~~~c~c~ 514 (562)
T 3a79_B 502 IWLHDNPWDCTCP 514 (562)
T ss_dssp EECCSCCBCCCHH
T ss_pred EEecCCCcCCCcc
Confidence 9999999998776
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-34 Score=333.03 Aligned_cols=358 Identities=17% Similarity=0.174 Sum_probs=245.7
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|++++..|..|..+++|++|+|++|+|++.+| .|.++++|++|+|++|+|+.+|.. .+++|++|+|
T Consensus 21 ~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~---~l~~L~~L~L 97 (520)
T 2z7x_B 21 QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH---PTVNLKHLDL 97 (520)
T ss_dssp TTCSEEECCSSCCCCCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC---CCCCCSEEEC
T ss_pred ccccEEECCCCcccccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc---ccCCccEEec
Confidence 579999999999998888899999999999999999999877 899999999999999999988876 7999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCC--CEEEccCCcC--CCCCCccccc-----------
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL--QNLRLSYNNF--TGSLPASFAK----------- 209 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L--~~L~L~~N~l--~~~~p~~~~~----------- 209 (933)
++|++... .+|..++++++|++|+|++|++.+ ..+..+++| ++|+|++|++ ++..|..+..
T Consensus 98 ~~N~l~~~-~~p~~~~~l~~L~~L~L~~n~l~~---~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~ 173 (520)
T 2z7x_B 98 SFNAFDAL-PICKEFGNMSQLKFLGLSTTHLEK---SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFP 173 (520)
T ss_dssp CSSCCSSC-CCCGGGGGCTTCCEEEEEESSCCG---GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECC
T ss_pred cCCccccc-cchhhhccCCcceEEEecCcccch---hhccccccceeeEEEeecccccccccccccccccccceEEEEec
Confidence 99998762 367899999999999999999977 467777888 9999999999 7777777755
Q ss_pred ----------------cccchhhcccccC-----CcccccccccCC---------------------------ccCcEEE
Q 002346 210 ----------------SDIQNLWMNDQQL-----GLSGTLDVLSGM---------------------------TQLRQVW 241 (933)
Q Consensus 210 ----------------~~l~~l~l~~n~~-----~~~~~~~~l~~l---------------------------~~L~~L~ 241 (933)
..|+.|++..|.. ...+.++.+..+ ++|+.|+
T Consensus 174 ~n~~~~~~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~ 253 (520)
T 2z7x_B 174 TNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFS 253 (520)
T ss_dssp SSSCCCCCCCCCCTTCSEEEECCEEECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEE
T ss_pred cCcchhhhhhhhhhcccceeeccccccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEE
Confidence 2344444444430 001111122222 2566666
Q ss_pred ecCCccCCCCCC-C-----CCCCCCCEEEccCCcccccCc-ccc-------------------------cCCCCCCEEEc
Q 002346 242 LHKNQFTGPIPD-L-----SKCESLFDLSLRDNQLTGVVP-ASV-------------------------ISLPALLNISL 289 (933)
Q Consensus 242 L~~N~l~~~~~~-~-----~~~~~L~~L~L~~N~l~~~~p-~~l-------------------------~~l~~L~~L~L 289 (933)
+++|+++|.+|. + ..+++|+.+++++|.+ .+| ..+ ..+++|++|++
T Consensus 254 l~~n~l~~~~p~~~~~~~~~~l~~L~~l~l~~n~~--~~p~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~L 331 (520)
T 2z7x_B 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVF--GFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331 (520)
T ss_dssp EEEEEEESCCCCCCCCCCSCCCCEEEEEEEEECCC--CSCTHHHHHHHHTCCCSEEEEESSCCCCCCCCSSCCCCCEEEC
T ss_pred eecccccCccccchhhcccccCceeEeccccccce--ecchhhhhcccccCceeEEEcCCCccccccchhhCCcccEEEe
Confidence 666666655553 4 6667777777766666 333 222 34455555555
Q ss_pred cCccCccCCCCC---CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccc-cCCCCCCCCCCCCCcc-cc
Q 002346 290 QNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL-SDSWEGNNACDGWPFV-TC 364 (933)
Q Consensus 290 s~N~l~~~~p~~---~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-~~~~~~~~~~~~~p~~-~~ 364 (933)
++|++++.+|.. ..+|+.|+|++|++.+. ..++..+.....+ ..++.+|...+.+|.. +.
T Consensus 332 s~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~l---------------~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~ 396 (520)
T 2z7x_B 332 SNNLLTDTVFENCGHLTELETLILQMNQLKEL---------------SKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396 (520)
T ss_dssp CSSCCCTTTTTTCCCCSSCCEEECCSSCCCBH---------------HHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCC
T ss_pred ECCccChhhhhhhccCCCCCEEEccCCccCcc---------------ccchHHHhhCCCCCEEECCCCcCCcccccchhc
Confidence 555555544432 23455555555555321 0111112222223 2344445544446664 56
Q ss_pred CCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC-CCC--Ccccc
Q 002346 365 SQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD-FGS--NVKFT 441 (933)
Q Consensus 365 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~-~~~--~~~~~ 441 (933)
.+++|+.|+|++|++++.+|..+. ++|+.|+|++|+++ .+|..+..+++|++|++++|+|++.++. +.. .++..
T Consensus 397 ~l~~L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L 473 (520)
T 2z7x_B 397 WTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKI 473 (520)
T ss_dssp CCTTCCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCccCCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCccCHHHhccCCcccEE
Confidence 678888888888888877777665 68888888888888 7888777888888888888888865444 332 33334
Q ss_pred cCCCCCCcC
Q 002346 442 VSPGNPFIG 450 (933)
Q Consensus 442 ~~~~n~~~~ 450 (933)
.+.+|||.|
T Consensus 474 ~l~~N~~~c 482 (520)
T 2z7x_B 474 WLHTNPWDC 482 (520)
T ss_dssp ECCSSCBCC
T ss_pred ECcCCCCcc
Confidence 567788765
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-33 Score=334.94 Aligned_cols=351 Identities=17% Similarity=0.164 Sum_probs=282.0
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
..++.|+|++|++++..+.+|+++++|++|+|++|.+++.+| .|.++++|++|+|++|+++.++...|+++++|++|+|
T Consensus 52 ~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 131 (570)
T 2z63_A 52 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131 (570)
T ss_dssp SSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCSCTTCTTCCEEEC
T ss_pred CCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCccccccccccccccccCCCccccccccccEEec
Confidence 579999999999998888899999999999999999999887 7999999999999999999999888999999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCC----CEEEccCCcCCCCCCcccccc----------
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNL----QNLRLSYNNFTGSLPASFAKS---------- 210 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L----~~L~L~~N~l~~~~p~~~~~~---------- 210 (933)
++|.+... .+|..++++++|++|++++|++.+..+..|+.+++| ..|++++|.+++..|..+...
T Consensus 132 ~~n~l~~~-~lp~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~~~~~L~l~~n~l~~~~~~~~~~~~L~~L~l~~n 210 (570)
T 2z63_A 132 AHNLIQSF-KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 210 (570)
T ss_dssp CSSCCCCC-CCCGGGGGCTTCCEEECTTSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred CCCcccee-cChhhhcccCCCCEEeCcCCccceecHHHccchhccchhhhhcccCCCCceecCHHHhccCcceeEecccc
Confidence 99998762 368999999999999999999998888877777777 677777777765444333221
Q ss_pred ------------------------------------------------------------------------ccchhhcc
Q 002346 211 ------------------------------------------------------------------------DIQNLWMN 218 (933)
Q Consensus 211 ------------------------------------------------------------------------~l~~l~l~ 218 (933)
.++.|++.
T Consensus 211 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~l~~l~l~~l~l~~~~~~~~~~~~~~~~l~~L~~L~l~ 290 (570)
T 2z63_A 211 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLV 290 (570)
T ss_dssp CSCTTHHHHHHHTTTTCEEEEEEEEECCCCSSCEECCTTTTGGGGGSEEEEEEEEETTEEESCSTTTTGGGTTCSEEEEE
T ss_pred cccccchhhhhcCccccceeeeccccccCchhhhhcchhhhccccccchhhhhhhcchhhhhhchhhhcCcCcccEEEec
Confidence 22233333
Q ss_pred cccCCc----------------------cccc------------------ccccCCccCcEEEecCCccCCCC---CCCC
Q 002346 219 DQQLGL----------------------SGTL------------------DVLSGMTQLRQVWLHKNQFTGPI---PDLS 255 (933)
Q Consensus 219 ~n~~~~----------------------~~~~------------------~~l~~l~~L~~L~L~~N~l~~~~---~~~~ 255 (933)
+|.+.. .... .....+++|+.|++++|++++.. ..+.
T Consensus 291 ~~~l~~l~~~~~~~~L~~L~l~~n~~~~l~~~~l~~L~~L~l~~n~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~ 370 (570)
T 2z63_A 291 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370 (570)
T ss_dssp SCEECSCCBCCSCCCCSEEEEESCBCSSCCBCBCSSCCEEEEESCBSCCBCCCCBCTTCCEEECCSSCCBEEEEEEHHHH
T ss_pred CccchhhhhhhccCCccEEeeccCcccccCcccccccCEEeCcCCccccccccccCCCCCEEeCcCCccCcccccccccc
Confidence 332221 0000 00035677888888888887653 3477
Q ss_pred CCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCC----CCCCccEEeccCCcCCCCCCCCCCCCCchhh
Q 002346 256 KCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL----FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVT 331 (933)
Q Consensus 256 ~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~ 331 (933)
.+++|+.|++++|++++..+ .+..+++|+.|++++|.+++..|. ...+|+.|++++|.+.+..+..+..
T Consensus 371 ~~~~L~~L~l~~n~l~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------ 443 (570)
T 2z63_A 371 GTTSLKYLDLSFNGVITMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG------ 443 (570)
T ss_dssp TCSCCCEEECCSCSEEEEEE-EEETCTTCCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTT------
T ss_pred ccCccCEEECCCCccccccc-cccccCCCCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhc------
Confidence 88999999999999996544 499999999999999999987662 2468999999999997765433221
Q ss_pred hhHhhhcccCCCccccCCCCCCCCC-CCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcc
Q 002346 332 TLLQIAGDMGYPAILSDSWEGNNAC-DGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410 (933)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~~~~~~~~-~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 410 (933)
.+..-...+.+|... +.+|..+..+++|+.|+|++|++++..|..|+++++|+.|+|++|++++..|..
T Consensus 444 ----------l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 513 (570)
T 2z63_A 444 ----------LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGI 513 (570)
T ss_dssp ----------CTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTT
T ss_pred ----------CCcCcEEECcCCcCccccchhhhhcccCCCEEECCCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHH
Confidence 112223344555554 468999999999999999999999999999999999999999999999988889
Q ss_pred cCCCCCcCEEeccCCcCcccCCCC
Q 002346 411 LTKLASLQNLDVSNNNLSGKVPDF 434 (933)
Q Consensus 411 ~~~l~~L~~l~ls~N~l~g~~p~~ 434 (933)
|..+++|+.|++++|+++|.+|..
T Consensus 514 ~~~l~~L~~L~l~~N~~~~~~~~~ 537 (570)
T 2z63_A 514 FDRLTSLQKIWLHTNPWDCSCPRI 537 (570)
T ss_dssp TTTCTTCCEEECCSSCBCCCTTTT
T ss_pred hhcccCCcEEEecCCcccCCCcch
Confidence 999999999999999999999864
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-34 Score=317.82 Aligned_cols=245 Identities=15% Similarity=0.163 Sum_probs=186.4
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccC------CchhHHHHHHHHHHHHhcC---------CCcceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTM------GNKGLSEFQAEIAVLTKVR---------HRHLVAL 644 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~~l~~l~---------h~niv~l 644 (933)
.++|++.+.||+|+||.||+|.. +|+.||||++..... .....+.+.+|+.+++.++ |||||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 46789999999999999999987 789999999987532 2334578999999999986 6666666
Q ss_pred EeEe-----------------ee-------------CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHH
Q 002346 645 LGYC-----------------IN-------------GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694 (933)
Q Consensus 645 ~~~~-----------------~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~ 694 (933)
.+.+ .+ +...++||||+++|++.+.+.+ ..+++.+++.++.||+
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~ 171 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLT 171 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHH
Confidence 6543 32 6789999999999987777633 4589999999999999
Q ss_pred HHHHHhh-hccCCCeEecCCCCCcEEecCCC--------------------cEEEecccccccCCCCCceeecccccccC
Q 002346 695 RGVEYLH-SLAQQSFIHRDLKPSNILIGDDM--------------------RAKVADFGLVKNAPDGKYSVETRLAGTFG 753 (933)
Q Consensus 695 ~~l~~LH-~~~~~~ivH~Dik~~Nill~~~~--------------------~~kl~DfGla~~~~~~~~~~~~~~~gt~~ 753 (933)
.||+||| + ++|+||||||+|||++.++ .+||+|||+|+..... ...||+.
T Consensus 172 ~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~ 242 (336)
T 2vuw_A 172 ASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV 242 (336)
T ss_dssp HHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred HHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence 9999999 8 8999999999999999887 8999999999865432 2479999
Q ss_pred cccccccCCCCCCCccchHhHHHH-HHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHH
Q 002346 754 YLAPEYAATGRVTTKIDVYAFGVV-LMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIY 832 (933)
Q Consensus 754 y~aPE~~~~~~~~~~~Dv~SlG~~-l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~ 832 (933)
|+|||++.+.. +.++||||+|++ .+++++|..||... ............ ...... ............
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~-----~~~~~~~~~~~~-~~~~~~-----~~~~~~~~~~s~ 310 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV-----LWLHYLTDKMLK-QMTFKT-----KCNTPAMKQIKR 310 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH-----HHHHHHHHHHHH-TCCCSS-----CCCSHHHHHHHH
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch-----hhhhHHHHhhhh-hhccCc-----ccchhhhhhcCH
Confidence 99999998665 889999998777 77888899887321 000001111111 111110 111223345567
Q ss_pred HHHHHHHHcccCCCCCCCCHHHHH-H
Q 002346 833 RVAELAGHCTAREPQQRPDMGHAV-N 857 (933)
Q Consensus 833 ~~~~li~~cl~~~P~~RPs~~evl-~ 857 (933)
++.+++.+||+.| |++|++ +
T Consensus 311 ~~~dli~~~L~~d-----sa~e~l~~ 331 (336)
T 2vuw_A 311 KIQEFHRTMLNFS-----SATDLLCQ 331 (336)
T ss_dssp HHHHHHHHGGGSS-----SHHHHHHH
T ss_pred HHHHHHHHHhccC-----CHHHHHhc
Confidence 7899999999976 899987 5
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=341.83 Aligned_cols=237 Identities=18% Similarity=0.174 Sum_probs=164.4
Q ss_pred CCEEEccCCcCCCCCCccccc-cccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEcc
Q 002346 189 LQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLR 266 (933)
Q Consensus 189 L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~ 266 (933)
|+.|+|++|.+++..|..|.. ..|+.|++.+|.+.... ...|.++++|+.|+|++|++++..+ .+..+++|+.|+|+
T Consensus 268 L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~i~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 346 (844)
T 3j0a_A 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA-DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQ 346 (844)
T ss_dssp CCEEECTTCCCCEECSCCSSSCCCCCEEEEESCCCCEEC-TTTTTTCSSCCEEEEESCCCSCCCSCSCSSCTTCCEEECC
T ss_pred ccEEECCCCcccccChhhhhcCCCCCEEECCCCcCCCCC-hHHhcCCCCCCEEECCCCCCCccCHHHhcCCCCCCEEECC
Confidence 344444444444333333332 35666666666654322 2468889999999999999998876 58999999999999
Q ss_pred CCcccccCcccccCCCCCCEEEccCccCccCCC------------------C-------------------------CCC
Q 002346 267 DNQLTGVVPASVISLPALLNISLQNNKLQGPYP------------------L-------------------------FPS 303 (933)
Q Consensus 267 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p------------------~-------------------------~~~ 303 (933)
+|++++..+..|..+++|+.|+|++|.+++... . ...
T Consensus 347 ~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~L~~L~l~~N~l~~l~~~~~~l~~L~ls~N~l~~l~~~~~~~~l~ 426 (844)
T 3j0a_A 347 KNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVP 426 (844)
T ss_dssp SCCCCCCCSSCSCSCCCCCEEEEETCCSCCCSSCCSCSEEEEESCCCCCCCCCCTTCCEEECCSCCCCSSTTHHHHTTCT
T ss_pred CCCCCccChhhhcCCCCCCEEECCCCCCCcccCCCCcchhccCCCCcccccccccccceeecccCccccCchhhhhhcCC
Confidence 999998888899999999999999999886321 1 123
Q ss_pred CccEEeccCCcCCCCCCCCCCCCCchhhhhHhhh--------------cccC-CCccccCCCCCCCCCCCCCccccCCCc
Q 002346 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIA--------------GDMG-YPAILSDSWEGNNACDGWPFVTCSQGR 368 (933)
Q Consensus 304 ~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~-~~~~l~~~~~~~~~~~~~p~~~~~l~~ 368 (933)
+|+.|+|++|++.+............... +.+. ..+. .+..-.+++.+|+..+..|..+..+++
T Consensus 427 ~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~-L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 505 (844)
T 3j0a_A 427 HLQILILNQNRFSSCSGDQTPSENPSLEQ-LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA 505 (844)
T ss_dssp TCCEEEEESCCCCCCCSSSSSCSCTTCCB-CEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred ccceeeCCCCcccccccccccccCCcccc-ccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhh
Confidence 45566666666654332211100000000 0000 0111 122334455666666667777899999
Q ss_pred eeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCC
Q 002346 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 369 L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p 432 (933)
|+.|+|++|+|++..|..+. ++|+.|+|++|+|++.+|..|. +|+.|++++|++.+..+
T Consensus 506 L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~---~L~~l~l~~Np~~C~c~ 564 (844)
T 3j0a_A 506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFV---SLSVLDITHNKFICECE 564 (844)
T ss_dssp CSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCS---SCCEEEEEEECCCCSSS
T ss_pred hheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhC---CcCEEEecCCCcccccc
Confidence 99999999999987777776 8999999999999999998764 78999999999998766
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-33 Score=312.45 Aligned_cols=305 Identities=23% Similarity=0.233 Sum_probs=179.5
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
+++.|+++++.++...+..+..+++|++|+|++|.|+++++ .|..+++|++|+|++|.++++++..|+++++|++|+|+
T Consensus 46 ~l~~l~l~~~~l~~l~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 125 (390)
T 3o6n_A 46 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 125 (390)
T ss_dssp CCSEEEEESCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEecCCchhhCChhHhcccccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECC
Confidence 34444555544443222334445555555555555554444 44455555555555555555544445555555555555
Q ss_pred CCCCCCCCCCCcc-ccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCc
Q 002346 146 DNPNLAPWPFPNE-LTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224 (933)
Q Consensus 146 ~N~~~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~ 224 (933)
+|++.. +|.. +.++++|++|+|++|++.+..+..|..+++|++|+|++|++++. +
T Consensus 126 ~n~l~~---l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~-~-------------------- 181 (390)
T 3o6n_A 126 RNDLSS---LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D-------------------- 181 (390)
T ss_dssp SSCCCC---CCTTTTTTCTTCCEEECCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBC-C--------------------
T ss_pred CCccCc---CCHHHhcCCCCCcEEECCCCccCccChhhccCCCCCCEEECCCCcCCcc-c--------------------
Confidence 554443 2222 34455555555555555544444455555555555555554421 1
Q ss_pred ccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC-CCCC
Q 002346 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPS 303 (933)
Q Consensus 225 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~ 303 (933)
+..+++|+.|++++|.+++. ....+|+.|++++|+++.. |..+ .++|+.|++++|.+++... ....
T Consensus 182 ------~~~l~~L~~L~l~~n~l~~~----~~~~~L~~L~l~~n~l~~~-~~~~--~~~L~~L~l~~n~l~~~~~l~~l~ 248 (390)
T 3o6n_A 182 ------LSLIPSLFHANVSYNLLSTL----AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDTAWLLNYP 248 (390)
T ss_dssp ------GGGCTTCSEEECCSSCCSEE----ECCSSCSEEECCSSCCCEE-ECCC--CSSCCEEECCSSCCCCCGGGGGCT
T ss_pred ------cccccccceeeccccccccc----CCCCcceEEECCCCeeeec-cccc--cccccEEECCCCCCcccHHHcCCC
Confidence 22366777777777776642 2335677777777777743 3322 3677777777777776421 1234
Q ss_pred CccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcC
Q 002346 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNI 383 (933)
Q Consensus 304 ~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 383 (933)
+|+.|+|++|.+.+. .|..+..+++|+.|+|++|++++ +
T Consensus 249 ~L~~L~Ls~n~l~~~----------------------------------------~~~~~~~l~~L~~L~L~~n~l~~-~ 287 (390)
T 3o6n_A 249 GLVEVDLSYNELEKI----------------------------------------MYHPFVKMQRLERLYISNNRLVA-L 287 (390)
T ss_dssp TCSEEECCSSCCCEE----------------------------------------ESGGGTTCSSCCEEECCSSCCCE-E
T ss_pred CccEEECCCCcCCCc----------------------------------------ChhHccccccCCEEECCCCcCcc-c
Confidence 677777777766443 35566677788888888888875 5
Q ss_pred chhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCCCCCcccccCCCCCCcC
Q 002346 384 SPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIG 450 (933)
Q Consensus 384 p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n~~~~ 450 (933)
|..+..+++|+.|+|++|+++ .+|..+..+++|+.|++++|+++.........++...+.+|||.|
T Consensus 288 ~~~~~~l~~L~~L~L~~n~l~-~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~L~~L~l~~N~~~~ 353 (390)
T 3o6n_A 288 NLYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDC 353 (390)
T ss_dssp ECSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEH
T ss_pred CcccCCCCCCCEEECCCCcce-ecCccccccCcCCEEECCCCccceeCchhhccCCEEEcCCCCccc
Confidence 666777888888888888887 667777778888888888888877654444555555667788776
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=328.50 Aligned_cols=307 Identities=22% Similarity=0.212 Sum_probs=196.0
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
.++.|+++++.+....+..+..+++|++|+|++|.|++++| .|..+++|++|+|++|.|+++++..|+++++|++|+|+
T Consensus 52 ~l~~l~l~~~~l~~lp~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~ 131 (597)
T 3oja_B 52 NQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLE 131 (597)
T ss_dssp CCSEEEESSCEESEECTHHHHHCCCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CceEEEeeCCCCCCcCHHHHccCCCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEee
Confidence 34556666666654444445566666666666666666555 56666666666666666666666666666666666666
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~ 225 (933)
+|.+.. ..+..|.++++|++|+|++|.+.+..|..|+.+++|++|+|++|++++. +
T Consensus 132 ~n~l~~--l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~--------------------- 187 (597)
T 3oja_B 132 RNDLSS--LPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTHV-D--------------------- 187 (597)
T ss_dssp SSCCCC--CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBC-C---------------------
T ss_pred CCCCCC--CCHHHhccCCCCCEEEeeCCcCCCCChhhhhcCCcCcEEECcCCCCCCc-C---------------------
Confidence 666655 2222345666666666666666666666666666666666666666532 2
Q ss_pred cccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC-CCCCC
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSK 304 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~ 304 (933)
+..+++|+.|++++|.+++. ....+|+.|++++|.++.. |..+ .++|+.|+|++|.+++... ....+
T Consensus 188 -----~~~l~~L~~L~l~~n~l~~l----~~~~~L~~L~ls~n~l~~~-~~~~--~~~L~~L~L~~n~l~~~~~l~~l~~ 255 (597)
T 3oja_B 188 -----LSLIPSLFHANVSYNLLSTL----AIPIAVEELDASHNSINVV-RGPV--NVELTILKLQHNNLTDTAWLLNYPG 255 (597)
T ss_dssp -----GGGCTTCSEEECCSSCCSEE----ECCTTCSEEECCSSCCCEE-ECSC--CSCCCEEECCSSCCCCCGGGGGCTT
T ss_pred -----hhhhhhhhhhhcccCccccc----cCCchhheeeccCCccccc-cccc--CCCCCEEECCCCCCCCChhhccCCC
Confidence 12256777777777776642 3345677777777777633 3222 2567777777777776421 12356
Q ss_pred ccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCc
Q 002346 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384 (933)
Q Consensus 305 l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 384 (933)
|+.|+|++|.+.+. .|..+..+++|+.|+|++|++++ +|
T Consensus 256 L~~L~Ls~N~l~~~----------------------------------------~~~~~~~l~~L~~L~Ls~N~l~~-l~ 294 (597)
T 3oja_B 256 LVEVDLSYNELEKI----------------------------------------MYHPFVKMQRLERLYISNNRLVA-LN 294 (597)
T ss_dssp CSEEECCSSCCCEE----------------------------------------ESGGGTTCSSCCEEECTTSCCCE-EE
T ss_pred CCEEECCCCccCCC----------------------------------------CHHHhcCccCCCEEECCCCCCCC-CC
Confidence 77777777776543 35566677788888888888876 56
Q ss_pred hhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCCCCCcccccCCCCCCcCC
Q 002346 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFIGT 451 (933)
Q Consensus 385 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n~~~~~ 451 (933)
..++.+++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|++..+.....++...+.+|||.|.
T Consensus 295 ~~~~~l~~L~~L~Ls~N~l~-~i~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~L~~L~l~~N~~~~~ 360 (597)
T 3oja_B 295 LYGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIVTLKLSTHHTLKNLTLSHNDWDCN 360 (597)
T ss_dssp CSSSCCTTCCEEECCSSCCC-CCGGGHHHHTTCSEEECCSSCCCCCCCCTTCCCSEEECCSSCEEHH
T ss_pred cccccCCCCcEEECCCCCCC-ccCcccccCCCCCEEECCCCCCCCcChhhcCCCCEEEeeCCCCCCh
Confidence 66777788888888888887 6777777788888888888888776555445555556677777763
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=308.17 Aligned_cols=267 Identities=17% Similarity=0.253 Sum_probs=149.6
Q ss_pred CccchHHHHHHHHHhcCCCCCC----CC--CCCCCCCccccceEeCC---------CCCEEEEEecCCCCccccCccccC
Q 002346 24 SLGDDGSVMLKLAQSLQNLPSD----WS--STSSTGYCEWTGINCDN---------SNRVTTISLAKSGLSGTLSPEISS 88 (933)
Q Consensus 24 ~~~~d~~~l~~~~~~~~~~~~~----w~--~~~~~~~C~w~gv~c~~---------~~~v~~L~l~~~~l~~~~~~~~~~ 88 (933)
+..+|+.||++||+++...+.. |. .....++|.|.|+.|.. ..+|+.|+|++|+++ .+|+.++.
T Consensus 24 ~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~~l~~ 102 (328)
T 4fcg_A 24 ALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFR 102 (328)
T ss_dssp CCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSCCSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCSCGGG
T ss_pred cCchHHHHHHHHHHhccCCchhhhhhhcccccccccccccCCcchhhhHHHHhcccccceeEEEccCCCch-hcChhhhh
Confidence 4568999999999999665544 42 12366889999999952 234555555555555 44444555
Q ss_pred CcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCee
Q 002346 89 LTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (933)
Q Consensus 89 l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L 168 (933)
+++|++|+|++|.|+.++..+..+++|++|+|++|.++.+ |..+.++++|++|
T Consensus 103 l~~L~~L~L~~n~l~~lp~~~~~l~~L~~L~Ls~n~l~~l---------------------------p~~l~~l~~L~~L 155 (328)
T 4fcg_A 103 LSHLQHMTIDAAGLMELPDTMQQFAGLETLTLARNPLRAL---------------------------PASIASLNRLREL 155 (328)
T ss_dssp GTTCSEEEEESSCCCCCCSCGGGGTTCSEEEEESCCCCCC---------------------------CGGGGGCTTCCEE
T ss_pred CCCCCEEECCCCCccchhHHHhccCCCCEEECCCCccccC---------------------------cHHHhcCcCCCEE
Confidence 5555555555555542222344444444444444444433 3333333333333
Q ss_pred eccCcccCCCCChhh---------cCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcE
Q 002346 169 YMDNANIFGLIPDFF---------DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQ 239 (933)
Q Consensus 169 ~L~~n~l~~~~p~~~---------~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~ 239 (933)
+|++|++.+.+|..+ ..+++|++|+|++|+++ .+|..
T Consensus 156 ~L~~n~~~~~~p~~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~--------------------------------- 201 (328)
T 4fcg_A 156 SIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS--------------------------------- 201 (328)
T ss_dssp EEEEETTCCCCCSCSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGG---------------------------------
T ss_pred ECCCCCCccccChhHhhccchhhhccCCCCCEEECcCCCcC-cchHh---------------------------------
Confidence 333333333333332 23444444444444444 44433
Q ss_pred EEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCC
Q 002346 240 VWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNS 319 (933)
Q Consensus 240 L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~ 319 (933)
+..+++|+.|+|++|+++ .+|..+..+++|++|+|++|.+.+.+|
T Consensus 202 --------------l~~l~~L~~L~L~~N~l~-~l~~~l~~l~~L~~L~Ls~n~~~~~~p-------------------- 246 (328)
T 4fcg_A 202 --------------IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYP-------------------- 246 (328)
T ss_dssp --------------GGGCTTCCEEEEESSCCC-CCCGGGGGCTTCCEEECTTCTTCCBCC--------------------
T ss_pred --------------hcCCCCCCEEEccCCCCC-cCchhhccCCCCCEEECcCCcchhhhH--------------------
Confidence 444444555555555554 234445555555555555555443322
Q ss_pred CCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecc
Q 002346 320 SDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQ 399 (933)
Q Consensus 320 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~ 399 (933)
..+..+++|+.|+|++|++.+.+|..++++++|+.|+|+
T Consensus 247 -----------------------------------------~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~ 285 (328)
T 4fcg_A 247 -----------------------------------------PIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLR 285 (328)
T ss_dssp -----------------------------------------CCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECT
T ss_pred -----------------------------------------HHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCC
Confidence 222333455555555555566677777888888888888
Q ss_pred cCcccCCCCcccCCCCCcCEEeccCCcCc
Q 002346 400 QNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (933)
Q Consensus 400 ~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 428 (933)
+|++.+.+|..+.+|++|+.+++..|.+.
T Consensus 286 ~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 286 GCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp TCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred CCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 88888888888888888888888876554
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-32 Score=308.84 Aligned_cols=303 Identities=19% Similarity=0.187 Sum_probs=251.3
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
.+++.|++++|++++. | .++.+++|++|+|++|+|+++ | +..+++|++|+|++|+|++++ ++++++|++|+|+
T Consensus 42 ~~L~~L~Ls~n~l~~~-~-~l~~l~~L~~L~Ls~n~l~~~-~-~~~l~~L~~L~Ls~N~l~~~~---~~~l~~L~~L~L~ 114 (457)
T 3bz5_A 42 ATLTSLDCHNSSITDM-T-GIEKLTGLTKLICTSNNITTL-D-LSQNTNLTYLACDSNKLTNLD---VTPLTKLTYLNCD 114 (457)
T ss_dssp TTCCEEECCSSCCCCC-T-TGGGCTTCSEEECCSSCCSCC-C-CTTCTTCSEEECCSSCCSCCC---CTTCTTCCEEECC
T ss_pred CCCCEEEccCCCcccC-h-hhcccCCCCEEEccCCcCCeE-c-cccCCCCCEEECcCCCCceee---cCCCCcCCEEECC
Confidence 5789999999999974 5 799999999999999999986 3 889999999999999999985 8899999999999
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCCc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGL 224 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~ 224 (933)
+|++.+ +| ++.+++|++|++++|++++. + ++.+++|++|++++|+..+.++ +.. ..|++|++++|.+..
T Consensus 115 ~N~l~~---l~--~~~l~~L~~L~l~~N~l~~l-~--l~~l~~L~~L~l~~n~~~~~~~--~~~l~~L~~L~ls~n~l~~ 184 (457)
T 3bz5_A 115 TNKLTK---LD--VSQNPLLTYLNCARNTLTEI-D--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITE 184 (457)
T ss_dssp SSCCSC---CC--CTTCTTCCEEECTTSCCSCC-C--CTTCTTCCEEECTTCSCCCCCC--CTTCTTCCEEECCSSCCCC
T ss_pred CCcCCe---ec--CCCCCcCCEEECCCCcccee-c--cccCCcCCEEECCCCCcccccc--cccCCcCCEEECCCCccce
Confidence 999988 44 89999999999999999986 3 8899999999999997766663 333 678889999988765
Q ss_pred ccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCC
Q 002346 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSK 304 (933)
Q Consensus 225 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 304 (933)
. + +..+++|+.|++++|++++. .+..+++|+.|+|++|++++ +| +..+++|+.|++++|++++..+..+..
T Consensus 185 l---~-l~~l~~L~~L~l~~N~l~~~--~l~~l~~L~~L~Ls~N~l~~-ip--~~~l~~L~~L~l~~N~l~~~~~~~l~~ 255 (457)
T 3bz5_A 185 L---D-VSQNKLLNRLNCDTNNITKL--DLNQNIQLTFLDCSSNKLTE-ID--VTPLTQLTYFDCSVNPLTELDVSTLSK 255 (457)
T ss_dssp C---C-CTTCTTCCEEECCSSCCSCC--CCTTCTTCSEEECCSSCCSC-CC--CTTCTTCSEEECCSSCCSCCCCTTCTT
T ss_pred e---c-cccCCCCCEEECcCCcCCee--ccccCCCCCEEECcCCcccc-cC--ccccCCCCEEEeeCCcCCCcCHHHCCC
Confidence 3 2 77788999999999999886 48888999999999999996 56 888899999999999999887777788
Q ss_pred ccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCc
Q 002346 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384 (933)
Q Consensus 305 l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 384 (933)
++.|+++.|++... ++.+|...+.+| .+.+++|+.|+|++|.+.|.+|
T Consensus 256 L~~L~l~~n~L~~L------------------------------~l~~n~~~~~~~--~~~l~~L~~L~Ls~n~~l~~l~ 303 (457)
T 3bz5_A 256 LTTLHCIQTDLLEI------------------------------DLTHNTQLIYFQ--AEGCRKIKELDVTHNTQLYLLD 303 (457)
T ss_dssp CCEEECTTCCCSCC------------------------------CCTTCTTCCEEE--CTTCTTCCCCCCTTCTTCCEEE
T ss_pred CCEEeccCCCCCEE------------------------------ECCCCccCCccc--ccccccCCEEECCCCcccceec
Confidence 88888888877543 334555556665 3567788888888888777776
Q ss_pred hh--------hcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcc
Q 002346 385 PA--------YANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429 (933)
Q Consensus 385 ~~--------~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g 429 (933)
.. +.++++|+.|+|++|+|++. + +..+++|+.|++++|+|++
T Consensus 304 ~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~--l~~l~~L~~L~l~~N~l~~ 353 (457)
T 3bz5_A 304 CQAAGITELDLSQNPKLVYLYLNNTELTEL-D--VSHNTKLKSLSCVNAHIQD 353 (457)
T ss_dssp CTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C--CTTCTTCSEEECCSSCCCB
T ss_pred cCCCcceEechhhcccCCEEECCCCccccc-c--cccCCcCcEEECCCCCCCC
Confidence 42 45567788888888888873 3 7888888888888888887
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=324.19 Aligned_cols=358 Identities=19% Similarity=0.212 Sum_probs=271.8
Q ss_pred eEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCC
Q 002346 60 INCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTN 138 (933)
Q Consensus 60 v~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 138 (933)
..|...+ + .++++++++ .+|..+. ++|++|+|++|.|++.+| .|.++++|++|+|++|+++++++..|.++++
T Consensus 2 ~~C~~~~-~--c~~~~~~l~-~ip~~~~--~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~ 75 (549)
T 2z81_A 2 LSCDASG-V--CDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGS 75 (549)
T ss_dssp CEECTTS-E--EECTTSCCS-SCCSCCC--TTCCEEECCSSCCCEECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTT
T ss_pred ccCCCCc-e--EECCCCccc-cccccCC--CCccEEECcCCccCccChhhhhcCCcccEEECCCCCcCccChhhcccccc
Confidence 3576543 3 789999998 6777665 799999999999999887 7999999999999999999999999999999
Q ss_pred CCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCC-CChhhcCCCCCCEEEccCCcCCCCCC-ccccc-cccchh
Q 002346 139 LQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLP-ASFAK-SDIQNL 215 (933)
Q Consensus 139 L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~-~~l~~l 215 (933)
|++|+|++|++.+ ..|..++++++|++|+|++|++.+. .|..|+.+++|++|+|++|++.+.+| ..+.. .+|++|
T Consensus 76 L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L 153 (549)
T 2z81_A 76 LEHLDLSDNHLSS--LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNEL 153 (549)
T ss_dssp CCEEECTTSCCCS--CCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred CCEEECCCCccCc--cCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCee
Confidence 9999999999998 4455699999999999999999874 57889999999999999999655665 45655 679999
Q ss_pred hcccccCCcccccc-----------------------cccCCccCcEEEecCCccCCCC----CCCCC------------
Q 002346 216 WMNDQQLGLSGTLD-----------------------VLSGMTQLRQVWLHKNQFTGPI----PDLSK------------ 256 (933)
Q Consensus 216 ~l~~n~~~~~~~~~-----------------------~l~~l~~L~~L~L~~N~l~~~~----~~~~~------------ 256 (933)
++.+|.+....... .+..+++|+.|++++|++++.. +....
T Consensus 154 ~L~~n~l~~~~~~~l~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~~L~~L~l~~n 233 (549)
T 2z81_A 154 EIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGS 233 (549)
T ss_dssp EEEETTCCEECTTTTTTCSEEEEEEEECSBSTTHHHHHHHSTTTBSEEEEESCBCTTCCCCCCSSCCCCCCCCEEEEESC
T ss_pred eccCCcccccChhhhhccccCceEecccCcccccchhhHhhcccccEEEccCCccccccccccchhhhhhcccceecccc
Confidence 99999876422110 1134778999999999888742 00011
Q ss_pred ---------------------------------------------------------------------------CCCCC
Q 002346 257 ---------------------------------------------------------------------------CESLF 261 (933)
Q Consensus 257 ---------------------------------------------------------------------------~~~L~ 261 (933)
..+|+
T Consensus 234 ~l~~~~~~~l~~~~~~~~~L~~l~l~~~~~~~~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~~~~~~~l~~~~~~~~~L~ 313 (549)
T 2z81_A 234 VLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVK 313 (549)
T ss_dssp EEEHHHHHHHHGGGGGCTTCCEEEEESCEEECCSCCCCCTTTCCCCCTTCCEEEEESCBCSCGGGSCCCCHHHHHSTTCC
T ss_pred ccchhHHHHHHHHhhhhccccccccccccccccccccccchhhhhhhcccccccccccccchhhhcccchhhhhhcccce
Confidence 13456
Q ss_pred EEEccCCcccccCcccc-cCCCCCCEEEccCccCccCCC------CCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhH
Q 002346 262 DLSLRDNQLTGVVPASV-ISLPALLNISLQNNKLQGPYP------LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLL 334 (933)
Q Consensus 262 ~L~L~~N~l~~~~p~~l-~~l~~L~~L~Ls~N~l~~~~p------~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~ 334 (933)
.|++++|+++ .+|..+ ..+++|+.|+|++|++++.+| ....+|+.|+|++|++.+...
T Consensus 314 ~L~l~~n~l~-~ip~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-------------- 378 (549)
T 2z81_A 314 RITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQK-------------- 378 (549)
T ss_dssp EEEEESSCCC-CCCHHHHHHCTTCCEEECCSSCCCHHHHHHHTCTTSSTTCCEEECTTSCCCCHHH--------------
T ss_pred EEEeccCccc-cCCHHHHhcCccccEEEccCCccccccccchhhhhccccCcEEEccCCccccccc--------------
Confidence 6666666665 566665 479999999999999998653 235689999999999965321
Q ss_pred hhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCC
Q 002346 335 QIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKL 414 (933)
Q Consensus 335 ~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l 414 (933)
....+.....++.+...+|.+..+|..+..+++|+.|+|++|++++ +|..+. ++|++|+|++|+|++.+ ..+
T Consensus 379 -~~~~~~~l~~L~~L~Ls~N~l~~lp~~~~~~~~L~~L~Ls~N~l~~-l~~~~~--~~L~~L~Ls~N~l~~~~----~~l 450 (549)
T 2z81_A 379 -TGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIRV-VKTCIP--QTLEVLDVSNNNLDSFS----LFL 450 (549)
T ss_dssp -HHHHGGGCTTCCEEECTTCCCCCCCSCCCCCTTCCEEECTTSCCSC-CCTTSC--TTCSEEECCSSCCSCCC----CCC
T ss_pred -chhhhhcCCCCCEEECCCCCCccCChhhcccccccEEECCCCCccc-ccchhc--CCceEEECCCCChhhhc----ccC
Confidence 0000112223333333444566899999999999999999999984 454442 68999999999999753 578
Q ss_pred CCcCEEeccCCcCcccCCCCC--CCcccccCCCCCCc
Q 002346 415 ASLQNLDVSNNNLSGKVPDFG--SNVKFTVSPGNPFI 449 (933)
Q Consensus 415 ~~L~~l~ls~N~l~g~~p~~~--~~~~~~~~~~n~~~ 449 (933)
++|++|+|++|+|+ .+|... ..++...+.+|.+.
T Consensus 451 ~~L~~L~Ls~N~l~-~ip~~~~l~~L~~L~Ls~N~l~ 486 (549)
T 2z81_A 451 PRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLK 486 (549)
T ss_dssp TTCCEEECCSSCCS-SCCCGGGCTTCCEEECCSSCCC
T ss_pred ChhcEEECCCCccC-cCCCcccCccCCEEecCCCccC
Confidence 99999999999999 566543 23333445566654
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-32 Score=325.71 Aligned_cols=286 Identities=19% Similarity=0.269 Sum_probs=218.3
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
..++.|+|++|.|++..+..|+.+++|++|+|++|.|++.+| .|+++++|++|+|++|.|+.+++..|+++++|++|+|
T Consensus 75 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 154 (597)
T 3oja_B 75 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 154 (597)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCcEEECCCCCCCCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEe
Confidence 478999999999998888899999999999999999999988 6899999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCc
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~ 224 (933)
++|.+.+ ..|..+.++++|++|+|++|.+++.. ++.+++|+.|++++|.+++. +. ...|+.|++++|.+..
T Consensus 155 s~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~---~~~l~~L~~L~l~~n~l~~l-~~---~~~L~~L~ls~n~l~~ 225 (597)
T 3oja_B 155 SNNNLER--IEDDTFQATTSLQNLQLSSNRLTHVD---LSLIPSLFHANVSYNLLSTL-AI---PIAVEELDASHNSINV 225 (597)
T ss_dssp CSSCCCB--CCTTTTTTCTTCCEEECTTSCCSBCC---GGGCTTCSEEECCSSCCSEE-EC---CTTCSEEECCSSCCCE
T ss_pred eCCcCCC--CChhhhhcCCcCcEEECcCCCCCCcC---hhhhhhhhhhhcccCccccc-cC---CchhheeeccCCcccc
Confidence 9999988 56778999999999999999998873 56688999999999999842 11 0234444555444432
Q ss_pred ccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCC
Q 002346 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSK 304 (933)
Q Consensus 225 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 304 (933)
.... ..++|+.|+|++|.+++. +.+..+++|+.|+|++|.+++.+|..|..+++|+.|+|++|.+++
T Consensus 226 ~~~~----~~~~L~~L~L~~n~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~-------- 292 (597)
T 3oja_B 226 VRGP----VNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-------- 292 (597)
T ss_dssp EECS----CCSCCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECTTSCCCE--------
T ss_pred cccc----cCCCCCEEECCCCCCCCC-hhhccCCCCCEEECCCCccCCCCHHHhcCccCCCEEECCCCCCCC--------
Confidence 2111 123455555555555542 334445555555555555554445555555555555555554443
Q ss_pred ccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCc
Q 002346 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384 (933)
Q Consensus 305 l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 384 (933)
+|..+..+++|+.|+|++|.++ .+|
T Consensus 293 ------------------------------------------------------l~~~~~~l~~L~~L~Ls~N~l~-~i~ 317 (597)
T 3oja_B 293 ------------------------------------------------------LNLYGQPIPTLKVLDLSHNHLL-HVE 317 (597)
T ss_dssp ------------------------------------------------------EECSSSCCTTCCEEECCSSCCC-CCG
T ss_pred ------------------------------------------------------CCcccccCCCCcEEECCCCCCC-ccC
Confidence 1223345678999999999999 588
Q ss_pred hhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccC
Q 002346 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKV 431 (933)
Q Consensus 385 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~ 431 (933)
..++.+++|+.|+|++|+|++. | +..+++|+.|+|++|++++..
T Consensus 318 ~~~~~l~~L~~L~L~~N~l~~~-~--~~~~~~L~~L~l~~N~~~~~~ 361 (597)
T 3oja_B 318 RNQPQFDRLENLYLDHNSIVTL-K--LSTHHTLKNLTLSHNDWDCNS 361 (597)
T ss_dssp GGHHHHTTCSEEECCSSCCCCC-C--CCTTCCCSEEECCSSCEEHHH
T ss_pred cccccCCCCCEEECCCCCCCCc-C--hhhcCCCCEEEeeCCCCCChh
Confidence 8899999999999999999854 3 778899999999999998764
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-32 Score=321.91 Aligned_cols=337 Identities=17% Similarity=0.213 Sum_probs=222.2
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCC-CCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|.+++..|..|+.+++|++|+|++|+|+++++. .+++|++|+|++|.+++++ +..|+++++|++|+|
T Consensus 45 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~lp~~--~l~~L~~L~L~~N~l~~~~~p~~~~~l~~L~~L~L 122 (520)
T 2z7x_B 45 SKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVKISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122 (520)
T ss_dssp TTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCCEEECC--CCCCCSEEECCSSCCSSCCCCGGGGGCTTCCEEEE
T ss_pred ccccEEecCCCccCCcChHHhhcccCCCEEecCCCceeecCcc--ccCCccEEeccCCccccccchhhhccCCcceEEEe
Confidence 5799999999999998899999999999999999999965445 8999999999999999864 467999999999999
Q ss_pred cCCCCCCCCCCCccccCCccC--CeeeccCccc--CCCCChhhcCCC---------------------------------
Q 002346 145 SDNPNLAPWPFPNELTKSTSL--TTLYMDNANI--FGLIPDFFDSFS--------------------------------- 187 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L--~~L~L~~n~l--~~~~p~~~~~l~--------------------------------- 187 (933)
++|++.. ..+..+++| +.|++++|.+ .+..|..+..+.
T Consensus 123 ~~n~l~~-----~~~~~l~~L~L~~L~l~~n~l~~~~~~~~~l~~l~~~~l~l~l~~n~~~~~~~~~~~~~l~~L~~L~l 197 (520)
T 2z7x_B 123 STTHLEK-----SSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNI 197 (520)
T ss_dssp EESSCCG-----GGGGGGTTSCEEEEEEEECTTTTSSCCTTTTTTCCEEEEEEECCSSSCCCCCCCCCCTTCSEEEECCE
T ss_pred cCcccch-----hhccccccceeeEEEeecccccccccccccccccccceEEEEeccCcchhhhhhhhhhcccceeeccc
Confidence 9999876 356677777 8888888888 666676665533
Q ss_pred --------------------------------------------------CCCEEEccCCcCCCCCCccc-----cc-cc
Q 002346 188 --------------------------------------------------NLQNLRLSYNNFTGSLPASF-----AK-SD 211 (933)
Q Consensus 188 --------------------------------------------------~L~~L~L~~N~l~~~~p~~~-----~~-~~ 211 (933)
+|++|+|++|+++|.+|..+ .. ..
T Consensus 198 ~~n~~~~~~~~~~~~~~~l~~l~~L~~L~l~~~~l~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~~~l~~ 277 (520)
T 2z7x_B 198 KCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKA 277 (520)
T ss_dssp EECCSTTTTHHHHHHHHGGGGCTTCCEEEEEEEEEEHHHHHHHHHHHHTSSCSEEEEEEEEEESCCCCCCCCCCSCCCCE
T ss_pred cccccccccceeecchhhhccccchhhccccccccCHHHHHHHHHHhhhCcccEEEeecccccCccccchhhcccccCce
Confidence 67777777777777777766 22 34
Q ss_pred cchhhcccccCCcccccccccCC---ccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEE
Q 002346 212 IQNLWMNDQQLGLSGTLDVLSGM---TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNIS 288 (933)
Q Consensus 212 l~~l~l~~n~~~~~~~~~~l~~l---~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 288 (933)
|+.+++..|.+... ...+..+ .+|+.|++++|.+.... ....+++|++|+|++|++++.+|..+..+++|++|+
T Consensus 278 L~~l~l~~n~~~~p--~~~~~~~~~~~~L~~L~l~~n~l~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~ 354 (520)
T 2z7x_B 278 LSIHQVVSDVFGFP--QSYIYEIFSNMNIKNFTVSGTRMVHML-CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLI 354 (520)
T ss_dssp EEEEEEEECCCCSC--THHHHHHHHTCCCSEEEEESSCCCCCC-CCSSCCCCCEEECCSSCCCTTTTTTCCCCSSCCEEE
T ss_pred eEeccccccceecc--hhhhhcccccCceeEEEcCCCcccccc-chhhCCcccEEEeECCccChhhhhhhccCCCCCEEE
Confidence 44455555544111 0011111 23444444444433211 113444455555555555544444455555555555
Q ss_pred ccCccCcc--CCC---CCCCCccEEeccCCcCCC-CCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCcc
Q 002346 289 LQNNKLQG--PYP---LFPSKVQKVSLDHNNFCK-NSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFV 362 (933)
Q Consensus 289 Ls~N~l~~--~~p---~~~~~l~~L~l~~n~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~ 362 (933)
|++|++++ .+| ....+|+.|+|++|.+.+ .+...+. ..+..-...+.+|...+.+|..
T Consensus 355 L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~----------------~l~~L~~L~Ls~N~l~~~~~~~ 418 (520)
T 2z7x_B 355 LQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS----------------WTKSLLSLNMSSNILTDTIFRC 418 (520)
T ss_dssp CCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCC----------------CCTTCCEEECCSSCCCGGGGGS
T ss_pred ccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhc----------------cCccCCEEECcCCCCCcchhhh
Confidence 55555543 111 123344455555554443 1111000 0001111122233333333433
Q ss_pred ccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcc-cCCCCCcCEEeccCCcCcccCC
Q 002346 363 TCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 363 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~g~~p 432 (933)
+. ++|+.|+|++|+++ .+|..+..+++|+.|+|++|+|+ .+|.. |..+++|+.|++++|++++..+
T Consensus 419 l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~-~l~~~~~~~l~~L~~L~l~~N~~~c~c~ 485 (520)
T 2z7x_B 419 LP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 485 (520)
T ss_dssp CC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCC-ccCHHHhccCCcccEEECcCCCCcccCC
Confidence 33 68999999999999 79998889999999999999999 67765 9999999999999999998765
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-32 Score=305.90 Aligned_cols=285 Identities=20% Similarity=0.285 Sum_probs=218.5
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|++++..+..|..+++|++|+|++|.+++.+| .|.++++|++|+|++|.++.++...|.++++|++|+|
T Consensus 69 ~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L 148 (390)
T 3o6n_A 69 RQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSM 148 (390)
T ss_dssp CCCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEEC
T ss_pred ccCcEEECCCCcccccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEEC
Confidence 479999999999998888899999999999999999999888 6899999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCc
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~ 224 (933)
++|++.. ..|..+..+++|++|++++|++++. .+..+++|++|++++|.+++ ++. ...+++|++.+|.+..
T Consensus 149 ~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~---~~~~l~~L~~L~l~~n~l~~-~~~---~~~L~~L~l~~n~l~~ 219 (390)
T 3o6n_A 149 SNNNLER--IEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLST-LAI---PIAVEELDASHNSINV 219 (390)
T ss_dssp CSSCCCB--CCTTTTSSCTTCCEEECCSSCCSBC---CGGGCTTCSEEECCSSCCSE-EEC---CSSCSEEECCSSCCCE
T ss_pred CCCccCc--cChhhccCCCCCCEEECCCCcCCcc---ccccccccceeecccccccc-cCC---CCcceEEECCCCeeee
Confidence 9999988 5567899999999999999999886 36678999999999999984 211 0234455555554432
Q ss_pred ccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCC
Q 002346 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSK 304 (933)
Q Consensus 225 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 304 (933)
... ...++|+.|+|++|++++. +.+..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++.
T Consensus 220 ~~~----~~~~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------- 287 (390)
T 3o6n_A 220 VRG----PVNVELTILKLQHNNLTDT-AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVAL------- 287 (390)
T ss_dssp EEC----CCCSSCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCCCEEESGGGTTCSSCCEEECCSSCCCEE-------
T ss_pred ccc----cccccccEEECCCCCCccc-HHHcCCCCccEEECCCCcCCCcChhHccccccCCEEECCCCcCccc-------
Confidence 211 1134555555555555543 3444555555555555555555555555555555555555554431
Q ss_pred ccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCc
Q 002346 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384 (933)
Q Consensus 305 l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 384 (933)
|.....+++|+.|+|++|+++ .+|
T Consensus 288 -------------------------------------------------------~~~~~~l~~L~~L~L~~n~l~-~~~ 311 (390)
T 3o6n_A 288 -------------------------------------------------------NLYGQPIPTLKVLDLSHNHLL-HVE 311 (390)
T ss_dssp -------------------------------------------------------ECSSSCCTTCCEEECCSSCCC-CCG
T ss_pred -------------------------------------------------------CcccCCCCCCCEEECCCCcce-ecC
Confidence 223345678999999999998 578
Q ss_pred hhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCccc
Q 002346 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430 (933)
Q Consensus 385 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~ 430 (933)
..++.+++|+.|+|++|+++. +| +..+++|+.|++++|++++.
T Consensus 312 ~~~~~l~~L~~L~L~~N~i~~-~~--~~~~~~L~~L~l~~N~~~~~ 354 (390)
T 3o6n_A 312 RNQPQFDRLENLYLDHNSIVT-LK--LSTHHTLKNLTLSHNDWDCN 354 (390)
T ss_dssp GGHHHHTTCSEEECCSSCCCC-CC--CCTTCCCSEEECCSSCEEHH
T ss_pred ccccccCcCCEEECCCCccce-eC--chhhccCCEEEcCCCCccch
Confidence 889999999999999999984 44 77899999999999999875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.98 E-value=7.7e-32 Score=308.55 Aligned_cols=332 Identities=18% Similarity=0.207 Sum_probs=200.8
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcC-------------ceeccccccccCCCCC
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSL-------------QDIYLDNNNFTSVPTG 131 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L-------------~~L~Ls~N~l~~~~~~ 131 (933)
.+++.|++++|++ |.+|++|+++++|++|++++|.++|.+| +++.+++| ++|++++|.++++|..
T Consensus 11 ~~L~~L~l~~n~l-~~iP~~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~~ 89 (454)
T 1jl5_A 11 TFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPEL 89 (454)
T ss_dssp ------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCSC
T ss_pred ccchhhhcccCch-hhCChhHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCCC
Confidence 4677888888888 6888888888888888888888887777 56665543 5666666666555431
Q ss_pred c--c--------------cCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEcc
Q 002346 132 C--F--------------DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (933)
Q Consensus 132 ~--~--------------~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 195 (933)
. + ..+++|++|++++|++.+ +|.. .++|++|++++|++++ +| .|+.+++|++|+++
T Consensus 90 ~~~L~~L~l~~n~l~~lp~~~~~L~~L~l~~n~l~~---l~~~---~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 90 PPHLESLVASCNSLTELPELPQSLKSLLVDNNNLKA---LSDL---PPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVD 161 (454)
T ss_dssp CTTCSEEECCSSCCSSCCCCCTTCCEEECCSSCCSC---CCSC---CTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECC
T ss_pred cCCCCEEEccCCcCCccccccCCCcEEECCCCccCc---ccCC---CCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECC
Confidence 0 0 012445555555554444 2211 1689999999999987 56 59999999999999
Q ss_pred CCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCc
Q 002346 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVP 275 (933)
Q Consensus 196 ~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p 275 (933)
+|++++ +|..+ ..|++|++.+|.+.. .+.+.++++|+.|++++|++++.+... .+|+.|++++|+++ .+|
T Consensus 162 ~N~l~~-lp~~~--~~L~~L~L~~n~l~~---l~~~~~l~~L~~L~l~~N~l~~l~~~~---~~L~~L~l~~n~l~-~lp 231 (454)
T 1jl5_A 162 NNSLKK-LPDLP--PSLEFIAAGNNQLEE---LPELQNLPFLTAIYADNNSLKKLPDLP---LSLESIVAGNNILE-ELP 231 (454)
T ss_dssp SSCCSC-CCCCC--TTCCEEECCSSCCSS---CCCCTTCTTCCEEECCSSCCSSCCCCC---TTCCEEECCSSCCS-SCC
T ss_pred CCcCcc-cCCCc--ccccEEECcCCcCCc---CccccCCCCCCEEECCCCcCCcCCCCc---CcccEEECcCCcCC-ccc
Confidence 999984 77655 378999999998775 235888999999999999998744322 58889999999888 677
Q ss_pred ccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhh--HhhhcccCCCccccCCCCCC
Q 002346 276 ASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTL--LQIAGDMGYPAILSDSWEGN 353 (933)
Q Consensus 276 ~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~~~~~ 353 (933)
. +..+++|++|++++|++++ +|..+.+++.|++++|.+.+.+... ... +...+ -.+......+..++.+...+
T Consensus 232 ~-~~~l~~L~~L~l~~N~l~~-l~~~~~~L~~L~l~~N~l~~l~~~~-~~L--~~L~ls~N~l~~l~~~~~~L~~L~l~~ 306 (454)
T 1jl5_A 232 E-LQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELP-QSL--TFLDVSENIFSGLSELPPNLYYLNASS 306 (454)
T ss_dssp C-CTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCC-TTC--CEEECCSSCCSEESCCCTTCCEEECCS
T ss_pred c-cCCCCCCCEEECCCCcCCc-ccccccccCEEECCCCcccccCccc-CcC--CEEECcCCccCcccCcCCcCCEEECcC
Confidence 4 8888899999999998886 4556678888888888887744321 000 00000 00000001112222222222
Q ss_pred CCCCCCCccccCC-CceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcc--c
Q 002346 354 NACDGWPFVTCSQ-GRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG--K 430 (933)
Q Consensus 354 ~~~~~~p~~~~~l-~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g--~ 430 (933)
+.+..++ .+ ++|+.|+|++|++++ +|.. +++|+.|+|++|+++ .+|. .+++|++|++++|++++ .
T Consensus 307 N~l~~i~----~~~~~L~~L~Ls~N~l~~-lp~~---~~~L~~L~L~~N~l~-~lp~---~l~~L~~L~L~~N~l~~l~~ 374 (454)
T 1jl5_A 307 NEIRSLC----DLPPSLEELNVSNNKLIE-LPAL---PPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLREFPD 374 (454)
T ss_dssp SCCSEEC----CCCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS-CCCC---CCTTCCEEECCSSCCSSCCC
T ss_pred CcCCccc----CCcCcCCEEECCCCcccc-cccc---CCcCCEEECCCCccc-cccc---hhhhccEEECCCCCCCcCCC
Confidence 3332222 22 467777777777775 5543 467777777777777 4665 36677777777777777 4
Q ss_pred CCC
Q 002346 431 VPD 433 (933)
Q Consensus 431 ~p~ 433 (933)
+|.
T Consensus 375 ip~ 377 (454)
T 1jl5_A 375 IPE 377 (454)
T ss_dssp CCT
T ss_pred ChH
Confidence 553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.98 E-value=4.6e-31 Score=292.86 Aligned_cols=301 Identities=22% Similarity=0.340 Sum_probs=237.4
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
..++.|+++++++.. ++ .+..+++|++|++++|.+++..+ +..+++|++|+|++|.++.++ .|.++++|++|+|+
T Consensus 44 ~~L~~L~l~~~~i~~-~~-~~~~~~~L~~L~l~~n~i~~~~~-~~~l~~L~~L~L~~n~i~~~~--~~~~l~~L~~L~l~ 118 (347)
T 4fmz_A 44 ESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDISP-LSNLVKLTNLYIGTNKITDIS--ALQNLTNLRELYLN 118 (347)
T ss_dssp TTCSEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCG--GGTTCTTCSEEECT
T ss_pred ccccEEEEeCCcccc-ch-hhhhcCCccEEEccCCccccchh-hhcCCcCCEEEccCCcccCch--HHcCCCcCCEEECc
Confidence 478999999999974 44 48999999999999999998766 999999999999999999975 49999999999999
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCCc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGL 224 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~ 224 (933)
+|.+.. ++. +..+++|+.|++++|.....++. +..+++|++|++++|.+++ ++. +.. ..|++|++++|.+..
T Consensus 119 ~n~i~~---~~~-~~~l~~L~~L~l~~n~~~~~~~~-~~~l~~L~~L~l~~~~~~~-~~~-~~~l~~L~~L~l~~n~l~~ 191 (347)
T 4fmz_A 119 EDNISD---ISP-LANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKD-VTP-IANLTDLYSLSLNYNQIED 191 (347)
T ss_dssp TSCCCC---CGG-GTTCTTCCEEECTTCTTCCCCGG-GTTCTTCCEEECCSSCCCC-CGG-GGGCTTCSEEECTTSCCCC
T ss_pred CCcccC---chh-hccCCceeEEECCCCCCcccccc-hhhCCCCcEEEecCCCcCC-chh-hccCCCCCEEEccCCcccc
Confidence 999987 444 89999999999999977666554 8999999999999999984 433 333 567777887777654
Q ss_pred ccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC-CCCC
Q 002346 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPS 303 (933)
Q Consensus 225 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~ 303 (933)
... +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++..+ +..+++|++|++++|.+++... ..+.
T Consensus 192 ~~~---~~~l~~L~~L~l~~n~l~~~~~-~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~~~~l~ 265 (347)
T 4fmz_A 192 ISP---LASLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISDINAVKDLT 265 (347)
T ss_dssp CGG---GGGCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGGGTTCT
T ss_pred ccc---ccCCCccceeecccCCCCCCch-hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCCChhHhcCC
Confidence 332 6667788888888888876655 7777888888888888874433 7778888888888888776421 1245
Q ss_pred CccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcC
Q 002346 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNI 383 (933)
Q Consensus 304 ~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 383 (933)
+|+.|++++|.+.+. ..+..+++|+.|+|++|.+++..
T Consensus 266 ~L~~L~l~~n~l~~~------------------------------------------~~~~~l~~L~~L~L~~n~l~~~~ 303 (347)
T 4fmz_A 266 KLKMLNVGSNQISDI------------------------------------------SVLNNLSQLNSLFLNNNQLGNED 303 (347)
T ss_dssp TCCEEECCSSCCCCC------------------------------------------GGGGGCTTCSEEECCSSCCCGGG
T ss_pred CcCEEEccCCccCCC------------------------------------------hhhcCCCCCCEEECcCCcCCCcC
Confidence 777788877776432 13556678888889888888888
Q ss_pred chhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCc
Q 002346 384 SPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (933)
Q Consensus 384 p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 428 (933)
|..|+.+++|+.|+|++|++++..| +..+++|+.|++++|+|+
T Consensus 304 ~~~l~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~l~~N~i~ 346 (347)
T 4fmz_A 304 MEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346 (347)
T ss_dssp HHHHHTCTTCSEEECCSSSCCCCGG--GGGCTTCSEESSSCC---
T ss_pred hhHhhccccCCEEEccCCccccccC--hhhhhccceeehhhhccc
Confidence 8888888889999999888886656 778888888888888875
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=292.44 Aligned_cols=282 Identities=19% Similarity=0.268 Sum_probs=203.8
Q ss_pred EEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCC
Q 002346 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (933)
Q Consensus 69 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 147 (933)
+.+++++++++ .+|..+. ++|++|+|++|.|++.+| .|.++++|++|+|++|+++++++..|.++++|++|+|++|
T Consensus 36 ~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n 112 (332)
T 2ft3_A 36 RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN 112 (332)
T ss_dssp TEEECCSSCCS-SCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred CEEECCCCCcc-ccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence 34455556666 5666553 688999999999988877 7888999999999999999888888999999999999999
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCC--CCCccccccccchhhcccccCCcc
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG--SLPASFAKSDIQNLWMNDQQLGLS 225 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~~l~~l~l~~n~~~~~ 225 (933)
++.. +|..+. ++|++|++++|++.+..+..|..+++|++|+|++|+++. ..|..+..
T Consensus 113 ~l~~---l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~---------------- 171 (332)
T 2ft3_A 113 HLVE---IPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDG---------------- 171 (332)
T ss_dssp CCCS---CCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCS----------------
T ss_pred cCCc---cCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccC----------------
Confidence 8886 666655 789999999999988888888999999999999999863 45555443
Q ss_pred cccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCC---C
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---P 302 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~---~ 302 (933)
+ +|+.|++++|++++.+..+. ++|+.|+|++|++++..+..+..+++|+.|+|++|++++..+.. .
T Consensus 172 --------l-~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l 240 (332)
T 2ft3_A 172 --------L-KLNYLRISEAKLTGIPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFL 240 (332)
T ss_dssp --------C-CCSCCBCCSSBCSSCCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGC
T ss_pred --------C-ccCEEECcCCCCCccCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCC
Confidence 4 66666677776666444433 56667777777776666666666777777777777766655422 2
Q ss_pred CCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCc
Q 002346 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382 (933)
Q Consensus 303 ~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 382 (933)
.+|+.|+|++|++. .+|..+..+++|+.|+|++|++++.
T Consensus 241 ~~L~~L~L~~N~l~-----------------------------------------~lp~~l~~l~~L~~L~l~~N~l~~~ 279 (332)
T 2ft3_A 241 PTLRELHLDNNKLS-----------------------------------------RVPAGLPDLKLLQVVYLHTNNITKV 279 (332)
T ss_dssp TTCCEEECCSSCCC-----------------------------------------BCCTTGGGCTTCCEEECCSSCCCBC
T ss_pred CCCCEEECCCCcCe-----------------------------------------ecChhhhcCccCCEEECCCCCCCcc
Confidence 35555555555552 2345566677788888888888876
Q ss_pred CchhhcCc------ccCCeEecccCccc--CCCCcccCCCCCcCEEeccCCc
Q 002346 383 ISPAYANL------TSLKNLYLQQNNLT--GPIPDGLTKLASLQNLDVSNNN 426 (933)
Q Consensus 383 ~p~~~~~l------~~L~~L~L~~N~l~--g~~p~~~~~l~~L~~l~ls~N~ 426 (933)
.+..|..+ ..|+.|+|++|.+. +..|..|..+++|+.+++++|+
T Consensus 280 ~~~~~~~~~~~~~~~~l~~L~l~~N~~~~~~~~~~~~~~l~~L~~l~l~~n~ 331 (332)
T 2ft3_A 280 GVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331 (332)
T ss_dssp CTTSSSCSSCCSSSCCBSEEECCSSSSCGGGSCGGGGTTBCCSTTEEC----
T ss_pred ChhHccccccccccccccceEeecCcccccccCcccccccchhhhhhccccc
Confidence 66666553 56788888888876 5677778888888888888774
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.97 E-value=6.4e-31 Score=303.64 Aligned_cols=339 Identities=23% Similarity=0.336 Sum_probs=217.4
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 146 (933)
+++.|++.++++.. +| .+..+++|++|+|++|.+++.++ +.++++|++|+|++|.++++++ +.++++|++|+|++
T Consensus 47 ~l~~L~l~~~~i~~-l~-~~~~l~~L~~L~Ls~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~ 121 (466)
T 1o6v_A 47 QVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFN 121 (466)
T ss_dssp TCCEEECCSSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred cccEEecCCCCCcc-Cc-chhhhcCCCEEECCCCccCCchh-hhccccCCEEECCCCccccChh--hcCCCCCCEEECCC
Confidence 56777777777763 44 36777777777777777777665 7777777777777777777765 77777777777777
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCCcc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLS 225 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~~ 225 (933)
|.+.. ++. +.++++|++|++++|.+.+. + .++.+++|++|+++ |.+.+. +. +.. ..|++|++++|.+...
T Consensus 122 n~l~~---~~~-~~~l~~L~~L~l~~n~l~~~-~-~~~~l~~L~~L~l~-~~~~~~-~~-~~~l~~L~~L~l~~n~l~~~ 192 (466)
T 1o6v_A 122 NQITD---IDP-LKNLTNLNRLELSSNTISDI-S-ALSGLTSLQQLSFG-NQVTDL-KP-LANLTTLERLDISSNKVSDI 192 (466)
T ss_dssp SCCCC---CGG-GTTCTTCSEEEEEEEEECCC-G-GGTTCTTCSEEEEE-ESCCCC-GG-GTTCTTCCEEECCSSCCCCC
T ss_pred CCCCC---ChH-HcCCCCCCEEECCCCccCCC-h-hhccCCcccEeecC-CcccCc-hh-hccCCCCCEEECcCCcCCCC
Confidence 77766 332 77777777777777777664 2 36667777777765 444422 22 322 4566666666665432
Q ss_pred cccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCC-CCCC
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSK 304 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~-~~~~ 304 (933)
+.+..+++|+.|++++|++++..+ +..+++|+.|++++|++++. ..+..+++|+.|++++|.+++..|. ...+
T Consensus 193 ---~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~~~~l~~ 266 (466)
T 1o6v_A 193 ---SVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSGLTK 266 (466)
T ss_dssp ---GGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTT
T ss_pred ---hhhccCCCCCEEEecCCccccccc-ccccCCCCEEECCCCCcccc--hhhhcCCCCCEEECCCCccccchhhhcCCC
Confidence 335566677777777777766554 55666777777777776642 3466667777777777777665441 2346
Q ss_pred ccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCc
Q 002346 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384 (933)
Q Consensus 305 l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 384 (933)
|+.|++++|.+.+..+ +.....++.+...++.+..++. +..+++|+.|+|++|++++..|
T Consensus 267 L~~L~l~~n~l~~~~~-------------------~~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~ 326 (466)
T 1o6v_A 267 LTELKLGANQISNISP-------------------LAGLTALTNLELNENQLEDISP-ISNLKNLTYLTLYFNNISDISP 326 (466)
T ss_dssp CSEEECCSSCCCCCGG-------------------GTTCTTCSEEECCSSCCSCCGG-GGGCTTCSEEECCSSCCSCCGG
T ss_pred CCEEECCCCccCcccc-------------------ccCCCccCeEEcCCCcccCchh-hcCCCCCCEEECcCCcCCCchh
Confidence 6777777776654321 0111122222222233333433 6677788888888888887665
Q ss_pred hhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCCCCC--cccccCCCCCCcC
Q 002346 385 PAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSN--VKFTVSPGNPFIG 450 (933)
Q Consensus 385 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~~--~~~~~~~~n~~~~ 450 (933)
++.+++|+.|+|++|++++. ..+..+++|+.|++++|++++.+| +... ++...+.+|+|.+
T Consensus 327 --~~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~l~~n~~~~ 389 (466)
T 1o6v_A 327 --VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP-LANLTRITQLGLNDQAWTN 389 (466)
T ss_dssp --GGGCTTCCEEECCSSCCCCC--GGGTTCTTCCEEECCSSCCCBCGG-GTTCTTCCEEECCCEEEEC
T ss_pred --hccCccCCEeECCCCccCCc--hhhccCCCCCEEeCCCCccCccch-hhcCCCCCEEeccCCcccC
Confidence 67788888888888888754 467778888888888888887777 3322 2223445666644
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-30 Score=286.67 Aligned_cols=282 Identities=20% Similarity=0.270 Sum_probs=226.0
Q ss_pred EEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCC
Q 002346 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148 (933)
Q Consensus 70 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 148 (933)
.+++++++++ .+|..+. +.|++|+|++|.|++.++ .|.++++|++|+|++|+++++.+..|.++++|++|+|++|+
T Consensus 35 ~l~~~~~~l~-~lp~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~ 111 (330)
T 1xku_A 35 VVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 111 (330)
T ss_dssp EEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSC
T ss_pred EEEecCCCcc-ccCccCC--CCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCCc
Confidence 4444555665 4565554 689999999999999888 79999999999999999999988889999999999999999
Q ss_pred CCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCC--CCCccccccccchhhcccccCCccc
Q 002346 149 NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG--SLPASFAKSDIQNLWMNDQQLGLSG 226 (933)
Q Consensus 149 ~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~--~~p~~~~~~~l~~l~l~~n~~~~~~ 226 (933)
+.. +|..+. ++|++|++++|++.+..+..|..+++|++|+|++|+++. ..+..+
T Consensus 112 l~~---l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~------------------- 167 (330)
T 1xku_A 112 LKE---LPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF------------------- 167 (330)
T ss_dssp CSB---CCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGG-------------------
T ss_pred CCc---cChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhc-------------------
Confidence 886 666655 799999999999999988899999999999999999963 444444
Q ss_pred ccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCC---CC
Q 002346 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---PS 303 (933)
Q Consensus 227 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~---~~ 303 (933)
.++++|+.|++++|+++..+..+. ++|+.|+|++|++++..|..+..+++|+.|+|++|.+++..+.. ..
T Consensus 168 -----~~l~~L~~L~l~~n~l~~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~ 240 (330)
T 1xku_A 168 -----QGMKKLSYIRIADTNITTIPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 240 (330)
T ss_dssp -----GGCTTCCEEECCSSCCCSCCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGST
T ss_pred -----cCCCCcCEEECCCCccccCCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeChhhccCCC
Confidence 348999999999999997665554 88999999999999888899999999999999999999876643 34
Q ss_pred CccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcC
Q 002346 304 KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNI 383 (933)
Q Consensus 304 ~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~ 383 (933)
+|+.|+|++|.+. .+|..+..+++|+.|+|++|++++..
T Consensus 241 ~L~~L~L~~N~l~-----------------------------------------~lp~~l~~l~~L~~L~l~~N~i~~~~ 279 (330)
T 1xku_A 241 HLRELHLNNNKLV-----------------------------------------KVPGGLADHKYIQVVYLHNNNISAIG 279 (330)
T ss_dssp TCCEEECCSSCCS-----------------------------------------SCCTTTTTCSSCCEEECCSSCCCCCC
T ss_pred CCCEEECCCCcCc-----------------------------------------cCChhhccCCCcCEEECCCCcCCccC
Confidence 6778888887764 24555667778888888888888766
Q ss_pred chhhcCc------ccCCeEecccCcccC--CCCcccCCCCCcCEEeccCCc
Q 002346 384 SPAYANL------TSLKNLYLQQNNLTG--PIPDGLTKLASLQNLDVSNNN 426 (933)
Q Consensus 384 p~~~~~l------~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~l~ls~N~ 426 (933)
+..|... +.|+.|+|++|.+.. ..|..|..+..|+.++|++|+
T Consensus 280 ~~~f~~~~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 280 SNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp TTSSSCSSCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred hhhcCCcccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 6666543 677888888888753 556778888888888888874
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.26 Aligned_cols=249 Identities=29% Similarity=0.470 Sum_probs=201.1
Q ss_pred cCceeccccccccC--CCCCcccCCCCCCEEEccC-CCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCC
Q 002346 114 SLQDIYLDNNNFTS--VPTGCFDGLTNLQVLSLSD-NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ 190 (933)
Q Consensus 114 ~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls~-N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 190 (933)
+++.|+|++|.+++ ..+..|.++++|++|+|++ |.+.+ .+|..+.++++|++|+|++|++++.+|..|..+++|+
T Consensus 51 ~l~~L~L~~~~l~~~~~~~~~l~~l~~L~~L~L~~~n~l~~--~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~ 128 (313)
T 1ogq_A 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG--PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLV 128 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEES--CCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCC
T ss_pred eEEEEECCCCCccCCcccChhHhCCCCCCeeeCCCCCcccc--cCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCC
Confidence 34444444444443 2333455566666666663 55555 4677888888888888888888888899999999999
Q ss_pred EEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCC-CCCEEEccCC
Q 002346 191 NLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCE-SLFDLSLRDN 268 (933)
Q Consensus 191 ~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~-~L~~L~L~~N 268 (933)
+|+|++|++++.+|..+.. +++|++|+|++|++++.+| .+..++ +|+.|+|++|
T Consensus 129 ~L~Ls~N~l~~~~p~~~~~------------------------l~~L~~L~L~~N~l~~~~p~~l~~l~~~L~~L~L~~N 184 (313)
T 1ogq_A 129 TLDFSYNALSGTLPPSISS------------------------LPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184 (313)
T ss_dssp EEECCSSEEESCCCGGGGG------------------------CTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSS
T ss_pred EEeCCCCccCCcCChHHhc------------------------CCCCCeEECcCCcccCcCCHHHhhhhhcCcEEECcCC
Confidence 9999999999888887655 8899999999999987666 477887 8999999999
Q ss_pred cccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccC
Q 002346 269 QLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348 (933)
Q Consensus 269 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (933)
++++.+|..+..++ |+.|+|++|.+++.+|
T Consensus 185 ~l~~~~~~~~~~l~-L~~L~Ls~N~l~~~~~------------------------------------------------- 214 (313)
T 1ogq_A 185 RLTGKIPPTFANLN-LAFVDLSRNMLEGDAS------------------------------------------------- 214 (313)
T ss_dssp EEEEECCGGGGGCC-CSEEECCSSEEEECCG-------------------------------------------------
T ss_pred eeeccCChHHhCCc-ccEEECcCCcccCcCC-------------------------------------------------
Confidence 99999999998887 9999999998886433
Q ss_pred CCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCc
Q 002346 349 SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (933)
Q Consensus 349 ~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 428 (933)
..+..+++|+.|+|++|++++.+|. +..+++|+.|+|++|+++|.+|..|..+++|+.|+|++|+|+
T Consensus 215 ------------~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 281 (313)
T 1ogq_A 215 ------------VLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLC 281 (313)
T ss_dssp ------------GGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEE
T ss_pred ------------HHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEECcCCcccCcCChHHhcCcCCCEEECcCCccc
Confidence 3455678999999999999987777 899999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCc--ccccCCCCCCcCC
Q 002346 429 GKVPDFGSNV--KFTVSPGNPFIGT 451 (933)
Q Consensus 429 g~~p~~~~~~--~~~~~~~n~~~~~ 451 (933)
|.+|...... +...+.+||+.|.
T Consensus 282 ~~ip~~~~l~~L~~l~l~~N~~lc~ 306 (313)
T 1ogq_A 282 GEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp EECCCSTTGGGSCGGGTCSSSEEES
T ss_pred ccCCCCccccccChHHhcCCCCccC
Confidence 9999875433 3345678998774
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=296.96 Aligned_cols=284 Identities=21% Similarity=0.290 Sum_probs=226.8
Q ss_pred CCCCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCC
Q 002346 51 STGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVP 129 (933)
Q Consensus 51 ~~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~ 129 (933)
..+.|.|.|+ | ++++++++ .+|..+. ++|++|++++|+|+++++ .|.++++|++|+|++|++++++
T Consensus 26 ~~~~C~~~~~-c---------~~~~~~l~-~iP~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~ 92 (353)
T 2z80_A 26 ASLSCDRNGI-C---------KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIE 92 (353)
T ss_dssp -CCEECTTSE-E---------ECCSTTCS-SCCTTCC--TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEEC
T ss_pred cCCCCCCCeE-e---------eCCCCCcc-ccccccc--ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccC
Confidence 3567999887 6 34677887 5676655 489999999999998887 7999999999999999999999
Q ss_pred CCcccCCCCCCEEEccCCCCCCCCCCCcc-ccCCccCCeeeccCcccCCCCC-hhhcCCCCCCEEEccCCc-CCCCCCcc
Q 002346 130 TGCFDGLTNLQVLSLSDNPNLAPWPFPNE-LTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNN-FTGSLPAS 206 (933)
Q Consensus 130 ~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~-~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~-l~~~~p~~ 206 (933)
+..|.++++|++|+|++|++.. +|.. +.++++|++|+|++|++.+..+ ..|..+++|++|++++|+ +++..+..
T Consensus 93 ~~~~~~l~~L~~L~Ls~n~l~~---~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~ 169 (353)
T 2z80_A 93 EDSFSSLGSLEHLDLSYNYLSN---LSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169 (353)
T ss_dssp TTTTTTCTTCCEEECCSSCCSS---CCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTT
T ss_pred HhhcCCCCCCCEEECCCCcCCc---CCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHH
Confidence 8889999999999999999987 4544 8889999999999999987655 578889999999999984 65444444
Q ss_pred ccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCcccccCCCCCC
Q 002346 207 FAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALL 285 (933)
Q Consensus 207 ~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 285 (933)
+. ++++|+.|++++|++++..| .+..+++|++|++++|+++...+..+..+++|+
T Consensus 170 ~~------------------------~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l~~~~~~~~~~~~~L~ 225 (353)
T 2z80_A 170 FA------------------------GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225 (353)
T ss_dssp TT------------------------TCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCSTTHHHHHHHHTTTEE
T ss_pred cc------------------------CCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCccccchhhhhhhccccc
Confidence 43 48889999999999988765 588889999999999998744334455688899
Q ss_pred EEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccC
Q 002346 286 NISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS 365 (933)
Q Consensus 286 ~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~ 365 (933)
.|+|++|.+++..+...+. ...
T Consensus 226 ~L~L~~n~l~~~~~~~l~~----------------------------------------------------------~~~ 247 (353)
T 2z80_A 226 CLELRDTDLDTFHFSELST----------------------------------------------------------GET 247 (353)
T ss_dssp EEEEESCBCTTCCCC----------------------------------------------------------------C
T ss_pred EEECCCCcccccccccccc----------------------------------------------------------ccc
Confidence 9999999888654321110 111
Q ss_pred CCceeEEEccCccccC----cCchhhcCcccCCeEecccCcccCCCCcc-cCCCCCcCEEeccCCcCcccCCC
Q 002346 366 QGRIITINLANKLLAG----NISPAYANLTSLKNLYLQQNNLTGPIPDG-LTKLASLQNLDVSNNNLSGKVPD 433 (933)
Q Consensus 366 l~~L~~L~Ls~N~l~g----~~p~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~l~ls~N~l~g~~p~ 433 (933)
...++.++|++|.+.+ .+|..+..+++|+.|+|++|+++ .+|.. |..+++|++|++++|++++..|.
T Consensus 248 ~~~l~~l~L~~~~l~~~~l~~l~~~l~~l~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~~ 319 (353)
T 2z80_A 248 NSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 319 (353)
T ss_dssp CCCCCEEEEESCBCCHHHHHHHHHHHHTCTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCBCCCHHH
T ss_pred cchhhccccccccccCcchhhhHHHHhcccCCCEEECCCCCCC-ccCHHHHhcCCCCCEEEeeCCCccCcCCC
Confidence 2456677777777776 47889999999999999999999 66666 58999999999999999998873
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-29 Score=290.35 Aligned_cols=314 Identities=18% Similarity=0.124 Sum_probs=255.1
Q ss_pred CCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCC
Q 002346 76 SGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPF 155 (933)
Q Consensus 76 ~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~ 155 (933)
.+..+..+..++++++|++|++++|.|++. |.+..+++|++|+|++|+|++++ ++.+++|++|+|++|++.+ +
T Consensus 28 ~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~-~~l~~l~~L~~L~Ls~n~l~~~~---~~~l~~L~~L~Ls~N~l~~---~ 100 (457)
T 3bz5_A 28 FEMQATDTISEEQLATLTSLDCHNSSITDM-TGIEKLTGLTKLICTSNNITTLD---LSQNTNLTYLACDSNKLTN---L 100 (457)
T ss_dssp TTCCTTSEEEHHHHTTCCEEECCSSCCCCC-TTGGGCTTCSEEECCSSCCSCCC---CTTCTTCSEEECCSSCCSC---C
T ss_pred cCcCcccccChhHcCCCCEEEccCCCcccC-hhhcccCCCCEEEccCCcCCeEc---cccCCCCCEEECcCCCCce---e
Confidence 344556666889999999999999999986 68999999999999999999985 8899999999999999998 3
Q ss_pred CccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCCcccccccccCC
Q 002346 156 PNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGM 234 (933)
Q Consensus 156 p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~~~~~~~l~~l 234 (933)
+ ++++++|++|++++|++++. | ++.+++|++|++++|++++ ++ +.. ..|++|++..|...... .+..+
T Consensus 101 ~--~~~l~~L~~L~L~~N~l~~l-~--~~~l~~L~~L~l~~N~l~~-l~--l~~l~~L~~L~l~~n~~~~~~---~~~~l 169 (457)
T 3bz5_A 101 D--VTPLTKLTYLNCDTNKLTKL-D--VSQNPLLTYLNCARNTLTE-ID--VSHNTQLTELDCHLNKKITKL---DVTPQ 169 (457)
T ss_dssp C--CTTCTTCCEEECCSSCCSCC-C--CTTCTTCCEEECTTSCCSC-CC--CTTCTTCCEEECTTCSCCCCC---CCTTC
T ss_pred e--cCCCCcCCEEECCCCcCCee-c--CCCCCcCCEEECCCCccce-ec--cccCCcCCEEECCCCCccccc---ccccC
Confidence 3 89999999999999999985 4 8999999999999999996 44 333 67999999998543222 36778
Q ss_pred ccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCc
Q 002346 235 TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNN 314 (933)
Q Consensus 235 ~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~ 314 (933)
++|+.|++++|++++.+ +..+++|+.|++++|++++. .+..+++|+.|++++|++++.......+|+.|++++|+
T Consensus 170 ~~L~~L~ls~n~l~~l~--l~~l~~L~~L~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~ip~~~l~~L~~L~l~~N~ 244 (457)
T 3bz5_A 170 TQLTTLDCSFNKITELD--VSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTEIDVTPLTQLTYFDCSVNP 244 (457)
T ss_dssp TTCCEEECCSSCCCCCC--CTTCTTCCEEECCSSCCSCC---CCTTCTTCSEEECCSSCCSCCCCTTCTTCSEEECCSSC
T ss_pred CcCCEEECCCCccceec--cccCCCCCEEECcCCcCCee---ccccCCCCCEEECcCCcccccCccccCCCCEEEeeCCc
Confidence 99999999999999853 88999999999999999965 48899999999999999999543345789999999999
Q ss_pred CCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCC
Q 002346 315 FCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLK 394 (933)
Q Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~ 394 (933)
|.+.+.... ..+........+|+.|++++|.+.|.+| ++++++|+
T Consensus 245 l~~~~~~~l---------------------------------~~L~~L~l~~n~L~~L~l~~n~~~~~~~--~~~l~~L~ 289 (457)
T 3bz5_A 245 LTELDVSTL---------------------------------SKLTTLHCIQTDLLEIDLTHNTQLIYFQ--AEGCRKIK 289 (457)
T ss_dssp CSCCCCTTC---------------------------------TTCCEEECTTCCCSCCCCTTCTTCCEEE--CTTCTTCC
T ss_pred CCCcCHHHC---------------------------------CCCCEEeccCCCCCEEECCCCccCCccc--ccccccCC
Confidence 987542211 1111112233578899999999999888 67899999
Q ss_pred eEecccCcccCCCCcc--------cCCCCCcCEEeccCCcCcccCCCCCC--CcccccCCCCCCc
Q 002346 395 NLYLQQNNLTGPIPDG--------LTKLASLQNLDVSNNNLSGKVPDFGS--NVKFTVSPGNPFI 449 (933)
Q Consensus 395 ~L~L~~N~l~g~~p~~--------~~~l~~L~~l~ls~N~l~g~~p~~~~--~~~~~~~~~n~~~ 449 (933)
.|+|++|++.|.+|.. +..+++|+.|++++|+|+|. + +.. .++.....+|.+.
T Consensus 290 ~L~Ls~n~~l~~l~~~~~~L~~L~l~~~~~L~~L~L~~N~l~~l-~-l~~l~~L~~L~l~~N~l~ 352 (457)
T 3bz5_A 290 ELDVTHNTQLYLLDCQAAGITELDLSQNPKLVYLYLNNTELTEL-D-VSHNTKLKSLSCVNAHIQ 352 (457)
T ss_dssp CCCCTTCTTCCEEECTTCCCSCCCCTTCTTCCEEECTTCCCSCC-C-CTTCTTCSEEECCSSCCC
T ss_pred EEECCCCcccceeccCCCcceEechhhcccCCEEECCCCccccc-c-cccCCcCcEEECCCCCCC
Confidence 9999999988877753 55668999999999999995 3 443 3333344566553
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-29 Score=281.61 Aligned_cols=303 Identities=20% Similarity=0.292 Sum_probs=251.1
Q ss_pred ccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccC
Q 002346 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165 (933)
Q Consensus 86 ~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L 165 (933)
+..+++|++|++++|.++.. +.+..+++|++|+|++|+++.+++ +..+++|++|+|++|.+.. + ..+.++++|
T Consensus 40 ~~~l~~L~~L~l~~~~i~~~-~~~~~~~~L~~L~l~~n~i~~~~~--~~~l~~L~~L~L~~n~i~~---~-~~~~~l~~L 112 (347)
T 4fmz_A 40 QEELESITKLVVAGEKVASI-QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITD---I-SALQNLTNL 112 (347)
T ss_dssp HHHHTTCSEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---C-GGGTTCTTC
T ss_pred chhcccccEEEEeCCccccc-hhhhhcCCccEEEccCCccccchh--hhcCCcCCEEEccCCcccC---c-hHHcCCCcC
Confidence 46789999999999999864 568999999999999999999887 9999999999999999987 3 469999999
Q ss_pred CeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCC
Q 002346 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245 (933)
Q Consensus 166 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N 245 (933)
++|++++|++.+..+ +..+++|++|++++|.....++..-....|++|++.+|.+..... +..+++|+.|++++|
T Consensus 113 ~~L~l~~n~i~~~~~--~~~l~~L~~L~l~~n~~~~~~~~~~~l~~L~~L~l~~~~~~~~~~---~~~l~~L~~L~l~~n 187 (347)
T 4fmz_A 113 RELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYN 187 (347)
T ss_dssp SEEECTTSCCCCCGG--GTTCTTCCEEECTTCTTCCCCGGGTTCTTCCEEECCSSCCCCCGG---GGGCTTCSEEECTTS
T ss_pred CEEECcCCcccCchh--hccCCceeEEECCCCCCcccccchhhCCCCcEEEecCCCcCCchh---hccCCCCCEEEccCC
Confidence 999999999987644 889999999999999777566553333678888998888764443 677889999999999
Q ss_pred ccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC-CCCCCccEEeccCCcCCCCCCCCCC
Q 002346 246 QFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSKVQKVSLDHNNFCKNSSDAGK 324 (933)
Q Consensus 246 ~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~l~~n~~~~~~~~~~~ 324 (933)
.+++..+ +..+++|+.|++++|++++..+ +..+++|+.|++++|.+++..+ ....+|+.|++++|.+...
T Consensus 188 ~l~~~~~-~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~------ 258 (347)
T 4fmz_A 188 QIEDISP-LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSPLANLSQLTWLEIGTNQISDI------ 258 (347)
T ss_dssp CCCCCGG-GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC------
T ss_pred ccccccc-ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCCcchhcCCCCCEEECCCCccCCC------
Confidence 9887655 8888999999999999986544 7888999999999999987655 2346788999998887442
Q ss_pred CCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCccc
Q 002346 325 PCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT 404 (933)
Q Consensus 325 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~ 404 (933)
..+..+++|+.|++++|++++. +.+..+++|+.|+|++|+++
T Consensus 259 ------------------------------------~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~L~~n~l~ 300 (347)
T 4fmz_A 259 ------------------------------------NAVKDLTKLKMLNVGSNQISDI--SVLNNLSQLNSLFLNNNQLG 300 (347)
T ss_dssp ------------------------------------GGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCC
T ss_pred ------------------------------------hhHhcCCCcCEEEccCCccCCC--hhhcCCCCCCEEECcCCcCC
Confidence 2356678999999999999975 56899999999999999999
Q ss_pred CCCCcccCCCCCcCEEeccCCcCcccCCCCCC--CcccccCCCCCC
Q 002346 405 GPIPDGLTKLASLQNLDVSNNNLSGKVPDFGS--NVKFTVSPGNPF 448 (933)
Q Consensus 405 g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~--~~~~~~~~~n~~ 448 (933)
+..|..+..+++|+.|++++|++++.+| +.. .++...+.+|++
T Consensus 301 ~~~~~~l~~l~~L~~L~L~~n~l~~~~~-~~~l~~L~~L~l~~N~i 345 (347)
T 4fmz_A 301 NEDMEVIGGLTNLTTLFLSQNHITDIRP-LASLSKMDSADFANQVI 345 (347)
T ss_dssp GGGHHHHHTCTTCSEEECCSSSCCCCGG-GGGCTTCSEESSSCC--
T ss_pred CcChhHhhccccCCEEEccCCccccccC-hhhhhccceeehhhhcc
Confidence 9999999999999999999999999887 332 333334456654
|
| >4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-29 Score=304.93 Aligned_cols=350 Identities=17% Similarity=0.166 Sum_probs=258.6
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|+|++|+|++..+.+|.++++|++|+|++|+|+++++ .|.++++|++|+|++|+|+++++..|+++++|++|+|
T Consensus 76 ~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~Ls~N~l~~l~~~~~~~L~~L~~L~L 155 (635)
T 4g8a_A 76 PELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 155 (635)
T ss_dssp TTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEEEC
T ss_pred CCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEECCCCcCCCCChhhhhcCcccCeecc
Confidence 479999999999998888899999999999999999999888 7999999999999999999999999999999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCC------------------------------------
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN------------------------------------ 188 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~------------------------------------ 188 (933)
++|.+... .+|..+..+++|++|+|++|++.+..+..|..+.+
T Consensus 156 s~N~l~~~-~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~l~~~~~~~~ls~n~l~~i~~~~~~~~~~~~l~l~~n 234 (635)
T 4g8a_A 156 AHNLIQSF-KLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNN 234 (635)
T ss_dssp CSSCCCCC-CCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCCEEECTTCCCCEECTTTTTTCEEEEEEEESC
T ss_pred ccCccccC-CCchhhccchhhhhhcccCccccccccccccchhhhhhhhhhhhcccCcccccCcccccchhhhhhhhhcc
Confidence 99998763 46889999999999999999998776655533222
Q ss_pred --------------------------------------------------------------------------------
Q 002346 189 -------------------------------------------------------------------------------- 188 (933)
Q Consensus 189 -------------------------------------------------------------------------------- 188 (933)
T Consensus 235 ~~~~~~~~~~~~~l~~l~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~~~~~~~~~~l~~l~~~ 314 (635)
T 4g8a_A 235 FDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDGIIDLFNCLTNVSSFSLV 314 (635)
T ss_dssp CSSHHHHHHHHHTTTTCEEEEEEEECCTTSCCCSCCCTTTTGGGGGSEEEEEEEECCCSCEEECTTTTGGGTTCSEEEEE
T ss_pred cccccccchhhcCCcccccccccccccccccccccccccccccccchhhhhhhhhhhcccccchhhhhhhhccccccccc
Confidence
Q ss_pred ---------------CCEEEccCCcCCCCCCccc--------------------cccccchhhcccccCCccccc-cccc
Q 002346 189 ---------------LQNLRLSYNNFTGSLPASF--------------------AKSDIQNLWMNDQQLGLSGTL-DVLS 232 (933)
Q Consensus 189 ---------------L~~L~L~~N~l~~~~p~~~--------------------~~~~l~~l~l~~n~~~~~~~~-~~l~ 232 (933)
|+.|++.+|++.+..+..+ ..+.++.|++..|.+...+.. ..+.
T Consensus 315 ~~~~~~~~~~~~~~~L~~L~l~~~~~~~~~~~~l~~L~~l~l~~n~~~~~~~~~~l~~L~~L~ls~n~l~~~~~~~~~~~ 394 (635)
T 4g8a_A 315 SVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 394 (635)
T ss_dssp SCEEEECGGGGSCCCCSEEEEESCEESSCCCCBCTTCCEEEEESCCSCCBCCCCBCTTCCEEECCSSCCBEEEECCHHHH
T ss_pred ccccccccccccchhhhhhhcccccccCcCcccchhhhhcccccccCCCCcccccccccccchhhccccccccccccchh
Confidence 2233333333221111110 012355566666666543332 2344
Q ss_pred CCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCc-ccccCCCCCCEEEccCccCccCCCCC---CCCccEE
Q 002346 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVP-ASVISLPALLNISLQNNKLQGPYPLF---PSKVQKV 308 (933)
Q Consensus 233 ~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L 308 (933)
.+.+|+.|++..|.+....+.+..+++|+.++++.|++....+ ..+..+++++.+++++|.+.+..+.. ...++.|
T Consensus 395 ~~~~L~~L~~~~~~~~~~~~~~~~l~~L~~l~l~~~~~~~~~~~~~~~~l~~l~~l~ls~n~l~~~~~~~~~~~~~L~~L 474 (635)
T 4g8a_A 395 GTISLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL 474 (635)
T ss_dssp SCSCCCEEECCSCSEEEECSCCTTCTTCCEEECTTSEEESTTSSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEE
T ss_pred hhhhhhhhhccccccccccccccccccccchhhhhccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence 5667777777777777666667777777777777766665443 44666777777777777777665543 3466777
Q ss_pred eccCCcCCC-CCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhh
Q 002346 309 SLDHNNFCK-NSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAY 387 (933)
Q Consensus 309 ~l~~n~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~ 387 (933)
+|++|++.. ..+..+. .....-.+++++|...+..|..+..+++|+.|+|++|+|++..|..|
T Consensus 475 ~Ls~N~~~~~~~~~~~~----------------~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~ 538 (635)
T 4g8a_A 475 KMAGNSFQENFLPDIFT----------------ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 538 (635)
T ss_dssp ECTTCEEGGGEECSCCT----------------TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCBCCCGGG
T ss_pred hhhhcccccccCchhhh----------------hccccCEEECCCCccCCcChHHHcCCCCCCEEECCCCcCCCCChhHH
Confidence 777776432 1111111 01112223445555555567888999999999999999999999999
Q ss_pred cCcccCCeEecccCcccCCCCcccCCC-CCcCEEeccCCcCcccCC
Q 002346 388 ANLTSLKNLYLQQNNLTGPIPDGLTKL-ASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 388 ~~l~~L~~L~L~~N~l~g~~p~~~~~l-~~L~~l~ls~N~l~g~~p 432 (933)
.++++|++|+|++|+|++..|..|..+ ++|++|+|++|+|++.-.
T Consensus 539 ~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C~ 584 (635)
T 4g8a_A 539 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE 584 (635)
T ss_dssp TTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSGG
T ss_pred hCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccCC
Confidence 999999999999999999999999998 689999999999987643
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-29 Score=277.98 Aligned_cols=263 Identities=21% Similarity=0.279 Sum_probs=213.6
Q ss_pred cccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeee
Q 002346 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (933)
Q Consensus 90 ~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~ 169 (933)
.+|+.+++++|.++.++..+. ++|++|+|++|+++++++..|.++++|++|+|++|++.. ..|..+.++++|++|+
T Consensus 33 c~l~~l~~~~~~l~~ip~~~~--~~l~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~ 108 (332)
T 2ft3_A 33 CHLRVVQCSDLGLKAVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK--IHEKAFSPLRKLQKLY 108 (332)
T ss_dssp EETTEEECCSSCCSSCCSCCC--TTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE--ECGGGSTTCTTCCEEE
T ss_pred ccCCEEECCCCCccccCCCCC--CCCeEEECCCCcCCccCHhHhhCCCCCcEEECCCCccCc--cCHhHhhCcCCCCEEE
Confidence 368999999999986655553 789999999999999999899999999999999999988 5688999999999999
Q ss_pred ccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCC
Q 002346 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (933)
Q Consensus 170 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 249 (933)
|++|++... |..+. ++|++|+|++|++++..+..| .++++|+.|++++|.++.
T Consensus 109 L~~n~l~~l-~~~~~--~~L~~L~l~~n~i~~~~~~~~------------------------~~l~~L~~L~l~~n~l~~ 161 (332)
T 2ft3_A 109 ISKNHLVEI-PPNLP--SSLVELRIHDNRIRKVPKGVF------------------------SGLRNMNCIEMGGNPLEN 161 (332)
T ss_dssp CCSSCCCSC-CSSCC--TTCCEEECCSSCCCCCCSGGG------------------------SSCSSCCEEECCSCCCBG
T ss_pred CCCCcCCcc-Ccccc--ccCCEEECCCCccCccCHhHh------------------------CCCccCCEEECCCCcccc
Confidence 999999855 55444 899999999999995444444 348999999999999963
Q ss_pred --CCC-CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCC---CCCccEEeccCCcCCCCCCCCC
Q 002346 250 --PIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---PSKVQKVSLDHNNFCKNSSDAG 323 (933)
Q Consensus 250 --~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~---~~~l~~L~l~~n~~~~~~~~~~ 323 (933)
..+ .+..+ +|+.|++++|++++ +|..+. ++|++|+|++|.+++..+.. ..+|+.|+|++|++.+..
T Consensus 162 ~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~---- 233 (332)
T 2ft3_A 162 SGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIE---- 233 (332)
T ss_dssp GGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCBCCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCC----
T ss_pred CCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCC----
Confidence 444 46666 99999999999995 676665 79999999999999877643 346777888887775432
Q ss_pred CCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcc
Q 002346 324 KPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403 (933)
Q Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l 403 (933)
|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++
T Consensus 234 ------------------------------------~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~l 276 (332)
T 2ft3_A 234 ------------------------------------NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNI 276 (332)
T ss_dssp ------------------------------------TTGGGGCTTCCEEECCSSCCC-BCCTTGGGCTTCCEEECCSSCC
T ss_pred ------------------------------------hhHhhCCCCCCEEECCCCcCe-ecChhhhcCccCCEEECCCCCC
Confidence 234566778888888888887 6777788888888888888888
Q ss_pred cCCCCcccCCC------CCcCEEeccCCcCc
Q 002346 404 TGPIPDGLTKL------ASLQNLDVSNNNLS 428 (933)
Q Consensus 404 ~g~~p~~~~~l------~~L~~l~ls~N~l~ 428 (933)
++..+..|..+ +.|+.|++++|++.
T Consensus 277 ~~~~~~~~~~~~~~~~~~~l~~L~l~~N~~~ 307 (332)
T 2ft3_A 277 TKVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307 (332)
T ss_dssp CBCCTTSSSCSSCCSSSCCBSEEECCSSSSC
T ss_pred CccChhHccccccccccccccceEeecCccc
Confidence 86666666553 56788888888876
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-29 Score=288.76 Aligned_cols=321 Identities=23% Similarity=0.294 Sum_probs=259.2
Q ss_pred cCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCC
Q 002346 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLT 166 (933)
Q Consensus 87 ~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~ 166 (933)
..+++|+.|++++|.++. +|.+..+++|++|+|++|.++++++ +.++++|++|+|++|.+.. ++. +.++++|+
T Consensus 43 ~~l~~l~~L~l~~~~i~~-l~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~l~~n~l~~---~~~-~~~l~~L~ 115 (466)
T 1o6v_A 43 TDLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD---ITP-LANLTNLT 115 (466)
T ss_dssp HHHHTCCEEECCSSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---CGG-GTTCTTCC
T ss_pred hHhccccEEecCCCCCcc-CcchhhhcCCCEEECCCCccCCchh--hhccccCCEEECCCCcccc---Chh-hcCCCCCC
Confidence 457899999999999986 5678899999999999999999986 9999999999999999988 444 99999999
Q ss_pred eeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCc
Q 002346 167 TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQ 246 (933)
Q Consensus 167 ~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~ 246 (933)
+|+|++|++.+..+ +..+++|++|+|++|++++ ++.--....|++|.+.+ .+.. ...+.++++|+.|++++|.
T Consensus 116 ~L~L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~~~~~~l~~L~~L~l~~-~~~~---~~~~~~l~~L~~L~l~~n~ 188 (466)
T 1o6v_A 116 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISD-ISALSGLTSLQQLSFGN-QVTD---LKPLANLTTLERLDISSNK 188 (466)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECC-CGGGTTCTTCSEEEEEE-SCCC---CGGGTTCTTCCEEECCSSC
T ss_pred EEECCCCCCCCChH--HcCCCCCCEEECCCCccCC-ChhhccCCcccEeecCC-cccC---chhhccCCCCCEEECcCCc
Confidence 99999999988744 8999999999999999984 55422336788888864 3322 2348889999999999999
Q ss_pred cCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC-CCCCCccEEeccCCcCCCCCCCCCCC
Q 002346 247 FTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSKVQKVSLDHNNFCKNSSDAGKP 325 (933)
Q Consensus 247 l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~l~~n~~~~~~~~~~~~ 325 (933)
+++. +.+..+++|+.|++++|++++..| +..+++|+.|++++|.+++... ....+|+.|++++|.+.+..+
T Consensus 189 l~~~-~~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~~~----- 260 (466)
T 1o6v_A 189 VSDI-SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP----- 260 (466)
T ss_dssp CCCC-GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG-----
T ss_pred CCCC-hhhccCCCCCEEEecCCccccccc--ccccCCCCEEECCCCCcccchhhhcCCCCCEEECCCCccccchh-----
Confidence 9875 458899999999999999997666 7889999999999999987422 124689999999999976532
Q ss_pred CCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccC
Q 002346 326 CDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG 405 (933)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g 405 (933)
+.....++.+...++.+..+|. +..+++|+.|+|++|++.+..| ++.+++|+.|+|++|++++
T Consensus 261 --------------~~~l~~L~~L~l~~n~l~~~~~-~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~ 323 (466)
T 1o6v_A 261 --------------LSGLTKLTELKLGANQISNISP-LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISD 323 (466)
T ss_dssp --------------GTTCTTCSEEECCSSCCCCCGG-GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEECCSSCCSC
T ss_pred --------------hhcCCCCCEEECCCCccCcccc-ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEECcCCcCCC
Confidence 1122233333334445555655 8889999999999999998655 8999999999999999998
Q ss_pred CCCcccCCCCCcCEEeccCCcCcccCCCCCC--CcccccCCCCCCc
Q 002346 406 PIPDGLTKLASLQNLDVSNNNLSGKVPDFGS--NVKFTVSPGNPFI 449 (933)
Q Consensus 406 ~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~--~~~~~~~~~n~~~ 449 (933)
..| +..+++|+.|++++|++++. +.+.. .++.....+|.+.
T Consensus 324 ~~~--~~~l~~L~~L~l~~n~l~~~-~~l~~l~~L~~L~l~~n~l~ 366 (466)
T 1o6v_A 324 ISP--VSSLTKLQRLFFYNNKVSDV-SSLANLTNINWLSAGHNQIS 366 (466)
T ss_dssp CGG--GGGCTTCCEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC
T ss_pred chh--hccCccCCEeECCCCccCCc-hhhccCCCCCEEeCCCCccC
Confidence 766 78999999999999999986 44443 2333344566653
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-29 Score=296.48 Aligned_cols=278 Identities=26% Similarity=0.357 Sum_probs=230.6
Q ss_pred CCCCccccceEeCC-------CCCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccc
Q 002346 51 STGYCEWTGINCDN-------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123 (933)
Q Consensus 51 ~~~~C~w~gv~c~~-------~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N 123 (933)
..++|.|+|..|.. ...++.|++++++|+ .+|..+. ++|++|+|++|.|+.+++ .+++|++|+|++|
T Consensus 18 ~~~~~~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~~l~--~~L~~L~L~~N~l~~lp~---~l~~L~~L~Ls~N 91 (622)
T 3g06_A 18 AAPAEESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTSLPA---LPPELRTLEVSGN 91 (622)
T ss_dssp TCCGGGHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCSCCC--TTCSEEEECSCCCSCCCC---CCTTCCEEEECSC
T ss_pred cCCcchhccccccCcccccccCCCCcEEEecCCCcC-ccChhhC--CCCcEEEecCCCCCCCCC---cCCCCCEEEcCCC
Confidence 45689997754321 236899999999998 7887776 899999999999996554 5789999999999
Q ss_pred cccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCC
Q 002346 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203 (933)
Q Consensus 124 ~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 203 (933)
+|++++. .+++|++|+|++|++.. +|. .+++|+.|++++|++++. |.. +++|++|+|++|+++ .+
T Consensus 92 ~l~~lp~----~l~~L~~L~Ls~N~l~~---l~~---~l~~L~~L~L~~N~l~~l-p~~---l~~L~~L~Ls~N~l~-~l 156 (622)
T 3g06_A 92 QLTSLPV----LPPGLLELSIFSNPLTH---LPA---LPSGLCKLWIFGNQLTSL-PVL---PPGLQELSVSDNQLA-SL 156 (622)
T ss_dssp CCSCCCC----CCTTCCEEEECSCCCCC---CCC---CCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS-CC
T ss_pred cCCcCCC----CCCCCCEEECcCCcCCC---CCC---CCCCcCEEECCCCCCCcC-CCC---CCCCCEEECcCCcCC-Cc
Confidence 9999887 68999999999999988 555 678999999999999875 443 489999999999998 45
Q ss_pred CccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCC
Q 002346 204 PASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA 283 (933)
Q Consensus 204 p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~ 283 (933)
|.. +++|+.|++++|+|++.+ ..+++|+.|+|++|+|++ +|.. +++
T Consensus 157 ~~~---------------------------~~~L~~L~L~~N~l~~l~---~~~~~L~~L~Ls~N~l~~-l~~~---~~~ 202 (622)
T 3g06_A 157 PAL---------------------------PSELCKLWAYNNQLTSLP---MLPSGLQELSVSDNQLAS-LPTL---PSE 202 (622)
T ss_dssp CCC---------------------------CTTCCEEECCSSCCSCCC---CCCTTCCEEECCSSCCSC-CCCC---CTT
T ss_pred CCc---------------------------cCCCCEEECCCCCCCCCc---ccCCCCcEEECCCCCCCC-CCCc---cch
Confidence 542 467899999999999855 456889999999999984 5543 478
Q ss_pred CCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccc
Q 002346 284 LLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT 363 (933)
Q Consensus 284 L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~ 363 (933)
|+.|++++|.++. +|..+.+|+.|+|++|+|.++ |
T Consensus 203 L~~L~L~~N~l~~-l~~~~~~L~~L~Ls~N~L~~l-----------------------------------------p--- 237 (622)
T 3g06_A 203 LYKLWAYNNRLTS-LPALPSGLKELIVSGNRLTSL-----------------------------------------P--- 237 (622)
T ss_dssp CCEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCC-----------------------------------------C---
T ss_pred hhEEECcCCcccc-cCCCCCCCCEEEccCCccCcC-----------------------------------------C---
Confidence 9999999999985 455678899999999988653 2
Q ss_pred cCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC
Q 002346 364 CSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (933)
Q Consensus 364 ~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 433 (933)
..+++|+.|+|++|+|++ +|. .+++|+.|+|++|+|+ .+|..|.++++|+.|+|++|+|++.+|.
T Consensus 238 ~~l~~L~~L~Ls~N~L~~-lp~---~~~~L~~L~Ls~N~L~-~lp~~l~~l~~L~~L~L~~N~l~~~~~~ 302 (622)
T 3g06_A 238 VLPSELKELMVSGNRLTS-LPM---LPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 302 (622)
T ss_dssp CCCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCC-SCCGGGGGSCTTCEEECCSCCCCHHHHH
T ss_pred CCCCcCcEEECCCCCCCc-CCc---ccccCcEEeCCCCCCC-cCCHHHhhccccCEEEecCCCCCCcCHH
Confidence 223689999999999984 666 6789999999999999 8899999999999999999999998875
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-28 Score=281.88 Aligned_cols=314 Identities=20% Similarity=0.269 Sum_probs=223.0
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
.+++.|++++|.+++ +|.. +++|++|++++|+++++.. + .++|++|+|++|+++++| .|+++++|++|+++
T Consensus 91 ~~L~~L~l~~n~l~~-lp~~---~~~L~~L~l~~n~l~~l~~-~--~~~L~~L~L~~n~l~~lp--~~~~l~~L~~L~l~ 161 (454)
T 1jl5_A 91 PHLESLVASCNSLTE-LPEL---PQSLKSLLVDNNNLKALSD-L--PPLLEYLGVSNNQLEKLP--ELQNSSFLKIIDVD 161 (454)
T ss_dssp TTCSEEECCSSCCSS-CCCC---CTTCCEEECCSSCCSCCCS-C--CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECC
T ss_pred CCCCEEEccCCcCCc-cccc---cCCCcEEECCCCccCcccC-C--CCCCCEEECcCCCCCCCc--ccCCCCCCCEEECC
Confidence 468888888888886 6643 3788888888888886432 2 168999999999999877 38889999999999
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~ 225 (933)
+|++.+ +|..+ .+|++|++++|++.+. | .++.+++|++|++++|++++ +|... ..|++|++++|.+..
T Consensus 162 ~N~l~~---lp~~~---~~L~~L~L~~n~l~~l-~-~~~~l~~L~~L~l~~N~l~~-l~~~~--~~L~~L~l~~n~l~~- 229 (454)
T 1jl5_A 162 NNSLKK---LPDLP---PSLEFIAAGNNQLEEL-P-ELQNLPFLTAIYADNNSLKK-LPDLP--LSLESIVAGNNILEE- 229 (454)
T ss_dssp SSCCSC---CCCCC---TTCCEEECCSSCCSSC-C-CCTTCTTCCEEECCSSCCSS-CCCCC--TTCCEEECCSSCCSS-
T ss_pred CCcCcc---cCCCc---ccccEEECcCCcCCcC-c-cccCCCCCCEEECCCCcCCc-CCCCc--CcccEEECcCCcCCc-
Confidence 998887 55443 4889999999998884 5 58889999999999999984 55543 478888998888762
Q ss_pred cccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCc
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 305 (933)
++.+..+++|+.|++++|++++.+.. .++|+.|++++|++++ +|.. +++|+.|++++|++++. |..+.++
T Consensus 230 --lp~~~~l~~L~~L~l~~N~l~~l~~~---~~~L~~L~l~~N~l~~-l~~~---~~~L~~L~ls~N~l~~l-~~~~~~L 299 (454)
T 1jl5_A 230 --LPELQNLPFLTTIYADNNLLKTLPDL---PPSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGL-SELPPNL 299 (454)
T ss_dssp --CCCCTTCTTCCEEECCSSCCSSCCSC---CTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEE-SCCCTTC
T ss_pred --ccccCCCCCCCEEECCCCcCCccccc---ccccCEEECCCCcccc-cCcc---cCcCCEEECcCCccCcc-cCcCCcC
Confidence 23477889999999999999875432 3788999999999885 5654 37889999999998873 3445788
Q ss_pred cEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCch
Q 002346 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385 (933)
Q Consensus 306 ~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 385 (933)
+.|++++|.+.+... .+..++.+...++.+..+|.. +++|+.|+|++|++++ +|.
T Consensus 300 ~~L~l~~N~l~~i~~---------------------~~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~L~~N~l~~-lp~ 354 (454)
T 1jl5_A 300 YYLNASSNEIRSLCD---------------------LPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLAE-VPE 354 (454)
T ss_dssp CEEECCSSCCSEECC---------------------CCTTCCEEECCSSCCSCCCCC---CTTCCEEECCSSCCSC-CCC
T ss_pred CEEECcCCcCCcccC---------------------CcCcCCEEECCCCcccccccc---CCcCCEEECCCCcccc-ccc
Confidence 999999998876321 112233333334445557765 5899999999999995 676
Q ss_pred hhcCcccCCeEecccCcccC--CCCcccCCC-------------CCcCEEeccCCcCcc--cCCCCCCCc
Q 002346 386 AYANLTSLKNLYLQQNNLTG--PIPDGLTKL-------------ASLQNLDVSNNNLSG--KVPDFGSNV 438 (933)
Q Consensus 386 ~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l-------------~~L~~l~ls~N~l~g--~~p~~~~~~ 438 (933)
.+++|++|+|++|++++ .+|.++..+ ++|+.|++++|+++| .+|.....+
T Consensus 355 ---~l~~L~~L~L~~N~l~~l~~ip~~l~~L~~n~~~~~i~~~~~~L~~L~ls~N~l~~~~~iP~sl~~L 421 (454)
T 1jl5_A 355 ---LPQNLKQLHVEYNPLREFPDIPESVEDLRMNSHLAEVPELPQNLKQLHVETNPLREFPDIPESVEDL 421 (454)
T ss_dssp ---CCTTCCEEECCSSCCSSCCCCCTTCCEEECCC-----------------------------------
T ss_pred ---hhhhccEEECCCCCCCcCCCChHHHHhhhhcccccccccccCcCCEEECCCCcCCccccchhhHhhe
Confidence 57999999999999999 899999888 899999999999998 777543333
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-29 Score=274.11 Aligned_cols=256 Identities=21% Similarity=0.255 Sum_probs=146.5
Q ss_pred CCCCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCC
Q 002346 51 STGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVP 129 (933)
Q Consensus 51 ~~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~ 129 (933)
..+.|.|.+|.|.. ++++ .+|..+. ++|++|+|++|+|+.+++ .|.++++|++|+|++|.++.+.
T Consensus 3 ~~C~C~~~~l~c~~-----------~~l~-~ip~~~~--~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~ 68 (306)
T 2z66_A 3 SRCSCSGTEIRCNS-----------KGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKG 68 (306)
T ss_dssp TTCEEETTEEECCS-----------SCCS-SCCSCCC--TTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEE
T ss_pred CCCeeCCCEEEcCC-----------CCcc-cCCCCCC--CCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCccc
Confidence 45668998888864 3444 4444332 467777777777765554 3566666666666666665432
Q ss_pred --CCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCC-hhhcCCCCCCEEEccCCcCCCCCCcc
Q 002346 130 --TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPAS 206 (933)
Q Consensus 130 --~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~ 206 (933)
+..+..+++|++|+|++|.+.. +|..+..+++|++|++++|++.+..+ ..+..+++|++|+|++|++++..|..
T Consensus 69 ~~~~~~~~~~~L~~L~Ls~n~i~~---l~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~ 145 (306)
T 2z66_A 69 CCSQSDFGTTSLKYLDLSFNGVIT---MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGI 145 (306)
T ss_dssp EEEHHHHSCSCCCEEECCSCSEEE---EEEEEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTT
T ss_pred CcccccccccccCEEECCCCcccc---ChhhcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhh
Confidence 2234445566666666655544 44445555555555555555554433 34555555555555555554433333
Q ss_pred ccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccc-cCcccccCCCCCC
Q 002346 207 FAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTG-VVPASVISLPALL 285 (933)
Q Consensus 207 ~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~-~~p~~l~~l~~L~ 285 (933)
+..+++|+.|+|++|++++ .+|..+..+++|+
T Consensus 146 -----------------------------------------------~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~ 178 (306)
T 2z66_A 146 -----------------------------------------------FNGLSSLEVLKMAGNSFQENFLPDIFTELRNLT 178 (306)
T ss_dssp -----------------------------------------------TTTCTTCCEEECTTCEEGGGEECSCCTTCTTCC
T ss_pred -----------------------------------------------cccCcCCCEEECCCCccccccchhHHhhCcCCC
Confidence 3444455555555555543 3445555555555
Q ss_pred EEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccC
Q 002346 286 NISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS 365 (933)
Q Consensus 286 ~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~ 365 (933)
+|+|++|++++..| ..+..
T Consensus 179 ~L~Ls~n~l~~~~~-------------------------------------------------------------~~~~~ 197 (306)
T 2z66_A 179 FLDLSQCQLEQLSP-------------------------------------------------------------TAFNS 197 (306)
T ss_dssp EEECTTSCCCEECT-------------------------------------------------------------TTTTT
T ss_pred EEECCCCCcCCcCH-------------------------------------------------------------HHhcC
Confidence 55555555543222 12223
Q ss_pred CCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCC-CcCEEeccCCcCcccC
Q 002346 366 QGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA-SLQNLDVSNNNLSGKV 431 (933)
Q Consensus 366 l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~l~ls~N~l~g~~ 431 (933)
+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|..+..++ +|++|+|++|++++..
T Consensus 198 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~L~L~~N~~~~~c 264 (306)
T 2z66_A 198 LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC 264 (306)
T ss_dssp CTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBCSSSSCCCCCTTCCEEECTTCCEECSG
T ss_pred CCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCcccCHHHHHhhhccCCEEEccCCCeeccc
Confidence 34455555555555555555667777777778887877777777777774 7888888888777653
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.1e-28 Score=280.37 Aligned_cols=247 Identities=25% Similarity=0.313 Sum_probs=189.4
Q ss_pred EEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCC
Q 002346 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148 (933)
Q Consensus 70 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 148 (933)
.++..+.+|+ .+|..+. ++++.|+|++|+|+++.+ .|.++++|++|+|++|+|+.+++..|.++++|++|+|++|+
T Consensus 47 ~v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~ 123 (440)
T 3zyj_A 47 KVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNR 123 (440)
T ss_dssp EEECCSCCCS-SCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSSC
T ss_pred EEEeCCCCcC-cCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCCc
Confidence 4555566776 6676655 689999999999999887 79999999999999999999998899999999999999999
Q ss_pred CCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccccc
Q 002346 149 NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL 228 (933)
Q Consensus 149 ~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~ 228 (933)
+.. ..+..+..+++|++|+|++|++....+..|..+++|++|+|++|+..+.++..
T Consensus 124 l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~---------------------- 179 (440)
T 3zyj_A 124 LTT--IPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEG---------------------- 179 (440)
T ss_dssp CSS--CCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT----------------------
T ss_pred CCe--eCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcc----------------------
Confidence 887 34457888999999999999998888888889999999999985544455442
Q ss_pred ccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEE
Q 002346 229 DVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKV 308 (933)
Q Consensus 229 ~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 308 (933)
.|.++++|+.|+|++|+++. +|.+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++
T Consensus 180 -~~~~l~~L~~L~L~~n~l~~-~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~------------ 245 (440)
T 3zyj_A 180 -AFEGLSNLRYLNLAMCNLRE-IPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV------------ 245 (440)
T ss_dssp -TTTTCSSCCEEECTTSCCSS-CCCCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCE------------
T ss_pred -hhhcccccCeecCCCCcCcc-ccccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeE------------
Confidence 13457888888888888874 3567777777777777777777667777777777777776666654
Q ss_pred eccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhc
Q 002346 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA 388 (933)
Q Consensus 309 ~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 388 (933)
..|..|.
T Consensus 246 -------------------------------------------------------------------------~~~~~~~ 252 (440)
T 3zyj_A 246 -------------------------------------------------------------------------IERNAFD 252 (440)
T ss_dssp -------------------------------------------------------------------------ECTTSST
T ss_pred -------------------------------------------------------------------------EChhhhc
Confidence 3344566
Q ss_pred CcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCccc
Q 002346 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430 (933)
Q Consensus 389 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~ 430 (933)
++++|+.|+|++|+|++..+..|..+++|+.|+|++|++...
T Consensus 253 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 253 NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp TCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred CCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 667777777777777766666677777777777777776543
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.7e-28 Score=266.43 Aligned_cols=287 Identities=18% Similarity=0.234 Sum_probs=221.3
Q ss_pred CCCCCccccceEeCC----------CCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCcee
Q 002346 50 SSTGYCEWTGINCDN----------SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDI 118 (933)
Q Consensus 50 ~~~~~C~w~gv~c~~----------~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L 118 (933)
+..+.|.|+.+.|.. ...++.|+|++|++++..+..|+.+++|++|+|++|.|++..| .|..+++|++|
T Consensus 26 p~~c~c~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L 105 (330)
T 1xku_A 26 PFRCQCHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL 105 (330)
T ss_dssp CTTCEEETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred CCCCcCCCeEEEecCCCccccCccCCCCCeEEECCCCcCCEeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEE
Confidence 345678999999974 2478999999999998877899999999999999999999877 89999999999
Q ss_pred ccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCC--CCChhhcCCCCCCEEEccC
Q 002346 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFG--LIPDFFDSFSNLQNLRLSY 196 (933)
Q Consensus 119 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~L~~ 196 (933)
+|++|+++.++...+ ++|++|+|++|++.. ..+..+.++++|+.|++++|.+.. ..+..|..+++|++|++++
T Consensus 106 ~Ls~n~l~~l~~~~~---~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~ 180 (330)
T 1xku_A 106 YLSKNQLKELPEKMP---KTLQELRVHENEITK--VRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIAD 180 (330)
T ss_dssp ECCSSCCSBCCSSCC---TTCCEEECCSSCCCB--BCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCS
T ss_pred ECCCCcCCccChhhc---ccccEEECCCCcccc--cCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCC
Confidence 999999999987754 799999999999988 445678999999999999999964 7888999999999999999
Q ss_pred CcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCc
Q 002346 197 NNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVP 275 (933)
Q Consensus 197 N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p 275 (933)
|+++ .+|..+ .++|+.|+|++|++++..+ .+..+++|+.|+|++|++++..+
T Consensus 181 n~l~-~l~~~~--------------------------~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~ 233 (330)
T 1xku_A 181 TNIT-TIPQGL--------------------------PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDN 233 (330)
T ss_dssp SCCC-SCCSSC--------------------------CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECT
T ss_pred Cccc-cCCccc--------------------------cccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCceeCh
Confidence 9998 677654 2566777777777766554 36667777777777777776666
Q ss_pred ccccCCCCCCEEEccCccCccCCCCC--CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCC
Q 002346 276 ASVISLPALLNISLQNNKLQGPYPLF--PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353 (933)
Q Consensus 276 ~~l~~l~~L~~L~Ls~N~l~~~~p~~--~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 353 (933)
..+..+++|++|+|++|+++..+..+ ..+|+.|+|++|+|++.....+.+.
T Consensus 234 ~~~~~l~~L~~L~L~~N~l~~lp~~l~~l~~L~~L~l~~N~i~~~~~~~f~~~--------------------------- 286 (330)
T 1xku_A 234 GSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP--------------------------- 286 (330)
T ss_dssp TTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCS---------------------------
T ss_pred hhccCCCCCCEEECCCCcCccCChhhccCCCcCEEECCCCcCCccChhhcCCc---------------------------
Confidence 66777777777777777776332222 2456677777777765543322110
Q ss_pred CCCCCCCccccCCCceeEEEccCccccC--cCchhhcCcccCCeEecccCc
Q 002346 354 NACDGWPFVTCSQGRIITINLANKLLAG--NISPAYANLTSLKNLYLQQNN 402 (933)
Q Consensus 354 ~~~~~~p~~~~~l~~L~~L~Ls~N~l~g--~~p~~~~~l~~L~~L~L~~N~ 402 (933)
........|+.|+|++|.+.. ..|..|..+.+|+.|+|++|+
T Consensus 287 -------~~~~~~~~l~~l~l~~N~~~~~~i~~~~f~~~~~l~~l~L~~N~ 330 (330)
T 1xku_A 287 -------GYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330 (330)
T ss_dssp -------SCCTTSCCCSEEECCSSSSCGGGSCGGGGTTCCCGGGEEC----
T ss_pred -------ccccccccccceEeecCcccccccCccccccccceeEEEecccC
Confidence 011224678899999998864 567889999999999999996
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3e-28 Score=280.10 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=192.0
Q ss_pred EEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCC
Q 002346 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149 (933)
Q Consensus 71 L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~ 149 (933)
++.++.+++ .+|..+. ++|++|+|++|+|+++.+ .|.++++|++|+|++|+|+++++..|.++++|++|+|++|++
T Consensus 59 v~c~~~~l~-~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n~l 135 (452)
T 3zyi_A 59 VVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWL 135 (452)
T ss_dssp EECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCC
T ss_pred EEECCCCcC-ccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCCcC
Confidence 444455666 5665554 689999999999999887 799999999999999999999988999999999999999998
Q ss_pred CCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccc
Q 002346 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLD 229 (933)
Q Consensus 150 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~ 229 (933)
.. ..+..+..+++|++|+|++|++....+..|..+++|++|+|++|+..+.++..
T Consensus 136 ~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~----------------------- 190 (452)
T 3zyi_A 136 TV--IPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEG----------------------- 190 (452)
T ss_dssp SB--CCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTT-----------------------
T ss_pred Cc--cChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChh-----------------------
Confidence 87 34556888999999999999998888888999999999999985544455542
Q ss_pred cccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEe
Q 002346 230 VLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVS 309 (933)
Q Consensus 230 ~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~ 309 (933)
.|.++++|+.|+|++|++++. |.+..+++|+.|+|++|+|++..|..|.++++|+.|+|++|++++.
T Consensus 191 ~~~~l~~L~~L~L~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~------------ 257 (452)
T 3zyi_A 191 AFEGLFNLKYLNLGMCNIKDM-PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLI------------ 257 (452)
T ss_dssp TTTTCTTCCEEECTTSCCSSC-CCCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEE------------
T ss_pred hccCCCCCCEEECCCCccccc-ccccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceE------------
Confidence 134578888888888888864 5677788888888888888877777777777777777777776643
Q ss_pred ccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcC
Q 002346 310 LDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN 389 (933)
Q Consensus 310 l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~ 389 (933)
.|..|.+
T Consensus 258 -------------------------------------------------------------------------~~~~~~~ 264 (452)
T 3zyi_A 258 -------------------------------------------------------------------------ERNAFDG 264 (452)
T ss_dssp -------------------------------------------------------------------------CTTTTTT
T ss_pred -------------------------------------------------------------------------CHHHhcC
Confidence 3445666
Q ss_pred cccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccC
Q 002346 390 LTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKV 431 (933)
Q Consensus 390 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~ 431 (933)
+++|+.|+|++|+|++..+..|..+++|+.|+|++|++....
T Consensus 265 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~CdC 306 (452)
T 3zyi_A 265 LASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCDC 306 (452)
T ss_dssp CTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECST
T ss_pred CCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCCC
Confidence 777777777777777666666777777777777777776543
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.95 E-value=1.9e-29 Score=274.89 Aligned_cols=250 Identities=19% Similarity=0.178 Sum_probs=161.8
Q ss_pred cccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCC-Cccc-------CCCCCCEEEccCCCCCCCCCC
Q 002346 85 EISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPT-GCFD-------GLTNLQVLSLSDNPNLAPWPF 155 (933)
Q Consensus 85 ~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~-~~~~-------~l~~L~~L~Ls~N~~~~~~~~ 155 (933)
.++..++|+.|++++|.+ .+| .+... |++|+|++|.++.+.. ..+. ++++|++|+|++|++.+ .+
T Consensus 38 ~~~~~~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~--~~ 111 (312)
T 1wwl_A 38 LYGGGRSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTG--TA 111 (312)
T ss_dssp EEEEEEECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBS--CC
T ss_pred EEccCCCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccc--hh
Confidence 345666777777777777 344 44433 7777777777754221 1122 46677777777776665 35
Q ss_pred Cccc--cCCccCCeeeccCcccCCCCChhhcCC-----CCCCEEEccCCcCCCCCCccccccccchhhcccccCCccccc
Q 002346 156 PNEL--TKSTSLTTLYMDNANIFGLIPDFFDSF-----SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL 228 (933)
Q Consensus 156 p~~~--~~l~~L~~L~L~~n~l~~~~p~~~~~l-----~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~ 228 (933)
|..+ ..+++|++|+|++|++++. |..++.+ ++|++|+|++|++++..|..|..
T Consensus 112 ~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~------------------- 171 (312)
T 1wwl_A 112 PPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV------------------- 171 (312)
T ss_dssp CCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCC-------------------
T ss_pred HHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhcc-------------------
Confidence 5554 6667777777777777666 6666555 67777777777776555554433
Q ss_pred ccccCCccCcEEEecCCccCCC---CCCC--CCCCCCCEEEccCCcccc--cCc-ccccCCCCCCEEEccCccCccCCCC
Q 002346 229 DVLSGMTQLRQVWLHKNQFTGP---IPDL--SKCESLFDLSLRDNQLTG--VVP-ASVISLPALLNISLQNNKLQGPYPL 300 (933)
Q Consensus 229 ~~l~~l~~L~~L~L~~N~l~~~---~~~~--~~~~~L~~L~L~~N~l~~--~~p-~~l~~l~~L~~L~Ls~N~l~~~~p~ 300 (933)
+++|++|+|++|++.+. ++.+ ..+++|+.|+|++|+|++ .++ ..+..+++|++|+|++|++++.+|.
T Consensus 172 -----l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~ 246 (312)
T 1wwl_A 172 -----FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGA 246 (312)
T ss_dssp -----CSSCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCC
T ss_pred -----CCCCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccch
Confidence 66677777777766553 2222 666777777777777762 122 3344667777777777777664431
Q ss_pred CCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCcccc
Q 002346 301 FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA 380 (933)
Q Consensus 301 ~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~ 380 (933)
..+..+++|+.|+|++|+++
T Consensus 247 ------------------------------------------------------------~~~~~l~~L~~L~Ls~N~l~ 266 (312)
T 1wwl_A 247 ------------------------------------------------------------PSCDWPSQLNSLNLSFTGLK 266 (312)
T ss_dssp ------------------------------------------------------------SCCCCCTTCCEEECTTSCCS
T ss_pred ------------------------------------------------------------hhhhhcCCCCEEECCCCccC
Confidence 01122467778888888887
Q ss_pred CcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCccc
Q 002346 381 GNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGK 430 (933)
Q Consensus 381 g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~ 430 (933)
.+|..+. ++|+.|+|++|+|++. |. +..+++|++|++++|+|++.
T Consensus 267 -~ip~~~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 267 -QVPKGLP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp -SCCSSCC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred -hhhhhcc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 6777666 7888888888888865 65 88888888888888888763
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-30 Score=298.69 Aligned_cols=221 Identities=21% Similarity=0.262 Sum_probs=171.6
Q ss_pred CcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCC
Q 002346 111 NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ 190 (933)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 190 (933)
.+++|++|+|++|.|+++++..|..+++|++|+|++|.+.+ ..| +..+++|++|+|++|.|++..+ .++|+
T Consensus 32 ~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~--l~~l~~L~~L~Ls~N~l~~l~~-----~~~L~ 102 (487)
T 3oja_A 32 SAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE--TLD--LESLSTLRTLDLNNNYVQELLV-----GPSIE 102 (487)
T ss_dssp TGGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEE--EEE--CTTCTTCCEEECCSSEEEEEEE-----CTTCC
T ss_pred cCCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCC--Ccc--cccCCCCCEEEecCCcCCCCCC-----CCCcC
Confidence 34577777777777777777777777888888888887766 222 7778888888888888776532 37888
Q ss_pred EEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCc
Q 002346 191 NLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQ 269 (933)
Q Consensus 191 ~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~ 269 (933)
+|+|++|++++..+. .+++|+.|+|++|.+++.+| .+..+++|+.|+|++|+
T Consensus 103 ~L~L~~N~l~~~~~~---------------------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 155 (487)
T 3oja_A 103 TLHAANNNISRVSCS---------------------------RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNE 155 (487)
T ss_dssp EEECCSSCCCCEEEC---------------------------CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSC
T ss_pred EEECcCCcCCCCCcc---------------------------ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCC
Confidence 888988888854332 15678889999999988766 57888999999999999
Q ss_pred ccccCccccc-CCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccC
Q 002346 270 LTGVVPASVI-SLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSD 348 (933)
Q Consensus 270 l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (933)
|++.+|..+. .+++|+.|+|++|.+++..+
T Consensus 156 l~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~------------------------------------------------- 186 (487)
T 3oja_A 156 IDTVNFAELAASSDTLEHLNLQYNFIYDVKG------------------------------------------------- 186 (487)
T ss_dssp CCEEEGGGGGGGTTTCCEEECTTSCCCEEEC-------------------------------------------------
T ss_pred CCCcChHHHhhhCCcccEEecCCCccccccc-------------------------------------------------
Confidence 9988888876 78999999999999886422
Q ss_pred CCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCc
Q 002346 349 SWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (933)
Q Consensus 349 ~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 428 (933)
...+++|+.|+|++|.+++ +|+.|+.+++|+.|+|++|+|++ +|..+..+++|+.|++++|++.
T Consensus 187 --------------~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~ 250 (487)
T 3oja_A 187 --------------QVVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFH 250 (487)
T ss_dssp --------------CCCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBC
T ss_pred --------------cccCCCCCEEECCCCCCCC-CCHhHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCc
Confidence 1124678888888888887 44458889999999999999994 7888888999999999999887
Q ss_pred -ccCC
Q 002346 429 -GKVP 432 (933)
Q Consensus 429 -g~~p 432 (933)
+.+|
T Consensus 251 c~~~~ 255 (487)
T 3oja_A 251 CGTLR 255 (487)
T ss_dssp HHHHH
T ss_pred CcchH
Confidence 4443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-27 Score=255.88 Aligned_cols=199 Identities=25% Similarity=0.337 Sum_probs=154.5
Q ss_pred EEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCC
Q 002346 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (933)
Q Consensus 69 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 147 (933)
+.+++++++++ .+|..+ .++|++|+|++|.|+++++ .|..+++|++|+|++|.++++.+..|.++++|++|+|++|
T Consensus 14 ~~~~c~~~~l~-~ip~~~--~~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n 90 (285)
T 1ozn_A 14 VTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (285)
T ss_dssp CEEECCSSCCS-SCCTTC--CTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCcCCcc-cCCcCC--CCCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCC
Confidence 67778888887 456543 4689999999999998877 6888999999999999999888888888999999999988
Q ss_pred C-CCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccc
Q 002346 148 P-NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (933)
Q Consensus 148 ~-~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~ 226 (933)
. +.. ..|..+..+++|++|+|++|++.+..|..|..+++|++|+|++|++++..+..|.
T Consensus 91 ~~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~------------------ 150 (285)
T 1ozn_A 91 AQLRS--VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR------------------ 150 (285)
T ss_dssp TTCCC--CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT------------------
T ss_pred CCccc--cCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhc------------------
Confidence 7 665 3467788888888888888888888788888888888888888888744443333
Q ss_pred ccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCcc
Q 002346 227 TLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 227 ~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
.+++|+.|+|++|++++.++. +..+++|+.|+|++|++++..|..|..+++|+.|+|++|++++
T Consensus 151 ------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~ 215 (285)
T 1ozn_A 151 ------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA 215 (285)
T ss_dssp ------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred ------cCCCccEEECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc
Confidence 367777777777777766654 6677777777777777777767777777777777777776664
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.95 E-value=8.1e-27 Score=248.53 Aligned_cols=217 Identities=26% Similarity=0.394 Sum_probs=193.6
Q ss_pred CCCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCC
Q 002346 52 TGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPT 130 (933)
Q Consensus 52 ~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~ 130 (933)
.++|.|.|+.|.....++.+++++++|+ .+|..+. ++|++|+|++|+|+++++ .|.++++|++|+|++|.|+.++.
T Consensus 2 ~~~C~~~~~~C~c~~~~~~l~~~~~~l~-~ip~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~i~~ 78 (270)
T 2o6q_A 2 EALCKKDGGVCSCNNNKNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPA 78 (270)
T ss_dssp CCCBGGGTCSBEEETTTTEEECTTSCCS-SCCSCCC--TTCSEEECCSSCCSCCCTTSSSSCTTCCEEECCSSCCSCCCT
T ss_pred CccCCCCCCCCEeCCCCCEEEccCCCCC-ccCCCCC--CCCCEEECcCCCCCeeCHHHhcCCCCCCEEECCCCccCeeCh
Confidence 3689999999987777889999999999 5776654 689999999999998887 79999999999999999999999
Q ss_pred CcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCcccccc
Q 002346 131 GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKS 210 (933)
Q Consensus 131 ~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 210 (933)
..|.++++|++|+|++|++.. ..+..+..+++|++|+|++|++.+..+..|..+++|++|+|++|++++..+..|
T Consensus 79 ~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~--- 153 (270)
T 2o6q_A 79 GIFKELKNLETLWVTDNKLQA--LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVF--- 153 (270)
T ss_dssp TTTSSCTTCCEEECCSSCCCC--CCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT---
T ss_pred hhhcCCCCCCEEECCCCcCCc--CCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHc---
Confidence 999999999999999999988 345677999999999999999999999999999999999999999995444434
Q ss_pred ccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEc
Q 002346 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISL 289 (933)
Q Consensus 211 ~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 289 (933)
..+++|+.|+|++|++++.++. +..+++|+.|+|++|++++..+..|..+++|+.|+|
T Consensus 154 ---------------------~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l 212 (270)
T 2o6q_A 154 ---------------------DKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212 (270)
T ss_dssp ---------------------TTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEEC
T ss_pred ---------------------cCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCcCCHHHhccccCCCEEEe
Confidence 3489999999999999998875 888999999999999999777778999999999999
Q ss_pred cCccCccC
Q 002346 290 QNNKLQGP 297 (933)
Q Consensus 290 s~N~l~~~ 297 (933)
++|++...
T Consensus 213 ~~N~~~c~ 220 (270)
T 2o6q_A 213 QENPWDCT 220 (270)
T ss_dssp CSSCBCCS
T ss_pred cCCCeeCC
Confidence 99998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9e-29 Score=289.73 Aligned_cols=187 Identities=20% Similarity=0.141 Sum_probs=132.4
Q ss_pred ccccCCCeEEEEE-EeCCCcEEEEEEeccccC--------CchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEEE
Q 002346 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTM--------GNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 588 ~lg~G~~g~Vy~~-~~~~~~~vavK~~~~~~~--------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv 657 (933)
..+.|++|.+..+ +..-|+.||||++.+... .....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4677777766665 344689999999976532 123356799999999999 799999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||++|++|.++|.+ .++++.. +|+.||+.||+|+|+ +|||||||||+|||+++++.+||+|||+|+..
T Consensus 321 MEyv~G~~L~d~i~~-----~~~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~ 389 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-----GEEIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTT 389 (569)
T ss_dssp EECCCSEEHHHHHHT-----TCCCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESC
T ss_pred EecCCCCcHHHHHHh-----CCCCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeC
Confidence 999999999999965 2456654 489999999999999 99999999999999999999999999999866
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCC
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKA 787 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p 787 (933)
..... .....+||++|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus 390 ~~~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 390 PQDCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp C---C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred CCCCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence 54332 2344689999999999874 567889999999998887665443
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=2.7e-27 Score=254.58 Aligned_cols=206 Identities=23% Similarity=0.293 Sum_probs=188.6
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceecccccc-ccCCCCCcccCCCCCCEEE
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN-FTSVPTGCFDGLTNLQVLS 143 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~ 143 (933)
..++.|+|++|++++..+..|..+++|++|+|++|.|+++.| .|.++++|++|+|++|. ++.+++..|..+++|++|+
T Consensus 32 ~~l~~L~l~~n~i~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L~ 111 (285)
T 1ozn_A 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLH 111 (285)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEE
T ss_pred CCceEEEeeCCcCCccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEEE
Confidence 479999999999998888889999999999999999999877 89999999999999997 9999888999999999999
Q ss_pred ccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCC
Q 002346 144 LSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLG 223 (933)
Q Consensus 144 Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~ 223 (933)
|++|++.. ..|..+.++++|++|+|++|++.+..+..|+.+++|++|+|++|++++..+..+.
T Consensus 112 l~~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~--------------- 174 (285)
T 1ozn_A 112 LDRCGLQE--LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR--------------- 174 (285)
T ss_dssp CTTSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT---------------
T ss_pred CCCCcCCE--ECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCcccccCHHHhc---------------
Confidence 99999998 5578899999999999999999999888899999999999999999954444443
Q ss_pred cccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccC
Q 002346 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297 (933)
Q Consensus 224 ~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 297 (933)
++++|+.|+|++|++++..| .+..+++|+.|+|++|++++..+..+..+++|+.|+|++|++...
T Consensus 175 ---------~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 240 (285)
T 1ozn_A 175 ---------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD 240 (285)
T ss_dssp ---------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred ---------CccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCcCCHHHcccCcccCEEeccCCCccCC
Confidence 48999999999999999866 588999999999999999987778899999999999999999853
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} | Back alignment and structure |
|---|
Probab=99.95 E-value=6.8e-27 Score=256.13 Aligned_cols=201 Identities=20% Similarity=0.267 Sum_probs=154.2
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCccc---------CC
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFD---------GL 136 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~---------~l 136 (933)
.+++.|+|++|+++ .+|..++.+++|++|+|++|.|+.+++.+.++++|++|+|++|++.+..+..+. ++
T Consensus 104 ~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~~~~~~~l 182 (328)
T 4fcg_A 104 SHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182 (328)
T ss_dssp TTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCCCCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-CCCEEES
T ss_pred CCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccccCcHHHhcCcCCCEEECCCCCCccccChhHhhccchhhhccC
Confidence 47999999999999 899999999999999999999995544899999999999999877765444444 37
Q ss_pred CCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhh
Q 002346 137 TNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLW 216 (933)
Q Consensus 137 ~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~ 216 (933)
++|++|+|++|++.. +|..+.++++|++|+|++|++.+. |..++.+++|++|+|++|++.+.+|..+..
T Consensus 183 ~~L~~L~L~~n~l~~---lp~~l~~l~~L~~L~L~~N~l~~l-~~~l~~l~~L~~L~Ls~n~~~~~~p~~~~~------- 251 (328)
T 4fcg_A 183 VNLQSLRLEWTGIRS---LPASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGG------- 251 (328)
T ss_dssp TTCCEEEEEEECCCC---CCGGGGGCTTCCEEEEESSCCCCC-CGGGGGCTTCCEEECTTCTTCCBCCCCTTC-------
T ss_pred CCCCEEECcCCCcCc---chHhhcCCCCCCEEEccCCCCCcC-chhhccCCCCCEEECcCCcchhhhHHHhcC-------
Confidence 777777777777764 677777777777777777777753 556777777777777777777777765543
Q ss_pred cccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCc
Q 002346 217 MNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295 (933)
Q Consensus 217 l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 295 (933)
+++|+.|+|++|++.+.+| .+..+++|+.|+|++|++.+.+|..+.++++|+.+++..|.+.
T Consensus 252 -----------------l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~iP~~l~~L~~L~~l~l~~~~~~ 314 (328)
T 4fcg_A 252 -----------------RAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQA 314 (328)
T ss_dssp -----------------CCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCCCGGGGGSCTTCEEECCGGGSC
T ss_pred -----------------CCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhccHHHhhccCceEEeCCHHHHH
Confidence 6777777777777766666 4667777777777777777777777777777777777766554
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=1.4e-28 Score=268.10 Aligned_cols=246 Identities=18% Similarity=0.182 Sum_probs=201.8
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeeccccccc-ccCC-Ccc-------CcCcCceeccccccccCCCCCcc--c
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA-GAIP-SLA-------NATSLQDIYLDNNNFTSVPTGCF--D 134 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~p-~~~-------~l~~L~~L~Ls~N~l~~~~~~~~--~ 134 (933)
.+++.|++++|.+ .+|..+... |+.|+|++|.++ +.+| .+. ++++|++|+|++|++++..+..+ .
T Consensus 43 ~~L~~l~l~~n~l--~~p~~~~~~--L~~L~L~~n~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~ 118 (312)
T 1wwl_A 43 RSLEYLLKRVDTE--ADLGQFTDI--IKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEA 118 (312)
T ss_dssp EECTTHHHHCCTT--CCCHHHHHH--HHHCCCCEEEEEEEECBHHHHHHHHHHHTTSCCCEEEEEEEBCBSCCCCCSSSC
T ss_pred CCceeEeeccccc--ccHHHHHHH--HhhcccccccccCCCcCHHHHHHHHHhcCcCCccEEEccCCcccchhHHHHHHh
Confidence 4678889999999 778777655 999999999994 4555 343 69999999999999996555444 8
Q ss_pred CCCCCCEEEccCCCCCCCCCCCccccCC-----ccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCC--Cccc
Q 002346 135 GLTNLQVLSLSDNPNLAPWPFPNELTKS-----TSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL--PASF 207 (933)
Q Consensus 135 ~l~~L~~L~Ls~N~~~~~~~~p~~~~~l-----~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--p~~~ 207 (933)
.+++|++|+|++|++.+ +|..+..+ ++|++|+|++|++.+..|..|+.+++|++|+|++|++.+.+ |..+
T Consensus 119 ~l~~L~~L~Ls~N~l~~---~~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~ 195 (312)
T 1wwl_A 119 TGPDLNILNLRNVSWAT---RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISAL 195 (312)
T ss_dssp CSCCCSEEEEESCBCSS---SSSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHS
T ss_pred cCCCccEEEccCCCCcc---hhHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHH
Confidence 99999999999999998 47888887 99999999999999999999999999999999999987652 2222
Q ss_pred cccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC---C-CCCCCCCCEEEccCCcccccCc-ccccCCC
Q 002346 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP---D-LSKCESLFDLSLRDNQLTGVVP-ASVISLP 282 (933)
Q Consensus 208 ~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~---~-~~~~~~L~~L~L~~N~l~~~~p-~~l~~l~ 282 (933)
. +..+++|++|+|++|++++... . +..+++|+.|+|++|++++.+| ..+..++
T Consensus 196 ~----------------------~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~ 253 (312)
T 1wwl_A 196 C----------------------PLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253 (312)
T ss_dssp C----------------------TTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCT
T ss_pred H----------------------hccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcC
Confidence 1 2458999999999999985332 2 4578999999999999998776 5566789
Q ss_pred CCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCcc
Q 002346 283 ALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFV 362 (933)
Q Consensus 283 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~ 362 (933)
+|++|+|++|+++ .+| ..
T Consensus 254 ~L~~L~Ls~N~l~-~ip-------------------------------------------------------------~~ 271 (312)
T 1wwl_A 254 QLNSLNLSFTGLK-QVP-------------------------------------------------------------KG 271 (312)
T ss_dssp TCCEEECTTSCCS-SCC-------------------------------------------------------------SS
T ss_pred CCCEEECCCCccC-hhh-------------------------------------------------------------hh
Confidence 9999999999988 333 22
Q ss_pred ccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCC
Q 002346 363 TCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGP 406 (933)
Q Consensus 363 ~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~ 406 (933)
+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|++++.
T Consensus 272 ~~--~~L~~L~Ls~N~l~~~-p~-~~~l~~L~~L~L~~N~l~~~ 311 (312)
T 1wwl_A 272 LP--AKLSVLDLSYNRLDRN-PS-PDELPQVGNLSLKGNPFLDS 311 (312)
T ss_dssp CC--SEEEEEECCSSCCCSC-CC-TTTSCEEEEEECTTCTTTCC
T ss_pred cc--CCceEEECCCCCCCCC-hh-HhhCCCCCEEeccCCCCCCC
Confidence 22 5788888888888876 55 88999999999999998853
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=4.9e-28 Score=268.90 Aligned_cols=258 Identities=18% Similarity=0.265 Sum_probs=215.7
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
..++.|++++|++++..+..|..+++|++|+|++|.|++.+| .|.++++|++|+|++|++++++...|.++++|++|+|
T Consensus 52 ~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L 131 (353)
T 2z80_A 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNL 131 (353)
T ss_dssp TTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEEC
T ss_pred ccCcEEECCCCcCcccCHHHhccCCCCCEEECCCCccCccCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEEC
Confidence 589999999999998777799999999999999999999887 7999999999999999999999988999999999999
Q ss_pred cCCCCCCCCCCCc--cccCCccCCeeeccCc-ccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhccccc
Q 002346 145 SDNPNLAPWPFPN--ELTKSTSLTTLYMDNA-NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQ 221 (933)
Q Consensus 145 s~N~~~~~~~~p~--~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~ 221 (933)
++|++.. +|. .+.++++|++|++++| .+.+..+..|..+++|++|+|++|++++..|..+..
T Consensus 132 ~~n~l~~---l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~------------ 196 (353)
T 2z80_A 132 LGNPYKT---LGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKS------------ 196 (353)
T ss_dssp TTCCCSS---SCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTT------------
T ss_pred CCCCCcc---cCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhc------------
Confidence 9999987 555 7899999999999999 577777889999999999999999999877877654
Q ss_pred CCcccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccC---CCCCCEEEccCccCccC
Q 002346 222 LGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVIS---LPALLNISLQNNKLQGP 297 (933)
Q Consensus 222 ~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~---l~~L~~L~Ls~N~l~~~ 297 (933)
+++|+.|++++|+++..++. +..+++|+.|+|++|++++..+..+.. .+.++.++|++|.+++.
T Consensus 197 ------------l~~L~~L~l~~n~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~~~~~~l~~l~L~~~~l~~~ 264 (353)
T 2z80_A 197 ------------IQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDE 264 (353)
T ss_dssp ------------CSEEEEEEEECSCSTTHHHHHHHHTTTEEEEEEESCBCTTCCCC------CCCCCCEEEEESCBCCHH
T ss_pred ------------cccCCeecCCCCccccchhhhhhhcccccEEECCCCccccccccccccccccchhhccccccccccCc
Confidence 89999999999999765544 456899999999999999766554432 34555566665555421
Q ss_pred CCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCc
Q 002346 298 YPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANK 377 (933)
Q Consensus 298 ~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N 377 (933)
. ...+|..+..+++|+.|+|++|
T Consensus 265 ----------------~-----------------------------------------l~~l~~~l~~l~~L~~L~Ls~N 287 (353)
T 2z80_A 265 ----------------S-----------------------------------------LFQVMKLLNQISGLLELEFSRN 287 (353)
T ss_dssp ----------------H-----------------------------------------HHHHHHHHHTCTTCCEEECCSS
T ss_pred ----------------c-----------------------------------------hhhhHHHHhcccCCCEEECCCC
Confidence 0 1124556778899999999999
Q ss_pred cccCcCchh-hcCcccCCeEecccCcccCCCC
Q 002346 378 LLAGNISPA-YANLTSLKNLYLQQNNLTGPIP 408 (933)
Q Consensus 378 ~l~g~~p~~-~~~l~~L~~L~L~~N~l~g~~p 408 (933)
+++ .+|.. |+++++|+.|+|++|.+.+..|
T Consensus 288 ~l~-~i~~~~~~~l~~L~~L~L~~N~~~~~~~ 318 (353)
T 2z80_A 288 QLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 318 (353)
T ss_dssp CCC-CCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred CCC-ccCHHHHhcCCCCCEEEeeCCCccCcCC
Confidence 999 56665 6999999999999999996554
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.94 E-value=3e-28 Score=266.07 Aligned_cols=264 Identities=20% Similarity=0.198 Sum_probs=157.9
Q ss_pred cceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeec
Q 002346 92 LETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170 (933)
Q Consensus 92 L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L 170 (933)
++.++++.+.+...+. .+..+++|++|+|++|+|+++++..|..+++|++|+|++|++.+ .+. +..+++|++|+|
T Consensus 12 l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~---~~~-~~~l~~L~~L~L 87 (317)
T 3o53_A 12 YKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE---TLD-LESLSTLRTLDL 87 (317)
T ss_dssp EEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEE---EEE-ETTCTTCCEEEC
T ss_pred eeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCc---chh-hhhcCCCCEEEC
Confidence 3444555555544333 23344556666666666666555556666666666666666554 121 566666666666
Q ss_pred cCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCC
Q 002346 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250 (933)
Q Consensus 171 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 250 (933)
++|++++.. ..++|++|++++|++++..+. .+++|+.|+|++|++++.
T Consensus 88 s~n~l~~l~-----~~~~L~~L~l~~n~l~~~~~~---------------------------~~~~L~~L~l~~N~l~~~ 135 (317)
T 3o53_A 88 NNNYVQELL-----VGPSIETLHAANNNISRVSCS---------------------------RGQGKKNIYLANNKITML 135 (317)
T ss_dssp CSSEEEEEE-----ECTTCCEEECCSSCCSEEEEC---------------------------CCSSCEEEECCSSCCCSG
T ss_pred cCCcccccc-----CCCCcCEEECCCCccCCcCcc---------------------------ccCCCCEEECCCCCCCCc
Confidence 666665432 236677777777766633221 145667777777777665
Q ss_pred CC-CCCCCCCCCEEEccCCcccccCccccc-CCCCCCEEEccCccCccCCCC-CCCCccEEeccCCcCCCCCCCCCCCCC
Q 002346 251 IP-DLSKCESLFDLSLRDNQLTGVVPASVI-SLPALLNISLQNNKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCD 327 (933)
Q Consensus 251 ~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~-~~~~l~~L~l~~n~~~~~~~~~~~~~~ 327 (933)
.+ .+..+++|+.|+|++|++++..+..+. .+++|++|+|++|.+++..+. ...+|+.|+|++|++.+
T Consensus 136 ~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~l~~L~~L~Ls~N~l~~---------- 205 (317)
T 3o53_A 136 RDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAF---------- 205 (317)
T ss_dssp GGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEEECCCCCTTCCEEECCSSCCCE----------
T ss_pred cchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCcccccccccccCCEEECCCCcCCc----------
Confidence 55 466667777777777777766665553 567777777777777654221 23445555555555432
Q ss_pred chhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCccc-CC
Q 002346 328 PQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT-GP 406 (933)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~-g~ 406 (933)
+|..+..+++|+.|+|++|+++ .+|..+..+++|+.|+|++|++. +.
T Consensus 206 -------------------------------l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~~ 253 (317)
T 3o53_A 206 -------------------------------MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGT 253 (317)
T ss_dssp -------------------------------ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHHH
T ss_pred -------------------------------chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCcC
Confidence 2233445567777777777777 35666777777777777777776 66
Q ss_pred CCcccCCCCCcCEEecc-CCcCcccCCC
Q 002346 407 IPDGLTKLASLQNLDVS-NNNLSGKVPD 433 (933)
Q Consensus 407 ~p~~~~~l~~L~~l~ls-~N~l~g~~p~ 433 (933)
+|..+..+++|+.++++ .+.++|..|.
T Consensus 254 ~~~~~~~~~~L~~l~l~~~~~l~~~~~~ 281 (317)
T 3o53_A 254 LRDFFSKNQRVQTVAKQTVKKLTGQNEE 281 (317)
T ss_dssp HHHHHHTCHHHHHHHHHHHHHHHSSSSC
T ss_pred HHHHHhccccceEEECCCchhccCCchh
Confidence 67777777777777777 4455665553
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.94 E-value=8.5e-27 Score=253.52 Aligned_cols=219 Identities=21% Similarity=0.217 Sum_probs=182.8
Q ss_pred ccccceEeCC---CCCEEEEEecCCCCccccCccccCCcccceeecccccccccC--C-CccCcCcCceeccccccccCC
Q 002346 55 CEWTGINCDN---SNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAI--P-SLANATSLQDIYLDNNNFTSV 128 (933)
Q Consensus 55 C~w~gv~c~~---~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~--p-~~~~l~~L~~L~Ls~N~l~~~ 128 (933)
|...|++-.. ...++.|+|++|+++...+..|..+++|++|+|++|.|+... + .+..+++|++|+|++|.++.+
T Consensus 14 c~~~~l~~ip~~~~~~l~~L~L~~n~l~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~l 93 (306)
T 2z66_A 14 CNSKGLTSVPTGIPSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM 93 (306)
T ss_dssp CCSSCCSSCCSCCCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCEEEEEEHHHHSCSCCCEEECCSCSEEEE
T ss_pred cCCCCcccCCCCCCCCCCEEECCCCccCccCHhHhhccccCCEEECCCCccCcccCcccccccccccCEEECCCCccccC
Confidence 5555544432 357999999999999655556899999999999999998542 3 677899999999999999988
Q ss_pred CCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCC-CCCccc
Q 002346 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG-SLPASF 207 (933)
Q Consensus 129 ~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~-~~p~~~ 207 (933)
+.. +..+++|++|+|++|++.... ....+..+++|++|++++|.+.+..+..|..+++|++|+|++|++++ .+|..+
T Consensus 94 ~~~-~~~l~~L~~L~l~~n~l~~~~-~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~ 171 (306)
T 2z66_A 94 SSN-FLGLEQLEHLDFQHSNLKQMS-EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIF 171 (306)
T ss_dssp EEE-EETCTTCCEEECTTSEEESST-TTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCC
T ss_pred hhh-cCCCCCCCEEECCCCcccccc-cchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHH
Confidence 765 889999999999999998721 12578999999999999999999999999999999999999999986 456654
Q ss_pred cccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCcccccCCCCCCE
Q 002346 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286 (933)
Q Consensus 208 ~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~ 286 (933)
. .+++|+.|+|++|++++.++ .+..+++|+.|+|++|++++..+..+..+++|+.
T Consensus 172 ~------------------------~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 227 (306)
T 2z66_A 172 T------------------------ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQV 227 (306)
T ss_dssp T------------------------TCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCE
T ss_pred h------------------------hCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCE
Confidence 4 38889999999999988766 4788888999999999888777777888888888
Q ss_pred EEccCccCccCCC
Q 002346 287 ISLQNNKLQGPYP 299 (933)
Q Consensus 287 L~Ls~N~l~~~~p 299 (933)
|+|++|++++..|
T Consensus 228 L~L~~N~l~~~~~ 240 (306)
T 2z66_A 228 LDYSLNHIMTSKK 240 (306)
T ss_dssp EECTTSCCCBCSS
T ss_pred eECCCCCCcccCH
Confidence 8888888886544
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A | Back alignment and structure |
|---|
Probab=99.94 E-value=8.1e-26 Score=259.81 Aligned_cols=245 Identities=19% Similarity=0.211 Sum_probs=169.5
Q ss_pred cceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeecc
Q 002346 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (933)
Q Consensus 92 L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~ 171 (933)
...++.+++.++.++..+. ++|++|+|++|+|+++++..|.++++|++|+|++|++.. ..+..|.++++|++|+|+
T Consensus 56 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~--~~~~~~~~l~~L~~L~L~ 131 (452)
T 3zyi_A 56 FSKVVCTRRGLSEVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIRQ--IEVGAFNGLASLNTLELF 131 (452)
T ss_dssp SCEEECCSSCCSSCCSCCC--TTCSEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE--ECTTTTTTCTTCCEEECC
T ss_pred CcEEEECCCCcCccCCCCC--CCccEEECcCCcCceECHHHcCCCCCCCEEECCCCccCC--cChhhccCcccCCEEECC
Confidence 3457777777776554443 577888888888877777777777777777777776665 334555666666666666
Q ss_pred CcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCC
Q 002346 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (933)
Q Consensus 172 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 251 (933)
+|++++..+..|..+++|++|+|++|+++ ..+
T Consensus 132 ~n~l~~~~~~~~~~l~~L~~L~L~~N~l~------------------------------------------------~~~ 163 (452)
T 3zyi_A 132 DNWLTVIPSGAFEYLSKLRELWLRNNPIE------------------------------------------------SIP 163 (452)
T ss_dssp SSCCSBCCTTTSSSCTTCCEEECCSCCCC------------------------------------------------EEC
T ss_pred CCcCCccChhhhcccCCCCEEECCCCCcc------------------------------------------------eeC
Confidence 66665555555555556666666655555 332
Q ss_pred C-CCCCCCCCCEEEccC-CcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCch
Q 002346 252 P-DLSKCESLFDLSLRD-NQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (933)
Q Consensus 252 ~-~~~~~~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~ 329 (933)
+ .+..+++|+.|+|++ |.+....+..|.++++|++|+|++|++++. |
T Consensus 164 ~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~------------------------------ 212 (452)
T 3zyi_A 164 SYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P------------------------------ 212 (452)
T ss_dssp TTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C------------------------------
T ss_pred HhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c------------------------------
Confidence 2 244455555555555 333333334566677777777777766642 1
Q ss_pred hhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCc
Q 002346 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPD 409 (933)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~ 409 (933)
.+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|.
T Consensus 213 --------------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 260 (452)
T 3zyi_A 213 --------------------------------NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERN 260 (452)
T ss_dssp --------------------------------CCTTCTTCCEEECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTT
T ss_pred --------------------------------cccccccccEEECcCCcCcccCcccccCccCCCEEEeCCCcCceECHH
Confidence 122346788888888888888889999999999999999999999999
Q ss_pred ccCCCCCcCEEeccCCcCcccCCCCC---CCcccccCCCCCCcCC
Q 002346 410 GLTKLASLQNLDVSNNNLSGKVPDFG---SNVKFTVSPGNPFIGT 451 (933)
Q Consensus 410 ~~~~l~~L~~l~ls~N~l~g~~p~~~---~~~~~~~~~~n~~~~~ 451 (933)
.|..+++|+.|+|++|+|++.++... ..++...+.+|||.|.
T Consensus 261 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 305 (452)
T 3zyi_A 261 AFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWNCD 305 (452)
T ss_dssp TTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEECS
T ss_pred HhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcCCC
Confidence 99999999999999999998887643 3344556789999884
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-25 Score=258.06 Aligned_cols=246 Identities=18% Similarity=0.212 Sum_probs=171.7
Q ss_pred cceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeecc
Q 002346 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (933)
Q Consensus 92 L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~ 171 (933)
...++.+++.++.++..+. ++++.|+|++|+|+.+++..|.++++|++|+|++|++.. ..+..|.++++|++|+|+
T Consensus 45 ~~~v~c~~~~l~~iP~~~~--~~l~~L~L~~n~i~~~~~~~~~~l~~L~~L~Ls~n~i~~--i~~~~~~~l~~L~~L~L~ 120 (440)
T 3zyj_A 45 FSKVICVRKNLREVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT--IEIGAFNGLANLNTLELF 120 (440)
T ss_dssp SCEEECCSCCCSSCCSCCC--TTCSEEECCSCCCCEECTTTTSSCSSCCEEECCSSCCCE--ECGGGGTTCSSCCEEECC
T ss_pred CCEEEeCCCCcCcCCCCCC--CCCcEEEccCCcCCeeCHHHhhCCCCCCEEECCCCcCCc--cChhhccCCccCCEEECC
Confidence 3467888888886665554 678888888888888887778778888888887777765 334556666666666666
Q ss_pred CcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCC
Q 002346 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (933)
Q Consensus 172 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 251 (933)
+|++++..+..|..+++|++|+|++|++++..+..
T Consensus 121 ~n~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~--------------------------------------------- 155 (440)
T 3zyj_A 121 DNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYA--------------------------------------------- 155 (440)
T ss_dssp SSCCSSCCTTTSCSCSSCCEEECCSCCCCEECTTT---------------------------------------------
T ss_pred CCcCCeeCHhHhhccccCceeeCCCCcccccCHHH---------------------------------------------
Confidence 66666555555666666666666666655222222
Q ss_pred CCCCCCCCCCEEEccCC-cccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchh
Q 002346 252 PDLSKCESLFDLSLRDN-QLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQV 330 (933)
Q Consensus 252 ~~~~~~~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~ 330 (933)
|..+++|+.|+|++| .+....+..|.++++|++|+|++|+++.. |
T Consensus 156 --~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~------------------------------- 201 (440)
T 3zyj_A 156 --FNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI-P------------------------------- 201 (440)
T ss_dssp --TTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSSC-C-------------------------------
T ss_pred --hhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCccc-c-------------------------------
Confidence 344455555555552 23323333566666666666666666521 1
Q ss_pred hhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcc
Q 002346 331 TTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410 (933)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 410 (933)
.+..+++|+.|+|++|++++..|..|.++++|+.|+|++|++++..|..
T Consensus 202 -------------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~ 250 (440)
T 3zyj_A 202 -------------------------------NLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNA 250 (440)
T ss_dssp -------------------------------CCTTCSSCCEEECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTS
T ss_pred -------------------------------ccCCCcccCEEECCCCccCccChhhhccCccCCEEECCCCceeEEChhh
Confidence 1233467777888888888778889999999999999999999999999
Q ss_pred cCCCCCcCEEeccCCcCcccCCCCC---CCcccccCCCCCCcCC
Q 002346 411 LTKLASLQNLDVSNNNLSGKVPDFG---SNVKFTVSPGNPFIGT 451 (933)
Q Consensus 411 ~~~l~~L~~l~ls~N~l~g~~p~~~---~~~~~~~~~~n~~~~~ 451 (933)
|..+++|+.|+|++|+|++..+... ..++...+.+|||.|.
T Consensus 251 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~Cd 294 (440)
T 3zyj_A 251 FDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWNCN 294 (440)
T ss_dssp STTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEECS
T ss_pred hcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCccCC
Confidence 9999999999999999998887643 3444556789999884
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.8e-25 Score=258.40 Aligned_cols=258 Identities=22% Similarity=0.252 Sum_probs=212.0
Q ss_pred CcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCee
Q 002346 89 LTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (933)
Q Consensus 89 l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L 168 (933)
..+++.|++++|.|+.+++.+. ++|++|+|++|+|+.++. .+++|++|+|++|+++. +|. .+++|++|
T Consensus 39 ~~~l~~L~ls~n~L~~lp~~l~--~~L~~L~L~~N~l~~lp~----~l~~L~~L~Ls~N~l~~---lp~---~l~~L~~L 106 (622)
T 3g06_A 39 NNGNAVLNVGESGLTTLPDCLP--AHITTLVIPDNNLTSLPA----LPPELRTLEVSGNQLTS---LPV---LPPGLLEL 106 (622)
T ss_dssp HHCCCEEECCSSCCSCCCSCCC--TTCSEEEECSCCCSCCCC----CCTTCCEEEECSCCCSC---CCC---CCTTCCEE
T ss_pred CCCCcEEEecCCCcCccChhhC--CCCcEEEecCCCCCCCCC----cCCCCCEEEcCCCcCCc---CCC---CCCCCCEE
Confidence 4569999999999996555565 899999999999999887 57999999999999987 666 78999999
Q ss_pred eccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccC
Q 002346 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248 (933)
Q Consensus 169 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 248 (933)
+|++|++++..+ .+++|++|+|++|+++ .+|.. +++|+.|+|++|+++
T Consensus 107 ~Ls~N~l~~l~~----~l~~L~~L~L~~N~l~-~lp~~---------------------------l~~L~~L~Ls~N~l~ 154 (622)
T 3g06_A 107 SIFSNPLTHLPA----LPSGLCKLWIFGNQLT-SLPVL---------------------------PPGLQELSVSDNQLA 154 (622)
T ss_dssp EECSCCCCCCCC----CCTTCCEEECCSSCCS-CCCCC---------------------------CTTCCEEECCSSCCS
T ss_pred ECcCCcCCCCCC----CCCCcCEEECCCCCCC-cCCCC---------------------------CCCCCEEECcCCcCC
Confidence 999999988644 5789999999999998 56643 578999999999999
Q ss_pred CCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCc
Q 002346 249 GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDP 328 (933)
Q Consensus 249 ~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~ 328 (933)
+.+. .+.+|+.|++++|+|++ +| ..+++|+.|+|++|.+++ +|..+.+|+.|++++|.+...+
T Consensus 155 ~l~~---~~~~L~~L~L~~N~l~~-l~---~~~~~L~~L~Ls~N~l~~-l~~~~~~L~~L~L~~N~l~~l~--------- 217 (622)
T 3g06_A 155 SLPA---LPSELCKLWAYNNQLTS-LP---MLPSGLQELSVSDNQLAS-LPTLPSELYKLWAYNNRLTSLP--------- 217 (622)
T ss_dssp CCCC---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSSCC---------
T ss_pred CcCC---ccCCCCEEECCCCCCCC-Cc---ccCCCCcEEECCCCCCCC-CCCccchhhEEECcCCcccccC---------
Confidence 8654 34789999999999994 66 457899999999999997 5556789999999999886432
Q ss_pred hhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCC
Q 002346 329 QVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408 (933)
Q Consensus 329 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p 408 (933)
. ..++|+.|+|++|+|++ +| ..+++|+.|+|++|+|+ .+|
T Consensus 218 --------------------------------~---~~~~L~~L~Ls~N~L~~-lp---~~l~~L~~L~Ls~N~L~-~lp 257 (622)
T 3g06_A 218 --------------------------------A---LPSGLKELIVSGNRLTS-LP---VLPSELKELMVSGNRLT-SLP 257 (622)
T ss_dssp --------------------------------C---CCTTCCEEECCSSCCSC-CC---CCCTTCCEEECCSSCCS-CCC
T ss_pred --------------------------------C---CCCCCCEEEccCCccCc-CC---CCCCcCcEEECCCCCCC-cCC
Confidence 1 12689999999999997 66 56789999999999999 677
Q ss_pred cccCCCCCcCEEeccCCcCcccCCCCCC--CcccccCCCCCCcC
Q 002346 409 DGLTKLASLQNLDVSNNNLSGKVPDFGS--NVKFTVSPGNPFIG 450 (933)
Q Consensus 409 ~~~~~l~~L~~l~ls~N~l~g~~p~~~~--~~~~~~~~~n~~~~ 450 (933)
. .+++|+.|+|++|+|+..++.+.. .++...+.+|++.+
T Consensus 258 ~---~~~~L~~L~Ls~N~L~~lp~~l~~l~~L~~L~L~~N~l~~ 298 (622)
T 3g06_A 258 M---LPSGLLSLSVYRNQLTRLPESLIHLSSETTVNLEGNPLSE 298 (622)
T ss_dssp C---CCTTCCEEECCSSCCCSCCGGGGGSCTTCEEECCSCCCCH
T ss_pred c---ccccCcEEeCCCCCCCcCCHHHhhccccCEEEecCCCCCC
Confidence 6 678999999999999954433433 33334566777753
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-29 Score=291.57 Aligned_cols=326 Identities=17% Similarity=0.227 Sum_probs=201.9
Q ss_pred CEEEEEecCCCCcc----ccCccccCCcccceeecccccccccCC-Cc-cCcC----cCceeccccccccCC----CCCc
Q 002346 67 RVTTISLAKSGLSG----TLSPEISSLTQLETLSFQMNNIAGAIP-SL-ANAT----SLQDIYLDNNNFTSV----PTGC 132 (933)
Q Consensus 67 ~v~~L~l~~~~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~-~~l~----~L~~L~Ls~N~l~~~----~~~~ 132 (933)
+++.|+|++|+++. .++..+..+++|++|+|++|.+++..+ .+ ..++ +|++|+|++|+++.. .+..
T Consensus 29 ~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~ 108 (461)
T 1z7x_W 29 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 108 (461)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhhCCCceeEEEccCCCCCHHHHHHHHHH
Confidence 46666666666653 345556666667777777766655322 22 2233 567777777766632 2445
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCccc-----cCCccCCeeeccCcccCCCC----ChhhcCCCCCCEEEccCCcCCCCC
Q 002346 133 FDGLTNLQVLSLSDNPNLAPWPFPNEL-----TKSTSLTTLYMDNANIFGLI----PDFFDSFSNLQNLRLSYNNFTGSL 203 (933)
Q Consensus 133 ~~~l~~L~~L~Ls~N~~~~~~~~p~~~-----~~l~~L~~L~L~~n~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~ 203 (933)
+..+++|++|+|++|.+.. ..+..+ ..+++|++|+|++|++++.. +..+..+++|++|+|++|++++..
T Consensus 109 l~~~~~L~~L~Ls~n~i~~--~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~ 186 (461)
T 1z7x_W 109 LRTLPTLQELHLSDNLLGD--AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAG 186 (461)
T ss_dssp TTSCTTCCEEECCSSBCHH--HHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred HccCCceeEEECCCCcCch--HHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHHHHHHhhCCCCCEEECcCCCcchHH
Confidence 6666677777777666543 111111 12445777777776666532 444555667777777777666443
Q ss_pred Cccccc------cccchhhcccccCCcccc---cccccCCccCcEEEecCCccCCCC-----CC-CCCCCCCCEEEccCC
Q 002346 204 PASFAK------SDIQNLWMNDQQLGLSGT---LDVLSGMTQLRQVWLHKNQFTGPI-----PD-LSKCESLFDLSLRDN 268 (933)
Q Consensus 204 p~~~~~------~~l~~l~l~~n~~~~~~~---~~~l~~l~~L~~L~L~~N~l~~~~-----~~-~~~~~~L~~L~L~~N 268 (933)
+..+.. ..|++|++++|.+...+. ...+..+++|+.|+|++|++++.. +. +..+++|+.|+|++|
T Consensus 187 ~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n 266 (461)
T 1z7x_W 187 VRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWEC 266 (461)
T ss_dssp HHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred HHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCC
Confidence 333322 256666666666654331 233445666777777777665421 11 224666777777777
Q ss_pred ccccc----CcccccCCCCCCEEEccCccCccCCC--------CCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhh
Q 002346 269 QLTGV----VPASVISLPALLNISLQNNKLQGPYP--------LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQI 336 (933)
Q Consensus 269 ~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~~p--------~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~ 336 (933)
+++.. ++..+..+++|++|+|++|.+++..+ ....+|+.|+|++|.+....
T Consensus 267 ~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~----------------- 329 (461)
T 1z7x_W 267 GITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAAC----------------- 329 (461)
T ss_dssp CCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGG-----------------
T ss_pred CCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHH-----------------
Confidence 76643 45566666777777777776653221 11236667777766654321
Q ss_pred hcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcC-----cccCCeEecccCcccC----CC
Q 002346 337 AGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN-----LTSLKNLYLQQNNLTG----PI 407 (933)
Q Consensus 337 ~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~-----l~~L~~L~L~~N~l~g----~~ 407 (933)
+..++..+..+++|+.|+|++|++++..+..+.. .++|+.|+|++|++++ .+
T Consensus 330 -------------------~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l 390 (461)
T 1z7x_W 330 -------------------CSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSL 390 (461)
T ss_dssp -------------------HHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHH
T ss_pred -------------------HHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHH
Confidence 0123455667789999999999998876666653 6799999999999986 78
Q ss_pred CcccCCCCCcCEEeccCCcCccc
Q 002346 408 PDGLTKLASLQNLDVSNNNLSGK 430 (933)
Q Consensus 408 p~~~~~l~~L~~l~ls~N~l~g~ 430 (933)
|..+..+++|++|++++|++++.
T Consensus 391 ~~~l~~~~~L~~L~l~~N~i~~~ 413 (461)
T 1z7x_W 391 AATLLANHSLRELDLSNNCLGDA 413 (461)
T ss_dssp HHHHHHCCCCCEEECCSSSCCHH
T ss_pred HHHHHhCCCccEEECCCCCCCHH
Confidence 88898999999999999998764
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-27 Score=257.89 Aligned_cols=267 Identities=20% Similarity=0.179 Sum_probs=155.4
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
+.+.++++.+.+...+...+..+++|++|+|++|.|++.+| .|..+++|++|+|++|.++++++ |..+++|++|+|+
T Consensus 11 ~l~i~~ls~~~l~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~--~~~l~~L~~L~Ls 88 (317)
T 3o53_A 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLN 88 (317)
T ss_dssp EEEEESCCTTTHHHHHHHHHTTGGGCSEEECTTSCCCCCCHHHHTTCTTCCEEECTTSCCEEEEE--ETTCTTCCEEECC
T ss_pred ceeEeeccccchhhhHHHHhccCCCCCEEECcCCccCcCCHHHhhCCCcCCEEECCCCcCCcchh--hhhcCCCCEEECc
Confidence 34455555555554444445555666666666666666655 56666666666666666665543 6666666666666
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~ 225 (933)
+|++.+ ++ ..++|++|++++|++++..+.. +++|++|+|++|++++..+..+..
T Consensus 89 ~n~l~~---l~----~~~~L~~L~l~~n~l~~~~~~~---~~~L~~L~l~~N~l~~~~~~~~~~---------------- 142 (317)
T 3o53_A 89 NNYVQE---LL----VGPSIETLHAANNNISRVSCSR---GQGKKNIYLANNKITMLRDLDEGC---------------- 142 (317)
T ss_dssp SSEEEE---EE----ECTTCCEEECCSSCCSEEEECC---CSSCEEEECCSSCCCSGGGBCTGG----------------
T ss_pred CCcccc---cc----CCCCcCEEECCCCccCCcCccc---cCCCCEEECCCCCCCCccchhhhc----------------
Confidence 666554 11 2356666666666666554332 455666666666666444444332
Q ss_pred cccccccCCccCcEEEecCCccCCCCCC-C-CCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCC--
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPD-L-SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF-- 301 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~-~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~-- 301 (933)
+++|+.|+|++|++++..+. + ..+++|++|+|++|++++. |. ...+++|++|+|++|++++..+.+
T Consensus 143 --------l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~~~~~ 212 (317)
T 3o53_A 143 --------RSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPEFQS 212 (317)
T ss_dssp --------GSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGGGGG
T ss_pred --------cCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-ccccccCCEEECCCCcCCcchhhhcc
Confidence 44444555555544443332 2 2344455555555544432 11 122444555555555544433322
Q ss_pred CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCcccc-
Q 002346 302 PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLA- 380 (933)
Q Consensus 302 ~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~- 380 (933)
..+|+.|+|++|+|.. +|..+..+++|+.|+|++|.+.
T Consensus 213 l~~L~~L~L~~N~l~~-----------------------------------------l~~~~~~l~~L~~L~l~~N~~~~ 251 (317)
T 3o53_A 213 AAGVTWISLRNNKLVL-----------------------------------------IEKALRFSQNLEHFDLRGNGFHC 251 (317)
T ss_dssp GTTCSEEECTTSCCCE-----------------------------------------ECTTCCCCTTCCEEECTTCCCBH
T ss_pred cCcccEEECcCCcccc-----------------------------------------hhhHhhcCCCCCEEEccCCCccC
Confidence 2344445555544422 2444566789999999999999
Q ss_pred CcCchhhcCcccCCeEecc-cCcccCCCCcccC
Q 002346 381 GNISPAYANLTSLKNLYLQ-QNNLTGPIPDGLT 412 (933)
Q Consensus 381 g~~p~~~~~l~~L~~L~L~-~N~l~g~~p~~~~ 412 (933)
+.+|..++.+++|+.|+++ .+.+.|..|....
T Consensus 252 ~~~~~~~~~~~~L~~l~l~~~~~l~~~~~~~~~ 284 (317)
T 3o53_A 252 GTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECT 284 (317)
T ss_dssp HHHHHHHHTCHHHHHHHHHHHHHHHSSSSCCCS
T ss_pred cCHHHHHhccccceEEECCCchhccCCchhccC
Confidence 8899999999999999999 5567877665543
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=99.93 E-value=6.7e-27 Score=270.30 Aligned_cols=234 Identities=22% Similarity=0.186 Sum_probs=153.4
Q ss_pred CcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCe
Q 002346 89 LTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (933)
Q Consensus 89 l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~ 167 (933)
.++|++|+|++|.|++.+| .|..+++|++|+|++|.|+++++ |..+++|++|+|++|.+.+ +| ..++|+.
T Consensus 33 ~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~~---l~----~~~~L~~ 103 (487)
T 3oja_A 33 AWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQE---LL----VGPSIET 103 (487)
T ss_dssp GGGCCEEECCSSCCCCCCGGGGTTCTTCCEEECTTSCCEEEEE--CTTCTTCCEEECCSSEEEE---EE----ECTTCCE
T ss_pred CCCccEEEeeCCcCCCCCHHHHhCCCCCCEEEeeCCCCCCCcc--cccCCCCCEEEecCCcCCC---CC----CCCCcCE
Confidence 3366777777777766655 56666677777777777665554 6666677777777766554 22 2266777
Q ss_pred eeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCcc
Q 002346 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247 (933)
Q Consensus 168 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l 247 (933)
|+|++|.+++..+. .+++|++|+|++|++++..|..+.. +++|+.|+|++|.+
T Consensus 104 L~L~~N~l~~~~~~---~l~~L~~L~L~~N~l~~~~~~~~~~------------------------l~~L~~L~Ls~N~l 156 (487)
T 3oja_A 104 LHAANNNISRVSCS---RGQGKKNIYLANNKITMLRDLDEGC------------------------RSRVQYLDLKLNEI 156 (487)
T ss_dssp EECCSSCCCCEEEC---CCSSCEEEECCSSCCCSGGGBCGGG------------------------GSSEEEEECTTSCC
T ss_pred EECcCCcCCCCCcc---ccCCCCEEECCCCCCCCCCchhhcC------------------------CCCCCEEECCCCCC
Confidence 77777777666443 3456777777777777555555433 66677777777777
Q ss_pred CCCCCC-CC-CCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCC
Q 002346 248 TGPIPD-LS-KCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKP 325 (933)
Q Consensus 248 ~~~~~~-~~-~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~ 325 (933)
++.+|. +. .+++|+.|+|++|.|++..+ +..+++|+.|+|++|.+++.+|
T Consensus 157 ~~~~~~~l~~~l~~L~~L~Ls~N~l~~~~~--~~~l~~L~~L~Ls~N~l~~~~~-------------------------- 208 (487)
T 3oja_A 157 DTVNFAELAASSDTLEHLNLQYNFIYDVKG--QVVFAKLKTLDLSSNKLAFMGP-------------------------- 208 (487)
T ss_dssp CEEEGGGGGGGTTTCCEEECTTSCCCEEEC--CCCCTTCCEEECCSSCCCEECG--------------------------
T ss_pred CCcChHHHhhhCCcccEEecCCCccccccc--cccCCCCCEEECCCCCCCCCCH--------------------------
Confidence 765543 33 56777777777777775422 3346677777777777665322
Q ss_pred CCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCccc-
Q 002346 326 CDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLT- 404 (933)
Q Consensus 326 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~- 404 (933)
.+..+++|+.|+|++|.+++ +|..++.+++|+.|+|++|.+.
T Consensus 209 ------------------------------------~~~~l~~L~~L~Ls~N~l~~-lp~~l~~l~~L~~L~l~~N~l~c 251 (487)
T 3oja_A 209 ------------------------------------EFQSAAGVTWISLRNNKLVL-IEKALRFSQNLEHFDLRGNGFHC 251 (487)
T ss_dssp ------------------------------------GGGGGTTCSEEECTTSCCCE-ECTTCCCCTTCCEEECTTCCBCH
T ss_pred ------------------------------------hHcCCCCccEEEecCCcCcc-cchhhccCCCCCEEEcCCCCCcC
Confidence 23344566777777777774 6667778888888888888887
Q ss_pred CCCCcccCCCCCcCEEecc
Q 002346 405 GPIPDGLTKLASLQNLDVS 423 (933)
Q Consensus 405 g~~p~~~~~l~~L~~l~ls 423 (933)
+.+|..+..++.|+.++++
T Consensus 252 ~~~~~~~~~l~~L~~l~~~ 270 (487)
T 3oja_A 252 GTLRDFFSKNQRVQTVAKQ 270 (487)
T ss_dssp HHHHHHHTTCHHHHHHHHH
T ss_pred cchHHHHHhCCCCcEEecc
Confidence 6777788888888877775
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-26 Score=264.46 Aligned_cols=186 Identities=17% Similarity=0.185 Sum_probs=147.9
Q ss_pred ccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCch------hHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 584 SEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK------GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
...+.||+|+||.||+|.. .++.+|+|+......... ..+++.+|++++++++||||+++..++...+..++|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 3457899999999999965 678899998655432211 245689999999999999999776666677888999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++++|.+++.. +..++.|+++||+|||+ ++|+||||||+|||++. .+||+|||+++..
T Consensus 418 mE~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~ 479 (540)
T 3en9_A 418 MSYINGKLAKDVIED-------------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKIS 479 (540)
T ss_dssp EECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEEC
T ss_pred EECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEEC
Confidence 999999999999943 55799999999999999 89999999999999998 9999999999977
Q ss_pred CCCCcee------ecccccccCcccccccCC--CCCCCccchHhHHHHHHHHHcCCCCC
Q 002346 738 PDGKYSV------ETRLAGTFGYLAPEYAAT--GRVTTKIDVYAFGVVLMETITGRKAL 788 (933)
Q Consensus 738 ~~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~SlG~~l~elltG~~p~ 788 (933)
....... .....||+.|+|||++.. ..|+.++|+|+..+-..+.+.++.+|
T Consensus 480 ~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 480 NLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred CCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 6533211 235689999999999976 56888899999999999988887665
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=232.02 Aligned_cols=210 Identities=23% Similarity=0.263 Sum_probs=163.2
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
.++.|+|++|++++..+..|..+++|++|+|++|.|+++.+ .|.++++|++|+|++|.++++++..|.++++|++|+|+
T Consensus 29 ~l~~L~ls~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~ 108 (276)
T 2z62_A 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAV 108 (276)
T ss_dssp TCCEEECTTCCCCEECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECT
T ss_pred CccEEECCCCcccccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECC
Confidence 57888888888887666678888888888888888887776 67888888888888888888887778888888888888
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCC-CChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~ 224 (933)
+|++.. ..+..+..+++|++|++++|++.+. +|..|..+++|++|+|++|++++..+..+..
T Consensus 109 ~n~l~~--~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--------------- 171 (276)
T 2z62_A 109 ETNLAS--LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRV--------------- 171 (276)
T ss_dssp TSCCCC--STTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHH---------------
T ss_pred CCCccc--cCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhh---------------
Confidence 888877 3344678888888888888888774 5788888888888888888888555555443
Q ss_pred ccccccccCCccCc-EEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC
Q 002346 225 SGTLDVLSGMTQLR-QVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (933)
Q Consensus 225 ~~~~~~l~~l~~L~-~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 299 (933)
+..++.|. .|++++|++++.++......+|+.|+|++|++++..+..|..+++|+.|+|++|++++..|
T Consensus 172 ------l~~L~~l~l~L~ls~n~l~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 241 (276)
T 2z62_A 172 ------LHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 241 (276)
T ss_dssp ------HHTCTTCCEEEECCSSCCCEECTTSSCSCCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTT
T ss_pred ------hhhccccceeeecCCCcccccCccccCCCcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCC
Confidence 22233333 7888888888877776666688889999888887666677888888888888888886544
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.1e-24 Score=230.82 Aligned_cols=43 Identities=28% Similarity=0.314 Sum_probs=30.8
Q ss_pred ccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCC
Q 002346 391 TSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPD 433 (933)
Q Consensus 391 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~ 433 (933)
.+|+.|+|++|++++..+..|..+++|+.|++++|++++..|.
T Consensus 200 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~~ 242 (276)
T 2z62_A 200 IRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR 242 (276)
T ss_dssp CCEEEEECCSSCCSCCCTTTTTTCCSCCEEECCSSCBCCCTTT
T ss_pred CcccEEECCCCceeecCHhHhcccccccEEEccCCcccccCCc
Confidence 3677777777777755555667777788888888887777664
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I | Back alignment and structure |
|---|
Probab=99.91 E-value=4.6e-28 Score=279.86 Aligned_cols=328 Identities=17% Similarity=0.180 Sum_probs=241.9
Q ss_pred CCEEEEEecCCCCccccCcc-ccCCcccceeeccccccccc----CC-CccCcCcCceeccccccccCCCCCc-ccCCC-
Q 002346 66 NRVTTISLAKSGLSGTLSPE-ISSLTQLETLSFQMNNIAGA----IP-SLANATSLQDIYLDNNNFTSVPTGC-FDGLT- 137 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~-~~~l~~L~~L~l~~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~~~~~~~-~~~l~- 137 (933)
.+++.|+|++++++...... +..+++|++|+|++|.+++. ++ .+..+++|++|+|++|.++...... +..++
T Consensus 3 ~~l~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~ 82 (461)
T 1z7x_W 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT 82 (461)
T ss_dssp EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred ccceehhhhhcccCchhHHHHHhhcCCccEEEccCCCCCHHHHHHHHHHHHhCCCcCEEeCCCCcCChHHHHHHHHHHhh
Confidence 36899999999997654433 78899999999999999853 33 5788899999999999998643322 23455
Q ss_pred ---CCCEEEccCCCCCCCC--CCCccccCCccCCeeeccCcccCCCCChhhc-----CCCCCCEEEccCCcCCCCCCccc
Q 002346 138 ---NLQVLSLSDNPNLAPW--PFPNELTKSTSLTTLYMDNANIFGLIPDFFD-----SFSNLQNLRLSYNNFTGSLPASF 207 (933)
Q Consensus 138 ---~L~~L~Ls~N~~~~~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~~~p~~~ 207 (933)
+|++|+|++|++.... .++..+..+++|++|+|++|.+....+..+. ..++|++|+|++|++++.....+
T Consensus 83 ~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l 162 (461)
T 1z7x_W 83 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 162 (461)
T ss_dssp TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred CCCceeEEEccCCCCCHHHHHHHHHHHccCCceeEEECCCCcCchHHHHHHHHHHhcCCCcceEEECCCCCCCHHHHHHH
Confidence 7999999999988421 3578899999999999999998765454443 36789999999999986543333
Q ss_pred ----cc-cccchhhcccccCCccccccccc----CCccCcEEEecCCccCCC-----CCCCCCCCCCCEEEccCCccccc
Q 002346 208 ----AK-SDIQNLWMNDQQLGLSGTLDVLS----GMTQLRQVWLHKNQFTGP-----IPDLSKCESLFDLSLRDNQLTGV 273 (933)
Q Consensus 208 ----~~-~~l~~l~l~~n~~~~~~~~~~l~----~l~~L~~L~L~~N~l~~~-----~~~~~~~~~L~~L~L~~N~l~~~ 273 (933)
.. ..|++|++++|.+...+...... ..++|+.|+|++|.+++. ...+..+++|+.|+|++|++++.
T Consensus 163 ~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~l~~~ 242 (461)
T 1z7x_W 163 ASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDV 242 (461)
T ss_dssp HHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHH
T ss_pred HHHHhhCCCCCEEECcCCCcchHHHHHHHHHHhcCCCCceEEEccCCCCcHHHHHHHHHHHHhCCCccEEeccCCcCChH
Confidence 22 57888888888876544332211 245889999999988863 22366788899999999988754
Q ss_pred C-----cccccCCCCCCEEEccCccCccC----CCCC---CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccC
Q 002346 274 V-----PASVISLPALLNISLQNNKLQGP----YPLF---PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMG 341 (933)
Q Consensus 274 ~-----p~~l~~l~~L~~L~Ls~N~l~~~----~p~~---~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 341 (933)
. +..+..+++|++|+|++|.+++. ++.. ..+|+.|+|++|.+..... ..
T Consensus 243 ~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~-------------~~------ 303 (461)
T 1z7x_W 243 GMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGA-------------RL------ 303 (461)
T ss_dssp HHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHH-------------HH------
T ss_pred HHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHH-------------HH------
Confidence 3 23334578899999999988863 2221 4578888988887743110 00
Q ss_pred CCccccCCCCCCCCCCCCCcccc-CCCceeEEEccCccccCc----CchhhcCcccCCeEecccCcccCCCCcccCC---
Q 002346 342 YPAILSDSWEGNNACDGWPFVTC-SQGRIITINLANKLLAGN----ISPAYANLTSLKNLYLQQNNLTGPIPDGLTK--- 413 (933)
Q Consensus 342 ~~~~l~~~~~~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~g~----~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~--- 413 (933)
+...+. ..++|+.|+|++|.+++. ++..+..+++|+.|+|++|++++..+..+..
T Consensus 304 -----------------l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~ 366 (461)
T 1z7x_W 304 -----------------LCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLG 366 (461)
T ss_dssp -----------------HHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHT
T ss_pred -----------------HHHHhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHc
Confidence 001111 225899999999999976 6777888899999999999998765655543
Q ss_pred --CCCcCEEeccCCcCcc
Q 002346 414 --LASLQNLDVSNNNLSG 429 (933)
Q Consensus 414 --l~~L~~l~ls~N~l~g 429 (933)
.++|+.|++++|++++
T Consensus 367 ~~~~~L~~L~L~~n~i~~ 384 (461)
T 1z7x_W 367 QPGSVLRVLWLADCDVSD 384 (461)
T ss_dssp STTCCCCEEECTTSCCCH
T ss_pred CCCCceEEEECCCCCCCh
Confidence 7799999999999986
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=230.67 Aligned_cols=229 Identities=21% Similarity=0.245 Sum_probs=170.9
Q ss_pred CcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCee
Q 002346 89 LTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (933)
Q Consensus 89 l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L 168 (933)
+.++..+++..+.+.... .+..+++|+.|++++|.++.++. +..+++|++|+|++|.+.. + ..+..+++|++|
T Consensus 18 ~~~l~~l~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~--l~~l~~L~~L~l~~n~l~~---~-~~l~~l~~L~~L 90 (272)
T 3rfs_A 18 FAETIKANLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD---I-SALKELTNLTYL 90 (272)
T ss_dssp HHHHHHHHHTCSCTTSEE-CHHHHTTCCEEECTTSCCCCCTT--GGGCTTCCEEECTTSCCCC---C-GGGTTCTTCCEE
T ss_pred HHHHHHHHhcCccccccc-ccccccceeeeeeCCCCcccccc--cccCCCCcEEECCCCCCCC---c-hhhcCCCCCCEE
Confidence 445556666666666443 35567778888888888776653 6778888888888888776 2 467788888888
Q ss_pred eccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccC
Q 002346 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT 248 (933)
Q Consensus 169 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~ 248 (933)
+|++|++++..+..|..+++|++|+|++|++++..+..|. ++++|++|+|++|+++
T Consensus 91 ~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~------------------------~l~~L~~L~L~~n~l~ 146 (272)
T 3rfs_A 91 ILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFD------------------------KLTNLTYLNLAHNQLQ 146 (272)
T ss_dssp ECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTT------------------------TCTTCCEEECCSSCCC
T ss_pred ECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhc------------------------cCCCCCEEECCCCccC
Confidence 8888888887777788888888888888888855554443 3778888888888888
Q ss_pred CCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCC
Q 002346 249 GPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD 327 (933)
Q Consensus 249 ~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~ 327 (933)
+.++. +..+++|+.|+|++|++++..+..+..+++|+.|+|++|++++..|.
T Consensus 147 ~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~--------------------------- 199 (272)
T 3rfs_A 147 SLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDG--------------------------- 199 (272)
T ss_dssp CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTT---------------------------
T ss_pred ccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHH---------------------------
Confidence 77765 57788888888888888877777778888888888888888764432
Q ss_pred chhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCC
Q 002346 328 PQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407 (933)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~ 407 (933)
.+..+++|+.|+|++|.+.+. +++|+.|+++.|+++|.+
T Consensus 200 ----------------------------------~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g~i 238 (272)
T 3rfs_A 200 ----------------------------------VFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSGVV 238 (272)
T ss_dssp ----------------------------------TTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGGGB
T ss_pred ----------------------------------HHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCCcc
Confidence 233456777777777777654 456888899999999999
Q ss_pred CcccCCCCC
Q 002346 408 PDGLTKLAS 416 (933)
Q Consensus 408 p~~~~~l~~ 416 (933)
|.+++.++.
T Consensus 239 p~~~~~~~~ 247 (272)
T 3rfs_A 239 RNSAGSVAP 247 (272)
T ss_dssp BCTTSCBCG
T ss_pred cCcccccCC
Confidence 998887765
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=229.67 Aligned_cols=225 Identities=19% Similarity=0.206 Sum_probs=191.6
Q ss_pred CcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCC
Q 002346 111 NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ 190 (933)
Q Consensus 111 ~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 190 (933)
.+.++..+++.++.+..+.. +..+++|+.|++++|.+.. + ..+..+++|++|+|++|++.+. ..+..+++|+
T Consensus 17 ~~~~l~~l~l~~~~~~~~~~--~~~l~~L~~L~l~~~~i~~---~-~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~ 88 (272)
T 3rfs_A 17 AFAETIKANLKKKSVTDAVT--QNELNSIDQIIANNSDIKS---V-QGIQYLPNVRYLALGGNKLHDI--SALKELTNLT 88 (272)
T ss_dssp HHHHHHHHHHTCSCTTSEEC--HHHHTTCCEEECTTSCCCC---C-TTGGGCTTCCEEECTTSCCCCC--GGGTTCTTCC
T ss_pred hHHHHHHHHhcCcccccccc--cccccceeeeeeCCCCccc---c-cccccCCCCcEEECCCCCCCCc--hhhcCCCCCC
Confidence 34567778888888876643 6788999999999999877 3 4688999999999999999874 4789999999
Q ss_pred EEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCc
Q 002346 191 NLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQ 269 (933)
Q Consensus 191 ~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~ 269 (933)
+|+|++|++++..+..+. ++++|++|+|++|++++.++. +..+++|++|+|++|+
T Consensus 89 ~L~L~~n~l~~~~~~~~~------------------------~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~ 144 (272)
T 3rfs_A 89 YLILTGNQLQSLPNGVFD------------------------KLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQ 144 (272)
T ss_dssp EEECTTSCCCCCCTTTTT------------------------TCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSC
T ss_pred EEECCCCccCccChhHhc------------------------CCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCc
Confidence 999999999965555444 489999999999999988876 7899999999999999
Q ss_pred ccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCC
Q 002346 270 LTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349 (933)
Q Consensus 270 l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 349 (933)
+++..+..+..+++|+.|+|++|++++..+
T Consensus 145 l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~-------------------------------------------------- 174 (272)
T 3rfs_A 145 LQSLPKGVFDKLTNLTELDLSYNQLQSLPE-------------------------------------------------- 174 (272)
T ss_dssp CCCCCTTTTTTCTTCCEEECCSSCCCCCCT--------------------------------------------------
T ss_pred cCccCHHHhccCccCCEEECCCCCcCccCH--------------------------------------------------
Confidence 998888888999999999999999886433
Q ss_pred CCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcc
Q 002346 350 WEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429 (933)
Q Consensus 350 ~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g 429 (933)
..+..+++|+.|+|++|++++..|..|+.+++|+.|+|++|.+.+. ++.|++|+++.|+++|
T Consensus 175 -----------~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~-------~~~l~~l~~~~n~~~g 236 (272)
T 3rfs_A 175 -----------GVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCT-------CPGIRYLSEWINKHSG 236 (272)
T ss_dssp -----------TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC-------TTTTHHHHHHHHHTGG
T ss_pred -----------HHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCcccc-------CcHHHHHHHHHHhCCC
Confidence 2234567899999999999998888899999999999999998855 4579999999999999
Q ss_pred cCCCCC
Q 002346 430 KVPDFG 435 (933)
Q Consensus 430 ~~p~~~ 435 (933)
.+|...
T Consensus 237 ~ip~~~ 242 (272)
T 3rfs_A 237 VVRNSA 242 (272)
T ss_dssp GBBCTT
T ss_pred cccCcc
Confidence 999743
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=3.8e-23 Score=222.00 Aligned_cols=202 Identities=22% Similarity=0.224 Sum_probs=173.3
Q ss_pred eCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCC
Q 002346 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140 (933)
Q Consensus 62 c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 140 (933)
|.+-..++.|++++++|+ .+|..+. ++|+.|+|++|.|++..+ .|..+++|++|+|++|.|++++.. +.+++|+
T Consensus 6 ~~~l~~l~~l~~~~~~l~-~ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~--~~l~~L~ 80 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVD--GTLPVLG 80 (290)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEECC--SCCTTCC
T ss_pred ccccCCccEEECCCCCCC-cCCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCcccCC--CCCCcCC
Confidence 444457889999999998 5666554 689999999999998877 789999999999999999988764 7899999
Q ss_pred EEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccc
Q 002346 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQ 220 (933)
Q Consensus 141 ~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n 220 (933)
+|+|++|++.. +|..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..+..|
T Consensus 81 ~L~Ls~N~l~~---l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~------------- 144 (290)
T 1p9a_G 81 TLDLSHNQLQS---LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL------------- 144 (290)
T ss_dssp EEECCSSCCSS---CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT-------------
T ss_pred EEECCCCcCCc---CchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhc-------------
Confidence 99999999986 78888999999999999999999888899999999999999999985444433
Q ss_pred cCCcccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCcc
Q 002346 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 221 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
..+++|+.|+|++|+|++.++. +..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 145 -----------~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 145 -----------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp -----------TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred -----------ccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 3488999999999999987775 678999999999999999 788888888899999999998874
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.8e-23 Score=218.38 Aligned_cols=202 Identities=14% Similarity=0.151 Sum_probs=158.6
Q ss_pred ccCccccCCcccceeecccccccccCC-CccCcCcCceecccccc-ccCCCCCcccCCCCCCEEEccC-CCCCCCCCCCc
Q 002346 81 TLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN-FTSVPTGCFDGLTNLQVLSLSD-NPNLAPWPFPN 157 (933)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~-l~~~~~~~~~~l~~L~~L~Ls~-N~~~~~~~~p~ 157 (933)
.+|. +. ++|++|+|++|+|+++++ .|.++++|++|+|++|. ++.+++..|.++++|++|+|++ |++.. ..+.
T Consensus 25 ~ip~-~~--~~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~L~~L~l~~~n~l~~--i~~~ 99 (239)
T 2xwt_C 25 RIPS-LP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTY--IDPD 99 (239)
T ss_dssp SCCC-CC--TTCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTTCCEEEEEEETTCCE--ECTT
T ss_pred ccCC-CC--CcccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcCCcEEECCCCCCeeE--cCHH
Confidence 4554 33 378888888888888777 78888888888888886 8888888888888888888888 88877 3346
Q ss_pred cccCCccCCeeeccCcccCCCCChhhcCCCCCC---EEEccCC-cCCCCCCccccccccchhhcccccCCcccccccccC
Q 002346 158 ELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ---NLRLSYN-NFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233 (933)
Q Consensus 158 ~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~---~L~L~~N-~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~ 233 (933)
.|.++++|++|++++|++++ +|. |..+++|+ +|+|++| ++++..+..| .+
T Consensus 100 ~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~------------------------~~ 153 (239)
T 2xwt_C 100 ALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAF------------------------QG 153 (239)
T ss_dssp SEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTT------------------------TT
T ss_pred HhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccc------------------------cc
Confidence 78888888888888888877 455 77888888 8888888 8874444333 34
Q ss_pred CccCc-EEEecCCccCCCCCCCCCCCCCCEEEccCCc-ccccCcccccCC-CCCCEEEccCccCccCCCCCCCCccEEec
Q 002346 234 MTQLR-QVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ-LTGVVPASVISL-PALLNISLQNNKLQGPYPLFPSKVQKVSL 310 (933)
Q Consensus 234 l~~L~-~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~-l~~~~p~~l~~l-~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l 310 (933)
+++|+ .|+|++|+++..++.....++|+.|+|++|+ +++..+..|..+ ++|+.|+|++|++++..+..+.+++.|++
T Consensus 154 l~~L~~~L~l~~n~l~~i~~~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~~l~~~~~~~L~~L~l 233 (239)
T 2xwt_C 154 LCNETLTLKLYNNGFTSVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIA 233 (239)
T ss_dssp TBSSEEEEECCSCCCCEECTTTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCCCCCCTTCTTCSEEEC
T ss_pred hhcceeEEEcCCCCCcccCHhhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccccCChhHhccCceeec
Confidence 78888 8888888888655554444788899999985 886667788888 88999999999988776666778888888
Q ss_pred cCC
Q 002346 311 DHN 313 (933)
Q Consensus 311 ~~n 313 (933)
+++
T Consensus 234 ~~~ 236 (239)
T 2xwt_C 234 RNT 236 (239)
T ss_dssp TTC
T ss_pred cCc
Confidence 765
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.4e-23 Score=220.80 Aligned_cols=204 Identities=20% Similarity=0.198 Sum_probs=138.6
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCcccccccc
Q 002346 133 FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDI 212 (933)
Q Consensus 133 ~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l 212 (933)
+.++++|+++++++|.++. +|..+. ++|+.|+|++|++.+..+..|..+++|++|+|++|++++ ++..
T Consensus 6 ~~~l~~l~~l~~~~~~l~~---ip~~~~--~~l~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~-~~~~------ 73 (290)
T 1p9a_G 6 VSKVASHLEVNCDKRNLTA---LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQVD------ 73 (290)
T ss_dssp EECSTTCCEEECTTSCCSS---CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCE-EECC------
T ss_pred ccccCCccEEECCCCCCCc---CCCCCC--CCCCEEEcCCCcCCccCHHHhhcCCCCCEEECCCCccCc-ccCC------
Confidence 3444455555555554444 343332 456666666666666666677777777777777777763 2211
Q ss_pred chhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCc
Q 002346 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292 (933)
Q Consensus 213 ~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 292 (933)
..+++|+.|+|++|+|+..+..+..+++|+.|+|++|+|++..|..|..+++|++|+|++|
T Consensus 74 -------------------~~l~~L~~L~Ls~N~l~~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~L~~N 134 (290)
T 1p9a_G 74 -------------------GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGN 134 (290)
T ss_dssp -------------------SCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTS
T ss_pred -------------------CCCCcCCEEECCCCcCCcCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEECCCC
Confidence 1366777777777777765555677777777777777777666677777777777777777
Q ss_pred cCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEE
Q 002346 293 KLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITI 372 (933)
Q Consensus 293 ~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L 372 (933)
++++..+ ..+..+++|+.|
T Consensus 135 ~l~~~~~-------------------------------------------------------------~~~~~l~~L~~L 153 (290)
T 1p9a_G 135 ELKTLPP-------------------------------------------------------------GLLTPTPKLEKL 153 (290)
T ss_dssp CCCCCCT-------------------------------------------------------------TTTTTCTTCCEE
T ss_pred CCCccCh-------------------------------------------------------------hhcccccCCCEE
Confidence 7764332 122344667777
Q ss_pred EccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcc
Q 002346 373 NLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429 (933)
Q Consensus 373 ~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g 429 (933)
+|++|+|++..+..|.++++|+.|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 154 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~-~ip~~~~~~~~L~~l~L~~Np~~C 209 (290)
T 1p9a_G 154 SLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (290)
T ss_dssp ECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ECCCCcCCccCHHHhcCcCCCCEEECCCCcCC-ccChhhcccccCCeEEeCCCCccC
Confidence 77777777655566788899999999999998 788888888889999888887754
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-22 Score=215.81 Aligned_cols=138 Identities=25% Similarity=0.287 Sum_probs=90.7
Q ss_pred CccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccC
Q 002346 234 MTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDH 312 (933)
Q Consensus 234 l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~ 312 (933)
+++|++|+|++|++++.++. +..+++|+.|+|++|++++..+..|..+++|++|+|++|.+++..+
T Consensus 84 l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~------------- 150 (270)
T 2o6q_A 84 LKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPK------------- 150 (270)
T ss_dssp CTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCT-------------
T ss_pred CCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEECCCCcCCccCH-------------
Confidence 45555555555555544443 4555566666666666665555556666666666666666553222
Q ss_pred CcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCccc
Q 002346 313 NNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTS 392 (933)
Q Consensus 313 n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~ 392 (933)
..+..+++|+.|+|++|++++..+..|.++++
T Consensus 151 ------------------------------------------------~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 182 (270)
T 2o6q_A 151 ------------------------------------------------GVFDKLTSLKELRLYNNQLKRVPEGAFDKLTE 182 (270)
T ss_dssp ------------------------------------------------TTTTTCTTCCEEECCSSCCSCCCTTTTTTCTT
T ss_pred ------------------------------------------------hHccCCcccceeEecCCcCcEeChhHhccCCC
Confidence 11233456666666666666656667888899
Q ss_pred CCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCC
Q 002346 393 LKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 393 L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p 432 (933)
|+.|+|++|++++..+..|..+++|+.|+|++|++.+..+
T Consensus 183 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~c~ 222 (270)
T 2o6q_A 183 LKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQENPWDCTCN 222 (270)
T ss_dssp CCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCSSS
T ss_pred cCEEECCCCcCCcCCHHHhccccCCCEEEecCCCeeCCCc
Confidence 9999999999997667778889999999999998876554
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-23 Score=216.78 Aligned_cols=141 Identities=25% Similarity=0.377 Sum_probs=92.0
Q ss_pred CCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCC
Q 002346 53 GYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTG 131 (933)
Q Consensus 53 ~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~ 131 (933)
+||.|.|++|.. ..+.+++++++++ .+|..+. ++|+.|+|++|.|++..+ .|.++++|++|+|++|.|+++++.
T Consensus 3 ~Cp~~~gC~C~~--~~~~l~~~~~~l~-~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~ 77 (251)
T 3m19_A 3 TCETVTGCTCNE--GKKEVDCQGKSLD-SVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAG 77 (251)
T ss_dssp -CHHHHSSEEEG--GGTEEECTTCCCS-SCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTT
T ss_pred cCCCCCceEcCC--CCeEEecCCCCcc-ccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCccCHh
Confidence 478999999953 3457888888887 5665554 577777777777777766 577777777777777777777766
Q ss_pred cccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCC
Q 002346 132 CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 132 ~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 200 (933)
.|.++++|++|+|++|++.. ..+..+..+++|++|+|++|+|++..+..|..+++|++|+|++|+|+
T Consensus 78 ~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 144 (251)
T 3m19_A 78 VFDDLTELGTLGLANNQLAS--LPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ 144 (251)
T ss_dssp TTTTCTTCCEEECTTSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred HhccCCcCCEEECCCCcccc--cChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEEECcCCcCC
Confidence 66666666666666666655 23344455555555555555555554444555555555555555554
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.6e-23 Score=227.78 Aligned_cols=203 Identities=17% Similarity=0.147 Sum_probs=121.3
Q ss_pred CCCCEEEccCCCCCCCCCCCccc--cCCccCCeeeccCcccCCCCC----hhhcCCCCCCEEEccCCcCCCCCCcccccc
Q 002346 137 TNLQVLSLSDNPNLAPWPFPNEL--TKSTSLTTLYMDNANIFGLIP----DFFDSFSNLQNLRLSYNNFTGSLPASFAKS 210 (933)
Q Consensus 137 ~~L~~L~Ls~N~~~~~~~~p~~~--~~l~~L~~L~L~~n~l~~~~p----~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~ 210 (933)
++|++|+|++|.+.+ ..|..+ ..+++|++|+|++|.+.+..+ ..+..+++|++|+|++|++++..|..+..
T Consensus 91 ~~L~~L~l~~n~l~~--~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~- 167 (310)
T 4glp_A 91 SRLKELTLEDLKITG--TMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRA- 167 (310)
T ss_dssp SCCCEEEEESCCCBS--CCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCC-
T ss_pred CceeEEEeeCCEecc--chhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhcc-
Confidence 345555555555544 334444 555555555555555555433 23345666666666666665444444332
Q ss_pred ccchhhcccccCCcccccccccCCccCcEEEecCCccCC---CCCC--CCCCCCCCEEEccCCcccccCcc----cccCC
Q 002346 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG---PIPD--LSKCESLFDLSLRDNQLTGVVPA----SVISL 281 (933)
Q Consensus 211 ~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~---~~~~--~~~~~~L~~L~L~~N~l~~~~p~----~l~~l 281 (933)
+++|++|+|++|++.+ ..+. +..+++|++|+|++|+++ .++. .+..+
T Consensus 168 -----------------------l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~~l 223 (310)
T 4glp_A 168 -----------------------FPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAALAAAG 223 (310)
T ss_dssp -----------------------CTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHHHHHHT
T ss_pred -----------------------CCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHHHHhcC
Confidence 5666666666666544 2211 356677777777777776 2222 24566
Q ss_pred CCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCc
Q 002346 282 PALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPF 361 (933)
Q Consensus 282 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~ 361 (933)
++|++|+|++|++++..|..+..
T Consensus 224 ~~L~~L~Ls~N~l~~~~p~~~~~--------------------------------------------------------- 246 (310)
T 4glp_A 224 VQPHSLDLSHNSLRATVNPSAPR--------------------------------------------------------- 246 (310)
T ss_dssp CCCSSEECTTSCCCCCCCSCCSS---------------------------------------------------------
T ss_pred CCCCEEECCCCCCCccchhhHHh---------------------------------------------------------
Confidence 77777777777777654421110
Q ss_pred cccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcc
Q 002346 362 VTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429 (933)
Q Consensus 362 ~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g 429 (933)
...+++|+.|+|++|+++ .+|..+. ++|+.|+|++|+|++. |. +..+++|+.|+|++|+|+.
T Consensus 247 -~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~Ls~N~l~~~-~~-~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 247 -CMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLDLSSNRLNRA-PQ-PDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp -CCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEECCSCCCCSC-CC-TTSCCCCSCEECSSTTTSC
T ss_pred -ccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEECCCCcCCCC-ch-hhhCCCccEEECcCCCCCC
Confidence 001246677777777777 5666554 6888888888888853 43 6777888888888888864
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.2e-24 Score=242.35 Aligned_cols=259 Identities=17% Similarity=0.247 Sum_probs=142.9
Q ss_pred eecccccccccCCCccCc-CcCceeccccccccCCCC----CcccCCC-CCCEEEccCCCCCCCCCCCccccCC-----c
Q 002346 95 LSFQMNNIAGAIPSLANA-TSLQDIYLDNNNFTSVPT----GCFDGLT-NLQVLSLSDNPNLAPWPFPNELTKS-----T 163 (933)
Q Consensus 95 L~l~~N~l~~~~p~~~~l-~~L~~L~Ls~N~l~~~~~----~~~~~l~-~L~~L~Ls~N~~~~~~~~p~~~~~l-----~ 163 (933)
++|+.|.++|.+|.+... ++|++|+|++|.|+.++. ..|..++ +|++|+|++|++.. ..+..+..+ +
T Consensus 3 ~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~--~~~~~l~~~l~~~~~ 80 (362)
T 3goz_A 3 YKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGF--KNSDELVQILAAIPA 80 (362)
T ss_dssp EECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGG--SCHHHHHHHHHTSCT
T ss_pred cccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCH--HHHHHHHHHHhccCC
Confidence 345555555555533222 235555555555555554 4455555 55555555555554 223344433 5
Q ss_pred cCCeeeccCcccCCCCChhhc----CC-CCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCC-ccC
Q 002346 164 SLTTLYMDNANIFGLIPDFFD----SF-SNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM-TQL 237 (933)
Q Consensus 164 ~L~~L~L~~n~l~~~~p~~~~----~l-~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l-~~L 237 (933)
+|++|+|++|.+++..+..+. .+ ++|++|+|++|++++..+..++. .+..+ ++|
T Consensus 81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~--------------------~l~~~~~~L 140 (362)
T 3goz_A 81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQ--------------------AFSNLPASI 140 (362)
T ss_dssp TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHH--------------------HHTTSCTTC
T ss_pred CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHH--------------------HHHhCCCce
Confidence 666666666666655554333 23 56666666666666444433322 12222 466
Q ss_pred cEEEecCCccCCCCCC-----CCCCC-CCCEEEccCCcccccCccccc----CC-CCCCEEEccCccCccCCCCCCCCcc
Q 002346 238 RQVWLHKNQFTGPIPD-----LSKCE-SLFDLSLRDNQLTGVVPASVI----SL-PALLNISLQNNKLQGPYPLFPSKVQ 306 (933)
Q Consensus 238 ~~L~L~~N~l~~~~~~-----~~~~~-~L~~L~L~~N~l~~~~p~~l~----~l-~~L~~L~Ls~N~l~~~~p~~~~~l~ 306 (933)
++|+|++|++++.... +..++ +|+.|+|++|++++..+..+. .+ ++|++|+|++|.+++...
T Consensus 141 ~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~------- 213 (362)
T 3goz_A 141 TSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSY------- 213 (362)
T ss_dssp CEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCH-------
T ss_pred eEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHH-------
Confidence 6666666666643221 23333 667777777777655554333 23 466667776666664211
Q ss_pred EEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccC-CCceeEEEccCccccCcCc-
Q 002346 307 KVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS-QGRIITINLANKLLAGNIS- 384 (933)
Q Consensus 307 ~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~-l~~L~~L~Ls~N~l~g~~p- 384 (933)
..++..+.. .++|+.|+|++|.+++..+
T Consensus 214 --------------------------------------------------~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~ 243 (362)
T 3goz_A 214 --------------------------------------------------AELAYIFSSIPNHVVSLNLCLNCLHGPSLE 243 (362)
T ss_dssp --------------------------------------------------HHHHHHHHHSCTTCCEEECCSSCCCCCCHH
T ss_pred --------------------------------------------------HHHHHHHhcCCCCceEEECcCCCCCcHHHH
Confidence 011222222 2366777777777766544
Q ss_pred ---hhhcCcccCCeEecccCcccCC-------CCcccCCCCCcCEEeccCCcCcccCC
Q 002346 385 ---PAYANLTSLKNLYLQQNNLTGP-------IPDGLTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 385 ---~~~~~l~~L~~L~L~~N~l~g~-------~p~~~~~l~~L~~l~ls~N~l~g~~p 432 (933)
..+..+++|+.|+|++|++.+. ++..+..+++|+.||+++|++....+
T Consensus 244 ~l~~~~~~l~~L~~L~L~~n~l~~i~~~~~~~l~~~~~~l~~L~~LdL~~N~l~~~~~ 301 (362)
T 3goz_A 244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPSHS 301 (362)
T ss_dssp HHHHTTTTTTTCSEEEEEHHHHTTCCHHHHHHHHTTSTTCCEEEEECTTSCBCCGGGC
T ss_pred HHHHHHhcCCCccEEEeccCCccccCHHHHHHHHHHhccCCceEEEecCCCcCCCcch
Confidence 3446678888888888885533 33467778888888888888876643
|
| >4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.1e-23 Score=222.29 Aligned_cols=225 Identities=21% Similarity=0.268 Sum_probs=163.5
Q ss_pred CEEEEEecCCCCccccCc---cccCCcccceeecccccccccCC-Cc--cCcCcCceeccccccccCCCC----CcccCC
Q 002346 67 RVTTISLAKSGLSGTLSP---EISSLTQLETLSFQMNNIAGAIP-SL--ANATSLQDIYLDNNNFTSVPT----GCFDGL 136 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~---~~~~l~~L~~L~l~~N~l~~~~p-~~--~~l~~L~~L~Ls~N~l~~~~~----~~~~~l 136 (933)
+++.+.+.+..++...-. .+..+++|++|+|++|.+++.+| .+ ..+++|++|+|++|.+++..+ ..+..+
T Consensus 65 ~l~~l~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~~~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~ 144 (310)
T 4glp_A 65 RVRRLTVGAAQVPAQLLVGALRVLAYSRLKELTLEDLKITGTMPPLPLEATGLALSSLRLRNVSWATGRSWLAELQQWLK 144 (310)
T ss_dssp CCCEEEECSCCCBHHHHHHHHHHHHHSCCCEEEEESCCCBSCCCCCSSSCCCBCCSSCEEESCCCSSTTSSHHHHHTTBC
T ss_pred ceeEEEEeCCcCCHHHHHHHHHhcccCceeEEEeeCCEeccchhhhhhhccCCCCCEEEeecccccchhhhhHHHHhhhc
Confidence 567788887777532111 12235668889999888888777 55 788889999999988886433 334578
Q ss_pred CCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCC---C-ChhhcCCCCCCEEEccCCcCCCCCCcccccccc
Q 002346 137 TNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL---I-PDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDI 212 (933)
Q Consensus 137 ~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~---~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l 212 (933)
++|++|+|++|++.. ..+..+..+++|++|+|++|++.+. . +..++.+++|++|+|++|+++ .++.....
T Consensus 145 ~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~-~l~~~~~~--- 218 (310)
T 4glp_A 145 PGLKVLSIAQAHSPA--FSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGME-TPTGVCAA--- 218 (310)
T ss_dssp SCCCEEEEECCSSCC--CCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCC-CHHHHHHH---
T ss_pred cCCCEEEeeCCCcch--hhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCC-chHHHHHH---
Confidence 889999999888877 4567888888899999998887652 1 233467888899999998886 33322100
Q ss_pred chhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCC---CCCCEEEccCCcccccCcccccCCCCCCEEE
Q 002346 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKC---ESLFDLSLRDNQLTGVVPASVISLPALLNIS 288 (933)
Q Consensus 213 ~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~---~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 288 (933)
.+..+++|++|+|++|++++..| .+..+ ++|++|+|++|+|+ .+|..+. ++|+.|+
T Consensus 219 -----------------l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~--~~L~~L~ 278 (310)
T 4glp_A 219 -----------------LAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLP--AKLRVLD 278 (310)
T ss_dssp -----------------HHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCC--SCCSCEE
T ss_pred -----------------HHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhc--CCCCEEE
Confidence 12347888888888888888744 45554 68888888888888 6777664 7888888
Q ss_pred ccCccCcc-CCCCCCCCccEEeccCCcCCC
Q 002346 289 LQNNKLQG-PYPLFPSKVQKVSLDHNNFCK 317 (933)
Q Consensus 289 Ls~N~l~~-~~p~~~~~l~~L~l~~n~~~~ 317 (933)
|++|++++ ..+..+.+|+.|+|++|.|..
T Consensus 279 Ls~N~l~~~~~~~~l~~L~~L~L~~N~l~~ 308 (310)
T 4glp_A 279 LSSNRLNRAPQPDELPEVDNLTLDGNPFLV 308 (310)
T ss_dssp CCSCCCCSCCCTTSCCCCSCEECSSTTTSC
T ss_pred CCCCcCCCCchhhhCCCccEEECcCCCCCC
Confidence 88888887 445556788888888888754
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-24 Score=239.13 Aligned_cols=211 Identities=20% Similarity=0.265 Sum_probs=139.0
Q ss_pred CCccccceEeCCCCCEEEEEecCCCCccccCccccCC--cccceeecccccccccCCCccCcCcCceeccccccccCC-C
Q 002346 53 GYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSL--TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV-P 129 (933)
Q Consensus 53 ~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l--~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~-~ 129 (933)
.|..|.++.|+. ..++.|+++++++. +..+..+ +.++.|++++|.+++.++.+..+++|++|+|++|.++.. .
T Consensus 35 vc~~W~~~~~~~-~~~~~l~l~~~~~~---~~~~~~~~~~~l~~L~l~~n~l~~~~~~~~~~~~L~~L~L~~~~l~~~~~ 110 (336)
T 2ast_B 35 VCKRWYRLASDE-SLWQTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTL 110 (336)
T ss_dssp SCHHHHHHHTCS-TTSSEEECTTCBCC---HHHHHHHHHTTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHH
T ss_pred HHHHHHHHhcCc-hhheeeccccccCC---HHHHHhhhhccceEEEcCCccccccchhhccCCCCCEEEccCCCcCHHHH
Confidence 445799998863 46789999998876 4566666 889999999999988888777888888888888888753 3
Q ss_pred CCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCc-ccCC-CCChhhcCCCCCCEEEccCC-cCCCC-CCc
Q 002346 130 TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA-NIFG-LIPDFFDSFSNLQNLRLSYN-NFTGS-LPA 205 (933)
Q Consensus 130 ~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n-~l~~-~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~ 205 (933)
+..+..+++|++|+|++|.+.. ..+..+..+++|++|+|++| .+++ .++..+..+++|++|+|++| .+++. ++.
T Consensus 111 ~~~~~~~~~L~~L~L~~~~l~~--~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~ 188 (336)
T 2ast_B 111 HGILSQCSKLQNLSLEGLRLSD--PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQV 188 (336)
T ss_dssp HHHHTTBCCCSEEECTTCBCCH--HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHH
T ss_pred HHHHhhCCCCCEEeCcCcccCH--HHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcChHHHHH
Confidence 3446777777777777777664 34556666777777777777 4554 24555666777777777777 66532 232
Q ss_pred cccccccchhhcccccCCcccccccccCCc-cCcEEEecCCc--cC-CCCC-CCCCCCCCCEEEccCCc-ccccCccccc
Q 002346 206 SFAKSDIQNLWMNDQQLGLSGTLDVLSGMT-QLRQVWLHKNQ--FT-GPIP-DLSKCESLFDLSLRDNQ-LTGVVPASVI 279 (933)
Q Consensus 206 ~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~-~L~~L~L~~N~--l~-~~~~-~~~~~~~L~~L~L~~N~-l~~~~p~~l~ 279 (933)
.+. .++ +|+.|+|++|. ++ +.++ .+..+++|+.|+|++|. +++..+..+.
T Consensus 189 ~~~------------------------~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~~~~l~ 244 (336)
T 2ast_B 189 AVA------------------------HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFF 244 (336)
T ss_dssp HHH------------------------HSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGG
T ss_pred HHH------------------------hcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHHHHHHh
Confidence 222 255 66666666663 32 1112 24455566666666665 4545555555
Q ss_pred CCCCCCEEEccCcc
Q 002346 280 SLPALLNISLQNNK 293 (933)
Q Consensus 280 ~l~~L~~L~Ls~N~ 293 (933)
.+++|+.|+|++|.
T Consensus 245 ~l~~L~~L~l~~~~ 258 (336)
T 2ast_B 245 QLNYLQHLSLSRCY 258 (336)
T ss_dssp GCTTCCEEECTTCT
T ss_pred CCCCCCEeeCCCCC
Confidence 55555555555553
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} | Back alignment and structure |
|---|
Probab=99.88 E-value=4.2e-24 Score=237.84 Aligned_cols=208 Identities=19% Similarity=0.187 Sum_probs=165.7
Q ss_pred EEEecCCCCccccCccccCCcccceeecccccccccCC-----CccCcC-cCceeccccccccCCCCCcccCC-----CC
Q 002346 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-----SLANAT-SLQDIYLDNNNFTSVPTGCFDGL-----TN 138 (933)
Q Consensus 70 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-----~~~~l~-~L~~L~Ls~N~l~~~~~~~~~~l-----~~ 138 (933)
...+++++++|.+|..+...++|++|+|++|.|++..+ .+..++ +|++|+|++|.|+......|..+ ++
T Consensus 2 ~~~ls~n~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~ 81 (362)
T 3goz_A 2 NYKLTLHPGSNPVEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPAN 81 (362)
T ss_dssp EEECCCCTTCCHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTT
T ss_pred ccccccccchHHHHHHHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCC
Confidence 46789999999999888888889999999999998764 467788 89999999999999887777775 99
Q ss_pred CCEEEccCCCCCCCCCCCcc----ccCC-ccCCeeeccCcccCCCCChhhc----C-CCCCCEEEccCCcCCCCCCcccc
Q 002346 139 LQVLSLSDNPNLAPWPFPNE----LTKS-TSLTTLYMDNANIFGLIPDFFD----S-FSNLQNLRLSYNNFTGSLPASFA 208 (933)
Q Consensus 139 L~~L~Ls~N~~~~~~~~p~~----~~~l-~~L~~L~L~~n~l~~~~p~~~~----~-l~~L~~L~L~~N~l~~~~p~~~~ 208 (933)
|++|+|++|++.. ..+.. +..+ ++|++|+|++|++++..+..+. . .++|++|+|++|++++..+..+.
T Consensus 82 L~~L~Ls~n~l~~--~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~ 159 (362)
T 3goz_A 82 VTSLNLSGNFLSY--KSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELI 159 (362)
T ss_dssp CCEEECCSSCGGG--SCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHH
T ss_pred ccEEECcCCcCCh--HHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHH
Confidence 9999999999887 33443 4444 8999999999999988776654 3 36999999999999965555443
Q ss_pred ccccchhhcccccCCcccccccccCCc-cCcEEEecCCccCCCCCC-----CCCC-CCCCEEEccCCccccc----Cccc
Q 002346 209 KSDIQNLWMNDQQLGLSGTLDVLSGMT-QLRQVWLHKNQFTGPIPD-----LSKC-ESLFDLSLRDNQLTGV----VPAS 277 (933)
Q Consensus 209 ~~~l~~l~l~~n~~~~~~~~~~l~~l~-~L~~L~L~~N~l~~~~~~-----~~~~-~~L~~L~L~~N~l~~~----~p~~ 277 (933)
. .+..++ +|++|+|++|++++..+. +..+ ++|+.|+|++|+|++. ++..
T Consensus 160 ~--------------------~l~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~i~~~~~~~l~~~ 219 (362)
T 3goz_A 160 Q--------------------ILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELAYI 219 (362)
T ss_dssp H--------------------HHHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGGGSCHHHHHHH
T ss_pred H--------------------HHhcCCccccEeeecCCCCchhhHHHHHHHHHhCCCCCCEEECCCCCCChhHHHHHHHH
Confidence 2 223344 899999999999876652 4445 5999999999999863 5556
Q ss_pred ccCC-CCCCEEEccCccCccCCC
Q 002346 278 VISL-PALLNISLQNNKLQGPYP 299 (933)
Q Consensus 278 l~~l-~~L~~L~Ls~N~l~~~~p 299 (933)
+..+ ++|++|+|++|.+++..+
T Consensus 220 l~~~~~~L~~L~Ls~N~l~~~~~ 242 (362)
T 3goz_A 220 FSSIPNHVVSLNLCLNCLHGPSL 242 (362)
T ss_dssp HHHSCTTCCEEECCSSCCCCCCH
T ss_pred HhcCCCCceEEECcCCCCCcHHH
Confidence 6653 589999999999886543
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=2.7e-22 Score=217.63 Aligned_cols=215 Identities=19% Similarity=0.260 Sum_probs=116.7
Q ss_pred cceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeecc
Q 002346 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (933)
Q Consensus 92 L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~ 171 (933)
+..+.+..+.+++.+ .+..+++|++|++++|.++.++ .+..+++|++|+|++|++.. ++. +..+++|++|+|+
T Consensus 21 ~~~~~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~l~--~~~~l~~L~~L~L~~n~i~~---~~~-~~~l~~L~~L~L~ 93 (308)
T 1h6u_A 21 AIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITD---LAP-LKNLTKITELELS 93 (308)
T ss_dssp HHHHHTTCSSTTSEE-CHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC---CGG-GTTCCSCCEEECC
T ss_pred HHHHHhCCCCcCcee-cHHHcCCcCEEEeeCCCccCch--hhhccCCCCEEEccCCcCCC---Chh-HccCCCCCEEEcc
Confidence 334445555555432 2444566666666666666654 25556666666666665555 233 5555555555555
Q ss_pred CcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCC
Q 002346 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (933)
Q Consensus 172 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 251 (933)
+|++.+. ..+..+++|++|+|++|+++ +..
T Consensus 94 ~n~l~~~--~~~~~l~~L~~L~l~~n~l~------------------------------------------------~~~ 123 (308)
T 1h6u_A 94 GNPLKNV--SAIAGLQSIKTLDLTSTQIT------------------------------------------------DVT 123 (308)
T ss_dssp SCCCSCC--GGGTTCTTCCEEECTTSCCC------------------------------------------------CCG
T ss_pred CCcCCCc--hhhcCCCCCCEEECCCCCCC------------------------------------------------Cch
Confidence 5555443 23555555555555555554 322
Q ss_pred CCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhh
Q 002346 252 PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVT 331 (933)
Q Consensus 252 ~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~ 331 (933)
.+..+++|+.|+|++|++++..+ +..+++|+.|+|++|.+++..+
T Consensus 124 -~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~-------------------------------- 168 (308)
T 1h6u_A 124 -PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-------------------------------- 168 (308)
T ss_dssp -GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--------------------------------
T ss_pred -hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCCChh--------------------------------
Confidence 24444444444444444443222 4444555555555554442110
Q ss_pred hhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCccc
Q 002346 332 TLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411 (933)
Q Consensus 332 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~ 411 (933)
+..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..| +
T Consensus 169 -------------------------------l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~L~~N~l~~~~~--l 213 (308)
T 1h6u_A 169 -------------------------------LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--L 213 (308)
T ss_dssp -------------------------------GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--G
T ss_pred -------------------------------hcCCCCCCEEECCCCccCcChh--hcCCCCCCEEEccCCccCcccc--c
Confidence 2223445555555555554332 6677788888888888875443 7
Q ss_pred CCCCCcCEEeccCCcCcccCCC
Q 002346 412 TKLASLQNLDVSNNNLSGKVPD 433 (933)
Q Consensus 412 ~~l~~L~~l~ls~N~l~g~~p~ 433 (933)
..+++|+.|++++|++++....
T Consensus 214 ~~l~~L~~L~l~~N~i~~~~~~ 235 (308)
T 1h6u_A 214 ANTSNLFIVTLTNQTITNQPVF 235 (308)
T ss_dssp TTCTTCCEEEEEEEEEECCCEE
T ss_pred cCCCCCCEEEccCCeeecCCee
Confidence 7788888888888888764443
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=5.8e-22 Score=206.82 Aligned_cols=196 Identities=19% Similarity=0.222 Sum_probs=120.5
Q ss_pred cCceeccccccccCCCCCcccCCCCCCEEEccCCC-CCCCCCCCccccCCccCCeeeccC-cccCCCCChhhcCCCCCCE
Q 002346 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP-NLAPWPFPNELTKSTSLTTLYMDN-ANIFGLIPDFFDSFSNLQN 191 (933)
Q Consensus 114 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~ 191 (933)
+|++|+|++|+|+++++..|.++++|++|+|++|+ +.. ..+..|.++++|++|+|++ |++++..+..|..
T Consensus 32 ~l~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~~l~~--i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~------ 103 (239)
T 2xwt_C 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQ--LESHSFYNLSKVTHIEIRNTRNLTYIDPDALKE------ 103 (239)
T ss_dssp TCCEEEEESCCCSEECTTTTTTCTTCCEEEEECCSSCCE--ECTTTEESCTTCCEEEEEEETTCCEECTTSEEC------
T ss_pred cccEEEEeCCcceEECHHHccCCCCCcEEeCCCCCCcce--eCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCC------
Confidence 66666666666666666666666666666666664 443 1222444444444444444 4444444444444
Q ss_pred EEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCC---EEEccCC
Q 002346 192 LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLF---DLSLRDN 268 (933)
Q Consensus 192 L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~---~L~L~~N 268 (933)
+++|+.|+|++|++++. |.+..+++|+ .|++++|
T Consensus 104 ------------------------------------------l~~L~~L~l~~n~l~~l-p~~~~l~~L~~L~~L~l~~N 140 (239)
T 2xwt_C 104 ------------------------------------------LPLLKFLGIFNTGLKMF-PDLTKVYSTDIFFILEITDN 140 (239)
T ss_dssp ------------------------------------------CTTCCEEEEEEECCCSC-CCCTTCCBCCSEEEEEEESC
T ss_pred ------------------------------------------CCCCCEEeCCCCCCccc-cccccccccccccEEECCCC
Confidence 44555555555555542 2244555555 6666666
Q ss_pred -cccccCcccccCCCCCC-EEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccc
Q 002346 269 -QLTGVVPASVISLPALL-NISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAIL 346 (933)
Q Consensus 269 -~l~~~~p~~l~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 346 (933)
++++..+..|..+++|+ .|++++|+++...+
T Consensus 141 ~~l~~i~~~~~~~l~~L~~~L~l~~n~l~~i~~----------------------------------------------- 173 (239)
T 2xwt_C 141 PYMTSIPVNAFQGLCNETLTLKLYNNGFTSVQG----------------------------------------------- 173 (239)
T ss_dssp TTCCEECTTTTTTTBSSEEEEECCSCCCCEECT-----------------------------------------------
T ss_pred cchhhcCcccccchhcceeEEEcCCCCCcccCH-----------------------------------------------
Confidence 66655555677777777 77777777662211
Q ss_pred cCCCCCCCCCCCCCccccCCCceeEEEccCcc-ccCcCchhhcCc-ccCCeEecccCcccCCCCcccCCCCCcCEEeccC
Q 002346 347 SDSWEGNNACDGWPFVTCSQGRIITINLANKL-LAGNISPAYANL-TSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSN 424 (933)
Q Consensus 347 ~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l-~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~ 424 (933)
.....++|+.|+|++|+ +++..+..|.++ ++|+.|+|++|+++ .+|.. .+++|+.|++++
T Consensus 174 ---------------~~~~~~~L~~L~L~~n~~l~~i~~~~~~~l~~~L~~L~l~~N~l~-~l~~~--~~~~L~~L~l~~ 235 (239)
T 2xwt_C 174 ---------------YAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSK--GLEHLKELIARN 235 (239)
T ss_dssp ---------------TTTTTCEEEEEECTTCTTCCEECTTTTTTCSBCCSEEECTTCCCC-CCCCT--TCTTCSEEECTT
T ss_pred ---------------hhcCCCCCCEEEcCCCCCcccCCHHHhhccccCCcEEECCCCccc-cCChh--HhccCceeeccC
Confidence 11112467888888884 776666778888 99999999999998 55554 677889999887
Q ss_pred C
Q 002346 425 N 425 (933)
Q Consensus 425 N 425 (933)
+
T Consensus 236 ~ 236 (239)
T 2xwt_C 236 T 236 (239)
T ss_dssp C
T ss_pred c
Confidence 6
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2.6e-21 Score=203.45 Aligned_cols=180 Identities=23% Similarity=0.294 Sum_probs=159.6
Q ss_pred cccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeee
Q 002346 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (933)
Q Consensus 90 ~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~ 169 (933)
...++++++++.++.+++.+. ++|++|+|++|+++++++..|.++++|++|+|++|++.. ..+..+.++++|++|+
T Consensus 14 ~~~~~l~~~~~~l~~~p~~~~--~~l~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~--~~~~~~~~l~~L~~L~ 89 (251)
T 3m19_A 14 EGKKEVDCQGKSLDSVPSGIP--ADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT--LSAGVFDDLTELGTLG 89 (251)
T ss_dssp GGGTEEECTTCCCSSCCSCCC--TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCC--CCTTTTTTCTTCCEEE
T ss_pred CCCeEEecCCCCccccCCCCC--CCCCEEEccCCCcCccCHhHhcCcccCCEEECCCCcCCc--cCHhHhccCCcCCEEE
Confidence 467889999999997766665 689999999999999999999999999999999999988 5667789999999999
Q ss_pred ccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCC
Q 002346 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (933)
Q Consensus 170 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 249 (933)
|++|++++..+..|..+++|++|+|++|+|++..+..|. ++++|+.|+|++|+|++
T Consensus 90 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~------------------------~l~~L~~L~Ls~N~l~~ 145 (251)
T 3m19_A 90 LANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFD------------------------RLTKLKELRLNTNQLQS 145 (251)
T ss_dssp CTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT------------------------TCTTCCEEECCSSCCCC
T ss_pred CCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhc------------------------cCCcccEEECcCCcCCc
Confidence 999999999889999999999999999999954444433 48999999999999998
Q ss_pred CCC-CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccC
Q 002346 250 PIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297 (933)
Q Consensus 250 ~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 297 (933)
.++ .+..+++|+.|+|++|+|++..+..|..+++|+.|+|++|++.+.
T Consensus 146 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~ 194 (251)
T 3m19_A 146 IPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS 194 (251)
T ss_dssp CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred cCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence 888 488999999999999999988888899999999999999999864
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=216.04 Aligned_cols=155 Identities=14% Similarity=0.076 Sum_probs=122.7
Q ss_pred HHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCc----------------hhHHHHHHHHHHHHhcC
Q 002346 574 EVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGN----------------KGLSEFQAEIAVLTKVR 637 (933)
Q Consensus 574 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~~l~~l~ 637 (933)
..+..-...|.+.+.||+|+||.||+|...+|+.||||+++...... .....+.+|+.++++++
T Consensus 83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~ 162 (282)
T 1zar_A 83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 162 (282)
T ss_dssp HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence 34444456777889999999999999987789999999997543211 13567899999999999
Q ss_pred CCcceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCc
Q 002346 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSN 717 (933)
Q Consensus 638 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~N 717 (933)
| +++.+++.. +..++||||+++++|.+ +.. .+...++.|+++||+|||+ ++|+||||||+|
T Consensus 163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~N 223 (282)
T 1zar_A 163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYN 223 (282)
T ss_dssp --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTS
T ss_pred --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHH
Confidence 4 666665533 55699999999999988 421 1244699999999999998 899999999999
Q ss_pred EEecCCCcEEEecccccccCCCCCceeecccccccCcccccccCC
Q 002346 718 ILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT 762 (933)
Q Consensus 718 ill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 762 (933)
||++ ++.+||+|||+++. +..|+|||++..
T Consensus 224 ILl~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r 253 (282)
T 1zar_A 224 VLVS-EEGIWIIDFPQSVE--------------VGEEGWREILER 253 (282)
T ss_dssp EEEE-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred EEEE-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence 9999 99999999999863 345789998753
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.87 E-value=2e-24 Score=242.90 Aligned_cols=205 Identities=19% Similarity=0.260 Sum_probs=131.5
Q ss_pred cCCccCCeeeccCcccCC----CCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCc
Q 002346 160 TKSTSLTTLYMDNANIFG----LIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMT 235 (933)
Q Consensus 160 ~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~ 235 (933)
..+++|++|+|++|.+.. .+|..+..+++|++|+|++|.+++..+..+... +..+ ..+.+ -...+
T Consensus 91 ~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~-l~~l--~~~~~--------~~~~~ 159 (386)
T 2ca6_A 91 LKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARA-LQEL--AVNKK--------AKNAP 159 (386)
T ss_dssp TTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHH-HHHH--HHHHH--------HHTCC
T ss_pred hhCCcccEEECCCCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHH-HHHH--hhhhh--------cccCC
Confidence 566677777777777766 356667777777777777777764333333320 0000 00000 00016
Q ss_pred cCcEEEecCCccC-CCCC----CCCCCCCCCEEEccCCccc--c---cCcccccCCCCCCEEEccCccCccCCCCCCCCc
Q 002346 236 QLRQVWLHKNQFT-GPIP----DLSKCESLFDLSLRDNQLT--G---VVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305 (933)
Q Consensus 236 ~L~~L~L~~N~l~-~~~~----~~~~~~~L~~L~L~~N~l~--~---~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 305 (933)
+|+.|+|++|+++ +.++ .+..+++|+.|+|++|+++ | ..|..+..+++|+.|+|++|.++...
T Consensus 160 ~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g------- 232 (386)
T 2ca6_A 160 PLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLG------- 232 (386)
T ss_dssp CCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHH-------
T ss_pred CCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHH-------
Confidence 7777777777776 2333 2456677777777777776 2 34446677777777777777765210
Q ss_pred cEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCc---
Q 002346 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN--- 382 (933)
Q Consensus 306 ~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~--- 382 (933)
...+|..+..+++|+.|+|++|.+++.
T Consensus 233 --------------------------------------------------~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~ 262 (386)
T 2ca6_A 233 --------------------------------------------------SSALAIALKSWPNLRELGLNDCLLSARGAA 262 (386)
T ss_dssp --------------------------------------------------HHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred --------------------------------------------------HHHHHHHHccCCCcCEEECCCCCCchhhHH
Confidence 001233455566777888888887765
Q ss_pred -Cchhh--cCcccCCeEecccCcccC----CCCccc-CCCCCcCEEeccCCcCcccCC
Q 002346 383 -ISPAY--ANLTSLKNLYLQQNNLTG----PIPDGL-TKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 383 -~p~~~--~~l~~L~~L~L~~N~l~g----~~p~~~-~~l~~L~~l~ls~N~l~g~~p 432 (933)
+|..+ +.+++|+.|+|++|++++ .+|..+ .++++|++|++++|++++..+
T Consensus 263 ~l~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 263 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 56666 448999999999999997 488877 668999999999999987654
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.87 E-value=8.7e-22 Score=200.75 Aligned_cols=188 Identities=29% Similarity=0.430 Sum_probs=146.9
Q ss_pred CCCCCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCC
Q 002346 50 SSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSV 128 (933)
Q Consensus 50 ~~~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~ 128 (933)
+..+.|.|.+|.|.. ++++ .+|..+ .++|++|++++|+|+++++ .|..+++|++|+|++|+|+++
T Consensus 2 p~~C~C~~~~v~c~~-----------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~ 67 (208)
T 2o6s_A 2 PSRCSCSGTTVECYS-----------QGRT-SVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSL 67 (208)
T ss_dssp CTTCEEETTEEECCS-----------SCCS-SCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCC
T ss_pred cCCCEECCCEEEecC-----------CCcc-CCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCcc
Confidence 345679999999975 3344 344433 4589999999999998777 578899999999999999999
Q ss_pred CCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCcccc
Q 002346 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFA 208 (933)
Q Consensus 129 ~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 208 (933)
++..|..+++|++|+|++|++.. ..+..+.++++|++|+|++|++++..+..|..+++|++|+|++|++++..+..+.
T Consensus 68 ~~~~~~~l~~L~~L~Ls~n~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~ 145 (208)
T 2o6s_A 68 PNGVFNKLTSLTYLNLSTNQLQS--LPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFD 145 (208)
T ss_dssp CTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT
T ss_pred ChhhcCCCCCcCEEECCCCcCCc--cCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhc
Confidence 88888899999999999998887 3445578888888888888888888777788888888888888888854443333
Q ss_pred ccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCC
Q 002346 209 KSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA 283 (933)
Q Consensus 209 ~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~ 283 (933)
.+++|+.|+|++|.+.+ .+++|+.|+++.|+++|.+|.+++.++.
T Consensus 146 ------------------------~l~~L~~L~l~~N~~~~------~~~~l~~L~~~~n~~~g~ip~~~~~l~~ 190 (208)
T 2o6s_A 146 ------------------------RLTSLQYIWLHDNPWDC------TCPGIRYLSEWINKHSGVVRNSAGSVAP 190 (208)
T ss_dssp ------------------------TCTTCCEEECCSCCBCC------CTTTTHHHHHHHHHCTTTBBCTTSSBCT
T ss_pred ------------------------cCCCccEEEecCCCeec------CCCCHHHHHHHHHhCCceeeccCccccC
Confidence 37788888888887764 3456777888888888888877776654
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=217.11 Aligned_cols=221 Identities=15% Similarity=0.170 Sum_probs=172.2
Q ss_pred CCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccC-CCC
Q 002346 53 GYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS-VPT 130 (933)
Q Consensus 53 ~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~-~~~ 130 (933)
|.|+|..|.|+ +++|+ .+|..+ .+++++|+|++|+|+.+++ .|.++++|++|+|++|++.+ ++.
T Consensus 7 C~C~~~~v~C~-----------~~~Lt-~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~ 72 (350)
T 4ay9_X 7 CHCSNRVFLCQ-----------ESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA 72 (350)
T ss_dssp SEEETTEEEEE-----------STTCC-SCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECT
T ss_pred cEeeCCEEEec-----------CCCCC-ccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccCh
Confidence 45777777774 45666 566655 3689999999999998877 68999999999999999854 778
Q ss_pred CcccCCCCCCE-EEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccC-CcCCCCCCcccc
Q 002346 131 GCFDGLTNLQV-LSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSY-NNFTGSLPASFA 208 (933)
Q Consensus 131 ~~~~~l~~L~~-L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~ 208 (933)
.+|.++++|++ +.++.|++.. ..|..|..+++|++|++++|++.+..+..+....++..|++.+ |++. .+|...
T Consensus 73 ~~f~~L~~l~~~l~~~~N~l~~--l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~-~l~~~~- 148 (350)
T 4ay9_X 73 DVFSNLPKLHEIRIEKANNLLY--INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIH-TIERNS- 148 (350)
T ss_dssp TSBCSCTTCCEEEEEEETTCCE--ECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCC-EECTTS-
T ss_pred hHhhcchhhhhhhcccCCcccc--cCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccc-cccccc-
Confidence 88999988775 5667788887 4567889999999999999999888887888888888999976 5565 444321
Q ss_pred ccccchhhcccccCCcccccccccCC-ccCcEEEecCCccCCCCCCCCCCCCCCEEEccC-CcccccCcccccCCCCCCE
Q 002346 209 KSDIQNLWMNDQQLGLSGTLDVLSGM-TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRD-NQLTGVVPASVISLPALLN 286 (933)
Q Consensus 209 ~~~l~~l~l~~n~~~~~~~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~-N~l~~~~p~~l~~l~~L~~ 286 (933)
|.++ ..++.|+|++|+|+.+.+......+|+.|++++ |.++...+..|..+++|++
T Consensus 149 ----------------------f~~~~~~l~~L~L~~N~i~~i~~~~f~~~~L~~l~l~~~n~l~~i~~~~f~~l~~L~~ 206 (350)
T 4ay9_X 149 ----------------------FVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206 (350)
T ss_dssp ----------------------STTSBSSCEEEECCSSCCCEECTTSSTTEEEEEEECTTCTTCCCCCTTTTTTEECCSE
T ss_pred ----------------------hhhcchhhhhhccccccccCCChhhccccchhHHhhccCCcccCCCHHHhccCcccch
Confidence 2224 468899999999998888777788999999985 6666444467899999999
Q ss_pred EEccCccCccCCCCCCCCccEEeccCC
Q 002346 287 ISLQNNKLQGPYPLFPSKVQKVSLDHN 313 (933)
Q Consensus 287 L~Ls~N~l~~~~p~~~~~l~~L~l~~n 313 (933)
|+|++|+|+..++..+..++.|.+.++
T Consensus 207 LdLs~N~l~~lp~~~~~~L~~L~~l~~ 233 (350)
T 4ay9_X 207 LDISRTRIHSLPSYGLENLKKLRARST 233 (350)
T ss_dssp EECTTSCCCCCCSSSCTTCCEEECTTC
T ss_pred hhcCCCCcCccChhhhccchHhhhccC
Confidence 999999999766655666666664443
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 | Back alignment and structure |
|---|
Probab=99.87 E-value=1.5e-21 Score=211.81 Aligned_cols=192 Identities=23% Similarity=0.432 Sum_probs=150.0
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
.+++.|++++++++. ++ .+..+++|++|+|++|.+++..+ +..+++|++|+|++|.+++++ .+..+++|++|+|+
T Consensus 41 ~~L~~L~l~~~~i~~-l~-~~~~l~~L~~L~L~~n~i~~~~~-~~~l~~L~~L~L~~n~l~~~~--~~~~l~~L~~L~l~ 115 (308)
T 1h6u_A 41 DGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLT 115 (308)
T ss_dssp HTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECT
T ss_pred CCcCEEEeeCCCccC-ch-hhhccCCCCEEEccCCcCCCChh-HccCCCCCEEEccCCcCCCch--hhcCCCCCCEEECC
Confidence 367888888888874 44 57788888888888888887666 888888888888888888775 47788888888888
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~ 225 (933)
+|++.. ++ .+..+++|++|+|++|++.+..+ +..+++|++|+|++|++++ ++. +
T Consensus 116 ~n~l~~---~~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~-~~~-l------------------ 169 (308)
T 1h6u_A 116 STQITD---VT-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSD-LTP-L------------------ 169 (308)
T ss_dssp TSCCCC---CG-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCC-CGG-G------------------
T ss_pred CCCCCC---ch-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEEEccCCcCCC-Chh-h------------------
Confidence 888877 33 37888888888888888877644 7788888888888888873 332 3
Q ss_pred cccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccC
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 297 (933)
..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++..+ +..+++|+.|+|++|++++.
T Consensus 170 ------~~l~~L~~L~l~~n~l~~~~~-l~~l~~L~~L~L~~N~l~~~~~--l~~l~~L~~L~l~~N~i~~~ 232 (308)
T 1h6u_A 170 ------ANLSKLTTLKADDNKISDISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ 232 (308)
T ss_dssp ------TTCTTCCEEECCSSCCCCCGG-GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEEEEEECC
T ss_pred ------cCCCCCCEEECCCCccCcChh-hcCCCCCCEEEccCCccCcccc--ccCCCCCCEEEccCCeeecC
Confidence 347888888888888887654 7888888888888888885543 78888888888888888764
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A | Back alignment and structure |
|---|
Probab=99.85 E-value=1.7e-23 Score=235.29 Aligned_cols=250 Identities=18% Similarity=0.200 Sum_probs=197.2
Q ss_pred ccCccccCCcccceeecccccccccCC-----CccCcCcCceeccccccccCCC---CCc-------ccCCCCCCEEEcc
Q 002346 81 TLSPEISSLTQLETLSFQMNNIAGAIP-----SLANATSLQDIYLDNNNFTSVP---TGC-------FDGLTNLQVLSLS 145 (933)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~N~l~~~~p-----~~~~l~~L~~L~Ls~N~l~~~~---~~~-------~~~l~~L~~L~Ls 145 (933)
.++..+..+++|++|+|++|.|++..+ .+..+++|++|+|++|.+..+. +.. |..+++|++|+|+
T Consensus 23 ~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~~~~~~l~~~~~~~~~~l~~~l~~~~~L~~L~Ls 102 (386)
T 2ca6_A 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLS 102 (386)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECC
T ss_pred HHHHHHhcCCCccEEECCCCCCCHHHHHHHHHHHHhCCCccEEeCcccccCccccchhHHHHHHHHHHhhCCcccEEECC
Confidence 566778889999999999999987533 4778999999999997665432 222 3788999999999
Q ss_pred CCCCCCCC--CCCccccCCccCCeeeccCcccCCCCChhhc----CC---------CCCCEEEccCCcCC-CCCCccccc
Q 002346 146 DNPNLAPW--PFPNELTKSTSLTTLYMDNANIFGLIPDFFD----SF---------SNLQNLRLSYNNFT-GSLPASFAK 209 (933)
Q Consensus 146 ~N~~~~~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~----~l---------~~L~~L~L~~N~l~-~~~p~~~~~ 209 (933)
+|.+.... .+|..+..+++|++|+|++|.+....+..+. .+ ++|++|+|++|+++ +.+|. ++
T Consensus 103 ~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l~~~~~~~-l~- 180 (386)
T 2ca6_A 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKE-WA- 180 (386)
T ss_dssp SCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHH-HH-
T ss_pred CCcCCHHHHHHHHHHHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCCCcHHHHH-HH-
Confidence 99987622 2566889999999999999999755444443 34 89999999999997 33332 11
Q ss_pred cccchhhcccccCCcccccccccCCccCcEEEecCCccC--C---CCC-CCCCCCCCCEEEccCCccc----ccCccccc
Q 002346 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT--G---PIP-DLSKCESLFDLSLRDNQLT----GVVPASVI 279 (933)
Q Consensus 210 ~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~--~---~~~-~~~~~~~L~~L~L~~N~l~----~~~p~~l~ 279 (933)
..+..+++|+.|+|++|+++ | ..+ .+..+++|+.|+|++|+++ +.+|..+.
T Consensus 181 -------------------~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~ 241 (386)
T 2ca6_A 181 -------------------KTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALK 241 (386)
T ss_dssp -------------------HHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGG
T ss_pred -------------------HHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHc
Confidence 12344889999999999998 3 445 6889999999999999996 67899999
Q ss_pred CCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCC
Q 002346 280 SLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGW 359 (933)
Q Consensus 280 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 359 (933)
.+++|+.|+|++|.+++... ..+
T Consensus 242 ~~~~L~~L~L~~n~i~~~~~---------------------------------------------------------~~l 264 (386)
T 2ca6_A 242 SWPNLRELGLNDCLLSARGA---------------------------------------------------------AAV 264 (386)
T ss_dssp GCTTCCEEECTTCCCCHHHH---------------------------------------------------------HHH
T ss_pred cCCCcCEEECCCCCCchhhH---------------------------------------------------------HHH
Confidence 99999999999999885311 001
Q ss_pred Cccc--cCCCceeEEEccCccccC----cCchhh-cCcccCCeEecccCcccCCCC
Q 002346 360 PFVT--CSQGRIITINLANKLLAG----NISPAY-ANLTSLKNLYLQQNNLTGPIP 408 (933)
Q Consensus 360 p~~~--~~l~~L~~L~Ls~N~l~g----~~p~~~-~~l~~L~~L~L~~N~l~g~~p 408 (933)
|..+ +.+++|+.|+|++|.+++ .+|..+ .++++|+.|+|++|++++..|
T Consensus 265 ~~~l~~~~~~~L~~L~L~~n~i~~~g~~~l~~~l~~~l~~L~~L~l~~N~l~~~~~ 320 (386)
T 2ca6_A 265 VDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDD 320 (386)
T ss_dssp HHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTTSH
T ss_pred HHHHhhccCCCeEEEECcCCcCCHHHHHHHHHHHHhcCCCceEEEccCCcCCcchh
Confidence 2233 336889999999999998 588887 779999999999999997775
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=226.71 Aligned_cols=192 Identities=21% Similarity=0.323 Sum_probs=163.1
Q ss_pred cccce-EeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCccc
Q 002346 56 EWTGI-NCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFD 134 (933)
Q Consensus 56 ~w~gv-~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 134 (933)
.|.|+ .|.. ++++.|+|++|+|++ +|..+. ++|++|+|++|.|+. +| ..+++|++|+|++|+|+++|. |.
T Consensus 49 ~~~~l~~C~~-~~L~~L~Ls~n~L~~-lp~~l~--~~L~~L~Ls~N~l~~-ip--~~l~~L~~L~Ls~N~l~~ip~--l~ 119 (571)
T 3cvr_A 49 AVSLLKECLI-NQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALIS-LP--ELPASLEYLDACDNRLSTLPE--LP 119 (571)
T ss_dssp HHHHHHHHHH-TTCSEEECCSSCCSC-CCSCCC--TTCSEEECCSSCCSC-CC--CCCTTCCEEECCSSCCSCCCC--CC
T ss_pred hhhhcccccc-CCccEEEeCCCCCCc-cCHhHc--CCCCEEECcCCCCcc-cc--cccCCCCEEEccCCCCCCcch--hh
Confidence 79999 7864 579999999999997 777664 899999999999995 45 567999999999999999887 55
Q ss_pred CCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccch
Q 002346 135 GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQN 214 (933)
Q Consensus 135 ~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~ 214 (933)
+ +|++|+|++|++++ +|. .+++|+.|+|++|+|++ +|. .+++|++|+|++|+|++ +|. |
T Consensus 120 ~--~L~~L~Ls~N~l~~---lp~---~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~-l------- 178 (571)
T 3cvr_A 120 A--SLKHLDVDNNQLTM---LPE---LPALLEYINADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPE-L------- 178 (571)
T ss_dssp T--TCCEEECCSSCCSC---CCC---CCTTCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCC-C-------
T ss_pred c--CCCEEECCCCcCCC---CCC---cCccccEEeCCCCccCc-CCC---cCCCcCEEECCCCCCCC-cch-h-------
Confidence 5 99999999999988 666 68999999999999988 455 57899999999999995 775 4
Q ss_pred hhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCC-------CEEEccCCcccccCcccccCCCCCCEE
Q 002346 215 LWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL-------FDLSLRDNQLTGVVPASVISLPALLNI 287 (933)
Q Consensus 215 l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L-------~~L~L~~N~l~~~~p~~l~~l~~L~~L 287 (933)
.++|+.|+|++|+|+..++ +.. +| +.|+|++|+|+ .+|..+..+++|+.|
T Consensus 179 -------------------~~~L~~L~Ls~N~L~~lp~-~~~--~L~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L 235 (571)
T 3cvr_A 179 -------------------PESLEALDVSTNLLESLPA-VPV--RNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTI 235 (571)
T ss_dssp -------------------CTTCCEEECCSSCCSSCCC-CC----------CCEEEECCSSCCC-CCCGGGGGSCTTEEE
T ss_pred -------------------hCCCCEEECcCCCCCchhh-HHH--hhhcccccceEEecCCCcce-ecCHHHhcCCCCCEE
Confidence 2689999999999996555 554 77 99999999999 689888889999999
Q ss_pred EccCccCccCCCC
Q 002346 288 SLQNNKLQGPYPL 300 (933)
Q Consensus 288 ~Ls~N~l~~~~p~ 300 (933)
+|++|+|++.+|.
T Consensus 236 ~L~~N~l~~~~p~ 248 (571)
T 3cvr_A 236 ILEDNPLSSRIRE 248 (571)
T ss_dssp ECCSSSCCHHHHH
T ss_pred EeeCCcCCCcCHH
Confidence 9999999986663
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.5e-21 Score=214.17 Aligned_cols=244 Identities=16% Similarity=0.166 Sum_probs=172.8
Q ss_pred ceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCC-ccccCCccCCe-eec
Q 002346 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFP-NELTKSTSLTT-LYM 170 (933)
Q Consensus 93 ~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p-~~~~~l~~L~~-L~L 170 (933)
++++.++++++.++..+ .+++++|+|++|+|+.++.++|.++++|++|+|++|++.+ .+| ..|.++++|.. +.+
T Consensus 12 ~~v~C~~~~Lt~iP~~l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~--~i~~~~f~~L~~l~~~l~~ 87 (350)
T 4ay9_X 12 RVFLCQESKVTEIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE--VIEADVFSNLPKLHEIRIE 87 (350)
T ss_dssp TEEEEESTTCCSCCTTC--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCC--EECTTSBCSCTTCCEEEEE
T ss_pred CEEEecCCCCCccCcCc--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCC--ccChhHhhcchhhhhhhcc
Confidence 56888999999765556 3689999999999999999999999999999999999866 343 46788888775 566
Q ss_pred cCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecC-CccCC
Q 002346 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK-NQFTG 249 (933)
Q Consensus 171 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~-N~l~~ 249 (933)
++|++....|..|..+++|++|++++|++++..+..+. ...++..|++.+ |+++.
T Consensus 88 ~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~------------------------~~~~l~~l~l~~~~~i~~ 143 (350)
T 4ay9_X 88 KANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKI------------------------HSLQKVLLDIQDNINIHT 143 (350)
T ss_dssp EETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTC------------------------CBSSCEEEEEESCTTCCE
T ss_pred cCCcccccCchhhhhccccccccccccccccCCchhhc------------------------ccchhhhhhhcccccccc
Confidence 77899998899999999999999999999844443332 255677788755 56665
Q ss_pred CCCC-CCCC-CCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCC
Q 002346 250 PIPD-LSKC-ESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCD 327 (933)
Q Consensus 250 ~~~~-~~~~-~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~ 327 (933)
..+. |..+ ..++.|+|++|+|+ .+|.......+|+.|++++|+..+.+|
T Consensus 144 l~~~~f~~~~~~l~~L~L~~N~i~-~i~~~~f~~~~L~~l~l~~~n~l~~i~---------------------------- 194 (350)
T 4ay9_X 144 IERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELP---------------------------- 194 (350)
T ss_dssp ECTTSSTTSBSSCEEEECCSSCCC-EECTTSSTTEEEEEEECTTCTTCCCCC----------------------------
T ss_pred ccccchhhcchhhhhhcccccccc-CCChhhccccchhHHhhccCCcccCCC----------------------------
Confidence 5543 5554 35778888888888 455555556677777776533222222
Q ss_pred chhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCC
Q 002346 328 PQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407 (933)
Q Consensus 328 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~ 407 (933)
+..+..+++|+.|+|++|+|+...+..|.+|++|+.+++ +++. .+
T Consensus 195 --------------------------------~~~f~~l~~L~~LdLs~N~l~~lp~~~~~~L~~L~~l~~--~~l~-~l 239 (350)
T 4ay9_X 195 --------------------------------NDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KL 239 (350)
T ss_dssp --------------------------------TTTTTTEECCSEEECTTSCCCCCCSSSCTTCCEEECTTC--TTCC-CC
T ss_pred --------------------------------HHHhccCcccchhhcCCCCcCccChhhhccchHhhhccC--CCcC-cC
Confidence 123445677888888888888544444555444444433 2333 66
Q ss_pred CcccCCCCCcCEEeccCCcCcc
Q 002346 408 PDGLTKLASLQNLDVSNNNLSG 429 (933)
Q Consensus 408 p~~~~~l~~L~~l~ls~N~l~g 429 (933)
| .+.++++|+.++++++.-..
T Consensus 240 P-~l~~l~~L~~l~l~~~~~c~ 260 (350)
T 4ay9_X 240 P-TLEKLVALMEASLTYPSHCC 260 (350)
T ss_dssp C-CTTTCCSCCEEECSCHHHHH
T ss_pred C-CchhCcChhhCcCCCCcccc
Confidence 7 47888888888888765543
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} | Back alignment and structure |
|---|
Probab=99.84 E-value=1.3e-20 Score=219.24 Aligned_cols=195 Identities=24% Similarity=0.326 Sum_probs=111.5
Q ss_pred cCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEE
Q 002346 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLR 193 (933)
Q Consensus 114 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ 193 (933)
+|+.|+|++|+|+++|...+ ++|++|+|++|++.. +| ..+++|+.|+|++|+|++ +|. |.. +|++|+
T Consensus 60 ~L~~L~Ls~n~L~~lp~~l~---~~L~~L~Ls~N~l~~---ip---~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~ 126 (571)
T 3cvr_A 60 QFSELQLNRLNLSSLPDNLP---PQITVLEITQNALIS---LP---ELPASLEYLDACDNRLST-LPE-LPA--SLKHLD 126 (571)
T ss_dssp TCSEEECCSSCCSCCCSCCC---TTCSEEECCSSCCSC---CC---CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEE
T ss_pred CccEEEeCCCCCCccCHhHc---CCCCEEECcCCCCcc---cc---cccCCCCEEEccCCCCCC-cch-hhc--CCCEEE
Confidence 55566666666655554422 456666666665554 44 335566666666666655 344 443 666666
Q ss_pred ccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCccccc
Q 002346 194 LSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGV 273 (933)
Q Consensus 194 L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~ 273 (933)
|++|+|++ +|. . +++|+.|+|++|+|++.++ .+++|+.|+|++|+|++
T Consensus 127 Ls~N~l~~-lp~---~------------------------l~~L~~L~Ls~N~l~~lp~---~l~~L~~L~Ls~N~L~~- 174 (571)
T 3cvr_A 127 VDNNQLTM-LPE---L------------------------PALLEYINADNNQLTMLPE---LPTSLEVLSVRNNQLTF- 174 (571)
T ss_dssp CCSSCCSC-CCC---C------------------------CTTCCEEECCSSCCSCCCC---CCTTCCEEECCSSCCSC-
T ss_pred CCCCcCCC-CCC---c------------------------CccccEEeCCCCccCcCCC---cCCCcCEEECCCCCCCC-
Confidence 66666663 443 1 4566666666666665333 45666677777777664
Q ss_pred CcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCC
Q 002346 274 VPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353 (933)
Q Consensus 274 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 353 (933)
+|. |. ++|+.|+|++|+|+. +|.+..+|
T Consensus 175 lp~-l~--~~L~~L~Ls~N~L~~-lp~~~~~L------------------------------------------------ 202 (571)
T 3cvr_A 175 LPE-LP--ESLEALDVSTNLLES-LPAVPVRN------------------------------------------------ 202 (571)
T ss_dssp CCC-CC--TTCCEEECCSSCCSS-CCCCC---------------------------------------------------
T ss_pred cch-hh--CCCCEEECcCCCCCc-hhhHHHhh------------------------------------------------
Confidence 555 44 666777777766663 22121111
Q ss_pred CCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCC
Q 002346 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415 (933)
Q Consensus 354 ~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~ 415 (933)
......|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|++.+|..+..+.
T Consensus 203 ---------~~~~~~L~~L~Ls~N~l~-~lp~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~ 254 (571)
T 3cvr_A 203 ---------HHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQT 254 (571)
T ss_dssp --------------CCEEEECCSSCCC-CCCGGGGGSCTTEEEECCSSSCCHHHHHHHHHHH
T ss_pred ---------hcccccceEEecCCCcce-ecCHHHhcCCCCCEEEeeCCcCCCcCHHHHHHhh
Confidence 001123466666666666 3666666677777777777777777776665543
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A | Back alignment and structure |
|---|
Probab=99.84 E-value=1.7e-22 Score=222.65 Aligned_cols=251 Identities=16% Similarity=0.163 Sum_probs=179.6
Q ss_pred ccceeecccccccccCCCccCc--CcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCee
Q 002346 91 QLETLSFQMNNIAGAIPSLANA--TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (933)
Q Consensus 91 ~L~~L~l~~N~l~~~~p~~~~l--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L 168 (933)
.++.|++++|.+.. ..+..+ ++++.|++++|.+++.++. +..+++|++|+|++|.+... .++..+..+++|++|
T Consensus 48 ~~~~l~l~~~~~~~--~~~~~~~~~~l~~L~l~~n~l~~~~~~-~~~~~~L~~L~L~~~~l~~~-~~~~~~~~~~~L~~L 123 (336)
T 2ast_B 48 LWQTLDLTGKNLHP--DVTGRLLSQGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS-TLHGILSQCSKLQNL 123 (336)
T ss_dssp TSSEEECTTCBCCH--HHHHHHHHTTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH-HHHHHHTTBCCCSEE
T ss_pred hheeeccccccCCH--HHHHhhhhccceEEEcCCccccccchh-hccCCCCCEEEccCCCcCHH-HHHHHHhhCCCCCEE
Confidence 47788888887762 245555 7888888888888887766 45688888888888876541 156677888888888
Q ss_pred eccCcccCCCCChhhcCCCCCCEEEccCC-cCCCC-CCccccccccchhhcccccCCcccccccccCCccCcEEEecCC-
Q 002346 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYN-NFTGS-LPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN- 245 (933)
Q Consensus 169 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N- 245 (933)
+|++|.+++..+..++.+++|++|+|++| .+++. ++..+ .++++|++|+|++|
T Consensus 124 ~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~------------------------~~~~~L~~L~l~~~~ 179 (336)
T 2ast_B 124 SLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLL------------------------SSCSRLDELNLSWCF 179 (336)
T ss_dssp ECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHH------------------------HHCTTCCEEECCCCT
T ss_pred eCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHH------------------------hcCCCCCEEcCCCCC
Confidence 88888887777888888888888888888 56532 33322 33788888888888
Q ss_pred ccCCC-CC-CCCCCC-CCCEEEccCC--ccc-ccCcccccCCCCCCEEEccCcc-CccCCCCCCCCccEEeccCCcCCCC
Q 002346 246 QFTGP-IP-DLSKCE-SLFDLSLRDN--QLT-GVVPASVISLPALLNISLQNNK-LQGPYPLFPSKVQKVSLDHNNFCKN 318 (933)
Q Consensus 246 ~l~~~-~~-~~~~~~-~L~~L~L~~N--~l~-~~~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~l~~n~~~~~ 318 (933)
.+++. ++ .+..++ +|+.|+|++| .++ +.+|..+..+++|+.|+|++|. +++..
T Consensus 180 ~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~~l~~~~-------------------- 239 (336)
T 2ast_B 180 DFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDC-------------------- 239 (336)
T ss_dssp TCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGG--------------------
T ss_pred CcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCCcCCHHH--------------------
Confidence 77753 23 366777 8888888888 454 4567777788888888888887 54321
Q ss_pred CCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCcc-ccCcCchhhcCcccCCeEe
Q 002346 319 SSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL-LAGNISPAYANLTSLKNLY 397 (933)
Q Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~-l~g~~p~~~~~l~~L~~L~ 397 (933)
+..+..+++|+.|+|++|. +.......++++++|+.|+
T Consensus 240 -----------------------------------------~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~~~~L~~L~ 278 (336)
T 2ast_B 240 -----------------------------------------FQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQ 278 (336)
T ss_dssp -----------------------------------------GGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred -----------------------------------------HHHHhCCCCCCEeeCCCCCCCCHHHHHHHhcCCCCCEEe
Confidence 2244556788999999885 3322223688899999999
Q ss_pred cccCcccCCCCcccCCC-CCcCEEeccCCcCcccCCCC
Q 002346 398 LQQNNLTGPIPDGLTKL-ASLQNLDVSNNNLSGKVPDF 434 (933)
Q Consensus 398 L~~N~l~g~~p~~~~~l-~~L~~l~ls~N~l~g~~p~~ 434 (933)
|++| ++. ..+..+ ..|..|++++|+|++..|..
T Consensus 279 l~~~-i~~---~~~~~l~~~l~~L~l~~n~l~~~~~~~ 312 (336)
T 2ast_B 279 VFGI-VPD---GTLQLLKEALPHLQINCSHFTTIARPT 312 (336)
T ss_dssp CTTS-SCT---TCHHHHHHHSTTSEESCCCSCCTTCSS
T ss_pred ccCc-cCH---HHHHHHHhhCcceEEecccCccccCCc
Confidence 9998 332 233333 23667778999999988854
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.83 E-value=2.9e-20 Score=189.41 Aligned_cols=103 Identities=26% Similarity=0.343 Sum_probs=44.6
Q ss_pred eeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCc
Q 002346 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173 (933)
Q Consensus 94 ~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n 173 (933)
.++++++.++.++..+ .++|++|+|++|+++++++..|..+++|++|+|++|++.. ..+..+..+++|++|+|++|
T Consensus 11 ~v~c~~~~l~~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~Ls~n 86 (208)
T 2o6s_A 11 TVECYSQGRTSVPTGI--PAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQS--LPNGVFNKLTSLTYLNLSTN 86 (208)
T ss_dssp EEECCSSCCSSCCSCC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC--CCTTTTTTCTTCCEEECCSS
T ss_pred EEEecCCCccCCCCCC--CCCCcEEEcCCCccCcCChhhhcccccCcEEECCCCccCc--cChhhcCCCCCcCEEECCCC
Confidence 4455555554433322 2345555555555555554444445555555555444443 11222333444444444444
Q ss_pred ccCCCCChhhcCCCCCCEEEccCCcCC
Q 002346 174 NIFGLIPDFFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 174 ~l~~~~p~~~~~l~~L~~L~L~~N~l~ 200 (933)
++++..+..|..+++|++|+|++|+++
T Consensus 87 ~l~~~~~~~~~~l~~L~~L~L~~N~l~ 113 (208)
T 2o6s_A 87 QLQSLPNGVFDKLTQLKELALNTNQLQ 113 (208)
T ss_dssp CCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred cCCccCHhHhcCccCCCEEEcCCCcCc
Confidence 443333333333344444444444333
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.83 E-value=6.1e-23 Score=244.83 Aligned_cols=350 Identities=13% Similarity=0.065 Sum_probs=213.6
Q ss_pred CEEEEEecCCC-Ccc-ccCccccCCcccceeeccccccccc----CC-CccCcCcCceeccccccccCCCCC----cccC
Q 002346 67 RVTTISLAKSG-LSG-TLSPEISSLTQLETLSFQMNNIAGA----IP-SLANATSLQDIYLDNNNFTSVPTG----CFDG 135 (933)
Q Consensus 67 ~v~~L~l~~~~-l~~-~~~~~~~~l~~L~~L~l~~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~ 135 (933)
+++.|+|+++. ++. .++..+..+++|++|+|++|.+++. ++ .+..+++|++|+|++|.++++... .+.+
T Consensus 139 ~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~ 218 (592)
T 3ogk_B 139 DLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARN 218 (592)
T ss_dssp GCCEEEEESCEEEEHHHHHHHHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHH
T ss_pred cCcEEECcCCCCcCHHHHHHHHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhh
Confidence 38888888765 211 1223334778888888888887665 22 245678888888888888754433 2456
Q ss_pred CCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccC---CCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cc
Q 002346 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIF---GLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SD 211 (933)
Q Consensus 136 l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~---~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~ 211 (933)
+++|+.|+|++|.+.+ +|..+.++++|+.|+++.+... +..+..+..+++|+.|+++++... .+|..+.. .+
T Consensus 219 ~~~L~~L~L~~~~~~~---l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~-~l~~~~~~~~~ 294 (592)
T 3ogk_B 219 CRSLVSVKVGDFEILE---LVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPN-EMPILFPFAAQ 294 (592)
T ss_dssp CTTCCEEECSSCBGGG---GHHHHHHCTTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCCTT-TGGGGGGGGGG
T ss_pred CCCCcEEeccCccHHH---HHHHHhhhhHHHhhcccccccccchHHHHHHhhccccccccCccccchh-HHHHHHhhcCC
Confidence 7888888888887766 6677778888888888753322 233455666777777777775433 55555543 56
Q ss_pred cchhhcccccCCcccccccccCCccCcEEEecCCccCC-CCCC-CCCCCCCCEEEcc-----------CCccccc-Cccc
Q 002346 212 IQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-PIPD-LSKCESLFDLSLR-----------DNQLTGV-VPAS 277 (933)
Q Consensus 212 l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~-~~~~~~L~~L~L~-----------~N~l~~~-~p~~ 277 (933)
|++|++.+|.+...+....+..+++|+.|+|+ |.+.. .++. +..+++|+.|+|+ .|.+++. ++..
T Consensus 295 L~~L~Ls~~~l~~~~~~~~~~~~~~L~~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l 373 (592)
T 3ogk_B 295 IRKLDLLYALLETEDHCTLIQKCPNLEVLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIAL 373 (592)
T ss_dssp CCEEEETTCCCCHHHHHHHHTTCTTCCEEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHH
T ss_pred CcEEecCCCcCCHHHHHHHHHhCcCCCEEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHH
Confidence 77777777775544443445667777777777 33332 2222 3456777777777 3555543 2223
Q ss_pred ccCCCCCCEEEccCccCccCCCC----CCCCccEEecc----CCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCC
Q 002346 278 VISLPALLNISLQNNKLQGPYPL----FPSKVQKVSLD----HNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDS 349 (933)
Q Consensus 278 l~~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~l~----~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 349 (933)
+..+++|++|+++.|.+++..+. ...+|+.|+++ .|.+.+.+.+ . .+..+.......+.+...
T Consensus 374 ~~~~~~L~~L~l~~~~l~~~~~~~l~~~~~~L~~L~l~~~~~~n~l~~~p~~------~---~~~~~~~~~~~L~~L~L~ 444 (592)
T 3ogk_B 374 AQGCQELEYMAVYVSDITNESLESIGTYLKNLCDFRLVLLDREERITDLPLD------N---GVRSLLIGCKKLRRFAFY 444 (592)
T ss_dssp HHHCTTCSEEEEEESCCCHHHHHHHHHHCCSCCEEEEEECSCCSCCSSCCCH------H---HHHHHHHHCTTCCEEEEE
T ss_pred HhhCccCeEEEeecCCccHHHHHHHHhhCCCCcEEEEeecCCCccccCchHH------H---HHHHHHHhCCCCCEEEEe
Confidence 44567777777777777654322 13467777775 4455432211 0 000111111111111111
Q ss_pred CCCCCCCCCCCcccc-CCCceeEEEccCccccC-cCchhhcCcccCCeEecccCcccCC-CCcccCCCCCcCEEeccCCc
Q 002346 350 WEGNNACDGWPFVTC-SQGRIITINLANKLLAG-NISPAYANLTSLKNLYLQQNNLTGP-IPDGLTKLASLQNLDVSNNN 426 (933)
Q Consensus 350 ~~~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~g-~~p~~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~l~ls~N~ 426 (933)
...+...+..+..+. .+++|+.|+|++|++++ .++..+.++++|+.|+|++|++++. ++..+..+++|++|+|++|+
T Consensus 445 ~~~~~l~~~~~~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~ 524 (592)
T 3ogk_B 445 LRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYR 524 (592)
T ss_dssp CCGGGCCHHHHHHHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCB
T ss_pred cCCCCccHHHHHHHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCc
Confidence 101111111122222 36789999999999887 4566678899999999999998755 44455678999999999999
Q ss_pred Cccc
Q 002346 427 LSGK 430 (933)
Q Consensus 427 l~g~ 430 (933)
+++.
T Consensus 525 it~~ 528 (592)
T 3ogk_B 525 ASMT 528 (592)
T ss_dssp CCTT
T ss_pred CCHH
Confidence 8764
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.82 E-value=6.2e-21 Score=230.35 Aligned_cols=224 Identities=21% Similarity=0.205 Sum_probs=122.1
Q ss_pred ccchHHHHHHHHHhcCC----CCCCCCCCCCCCCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccc
Q 002346 25 LGDDGSVMLKLAQSLQN----LPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMN 100 (933)
Q Consensus 25 ~~~d~~~l~~~~~~~~~----~~~~w~~~~~~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N 100 (933)
...++.+|+++..+... ....|.. ..+..+.|.++.+.. .+++.|+|.++++.. ++. ..|+.++|+.|
T Consensus 130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~-~~~~~l~L~~n~~~~-~~~-----~~l~~l~Ls~~ 201 (727)
T 4b8c_D 130 VDCTKQALMEMADTLTDSKTAKKQQPTG-DSTPSGTATNSAVST-PLTPKIELFANGKDE-ANQ-----ALLQHKKLSQY 201 (727)
T ss_dssp --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred cccchhhhhhhhhhcccccCcccCCCcC-CCCccccCCCceecC-CccceEEeeCCCCCc-chh-----hHhhcCccCcc
Confidence 34678899999877643 2234542 345567899988876 678999999998875 232 34566777777
Q ss_pred cccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCC
Q 002346 101 NIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP 180 (933)
Q Consensus 101 ~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p 180 (933)
.|.+. +++.|.+. +++..|..+++|+.|+|++|.+.. +|..+.++++|++|+|++|.|+ .+|
T Consensus 202 ~i~~~-------------~~~~n~~~-~~~~~~~~l~~L~~L~Ls~n~l~~---l~~~~~~l~~L~~L~Ls~N~l~-~lp 263 (727)
T 4b8c_D 202 SIDED-------------DDIENRMV-MPKDSKYDDQLWHALDLSNLQIFN---ISANIFKYDFLTRLYLNGNSLT-ELP 263 (727)
T ss_dssp ----------------------------------CCCCCCEEECTTSCCSC---CCGGGGGCCSCSCCBCTTSCCS-CCC
T ss_pred cccCc-------------ccccccee-cChhhhccCCCCcEEECCCCCCCC---CChhhcCCCCCCEEEeeCCcCc-ccC
Confidence 66532 44556665 556678888888888888888876 7778888899999999999888 678
Q ss_pred hhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCC
Q 002346 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESL 260 (933)
Q Consensus 181 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L 260 (933)
..|+.+++|++|+|++|+|+ .+|..|+. +++|++|+|++|.|+.++..|..+++|
T Consensus 264 ~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~------------------------l~~L~~L~L~~N~l~~lp~~~~~l~~L 318 (727)
T 4b8c_D 264 AEIKNLSNLRVLDLSHNRLT-SLPAELGS------------------------CFQLKYFYFFDNMVTTLPWEFGNLCNL 318 (727)
T ss_dssp GGGGGGTTCCEEECTTSCCS-SCCSSGGG------------------------GTTCSEEECCSSCCCCCCSSTTSCTTC
T ss_pred hhhhCCCCCCEEeCcCCcCC-ccChhhcC------------------------CCCCCEEECCCCCCCccChhhhcCCCc
Confidence 88888999999999999998 77877654 788888888888888666678888888
Q ss_pred CEEEccCCcccccCcccccCCCC-CCEEEccCccCccCCC
Q 002346 261 FDLSLRDNQLTGVVPASVISLPA-LLNISLQNNKLQGPYP 299 (933)
Q Consensus 261 ~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p 299 (933)
+.|+|++|+|++.+|..+..+.. +..|+|++|.++|.+|
T Consensus 319 ~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~~p 358 (727)
T 4b8c_D 319 QFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIPLP 358 (727)
T ss_dssp CCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_pred cEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCcCc
Confidence 88888888888888887765432 2346777777777655
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.2e-19 Score=213.42 Aligned_cols=189 Identities=20% Similarity=0.309 Sum_probs=136.9
Q ss_pred EEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCC
Q 002346 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNL 150 (933)
Q Consensus 71 L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~ 150 (933)
+.+..+.+...++ +..|++|+.|++++|.|..+ +.+..+++|+.|+|++|+|+++++ +..+++|+.|+|++|++.
T Consensus 26 l~l~~~~i~~~~~--~~~L~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~l~ 100 (605)
T 1m9s_A 26 DNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK 100 (605)
T ss_dssp HHTTCSCTTSEEC--HHHHTTCCCCBCTTCCCCCC-TTGGGCTTCCEEECTTSCCCCCGG--GGGCTTCCEEECCSSCCC
T ss_pred HhccCCCcccccc--hhcCCCCCEEECcCCCCCCC-hHHccCCCCCEEEeeCCCCCCChh--hccCCCCCEEECcCCCCC
Confidence 3444445544332 45677777888888777754 467777888888888888877765 777888888888888777
Q ss_pred CCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccccccc
Q 002346 151 APWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDV 230 (933)
Q Consensus 151 ~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~ 230 (933)
. +| .+..+++|+.|+|++|++.+. ..+..+++|+.|+|++|+|++. ..
T Consensus 101 ~---l~-~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~------------------------ 148 (605)
T 1m9s_A 101 D---LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV------------------------ 148 (605)
T ss_dssp C---CT-TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GG------------------------
T ss_pred C---Ch-hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hh------------------------
Confidence 6 33 677778888888888887764 4577778888888888877742 22
Q ss_pred ccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC
Q 002346 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (933)
Q Consensus 231 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 299 (933)
+..+++|+.|+|++|+|++.+| +..+++|+.|+|++|+|++. ..+..+++|+.|+|++|++++...
T Consensus 149 l~~l~~L~~L~Ls~N~l~~~~~-l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~L~~N~l~~~p~ 214 (605)
T 1m9s_A 149 LSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPI 214 (605)
T ss_dssp GGSCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEECCSEEEECCCC
T ss_pred hcccCCCCEEECcCCcCCCchh-hccCCCCCEEECcCCCCCCC--hHHccCCCCCEEEccCCcCcCCcc
Confidence 3347888888888888887766 77888888888888888853 357788888888888888876543
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.81 E-value=1.1e-19 Score=187.75 Aligned_cols=151 Identities=23% Similarity=0.304 Sum_probs=137.4
Q ss_pred CCCCccccceEeCCC----------CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceec
Q 002346 51 STGYCEWTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIY 119 (933)
Q Consensus 51 ~~~~C~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~ 119 (933)
+.+.|+|.+|.|... ..++.|+|++|+|++..+..|..+++|++|+|++|+|+++++ .|..+++|++|+
T Consensus 15 ~~~~Cs~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~L~~L~ 94 (229)
T 3e6j_A 15 SQCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLD 94 (229)
T ss_dssp TTCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCEEeCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhcccCCCcCEEE
Confidence 668899999999752 478999999999999889999999999999999999988777 578999999999
Q ss_pred cccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcC
Q 002346 120 LDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNF 199 (933)
Q Consensus 120 Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l 199 (933)
|++|+|+++++..|..+++|++|+|++|++.. +|..+..+++|++|+|++|+|.+..+..|..+++|++|+|++|++
T Consensus 95 Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~---lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~ 171 (229)
T 3e6j_A 95 LGTNQLTVLPSAVFDRLVHLKELFMCCNKLTE---LPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGNPW 171 (229)
T ss_dssp CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCS---CCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCB
T ss_pred CCCCcCCccChhHhCcchhhCeEeccCCcccc---cCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCCc
Confidence 99999999999999999999999999999986 788999999999999999999998888899999999999999999
Q ss_pred CCCCC
Q 002346 200 TGSLP 204 (933)
Q Consensus 200 ~~~~p 204 (933)
.+..+
T Consensus 172 ~c~c~ 176 (229)
T 3e6j_A 172 DCECR 176 (229)
T ss_dssp CTTBG
T ss_pred cCCcc
Confidence 86554
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.81 E-value=1.5e-19 Score=194.11 Aligned_cols=188 Identities=20% Similarity=0.316 Sum_probs=146.1
Q ss_pred EecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCC
Q 002346 72 SLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151 (933)
Q Consensus 72 ~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~ 151 (933)
.+..+.+++.. .+..+++|++|++++|.++.. +.+..+++|++|+|++|+++++++ +..+++|++|+|++|++..
T Consensus 30 ~l~~~~~~~~~--~~~~l~~L~~L~l~~~~i~~~-~~~~~l~~L~~L~L~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~ 104 (291)
T 1h6t_A 30 NLKKKSVTDAV--TQNELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD 104 (291)
T ss_dssp HTTCSCTTSEE--CHHHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HhcCCCccccc--chhhcCcccEEEccCCCcccC-hhHhcCCCCCEEEccCCccCCCcc--cccCCCCCEEECCCCcCCC
Confidence 34444444332 245678888888888888765 567778888888888888888776 7888888888888888876
Q ss_pred CCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccc
Q 002346 152 PWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVL 231 (933)
Q Consensus 152 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l 231 (933)
+ ..+..+++|++|+|++|++.+. ..+..+++|++|+|++|++++. .. +
T Consensus 105 ---~-~~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~------------------------l 152 (291)
T 1h6t_A 105 ---L-SSLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TV------------------------L 152 (291)
T ss_dssp ---G-GGGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GG------------------------G
T ss_pred ---C-hhhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hh------------------------h
Confidence 3 3488888888888888888775 4678888889999988888743 23 3
Q ss_pred cCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC
Q 002346 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (933)
Q Consensus 232 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 299 (933)
..+++|+.|+|++|++++..+ +..+++|+.|+|++|+|++ +| .+..+++|+.|++++|+++....
T Consensus 153 ~~l~~L~~L~L~~N~l~~~~~-l~~l~~L~~L~L~~N~i~~-l~-~l~~l~~L~~L~l~~n~i~~~~~ 217 (291)
T 1h6t_A 153 SRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD-LR-ALAGLKNLDVLELFSQECLNKPI 217 (291)
T ss_dssp GGCTTCSEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCB-CG-GGTTCTTCSEEEEEEEEEECCCE
T ss_pred ccCCCCCEEEccCCccccchh-hcCCCccCEEECCCCcCCC-Ch-hhccCCCCCEEECcCCcccCCcc
Confidence 348889999999999988766 8889999999999999985 44 48889999999999999886433
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* | Back alignment and structure |
|---|
Probab=99.80 E-value=1.7e-21 Score=232.44 Aligned_cols=342 Identities=15% Similarity=0.119 Sum_probs=219.2
Q ss_pred CCEEEEEecCCCCccc----cCccccCCcccceeeccccccccc----CC-CccCcCcCceeccccccccCCCCCcccCC
Q 002346 66 NRVTTISLAKSGLSGT----LSPEISSLTQLETLSFQMNNIAGA----IP-SLANATSLQDIYLDNNNFTSVPTGCFDGL 136 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 136 (933)
..++.|+|++|.+++. ++..+..+++|++|+|++|.+++. ++ .+.++++|++|+|++|.+.+++ ..+..+
T Consensus 164 ~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~~~~~L~~L~L~~~~~~~l~-~~~~~~ 242 (592)
T 3ogk_B 164 RKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELV-GFFKAA 242 (592)
T ss_dssp TTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHHHCTTCCEEECSSCBGGGGH-HHHHHC
T ss_pred CCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHhhCCCCcEEeccCccHHHHH-HHHhhh
Confidence 4789999999988765 445567889999999999998732 33 3567899999999999998876 558888
Q ss_pred CCCCEEEccCCCCC-CCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCcc-cc-ccccc
Q 002346 137 TNLQVLSLSDNPNL-APWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS-FA-KSDIQ 213 (933)
Q Consensus 137 ~~L~~L~Ls~N~~~-~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~-~~-~~~l~ 213 (933)
++|+.|+++.+... .....+..+..+++|+.|+++++. .+.+|..+..+++|++|+|++|.+++..... +. .++|+
T Consensus 243 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~-~~~l~~~~~~~~~L~~L~Ls~~~l~~~~~~~~~~~~~~L~ 321 (592)
T 3ogk_B 243 ANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMG-PNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLE 321 (592)
T ss_dssp TTCCEEEECBCCCCTTCTTSSSCCCCCTTCCEEEETTCC-TTTGGGGGGGGGGCCEEEETTCCCCHHHHHHHHTTCTTCC
T ss_pred hHHHhhcccccccccchHHHHHHhhccccccccCccccc-hhHHHHHHhhcCCCcEEecCCCcCCHHHHHHHHHhCcCCC
Confidence 99999998854322 112345567777788888887753 3455677777788888888888765433322 11 24677
Q ss_pred hhhcccccCCcccccccccCCccCcEEEecC-----------CccCCC-CCC-CCCCCCCCEEEccCCcccccCcccccC
Q 002346 214 NLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK-----------NQFTGP-IPD-LSKCESLFDLSLRDNQLTGVVPASVIS 280 (933)
Q Consensus 214 ~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~-----------N~l~~~-~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~ 280 (933)
.|++. +.+...+....+..+++|+.|+|++ |.+++. ++. ...+++|+.|+++.|++++..+..+..
T Consensus 322 ~L~L~-~~~~~~~l~~~~~~~~~L~~L~L~~g~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~L~l~~~~l~~~~~~~l~~ 400 (592)
T 3ogk_B 322 VLETR-NVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGT 400 (592)
T ss_dssp EEEEE-GGGHHHHHHHHHHHCTTCCEEEEECCCCSSTTSSTTCCCCHHHHHHHHHHCTTCSEEEEEESCCCHHHHHHHHH
T ss_pred EEecc-CccCHHHHHHHHHhCCCCCEEEeecCccccccccccCccCHHHHHHHHhhCccCeEEEeecCCccHHHHHHHHh
Confidence 77776 4444333333445567777777773 455432 111 344677777777777777766666655
Q ss_pred -CCCCCEEEcc----CccCccCCC--------CCCCCccEEeccCCc--CCCCCCCCCCCCCchhhhhHhhhcccCCCcc
Q 002346 281 -LPALLNISLQ----NNKLQGPYP--------LFPSKVQKVSLDHNN--FCKNSSDAGKPCDPQVTTLLQIAGDMGYPAI 345 (933)
Q Consensus 281 -l~~L~~L~Ls----~N~l~~~~p--------~~~~~l~~L~l~~n~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 345 (933)
+++|+.|+|+ .|.+++.+. ....+|+.|+|+++. +.+. .+..+.......+
T Consensus 401 ~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~-------------~~~~~~~~~~~L~- 466 (592)
T 3ogk_B 401 YLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDL-------------GLSYIGQYSPNVR- 466 (592)
T ss_dssp HCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHH-------------HHHHHHHSCTTCC-
T ss_pred hCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHH-------------HHHHHHHhCccce-
Confidence 7777777775 566665311 113467777776432 2211 1111111111111
Q ss_pred ccCCCCCCCCCC-CCCccccCCCceeEEEccCccccCc-CchhhcCcccCCeEecccCcccCCCCccc-CCCCCcCEEec
Q 002346 346 LSDSWEGNNACD-GWPFVTCSQGRIITINLANKLLAGN-ISPAYANLTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDV 422 (933)
Q Consensus 346 l~~~~~~~~~~~-~~p~~~~~l~~L~~L~Ls~N~l~g~-~p~~~~~l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~l~l 422 (933)
...+..|...+ .++..+..+++|+.|+|++|.+++. ++..+..+++|+.|+|++|+++..--..+ ..++.|....+
T Consensus 467 -~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~~~~~~l~~~~p~l~~~~~ 545 (592)
T 3ogk_B 467 -WMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELI 545 (592)
T ss_dssp -EEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCTTCTTGGGGCCTTEEEEEE
T ss_pred -EeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCHHHHHHHHHhCCCcEEEEe
Confidence 11222333222 3455567789999999999998766 45556789999999999999987644444 35777777666
Q ss_pred cCC
Q 002346 423 SNN 425 (933)
Q Consensus 423 s~N 425 (933)
..+
T Consensus 546 ~~~ 548 (592)
T 3ogk_B 546 PSR 548 (592)
T ss_dssp CCC
T ss_pred cCc
Confidence 654
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-19 Score=193.95 Aligned_cols=100 Identities=20% Similarity=0.294 Sum_probs=49.0
Q ss_pred cceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeecc
Q 002346 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (933)
Q Consensus 92 L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~ 171 (933)
+..+.+..+.+++.. .+..+++|++|++++|.++.++. +..+++|++|+|++|++.. ++. +.++++|++|+|+
T Consensus 26 ~~~~~l~~~~~~~~~-~~~~l~~L~~L~l~~~~i~~~~~--~~~l~~L~~L~L~~n~l~~---~~~-l~~l~~L~~L~l~ 98 (291)
T 1h6t_A 26 TIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTD---IKP-LANLKNLGWLFLD 98 (291)
T ss_dssp HHHHHTTCSCTTSEE-CHHHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCC---CGG-GTTCTTCCEEECC
T ss_pred HHHHHhcCCCccccc-chhhcCcccEEEccCCCcccChh--HhcCCCCCEEEccCCccCC---Ccc-cccCCCCCEEECC
Confidence 334445555554332 23445556666666666555532 4555555555555555554 222 4455555555555
Q ss_pred CcccCCCCChhhcCCCCCCEEEccCCcCC
Q 002346 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 172 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 200 (933)
+|++.+. ..+..+++|++|+|++|+++
T Consensus 99 ~n~l~~~--~~l~~l~~L~~L~L~~n~i~ 125 (291)
T 1h6t_A 99 ENKVKDL--SSLKDLKKLKSLSLEHNGIS 125 (291)
T ss_dssp SSCCCCG--GGGTTCTTCCEEECTTSCCC
T ss_pred CCcCCCC--hhhccCCCCCEEECCCCcCC
Confidence 5554442 22444444444444444444
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.7e-19 Score=210.47 Aligned_cols=191 Identities=24% Similarity=0.322 Sum_probs=155.4
Q ss_pred CCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCe
Q 002346 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (933)
Q Consensus 88 ~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~ 167 (933)
.+..+..+.++.+.+...++ +..+++|+.|+|++|.|..++ .|..+++|+.|+|++|++.. ++. +..+++|+.
T Consensus 19 ~l~~l~~l~l~~~~i~~~~~-~~~L~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~Ls~N~l~~---~~~-l~~l~~L~~ 91 (605)
T 1m9s_A 19 AFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTD---IKP-LTNLKNLGW 91 (605)
T ss_dssp HHHHHHHHHTTCSCTTSEEC-HHHHTTCCCCBCTTCCCCCCT--TGGGCTTCCEEECTTSCCCC---CGG-GGGCTTCCE
T ss_pred HHHHHHHHhccCCCcccccc-hhcCCCCCEEECcCCCCCCCh--HHccCCCCCEEEeeCCCCCC---Chh-hccCCCCCE
Confidence 35566777888888876554 677899999999999999986 38899999999999999988 444 899999999
Q ss_pred eeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCcc
Q 002346 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247 (933)
Q Consensus 168 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l 247 (933)
|+|++|.|.+. ..+..+++|++|+|++|+|++ ++ . +..+++|+.|+|++|+|
T Consensus 92 L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~-l~-~------------------------l~~l~~L~~L~Ls~N~l 143 (605)
T 1m9s_A 92 LFLDENKIKDL--SSLKDLKKLKSLSLEHNGISD-IN-G------------------------LVHLPQLESLYLGNNKI 143 (605)
T ss_dssp EECCSSCCCCC--TTSTTCTTCCEEECTTSCCCC-CG-G------------------------GGGCTTCSEEECCSSCC
T ss_pred EECcCCCCCCC--hhhccCCCCCEEEecCCCCCC-Cc-c------------------------ccCCCccCEEECCCCcc
Confidence 99999999874 378899999999999999984 33 2 33489999999999999
Q ss_pred CCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCC--CCCCccEEeccCCcCCC
Q 002346 248 TGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL--FPSKVQKVSLDHNNFCK 317 (933)
Q Consensus 248 ~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~--~~~~l~~L~l~~n~~~~ 317 (933)
++. +.+..+++|+.|+|++|+|++..| +..+++|+.|+|++|+|++. |. .+.+|+.|+|++|.+.+
T Consensus 144 ~~l-~~l~~l~~L~~L~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~ 211 (605)
T 1m9s_A 144 TDI-TVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLN 211 (605)
T ss_dssp CCC-GGGGSCTTCSEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEEC
T ss_pred CCc-hhhcccCCCCEEECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcC
Confidence 986 678899999999999999997666 88999999999999998864 22 13455666666665544
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.79 E-value=7e-19 Score=180.52 Aligned_cols=152 Identities=22% Similarity=0.278 Sum_probs=131.5
Q ss_pred EEEecCCCCccccCccccCCcccceeecccccccccCC--CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCC
Q 002346 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (933)
Q Consensus 70 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 147 (933)
.+++++++++ .+|..+. ..+++|+|++|+|++.++ .|..+++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 15 ~l~~s~n~l~-~iP~~~~--~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 91 (220)
T 2v70_A 15 TVDCSNQKLN-KIPEHIP--QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN 91 (220)
T ss_dssp EEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EeEeCCCCcc-cCccCCC--CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEEECCCC
Confidence 4566667777 4676654 356899999999999866 4889999999999999999999989999999999999999
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccc
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~ 227 (933)
++.. ..+..|..+++|++|+|++|+|.+..|..|..+++|++|+|++|+|++..|..|..
T Consensus 92 ~l~~--~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~------------------ 151 (220)
T 2v70_A 92 RLEN--VQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDT------------------ 151 (220)
T ss_dssp CCCC--CCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTT------------------
T ss_pred ccCc--cCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcC------------------
Confidence 9988 45567999999999999999999999999999999999999999999777876654
Q ss_pred cccccCCccCcEEEecCCccCCC
Q 002346 228 LDVLSGMTQLRQVWLHKNQFTGP 250 (933)
Q Consensus 228 ~~~l~~l~~L~~L~L~~N~l~~~ 250 (933)
+++|+.|+|++|.+...
T Consensus 152 ------l~~L~~L~L~~N~l~c~ 168 (220)
T 2v70_A 152 ------LHSLSTLNLLANPFNCN 168 (220)
T ss_dssp ------CTTCCEEECCSCCEECS
T ss_pred ------CCCCCEEEecCcCCcCC
Confidence 88899999999888754
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.79 E-value=7e-19 Score=180.51 Aligned_cols=151 Identities=21% Similarity=0.332 Sum_probs=129.4
Q ss_pred CCCCCCccccceEeCCC----------CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCce
Q 002346 49 TSSTGYCEWTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQD 117 (933)
Q Consensus 49 ~~~~~~C~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~ 117 (933)
.+..+.|.|..|.|.+. ..++.|+|++|+|++..+..|..+++|++|+|++|+|+++.| .|.++++|++
T Consensus 5 CP~~C~C~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~ 84 (220)
T 2v9t_B 5 CPAACTCSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNS 84 (220)
T ss_dssp SCTTSEEETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCE
T ss_pred CCCCCEECCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCE
Confidence 34567799999999752 368889999999987777788889999999999999988877 7888999999
Q ss_pred eccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCC
Q 002346 118 IYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYN 197 (933)
Q Consensus 118 L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N 197 (933)
|+|++|+|+.++...|.++++|++|+|++|++.. ..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|
T Consensus 85 L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 162 (220)
T 2v9t_B 85 LVLYGNKITELPKSLFEGLFSLQLLLLNANKINC--LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162 (220)
T ss_dssp EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred EECCCCcCCccCHhHccCCCCCCEEECCCCCCCE--eCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCC
Confidence 9999999999988888889999999999998888 55778888999999999999998888888888999999999999
Q ss_pred cCCC
Q 002346 198 NFTG 201 (933)
Q Consensus 198 ~l~~ 201 (933)
++..
T Consensus 163 ~~~c 166 (220)
T 2v9t_B 163 PFIC 166 (220)
T ss_dssp CEEC
T ss_pred CcCC
Confidence 8874
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.78 E-value=2.1e-21 Score=231.62 Aligned_cols=243 Identities=16% Similarity=0.212 Sum_probs=146.1
Q ss_pred CCEEEEEecCCCCccccCcccc-CCcccceeecccc-ccccc-CCC-ccCcCcCceeccccccccCCCCCccc----CCC
Q 002346 66 NRVTTISLAKSGLSGTLSPEIS-SLTQLETLSFQMN-NIAGA-IPS-LANATSLQDIYLDNNNFTSVPTGCFD----GLT 137 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~-~l~~L~~L~l~~N-~l~~~-~p~-~~~l~~L~~L~Ls~N~l~~~~~~~~~----~l~ 137 (933)
.+++.|+|+++.+++..+..+. .+++|++|+|++| .++.. ++. +.++++|++|+|++|.+++.....+. .++
T Consensus 105 ~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~ 184 (594)
T 2p1m_B 105 TWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYT 184 (594)
T ss_dssp TTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCC
T ss_pred CCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCC
Confidence 4688999999888877666665 6889999999988 55542 333 44788999999999988875544333 567
Q ss_pred CCCEEEccCCC--CCCCCCCCccccCCccCCeeeccCc-ccCCCCChhhcCCCCCCEEEccCCc----------------
Q 002346 138 NLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNA-NIFGLIPDFFDSFSNLQNLRLSYNN---------------- 198 (933)
Q Consensus 138 ~L~~L~Ls~N~--~~~~~~~p~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~L~~N~---------------- 198 (933)
+|+.|+|++|. +.. ..++..+.++++|++|+|++| .+.+ ++..+..+++|++|+++.+.
T Consensus 185 ~L~~L~l~~~~~~~~~-~~l~~l~~~~~~L~~L~L~~~~~~~~-l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~ 262 (594)
T 2p1m_B 185 SLVSLNISCLASEVSF-SALERLVTRCPNLKSLKLNRAVPLEK-LATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALS 262 (594)
T ss_dssp CCCEEECTTCCSCCCH-HHHHHHHHHCTTCCEEECCTTSCHHH-HHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHH
T ss_pred cCcEEEecccCCcCCH-HHHHHHHHhCCCCcEEecCCCCcHHH-HHHHHhcCCcceEcccccccCccchhhHHHHHHHHh
Confidence 89999999886 111 011222345689999999888 4444 67777788888888866552
Q ss_pred ----------CCCCCCcccc-----ccccchhhcccccCCcccccccccCCccCcEEEecCCccCC-CCCC-CCCCCCCC
Q 002346 199 ----------FTGSLPASFA-----KSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG-PIPD-LSKCESLF 261 (933)
Q Consensus 199 ----------l~~~~p~~~~-----~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~-~~~~-~~~~~~L~ 261 (933)
+....+..+. ...|++|++..|.+...+....+..+++|+.|++++| ++. .++. ...+++|+
T Consensus 263 ~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~ 341 (594)
T 2p1m_B 263 GCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLR 341 (594)
T ss_dssp TCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCHHHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCC
T ss_pred cCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCHHHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCC
Confidence 1111111111 1456666666666443333333445666666666666 321 1111 22356666
Q ss_pred EEEc---------cCCcccccCccccc-CCCCCCEEEccCccCccCCCC----CCCCccEEecc
Q 002346 262 DLSL---------RDNQLTGVVPASVI-SLPALLNISLQNNKLQGPYPL----FPSKVQKVSLD 311 (933)
Q Consensus 262 ~L~L---------~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~l~ 311 (933)
.|+| +.|.+++.....+. .+++|+.|+++.|.+++.... ...+|+.|+|+
T Consensus 342 ~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~ 405 (594)
T 2p1m_B 342 ELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLC 405 (594)
T ss_dssp EEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEE
T ss_pred EEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEee
Confidence 6666 23444433333332 356666666666666643221 13466677766
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.78 E-value=1.2e-18 Score=178.80 Aligned_cols=155 Identities=18% Similarity=0.243 Sum_probs=134.4
Q ss_pred CEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCC--CCCCCCCCEEEccC
Q 002346 190 QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD--LSKCESLFDLSLRD 267 (933)
Q Consensus 190 ~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~--~~~~~~L~~L~L~~ 267 (933)
+.+++++|.++ .+|..+. ..++.|+|++|+|++.++. |..+++|+.|+|++
T Consensus 14 ~~l~~s~n~l~-~iP~~~~--------------------------~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~ 66 (220)
T 2v70_A 14 TTVDCSNQKLN-KIPEHIP--------------------------QYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSN 66 (220)
T ss_dssp TEEECCSSCCS-SCCSCCC--------------------------TTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCS
T ss_pred CEeEeCCCCcc-cCccCCC--------------------------CCCCEEEcCCCcCCccCchhhhccCCCCCEEECCC
Confidence 58899999988 6776652 3568999999999987653 78899999999999
Q ss_pred CcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCcccc
Q 002346 268 NQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347 (933)
Q Consensus 268 N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 347 (933)
|+|++..+..|..+++|++|+|++|++++..+
T Consensus 67 N~i~~i~~~~~~~l~~L~~L~Ls~N~l~~~~~------------------------------------------------ 98 (220)
T 2v70_A 67 NKITDIEEGAFEGASGVNEILLTSNRLENVQH------------------------------------------------ 98 (220)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCCCCCG------------------------------------------------
T ss_pred CcCCEECHHHhCCCCCCCEEECCCCccCccCH------------------------------------------------
Confidence 99998888889999999999999999885433
Q ss_pred CCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcC
Q 002346 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427 (933)
Q Consensus 348 ~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l 427 (933)
..+..+++|++|+|++|++++..|..|.++++|+.|+|++|+|++..|..|..+++|+.|+|++|++
T Consensus 99 -------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 165 (220)
T 2v70_A 99 -------------KMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165 (220)
T ss_dssp -------------GGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCE
T ss_pred -------------hHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCC
Confidence 3455678999999999999999999999999999999999999999899999999999999999999
Q ss_pred cccCC
Q 002346 428 SGKVP 432 (933)
Q Consensus 428 ~g~~p 432 (933)
++..+
T Consensus 166 ~c~c~ 170 (220)
T 2v70_A 166 NCNCY 170 (220)
T ss_dssp ECSGG
T ss_pred cCCCc
Confidence 98765
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.77 E-value=6.8e-19 Score=195.46 Aligned_cols=178 Identities=25% Similarity=0.312 Sum_probs=124.0
Q ss_pred EEEecCCCCccccCccccCCcccceeecccccccccCC-Ccc-CcCcCceeccccccccCCCCCcccCCCCCCEEEccCC
Q 002346 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLA-NATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (933)
Q Consensus 70 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~-~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 147 (933)
.+++++++|+ .+|..+. ..++.|+|++|+|+++.+ .+. ++++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 22 ~l~c~~~~l~-~iP~~~~--~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L~Ls~N 98 (361)
T 2xot_A 22 ILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN 98 (361)
T ss_dssp EEECCSSCCS-SCCSSCC--TTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred EEEeCCCCcC-ccCccCC--CCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCEEECCCC
Confidence 4566667777 4666554 358889999999988877 565 8888888888888888888888888888888888888
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccc
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~ 227 (933)
++.. ..+..|..+++|++|+|++|+|.+..|..|..+++|++|+|++|+|+ .+|..+..
T Consensus 99 ~l~~--~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~------------------ 157 (361)
T 2xot_A 99 HLHT--LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIK------------------ 157 (361)
T ss_dssp CCCE--ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCC-SCCGGGTC------------------
T ss_pred cCCc--CCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCC-eeCHHHhc------------------
Confidence 8776 33446677777777777777777777777777777777777777776 34433210
Q ss_pred cccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCC--CCEEEccCccCcc
Q 002346 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA--LLNISLQNNKLQG 296 (933)
Q Consensus 228 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~--L~~L~Ls~N~l~~ 296 (933)
.+..+++|+.|+|++|+|++..+..+..++. |+.|+|++|++..
T Consensus 158 -------------------------~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C 203 (361)
T 2xot_A 158 -------------------------DGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLEC 203 (361)
T ss_dssp -----------------------------CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEEC
T ss_pred -------------------------CcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccC
Confidence 0134566666666666666544556666665 3677777777763
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A | Back alignment and structure |
|---|
Probab=99.77 E-value=3.7e-18 Score=175.12 Aligned_cols=162 Identities=22% Similarity=0.345 Sum_probs=140.4
Q ss_pred CccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCc
Q 002346 54 YCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGC 132 (933)
Q Consensus 54 ~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~ 132 (933)
.|. .+..|.. +.+++++++++ .+|..+. ++|++|+|++|+|+++++ .|..+++|++|+|++|+|+++.+..
T Consensus 4 ~CP-~~C~C~~----~~v~c~~~~l~-~iP~~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~ 75 (220)
T 2v9t_B 4 HCP-AACTCSN----NIVDCRGKGLT-EIPTNLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA 75 (220)
T ss_dssp CSC-TTSEEET----TEEECTTSCCS-SCCSSCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTT
T ss_pred CCC-CCCEECC----CEEEcCCCCcC-cCCCccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHH
Confidence 354 2456653 57899999998 5776665 789999999999999888 7999999999999999999999999
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCcccccccc
Q 002346 133 FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDI 212 (933)
Q Consensus 133 ~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l 212 (933)
|.++++|++|+|++|++.. ..+..|..+++|++|+|++|+|.+..|..|..+++|++|+|++|+|++..+..|.
T Consensus 76 ~~~l~~L~~L~Ls~N~l~~--l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~---- 149 (220)
T 2v9t_B 76 FQGLRSLNSLVLYGNKITE--LPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFS---- 149 (220)
T ss_dssp TTTCSSCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTT----
T ss_pred hhCCcCCCEEECCCCcCCc--cCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHh----
Confidence 9999999999999999997 3345578999999999999999999999999999999999999999965555544
Q ss_pred chhhcccccCCcccccccccCCccCcEEEecCCccCC
Q 002346 213 QNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (933)
Q Consensus 213 ~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 249 (933)
.+++|+.|+|++|.+..
T Consensus 150 --------------------~l~~L~~L~L~~N~~~c 166 (220)
T 2v9t_B 150 --------------------PLRAIQTMHLAQNPFIC 166 (220)
T ss_dssp --------------------TCTTCCEEECCSSCEEC
T ss_pred --------------------CCCCCCEEEeCCCCcCC
Confidence 38889999999998864
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=1.1e-18 Score=183.68 Aligned_cols=139 Identities=22% Similarity=0.210 Sum_probs=107.7
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcE--EEEEEeccccCCc----------------------hhHHHHHHHHHHHHhc
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTK--IAVKRMESNTMGN----------------------KGLSEFQAEIAVLTKV 636 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~~l~~l 636 (933)
-|++.+.||+|+||.||+|.. .+|+. ||||+++...... .....+.+|+.++..+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999976 68999 9999876542110 1124688999999999
Q ss_pred CCCcc--eeEEeEeeeCceeEEEEeecCC-C----ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhh-hccCCCe
Q 002346 637 RHRHL--VALLGYCINGSERLLVYEYMPR-G----TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH-SLAQQSF 708 (933)
Q Consensus 637 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH-~~~~~~i 708 (933)
+|+++ +.++++ ...++||||+.+ | +|.++... .++.++..++.|++.|++||| + .+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~---~gi 192 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQE---AEL 192 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHT---SCE
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHH---CCE
Confidence 88754 344442 356899999942 4 66665422 224567789999999999999 7 899
Q ss_pred EecCCCCCcEEecCCCcEEEecccccccC
Q 002346 709 IHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 709 vH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
+||||||+|||++. .++|+|||+|...
T Consensus 193 vHrDlkp~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 193 VHADLSEYNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence 99999999999998 9999999998754
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.3e-17 Score=172.36 Aligned_cols=109 Identities=28% Similarity=0.361 Sum_probs=56.2
Q ss_pred ceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccC
Q 002346 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172 (933)
Q Consensus 93 ~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~ 172 (933)
+.++++++.++.++..+. ++|++|+|++|+|+++++..|.++++|++|+|++|++.. ..+..|..+++|++|+|++
T Consensus 22 ~~v~c~~~~l~~ip~~~~--~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~--i~~~~~~~l~~L~~L~Ls~ 97 (229)
T 3e6j_A 22 TTVDCRSKRHASVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA--LPVGVFDSLTQLTVLDLGT 97 (229)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCS
T ss_pred CEeEccCCCcCccCCCCC--CCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCC--cChhhcccCCCcCEEECCC
Confidence 445566666554443332 555666666666665555555555555555555555544 1223344555555555555
Q ss_pred cccCCCCChhhcCCCCCCEEEccCCcCCCCCCcc
Q 002346 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS 206 (933)
Q Consensus 173 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 206 (933)
|+|++..+..|..+++|++|+|++|+|+ .+|..
T Consensus 98 N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~ 130 (229)
T 3e6j_A 98 NQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRG 130 (229)
T ss_dssp SCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTT
T ss_pred CcCCccChhHhCcchhhCeEeccCCccc-ccCcc
Confidence 5555444444455555555555555554 44433
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.75 E-value=1.4e-18 Score=183.43 Aligned_cols=173 Identities=22% Similarity=0.226 Sum_probs=136.7
Q ss_pred CCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCe
Q 002346 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (933)
Q Consensus 88 ~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~ 167 (933)
.+.+++.+++++|.+++.. .+..+++|++|++++|.|+.++ .+..+++|++|+|++|++.. ++. +.++++|++
T Consensus 17 ~l~~l~~l~l~~~~i~~~~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~L~~N~i~~---~~~-l~~l~~L~~ 89 (263)
T 1xeu_A 17 GLANAVKQNLGKQSVTDLV-SQKELSGVQNFNGDNSNIQSLA--GMQFFTNLKELHLSHNQISD---LSP-LKDLTKLEE 89 (263)
T ss_dssp HHHHHHHHHHTCSCTTSEE-CHHHHTTCSEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC---CGG-GTTCSSCCE
T ss_pred HHHHHHHHHhcCCCccccc-chhhcCcCcEEECcCCCcccch--HHhhCCCCCEEECCCCccCC---Chh-hccCCCCCE
Confidence 5667778888888887655 6778888888888888888876 47888888888888888887 444 888888888
Q ss_pred eeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCcc
Q 002346 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247 (933)
Q Consensus 168 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l 247 (933)
|+|++|++++. |. +.. ++|++|+|++|++++ ++ . +..+++|+.|+|++|++
T Consensus 90 L~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~-~~-~------------------------l~~l~~L~~L~Ls~N~i 140 (263)
T 1xeu_A 90 LSVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRD-TD-S------------------------LIHLKNLEILSIRNNKL 140 (263)
T ss_dssp EECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSB-SG-G------------------------GTTCTTCCEEECTTSCC
T ss_pred EECCCCccCCc-Cc-ccc-CcccEEEccCCccCC-Ch-h------------------------hcCcccccEEECCCCcC
Confidence 88888888775 33 222 888888888888874 32 2 34488899999999998
Q ss_pred CCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC
Q 002346 248 TGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (933)
Q Consensus 248 ~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 299 (933)
++. +.+..+++|+.|+|++|++++. ..+..+++|+.|++++|++++...
T Consensus 141 ~~~-~~l~~l~~L~~L~L~~N~i~~~--~~l~~l~~L~~L~l~~N~~~~~~~ 189 (263)
T 1xeu_A 141 KSI-VMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDLTGQKCVNEPV 189 (263)
T ss_dssp CBC-GGGGGCTTCCEEECTTSCCCBC--TTSTTCCCCCEEEEEEEEEECCCE
T ss_pred CCC-hHHccCCCCCEEECCCCcCcch--HHhccCCCCCEEeCCCCcccCCcc
Confidence 876 4688889999999999999865 678888999999999999887643
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.75 E-value=9.5e-21 Score=221.64 Aligned_cols=203 Identities=18% Similarity=0.169 Sum_probs=128.5
Q ss_pred CCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcc-------------cCCCCChhhcCCCCCCEEE-ccCCcCC
Q 002346 135 GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN-------------IFGLIPDFFDSFSNLQNLR-LSYNNFT 200 (933)
Q Consensus 135 ~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~-------------l~~~~p~~~~~l~~L~~L~-L~~N~l~ 200 (933)
.+++|+.|+|++|++.. +|..++++++|+.|++++|. +.+.+|..++.+++|+.|+ ++.|.+.
T Consensus 347 ~~~~L~~L~Ls~n~L~~---Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~ 423 (567)
T 1dce_A 347 TDEQLFRCELSVEKSTV---LQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLD 423 (567)
T ss_dssp TTTTSSSCCCCHHHHHH---HHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHH
T ss_pred cCccceeccCChhhHHh---hHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccc
Confidence 34555555555555543 55566666666666665543 4566677777777777777 6666543
Q ss_pred CCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccC
Q 002346 201 GSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVIS 280 (933)
Q Consensus 201 ~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~ 280 (933)
.+..+.+.+|.+.... ...|+.|+|++|+|++. |.+..+++|+.|+|++|+|+ .+|..|+.
T Consensus 424 ----------~L~~l~l~~n~i~~l~-------~~~L~~L~Ls~n~l~~l-p~~~~l~~L~~L~Ls~N~l~-~lp~~~~~ 484 (567)
T 1dce_A 424 ----------DLRSKFLLENSVLKME-------YADVRVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLR-ALPPALAA 484 (567)
T ss_dssp ----------HHHHHHHHHHHHHHHH-------HTTCSEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCC-CCCGGGGG
T ss_pred ----------hhhhhhhhcccccccC-------ccCceEEEecCCCCCCC-cCccccccCcEeecCccccc-ccchhhhc
Confidence 3344444444432111 12477788888888774 34777788888888888887 67777777
Q ss_pred CCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCC
Q 002346 281 LPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWP 360 (933)
Q Consensus 281 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p 360 (933)
+++|+.|+|++|+|++ +|
T Consensus 485 l~~L~~L~Ls~N~l~~--------------------------------------------------------------lp 502 (567)
T 1dce_A 485 LRCLEVLQASDNALEN--------------------------------------------------------------VD 502 (567)
T ss_dssp CTTCCEEECCSSCCCC--------------------------------------------------------------CG
T ss_pred CCCCCEEECCCCCCCC--------------------------------------------------------------Cc
Confidence 8888877777777764 12
Q ss_pred ccccCCCceeEEEccCccccCcC-chhhcCcccCCeEecccCcccCCCCcc---cCCCCCcCEEec
Q 002346 361 FVTCSQGRIITINLANKLLAGNI-SPAYANLTSLKNLYLQQNNLTGPIPDG---LTKLASLQNLDV 422 (933)
Q Consensus 361 ~~~~~l~~L~~L~Ls~N~l~g~~-p~~~~~l~~L~~L~L~~N~l~g~~p~~---~~~l~~L~~l~l 422 (933)
.++.+++|+.|+|++|+|++.+ |..|+.|++|+.|+|++|+|++..|.. +..+++|+.||+
T Consensus 503 -~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~l~~~lp~L~~L~l 567 (567)
T 1dce_A 503 -GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSILT 567 (567)
T ss_dssp -GGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEEEC
T ss_pred -ccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHHHHHHCcccCccCC
Confidence 3445566777777777777665 777777777777777777777554421 223666666653
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.75 E-value=2.9e-18 Score=190.36 Aligned_cols=153 Identities=21% Similarity=0.305 Sum_probs=136.6
Q ss_pred CCCCCCccccceEeCCC----------CCEEEEEecCCCCccccCcccc-CCcccceeecccccccccCC-CccCcCcCc
Q 002346 49 TSSTGYCEWTGINCDNS----------NRVTTISLAKSGLSGTLSPEIS-SLTQLETLSFQMNNIAGAIP-SLANATSLQ 116 (933)
Q Consensus 49 ~~~~~~C~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~~~-~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~ 116 (933)
.+..+.|.|..|.|.+. ..++.|+|++|+|++..+..+. .+++|++|+|++|+|+++.+ .|.++++|+
T Consensus 12 Cp~~C~C~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~ 91 (361)
T 2xot_A 12 CPANCLCASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLR 91 (361)
T ss_dssp CCTTCEEETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCCEECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCC
T ss_pred CCCCCEECCCEEEeCCCCcCccCccCCCCCCEEECCCCCCCccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCC
Confidence 45667799999999752 3588999999999988888887 99999999999999999988 799999999
Q ss_pred eeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhh---cCCCCCCEEE
Q 002346 117 DIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF---DSFSNLQNLR 193 (933)
Q Consensus 117 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~---~~l~~L~~L~ 193 (933)
+|+|++|+|+.+++..|.++++|++|+|++|++.. ..|..|..+++|+.|+|++|+|++..+..| ..+++|++|+
T Consensus 92 ~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~--~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~ 169 (361)
T 2xot_A 92 YLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVV--VDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLD 169 (361)
T ss_dssp EEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCE--ECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEE
T ss_pred EEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccE--ECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEE
Confidence 99999999999999999999999999999999998 457899999999999999999999877766 6799999999
Q ss_pred ccCCcCCCCCC
Q 002346 194 LSYNNFTGSLP 204 (933)
Q Consensus 194 L~~N~l~~~~p 204 (933)
|++|+|+ .+|
T Consensus 170 L~~N~l~-~l~ 179 (361)
T 2xot_A 170 LSSNKLK-KLP 179 (361)
T ss_dssp CCSSCCC-CCC
T ss_pred CCCCCCC-ccC
Confidence 9999999 454
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.74 E-value=4.4e-18 Score=171.48 Aligned_cols=156 Identities=17% Similarity=0.169 Sum_probs=107.9
Q ss_pred ccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCC
Q 002346 109 LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSN 188 (933)
Q Consensus 109 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 188 (933)
...+++|++|++++|.++.++ .+..+++|++|+|++|.+.. +..+..+++|++|++++|++++..+..|+.+++
T Consensus 40 ~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~n~~~~----~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~ 113 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVTDLT--GIEYAHNIKDLTINNIHATN----YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTS 113 (197)
T ss_dssp HHHHHTCCEEEEESSCCSCCT--TGGGCTTCSEEEEESCCCSC----CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTT
T ss_pred hhhcCCccEEeccCCCccChH--HHhcCCCCCEEEccCCCCCc----chhhhcCCCCCEEEeECCccCcccChhhcCCCC
Confidence 355667777777777777666 36777777777777775544 346777777777777777777766777777777
Q ss_pred CCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCC
Q 002346 189 LQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDN 268 (933)
Q Consensus 189 L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N 268 (933)
|++|+|++|++++..|..+. .+++|+.|+|++|.+.+.++.+..+++|+.|++++|
T Consensus 114 L~~L~Ls~n~i~~~~~~~l~------------------------~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n 169 (197)
T 4ezg_A 114 LTLLDISHSAHDDSILTKIN------------------------TLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFD 169 (197)
T ss_dssp CCEEECCSSBCBGGGHHHHT------------------------TCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTB
T ss_pred CCEEEecCCccCcHhHHHHh------------------------hCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCC
Confidence 88888888777755555443 377777778877773333456777778888888888
Q ss_pred cccccCcccccCCCCCCEEEccCccCcc
Q 002346 269 QLTGVVPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 269 ~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
++++ ++ .+..+++|+.|++++|++.+
T Consensus 170 ~i~~-~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 170 GVHD-YR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp CCCC-CT-TGGGCSSCCEEEECBC----
T ss_pred CCcC-hH-HhccCCCCCEEEeeCcccCC
Confidence 8774 33 67777888888888887754
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* | Back alignment and structure |
|---|
Probab=99.74 E-value=6e-20 Score=214.83 Aligned_cols=193 Identities=17% Similarity=0.184 Sum_probs=155.5
Q ss_pred cCCcccceeecccccccccCCCccCcCcCceecccccc-------------ccCCCCCcccCCCCCCEEE-ccCCCCCCC
Q 002346 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNN-------------FTSVPTGCFDGLTNLQVLS-LSDNPNLAP 152 (933)
Q Consensus 87 ~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~-------------l~~~~~~~~~~l~~L~~L~-Ls~N~~~~~ 152 (933)
..+++|+.|+|++|.|+.+++.++++++|+.|++++|. +.+.++..++.+++|+.|+ ++.|.+..
T Consensus 346 ~~~~~L~~L~Ls~n~L~~Lp~~i~~l~~L~~L~l~~n~~l~~l~~ll~~~~~~~~~~~~l~~l~~L~~L~~l~~n~~~~- 424 (567)
T 1dce_A 346 ATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDD- 424 (567)
T ss_dssp STTTTSSSCCCCHHHHHHHHHHHHHHHHHHHHCTTCHHHHHHHHHHHHHHCTGGGHHHHHHHHHHHHHHCGGGHHHHHH-
T ss_pred ccCccceeccCChhhHHhhHHHHHHHHHHHHhccccchhhhhHHHHHHhcccccCCHHHHHHHHhcccCcchhhcccch-
Confidence 67889999999999998666689999999999998775 4566666788888888888 56553322
Q ss_pred CCCCc------cccC--CccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCc
Q 002346 153 WPFPN------ELTK--STSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224 (933)
Q Consensus 153 ~~~p~------~~~~--l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~ 224 (933)
++. .+.. ...|+.|+|++|+|++. |. |+.+++|++|+|++|+|+ .+|..++.
T Consensus 425 --L~~l~l~~n~i~~l~~~~L~~L~Ls~n~l~~l-p~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~--------------- 484 (567)
T 1dce_A 425 --LRSKFLLENSVLKMEYADVRVLHLAHKDLTVL-CH-LEQLLLVTHLDLSHNRLR-ALPPALAA--------------- 484 (567)
T ss_dssp --HHHHHHHHHHHHHHHHTTCSEEECTTSCCSSC-CC-GGGGTTCCEEECCSSCCC-CCCGGGGG---------------
T ss_pred --hhhhhhhcccccccCccCceEEEecCCCCCCC-cC-ccccccCcEeecCccccc-ccchhhhc---------------
Confidence 111 1111 12588999999999884 65 889999999999999998 88877655
Q ss_pred ccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccC-cccccCCCCCCEEEccCccCccCCCCC--
Q 002346 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVV-PASVISLPALLNISLQNNKLQGPYPLF-- 301 (933)
Q Consensus 225 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~~~~p~~-- 301 (933)
+++|+.|+|++|+|+++ |.+..+++|+.|+|++|+|++.+ |..+..+++|+.|+|++|++++.+|..
T Consensus 485 ---------l~~L~~L~Ls~N~l~~l-p~l~~l~~L~~L~Ls~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~~~ 554 (567)
T 1dce_A 485 ---------LRCLEVLQASDNALENV-DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQER 554 (567)
T ss_dssp ---------CTTCCEEECCSSCCCCC-GGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTH
T ss_pred ---------CCCCCEEECCCCCCCCC-cccCCCCCCcEEECCCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccHHHH
Confidence 89999999999999985 58999999999999999999877 999999999999999999999987753
Q ss_pred ----CCCccEEec
Q 002346 302 ----PSKVQKVSL 310 (933)
Q Consensus 302 ----~~~l~~L~l 310 (933)
+.+|+.|+|
T Consensus 555 l~~~lp~L~~L~l 567 (567)
T 1dce_A 555 LAEMLPSVSSILT 567 (567)
T ss_dssp HHHHCTTCSEEEC
T ss_pred HHHHCcccCccCC
Confidence 356666653
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.73 E-value=9.1e-18 Score=169.15 Aligned_cols=155 Identities=17% Similarity=0.239 Sum_probs=125.0
Q ss_pred ccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccC
Q 002346 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165 (933)
Q Consensus 86 ~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L 165 (933)
.+.+++|++|++++|.|+.. |.+..+++|++|++++|.++.++ .+..+++|++|+|++|++.. ..+..+..+++|
T Consensus 40 ~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~l~~n~l~~--~~~~~l~~l~~L 114 (197)
T 4ezg_A 40 EAQMNSLTYITLANINVTDL-TGIEYAHNIKDLTINNIHATNYN--PISGLSNLERLRIMGKDVTS--DKIPNLSGLTSL 114 (197)
T ss_dssp HHHHHTCCEEEEESSCCSCC-TTGGGCTTCSEEEEESCCCSCCG--GGTTCTTCCEEEEECTTCBG--GGSCCCTTCTTC
T ss_pred hhhcCCccEEeccCCCccCh-HHHhcCCCCCEEEccCCCCCcch--hhhcCCCCCEEEeECCccCc--ccChhhcCCCCC
Confidence 36677888888888888843 47888888888888888777664 57888999999999998876 456788899999
Q ss_pred CeeeccCcccCCCCChhhcCCCCCCEEEccCCc-CCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecC
Q 002346 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNN-FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK 244 (933)
Q Consensus 166 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~-l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~ 244 (933)
++|+|++|++++..|..++.+++|++|+|++|+ ++ .+| .+ ..+++|+.|++++
T Consensus 115 ~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~-~~~-~l------------------------~~l~~L~~L~l~~ 168 (197)
T 4ezg_A 115 TLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAIT-DIM-PL------------------------KTLPELKSLNIQF 168 (197)
T ss_dssp CEEECCSSBCBGGGHHHHTTCSSCCEEECCSCTBCC-CCG-GG------------------------GGCSSCCEEECTT
T ss_pred CEEEecCCccCcHhHHHHhhCCCCCEEEccCCCCcc-ccH-hh------------------------cCCCCCCEEECCC
Confidence 999999999988888899999999999999998 55 555 33 3488999999999
Q ss_pred CccCCCCCCCCCCCCCCEEEccCCcccc
Q 002346 245 NQFTGPIPDLSKCESLFDLSLRDNQLTG 272 (933)
Q Consensus 245 N~l~~~~~~~~~~~~L~~L~L~~N~l~~ 272 (933)
|++++.. .+..+++|+.|++++|++.+
T Consensus 169 n~i~~~~-~l~~l~~L~~L~l~~N~i~~ 195 (197)
T 4ezg_A 169 DGVHDYR-GIEDFPKLNQLYAFSQTIGG 195 (197)
T ss_dssp BCCCCCT-TGGGCSSCCEEEECBC----
T ss_pred CCCcChH-HhccCCCCCEEEeeCcccCC
Confidence 9998754 78889999999999998864
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} | Back alignment and structure |
|---|
Probab=99.72 E-value=1.3e-17 Score=176.07 Aligned_cols=167 Identities=19% Similarity=0.279 Sum_probs=143.5
Q ss_pred EEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCC
Q 002346 68 VTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (933)
Q Consensus 68 v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 147 (933)
++.+++.++++++.. .+..+++|++|++++|.|+.+ +.+..+++|++|+|++|+|+++++ +..+++|++|+|++|
T Consensus 21 l~~l~l~~~~i~~~~--~~~~l~~L~~L~l~~n~i~~l-~~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N 95 (263)
T 1xeu_A 21 AVKQNLGKQSVTDLV--SQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRN 95 (263)
T ss_dssp HHHHHHTCSCTTSEE--CHHHHTTCSEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred HHHHHhcCCCccccc--chhhcCcCcEEECcCCCcccc-hHHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCC
Confidence 456677888887543 578999999999999999864 478899999999999999999887 899999999999999
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccc
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~ 227 (933)
++.. +|.... ++|+.|+|++|++++. ..+..+++|++|+|++|++++ ++ .+
T Consensus 96 ~l~~---l~~~~~--~~L~~L~L~~N~l~~~--~~l~~l~~L~~L~Ls~N~i~~-~~-~l-------------------- 146 (263)
T 1xeu_A 96 RLKN---LNGIPS--ACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKS-IV-ML-------------------- 146 (263)
T ss_dssp CCSC---CTTCCC--SSCCEEECCSSCCSBS--GGGTTCTTCCEEECTTSCCCB-CG-GG--------------------
T ss_pred ccCC---cCcccc--CcccEEEccCCccCCC--hhhcCcccccEEECCCCcCCC-Ch-HH--------------------
Confidence 9988 443333 9999999999999885 469999999999999999984 33 33
Q ss_pred cccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCccccc
Q 002346 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGV 273 (933)
Q Consensus 228 ~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~ 273 (933)
..+++|+.|+|++|++++. +.+..+++|+.|+|++|++++.
T Consensus 147 ----~~l~~L~~L~L~~N~i~~~-~~l~~l~~L~~L~l~~N~~~~~ 187 (263)
T 1xeu_A 147 ----GFLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNE 187 (263)
T ss_dssp ----GGCTTCCEEECTTSCCCBC-TTSTTCCCCCEEEEEEEEEECC
T ss_pred ----ccCCCCCEEECCCCcCcch-HHhccCCCCCEEeCCCCcccCC
Confidence 3489999999999999987 7789999999999999999855
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.71 E-value=1.6e-17 Score=166.52 Aligned_cols=131 Identities=21% Similarity=0.315 Sum_probs=117.4
Q ss_pred EEEecCCCCccccCccccCCcccceeecccccccccCCC--ccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCC
Q 002346 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPS--LANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (933)
Q Consensus 70 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~--~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 147 (933)
.|++++++|+ .+|..+.. +|++|+|++|.|+++++. |..+++|++|+|++|+|+++++..|.++++|++|+|++|
T Consensus 12 ~l~~s~~~l~-~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 88 (192)
T 1w8a_A 12 TVDCTGRGLK-EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN 88 (192)
T ss_dssp EEECTTSCCS-SCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSC
T ss_pred EEEcCCCCcC-cCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEECCCC
Confidence 4555667775 67776654 999999999999998874 899999999999999999999999999999999999999
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCc
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 205 (933)
++.. ..+..+.++++|++|+|++|+|++..|..|..+++|++|+|++|+|++..+-
T Consensus 89 ~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~l 144 (192)
T 1w8a_A 89 KIKE--ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CCCE--ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred cCCc--cCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCcc
Confidence 9998 5567799999999999999999999999999999999999999999977654
|
| >4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} | Back alignment and structure |
|---|
Probab=99.71 E-value=1.1e-18 Score=210.81 Aligned_cols=161 Identities=22% Similarity=0.218 Sum_probs=79.7
Q ss_pred cccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeee
Q 002346 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (933)
Q Consensus 90 ~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~ 169 (933)
+.++.|+|..|.+..... ..|+.++|++|.|.+ ++++.|++.. .+..+..++.|+.|+
T Consensus 173 ~~~~~l~L~~n~~~~~~~-----~~l~~l~Ls~~~i~~--------------~~~~~n~~~~---~~~~~~~l~~L~~L~ 230 (727)
T 4b8c_D 173 PLTPKIELFANGKDEANQ-----ALLQHKKLSQYSIDE--------------DDDIENRMVM---PKDSKYDDQLWHALD 230 (727)
T ss_dssp -----------------------------------------------------------------------CCCCCCEEE
T ss_pred CccceEEeeCCCCCcchh-----hHhhcCccCcccccC--------------ccccccceec---ChhhhccCCCCcEEE
Confidence 345566666666554322 223444455554433 2334444443 466677777777777
Q ss_pred ccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCC
Q 002346 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (933)
Q Consensus 170 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 249 (933)
|++|.+. .+|..+..+++|++|+|++|+|+ .+|..|.. +++|+.|+|++|+|+.
T Consensus 231 Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~------------------------l~~L~~L~Ls~N~l~~ 284 (727)
T 4b8c_D 231 LSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKN------------------------LSNLRVLDLSHNRLTS 284 (727)
T ss_dssp CTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGG------------------------GTTCCEEECTTSCCSS
T ss_pred CCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhC------------------------CCCCCEEeCcCCcCCc
Confidence 7777776 44555557777777777777777 67766544 6777777777777775
Q ss_pred CCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC
Q 002346 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP 299 (933)
Q Consensus 250 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 299 (933)
++..+..+++|++|+|++|.|+ .+|..|+.+++|+.|+|++|+|++.+|
T Consensus 285 lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p 333 (727)
T 4b8c_D 285 LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFL 333 (727)
T ss_dssp CCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHH
T ss_pred cChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCCh
Confidence 5445777777777777777776 667667777777777777777776544
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* | Back alignment and structure |
|---|
Probab=99.70 E-value=2.9e-19 Score=213.06 Aligned_cols=348 Identities=14% Similarity=0.091 Sum_probs=204.5
Q ss_pred CCEEEEEecCCCCcc---ccC------------ccccCCcccceeecccccccccCC-Ccc-CcCcCceeccccc-cccC
Q 002346 66 NRVTTISLAKSGLSG---TLS------------PEISSLTQLETLSFQMNNIAGAIP-SLA-NATSLQDIYLDNN-NFTS 127 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~---~~~------------~~~~~l~~L~~L~l~~N~l~~~~p-~~~-~l~~L~~L~Ls~N-~l~~ 127 (933)
.+++.|+|.++.... ..| .....+++|++|+|++|.+++..+ .+. .+++|++|+|++| .++.
T Consensus 66 ~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~~l~~l~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~ 145 (594)
T 2p1m_B 66 PKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFST 145 (594)
T ss_dssp TTCCEEEEECSCGGGGGTCSCTTSCCBCHHHHHHHHHHCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEH
T ss_pred CCceEEeccCCCchhhcccccccccchhhHHHHHHHHhCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCH
Confidence 467888888765321 111 123467889999999998887655 454 6889999999988 5554
Q ss_pred C-CCCcccCCCCCCEEEccCCCCCCCCC--CCccccCCccCCeeeccCcccCCCCCh----hhcCCCCCCEEEccCC-cC
Q 002346 128 V-PTGCFDGLTNLQVLSLSDNPNLAPWP--FPNELTKSTSLTTLYMDNANIFGLIPD----FFDSFSNLQNLRLSYN-NF 199 (933)
Q Consensus 128 ~-~~~~~~~l~~L~~L~Ls~N~~~~~~~--~p~~~~~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~L~~N-~l 199 (933)
. ....+.++++|++|+|++|.+..... ++.....+++|+.|++++|. ...... .+..+++|++|+|++| .+
T Consensus 146 ~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~~~~L~~L~l~~~~-~~~~~~~l~~l~~~~~~L~~L~L~~~~~~ 224 (594)
T 2p1m_B 146 DGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLA-SEVSFSALERLVTRCPNLKSLKLNRAVPL 224 (594)
T ss_dssp HHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTTCCCCCEEECTTCC-SCCCHHHHHHHHHHCTTCCEEECCTTSCH
T ss_pred HHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhcCCcCcEEEecccC-CcCCHHHHHHHHHhCCCCcEEecCCCCcH
Confidence 2 22234478899999999998665211 22333467799999999886 222122 2345689999999988 33
Q ss_pred CCCCCccccc-cccchhhcccccC-----------------------------CcccccccccCCccCcEEEecCCccCC
Q 002346 200 TGSLPASFAK-SDIQNLWMNDQQL-----------------------------GLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (933)
Q Consensus 200 ~~~~p~~~~~-~~l~~l~l~~n~~-----------------------------~~~~~~~~l~~l~~L~~L~L~~N~l~~ 249 (933)
+ .+|..+.. ..|++|.+..+.. ........+..+++|+.|+|++|.+++
T Consensus 225 ~-~l~~~~~~~~~L~~L~l~~~~~~~~~~~~~~l~~~l~~~~~L~~Ls~~~~~~~~~l~~~~~~~~~L~~L~L~~~~l~~ 303 (594)
T 2p1m_B 225 E-KLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQS 303 (594)
T ss_dssp H-HHHHHHHHCTTCSEEECSBCCCCCCHHHHHHHHHHHHTCTTCCEEECCBTCCGGGGGGGHHHHTTCCEEECTTCCCCH
T ss_pred H-HHHHHHhcCCcceEcccccccCccchhhHHHHHHHHhcCCCcccccCCcccchhhHHHHHHhhCCCCEEEccCCCCCH
Confidence 3 34444433 4566665443321 000011112245677777777777553
Q ss_pred CCC-C-CCCCCCCCEEEccCCccccc-CcccccCCCCCCEEEccC---------ccCccCCC----CCCCCccEEeccCC
Q 002346 250 PIP-D-LSKCESLFDLSLRDNQLTGV-VPASVISLPALLNISLQN---------NKLQGPYP----LFPSKVQKVSLDHN 313 (933)
Q Consensus 250 ~~~-~-~~~~~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~---------N~l~~~~p----~~~~~l~~L~l~~n 313 (933)
... . +..+++|+.|++++| ++.. ++.....+++|++|+|++ |.+++... ....+|+.|.+..|
T Consensus 304 ~~l~~~~~~~~~L~~L~l~~~-~~~~~l~~l~~~~~~L~~L~L~~~~~~g~~~~~~l~~~~l~~l~~~~~~L~~L~~~~~ 382 (594)
T 2p1m_B 304 YDLVKLLCQCPKLQRLWVLDY-IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKLESVLYFCR 382 (594)
T ss_dssp HHHHHHHTTCTTCCEEEEEGG-GHHHHHHHHHHHCTTCCEEEEECSCTTCSSCSSCCCHHHHHHHHHHCTTCCEEEEEES
T ss_pred HHHHHHHhcCCCcCEEeCcCc-cCHHHHHHHHHhCCCCCEEEEecCcccccccCCCCCHHHHHHHHHhchhHHHHHHhcC
Confidence 221 1 446677777777766 3322 222233467777777733 34432111 11346777766666
Q ss_pred cCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCC---CCCCCCCCc------cccCCCceeEEEccCccccCcCc
Q 002346 314 NFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEG---NNACDGWPF------VTCSQGRIITINLANKLLAGNIS 384 (933)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~---~~~~~~~p~------~~~~l~~L~~L~Ls~N~l~g~~p 384 (933)
++... ....+.......+.+...+.+ ++..+..|. .+..+++|+.|+|++ .+++..+
T Consensus 383 ~l~~~-------------~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~ 448 (594)
T 2p1m_B 383 QMTNA-------------ALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVF 448 (594)
T ss_dssp CCCHH-------------HHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHH
T ss_pred CcCHH-------------HHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHH
Confidence 66331 111111112222333332212 233343332 255678899999977 7776666
Q ss_pred hhhcC-cccCCeEecccCcccCCCCccc-CCCCCcCEEeccCCcCccc
Q 002346 385 PAYAN-LTSLKNLYLQQNNLTGPIPDGL-TKLASLQNLDVSNNNLSGK 430 (933)
Q Consensus 385 ~~~~~-l~~L~~L~L~~N~l~g~~p~~~-~~l~~L~~l~ls~N~l~g~ 430 (933)
..++. +++|+.|+|++|++++..+..+ ..+++|+.|+|++|++++.
T Consensus 449 ~~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~~~~ 496 (594)
T 2p1m_B 449 EYIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDK 496 (594)
T ss_dssp HHHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSCCHH
T ss_pred HHHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCCcHH
Confidence 66665 8889999999999876655555 5688899999999988543
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.67 E-value=3.5e-16 Score=154.62 Aligned_cols=138 Identities=28% Similarity=0.420 Sum_probs=119.0
Q ss_pred CCCCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCC
Q 002346 51 STGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVP 129 (933)
Q Consensus 51 ~~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~ 129 (933)
..+.|.|++|.|.. ++++ .+|..+ .++|++|++++|++++.++ .|..+++|++|+|++|+|++++
T Consensus 3 ~~C~C~~~~l~~~~-----------~~l~-~~p~~~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~ 68 (177)
T 2o6r_A 3 SRCSCSGTEIRCNS-----------KGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLP 68 (177)
T ss_dssp TTCEEETTEEECCS-----------SCCS-SCCTTC--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCC
T ss_pred CCCEeCCCEEEecC-----------CCCc-cCCCCC--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeC
Confidence 44668898888864 3554 345433 3689999999999998887 5789999999999999999999
Q ss_pred CCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCC
Q 002346 130 TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204 (933)
Q Consensus 130 ~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 204 (933)
+..|..+++|++|+|++|++.. ..+..+..+++|++|+|++|++++..+..|..+++|++|+|++|++++..|
T Consensus 69 ~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~ 141 (177)
T 2o6r_A 69 DGVFDKLTKLTILYLHENKLQS--LPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP 141 (177)
T ss_dssp TTTTTTCTTCCEEECCSSCCCC--CCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred hhHccCCCccCEEECCCCCccc--cCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence 9999999999999999999998 445568999999999999999998888888999999999999999997665
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 | Back alignment and structure |
|---|
Probab=99.66 E-value=1.2e-16 Score=159.97 Aligned_cols=111 Identities=19% Similarity=0.300 Sum_probs=64.8
Q ss_pred ceeecccccccccCCCccCcCcCceeccccccccCCCCC-cccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeecc
Q 002346 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTG-CFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (933)
Q Consensus 93 ~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~ 171 (933)
+.|++++|+|+.++..+.. +|++|+|++|+|+++++. .|..+++|++|+|++|++++ ..|..|.++++|++|+|+
T Consensus 11 ~~l~~s~~~l~~ip~~~~~--~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~--~~~~~~~~l~~L~~L~Ls 86 (192)
T 1w8a_A 11 TTVDCTGRGLKEIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG--IEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCSSCCSCCCT--TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC--BCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCcCcCccCCCC--CCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCC--cCHhHcCCcccCCEEECC
Confidence 5666666666544433332 666666666666666553 35666666666666666655 345555566666666666
Q ss_pred CcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccc
Q 002346 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207 (933)
Q Consensus 172 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 207 (933)
+|+|++..+..|..+++|++|+|++|+|++..|..|
T Consensus 87 ~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~ 122 (192)
T 1w8a_A 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSF 122 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSS
T ss_pred CCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHh
Confidence 666655555555555666666666666655445443
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=1e-16 Score=174.37 Aligned_cols=145 Identities=15% Similarity=0.157 Sum_probs=103.8
Q ss_pred HHHHHhcC---CccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC------------chhHH--------HHHHHHH
Q 002346 575 VLRQVTDN---FSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG------------NKGLS--------EFQAEIA 631 (933)
Q Consensus 575 ~l~~~~~~---~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~------------~~~~~--------~~~~E~~ 631 (933)
.+....++ |++.+.||+|+||.||+|...+|+.||||+++....+ ..... ...+|..
T Consensus 86 AL~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~ 165 (397)
T 4gyi_A 86 ALHTHAARKDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFA 165 (397)
T ss_dssp HHHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHCCCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHH
Confidence 34444444 8999999999999999998889999999987643211 00111 1234566
Q ss_pred HHHhcCCCcce--eEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeE
Q 002346 632 VLTKVRHRHLV--ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFI 709 (933)
Q Consensus 632 ~l~~l~h~niv--~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~iv 709 (933)
.|.++.+.++. ..+++ ...++||||++|++|.+.... .....++.|++.++.|||+ .+||
T Consensus 166 nL~rL~~~gv~vp~p~~~----~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~---~gIV 227 (397)
T 4gyi_A 166 FMKALYEEGFPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAK---HGLI 227 (397)
T ss_dssp HHHHHHHTTCSCCCEEEE----ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHH---TTEE
T ss_pred HHHHHHhcCCCCCeeeec----cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHH---CCCc
Confidence 66666444332 22222 223799999999888665411 1245688999999999998 8999
Q ss_pred ecCCCCCcEEecCCC----------cEEEecccccccC
Q 002346 710 HRDLKPSNILIGDDM----------RAKVADFGLVKNA 737 (933)
Q Consensus 710 H~Dik~~Nill~~~~----------~~kl~DfGla~~~ 737 (933)
||||||.|||+++++ .+.|+||+-+...
T Consensus 228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCCCCHHHEEEeCCCCcccccccccceEEEEeCCcccC
Confidence 999999999998876 3899999976643
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.64 E-value=3.9e-16 Score=152.77 Aligned_cols=136 Identities=21% Similarity=0.207 Sum_probs=123.2
Q ss_pred CCEEEEEecCCCCc-cccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLS-GTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|++++|+++ +.+|..+..+++|++|+|++|.|++. +.+..+++|++|+|++|++++..+..+..+++|++|+|
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 102 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSSCCGGGGGCCEEEEESSCCCCC-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEEC
T ss_pred ccCCEEECCCCCCChhhHHHHHHhCCCCCEEeCcCCCCCCh-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEec
Confidence 57899999999998 78899899999999999999999987 88999999999999999999977777888999999999
Q ss_pred cCCCCCCCCCCC--ccccCCccCCeeeccCcccCCCCC---hhhcCCCCCCEEEccCCcCCCCCCcc
Q 002346 145 SDNPNLAPWPFP--NELTKSTSLTTLYMDNANIFGLIP---DFFDSFSNLQNLRLSYNNFTGSLPAS 206 (933)
Q Consensus 145 s~N~~~~~~~~p--~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~L~~N~l~~~~p~~ 206 (933)
++|++.. +| ..+..+++|++|++++|.+++..+ ..+..+++|++|++++|.+. .+|.+
T Consensus 103 s~N~l~~---~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~~ 165 (168)
T 2ell_A 103 SGNKLKD---ISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPDS 165 (168)
T ss_dssp BSSSCCS---SGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCSS
T ss_pred cCCccCc---chhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hcccc
Confidence 9999987 44 788999999999999999998876 68999999999999999998 66654
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.63 E-value=1.1e-15 Score=152.92 Aligned_cols=128 Identities=23% Similarity=0.267 Sum_probs=113.7
Q ss_pred EEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCC
Q 002346 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149 (933)
Q Consensus 70 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~ 149 (933)
.+++++++|+ .+|..+. ++|++|+|++|+|+.++..|.++++|++|+|++|+|+++++..|.++++|++|+|++|++
T Consensus 14 ~l~~~~~~l~-~ip~~~~--~~l~~L~L~~n~i~~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~l 90 (193)
T 2wfh_A 14 VVRCSNKGLK-VLPKGIP--RDVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRL 90 (193)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCCEEECCSSCCCSCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCC
T ss_pred EEEcCCCCCC-cCCCCCC--CCCCEEECCCCcCchhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCCcc
Confidence 4555667777 5666554 689999999999996656899999999999999999999999999999999999999999
Q ss_pred CCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCC
Q 002346 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202 (933)
Q Consensus 150 ~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 202 (933)
.. ..|..|..+++|++|+|++|+|++..+..|..+++|++|+|++|++...
T Consensus 91 ~~--i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~ 141 (193)
T 2wfh_A 91 RC--IPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCD 141 (193)
T ss_dssp CB--CCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECS
T ss_pred CE--eCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecC
Confidence 98 5567899999999999999999998888899999999999999999853
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A | Back alignment and structure |
|---|
Probab=99.60 E-value=2.3e-15 Score=147.21 Aligned_cols=83 Identities=25% Similarity=0.367 Sum_probs=49.8
Q ss_pred CcCceecccccccc--CCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCC
Q 002346 113 TSLQDIYLDNNNFT--SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ 190 (933)
Q Consensus 113 ~~L~~L~Ls~N~l~--~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 190 (933)
++|++|+|++|.++ .++. .+..+++|++|+|++|.+.. + ..+..+++|++|+|++|++.+.+|..+..+++|+
T Consensus 24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~---~-~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 98 (168)
T 2ell_A 24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLIS---V-SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLT 98 (168)
T ss_dssp TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCC---C-SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCC
T ss_pred ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCC---h-hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCC
Confidence 56677777777766 4433 35666666666666666555 2 4555566666666666666555555555555666
Q ss_pred EEEccCCcCC
Q 002346 191 NLRLSYNNFT 200 (933)
Q Consensus 191 ~L~L~~N~l~ 200 (933)
+|+|++|+++
T Consensus 99 ~L~Ls~N~l~ 108 (168)
T 2ell_A 99 HLNLSGNKLK 108 (168)
T ss_dssp EEECBSSSCC
T ss_pred EEeccCCccC
Confidence 6666666555
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.59 E-value=8.7e-16 Score=168.13 Aligned_cols=60 Identities=13% Similarity=0.092 Sum_probs=45.2
Q ss_pred cccCCCcee-EEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEec
Q 002346 362 VTCSQGRII-TINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDV 422 (933)
Q Consensus 362 ~~~~l~~L~-~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~l 422 (933)
.+..+++|+ .|+|.+ .++..-+..|.++++|+.|+|++|+++..-+.+|.++++|+.++.
T Consensus 268 aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 268 VFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred HhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 344556777 788877 666556678888888888888888888666778888888888763
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.57 E-value=1.4e-14 Score=144.90 Aligned_cols=80 Identities=26% Similarity=0.352 Sum_probs=40.8
Q ss_pred ceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEcc
Q 002346 116 QDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195 (933)
Q Consensus 116 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~ 195 (933)
+++++++|+|+.+|...+ ++|++|+|++|++.. +|..+.++++|+.|+|++|+|++..+..|..+++|++|+|+
T Consensus 13 ~~l~~~~~~l~~ip~~~~---~~l~~L~L~~n~i~~---ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls 86 (193)
T 2wfh_A 13 TVVRCSNKGLKVLPKGIP---RDVTELYLDGNQFTL---VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILS 86 (193)
T ss_dssp TEEECTTSCCSSCCSCCC---TTCCEEECCSSCCCS---CCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECC
T ss_pred CEEEcCCCCCCcCCCCCC---CCCCEEECCCCcCch---hHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECC
Confidence 345555555555544321 345555555555543 44455555555555555555555555555555555555555
Q ss_pred CCcCCC
Q 002346 196 YNNFTG 201 (933)
Q Consensus 196 ~N~l~~ 201 (933)
+|+|++
T Consensus 87 ~N~l~~ 92 (193)
T 2wfh_A 87 YNRLRC 92 (193)
T ss_dssp SSCCCB
T ss_pred CCccCE
Confidence 555553
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.57 E-value=1.8e-15 Score=144.81 Aligned_cols=129 Identities=22% Similarity=0.193 Sum_probs=96.3
Q ss_pred CCEEEEEecCCCCc-cccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLS-GTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~-~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.+++.|++++|+++ +.+|..+..+++|++|++++|.|++. +.+..+++|++|+|++|.+++..+..+..+++|++|+|
T Consensus 17 ~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l 95 (149)
T 2je0_A 17 SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95 (149)
T ss_dssp GGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEEEC
T ss_pred ccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEEEC
Confidence 35778888888887 67777778888888888888888776 66777888888888888888755556667788888888
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCC---hhhcCCCCCCEEEccC
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP---DFFDSFSNLQNLRLSY 196 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p---~~~~~l~~L~~L~L~~ 196 (933)
++|++... +.+..+..+++|++|++++|++++..+ ..+..+++|++|++++
T Consensus 96 s~N~i~~~-~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~d 149 (149)
T 2je0_A 96 SGNKIKDL-STIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQLTYLDGYD 149 (149)
T ss_dssp TTSCCCSH-HHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTCCEETTBC
T ss_pred CCCcCCCh-HHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCcccccCCC
Confidence 88877661 122667778888888888888877765 5677778888887753
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} | Back alignment and structure |
|---|
Probab=99.56 E-value=1.7e-14 Score=142.30 Aligned_cols=133 Identities=28% Similarity=0.480 Sum_probs=113.5
Q ss_pred cceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeecc
Q 002346 92 LETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (933)
Q Consensus 92 L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~ 171 (933)
.+.+++++|+++.++..+. ++|++|+|++|+++++++..|..+++|++|+|++|++.. ..+..+..+++|++|+|+
T Consensus 9 ~~~l~~~~~~l~~~p~~~~--~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~--~~~~~~~~l~~L~~L~l~ 84 (177)
T 2o6r_A 9 GTEIRCNSKGLTSVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS--LPDGVFDKLTKLTILYLH 84 (177)
T ss_dssp TTEEECCSSCCSSCCTTCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCC--CCTTTTTTCTTCCEEECC
T ss_pred CCEEEecCCCCccCCCCCC--CCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceE--eChhHccCCCccCEEECC
Confidence 5789999999987665443 789999999999999999999999999999999999987 344567999999999999
Q ss_pred CcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCC
Q 002346 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251 (933)
Q Consensus 172 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~ 251 (933)
+|++++..+..|..+++|++|+|++|++++ +|..+ +..+++|+.|+|++|.+.+..
T Consensus 85 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~-~~~~~-----------------------~~~l~~L~~L~l~~N~~~~~~ 140 (177)
T 2o6r_A 85 ENKLQSLPNGVFDKLTQLKELALDTNQLKS-VPDGI-----------------------FDRLTSLQKIWLHTNPWDCSC 140 (177)
T ss_dssp SSCCCCCCTTTTTTCTTCCEEECCSSCCSC-CCTTT-----------------------TTTCTTCCEEECCSSCBCCCH
T ss_pred CCCccccCHHHhhCCcccCEEECcCCcceE-eCHHH-----------------------hcCCcccCEEEecCCCeeccC
Confidence 999999988889999999999999999994 44432 234788999999999888755
Q ss_pred C
Q 002346 252 P 252 (933)
Q Consensus 252 ~ 252 (933)
+
T Consensus 141 ~ 141 (177)
T 2o6r_A 141 P 141 (177)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A | Back alignment and structure |
|---|
Probab=99.56 E-value=3.4e-15 Score=142.87 Aligned_cols=85 Identities=22% Similarity=0.296 Sum_probs=49.0
Q ss_pred cCcCceecccccccc-CCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCC
Q 002346 112 ATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQ 190 (933)
Q Consensus 112 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 190 (933)
.++|++|++++|.++ +..+..+..+++|++|+|++|.+.. + ..+..+++|++|+|++|.+++.+|..+..+++|+
T Consensus 16 ~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~---~-~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~ 91 (149)
T 2je0_A 16 PSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTS---I-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLT 91 (149)
T ss_dssp GGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCC---C-TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCC
T ss_pred CccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCC---c-hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCC
Confidence 356677777777766 2222345666666666666666655 2 4455555555555555555555555555555555
Q ss_pred EEEccCCcCC
Q 002346 191 NLRLSYNNFT 200 (933)
Q Consensus 191 ~L~L~~N~l~ 200 (933)
+|+|++|+++
T Consensus 92 ~L~ls~N~i~ 101 (149)
T 2je0_A 92 HLNLSGNKIK 101 (149)
T ss_dssp EEECTTSCCC
T ss_pred EEECCCCcCC
Confidence 5555555555
|
| >3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} | Back alignment and structure |
|---|
Probab=99.54 E-value=6.4e-15 Score=161.19 Aligned_cols=237 Identities=14% Similarity=0.086 Sum_probs=133.1
Q ss_pred Ccccceeeccccccc--ccCCCccCcCcCceeccccccccCCCCCcccC--------CCCCCEEEccCCCCCCCCCCCcc
Q 002346 89 LTQLETLSFQMNNIA--GAIPSLANATSLQDIYLDNNNFTSVPTGCFDG--------LTNLQVLSLSDNPNLAPWPFPNE 158 (933)
Q Consensus 89 l~~L~~L~l~~N~l~--~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~--------l~~L~~L~Ls~N~~~~~~~~p~~ 158 (933)
+++|+.|||++|+|. ...+ +.++.++.+.+..| .++..+|.+ +++|+.|+|.+ .+.. .-+.+
T Consensus 48 l~~L~~LdLs~n~i~~~~~~~--~~~~~~~~~~~~~~---~I~~~aF~~~~~~~~~g~~~L~~l~L~~-~i~~--I~~~a 119 (329)
T 3sb4_A 48 FPSLKVLDISNAEIKMYSGKA--GTYPNGKFYIYMAN---FVPAYAFSNVVNGVTKGKQTLEKVILSE-KIKN--IEDAA 119 (329)
T ss_dssp CTTCCEEEEEEEEECCEEESS--SSSGGGCCEEECTT---EECTTTTEEEETTEEEECTTCCC-CBCT-TCCE--ECTTT
T ss_pred hccCeEEecCcceeEEecCcc--cccccccccccccc---ccCHHHhcccccccccccCCCcEEECCc-cccc--hhHHH
Confidence 566777777777766 2111 11111233333333 455566666 67777777766 5554 23456
Q ss_pred ccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcC----CCCCCccccc-------------------------
Q 002346 159 LTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNF----TGSLPASFAK------------------------- 209 (933)
Q Consensus 159 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l----~~~~p~~~~~------------------------- 209 (933)
|.++++|+.|++++|.+..+.+..|..+.++..|.+..+.. ...-...|..
T Consensus 120 F~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L~~~i~~~~~~~l~~~~~~~~~ 199 (329)
T 3sb4_A 120 FKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPLETTIQVGAMGKLEDEIMKAGL 199 (329)
T ss_dssp TTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCCEEEEEECTTCCHHHHHHHTTC
T ss_pred hhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhccccccccccccccccceeEEecCCCcHHHHHhhccc
Confidence 66677777777777766666666666666665555544221 1011111110
Q ss_pred --cccchhhcccccCCcccccccc-cCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCC
Q 002346 210 --SDIQNLWMNDQQLGLSGTLDVL-SGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALL 285 (933)
Q Consensus 210 --~~l~~l~l~~n~~~~~~~~~~l-~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~ 285 (933)
..+..+.+.++ +. ......+ ..+++|+.|+|++|+++.+.+. |.+|.+|+.|+|.+| ++...+.+|.++++|+
T Consensus 200 ~~~~~~~l~~~~~-l~-~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~ 276 (329)
T 3sb4_A 200 QPRDINFLTIEGK-LD-NADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLA 276 (329)
T ss_dssp CGGGCSEEEEEEC-CC-HHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCC
T ss_pred CccccceEEEeee-ec-HHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhcc
Confidence 01111111110 00 0000001 1256677777777777655543 667777777777776 6655556677777777
Q ss_pred -EEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCcccc
Q 002346 286 -NISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC 364 (933)
Q Consensus 286 -~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~ 364 (933)
.|+|.+ .++... +..+.
T Consensus 277 ~~l~l~~-~l~~I~-------------------------------------------------------------~~aF~ 294 (329)
T 3sb4_A 277 GTLELPA-SVTAIE-------------------------------------------------------------FGAFM 294 (329)
T ss_dssp EEEEECT-TCCEEC-------------------------------------------------------------TTTTT
T ss_pred EEEEEcc-cceEEc-------------------------------------------------------------hhhhh
Confidence 776665 333211 23456
Q ss_pred CCCceeEEEccCccccCcCchhhcCcccCCeEec
Q 002346 365 SQGRIITINLANKLLAGNISPAYANLTSLKNLYL 398 (933)
Q Consensus 365 ~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L 398 (933)
.+++|+.|+|++|+++..-+..|.++++|+.|+.
T Consensus 295 ~c~~L~~l~l~~n~i~~I~~~aF~~~~~L~~ly~ 328 (329)
T 3sb4_A 295 GCDNLRYVLATGDKITTLGDELFGNGVPSKLIYK 328 (329)
T ss_dssp TCTTEEEEEECSSCCCEECTTTTCTTCCCCEEEC
T ss_pred CCccCCEEEeCCCccCccchhhhcCCcchhhhcc
Confidence 6789999999999999888889999999999874
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=2.2e-14 Score=141.42 Aligned_cols=128 Identities=16% Similarity=0.227 Sum_probs=111.5
Q ss_pred CCEEEEEecCCCCccccCccccCCc-ccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLT-QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~-~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
..++.|++++|+++. ++. +..+. +|++|+|++|.|++. +.+..+++|++|+|++|.|+++++..|..+++|++|+|
T Consensus 19 ~~L~~L~l~~n~l~~-i~~-~~~~~~~L~~L~Ls~N~l~~~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 95 (176)
T 1a9n_A 19 VRDRELDLRGYKIPV-IEN-LGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95 (176)
T ss_dssp TSCEEEECTTSCCCS-CCC-GGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEEC
T ss_pred CCceEEEeeCCCCch-hHH-hhhcCCCCCEEECCCCCCCcc-cccccCCCCCEEECCCCcccccCcchhhcCCCCCEEEC
Confidence 468999999999984 554 55555 999999999999987 78999999999999999999998887899999999999
Q ss_pred cCCCCCCCCCCCc--cccCCccCCeeeccCcccCCCCCh----hhcCCCCCCEEEccCCcCC
Q 002346 145 SDNPNLAPWPFPN--ELTKSTSLTTLYMDNANIFGLIPD----FFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 145 s~N~~~~~~~~p~--~~~~l~~L~~L~L~~n~l~~~~p~----~~~~l~~L~~L~L~~N~l~ 200 (933)
++|++.. +|. .+..+++|+.|++++|.+... |. .+..+++|++|++++|.+.
T Consensus 96 ~~N~i~~---~~~~~~l~~l~~L~~L~l~~N~i~~~-~~~~~~~~~~l~~L~~Ld~~~n~~~ 153 (176)
T 1a9n_A 96 TNNSLVE---LGDLDPLASLKSLTYLCILRNPVTNK-KHYRLYVIYKVPQVRVLDFQKVKLK 153 (176)
T ss_dssp CSCCCCC---GGGGGGGGGCTTCCEEECCSSGGGGS-TTHHHHHHHHCTTCSEETTEECCHH
T ss_pred CCCcCCc---chhhHhhhcCCCCCEEEecCCCCCCc-HhHHHHHHHHCCccceeCCCcCCHH
Confidence 9999976 665 788999999999999999765 55 4889999999999999876
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 | Back alignment and structure |
|---|
Probab=99.50 E-value=1.6e-14 Score=142.47 Aligned_cols=86 Identities=17% Similarity=0.265 Sum_probs=42.3
Q ss_pred ccCcCcCceeccccccccCCCCCcccCCC-CCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCC
Q 002346 109 LANATSLQDIYLDNNNFTSVPTGCFDGLT-NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187 (933)
Q Consensus 109 ~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~-~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 187 (933)
+.++.+|++|+|++|+++.++. +..+. +|++|+|++|.+.. + ..+..+++|++|+|++|++++..+..|..++
T Consensus 15 ~~~~~~L~~L~l~~n~l~~i~~--~~~~~~~L~~L~Ls~N~l~~---~-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~ 88 (176)
T 1a9n_A 15 YTNAVRDRELDLRGYKIPVIEN--LGATLDQFDAIDFSDNEIRK---L-DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 88 (176)
T ss_dssp EECTTSCEEEECTTSCCCSCCC--GGGGTTCCSEEECCSSCCCE---E-CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred cCCcCCceEEEeeCCCCchhHH--hhhcCCCCCEEECCCCCCCc---c-cccccCCCCCEEECCCCcccccCcchhhcCC
Confidence 4444555555555555554421 22222 55555555555544 1 3444455555555555555544444445555
Q ss_pred CCCEEEccCCcCC
Q 002346 188 NLQNLRLSYNNFT 200 (933)
Q Consensus 188 ~L~~L~L~~N~l~ 200 (933)
+|++|+|++|+++
T Consensus 89 ~L~~L~L~~N~i~ 101 (176)
T 1a9n_A 89 DLTELILTNNSLV 101 (176)
T ss_dssp TCCEEECCSCCCC
T ss_pred CCCEEECCCCcCC
Confidence 5555555555553
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.50 E-value=3.9e-13 Score=150.17 Aligned_cols=171 Identities=11% Similarity=0.189 Sum_probs=112.5
Q ss_pred CcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCe
Q 002346 89 LTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (933)
Q Consensus 89 l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~ 167 (933)
...++.+.+.+ .++.+.. .|.+. +|+.+.|.+| ++.|...+|.++ +|+.+.|.. .+.. .-+.+|.++++|+.
T Consensus 112 ~~~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~~-~L~~i~lp~-~l~~--I~~~aF~~c~~L~~ 184 (401)
T 4fdw_A 112 LKGYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFNS-TVQEIVFPS-TLEQ--LKEDIFYYCYNLKK 184 (401)
T ss_dssp CSSCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTTC-CCCEEECCT-TCCE--ECSSTTTTCTTCCE
T ss_pred cCCccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCCC-CceEEEeCC-CccE--ehHHHhhCcccCCe
Confidence 45666666654 3554544 56664 6888888765 777888888774 688888875 4444 33467788888888
Q ss_pred eeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCcc
Q 002346 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247 (933)
Q Consensus 168 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l 247 (933)
++|.+|++..+....|. .++|+.+.|..| ++ .++.. +|.++++|+.|+|..| +
T Consensus 185 l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~-~I~~~-----------------------aF~~~~~L~~l~l~~~-l 237 (401)
T 4fdw_A 185 ADLSKTKITKLPASTFV-YAGIEEVLLPVT-LK-EIGSQ-----------------------AFLKTSQLKTIEIPEN-V 237 (401)
T ss_dssp EECTTSCCSEECTTTTT-TCCCSEEECCTT-CC-EECTT-----------------------TTTTCTTCCCEECCTT-C
T ss_pred eecCCCcceEechhhEe-ecccCEEEeCCc-hh-eehhh-----------------------HhhCCCCCCEEecCCC-c
Confidence 88888888777667776 478888888744 55 33322 2344677777777664 4
Q ss_pred CCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCc
Q 002346 248 TGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295 (933)
Q Consensus 248 ~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 295 (933)
+.+... |.+ .+|+.+.| .|.++.....+|.++++|+.+++.+|.+.
T Consensus 238 ~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~ 284 (401)
T 4fdw_A 238 STIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFN 284 (401)
T ss_dssp CEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCC
T ss_pred cCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCcccc
Confidence 433332 444 67777777 34466455667777777777777777654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.47 E-value=3.6e-16 Score=157.59 Aligned_cols=133 Identities=24% Similarity=0.294 Sum_probs=115.4
Q ss_pred CEEEEEecCCCCccccCc------cccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCC
Q 002346 67 RVTTISLAKSGLSGTLSP------EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~------~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 140 (933)
.++.++++.+.+.|.+|. .+..+++|++|+|++|.|+++ |.+..+++|++|+|++|.|+.++. .+..+++|+
T Consensus 19 ~l~~l~l~~~~l~~~~~~l~~l~~~~~~l~~L~~L~ls~n~l~~l-~~~~~l~~L~~L~l~~n~l~~l~~-~~~~~~~L~ 96 (198)
T 1ds9_A 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTLE 96 (198)
T ss_dssp CCCCTTCSEEECCBCCTTCCCCHHHHHHTTTCSEEECSEEEESCC-CCHHHHTTCCEEEEEEEEECSCSS-HHHHHHHCS
T ss_pred cccCcchheeEeccccCcHhhhhHHHhcCCCCCEEECCCCCCccc-cccccCCCCCEEECCCCCcccccc-hhhcCCcCC
Confidence 566667777777777766 899999999999999999984 589999999999999999998875 577789999
Q ss_pred EEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCC-hhhcCCCCCCEEEccCCcCCCCCCc
Q 002346 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPA 205 (933)
Q Consensus 141 ~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~ 205 (933)
+|+|++|++.. +| .+..+++|++|+|++|++.+..+ ..+..+++|++|++++|++++.+|.
T Consensus 97 ~L~L~~N~l~~---l~-~~~~l~~L~~L~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~ 158 (198)
T 1ds9_A 97 ELWISYNQIAS---LS-GIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158 (198)
T ss_dssp EEEEEEEECCC---HH-HHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHT
T ss_pred EEECcCCcCCc---CC-ccccCCCCCEEECCCCcCCchhHHHHHhcCCCCCEEEecCCcccccccc
Confidence 99999999988 55 68999999999999999987643 5789999999999999999876654
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A | Back alignment and structure |
|---|
Probab=99.46 E-value=6.4e-16 Score=155.69 Aligned_cols=160 Identities=21% Similarity=0.272 Sum_probs=87.0
Q ss_pred ccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccC
Q 002346 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165 (933)
Q Consensus 86 ~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L 165 (933)
+.....++.++++.+.++|.+|.+. .++. .|..+++|++|+|++|++.. +| .+.++++|
T Consensus 14 ~~~~~~l~~l~l~~~~l~~~~~~l~----------------~l~~-~~~~l~~L~~L~ls~n~l~~---l~-~~~~l~~L 72 (198)
T 1ds9_A 14 FEERKSVVATEAEKVELHGMIPPIE----------------KMDA-TLSTLKACKHLALSTNNIEK---IS-SLSGMENL 72 (198)
T ss_dssp HHHTTCCCCTTCSEEECCBCCTTCC----------------CCHH-HHHHTTTCSEEECSEEEESC---CC-CHHHHTTC
T ss_pred HHhcccccCcchheeEeccccCcHh----------------hhhH-HHhcCCCCCEEECCCCCCcc---cc-ccccCCCC
Confidence 3445566666666666666554211 0000 24444445555555544444 33 44555555
Q ss_pred CeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCC
Q 002346 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN 245 (933)
Q Consensus 166 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N 245 (933)
++|+|++|++.. +|..+..+++|++|+|++|++++ +| .+. .+++|+.|+|++|
T Consensus 73 ~~L~l~~n~l~~-l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~------------------------~l~~L~~L~l~~N 125 (198)
T 1ds9_A 73 RILSLGRNLIKK-IENLDAVADTLEELWISYNQIAS-LS-GIE------------------------KLVNLRVLYMSNN 125 (198)
T ss_dssp CEEEEEEEEECS-CSSHHHHHHHCSEEEEEEEECCC-HH-HHH------------------------HHHHSSEEEESEE
T ss_pred CEEECCCCCccc-ccchhhcCCcCCEEECcCCcCCc-CC-ccc------------------------cCCCCCEEECCCC
Confidence 555555555542 34455555556666666666652 33 222 2556666666666
Q ss_pred ccCCCCC--CCCCCCCCCEEEccCCcccccCcc----------cccCCCCCCEEEccCccCc
Q 002346 246 QFTGPIP--DLSKCESLFDLSLRDNQLTGVVPA----------SVISLPALLNISLQNNKLQ 295 (933)
Q Consensus 246 ~l~~~~~--~~~~~~~L~~L~L~~N~l~~~~p~----------~l~~l~~L~~L~Ls~N~l~ 295 (933)
++++..+ .+..+++|+.|++++|.+++.+|. .+..+++|+.|| +|.++
T Consensus 126 ~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld--~~~i~ 185 (198)
T 1ds9_A 126 KITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD--GMPVD 185 (198)
T ss_dssp ECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEEC--CGGGT
T ss_pred cCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEEC--CcccC
Confidence 6665332 356666777777777777655554 266777777775 56655
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=4.8e-13 Score=130.76 Aligned_cols=104 Identities=28% Similarity=0.423 Sum_probs=60.3
Q ss_pred EEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCC
Q 002346 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148 (933)
Q Consensus 70 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 148 (933)
.|++++++|+ .+|..+. ++|++|+|++|+|++++| .|.++++|++|+|++|+|+++++..|.
T Consensus 13 ~l~~s~n~l~-~ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~-------------- 75 (170)
T 3g39_A 13 TVDCSGKSLA-SVPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFD-------------- 75 (170)
T ss_dssp EEECTTSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTT--------------
T ss_pred EEEeCCCCcC-ccCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhcc--------------
Confidence 4455556665 3554442 556666666666665555 455555555555555555555554444
Q ss_pred CCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCC
Q 002346 149 NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGS 202 (933)
Q Consensus 149 ~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 202 (933)
++++|++|+|++|+|++..+..|..+++|++|+|++|+++..
T Consensus 76 ------------~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~ 117 (170)
T 3g39_A 76 ------------KLTQLTQLSLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDCA 117 (170)
T ss_dssp ------------TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCTT
T ss_pred ------------CCCCCCEEECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCCC
Confidence 455555555555555555555667777777777777777643
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D | Back alignment and structure |
|---|
Probab=99.43 E-value=4.4e-13 Score=131.00 Aligned_cols=102 Identities=25% Similarity=0.381 Sum_probs=92.3
Q ss_pred CCCCCccccceEeCCC----------CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCcee
Q 002346 50 SSTGYCEWTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDI 118 (933)
Q Consensus 50 ~~~~~C~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L 118 (933)
+..+.|.|+.+.|++. ..++.|+|++|+|++..|..|..+++|++|+|++|+|+++++ .|.++++|++|
T Consensus 4 P~~C~C~~~~l~~s~n~l~~ip~~~~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L 83 (170)
T 3g39_A 4 PSQCSCSGTTVDCSGKSLASVPTGIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQL 83 (170)
T ss_dssp C-CCEEETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred cCcCCcCCCEEEeCCCCcCccCccCCCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEE
Confidence 4556789999999752 478999999999999889999999999999999999999888 57899999999
Q ss_pred ccccccccCCCCCcccCCCCCCEEEccCCCCCC
Q 002346 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151 (933)
Q Consensus 119 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~ 151 (933)
+|++|+|+++++..|..+++|++|+|++|.+..
T Consensus 84 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~c 116 (170)
T 3g39_A 84 SLNDNQLKSIPRGAFDNLKSLTHIWLLNNPWDC 116 (170)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCCEEECCSSCBCT
T ss_pred ECCCCccCEeCHHHhcCCCCCCEEEeCCCCCCC
Confidence 999999999999999999999999999998876
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.39 E-value=1.4e-12 Score=127.82 Aligned_cols=103 Identities=26% Similarity=0.455 Sum_probs=62.9
Q ss_pred EEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCC
Q 002346 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147 (933)
Q Consensus 69 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N 147 (933)
+.+++++++|+ .+|..+. ++|++|+|++|+|++++| .|.++++|++|+|++|+|+++++..|.++++|++
T Consensus 15 ~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~------ 85 (174)
T 2r9u_A 15 TLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQ------ 85 (174)
T ss_dssp SEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE------
T ss_pred cEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhE------
Confidence 56777777775 5555443 566666666666666655 4555666666666666666555554444555554
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCC
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 200 (933)
|+|++|+|.+..+..|..+++|++|+|++|+|.
T Consensus 86 --------------------L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~ 118 (174)
T 2r9u_A 86 --------------------LDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWD 118 (174)
T ss_dssp --------------------EECCSSCCCCCCTTTTTTCTTCSEEECCSSCBC
T ss_pred --------------------EECCCCccceeCHHHhccccCCCEEEeCCCCcc
Confidence 455555555554555666777777777777776
|
| >4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A | Back alignment and structure |
|---|
Probab=99.39 E-value=6.3e-12 Score=140.42 Aligned_cols=262 Identities=11% Similarity=0.153 Sum_probs=192.2
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
.++.+.+.+ +++.+-..+|.+. +|+.+.|..| ++.+.. +|.+ .+|+.+.|.+ .++.+...+|.++++|+.++|+
T Consensus 114 ~l~~i~ip~-~i~~I~~~aF~~~-~L~~i~l~~~-i~~I~~~aF~~-~~L~~i~lp~-~l~~I~~~aF~~c~~L~~l~l~ 188 (401)
T 4fdw_A 114 GYNEIILPN-SVKSIPKDAFRNS-QIAKVVLNEG-LKSIGDMAFFN-STVQEIVFPS-TLEQLKEDIFYYCYNLKKADLS 188 (401)
T ss_dssp SCSEEECCT-TCCEECTTTTTTC-CCSEEECCTT-CCEECTTTTTT-CCCCEEECCT-TCCEECSSTTTTCTTCCEEECT
T ss_pred CccEEEECC-ccCEehHhhcccC-CccEEEeCCC-ccEECHHhcCC-CCceEEEeCC-CccEehHHHhhCcccCCeeecC
Confidence 344555543 4554445677774 7999999877 776666 6877 4799999986 8999999999999999999999
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~ 225 (933)
.|++.. ++.......+|+.+.|.+ ++..+....|.++++|+.|+|..| ++ .++...
T Consensus 189 ~n~l~~---I~~~aF~~~~L~~l~lp~-~l~~I~~~aF~~~~~L~~l~l~~~-l~-~I~~~a------------------ 244 (401)
T 4fdw_A 189 KTKITK---LPASTFVYAGIEEVLLPV-TLKEIGSQAFLKTSQLKTIEIPEN-VS-TIGQEA------------------ 244 (401)
T ss_dssp TSCCSE---ECTTTTTTCCCSEEECCT-TCCEECTTTTTTCTTCCCEECCTT-CC-EECTTT------------------
T ss_pred CCcceE---echhhEeecccCEEEeCC-chheehhhHhhCCCCCCEEecCCC-cc-Cccccc------------------
Confidence 999887 444444478999999985 588888899999999999999875 44 333322
Q ss_pred cccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCccc-----ccCcccccCCCCCCEEEccCccCccCCC
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLT-----GVVPASVISLPALLNISLQNNKLQGPYP 299 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~-----~~~p~~l~~l~~L~~L~Ls~N~l~~~~p 299 (933)
|.+ .+|+.+.| .|.++.+.. .|.+|++|+.+++.+|.+. ...+.+|.++++|+.++|.+ .++...
T Consensus 245 -----F~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~L~~l~l~~-~i~~I~- 315 (401)
T 4fdw_A 245 -----FRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPKLARFEIPE-SIRILG- 315 (401)
T ss_dssp -----TTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTTCCEECCCT-TCCEEC-
T ss_pred -----ccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCccCCeEEeCC-ceEEEh-
Confidence 233 56778888 344554433 4788888888888877765 35567788888888888773 344211
Q ss_pred CCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccc
Q 002346 300 LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLL 379 (933)
Q Consensus 300 ~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l 379 (933)
...+..+++|+.|.|.+| +
T Consensus 316 ------------------------------------------------------------~~aF~~c~~L~~l~lp~~-l 334 (401)
T 4fdw_A 316 ------------------------------------------------------------QGLLGGNRKVTQLTIPAN-V 334 (401)
T ss_dssp ------------------------------------------------------------TTTTTTCCSCCEEEECTT-C
T ss_pred ------------------------------------------------------------hhhhcCCCCccEEEECcc-c
Confidence 123344567777888554 5
Q ss_pred cCcCchhhcCcccCCeEecccCcccCCCCcccCCCC-CcCEEeccCCcCc
Q 002346 380 AGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA-SLQNLDVSNNNLS 428 (933)
Q Consensus 380 ~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~l~ls~N~l~ 428 (933)
+..-+..|.++ +|+.|++++|.+....+..|..++ .+..|++..|.+.
T Consensus 335 ~~I~~~aF~~~-~L~~l~l~~n~~~~l~~~~F~~~~~~l~~l~vp~~~~~ 383 (401)
T 4fdw_A 335 TQINFSAFNNT-GIKEVKVEGTTPPQVFEKVWYGFPDDITVIRVPAESVE 383 (401)
T ss_dssp CEECTTSSSSS-CCCEEEECCSSCCBCCCSSCCCSCTTCCEEEECGGGHH
T ss_pred cEEcHHhCCCC-CCCEEEEcCCCCcccccccccCCCCCccEEEeCHHHHH
Confidence 55556789999 999999999999877777888885 7889999887654
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} | Back alignment and structure |
|---|
Probab=99.38 E-value=2.1e-12 Score=126.53 Aligned_cols=102 Identities=25% Similarity=0.409 Sum_probs=91.2
Q ss_pred CCCCCccccceEeCCC----------CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCcee
Q 002346 50 SSTGYCEWTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDI 118 (933)
Q Consensus 50 ~~~~~C~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L 118 (933)
+..+.|....+.|.+. ..++.|+|++|+|++..|..|..+++|++|+|++|+|+++++ .|.++++|++|
T Consensus 7 P~~C~C~~~~l~~~~n~l~~iP~~~~~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L 86 (174)
T 2r9u_A 7 PSQCSCDQTLVNCQNIRLASVPAGIPTDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQL 86 (174)
T ss_dssp CTTSEECSSEEECCSSCCSSCCSCCCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred CCCCEECCcEEEeCCCCCCccCCCcCCCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEE
Confidence 3455677788888742 478999999999999889999999999999999999999887 57899999999
Q ss_pred ccccccccCCCCCcccCCCCCCEEEccCCCCCC
Q 002346 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151 (933)
Q Consensus 119 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~ 151 (933)
+|++|+|+++++..|..+++|++|+|++|.+..
T Consensus 87 ~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c 119 (174)
T 2r9u_A 87 DLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDC 119 (174)
T ss_dssp ECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCT
T ss_pred ECCCCccceeCHHHhccccCCCEEEeCCCCccc
Confidence 999999999999889999999999999998876
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.24 E-value=1.7e-11 Score=135.02 Aligned_cols=85 Identities=18% Similarity=0.222 Sum_probs=64.4
Q ss_pred CccccceEeCCCCCEEEEEecCC-CCccccCccccCCcccceeeccc-ccccccCC-CccCcCcCceeccccccccCCCC
Q 002346 54 YCEWTGINCDNSNRVTTISLAKS-GLSGTLSPEISSLTQLETLSFQM-NNIAGAIP-SLANATSLQDIYLDNNNFTSVPT 130 (933)
Q Consensus 54 ~C~w~gv~c~~~~~v~~L~l~~~-~l~~~~~~~~~~l~~L~~L~l~~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~ 130 (933)
.|.|.+|.|.+ + +|+ .+|. |..+++|++|+|++ |.|+++++ .|.++++|++|+|++|+|+++++
T Consensus 7 ~C~~~~v~~~~-----------~n~l~-~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~ 73 (347)
T 2ifg_A 7 PHGSSGLRCTR-----------DGALD-SLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAP 73 (347)
T ss_dssp CSSSSCEECCS-----------SCCCT-TTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECT
T ss_pred cccCCEEEcCC-----------CCCCC-ccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCH
Confidence 58887777753 3 576 4677 88888888888885 88888876 68888888888888888888777
Q ss_pred CcccCCCCCCEEEccCCCCCC
Q 002346 131 GCFDGLTNLQVLSLSDNPNLA 151 (933)
Q Consensus 131 ~~~~~l~~L~~L~Ls~N~~~~ 151 (933)
..|.++++|+.|+|++|++..
T Consensus 74 ~~~~~l~~L~~L~l~~N~l~~ 94 (347)
T 2ifg_A 74 DAFHFTPRLSRLNLSFNALES 94 (347)
T ss_dssp TGGGSCSCCCEEECCSSCCSC
T ss_pred HHhcCCcCCCEEeCCCCccce
Confidence 777777777777777666654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.24 E-value=3e-11 Score=127.33 Aligned_cols=147 Identities=15% Similarity=0.114 Sum_probs=115.3
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCcee
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSER 654 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~ 654 (933)
+...-+.|++...++.|+++.||++.. +++.+++|+...... .....+.+|+++++.+. +..+.++++++...+..
T Consensus 9 l~~~l~~~~~~~~~~g~s~~~v~~~~~-~~~~~vlK~~~~~~~--~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~ 85 (263)
T 3tm0_A 9 LKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYK--GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHTTSEEEECCSCCSSSEEEEEEC-SSCEEEEEEECGGGT--TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHhccceeEeeccCCCCCeEEEEEC-CCCcEEEEeCCcccC--CCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCce
Confidence 344556798888999999999999976 478999999875321 11246889999999994 67788999999988899
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc------------------------------
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA------------------------------ 704 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~------------------------------ 704 (933)
|+||||++|.+|.+.+.. ......++.+++++++.||+..
T Consensus 86 ~lv~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 155 (263)
T 3tm0_A 86 NLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC 155 (263)
T ss_dssp EEEEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred EEEEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence 999999999999876411 1223468899999999999821
Q ss_pred --------------------------CCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 705 --------------------------QQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 705 --------------------------~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
...++|+|++|.||+++++..+.|+||+.+.
T Consensus 156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 1458999999999999876667799998654
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=99.21 E-value=4.3e-10 Score=126.05 Aligned_cols=289 Identities=13% Similarity=0.125 Sum_probs=170.4
Q ss_pred CccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCC-------------
Q 002346 83 SPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP------------- 148 (933)
Q Consensus 83 ~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~------------- 148 (933)
..+|.++.+|+.+.|..+ ++.+.. +|.++.+|+.++|.++ ++.+...+|.++++|+.+.+..+-
T Consensus 64 ~~AF~~c~~L~~i~lp~~-i~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p~~l~~i~~~aF~~~~~ 141 (394)
T 4fs7_A 64 YAAFQGCRKVTEIKIPST-VREIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLPLMLKSIGVEAFKGCDF 141 (394)
T ss_dssp TTTTTTCTTEEEEECCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCCTTCCEECTTTTTTCCC
T ss_pred HHHhhCCCCceEEEeCCC-ccCcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhcccCceeeecceeeecccc
Confidence 345555666666666532 444433 5566666666666533 555555556666555555543321
Q ss_pred --------CCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhccc
Q 002346 149 --------NLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMND 219 (933)
Q Consensus 149 --------~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~ 219 (933)
... .-..+|.++++|+.+.+.++ +.......|.++.+|+.+++..| ++..-...|.. ..|+.+.+..
T Consensus 142 ~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~-~~~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~~~L~~i~~~~ 217 (394)
T 4fs7_A 142 KEITIPEGVTV--IGDEAFATCESLEYVSLPDS-METLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAECILLENMEFPN 217 (394)
T ss_dssp SEEECCTTCCE--ECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTCTTCCBCCCCT
T ss_pred cccccCccccc--cchhhhcccCCCcEEecCCc-cceeccccccCCCCceEEEcCCC-ceEeCchhhccccccceeecCC
Confidence 011 12356788899999999754 45566678888899999988776 44222333332 2344444433
Q ss_pred ccCCcccccccccCCccCcEEEecCCccCCCC-CCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCC
Q 002346 220 QQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPY 298 (933)
Q Consensus 220 n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~-~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~ 298 (933)
+..... +......+|+.+.+..+. +... ..+..+.+|+.+.+..+... .....|..+..++.+.+..+.+....
T Consensus 218 ~~~~i~---~~~~~~~~l~~i~ip~~~-~~i~~~~f~~~~~l~~~~~~~~~~~-i~~~~F~~~~~l~~~~~~~~~i~~~~ 292 (394)
T 4fs7_A 218 SLYYLG---DFALSKTGVKNIIIPDSF-TELGKSVFYGCTDLESISIQNNKLR-IGGSLFYNCSGLKKVIYGSVIVPEKT 292 (394)
T ss_dssp TCCEEC---TTTTTTCCCCEEEECTTC-CEECSSTTTTCSSCCEEEECCTTCE-ECSCTTTTCTTCCEEEECSSEECTTT
T ss_pred CceEee---hhhcccCCCceEEECCCc-eecccccccccccceeEEcCCCcce-eeccccccccccceeccCceeecccc
Confidence 322111 112224567777765432 2222 23667777888877776554 55666777777777777665543322
Q ss_pred CCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCcc
Q 002346 299 PLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL 378 (933)
Q Consensus 299 p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~ 378 (933)
-....+|+.+.+..+ +..+. ...+..+.+|+.++|.++
T Consensus 293 F~~~~~L~~i~l~~~-i~~I~----------------------------------------~~aF~~c~~L~~i~lp~~- 330 (394)
T 4fs7_A 293 FYGCSSLTEVKLLDS-VKFIG----------------------------------------EEAFESCTSLVSIDLPYL- 330 (394)
T ss_dssp TTTCTTCCEEEECTT-CCEEC----------------------------------------TTTTTTCTTCCEECCCTT-
T ss_pred ccccccccccccccc-cceec----------------------------------------hhhhcCCCCCCEEEeCCc-
Confidence 222345666665432 21111 123456678888888754
Q ss_pred ccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCC
Q 002346 379 LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425 (933)
Q Consensus 379 l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N 425 (933)
++..-...|.++++|+.++|..| ++..-..+|.++.+|+.+++..|
T Consensus 331 v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~lp~~ 376 (394)
T 4fs7_A 331 VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINLKKVELPKR 376 (394)
T ss_dssp CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTCCEEEEEGG
T ss_pred ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCCCEEEECCC
Confidence 55445568889999999999877 76556778999999999988754
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 | Back alignment and structure |
|---|
Probab=99.19 E-value=3.3e-11 Score=132.73 Aligned_cols=105 Identities=20% Similarity=0.248 Sum_probs=95.3
Q ss_pred ceeecccc-cccccCCCccCcCcCceecccc-ccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeec
Q 002346 93 ETLSFQMN-NIAGAIPSLANATSLQDIYLDN-NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170 (933)
Q Consensus 93 ~~L~l~~N-~l~~~~p~~~~l~~L~~L~Ls~-N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L 170 (933)
..++++++ +|+++++ +..+++|++|+|++ |+|+++++..|.++++|+.|+|++|+|.+ ..|..|.++++|+.|+|
T Consensus 11 ~~v~~~~~n~l~~ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~--~~~~~~~~l~~L~~L~l 87 (347)
T 2ifg_A 11 SGLRCTRDGALDSLHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF--VAPDAFHFTPRLSRLNL 87 (347)
T ss_dssp SCEECCSSCCCTTTTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE--ECTTGGGSCSCCCEEEC
T ss_pred CEEEcCCCCCCCccCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccce--eCHHHhcCCcCCCEEeC
Confidence 35788888 8998776 99999999999996 99999999999999999999999999998 56778999999999999
Q ss_pred cCcccCCCCChhhcCCCCCCEEEccCCcCCC
Q 002346 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTG 201 (933)
Q Consensus 171 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 201 (933)
++|+|++..+..|..++ |++|+|++|+|..
T Consensus 88 ~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c 117 (347)
T 2ifg_A 88 SFNALESLSWKTVQGLS-LQELVLSGNPLHC 117 (347)
T ss_dssp CSSCCSCCCSTTTCSCC-CCEEECCSSCCCC
T ss_pred CCCccceeCHHHcccCC-ceEEEeeCCCccC
Confidence 99999998888887776 9999999999984
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.18 E-value=1.2e-13 Score=152.93 Aligned_cols=62 Identities=19% Similarity=0.214 Sum_probs=33.0
Q ss_pred CccCcEEEecCCccCCCCCC-----C-CCCCCCCEEEccCCccccc----CcccccCCCCCCEEEccCccCc
Q 002346 234 MTQLRQVWLHKNQFTGPIPD-----L-SKCESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQ 295 (933)
Q Consensus 234 l~~L~~L~L~~N~l~~~~~~-----~-~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 295 (933)
+++|+.|+|++|+|+..... + ...++|+.|+|++|.|+.. ++..+..+++|++|+|++|.++
T Consensus 125 L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~ 196 (372)
T 3un9_A 125 FLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLG 196 (372)
T ss_dssp HHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCH
T ss_pred HHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCC
Confidence 34555566666555432211 1 2345566666666666532 3344455666666666666665
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.13 E-value=4.7e-13 Score=148.08 Aligned_cols=163 Identities=18% Similarity=0.134 Sum_probs=96.0
Q ss_pred CcCceeccccccccCCCCCcccC-----CCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhh----
Q 002346 113 TSLQDIYLDNNNFTSVPTGCFDG-----LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF---- 183 (933)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~---- 183 (933)
+.|++|+|++|.|+......+.. .++|++|+|++|.+.... +......+++|+.|+|++|+|+......+
T Consensus 72 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~~L~~L~Ls~n~l~~~~-~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L 150 (372)
T 3un9_A 72 SSLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAG-LRTLLPVFLRARKLGLQLNSLGPEACKDLRDLL 150 (372)
T ss_dssp TTCCEEECTTSCCCHHHHHHHHHHHSSCSSCEEEEECTTCCCCHHH-HHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHH
T ss_pred hhCCEEEecCCCCCHHHHHHHHHHHhhCCCCceEEEecCCCCCHHH-HHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHH
Confidence 45666666666666433322222 256777777777654310 11112334567777777777654433333
Q ss_pred -cCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCC-----CCCCCC
Q 002346 184 -DSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-----PDLSKC 257 (933)
Q Consensus 184 -~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~-----~~~~~~ 257 (933)
...++|++|+|++|.|+......++ ..+..+++|++|+|++|.|++.. ..+..+
T Consensus 151 ~~~~~~L~~L~Ls~n~l~~~~~~~l~--------------------~~L~~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~ 210 (372)
T 3un9_A 151 LHDQCQITTLRLSNNPLTAAGVAVLM--------------------EGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRN 210 (372)
T ss_dssp HSTTCCCCEEECCSSCCHHHHHHHHH--------------------HHHHTCSSCCEEECTTSSCHHHHHHHHHHHGGGC
T ss_pred HhcCCccceeeCCCCCCChHHHHHHH--------------------HHHhcCCCcCEEeCCCCCCCcHHHHHHHHHHhcC
Confidence 2456788888888877632222221 12334677888888888776422 125566
Q ss_pred CCCCEEEccCCccccc----CcccccCCCCCCEEEccCccCcc
Q 002346 258 ESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 258 ~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
++|+.|+|++|.|+.. ++..+...++|++|+|++|.|++
T Consensus 211 ~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~ 253 (372)
T 3un9_A 211 RQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSS 253 (372)
T ss_dssp SCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCH
T ss_pred CCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCH
Confidence 7788888888888753 34445566788888888888774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.11 E-value=1.6e-10 Score=121.54 Aligned_cols=136 Identities=20% Similarity=0.153 Sum_probs=100.5
Q ss_pred CCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCc--ceeEEeEeeeCceeEEEEe
Q 002346 582 NFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH--LVALLGYCINGSERLLVYE 659 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e 659 (933)
.|.+....+.|..+.||++...+|+.+++|..... ....+.+|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~-----~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG-----ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC-----TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc-----cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 34443333455669999998877888999987643 1245788999999996444 5568888887778899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----------------------------------
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA----------------------------------- 704 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 704 (933)
|++|.+|. ... .+ ...++.++++.++.||+..
T Consensus 96 ~i~G~~l~--~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 96 EVPGQDLL--SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp CCSSEETT--TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred ecCCcccC--cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99998884 211 11 2357788888888888732
Q ss_pred --------------------CCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 705 --------------------QQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 705 --------------------~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
...++|+|++|.||++++++.+.|+|||.+.
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 213 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence 1129999999999999887667899999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.99 E-value=1.7e-09 Score=119.61 Aligned_cols=143 Identities=13% Similarity=0.232 Sum_probs=108.0
Q ss_pred cCCccccCCCeEEEEEEeCCCcEEEEEEec--cccCCchhHHHHHHHHHHHHhcC--CCcceeEEeEeeeC---ceeEEE
Q 002346 585 EANILGRGGFGVVYGGELPDGTKIAVKRME--SNTMGNKGLSEFQAEIAVLTKVR--HRHLVALLGYCING---SERLLV 657 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv 657 (933)
..+.|+.|.++.||+.... +..+++|+.. .... ......+.+|+.+++.+. +..+++++.++.+. +..++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEECS-SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 4578999999999999875 4688899776 3321 122357889999999996 45688899988776 457999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc---------------------------------
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA--------------------------------- 704 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--------------------------------- 704 (933)
|||++|..+.+.. ...++..++..++.+++++|+.||+..
T Consensus 120 me~v~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 120 MEFVSGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EECCCCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEecCCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 9999998775422 134678889999999999999999731
Q ss_pred ----------------------CCCeEecCCCCCcEEecCCCc--EEEeccccccc
Q 002346 705 ----------------------QQSFIHRDLKPSNILIGDDMR--AKVADFGLVKN 736 (933)
Q Consensus 705 ----------------------~~~ivH~Dik~~Nill~~~~~--~kl~DfGla~~ 736 (933)
...++|||+++.||+++.++. +.|+||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 257999999999999997753 68999998763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.92 E-value=4.5e-08 Score=109.51 Aligned_cols=37 Identities=19% Similarity=0.450 Sum_probs=27.6
Q ss_pred CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEcc
Q 002346 253 DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290 (933)
Q Consensus 253 ~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 290 (933)
.|.++.+|+.+.+.++... ....+|.+++.|+.+.+.
T Consensus 260 aF~~c~~L~~i~lp~~~~~-I~~~aF~~c~~L~~i~l~ 296 (394)
T 4gt6_A 260 AFDSCAYLASVKMPDSVVS-IGTGAFMNCPALQDIEFS 296 (394)
T ss_dssp TTTTCSSCCEEECCTTCCE-ECTTTTTTCTTCCEEECC
T ss_pred eeeecccccEEecccccce-ecCcccccccccccccCC
Confidence 3777888888888766554 556678888888888875
|
| >4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} | Back alignment and structure |
|---|
Probab=98.91 E-value=2.4e-08 Score=111.76 Aligned_cols=293 Identities=12% Similarity=0.105 Sum_probs=151.7
Q ss_pred cccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCC
Q 002346 101 NIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI 179 (933)
Q Consensus 101 ~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 179 (933)
.++.+.. +|.++.+|+.+.|.. .++.|...+|.++++|+.++|.+| ++. .-...|.++.+|+.+.+..+ +....
T Consensus 58 ~VtsIg~~AF~~c~~L~~i~lp~-~i~~I~~~aF~~c~~L~~i~lp~~-l~~--I~~~aF~~c~~L~~i~~p~~-l~~i~ 132 (394)
T 4fs7_A 58 DVVSIGYAAFQGCRKVTEIKIPS-TVREIGEFAFENCSKLEIINIPDS-VKM--IGRCTFSGCYALKSILLPLM-LKSIG 132 (394)
T ss_dssp EEEEECTTTTTTCTTEEEEECCT-TCCEECTTTTTTCTTCCEECCCTT-CCE--ECTTTTTTCTTCCCCCCCTT-CCEEC
T ss_pred eEeEhHHHHhhCCCCceEEEeCC-CccCcchhHhhCCCCCcEEEeCCC-ceE--ccchhhcccccchhhcccCc-eeeec
Confidence 3555555 799999999999974 599999999999999999999866 443 23467888888888777643 33333
Q ss_pred ChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCC
Q 002346 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKC 257 (933)
Q Consensus 180 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~ 257 (933)
...|.....++......... .-...|.. ..|+.+.+.++.. ......|.++.+|+.+.+..| ++.... .|.++
T Consensus 133 ~~aF~~~~~~~~~~~~~~~~--i~~~aF~~c~~L~~i~l~~~~~--~I~~~~F~~c~~L~~i~l~~~-~~~I~~~~F~~~ 207 (394)
T 4fs7_A 133 VEAFKGCDFKEITIPEGVTV--IGDEAFATCESLEYVSLPDSME--TLHNGLFSGCGKLKSIKLPRN-LKIIRDYCFAEC 207 (394)
T ss_dssp TTTTTTCCCSEEECCTTCCE--ECTTTTTTCTTCCEEECCTTCC--EECTTTTTTCTTCCBCCCCTT-CCEECTTTTTTC
T ss_pred ceeeecccccccccCccccc--cchhhhcccCCCcEEecCCccc--eeccccccCCCCceEEEcCCC-ceEeCchhhccc
Confidence 33333332222111111110 11111211 2233333222111 111123445666666666554 222222 35556
Q ss_pred CCCCEEEccCCcccccCcccccCCCCCCEEEccCccCc--cCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHh
Q 002346 258 ESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ--GPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQ 335 (933)
Q Consensus 258 ~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~--~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~ 335 (933)
..|+.+.+..+... +.+.......|+.+.+..+.-. ...-.....++.+.+..+.. .+....+..+..
T Consensus 208 ~~L~~i~~~~~~~~--i~~~~~~~~~l~~i~ip~~~~~i~~~~f~~~~~l~~~~~~~~~~-~i~~~~F~~~~~------- 277 (394)
T 4fs7_A 208 ILLENMEFPNSLYY--LGDFALSKTGVKNIIIPDSFTELGKSVFYGCTDLESISIQNNKL-RIGGSLFYNCSG------- 277 (394)
T ss_dssp TTCCBCCCCTTCCE--ECTTTTTTCCCCEEEECTTCCEECSSTTTTCSSCCEEEECCTTC-EECSCTTTTCTT-------
T ss_pred cccceeecCCCceE--eehhhcccCCCceEEECCCceecccccccccccceeEEcCCCcc-eeeccccccccc-------
Confidence 66666655554332 2222333345555555432111 00111122344444433321 111111100000
Q ss_pred hhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCC
Q 002346 336 IAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLA 415 (933)
Q Consensus 336 ~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~ 415 (933)
+.....+.... ....+..+.+|+.+.+.++ ++..-...|.++++|+.++|.++ ++..-..+|.++.
T Consensus 278 ----------l~~~~~~~~~i--~~~~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~ 343 (394)
T 4fs7_A 278 ----------LKKVIYGSVIV--PEKTFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCT 343 (394)
T ss_dssp ----------CCEEEECSSEE--CTTTTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCT
T ss_pred ----------cceeccCceee--ccccccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCC
Confidence 00000000000 0123445678888888765 55445568999999999999754 7655578899999
Q ss_pred CcCEEeccCCcCc
Q 002346 416 SLQNLDVSNNNLS 428 (933)
Q Consensus 416 ~L~~l~ls~N~l~ 428 (933)
+|+.+++..| ++
T Consensus 344 ~L~~i~lp~~-l~ 355 (394)
T 4fs7_A 344 SLSNINFPLS-LR 355 (394)
T ss_dssp TCCEECCCTT-CC
T ss_pred CCCEEEECcc-cc
Confidence 9999998766 44
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.86 E-value=4.1e-11 Score=124.28 Aligned_cols=149 Identities=16% Similarity=0.151 Sum_probs=103.9
Q ss_pred CCccccceEeCCC-CCEEEEEecC---CCCccccC-ccccCCcccceeecccccccccCC--CccCcCcCce--eccccc
Q 002346 53 GYCEWTGINCDNS-NRVTTISLAK---SGLSGTLS-PEISSLTQLETLSFQMNNIAGAIP--SLANATSLQD--IYLDNN 123 (933)
Q Consensus 53 ~~C~w~gv~c~~~-~~v~~L~l~~---~~l~~~~~-~~~~~l~~L~~L~l~~N~l~~~~p--~~~~l~~L~~--L~Ls~N 123 (933)
..|.|.|+.|+.. .+|+.+...+ ..+.+.+. ..+..++. .|...+|.-++..+ .|...+.|+. ++++.|
T Consensus 76 ~l~~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~--~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N 153 (267)
T 3rw6_A 76 ALKAVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKL--IMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLN 153 (267)
T ss_dssp HHHHTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHH--HHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTT
T ss_pred HHHhcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHH--HHHhccchhccccCHHHcCCCcchhhcCccccCC
Confidence 4688999999864 3666665544 23334443 23333333 45566676666555 4777777777 778888
Q ss_pred cccCCC---CCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCC--CCCEEEccCCc
Q 002346 124 NFTSVP---TGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS--NLQNLRLSYNN 198 (933)
Q Consensus 124 ~l~~~~---~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~--~L~~L~L~~N~ 198 (933)
....++ .....++++|+.|+|++|++.+...+|..+..+++|+.|+|++|+|.+. ..+..+. +|++|+|++|.
T Consensus 154 ~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Np 231 (267)
T 3rw6_A 154 RRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNS 231 (267)
T ss_dssp SHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTST
T ss_pred HHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCc
Confidence 555332 2223568899999999999988545667778999999999999999886 3444444 99999999999
Q ss_pred CCCCCCc
Q 002346 199 FTGSLPA 205 (933)
Q Consensus 199 l~~~~p~ 205 (933)
+.+.+|.
T Consensus 232 l~~~~~~ 238 (267)
T 3rw6_A 232 LCDTFRD 238 (267)
T ss_dssp TGGGCSS
T ss_pred CccccCc
Confidence 9987773
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=1.3e-09 Score=117.36 Aligned_cols=186 Identities=16% Similarity=0.225 Sum_probs=123.0
Q ss_pred CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCc--ceeEEeEeeeCc---eeEEEEe
Q 002346 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRH--LVALLGYCINGS---ERLLVYE 659 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lv~e 659 (933)
++.++.|....||+.. ..+++|+.... .....+.+|+++++.+. +.. +.+++.....+. ..|+|||
T Consensus 25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~ 96 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFT 96 (304)
T ss_dssp CCEEEECSSEEEEEST----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEE
T ss_pred eEecCCCCcceEEEEC----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEc
Confidence 4668999999999863 46889975432 34567899999999883 333 445555544333 3478999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----------------------------------
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA----------------------------------- 704 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~----------------------------------- 704 (933)
+++|.++.+... ..++..++..++.++++.++.||+..
T Consensus 97 ~i~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 97 KIKGVPLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp CCCCEECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ccCCeECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 999988875432 23677888889999999999998611
Q ss_pred --------------------CCCeEecCCCCCcEEecC--CCcEEEecccccccCCCCCceeec-------------ccc
Q 002346 705 --------------------QQSFIHRDLKPSNILIGD--DMRAKVADFGLVKNAPDGKYSVET-------------RLA 749 (933)
Q Consensus 705 --------------------~~~ivH~Dik~~Nill~~--~~~~kl~DfGla~~~~~~~~~~~~-------------~~~ 749 (933)
...++|+|++|.||++++ ...+.|+||+.+........-... ...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l 249 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKIL 249 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHH
Confidence 135899999999999998 456889999987643221100000 000
Q ss_pred cccCccc-ccccCCCCCCCccchHhHHHHHHHHHcCCCCC
Q 002346 750 GTFGYLA-PEYAATGRVTTKIDVYAFGVVLMETITGRKAL 788 (933)
Q Consensus 750 gt~~y~a-PE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~ 788 (933)
...++.. |+.... .....+.|++|.++|++.+|+.+|
T Consensus 250 ~~Y~~~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 250 NHYKHKDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHTCSCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHcCCCCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHH
Confidence 0011111 222111 112368999999999999998655
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.84 E-value=4.4e-10 Score=123.03 Aligned_cols=139 Identities=15% Similarity=0.160 Sum_probs=70.2
Q ss_pred ccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhc--CCCCCCEEEccC--CcCCCCC-Cccc
Q 002346 133 FDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFD--SFSNLQNLRLSY--NNFTGSL-PASF 207 (933)
Q Consensus 133 ~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~--~l~~L~~L~L~~--N~l~~~~-p~~~ 207 (933)
+..+++|+.|+|++|.-.. ++. + .+++|+.|+|..|.+.......+. .+++|++|+|+. |...+.. ...+
T Consensus 168 l~~~P~L~~L~L~g~~~l~---l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l 242 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNLS---IGK-K-PRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVF 242 (362)
T ss_dssp HHTCTTCCEEEEECCBTCB---CCS-C-BCTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGT
T ss_pred HhcCCCCcEEEEeCCCCce---ecc-c-cCCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHH
Confidence 3445566666665552111 222 2 256666666666655433333333 567777777643 2211110 0011
Q ss_pred cccccchhhcccccCCcccccccc--cCCccCcEEEecCCccCCCCC----CCCCCCCCCEEEccCCccccc----Cccc
Q 002346 208 AKSDIQNLWMNDQQLGLSGTLDVL--SGMTQLRQVWLHKNQFTGPIP----DLSKCESLFDLSLRDNQLTGV----VPAS 277 (933)
Q Consensus 208 ~~~~l~~l~l~~n~~~~~~~~~~l--~~l~~L~~L~L~~N~l~~~~~----~~~~~~~L~~L~L~~N~l~~~----~p~~ 277 (933)
.. .+ ..+++|+.|+|.+|.+.+..+ ....+++|++|+|+.|.|++. ++..
T Consensus 243 ~~--------------------~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~ 302 (362)
T 2ra8_A 243 RP--------------------LFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDH 302 (362)
T ss_dssp GG--------------------GSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTT
T ss_pred HH--------------------HHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhh
Confidence 00 01 125667777777766653221 123456777777777777653 2333
Q ss_pred ccCCCCCCEEEccCccCcc
Q 002346 278 VISLPALLNISLQNNKLQG 296 (933)
Q Consensus 278 l~~l~~L~~L~Ls~N~l~~ 296 (933)
+..+++|+.|+|++|.++.
T Consensus 303 L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 303 VDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp HHHHTTCSEEECCSBBCCH
T ss_pred cccCCcceEEECCCCcCCH
Confidence 3445677777777776663
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} | Back alignment and structure |
|---|
Probab=98.79 E-value=3e-09 Score=116.48 Aligned_cols=141 Identities=16% Similarity=0.158 Sum_probs=89.6
Q ss_pred ccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCccccc--CCCCCCEEEccCc--cCccCCCCCCCCcc
Q 002346 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVI--SLPALLNISLQNN--KLQGPYPLFPSKVQ 306 (933)
Q Consensus 231 l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~--~l~~L~~L~Ls~N--~l~~~~p~~~~~l~ 306 (933)
+..+++|+.|+|++|.-. .++.+. +++|+.|+|..|.++......+. .+++|+.|+|+.+ ...+... ++
T Consensus 168 l~~~P~L~~L~L~g~~~l-~l~~~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~-----~~ 240 (362)
T 2ra8_A 168 LDAMPLLNNLKIKGTNNL-SIGKKP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGD-----MN 240 (362)
T ss_dssp HHTCTTCCEEEEECCBTC-BCCSCB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSC-----GG
T ss_pred HhcCCCCcEEEEeCCCCc-eecccc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchh-----HH
Confidence 455788888888877311 223343 78899999988887755444554 6888888888642 2111100 00
Q ss_pred EEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccc--cCCCceeEEEccCccccCcCc
Q 002346 307 KVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVT--CSQGRIITINLANKLLAGNIS 384 (933)
Q Consensus 307 ~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~--~~l~~L~~L~Ls~N~l~g~~p 384 (933)
.+...+ ..+++|+.|+|++|.+.+..+
T Consensus 241 ---------------------------------------------------~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~ 269 (362)
T 2ra8_A 241 ---------------------------------------------------VFRPLFSKDRFPNLKWLGIVDAEEQNVVV 269 (362)
T ss_dssp ---------------------------------------------------GTGGGSCTTTCTTCCEEEEESCTTHHHHH
T ss_pred ---------------------------------------------------HHHHHHhcCCCCCcCEEeCCCCCCchHHH
Confidence 000000 234688888888888876544
Q ss_pred hhhc---CcccCCeEecccCcccCC----CCcccCCCCCcCEEeccCCcCcc
Q 002346 385 PAYA---NLTSLKNLYLQQNNLTGP----IPDGLTKLASLQNLDVSNNNLSG 429 (933)
Q Consensus 385 ~~~~---~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~l~ls~N~l~g 429 (933)
..+. .+++|+.|+|+.|+|.+. ++..+..+++|+.|+|++|.++.
T Consensus 270 ~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~d 321 (362)
T 2ra8_A 270 EMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSD 321 (362)
T ss_dssp HHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCCH
T ss_pred HHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCCH
Confidence 4443 578888888888888763 44445567888888888887763
|
| >4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} | Back alignment and structure |
|---|
Probab=98.79 E-value=1.9e-07 Score=104.46 Aligned_cols=292 Identities=11% Similarity=0.125 Sum_probs=178.7
Q ss_pred ccccCC-cccceeecccccccccCC-CccCcCcCceecccccc---ccCCCCCcccCCCCCCEEEccCCCCCCCCCCCcc
Q 002346 84 PEISSL-TQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNN---FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNE 158 (933)
Q Consensus 84 ~~~~~l-~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~---l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~ 158 (933)
.+|.+. ..|+.+.+..+ ++.+.. +|.++.+|+.+.+..|. ++.|...+|.++.+|+.+.+..+ +.. .-...
T Consensus 57 ~aF~~~~~~L~sI~iP~s-vt~Ig~~AF~~C~~L~~i~~~~n~p~~l~~Ig~~aF~~c~~L~~i~~~~~-~~~--I~~~a 132 (394)
T 4gt6_A 57 RVFCNYKYVLTSVQIPDT-VTEIGSNAFYNCTSLKRVTIQDNKPSCVKKIGRQAFMFCSELTDIPILDS-VTE--IDSEA 132 (394)
T ss_dssp TTTTTCCSCCCEEEECTT-CCEECTTTTTTCTTCCEEEEGGGCCCCCCEECTTTTTTCTTCCBCGGGTT-CSE--ECTTT
T ss_pred hhccCCCCcCEEEEECCC-eeEEhHHHhhCCccCceEeecCCCCCeeeEechhhchhcccceeeccCCc-cce--ehhhh
Confidence 456565 35777777654 555555 68888888888887764 66777778888888887777655 333 23456
Q ss_pred ccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCc
Q 002346 159 LTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLR 238 (933)
Q Consensus 159 ~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~ 238 (933)
|..+.+|+.+.+.. .+.......|..+.+|+.+.+..+ ++..-...|....|+.+.+..+... .....+.++.+|.
T Consensus 133 F~~c~~L~~i~lp~-~~~~I~~~~F~~c~~L~~i~~~~~-~~~I~~~aF~~~~l~~i~ip~~~~~--i~~~af~~c~~l~ 208 (394)
T 4gt6_A 133 FHHCEELDTVTIPE-GVTSVADGMFSYCYSLHTVTLPDS-VTAIEERAFTGTALTQIHIPAKVTR--IGTNAFSECFALS 208 (394)
T ss_dssp TTTCTTCCEEECCT-TCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCCCSEEEECTTCCE--ECTTTTTTCTTCC
T ss_pred hhhhcccccccccc-eeeeecccceecccccccccccce-eeEeccccccccceeEEEECCcccc--cccchhhhccccc
Confidence 77788888888864 345555667777888888887654 3323334444444444444332211 1123455666777
Q ss_pred EEEecCCccCCCCCC--------------CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCC-C--C
Q 002346 239 QVWLHKNQFTGPIPD--------------LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-L--F 301 (933)
Q Consensus 239 ~L~L~~N~l~~~~~~--------------~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~--~ 301 (933)
......+........ +.....+..+.+. +.++..-..+|.++..|+.+.+.++..+ ... . .
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ip-~~v~~i~~~aF~~c~~L~~i~lp~~~~~-I~~~aF~~ 286 (394)
T 4gt6_A 209 TITSDSESYPAIDNVLYEKSANGDYALIRYPSQREDPAFKIP-NGVARIETHAFDSCAYLASVKMPDSVVS-IGTGAFMN 286 (394)
T ss_dssp EEEECCSSSCBSSSCEEEECTTSCEEEEECCTTCCCSEEECC-TTEEEECTTTTTTCSSCCEEECCTTCCE-ECTTTTTT
T ss_pred eecccccccccccceeecccccccccccccccccccceEEcC-CcceEcccceeeecccccEEecccccce-ecCccccc
Confidence 776665544322111 1122334444443 3344345567888899999998765443 111 1 1
Q ss_pred CCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccC
Q 002346 302 PSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAG 381 (933)
Q Consensus 302 ~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g 381 (933)
...|+.+.+.. .+..+. ...+..+.+|+.++|..+ ++.
T Consensus 287 c~~L~~i~l~~-~i~~I~----------------------------------------~~aF~~c~~L~~i~lp~~-v~~ 324 (394)
T 4gt6_A 287 CPALQDIEFSS-RITELP----------------------------------------ESVFAGCISLKSIDIPEG-ITQ 324 (394)
T ss_dssp CTTCCEEECCT-TCCEEC----------------------------------------TTTTTTCTTCCEEECCTT-CCE
T ss_pred ccccccccCCC-cccccC----------------------------------------ceeecCCCCcCEEEeCCc-ccE
Confidence 23566666532 221111 123455678899999765 554
Q ss_pred cCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCc
Q 002346 382 NISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428 (933)
Q Consensus 382 ~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~ 428 (933)
.-...|.++++|+.+.|..+ ++..-..+|.++.+|+.+++.+|...
T Consensus 325 I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~~~~~~~ 370 (394)
T 4gt6_A 325 ILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEYSGSRSQ 370 (394)
T ss_dssp ECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEESSCHHH
T ss_pred ehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEECCceee
Confidence 45568999999999999654 76455678999999999999887643
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.51 E-value=2.7e-06 Score=94.44 Aligned_cols=293 Identities=10% Similarity=0.103 Sum_probs=147.7
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
+++.+.+.. +++.+-..+|.++.+|+.++|..+ ++.+.. +|.++ +|+.+.+.. +++.+...+|... +|+.+.+.
T Consensus 47 ~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~~-v~~Ig~~aF~~c-~l~~i~~~~-~l~~I~~~aF~~~-~L~~i~lp 121 (379)
T 4h09_A 47 RISEVRVNS-GITSIGEANFNSCYNMTKVTVAST-VTSIGDGAFADT-KLQSYTGME-RVKKFGDYVFQGT-DLDDFEFP 121 (379)
T ss_dssp GCSEEEECT-TEEEECTTTTTTCTTCCEEEECTT-CCEECTTTTTTC-CCCEEEECT-TCCEECTTTTTTC-CCSEEECC
T ss_pred CCEEEEeCC-CccChHHHHhhCCCCCCEEEeCCc-ceEechhhhcCC-CCceEECCc-eeeEeccceeccC-CcccccCC
Confidence 455555542 454333456666666666666543 444433 45554 455555543 3556666666554 56666665
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~ 225 (933)
.+- .. .-...|.+. +|+.+.+.. .+.......|....+|+.+.+..+.........+..... .
T Consensus 122 ~~~-~~--i~~~~F~~~-~l~~~~~~~-~v~~i~~~~f~~~~~l~~~~~~~~~~~~~~~~~~~~~~~------------~ 184 (379)
T 4h09_A 122 GAT-TE--IGNYIFYNS-SVKRIVIPK-SVTTIKDGIGYKAENLEKIEVSSNNKNYVAENYVLYNKN------------K 184 (379)
T ss_dssp TTC-CE--ECTTTTTTC-CCCEEEECT-TCCEECSCTTTTCTTCCEEEECTTCSSEEEETTEEEETT------------S
T ss_pred Ccc-cc--ccccccccc-eeeeeeccc-eeeccccchhcccccccccccccccceeecccceecccc------------c
Confidence 442 21 112233332 455544433 344444555666667776666655433111110000000 0
Q ss_pred cccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCC---C
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLF---P 302 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~---~ 302 (933)
.....+.....+..+.+..+.-.-....+..+.+|+.+.+..+ +.......+.++..|+.+.+..+ ++...... .
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~ 262 (379)
T 4h09_A 185 TILESYPAAKTGTEFTIPSTVKTVTAYGFSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNC 262 (379)
T ss_dssp SEEEECCTTCCCSEEECCTTCCEECTTTTTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTC
T ss_pred ceeccccccccccccccccceeEEeecccccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCcccccee
Confidence 0001122234444444433322222223555666666666544 33244455666666666666544 33221111 1
Q ss_pred CCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCc
Q 002346 303 SKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382 (933)
Q Consensus 303 ~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~ 382 (933)
..++.+.+..+ +..+. ...+..+.+|+.+.+.++.++..
T Consensus 263 ~~l~~i~l~~~-i~~i~----------------------------------------~~aF~~c~~L~~i~l~~~~i~~I 301 (379)
T 4h09_A 263 TALKTLNFYAK-VKTVP----------------------------------------YLLCSGCSNLTKVVMDNSAIETL 301 (379)
T ss_dssp TTCCEEEECCC-CSEEC----------------------------------------TTTTTTCTTCCEEEECCTTCCEE
T ss_pred ehhcccccccc-ceecc----------------------------------------cccccccccccccccccccccee
Confidence 23344433221 11100 12344567788888888877765
Q ss_pred CchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCC
Q 002346 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425 (933)
Q Consensus 383 ~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N 425 (933)
-...|.++++|+.+.|..+ ++..-..+|.++.+|+.+.+..|
T Consensus 302 ~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L~~i~ip~~ 343 (379)
T 4h09_A 302 EPRVFMDCVKLSSVTLPTA-LKTIQVYAFKNCKALSTISYPKS 343 (379)
T ss_dssp CTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCCCCCCTT
T ss_pred hhhhhcCCCCCCEEEcCcc-ccEEHHHHhhCCCCCCEEEECCc
Confidence 6678888888888888654 66455667888888888877543
|
| >3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A | Back alignment and structure |
|---|
Probab=98.33 E-value=7.9e-08 Score=99.56 Aligned_cols=117 Identities=21% Similarity=0.276 Sum_probs=87.2
Q ss_pred cCCCCccccCc-cccCCcccce--eeccccccc---ccCC-CccCcCcCceeccccccccCCCC--CcccCCCCCCEEEc
Q 002346 74 AKSGLSGTLSP-EISSLTQLET--LSFQMNNIA---GAIP-SLANATSLQDIYLDNNNFTSVPT--GCFDGLTNLQVLSL 144 (933)
Q Consensus 74 ~~~~l~~~~~~-~~~~l~~L~~--L~l~~N~l~---~~~p-~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~L 144 (933)
+++..++.++- .+...+.|.. ++++.|... +.++ ...++++|+.|+|++|+|++++. ..+..+++|+.|+|
T Consensus 124 ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~L 203 (267)
T 3rw6_A 124 RYDGSQQALDLKGLRSDPDLVAQNIDVVLNRRSCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNL 203 (267)
T ss_dssp TEETTTTEEECTTGGGCHHHHHTTCCCCTTSHHHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEEC
T ss_pred ccchhccccCHHHcCCCcchhhcCccccCCHHHHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEEC
Confidence 34444444442 3667777777 778888543 3333 23568999999999999998763 55678999999999
Q ss_pred cCCCCCCCCCCCccccCCc--cCCeeeccCcccCCCCC-------hhhcCCCCCCEEEc
Q 002346 145 SDNPNLAPWPFPNELTKST--SLTTLYMDNANIFGLIP-------DFFDSFSNLQNLRL 194 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~--~L~~L~L~~n~l~~~~p-------~~~~~l~~L~~L~L 194 (933)
++|++.+. ..+..++ +|++|+|++|.+.+.+| ..+..+++|+.||=
T Consensus 204 s~N~i~~~----~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~~il~~~P~L~~LDg 258 (267)
T 3rw6_A 204 SGNELKSE----RELDKIKGLKLEELWLDGNSLCDTFRDQSTYISAIRERFPKLLRLDG 258 (267)
T ss_dssp TTSCCCSG----GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHHHHHHHCTTCCEESS
T ss_pred CCCccCCc----hhhhhcccCCcceEEccCCcCccccCcchhHHHHHHHHCcccCeECC
Confidence 99999882 3455555 99999999999998766 34778999999873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=3e-06 Score=90.80 Aligned_cols=135 Identities=19% Similarity=0.203 Sum_probs=95.6
Q ss_pred CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCC---cceeEEeEee-eCceeEEEEeec
Q 002346 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR---HLVALLGYCI-NGSERLLVYEYM 661 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~ 661 (933)
++.++.|....||+. |..+++|+-.. ......+.+|+++++.+.+. .+.+++.++. ..+..++||||+
T Consensus 24 v~~l~~G~~n~v~~v----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i 95 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKV 95 (306)
T ss_dssp EEEEEECSSEEEEEE----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECC
T ss_pred eeecCCCcceeEEEE----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEecc
Confidence 456888888899988 56788887432 23456889999999999642 3566777764 345678999999
Q ss_pred CCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------
Q 002346 662 PRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSL-------------------------------------- 703 (933)
Q Consensus 662 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-------------------------------------- 703 (933)
+|.++.+... ..++..++..++.++++.|+.||+.
T Consensus 96 ~G~~l~~~~~-------~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~ 168 (306)
T 3tdw_A 96 QGQILGEDGM-------AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESL 168 (306)
T ss_dssp CSEECHHHHH-------TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHH
T ss_pred CCeECchhhh-------hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhh
Confidence 9988876321 1234555556666666666666642
Q ss_pred -------------------cCCCeEecCCCCCcEEecC---CCc-EEEecccccc
Q 002346 704 -------------------AQQSFIHRDLKPSNILIGD---DMR-AKVADFGLVK 735 (933)
Q Consensus 704 -------------------~~~~ivH~Dik~~Nill~~---~~~-~kl~DfGla~ 735 (933)
....++|+|+++.||+++. ++. +.|+||+.+.
T Consensus 169 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~ 223 (306)
T 3tdw_A 169 RDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAA 223 (306)
T ss_dssp HHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCE
T ss_pred HHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcC
Confidence 1235699999999999987 455 5899999765
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.30 E-value=3.6e-06 Score=88.60 Aligned_cols=134 Identities=18% Similarity=0.168 Sum_probs=99.3
Q ss_pred ccccCCCe-EEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 588 ILGRGGFG-VVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 588 ~lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
.+..|..+ .||+.... ++..+++|+-... ...++.+|...++.+. +--+.++++++.+++..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 45556665 68988654 4678999976533 3457889999999884 444778899999999999999999998
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------------------
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA---------------------------------------- 704 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 704 (933)
++.+..... ......++.++++.++.||+..
T Consensus 106 ~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 106 TAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp EHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred cccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 887765321 1223456777777777787521
Q ss_pred ---------------CCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 705 ---------------QQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 705 ---------------~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
...++|+|+.+.||++++++.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence 1237899999999999988777899999764
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.27 E-value=7.4e-08 Score=95.01 Aligned_cols=62 Identities=16% Similarity=0.257 Sum_probs=36.0
Q ss_pred CccCcEEEecCCccCCC-----CCCCCCCCCCCEEEc--cCCccccc----CcccccCCCCCCEEEccCccCc
Q 002346 234 MTQLRQVWLHKNQFTGP-----IPDLSKCESLFDLSL--RDNQLTGV----VPASVISLPALLNISLQNNKLQ 295 (933)
Q Consensus 234 l~~L~~L~L~~N~l~~~-----~~~~~~~~~L~~L~L--~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~ 295 (933)
.++|++|+|++|.|+.. ...+...++|++|+| ++|.|+.. +...+...++|++|+|++|.+.
T Consensus 92 n~~L~~L~L~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 92 NNTLKSLNVESNFISGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CSSCCEEECCSSCCCHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CCCcCEEECcCCcCCHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 44566666666665542 112455566777777 66766643 3344445567777777777665
|
| >1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=98.26 E-value=4.7e-08 Score=96.47 Aligned_cols=121 Identities=15% Similarity=0.135 Sum_probs=86.3
Q ss_pred cccCccccCCcccceeecccc-ccccc-----CCCccCcCcCceeccccccccCCC----CCcccCCCCCCEEEccCCCC
Q 002346 80 GTLSPEISSLTQLETLSFQMN-NIAGA-----IPSLANATSLQDIYLDNNNFTSVP----TGCFDGLTNLQVLSLSDNPN 149 (933)
Q Consensus 80 ~~~~~~~~~l~~L~~L~l~~N-~l~~~-----~p~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~~ 149 (933)
..+...+...+.|++|+|++| .|... ...+...++|++|+|++|.|+... ...+...++|++|+|++|.+
T Consensus 26 ~~l~~~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i 105 (185)
T 1io0_A 26 ETLKRIQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFI 105 (185)
T ss_dssp HHHHHHHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCC
T ss_pred HHHHHHHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcC
Confidence 345556777888888888888 77542 124666788888888888887422 23345567888999998887
Q ss_pred CCCC--CCCccccCCccCCeeec--cCcccCCC----CChhhcCCCCCCEEEccCCcCC
Q 002346 150 LAPW--PFPNELTKSTSLTTLYM--DNANIFGL----IPDFFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 150 ~~~~--~~p~~~~~l~~L~~L~L--~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~ 200 (933)
...+ .+...+...++|++|+| ++|.|... +...+...++|++|+|++|.+.
T Consensus 106 ~~~g~~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~ 164 (185)
T 1io0_A 106 SGSGILALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG 164 (185)
T ss_dssp CHHHHHHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred CHHHHHHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence 6521 13456677788999999 77888654 3445556688999999999886
|
| >4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} | Back alignment and structure |
|---|
Probab=98.09 E-value=0.00012 Score=81.06 Aligned_cols=262 Identities=10% Similarity=0.077 Sum_probs=150.8
Q ss_pred ccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCcc
Q 002346 86 ISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTS 164 (933)
Q Consensus 86 ~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~ 164 (933)
+....+|+.+.+.. .++.+.. +|.++.+|+.++|.. .++.|...+|.++ +|+.+.+..+ +.. .-..+|.. .+
T Consensus 42 ~~~~~~i~~v~ip~-~vt~Ig~~aF~~C~~L~~I~lp~-~v~~Ig~~aF~~c-~l~~i~~~~~-l~~--I~~~aF~~-~~ 114 (379)
T 4h09_A 42 YKDRDRISEVRVNS-GITSIGEANFNSCYNMTKVTVAS-TVTSIGDGAFADT-KLQSYTGMER-VKK--FGDYVFQG-TD 114 (379)
T ss_dssp GGGGGGCSEEEECT-TEEEECTTTTTTCTTCCEEEECT-TCCEECTTTTTTC-CCCEEEECTT-CCE--ECTTTTTT-CC
T ss_pred cccccCCEEEEeCC-CccChHHHHhhCCCCCCEEEeCC-cceEechhhhcCC-CCceEECCce-eeE--eccceecc-CC
Confidence 44556677776654 3554444 677777777777754 3677777777766 5666666543 222 11223333 35
Q ss_pred CCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecC
Q 002346 165 LTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHK 244 (933)
Q Consensus 165 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~ 244 (933)
|+.+.+..+ +.......|.+ .+|+.+.+..+ ++..-. ..+.+..+++.+.+..
T Consensus 115 L~~i~lp~~-~~~i~~~~F~~-~~l~~~~~~~~-v~~i~~------------------------~~f~~~~~l~~~~~~~ 167 (379)
T 4h09_A 115 LDDFEFPGA-TTEIGNYIFYN-SSVKRIVIPKS-VTTIKD------------------------GIGYKAENLEKIEVSS 167 (379)
T ss_dssp CSEEECCTT-CCEECTTTTTT-CCCCEEEECTT-CCEECS------------------------CTTTTCTTCCEEEECT
T ss_pred cccccCCCc-ccccccccccc-ceeeeeeccce-eecccc------------------------chhccccccccccccc
Confidence 666666543 33333334433 24444444322 221111 1234466666666655
Q ss_pred CccCCCC-------------CCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCC---CCCCccEE
Q 002346 245 NQFTGPI-------------PDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL---FPSKVQKV 308 (933)
Q Consensus 245 N~l~~~~-------------~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L 308 (933)
+...... ..+..+.++..+.+..+.-. .....+....+|+.+.+..+- +..... ....|+.+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~f~~~~~l~~i~~~~~~-~~i~~~~f~~~~~L~~i 245 (379)
T 4h09_A 168 NNKNYVAENYVLYNKNKTILESYPAAKTGTEFTIPSTVKT-VTAYGFSYGKNLKKITITSGV-TTLGDGAFYGMKALDEI 245 (379)
T ss_dssp TCSSEEEETTEEEETTSSEEEECCTTCCCSEEECCTTCCE-ECTTTTTTCSSCSEEECCTTC-CEECTTTTTTCSSCCEE
T ss_pred ccceeecccceecccccceeccccccccccccccccceeE-Eeecccccccccceeeeccce-eEEccccccCCccceEE
Confidence 4432111 12455566777766554433 556677788899999886552 222111 12356666
Q ss_pred eccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhc
Q 002346 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYA 388 (933)
Q Consensus 309 ~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~ 388 (933)
.+..+ +..+. ...+..+..|+.+.+..+ +...-...|.
T Consensus 246 ~lp~~-v~~I~----------------------------------------~~aF~~~~~l~~i~l~~~-i~~i~~~aF~ 283 (379)
T 4h09_A 246 AIPKN-VTSIG----------------------------------------SFLLQNCTALKTLNFYAK-VKTVPYLLCS 283 (379)
T ss_dssp EECTT-CCEEC----------------------------------------TTTTTTCTTCCEEEECCC-CSEECTTTTT
T ss_pred EcCCC-ccEeC----------------------------------------ccccceeehhcccccccc-ceeccccccc
Confidence 65443 21111 123445567888888654 4444456889
Q ss_pred CcccCCeEecccCcccCCCCcccCCCCCcCEEeccCC
Q 002346 389 NLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425 (933)
Q Consensus 389 ~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N 425 (933)
++++|+.+.+.+|.++..-..+|.++.+|+.++|..+
T Consensus 284 ~c~~L~~i~l~~~~i~~I~~~aF~~c~~L~~i~lp~~ 320 (379)
T 4h09_A 284 GCSNLTKVVMDNSAIETLEPRVFMDCVKLSSVTLPTA 320 (379)
T ss_dssp TCTTCCEEEECCTTCCEECTTTTTTCTTCCEEECCTT
T ss_pred cccccccccccccccceehhhhhcCCCCCCEEEcCcc
Confidence 9999999999999998666789999999999999754
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.08 E-value=7.2e-06 Score=90.14 Aligned_cols=83 Identities=7% Similarity=-0.047 Sum_probs=56.8
Q ss_pred CCcc-ccCCCeEEEEEEeC-------CCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcC-C--CcceeEEeEeeeC--
Q 002346 586 ANIL-GRGGFGVVYGGELP-------DGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVR-H--RHLVALLGYCING-- 651 (933)
Q Consensus 586 ~~~l-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~-- 651 (933)
.+.| +.|....+|+.... +++.+++|+...... .......+.+|+.+++.+. + -.+.+++.++.++
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3567 88888999998664 267899997654320 0001135788888888884 3 3577888887655
Q ss_pred -ceeEEEEeecCCCChhh
Q 002346 652 -SERLLVYEYMPRGTLAQ 668 (933)
Q Consensus 652 -~~~~lv~e~~~~gsL~~ 668 (933)
+..++||||++|..+.+
T Consensus 105 ~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp TSSCEEEEECCCCBCCCB
T ss_pred cCCceEEEEecCCCChhh
Confidence 35689999999876653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.90 E-value=9.2e-05 Score=80.62 Aligned_cols=142 Identities=16% Similarity=0.228 Sum_probs=81.4
Q ss_pred CccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC--CCcceeEEe------EeeeCceeEEEE
Q 002346 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR--HRHLVALLG------YCINGSERLLVY 658 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~------~~~~~~~~~lv~ 658 (933)
+.|+.|..+.||+....+| .+++|+.... . .++..|+.+++.+. .-.+.+++. +...++..++||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~ 110 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY 110 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence 4566677889999987554 5999988752 1 33445556665553 112344443 123456788999
Q ss_pred eecCCCChh--------------hHhhhcccCC---------CCCCCHHHH-----------------------------
Q 002346 659 EYMPRGTLA--------------QHLFEWHDHG---------YTPLTWKQR----------------------------- 686 (933)
Q Consensus 659 e~~~~gsL~--------------~~l~~~~~~~---------~~~l~~~~~----------------------------- 686 (933)
||++|..+. ..+|...... ...-.|...
T Consensus 111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 190 (346)
T 2q83_A 111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ 190 (346)
T ss_dssp ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence 999986542 1122211100 001123221
Q ss_pred --HHHHHHHHHHHHHhhh----------ccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 687 --VTIALDVARGVEYLHS----------LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 687 --~~i~~~i~~~l~~LH~----------~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
..+...+.+++++|++ .....++|+|+++.||+++.++.+.|+||+.+.
T Consensus 191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 1111224445666653 124789999999999999888899999999754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00015 Score=77.26 Aligned_cols=141 Identities=18% Similarity=0.177 Sum_probs=94.3
Q ss_pred cCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC---CCcceeEEeEeeeCceeEEEEeec
Q 002346 585 EANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGYCINGSERLLVYEYM 661 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~ 661 (933)
..+.|+.|....+|+... ++..+++|+.... ....+.+|.+.|+.+. ...++++++++...+..++||||+
T Consensus 40 ~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND-EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEEECCSSSSEEEEEES-SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eeEEeCCccceeeeEEEE-CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 346789999999999987 5778999987543 2467899999999883 367888999888888899999999
Q ss_pred CCCChh--------h---Hhhhccc-CCC----------------CCCCHHHHH---HHHH----------------HHH
Q 002346 662 PRGTLA--------Q---HLFEWHD-HGY----------------TPLTWKQRV---TIAL----------------DVA 694 (933)
Q Consensus 662 ~~gsL~--------~---~l~~~~~-~~~----------------~~l~~~~~~---~i~~----------------~i~ 694 (933)
++..+. + .||.... ... -.-+|.+.. ++.. .++
T Consensus 114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~ 193 (312)
T 3jr1_A 114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV 193 (312)
T ss_dssp CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence 987652 1 2333111 000 012455432 1111 111
Q ss_pred H-HHHHhhh-ccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 695 R-GVEYLHS-LAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 695 ~-~l~~LH~-~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
+ ....|.. .....+||+|+.+.|++++.++ +.|.||.
T Consensus 194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 1 1223321 1246899999999999999887 8899984
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.74 E-value=0.00011 Score=81.96 Aligned_cols=77 Identities=13% Similarity=0.147 Sum_probs=50.4
Q ss_pred CCccccCCCeEEEEEEeC-CCcEEEEEEeccccC--C---chhHHHHHHHHHHHHhcCC--Cc-ceeEEeEeeeCceeEE
Q 002346 586 ANILGRGGFGVVYGGELP-DGTKIAVKRMESNTM--G---NKGLSEFQAEIAVLTKVRH--RH-LVALLGYCINGSERLL 656 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~---~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l 656 (933)
.+.||.|.++.||++... +++.|+||....... . ....+++..|.++++.+.. +. +.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 467999999999999654 468899998653211 0 1123467789899888742 43 4455554 3445689
Q ss_pred EEeecCCC
Q 002346 657 VYEYMPRG 664 (933)
Q Consensus 657 v~e~~~~g 664 (933)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999763
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.62 E-value=0.00017 Score=76.29 Aligned_cols=80 Identities=21% Similarity=0.222 Sum_probs=58.6
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-C--CcceeEEeEeeeCceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-H--RHLVALLGYCINGSERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv 657 (933)
.....++.+|.|..+.||+.+..+|+.|+||+-.... ......|.+|+..|+.+. . -.+.+++++. ..++|
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv 88 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDA--PALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA 88 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTC--CCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCC--cchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence 4556678899999999999999999999999865442 222346889999999884 2 2345556542 34789
Q ss_pred EeecCCCCh
Q 002346 658 YEYMPRGTL 666 (933)
Q Consensus 658 ~e~~~~gsL 666 (933)
|||++++..
T Consensus 89 ~e~l~~~~~ 97 (288)
T 3f7w_A 89 MEWVDERPP 97 (288)
T ss_dssp EECCCCCCC
T ss_pred EEeecccCC
Confidence 999987654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.53 E-value=0.00062 Score=76.30 Aligned_cols=78 Identities=22% Similarity=0.219 Sum_probs=48.4
Q ss_pred CCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCceeeccccc--ccCcccccccCCC---CCCCccchHhHHHHHH
Q 002346 705 QQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG--TFGYLAPEYAATG---RVTTKIDVYAFGVVLM 779 (933)
Q Consensus 705 ~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~Dv~SlG~~l~ 779 (933)
...++|+|+++.||+++.++ ++|+||+.+........- ....+ ...|++|+..... ......++......+|
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl--a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI--GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH--HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH--HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 37899999999999998876 999999987643321110 00000 1345666655321 1122345567788888
Q ss_pred HHHcCC
Q 002346 780 ETITGR 785 (933)
Q Consensus 780 elltG~ 785 (933)
+.++++
T Consensus 308 ~~y~~~ 313 (420)
T 2pyw_A 308 NLFNKR 313 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 877653
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.39 E-value=0.0015 Score=70.25 Aligned_cols=160 Identities=12% Similarity=0.118 Sum_probs=89.8
Q ss_pred ecHHHHHHHhcCCcc-----CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCc--cee
Q 002346 571 ISIEVLRQVTDNFSE-----ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH--LVA 643 (933)
Q Consensus 571 ~~~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~ 643 (933)
++.+++..+-..|.+ .+.|+.|....+|+....+| .+++|...... . ..++..|+.++..+.... +.+
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~-~---~~~l~~e~~~l~~L~~~g~~vP~ 81 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-E---KNDLPFFLGLMQHLAAKGLSCPL 81 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC-C---HHHHHHHHHHHHHHHHCCCCCCc
Confidence 455666666666765 34566788889999987555 68899886531 1 134566777777774212 333
Q ss_pred EEeE------eeeCceeEEEEeecCCCChhh--------------HhhhcccC-CC------CCCCHHHHHH--------
Q 002346 644 LLGY------CINGSERLLVYEYMPRGTLAQ--------------HLFEWHDH-GY------TPLTWKQRVT-------- 688 (933)
Q Consensus 644 l~~~------~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~~-~~------~~l~~~~~~~-------- 688 (933)
++.. ....+..+++|+|++|..+.. .+|..... .. ....|.....
T Consensus 82 ~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~ 161 (322)
T 2ppq_A 82 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 161 (322)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred ccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHh
Confidence 3321 122456789999998865421 12211000 00 0012322111
Q ss_pred ----HHHHHHHHHHHhhhc----cCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 689 ----IALDVARGVEYLHSL----AQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 689 ----i~~~i~~~l~~LH~~----~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+...+.+.++++++. ...+++|+|+.+.||+++++..+.|+||+.+.
T Consensus 162 ~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 162 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 011234455555532 13579999999999999987666899998654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00084 Score=72.60 Aligned_cols=144 Identities=17% Similarity=0.122 Sum_probs=75.3
Q ss_pred CccccCCCeE-EEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-C-CcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGV-VYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-H-RHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.|+.|+... +|+....+|+.+++|....... .++..|+.+++.+. + -.+.+++.+....+ +++||++.+
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~ 96 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGD 96 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCS
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCC
Confidence 4566565544 6777664477888886544310 23455677777663 2 23556776643333 789999977
Q ss_pred CChhhHhhhc------------------ccC---CCCCCCHHHHH-------H-------------HHHHHHHHHHHhhh
Q 002346 664 GTLAQHLFEW------------------HDH---GYTPLTWKQRV-------T-------------IALDVARGVEYLHS 702 (933)
Q Consensus 664 gsL~~~l~~~------------------~~~---~~~~l~~~~~~-------~-------------i~~~i~~~l~~LH~ 702 (933)
..+.+++... +.. ....++..... . ....+.+.++.+.+
T Consensus 97 ~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~ 176 (333)
T 3csv_A 97 ALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILS 176 (333)
T ss_dssp CBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHH
T ss_pred cchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHH
Confidence 6665444221 110 11112221110 0 00111122222211
Q ss_pred ---ccCCCeEecCCCCCcEEecCC----CcEEEecccccccC
Q 002346 703 ---LAQQSFIHRDLKPSNILIGDD----MRAKVADFGLVKNA 737 (933)
Q Consensus 703 ---~~~~~ivH~Dik~~Nill~~~----~~~kl~DfGla~~~ 737 (933)
.....++|||+.+.||+++.+ +.+.|+||+.+..-
T Consensus 177 ~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 177 AQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp HHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred hcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 123689999999999999875 67999999987643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.28 E-value=0.003 Score=68.05 Aligned_cols=158 Identities=10% Similarity=0.042 Sum_probs=88.8
Q ss_pred cHHHHHHHhcCCcc-----CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCC--cceeE
Q 002346 572 SIEVLRQVTDNFSE-----ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR--HLVAL 644 (933)
Q Consensus 572 ~~~~l~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l 644 (933)
+.+.+..+-+.|.+ ...++ |....||+....+|+.+++|....... ....+..|..++..+... .++++
T Consensus 12 ~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~---~~~~~~~E~~~~~~L~~~g~~vp~~ 87 (328)
T 1zyl_A 12 HPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAP 87 (328)
T ss_dssp CHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCC
T ss_pred CHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC---CHHHHHHHHHHHHHHHHcCCeecce
Confidence 34444444444432 34566 778899998877788899999864322 234667788888877421 24444
Q ss_pred EeE-----eeeCceeEEEEeecCCCChh-----------hH---hhhcccC----CCCCCCHHHH----HHH--------
Q 002346 645 LGY-----CINGSERLLVYEYMPRGTLA-----------QH---LFEWHDH----GYTPLTWKQR----VTI-------- 689 (933)
Q Consensus 645 ~~~-----~~~~~~~~lv~e~~~~gsL~-----------~~---l~~~~~~----~~~~l~~~~~----~~i-------- 689 (933)
+.. ...++..++||||++|..+. .. +|..... .....++... ..+
T Consensus 88 ~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 167 (328)
T 1zyl_A 88 VAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIP 167 (328)
T ss_dssp CCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSC
T ss_pred eecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCC
Confidence 443 12245668899999875432 11 1211000 0011222211 001
Q ss_pred -------HHHHHHHHHHhhhc----cCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 690 -------ALDVARGVEYLHSL----AQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 690 -------~~~i~~~l~~LH~~----~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
...+.+.++.+.+. ....++|+|+++.||+++ + .+.|+||+.+.
T Consensus 168 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 168 SGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp TTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 11111223333211 235689999999999999 4 89999998765
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=97.20 E-value=0.00011 Score=70.46 Aligned_cols=82 Identities=17% Similarity=0.122 Sum_probs=40.3
Q ss_pred CceeccccccccCCCCCcccCCCCCCEEEccCCC-CCCCCCCCccccCC----ccCCeeeccCcc-cCCCCChhhcCCCC
Q 002346 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP-NLAPWPFPNELTKS----TSLTTLYMDNAN-IFGLIPDFFDSFSN 188 (933)
Q Consensus 115 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~-~~~~~~~p~~~~~l----~~L~~L~L~~n~-l~~~~p~~~~~l~~ 188 (933)
|+.|||+++.|+......+.++++|+.|+|+++. ++.. --..+..+ ++|++|+|++|. ++..--..+..+++
T Consensus 63 L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~--gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~ 140 (176)
T 3e4g_A 63 IQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDG--CLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRN 140 (176)
T ss_dssp EEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHH--HHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTT
T ss_pred EeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHH--HHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCC
Confidence 4444444444333333334445555555555553 2220 01122332 246666666653 54433345667788
Q ss_pred CCEEEccCCc
Q 002346 189 LQNLRLSYNN 198 (933)
Q Consensus 189 L~~L~L~~N~ 198 (933)
|++|+|+++.
T Consensus 141 L~~L~L~~c~ 150 (176)
T 3e4g_A 141 LKYLFLSDLP 150 (176)
T ss_dssp CCEEEEESCT
T ss_pred CCEEECCCCC
Confidence 8888887765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00085 Score=71.39 Aligned_cols=71 Identities=11% Similarity=0.062 Sum_probs=45.2
Q ss_pred CCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcc-eeEEeEeeeCceeEEEEeec-CC
Q 002346 586 ANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL-VALLGYCINGSERLLVYEYM-PR 663 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~ 663 (933)
.+.|+.|....+|+. +.+++|+....... ..+..+|+.+++.+....+ .++++++ .+.-++|+||+ ++
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTC
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCC
Confidence 678999999999998 56888987653111 1123568877777742223 4666543 33447899999 66
Q ss_pred CCh
Q 002346 664 GTL 666 (933)
Q Consensus 664 gsL 666 (933)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=97.09 E-value=6.6e-05 Score=73.33 Aligned_cols=94 Identities=11% Similarity=0.155 Sum_probs=49.6
Q ss_pred hhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC-----CCC
Q 002346 181 DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-----DLS 255 (933)
Q Consensus 181 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-----~~~ 255 (933)
+.+..-+.|+.|+|++|+|....-..++. .+...+.|+.|+|+.|+|+...- .+.
T Consensus 64 ~aL~~N~~L~~L~L~~n~igd~ga~alA~--------------------aL~~N~tL~~L~L~~N~Ig~~Ga~ala~aL~ 123 (197)
T 1pgv_A 64 EAACNSKHIEKFSLANTAISDSEARGLIE--------------------LIETSPSLRVLNVESNFLTPELLARLLRSTL 123 (197)
T ss_dssp HHHTTCSCCCEEECTTSCCBHHHHTTHHH--------------------HHHHCSSCCEEECCSSBCCHHHHHHHHHHTT
T ss_pred HHHhhCCCcCEEEccCCCCChHHHHHHHH--------------------HHhcCCccCeEecCCCcCCHHHHHHHHHHHh
Confidence 44445556666666666665333222221 22224556666666666654211 244
Q ss_pred CCCCCCEEEccCC---cccc----cCcccccCCCCCCEEEccCccC
Q 002346 256 KCESLFDLSLRDN---QLTG----VVPASVISLPALLNISLQNNKL 294 (933)
Q Consensus 256 ~~~~L~~L~L~~N---~l~~----~~p~~l~~l~~L~~L~Ls~N~l 294 (933)
..+.|+.|+|++| .+.. .+.+.+..-+.|+.|+++.|..
T Consensus 124 ~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~ 169 (197)
T 1pgv_A 124 VTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 169 (197)
T ss_dssp TTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred hCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence 5556777777654 3332 2344455556777777766554
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00087 Score=61.11 Aligned_cols=38 Identities=32% Similarity=0.532 Sum_probs=31.0
Q ss_pred CcCceeccccccccCCCCCcccCCCCCCEEEccCCCCC
Q 002346 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNL 150 (933)
Q Consensus 113 ~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~ 150 (933)
.+|++|+|++|+|+.++.+.|..+++|+.|+|++|.+.
T Consensus 31 ~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 31 VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 45788888888888888888888888888888888654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.97 E-value=0.003 Score=69.08 Aligned_cols=143 Identities=14% Similarity=0.198 Sum_probs=84.4
Q ss_pred CCccccCCCeEEEEEEeC--------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEE
Q 002346 586 ANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLL 656 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 656 (933)
++.|..|-...+|+.... +++.|++|+.... ......+.+|.++++.+. +.-..++++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~---~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI---LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc---cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 356777777899998764 2578999985332 123456779999998884 3334667776643 28
Q ss_pred EEeecCCCChhh--------------HhhhcccC---CCCCCC--HHHHHHHHHHHHH-------------------HHH
Q 002346 657 VYEYMPRGTLAQ--------------HLFEWHDH---GYTPLT--WKQRVTIALDVAR-------------------GVE 698 (933)
Q Consensus 657 v~e~~~~gsL~~--------------~l~~~~~~---~~~~l~--~~~~~~i~~~i~~-------------------~l~ 698 (933)
||||++|.+|.. .|.+.+.. ...+.. |.++.++..++.. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 999999865531 11111111 111222 4555555544322 223
Q ss_pred Hhhh----c-cCCCeEecCCCCCcEEecCC----CcEEEecccccc
Q 002346 699 YLHS----L-AQQSFIHRDLKPSNILIGDD----MRAKVADFGLVK 735 (933)
Q Consensus 699 ~LH~----~-~~~~ivH~Dik~~Nill~~~----~~~kl~DfGla~ 735 (933)
.|.+ . ....++|+|+.+.||+++.+ +.+.++||..+.
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 3321 1 23578999999999999876 789999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.85 E-value=0.0026 Score=71.22 Aligned_cols=73 Identities=21% Similarity=0.233 Sum_probs=49.8
Q ss_pred CCccccCCCeEEEEEEeCC--------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCc-ceeEEeEeeeCceeEE
Q 002346 586 ANILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH-LVALLGYCINGSERLL 656 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~l 656 (933)
.+.|+.|....+|+....+ ++.|++|+..... . ...+.+|..+++.+...+ ..++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4568888889999997653 5789999874321 1 135567999988884333 3567776542 38
Q ss_pred EEeecCCCCh
Q 002346 657 VYEYMPRGTL 666 (933)
Q Consensus 657 v~e~~~~gsL 666 (933)
||||++|.++
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999986444
|
| >1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 | Back alignment and structure |
|---|
Probab=96.84 E-value=8.7e-05 Score=72.46 Aligned_cols=71 Identities=14% Similarity=0.188 Sum_probs=41.6
Q ss_pred ccCccccCCcccceeecccc-ccccc-----CCCccCcCcCceeccccccccCCCCC----cccCCCCCCEEEccCCCCC
Q 002346 81 TLSPEISSLTQLETLSFQMN-NIAGA-----IPSLANATSLQDIYLDNNNFTSVPTG----CFDGLTNLQVLSLSDNPNL 150 (933)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~N-~l~~~-----~p~~~~l~~L~~L~Ls~N~l~~~~~~----~~~~l~~L~~L~Ls~N~~~ 150 (933)
.+...+.+.+.|++|+|++| +|... ...+..-+.|+.|+|++|+|+..... .+...+.|+.|+|+.|.|.
T Consensus 32 ~l~~ll~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig 111 (197)
T 1pgv_A 32 CINRLREDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLT 111 (197)
T ss_dssp HHHHHHTTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCC
T ss_pred HHHHHHhcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCC
Confidence 34445566778888888875 66431 11355566777777777777643222 2334455666666666554
Q ss_pred C
Q 002346 151 A 151 (933)
Q Consensus 151 ~ 151 (933)
.
T Consensus 112 ~ 112 (197)
T 1pgv_A 112 P 112 (197)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A | Back alignment and structure |
|---|
Probab=96.71 E-value=0.00043 Score=66.24 Aligned_cols=34 Identities=21% Similarity=0.102 Sum_probs=16.6
Q ss_pred cCcEEEecCCc-cCCC-CCCCCCCCCCCEEEccCCc
Q 002346 236 QLRQVWLHKNQ-FTGP-IPDLSKCESLFDLSLRDNQ 269 (933)
Q Consensus 236 ~L~~L~L~~N~-l~~~-~~~~~~~~~L~~L~L~~N~ 269 (933)
+|++|+|++|. ++.. +..+..+++|+.|+|+++.
T Consensus 115 ~L~~L~Ls~C~~ITD~Gl~~L~~~~~L~~L~L~~c~ 150 (176)
T 3e4g_A 115 SMLEMEIISCGNVTDKGIIALHHFRNLKYLFLSDLP 150 (176)
T ss_dssp HCCEEEEESCTTCCHHHHHHGGGCTTCCEEEEESCT
T ss_pred CCCEEEcCCCCcCCHHHHHHHhcCCCCCEEECCCCC
Confidence 45555555543 4331 1124455666666666553
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.63 E-value=0.0087 Score=64.64 Aligned_cols=64 Identities=5% Similarity=0.076 Sum_probs=42.3
Q ss_pred CeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC---CCcceeEEeE------eeeCceeEEEEeecCCC
Q 002346 594 FGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR---HRHLVALLGY------CINGSERLLVYEYMPRG 664 (933)
Q Consensus 594 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~------~~~~~~~~lv~e~~~~g 664 (933)
...||+....+| .+++|+...... ..|+.++..|. -|.+++++.. ....+..++||+|++|.
T Consensus 36 ~N~vy~v~~~~g-~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~ 106 (339)
T 3i1a_A 36 NAFAYQADSESK-SYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAP 106 (339)
T ss_dssp SCEEEEEECSSC-EEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCC
T ss_pred ccceEEEEeCCC-CEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCC
Confidence 579999988777 899998765431 34556665552 2224555432 23356778999999987
Q ss_pred Ch
Q 002346 665 TL 666 (933)
Q Consensus 665 sL 666 (933)
.+
T Consensus 107 ~~ 108 (339)
T 3i1a_A 107 NG 108 (339)
T ss_dssp BT
T ss_pred cC
Confidence 65
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.47 E-value=0.013 Score=65.76 Aligned_cols=74 Identities=11% Similarity=0.117 Sum_probs=47.8
Q ss_pred CCccccCCCeEEEEEEeCC-CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcc-eeEEeEeeeCceeEEEEeecCC
Q 002346 586 ANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL-VALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~ 663 (933)
++.|+.|-...+|+....+ +..+++|+..... .. .-+..+|..+++.+...++ .++++++. + .+||||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~--~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT--DE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-C--CS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh--hh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 3568888889999998754 4788999875431 11 1122588899998864444 56777663 2 359999987
Q ss_pred CCh
Q 002346 664 GTL 666 (933)
Q Consensus 664 gsL 666 (933)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 544
|
| >3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* | Back alignment and structure |
|---|
Probab=96.39 E-value=0.0051 Score=55.95 Aligned_cols=56 Identities=25% Similarity=0.246 Sum_probs=46.8
Q ss_pred cEEEecCCccC--CCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCc
Q 002346 238 RQVWLHKNQFT--GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295 (933)
Q Consensus 238 ~~L~L~~N~l~--~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 295 (933)
..++.+++.|+ .++..+. .+|+.|+|++|+|+...+..|..+++|+.|+|++|.+.
T Consensus 11 ~~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~ 68 (130)
T 3rfe_A 11 TLVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR 68 (130)
T ss_dssp TEEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred CEEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence 47889999998 5554443 56999999999999777778899999999999999987
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.38 E-value=0.006 Score=66.90 Aligned_cols=74 Identities=14% Similarity=0.119 Sum_probs=44.5
Q ss_pred CCccccCCCeEEEEEEeCC---------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCc-ceeEEeEeeeCceeE
Q 002346 586 ANILGRGGFGVVYGGELPD---------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH-LVALLGYCINGSERL 655 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~ 655 (933)
.+.|+.|..-.+|+....+ ++.+++|+..... ....+...|..+++.+...+ +.++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3567778888999997643 2688888765431 11112467888888884323 44666544 2 36
Q ss_pred EEEeecCCCCh
Q 002346 656 LVYEYMPRGTL 666 (933)
Q Consensus 656 lv~e~~~~gsL 666 (933)
+||||++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999987543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.32 E-value=0.039 Score=53.97 Aligned_cols=103 Identities=14% Similarity=0.109 Sum_probs=66.6
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
-+|.+.|..+ ..+++++++|.++.|.+++|.-.-... .. ..+=+.|..|++..+|.|.+.+ +.+.
T Consensus 33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-------- 97 (229)
T 2yle_A 33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD-------- 97 (229)
T ss_dssp EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc--------
Confidence 3788988663 368999999999999999987762100 11 1233457999999999998763 1110
Q ss_pred eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCC
Q 002346 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKA 787 (933)
Q Consensus 744 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p 787 (933)
.....+.|||... ...+.+.=|||+|+++|..+--..|
T Consensus 98 -----~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 98 -----AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred -----ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 1122456888763 3556788999999999999864443
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.028 Score=62.21 Aligned_cols=142 Identities=12% Similarity=0.160 Sum_probs=84.1
Q ss_pred CCccccCCCeEEEEEEeCC--------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEE
Q 002346 586 ANILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLL 656 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 656 (933)
++.+..|-.-.+|+....+ ++.|++|+..... ...-+..+|..+++.+. +.-..++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 4567777778999997753 5789999864431 11123457888888884 333456665432 278
Q ss_pred EEeecCCCChhh--------------H---hhhccc-----C---CCCCCCHHHHHHHHHHHH-----------------
Q 002346 657 VYEYMPRGTLAQ--------------H---LFEWHD-----H---GYTPLTWKQRVTIALDVA----------------- 694 (933)
Q Consensus 657 v~e~~~~gsL~~--------------~---l~~~~~-----~---~~~~l~~~~~~~i~~~i~----------------- 694 (933)
||||++|.+|.. . +|.... . +..+--|.++.++..++-
T Consensus 148 I~efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~ 227 (424)
T 3mes_A 148 IEEFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSK 227 (424)
T ss_dssp EEECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHH
T ss_pred EEEEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHH
Confidence 999999866421 1 111111 0 112223444444433321
Q ss_pred --HHHHHhhh---------------------ccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 695 --RGVEYLHS---------------------LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 695 --~~l~~LH~---------------------~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
..+..|.+ .....++|+|+.+.||+ +.++.+.++||..+.
T Consensus 228 l~~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~ 290 (424)
T 3mes_A 228 ILEEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSA 290 (424)
T ss_dssp HHHHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred HHHHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCC
Confidence 22233321 11356889999999999 888899999998765
|
| >2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A | Back alignment and structure |
|---|
Probab=90.94 E-value=0.18 Score=34.00 Aligned_cols=32 Identities=22% Similarity=0.241 Sum_probs=20.5
Q ss_pred CCccceeehhhhHHHHHHHHHHHHHHHHHHhh
Q 002346 480 SKLSVGTIVAIVVVVVIFIAVVFFVVYKFIAR 511 (933)
Q Consensus 480 ~~~~~~~i~~~v~~~~~~i~~~~~~~~~~~~r 511 (933)
++++.+.|.++++++++.++++..+.+++++|
T Consensus 6 ~~ls~GaIAGiVvG~v~gv~li~~l~~~~~rr 37 (38)
T 2k1k_A 6 RGLTGGEIVAVIFGLLLGAALLLGILVFRSRR 37 (38)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCCceeeeehHHHHHHHHHHHHHHHHeec
Confidence 45567778888887776666655555555433
|
| >2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.60 E-value=0.53 Score=32.82 Aligned_cols=29 Identities=24% Similarity=0.330 Sum_probs=12.9
Q ss_pred eehhhhHHHHHHHHHHHHHHHHHHhhhcc
Q 002346 486 TIVAIVVVVVIFIAVVFFVVYKFIARRKH 514 (933)
Q Consensus 486 ~i~~~v~~~~~~i~~~~~~~~~~~~rr~~ 514 (933)
.|++.|++.+++++++.++++++.+||+.
T Consensus 12 ~IA~gVVgGv~~~~ii~~~~~~~~RRr~~ 40 (44)
T 2ks1_B 12 SIATGMVGALLLLLVVALGIGLFMRRRHI 40 (44)
T ss_dssp SSTHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred eEEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence 34444444333333444444555455443
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.34 E-value=1.6 Score=42.60 Aligned_cols=116 Identities=11% Similarity=0.111 Sum_probs=79.4
Q ss_pred CCCcceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCC
Q 002346 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPS 716 (933)
Q Consensus 637 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~ 716 (933)
.||+++.. .+-..++...+.|+.-+.+.=...+ ...+...+++++..|+....++++ -+|--+.|+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i--------k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~ 108 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI--------KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPD 108 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG--------GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGG
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH--------HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecc
Confidence 58888866 4556666666767654422222223 347889999999999998866664 378889999
Q ss_pred cEEecCCCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCC
Q 002346 717 NILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALD 789 (933)
Q Consensus 717 Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~ 789 (933)
|++++.++.+++.--|+-... +|. ..++..=.-.+=+++..+++++..|+
T Consensus 109 NL~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 109 ELFFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp GEEECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred eEEEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999876653322 222 11111123367789999999998875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=88.03 E-value=1.9 Score=47.20 Aligned_cols=29 Identities=28% Similarity=0.508 Sum_probs=24.3
Q ss_pred CeEecCCCCCcEEe------cCCCcEEEecccccc
Q 002346 707 SFIHRDLKPSNILI------GDDMRAKVADFGLVK 735 (933)
Q Consensus 707 ~ivH~Dik~~Nill------~~~~~~kl~DfGla~ 735 (933)
.++|+|+.+.||++ +++..++++||.+|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 35799999999999 456779999998765
|
| >2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.68 E-value=0.61 Score=32.43 Aligned_cols=29 Identities=17% Similarity=0.228 Sum_probs=12.3
Q ss_pred eehhhhHHHHHHHHHHHHHHHHHHhhhcc
Q 002346 486 TIVAIVVVVVIFIAVVFFVVYKFIARRKH 514 (933)
Q Consensus 486 ~i~~~v~~~~~~i~~~~~~~~~~~~rr~~ 514 (933)
.|++.|++.+++++++.++++++.+||+.
T Consensus 11 aIA~gVVgGv~~v~ii~~~~~~~~RRRr~ 39 (44)
T 2l2t_A 11 LIAAGVIGGLFILVIVGLTFAVYVRRKSI 39 (44)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred eEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence 34444444333333334444444444443
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=86.56 E-value=0.094 Score=58.93 Aligned_cols=62 Identities=5% Similarity=0.062 Sum_probs=18.0
Q ss_pred cCCccccCCCeEEEEEEeCC-CcEEEE------EEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEee
Q 002346 585 EANILGRGGFGVVYGGELPD-GTKIAV------KRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 649 (933)
+.+.|| ||.||+|.+.. ..+||| |..+....+.+....|.+|..+++.++|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 456676 99999997743 367888 777665555556678899999999999999999988764
|
| >2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A | Back alignment and structure |
|---|
Probab=84.63 E-value=0.98 Score=31.35 Aligned_cols=28 Identities=29% Similarity=0.462 Sum_probs=12.1
Q ss_pred eehhhhHHHHHHHHHHHHHHHHHHhhhcc
Q 002346 486 TIVAIVVVVVIFIAVVFFVVYKFIARRKH 514 (933)
Q Consensus 486 ~i~~~v~~~~~~i~~~~~~~~~~~~rr~~ 514 (933)
.++++++++ ++++++.++++++.+||+.
T Consensus 13 ~Ia~~vVGv-ll~vi~~l~~~~~~RRR~~ 40 (44)
T 2jwa_A 13 SIISAVVGI-LLVVVLGVVFGILIKRRQQ 40 (44)
T ss_dssp HHHHHHHHH-HHHHHHHHHHHHHHHHHCS
T ss_pred chHHHHHHH-HHHHHHHHHHHhheehhhh
Confidence 345555552 2333333344444455443
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=83.54 E-value=3.6 Score=40.28 Aligned_cols=115 Identities=11% Similarity=0.093 Sum_probs=78.9
Q ss_pred CCCcceeEEeEeeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHH-HhhhccCCCeEecCCCC
Q 002346 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE-YLHSLAQQSFIHRDLKP 715 (933)
Q Consensus 637 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~-~LH~~~~~~ivH~Dik~ 715 (933)
.||++ -...-.+++...+.|+.-+++.=...+ ...+..++++++..++.... ++++ -+|--+.|
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i--------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P 112 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI--------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP 112 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH--------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH--------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence 58888 344446677777777765444333344 23788999999999999877 6654 47788999
Q ss_pred CcEEecCCCcEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCC
Q 002346 716 SNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALD 789 (933)
Q Consensus 716 ~Nill~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~ 789 (933)
+|+++|.++.++|.-.|+-.. ++|.-.. +..=.-.+=+++..++.++..|+
T Consensus 113 ~NL~f~~~~~p~i~hRGi~~~------------------lpP~e~~-----ee~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 113 ENLMFNRALEPFFLHVGVKES------------------LPPDEWD-----DERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp GGEEECTTCCEEESCCEETTT------------------BSSCSCC-----HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred ceEEEeCCCcEEEEEcCCccc------------------CCCCCCC-----HHHHHHHHHHHHHHHHcCCCCHH
Confidence 999999999999987775322 2222111 11112367788899999987774
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 933 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-68 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-67 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-65 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-62 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-62 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-62 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-62 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-62 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-60 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-59 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-58 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-58 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 6e-58 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-58 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 7e-58 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-57 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-56 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-55 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 2e-54 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-54 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-54 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-53 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-51 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-49 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-48 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 3e-47 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-46 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-46 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 4e-46 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-44 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-44 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-42 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-41 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-41 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-38 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-32 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-15 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-04 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-04 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-09 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-08 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.001 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-12 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-09 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 9e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.002 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 6e-08 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 9e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-08 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 1e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 2e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 5e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (579), Expect = 2e-68
Identities = 72/288 (25%), Positives = 121/288 (42%), Gaps = 27/288 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ +G G FG VY G+ +AVK + + L F+ E+ VL K RH +
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 65
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
++ +GY + +V ++ +L HL T + + IA A+G++YL
Sbjct: 66 ILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYL 120
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE-TRLAGTFGYLAPEY 759
H +S IHRDLK +NI + +D+ K+ DFGL S + +L+G+ ++APE
Sbjct: 121 H---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEV 177
Query: 760 AAT---GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816
+ + DVYAFG+VL E +TG+ + D ++ P
Sbjct: 178 IRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGRGYLSPDL 231
Query: 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864
N + + L C ++ +RP + + L
Sbjct: 232 SKVRSNCPKA-------MKRLMAECLKKKRDERPLFPQILASIELLAR 272
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 5e-67
Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 27/279 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ LG G FG V+ G TK+AVK ++ +M F AE ++ +++H+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLMKQLQHQR 69
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
LV L ++ EYM G+L L LT + + +A +A G+ ++
Sbjct: 70 LVRLYAVVTQE-PIYIITEYMENGSLVDFL---KTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+++IHRDL+ +NIL+ D + K+ADFGL + D +Y+ + APE
Sbjct: 126 EE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAI 182
Query: 761 ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
G T K DV++FG++L E +T + M + ++ +N P+
Sbjct: 183 NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPE----- 237
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+ +L C P+ RP + +VL
Sbjct: 238 ------------ELYQLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 218 bits (555), Expect = 3e-65
Identities = 70/284 (24%), Positives = 122/284 (42%), Gaps = 27/284 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ +G G FG+V+ G + K+A+K + M + +F E V+ K+ H
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLSHPK 61
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
LV L G C+ + LV+E+M G L ++ + + + LDV G+ YL
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCL----SDYLRTQRGLFAAETLLGMCLDVCEGMAYL 117
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+ IHRDL N L+G++ KV+DFG+ + D +Y+ T + +PE
Sbjct: 118 E---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVF 174
Query: 761 ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
+ R ++K DV++FGV++ E + K + + + + I
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE----------------VVEDISTG 218
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864
L + + S V ++ HC P+ RP + L + E
Sbjct: 219 FRLYKPRLAST-HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 211 bits (538), Expect = 1e-62
Identities = 78/295 (26%), Positives = 128/295 (43%), Gaps = 27/295 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
++ LG+G FG V+ G T++A+K ++ TM + F E V+ K+RH
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKKLRHEK 73
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
LV L +V EYM +G+L L Q V +A +A G+ Y+
Sbjct: 74 LVQLYAVVSEE-PIYIVTEYMSKGSLLDF---LKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+ +++HRDL+ +NIL+G+++ KVADFGL + D +Y+ + APE A
Sbjct: 130 E---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAA 186
Query: 761 ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
GR T K DV++FG++L E T + M + +V + P
Sbjct: 187 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-----LDQV---ERGYRMPCPPE 238
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPATREDED 875
+ +L C +EP++RP + L +P + E+
Sbjct: 239 CPES---------LHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (534), Expect = 2e-62
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 27/279 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ + LG G FGVV G+ +A+K ++ +M EF E V+ + H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLSHEK 60
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
LV L G C ++ EYM G L +L E +Q + + DV +EYL
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYL 116
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+ F+HRDL N L+ D KV+DFGL + D +Y+ + PE
Sbjct: 117 E---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVL 173
Query: 761 ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820
+ ++K D++AFGV++ E + K + + + I
Sbjct: 174 MYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQG 217
Query: 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
L L + S +V + C + +RP ++ +
Sbjct: 218 LRLYRPHLASE-KVYTIMYSCWHEKADERPTFKILLSNI 255
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (533), Expect = 3e-62
Identities = 66/279 (23%), Positives = 117/279 (41%), Gaps = 32/279 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSE-FQAEIAVLTKVRH 638
++F LG+G FG VY +A+K + + G+ + E+ + + +RH
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
+++ L GY + + L+ EY P GT+ + L + ++ T ++A +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALS 120
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
Y HS + IHRD+KP N+L+G K+ADFG +AP + T L GT YL PE
Sbjct: 121 YCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR---TTLCGTLDYLPPE 174
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818
K+D+++ GV+ E + G+ + + ++R+ + P +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------TYKRISRVEFTFPDFVT 228
Query: 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
+L P QRP + +
Sbjct: 229 EGA-------------RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 209 bits (532), Expect = 4e-62
Identities = 81/281 (28%), Positives = 125/281 (44%), Gaps = 35/281 (12%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+G+G FG V G+ G K+AVK ++++ F AE +V+T++RH +
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSN 61
Query: 641 LVALLGYCINGSERL-LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
LV LLG + L +V EYM +G+L +L G + L + +LDV +EY
Sbjct: 62 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEY 118
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
L +F+HRDL N+L+ +D AKV+DFGL K A S + + APE
Sbjct: 119 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS----STQDTGKLPVKWTAPEA 171
Query: 760 AATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL-ISKENIPKAID 818
+ +TK DV++FG++L E + + +P R L RV K + P
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVVPRVEKGYKMDAPDGCP 226
Query: 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
P + E+ +C + RP L
Sbjct: 227 PAV-------------YEVMKNCWHLDAAMRPSFLQLREQL 254
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 6e-62
Identities = 61/299 (20%), Positives = 113/299 (37%), Gaps = 37/299 (12%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
D+F + + LG G GVV+ P G +A K + + ++ E+ VL +
Sbjct: 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHECNS 63
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V G + E + E+M G+L Q L + + +++ V +G+
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQILGKVSIAVIKGLT 118
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YL + +HRD+KPSNIL+ K+ DFG+ D GT Y++PE
Sbjct: 119 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSPE 173
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHL----VTWFRRVLISKENIP 814
+ + D+++ G+ L+E GR + + + V + P
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233
Query: 815 KAIDPNLNLDEETIESIYRV---------------------AELAGHCTAREPQQRPDM 852
+ +D +I+ + + C + P +R D+
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (526), Expect = 1e-60
Identities = 65/299 (21%), Positives = 114/299 (38%), Gaps = 33/299 (11%)
Query: 589 LGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYC 648
+G+G FG V+ G+ G ++AVK S + +AEI +RH +++ +
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREERSW---FREAEIYQTVMLRHENILGFIAAD 66
Query: 649 I----NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS-- 702
++ LV +Y G+L +L +T + + +AL A G+ +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 703 ---LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE---TRLAGTFGYLA 756
+ + HRDLK NIL+ + +AD GL +++ GT Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 757 PEYAAT------GRVTTKIDVYAFGVVLMETITGRK----ALDDTMPDDRAHLVTWFRRV 806
PE + D+YA G+V E D +P
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE 240
Query: 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
+ K + + PN+ ++ E++ +A++ C R L L +Q
Sbjct: 241 MR-KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 202 bits (514), Expect = 3e-59
Identities = 71/286 (24%), Positives = 123/286 (43%), Gaps = 27/286 (9%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ + + LG G +G VY G +AVK ++ +TM + EF E AV+ +++H
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAAVMKEIKHP 73
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
+LV LLG C ++ E+M G L +L + ++ + +A ++ +EY
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYL---RECNRQEVSAVVLLYMATQISSAMEY 130
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
L ++FIHRDL N L+G++ KVADFGL + Y+ + APE
Sbjct: 131 LEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPES 187
Query: 760 AATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819
A + + K DV+AFGV+L E T + + + + + ++
Sbjct: 188 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY----------------ELLEK 231
Query: 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
+ ++ +V EL C P RP + ++
Sbjct: 232 DYRMERPEGCPE-KVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (512), Expect = 7e-59
Identities = 81/310 (26%), Positives = 124/310 (40%), Gaps = 47/310 (15%)
Query: 581 DNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
+N +G G FG V+ P T +AVK ++ ++FQ E A++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMA 71
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFE-------------------WHD 675
+ + ++V LLG C G L++EYM G L + L
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 676 HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
G PL+ +++ IA VA G+ YL + F+HRDL N L+G++M K+ADFGL +
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 736 NAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD 794
N Y + A ++ PE R TT+ DV+A+GVVL E + M
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 795 DRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGH 854
+ +L EN P + L C ++ P RP
Sbjct: 249 EEVIYYVRDGNILACPENCPL-----------------ELYNLMRLCWSKLPADRPSFCS 291
Query: 855 AVNVLGPLVE 864
+L + E
Sbjct: 292 IHRILQRMCE 301
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (508), Expect = 1e-58
Identities = 52/282 (18%), Positives = 99/282 (35%), Gaps = 25/282 (8%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+++ +G G +G DG + K ++ +M +E+ +L +++H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 640 HLVALLGYCINGSERLL--VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
++V I+ + L V EY G LA + + L + + + + +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK-GTKERQYLDEEFVLRVMTQLTLAL 122
Query: 698 EYLHSL--AQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
+ H + +HRDLKP+N+ + K+ DFGL + S GT Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT-SFAKAFVGTPYYM 181
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815
+PE K D+++ G +L E + A + + IP
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----RRIPY 236
Query: 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
LN E+ + RP + +
Sbjct: 237 RYSDELN-------------EIITRMLNLKDYHRPSVEEILE 265
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (511), Expect = 2e-58
Identities = 65/312 (20%), Positives = 112/312 (35%), Gaps = 46/312 (14%)
Query: 580 TDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRME-SNTMGNKGLSEFQAEIAVLTKVR 637
FS+ +G G FG VY ++ + +A+K+M S N+ + E+ L K+R
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H + + G + LV EY PL + + +G+
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE-----VHKKPLQEVEIAAVTHGALQGL 128
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
YLHS + IHRD+K NIL+ + K+ DFG GT ++AP
Sbjct: 129 AYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NSFVGTPYWMAP 180
Query: 758 EYAAT---GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814
E G+ K+DV++ G+ +E + L + + + + +
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS 240
Query: 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN-----------VLGPLV 863
+ C + PQ RP + V+ L+
Sbjct: 241 EYF-----------------RNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLI 283
Query: 864 EQWKPATREDED 875
++ K A RE ++
Sbjct: 284 QRTKDAVRELDN 295
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 200 bits (509), Expect = 2e-58
Identities = 66/310 (21%), Positives = 127/310 (40%), Gaps = 42/310 (13%)
Query: 572 SIEVLRQVTDNFSEA---------NILGRGGFGVVYGGELPDGTK----IAVKRMESNTM 618
+ E + F++ ++G G FG V G L K +A+K ++S
Sbjct: 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT 67
Query: 619 GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY 678
K +F +E +++ + H +++ L G + +++ E+M G+L +
Sbjct: 68 -EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSL----DSFLRQND 122
Query: 679 TPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738
T Q V + +A G++YL +++HRDL NIL+ ++ KV+DFGL +
Sbjct: 123 GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179
Query: 739 DGKYSVETRLA----GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD 794
D A + APE + T+ DV+++G+V+ E ++ + M
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM-- 237
Query: 795 DRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGH 854
+ +++ AI+ + L + +L C ++ RP G
Sbjct: 238 --------------TNQDVINAIEQDYRLPPPMDCPS-ALHQLMLDCWQKDRNHRPKFGQ 282
Query: 855 AVNVLGPLVE 864
VN L ++
Sbjct: 283 IVNTLDKMIR 292
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-58
Identities = 65/281 (23%), Positives = 114/281 (40%), Gaps = 33/281 (11%)
Query: 585 EANILGRGGFGVVYGGELPD---GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL 641
E LG G FG V G +AVK +++ E AE V+ ++ + ++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 642 VALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
V ++G C S +LV E G L ++L + + K + + V+ G++YL
Sbjct: 71 VRMIGICEAES-WMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLE 124
Query: 702 SLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYLAPEY 759
+ +F+HRDL N+L+ AK++DFGL K + Y +T + APE
Sbjct: 125 ---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPEC 181
Query: 760 AATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818
+ ++K DV++FGV++ E + G+K + ++ R+ P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM-----GCPAGCP 236
Query: 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+ +L C + + RP L
Sbjct: 237 REM-------------YDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 4e-58
Identities = 66/287 (22%), Positives = 117/287 (40%), Gaps = 34/287 (11%)
Query: 580 TDNFSEANI-LGRGGFGVVYGGEL---PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
DN A+I LG G FG V G +A+K ++ T E E ++ +
Sbjct: 7 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQ 65
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+ + ++V L+G C +LV E G L + L + + + V+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSM 120
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK--NAPDGKYSVETRLAGTFG 753
G++YL +++F+HRDL N+L+ + AK++DFGL K A D Y+ +
Sbjct: 121 GMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLK 177
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812
+ APE + +++ DV+++GV + E ++ G+K + + +R+
Sbjct: 178 WYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRM-----E 232
Query: 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
P P L L C + + RPD +
Sbjct: 233 CPPECPPEL-------------YALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (503), Expect = 6e-58
Identities = 62/279 (22%), Positives = 107/279 (38%), Gaps = 36/279 (12%)
Query: 587 NILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALL 645
+GRG F VY G + ++A ++ + F+ E +L ++H ++V
Sbjct: 15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
+ + +LV E M GTL +L + + K + + +G+++LH
Sbjct: 75 DSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 702 SLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
+ IHRDLK NI I G K+ D GL S + GT ++APE
Sbjct: 130 TRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEM- 184
Query: 761 ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL--ISKENIPKAID 818
+ +DVYAFG+ ++E T + +RRV + + K
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QIYRRVTSGVKPASFDKVAI 239
Query: 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
P + E+ C + +R + +N
Sbjct: 240 PEV-------------KEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 6e-58
Identities = 67/291 (23%), Positives = 123/291 (42%), Gaps = 32/291 (10%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGT-----KIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
+ ++G G FG VY G L + +A+K +++ K +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQ 65
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
H +++ L G +++ EYM G L + L E + Q V + +A
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAA 121
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA--GTFG 753
G++YL + +++HRDL NIL+ ++ KV+DFGL + D + T
Sbjct: 122 GMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813
+ APE + + T+ DV++FG+V+ E +T + + + +
Sbjct: 179 WTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------------HEV 222
Query: 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864
KAI+ L + +L C +E +RP V++L L+
Sbjct: 223 MKAINDGFRLPTPMDCPS-AIYQLMMQCWQQERARRPKFADIVSILDKLIR 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 7e-58
Identities = 84/320 (26%), Positives = 134/320 (41%), Gaps = 42/320 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKV- 636
++ +++G G FG V + A+KRM+ +F E+ VL K+
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLG 68
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHL-----------FEWHDHGYTPLTWKQ 685
H +++ LLG C + L EY P G L L F + + L+ +Q
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 686 RVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE 745
+ A DVARG++YL + FIHRDL NIL+G++ AK+ADFGL + Y +
Sbjct: 129 LLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEV--YVKK 183
Query: 746 TRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805
T ++A E TT DV+++GV+L E ++ P + +
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTCAELYEK 238
Query: 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
+ ++ LN D+E V +L C +P +RP + L ++E+
Sbjct: 239 LPQGYR-----LEKPLNCDDE-------VYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286
Query: 866 WKPAT----REDEDGYGIDL 881
K E GID
Sbjct: 287 RKTYVNTTLYEKFTYAGIDC 306
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 1e-57
Identities = 70/306 (22%), Positives = 122/306 (39%), Gaps = 46/306 (15%)
Query: 581 DNFSEANILGRGGFGVVY------GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
+N +LG G FG V + ++AVK ++ + +E+ ++T
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSELKMMT 95
Query: 635 KV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDH----------------- 676
++ H ++V LLG C L++EY G L +L +
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 677 -GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735
LT++ + A VA+G+E+L +S +HRDL N+L+ K+ DFGL +
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLAR 212
Query: 736 NA-PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPD 794
+ D Y V ++APE G T K DV+++G++L E + +P
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 795 DRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGH 854
D N K I +D+ + + + C A + ++RP +
Sbjct: 273 D---------------ANFYKLIQNGFKMDQPFYATE-EIYIIMQSCWAFDSRKRPSFPN 316
Query: 855 AVNVLG 860
+ LG
Sbjct: 317 LTSFLG 322
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (495), Expect = 2e-56
Identities = 69/306 (22%), Positives = 120/306 (39%), Gaps = 41/306 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
+ S LG G FG V +AVK ++ + +E+ VL+
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLS 81
Query: 635 KV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYT-------------P 680
+ H ++V LLG C G L++ EY G L L D
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP-D 739
L + ++ + VA+G+ +L S ++ IHRDL NIL+ K+ DFGL ++ D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHL 799
Y V+ ++APE T + DV+++G+ L E + + MP D
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD---- 254
Query: 800 VTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+ F +++ KE + + + ++ C +P +RP V ++
Sbjct: 255 -SKFYKMI--KEGFRMLSPEHAPAE---------MYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 860 GPLVEQ 865
+ +
Sbjct: 303 EKQISE 308
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 3e-56
Identities = 53/280 (18%), Positives = 99/280 (35%), Gaps = 28/280 (10%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+++ LG G +G V +AVK ++ + EI + + H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHE 63
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V G+ G+ + L EY G L + + + GV Y
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRI-----EPDIGMPEPDAQRFFHQLMAGVVY 118
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA-PDGKYSVETRLAGTFGYLAPE 758
LH HRD+KP N+L+ + K++DFGL + + + ++ GT Y+APE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175
Query: 759 YAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817
+DV++ G+VL + G D + + + +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---------WKEKKTYL 226
Query: 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
+P +D + +++ P R +
Sbjct: 227 NPWKKIDSAPLALLHK-------ILVENPSARITIPDIKK 259
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 4e-56
Identities = 77/307 (25%), Positives = 130/307 (42%), Gaps = 38/307 (12%)
Query: 568 NVAISIEVLRQVTDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGL 623
+V I + +F+E ++GRG FG VY G L D AVK + T +
Sbjct: 19 HVVIGPS---SLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD-IGEV 72
Query: 624 SEFQAEIAVLTKVRHRHLVALLGYCING-SERLLVYEYMPRGTLAQHLFEWHDHGYTPLT 682
S+F E ++ H ++++LLG C+ L+V YM G L + + T
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDL----RNFIRNETHNPT 128
Query: 683 WKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKY 742
K + L VA+G+++L + F+HRDL N ++ + KVADFGL ++ D ++
Sbjct: 129 VKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 185
Query: 743 ---SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHL 799
+T ++A E T + TTK DV++FGV+L E +T P +
Sbjct: 186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNT 240
Query: 800 VTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+L + + P D + E+ C + + RP V+ +
Sbjct: 241 FDITVYLL----QGRRLLQPEYCPDP--------LYEVMLKCWHPKAEMRPSFSELVSRI 288
Query: 860 GPLVEQW 866
+ +
Sbjct: 289 SAIFSTF 295
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 2e-55
Identities = 61/279 (21%), Positives = 97/279 (34%), Gaps = 32/279 (11%)
Query: 580 TDNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH 638
D + LG G FG VY + + A K +++ + + L ++ EI +L H
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDH 68
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++V LL + ++ E+ G + + E PLT Q + +
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALN 124
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLH IHRDLK NIL D K+ADFG+ GT ++APE
Sbjct: 125 YLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRRDSFIGTPYWMAPE 180
Query: 759 YAAT-----GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813
K DV++ G+ L+E P + + + I+K
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLK--IAKSEP 232
Query: 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
P P+ + C + R
Sbjct: 233 PTLAQPS-RWSSN-------FKDFLKKCLEKNVDARWTT 263
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-54
Identities = 70/298 (23%), Positives = 126/298 (42%), Gaps = 33/298 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
+ + + LG+G FG+VY G T++A+K + + + EF E +V+
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMK 78
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG-----YTPLTWKQRVTI 689
+ H+V LLG G L++ E M RG L +L P + + + +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE-TRL 748
A ++A G+ YL++ F+HRDL N ++ +D K+ DFG+ ++ + Y + +
Sbjct: 139 AGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808
+++PE G TT DV++FGVVL E T + + +++ +L
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255
Query: 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866
+N P + EL C P+ RP ++ + +E
Sbjct: 256 KPDNCPD-----------------MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 3e-54
Identities = 72/324 (22%), Positives = 127/324 (39%), Gaps = 43/324 (13%)
Query: 559 SDRHLFEGGNVAISIEVLRQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNT 617
SD + E +S+ ++ +G+G G VY ++ G ++A+++M
Sbjct: 1 SDEEILEKLRSIVSVG---DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ 57
Query: 618 MGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHG 677
K EI V+ + ++ ++V L + G E +V EY+ G+L + E
Sbjct: 58 QPKK--ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-- 113
Query: 678 YTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737
Q + + + +E+LHS IHRD+K NIL+G D K+ DFG
Sbjct: 114 ----DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRA 797
+ T GT ++APE K+D+++ G++ +E I G + P
Sbjct: 167 TPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL 225
Query: 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
+ LI+ P+ +P L + + R C + ++R +
Sbjct: 226 Y--------LIATNGTPELQNPE-KLSAIFRDFLNR-------CLDMDVEKRGSAKELLQ 269
Query: 858 -----------VLGPLVEQWKPAT 870
L PL+ K AT
Sbjct: 270 HQFLKIAKPLSSLTPLIAAAKEAT 293
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 4e-54
Identities = 67/286 (23%), Positives = 113/286 (39%), Gaps = 31/286 (10%)
Query: 581 DNFSEANILGRGGFGVVYGGELP----DGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTK 635
+ LG G FGVV GE +AVK ++ + + + + +F E+ +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+ HR+L+ L G + ++ V E P G+L + A+ VA
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAE 122
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFG 753
G+ YL S + FIHRDL N+L+ K+ DFGL++ P Y ++ F
Sbjct: 123 GMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813
+ APE T + D + FGV L E T + P + ++ E +
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERL 234
Query: 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
P+ + ++ + + C A +P+ RP + L
Sbjct: 235 PR----PEDCPQD-------IYNVMVQCWAHKPEDRPTFVALRDFL 269
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 6e-54
Identities = 64/299 (21%), Positives = 109/299 (36%), Gaps = 35/299 (11%)
Query: 574 EVLRQVTDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAE 629
E+ R + +G G FG V+ G +A+K ++ T + +F E
Sbjct: 3 EIQR---ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQE 58
Query: 630 IAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
+ + H H+V L+G ++ E G L + L +
Sbjct: 59 ALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGEL----RSFLQVRKYSLDLASLILY 113
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLA 749
A ++ + YL S + F+HRD+ N+L+ + K+ DFGL + D Y ++
Sbjct: 114 AYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 170
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL-I 808
++APE R T+ DV+ FGV + E + P R+
Sbjct: 171 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENG 225
Query: 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWK 867
+ +P P L L C A +P +RP L ++E+ K
Sbjct: 226 ERLPMPPNCPPTL-------------YSLMTKCWAYDPSRRPRFTELKAQLSTILEEEK 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (477), Expect = 8e-54
Identities = 67/309 (21%), Positives = 119/309 (38%), Gaps = 34/309 (11%)
Query: 573 IEVLRQVTDNFSEANILGRGGFGVVYGGE-LPDGT----KIAVKRMESNTMGNKGLSEFQ 627
+ +L++ F + +LG G FG VY G +P+G +A+K + T K E
Sbjct: 3 LRILKE--TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEIL 59
Query: 628 AEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
E V+ V + H+ LLG C+ + +L + + MP G L ++ + + +
Sbjct: 60 DEAYVMASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCL----LDYVREHKDNIGSQYLL 114
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN-APDGKYSVET 746
+ +A+G+ YL + +HRDL N+L+ K+ DFGL K + K
Sbjct: 115 NWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 171
Query: 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806
++A E T + DV+++GV + E +T D +P
Sbjct: 172 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA------------ 219
Query: 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866
I ++ L + I +I V + C + RP + +
Sbjct: 220 ----SEISSILEKGERLPQPPICTI-DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 274
Query: 867 KPATREDED 875
+ D
Sbjct: 275 QRYLVIQGD 283
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (472), Expect = 2e-53
Identities = 56/293 (19%), Positives = 106/293 (36%), Gaps = 30/293 (10%)
Query: 577 RQVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLT 634
++ ++F ILG G F V EL + A+K +E + + + E V++
Sbjct: 4 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVA 694
++ H V L + + Y G L +++ + ++
Sbjct: 64 RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIV 118
Query: 695 RGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK-NAPDGKYSVETRLAGTFG 753
+EYLH + IHRDLKP NIL+ +DM ++ DFG K +P+ K + GT
Sbjct: 119 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813
Y++PE D++A G ++ + + G F++++ + +
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI------FQKIIKLEYDF 229
Query: 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866
P+ P +L + +R +
Sbjct: 230 PEKFFPKA-------------RDLVEKLLVLDATKRLGCEEMEGYGPLKAHPF 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (462), Expect = 2e-51
Identities = 63/278 (22%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 578 QVTDNFSEANILGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
V D++ LG G FGVV+ E G A K + + +K + EI ++ +
Sbjct: 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDK--ETVRKEIQTMSVL 80
Query: 637 RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
RH LV L + +E +++YE+M G L + + + H ++ + V V +G
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKG 136
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDM--RAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
+ ++H +++H DLKP NI+ K+ DFGL + + T GT +
Sbjct: 137 LCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEF 191
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814
APE A V D+++ GV+ ++G D+ R V N+
Sbjct: 192 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------TLRNVKSCDWNMD 245
Query: 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
+ ++ D + +P R +
Sbjct: 246 DSAFSGISED---------GKDFIRKLLLADPNTRMTI 274
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 5e-51
Identities = 79/305 (25%), Positives = 124/305 (40%), Gaps = 42/305 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAV 632
D LG G FG V E TK+AVK ++S+ K LS+ +E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEM 71
Query: 633 LTKV-RHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGY-----------TP 680
+ + +H++++ LLG C ++ EY +G L ++L G
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 681 LTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740
L+ K V+ A VARG+EYL S + IHRDL N+L+ +D K+ADFGL ++
Sbjct: 132 LSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188
Query: 741 KYSVETRL-AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHL 799
Y +T ++APE T + DV++FGV+L E T + +P +
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 248
Query: 800 VTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
+ + N + + C P QRP V L
Sbjct: 249 LLKEGHRMDKPSNCTN-----------------ELYMMMRDCWHAVPSQRPTFKQLVEDL 291
Query: 860 GPLVE 864
+V
Sbjct: 292 DRIVA 296
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 174 bits (442), Expect = 1e-49
Identities = 69/287 (24%), Positives = 110/287 (38%), Gaps = 31/287 (10%)
Query: 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKG-LSEFQAEIAVLTK 635
++D + ILG GG V+ L +AVK + ++ + F+ E
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 636 VRHRHLVALLGYCIN----GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
+ H +VA+ G +V EY+ TL + P+T K+ + +
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIA 118
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVE--TRLA 749
D + + + H IHRD+KP+NI+I KV DFG+ + D SV +
Sbjct: 119 DACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 175
Query: 750 GTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809
GT YL+PE A V + DVY+ G VL E +TG P + +
Sbjct: 176 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVRE 229
Query: 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAV 856
P A L+ D + + A+ P+ R +
Sbjct: 230 DPIPPSARHEGLSAD---------LDAVVLKALAKNPENRYQTAAEM 267
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 174 bits (442), Expect = 1e-49
Identities = 66/287 (22%), Positives = 108/287 (37%), Gaps = 40/287 (13%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSE-------FQAEIAV 632
+N+ ILGRG VV P + AVK ++ G+ E E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 633 LTKVR-HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
L KV H +++ L + LV++ M +G L +L L+ K+ I
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-----TEKVTLSEKETRKIMR 117
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
+ + LH + +HRDLKP NIL+ DDM K+ DFG G+ + GT
Sbjct: 118 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKL--REVCGT 172
Query: 752 FGYLAPEYAATGRV------TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRR 805
YLAPE ++D+++ GV++ + G P + R
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQMLMLRM 226
Query: 806 VLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
++ + + V +L +PQ+R
Sbjct: 227 IMSGNYQFGSPEWDDYSDT---------VKDLVSRFLVVQPQKRYTA 264
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (443), Expect = 2e-49
Identities = 72/306 (23%), Positives = 113/306 (36%), Gaps = 44/306 (14%)
Query: 581 DNFSEANILGRGGFGVVY------GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLT 634
D LGRG FG V + +AVK ++ + +E+ +L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILI 71
Query: 635 KVRHRHLVALLGYCI--NGSERLLVYEYMPRGTLAQHLFE-----------WHDHGYTPL 681
+ H V L G +++ E+ G L+ +L D L
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 682 TWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP-DG 740
T + + + VA+G+E+L S + IHRDL NIL+ + K+ DFGL ++ D
Sbjct: 132 TLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188
Query: 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV 800
Y + ++APE T + DV++FGV+L E + P +
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKID 243
Query: 801 TWFRRVLIS--KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNV 858
F R L + P P + + C EP QRP V
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEM-------------YQTMLDCWHGEPSQRPTFSELVEH 290
Query: 859 LGPLVE 864
LG L++
Sbjct: 291 LGNLLQ 296
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 174 bits (441), Expect = 2e-48
Identities = 60/276 (21%), Positives = 109/276 (39%), Gaps = 33/276 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEF----QAEIAVLTK 635
++FS I+GRGGFG VYG D G A+K ++ + K + +++++
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+V + + + + M G L HL + + A ++
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAEIIL 118
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
G+E++H+ + ++RDLKP+NIL+ + +++D GL + K GT GY+
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHGYM 172
Query: 756 APEYAATGR-VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814
APE G + D ++ G +L + + G D+ + R L +P
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRMTLTMAVELP 229
Query: 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
+ P L L R+ +R
Sbjct: 230 DSFSPEL-------------RSLLEGLLQRDVNRRL 252
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 172 bits (438), Expect = 4e-48
Identities = 53/279 (18%), Positives = 103/279 (36%), Gaps = 29/279 (10%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
V D + LG G FGVV+ E G K + + +K + EI+++ +
Sbjct: 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK--YTVKNEISIMNQ 82
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+ H L+ L + E +L+ E++ G L + Y ++ + +
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRI---AAEDY-KMSEAEVINYMRQACE 138
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILI--GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
G++++H S +H D+KP NI+ K+ DFGL + T T
Sbjct: 139 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT--ATAE 193
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813
+ APE V D++A GV+ ++G + + V
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------TLQNVKRCDWEF 247
Query: 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
+ +++ + + + +EP++R +
Sbjct: 248 DEDAFSSVSPE---------AKDFIKNLLQKEPRKRLTV 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 169 bits (428), Expect = 3e-47
Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 30/278 (10%)
Query: 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
+ D + ++LG G F V E +A+K + + K + EIAVL K++
Sbjct: 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIK 65
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H ++VAL +G L+ + + G L + T + + V V
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI-----VEKGFYTERDASRLIFQVLDAV 120
Query: 698 EYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGY 754
+YLH +HRDLKP N+L +D + ++DFGL K G SV + GT GY
Sbjct: 121 KYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPGY 175
Query: 755 LAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814
+APE A + +D ++ GV+ + G D F ++L ++
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------LFEQILKAEYEFD 229
Query: 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
+++ + H ++P++R
Sbjct: 230 SPYWDDISDS---------AKDFIRHLMEKDPEKRFTC 258
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 167 bits (424), Expect = 1e-46
Identities = 64/272 (23%), Positives = 112/272 (41%), Gaps = 33/272 (12%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRH 638
+F LG G FG V+ +G A+K ++ + K + E +L+ V H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
++ + G + + ++ +Y+ G L L + A +V +E
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALE 118
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLHS + I+RDLKP NIL+ + K+ DFG K PD Y++ GT Y+APE
Sbjct: 119 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL----CGTPDYIAPE 171
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818
+T ID ++FG+++ E + G D+ + ++L ++ P +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAELRFPPFFN 225
Query: 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
++ +L R+ QR
Sbjct: 226 EDV-------------KDLLSRLITRDLSQRL 244
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 166 bits (421), Expect = 1e-46
Identities = 59/287 (20%), Positives = 108/287 (37%), Gaps = 18/287 (6%)
Query: 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRH 640
+ + +G G +GVVY + G A+K++ S EI++L +++H +
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
+V L +LV+E++ Q L + D L + L + G+ Y
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD-----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 701 HSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYA 760
H + +HRDLKP N+LI + K+ADFGL + + +
Sbjct: 117 HD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLM 173
Query: 761 ATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV-----TWFRRVLISKENIPK 815
+ + +T ID+++ G + E + G D+ + T + + +PK
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK 233
Query: 816 AIDPNLNLDEETIESIYR-----VAELAGHCTAREPQQRPDMGHAVN 857
+ ES + +L +P QR A+
Sbjct: 234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 4e-46
Identities = 62/279 (22%), Positives = 111/279 (39%), Gaps = 31/279 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKV-R 637
++F +LG+G FG V+ E A+K ++ + + + + E VL+
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H L + V EY+ G L H+ H + A ++ G+
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGL 116
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAP 757
++LHS + ++RDLK NIL+ D K+ADFG+ K G + GT Y+AP
Sbjct: 117 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-AKTNTFCGTPDYIAP 172
Query: 758 EYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817
E + +D ++FGV+L E + G+ ++ F + + P+ +
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE------LFHSIRMDNPFYPRWL 226
Query: 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAV 856
+ +L REP++R + +
Sbjct: 227 EKEA-------------KDLLVKLFVREPEKRLGVRGDI 252
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 4e-46
Identities = 46/279 (16%), Positives = 106/279 (37%), Gaps = 30/279 (10%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
+++ + + A LGRG FG+V+ E K ++ + EI++L
Sbjct: 1 KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV---LVKKEISILNI 57
Query: 636 VRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
RHR+++ L + E ++++E++ + + + + + L ++ V+ V
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERI---NTSAF-ELNEREIVSYVHQVCE 113
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
+++LHS + H D++P NI+ K+ +FG + G L
Sbjct: 114 ALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPE 168
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813
Y APE V+T D+++ G ++ ++G ++ ++
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTF 222
Query: 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
+ ++++ + +E + R
Sbjct: 223 DEEAFKEISIE---------AMDFVDRLLVKERKSRMTA 252
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 165 bits (417), Expect = 6e-46
Identities = 55/295 (18%), Positives = 102/295 (34%), Gaps = 38/295 (12%)
Query: 578 QVTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+V + + +G G FG +Y G + G ++A+K T + E + +
Sbjct: 4 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMM 59
Query: 637 RHRHLVALLGYCI-NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVAR 695
+ + + +C G ++V E + L + + + K + +A +
Sbjct: 60 QGGVGIPTIRWCGAEGDYNVMVMELLGPS-----LEDLFNFCSRKFSLKTVLLLADQMIS 114
Query: 696 GVEYLHSLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGK------YSVET 746
+EY+HS ++FIHRD+KP N L+ + DFGL K D + Y
Sbjct: 115 RIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENK 171
Query: 747 RLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV--TWFR 804
L GT Y + + + D+ + G VLM G + +
Sbjct: 172 NLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK 231
Query: 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVL 859
++ E + K A C + +PD + +
Sbjct: 232 KMSTPIEVLCKGYPSEF-------------ATYLNFCRSLRFDDKPDYSYLRQLF 273
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 4e-44
Identities = 60/289 (20%), Positives = 104/289 (35%), Gaps = 23/289 (7%)
Query: 580 TDNFSEANILGRGGFGVVYGGE--LPDGTKIAVKRMESNTMGNKGLSEFQAEIAV---LT 634
+ +G G +G V+ G +A+KR+ T E+AV L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLE 65
Query: 635 KVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTP-LTWKQRVTIALDV 693
H ++V L C + + Q L + D P + + + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL 125
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
RG+++LHS +HRDLKP NIL+ + K+ADFGL + T + T
Sbjct: 126 LRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLW 180
Query: 754 YLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV----------TWF 803
Y APE T +D+++ G + E + + D+ + W
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
R V + ++ + I+ + + +L C P +R
Sbjct: 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGK--DLLLKCLTFNPAKRISA 287
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 6e-44
Identities = 55/274 (20%), Positives = 97/274 (35%), Gaps = 35/274 (12%)
Query: 588 ILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALL 645
+LG G G V K A+K + + + + E+ + + + H+V ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 71
Query: 646 GYCINGSER----LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLH 701
N L+V E + G L + D G T ++ I + ++YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRI---QDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 702 SLAQQSFIHRDLKPSNILI---GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
S + HRD+KP N+L + K+ DFG K T Y+APE
Sbjct: 129 S---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPC--YTPYYVAPE 183
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818
+ D+++ GV++ + G A R+ + + P
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYS--NHGLAISPGMKTRIRMGQYEFPNPEW 241
Query: 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
++ + V L + EP QR +
Sbjct: 242 SEVSEE---------VKMLIRNLLKTEPTQRMTI 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 159 bits (402), Expect = 6e-44
Identities = 53/290 (18%), Positives = 100/290 (34%), Gaps = 36/290 (12%)
Query: 589 LGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR-HLVALLG 646
+G G FGV++ G L + ++A+K + + + E + + +
Sbjct: 13 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 647 YCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQ 706
+ G +LV + + + D + K A + V+ +H +
Sbjct: 69 FGQEGLHNVLVIDLLGPSL-----EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---K 120
Query: 707 SFIHRDLKPSNILIGDDMR-----AKVADFGLVKNAPDG------KYSVETRLAGTFGYL 755
S ++RD+KP N LIG V DFG+VK D Y + L+GT Y+
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180
Query: 756 APEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815
+ + + D+ A G V M + G + R+ K++ P
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQ---KYERIGEKKQSTPL 237
Query: 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865
+ EE + + PD + + ++E+
Sbjct: 238 R-ELCAGFPEE-------FYKYMHYARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 56/288 (19%), Positives = 107/288 (37%), Gaps = 18/288 (6%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+NF + +G G +GVVY G +A+K++ +T S EI++L ++ H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V LL ++ LV+E++ + T + + + +G+ +
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL----TGIPLPLIKSYLFQLLQGLAF 117
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
HS +HRDLKP N+LI + K+ADFGL + + + +
Sbjct: 118 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 760 AATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV-----TWFRRVLISKENIP 814
+T +D+++ G + E +T R D+ + T V ++P
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 815 KAIDPNLNLDEETIESIYRVA-----ELAGHCTAREPQQRPDMGHAVN 857
+ + L +P +R A+
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-43
Identities = 57/296 (19%), Positives = 115/296 (38%), Gaps = 24/296 (8%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V ++ + +G G +G+V + + ++A+K++ EI +L + R
Sbjct: 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFR 64
Query: 638 HRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGV 697
H +++ + + + Y+ + L++ L+ + RG+
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGL 122
Query: 698 EYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGK--YSVETRLAGTFGYL 755
+Y+HS + +HRDLKPSN+L+ K+ DFGL + A T T Y
Sbjct: 123 KYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 756 APEYAATGRVTT-KIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814
APE + T ID+++ G +L E ++ R D+ + + S+E++
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG-SPSQEDLN 238
Query: 815 KAIDPNLNLDEETIESIYRV-------------AELAGHCTAREPQQRPDMGHAVN 857
I+ ++ +V +L P +R ++ A+
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 6e-42
Identities = 62/289 (21%), Positives = 108/289 (37%), Gaps = 36/289 (12%)
Query: 575 VLRQ--VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNK----GLSEFQ 627
V RQ V D + LG G F VV E G + A K ++ + + +
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 628 AEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRV 687
E+++L +++H +++ L N ++ +L+ E + G L L E LT ++
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE-----SLTEEEAT 116
Query: 688 TIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD----MRAKVADFGLVKNAPDGKYS 743
+ GV YLHS H DLKP NI++ D R K+ DFGL G
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEF 173
Query: 744 VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWF 803
+ GT ++APE + + D+++ GV+ ++G +
Sbjct: 174 --KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------TL 225
Query: 804 RRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDM 852
V N + + ++P++R +
Sbjct: 226 ANVSAVNYEFEDEYFSNTSAL---------AKDFIRRLLVKDPKKRMTI 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (381), Expect = 2e-41
Identities = 59/279 (21%), Positives = 95/279 (34%), Gaps = 44/279 (15%)
Query: 588 ILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKG----LSEFQAEIAVLTKVRHRH-- 640
+LG GGFG VY G + D +A+K +E + + + G + E+ +L KV
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 641 LVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYL 700
++ LL + +L+ E L + + V V +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHC 126
Query: 701 HSLAQQSFIHRDLKPSNILI-GDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
H+ +HRD+K NILI + K+ DFG D Y T GT Y PE+
Sbjct: 127 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEW 180
Query: 760 AATGRVTTK-IDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818
R + V++ G++L + + G + R + + +
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV------------FFRQRVS 228
Query: 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
L C A P RP N
Sbjct: 229 SEC-------------QHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-41
Identities = 66/277 (23%), Positives = 105/277 (37%), Gaps = 30/277 (10%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNK-GLSEFQAEIAVLTKVRH 638
++F +LG+G FG V G A+K + + K ++ E VL RH
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
L AL V EY G L HL T ++ ++ +E
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER-----VFTEERARFYGAEIVSALE 119
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLHS + ++RD+K N+++ D K+ DFGL K ++ GT YLAPE
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM-KTFCGTPEYLAPE 175
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818
+D + GVV+ E + GR + + F +L+ + P+ +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEIRFPRTLS 229
Query: 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHA 855
P L ++P+QR G +
Sbjct: 230 PEA-------------KSLLAGLLKKDPKQRLGGGPS 253
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 5e-41
Identities = 58/299 (19%), Positives = 103/299 (34%), Gaps = 30/299 (10%)
Query: 577 RQVTDNFSEANILGRGGFGVVYGGELPD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTK 635
R ++++ ++G G FGVVY +L D G +A+K++ + E+ ++ K
Sbjct: 16 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV------LQDKRFKNRELQIMRK 69
Query: 636 VRHRHLVALLGYCINGSER------LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTI 689
+ H ++V L + + E+ LV +Y+P + + L
Sbjct: 70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVKLY 127
Query: 690 ALDVARGVEYLHSLAQQSFIHRDLKPSNI-LIGDDMRAKVADFGLVKNAPDGKYSVETRL 748
+ R + Y+HS HRD+KP N+ L D K+ DFG K G+ + +
Sbjct: 128 MYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVSYI 183
Query: 749 AGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV-------- 800
+ T+ IDV++ G VL E + G+ D+ +
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 801 -TWFRRVLISKENIPKAIDPNLNLDEETIESIYRVA-ELAGHCTAREPQQRPDMGHAVN 857
R + + + A L P R A
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 8e-41
Identities = 61/285 (21%), Positives = 104/285 (36%), Gaps = 23/285 (8%)
Query: 587 NILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKG---LSEFQAEIAVLTKVRHRHLV 642
+ LG G F VY +A+K+++ EI +L ++ H +++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 643 ALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHS 702
LL + S LV+++M LT L +G+EYLH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLE-----VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 703 LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT 762
+HRDLKP+N+L+ ++ K+ADFGL K+ T T Y APE
Sbjct: 119 ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFG 174
Query: 763 GRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT---------WFRRVLISKEN 812
R+ +D++A G +L E + L D+ + + + +
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234
Query: 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
+ P + L + + +L P R A+
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 51/289 (17%), Positives = 106/289 (36%), Gaps = 20/289 (6%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ + +G G +G V+ + +A+KR+ + S EI +L +++H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 640 HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEY 699
++V L + + LV+E+ + +G + + + +G+ +
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYF---DSCNGDLD--PEIVKSFLFQLLKGLGF 116
Query: 700 LHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEY 759
H ++ +HRDLKP N+LI + K+A+FGL + + +
Sbjct: 117 CH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173
Query: 760 AATGRVTTKIDVYAFGVVLMETITGRKAL------DDTMPDDRAHLVTWFRRVLISKENI 813
+T ID+++ G + E + L DD + L T S +
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233
Query: 814 PKAIDPNLNLDEETIESIYRVA-----ELAGHCTAREPQQRPDMGHAVN 857
P + ++ ++ +L + P QR A+
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 58/303 (19%), Positives = 107/303 (35%), Gaps = 34/303 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHR 639
+ + +G+G FG V+ G K+A+K++ EI +L ++H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 640 HLVALLGYCINGSER--------LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
++V L+ C + LV+++ + T + +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA-----GLLSNVLVKFTLSEIKRVMQ 124
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK---NAPDGKYSVETRL 748
+ G L+ + + +HRD+K +N+LI D K+ADFGL + A + + + T
Sbjct: 125 MLLNG---LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181
Query: 749 AGTFGYLAPEYAATGR-VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT------ 801
T Y PE R ID++ G ++ E T + + L++
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241
Query: 802 -------WFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGH 854
L K + K + + +L +P QR D
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301
Query: 855 AVN 857
A+N
Sbjct: 302 ALN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (360), Expect = 9e-38
Identities = 63/272 (23%), Positives = 96/272 (35%), Gaps = 33/272 (12%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGN-KGLSEFQAEIAVLTKVRH 638
D F LG G FG V + G A+K ++ + K + E +L V
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
LV L + S +V EY+ G + HL + A + E
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFE 155
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPE 758
YLHS I+RDLKP N+LI +V DFG K +++ GT LAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC----GTPEALAPE 208
Query: 759 YAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818
+ +D +A GV++ E G P + +++ K P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGKVRFPSHFS 262
Query: 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRP 850
+L +L + + +R
Sbjct: 263 SDLK-------------DLLRNLLQVDLTKRF 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 2e-37
Identities = 57/299 (19%), Positives = 111/299 (37%), Gaps = 32/299 (10%)
Query: 578 QVTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV 636
+V + + +G G +G V + G K+A+K++ E+ +L +
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74
Query: 637 RHRHLVALLGYCINGS------ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIA 690
RH +++ LL + LV +M L + H L + +
Sbjct: 75 RHENVIGLLDVFTPDETLDDFTDFYLVMPFMG-----TDLGKLMKHE--KLGEDRIQFLV 127
Query: 691 LDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
+ +G+ Y+H+ IHRDLKP N+ + +D K+ DFGL + D + + +
Sbjct: 128 YQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQ-ADSEMT--GYVVT 181
Query: 751 TFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL--- 807
+ R T +D+++ G ++ E ITG+ + D+ +
Sbjct: 182 RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 241
Query: 808 ----ISKENIPKAIDPNLNLDEETIESIYRVA-----ELAGHCTAREPQQRPDMGHAVN 857
+ + + L+++ SI A L + +QR G A+
Sbjct: 242 FVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-36
Identities = 62/284 (21%), Positives = 109/284 (38%), Gaps = 32/284 (11%)
Query: 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTMGN--KGLSEFQAEIAVLT 634
+NF +LG G +G V+ G A+K ++ T+ K + E VL
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 635 KVRHR-HLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDV 693
+R LV L ++ L+ +Y+ G L HL + T + ++
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEI 138
Query: 694 ARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFG 753
+E+LH + I+RD+K NIL+ + + DFGL K + GT
Sbjct: 139 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 754 YLAPEYAATGR--VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811
Y+AP+ G +D ++ GV++ E +TG + + RR+L S+
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEP 253
Query: 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHA 855
P+ + +L ++P++R G
Sbjct: 254 PYPQEMSALA-------------KDLIQRLLMKDPKKRLGCGPR 284
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-34
Identities = 58/309 (18%), Positives = 104/309 (33%), Gaps = 43/309 (13%)
Query: 579 VTDNFSEANILGRGGFGVVYGG-ELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V + +G G G+V + +A+K++ E+ ++ V
Sbjct: 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74
Query: 638 HRHLVALLGYCI------NGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIAL 691
H+++++LL + LV E M E ++ +
Sbjct: 75 HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--------DHERMSYLLY 126
Query: 692 DVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGT 751
+ G+++LHS IHRDLKPSNI++ D K+ DFGL + A T T
Sbjct: 127 QMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVT 181
Query: 752 FGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR----------------KALDDTMPDD 795
Y APE +D+++ G ++ E + + + L P+
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 796 RAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVA-------ELAGHCTAREPQQ 848
L R + ++ P L D +L +P +
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 849 RPDMGHAVN 857
R + A+
Sbjct: 302 RISVDDALQ 310
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (321), Expect = 1e-32
Identities = 58/293 (19%), Positives = 107/293 (36%), Gaps = 22/293 (7%)
Query: 579 VTDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR 637
V + + + +G G +G V G ++AVK++ E+ +L ++
Sbjct: 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 75
Query: 638 HRHLVALLGYCING-SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H +++ LL S Y+ + L LT + + RG
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRG 133
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYLA 756
++Y+HS IHRDLKPSN+ + +D K+ DFGL A + +A +
Sbjct: 134 LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL---ARHTDDEMTGYVATRWYRAP 187
Query: 757 PEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV----------TWFRRV 806
+D+++ G ++ E +TGR T D+ L+ +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 247
Query: 807 LISKENIPKAI--DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857
S N +++ P +N I + +L + +R A+
Sbjct: 248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 2e-32
Identities = 54/297 (18%), Positives = 105/297 (35%), Gaps = 43/297 (14%)
Query: 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-H 638
D++ LGRG + V+ + + K+ VK ++ + + EI +L +R
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK-----KKIKREIKILENLRGG 89
Query: 639 RHLVALLGYCINGSERL--LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
+++ L + R LV+E++ Q Y LT ++ +
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQL--------YQTLTDYDIRFYMYEILKA 141
Query: 697 VEYLHSLAQQSFIHRDLKPSNILIG-DDMRAKVADFGLVKNAPDGKYSVETRLAGTFGYL 755
++Y HS +HRD+KP N++I + + ++ D+GL + G+ + +
Sbjct: 142 LDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFK 196
Query: 756 APEYAATGR-VTTKIDVYAFGVVLMETITGRKALD------DTMPDDRAHLVTWFRRVLI 808
PE + +D+++ G +L I ++ D + L T I
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 809 SKENIPKAIDPNLNLDEETIESIYRVA-------------ELAGHCTAREPQQRPDM 852
K NI N L + + R + + Q R
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (281), Expect = 2e-27
Identities = 40/215 (18%), Positives = 83/215 (38%), Gaps = 27/215 (12%)
Query: 589 LGRGGFGVVY-GGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH--------- 638
LG G F V+ ++ + T +A+K + + + + + EI +L +V
Sbjct: 21 LGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDSM 77
Query: 639 --RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARG 696
H++ LL + + + + L + + + I+ + G
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 697 VEYLHSLAQQSFIHRDLKPSNILI------GDDMRAKVADFGLVKNAPDGKYSVETRLAG 750
++Y+H + IH D+KP N+L+ + ++ K+AD G + +
Sbjct: 138 LDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----Q 191
Query: 751 TFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR 785
T Y +PE D+++ ++ E ITG
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 101 bits (252), Expect = 4e-24
Identities = 58/300 (19%), Positives = 107/300 (35%), Gaps = 13/300 (4%)
Query: 27 DDGSVMLKLAQSLQNLP--SDWSSTSSTGYCEWTGINCDNSN---RVTTISLAKSGLSG- 80
D +L++ + L N S W T+ W G+ CD RV + L+ L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 81 -TLSPEISSLTQLE--TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLT 137
+ +++L L + N + P++A T L +Y+ + N + +
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 138 NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYN 197
L L S N P ++ +L + D I G IPD + SFS L
Sbjct: 126 TLVTLDFSYNAL--SGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 198 NFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKC 257
N + + + + +++ L KN + +
Sbjct: 184 NRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLS 243
Query: 258 ESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFP--SKVQKVSLDHNNF 315
++L L LR+N++ G +P + L L ++++ N L G P + + +N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 74.4 bits (181), Expect = 6e-15
Identities = 69/312 (22%), Positives = 112/312 (35%), Gaps = 31/312 (9%)
Query: 143 SLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG- 201
L + L+ W +T N G++ D + NL LS N
Sbjct: 17 DLGNPTTLSSW------LPTTDCC-----NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 202 -SLPASFAK-SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCES 259
+P+S A + L++ + ++ +TQL +++ +G IPD
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 260 -LFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKN 318
L L N L+G +P S+ SLP L+ I+ N++ G + S L +
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGA--IPDSYGSFSKLFTSMTISR 183
Query: 319 SSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKL 378
+ L L+ N +G V + K
Sbjct: 184 NR------------LTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 379 LAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNV 438
+L L L+ N + G +P GLT+L L +L+VS NNL G++P G+
Sbjct: 232 SLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQ 291
Query: 439 KFTVS--PGNPF 448
+F VS N
Sbjct: 292 RFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.3 bits (134), Expect = 5e-09
Identities = 36/110 (32%), Positives = 50/110 (45%), Gaps = 9/110 (8%)
Query: 326 CDP-QVTTLLQIAGDMGYPAILSDSWEGNNACDG-WPFVTCSQ----GRIITINLANKLL 379
C+P LLQI D+G P LS + C+ W V C R+ ++L+ L
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNL 62
Query: 380 AGN--ISPAYANLTSLKNLYLQQN-NLTGPIPDGLTKLASLQNLDVSNNN 426
I + ANL L LY+ NL GPIP + KL L L +++ N
Sbjct: 63 PKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTN 112
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 16/59 (27%), Positives = 23/59 (38%), Gaps = 4/59 (6%)
Query: 100 NNIAGAIP-SLANATSLQDIYLDNNNFT-SVPTGCFDGLTNLQVLSLSDNPNLAPWPFP 156
N I G +P L L + + NN +P G L V + ++N L P P
Sbjct: 254 NRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG--NLQRFDVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.8 bits (99), Expect = 1e-04
Identities = 11/51 (21%), Positives = 17/51 (33%), Gaps = 1/51 (1%)
Query: 154 PFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
P LT+ L +L + N+ G IP + + N P
Sbjct: 259 TLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 42.4 bits (98), Expect = 2e-04
Identities = 31/212 (14%), Positives = 54/212 (25%), Gaps = 28/212 (13%)
Query: 46 WSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGA 105
S + + + I+ + +SG + S ++L T N
Sbjct: 129 TLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188
Query: 106 IPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSL 165
A + N G +LA L+K+ +
Sbjct: 189 KIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG 248
Query: 166 TTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLS 225
L N I+G +P L +L +S+NN G +P
Sbjct: 249 LDLR--NNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP--------------------- 285
Query: 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKC 257
+ + N+ P L C
Sbjct: 286 ----QGGNLQRFDVSAYANNKCLCGSP-LPAC 312
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.2 bits (241), Expect = 1e-23
Identities = 23/155 (14%), Positives = 44/155 (28%), Gaps = 20/155 (12%)
Query: 587 NILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNK--------GLSEFQAEIAVLTKVRH 638
++G G V+ + VK + K G F +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 639 RHLVALLGYCINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVE 698
R L L G + VY + + L + + + + + V
Sbjct: 66 RALQKLQGLAVPK-----VYAWE-GNAVLMELIDAKELYRVRVENPDE--VLDMILEEVA 117
Query: 699 YLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733
+ + +H DL N+L+ + + DF
Sbjct: 118 KFY---HRGIVHGDLSQYNVLV-SEEGIWIIDFPQ 148
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.4 bits (241), Expect = 4e-22
Identities = 67/382 (17%), Positives = 122/382 (31%), Gaps = 44/382 (11%)
Query: 63 DNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDN 122
L K+ ++ T+S + L Q+ TL I +I + +L I N
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSN 75
Query: 123 NNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDF 182
N T + LT L + +++N P N +
Sbjct: 76 NQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTN 133
Query: 183 FDSFSNLQNL--------RLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234
+ N L+ + NL ++ S + +S +
Sbjct: 134 LNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVL 193
Query: 235 TQLRQVW---LHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+L + NQ + P +L +LSL NQL ++ SL L ++ L N
Sbjct: 194 AKLTNLESLIATNNQISDITPL-GILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 292 NKLQGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
N++ PL +K+ ++ L N I+ G A+ +
Sbjct: 251 NQISNLAPLSGLTKLTELKLGANQISN------------------ISPLAGLTALTNLEL 292
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410
N D P + + L ++ ++LT L+ L+ N ++
Sbjct: 293 NENQLEDISPISNLKN--LTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVSDV--SS 346
Query: 411 LTKLASLQNLDVSNNNLSGKVP 432
L L ++ L +N +S P
Sbjct: 347 LANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 64.3 bits (155), Expect = 2e-11
Identities = 23/104 (22%), Positives = 45/104 (43%), Gaps = 5/104 (4%)
Query: 44 SDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIA 103
+ ++ N +T ++L + +S +SSLT+L+ L F N ++
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISD--ISPVSSLTKLQRLFFANNKVS 342
Query: 104 GAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+ SLAN T++ + +N + + LT + L L+D
Sbjct: 343 D-VSSLANLTNINWLSAGHNQISDLT--PLANLTRITQLGLNDQ 383
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 93.2 bits (230), Expect = 3e-21
Identities = 48/321 (14%), Positives = 97/321 (30%), Gaps = 52/321 (16%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
L+ + + VP + +L L +N + + +L TL + N
Sbjct: 11 HLRVVQCSDLGLEKVPKDLP---PDTALLDLQNN-KITEIK-DGDFKNLKNLHTLILINN 65
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSG 233
I + P F L+ L LS N LP K+
Sbjct: 66 KISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPKT----------------------- 101
Query: 234 MTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
+ +LR + + + + +L + +G+ + + L I + +
Sbjct: 102 LQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 161
Query: 294 LQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353
+ P + ++ LD N K + + G + N
Sbjct: 162 ITTIPQGLPPSLTELHLDGNKITKVDAAS----------------LKGLNNLAKLGLSFN 205
Query: 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG------PI 407
+ + + ++L N L A+ ++ +YL NN++
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 408 PDGLTKLASLQNLDVSNNNLS 428
P TK AS + + +N +
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 2e-16
Identities = 43/290 (14%), Positives = 77/290 (26%), Gaps = 63/290 (21%)
Query: 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANAT 113
C + C + + + L L Q N I N
Sbjct: 10 CHLRVVQCSD-LGLEKVP---KDLP----------PDTALLDLQNNKITEIKDGDFKNLK 55
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP-------------------NLAPWP 154
+L + L NN + + G F L L+ L LS N N
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 155 FPNELTKSTSLTTLYMDNANI--FGLIPDFFDSFSNL---------------------QN 191
+ + + + + G+ F L
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTE 175
Query: 192 LRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI 251
L L N T AS + + L+ LR++ L+ N+
Sbjct: 176 LHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVP 235
Query: 252 PDLSKCESLFDLSLRDNQLTGV------VPASVISLPALLNISLQNNKLQ 295
L+ + + + L +N ++ + P + +SL +N +Q
Sbjct: 236 GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 57.0 bits (136), Expect = 3e-09
Identities = 34/201 (16%), Positives = 67/201 (33%), Gaps = 18/201 (8%)
Query: 235 TQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNK 293
+ L N+ T D ++L L L +N+++ + P + L L + L N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 294 LQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGN 353
L+ P +Q++ + N K + + ++
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKS--------------VFNGLNQMIVVELGTNPL 136
Query: 354 NACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTK 413
+ ++ I +A+ + I SL L+L N +T L
Sbjct: 137 KSSGIENGAFQGMKKLSYIRIADTNI-TTIPQG--LPPSLTELHLDGNKITKVDAASLKG 193
Query: 414 LASLQNLDVSNNNLSGKVPDF 434
L +L L +S N++S
Sbjct: 194 LNNLAKLGLSFNSISAVDNGS 214
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 31/216 (14%), Positives = 71/216 (32%), Gaps = 25/216 (11%)
Query: 76 SGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDG 135
+ + ++ ++ + +E + + + + L I + + N T++P G
Sbjct: 113 TKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLP-- 170
Query: 136 LTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLS 195
+L L L N L +L L + +I + + +L+ L L+
Sbjct: 171 -PSLTELHLDGNKIT--KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLN 227
Query: 196 YNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLS 255
N IQ +++++ + + N F P +
Sbjct: 228 NNKLVKVPGGLADHKYIQVVYLHNNNI-----------------SAIGSNDFCPPGY-NT 269
Query: 256 KCESLFDLSLRDNQLT--GVVPASVISLPALLNISL 289
K S +SL N + + P++ + + L
Sbjct: 270 KKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 45.4 bits (106), Expect = 2e-05
Identities = 26/148 (17%), Positives = 48/148 (32%), Gaps = 6/148 (4%)
Query: 53 GYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANA 112
T I +T + L + ++ + + L L L N+I+
Sbjct: 158 ADTNITTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLAN 217
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPF--PNELTKSTSLTTL 168
T NNN G +QV+ L +N + F P TK S + +
Sbjct: 218 TPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 277
Query: 169 YMDNANI--FGLIPDFFDSFSNLQNLRL 194
+ + + + + P F ++L
Sbjct: 278 SLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (177), Expect = 2e-14
Identities = 46/318 (14%), Positives = 82/318 (25%), Gaps = 67/318 (21%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ Q I+L N + VP F NL + + LA + DN
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTI-LWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
A + + P F L L L Q L +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGL-------------QELGPGLFR----------- 126
Query: 233 GMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
G+ L+ ++L N D +L L L N+++ V + L +L + L
Sbjct: 127 GLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 292 NKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
N++ +P +
Sbjct: 187 NRVAHVHPH--------AFRDLGRLMT-----------------------------LYLF 209
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
NN + + L + + L+ + + +P
Sbjct: 210 ANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARP-LWAWLQKFRGSSSEVPCSLPQ-- 266
Query: 412 TKLASLQNLDVSNNNLSG 429
+LA ++ N+L G
Sbjct: 267 -RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (175), Expect = 3e-14
Identities = 47/280 (16%), Positives = 81/280 (28%), Gaps = 34/280 (12%)
Query: 46 WSSTSSTGYCEWTG---INCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNI 102
++ T C G + I L + +S + + L L N +
Sbjct: 9 YNEPKVTTSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL 68
Query: 103 AGAIP--------------------------SLANATSLQDIYLDNNNFTSVPTGCFDGL 136
A + L ++LD + G F GL
Sbjct: 69 ARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGL 128
Query: 137 TNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSY 196
LQ L L DN L P + +LT L++ I + F +L L L
Sbjct: 129 AALQYLYLQDN-ALQALP-DDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186
Query: 197 NNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSK 256
N P +F + + L+ + L+ + L+ N +
Sbjct: 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL 246
Query: 257 CESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296
L +++ +P + L ++ N LQG
Sbjct: 247 WAWLQKFRGSSSEVPCSLPQRLAGRD-LKRLA--ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 0.001
Identities = 25/172 (14%), Positives = 52/172 (30%), Gaps = 12/172 (6%)
Query: 263 LSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDA 322
+ L N+++ V AS + L + L +N L + + + +
Sbjct: 37 IFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV 96
Query: 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN 382
+ L + D L A + ++ + L
Sbjct: 97 DPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNA------------LQAL 144
Query: 383 ISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434
+ +L +L +L+L N ++ L SL L + N ++ P
Sbjct: 145 PDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHA 196
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 63.9 bits (154), Expect = 6e-12
Identities = 30/216 (13%), Positives = 66/216 (30%), Gaps = 18/216 (8%)
Query: 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDN 147
+L ++ +N+ + + A+ + + T++ L NL L L DN
Sbjct: 17 ALANAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDN 73
Query: 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207
P N + + + G
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 208 AKSDIQNLWM------------NDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLS 255
D+ + L L+ +++L + N+ + I L+
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLA 192
Query: 256 KCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+L ++ L++NQ++ V P + + L ++L N
Sbjct: 193 SLPNLIEVHLKNNQISDVSPLA--NTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 53.9 bits (128), Expect = 2e-08
Identities = 37/257 (14%), Positives = 75/257 (29%), Gaps = 38/257 (14%)
Query: 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDV 230
I + PD + +N + +N T ++
Sbjct: 5 QPTAINVIFPD--PALANAIKIAAGKSNVTDTVT-------------------------- 36
Query: 231 LSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290
+ + + + T I + +L L L+DNQ+T + P ++ L +S
Sbjct: 37 QADLDGITTLSAFGTGVTT-IEGVQYLNNLIGLELKDNQITDLAPLKNLTKITELELSGN 95
Query: 291 NNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSW 350
K S + + + L + + L+
Sbjct: 96 PLKNVSAIAGLQSIKT----LDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLT 151
Query: 351 EGNNACDGWPFVTCSQGRIITINLANKLLAGN-IS--PAYANLTSLKNLYLQQNNLTGPI 407
G V+ L N IS A+L +L ++L+ N ++
Sbjct: 152 NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVS 211
Query: 408 PDGLTKLASLQNLDVSN 424
P L ++L + ++N
Sbjct: 212 P--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 48.1 bits (113), Expect = 1e-06
Identities = 17/63 (26%), Positives = 35/63 (55%), Gaps = 3/63 (4%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLS 143
+++L++L TL N I+ I LA+ +L +++L NN + V +NL +++
Sbjct: 167 TPLANLSKLTTLKADDNKISD-ISPLASLPNLIEVHLKNNQISDVS--PLANTSNLFIVT 223
Query: 144 LSD 146
L++
Sbjct: 224 LTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 3e-06
Identities = 36/201 (17%), Positives = 72/201 (35%), Gaps = 6/201 (2%)
Query: 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNN 292
+ ++ K+ T + + + + LS +T + V L L+ + L++N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDN 73
Query: 293 KL-QGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
++ +K+ ++ L N S+ AG + D+ A LS+
Sbjct: 74 QITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQV 133
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGL 411
+ ++ G L+ + ANL+ L L N ++ P L
Sbjct: 134 LYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--L 191
Query: 412 TKLASLQNLDVSNNNLSGKVP 432
L +L + + NN +S P
Sbjct: 192 ASLPNLIEVHLKNNQISDVSP 212
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (155), Expect = 7e-12
Identities = 33/212 (15%), Positives = 61/212 (28%), Gaps = 9/212 (4%)
Query: 85 EISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSL 144
E+S + ++ N+ A+P ++L N + T L L+L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPP-DLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
L L +L + ++ L + +N T
Sbjct: 63 D-RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVS----FNRLTSLPL 117
Query: 205 ASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDL 263
+ + +L+ +L ++ L N T L+ E+L L
Sbjct: 118 GALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTL 177
Query: 264 SLRDNQLTGVVPASVISLPALLNISLQNNKLQ 295
L++N L +P L L N
Sbjct: 178 LLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.5 bits (132), Expect = 7e-09
Identities = 38/204 (18%), Positives = 63/204 (30%), Gaps = 11/204 (5%)
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
S + +V K T PDL K L L +N L A+++ L ++L
Sbjct: 7 SKVASHLEVNCDKRNLTALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 292 NKLQGPYP--------LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343
+L ++ + T L + G
Sbjct: 65 AELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 344 AILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403
+ +GN P + ++ ++LAN L + L +L L LQ+N+L
Sbjct: 125 ELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL 184
Query: 404 TGPIPDGLTKLASLQNLDVSNNNL 427
IP G L + N
Sbjct: 185 Y-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 5e-10
Identities = 35/251 (13%), Positives = 74/251 (29%), Gaps = 9/251 (3%)
Query: 190 QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFT- 248
Q L L+ N + + + + L +++ + L +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCP--RSFMDQPLAEHFSPFRVQHMDLSNSVIEV 60
Query: 249 -GPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQK 307
LS+C L +LSL +L+ + ++ L+ ++L + L
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 308 VSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQG 367
LD N K + + LS + D V
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVA----VAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPN 176
Query: 368 RIITINLANKLLAGNISPAYANLTSLKNLYLQQ-NNLTGPIPDGLTKLASLQNLDVSNNN 426
+ + +L + + L L++L L + ++ L ++ +L+ L V
Sbjct: 177 LVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIV 236
Query: 427 LSGKVPDFGSN 437
G +
Sbjct: 237 PDGTLQLLKEA 247
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.9 bits (107), Expect = 1e-05
Identities = 40/271 (14%), Positives = 79/271 (29%), Gaps = 21/271 (7%)
Query: 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFT-S 127
T+ L L ++ + S + + + + + +Q + L N+ S
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVS 61
Query: 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187
G + LQ LSL P N L K+++L L + + F S
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPI--VNTLAKNSNLVRLNLSGCSGFSEFA-LQTLLS 118
Query: 188 NLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLH---- 243
+ L ++ + + ++ QL LSG L V
Sbjct: 119 SCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178
Query: 244 -------KNQFTGPIPDLSKCESLFDLSLRD-NQLTGVVPASVISLPALLNISLQNNKLQ 295
+ + L LSL + + +P L + +
Sbjct: 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPD 238
Query: 296 GPYPLFPSKVQKVSLDHNNFCKNSSDAGKPC 326
G L + + ++ C + + +P
Sbjct: 239 GTLQLLKEALPHLQIN----CSHFTTIARPT 265
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 4e-05
Identities = 26/108 (24%), Positives = 44/108 (40%), Gaps = 8/108 (7%)
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
D+ + F L LQ LSLS ++ EL + +L TL +FG+
Sbjct: 182 LSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDI-IPETLLELGEIPTLKTL-----QVFGI 235
Query: 179 IPD--FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224
+PD L +L+++ ++FT + Q +W +L L
Sbjct: 236 VPDGTLQLLKEALPHLQINCSHFTTIARPTIGNKKNQEIWGIKCRLTL 283
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 54.6 bits (130), Expect = 6e-09
Identities = 33/194 (17%), Positives = 63/194 (32%), Gaps = 6/194 (3%)
Query: 232 SGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ + L K T + ++ S+ + ++ + V LP + + L
Sbjct: 21 DAFAETIKDNLKKKSVTDAVT-QNELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 292 NKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWE 351
NKL PL K N K+ S + +L + E
Sbjct: 78 NKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLE 137
Query: 352 GNNACDGWPFVTCSQGRIITINLANKLLAGNIS-PAYANLTSLKNLYLQQNNLTGPIPDG 410
+ R+ ++ + A LT L+NLYL +N+++
Sbjct: 138 SLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD--LRA 195
Query: 411 LTKLASLQNLDVSN 424
L L +L L++ +
Sbjct: 196 LAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.6 bits (117), Expect = 3e-07
Identities = 31/206 (15%), Positives = 63/206 (30%), Gaps = 18/206 (8%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
+ + + + ++ A+ + S+ I +N++ SV L N+ L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAV-TQNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNG 77
Query: 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS 206
N L L L ++ L +L++ +S N LP
Sbjct: 78 N-KLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 207 FAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLR 266
+ N + ++ I L+ L +L L
Sbjct: 137 ESLYLGNNKITDITV----------LSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLS 186
Query: 267 DNQLTGVVPASVISLPAL--LNISLQ 290
N ++ + ++ L L L + Q
Sbjct: 187 KNHISDL--RALAGLKNLDVLELFSQ 210
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 33/191 (17%), Positives = 62/191 (32%), Gaps = 9/191 (4%)
Query: 250 PIPDL---SKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKV 305
PI + +L+ +T V + L ++ I N+ ++ + + V
Sbjct: 13 PIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQYLPNV 70
Query: 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCS 365
K+ L+ N A + D+ L + +G +
Sbjct: 71 TKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGL 130
Query: 366 QGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNN 425
+L + LT L L L+ N ++ +P L L LQNL +S N
Sbjct: 131 VHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSKN 188
Query: 426 NLSGKVPDFGS 436
++S +
Sbjct: 189 HISD-LRALAG 198
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 3e-08
Identities = 50/332 (15%), Positives = 90/332 (27%), Gaps = 47/332 (14%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
++ L+N +S+P + +L+ L S N SLT L
Sbjct: 38 RQAHELELNNLGLSSLP----ELPPHLESLVASCN----------------SLTELP--- 74
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTG-----SLPASFAKSDIQNLWMNDQQLGLSGT 227
+ +L++L + NN L S+ Q + + Q
Sbjct: 75 -----------ELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLK 123
Query: 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNI 287
+ + + + L + + E +L S+ LP L
Sbjct: 124 IIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLS 183
Query: 288 SLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
P L N P + + Y L
Sbjct: 184 LESIVAGNNILEELPELQNLPFLTTIYADNNLLKTLPDLPPSLE---ALNVRDNYLTDLP 240
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
+ + D + + + I SL+ L + N L +
Sbjct: 241 ELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-L 299
Query: 408 PDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
P L+ L S N+L+ +VP+ N+K
Sbjct: 300 PALPP---RLERLIASFNHLA-EVPELPQNLK 327
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 52.9 bits (125), Expect = 9e-08
Identities = 46/350 (13%), Positives = 94/350 (26%), Gaps = 40/350 (11%)
Query: 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPN 149
Q L ++ ++P L L+ + N+ T +P + +L+ L + +N
Sbjct: 38 RQAHELELNNLGLS-SLPELP--PHLESLVASCNSLTELP----ELPQSLKSLLVDNNNL 90
Query: 150 LAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK 209
A P L + N +L + A+
Sbjct: 91 KALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNN 150
Query: 210 SDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQ 269
+ + + + D S ++ G E L
Sbjct: 151 QLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIY 210
Query: 270 LTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329
+N L P P ++ +++ N
Sbjct: 211 --------------------ADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLD 250
Query: 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYAN 389
V+ + P + + N + + +N++N + A
Sbjct: 251 VSENIFSGLSELPPNLYYLNASSNE----IRSLCDLPPSLEELNVSN----NKLIELPAL 302
Query: 390 LTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGSNVK 439
L+ L N+L +P+ +L+ L V N L + PD +V+
Sbjct: 303 PPRLERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLR-EFPDIPESVE 347
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 20/86 (23%), Positives = 38/86 (44%), Gaps = 16/86 (18%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
SL+++ + NN +P L+ L S N +LA P +L L+++
Sbjct: 284 PSLEELNVSNNKLIELP----ALPPRLERLIASFN-HLA--EVPELP---QNLKQLHVEY 333
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNN 198
+ PD +S +++LR+ N+
Sbjct: 334 NPLREF-PDIPES---VEDLRM--NS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.9 bits (112), Expect = 3e-06
Identities = 21/100 (21%), Positives = 35/100 (35%), Gaps = 13/100 (13%)
Query: 119 YLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL 178
N ++ D +L+ L++S+N L P L L N
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNN-KLI--ELPALP---PRLERLIASF-NHLAE 318
Query: 179 IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMN 218
+P + NL+ L + YN P +++L MN
Sbjct: 319 VP---ELPQNLKQLHVEYNPLR-EFPDIPES--VEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.2 bits (92), Expect = 8e-04
Identities = 10/55 (18%), Positives = 26/55 (47%), Gaps = 4/55 (7%)
Query: 87 SSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV 141
+ +LE L N++ +P L +L+ ++++ N P + + +L++
Sbjct: 301 ALPPRLERLIASFNHL-AEVPELP--QNLKQLHVEYNPLREFPD-IPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.8 bits (91), Expect = 0.001
Identities = 20/116 (17%), Positives = 32/116 (27%), Gaps = 32/116 (27%)
Query: 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTL 228
I D +L+ L +S N LPA
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP--------------------- 303
Query: 229 DVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPAL 284
+L ++ N +P+L ++L L + N L P S+ L
Sbjct: 304 ------PRLERLIASFNHLAE-VPEL--PQNLKQLHVEYNPLRE-FPDIPESVEDL 349
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.9 bits (121), Expect = 3e-08
Identities = 16/109 (14%), Positives = 28/109 (25%), Gaps = 7/109 (6%)
Query: 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPW 153
L ++ + L + + L +N L L+ L + + A
Sbjct: 2 VLHLAHKDLTV-LCHLEQLLLVTHLDLSHNRLR----ALPPALAALRCLEVLQASDNALE 56
Query: 154 PFPNELTKSTSLTTLYMDNANIFGL-IPDFFDSFSNLQNLRLSYNNFTG 201
L L + N + S L L L N+
Sbjct: 57 NVDGV-ANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.9 bits (116), Expect = 1e-07
Identities = 24/126 (19%), Positives = 53/126 (42%), Gaps = 10/126 (7%)
Query: 167 TLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226
L++ + ++ L + + +L LS+N PA + ++ L +
Sbjct: 2 VLHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPAL---AALRCLEVLQASDNALE 56
Query: 227 TLDVLSGMTQLRQVWLHKNQFTG--PIPDLSKCESLFDLSLRDNQLTGV--VPASVIS-L 281
+D ++ + +L+++ L N+ I L C L L+L+ N L + + L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEML 116
Query: 282 PALLNI 287
P++ +I
Sbjct: 117 PSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.8 bits (113), Expect = 4e-07
Identities = 20/115 (17%), Positives = 37/115 (32%), Gaps = 6/115 (5%)
Query: 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140
T+ + L + L N + P+LA L+ + +N +V LQ
Sbjct: 11 TVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANL--PRLQ 68
Query: 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN---ANIFGLIPDFFDSFSNLQNL 192
L L +N L L L L + G+ + ++ ++
Sbjct: 69 ELLLCNN-RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 4e-04
Identities = 25/114 (21%), Positives = 45/114 (39%), Gaps = 8/114 (7%)
Query: 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLN 286
L L + + + L N+ P L+ L L DN L V + + L
Sbjct: 12 VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQELL 71
Query: 287 ISLQNNKLQGPYPLFP----SKVQKVSLDHNNFCKNSSDAGKPCD--PQVTTLL 334
L NN+LQ + P ++ ++L N+ C+ + + P V+++L
Sbjct: 72 --LCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 6e-04
Identities = 12/43 (27%), Positives = 22/43 (51%), Gaps = 2/43 (4%)
Query: 394 KNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGS 436
+ L+L +LT + L +L + +LD+S+N L P +
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAA 41
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.002
Identities = 13/47 (27%), Positives = 18/47 (38%), Gaps = 1/47 (2%)
Query: 385 PAYANLTSLKNLYLQQNNLTG-PIPDGLTKLASLQNLDVSNNNLSGK 430
ANL L+ L L N L L L L++ N+L +
Sbjct: 59 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 51.3 bits (121), Expect = 6e-08
Identities = 29/179 (16%), Positives = 53/179 (29%), Gaps = 7/179 (3%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNA 173
+ +P + L L+DN + L L +
Sbjct: 9 EGTTVDCTGRGLKEIPRDIP---LHTTELLLNDNEL-GRISSDGLFGRLPHLVKLELKRN 64
Query: 174 NIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLSGTLDVLS 232
+ G+ P+ F+ S++Q L+L N F ++ L + D Q+
Sbjct: 65 QLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQI-SCVMPGSFE 123
Query: 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291
+ L + L N F E L SL P+ V + + ++
Sbjct: 124 HLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQ-IKDLPHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 42.1 bits (97), Expect = 9e-05
Identities = 34/203 (16%), Positives = 67/203 (33%), Gaps = 18/203 (8%)
Query: 55 CEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATS 114
CE T ++C + I +I T L+ +
Sbjct: 8 CEGTTVDCTG-RGLKEI-----------PRDIPLHTTELLLNDNELGRISSDGLFGRLPH 55
Query: 115 LQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNAN 174
L + L N T + F+G +++Q L L +N L TL + +
Sbjct: 56 LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK--EISNKMFLGLHQLKTLNLYDNQ 113
Query: 175 IFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234
I ++P F+ ++L +L L+ N F + ++ ++ +N G + +
Sbjct: 114 ISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAA-RCGAPSKVRDV 172
Query: 235 TQLRQVWLHKNQFTGPIPDLSKC 257
L ++F + C
Sbjct: 173 QIKD---LPHSEFKCSSENSEGC 192
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 52.6 bits (124), Expect = 9e-08
Identities = 31/326 (9%), Positives = 69/326 (21%), Gaps = 30/326 (9%)
Query: 114 SLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMD 171
SL+ + + SV + +++ + LS N A + L
Sbjct: 9 SLKLDAITTEDEKSVFAVLLE-DDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 172 NANIFGLIPDFFDSFSNL----QNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGT 227
+ + + ++ L + + +++
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 228 LDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNI 287
L Q Q L + N+L +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 288 SLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILS 347
+Q + + D + L+
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT-----------HLGSSALA 236
Query: 348 DSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPI 407
+ + C + + + L+ L LQ N +
Sbjct: 237 IALKSWPNLRELGLNDCLLSARGAAAVVDAF-------SKLENIGLQTLRLQYNEIELDA 289
Query: 408 PDGL-----TKLASLQNLDVSNNNLS 428
L K+ L L+++ N S
Sbjct: 290 VRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.2 bits (119), Expect = 1e-07
Identities = 16/123 (13%), Positives = 40/123 (32%), Gaps = 2/123 (1%)
Query: 82 LSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV 141
L +S + + + + P L + ++ ++ + + L
Sbjct: 12 LKLIMSKRYDGSQQALDLKGL-RSDPDLVAQNIDVVLNRRSSMAATLR-IIEENIPELLS 69
Query: 142 LSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTG 201
L+LS+N + + K+ +L L + + L+ L L N+ +
Sbjct: 70 LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD 129
Query: 202 SLP 204
+
Sbjct: 130 TFR 132
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 27/159 (16%), Positives = 45/159 (28%), Gaps = 5/159 (3%)
Query: 211 DIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG----PIPD-LSKCESLFDLSL 265
DIQ+L + ++L + ++L + Q + V L T I L +L +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 266 RDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKP 325
R N+L V V+ + +Q LQ S
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDN 122
Query: 326 CDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC 364
L G + L +
Sbjct: 123 LLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPL 161
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 5e-06
Identities = 14/93 (15%), Positives = 26/93 (27%), Gaps = 6/93 (6%)
Query: 138 NLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANI----FGLIPDFFDSFSNLQNLR 193
++Q L + L+ + L + +D+ + I L L
Sbjct: 3 DIQSLDIQCE-ELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 194 LSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226
L N + +Q Q+L L
Sbjct: 62 LRSNELGDVGVHCVLQG-LQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.7 bits (111), Expect = 6e-06
Identities = 50/437 (11%), Positives = 101/437 (23%), Gaps = 49/437 (11%)
Query: 15 LLLLQLTTTSLGDDGSVMLKLAQSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLA 74
+ L + L D +L LQ + L
Sbjct: 4 IQSLDIQCEELSDAR--WAELLPLLQQC--------------------------QVVRLD 35
Query: 75 KSGLSG----TLSPEISSLTQLETLSFQMNNIAG-AIPSLANA-----TSLQDIYLDNNN 124
GL+ +S + L L+ + N + + + +Q + L N
Sbjct: 36 DCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
Query: 125 FTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFD 184
T G + + L +
Sbjct: 96 LTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSA 155
Query: 185 SFSNLQNLRLSYNNFTGSLPASF-------AKSDIQNLWMNDQQLGLSGTLDVLSGMTQL 237
+ L L S + Q L + QL
Sbjct: 156 ASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNC 215
Query: 238 RQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297
R + L D+ + + + P+S + + +
Sbjct: 216 RDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDL 275
Query: 298 YPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACD 357
+ +K L A C+ + Q+ + + + +
Sbjct: 276 CRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSV 335
Query: 358 GWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTG----PIPDGLTK 413
+ +I L + + + L+ L+L +++ + L
Sbjct: 336 LAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLA 395
Query: 414 LASLQNLDVSNNNLSGK 430
SL+ LD+SNN L
Sbjct: 396 NHSLRELDLSNNCLGDA 412
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 5e-05
Identities = 15/94 (15%), Positives = 29/94 (30%), Gaps = 11/94 (11%)
Query: 350 WEGNNACDGWPFVTCSQGRIITINLANKLL----AGNISPAYANLTSLKNLYLQQNNLTG 405
G S + + LA+ + +++ SL+ L L N L
Sbjct: 354 DAGVRELCQGLGQPGSV--LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411
Query: 406 PIPDGLTK-----LASLQNLDVSNNNLSGKVPDF 434
L + L+ L + + S ++ D
Sbjct: 412 AGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 15/90 (16%), Positives = 30/90 (33%), Gaps = 7/90 (7%)
Query: 122 NNNFTSVPTGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYMDNANI---- 175
+ + G + L+VL L+D + + L + SL L + N +
Sbjct: 354 DAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAG 413
Query: 176 -FGLIPDFFDSFSNLQNLRLSYNNFTGSLP 204
L+ L+ L L ++ +
Sbjct: 414 ILQLVESVRQPGCLLEQLVLYDIYWSEEME 443
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 12/94 (12%), Positives = 26/94 (27%), Gaps = 8/94 (8%)
Query: 114 SLQDIYLDNNNFTSVP-TGCFDGLTNLQVLSLSDNP--NLAPWPFPNELTKSTSLTTLYM 170
+Q + + + L QV+ L D + L + +L L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 171 DNANI-----FGLIPDFFDSFSNLQNLRLSYNNF 199
+ + ++ +Q L L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 18/100 (18%), Positives = 32/100 (32%), Gaps = 11/100 (11%)
Query: 65 SNRVTTISLAKSGLSGTLSPEI-SSLTQLETLSFQMNNI----AGAIPS-LANATSLQDI 118
S + ++ + LS E+ L Q + + + I S L +L ++
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 119 YLDNNNFT-----SVPTGCFDGLTNLQVLSLSDNPNLAPW 153
L +N V G +Q LSL +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAG 100
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 19/101 (18%), Positives = 39/101 (38%), Gaps = 14/101 (13%)
Query: 180 PDFFDSFSNLQNLRLSYNNFTGSLPASFAKS-----DIQNLWMNDQQLGLSGTLDVLSGM 234
S L+ L L+ + + S +S A + ++ L +++ LG +G L ++ +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 235 ----TQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLT 271
L Q+ L+ ++ + D L L L
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDR-----LQALEKDKPSLR 457
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.002
Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 17/124 (13%)
Query: 37 QSLQNLPSDWSSTSSTGYCEWTGINCDNSNRVTTISLAKSGLSGT----LSPEISSLTQL 92
+ L L + G E + + + LA +S + L+ + + L
Sbjct: 340 RFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSL 399
Query: 93 ETLSFQMNNIAGA-IPSLANA-----TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146
L N + A I L + L+ + L + ++ + LQ L D
Sbjct: 400 RELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE------EMEDRLQAL-EKD 452
Query: 147 NPNL 150
P+L
Sbjct: 453 KPSL 456
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.6 bits (111), Expect = 2e-06
Identities = 7/45 (15%), Positives = 15/45 (33%)
Query: 108 SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAP 152
A+ + + S+P+ + L L+ S + L
Sbjct: 196 VFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKKLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.4 bits (108), Expect = 5e-06
Identities = 27/208 (12%), Positives = 51/208 (24%), Gaps = 27/208 (12%)
Query: 113 TSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172
+ ++ + G F G +L+ + +S N L
Sbjct: 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 88
Query: 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232
N+ + P+ F + NLQ L +S S + L + +
Sbjct: 89 NNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSF 148
Query: 233 GMTQLRQVWL-------------------------HKNQFTGPIPD--LSKCESLFDLSL 265
V L N +P+ L +
Sbjct: 149 VGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDI 208
Query: 266 RDNQLTGVVPASVISLPALLNISLQNNK 293
++ + + +L L S N K
Sbjct: 209 SRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 23/265 (8%), Positives = 50/265 (18%), Gaps = 37/265 (13%)
Query: 164 SLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLG 223
S + + + D N LR
Sbjct: 9 SNRVFLCQESKVTEIPSDLP---RNAIELRFVLTKLRVIQK------------------- 46
Query: 224 LSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPA 283
SG L ++ + +N I +R + ++ + +
Sbjct: 47 -----GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAF-- 99
Query: 284 LLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343
L +
Sbjct: 100 --QNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI 157
Query: 344 AILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNL 403
L+ + + + + N +L + + + L + + +
Sbjct: 158 LWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL----PNDVFHGASGPVILDISRTRI 213
Query: 404 TGPIPDGLTKLASLQNLDVSNNNLS 428
GL L L+ S NL
Sbjct: 214 HSLPSYGLENLKKLRAR--STYNLK 236
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 4e-05
Identities = 9/44 (20%), Positives = 17/44 (38%), Gaps = 1/44 (2%)
Query: 384 SPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNL 427
+ Y N + L L+ + I + L +D S+N +
Sbjct: 11 AAQYTNAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEI 53
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 24/130 (18%), Positives = 46/130 (35%), Gaps = 3/130 (2%)
Query: 64 NSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN 123
N+ R + L + + ++L Q + + F N I + L+ + ++NN
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI-RKLDGFPLLRRLKTLLVNNN 73
Query: 124 NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFF 183
+ G L +L L L+ N +L + L SLT L + +
Sbjct: 74 RICRIGEGLDQALPDLTELILT-NNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRL 132
Query: 184 DSFSNLQNLR 193
+ +R
Sbjct: 133 YVIYKVPQVR 142
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (87), Expect = 0.002
Identities = 20/119 (16%), Positives = 41/119 (34%), Gaps = 5/119 (4%)
Query: 83 SPEISSLTQLETLSFQMNNIAGAIPSL-ANATSLQDIYLDNNNFTSVPTGCFDGLTNLQV 141
+ + ++ + L + I I +L A I +N + F L L+
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKT 67
Query: 142 LSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200
L +++N ++ + L ++ G + D S +L L + N T
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRNPVT 125
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.3 bits (95), Expect = 1e-04
Identities = 19/117 (16%), Positives = 38/117 (32%), Gaps = 4/117 (3%)
Query: 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNF-TSVPTGCFDGLTNLQVL 142
P+ L + ++ L A +L ++Y++N + GL L+ L
Sbjct: 2 PDACCPHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 143 SLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNF 199
++ + P + L+ L + + L S + LS N
Sbjct: 62 TIVKSGLRFVAPDAF--HFTPRLSRLNLSFNALESLSWKTVQGLSLQEL-VLSGNPL 115
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.6 bits (96), Expect = 1e-04
Identities = 27/188 (14%), Positives = 61/188 (32%), Gaps = 9/188 (4%)
Query: 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPL-FPSKVQKV 308
L++ L +T V + L + + ++ + + + + ++
Sbjct: 13 TDTALAEKMKT---VLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVEYLNNLTQI 67
Query: 309 SLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGR 368
+ +N + + D+ A L++ + + +
Sbjct: 68 NFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNL 127
Query: 369 IITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLS 428
L + A + LTSL+ L N +T P L L +L+ LD+S+N +S
Sbjct: 128 TNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVS 185
Query: 429 GKVPDFGS 436
+
Sbjct: 186 D-ISVLAK 192
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 11/37 (29%), Positives = 20/37 (54%), Gaps = 2/37 (5%)
Query: 106 IPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVL 142
+ LAN T+L+ + + +N + + LTNL+ L
Sbjct: 165 LKPLANLTTLERLDISSNKVSDIS--VLAKLTNLESL 199
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 933 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.96 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.94 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.94 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.92 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.91 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.9 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.88 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.87 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.82 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.77 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.76 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.76 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.73 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.72 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.71 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.7 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.7 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.68 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.6 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.48 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.47 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.46 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.45 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.44 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.42 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.41 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.38 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.38 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.27 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.24 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.22 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.22 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.37 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.3 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.08 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.55 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.42 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.38 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.04 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.6 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.49 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 95.67 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-50 Score=422.72 Aligned_cols=260 Identities=28% Similarity=0.468 Sum_probs=207.5
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||+||+|+.+ ..||||+++....+....++|.+|+.++++++|||||++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 467899999999999999999874 369999998776667778899999999999999999999998754 56899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.++++.. ...+++.++..|+.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 84 y~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~ 156 (276)
T d1uwha_ 84 WCEGSSLYHHLHII----ETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156 (276)
T ss_dssp CCCEEEHHHHHHTS----CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred cCCCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence 99999999999652 2469999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCc-eeecccccccCcccccccCC---CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 740 GKY-SVETRLAGTFGYLAPEYAAT---GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 740 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
... .......||+.|+|||++.+ +.|+.++|||||||++|||+||+.||....+.... ...+.. ....+.
T Consensus 157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~----~~~~p~ 230 (276)
T d1uwha_ 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGR----GYLSPD 230 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHH----TSCCCC
T ss_pred cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhc----CCCCCc
Confidence 322 23345689999999999864 35889999999999999999999999875443221 111111 111111
Q ss_pred --ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 816 --AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 816 --~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.+.... ..++.+++.+||+.||++|||++|+++.|+.+.+
T Consensus 231 ~~~~~~~~---------~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~ 272 (276)
T d1uwha_ 231 LSKVRSNC---------PKAMKRLMAECLKKKRDERPLFPQILASIELLAR 272 (276)
T ss_dssp GGGSCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred chhccccc---------hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 111111 2467899999999999999999999999988754
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-49 Score=416.61 Aligned_cols=257 Identities=27% Similarity=0.460 Sum_probs=200.7
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|++.+.||+|+||.||+|.+.+++.||||+++... ...++|.+|++++++++|||||+++|+|.+++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA---MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc---CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence 5788899999999999999998889999999997653 3346899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++|+|.+++... ...+++..++.++.|+|+||+|||+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 82 ~~~g~L~~~l~~~----~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 154 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQ----RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 154 (263)
T ss_dssp CTTCBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred cCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCC
Confidence 9999999998652 2568999999999999999999999 89999999999999999999999999999876655
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.........||+.|+|||++.+..++.++|||||||++|||+|++.|+...... ..+...+.. ... ...|.
T Consensus 155 ~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~----~~~---~~~p~ 225 (263)
T d1sm2a_ 155 QYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDIST----GFR---LYKPR 225 (263)
T ss_dssp ----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHHH----TCC---CCCCT
T ss_pred CceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHHh----cCC---CCCcc
Confidence 444445568999999999999999999999999999999999965554433221 112221111 111 11111
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.. ..++.+++.+||+.||++||+|+|+++.|+++.+
T Consensus 226 ~~--------~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LA--------STHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp TS--------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cc--------CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence 11 1357799999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-49 Score=414.66 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=206.4
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||+||+|.. .+|+.||||++..... ....+++.+|++++++++|||||++++++.+++..|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 6799999999999999999965 5799999999976532 2334679999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 84 y~~gg~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~ 155 (271)
T d1nvra_ 84 YCSGGELFDRIEP-----DIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRY 155 (271)
T ss_dssp CCTTEEGGGGSBT-----TTBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ccCCCcHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence 9999999999954 3569999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCc-eeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 740 GKY-SVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 740 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... ......+||+.|+|||++.+..+ +.++||||+||++|||+||+.||......... ... ... ...... .
T Consensus 156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~----~~~-~~~~~~-~ 228 (271)
T d1nvra_ 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD----WKE-KKTYLN-P 228 (271)
T ss_dssp TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHH----HHT-TCTTST-T
T ss_pred CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHH----Hhc-CCCCCC-c
Confidence 332 22345689999999999987776 67899999999999999999999765432221 111 111 111100 0
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.+. ...++.+++.+||+.||++|||++|+++ ++|..
T Consensus 229 ~~~---------~s~~~~~li~~~L~~dP~~R~t~~eil~------hpwf~ 264 (271)
T d1nvra_ 229 WKK---------IDSAPLALLHKILVENPSARITIPDIKK------DRWYN 264 (271)
T ss_dssp GGG---------SCHHHHHHHHHHSCSSTTTSCCHHHHTT------CTTTT
T ss_pred ccc---------CCHHHHHHHHHHcCCChhHCcCHHHHhc------CHhhC
Confidence 001 1135678999999999999999999975 77764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-48 Score=416.06 Aligned_cols=254 Identities=23% Similarity=0.383 Sum_probs=210.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++.+.||+|+||+||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG--CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEeccc--ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999964 579999999997653 2345789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++.. ..+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 98 y~~gg~L~~~~~~------~~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~ 168 (293)
T d1yhwa1 98 YLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (293)
T ss_dssp CCTTCBHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecCCCcHHHHhhc------cCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence 9999999998855 458999999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
... ......||+.|+|||++.+..++.++||||+||++|||+||+.||........ +. ...... ...-...+
T Consensus 169 ~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~----~~~~~~-~~~~~~~~ 240 (293)
T d1yhwa1 169 EQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LIATNG-TPELQNPE 240 (293)
T ss_dssp TTC-CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHHC-SCCCSSGG
T ss_pred ccc-cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HH----HHHhCC-CCCCCCcc
Confidence 332 23456899999999999999999999999999999999999999976543221 11 111111 10000111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.+ ...+.+++.+||+.||++|||++|+++ ++|..
T Consensus 241 ~~---------s~~~~~li~~~L~~dP~~R~s~~eil~------Hp~~~ 274 (293)
T d1yhwa1 241 KL---------SAIFRDFLNRCLDMDVEKRGSAKELLQ------HQFLK 274 (293)
T ss_dssp GS---------CHHHHHHHHHHTCSSTTTSCCHHHHTT------CGGGG
T ss_pred cC---------CHHHHHHHHHHccCChhHCcCHHHHhc------CHhhC
Confidence 11 245779999999999999999999975 66664
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-49 Score=414.65 Aligned_cols=257 Identities=27% Similarity=0.434 Sum_probs=210.6
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
.++|++.+.||+|+||.||+|.+++++.||||+++... ...++|.+|++++++++|||||+++|++.+ +..++|||
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS---MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS---SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc---CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 46788999999999999999999888999999997653 334689999999999999999999998754 56789999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++.... ..++++.+++.|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+....
T Consensus 88 y~~~g~L~~~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~ 161 (272)
T d1qpca_ 88 YMENGSLVDFLKTPS---GIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (272)
T ss_dssp CCTTCBHHHHTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred eCCCCcHHHHHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccC
Confidence 999999999885522 2458999999999999999999999 8999999999999999999999999999998776
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
..........||+.|+|||++.++.++.++|||||||++|||+||+.|+....... .... .... .. ......
T Consensus 162 ~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~---~i~~-~~--~~~~p~ 233 (272)
T d1qpca_ 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQ---NLER-GY--RMVRPD 233 (272)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHH---HHHT-TC--CCCCCT
T ss_pred CccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHH---HHHh-cC--CCCCcc
Confidence 65555566789999999999998999999999999999999999766655433221 1111 1111 11 111111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
.+ ..++.+++.+||+.||++||||+|++++|+...
T Consensus 234 ~~---------~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 234 NC---------PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp TC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred cC---------hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence 11 135789999999999999999999999987653
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=414.48 Aligned_cols=247 Identities=26% Similarity=0.492 Sum_probs=208.2
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||.||+|.. .+++.||+|++.+.... ....+.+.+|++++++++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999965 57899999998764322 234578899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++.+++.++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 86 Ey~~~g~L~~~l~~-----~~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~ 157 (263)
T d2j4za1 86 EYAPLGTVYRELQK-----LSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157 (263)
T ss_dssp ECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred eecCCCcHHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecC
Confidence 99999999999965 2569999999999999999999999 899999999999999999999999999998665
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+. ..........+++.
T Consensus 158 ~~~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~p~~-- 226 (263)
T d2j4za1 158 SSR---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDF-- 226 (263)
T ss_dssp CCC---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHTTCCCCCTT--
T ss_pred CCc---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHH------HHHHHcCCCCCCcc--
Confidence 433 2346899999999999999999999999999999999999999976533221 12222222222221
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+ ..++.+++.+||+.||++|||++|+++
T Consensus 227 --~---------s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 227 --V---------TEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp --S---------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred --C---------CHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence 1 135779999999999999999999986
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9.4e-49 Score=417.11 Aligned_cols=258 Identities=28% Similarity=0.422 Sum_probs=214.2
Q ss_pred hcCCccCCccccCCCeEEEEEEeC-CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP-DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||+||+|... +++.||||+++... ...++|.+|++++++++|||||+++++|.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC---SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc---chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 467889999999999999999664 68899999997653 34578999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++... ....+++..+..|+.||++||+|||+ ++|+||||||+|||+++++.+||+|||+|+...
T Consensus 93 E~~~~g~l~~~l~~~---~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (287)
T d1opja_ 93 EFMTYGNLLDYLREC---NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 166 (287)
T ss_dssp ECCTTCBHHHHHHHS---CTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCC
T ss_pred ecccCcchHHHhhhc---cccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecC
Confidence 999999999999652 23579999999999999999999999 899999999999999999999999999999776
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
...........|++.|+|||++.++.++.++|||||||++|||++|+.|+........ +... .... ......
T Consensus 167 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~~~~----i~~~--~~~~~~ 238 (287)
T d1opja_ 167 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--VYEL----LEKD--YRMERP 238 (287)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--HHHH----HHTT--CCCCCC
T ss_pred CCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--HHHH----HhcC--CCCCCC
Confidence 6555555666789999999999999999999999999999999998877655433221 1111 1111 111111
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
+.. ..++.+++.+||+.||++|||++|+++.|+.+.
T Consensus 239 ~~~---------~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~ 274 (287)
T d1opja_ 239 EGC---------PEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 274 (287)
T ss_dssp TTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred ccc---------hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence 111 235789999999999999999999999987764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-49 Score=416.25 Aligned_cols=257 Identities=18% Similarity=0.306 Sum_probs=198.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--CceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--GSERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv 657 (933)
++|++.+.||+|+||+||+|.. .+|+.||||++.....+....+.+.+|++++++++|||||++++++.+ +...|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 6899999999999999999954 579999999998876666677889999999999999999999999865 4567999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc--CCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA--QQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
|||+++|+|.+++...... ...+++.+++.++.|++.||+|||+.. ..+||||||||+|||++.++.+||+|||+++
T Consensus 84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 9999999999998653222 356999999999999999999999831 1349999999999999999999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
....... ......||+.|+|||++.+..++.++|||||||++|||+||+.||......+ +.. .+.. ...+.
T Consensus 163 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~~---~i~~--~~~~~ 233 (269)
T d2java1 163 ILNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LAG---KIRE--GKFRR 233 (269)
T ss_dssp HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH---HHHH--TCCCC
T ss_pred ecccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HHH---HHHc--CCCCC
Confidence 7654332 2345689999999999999999999999999999999999999997653322 111 1111 11111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
+...+ ..++.+++.+||+.||++|||++|+++
T Consensus 234 -~~~~~---------s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 234 -IPYRY---------SDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp -CCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -CCccc---------CHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence 11111 135779999999999999999999975
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-48 Score=403.69 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=212.9
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|++.+.||+|+||+||+|+.++++.||||+++.... ..++|.+|+.++++++|||||+++|+|.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC---CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence 57899999999999999999998888999999987533 346899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++|+|.+++... ...+++..+++++.|+++||+|||+ ++|+||||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~g~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~ 153 (258)
T d1k2pa_ 81 MANGCLLNYLREM----RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 153 (258)
T ss_dssp CTTEEHHHHHHSG----GGCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred cCCCcHHHhhhcc----ccCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence 9999999997552 2468999999999999999999999 89999999999999999999999999999876655
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDP 819 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 819 (933)
.........||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+. . ..+.. .... ..|
T Consensus 154 ~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~---~---~~i~~-~~~~---~~p 223 (258)
T d1k2pa_ 154 EYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET---A---EHIAQ-GLRL---YRP 223 (258)
T ss_dssp SCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHH---H---HHHHT-TCCC---CCC
T ss_pred CceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHH---H---HHHHh-CCCC---CCc
Confidence 5444555679999999999999999999999999999999998 7999976543221 1 11111 1111 111
Q ss_pred CCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhh
Q 002346 820 NLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGP 861 (933)
Q Consensus 820 ~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~ 861 (933)
.. ...++.+++.+||+.||++|||++++++.|.+
T Consensus 224 ~~--------~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d 257 (258)
T d1k2pa_ 224 HL--------ASEKVYTIMYSCWHEKADERPTFKILLSNILD 257 (258)
T ss_dssp TT--------CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred cc--------ccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence 11 11367899999999999999999999998754
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.8e-48 Score=414.18 Aligned_cols=258 Identities=25% Similarity=0.438 Sum_probs=199.9
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CC---cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DG---TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
++|++.+.||+|+||+||+|... ++ ..||||++.... .....++|.+|++++++++|||||+++|+|.+++..++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 56788899999999999999764 23 368999887553 44556789999999999999999999999999999999
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++|+|.+++... ...++|.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus 105 v~Ey~~~g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~ 177 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177 (299)
T ss_dssp EEECCTTEEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred EEEecCCCcceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceE
Confidence 99999999999988652 2469999999999999999999999 8999999999999999999999999999986
Q ss_pred CCCCCcee----ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 737 APDGKYSV----ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 737 ~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
........ .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+ +.. .+.. ..
T Consensus 178 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~---~i~~-~~ 250 (299)
T d1jpaa_ 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VIN---AIEQ-DY 250 (299)
T ss_dssp ------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHT-TC
T ss_pred ccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHH---HHHc-CC
Confidence 65432211 123468999999999999999999999999999999998 899997654322 221 1111 11
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
..+ ... +....+.+++.+||+.||++||+++|+++.|+++++
T Consensus 251 ~~~--~~~---------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 251 RLP--PPM---------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp CCC--CCT---------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCC--CCc---------cchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence 111 111 112457799999999999999999999999988764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-48 Score=415.97 Aligned_cols=261 Identities=20% Similarity=0.321 Sum_probs=211.6
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++.+.||+|+||+||+|.. .+|+.||||++.+... .....+.+.+|++++++++|||||++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 6799999999999999999965 5799999999976432 2344678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. .+.+++.+++.++.|++.||+|||+ ++||||||||+|||+++++.+||+|||+|+...
T Consensus 88 Ey~~gg~L~~~~~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~ 159 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK-----IGSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLS 159 (288)
T ss_dssp CCCTTEEHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EccCCCCHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecc
Confidence 99999999999865 2569999999999999999999999 899999999999999999999999999998765
Q ss_pred CCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 739 DGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 739 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... .......+||+.|+|||++.+..++.++||||+||++|||++|+.||....+.. ....+......++.
T Consensus 160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~~~~i~~~~~~~p~-- 231 (288)
T d1uu3a_ 160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL------IFQKIIKLEYDFPE-- 231 (288)
T ss_dssp ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHTTCCCCCT--
T ss_pred cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH------HHHHHHcCCCCCCc--
Confidence 432 223345689999999999999999999999999999999999999998653221 12222222222222
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.+. .++.+++.+||+.||++|||++|+++.-.-..++|..
T Consensus 232 --~~s---------~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~ 271 (288)
T d1uu3a_ 232 --KFF---------PKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 271 (288)
T ss_dssp --TCC---------HHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGT
T ss_pred --cCC---------HHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccC
Confidence 111 3577999999999999999999986543333356654
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=402.43 Aligned_cols=246 Identities=25% Similarity=0.402 Sum_probs=200.1
Q ss_pred ccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee----CceeEEEE
Q 002346 584 SEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN----GSERLLVY 658 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~ 658 (933)
+..+.||+|+||+||+|.. .+++.||+|++..........+.|.+|++++++++|||||++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 5567899999999999965 568899999998776666667889999999999999999999999865 35678999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCC--eEecCCCCCcEEec-CCCcEEEecccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQS--FIHRDLKPSNILIG-DDMRAKVADFGLVK 735 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~--ivH~Dik~~Nill~-~~~~~kl~DfGla~ 735 (933)
||+++|+|.+++.. ...+++.+++.++.||++||+|||+ ++ |+||||||+|||++ +++.+||+|||+|+
T Consensus 92 E~~~~g~L~~~l~~-----~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~ 163 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR-----FKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 163 (270)
T ss_dssp ECCCSCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred eCCCCCcHHHHHhc-----cccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence 99999999999966 2568999999999999999999998 66 99999999999996 57899999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
...... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||........ + ..... ....+.
T Consensus 164 ~~~~~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~---~~~i~--~~~~~~ 232 (270)
T d1t4ha_ 164 LKRASF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I---YRRVT--SGVKPA 232 (270)
T ss_dssp GCCTTS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H---HHHHT--TTCCCG
T ss_pred eccCCc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H---HHHHH--cCCCCc
Confidence 654432 234689999999999865 699999999999999999999999976433221 1 11111 111122
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.++... ..++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~---------~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 SFDKVA---------IPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp GGGGCC---------CHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ccCccC---------CHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence 222111 135779999999999999999999976
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=406.14 Aligned_cols=257 Identities=30% Similarity=0.465 Sum_probs=203.1
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|++.+.||+|+||.||+|...+++.||||+++.... ..+.|.+|+.++++++|||||+++|+|.+ +..++||||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey 92 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEY 92 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC---CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEe
Confidence 67999999999999999999988888999999976532 34689999999999999999999999854 567899999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++|+|..++.... ...++|.+++.++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 93 ~~~g~l~~~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 93 MSKGSLLDFLKGET---GKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp CTTCBHHHHHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred cCCCchhhhhhhcc---cccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 99999999986532 2458999999999999999999999 89999999999999999999999999999876655
Q ss_pred CceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 741 KYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
.........||+.|+|||++..+.++.++|||||||++|||+||+.|+....... .....+. . . ....+++.
T Consensus 167 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~i~---~-~--~~~~~~~~ 238 (285)
T d1fmka3 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVE---R-G--YRMPCPPE 238 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH---T-T--CCCCCCTT
T ss_pred CceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHH---h-c--CCCCCCcc
Confidence 4444455679999999999999999999999999999999999777665543221 1222111 1 1 11112222
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.. .++.+++.+||+.||++||++++|+++|+....
T Consensus 239 ~~---------~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 239 CP---------ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp SC---------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred cC---------HHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence 21 357899999999999999999999998876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-47 Score=404.31 Aligned_cols=258 Identities=23% Similarity=0.377 Sum_probs=208.4
Q ss_pred cCCccCCc-cccCCCeEEEEEEeC---CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANI-LGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~-lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l 656 (933)
++|.+.+. ||+|+||.||+|... ++..||||+++... .....++|.+|++++++++|||||+++|++.. +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 56667774 999999999999653 35579999997653 44557889999999999999999999999865 56789
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKN 736 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~ 736 (933)
||||+++|+|.+++... ...+++.++..++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++.
T Consensus 86 vmE~~~~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 158 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKA 158 (285)
T ss_dssp EEECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEeCCCCcHHHHhhcc----ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhc
Confidence 99999999999998542 2569999999999999999999999 8999999999999999999999999999987
Q ss_pred CCCCCcee--ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 737 APDGKYSV--ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 737 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
........ .....||+.|+|||++.++.++.++|||||||++|||+| |+.||......+. ... +. .+..
T Consensus 159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~---~~~---i~--~~~~ 230 (285)
T d1u59a_ 159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAF---IE--QGKR 230 (285)
T ss_dssp CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHH---HH--TTCC
T ss_pred ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHH---HHH---HH--cCCC
Confidence 66543322 234578999999999999999999999999999999998 8999986543221 111 11 1111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
++ +++.. ..++.+++.+||+.+|++||++.+|++.|+.....
T Consensus 231 ~~-~p~~~---------~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 231 ME-CPPEC---------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CC-CCTTC---------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC-CCCcC---------CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 11 11111 13577999999999999999999999998876443
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=403.68 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=199.3
Q ss_pred CccccCCCeEEEEEEeC---CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEeecCC
Q 002346 587 NILGRGGFGVVYGGELP---DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEYMPR 663 (933)
Q Consensus 587 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~ 663 (933)
+.||+|+||.||+|.+. .++.||||+++....+....++|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 47999999999999653 35689999998765555667889999999999999999999999865 457899999999
Q ss_pred CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCCCce
Q 002346 664 GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDGKYS 743 (933)
Q Consensus 664 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~~~~ 743 (933)
|+|.+++.. ...+++.++..++.||++||+|||+ ++||||||||+|||++.++.+||+|||+++........
T Consensus 92 g~L~~~l~~-----~~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 92 GPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EEHHHHHHH-----CTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred CcHHHHHhh-----ccCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 999999965 2569999999999999999999999 89999999999999999999999999999876544332
Q ss_pred e--ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccCCC
Q 002346 744 V--ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAIDPN 820 (933)
Q Consensus 744 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 820 (933)
. .....||++|+|||.+.+..++.++|||||||++|||+| |+.||......+ +...+ . .+..+ ..+..
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~~~i----~-~~~~~-~~p~~ 234 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAML----E-KGERM-GCPAG 234 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----H-TTCCC-CCCTT
T ss_pred cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HHHHH----H-cCCCC-CCCcc
Confidence 2 234579999999999999999999999999999999998 899998654322 11111 1 11111 11111
Q ss_pred CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 821 LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 821 l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
+ ..++.+++.+||+.||++||++++|++.|+..
T Consensus 235 ~---------~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 235 C---------PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp C---------CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred c---------CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence 1 24577999999999999999999999988654
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-47 Score=407.74 Aligned_cols=256 Identities=23% Similarity=0.355 Sum_probs=207.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
+.|++.+.||+|+||.||+|.. .+|+.||||++... .....+.|.+|++++++++|||||++++++.+++..++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 5689999999999999999965 57899999999765 34456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++.+. ..++++.++..++.||++||+|||+ ++|+||||||+|||++.++.+||+|||+|+....
T Consensus 90 y~~~g~L~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~ 162 (288)
T d2jfla1 90 FCAGGAVDAVMLEL----ERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR 162 (288)
T ss_dssp CCTTEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred cCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCC
Confidence 99999999998652 2469999999999999999999999 8999999999999999999999999999875433
Q ss_pred CCceeecccccccCcccccccC-----CCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAA-----TGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
.. .......||+.|+|||++. ...|+.++|||||||++|||+||+.||....+.+.. ....... .+
T Consensus 163 ~~-~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~~~~--~~ 233 (288)
T d2jfla1 163 TI-QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIAKSE--PP 233 (288)
T ss_dssp HH-HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHHHSC--CC
T ss_pred Cc-ccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH------HHHHcCC--CC
Confidence 21 1223468999999999883 456889999999999999999999999876543321 1111111 11
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
. +. .......++.+++.+||+.||++|||++|+++ ++|..
T Consensus 234 ~-----~~---~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~------hp~~~ 273 (288)
T d2jfla1 234 T-----LA---QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ------HPFVT 273 (288)
T ss_dssp C-----CS---SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT------SGGGC
T ss_pred C-----CC---ccccCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccC
Confidence 1 00 00111245779999999999999999999875 56654
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.1e-47 Score=408.68 Aligned_cols=258 Identities=26% Similarity=0.431 Sum_probs=195.8
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+.+.|++.+.||+|+||+||+|.. .+|+.||||++...... ...+.+.+|+.++++++|||||++++++.+++..|+|
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE-GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh-hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 457899999999999999999965 57899999999866432 2346788999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec---CCCcEEEeccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG---DDMRAKVADFGLV 734 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~---~~~~~kl~DfGla 734 (933)
|||+++|+|.+++.. ...+++.++..++.|++.||+|||+ ++|+||||||+||++. +++.+||+|||++
T Consensus 86 mE~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a 157 (307)
T d1a06a_ 86 MQLVSGGELFDRIVE-----KGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157 (307)
T ss_dssp ECCCCSCBHHHHHHT-----CSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---
T ss_pred EeccCCCcHHHhhhc-----ccCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEecccee
Confidence 999999999999965 2569999999999999999999999 8999999999999994 5789999999999
Q ss_pred ccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 735 KNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 735 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
+...... .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....... . ...+.......+
T Consensus 158 ~~~~~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~---~~~i~~~~~~~~ 229 (307)
T d1a06a_ 158 KMEDPGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---L---FEQILKAEYEFD 229 (307)
T ss_dssp -----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHHHTTCCCCC
T ss_pred EEccCCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---H---HHHHhccCCCCC
Confidence 8665433 2234689999999999999999999999999999999999999997653321 1 122222222222
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....+.+. ..+.+++.+||+.||++|||++|+++ ++|..
T Consensus 230 ~~~~~~~s---------~~~~~li~~~L~~dP~~R~s~~eil~------hp~~~ 268 (307)
T d1a06a_ 230 SPYWDDIS---------DSAKDFIRHLMEKDPEKRFTCEQALQ------HPWIA 268 (307)
T ss_dssp TTTTTTSC---------HHHHHHHHHHSCSSGGGSCCHHHHHH------STTTT
T ss_pred CccccCCC---------HHHHHHHHHHccCCHhHCcCHHHHhc------CHhhC
Confidence 21112222 35779999999999999999999986 67764
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-47 Score=403.13 Aligned_cols=259 Identities=24% Similarity=0.407 Sum_probs=202.1
Q ss_pred cCCccCCccccCCCeEEEEEEeCCC-----cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDG-----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
+.|+..++||+|+||.||+|.++.. ..||||++.... ......+|.+|+.++++++|||||+++|++.+....+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 4678889999999999999976432 479999997653 4455678999999999999999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+.++++.+++... ...+++.++..++.||++|++|||+ ++|+||||||+|||++.++.+||+|||+++
T Consensus 86 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~ 158 (283)
T d1mqba_ 86 IITEYMENGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSR 158 (283)
T ss_dssp EEEECCTTEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEecccCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhh
Confidence 999999999999987552 2569999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCce--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 736 NAPDGKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 736 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
........ ......||+.|+|||++.++.++.++|||||||++|||++|+.|+....... .+.. . .......
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~---~-i~~~~~~ 232 (283)
T d1mqba_ 159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMK---A-INDGFRL 232 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH---H-HHTTCCC
T ss_pred cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHH---H-HhccCCC
Confidence 76543321 2234578999999999999999999999999999999999776665433221 1111 1 1111111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
..+.. ...++.+++.+||+.+|++||+|+||++.|+.+++
T Consensus 233 --~~~~~---------~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 233 --PTPMD---------CPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp --CCCTT---------CBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred --CCchh---------hHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhh
Confidence 11111 12457899999999999999999999999988764
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-48 Score=418.54 Aligned_cols=202 Identities=26% Similarity=0.408 Sum_probs=179.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||+||+|.. .+|+.||+|+++... .....+++.+|+.++++++|||||+++++|.++++.++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57899999999999999999964 578999999997653 3444678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.+. ..+++.+++.++.|+++||+|||+. ++|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~ 156 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 156 (322)
T ss_dssp ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence 999999999999752 4689999999999999999999971 489999999999999999999999999998653
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTM 792 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~ 792 (933)
+. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....
T Consensus 157 ~~---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~ 207 (322)
T d1s9ja_ 157 DS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD 207 (322)
T ss_dssp HH---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred CC---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 32 2234689999999999999999999999999999999999999997654
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.6e-47 Score=406.72 Aligned_cols=247 Identities=24% Similarity=0.388 Sum_probs=203.6
Q ss_pred cCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
+.|+..+.||+|+||.||+|. ..+|+.||||++...... ....+++.+|+.++++++|||||++++++.+++..|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 458999999999999999995 467899999999766432 344577999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|..++.. ..++++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 95 E~~~~g~l~~~~~~-----~~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-----KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 166 (309)
T ss_dssp ECCSEEHHHHHHHH-----TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred EecCCCchHHHHHh-----CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccC
Confidence 99999999877644 2569999999999999999999999 899999999999999999999999999998654
Q ss_pred CCCceeecccccccCcccccccCC---CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAAT---GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
.. ....||+.|+|||++.+ +.|+.++|||||||++|||++|+.||........ +...... ..+.
T Consensus 167 ~~-----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~~--~~~~ 233 (309)
T d1u5ra_ 167 PA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN--ESPA 233 (309)
T ss_dssp SB-----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS--CCCC
T ss_pred CC-----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhC--CCCC
Confidence 32 34579999999999853 4689999999999999999999999976533221 1122211 1111
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
..+..+ ...+.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~---------s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 234 LQSGHW---------SEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CSCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCCCC---------CHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence 111111 135779999999999999999999976
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=3.1e-46 Score=407.86 Aligned_cols=258 Identities=23% Similarity=0.356 Sum_probs=211.9
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
-++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 36899999999999999999964 579999999997653 344578999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec--CCCcEEEeccccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGLVKN 736 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~~~kl~DfGla~~ 736 (933)
||+++|+|.+++... ...+++.++..|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+++.
T Consensus 103 E~~~gg~L~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~ 175 (350)
T d1koaa2 103 EFMSGGELFEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAH 175 (350)
T ss_dssp CCCCSCBHHHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred EcCCCCCHHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence 999999999998541 2469999999999999999999999 8999999999999996 467899999999987
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
...... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+. +..+.......+..
T Consensus 176 ~~~~~~--~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~~~~ 247 (350)
T d1koaa2 176 LDPKQS--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWNMDDS 247 (350)
T ss_dssp CCTTSC--EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCCSCCG
T ss_pred cccccc--cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCCCcc
Confidence 665432 2345899999999999999999999999999999999999999976533211 22222222222211
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
..+.+ ...+.+++.+||+.||++|||++|+++ ++|...
T Consensus 248 ~~~~~---------s~~~~~li~~~L~~dP~~R~t~~eil~------hp~~~~ 285 (350)
T d1koaa2 248 AFSGI---------SEDGKDFIRKLLLADPNTRMTIHQALE------HPWLTP 285 (350)
T ss_dssp GGGGC---------CHHHHHHHHHHCCSSGGGSCCHHHHHH------STTTSC
T ss_pred cccCC---------CHHHHHHHHHHccCChhHCcCHHHHhc------CcccCC
Confidence 11111 235779999999999999999999987 666643
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-47 Score=410.35 Aligned_cols=260 Identities=25% Similarity=0.429 Sum_probs=206.1
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC------CcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 652 (933)
.++|++.+.||+|+||+||+|.... ...||||++.... .......|.+|+.++.++ +|||||++++++.+.+
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 3679999999999999999996532 2369999987653 334456899999999998 8999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhccc------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCC
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHD------------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLK 714 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik 714 (933)
..++||||+++|+|.++++.... .....+++.+++.++.||++||+|||+ ++|||||||
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlK 191 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCS
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCc
Confidence 99999999999999999976321 112458999999999999999999999 899999999
Q ss_pred CCcEEecCCCcEEEecccccccCCCCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCC
Q 002346 715 PSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTM 792 (933)
Q Consensus 715 ~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~ 792 (933)
|+||+++.++.+||+|||+|+...... ........||+.|+|||++.++.++.++|||||||++|||+| |+.||....
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~ 271 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998654433 233445678999999999999999999999999999999998 899997654
Q ss_pred CchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHh
Q 002346 793 PDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLG 860 (933)
Q Consensus 793 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~ 860 (933)
.... +.. ........ ..+... ..++.+++.+||+.||++|||++||++.|.
T Consensus 272 ~~~~--~~~----~~~~~~~~--~~p~~~---------~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 272 VDAN--FYK----LIQNGFKM--DQPFYA---------TEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp CSHH--HHH----HHHTTCCC--CCCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHH--HHH----HHhcCCCC--CCCCcC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence 3322 111 12111111 111111 135789999999999999999999999885
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-46 Score=401.80 Aligned_cols=259 Identities=23% Similarity=0.363 Sum_probs=213.0
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCC----chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMG----NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
+.++|++.+.||+|+||+||+|.. .+|+.||||++.+.... ....+.|.+|++++++++|||||++++++.+++.
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence 357899999999999999999965 57999999999765432 2246789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC----cEEEe
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM----RAKVA 729 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~----~~kl~ 729 (933)
.++||||+++|+|.+++... ..+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++ .+|++
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~ 159 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKII 159 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEEC
T ss_pred EEEEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEec
Confidence 99999999999999999662 469999999999999999999999 8999999999999998776 49999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||+++....... .....||+.|+|||++.+..++.++||||+||++|||++|+.||......+. ...+...
T Consensus 160 DfG~a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~ 231 (293)
T d1jksa_ 160 DFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET------LANVSAV 231 (293)
T ss_dssp CCTTCEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHTT
T ss_pred chhhhhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH------HHHHHhc
Confidence 9999987654432 3345799999999999999999999999999999999999999986543221 1122222
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....+....+.+ ...+.+++.+||+.||++|||++|+++ ++|..
T Consensus 232 ~~~~~~~~~~~~---------s~~~~~li~~~L~~dP~~R~s~~eil~------hp~~~ 275 (293)
T d1jksa_ 232 NYEFEDEYFSNT---------SALAKDFIRRLLVKDPKKRMTIQDSLQ------HPWIK 275 (293)
T ss_dssp CCCCCHHHHTTS---------CHHHHHHHHTTSCSSGGGSCCHHHHHH------STTTC
T ss_pred CCCCCchhcCCC---------CHHHHHHHHHHccCChhHCcCHHHHhc------CcccC
Confidence 222222111111 245779999999999999999999986 66664
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=9.3e-46 Score=404.39 Aligned_cols=258 Identities=19% Similarity=0.300 Sum_probs=212.6
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++.... ....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 46799999999999999999964 679999999987653 334567899999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEec--CCCcEEEeccccccc
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIG--DDMRAKVADFGLVKN 736 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~--~~~~~kl~DfGla~~ 736 (933)
||+++|+|.+++.. ...++++.+++.|+.||+.||+|||+ ++||||||||+|||++ .++.+||+|||+|+.
T Consensus 106 E~~~gg~L~~~~~~----~~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~ 178 (352)
T d1koba_ 106 EFLSGGELFDRIAA----EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATK 178 (352)
T ss_dssp ECCCCCBHHHHTTC----TTCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred EcCCCChHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeeccccee
Confidence 99999999988754 12469999999999999999999999 8999999999999998 678999999999997
Q ss_pred CCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcc
Q 002346 737 APDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKA 816 (933)
Q Consensus 737 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 816 (933)
...... .....||+.|+|||++.+..++.++||||+||++|||+||+.||......+ . +..+.......+..
T Consensus 179 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~---~~~i~~~~~~~~~~ 250 (352)
T d1koba_ 179 LNPDEI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---T---LQNVKRCDWEFDED 250 (352)
T ss_dssp CCTTSC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---H---HHHHHHCCCCCCSS
T ss_pred cCCCCc--eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHHhCCCCCCcc
Confidence 765432 234579999999999999999999999999999999999999997653322 1 12222222222222
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 817 IDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 817 ~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
..+.+. .++.+++.+||+.||++|||++|+++ ++|...
T Consensus 251 ~~~~~s---------~~~~~li~~~L~~dp~~R~s~~eil~------Hp~~~~ 288 (352)
T d1koba_ 251 AFSSVS---------PEAKDFIKNLLQKEPRKRLTVHDALE------HPWLKG 288 (352)
T ss_dssp TTTTSC---------HHHHHHHHTTSCSSGGGSCCHHHHHT------STTTSS
T ss_pred cccCCC---------HHHHHHHHHHccCChhHCcCHHHHhc------CHhhCC
Confidence 222222 35779999999999999999999976 666643
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-46 Score=394.98 Aligned_cols=259 Identities=25% Similarity=0.404 Sum_probs=200.2
Q ss_pred hcCCccCCccccCCCeEEEEEEeCC----CcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPD----GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
.++|++.+.||+|+||.||+|.... +..||||+++... .....+.|.+|+.++++++|||||++++++. ++..+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~ 83 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW 83 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence 4689999999999999999996532 3568999886543 4455678999999999999999999999986 46789
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++... ..++++.+++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 84 iv~E~~~~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~ 156 (273)
T d1mp8a_ 84 IIMELCTLGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSR 156 (273)
T ss_dssp EEEECCTTEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred EEEEeccCCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhhe
Confidence 999999999999987652 2568999999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
..............||+.|+|||++.++.++.++|||||||++|||+| |++||......+.. . .+.. ....
T Consensus 157 ~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~---~---~i~~-~~~~- 228 (273)
T d1mp8a_ 157 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---G---RIEN-GERL- 228 (273)
T ss_dssp --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---H---HHHT-TCCC-
T ss_pred eccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHH---H---HHHc-CCCC-
Confidence 766554444556678999999999999999999999999999999998 88899876543321 1 1111 1111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
.+++.+. ..+.+++.+||+.||++|||+.|+++.|+.++++
T Consensus 229 -~~~~~~~---------~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 229 -PMPPNCP---------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp -CCCTTCC---------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CCCCCCC---------HHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 1222222 4578999999999999999999999999887654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-46 Score=403.37 Aligned_cols=266 Identities=30% Similarity=0.481 Sum_probs=213.0
Q ss_pred HHHHhcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEee
Q 002346 576 LRQVTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCI 649 (933)
Q Consensus 576 l~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~ 649 (933)
++...++|++.+.||+|+||.||+|+.. +++.||||++.... .....++|.+|++++++++||||++++++|.
T Consensus 8 ~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred ccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 4445678999999999999999999753 46789999997653 3445678999999999999999999999999
Q ss_pred eCceeEEEEeecCCCChhhHhhhccc-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEe
Q 002346 650 NGSERLLVYEYMPRGTLAQHLFEWHD-------------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIH 710 (933)
Q Consensus 650 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH 710 (933)
.....++||||+++|+|.++++.... .....+++.+++.|+.|+++||+|||+ ++|||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEe
Confidence 99999999999999999999965221 112358999999999999999999999 89999
Q ss_pred cCCCCCcEEecCCCcEEEecccccccCCCCC-ceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCC-CCC
Q 002346 711 RDLKPSNILIGDDMRAKVADFGLVKNAPDGK-YSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR-KAL 788 (933)
Q Consensus 711 ~Dik~~Nill~~~~~~kl~DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~-~p~ 788 (933)
|||||+|||++.++.+||+|||+++...... ....+...|++.|+|||.+.+..++.++|||||||++|||++|. +||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~ 243 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY 243 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence 9999999999999999999999998554332 22334567899999999999999999999999999999999996 566
Q ss_pred CCCCCchhhHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 789 DDTMPDDRAHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 789 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
....+.+. .. .+. ....+. .+..+. .++.+++.+||+.+|++||||.||+++|+++.
T Consensus 244 ~~~~~~e~---~~---~v~--~~~~~~-~p~~~~---------~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~ 300 (301)
T d1lufa_ 244 YGMAHEEV---IY---YVR--DGNILA-CPENCP---------LELYNLMRLCWSKLPADRPSFCSIHRILQRMC 300 (301)
T ss_dssp TTSCHHHH---HH---HHH--TTCCCC-CCTTCC---------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred CCCCHHHH---HH---HHH--cCCCCC-CCccch---------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence 65433221 11 111 111111 111111 35789999999999999999999999998874
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-46 Score=403.41 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=208.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++++.||+|+||.||+|.. .+|+.||||++++... .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 5799999999999999999964 6799999999976532 2345678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|.+++.. ...+++..++.++.|++.||+|||+ ++||||||||+|||++.+|.+||+|||+|+...
T Consensus 85 ey~~gg~L~~~~~~-----~~~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~ 156 (337)
T d1o6la_ 85 EYANGGELFFHLSR-----ERVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGI 156 (337)
T ss_dssp ECCTTCBHHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred eccCCCchhhhhhc-----ccCCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccc
Confidence 99999999999876 2568999999999999999999999 899999999999999999999999999998655
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.... .....+||+.|+|||++.+..|+.++||||+||++|||++|++||....... .+.........++..++
T Consensus 157 ~~~~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~~~~i~~~~~~~p~~~s 229 (337)
T d1o6la_ 157 SDGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------LFELILMEEIRFPRTLS 229 (337)
T ss_dssp CTTC-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCTTSC
T ss_pred cCCc-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------HHHHHhcCCCCCCccCC
Confidence 4332 2345689999999999999999999999999999999999999998754321 12223332333332221
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
.++.+++.+||+.||++||+ ++|+++
T Consensus 230 -------------~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 230 -------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp -------------HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred -------------HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence 35679999999999999995 677765
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=6.4e-46 Score=394.65 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=206.0
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc----e
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----E 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~ 653 (933)
.++|++.+.||+|+||.||+|. ..+|+.||||+++..... ....++|.+|+++++.++|||||++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 5789999999999999999995 467999999999876443 344678999999999999999999999987643 4
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.|+||||+++++|.+++.. ..++++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.++++|||.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-----~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~ 157 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGI 157 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred EEEEEECCCCCEehhhhcc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhh
Confidence 7899999999999998865 2569999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCc--eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 734 VKNAPDGKY--SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 734 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
++....... .......||+.|+|||++.+..++.++||||+||++|||+||++||....+.+. .........
T Consensus 158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~~~~~ 231 (277)
T d1o6ya_ 158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHVREDP 231 (277)
T ss_dssp CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHHCCC
T ss_pred hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH------HHHHHhcCC
Confidence 875543221 223456899999999999999999999999999999999999999976533221 222222222
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHhhhh
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRP-DMGHAVNVLGPLV 863 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-s~~evl~~L~~~~ 863 (933)
..+....+.+. .++.+++.+|++.||++|| +++++.+.|.++.
T Consensus 232 ~~~~~~~~~~s---------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 232 IPPSARHEGLS---------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp CCGGGTSSSCC---------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCchhccCCC---------HHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence 22222222332 4577999999999999999 8999998887653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-46 Score=401.61 Aligned_cols=246 Identities=27% Similarity=0.418 Sum_probs=207.5
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++++.||+|+||+||+|.. .+|+.||||++++... .....+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 5799999999999999999965 5799999999976532 2344678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+++|+|..++.. ...+++..+..++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 84 E~~~gg~l~~~~~~-----~~~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~ 155 (316)
T d1fota_ 84 DYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155 (316)
T ss_dssp CCCCSCBHHHHHHH-----TSSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred eecCCccccccccc-----cccccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEec
Confidence 99999999999866 3568899999999999999999998 899999999999999999999999999998765
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... ....||+.|+|||++.+..|+.++||||+||++|||+||+.||......+ ....+.......+..
T Consensus 156 ~~~----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~~~~p~~-- 223 (316)
T d1fota_ 156 DVT----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------TYEKILNAELRFPPF-- 223 (316)
T ss_dssp SCB----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHCCCCCCTT--
T ss_pred ccc----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------HHHHHHcCCCCCCCC--
Confidence 432 34689999999999999999999999999999999999999998653322 122233323222222
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVN 857 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~ 857 (933)
+. ..+.+++.+|++.||.+|| +++++++
T Consensus 224 --~s---------~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 224 --FN---------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --SC---------HHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CC---------HHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence 21 3577999999999999996 8888875
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-46 Score=389.50 Aligned_cols=250 Identities=30% Similarity=0.451 Sum_probs=198.1
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee-CceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e 659 (933)
++|++.+.||+|+||.||+|+. .|+.||||+++.+ ...++|.+|++++++++|||||+++|+|.+ .+..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHeEEeEEEecCCCeEEEEEEE-CCeEEEEEEECcH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence 5688899999999999999998 5889999999754 234689999999999999999999999865 456899999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+++|+|.+++.... ...++|..++.|+.||+.||+|||+ .+|+||||||+||+++.++.+|++|||+++....
T Consensus 82 y~~~g~L~~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp CCTTEEHHHHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred ccCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999996522 2358999999999999999999999 8999999999999999999999999999986543
Q ss_pred CCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
.. ....+++.|+|||++.++.++.++|||||||++|||+| |+.||......+ +..++. ....++ ++
T Consensus 156 ~~----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i~-----~~~~~~-~~ 222 (262)
T d1byga_ 156 TQ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE-----KGYKMD-AP 222 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHT-----TTCCCC-CC
T ss_pred CC----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHHH-----cCCCCC-CC
Confidence 22 23468899999999999999999999999999999998 677776543322 222211 111111 11
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhh
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLV 863 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~ 863 (933)
+... .++.+++.+||+.||++|||+.+++++|+++.
T Consensus 223 ~~~~---------~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~ 258 (262)
T d1byga_ 223 DGCP---------PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258 (262)
T ss_dssp TTCC---------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ccCC---------HHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence 1111 36779999999999999999999999998875
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-45 Score=395.55 Aligned_cols=252 Identities=18% Similarity=0.288 Sum_probs=208.1
Q ss_pred HhcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEE
Q 002346 579 VTDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv 657 (933)
+.++|++.+.||+|+||+||+|.. .+|+.||||+++... .....+.+|++++++++|||||++++++.+++..|+|
T Consensus 3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 457899999999999999999955 578999999997652 2345688999999999999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCC--CcEEEecccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDD--MRAKVADFGLVK 735 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~--~~~kl~DfGla~ 735 (933)
|||+++|+|.+++... ...+++.+++.++.||++||+|||+ ++|+||||||+|||++.+ ..+||+|||+++
T Consensus 80 mE~~~gg~L~~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~ 152 (321)
T d1tkia_ 80 FEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR 152 (321)
T ss_dssp ECCCCCCBHHHHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred EecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhh
Confidence 9999999999999541 2469999999999999999999999 899999999999999854 589999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCc
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPK 815 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 815 (933)
....... .....||+.|+|||...+..++.++||||+||++|||++|+.||......+ .+..+.......+.
T Consensus 153 ~~~~~~~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~------~~~~i~~~~~~~~~ 224 (321)
T d1tkia_ 153 QLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ------IIENIMNAEYTFDE 224 (321)
T ss_dssp ECCTTCE--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH------HHHHHHHTCCCCCH
T ss_pred ccccCCc--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH------HHHHHHhCCCCCCh
Confidence 7655432 234578999999999999999999999999999999999999998654322 12222222222222
Q ss_pred ccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 816 AIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 816 ~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...+.+ ..++.+++.+|++.||++|||++|+++
T Consensus 225 ~~~~~~---------s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 225 EAFKEI---------SIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HHHTTS---------CHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred hhccCC---------CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 211122 245779999999999999999999986
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.5e-45 Score=385.75 Aligned_cols=253 Identities=26% Similarity=0.347 Sum_probs=206.7
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-------hhHHHHHHHHHHHHhcC-CCcceeEEeEeee
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-------KGLSEFQAEIAVLTKVR-HRHLVALLGYCIN 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~ 650 (933)
.++|++.+.||+|+||+||+|+. .+|+.||||+++...... ...+.+.+|+.++++++ |||||++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 47899999999999999999965 579999999997754322 22356889999999997 9999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEec
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
++..|+||||+++|+|.+++.. ..++++.+++.++.||++||+|||+ ++|+||||||+||+++.++.+||+|
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~-----~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~D 153 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE-----KVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTD 153 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECC
T ss_pred CcceEEEEEcCCCchHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEcc
Confidence 9999999999999999999965 2569999999999999999999999 8999999999999999999999999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCC------CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAAT------GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~ 804 (933)
||+++...... ......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....+... ..
T Consensus 154 FG~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~------~~ 225 (277)
T d1phka_ 154 FGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM------LR 225 (277)
T ss_dssp CTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HH
T ss_pred chheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHH------HH
Confidence 99998766533 2345689999999998853 3578899999999999999999999987543221 11
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+.......+....+. ...++.+++.+||+.||++||+++|+++
T Consensus 226 ~i~~~~~~~~~~~~~~---------~s~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 226 MIMSGNYQFGSPEWDD---------YSDTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp HHHHTCCCCCTTTGGG---------SCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred HHHhCCCCCCCccccc---------CCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 2222221111111111 1246789999999999999999999875
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-45 Score=394.17 Aligned_cols=271 Identities=24% Similarity=0.319 Sum_probs=205.3
Q ss_pred hcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc----eeE
Q 002346 580 TDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ERL 655 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~ 655 (933)
.++|.+.+.||+|+||.||+|+. +|+.||||++.... .....+..|+..+.+++|||||+++++|.+.+ ..+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 45778889999999999999987 78999999986542 11122334555566789999999999997643 678
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc-----CCCeEecCCCCCcEEecCCCcEEEec
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA-----QQSFIHRDLKPSNILIGDDMRAKVAD 730 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~-----~~~ivH~Dik~~Nill~~~~~~kl~D 730 (933)
+||||+++|+|.+++++ .+++|.+++.++.|+|+||+|+|+.. .++||||||||+|||++.++.+||+|
T Consensus 78 lv~Ey~~~g~L~~~l~~------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHH------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEecccCCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEe
Confidence 99999999999999976 45899999999999999999999631 36999999999999999999999999
Q ss_pred ccccccCCCCCce---eecccccccCcccccccCCC------CCCCccchHhHHHHHHHHHcCCCCCCCCCCchh-----
Q 002346 731 FGLVKNAPDGKYS---VETRLAGTFGYLAPEYAATG------RVTTKIDVYAFGVVLMETITGRKALDDTMPDDR----- 796 (933)
Q Consensus 731 fGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~----- 796 (933)
||+++........ ......||+.|+|||++.+. .++.++|||||||++|||+||..||........
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred cCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc
Confidence 9999866543322 22356899999999998654 267799999999999999999987753221110
Q ss_pred ---hHHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 797 ---AHLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 797 ---~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
............ ...++|.+.......+....+.+++.+||+.||++|||+.||++.|+++.++
T Consensus 232 ~~~~~~~~~~~~~~~-----~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 298 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVC-----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ 298 (303)
T ss_dssp SCSSCCHHHHHHHHT-----TSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ccccchHHHHHHHHh-----ccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence 001111122211 1122333332233445566788999999999999999999999999988654
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-45 Score=387.52 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=196.8
Q ss_pred cCCccCCccccCCCeEEEEEEeC--CC--cEEEEEEeccccCC-chhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP--DG--TKIAVKRMESNTMG-NKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
++|++.+.||+|+||.||+|... ++ ..||||++...... ....++|.+|+.++++++|||||+++|+|.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 57999999999999999999653 22 37899998765432 3446789999999999999999999999975 4678
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|++.+++... ..++++..++.++.|+++||+|||+ ++|+||||||+||+++.++.+||+|||+++
T Consensus 87 lv~e~~~~~~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~ 159 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH----QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMR 159 (273)
T ss_dssp EEEECCTTCBHHHHHHHH----GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred eeeeeecCcchhhhhhcc----cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhh
Confidence 999999999999988652 2469999999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCce--eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 736 NAPDGKYS--VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 736 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
........ ......|++.|+|||++.+..++.++|||||||++|||+| |+.||......+ ... .+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~---~i~~~~~~ 233 (273)
T d1u46a_ 160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILH---KIDKEGER 233 (273)
T ss_dssp ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH---HHHTSCCC
T ss_pred hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHH---HHHhCCCC
Confidence 76554322 2234568889999999999999999999999999999998 899997653322 222 22211111
Q ss_pred CCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhh
Q 002346 813 IPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPL 862 (933)
Q Consensus 813 ~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~ 862 (933)
. ...+.+. ..+.+++.+||+.||++|||++||++.|+++
T Consensus 234 ~--~~~~~~~---------~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 234 L--PRPEDCP---------QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp C--CCCTTCC---------HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred C--CCccccc---------HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence 1 1111111 3577999999999999999999999988764
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-45 Score=395.13 Aligned_cols=258 Identities=25% Similarity=0.420 Sum_probs=202.7
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCc----EEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGT----KIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
++|++++.||+|+||+||+|... +|+ +||+|+++... +....++|.+|+.++++++|||||+++|+|.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Cee
Confidence 46999999999999999999653 444 68999887543 445578899999999999999999999999865 567
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
++|||+.+|+|.+++... ...+++..++.++.||++||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 87 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~ 159 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAK 159 (317)
T ss_dssp EEEECCTTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHH
T ss_pred EEEEeccCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccce
Confidence 888999999999988652 3569999999999999999999999 899999999999999999999999999999
Q ss_pred cCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhhHHHHHHHHHhhccCCC
Q 002346 736 NAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRAHLVTWFRRVLISKENI 813 (933)
Q Consensus 736 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 813 (933)
......... .....||+.|+|||++.++.++.++|||||||++|||+| |+.||........ ...+.. ....
T Consensus 160 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~---~~~i~~----~~~~ 232 (317)
T d1xkka_ 160 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI---SSILEK----GERL 232 (317)
T ss_dssp HTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGH---HHHHHH----TCCC
T ss_pred ecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHc----CCCC
Confidence 765543322 234578999999999999999999999999999999999 7888876543322 111111 1111
Q ss_pred CcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhh
Q 002346 814 PKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQ 865 (933)
Q Consensus 814 ~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~ 865 (933)
+ .++.. ...+.+++.+||+.||++|||+.|+++.|+.+...
T Consensus 233 ~--~p~~~---------~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~ 273 (317)
T d1xkka_ 233 P--QPPIC---------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273 (317)
T ss_dssp C--CCTTB---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred C--CCccc---------CHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence 1 11111 13577999999999999999999999999877543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-45 Score=400.63 Aligned_cols=251 Identities=26% Similarity=0.369 Sum_probs=209.7
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVY 658 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~ 658 (933)
++|++++.||+|+||.||+|.. .+|+.||||++.+... .....+.+.+|+++++.++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5799999999999999999965 5799999999875432 2344678999999999999999999999999999999999
Q ss_pred eecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCC
Q 002346 659 EYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAP 738 (933)
Q Consensus 659 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~ 738 (933)
||+.+|+|.+++... ..+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+...
T Consensus 121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~ 192 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK 192 (350)
T ss_dssp ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence 999999999999662 468999999999999999999999 899999999999999999999999999998765
Q ss_pred CCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCcccC
Q 002346 739 DGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAID 818 (933)
Q Consensus 739 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 818 (933)
... ....||+.|+|||++.+..++.++|||||||++|||+||+.||....+.. ....+.......+.
T Consensus 193 ~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~~i~~~~~~~p~--- 259 (350)
T d1rdqe_ 193 GRT----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ------IYEKIVSGKVRFPS--- 259 (350)
T ss_dssp SCB----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHHHHHHCCCCCCT---
T ss_pred ccc----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH------HHHHHhcCCCCCCc---
Confidence 432 34689999999999999999999999999999999999999997643221 12222222222221
Q ss_pred CCCCCChhhHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHHhhhhhhcCC
Q 002346 819 PNLNLDEETIESIYRVAELAGHCTAREPQQRP-----DMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 819 ~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RP-----s~~evl~~L~~~~~~~~~ 868 (933)
.+. .++.+++.+||+.||.+|+ +++++++ ++|..
T Consensus 260 -~~s---------~~~~~li~~~L~~dP~kR~~~~r~t~~ell~------Hp~f~ 298 (350)
T d1rdqe_ 260 -HFS---------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN------HKWFA 298 (350)
T ss_dssp -TCC---------HHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT------SGGGT
T ss_pred -cCC---------HHHHHHHHHHhhhCHHhccccccccHHHHHc------Ccccc
Confidence 111 3577999999999999994 8888875 66654
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=393.12 Aligned_cols=265 Identities=25% Similarity=0.376 Sum_probs=200.6
Q ss_pred HhcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeC
Q 002346 579 VTDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCING 651 (933)
Q Consensus 579 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~ 651 (933)
-.++|++.+.||+|+||.||+|... +++.||||+++... .....+.+.+|..++.++ +|+|||.+++++.+.
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3478999999999999999999642 35689999997653 344567788888888887 689999999998764
Q ss_pred -ceeEEEEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 652 -SERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 652 -~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
...++||||+++|+|.++++..... ....+++.+++.++.||++||+|||+ ++||||||||+|||
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NIL 166 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNIL 166 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEE
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcccee
Confidence 4689999999999999999763221 12358999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCC-CCCCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR-KALDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~-~p~~~~~~~~~~ 797 (933)
+++++.+||+|||+|+....... .......||+.|+|||++.++.++.++|||||||++|||+||. +||........
T Consensus 167 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~- 245 (299)
T d1ywna1 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE- 245 (299)
T ss_dssp ECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH-
T ss_pred ECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999986554332 2334568999999999999999999999999999999999975 56755433221
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
+.. ..... ..+. ..... ..++.+++.+||+.||++|||++|+++.|+++++
T Consensus 246 -~~~----~~~~~-~~~~-~~~~~---------~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 246 -FCR----RLKEG-TRMR-APDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp -HHH----HHHHT-CCCC-CCTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHH----HHhcC-CCCC-CCccC---------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence 111 11111 1111 11111 1357799999999999999999999999998865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=391.13 Aligned_cols=264 Identities=23% Similarity=0.381 Sum_probs=212.4
Q ss_pred hcCCccCCccccCCCeEEEEEEe------CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL------PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~ 652 (933)
.++|++.++||+|+||.||+|.+ .+++.||||+++... ......+|.+|+.+++++ +|||||+++++|.++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~ 100 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCC
Confidence 36788999999999999999964 346789999998654 344567899999999999 6999999999999999
Q ss_pred eeEEEEeecCCCChhhHhhhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHD-------------HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
..++||||+++|+|.++++.... .....+++.++..++.||++|++|||+ ++||||||||+||+
T Consensus 101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNIL 177 (311)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccccccccc
Confidence 99999999999999999976332 123469999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCC-CCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKA-LDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p-~~~~~~~~~~ 797 (933)
++.++.+|++|||+++....... .......||+.|+|||++.++.++.++|||||||++|||+|++.| |........
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~- 256 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK- 256 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH-
T ss_pred ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH-
Confidence 99999999999999997665433 334557899999999999999999999999999999999995555 444332221
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
+...+.. . .+...+... ...+.+++.+||+.||++||+|+|++++|++.+.
T Consensus 257 -~~~~i~~----~--~~~~~~~~~---------~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 257 -FYKMIKE----G--FRMLSPEHA---------PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp -HHHHHHH----T--CCCCCCTTS---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHHHhc----C--CCCCCcccc---------cHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence 1111111 1 111111111 1457899999999999999999999999987654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.3e-45 Score=400.12 Aligned_cols=250 Identities=22% Similarity=0.360 Sum_probs=199.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc-hhHHHHHH---HHHHHHhcCCCcceeEEeEeeeCceeE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN-KGLSEFQA---EIAVLTKVRHRHLVALLGYCINGSERL 655 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~ 655 (933)
++|++.+.||+|+||.||+|.. .+|+.||||++.+..... .....+.+ |+.+++.++|||||++++++.+.+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 5799999999999999999965 579999999987543211 12233444 466777778999999999999999999
Q ss_pred EEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 656 LVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 656 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
+||||+++|+|.+++.. ...+++.+++.++.||+.||+|||+ ++||||||||+|||++.++.+||+|||+|+
T Consensus 84 ivmE~~~gg~L~~~l~~-----~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~ 155 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC 155 (364)
T ss_dssp EEECCCCSCBHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCE
T ss_pred EEEEecCCCcHHHHHHh-----cccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceee
Confidence 99999999999999966 2468899999999999999999999 899999999999999999999999999998
Q ss_pred cCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCC
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIP 814 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 814 (933)
...... .....||+.|+|||++.. ..|+.++|||||||++|||+||+.||......+... ............+
T Consensus 156 ~~~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~~~~~~~~~ 229 (364)
T d1omwa3 156 DFSKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLTMAVELP 229 (364)
T ss_dssp ECSSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH---HHHHSSSCCCCCC
T ss_pred ecCCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcccCCCCCC
Confidence 765432 234589999999999865 468999999999999999999999998754433221 1112111111111
Q ss_pred cccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 002346 815 KAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVN 857 (933)
Q Consensus 815 ~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~ 857 (933)
..+. .++.+++.+||+.||++||+ ++|+++
T Consensus 230 ----~~~s---------~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 230 ----DSFS---------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp ----SSSC---------HHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred ----CCCC---------HHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence 1121 35779999999999999999 577765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-45 Score=395.93 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=204.7
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccC-CchhHHHHHHHHHHHH-hcCCCcceeEEeEeeeCceeEEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTM-GNKGLSEFQAEIAVLT-KVRHRHLVALLGYCINGSERLLV 657 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv 657 (933)
++|.+.+.||+|+||+||+|.. .+|+.||||++++... .....+.+..|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999955 5799999999976432 2334566777777765 68999999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccC
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNA 737 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~ 737 (933)
|||+++|+|.+++.. ...+++.+++.++.||+.||+|||+ ++|+||||||+|||+++++.+||+|||+++..
T Consensus 82 mEy~~~g~L~~~i~~-----~~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~ 153 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-----CHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKEN 153 (320)
T ss_dssp EECCTTCBHHHHHHH-----HSSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EeecCCCcHHHHhhc-----cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhc
Confidence 999999999999976 2458999999999999999999999 89999999999999999999999999999865
Q ss_pred CCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 738 PDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 738 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
..... ......||+.|+|||++.+..++.++||||+||++|||+||+.||....+... ...+.......+..
T Consensus 154 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~------~~~i~~~~~~~p~~- 225 (320)
T d1xjda_ 154 MLGDA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMDNPFYPRW- 225 (320)
T ss_dssp CCTTC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCCCCTT-
T ss_pred ccccc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCCCCCcc-
Confidence 54332 23446899999999999999999999999999999999999999986543221 12222222222221
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMG-HAVN 857 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~-evl~ 857 (933)
+. .++.+++.+||+.||++||++. |+++
T Consensus 226 ---~s---------~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 226 ---LE---------KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ---SC---------HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ---CC---------HHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence 11 3577999999999999999985 6643
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=389.01 Aligned_cols=263 Identities=30% Similarity=0.454 Sum_probs=207.5
Q ss_pred hcCCccCCccccCCCeEEEEEEeC--------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP--------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~ 650 (933)
.++|++.+.||+|+||.||+|+.. ++..||||+++... ......++.+|+..+.++ +|||||+++++|.+
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~ 90 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence 367889999999999999999642 23579999998654 445567899999999888 89999999999999
Q ss_pred CceeEEEEeecCCCChhhHhhhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEE
Q 002346 651 GSERLLVYEYMPRGTLAQHLFEWHDH-----------GYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNIL 719 (933)
Q Consensus 651 ~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nil 719 (933)
++..++||||+++|+|.+++...... ....+++.+++.++.|++.||+|||+ ++||||||||+|||
T Consensus 91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVL 167 (299)
T ss_dssp SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEE
T ss_pred CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeeccccee
Confidence 99999999999999999999763211 23468999999999999999999999 89999999999999
Q ss_pred ecCCCcEEEecccccccCCCCCc-eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHc-CCCCCCCCCCchhh
Q 002346 720 IGDDMRAKVADFGLVKNAPDGKY-SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETIT-GRKALDDTMPDDRA 797 (933)
Q Consensus 720 l~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~ellt-G~~p~~~~~~~~~~ 797 (933)
++.++.+||+|||+++....... .......|++.|+|||.+.++.|+.++|||||||++|||++ |++||.......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-- 245 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-- 245 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--
T ss_pred ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH--
Confidence 99999999999999986554332 22345678999999999999999999999999999999998 677886543321
Q ss_pred HHHHHHHHHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 798 HLVTWFRRVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 798 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
+... ....... ..+... ..++.+++.+||+.||++|||+.||++.|++++.
T Consensus 246 -~~~~----i~~~~~~--~~p~~~---------~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 246 -LFKL----LKEGHRM--DKPSNC---------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp -HHHH----HHTTCCC--CCCSSC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred -HHHH----HHcCCCC--CCCccc---------hHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence 1111 1111111 111111 1357899999999999999999999999988753
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-44 Score=389.36 Aligned_cols=258 Identities=28% Similarity=0.431 Sum_probs=205.4
Q ss_pred CCccccCCCeEEEEEEeCCC----cEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee-CceeEEEEee
Q 002346 586 ANILGRGGFGVVYGGELPDG----TKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN-GSERLLVYEY 660 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e~ 660 (933)
.++||+|+||+||+|.+.++ ..||||+++... .....++|.+|++++++++|||||+++|++.+ +...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEE
Confidence 46799999999999976432 368999997532 45567889999999999999999999999876 4688999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+++|+|.++++.. ...+++..+++++.|+++||.|+|+ ++|+||||||+|||+++++.+||+|||+++.....
T Consensus 111 ~~~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 111 MKHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp CTTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred eecCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccc
Confidence 9999999998652 3457889999999999999999999 89999999999999999999999999999866543
Q ss_pred Cce---eecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCCCCccc
Q 002346 741 KYS---VETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKENIPKAI 817 (933)
Q Consensus 741 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 817 (933)
... ......||+.|+|||.+.++.++.++||||||+++|||+||+.||....... +... ...... .+ ..
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~---~i~~g~--~~-~~ 255 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITV---YLLQGR--RL-LQ 255 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHH---HHHTTC--CC-CC
T ss_pred ccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHH---HHHcCC--CC-CC
Confidence 322 2234578999999999999999999999999999999999888886543211 1111 111111 11 11
Q ss_pred CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 818 DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 818 d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.+.. ...+.+++.+||+.||++||+|.||++.|+++...+..
T Consensus 256 p~~~---------~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 256 PEYC---------PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp CTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred cccC---------cHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence 1111 13577999999999999999999999999999876654
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-44 Score=388.62 Aligned_cols=262 Identities=29% Similarity=0.448 Sum_probs=205.0
Q ss_pred cCCccCCccccCCCeEEEEEEeC-CCc--EEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeeeCceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGELP-DGT--KIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCINGSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l 656 (933)
++|++.+.||+|+||.||+|... +|. .||||++.... .....++|.+|+++++++ +|||||+++|+|.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 67889999999999999999664 444 47788875442 334567899999999999 79999999999999999999
Q ss_pred EEeecCCCChhhHhhhcc-----------cCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCc
Q 002346 657 VYEYMPRGTLAQHLFEWH-----------DHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMR 725 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~ 725 (933)
||||+++|+|.++++... ......+++.++..++.||++|+.|+|+ ++|+||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCc
Confidence 999999999999997531 1223579999999999999999999999 89999999999999999999
Q ss_pred EEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCC-CCCCCCCchhhHHHHHHH
Q 002346 726 AKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRK-ALDDTMPDDRAHLVTWFR 804 (933)
Q Consensus 726 ~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~-p~~~~~~~~~~~~~~~~~ 804 (933)
+||+|||+++....... .....||+.|+|||.+..+.++.++|||||||++|||++|.. ||...... .+. .
T Consensus 166 ~kl~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~~~---~ 237 (309)
T d1fvra_ 166 AKIADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---ELY---E 237 (309)
T ss_dssp EEECCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHH---H
T ss_pred eEEcccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---HHH---H
Confidence 99999999985543221 223468999999999999999999999999999999999765 56543221 111 1
Q ss_pred HHhhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 805 RVLISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 805 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
.+.. ... +. .... ...++.+++.+||+.||++||+|+||++.|++++++.
T Consensus 238 ~i~~-~~~-~~-~~~~---------~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 238 KLPQ-GYR-LE-KPLN---------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp HGGG-TCC-CC-CCTT---------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHHh-cCC-CC-CCcc---------CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence 1111 111 11 1111 1246789999999999999999999999999987644
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=388.94 Aligned_cols=265 Identities=26% Similarity=0.437 Sum_probs=213.6
Q ss_pred hcCCccCCccccCCCeEEEEEEeC------CCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCce
Q 002346 580 TDNFSEANILGRGGFGVVYGGELP------DGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~ 653 (933)
.++|++.+.||+|+||.||+|.+. +++.||||+++... .......|.+|+.++++++|||||+++++|..+..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~ 97 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 97 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCc
Confidence 368889999999999999999652 35789999997653 44556789999999999999999999999999999
Q ss_pred eEEEEeecCCCChhhHhhhccc-----CCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEE
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHD-----HGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKV 728 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl 728 (933)
.++||||+++|+|.++++.... .....+++..+..++.|+++||+|||+ ++|+||||||+|||+++++++||
T Consensus 98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEE
T ss_pred eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEE
Confidence 9999999999999999875321 223457999999999999999999999 89999999999999999999999
Q ss_pred ecccccccCCCCCcee-ecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCC-CCCCCCCCchhhHHHHHHHHH
Q 002346 729 ADFGLVKNAPDGKYSV-ETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGR-KALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 729 ~DfGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~-~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+|||+++......... .....||+.|+|||.+.++.++.++||||||+++|||+||+ .||....... ....+
T Consensus 175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~~~~i 248 (308)
T d1p4oa_ 175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VLRFV 248 (308)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------HHHHH
T ss_pred eecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------HHHHH
Confidence 9999998655433322 33457899999999999999999999999999999999986 5665432221 11222
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhc
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQW 866 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~ 866 (933)
. ....+.. .+.. ...+.+++.+||+.+|++|||+.+|+++|++.++++
T Consensus 249 ~--~~~~~~~-p~~~---------~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 249 M--EGGLLDK-PDNC---------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp H--TTCCCCC-CTTC---------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred H--hCCCCCC-cccc---------hHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence 1 1111111 1111 135889999999999999999999999998876554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-44 Score=393.53 Aligned_cols=252 Identities=23% Similarity=0.299 Sum_probs=198.5
Q ss_pred hcCCccCC-ccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhc-CCCcceeEEeEeee----Cc
Q 002346 580 TDNFSEAN-ILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV-RHRHLVALLGYCIN----GS 652 (933)
Q Consensus 580 ~~~~~~~~-~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~ 652 (933)
.++|.+.+ .||+|+||.||+|.. .+++.||||+++.. ..+.+|+.++.++ +|||||++++++.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 46888875 699999999999954 67999999998643 4678899987655 89999999999865 45
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---CCcEEEe
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVA 729 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~ 729 (933)
..|+|||||+||+|.+++.. .+...+++.+++.++.||+.||+|||+ ++|+||||||+|||++. ++.+||+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~---~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQD---RGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHS---CSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred EEEEEEECCCCCcHHHHHHh---cCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCcccccccccccccccccccccccc
Confidence 68999999999999999965 223569999999999999999999999 89999999999999985 5679999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||+|+....... .....||+.|+|||++.+..|+.++|||||||++|||+||+.||........... ........
T Consensus 157 DFG~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~--~~~~i~~~ 232 (335)
T d2ozaa1 157 DFGFAKETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIRMG 232 (335)
T ss_dssp CCTTCEECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------CCCSC
T ss_pred ccceeeeccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH--HHHHHhcC
Confidence 9999987655432 2446899999999999999999999999999999999999999976433221100 00000000
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
. ..++ .........++.+++.+||+.||++||++.|+++
T Consensus 233 ~--------~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 233 Q--------YEFP-NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp S--------SSCC-TTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred C--------CCCC-CcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence 0 0111 1111223456889999999999999999999986
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=388.53 Aligned_cols=266 Identities=23% Similarity=0.276 Sum_probs=198.4
Q ss_pred cCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCch---hHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 585 EANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNK---GLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 585 ~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
.+++||+|+||+||+|.. .+|+.||||+++....... ..+.+.+|+.++++++|||||++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 357899999999999965 5699999999976543221 235689999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+.++++...... ...+++.++..++.||+.||+|||+ ++|+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP 153 (299)
T ss_dssp CSEEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred hcchHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCC
Confidence 988777665532 3568899999999999999999999 89999999999999999999999999999866543
Q ss_pred CceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc--cCCCCccc
Q 002346 741 KYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS--KENIPKAI 817 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 817 (933)
... ....+||+.|+|||++... .++.++||||+||++|||+||+.||....+.+. ...+...... ....+...
T Consensus 154 ~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~---l~~i~~~~~~~~~~~~~~~~ 229 (299)
T d1ua2a_ 154 NRA-YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ---LTRIFETLGTPTEEQWPDMC 229 (299)
T ss_dssp CCC-CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHHHHHHCCCCTTTSSSTT
T ss_pred ccc-ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHH---HHHHHHhcCCCChhhccchh
Confidence 322 2345799999999988654 579999999999999999999999976543222 1111111110 00111000
Q ss_pred C----CCCC-CChhhH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 818 D----PNLN-LDEETI-----ESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 818 d----~~l~-~~~~~~-----~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
. .... ...... .....+.+++.+||+.||++|||++|+++ ++|..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~------Hp~f~ 284 (299)
T d1ua2a_ 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK------MKYFS 284 (299)
T ss_dssp SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT------SGGGT
T ss_pred ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC------CHhhC
Confidence 0 0000 000000 11246789999999999999999999976 67764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-44 Score=384.11 Aligned_cols=272 Identities=24% Similarity=0.349 Sum_probs=203.4
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++++.||+|+||+||+|.. .+|+.||||+++.........+++.+|++++++++|||||++++++.++...|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 6899999999999999999954 679999999997765444456789999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
|+.+ ++.+++... ....+++.++..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+....
T Consensus 82 ~~~~-~~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~ 154 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV 154 (298)
T ss_dssp CCSE-EHHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ecCC-chhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccC
Confidence 9965 555555331 23569999999999999999999999 8999999999999999999999999999986654
Q ss_pred CCceeecccccccCcccccccCCCC-CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC-CCcc-
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGR-VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN-IPKA- 816 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~- 816 (933)
... ......||+.|+|||.+.... ++.++||||+||++|||++|+.||......+. +............. .+..
T Consensus 155 ~~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~ 231 (298)
T d1gz8a_ 155 PVR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVWPGVT 231 (298)
T ss_dssp CSB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGG
T ss_pred Ccc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHH--HHHHHHhcCCCchhhccccc
Confidence 332 234458999999999876655 57899999999999999999999986543221 11111111100000 0000
Q ss_pred -----cC--CCCCCChh---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 817 -----ID--PNLNLDEE---TIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 817 -----~d--~~l~~~~~---~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.. +....... .......+.+++.+||+.||++|||++|+++ ++|..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~------H~ff~ 287 (298)
T d1gz8a_ 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA------HPFFQ 287 (298)
T ss_dssp GSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT------SGGGT
T ss_pred cccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC------CHhhc
Confidence 00 00000000 0111246789999999999999999999986 66664
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-44 Score=382.27 Aligned_cols=242 Identities=24% Similarity=0.368 Sum_probs=198.0
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCc----hhHHHHHHHHHHHHhcC--CCcceeEEeEeeeCc
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGN----KGLSEFQAEIAVLTKVR--HRHLVALLGYCINGS 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~----~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~ 652 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++....... ....++.+|+.++++++ |||||++++++.+++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence 46899999999999999999954 579999999997654322 12234778999999996 899999999999999
Q ss_pred eeEEEEeecCC-CChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-CCcEEEec
Q 002346 653 ERLLVYEYMPR-GTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-DMRAKVAD 730 (933)
Q Consensus 653 ~~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-~~~~kl~D 730 (933)
..++||||+.+ +++.+++.. ...+++.+++.++.|+++||+|||+ ++|+||||||+|||++. ++.+||+|
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~-----~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~D 154 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE-----RGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH-----HCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECC
T ss_pred eEEEEEEeccCcchHHHHHhc-----cCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECc
Confidence 99999999976 677788755 2568999999999999999999999 89999999999999985 47999999
Q ss_pred ccccccCCCCCceeecccccccCcccccccCCCCC-CCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 731 FGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRV-TTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 731 fGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
||+|+...... .+...||+.|+|||++.+..+ +.++||||+||++|||+||+.||.... .....
T Consensus 155 FG~a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------~i~~~ 219 (273)
T d1xwsa_ 155 FGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------EIIRG 219 (273)
T ss_dssp CTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------HHHHC
T ss_pred cccceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------------HHhhc
Confidence 99998655432 345689999999999987665 677999999999999999999996421 11111
Q ss_pred cCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 810 KENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 810 ~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
...++ +.+. .++.+++.+||+.||++|||++|+++
T Consensus 220 ~~~~~----~~~s---------~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 220 QVFFR----QRVS---------SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp CCCCS----SCCC---------HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ccCCC----CCCC---------HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence 22222 2222 35779999999999999999999976
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.9e-44 Score=381.16 Aligned_cols=266 Identities=24% Similarity=0.353 Sum_probs=202.8
Q ss_pred cCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEee
Q 002346 581 DNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYEY 660 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~ 660 (933)
++|++++.||+|+||+||+|..++|+.||||++..........+++.+|+.++++++|||||++++++..++..+++|||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 68999999999999999999888999999999977654455567899999999999999999999999999999999999
Q ss_pred cCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCCC
Q 002346 661 MPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPDG 740 (933)
Q Consensus 661 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~~ 740 (933)
+.++.+..+... ...+++.++..++.||+.||+|||+ .+||||||||+|||++.++.+|++|||.+......
T Consensus 82 ~~~~~~~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHhh-----cCCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 987766666533 3569999999999999999999999 89999999999999999999999999999865543
Q ss_pred CceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc-cCCCCcc--
Q 002346 741 KYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS-KENIPKA-- 816 (933)
Q Consensus 741 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-- 816 (933)
.. ......|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+. +.......... ....+..
T Consensus 154 ~~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~ 230 (286)
T d1ob3a_ 154 VR-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQ--LMRIFRILGTPNSKNWPNVTE 230 (286)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGG
T ss_pred cc-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHH--HHHHHHhhCCCChhhccchhh
Confidence 32 22344789999999998654 568999999999999999999999976543222 11111111000 0000000
Q ss_pred ---cCCCCC----C--ChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 817 ---IDPNLN----L--DEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 817 ---~d~~l~----~--~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.+.... . ..........+.+++.+||+.||++|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 231 LPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred hhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000000 0 0000111245779999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-43 Score=377.39 Aligned_cols=271 Identities=22% Similarity=0.311 Sum_probs=201.8
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CC-CcEEEEEEeccccCCchhHHHHHHHHHHHHhc---CCCcceeEEeEeee----
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PD-GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKV---RHRHLVALLGYCIN---- 650 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---- 650 (933)
.++|++++.||+|+||+||+|.. .+ ++.||||+++...........+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 47899999999999999999965 44 66799999976644443344567788777766 79999999999853
Q ss_pred -CceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEe
Q 002346 651 -GSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVA 729 (933)
Q Consensus 651 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~ 729 (933)
....+++|||++++.+...... ....+++..++.++.|++.||+|||+ ++||||||||+|||++.++.+||+
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~ 158 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLA 158 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEEC
T ss_pred cCceEEEEEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeec
Confidence 3467899999988776544432 23568999999999999999999999 899999999999999999999999
Q ss_pred cccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhc
Q 002346 730 DFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLIS 809 (933)
Q Consensus 730 DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 809 (933)
|||+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|+.||....+.+... . +......
T Consensus 159 dfg~~~~~~~~~--~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--~-i~~~~~~ 233 (305)
T d1blxa_ 159 DFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--K-ILDVIGL 233 (305)
T ss_dssp SCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--H-HHHHHCC
T ss_pred chhhhhhhcccc--cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH--H-HHHhhCC
Confidence 999987554332 2345689999999999999999999999999999999999999998654332211 1 1111100
Q ss_pred --cCCCCcc------c-CCCCC--CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 810 --KENIPKA------I-DPNLN--LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 810 --~~~~~~~------~-d~~l~--~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
....+.. . ..... ...........+.+++.+||+.||++|||++|+++ ++|..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~------Hpff~ 297 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS------HPYFQ 297 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT------SGGGT
T ss_pred CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc------Chhhc
Confidence 0000000 0 00000 00001111235678999999999999999999976 66664
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-42 Score=370.85 Aligned_cols=271 Identities=21% Similarity=0.283 Sum_probs=201.9
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee--------C
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN--------G 651 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~ 651 (933)
++|++++.||+|+||+||+|.. .+|+.||||++..........+++.+|+.++++++||||+++++++.. .
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 6899999999999999999965 689999999997765555566789999999999999999999998865 3
Q ss_pred ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecc
Q 002346 652 SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADF 731 (933)
Q Consensus 652 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~Df 731 (933)
...++||||++++.+..+... ...+++.+++.++.|+++||.|||+ ++|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~df 161 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADF 161 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCC
T ss_pred ceEEEEEeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeec
Confidence 457899999987766655432 3568899999999999999999999 89999999999999999999999999
Q ss_pred cccccCCCCCce---eecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHh
Q 002346 732 GLVKNAPDGKYS---VETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVL 807 (933)
Q Consensus 732 Gla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~ 807 (933)
|+++........ ......||+.|+|||++.+. .++.++||||+||++|||++|+.||....+.... ..+....
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~---~~i~~~~ 238 (318)
T d3blha1 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL---ALISQLC 238 (318)
T ss_dssp TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHH
T ss_pred ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH---HHHHHhc
Confidence 999866543321 12335799999999998755 6899999999999999999999999765432222 1122211
Q ss_pred hc-cCCCCcccCCC---------CCCChhhH------HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 808 IS-KENIPKAIDPN---------LNLDEETI------ESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 808 ~~-~~~~~~~~d~~---------l~~~~~~~------~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.. ........+.. ........ .....+.+++.+||+.||++|||++|+++ ++|..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~------Hpff~ 309 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN------HDFFW 309 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc------Chhhc
Confidence 11 00100000000 00000001 11234678999999999999999999987 77765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=375.44 Aligned_cols=264 Identities=22% Similarity=0.355 Sum_probs=199.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc------
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS------ 652 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------ 652 (933)
.++|++++.||+|+||+||+|.. .+|+.||||+++.........+.+.+|+++|++++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 47899999999999999999964 57999999999876556666788999999999999999999999997654
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccc
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFG 732 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfG 732 (933)
+.++||||+ +.+|..+.+. ..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+|++|||
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg 166 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFG 166 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccc
Confidence 569999999 6678777654 469999999999999999999999 899999999999999999999999999
Q ss_pred ccccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc-
Q 002346 733 LVKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK- 810 (933)
Q Consensus 733 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~- 810 (933)
+|+...... +...||+.|+|||.+.+. .++.++||||+||++|||++|+.||......+.... .. ......
T Consensus 167 ~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~--~~-~~~~~~~ 239 (346)
T d1cm8a_ 167 LARQADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE--IM-KVTGTPP 239 (346)
T ss_dssp TCEECCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HH-HHHCCCC
T ss_pred ceeccCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH--HH-hccCCCc
Confidence 998765432 346899999999998654 568999999999999999999999976533221111 11 000000
Q ss_pred ----------------CCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 811 ----------------ENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 811 ----------------~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
...++.....+. .........+.+++.+||+.||++|||++|+++ ++|..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~------Hp~f~ 305 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALA------HPYFE 305 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH------SGGGT
T ss_pred HHHHhhhcchhhhhhhccCCcccccchH--HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc------ChhhC
Confidence 000000000000 000011135679999999999999999999987 66654
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=372.89 Aligned_cols=265 Identities=20% Similarity=0.309 Sum_probs=197.0
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCc----ee
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGS----ER 654 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~ 654 (933)
+++|++++.||+|+||+||+|. ..+|+.||||++.+.. .....+++.+|+.+|++++||||+++++++.... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 5689999999999999999995 5689999999997653 3445678999999999999999999999987543 23
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEeccccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLV 734 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla 734 (933)
+++++|+.+|+|.+++.. ..+++..++.++.|++.||+|||+ ++||||||||+|||++.++.+||+|||++
T Consensus 86 ~~l~~~~~~g~L~~~l~~------~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a 156 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLA 156 (345)
T ss_dssp EEEEEECCCEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEeecCCchhhhhhc------CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCce
Confidence 455566779999999965 458999999999999999999999 89999999999999999999999999999
Q ss_pred ccCCCCCce--eecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 735 KNAPDGKYS--VETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 735 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
+........ ......||+.|+|||++.. ..++.++||||+||++|||++|+.||......+..... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~---~~~~~~~~ 233 (345)
T d1pmea_ 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGSPS 233 (345)
T ss_dssp EECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH---HHHHCSCC
T ss_pred eeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH---hhhccCCC
Confidence 865443221 1234679999999999854 46789999999999999999999999765432221111 11100000
Q ss_pred CCC-------------cccCCCCCCCh--hhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 812 NIP-------------KAIDPNLNLDE--ETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 812 ~~~-------------~~~d~~l~~~~--~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
... ........... .......++.+++.+||+.||++|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000 00000000000 00011135789999999999999999999986
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.8e-41 Score=360.08 Aligned_cols=266 Identities=18% Similarity=0.233 Sum_probs=211.1
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCC-CcceeEEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-RHLVALLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||+||+|.. .+|+.||||++...... ..+.+|++.++.++| +|++.+++++..+...++|
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 57899999999999999999964 57899999988654322 357788999999965 8999999999999999999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC-----CCcEEEeccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD-----DMRAKVADFG 732 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~-----~~~~kl~DfG 732 (933)
|||+ +++|.+++... ...+++.++..++.|++.||+|||+ ++|+||||||+|||++. ++.+||+|||
T Consensus 80 me~~-~~~l~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG 151 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 151 (293)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred EEec-CCCHHHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccc
Confidence 9999 78999988652 2468999999999999999999999 89999999999999974 5789999999
Q ss_pred ccccCCCCCc------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHH
Q 002346 733 LVKNAPDGKY------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRV 806 (933)
Q Consensus 733 la~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~ 806 (933)
+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||+.||..............+...
T Consensus 152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~ 231 (293)
T d1csna_ 152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 231 (293)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhc
Confidence 9986543221 1233467999999999999999999999999999999999999999865544332222222111
Q ss_pred hhccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 807 LISKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 807 ~~~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
.. .... +.+.+.+ +.++.+++..|+..+|++||+++.+.+.|++++++...
T Consensus 232 ~~-~~~~-~~l~~~~---------p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~ 282 (293)
T d1csna_ 232 KQ-STPL-RELCAGF---------PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT 282 (293)
T ss_dssp HH-HSCH-HHHTTTS---------CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred cC-CCCh-HHhcCCC---------CHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence 11 0111 1111111 14578999999999999999999999999988876654
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=365.78 Aligned_cols=271 Identities=20% Similarity=0.261 Sum_probs=210.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeCceeEEEEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCINGSERLLVYE 659 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e 659 (933)
++|++++.||+|+||+||+|+. .+|+.||||+++..........++.+|+.+++.++|||||++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5899999999999999999964 678999999998766555667899999999999999999999999999999999999
Q ss_pred ecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccccccCCC
Q 002346 660 YMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGLVKNAPD 739 (933)
Q Consensus 660 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~~~~~ 739 (933)
++.+++|..++.. .+.+++..++.++.|+++||+|||+ ++|+||||||+|||++.++.+||+|||.++....
T Consensus 82 ~~~~~~l~~~~~~-----~~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~ 153 (292)
T d1unla_ 82 FCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSEEHHHHHHHT-----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred ecccccccccccc-----ccccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccC
Confidence 9999988887754 3568899999999999999999999 8999999999999999999999999999987654
Q ss_pred CCceeecccccccCcccccccCCCC-CCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhcc--CCCC--
Q 002346 740 GKYSVETRLAGTFGYLAPEYAATGR-VTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISK--ENIP-- 814 (933)
Q Consensus 740 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~-- 814 (933)
... ......+++.|+|||.+.... ++.++||||+||++|||++|+.||........ ....+....... ...+
T Consensus 154 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 230 (292)
T d1unla_ 154 PVR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSM 230 (292)
T ss_dssp CCS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTG
T ss_pred CCc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhh
Confidence 432 223446788999999887655 68999999999999999999999865433221 111111111100 0000
Q ss_pred ----ccc-----CCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 815 ----KAI-----DPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 815 ----~~~-----d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
+.. ................+.+++.+|++.||++|||++|+++ ++|..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~------Hp~f~ 287 (292)
T d1unla_ 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ------HPYFS 287 (292)
T ss_dssp GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT------SGGGS
T ss_pred hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc------Chhhc
Confidence 000 0000000111112245778999999999999999999976 66664
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-41 Score=360.53 Aligned_cols=262 Identities=20% Similarity=0.283 Sum_probs=199.5
Q ss_pred hcCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCccee-EEeEeeeCceeEEE
Q 002346 580 TDNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVA-LLGYCINGSERLLV 657 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv 657 (933)
.++|++.+.||+|+||.||+|.. .+|+.||||++..... ..++.+|+++++.++|++++. +.+++.+++..++|
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc----CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 46899999999999999999954 5789999998876432 235789999999998776555 45556777888999
Q ss_pred EeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecC---CCcEEEeccccc
Q 002346 658 YEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGD---DMRAKVADFGLV 734 (933)
Q Consensus 658 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~---~~~~kl~DfGla 734 (933)
|||+ ++++.+.+... ...+++.++..++.|+++||+|||+ ++||||||||+|||++. +..+||+|||+|
T Consensus 82 me~~-~~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC----SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA 153 (299)
T ss_dssp EECC-CCBHHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred EEEc-CCchhhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcc
Confidence 9999 56777766441 2569999999999999999999999 89999999999999864 557999999999
Q ss_pred ccCCCCCc------eeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhh
Q 002346 735 KNAPDGKY------SVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLI 808 (933)
Q Consensus 735 ~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~ 808 (933)
+....... .......||+.|+|||.+.+..++.++|||||||++|||+||+.||....................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 87654332 123446899999999999999999999999999999999999999987554333222211111110
Q ss_pred ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhh
Q 002346 809 SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVE 864 (933)
Q Consensus 809 ~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~ 864 (933)
.... ..+.+.+ ..++.+++.+|++.+|++||+++++.+.|+.+..
T Consensus 234 -~~~~-~~~~~~~---------p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~ 278 (299)
T d1ckia_ 234 -STPI-EVLCKGY---------PSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278 (299)
T ss_dssp -HSCH-HHHTTTS---------CHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred -CCCh-hHhccCC---------CHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence 0000 1111111 2457899999999999999999999999887654
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-41 Score=366.50 Aligned_cols=259 Identities=24% Similarity=0.349 Sum_probs=206.4
Q ss_pred cCCccCCccccCCCeEEEEEEe----CCCcEEEEEEeccccC--CchhHHHHHHHHHHHHhcCC-CcceeEEeEeeeCce
Q 002346 581 DNFSEANILGRGGFGVVYGGEL----PDGTKIAVKRMESNTM--GNKGLSEFQAEIAVLTKVRH-RHLVALLGYCINGSE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~ 653 (933)
++|++++.||+|+||+||+|.. .+|+.||||++..... .....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 6799999999999999999953 2588999999876532 22334678899999999976 899999999999999
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.++||||+.+|+|.+++... ..+++..+..++.|++.|++|+|+ ++|+||||||+||+++.++.+||+|||+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~ 175 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGL 175 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccc
Confidence 99999999999999999762 457889999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCC--CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATG--RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKE 811 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 811 (933)
++..............|++.|+|||.+.+. .++.++||||+||++|||++|+.||......+..... .........
T Consensus 176 a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i--~~~~~~~~~ 253 (322)
T d1vzoa_ 176 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI--SRRILKSEP 253 (322)
T ss_dssp EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH--HHHHHHCCC
T ss_pred hhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcccCCC
Confidence 987665444444556899999999998654 4688999999999999999999999876543332221 111111111
Q ss_pred CCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHHHhhhhhhcCC
Q 002346 812 NIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPD-----MGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 812 ~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs-----~~evl~~L~~~~~~~~~ 868 (933)
..+. . ...++.+++.+||+.||++||+ ++|+++ ++|..
T Consensus 254 ~~~~----~---------~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~------Hpff~ 296 (322)
T d1vzoa_ 254 PYPQ----E---------MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE------HLFFQ 296 (322)
T ss_dssp CCCT----T---------SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT------SGGGT
T ss_pred CCcc----c---------CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc------CHhhc
Confidence 1111 1 1246779999999999999995 677764 56653
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-41 Score=369.40 Aligned_cols=260 Identities=23% Similarity=0.333 Sum_probs=191.8
Q ss_pred CCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC------cee
Q 002346 582 NFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING------SER 654 (933)
Q Consensus 582 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~ 654 (933)
+|+..++||+|+||+||+|.. .+|+.||||++..... .+.+|++++++++|||||++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 578889999999999999965 5799999999976532 234799999999999999999998543 346
Q ss_pred EEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEEecccc
Q 002346 655 LLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGL 733 (933)
Q Consensus 655 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGl 733 (933)
++||||++++ +.+.+..... ....+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++ .+||+|||+
T Consensus 95 ~lv~Ey~~~~-~~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 95 NLVLDYVPET-VYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEECCSEE-HHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTT
T ss_pred EEEEeccCCc-cHHHHHhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccc
Confidence 8999999765 4444432111 23579999999999999999999998 8999999999999999775 899999999
Q ss_pred cccCCCCCceeecccccccCcccccccCC-CCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHH--------
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAAT-GRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFR-------- 804 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~-------- 804 (933)
++....... .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.||......+. +.....
T Consensus 170 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~--l~~i~~~~g~~~~~ 245 (350)
T d1q5ka_ 170 AKQLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ--LVEIIKVLGTPTRE 245 (350)
T ss_dssp CEECCTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred hhhccCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHH--HHHHHHHhCCChHH
Confidence 987655432 234589999999998764 5789999999999999999999999976543222 111111
Q ss_pred ---HHhh--ccCCCCcccCCCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 002346 805 ---RVLI--SKENIPKAIDPNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVN 857 (933)
Q Consensus 805 ---~~~~--~~~~~~~~~d~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~ 857 (933)
.... .....+........ ..........+.+++.+||+.||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~ 302 (350)
T d1q5ka_ 246 QIREMNPNYTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302 (350)
T ss_dssp HHHHHCC---CCCCCCCCCCCGG-GTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred hhhhhccchhhccccccccCchh-hhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0000 00001100000000 0000111235779999999999999999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.1e-40 Score=361.44 Aligned_cols=265 Identities=17% Similarity=0.266 Sum_probs=200.8
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeee--CceeEE
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCIN--GSERLL 656 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~l 656 (933)
++|++++.||+|+||+||+|.. .+|+.||||+++.. ..+++.+|+++|++++ ||||+++++++.. ....++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~-----~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS-----CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH-----HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 6899999999999999999955 67999999998653 2467899999999995 9999999999874 356899
Q ss_pred EEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC-cEEEecccccc
Q 002346 657 VYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-RAKVADFGLVK 735 (933)
Q Consensus 657 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-~~kl~DfGla~ 735 (933)
||||+++++|..+. ..+++.+++.++.||++||+|||+ ++|+||||||+|||++.++ .+||+|||+|+
T Consensus 110 v~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~ 178 (328)
T d3bqca1 110 VFEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178 (328)
T ss_dssp EEECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred EEeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccce
Confidence 99999999997765 358999999999999999999999 8999999999999998655 69999999998
Q ss_pred cCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHH-----------HHH
Q 002346 736 NAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLV-----------TWF 803 (933)
Q Consensus 736 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~-----------~~~ 803 (933)
....... .....||+.|+|||.+.+. .++.++||||+||++|||++|+.||............ .+.
T Consensus 179 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 179 FYHPGQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp ECCTTCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred eccCCCc--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhh
Confidence 7654432 2445789999999998765 4799999999999999999999999765442211100 010
Q ss_pred HHHhhc-cCCCCcccCCC-------CCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 804 RRVLIS-KENIPKAIDPN-------LNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 804 ~~~~~~-~~~~~~~~d~~-------l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
...... ........... ............++.+++.+||+.||++|||++|+++ ++|+..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~------Hp~F~~ 324 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME------HPYFYT 324 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTT
T ss_pred hhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc------CcccCC
Confidence 000000 00000000000 0000011112245779999999999999999999986 777653
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.7e-40 Score=360.27 Aligned_cols=293 Identities=26% Similarity=0.404 Sum_probs=214.2
Q ss_pred CccchHHHHHHHHHhcCCCC--CCCCCCCCCCCc--cccceEeCCC---CCEEEEEecCCCCcc--ccCccccCCcccce
Q 002346 24 SLGDDGSVMLKLAQSLQNLP--SDWSSTSSTGYC--EWTGINCDNS---NRVTTISLAKSGLSG--TLSPEISSLTQLET 94 (933)
Q Consensus 24 ~~~~d~~~l~~~~~~~~~~~--~~w~~~~~~~~C--~w~gv~c~~~---~~v~~L~l~~~~l~~--~~~~~~~~l~~L~~ 94 (933)
|.++|++||++||+++.+.. ++|. .+++|| .|+||+|+.. .+|+.|+|++++++| .+|++|++|++|++
T Consensus 3 c~~~e~~aLl~~k~~~~~~~~l~sW~--~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~ 80 (313)
T d1ogqa_ 3 CNPQDKQALLQIKKDLGNPTTLSSWL--PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNF 80 (313)
T ss_dssp SCHHHHHHHHHHHHHTTCCGGGTTCC--TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCSE
T ss_pred CCHHHHHHHHHHHHHCCCCCcCCCCC--CCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCChHHhcCccccc
Confidence 67899999999999998754 4664 466888 5999999864 379999999999998 58899999999999
Q ss_pred eeccc-ccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccC
Q 002346 95 LSFQM-NNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172 (933)
Q Consensus 95 L~l~~-N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~ 172 (933)
|+|++ |+++|.+| +|+++++|++|+|++|+|.++++..+..+.+|+.++++.|.+.. .+|..+.+++.|+.+++++
T Consensus 81 L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~--~~p~~l~~l~~L~~l~l~~ 158 (313)
T d1ogqa_ 81 LYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG--TLPPSISSLPNLVGITFDG 158 (313)
T ss_dssp EEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES--CCCGGGGGCTTCCEEECCS
T ss_pred cccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccc--cCchhhccCcccceeeccc
Confidence 99986 89998887 78999999999999999888777666666666666666665554 3445555555555555555
Q ss_pred cccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCC
Q 002346 173 ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP 252 (933)
Q Consensus 173 n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 252 (933)
|.+.+.+|..+..+..+ ++.++++.|++++..+
T Consensus 159 n~l~~~ip~~~~~l~~l-----------------------------------------------~~~l~~~~n~l~~~~~ 191 (313)
T d1ogqa_ 159 NRISGAIPDSYGSFSKL-----------------------------------------------FTSMTISRNRLTGKIP 191 (313)
T ss_dssp SCCEEECCGGGGCCCTT-----------------------------------------------CCEEECCSSEEEEECC
T ss_pred ccccccccccccccccc-----------------------------------------------cccccccccccccccc
Confidence 55554445444444443 2444444444444444
Q ss_pred CCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhh
Q 002346 253 DLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTT 332 (933)
Q Consensus 253 ~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~ 332 (933)
.......+..+++++|.+.+.+|..+..+++|+.+++++|.+++.+|
T Consensus 192 ~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~--------------------------------- 238 (313)
T d1ogqa_ 192 PTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLG--------------------------------- 238 (313)
T ss_dssp GGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGG---------------------------------
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccc---------------------------------
Confidence 32222234467777777777778777788888888888877776433
Q ss_pred hHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccC
Q 002346 333 LLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLT 412 (933)
Q Consensus 333 ~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~ 412 (933)
.++.+++|+.|+|++|+++|.+|.+|++|++|++|+|++|+|+|.+|. +.
T Consensus 239 -----------------------------~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~ 288 (313)
T d1ogqa_ 239 -----------------------------KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GG 288 (313)
T ss_dssp -----------------------------GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-ST
T ss_pred -----------------------------ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCC-cc
Confidence 223345677788888888888888888888899999999999888884 67
Q ss_pred CCCCcCEEeccCCc-Cccc
Q 002346 413 KLASLQNLDVSNNN-LSGK 430 (933)
Q Consensus 413 ~l~~L~~l~ls~N~-l~g~ 430 (933)
+|++|+.+++++|+ ++|.
T Consensus 289 ~L~~L~~l~l~~N~~l~g~ 307 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGS 307 (313)
T ss_dssp TGGGSCGGGTCSSSEEEST
T ss_pred cCCCCCHHHhCCCccccCC
Confidence 88888888888886 5664
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-40 Score=362.27 Aligned_cols=269 Identities=22% Similarity=0.299 Sum_probs=197.3
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeee------Cce
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCIN------GSE 653 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~ 653 (933)
++|+++++||+|+||+||+|.. .+|+.||||++.....+....+++.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 6899999999999999999964 579999999998776666667789999999999999999999999864 367
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.|+||||+.++ +.+.+. ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~iv~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~ 165 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_dssp EEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred eEEEEeccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhh
Confidence 89999999654 545542 348999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHH------------
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVT------------ 801 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~------------ 801 (933)
++...... ......||+.|+|||++.+..++.++||||+||++|||++|+.||.............
T Consensus 166 ~~~~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (355)
T d2b1pa1 166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK 243 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hhcccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHH
Confidence 88655432 2344579999999999999999999999999999999999999997653221111000
Q ss_pred ----HHHHHhhccCCC-----CcccCCC-CC-CChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCC
Q 002346 802 ----WFRRVLISKENI-----PKAIDPN-LN-LDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 802 ----~~~~~~~~~~~~-----~~~~d~~-l~-~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~ 868 (933)
............ +..+... .. ...........+.+|+.+|++.||++|||++|+++ ++|..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~------Hpw~~ 315 (355)
T d2b1pa1 244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ------HPYIN 315 (355)
T ss_dssp TSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT------STTTG
T ss_pred HhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc------CcccC
Confidence 000000000000 0000000 00 11223344567889999999999999999999986 66664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-40 Score=363.99 Aligned_cols=265 Identities=22% Similarity=0.357 Sum_probs=201.3
Q ss_pred hcCCccCCccccCCCeEEEEEE-eCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcceeEEeEeeeC-----ce
Q 002346 580 TDNFSEANILGRGGFGVVYGGE-LPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHLVALLGYCING-----SE 653 (933)
Q Consensus 580 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~ 653 (933)
.++|++++.||+|+||+||+|. ..+|+.||||++.....+....+++.+|++++++++|||||++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 5789999999999999999995 46799999999987765666677899999999999999999999998643 34
Q ss_pred eEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEEEecccc
Q 002346 654 RLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAKVADFGL 733 (933)
Q Consensus 654 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~kl~DfGl 733 (933)
.+++|+|+.+|+|.+++.. ..+++.+++.++.||+.||+|||+ ++|+||||||+|||++.++.+|++|||+
T Consensus 97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~ 167 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGL 167 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccch
Confidence 4667788889999999854 459999999999999999999999 8999999999999999999999999999
Q ss_pred cccCCCCCceeecccccccCcccccccCCC-CCCCccchHhHHHHHHHHHcCCCCCCCCCCchhhHHHHHHHHHhhccCC
Q 002346 734 VKNAPDGKYSVETRLAGTFGYLAPEYAATG-RVTTKIDVYAFGVVLMETITGRKALDDTMPDDRAHLVTWFRRVLISKEN 812 (933)
Q Consensus 734 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 812 (933)
+...... .....|++.|+|||...+. .++.++||||+||++|||++|+.||........... +.... ..
T Consensus 168 a~~~~~~----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~---~~ 237 (348)
T d2gfsa1 168 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLV---GT 237 (348)
T ss_dssp --CCTGG----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHH---CC
T ss_pred hcccCcc----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHHhc---CC
Confidence 8755432 2345789999999987665 468999999999999999999999976533222111 11110 00
Q ss_pred CCccc----------------C--CCCCCChhhHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHhhhhhhcCCC
Q 002346 813 IPKAI----------------D--PNLNLDEETIESIYRVAELAGHCTAREPQQRPDMGHAVNVLGPLVEQWKPA 869 (933)
Q Consensus 813 ~~~~~----------------d--~~l~~~~~~~~~~~~~~~li~~cl~~~P~~RPs~~evl~~L~~~~~~~~~~ 869 (933)
....+ . +..............+.+++.+||+.||++|||++|+++ ++|...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~------Hp~f~~ 306 (348)
T d2gfsa1 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA------HAYFAQ 306 (348)
T ss_dssp CCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT------SGGGTT
T ss_pred CChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc------CHhhCC
Confidence 00000 0 000000000011245779999999999999999999986 666643
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.1e-35 Score=329.20 Aligned_cols=270 Identities=20% Similarity=0.256 Sum_probs=193.0
Q ss_pred cCCccCCccccCCCeEEEEEEe-CCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-----------CCcceeEEeEe
Q 002346 581 DNFSEANILGRGGFGVVYGGEL-PDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-----------HRHLVALLGYC 648 (933)
Q Consensus 581 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~ 648 (933)
.+|+++++||+|+||+||+|+. .+|+.||||+++.. ....+.+.+|+.+++.++ |+|||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 3599999999999999999964 67999999999764 233467888999888875 57899999887
Q ss_pred eeC--ceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCC--
Q 002346 649 ING--SERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDM-- 724 (933)
Q Consensus 649 ~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~-- 724 (933)
... ...+++|+++..+........ ......+++..+..++.||++|++|||+ ..+|+||||||+|||++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETT
T ss_pred eeccccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcc
Confidence 643 455667776655443333222 2234568999999999999999999997 37899999999999998665
Q ss_pred ----cEEEecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHHHHHHcCCCCCCCCCCchh----
Q 002346 725 ----RAKVADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVLMETITGRKALDDTMPDDR---- 796 (933)
Q Consensus 725 ----~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l~elltG~~p~~~~~~~~~---- 796 (933)
.++++|||.+...... .....||+.|+|||++....++.++||||+||+++||++|+.||........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~ 241 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 241 (362)
T ss_dssp TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred cccceeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence 3999999998865432 2345799999999999999999999999999999999999999975432111
Q ss_pred hHHHHHHHHHhhc-----------------cCCCCcccCCCCC---------CChhhHHHHHHHHHHHHHcccCCCCCCC
Q 002346 797 AHLVTWFRRVLIS-----------------KENIPKAIDPNLN---------LDEETIESIYRVAELAGHCTAREPQQRP 850 (933)
Q Consensus 797 ~~~~~~~~~~~~~-----------------~~~~~~~~d~~l~---------~~~~~~~~~~~~~~li~~cl~~~P~~RP 850 (933)
..+...+. .+.. .......+..... ..........++.+++.+|++.||++||
T Consensus 242 ~~~~~~~~-~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 242 DHIAQIIE-LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHH-HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHH-HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCc
Confidence 11111111 0000 0000000000000 0011234556788999999999999999
Q ss_pred CHHHHHHHHhhhhhhcCC
Q 002346 851 DMGHAVNVLGPLVEQWKP 868 (933)
Q Consensus 851 s~~evl~~L~~~~~~~~~ 868 (933)
|++|+++ ++|..
T Consensus 321 ta~e~L~------Hp~f~ 332 (362)
T d1q8ya_ 321 DAGGLVN------HPWLK 332 (362)
T ss_dssp CHHHHHT------CGGGT
T ss_pred CHHHHhc------CcccC
Confidence 9999975 77765
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.96 E-value=4.9e-29 Score=269.47 Aligned_cols=247 Identities=26% Similarity=0.431 Sum_probs=146.2
Q ss_pred CEEEccCCCCCCCCCCCccccCCccCCeeeccC-cccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcc
Q 002346 140 QVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN-ANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMN 218 (933)
Q Consensus 140 ~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~-n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~ 218 (933)
+.|+|++|.+.+...+|..++++++|++|+|++ |++.|.+|..|+++++|++|+|++|++.+..+..+..
T Consensus 53 ~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~--------- 123 (313)
T d1ogqa_ 53 NNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ--------- 123 (313)
T ss_dssp EEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGG---------
T ss_pred EEEECCCCCCCCCCCCChHHhcCccccccccccccccccccccccccccccchhhhccccccccccccccc---------
Confidence 333333333333223444444444444444443 4444444444444444444444444444433333222
Q ss_pred cccCCcccccccccCCccCcEEEecCCccCCCCC-CCCCCCCCCEEEccCCcccccCcccccCCCCC-CEEEccCccCcc
Q 002346 219 DQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIP-DLSKCESLFDLSLRDNQLTGVVPASVISLPAL-LNISLQNNKLQG 296 (933)
Q Consensus 219 ~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~-~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L-~~L~Ls~N~l~~ 296 (933)
+..|+.++++.|++.+.+| .+..+++|+.+++++|.+.+.+|..+..+..+ +.+++++|+++|
T Consensus 124 ---------------~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~ 188 (313)
T d1ogqa_ 124 ---------------IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTG 188 (313)
T ss_dssp ---------------CTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEE
T ss_pred ---------------hhhhcccccccccccccCchhhccCcccceeeccccccccccccccccccccccccccccccccc
Confidence 4444444444444444433 24444445555555555554455444444443 444555555554
Q ss_pred CCCCCCC--CccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEc
Q 002346 297 PYPLFPS--KVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINL 374 (933)
Q Consensus 297 ~~p~~~~--~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~L 374 (933)
..|.... ....+++++|.+. +.+|..+..++.|+.|++
T Consensus 189 ~~~~~~~~l~~~~l~l~~~~~~----------------------------------------~~~~~~~~~~~~l~~l~~ 228 (313)
T d1ogqa_ 189 KIPPTFANLNLAFVDLSRNMLE----------------------------------------GDASVLFGSDKNTQKIHL 228 (313)
T ss_dssp ECCGGGGGCCCSEEECCSSEEE----------------------------------------ECCGGGCCTTSCCSEEEC
T ss_pred cccccccccccccccccccccc----------------------------------------cccccccccccccccccc
Confidence 4443222 1122333333332 223455667789999999
Q ss_pred cCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCCCC--CcccccCCCCCCcCC
Q 002346 375 ANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDFGS--NVKFTVSPGNPFIGT 451 (933)
Q Consensus 375 s~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~~~--~~~~~~~~~n~~~~~ 451 (933)
++|.+.+.+| .++.+++|+.|+|++|+|+|.+|.+|.+|++|++|||++|+|+|.+|++++ .++...+.+|++.|.
T Consensus 229 ~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g 306 (313)
T d1ogqa_ 229 AKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG 306 (313)
T ss_dssp CSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred cccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC
Confidence 9999998765 699999999999999999999999999999999999999999999999865 334445678887664
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.94 E-value=9.1e-26 Score=251.14 Aligned_cols=298 Identities=26% Similarity=0.368 Sum_probs=185.5
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
..+++|++++++|+. + +.|..+++|++|+|++|+|+++++ +.++++|++|+|++|.++++++ ++++++|+.|+++
T Consensus 44 ~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~-l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~ 118 (384)
T d2omza2 44 DQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP-LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLF 118 (384)
T ss_dssp TTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECC
T ss_pred CCCCEEECCCCCCCC-c-cccccCCCCCEEeCcCCcCCCCcc-ccCCcccccccccccccccccc--ccccccccccccc
Confidence 468999999999984 4 358899999999999999998654 9999999999999999998864 8899999999999
Q ss_pred CCCCCCCCCCCccccCCccCCeeeccCcccCCC-----------------------------------------CChhhc
Q 002346 146 DNPNLAPWPFPNELTKSTSLTTLYMDNANIFGL-----------------------------------------IPDFFD 184 (933)
Q Consensus 146 ~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------------------------------------~p~~~~ 184 (933)
+|.+... ........+..+....|.+... ....+.
T Consensus 119 ~~~~~~~----~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (384)
T d2omza2 119 NNQITDI----DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194 (384)
T ss_dssp SSCCCCC----GGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGG
T ss_pred ccccccc----ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccccccccccc
Confidence 9988762 1233344444554444443221 223445
Q ss_pred CCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEE
Q 002346 185 SFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLS 264 (933)
Q Consensus 185 ~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~ 264 (933)
.+++++.|++++|.+++..|. .....++.|.+.+|.+... +.+..+++|+.|++++|++++.. .+..+++|+.|+
T Consensus 195 ~l~~~~~l~l~~n~i~~~~~~-~~~~~L~~L~l~~n~l~~~---~~l~~l~~L~~L~l~~n~l~~~~-~~~~~~~L~~L~ 269 (384)
T d2omza2 195 KLTNLESLIATNNQISDITPL-GILTNLDELSLNGNQLKDI---GTLASLTNLTDLDLANNQISNLA-PLSGLTKLTELK 269 (384)
T ss_dssp GCTTCSEEECCSSCCCCCGGG-GGCTTCCEEECCSSCCCCC---GGGGGCTTCSEEECCSSCCCCCG-GGTTCTTCSEEE
T ss_pred cccccceeeccCCccCCCCcc-cccCCCCEEECCCCCCCCc---chhhcccccchhccccCccCCCC-cccccccCCEee
Confidence 566677777777776643332 2223455555555544432 23444555555555555555433 244555555555
Q ss_pred ccCCcccccCcccccCCCCCCEEEccCccCccCCC-CCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCC
Q 002346 265 LRDNQLTGVVPASVISLPALLNISLQNNKLQGPYP-LFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYP 343 (933)
Q Consensus 265 L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (933)
+++|++++.. .+..++.++.++++.|.+++... .....++.|++++|++.+.
T Consensus 270 l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l------------------------- 322 (384)
T d2omza2 270 LGANQISNIS--PLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI------------------------- 322 (384)
T ss_dssp CCSSCCCCCG--GGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSSCCSCC-------------------------
T ss_pred ccCcccCCCC--ccccccccccccccccccccccccchhcccCeEECCCCCCCCC-------------------------
Confidence 5555555322 24455555555555555554221 1233455555555555331
Q ss_pred ccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEecc
Q 002346 344 AILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVS 423 (933)
Q Consensus 344 ~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls 423 (933)
+ .+..+++|+.|+|++|++++ ++ .|+++++|++|+|++|+|++..| +.++++|+.|+|+
T Consensus 323 ----------------~-~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~ 381 (384)
T d2omza2 323 ----------------S-PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLN 381 (384)
T ss_dssp ----------------G-GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECC
T ss_pred ----------------c-ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh--hccCCCCCEeeCC
Confidence 1 24455667777777777664 33 46667777777777777765443 6667777777777
Q ss_pred CC
Q 002346 424 NN 425 (933)
Q Consensus 424 ~N 425 (933)
+|
T Consensus 382 ~N 383 (384)
T d2omza2 382 DQ 383 (384)
T ss_dssp CE
T ss_pred CC
Confidence 66
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.94 E-value=1.9e-25 Score=240.15 Aligned_cols=275 Identities=22% Similarity=0.311 Sum_probs=224.4
Q ss_pred CCCCCCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccC
Q 002346 49 TSSTGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS 127 (933)
Q Consensus 49 ~~~~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~ 127 (933)
.+..|.|.|.+|.|.+ ++|+ .+|..+. ++|++|+|++|+|+.+++ +|.++++|++|++++|.+..
T Consensus 4 ~p~~c~c~~~~~~C~~-----------~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~ 69 (305)
T d1xkua_ 4 CPFRCQCHLRVVQCSD-----------LGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69 (305)
T ss_dssp CCTTCEEETTEEECTT-----------SCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC
T ss_pred CCCCCEecCCEEEecC-----------CCCC-ccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc
Confidence 3566778999999974 4566 6676664 689999999999999887 79999999999999999999
Q ss_pred CCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccc
Q 002346 128 VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASF 207 (933)
Q Consensus 128 ~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 207 (933)
+++..|.++++|++|+|++|+++. +|..+ ...|..|++..|.+.+..+..+.....+..++...|...... ..
T Consensus 70 i~~~~f~~l~~L~~L~l~~n~l~~---l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~-~~- 142 (305)
T d1xkua_ 70 ISPGAFAPLVKLERLYLSKNQLKE---LPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSG-IE- 142 (305)
T ss_dssp BCTTTTTTCTTCCEEECCSSCCSB---CCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGG-BC-
T ss_pred cchhhhhCCCccCEecccCCccCc---Cccch--hhhhhhhhccccchhhhhhhhhhccccccccccccccccccC-CC-
Confidence 999999999999999999999987 55543 458899999999999988888888889999999888764211 10
Q ss_pred cccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEE
Q 002346 208 AKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNI 287 (933)
Q Consensus 208 ~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 287 (933)
...+.++++|+.+++++|.++.....+ +++|+.|++++|.+.+..+..|..++.++.|
T Consensus 143 --------------------~~~~~~l~~L~~l~l~~n~l~~l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L 200 (305)
T d1xkua_ 143 --------------------NGAFQGMKKLSYIRIADTNITTIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKL 200 (305)
T ss_dssp --------------------TTGGGGCTTCCEEECCSSCCCSCCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEE
T ss_pred --------------------ccccccccccCccccccCCccccCccc--CCccCEEECCCCcCCCCChhHhhcccccccc
Confidence 112445889999999999998654443 6899999999999999999999999999999
Q ss_pred EccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCC
Q 002346 288 SLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQG 367 (933)
Q Consensus 288 ~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~ 367 (933)
++++|.+++..+ ..+..++
T Consensus 201 ~~s~n~l~~~~~-------------------------------------------------------------~~~~~l~ 219 (305)
T d1xkua_ 201 GLSFNSISAVDN-------------------------------------------------------------GSLANTP 219 (305)
T ss_dssp ECCSSCCCEECT-------------------------------------------------------------TTGGGST
T ss_pred cccccccccccc-------------------------------------------------------------ccccccc
Confidence 999999886433 2344567
Q ss_pred ceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcc------cCCCCCcCEEeccCCcCc
Q 002346 368 RIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG------LTKLASLQNLDVSNNNLS 428 (933)
Q Consensus 368 ~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~------~~~l~~L~~l~ls~N~l~ 428 (933)
+|++|+|++|+|+ .+|..|.++++|++|+|++|+|+..-... +..+.+|+.|++++|+++
T Consensus 220 ~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 220 HLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp TCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred cceeeeccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCc
Confidence 8889999999888 46888999999999999999998433223 445788999999999885
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=3.2e-24 Score=238.46 Aligned_cols=323 Identities=25% Similarity=0.324 Sum_probs=234.5
Q ss_pred EecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCC
Q 002346 72 SLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151 (933)
Q Consensus 72 ~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~ 151 (933)
.+...++++.+. ...+.+|++|++++|.|+.+ +.+..+++|++|+|++|+|+++++ |+++++|++|+|++|++..
T Consensus 28 ~l~~~~~~~~~~--~~~l~~l~~L~l~~~~I~~l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~ 102 (384)
T d2omza2 28 VLGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 102 (384)
T ss_dssp HTTCSSTTSEEC--HHHHTTCCEEECCSSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HhCCCCCCCccC--HHHhCCCCEEECCCCCCCCc-cccccCCCCCEEeCcCCcCCCCcc--ccCCccccccccccccccc
Confidence 344555555544 34677899999999999853 568889999999999999999875 8899999999999999887
Q ss_pred CCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-----------cccchhh----
Q 002346 152 PWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-----------SDIQNLW---- 216 (933)
Q Consensus 152 ~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-----------~~l~~l~---- 216 (933)
++ .++++++|+.|++++|.+++..+ ......+..+....|.+....+..... ..+..+.
T Consensus 103 ---i~-~l~~l~~L~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (384)
T d2omza2 103 ---IT-PLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTT 176 (384)
T ss_dssp ---CG-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTT
T ss_pred ---cc-ccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccchhhhhccccc
Confidence 33 48899999999999999877643 345567788888777765322211110 0000000
Q ss_pred --cccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccC
Q 002346 217 --MNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294 (933)
Q Consensus 217 --l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 294 (933)
..............+..+++++.+++++|.+++..+ +..+++|+.|++++|+++. + ..+..+++|+.|++++|.+
T Consensus 177 ~~~~~~~~~~~~~~~~~~~l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~-~-~~l~~l~~L~~L~l~~n~l 253 (384)
T d2omza2 177 LERLDISSNKVSDISVLAKLTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKD-I-GTLASLTNLTDLDLANNQI 253 (384)
T ss_dssp CCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-C-GGGGGCTTCSEEECCSSCC
T ss_pred cccccccccccccccccccccccceeeccCCccCCCCc-ccccCCCCEEECCCCCCCC-c-chhhcccccchhccccCcc
Confidence 000000112222346678899999999999998654 5667899999999999984 3 4688899999999999999
Q ss_pred ccCCCC-CCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEE
Q 002346 295 QGPYPL-FPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITIN 373 (933)
Q Consensus 295 ~~~~p~-~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~ 373 (933)
++..+. ...+++.|++++|++.+..+-. .... +.......+.+..+ ..+..+++++.|+
T Consensus 254 ~~~~~~~~~~~L~~L~l~~~~l~~~~~~~------------------~~~~-l~~l~~~~n~l~~~-~~~~~~~~l~~L~ 313 (384)
T d2omza2 254 SNLAPLSGLTKLTELKLGANQISNISPLA------------------GLTA-LTNLELNENQLEDI-SPISNLKNLTYLT 313 (384)
T ss_dssp CCCGGGTTCTTCSEEECCSSCCCCCGGGT------------------TCTT-CSEEECCSSCCSCC-GGGGGCTTCSEEE
T ss_pred CCCCcccccccCCEeeccCcccCCCCccc------------------cccc-cccccccccccccc-cccchhcccCeEE
Confidence 986653 3568999999999987643211 0111 11111222333333 3477889999999
Q ss_pred ccCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCC
Q 002346 374 LANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 374 Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p 432 (933)
|++|++++.. .+..+++|+.|+|++|+|++ +| .+.++++|++|++++|+|++.+|
T Consensus 314 ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~ 368 (384)
T d2omza2 314 LYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP 368 (384)
T ss_dssp CCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG
T ss_pred CCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCChh
Confidence 9999999754 38999999999999999984 55 69999999999999999998776
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=9.3e-25 Score=231.87 Aligned_cols=200 Identities=25% Similarity=0.328 Sum_probs=158.7
Q ss_pred EEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC-
Q 002346 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD- 146 (933)
Q Consensus 69 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~- 146 (933)
..++.++.+++ .+|..+. +.+++|+|++|+|+++++ +|.++++|++|++++|+|..++...+..++.++.++...
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred eEEEcCCCCCC-ccCCCCC--CCCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccc
Confidence 34466677787 6676554 578999999999998887 789999999999999999999999899999999988754
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~ 226 (933)
|.+.. ..+..+.++++|++|++++|.+....+..+..+++|+.+++++|+|++..+..|.
T Consensus 91 ~~~~~--l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~------------------ 150 (284)
T d1ozna_ 91 AQLRS--VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFR------------------ 150 (284)
T ss_dssp TTCCC--CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT------------------
T ss_pred ccccc--ccchhhcccccCCEEecCCcccccccccccchhcccchhhhccccccccChhHhc------------------
Confidence 44544 3467788888899999988888888788888888888888888888854444443
Q ss_pred ccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccC
Q 002346 227 TLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGP 297 (933)
Q Consensus 227 ~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 297 (933)
.+++|+.|+|++|+|++.++. |.++++|+.|++++|++++..|..|..+++|++|++++|++.+.
T Consensus 151 ------~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~ 216 (284)
T d1ozna_ 151 ------DLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSAL 216 (284)
T ss_dssp ------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCC
T ss_pred ------cccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccccccccccccc
Confidence 367788888888888876664 67788888888888888877788888888888888888887754
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.91 E-value=3.5e-23 Score=222.12 Aligned_cols=268 Identities=22% Similarity=0.253 Sum_probs=166.7
Q ss_pred ccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeec
Q 002346 91 QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170 (933)
Q Consensus 91 ~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L 170 (933)
.++.++-++++++.+++.+. +++++|+|++|+|+.+++..|.++++|++|++++|.+.. ..|..|.++++|++|++
T Consensus 11 ~~~~~~C~~~~L~~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~--i~~~~f~~l~~L~~L~l 86 (305)
T d1xkua_ 11 HLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK--ISPGAFAPLVKLERLYL 86 (305)
T ss_dssp ETTEEECTTSCCCSCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCC--BCTTTTTTCTTCCEEEC
T ss_pred cCCEEEecCCCCCccCCCCC--CCCCEEECcCCcCCCcChhHhhccccccccccccccccc--cchhhhhCCCccCEecc
Confidence 45667777777776555553 567777777777777777667777777777777776665 33455666666666666
Q ss_pred cCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCC
Q 002346 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP 250 (933)
Q Consensus 171 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~ 250 (933)
++|+++.. |..+ ...|..|++++|.+.+..+..+ .....+..++...|.....
T Consensus 87 ~~n~l~~l-~~~~--~~~l~~L~~~~n~l~~l~~~~~------------------------~~~~~~~~l~~~~n~~~~~ 139 (305)
T d1xkua_ 87 SKNQLKEL-PEKM--PKTLQELRVHENEITKVRKSVF------------------------NGLNQMIVVELGTNPLKSS 139 (305)
T ss_dssp CSSCCSBC-CSSC--CTTCCEEECCSSCCCBBCHHHH------------------------TTCTTCCEEECCSSCCCGG
T ss_pred cCCccCcC-ccch--hhhhhhhhccccchhhhhhhhh------------------------hcccccccccccccccccc
Confidence 66666544 2222 2455666666666553222211 1234444555555443221
Q ss_pred CCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchh
Q 002346 251 IPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQV 330 (933)
Q Consensus 251 ~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~ 330 (933)
...+..+..+++|+.+++++|.++......+.+++.|++++|.+...
T Consensus 140 ---------------------~~~~~~~~~l~~L~~l~l~~n~l~~l~~~~~~~L~~L~l~~n~~~~~------------ 186 (305)
T d1xkua_ 140 ---------------------GIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELHLDGNKITKV------------ 186 (305)
T ss_dssp ---------------------GBCTTGGGGCTTCCEEECCSSCCCSCCSSCCTTCSEEECTTSCCCEE------------
T ss_pred ---------------------CCCccccccccccCccccccCCccccCcccCCccCEEECCCCcCCCC------------
Confidence 12223344444444444444444433223334444444444443221
Q ss_pred hhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCCcc
Q 002346 331 TTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDG 410 (933)
Q Consensus 331 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~ 410 (933)
.+..+..++.++.|++++|.+.+..+..|.++++|++|+|++|+|+ .+|.+
T Consensus 187 ----------------------------~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~ 237 (305)
T d1xkua_ 187 ----------------------------DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGG 237 (305)
T ss_dssp ----------------------------CTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTT
T ss_pred ----------------------------ChhHhhccccccccccccccccccccccccccccceeeeccccccc-ccccc
Confidence 2345566788999999999999999999999999999999999999 78999
Q ss_pred cCCCCCcCEEeccCCcCcccCCCCC---------CCcccccCCCCCCcCC
Q 002346 411 LTKLASLQNLDVSNNNLSGKVPDFG---------SNVKFTVSPGNPFIGT 451 (933)
Q Consensus 411 ~~~l~~L~~l~ls~N~l~g~~p~~~---------~~~~~~~~~~n~~~~~ 451 (933)
|.++++|++|+|++|+|+....... ..++...+.+|||.+.
T Consensus 238 l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~ 287 (305)
T d1xkua_ 238 LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 287 (305)
T ss_dssp TTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred cccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence 9999999999999999996543221 1223335678888653
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.9e-24 Score=226.22 Aligned_cols=204 Identities=24% Similarity=0.303 Sum_probs=184.8
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceecc-ccccccCCCCCcccCCCCCCEEEc
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYL-DNNNFTSVPTGCFDGLTNLQVLSL 144 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~L-s~N~l~~~~~~~~~~l~~L~~L~L 144 (933)
.++.|+|++|+|+...+.+|.++++|++|++++|.|.++.+ .+..+..++.+.. ..|.++.+++..|.++++|++|+|
T Consensus 33 ~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~l~~L~~L~l 112 (284)
T d1ozna_ 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHL 112 (284)
T ss_dssp TCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEEEC
T ss_pred CCCEEECcCCcCCCCCHHHhhccccccccccccccccccccccccccccccccccccccccccccchhhcccccCCEEec
Confidence 57899999999997666789999999999999999999888 6788899999875 578899999999999999999999
Q ss_pred cCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCc
Q 002346 145 SDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGL 224 (933)
Q Consensus 145 s~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~ 224 (933)
++|.+.. ..+..+..+++|+.+++++|+|++..+..|..+++|+.|+|++|++++..+..|.
T Consensus 113 ~~n~~~~--~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~---------------- 174 (284)
T d1ozna_ 113 DRCGLQE--LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR---------------- 174 (284)
T ss_dssp TTSCCCC--CCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT----------------
T ss_pred CCccccc--ccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhc----------------
Confidence 9999877 4566788899999999999999999889999999999999999999965565543
Q ss_pred ccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCcc
Q 002346 225 SGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 225 ~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
++++|+.|++++|++++..|. |..+++|++|++++|++.+..|..|..+++|++|+|++|++.+
T Consensus 175 --------~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 175 --------GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp --------TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred --------cccccchhhhhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCC
Confidence 499999999999999998774 8999999999999999999899999999999999999999985
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.90 E-value=4.1e-23 Score=216.49 Aligned_cols=202 Identities=22% Similarity=0.217 Sum_probs=177.2
Q ss_pred eCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCC
Q 002346 62 CDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQ 140 (933)
Q Consensus 62 c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~ 140 (933)
|.......+++.++++|+ .+|+.|. ++|++|+|++|.|+++++ .|.++++|++|+|++|+|+.++. ++.+++|+
T Consensus 6 ~~~~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l~~--~~~l~~L~ 80 (266)
T d1p9ag_ 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQV--DGTLPVLG 80 (266)
T ss_dssp EECSTTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEEEC--CSCCTTCC
T ss_pred EcccCCCeEEEccCCCCC-eeCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccccccc--cccccccc
Confidence 444445566788999998 5787664 579999999999999887 79999999999999999998875 57899999
Q ss_pred EEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccc
Q 002346 141 VLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQ 220 (933)
Q Consensus 141 ~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n 220 (933)
+|+|++|++.. .+..+..+++|+.|++++|.+.+..+..+..+.+|++|++++|.++...+..+
T Consensus 81 ~L~Ls~N~l~~---~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~------------- 144 (266)
T d1p9ag_ 81 TLDLSHNQLQS---LPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLL------------- 144 (266)
T ss_dssp EEECCSSCCSS---CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTT-------------
T ss_pred ccccccccccc---cccccccccccccccccccccceeeccccccccccccccccccccceeccccc-------------
Confidence 99999999987 67789999999999999999999999999999999999999999994444333
Q ss_pred cCCcccccccccCCccCcEEEecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCcc
Q 002346 221 QLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 221 ~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
..+++|+.|++++|+|++.++. +..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 145 -----------~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 145 -----------TPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp -----------TTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred -----------cccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 3488999999999999998875 788999999999999999 899999999999999999999874
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.88 E-value=2.4e-22 Score=210.57 Aligned_cols=202 Identities=20% Similarity=0.193 Sum_probs=152.6
Q ss_pred CCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccch
Q 002346 135 GLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQN 214 (933)
Q Consensus 135 ~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~ 214 (933)
+...+.+++.+++.++. +|..+. ++|++|+|++|+|++..+..|.++++|++|+|++|+|+ .+|.
T Consensus 8 ~~~~~~~v~C~~~~L~~---iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~~--------- 72 (266)
T d1p9ag_ 8 KVASHLEVNCDKRNLTA---LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQV--------- 72 (266)
T ss_dssp CSTTCCEEECTTSCCSS---CCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEEC---------
T ss_pred ccCCCeEEEccCCCCCe---eCcCcC--cCCCEEECcCCcCCCcCHHHhhcccccccccccccccc-cccc---------
Confidence 34445555666555554 454443 46777777777777776777888888888888888887 3332
Q ss_pred hhcccccCCcccccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccC
Q 002346 215 LWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKL 294 (933)
Q Consensus 215 l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 294 (933)
+..+++|+.|+|++|++++..+.+..+++|+.|++++|++....+..+..+.+++.|++++|.+
T Consensus 73 ----------------~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l 136 (266)
T d1p9ag_ 73 ----------------DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNEL 136 (266)
T ss_dssp ----------------CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCC
T ss_pred ----------------ccccccccccccccccccccccccccccccccccccccccceeecccccccccccccccccccc
Confidence 2237788888888888887777778888888888888888877777778888888888888887
Q ss_pred ccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEc
Q 002346 295 QGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINL 374 (933)
Q Consensus 295 ~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~L 374 (933)
++..+ ..+..+++|+.|++
T Consensus 137 ~~l~~-------------------------------------------------------------~~~~~l~~l~~l~l 155 (266)
T d1p9ag_ 137 KTLPP-------------------------------------------------------------GLLTPTPKLEKLSL 155 (266)
T ss_dssp CCCCT-------------------------------------------------------------TTTTTCTTCCEEEC
T ss_pred ceecc-------------------------------------------------------------ccccccccchhccc
Confidence 75433 12334567888888
Q ss_pred cCccccCcCchhhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcc
Q 002346 375 ANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSG 429 (933)
Q Consensus 375 s~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g 429 (933)
++|++++..+..|..+++|++|+|++|+|+ .+|..+..+++|+.|+|++|++..
T Consensus 156 ~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 156 ANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp TTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred ccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCC
Confidence 888888878888999999999999999999 899988899999999998876643
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.87 E-value=6.2e-23 Score=203.39 Aligned_cols=171 Identities=13% Similarity=0.128 Sum_probs=121.7
Q ss_pred ccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCC----------------chhHHHHHHHHHHHHhcCCCcceeEEeE
Q 002346 584 SEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMG----------------NKGLSEFQAEIAVLTKVRHRHLVALLGY 647 (933)
Q Consensus 584 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~~l~~l~h~niv~l~~~ 647 (933)
.+.++||+|+||.||+|...+|+.||||+++..... ......+..|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 467899999999999998889999999987643211 0112345678899999999999998876
Q ss_pred eeeCceeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhccCCCeEecCCCCCcEEecCCCcEE
Q 002346 648 CINGSERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLAQQSFIHRDLKPSNILIGDDMRAK 727 (933)
Q Consensus 648 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~~~~ivH~Dik~~Nill~~~~~~k 727 (933)
.. .+++|||+++..+.+ ++......++.|+++|++|||+ ++|+||||||+|||++++ .++
T Consensus 83 ~~----~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~ 142 (191)
T d1zara2 83 EG----NAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIW 142 (191)
T ss_dssp ET----TEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEE
T ss_pred cC----CEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEE
Confidence 42 379999998755432 2334466799999999999999 899999999999999865 489
Q ss_pred EecccccccCCCCCceeecccccccCcccccccCCCCCCCccchHhHHHHH
Q 002346 728 VADFGLVKNAPDGKYSVETRLAGTFGYLAPEYAATGRVTTKIDVYAFGVVL 778 (933)
Q Consensus 728 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~SlG~~l 778 (933)
|+|||.|+.......... ...+... -.|.+ ...|+.++|+||..--+
T Consensus 143 liDFG~a~~~~~~~~~~~--l~rd~~~-~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 143 IIDFPQSVEVGEEGWREI--LERDVRN-IITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ECCCTTCEETTSTTHHHH--HHHHHHH-HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred EEECCCcccCCCCCcHHH--HHHHHHH-HHHHH-cCCCCCcccHHHHHHHH
Confidence 999999876543321100 0000000 01111 35678899999976544
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.82 E-value=2.9e-18 Score=187.21 Aligned_cols=303 Identities=21% Similarity=0.275 Sum_probs=171.4
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 146 (933)
++++|+|++++|+ .+|+. .++|++|+|++|+|+.++.. +.+|+.|++++|+++.++.- .+.|++|+|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~~lp~~---~~~L~~L~l~~n~l~~l~~l----p~~L~~L~L~~ 107 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLTELPEL---PQSLKSLLVDNNNLKALSDL----PPLLEYLGVSN 107 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCSSCCCC---CTTCCEEECCSSCCSCCCSC----CTTCCEEECCS
T ss_pred CCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCcccccc---hhhhhhhhhhhcccchhhhh----ccccccccccc
Confidence 5778889888887 56753 46788888888888854323 35788888888888876531 24688888888
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccc-cccchhhcccccCCcc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAK-SDIQNLWMNDQQLGLS 225 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-~~l~~l~l~~n~~~~~ 225 (933)
|.+.. +|. ++.+++|+.|++++|.+..... ....+..|.+..+.... +..+.. ..++.+.+..|.....
T Consensus 108 n~l~~---lp~-~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~~--~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 108 NQLEK---LPE-LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLEE--LPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp SCCSS---CCC-CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCSS--CCCCTTCTTCCEEECCSSCCSSC
T ss_pred ccccc---ccc-hhhhccceeecccccccccccc----ccccccchhhccccccc--cccccccccceeccccccccccc
Confidence 88776 553 5778888888888887765432 24566677776665542 111211 1222233333322211
Q ss_pred cccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCc
Q 002346 226 GTLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKV 305 (933)
Q Consensus 226 ~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l 305 (933)
.. .....+.+.+.++.+. .++.+..++.|+.+++++|... .+|. ...++..+.+.+|.+... +..+..+
T Consensus 178 ~~-----~~~~~~~l~~~~~~~~-~~~~~~~l~~L~~l~l~~n~~~-~~~~---~~~~l~~~~~~~~~~~~~-~~~~~~l 246 (353)
T d1jl5a_ 178 PD-----LPLSLESIVAGNNILE-ELPELQNLPFLTTIYADNNLLK-TLPD---LPPSLEALNVRDNYLTDL-PELPQSL 246 (353)
T ss_dssp CC-----CCTTCCEEECCSSCCS-SCCCCTTCTTCCEEECCSSCCS-SCCS---CCTTCCEEECCSSCCSCC-CCCCTTC
T ss_pred cc-----cccccccccccccccc-cccccccccccccccccccccc-cccc---cccccccccccccccccc-ccccccc
Confidence 10 0112223333333222 2233444455555555555444 2222 123344445555544422 2233344
Q ss_pred cEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCch
Q 002346 306 QKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNISP 385 (933)
Q Consensus 306 ~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p~ 385 (933)
..+++..|.+.+...- + ......+.....++.....+++|++|+|++|+|+ .+|.
T Consensus 247 ~~~~~~~~~~~~l~~l---------------------~---~~~~~~~~~~~~~~~~~~~~~~L~~L~Ls~N~l~-~lp~ 301 (353)
T d1jl5a_ 247 TFLDVSENIFSGLSEL---------------------P---PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPA 301 (353)
T ss_dssp CEEECCSSCCSEESCC---------------------C---TTCCEEECCSSCCSEECCCCTTCCEEECCSSCCS-CCCC
T ss_pred cccccccccccccccc---------------------c---chhcccccccCccccccccCCCCCEEECCCCccC-cccc
Confidence 4444444433322110 0 0000011111223333344578999999999998 5675
Q ss_pred hhcCcccCCeEecccCcccCCCCcccCCCCCcCEEeccCCcCcccCCCC
Q 002346 386 AYANLTSLKNLYLQQNNLTGPIPDGLTKLASLQNLDVSNNNLSGKVPDF 434 (933)
Q Consensus 386 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~p~~ 434 (933)
. +++|+.|+|++|+|+ .+|.. +++|+.|+|++|+|+. +|.+
T Consensus 302 ~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~~-lp~~ 342 (353)
T d1jl5a_ 302 L---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLRE-FPDI 342 (353)
T ss_dssp C---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCSS-CCCC
T ss_pred c---cCCCCEEECCCCcCC-ccccc---cCCCCEEECcCCcCCC-CCcc
Confidence 3 678999999999998 77754 4679999999999984 5543
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.77 E-value=9.1e-17 Score=175.10 Aligned_cols=299 Identities=21% Similarity=0.248 Sum_probs=208.8
Q ss_pred cccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeee
Q 002346 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLY 169 (933)
Q Consensus 90 ~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~ 169 (933)
.+|++|||++|.|+.+ |.+ +++|++|+|++|+|+.+|.. +.+|+.|++++|+++. ++.. .+.|++|+
T Consensus 38 ~~l~~LdLs~~~L~~l-p~~--~~~L~~L~Ls~N~l~~lp~~----~~~L~~L~l~~n~l~~---l~~l---p~~L~~L~ 104 (353)
T d1jl5a_ 38 RQAHELELNNLGLSSL-PEL--PPHLESLVASCNSLTELPEL----PQSLKSLLVDNNNLKA---LSDL---PPLLEYLG 104 (353)
T ss_dssp HTCSEEECTTSCCSCC-CSC--CTTCSEEECCSSCCSSCCCC----CTTCCEEECCSSCCSC---CCSC---CTTCCEEE
T ss_pred cCCCEEEeCCCCCCCC-CCC--CCCCCEEECCCCCCcccccc----hhhhhhhhhhhcccch---hhhh---cccccccc
Confidence 4789999999999865 432 57899999999999998753 5689999999999887 3321 14699999
Q ss_pred ccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCC
Q 002346 170 MDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTG 249 (933)
Q Consensus 170 L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~ 249 (933)
+++|.+... |. ++.+++|++|++++|.++ ..+.... .+..+.+..+.... ...+..++.++.|++++|.+..
T Consensus 105 L~~n~l~~l-p~-~~~l~~L~~L~l~~~~~~-~~~~~~~--~l~~l~~~~~~~~~---~~~l~~l~~l~~L~l~~n~~~~ 176 (353)
T d1jl5a_ 105 VSNNQLEKL-PE-LQNSSFLKIIDVDNNSLK-KLPDLPP--SLEFIAAGNNQLEE---LPELQNLPFLTAIYADNNSLKK 176 (353)
T ss_dssp CCSSCCSSC-CC-CTTCTTCCEEECCSSCCS-CCCCCCT--TCCEEECCSSCCSS---CCCCTTCTTCCEEECCSSCCSS
T ss_pred ccccccccc-cc-hhhhccceeecccccccc-ccccccc--cccchhhccccccc---cccccccccceecccccccccc
Confidence 999999765 54 678999999999999998 4444332 23444444433322 2335668899999999999886
Q ss_pred CCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCCccEEeccCCcCCCCCCCCCCCCCch
Q 002346 250 PIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSKVQKVSLDHNNFCKNSSDAGKPCDPQ 329 (933)
Q Consensus 250 ~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~l~~n~~~~~~~~~~~~~~~~ 329 (933)
..... ...+.+.++++.+. .++ .+..++.|+.+++++|.... ++.....+..+.+.+|.+.........
T Consensus 177 ~~~~~---~~~~~l~~~~~~~~-~~~-~~~~l~~L~~l~l~~n~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~----- 245 (353)
T d1jl5a_ 177 LPDLP---LSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLKT-LPDLPPSLEALNVRDNYLTDLPELPQS----- 245 (353)
T ss_dssp CCCCC---TTCCEEECCSSCCS-SCC-CCTTCTTCCEEECCSSCCSS-CCSCCTTCCEEECCSSCCSCCCCCCTT-----
T ss_pred ccccc---cccccccccccccc-ccc-cccccccccccccccccccc-ccccccccccccccccccccccccccc-----
Confidence 54322 33456777777766 444 36788999999999998775 566777889999999988654321100
Q ss_pred hhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCC-CceeEEEccCccccCcCchhhcCcccCCeEecccCcccCCCC
Q 002346 330 VTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQ-GRIITINLANKLLAGNISPAYANLTSLKNLYLQQNNLTGPIP 408 (933)
Q Consensus 330 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l-~~L~~L~Ls~N~l~g~~p~~~~~l~~L~~L~L~~N~l~g~~p 408 (933)
........ +.+. .+..+ ......++..|.+.+. ...+++|++|+|++|+|+ .+|
T Consensus 246 -------------l~~~~~~~---~~~~----~l~~l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~Ls~N~l~-~lp 300 (353)
T d1jl5a_ 246 -------------LTFLDVSE---NIFS----GLSELPPNLYYLNASSNEIRSL----CDLPPSLEELNVSNNKLI-ELP 300 (353)
T ss_dssp -------------CCEEECCS---SCCS----EESCCCTTCCEEECCSSCCSEE----CCCCTTCCEEECCSSCCS-CCC
T ss_pred -------------cccccccc---cccc----ccccccchhcccccccCccccc----cccCCCCCEEECCCCccC-ccc
Confidence 00000000 0111 11111 3455677777777642 344689999999999999 788
Q ss_pred cccCCCCCcCEEeccCCcCcccCCCCCCCcccccCCCCCCc
Q 002346 409 DGLTKLASLQNLDVSNNNLSGKVPDFGSNVKFTVSPGNPFI 449 (933)
Q Consensus 409 ~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~n~~~ 449 (933)
.. +++|+.|++++|+|+ .+|.....++...+.+|+..
T Consensus 301 ~~---~~~L~~L~L~~N~L~-~l~~~~~~L~~L~L~~N~L~ 337 (353)
T d1jl5a_ 301 AL---PPRLERLIASFNHLA-EVPELPQNLKQLHVEYNPLR 337 (353)
T ss_dssp CC---CTTCCEEECCSSCCS-CCCCCCTTCCEEECCSSCCS
T ss_pred cc---cCCCCEEECCCCcCC-ccccccCCCCEEECcCCcCC
Confidence 54 578999999999998 46666556665667778764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.76 E-value=1.4e-18 Score=177.01 Aligned_cols=101 Identities=17% Similarity=0.229 Sum_probs=57.9
Q ss_pred ccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeec
Q 002346 91 QLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYM 170 (933)
Q Consensus 91 ~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L 170 (933)
++..++++.+.+++.+ .+..+.+|++|++.+|+|+.+. .+..+++|++|+|++|++.. + ..+..+++|+.|++
T Consensus 20 ~~~~~~l~~~~~~d~~-~~~~l~~L~~L~l~~~~i~~l~--~l~~l~~L~~L~ls~n~i~~---~-~~l~~l~~l~~l~~ 92 (227)
T d1h6ua2 20 NAIKIAAGKSNVTDTV-TQADLDGITTLSAFGTGVTTIE--GVQYLNNLIGLELKDNQITD---L-APLKNLTKITELEL 92 (227)
T ss_dssp HHHHHHTTCSSTTSEE-CHHHHHTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC---C-GGGTTCCSCCEEEC
T ss_pred HHHHHHhCCCCcCCcC-CHHHcCCcCEEECCCCCCCcch--hHhcCCCCcEeecCCceeec---c-cccccccccccccc
Confidence 3344556666666543 3455666777777777766653 26666666666666666655 1 12555566666666
Q ss_pred cCcccCCCCChhhcCCCCCCEEEccCCcCC
Q 002346 171 DNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 171 ~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 200 (933)
++|.++.. ..+..+++|++|++++|...
T Consensus 93 ~~n~~~~i--~~l~~l~~L~~l~l~~~~~~ 120 (227)
T d1h6ua2 93 SGNPLKNV--SAIAGLQSIKTLDLTSTQIT 120 (227)
T ss_dssp CSCCCSCC--GGGTTCTTCCEEECTTSCCC
T ss_pred cccccccc--cccccccccccccccccccc
Confidence 65555432 23455555666665555544
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.76 E-value=1.1e-18 Score=172.54 Aligned_cols=139 Identities=22% Similarity=0.343 Sum_probs=120.1
Q ss_pred CCCCccccceEeCCCCCEEEEEecCCCCccccCccccCCcccceeecccccccccCC--CccCcCcCceeccccccccCC
Q 002346 51 STGYCEWTGINCDNSNRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYLDNNNFTSV 128 (933)
Q Consensus 51 ~~~~C~w~gv~c~~~~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--~~~~l~~L~~L~Ls~N~l~~~ 128 (933)
..+.|.|..|.| ++++|+ .+|..+. +++++|+|++|+|++.++ .|.++++|++|+|++|++..+
T Consensus 4 ~~C~C~~~~v~C-----------s~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~ 69 (192)
T d1w8aa_ 4 AMCHCEGTTVDC-----------TGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGI 69 (192)
T ss_dssp TTSEEETTEEEC-----------TTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCB
T ss_pred CCCEEcCCEEEE-----------eCCCcC-ccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeeccccccccc
Confidence 334566655555 456777 6776664 689999999999987654 689999999999999999999
Q ss_pred CCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCc
Q 002346 129 PTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPA 205 (933)
Q Consensus 129 ~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 205 (933)
+...|..+++|++|+|++|++.. ..|..|.++++|++|+|++|+|+++.+..|..+++|++|+|++|.+....+.
T Consensus 70 ~~~~~~~~~~L~~L~Ls~N~l~~--l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~ 144 (192)
T d1w8aa_ 70 EPNAFEGASHIQELQLGENKIKE--ISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHL 144 (192)
T ss_dssp CTTTTTTCTTCCEEECCSCCCCE--ECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGG
T ss_pred cccccccccccceeeeccccccc--cCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccch
Confidence 99999999999999999999998 4567899999999999999999999999999999999999999999855443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.1e-17 Score=167.69 Aligned_cols=179 Identities=21% Similarity=0.326 Sum_probs=120.1
Q ss_pred ecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCC
Q 002346 73 LAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAP 152 (933)
Q Consensus 73 l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~ 152 (933)
+..+.+++.++. ..+..|++|++++|.++.. +.+..+++|++|+|++|+|+++++ ++.+++|++|++++|+++.
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l-~~l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~- 104 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSV-QGIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD- 104 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCC-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-
T ss_pred hCcCccCCccCH--HHhcCccEEECcCCCCCCc-hhHhhCCCCCEEeCCCccccCccc--cccCccccccccccccccc-
Confidence 334444443332 2456677777777777653 346667777777777777777653 5667777777777777665
Q ss_pred CCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccccccccc
Q 002346 153 WPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLS 232 (933)
Q Consensus 153 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~ 232 (933)
+| .+..+++|+.|++++|.+... ..+..+++|+.+++++|.+++ .+ . +.
T Consensus 105 --l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~~-~~-~------------------------~~ 153 (210)
T d1h6ta2 105 --LS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD-IT-V------------------------LS 153 (210)
T ss_dssp --GG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCC-CG-G------------------------GG
T ss_pred --cc-ccccccccccccccccccccc--ccccccccccccccccccccc-cc-c------------------------cc
Confidence 33 466777777777777776543 356667777777777777762 11 1 23
Q ss_pred CCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEccC
Q 002346 233 GMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQN 291 (933)
Q Consensus 233 ~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 291 (933)
.+++|+.+++++|++++. +.+.++++|+.|+|++|+|+ .+| .+.++++|++|+|++
T Consensus 154 ~l~~L~~l~l~~n~l~~i-~~l~~l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 154 RLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp GCTTCSEEECCSSCCCCC-GGGTTCTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred cccccccccccccccccc-ccccCCCCCCEEECCCCCCC-CCh-hhcCCCCCCEEEccC
Confidence 377888888888888764 34778888888888888887 454 578888888888764
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.73 E-value=1.2e-17 Score=170.01 Aligned_cols=184 Identities=22% Similarity=0.379 Sum_probs=100.9
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 146 (933)
.++.|++.+++|+. ++ .+..+++|++|++++|.|++..| +..+++|++|++++|.++.++ .+.++++|+.|++++
T Consensus 42 ~L~~L~l~~~~i~~-l~-~l~~l~~L~~L~ls~n~i~~~~~-l~~l~~l~~l~~~~n~~~~i~--~l~~l~~L~~l~l~~ 116 (227)
T d1h6ua2 42 GITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAP-LKNLTKITELELSGNPLKNVS--AIAGLQSIKTLDLTS 116 (227)
T ss_dssp TCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG-GTTCCSCCEEECCSCCCSCCG--GGTTCTTCCEEECTT
T ss_pred CcCEEECCCCCCCc-ch-hHhcCCCCcEeecCCceeecccc-ccccccccccccccccccccc--ccccccccccccccc
Confidence 45555555555552 32 35555555666665555554333 555555555555555555443 245555555555555
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~ 226 (933)
|.... ...+...+.++.+.++++.+... ..+..+++|++|++++|.+++..
T Consensus 117 ~~~~~----~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~~~----------------------- 167 (227)
T d1h6ua2 117 TQITD----VTPLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLT----------------------- 167 (227)
T ss_dssp SCCCC----CGGGTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCCCG-----------------------
T ss_pred ccccc----cchhccccchhhhhchhhhhchh--hhhccccccccccccccccccch-----------------------
Confidence 55443 12344455555555555555433 22444555555555555554211
Q ss_pred ccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEEEcc
Q 002346 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNISLQ 290 (933)
Q Consensus 227 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls 290 (933)
.+.++++|+.|+|++|++++. +.+..+++|++|+|++|+|+.. + .+.++++|+.|+|+
T Consensus 168 ---~l~~l~~L~~L~Ls~n~l~~l-~~l~~l~~L~~L~Ls~N~lt~i-~-~l~~l~~L~~L~ls 225 (227)
T d1h6ua2 168 ---PLANLSKLTTLKADDNKISDI-SPLASLPNLIEVHLKNNQISDV-S-PLANTSNLFIVTLT 225 (227)
T ss_dssp ---GGTTCTTCCEEECCSSCCCCC-GGGGGCTTCCEEECTTSCCCBC-G-GGTTCTTCCEEEEE
T ss_pred ---hhcccccceecccCCCccCCC-hhhcCCCCCCEEECcCCcCCCC-c-ccccCCCCCEEEee
Confidence 133466677777777776653 3466667777777777776643 3 26666777777665
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.72 E-value=2.5e-17 Score=163.56 Aligned_cols=162 Identities=27% Similarity=0.384 Sum_probs=97.0
Q ss_pred CCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCe
Q 002346 88 SLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTT 167 (933)
Q Consensus 88 ~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~ 167 (933)
.+.+|++|++++|.|+. ++.+..+++|++|+|++|+|+++++ ++++++|++|++++|.+.. ++ .+.++++|+.
T Consensus 38 ~l~~l~~L~l~~~~i~~-l~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~---~~-~l~~l~~L~~ 110 (199)
T d2omxa2 38 DLDQVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD---IT-PLANLTNLTG 110 (199)
T ss_dssp HHTTCCEEECTTSCCCC-CTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC---CG-GGTTCTTCSE
T ss_pred HhcCCCEEECCCCCCCC-ccccccCCCcCcCccccccccCccc--ccCCccccccccccccccc---cc-cccccccccc
Confidence 45566666666666653 2345556666666666666666543 5666666666666666554 22 3566666666
Q ss_pred eeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCcc
Q 002346 168 LYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQF 247 (933)
Q Consensus 168 L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l 247 (933)
|++++|.+... ..+..+++|+.|++++|++. .++ . +..+++|+.|++.+|++
T Consensus 111 L~l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~-~~~-~------------------------l~~~~~L~~L~l~~n~l 162 (199)
T d2omxa2 111 LTLFNNQITDI--DPLKNLTNLNRLELSSNTIS-DIS-A------------------------LSGLTSLQQLNFSSNQV 162 (199)
T ss_dssp EECCSSCCCCC--GGGTTCTTCSEEECCSSCCC-CCG-G------------------------GTTCTTCSEEECCSSCC
T ss_pred ccccccccccc--cccchhhhhHHhhhhhhhhc-ccc-c------------------------ccccccccccccccccc
Confidence 66666665443 33556666666666666665 222 1 23366677777777766
Q ss_pred CCCCCCCCCCCCCCEEEccCCcccccCcccccCCCCCCEE
Q 002346 248 TGPIPDLSKCESLFDLSLRDNQLTGVVPASVISLPALLNI 287 (933)
Q Consensus 248 ~~~~~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L 287 (933)
++. +.+.++++|+.|++++|+++. ++ .+.++++|++|
T Consensus 163 ~~l-~~l~~l~~L~~L~ls~N~i~~-i~-~l~~L~~L~~L 199 (199)
T d2omxa2 163 TDL-KPLANLTTLERLDISSNKVSD-IS-VLAKLTNLESL 199 (199)
T ss_dssp CCC-GGGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCSEE
T ss_pred cCC-ccccCCCCCCEEECCCCCCCC-Cc-cccCCCCCCcC
Confidence 653 346666777777777777663 33 46666666654
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.72 E-value=7.8e-18 Score=173.34 Aligned_cols=217 Identities=15% Similarity=0.168 Sum_probs=151.3
Q ss_pred EEecCCCCccccCccccCCcccceeecccccccccCC-CccCcCcCceeccccccccC-CCCCcccCCCCCCEEEccC-C
Q 002346 71 ISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTS-VPTGCFDGLTNLQVLSLSD-N 147 (933)
Q Consensus 71 L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~-N 147 (933)
++.++.+++ .+|+.+. +++++|+|++|.|+.+++ .|.++++|++|+|++|.+.. ++...|.+++++++|++.. |
T Consensus 13 i~c~~~~l~-~iP~~l~--~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n 89 (242)
T d1xwdc1 13 FLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89 (242)
T ss_dssp EEEESCSCS-SCCSCSC--SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCT
T ss_pred EEEeCCCCC-CcCCCCC--CCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccccccc
Confidence 344445666 5665553 578899999999987777 68889999999999998875 6777888899999998764 5
Q ss_pred CCCCCCCCCccccCCccCCeeeccCcccCCCCC-hhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccc
Q 002346 148 PNLAPWPFPNELTKSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (933)
Q Consensus 148 ~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~ 226 (933)
++.. ..+..+.++++|++|++++|++....+ ..+..+..|..+...++++....+..|.
T Consensus 90 ~l~~--~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~------------------ 149 (242)
T d1xwdc1 90 NLLY--INPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV------------------ 149 (242)
T ss_dssp TCCE--ECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSST------------------
T ss_pred cccc--cccccccccccccccccchhhhcccccccccccccccccccccccccccccccccc------------------
Confidence 5555 456678889999999999988865533 2345566677777777777633333332
Q ss_pred ccccccCC-ccCcEEEecCCccCCCCCCCCCCCCCCEE-EccCCcccccCcccccCCCCCCEEEccCccCccCCCCCCCC
Q 002346 227 TLDVLSGM-TQLRQVWLHKNQFTGPIPDLSKCESLFDL-SLRDNQLTGVVPASVISLPALLNISLQNNKLQGPYPLFPSK 304 (933)
Q Consensus 227 ~~~~l~~l-~~L~~L~L~~N~l~~~~~~~~~~~~L~~L-~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 304 (933)
++ ..++.|++++|+++...+......+++.+ ++++|+|+...+..|.++++|++|+|++|+++...+..+..
T Consensus 150 ------~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~ 223 (242)
T d1xwdc1 150 ------GLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 223 (242)
T ss_dssp ------TSBSSCEEEECCSSCCCEECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTT
T ss_pred ------cccccceeeecccccccccccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcC
Confidence 23 36778888888888766665555665544 56777787444456778888888888888888655555666
Q ss_pred ccEEe-ccCCcCC
Q 002346 305 VQKVS-LDHNNFC 316 (933)
Q Consensus 305 l~~L~-l~~n~~~ 316 (933)
+..|. ++.+++.
T Consensus 224 l~~L~~l~~~~l~ 236 (242)
T d1xwdc1 224 LKKLRARSTYNLK 236 (242)
T ss_dssp CCEEESSSEESSS
T ss_pred CcccccCcCCCCC
Confidence 66664 3333443
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.71 E-value=7e-17 Score=166.05 Aligned_cols=213 Identities=19% Similarity=0.215 Sum_probs=170.5
Q ss_pred CCccccceEeCCC----------CCEEEEEecCCCCccccCccccCCcccceeecccccccccCC--CccCcCcCceecc
Q 002346 53 GYCEWTGINCDNS----------NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIP--SLANATSLQDIYL 120 (933)
Q Consensus 53 ~~C~w~gv~c~~~----------~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p--~~~~l~~L~~L~L 120 (933)
|-|.+..|.|.+. ..++.|+|++|.|+...+.+|.++++|++|+|++|.+...++ .|.+++++++|.+
T Consensus 6 C~C~~~~i~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~ 85 (242)
T d1xwdc1 6 CHCSNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRI 85 (242)
T ss_dssp EEECSSEEEEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEE
T ss_pred CCCcCCEEEEeCCCCCCcCCCCCCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeeccccccccccccccc
Confidence 5588889999642 369999999999986666689999999999999999987655 6889999999997
Q ss_pred c-cccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCC-CCCEEEccCCc
Q 002346 121 D-NNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS-NLQNLRLSYNN 198 (933)
Q Consensus 121 s-~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~-~L~~L~L~~N~ 198 (933)
. .|++..+++..|.++++|+.|++++|++... +....+..+..|..+...++.+....+..|..++ .++.|++++|+
T Consensus 86 ~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~~~-~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~ 164 (242)
T d1xwdc1 86 EKANNLLYINPEAFQNLPNLQYLLISNTGIKHL-PDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 164 (242)
T ss_dssp ECCTTCCEECTTSEECCTTCCEEEEESCCCCSC-CCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSC
T ss_pred cccccccccccccccccccccccccchhhhccc-ccccccccccccccccccccccccccccccccccccceeeeccccc
Confidence 6 4789999999999999999999999998762 2233456677777778888888888778887765 79999999999
Q ss_pred CCCCCCccccccccchhhcccccCCcccccccccCCccCcEE-EecCCccCCCCCC-CCCCCCCCEEEccCCcccccCcc
Q 002346 199 FTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQV-WLHKNQFTGPIPD-LSKCESLFDLSLRDNQLTGVVPA 276 (933)
Q Consensus 199 l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L-~L~~N~l~~~~~~-~~~~~~L~~L~L~~N~l~~~~p~ 276 (933)
++ .++..... .++++.+ ++++|+++..++. |.++++|++|+|++|+|+...+.
T Consensus 165 l~-~i~~~~~~------------------------~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~ 219 (242)
T d1xwdc1 165 IQ-EIHNCAFN------------------------GTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSY 219 (242)
T ss_dssp CC-EECTTTTT------------------------TCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSS
T ss_pred cc-cccccccc------------------------chhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHH
Confidence 98 45443322 3455545 5788899987665 88999999999999999965566
Q ss_pred cccCCCCCCEEEccC
Q 002346 277 SVISLPALLNISLQN 291 (933)
Q Consensus 277 ~l~~l~~L~~L~Ls~ 291 (933)
.|.++++|+.+++.+
T Consensus 220 ~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 220 GLENLKKLRARSTYN 234 (242)
T ss_dssp SCTTCCEEESSSEES
T ss_pred HHcCCcccccCcCCC
Confidence 788888887776644
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.70 E-value=6.3e-18 Score=166.97 Aligned_cols=110 Identities=19% Similarity=0.290 Sum_probs=71.0
Q ss_pred ceeecccccccccCCCccCcCcCceeccccccccC-CCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeecc
Q 002346 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTS-VPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (933)
Q Consensus 93 ~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~ 171 (933)
+.++.++|+++.+++.+. +++++|+|++|+|+. ++...|.++++|+.|+|++|++.. ..+..+..+++|++|+|+
T Consensus 11 ~~v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~--~~~~~~~~~~~L~~L~Ls 86 (192)
T d1w8aa_ 11 TTVDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG--IEPNAFEGASHIQELQLG 86 (192)
T ss_dssp TEEECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCC--BCTTTTTTCTTCCEEECC
T ss_pred CEEEEeCCCcCccCCCCC--CCCCEEEeCCCCCcccccccccCCCceEeeeecccccccc--ccccccccccccceeeec
Confidence 456777777775544442 567777777777764 555666677777777777776666 445666666666666666
Q ss_pred CcccCCCCChhhcCCCCCCEEEccCCcCCCCCCcc
Q 002346 172 NANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPAS 206 (933)
Q Consensus 172 ~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 206 (933)
+|+|..+.+..|.++++|++|+|++|+|++..|..
T Consensus 87 ~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~ 121 (192)
T d1w8aa_ 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGS 121 (192)
T ss_dssp SCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTS
T ss_pred cccccccCHHHHhCCCcccccccCCccccccCHHH
Confidence 66666666666666666666666666666433433
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.70 E-value=2e-17 Score=164.40 Aligned_cols=55 Identities=15% Similarity=0.222 Sum_probs=24.6
Q ss_pred eeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCC
Q 002346 94 TLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151 (933)
Q Consensus 94 ~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~ 151 (933)
.+.++.+.+++.++ ...+.+|++|++++|.++.+. .+..+++|++|+|++|+++.
T Consensus 22 ~~~l~~~~~~~~~~-~~~l~~l~~L~l~~~~i~~l~--~l~~l~nL~~L~Ls~N~l~~ 76 (199)
T d2omxa2 22 KTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIKSID--GVEYLNNLTQINFSNNQLTD 76 (199)
T ss_dssp HHHTTCSSTTSEEC-HHHHTTCCEEECTTSCCCCCT--TGGGCTTCCEEECCSSCCCC
T ss_pred HHHhCCCCCCCccC-HHHhcCCCEEECCCCCCCCcc--ccccCCCcCcCccccccccC
Confidence 34444455444332 223444555555555554432 13444444444444444443
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.68 E-value=1.6e-16 Score=159.11 Aligned_cols=163 Identities=25% Similarity=0.387 Sum_probs=141.0
Q ss_pred CEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccC
Q 002346 67 RVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSD 146 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~ 146 (933)
.++.|++++++++.. + .+..+++|++|+|++|.|+++. .+..+++|++|++++|+|++++ .+.++++|+.|++++
T Consensus 47 ~L~~L~l~~~~i~~l-~-~l~~l~~L~~L~L~~n~i~~l~-~~~~l~~L~~L~l~~n~i~~l~--~l~~l~~L~~L~l~~ 121 (210)
T d1h6ta2 47 SIDQIIANNSDIKSV-Q-GIQYLPNVTKLFLNGNKLTDIK-PLANLKNLGWLFLDENKVKDLS--SLKDLKKLKSLSLEH 121 (210)
T ss_dssp TCCEEECTTSCCCCC-T-TGGGCTTCCEEECCSSCCCCCG-GGTTCTTCCEEECCSSCCCCGG--GGTTCTTCCEEECTT
T ss_pred CccEEECcCCCCCCc-h-hHhhCCCCCEEeCCCccccCcc-ccccCccccccccccccccccc--ccccccccccccccc
Confidence 588999999999853 3 3889999999999999999755 5788999999999999999987 388999999999999
Q ss_pred CCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCccc
Q 002346 147 NPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSG 226 (933)
Q Consensus 147 N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~ 226 (933)
|.+.. ...+..+++|+.+++++|.++.. ..+..+++|+++++++|++++ ++.
T Consensus 122 ~~~~~----~~~l~~l~~l~~l~~~~n~l~~~--~~~~~l~~L~~l~l~~n~l~~-i~~--------------------- 173 (210)
T d1h6ta2 122 NGISD----INGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISD-IVP--------------------- 173 (210)
T ss_dssp SCCCC----CGGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCC-CGG---------------------
T ss_pred ccccc----ccccccccccccccccccccccc--ccccccccccccccccccccc-ccc---------------------
Confidence 98876 35789999999999999999764 467889999999999999984 332
Q ss_pred ccccccCCccCcEEEecCCccCCCCCCCCCCCCCCEEEccC
Q 002346 227 TLDVLSGMTQLRQVWLHKNQFTGPIPDLSKCESLFDLSLRD 267 (933)
Q Consensus 227 ~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~L~~L~L~~ 267 (933)
+.++++|+.|+|++|+++. ++.+.++++|++|+|++
T Consensus 174 ----l~~l~~L~~L~Ls~N~i~~-l~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 174 ----LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFS 209 (210)
T ss_dssp ----GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEE
T ss_pred ----ccCCCCCCEEECCCCCCCC-ChhhcCCCCCCEEEccC
Confidence 3458999999999999986 46799999999999974
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.60 E-value=2.1e-18 Score=195.59 Aligned_cols=327 Identities=16% Similarity=0.198 Sum_probs=203.2
Q ss_pred CEEEEEecCCCCcccc-CccccCCcccceeeccccccccc----CC-CccCcCcCceeccccccccCCCC----Ccc-cC
Q 002346 67 RVTTISLAKSGLSGTL-SPEISSLTQLETLSFQMNNIAGA----IP-SLANATSLQDIYLDNNNFTSVPT----GCF-DG 135 (933)
Q Consensus 67 ~v~~L~l~~~~l~~~~-~~~~~~l~~L~~L~l~~N~l~~~----~p-~~~~l~~L~~L~Ls~N~l~~~~~----~~~-~~ 135 (933)
+++.||++++++++.- ..-+..+++++.|+|++|.|+.. +. .+..+++|++|+|++|.|+.... ..+ ..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcC
Confidence 5889999999997632 34466788899999999988732 22 46778899999999998863221 112 23
Q ss_pred CCCCCEEEccCCCCCCCC--CCCccccCCccCCeeeccCcccCCCCChhh------------------------------
Q 002346 136 LTNLQVLSLSDNPNLAPW--PFPNELTKSTSLTTLYMDNANIFGLIPDFF------------------------------ 183 (933)
Q Consensus 136 l~~L~~L~Ls~N~~~~~~--~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~------------------------------ 183 (933)
..+|++|+|++|+++... .++..+..+++|++|+|++|.+.......+
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCccccccccccchhhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhcccc
Confidence 457999999999886521 234567788999999999988753211111
Q ss_pred ---cCCCCCCEEEccCCcCCCCCCcc----ccc--cccchhhcccccCCccccc---ccccCCccCcEEEecCCccCCCC
Q 002346 184 ---DSFSNLQNLRLSYNNFTGSLPAS----FAK--SDIQNLWMNDQQLGLSGTL---DVLSGMTQLRQVWLHKNQFTGPI 251 (933)
Q Consensus 184 ---~~l~~L~~L~L~~N~l~~~~p~~----~~~--~~l~~l~l~~n~~~~~~~~---~~l~~l~~L~~L~L~~N~l~~~~ 251 (933)
.....++.++++++.+....-.. +.. .....+.+..+.....+.. ..+...+.++.++++.|++....
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccc
Confidence 12344555555555443110000 000 1122333333433322221 23344677888888888764311
Q ss_pred -----C-CCCCCCCCCEEEccCCccccc----CcccccCCCCCCEEEccCccCccC--------CCCCCCCccEEeccCC
Q 002346 252 -----P-DLSKCESLFDLSLRDNQLTGV----VPASVISLPALLNISLQNNKLQGP--------YPLFPSKVQKVSLDHN 313 (933)
Q Consensus 252 -----~-~~~~~~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~--------~p~~~~~l~~L~l~~n 313 (933)
. .......|+.|++++|.+... ....+...+.++.+++++|.++.. .......++.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred cchhhcccccccccccccccccccccccccccccccccccccccccccccccccccccchhhcccccccccccccccccc
Confidence 1 134466788888888877643 333455677888888888887632 1223346788888887
Q ss_pred cCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCc----Cchhhc-
Q 002346 314 NFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGN----ISPAYA- 388 (933)
Q Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~----~p~~~~- 388 (933)
.+..... . .+...+.....|++|+|++|++.+. ++..+.
T Consensus 323 ~l~~~~~----------~--------------------------~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~ 366 (460)
T d1z7xw1 323 SFTAACC----------S--------------------------HFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ 366 (460)
T ss_dssp CCBGGGH----------H--------------------------HHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTS
T ss_pred chhhhhh----------h--------------------------hcccccccccchhhhheeeecccCcccchhhhhhhc
Confidence 7643210 0 0111233446789999999988753 344443
Q ss_pred CcccCCeEecccCcccC----CCCcccCCCCCcCEEeccCCcCcc
Q 002346 389 NLTSLKNLYLQQNNLTG----PIPDGLTKLASLQNLDVSNNNLSG 429 (933)
Q Consensus 389 ~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~l~ls~N~l~g 429 (933)
..+.|++|+|++|+|+. .++..+..+++|++|||++|+|+.
T Consensus 367 ~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~ 411 (460)
T d1z7xw1 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD 411 (460)
T ss_dssp TTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred ccCCCCEEECCCCCCChHHHHHHHHHHhcCCCCCEEECCCCcCCH
Confidence 45679999999999874 255667777899999999998864
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.48 E-value=5.3e-14 Score=126.84 Aligned_cols=102 Identities=20% Similarity=0.206 Sum_probs=70.7
Q ss_pred ceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccC
Q 002346 93 ETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDN 172 (933)
Q Consensus 93 ~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~ 172 (933)
++|+|++|+|+.. +.+..+++|++|+|++|.|+.+|+ .|+.+++|++|++++|+++. +| .+..+++|++|++++
T Consensus 1 R~L~Ls~n~l~~l-~~l~~l~~L~~L~ls~N~l~~lp~-~~~~l~~L~~L~l~~N~i~~---l~-~~~~l~~L~~L~l~~ 74 (124)
T d1dcea3 1 RVLHLAHKDLTVL-CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN---VD-GVANLPRLQELLLCN 74 (124)
T ss_dssp SEEECTTSCCSSC-CCGGGGTTCCEEECCSSCCCCCCG-GGGGCTTCCEEECCSSCCCC---CG-GGTTCSSCCEEECCS
T ss_pred CEEEcCCCCCCCC-cccccCCCCCEEECCCCccCcchh-hhhhhhcccccccccccccc---cC-ccccccccCeEECCC
Confidence 4567777777633 456677777777777777777664 36677777777777777766 33 467777777777777
Q ss_pred cccCCCC-ChhhcCCCCCCEEEccCCcCC
Q 002346 173 ANIFGLI-PDFFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 173 n~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 200 (933)
|++.... ...+..+++|++|++++|+++
T Consensus 75 N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 75 NRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp SCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred CccCCCCCchhhcCCCCCCEEECCCCcCC
Confidence 7776553 256777778888888888876
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.47 E-value=3.4e-14 Score=134.84 Aligned_cols=124 Identities=18% Similarity=0.221 Sum_probs=91.5
Q ss_pred CCEEEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEcc
Q 002346 66 NRVTTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLS 145 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls 145 (933)
.+++.|+|++|+|+ .++..+..+++|+.|+|++|.|+.+ +.|..+++|++|+|++|+|+.+++..+..+++|+.|+|+
T Consensus 18 ~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l-~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~L~ 95 (162)
T d1a9na_ 18 VRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILT 95 (162)
T ss_dssp TSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE-CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECC
T ss_pred CcCcEEECCCCCCC-ccCccccccccCCEEECCCCCCCcc-CCcccCcchhhhhcccccccCCCccccccccccccceec
Confidence 35778888888887 4466667778888888888888754 567778888888888888888877777778888888888
Q ss_pred CCCCCCCCCCC--ccccCCccCCeeeccCcccCCCC---ChhhcCCCCCCEEEc
Q 002346 146 DNPNLAPWPFP--NELTKSTSLTTLYMDNANIFGLI---PDFFDSFSNLQNLRL 194 (933)
Q Consensus 146 ~N~~~~~~~~p--~~~~~l~~L~~L~L~~n~l~~~~---p~~~~~l~~L~~L~L 194 (933)
+|++.. ++ ..+..+++|++|++++|.++... +..+..+++|++||-
T Consensus 96 ~N~i~~---~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 96 NNSLVE---LGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp SCCCCC---GGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred cccccc---cccccccccccccchhhcCCCccccccchHHHHHHHCCCcCeeCC
Confidence 888776 33 35677788888888888776553 234667788887763
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.46 E-value=8.6e-14 Score=125.44 Aligned_cols=119 Identities=18% Similarity=0.245 Sum_probs=101.2
Q ss_pred EEEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCC
Q 002346 69 TTISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNP 148 (933)
Q Consensus 69 ~~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~ 148 (933)
+.|+|++|+|+ .++ .+..+++|++|++++|.|+.+++.+..+++|++|++++|.|+.++ .+..+++|++|++++|+
T Consensus 1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~l~--~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVD--GVANLPRLQELLLCNNR 76 (124)
T ss_dssp SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCSSCCEEECCSSC
T ss_pred CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccCcchhhhhhhhcccccccccccccccC--ccccccccCeEECCCCc
Confidence 36899999998 555 489999999999999999987668999999999999999999986 38999999999999999
Q ss_pred CCCCCCCCccccCCccCCeeeccCcccCCC---CChhhcCCCCCCEE
Q 002346 149 NLAPWPFPNELTKSTSLTTLYMDNANIFGL---IPDFFDSFSNLQNL 192 (933)
Q Consensus 149 ~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~---~p~~~~~l~~L~~L 192 (933)
+.... ....+..+++|+.|++++|.++.. ....+..+++|+.|
T Consensus 77 i~~~~-~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 77 LQQSA-AIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCSSS-TTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred cCCCC-CchhhcCCCCCCEEECCCCcCCcCccHHHHHHHHCcCcceE
Confidence 98731 235789999999999999999643 34455667888776
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=1.6e-16 Score=179.72 Aligned_cols=330 Identities=19% Similarity=0.179 Sum_probs=216.3
Q ss_pred CEEEEEecCCCCcc----ccCccccCCcccceeeccccccccc----CC-Ccc-CcCcCceeccccccccCCC----CCc
Q 002346 67 RVTTISLAKSGLSG----TLSPEISSLTQLETLSFQMNNIAGA----IP-SLA-NATSLQDIYLDNNNFTSVP----TGC 132 (933)
Q Consensus 67 ~v~~L~l~~~~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~----~p-~~~-~l~~L~~L~Ls~N~l~~~~----~~~ 132 (933)
+++.|+|++|+|+. .+...+..+++|++|||++|.|+.. +. .+. ...+|++|+|++|+++... ...
T Consensus 28 ~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~it~~~~~~l~~~ 107 (460)
T d1z7xw1 28 QCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSST 107 (460)
T ss_dssp TCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCSTTCCCCEEECTTSCCBGGGHHHHHHH
T ss_pred CCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhcCCCCCCEEECCCCCccccccccccch
Confidence 56789999999873 4456678899999999999998632 11 233 2357999999999998643 345
Q ss_pred ccCCCCCCEEEccCCCCCCCC-----------------------CC--------CccccCCccCCeeeccCcccCCCC--
Q 002346 133 FDGLTNLQVLSLSDNPNLAPW-----------------------PF--------PNELTKSTSLTTLYMDNANIFGLI-- 179 (933)
Q Consensus 133 ~~~l~~L~~L~Ls~N~~~~~~-----------------------~~--------p~~~~~l~~L~~L~L~~n~l~~~~-- 179 (933)
+..+++|++|+|++|.+...+ .. -..+.....++.++++++.+....
T Consensus 108 l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~ 187 (460)
T d1z7xw1 108 LRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVR 187 (460)
T ss_dssp TTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHH
T ss_pred hhccccccccccccccchhhhhhhhhhcccccccccccccccccccchhhhccccccccccccccccccccccccccccc
Confidence 678899999999999764310 00 011123456777887776653211
Q ss_pred --Chhh-cCCCCCCEEEccCCcCCCCCCccc-----cccccchhhcccccCCccccc----ccccCCccCcEEEecCCcc
Q 002346 180 --PDFF-DSFSNLQNLRLSYNNFTGSLPASF-----AKSDIQNLWMNDQQLGLSGTL----DVLSGMTQLRQVWLHKNQF 247 (933)
Q Consensus 180 --p~~~-~~l~~L~~L~L~~N~l~~~~p~~~-----~~~~l~~l~l~~n~~~~~~~~----~~l~~l~~L~~L~L~~N~l 247 (933)
...+ ........|++..+.+...-...+ ....++.+.+..|.....+.. ........++.|++++|.+
T Consensus 188 ~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i 267 (460)
T d1z7xw1 188 VLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI 267 (460)
T ss_dssp HHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCC
T ss_pred ccccccccccccccccccccccccchhhhcccccccccccccccchhhccccccccchhhcccccccccccccccccccc
Confidence 1111 233467788888887652211111 114566677777665433221 2334467899999999988
Q ss_pred CCCCC-----CCCCCCCCCEEEccCCcccccCcccc-----cCCCCCCEEEccCccCccCCCC-------CCCCccEEec
Q 002346 248 TGPIP-----DLSKCESLFDLSLRDNQLTGVVPASV-----ISLPALLNISLQNNKLQGPYPL-------FPSKVQKVSL 310 (933)
Q Consensus 248 ~~~~~-----~~~~~~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~~p~-------~~~~l~~L~l 310 (933)
..... .+...+.++.+++++|.++......+ .....|+.+++++|.++..... ....|++|+|
T Consensus 268 ~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~L 347 (460)
T d1z7xw1 268 TAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQI 347 (460)
T ss_dssp CHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEEC
T ss_pred cccccccccccccccccccccccccccccccccchhhccccccccccccccccccchhhhhhhhcccccccccchhhhhe
Confidence 75332 24567889999999999875333222 2346799999999998754211 2247999999
Q ss_pred cCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCcccc-CCCceeEEEccCccccCc----Cch
Q 002346 311 DHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTC-SQGRIITINLANKLLAGN----ISP 385 (933)
Q Consensus 311 ~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~-~l~~L~~L~Ls~N~l~g~----~p~ 385 (933)
++|.|.... ... ++..+. ..+.|+.|+|++|+|+.. ++.
T Consensus 348 s~N~i~~~g-------------~~~-----------------------l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~ 391 (460)
T d1z7xw1 348 SNNRLEDAG-------------VRE-----------------------LCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 391 (460)
T ss_dssp CSSBCHHHH-------------HHH-----------------------HHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred eeecccCcc-------------cch-----------------------hhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence 999884310 000 111222 245799999999999853 556
Q ss_pred hhcCcccCCeEecccCcccCCCCcc----cC-CCCCcCEEeccCCcCcccCC
Q 002346 386 AYANLTSLKNLYLQQNNLTGPIPDG----LT-KLASLQNLDVSNNNLSGKVP 432 (933)
Q Consensus 386 ~~~~l~~L~~L~L~~N~l~g~~p~~----~~-~l~~L~~l~ls~N~l~g~~p 432 (933)
.+..+++|++|+|++|+|+...... +. +...|+.|++++|.+.....
T Consensus 392 ~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~ 443 (460)
T d1z7xw1 392 TLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEME 443 (460)
T ss_dssp HHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHH
T ss_pred HHhcCCCCCEEECCCCcCCHHHHHHHHHHHHhCCCccCEEECCCCCCCHHHH
Confidence 6778899999999999998543333 32 34479999999999876443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=5.4e-14 Score=133.45 Aligned_cols=116 Identities=18% Similarity=0.143 Sum_probs=98.0
Q ss_pred ccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCc-cccCC
Q 002346 84 PEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPN-ELTKS 162 (933)
Q Consensus 84 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~-~~~~l 162 (933)
+.+.+...|++|+|++|+|+.+...+..+++|++|+|++|+|+.++ .|..+++|++|+|++|++.. ++. .+..+
T Consensus 12 ~~~~n~~~lr~L~L~~n~I~~i~~~~~~l~~L~~L~Ls~N~i~~l~--~~~~l~~L~~L~ls~N~i~~---l~~~~~~~l 86 (162)
T d1a9na_ 12 AQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIRKLD--GFPLLRRLKTLLVNNNRICR---IGEGLDQAL 86 (162)
T ss_dssp CEEECTTSCEEEECTTSCCCSCCCGGGGTTCCSEEECCSSCCCEEC--CCCCCSSCCEEECCSSCCCE---ECSCHHHHC
T ss_pred HhccCcCcCcEEECCCCCCCccCccccccccCCEEECCCCCCCccC--CcccCcchhhhhcccccccC---CCccccccc
Confidence 3467888999999999999987545677899999999999999884 38899999999999999988 444 45789
Q ss_pred ccCCeeeccCcccCCCCC-hhhcCCCCCCEEEccCCcCCCCCCc
Q 002346 163 TSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLPA 205 (933)
Q Consensus 163 ~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~ 205 (933)
++|+.|++++|++..... ..+..+++|++|++++|+++ ..|.
T Consensus 87 ~~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~ 129 (162)
T d1a9na_ 87 PDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKH 129 (162)
T ss_dssp TTCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTT
T ss_pred cccccceeccccccccccccccccccccchhhcCCCccc-cccc
Confidence 999999999999977532 56889999999999999997 4553
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.42 E-value=1.5e-15 Score=164.82 Aligned_cols=262 Identities=17% Similarity=0.189 Sum_probs=132.2
Q ss_pred ccccCCcccceeecccccccccC-----CCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCcc
Q 002346 84 PEISSLTQLETLSFQMNNIAGAI-----PSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNE 158 (933)
Q Consensus 84 ~~~~~l~~L~~L~l~~N~l~~~~-----p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~ 158 (933)
.++.+...|++|+|++|.|...- ..+...++|+.|+++++.+..........+ ..+...
T Consensus 25 ~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~----------------~~l~~~ 88 (344)
T d2ca6a1 25 AVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL----------------RLLLQA 88 (344)
T ss_dssp HHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHH----------------HHHHHH
T ss_pred HHHhhCCCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHH----------------HHHHHH
Confidence 44555666666666666654311 134455555555555554432211100000 001122
Q ss_pred ccCCccCCeeeccCcccCCC----CChhhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCC
Q 002346 159 LTKSTSLTTLYMDNANIFGL----IPDFFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGM 234 (933)
Q Consensus 159 ~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l 234 (933)
+..+++|+.|+|++|.+... +...+...++|++|++++|.++......++. .+..+.... .....
T Consensus 89 l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~-~l~~~~~~~----------~~~~~ 157 (344)
T d2ca6a1 89 LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR-ALQELAVNK----------KAKNA 157 (344)
T ss_dssp HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHH-HHHHHHHHH----------HHHTC
T ss_pred HhhCCCcccccccccccccccccchhhhhcccccchheecccccccccccccccc-ccccccccc----------ccccC
Confidence 34455566666666655443 2233445667777777777664211111111 011111110 01234
Q ss_pred ccCcEEEecCCccCCCCC-----CCCCCCCCCEEEccCCccccc-----CcccccCCCCCCEEEccCccCccCCCCCCCC
Q 002346 235 TQLRQVWLHKNQFTGPIP-----DLSKCESLFDLSLRDNQLTGV-----VPASVISLPALLNISLQNNKLQGPYPLFPSK 304 (933)
Q Consensus 235 ~~L~~L~L~~N~l~~~~~-----~~~~~~~L~~L~L~~N~l~~~-----~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~ 304 (933)
+.|+.|++++|+++...- .+..+.+|+.|+|++|+++.. +...+..+++|+.|+|++|.++....
T Consensus 158 ~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~----- 232 (344)
T d2ca6a1 158 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGS----- 232 (344)
T ss_dssp CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHH-----
T ss_pred cccceeecccccccccccccccchhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccccccc-----
Confidence 566777777776653211 134456677777777776532 23445566677777777776652100
Q ss_pred ccEEeccCCcCCCCCCCCCCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCccccCcCc
Q 002346 305 VQKVSLDHNNFCKNSSDAGKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANKLLAGNIS 384 (933)
Q Consensus 305 l~~L~l~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N~l~g~~p 384 (933)
..+...+...++|+.|+|++|.|++.-.
T Consensus 233 ----------------------------------------------------~~L~~~l~~~~~L~~L~Ls~n~i~~~g~ 260 (344)
T d2ca6a1 233 ----------------------------------------------------SALAIALKSWPNLRELGLNDCLLSARGA 260 (344)
T ss_dssp ----------------------------------------------------HHHHHHGGGCTTCCEEECTTCCCCHHHH
T ss_pred ----------------------------------------------------ccccccccccccchhhhhhcCccCchhh
Confidence 0011223344567777777777665422
Q ss_pred hh----hcC--cccCCeEecccCcccCC----CCcccC-CCCCcCEEeccCCcCcc
Q 002346 385 PA----YAN--LTSLKNLYLQQNNLTGP----IPDGLT-KLASLQNLDVSNNNLSG 429 (933)
Q Consensus 385 ~~----~~~--l~~L~~L~L~~N~l~g~----~p~~~~-~l~~L~~l~ls~N~l~g 429 (933)
.. +.. .+.|+.|+|++|+|+.. +...+. ++++|+.|+|++|++..
T Consensus 261 ~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~ 316 (344)
T d2ca6a1 261 AAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSE 316 (344)
T ss_dssp HHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCT
T ss_pred HHHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCC
Confidence 22 222 35688888888887642 333342 46778888888888764
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.41 E-value=2.2e-14 Score=155.35 Aligned_cols=189 Identities=23% Similarity=0.288 Sum_probs=118.9
Q ss_pred CCEEEEEecCCCCcc----ccCccccCCcccceeecccccccccC---C--------CccCcCcCceeccccccccCCCC
Q 002346 66 NRVTTISLAKSGLSG----TLSPEISSLTQLETLSFQMNNIAGAI---P--------SLANATSLQDIYLDNNNFTSVPT 130 (933)
Q Consensus 66 ~~v~~L~l~~~~l~~----~~~~~~~~l~~L~~L~l~~N~l~~~~---p--------~~~~l~~L~~L~Ls~N~l~~~~~ 130 (933)
..++.|+|++|.+.. .+...+..+++|+.|+++++.+.... + .+...++|+.|+|++|.++....
T Consensus 31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 110 (344)
T d2ca6a1 31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110 (344)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCCCEEECcCCcCCHHHHHHHHHHHHhCCCCCEEECCCCcccccccccchHHHHHHHHHhhCCCcccccccccccccccc
Confidence 468999999998844 34556788999999999987654221 1 13445556666666665554321
Q ss_pred CcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCC-------------ChhhcCCCCCCEEEccCC
Q 002346 131 GCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLI-------------PDFFDSFSNLQNLRLSYN 197 (933)
Q Consensus 131 ~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~-------------p~~~~~l~~L~~L~L~~N 197 (933)
.. +...+..+++|++|++++|.+.... .......+.|+.|++++|
T Consensus 111 ~~----------------------l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n 168 (344)
T d2ca6a1 111 EP----------------------LIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN 168 (344)
T ss_dssp HH----------------------HHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSS
T ss_pred cc----------------------hhhhhcccccchheecccccccccccccccccccccccccccccCcccceeecccc
Confidence 11 1222333445555555554432110 011235678889999888
Q ss_pred cCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCC------CCCCCCCCCCCEEEccCCccc
Q 002346 198 NFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGP------IPDLSKCESLFDLSLRDNQLT 271 (933)
Q Consensus 198 ~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~------~~~~~~~~~L~~L~L~~N~l~ 271 (933)
+++...-..++. .+...+.|+.|+|++|+++.. ...+..+++|+.|+|++|.++
T Consensus 169 ~i~~~~~~~l~~--------------------~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~ 228 (344)
T d2ca6a1 169 RLENGSMKEWAK--------------------TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 228 (344)
T ss_dssp CCTGGGHHHHHH--------------------HHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCH
T ss_pred cccccccccccc--------------------hhhhhhhhcccccccccccccccccchhhhhcchhhhccccccccccc
Confidence 876322222221 233467888999999888642 124677888999999999886
Q ss_pred cc----CcccccCCCCCCEEEccCccCcc
Q 002346 272 GV----VPASVISLPALLNISLQNNKLQG 296 (933)
Q Consensus 272 ~~----~p~~l~~l~~L~~L~Ls~N~l~~ 296 (933)
.. +...+...++|++|+|++|.+++
T Consensus 229 ~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~ 257 (344)
T d2ca6a1 229 HLGSSALAIALKSWPNLRELGLNDCLLSA 257 (344)
T ss_dssp HHHHHHHHHHGGGCTTCCEEECTTCCCCH
T ss_pred ccccccccccccccccchhhhhhcCccCc
Confidence 43 45567788899999999998874
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=8.6e-15 Score=153.62 Aligned_cols=246 Identities=17% Similarity=0.230 Sum_probs=137.1
Q ss_pred EEEecCCCCccccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCC-CCCcccCCCCCCEEEccCCC
Q 002346 70 TISLAKSGLSGTLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSV-PTGCFDGLTNLQVLSLSDNP 148 (933)
Q Consensus 70 ~L~l~~~~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~Ls~N~ 148 (933)
.|||+++.+.+.....+.. ..+..+.++...+...+.......+|++|+|++|.++.. ....+.++++|++|+|+++.
T Consensus 4 ~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLR 82 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCB
T ss_pred EEECCCCCCCchHHHHHHh-ccceEeeccccccccchhhhccCCCCCEEECCCCccCHHHHHHHHHhCCCcccccccccC
Confidence 5666666554322211111 123344444444443333344455667777766666532 22235566677777777666
Q ss_pred CCCCCCCCccccCCccCCeeeccCc-ccCCC-CChhhcCCCCCCEEEccCC-cCCCC-CCccccc--cccchhhcccc--
Q 002346 149 NLAPWPFPNELTKSTSLTTLYMDNA-NIFGL-IPDFFDSFSNLQNLRLSYN-NFTGS-LPASFAK--SDIQNLWMNDQ-- 220 (933)
Q Consensus 149 ~~~~~~~p~~~~~l~~L~~L~L~~n-~l~~~-~p~~~~~l~~L~~L~L~~N-~l~~~-~p~~~~~--~~l~~l~l~~n-- 220 (933)
+.. ..+..+.++++|++|+++++ .++.. +...+..+++|++|+|+++ .++.. +...+.. ..++.|.+.++
T Consensus 83 l~~--~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 83 LSD--PIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CCH--HHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred CCc--HHHHHHhcCCCCcCccccccccccccccchhhHHHHhccccccccccccccccchhhhcccccccchhhhccccc
Confidence 554 34455666667777777664 33321 1222345667777777664 33311 1111111 34566666543
Q ss_pred cCCcccccccccCCccCcEEEecCCc-cCCC-CCCCCCCCCCCEEEccCC-cccccCcccccCCCCCCEEEccCccCccC
Q 002346 221 QLGLSGTLDVLSGMTQLRQVWLHKNQ-FTGP-IPDLSKCESLFDLSLRDN-QLTGVVPASVISLPALLNISLQNNKLQGP 297 (933)
Q Consensus 221 ~~~~~~~~~~l~~l~~L~~L~L~~N~-l~~~-~~~~~~~~~L~~L~L~~N-~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ 297 (933)
.+...+....+..+++|++|+|++|. +++. +..+..+++|++|+|++| .+++.....++++++|+.|+++++--.+.
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~ 240 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTC
T ss_pred ccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCCCCHHH
Confidence 22222222334568899999999864 6653 345788899999999994 68877777888999999999988722222
Q ss_pred CCCCCCCccEEeccCCcCCCC
Q 002346 298 YPLFPSKVQKVSLDHNNFCKN 318 (933)
Q Consensus 298 ~p~~~~~l~~L~l~~n~~~~~ 318 (933)
++.....+..|.+..++++..
T Consensus 241 l~~l~~~lp~L~i~~~~ls~~ 261 (284)
T d2astb2 241 LQLLKEALPHLQINCSHFTTI 261 (284)
T ss_dssp HHHHHHHSTTSEESCCCSCCT
T ss_pred HHHHHHhCccccccCccCCCC
Confidence 222222344566666666554
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.38 E-value=2.4e-14 Score=150.20 Aligned_cols=249 Identities=16% Similarity=0.159 Sum_probs=144.4
Q ss_pred ceeecccccccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeecc
Q 002346 93 ETLSFQMNNIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMD 171 (933)
Q Consensus 93 ~~L~l~~N~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~ 171 (933)
+.|||+++.+..... .+.. ..+..+.++.+.+...... .....+|++|||+++.+... .+...+.++++|++|+|+
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~-~~~~~lrl~~~~~~~~~~~-~~~~~~L~~LdLs~~~i~~~-~l~~l~~~c~~L~~L~L~ 79 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVS-TLHGILSQCSKLQNLSLE 79 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHH-TTCSEEECTTCEECSCCCS-CCCCBCCCEEECTTCEECHH-HHHHHHTTBCCCSEEECT
T ss_pred CEEECCCCCCCchHHHHHHh-ccceEeeccccccccchhh-hccCCCCCEEECCCCccCHH-HHHHHHHhCCCccccccc
Confidence 478888887753322 1211 2355666766666544333 33556888888888876541 134456778888888888
Q ss_pred CcccCCCCChhhcCCCCCCEEEccCC-cCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCC-ccCC
Q 002346 172 NANIFGLIPDFFDSFSNLQNLRLSYN-NFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKN-QFTG 249 (933)
Q Consensus 172 ~n~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N-~l~~ 249 (933)
+|.+....+..++.+++|++|+|+++ .++.. .+. ....++++|++|+++++ .++.
T Consensus 80 ~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~---~l~--------------------~l~~~~~~L~~L~ls~c~~~~~ 136 (284)
T d2astb2 80 GLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEF---ALQ--------------------TLLSSCSRLDELNLSWCFDFTE 136 (284)
T ss_dssp TCBCCHHHHHHHTTCTTCSEEECTTCBSCCHH---HHH--------------------HHHHHCTTCCEEECCCCTTCCH
T ss_pred ccCCCcHHHHHHhcCCCCcCcccccccccccc---ccc--------------------hhhHHHHhcccccccccccccc
Confidence 88887777778888888888888875 44311 000 01223677888888774 3432
Q ss_pred CC--CCC-CCCCCCCEEEccCC--ccccc-CcccccCCCCCCEEEccCcc-CccCCCCCCCCccEEeccCCcCCCCCCCC
Q 002346 250 PI--PDL-SKCESLFDLSLRDN--QLTGV-VPASVISLPALLNISLQNNK-LQGPYPLFPSKVQKVSLDHNNFCKNSSDA 322 (933)
Q Consensus 250 ~~--~~~-~~~~~L~~L~L~~N--~l~~~-~p~~l~~l~~L~~L~Ls~N~-l~~~~p~~~~~l~~L~l~~n~~~~~~~~~ 322 (933)
.. ..+ ..+++|+.|+++++ .++.. +...+..+++|++|+|++|. +++.
T Consensus 137 ~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~------------------------- 191 (284)
T d2astb2 137 KHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKND------------------------- 191 (284)
T ss_dssp HHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGG-------------------------
T ss_pred ccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCch-------------------------
Confidence 11 112 22456777777754 23322 22333456677777776653 3321
Q ss_pred CCCCCchhhhhHhhhcccCCCccccCCCCCCCCCCCCCccccCCCceeEEEccCc-cccCcCchhhcCcccCCeEecccC
Q 002346 323 GKPCDPQVTTLLQIAGDMGYPAILSDSWEGNNACDGWPFVTCSQGRIITINLANK-LLAGNISPAYANLTSLKNLYLQQN 401 (933)
Q Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~p~~~~~l~~L~~L~Ls~N-~l~g~~p~~~~~l~~L~~L~L~~N 401 (933)
....+..+++|++|+|++| .+++.....++++++|+.|+++++
T Consensus 192 ------------------------------------~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 192 ------------------------------------CFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp ------------------------------------GGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred ------------------------------------hhhhhcccCcCCEEECCCCCCCChHHHHHHhcCCCCCEEeeeCC
Confidence 1123445567777777774 566666666777788888888776
Q ss_pred cccCCCCcccCCCCCcCEEeccCCcCcccC
Q 002346 402 NLTGPIPDGLTKLASLQNLDVSNNNLSGKV 431 (933)
Q Consensus 402 ~l~g~~p~~~~~l~~L~~l~ls~N~l~g~~ 431 (933)
--.+.++.-...+|+|+ +..++++...
T Consensus 236 ~~d~~l~~l~~~lp~L~---i~~~~ls~~~ 262 (284)
T d2astb2 236 VPDGTLQLLKEALPHLQ---INCSHFTTIA 262 (284)
T ss_dssp SCTTCHHHHHHHSTTSE---ESCCCSCCTT
T ss_pred CCHHHHHHHHHhCcccc---ccCccCCCCC
Confidence 22222232223344443 4566666543
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.27 E-value=2.6e-14 Score=140.71 Aligned_cols=118 Identities=23% Similarity=0.275 Sum_probs=101.3
Q ss_pred ccCccccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCcccc
Q 002346 81 TLSPEISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELT 160 (933)
Q Consensus 81 ~~~~~~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~ 160 (933)
.++..+..+++|++|+|++|+|+.+ +.+..+++|++|+|++|.|+.++. .+..+++|++|++++|+++. + ..+.
T Consensus 39 ~l~~sl~~L~~L~~L~Ls~n~I~~i-~~l~~l~~L~~L~Ls~N~i~~i~~-~~~~~~~L~~L~l~~N~i~~---l-~~~~ 112 (198)
T d1m9la_ 39 KMDATLSTLKACKHLALSTNNIEKI-SSLSGMENLRILSLGRNLIKKIEN-LDAVADTLEELWISYNQIAS---L-SGIE 112 (198)
T ss_dssp CCHHHHHHTTTCCEEECSEEEESCC-CCHHHHTTCCEEECCEEEECSCSS-HHHHHHHCCEEECSEEECCC---H-HHHH
T ss_pred hhhhHHhcccccceeECcccCCCCc-ccccCCccccChhhcccccccccc-cccccccccccccccccccc---c-cccc
Confidence 4667899999999999999999965 678999999999999999998864 35556789999999999987 3 4688
Q ss_pred CCccCCeeeccCcccCCCCC-hhhcCCCCCCEEEccCCcCCCCCC
Q 002346 161 KSTSLTTLYMDNANIFGLIP-DFFDSFSNLQNLRLSYNNFTGSLP 204 (933)
Q Consensus 161 ~l~~L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p 204 (933)
.+++|+.|+|++|+++.... ..|..+++|++|+|++|++....+
T Consensus 113 ~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~ 157 (198)
T d1m9la_ 113 KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYK 157 (198)
T ss_dssp HHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHC
T ss_pred ccccccccccccchhccccccccccCCCccceeecCCCccccCcc
Confidence 99999999999999987633 578999999999999999874444
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.24 E-value=5.4e-14 Score=138.38 Aligned_cols=86 Identities=26% Similarity=0.374 Sum_probs=57.0
Q ss_pred CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCC
Q 002346 108 SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFS 187 (933)
Q Consensus 108 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 187 (933)
++..+++|++|+|++|+|+.++ .|.++++|++|+|++|++.. +|..+..+++|+.|++++|+++.. ..+..++
T Consensus 43 sl~~L~~L~~L~Ls~n~I~~i~--~l~~l~~L~~L~Ls~N~i~~---i~~~~~~~~~L~~L~l~~N~i~~l--~~~~~l~ 115 (198)
T d1m9la_ 43 TLSTLKACKHLALSTNNIEKIS--SLSGMENLRILSLGRNLIKK---IENLDAVADTLEELWISYNQIASL--SGIEKLV 115 (198)
T ss_dssp HHHHTTTCCEEECSEEEESCCC--CHHHHTTCCEEECCEEEECS---CSSHHHHHHHCCEEECSEEECCCH--HHHHHHH
T ss_pred HHhcccccceeECcccCCCCcc--cccCCccccChhhccccccc---cccccccccccccccccccccccc--ccccccc
Confidence 5667777888888888887764 26777777777777777665 454445555666666666666543 3355566
Q ss_pred CCCEEEccCCcCC
Q 002346 188 NLQNLRLSYNNFT 200 (933)
Q Consensus 188 ~L~~L~L~~N~l~ 200 (933)
+|++|+|++|+++
T Consensus 116 ~L~~L~L~~N~i~ 128 (198)
T d1m9la_ 116 NLRVLYMSNNKIT 128 (198)
T ss_dssp HSSEEEESEEECC
T ss_pred cccccccccchhc
Confidence 6666666666665
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=1.7e-11 Score=115.13 Aligned_cols=76 Identities=16% Similarity=0.149 Sum_probs=47.8
Q ss_pred CCCCccccCccccCCcccceeecccc-cccccCC-CccCcCcCceeccccccccCCCCCcccCCCCCCEEEccCCCCCC
Q 002346 75 KSGLSGTLSPEISSLTQLETLSFQMN-NIAGAIP-SLANATSLQDIYLDNNNFTSVPTGCFDGLTNLQVLSLSDNPNLA 151 (933)
Q Consensus 75 ~~~l~~~~~~~~~~l~~L~~L~l~~N-~l~~~~p-~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~~~~ 151 (933)
++++. ..|..+..+++|++|++++| .|+.+.+ .|.++++|+.|+|++|+|+.+++.+|..+++|++|+|++|+++.
T Consensus 17 ~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~ 94 (156)
T d2ifga3 17 RDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALES 94 (156)
T ss_dssp SSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSC
T ss_pred CCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccceeccCCCCcc
Confidence 34444 34555666777777777654 3665554 56667777777777777776666666666666666666665554
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.22 E-value=1.8e-11 Score=114.82 Aligned_cols=108 Identities=19% Similarity=0.242 Sum_probs=94.2
Q ss_pred cccceeecccccccccCCCccCcCcCceeccccc-cccCCCCCcccCCCCCCEEEccCCCCCCCCCCCccccCCccCCee
Q 002346 90 TQLETLSFQMNNIAGAIPSLANATSLQDIYLDNN-NFTSVPTGCFDGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTL 168 (933)
Q Consensus 90 ~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N-~l~~~~~~~~~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L 168 (933)
...+.++.+++++...+..+..+++|++|+|++| .|+.++...|.++++|+.|+|++|++.. .-+.+|..+++|++|
T Consensus 8 ~~~~~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~--i~~~~f~~l~~L~~L 85 (156)
T d2ifga3 8 HGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF--VAPDAFHFTPRLSRL 85 (156)
T ss_dssp SSSSCEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE--ECTTGGGSCSCCCEE
T ss_pred CCCCeEEecCCCCccCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC--cccccccccccccce
Confidence 3456688899988877668889999999999766 5999999999999999999999999988 456789999999999
Q ss_pred eccCcccCCCCChhhcCCCCCCEEEccCCcCC
Q 002346 169 YMDNANIFGLIPDFFDSFSNLQNLRLSYNNFT 200 (933)
Q Consensus 169 ~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~ 200 (933)
+|++|+|+...+..|..+ +|+.|+|++|+|.
T Consensus 86 ~Ls~N~l~~l~~~~~~~~-~l~~L~L~~Np~~ 116 (156)
T d2ifga3 86 NLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116 (156)
T ss_dssp ECCSSCCSCCCSTTTCSC-CCCEEECCSSCCC
T ss_pred eccCCCCcccChhhhccc-cccccccCCCccc
Confidence 999999998877777655 7999999999996
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=1.9e-07 Score=95.39 Aligned_cols=149 Identities=15% Similarity=0.112 Sum_probs=105.6
Q ss_pred HHHHHHhcCCccCCccccCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCc
Q 002346 574 EVLRQVTDNFSEANILGRGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGS 652 (933)
Q Consensus 574 ~~l~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~ 652 (933)
.++...-+.|+..+..+.++.+.||+... +++.+++|+..... ......+.+|...+..+. +--+.+++.++..++
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~--~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~ 83 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRY--KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDG 83 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGG--TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETT
T ss_pred HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCc--ccchhhHHHHHHHHHHHhccCCCCcEEEEEecCC
Confidence 34566667888777655555679999876 56678888876542 222345778888888874 444678888888888
Q ss_pred eeEEEEeecCCCChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------
Q 002346 653 ERLLVYEYMPRGTLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA---------------------------- 704 (933)
Q Consensus 653 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------- 704 (933)
..++||++++|.++.+.... ......++.++++.++.||+..
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~----------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADV 153 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT----------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCC
T ss_pred ceEEEEEecccccccccccc----------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhh
Confidence 89999999999888655421 0112335666677777777421
Q ss_pred ----------------------------CCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 705 ----------------------------QQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 705 ----------------------------~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
...++|+|+.|.||++++++.+.|+||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 154 DCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp CGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred hhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence 1237899999999999987777899998764
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.37 E-value=1.5e-08 Score=95.23 Aligned_cols=70 Identities=17% Similarity=0.116 Sum_probs=40.1
Q ss_pred cCCCCCCEEEccCCCCCCCCCCCccccCCccCCeeeccCcccCCCCChhhcCCCCCCEEEccCCcCCCCC
Q 002346 134 DGLTNLQVLSLSDNPNLAPWPFPNELTKSTSLTTLYMDNANIFGLIPDFFDSFSNLQNLRLSYNNFTGSL 203 (933)
Q Consensus 134 ~~l~~L~~L~Ls~N~~~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 203 (933)
..+++|++|+|++|+++....++..+..+++|+.|+|++|.|+...+-.+....+|+.|+|++|+++...
T Consensus 62 ~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~ 131 (162)
T d1koha1 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTF 131 (162)
T ss_dssp HHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSS
T ss_pred HhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCcCc
Confidence 3455555555555555542223444556666666666666666554433334456777777777776443
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.30 E-value=2.6e-08 Score=93.46 Aligned_cols=105 Identities=20% Similarity=0.204 Sum_probs=74.2
Q ss_pred ccCCcccceeecccccccccCCCccCcCcCceeccccccccCCCC--CcccCCCCCCEEEccCCCCCCCCCCCc-cccCC
Q 002346 86 ISSLTQLETLSFQMNNIAGAIPSLANATSLQDIYLDNNNFTSVPT--GCFDGLTNLQVLSLSDNPNLAPWPFPN-ELTKS 162 (933)
Q Consensus 86 ~~~l~~L~~L~l~~N~l~~~~p~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~l~~L~~L~Ls~N~~~~~~~~p~-~~~~l 162 (933)
+..+..+..|+..++.+......+..+++|++|+|++|+|+.+.+ ..+..+++|+.|+|++|++.. ++. .....
T Consensus 38 l~~~~~~~~l~~~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~---l~~l~~l~~ 114 (162)
T d1koha1 38 LVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKS---ERELDKIKG 114 (162)
T ss_dssp TTTTTCCCCTTSHHHHHHHHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCC---GGGHHHHTT
T ss_pred hhhccchhhcchhhhHhhhhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCcccc---chhhhhhhc
Confidence 444555555655555443322244568889999999999998753 456778999999999999887 332 33345
Q ss_pred ccCCeeeccCcccCCCCCh-------hhcCCCCCCEEE
Q 002346 163 TSLTTLYMDNANIFGLIPD-------FFDSFSNLQNLR 193 (933)
Q Consensus 163 ~~L~~L~L~~n~l~~~~p~-------~~~~l~~L~~L~ 193 (933)
.+|+.|++++|.+...... .+..+|+|+.||
T Consensus 115 ~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred cccceeecCCCCcCcCcccchhHHHHHHHHCCCCCEEC
Confidence 5789999999999876543 366789999886
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.08 E-value=6.6e-06 Score=83.05 Aligned_cols=130 Identities=21% Similarity=0.162 Sum_probs=87.8
Q ss_pred ccccCCC-eEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcC--CCcceeEEeEeeeCceeEEEEeecCCC
Q 002346 588 ILGRGGF-GVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR--HRHLVALLGYCINGSERLLVYEYMPRG 664 (933)
Q Consensus 588 ~lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~g 664 (933)
.+..|.. +.||+....++..+++|...... ...+.+|+..++.+. .-.+.++++++.+++..++||+|++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~-----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccC-----HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4555554 58999988888889999765442 134677888888774 334667888888888899999999886
Q ss_pred ChhhHhhhcccCCCCCCCHHHHHHHHHHHHHHHHHhhhcc----------------------------------------
Q 002346 665 TLAQHLFEWHDHGYTPLTWKQRVTIALDVARGVEYLHSLA---------------------------------------- 704 (933)
Q Consensus 665 sL~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------- 704 (933)
++.+.- ... ..++.++++.++-||+..
T Consensus 92 ~~~~~~----------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (255)
T d1nd4a_ 92 DLLSSH----------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP 158 (255)
T ss_dssp ETTTSC----------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH
T ss_pred cccccc----------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHH
Confidence 653311 110 112233444444444210
Q ss_pred ---------------CCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 705 ---------------QQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 705 ---------------~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
...++|+|+.|.||+++++..+.|+||+.+.
T Consensus 159 ~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 159 AELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 1247999999999999987777899998754
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.55 E-value=6.5e-06 Score=77.03 Aligned_cols=60 Identities=12% Similarity=0.164 Sum_probs=31.5
Q ss_pred CccCcEEEecCCccCCCC-----CCCCCCCCCCEEEccCCccccc-------CcccccCCCCCCEEEccCcc
Q 002346 234 MTQLRQVWLHKNQFTGPI-----PDLSKCESLFDLSLRDNQLTGV-------VPASVISLPALLNISLQNNK 293 (933)
Q Consensus 234 l~~L~~L~L~~N~l~~~~-----~~~~~~~~L~~L~L~~N~l~~~-------~p~~l~~l~~L~~L~Ls~N~ 293 (933)
.+.|+.|+|++|.++... ..+...++|+.|+|++|++... +...+...+.|+.|+++.+.
T Consensus 71 n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 71 SPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp CSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred cccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCC
Confidence 445555555555554311 1244555666666666654321 33444455667777666554
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.42 E-value=1e-05 Score=75.62 Aligned_cols=112 Identities=14% Similarity=0.169 Sum_probs=62.9
Q ss_pred CCcccceeecccc-ccccc-----CCCccCcCcCceeccccccccCC----CCCcccCCCCCCEEEccCCCCCCCC--CC
Q 002346 88 SLTQLETLSFQMN-NIAGA-----IPSLANATSLQDIYLDNNNFTSV----PTGCFDGLTNLQVLSLSDNPNLAPW--PF 155 (933)
Q Consensus 88 ~l~~L~~L~l~~N-~l~~~-----~p~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~Ls~N~~~~~~--~~ 155 (933)
+.+.|++|+|+++ .++.. ...+...+.|++|+|++|.++.- ....+...+.|+.|+|++|.+...+ .+
T Consensus 13 n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l 92 (167)
T d1pgva_ 13 DDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL 92 (167)
T ss_dssp TCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred CCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHH
Confidence 4466666666653 34321 11345556667777777666531 1123344566777777777665421 12
Q ss_pred CccccCCccCCeeeccCcccCCC-------CChhhcCCCCCCEEEccCCcC
Q 002346 156 PNELTKSTSLTTLYMDNANIFGL-------IPDFFDSFSNLQNLRLSYNNF 199 (933)
Q Consensus 156 p~~~~~l~~L~~L~L~~n~l~~~-------~p~~~~~l~~L~~L~L~~N~l 199 (933)
-..+...++|++|+|++|.+... +...+..-+.|+.|+++.+..
T Consensus 93 ~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~~ 143 (167)
T d1pgva_ 93 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM 143 (167)
T ss_dssp HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred HHHHHhCCcCCEEECCCCcCCCccHHHHHHHHHHHHhCCCccEeeCcCCCc
Confidence 23455666777777777755432 234445567788888876543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.38 E-value=0.00035 Score=74.73 Aligned_cols=78 Identities=12% Similarity=0.104 Sum_probs=49.2
Q ss_pred CCccccCCCeEEEEEEeCC-CcEEEEEEecccc----C-CchhHHHHHHHHHHHHhcC-C--CcceeEEeEeeeCceeEE
Q 002346 586 ANILGRGGFGVVYGGELPD-GTKIAVKRMESNT----M-GNKGLSEFQAEIAVLTKVR-H--RHLVALLGYCINGSERLL 656 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~----~-~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l 656 (933)
.+.||.|..-.||+....+ ++.|+||.-.... . -+....+...|.+.++.+. + ..+.+++.+ +++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3568999999999997654 6789999644311 0 0112334567888887773 3 345566654 3455689
Q ss_pred EEeecCCCC
Q 002346 657 VYEYMPRGT 665 (933)
Q Consensus 657 v~e~~~~gs 665 (933)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.04 E-value=0.00054 Score=71.22 Aligned_cols=136 Identities=11% Similarity=0.056 Sum_probs=77.6
Q ss_pred eEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCCCcc--eeEEe-----EeeeCceeEEEEeecCCCChh
Q 002346 595 GVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRHRHL--VALLG-----YCINGSERLLVYEYMPRGTLA 667 (933)
Q Consensus 595 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~-----~~~~~~~~~lv~e~~~~gsL~ 667 (933)
=.||++..++|+.|++|+.+....+ .+++..|...+..|....+ +..+. ....++..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~~s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~ 112 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE 112 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred ceeEEEEcCCCCEEEEEEeCCCCCC---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence 4899999999999999998765333 3567788888888742222 22211 223456778899999764331
Q ss_pred h--------------Hhhhc----ccCCCCCCCHH-------------------HHHHHHHHHHHHHHHhhh----ccCC
Q 002346 668 Q--------------HLFEW----HDHGYTPLTWK-------------------QRVTIALDVARGVEYLHS----LAQQ 706 (933)
Q Consensus 668 ~--------------~l~~~----~~~~~~~l~~~-------------------~~~~i~~~i~~~l~~LH~----~~~~ 706 (933)
. .+|.. ........++. .+..+...+.+.++.+.. ....
T Consensus 113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence 1 11110 00000111111 111222222233333322 1246
Q ss_pred CeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 707 SFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 707 ~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
++||+|+.+.|||++++ ..++||+-+.
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred eeecCCCCcccEEEeCC--ceEEechhcc
Confidence 78999999999999753 4589999765
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.60 E-value=9.7e-05 Score=68.67 Aligned_cols=93 Identities=13% Similarity=0.187 Sum_probs=49.6
Q ss_pred hhcCCCCCCEEEccCCcCCCCCCccccccccchhhcccccCCcccccccccCCccCcEEEecCCccCCCC-----CCCCC
Q 002346 182 FFDSFSNLQNLRLSYNNFTGSLPASFAKSDIQNLWMNDQQLGLSGTLDVLSGMTQLRQVWLHKNQFTGPI-----PDLSK 256 (933)
Q Consensus 182 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~l~~l~l~~n~~~~~~~~~~l~~l~~L~~L~L~~N~l~~~~-----~~~~~ 256 (933)
.+...++|++|+|++|.++...-..++. .+...+.++.|++++|.++... ..+..
T Consensus 41 al~~n~~L~~L~Ls~n~l~~~~~~~L~~--------------------~l~~~~~l~~l~l~~~~~~~~g~~~l~~~l~~ 100 (166)
T d1io0a_ 41 ALKTNTYVKKFSIVGTRSNDPVAFALAE--------------------MLKVNNTLKSLNVESNFISGSGILALVEALQS 100 (166)
T ss_dssp HHTTCCSCCEEECTTSCCCHHHHHHHHH--------------------HHHHCSSCCEEECCSSCCCHHHHHHHHHGGGG
T ss_pred HHhcCCccCeeeccCCcccHHHHHHHHH--------------------HHhhcccchhhhhccccccchhHHHHHHHHHh
Confidence 3445666777777776665322222221 1223456666666666654321 13455
Q ss_pred CCCCCEEEc--cCCcccc----cCcccccCCCCCCEEEccCccC
Q 002346 257 CESLFDLSL--RDNQLTG----VVPASVISLPALLNISLQNNKL 294 (933)
Q Consensus 257 ~~~L~~L~L--~~N~l~~----~~p~~l~~l~~L~~L~Ls~N~l 294 (933)
.++|+.++| ++|.+.. .+...+...++|+.|+++.+..
T Consensus 101 ~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 101 NTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp CSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred CccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 666665444 4556643 2444555667777777766543
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.49 E-value=5.7e-05 Score=70.34 Aligned_cols=115 Identities=14% Similarity=0.133 Sum_probs=69.3
Q ss_pred cccCCcccceeeccc-ccccccC-----CCccCcCcCceeccccccccCCC----CCcccCCCCCCEEEccCCCCCCCC-
Q 002346 85 EISSLTQLETLSFQM-NNIAGAI-----PSLANATSLQDIYLDNNNFTSVP----TGCFDGLTNLQVLSLSDNPNLAPW- 153 (933)
Q Consensus 85 ~~~~l~~L~~L~l~~-N~l~~~~-----p~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L~~L~Ls~N~~~~~~- 153 (933)
...+.+.|++|+|++ +.|+... ..+...++|++|+|++|.++... ...+...+.|+.|++++|.+...+
T Consensus 12 ~~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~ 91 (166)
T d1io0a_ 12 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI 91 (166)
T ss_dssp HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred HHhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhH
Confidence 344567777777776 4453211 13556677777777777776321 223455677888888777765421
Q ss_pred -CCCccccCCccCCeeec--cCcccCC----CCChhhcCCCCCCEEEccCCcC
Q 002346 154 -PFPNELTKSTSLTTLYM--DNANIFG----LIPDFFDSFSNLQNLRLSYNNF 199 (933)
Q Consensus 154 -~~p~~~~~l~~L~~L~L--~~n~l~~----~~p~~~~~l~~L~~L~L~~N~l 199 (933)
.+-..+...++|+.++| ++|.+.. .+...+...++|+.|+++.+..
T Consensus 92 ~~l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~ 144 (166)
T d1io0a_ 92 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ 144 (166)
T ss_dssp HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred HHHHHHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence 13345666777876555 4555533 2345556778899998877654
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.42 E-value=0.0047 Score=63.47 Aligned_cols=160 Identities=10% Similarity=0.033 Sum_probs=84.3
Q ss_pred ecHHHHHHHhcCCccCCccc-----cCCCeEEEEEEeCCCcEEEEEEeccccCCchhHHHHHHHHHHHHhcCC-----Cc
Q 002346 571 ISIEVLRQVTDNFSEANILG-----RGGFGVVYGGELPDGTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVRH-----RH 640 (933)
Q Consensus 571 ~~~~~l~~~~~~~~~~~~lg-----~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h-----~n 640 (933)
.+.++++.+..+|.+.+... .|--=+.|+.+..+| .+++|+..... +. ++...|++++..+.. |.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~-~~---~~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV-EK---NDLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCC-CH---HHHHHHHHHHHhhhhccccccc
Confidence 45678888888998765554 444467899988655 48999886532 22 345556677777642 22
Q ss_pred ceeEE-e--EeeeCceeEEEEeecCCCChhh--------------Hhhhccc----CCCCC------------------C
Q 002346 641 LVALL-G--YCINGSERLLVYEYMPRGTLAQ--------------HLFEWHD----HGYTP------------------L 681 (933)
Q Consensus 641 iv~l~-~--~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~~~----~~~~~------------------l 681 (933)
.+... | +.........++.+..+..... .++.... ..... .
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred cceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhh
Confidence 22111 0 1122345566777766533211 0000000 00000 0
Q ss_pred CHHHHHHHHHHHHHHHHHhhh-ccCCCeEecCCCCCcEEecCCCcEEEecccccc
Q 002346 682 TWKQRVTIALDVARGVEYLHS-LAQQSFIHRDLKPSNILIGDDMRAKVADFGLVK 735 (933)
Q Consensus 682 ~~~~~~~i~~~i~~~l~~LH~-~~~~~ivH~Dik~~Nill~~~~~~kl~DfGla~ 735 (933)
........+......+...+. .-..++||+|+.++||+++.+...-|+||+.+.
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred cchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 001111222222222222221 124689999999999999998878899999764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=95.67 E-value=0.019 Score=60.72 Aligned_cols=73 Identities=18% Similarity=0.190 Sum_probs=48.5
Q ss_pred CCccccCCCeEEEEEEeCC--------CcEEEEEEeccccCCchhHHHHHHHHHHHHhcC-CCcceeEEeEeeeCceeEE
Q 002346 586 ANILGRGGFGVVYGGELPD--------GTKIAVKRMESNTMGNKGLSEFQAEIAVLTKVR-HRHLVALLGYCINGSERLL 656 (933)
Q Consensus 586 ~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l 656 (933)
++.|+.|-.=.+|++...+ .+.|.+++.... .. ..+..+|..+++.+. +.-..++++++.. .+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~---~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP---ET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC---CC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc---ch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 3567777777999997654 346777765421 12 235568888888884 4434577777643 68
Q ss_pred EEeecCCCCh
Q 002346 657 VYEYMPRGTL 666 (933)
Q Consensus 657 v~e~~~~gsL 666 (933)
||||++|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 9999987554
|